PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	ETGEN, GJ; MEMON, AR; THOMPSON, GA; IVY, JL				ETGEN, GJ; MEMON, AR; THOMPSON, GA; IVY, JL			INSULIN-STIMULATED AND CONTRACTION-STIMULATED TRANSLOCATION OF GTP-BINDING PROTEINS AND GLUT4 PROTEIN IN SKELETAL-MUSCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE GLUCOSE TRANSPORTERS; PLASMA-MEMBRANE; RAT HINDLIMB; LOCALIZATION; ADIPOCYTES; IDENTIFICATION; VESICLES; SUPERFAMILY; MECHANISM; INCREASES	Low molecular weight GTP-binding proteins and GLUT4 protein were isolated in purified plasma membrane and low density microsome fractions from rat skeletal muscle. GTP-binding proteins were detected via the ability of these proteins to bind [P-32]GTP subsequent to Western blotting. GLUT4 protein was detected via the anti-GLUT4 antibody F349 subsequent to Western blotting. The possible involvement of GTP-binding proteins in the regulation of GLUT4 protein movement was investigated by examining the subcellular distribution of GTP-binding proteins and GLUT4 protein under basal conditions and following stimulation by insulin or muscle contraction. Insulin stimulation caused a 111 +/- 34.8% increase in the plasma membrane content of GTP-binding proteins which was paralleled by a 74 +/- 19.1% increase in the plasma membrane content of GLUT4 protein. The insulin-stimulated increase in plasma membrane GTP-binding proteins and GLUT4 protein occurred coincident with 27 +/- 4.6 and 33 +/- 7.4% decreases, respectively, in the low density microsome content of these proteins. In addition, muscle contraction significantly increased the plasma membrane content of GTP-binding proteins (63 +/- 18.1%) and GLUT4 protein (67 +/- 22.2%). However, with muscle contraction the concentrations of GTP-binding proteins and GLUT4 protein were not altered in low density microsome fractions. The similar patterns with which the GTP-binding proteins and GLUT4 protein responded to stimulation by insulin and muscle contraction suggests a possible, but yet unidentified functional relationship between these proteins.	UNIV TEXAS,DEPT KINESIOL,EXERCISE PHYSIOL & METAB LAB,BELLMONT HALL 222,AUSTIN,TX 78712; UNIV TEXAS,DEPT BOT,AUSTIN,TX 78712	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin			Memon, Abdul/AAW-1291-2020	MEMON, Abdulrezzak/0000-0001-9447-6453				ARIANO MA, 1973, J HISTOCHEM CYTOCHEM, V21, P51, DOI 10.1177/21.1.51; BALCH WE, 1990, TRENDS BIOCHEM SCI, V15, P473, DOI 10.1016/0968-0004(90)90301-Q; BALDINI G, 1991, J BIOL CHEM, V266, P4037; BALDINI G, 1992, P NATL ACAD SCI USA, V89, P5049, DOI 10.1073/pnas.89.11.5049; BELL GI, 1990, DIABETES CARE, V13, P198, DOI 10.2337/diacare.13.3.198; BERS DM, 1980, BIOCHIM BIOPHYS ACTA, V601, P358, DOI 10.1016/0005-2736(80)90540-4; BORNEMANN A, 1992, DIABETES, V41, P215, DOI 10.2337/diabetes.41.2.215; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROZINICK JT, 1992, J APPL PHYSIOL, V73, P382, DOI 10.1152/jappl.1992.73.1.382; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CORMONT M, 1991, ENDOCRINOLOGY, V129, P3343, DOI 10.1210/endo-129-6-3343; DOUCET JP, 1991, J BIOL CHEM, V266, P17613; DOUEN AG, 1989, ENDOCRINOLOGY, V124, P449, DOI 10.1210/endo-124-1-449; DOUEN AG, 1990, J BIOL CHEM, V265, P13427; DOWNWARD J, 1990, TRENDS BIOCHEM SCI, V15, P469, DOI 10.1016/0968-0004(90)90300-Z; GOODYEAR LJ, 1991, AM J PHYSIOL, V261, pE795, DOI 10.1152/ajpendo.1991.261.6.E795; GOODYEAR LJ, 1990, AM J PHYSIOL, V258, pE667, DOI 10.1152/ajpendo.1990.258.4.E667; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GOUD B, 1990, NATURE, V345, P553, DOI 10.1038/345553a0; HALL A, 1990, G PROTEINS MEDIATORS, P173; HIRSHMAN MF, 1990, J BIOL CHEM, V265, P987; HIRSHMAN MF, 1988, FEBS LETT, V238, P235, DOI 10.1016/0014-5793(88)80486-1; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; KHYSEANDERSON J, 1984, J BIOCHEM BIOPH METH, V10, P203; KLIP A, 1987, FEBS LETT, V224, P224, DOI 10.1016/0014-5793(87)80452-0; KUBO K, 1986, AM J PHYSIOL, V250, pE100, DOI 10.1152/ajpendo.1986.250.1.E100; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MEMON AR, 1993, IN PRESS BIOCH BIOPH; NESHER R, 1985, AM J PHYSIOL, V249, pC226, DOI 10.1152/ajpcell.1985.249.3.C226; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; RODRIGUEZROSALES MP, 1992, PLANT PHYSIOL, V98, P446, DOI 10.1104/pp.98.2.446; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; RUDERMAN NB, 1971, BIOCHEM J, V124, P639, DOI 10.1042/bj1240639; SCHURMANN A, 1992, BIOCHEM J, V283, P795, DOI 10.1042/bj2830795; SEILER S, 1982, J BIOL CHEM, V257, P13862; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; WARDZALA LJ, 1981, J BIOL CHEM, V256, P7090	38	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20164	20169						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376376				2022-12-27	WOS:A1993LY01900038
J	GRINSTEIN, S; FURUYA, W; BUTLER, JR; TSENG, J				GRINSTEIN, S; FURUYA, W; BUTLER, JR; TSENG, J			RECEPTOR-MEDIATED ACTIVATION OF MULTIPLE SERINE THREONINE KINASES IN HUMAN-LEUKOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY BURST OXIDASE; COLONY-STIMULATING FACTOR; CHRONIC GRANULOMATOUS-DISEASE; HISTONE-H4 PROTEIN-KINASE; HUMAN-NEUTROPHILS; MAP KINASE; TYROSINE PHOSPHORYLATION; CHEMOTACTIC FACTORS; NADPH-OXIDASE; POLYMORPHONUCLEAR LEUKOCYTES	Activation of the microbicidal response of phagocytes requires cytosolic ATP and is associated with extensive protein phosphorylation, suggesting the involvement of protein kinases in the signal transduction cascade. An in vitro renaturation assay was used to identify the protein kinase(s) activated by chemoattractants in human blood neutrophils. Four distinct kinases were activated by the chemotactic peptide formyl-methionyl-leucyl-phenyl-alanine with molecular masses of 72, 65, 49, and 41 kDa (designated PK72, PK65, PK49, and PK41, respectively). PK72 and PK65 were activated very rapidly (5-15 s), yet transiently. By comparison, PK49 and PK41 responded in a slower, more sustained manner. Treatment of extracts of activated cells with alkaline phosphatase reverted the stimulation of the kinases, suggesting that phosphorylation is the post-translational modification that underlies activation of the kinases. Stimulation of PK72 and PK65 by chemoattractant was independent of calcium and protein kinase C. In contrast, elevation of cytosolic free calcium levels was sufficient and appeared to be necessary for full activation of PK49 and PK41. While phorbol esters can mimic the effects of formyl-methionyl-leucyl-phenylalanine on PK49 and PK41, inhibition of protein kinase C by staurosporine did not prevent the receptor-mediated activation of these kinases. PK41 most likely corresponds to the Erk-1 isoform of mitogen-activated protein (MAP) kinase. Accordingly, PK41 effectively phosphorylated myelin basic protein, known to be a good substrate for Erk-1. The electrophoretic mobility of PK49 is similar to that of MAP kinase-kinase (MAP/Erk kinase). However, immunoprecipitation experiments indicated that PK49 is not MAP/Erk kinase. The identity of this and other kinases remains to be defined, but possible candidates are discussed. In addition to autophosphorylating, PK72, PK65, and PK41 were shown to effectively phosphorylate exogenous substrates. These kinases may therefore play a role in signal transduction during stimulation by chemoattractants.			GRINSTEIN, S (corresponding author), HOSP SICK CHILDREN, RES INST, DIV CELL BIOL, 555 UNIV AVE, TORONTO M5G 1X8, ONTARIO, CANADA.							ADAMS PD, 1992, J BIOL CHEM, V267, P13135; BABIOR BM, 1988, ARCH BIOCHEM BIOPHYS, V264, P361, DOI 10.1016/0003-9861(88)90300-1; CELENZA JL, 1986, SCIENCE, V233, P1175, DOI 10.1126/science.3526554; CLARK RA, 1990, J INFECT DIS, V161, P1140, DOI 10.1093/infdis/161.6.1140; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; DING J, 1992, MOL BIOL CELL, V3, pA147; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P464; FERRELL JE, 1991, METHOD ENZYMOL, V200, P430; GERARD C, 1986, J CLIN INVEST, V77, P61, DOI 10.1172/JCI112302; GOMEZCAMBRONERO J, 1992, P NATL ACAD SCI USA, V89, P7551, DOI 10.1073/pnas.89.16.7551; GRINSTEIN S, 1988, J BIOL CHEM, V263, P1779; GRINSTEIN S, 1992, J BIOL CHEM, V267, P18122; HALLETT MB, 1984, CELL CALCIUM, V5, P1, DOI 10.1016/0143-4160(84)90150-7; HUANG CK, 1988, J BIOL CHEM, V263, P13144; HUANG CK, 1990, J CELL BIOCHEM, V44, P221, DOI 10.1002/jcb.240440404; HUANG CK, 1991, J LEUKOCYTE BIOL, V49, P158, DOI 10.1002/jlb.49.2.158; HUANG CK, 1989, MEMBRANE BIOCHEM, V8, P61, DOI 10.3109/09687688909082261; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; KOSHIO O, 1990, CELL SIGNAL, V2, P471, DOI 10.1016/0898-6568(90)90043-A; KRAUSE KH, 1990, CLIN BIOCHEM, V23, P159, DOI 10.1016/0009-9120(90)80030-M; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBETH JD, 1988, J BIOENERG BIOMEMBR, V20, P709, DOI 10.1007/BF00762549; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; MORRISON DK, 1990, CANCER CELL-MON REV, V2, P377; OKAMURA N, 1988, J BIOL CHEM, V263, P6777; OKUDA K, 1992, BLOOD, V79, P2880; PONTREMOLI S, 1990, P NATL ACAD SCI USA, V87, P3705, DOI 10.1073/pnas.87.10.3705; POZZAN T, 1983, SCIENCE, V221, P1413, DOI 10.1126/science.6310757; QUILLIAM LA, 1992, CELL MOL MECH INFLAM, V3, P25; RAINES MA, 1992, BLOOD, V79, P3350; ROSSI F, 1986, BIOCHIM BIOPHYS ACTA, V853, P65, DOI 10.1016/0304-4173(86)90005-4; ROTROSEN D, 1990, J BIOL CHEM, V265, P19910; SHAAFI RI, 1988, PROG ALLERGY, V42, P1; Snyderman R, 1992, INFLAMMATION BASIC P; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; TAUBER AI, 1987, BLOOD, V69, P711; THASTRUP O, 1990, AGENTS ACTIONS, V29, P8, DOI 10.1007/BF01964706; THOMAS G, 1992, CELL, V68, P3, DOI 10.1016/0092-8674(92)90199-M; TRAYNORKAPLAN AE, 1988, NATURE, V334, P353, DOI 10.1038/334353a0; VOLPP BD, 1989, P NATL ACAD SCI USA, V86, P7195, DOI 10.1073/pnas.86.18.7195; VOLPP BD, 1989, P NATL ACAD SCI USA, V86, P9563	43	46	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20223	20231						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376383				2022-12-27	WOS:A1993LY01900048
J	ITO, W; KUROSAWA, Y				ITO, W; KUROSAWA, Y			DEVELOPMENT OF AN ARTIFICIAL ANTIBODY SYSTEM WITH MULTIPLE VALENCY USING AN FV FRAGMENT FUSED TO A FRAGMENT OF PROTEIN-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSPECIFIC INTERACTION ANALYSIS; ESCHERICHIA-COLI; 3-DIMENSIONAL STRUCTURE; MONOCLONAL-ANTIBODY; BINDING-SITE; ANTIGEN; COMPLEX; GENE; REPERTOIRE; RESOLUTION	In antigen-antibody interactions, the high avidity of antibodies for their specific antigens can be achieved both by exploiting the high affinity of each binding site and by multivalence of antibodies. In this study, we developed artificial antibodies with multiple valency. The Fv fragments of an antibody fused with one and with two domains of the Fc-binding protein A from Staphylococcus aureus (designated Fv-P and Fv-PP, respectively) were expressed in secreted forms in Escherichia coli. Their physical characteristics were examined. The Fv portions of Fv-P and Fv-PP had virtually the same affinity for the antigen as that of the original Fv molecules, and each protein A-derived domain could be bound to IgG. When Fv-P was mixed with IgG, the complex formed was composed of two Fv-P molecules and one IgG molecule. In the case of Fv-PP, a complex composed of three Fv-PP molecules and two IgG molecules was preferentially formed. Analysis of surface plasmon resonance in a BIAcore system indicated multivalency of these complexes for antigens. There was 3.5-fold decrease in the dissociation constant of the complex between Fv-PP and the antigen upon the addition of IgG. The use of these complexes as reagents in enzyme-linked immunosorbent assay and Western blotting gave much stronger signals than Fv, Fv-P, and Fv-PP alone.	FUJITA HLTH UNIV,INST COMPREHENS MED SCI,TOYOAKE,AICHI 47011,JAPAN	Fujita Health University				Ito, Wataru/0000-0002-5631-8267				AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; AUSUBELFM, 1989, CURRENT PROTOCOLS MO; BERZOFSKY JA, 1989, FUNDAMENTAL IMMUNOLO, P315; BETTER M, 1988, SCIENCE, V240, P1041, DOI 10.1126/science.3285471; BHAT TN, 1990, NATURE, V347, P483, DOI 10.1038/347483a0; BOULOT G, 1990, J MOL BIOL, V213, P617, DOI 10.1016/S0022-2836(05)80248-7; CHAIKEN I, 1992, ANAL BIOCHEM, V201, P197, DOI 10.1016/0003-2697(92)90329-6; FAGERSTAM LG, 1992, J CHROMATOGR, V597, P397, DOI 10.1016/0021-9673(92)80137-J; FISCHMANN TO, 1991, J BIOL CHEM, V266, P12915; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; HARLOW E, 1988, ANTIBODIES LABORATOR; HUSE WD, 1989, SCIENCE, V246, P1275, DOI 10.1126/science.2531466; ITO W, 1993, J BIOL CHEM, V268, P16639; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; LEI SP, 1987, J BACTERIOL, V169, P4379, DOI 10.1128/jb.169.9.4379-4383.1987; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; MYHRE EB, 1980, MOL IMMUNOL, V17, P1563, DOI 10.1016/0161-5890(80)90182-0; NILSSON B, 1985, EMBO J, V4, P1975; SIGURSKJOLD BW, 1991, EUR J BIOCHEM, V197, P239, DOI 10.1111/j.1432-1033.1991.tb15904.x; SIGURSKJOLD BW, 1992, J BIOL CHEM, V267, P8371; SJODAHL J, 1977, EUR J BIOCHEM, V78, P471, DOI 10.1111/j.1432-1033.1977.tb11760.x; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; TONOMURA B, 1978, ANAL BIOCHEM, V84, P370, DOI 10.1016/0003-2697(78)90054-4; UHLEN M, 1984, J BIOL CHEM, V259, P1695; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	27	60	72	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20668	20675						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376416				2022-12-27	WOS:A1993LY01900106
J	MALHOTRA, P; MANOHAR, CF; SWAMINATHAN, S; TOYAMA, R; DHAR, R; REICHEL, R; THIMMAPAYA, B				MALHOTRA, P; MANOHAR, CF; SWAMINATHAN, S; TOYAMA, R; DHAR, R; REICHEL, R; THIMMAPAYA, B			E2F SITE ACTIVATES TRANSCRIPTION IN FISSION YEAST SCHIZOSACCHAROMYCES-POMBE AND BINDS TO A 30-KDA TRANSCRIPTION FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE ADENOVIRUS PROMOTER; RETINOBLASTOMA GENE-PRODUCT; DNA-SYNTHESIS GENES; CELL-CYCLE CONTROL; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; PROTEIN; SEQUENCE; COMPLEX; IDENTIFICATION	The mammalian transcription factor E2F binds to several cellular proteins including Rb, p107, cyclin A, cyclin E, and p33cdk2 protein kinase in a stage-specific manner during cell cycle. Its recognition sequence, TTTCGCGC, is present in two of the human adenovirus early promoters and in several promoters of cellular genes whose products are implicated in the control of cell proliferation. These observations suggest that E2F may play an important role in cell-cycle regulation and prompted us to ask whether E2F-like activities are present in yeast. We found that the E2F motif can function as an activating sequence in Schizosaccharomyces pombe when cloned upstream of a reporter gene. Consistent with this, the expression of adenovirus E2 promoter in S. pombe was dependent on both E2F motifs of this promoter. A protein, spE2F, that binds to the E2F site was partially purified from S. pombe using DNA-affinity chromatography. The binding specificity of this protein was compared to that of human E2F using a number of mutant E2F sites as competitors. These studies showed that spE2F recognizes a sequence closely related to the E2F site. Ultraviolet cross-linking and Southwestern blot studies indicated that the molecular size of spE2F is 30 kDa. Previous studies have shown that a cis-acting element, ACGCGTNA, also called MluI cell cycle box, or MCB, is critical for the regulated expression of cell cycle related genes both in fission and budding yeast. In S. pombe, the cdc10 gene product binds to this element and controls the cell cycle related genes. Electrophoretic mobility shift assays and molecular size determination studies indicated that spE2F is different from that encoded by cdc10. Thus, our studies suggest that spE2F is a novel transcription factor. We discuss these results in light of recent observations about the periodically expressed genes involved in the cell cycle progression in yeast.	NORTHWESTERN UNIV,SCH MED,DEPT MICROBIOL IMMUNOL,CHICAGO,IL 60611; NCI,MOLEC VIROL LAB,BETHESDA,MD 20892; CHICAGO MED SCH,DEPT PHARMACOL & MOLEC BIOL,N CHICAGO,IL 60064	Northwestern University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chicago Medical School				Swaminathan, Sathyamangalam/0000-0002-4388-2248	NIAID NIH HHS [AI 18029, AI 20156] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018029, R01AI020156] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDREWS BJ, 1992, NATURE, V355, P393, DOI 10.1038/355393a0; ANDREWS BJ, 1989, NATURE, V342, P803; ANDREWS BJ, 1990, J BIOFL CHEM, V265; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; AVES SJ, 1985, EMBO J, V4, P457, DOI 10.1002/j.1460-2075.1985.tb03651.x; BAGCHI S, 1991, CELL, V65, P1063, DOI 10.1016/0092-8674(91)90558-G; BANDARA LR, 1991, NATURE, V352, P249, DOI 10.1038/352249a0; BANDARA LR, 1991, NATURE, V351, P494, DOI 10.1038/351494a0; BARKER DG, 1985, MOL GEN GENET, V200, P458, DOI 10.1007/BF00425731; BEACH DH, 1981, NATURE, V200, P140; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREEDEN L, 1987, NATURE, V329, P651, DOI 10.1038/329651a0; CALIGIURI M, 1993, CELL, V72, P607, DOI 10.1016/0092-8674(93)90079-6; CAO L, 1992, NATURE, V355, P176, DOI 10.1038/355176a0; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; CHITTENDEN T, 1991, CELL, V65, P1073, DOI 10.1016/0092-8674(91)90559-H; CHODOSH LA, 1986, MOL CELL BIOL, V6, P4723, DOI 10.1128/MCB.6.12.4723; DEVOTO SH, 1992, CELL, V68, P167, DOI 10.1016/0092-8674(92)90215-X; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DIRICK L, 1992, NATURE, V357, P508, DOI 10.1038/357508a0; DURKACZ B, 1985, MOL GEN GENET, V201, P543, DOI 10.1007/BF00331353; FLINT J, 1989, ANNU REV GENET, V23, P141, DOI 10.1146/annurev.genet.23.1.141; GIRLING R, 1993, NATURE, V362, P83, DOI 10.1038/362083a0; GORDON CB, 1986, EMBO J, V5, P2981, DOI 10.1002/j.1460-2075.1986.tb04595.x; HARDY S, 1989, MOL CELL BIOL, V9, P4495, DOI 10.1128/MCB.9.10.4495; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; JALINOT P, 1988, P NATL ACAD SCI USA, V85, P2484, DOI 10.1073/pnas.85.8.2484; JOHNSTON LH, 1992, NUCLEIC ACIDS RES, V20, P2403, DOI 10.1093/nar/20.10.2403; JONES RH, 1988, CELL, V53, P659, DOI 10.1016/0092-8674(88)90581-8; JONES RH, 1989, P NATL ACAD SCI USA, V86, P2176, DOI 10.1073/pnas.86.7.2176; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; KOVESDI I, 1986, CELL, V45, P219, DOI 10.1016/0092-8674(86)90386-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE KAW, 1987, P NATL ACAD SCI USA, V84, P8355, DOI 10.1073/pnas.84.23.8355; LEES E, 1992, GENE DEV, V6, P1874, DOI 10.1101/gad.6.10.1874; LIN YS, 1989, P NATL ACAD SCI USA, V86, P109, DOI 10.1073/pnas.86.1.109; LOWNDES NF, 1992, NATURE, V357, P505, DOI 10.1038/357505a0; LOWNDES NF, 1992, NATURE, V355, P449, DOI 10.1038/355449a0; MAI B, 1993, FEBS LETT, V321, P153, DOI 10.1016/0014-5793(93)80098-F; MANOHAR CF, 1990, J VIROL, V64, P2457, DOI 10.1128/JVI.64.6.2457-2466.1990; MATHIS DJ, 1981, P NATL ACAD SCI-BIOL, V78, P7383, DOI 10.1073/pnas.78.12.7383; MUDRYJ M, 1991, CELL, V65, P1243, DOI 10.1016/0092-8674(91)90019-U; MURTHY SCS, 1985, P NATL ACAD SCI USA, V82, P2230, DOI 10.1073/pnas.82.8.2230; NEVINS JR, 1992, SCIENCE, V258, P424; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; PAGANO M, 1992, SCIENCE, V255, P1144, DOI 10.1126/science.1312258; PRENTICE HL, 1992, NUCLEIC ACIDS RES, V20, P3383, DOI 10.1093/nar/20.13.3383; Reichel Ronald R., 1992, Gene Expression, V2, P259; RUSSELL PR, 1983, J BIOL CHEM, V258, P143; SHIRODKAR S, 1992, CELL, V68, P157, DOI 10.1016/0092-8674(92)90214-W; SIDEROVA J, 1993, MOL CELL BIOL, V13, P1069; SILVA CM, 1987, P NATL ACAD SCI USA, V84, P1744, DOI 10.1073/pnas.84.7.1744; SIVARAMAN L, 1986, P NATL ACAD SCI USA, V83, P5914, DOI 10.1073/pnas.83.16.5914; SIVARAMAN L, 1987, P NATL ACAD SCI USA, V84, P6112, DOI 10.1073/pnas.84.17.6112; SWAMINATHAN S, 1993, NUCLEIC ACIDS RES, V21, P2737, DOI 10.1093/nar/21.11.2737; TABA MRM, 1991, GENE DEV, V5, P2000, DOI 10.1101/gad.5.11.2000; TOYAMA R, 1992, NUCLEIC ACIDS RES, V20, P2591, DOI 10.1093/nar/20.10.2591; TOYAMA R, 1990, FEBS LETT, V268, P217, DOI 10.1016/0014-5793(90)81012-D; VERMA R, 1991, P NATL ACAD SCI USA, V88, P7155, DOI 10.1073/pnas.88.16.7155; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; YEE AS, 1987, EMBO J, V6, P2061, DOI 10.1002/j.1460-2075.1987.tb02471.x; ZAJCHOWSKI DA, 1985, EMBO J, V4, P1293, DOI 10.1002/j.1460-2075.1985.tb03775.x	63	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20392	20401						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376397				2022-12-27	WOS:A1993LY01900071
J	RUFAUT, NW; BRENNAN, SO; HAKES, DJ; DIXON, JE; BIRCH, NP				RUFAUT, NW; BRENNAN, SO; HAKES, DJ; DIXON, JE; BIRCH, NP			PURIFICATION AND CHARACTERIZATION OF THE CANDIDATE PROHORMONE-PROCESSING ENZYME SPC3 PRODUCED IN A MOUSE L-CELL LINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST KEX2 PROTEASE; AMINO-ACID-SEQUENCE; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; KEX2-LIKE ENDOPROTEASE; FUNCTIONAL EXPRESSION; HORMONE BIOSYNTHESIS; CONSENSUS SEQUENCE; SUBTILISIN FAMILY; HUMAN PROALBUMINS	SPC3 is a member of a growing family of mammalian subtilisin-like serine proteases which play a probable role in proprotein maturation. In this study we have prepared a mouse L cell line stably expressing rat SPC3 cDNA and characterized the recombinant SPC3 protein secreted into the medium. Three molecular forms of recombinant SPC3 were identified with molecular masses of 86, 75, and 64 kDa. NH2-terminal sequence analysis indicated that all three forms were cleaved following the sequence -Arg107-Arg-Lys-Arg110, indicating removal of an SPC3 prosequence. All three molecular forms showed a 3-4-kDa decrease in molecular mass following incubation with endoglycosidase F. Two SPC3 carboxyl-terminal-directed antisera recognized only the 86-kDa molecular form of recombinant SPC3, demonstrating that COOH-terminal truncation of SPC3 protein is responsible for the different molecular mass forms. Recombinant SPC3 had a pH optimum of 6.0 and was stimulated by calcium, with maximum activity at 10 mM. Recombinant SPC3 was inhibited most effectively by the thiol-reactive reagent p-hydroxymecuribenzoate and the heavy metal chelators EDTA and EGTA. Recombinant SPC3 was also inhibited by alpha1-antitrypsin Pittsburgh as well as wild type alpha1-antitrypsin and antithrombin III. The inhibitor specificities revealed using these high molecular mass serpins differ from those reported for other members of the subtilisin-like serine protease family and may be able to be exploited to distinguish between closely related members of this new enzyme superfamily. Studies of cleavage specificity using tri- and tetrapeptidyl coumarins that contained pairs of basic residues indicated that tetrapeptide substrates that contained an S4 Arg residue as part of an -Arg-X-Lys/Arg-Arg motif were the most effective synthetic peptide substrates. Recombinant SPC3 also cleaved human proalbumin following the Arg-Gly-Val-Phe-Arg-Arg prosequence. Circulating human proalbumin variants that contained a mutation at either of the basic amino acids adjacent to the cleavage site were not cleaved by recombinant SPC3. Recombinant SPC3 was also able to cleave after a single arginine residue in chicken proalbumin following the Arg-Asn-Leu-Gln-Arg-Phe-Ala-Arg prosequence. These results define the primary structure requirements for cleavage by recombinant SPC3 and remain consistent with a role for SPC3 in proprotein/prohormone maturation.	UNIV AUCKLAND, SCH BIOL SCI, BIOCHEM & MOLEC BIOL RES GRP, PRIVATE BAG 92019, AUCKLAND, NEW ZEALAND; CHRISTCHURCH HOSP, DEPT CLIN BIOCHEM, MOLEC PATHOL LAB, CHRISTCHURCH 8001, NEW ZEALAND; UNIV MICHIGAN, SCH MED, DEPT BIOL CHEM, ANN ARBOR, MI 48109 USA	University of Auckland; Christchurch Hospital New Zealand; University of Michigan System; University of Michigan			Brennan, Stephen/AAW-9929-2020; Birch, Nigel/H-2498-2011	Birch, Nigel/0000-0002-8417-3587	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON RGW, 1988, J CELL BIOL, V106, P539, DOI 10.1083/jcb.106.3.539; BAILYES EM, 1992, BIOCHEM J, V285, P391, DOI 10.1042/bj2850391; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; BATHURST IC, 1987, SCIENCE, V235, P348, DOI 10.1126/science.3541206; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BENJANNET S, 1992, J BIOL CHEM, V267, P11417; BIRCH NP, 1986, J BIOL CHEM, V261, P2213; BLOOMQUIST BT, 1991, MOL ENDOCRINOL, V5, P2014, DOI 10.1210/mend-5-12-2014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN SO, 1991, J BIOL CHEM, V266, P21504; BRENNAN SO, 1984, BIOCHIM BIOPHYS ACTA, V802, P24, DOI 10.1016/0304-4165(84)90029-1; BRENNAN SO, 1990, J BIOL CHEM, V265, P21494; BRENNAN SO, 1989, MOL BIOL MED, V6, P87; BRENNAN SO, 1988, FEBS LETT, V229, P167, DOI 10.1016/0014-5793(88)80819-6; CHAN SJ, 1992, P NATL ACAD SCI USA, V89, P6678, DOI 10.1073/pnas.89.15.6678; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; CHRISTIE DL, 1991, J BIOL CHEM, V266, P15679; DAVIDSON HW, 1988, NATURE, V333, P93, DOI 10.1038/333093a0; DEVI L, 1991, FEBS LETT, V280, P189, DOI 10.1016/0014-5793(91)80290-J; DOCHERTY K, 1982, ANNU REV PHYSIOL, V44, P625, DOI 10.1146/annurev.ph.44.030182.003205; FULLER RS, 1989, P NATL ACAD SCI USA, V86, P1434, DOI 10.1073/pnas.86.5.1434; GERMAIN D, 1992, FEBS LETT, V299, P283, DOI 10.1016/0014-5793(92)80132-Z; GERMAIN D, 1992, EUR J BIOCHEM, V204, P121, DOI 10.1111/j.1432-1033.1992.tb16613.x; GRUMMT F, 1989, CELL, V56, P143, DOI 10.1016/0092-8674(89)90886-6; HACHE RJG, 1983, J BIOL CHEM, V258, P4556; HAKES DJ, 1991, ENDOCRINOLOGY, V129, P3053, DOI 10.1210/endo-129-6-3053; HATSUZAWA K, 1992, J BIOCHEM-TOKYO, V111, P296, DOI 10.1093/oxfordjournals.jbchem.a123753; HOLST A, 1988, CELL, V52, P355; KATO I, 1987, BIOCHEMISTRY-US, V26, P193, DOI 10.1021/bi00375a027; KIEFER MC, 1991, DNA CELL BIOL, V10, P757, DOI 10.1089/dna.1991.10.757; KORNER J, 1991, P NATL ACAD SCI USA, V88, P6834, DOI 10.1073/pnas.88.15.6834; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LINDBERG I, 1991, MOL ENDOCRINOL, V5, P1361, DOI 10.1210/mend-5-10-1361; Loh Y. P., 1993, MECHANISMS INTRACELL, P179; LOH YP, 1984, ANNU REV NEUROSCI, V7, P189, DOI 10.1146/annurev.ne.07.030184.001201; MAINS RE, 1990, FRONT NEUROENDOCRIN, V11, P52; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MIZUNO K, 1989, BIOCHEM BIOPH RES CO, V159, P305, DOI 10.1016/0006-291X(89)92438-8; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; NAKAYAMA K, 1992, J BIOL CHEM, V267, P16335; NAKAYAMA K, 1991, J BIOCHEM, V109, P803, DOI 10.1093/oxfordjournals.jbchem.a123461; NAKAYAMA K, 1992, J BIOL CHEM, V267, P5897; ODA K, 1992, BIOCHEM BIOPH RES CO, V189, P1353, DOI 10.1016/0006-291X(92)90223-8; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; QUINN PS, 1975, BIOCHEM J, V146, P389, DOI 10.1042/bj1460389; RHODES CJ, 1989, J BIOL CHEM, V264, P14240; RUSSELL JT, 1981, J BIOL CHEM, V256, P5950; SEIDAH NG, 1992, TRENDS ENDOCRIN MET, V3, P133, DOI 10.1016/1043-2760(92)90102-7; SEIDAH NG, 1991, MOL ENDOCRINOL, V5, P111, DOI 10.1210/mend-5-1-111; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; SMEEKENS SP, 1992, P NATL ACAD SCI USA, V89, P8822, DOI 10.1073/pnas.89.18.8822; STEINER DF, 1992, J BIOL CHEM, V267, P23435; THOMAS G, 1988, ANNU REV PHYSIOL, V50, P323; THOMAS L, 1991, P NATL ACAD SCI USA, V88, P5297, DOI 10.1073/pnas.88.12.5297; VANDENOUWELAND AMW, 1990, NUCLEIC ACIDS RES, V18, P664, DOI 10.1093/nar/18.3.664; VINDROLA O, 1992, MOL ENDOCRINOL, V6, P1088, DOI 10.1210/me.6.7.1088; WEIDLE UH, 1988, GENE, V73, P427, DOI 10.1016/0378-1119(88)90507-0; YI Z, 1993, J BIOL CHEM, V268, P5615; ZASTROW G, 1989, NUCLEIC ACIDS RES, V17, P1867, DOI 10.1093/nar/17.5.1867	62	60	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20291	20298						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376387				2022-12-27	WOS:A1993LY01900057
J	BESSHO, T; TANO, K; KASAI, H; OHTSUKA, E; NISHIMURA, S				BESSHO, T; TANO, K; KASAI, H; OHTSUKA, E; NISHIMURA, S			EVIDENCE FOR 2 DNA-REPAIR ENZYMES FOR 8-HYDROXYGUANINE (7,8-DIHYDRO-8-OXOGUANINE) IN HUMAN-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ENDONUCLEASE ACTIVITY; NUCLEAR EXTRACTS; OXYGEN RADICALS; G.T MISPAIRS; GLYCOSYLASE; RESIDUES; PROTEIN; MUTM; MUTAGENESIS	Two DNA repair enzymes for 8-hydroxyguanine (also known as 7,8-dihydro-8-oxoguanine; OH8Gua, oxo8Gua) have been identified in human HeLa cell nuclear extract. One is OH8Gua-glycosylase and the other is OH8Gua-endonuclease that lacks OH8Gua-glycosylase activity. They were separated by heparin-Sepharose column chromatography and characterized by endonuclease nicking assay or by measuring the OH8Gua released from substrate DNA using high pressure liquid chromatography-electrochemical detection. Both OH8Gua repair enzymes act only on the OH8Gua-containing strand of the duplex substrate DNA containing OH8Gua/C, OH8Gua/T, or OH8Gua/G. DNA containing OH8Gua/A base pair was very poor substrate for either enzymes. OH8Gua-endonuclease simultaneously cleaves phosphodiester bonds on both sides of the OH8Gua residue, leaving 5'-hydroxy and 3'-hydroxy groups.	NATL CANC CTR,RES INST,DIV BIOL,TOKYO 104,JAPAN; HOKKAIDO UNIV,FAC PHARMACEUT SCI,SAPPORO,HOKKAIDO 060,JAPAN	National Cancer Center - Japan; Hokkaido University	BESSHO, T (corresponding author), MERCK RES LABS,BANYU TSUKUBA RES INST,TSUKUBA,IBARAKI 30033,JAPAN.							AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; BESSHO T, 1992, BIOCHEM BIOPH RES CO, V188, P372, DOI 10.1016/0006-291X(92)92395-E; CHAKRAVARTI D, 1991, J BIOL CHEM, V266, P15710; CHENG KC, 1992, J BIOL CHEM, V267, P166; CHUNG MH, 1991, BIOCHEM BIOPH RES CO, V178, P1472, DOI 10.1016/0006-291X(91)91059-L; CHUNG MH, 1991, MUTAT RES, V254, P1, DOI 10.1016/0921-8777(91)90035-N; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOETSCH PW, 1990, MUTAT RES, V236, P173, DOI 10.1016/0921-8777(90)90004-O; GAJEWSKI E, 1990, BIOCHEMISTRY-US, V29, P7876, DOI 10.1021/bi00486a014; HAMILTON KK, 1992, NATURE, V356, P725, DOI 10.1038/356725a0; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; KAMIYA H, 1992, CANCER RES, V52, P3483; KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849; KASAI H, 1991, OXIDATIVE STRESS OXI, P99; KUCHINO Y, 1987, NATURE, V327, P77, DOI 10.1038/327077a0; MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022; MICHAELS ML, 1991, NUCLEIC ACIDS RES, V19, P3629, DOI 10.1093/nar/19.13.3629; MORIYA M, 1991, MUTAT RES, V254, P281, DOI 10.1016/0921-8777(91)90067-Y; OCONNOR TR, 1989, P NATL ACAD SCI USA, V86, P5222, DOI 10.1073/pnas.86.14.5222; RYDBERG B, 1992, CANCER RES, V52, P1377; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; SINGER B, 1992, P NATL ACAD SCI USA, V89, P9386, DOI 10.1073/pnas.89.20.9386; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; WIEBAUER K, 1990, P NATL ACAD SCI USA, V87, P5842, DOI 10.1073/pnas.87.15.5842; WIEBAUER K, 1989, NATURE, V339, P234, DOI 10.1038/339234a0; WOOD ML, 1990, BIOCHEMISTRY-US, V29, P7024, DOI 10.1021/bi00482a011; YAMAMOTO F, 1992, JPN J CANCER RES, V83, P351, DOI 10.1111/j.1349-7006.1992.tb00114.x; YEH YC, 1991, J BIOL CHEM, V266, P6480	28	188	191	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19416	19421						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366089				2022-12-27	WOS:A1993LW81900043
J	VANVEEN, HW; ABEE, T; KORTSTEE, GJJ; KONINGS, WN; ZEHNDER, AJB				VANVEEN, HW; ABEE, T; KORTSTEE, GJJ; KONINGS, WN; ZEHNDER, AJB			MECHANISM AND ENERGETICS OF THE SECONDARY PHOSPHATE-TRANSPORT SYSTEM OF ACINETOBACTER-JOHNSONII-210A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXOSE 6-PHOSPHATE ANTIPORT; ESCHERICHIA-COLI; MEMBRANE-VESICLES; STREPTOCOCCUS-LACTIS; INORGANIC-PHOSPHATE; LACTOSE TRANSLOCATION; RECONSTITUTION; ACINETOBACTER; EXCHANGE; ENERGY	The mechanism and energetics of the secondary P(i) transport system of A. johnsonii were studied in membrane vesicles and proteoliposomes in which the transport protein was functionally reconstituted. P(i) uptake is strictly dependent on the presence of divalent cations, like Mg2+, Ca2+, Mn2+, or Co2+. These cations form a MeHPO4 complex with up to 87% of the P(i) present in the incubation mixture, suggesting that divalent cations and P(i) are co-transported via a metal-phosphate chelate. Metal-phosphate uptake is driven by the proton motive force (interior negative and alkaline). The metal-phosphate/proton stoichiometry was close to unity. The transport system mediates efflux and homologous exchange of metal-phosphate, but not heterologous exchange of metal-phosphate and glycerol-3-P or glucose-6-P. Exchange and counterflow were essentially pH-independent while efflux and uptake increased with increasing pH. Efflux was inhibited by the proton motive force, whereas exchange was inhibited by the membrane potential only. These observations are consistent with an ordered mechanism for binding and dissociation of metal-phosphate and proton to and from the carrier protein and point to the recycling of a positively charged, protonated carrier protein during exchange.	AGR UNIV WAGENINGEN,DEPT FOOD SCI,6703 HD WAGENINGEN,NETHERLANDS; UNIV GRONINGEN,DEPT MICROBIOL,9751 NN HAREN,NETHERLANDS; SWISS FED INST TECHNOL,EAWAG,CH-8600 DUBENDORF,SWITZERLAND	Wageningen University & Research; University of Groningen; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	VANVEEN, HW (corresponding author), AGR UNIV WAGENINGEN,DEPT MICROBIOL,HESSELINK VAN SUCHTELENWEG 4,6703 CT WAGENINGEN,NETHERLANDS.		Konings, Wilhelmus N./C-7063-2013; Van Veen, Hendrik W./A-4162-2008	Van Veen, Hendrik W./0000-0002-9658-8077				AMBUDKAR SV, 1986, J BIOL CHEM, V261, P9083; AMBUDKAR SV, 1986, J BIOL CHEM, V261, P79; AMBUDKAR SV, 1984, J BIOL CHEM, V259, P2576; BERGSMA J, 1983, EUR J BIOCHEM, V134, P151, DOI 10.1111/j.1432-1033.1983.tb07545.x; BISHOP L, 1989, P NATL ACAD SCI USA, V86, P6953, DOI 10.1073/pnas.86.18.6953; BONTING CFC, 1988, ARCH MICROBIOL, V159, P428; DRIESSEN AJM, 1987, J BACTERIOL, V169, P2748, DOI 10.1128/jb.169.6.2748-2754.1987; DRIESSEN AJM, 1987, J BACTERIOL, V169, P5193, DOI 10.1128/jb.169.11.5193-5200.1987; ELVIN CM, 1985, J BACTERIOL, V161, P1054, DOI 10.1128/JB.161.3.1054-1058.1985; GERDES RG, 1977, J BACTERIOL, V131, P512, DOI 10.1128/JB.131.2.512-518.1977; HOSHINO T, 1979, J BACTERIOL, V137, P73, DOI 10.1128/JB.137.1.73-81.1979; KABACK HR, 1971, J BIOL CHEM, V246, P5523; KACZOROWSKI GJ, 1979, BIOCHEMISTRY-US, V18, P3691, DOI 10.1021/bi00584a009; KACZOROWSKI GJ, 1979, BIOCHEMISTRY-US, V18, P3697, DOI 10.1021/bi00584a010; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; KONINGS WN, 1978, BIOCHIM BIOPHYS ACTA, V508, P370, DOI 10.1016/0005-2736(78)90339-5; KONINGS WN, 1985, TRENDS BIOCHEM SCI, V10, P317, DOI 10.1016/0968-0004(85)90172-0; LOLKEMA JS, 1982, BIOCHIM BIOPHYS ACTA, V681, P85, DOI 10.1016/0005-2728(82)90281-X; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALONEY PC, 1984, J BACTERIOL, V158, P238, DOI 10.1128/JB.158.1.238-245.1984; MEDVECZKY N, 1971, BIOCHIM BIOPHYS ACTA, V241, P494, DOI 10.1016/0005-2736(71)90048-4; MICHELS PAM, 1979, FEMS MICROBIOL LETT, V5, P357, DOI 10.1111/j.1574-6968.1979.tb03339.x; MITCHELL P, 1954, J GEN MICROBIOL, V11, P73, DOI 10.1099/00221287-11-1-73; NEWMAN MJ, 1980, J BIOL CHEM, V255, P583; ROSENBERG H, 1977, J BACTERIOL, V131, P505, DOI 10.1128/JB.131.2.505-511.1977; ROSENBERG H, 1979, BIOCHEM J, V178, P133, DOI 10.1042/bj1780133; SHINBO T, 1978, ARCH BIOCHEM BIOPHYS, V187, P414, DOI 10.1016/0003-9861(78)90052-8; SILLEN LG, 1964, STABILITY CONSTANTS, P180; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SONNA LA, 1988, J MEMBRANE BIOL, V101, P267, DOI 10.1007/BF01872841; SONNA LA, 1988, J BIOL CHEM, V263, P6625; STINNETT JD, 1973, BIOCHEM BIOPH RES CO, V52, P284, DOI 10.1016/0006-291X(73)90985-6; van Groenestijn J.W., 1988, THESIS AGR U WAGENIN; VANGROENESTIJN JW, 1988, APPL ENVIRON MICROB, V54, P2894, DOI 10.1128/AEM.54.12.2894-2901.1988; VANSCHIE BJ, 1987, J GEN MICROBIOL, V133, P867; VANSCHIE BJ, 1987, J GEN MICROBIOL, V133, P3427; VANVEEN HW, 1993, J BACTERIOL, V175, P200, DOI 10.1128/JB.175.1.200-206.1993; VELD GI, 1992, BIOCHIM BIOPHYS ACTA, V1104, P250; VIITANEN P, 1986, METHOD ENZYMOL, V125, P429; WILLSKY GR, 1980, J BACTERIOL, V144, P356, DOI 10.1128/JB.144.1.356-365.1980; YASHPHE J, 1992, CURR MICROBIOL, V24, P275, DOI 10.1007/BF01577332	41	40	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19377	19383						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366084				2022-12-27	WOS:A1993LW81900037
J	ARORA, KK; FILBURN, CR; PEDERSEN, PL				ARORA, KK; FILBURN, CR; PEDERSEN, PL			STRUCTURE-FUNCTION-RELATIONSHIPS IN HEXOKINASE - SITE-DIRECTED MUTATIONAL ANALYSES AND CHARACTERIZATION OF OVEREXPRESSED FRAGMENTS IMPLICATE DIFFERENT FUNCTIONS FOR THE N-TERMINAL AND C-TERMINAL HALVES OF THE ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; RAT-BRAIN HEXOKINASE; MITOCHONDRIAL BOUND HEXOKINASE; NOVIKOFF ASCITES TUMOR; CLONED CDNA; INTRACELLULAR-LOCALIZATION; GLUCOSE PHOSPHORYLATION; MAMMALIAN HEXOKINASE; BINDABLE FORM; BINDING	Hexokinases are comprised of two highly homologous approximately 50-kDa halves and are product-inhibited by glucose-6-P. Four amino acid residues, Ser603, Asp657, Glu708, and Glu742, located in the C-terminal half of the tumor mitochondrial enzyme have been shown to be essential for enzyme function (Arora, K. K., Filburn, C. R., and Pedersen, P. L. (1991) J. Biol. Chem. 266, 5359-5362). Here we have assessed also the role of the N-terminal half of the same enzyme. Site-directed mutagenesis of residues predicted to interact with glucose in the N-terminal half, i.e. Ser155, Asp209, and Glu260, to Ala, have no effect on hexokinase activity. In addition, inhibition by hexose mono- and bisphosphates is unchanged for each of the mutant enzymes. Significantly, the overexpressed N-terminal polypeptide is devoid of catalytic activity but does have the capacity to bind ATP-agarose and be released with ATP and glucose-6-P. In contrast, the overexpressed C-terminal polypeptide is catalytically active and shows the same-product inhibition pattern as the complete 100-kDa parent enzyme. These results emphasize that the N-terminal half of tumor hexokinase is essential neither for catalysis nor product modulation. Rather, the N-terminal half may play another role, perhaps in modulation of the ATP/glucose-6-P-dependent binding of the enzyme to tumor mitochondria or by acting as a spacer between the outer mitochondrial membrane and the C-terminal catalytic unit.	JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,MOLEC & CELLULAR BIOENERGET LAB,BALTIMORE,MD 21205; NIA,GERONTOL RES CTR,BIOL CHEM LAB,BALTIMORE,MD 21224	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)					NATIONAL CANCER INSTITUTE [R01CA032742] Funding Source: NIH RePORTER; NCI NIH HHS [CA 32742] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON CM, 1978, J MOL BIOL, V123, P207, DOI 10.1016/0022-2836(78)90321-2; ANDREONE TL, 1989, J BIOL CHEM, V264, P363; ARORA KK, 1990, J BIOL CHEM, V265, P6481; ARORA KK, 1988, J BIOL CHEM, V263, P17422; ARORA KK, 1991, J BIOL CHEM, V266, P5359; BAIJAL M, 1992, ARCH BIOCHEM BIOPHYS, V289, P271; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BENNETT WS, 1980, J MOL BIOL, V140, P211, DOI 10.1016/0022-2836(80)90103-5; BUSTAMANTE E, 1981, J BIOL CHEM, V256, P8699; BUSTAMANTE E, 1980, BIOCHEMISTRY-US, V19, P4972, DOI 10.1021/bi00563a006; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Colowick SP., 1973, ENZYMES, V9, P1, DOI DOI 10.1016/S1874-6047(08)60113-4; CRANE RK, 1954, J BIOL CHEM, V210, P597; ELLISON WR, 1975, J BIOL CHEM, V250, P1864; FERRARI RICHARD A., 1959, ARCH BIOCHEM AND BIOPHYS, V80, P372, DOI 10.1016/0003-9861(59)90264-4; FROHLICH KU, 1985, GENE, V36, P105, DOI 10.1016/0378-1119(85)90074-5; FROMM HJ, 1962, J BIOL CHEM, V237, P1661; GRIFFIN LD, 1991, GENOMICS, V11, P1014, DOI 10.1016/0888-7543(91)90027-C; GROSSBARD L, 1966, J BIOL CHEM, V241, P3546; JARORI GK, 1990, EUR J BIOCHEM, V188, P9, DOI 10.1111/j.1432-1033.1990.tb15364.x; KATZEN HM, 1965, P NATL ACAD SCI USA, V54, P1218, DOI 10.1073/pnas.54.4.1218; KOPETZKI E, 1985, GENE, V39, P95, DOI 10.1016/0378-1119(85)90113-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAGNANI M, 1992, BIOCHEM J, V285, P193, DOI 10.1042/bj2850193; MEHTA A, 1988, J BIOL CHEM, V263, P15492; MOCHIZUKI Y, 1981, COMP BIOCHEM PHYS B, V70, P745, DOI 10.1016/0305-0491(81)90011-0; MOCHIZUKI Y, 1977, J BIOCHEM, V81, P1849, DOI 10.1093/oxfordjournals.jbchem.a131646; NAKASHIMA RA, 1988, CANCER RES, V48, P913; NISHI S, 1988, BIOCHEM BIOPH RES CO, V157, P937, DOI 10.1016/S0006-291X(88)80964-1; PARRY DM, 1983, J BIOL CHEM, V258, P904; PARRY DM, 1990, J BIOL CHEM, V265, P1059; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWAB DA, 1989, P NATL ACAD SCI USA, V86, P2563, DOI 10.1073/pnas.86.8.2563; SCHWAB DA, 1991, ARCH BIOCHEM BIOPHYS, V285, P365, DOI 10.1016/0003-9861(91)90373-Q; SOLHEIM LP, 1981, ARCH BIOCHEM BIOPHYS, V211, P92, DOI 10.1016/0003-9861(81)90433-1; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8764; THELEN AP, 1991, ARCH BIOCHEM BIOPHYS, V286, P645, DOI 10.1016/0003-9861(91)90094-Y; URETA T, 1982, COMP BIOCHEM PHYS B, V71, P549, DOI 10.1016/0305-0491(82)90461-8; WHITE TK, 1989, ARCH BIOCHEM BIOPHYS, V274, P375, DOI 10.1016/0003-9861(89)90451-7; WHITE TK, 1987, ARCH BIOCHEM BIOPHYS, V259, P402, DOI 10.1016/0003-9861(87)90506-6; [No title captured]	42	67	70	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18259	18266						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349702				2022-12-27	WOS:A1993LT74300090
J	MARGOLESE, L; WANECK, GL; SUZUKI, CK; DEGEN, E; FLAVELL, RA; WILLIAMS, DB				MARGOLESE, L; WANECK, GL; SUZUKI, CK; DEGEN, E; FLAVELL, RA; WILLIAMS, DB			IDENTIFICATION OF THE REGION ON THE CLASS-I HISTOCOMPATIBILITY MOLECULE THAT INTERACTS WITH THE MOLECULAR CHAPERONE, P88 (CALNEXIN, IP90)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN BINDING-PROTEIN; ENDOPLASMIC-RETICULUM MEMBRANE; VIRUS-G-PROTEIN; HEAVY-CHAIN; T-CELL; INTRACELLULAR-TRANSPORT; SURFACE EXPRESSION; PEPTIDE-BINDING; QA-2 ANTIGEN; BETA-2-MICROGLOBULIN	During early stages in their biogenesis, murine class I histocompatibility molecules interact transiently with a molecular chaperone of the endoplasmic reticulum designated p88. Using a series of mutant class I heavy chains we mapped the region of the heavy chain that interacts with p88. Domain deletion mutants of the H-2D(b) and H-2K(b) molecules revealed that most of the extracellular portion of the heavy chain and the bulk of the cytoplasmic domain were not required for the association. However, replacement of the transmembrane segment and cytoplasmic domain with a glycosyl phosphatidylinositol anchor from Q7b resulted in a heavy chain that was incapable of interaction with p88. These results suggested that the primary site of interaction with p88 is within a region containing the transmembrane segment and several flanking amino acids of the class I heavy chain. This finding was supported by replacing the glycosyl phosphatidylinositol anchor of the noninteracting Q7b protein with segments of the D(b) heavy chain containing the putative interaction site and showing that the hybrids were capable of associating with p88. The apparent lack of interaction between segments of p88 and the class I heavy chain that are present within the lumen of the endoplasmic reticulum was also observed when the association between p88 and the a chain of the T cell receptor was examined. The full-length transmembrane a chain formed a complex with p88, whereas a soluble variant consisting of most of the luminal portion of the alpha chain exhibited only minimal interaction. Thus, p88 is capable of associating with nascent integral membrane proteins through transmembrane interactions that are unavailable to the major soluble chaperone of the endoplasmic reticulum, BiP (GRP78).	UNIV TORONTO,DEPT BIOCHEM,MED SCI BLDG,TORONTO M5S 1A8,ONTARIO,CANADA; MASSACHUSETTS GEN HOSP,DEPT SURG,BOSTON,MA 02129; NICHHD,CELL BIOL & METAB BRANCH,BETHESDA,MD 20892; YALE UNIV,SCH MED,IMMUNOBIOL SECT,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06510	University of Toronto; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Yale University; Howard Hughes Medical Institute; Yale University					NIGMS NIH HHS [GM46467] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046467] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHLUWALIA N, 1992, J BIOL CHEM, V267, P10914; ALLEN H, 1986, P NATL ACAD SCI USA, V83, P7447, DOI 10.1073/pnas.83.19.7447; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; CHIEN Y, 1984, NATURE, V312, P31, DOI 10.1038/312031a0; COSSON P, 1992, SCIENCE, V258, P659, DOI 10.1126/science.1329208; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; DEGEN E, 1992, J EXP MED, V175, P1653, DOI 10.1084/jem.175.6.1653; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; DOMS RW, 1988, J CELL BIOL, V107, P89, DOI 10.1083/jcb.107.1.89; DORNER AJ, 1988, MOL CELL BIOL, V8, P4063, DOI 10.1128/MCB.8.10.4063; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; GALVIN K, 1992, P NATL ACAD SCI USA, V89, P8452, DOI 10.1073/pnas.89.18.8452; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GREEN NM, 1991, NATURE, V351, P349, DOI 10.1038/351349a0; GUAGLIARDI LE, 1991, ANNU REV IMMUNOL, V9, P707; Helenius Ari, 1992, Trends in Cell Biology, V2, P227, DOI 10.1016/0962-8924(92)90309-B; HENDERSHOT L, 1987, IMMUNOL TODAY, V8, P111, DOI 10.1016/0167-5699(87)90861-9; HERRMANN SH, 1982, J BIOL CHEM, V257, P4181; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; HURTLEY SM, 1989, J CELL BIOL, V108, P2117, DOI 10.1083/jcb.108.6.2117; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANCET D, 1979, P NATL ACAD SCI USA, V76, P3844, DOI 10.1073/pnas.76.8.3844; LEMKE H, 1979, IMMUNOL REV, V47, P176; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; LOUVARD D, 1982, J CELL BIOL, V92, P92, DOI 10.1083/jcb.92.1.92; MACHAMER CE, 1990, J BIOL CHEM, V265, P6879; MELNICK JR, 1992, MOL BIOL CELL, V3, P4; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; OZATO K, 1981, J IMMUNOL, V126, P317; PARKER KC, 1992, J IMMUNOL, V149, P1896; PAULSON JC, 1989, TRENDS BIOCHEM SCI, V14, P272, DOI 10.1016/0968-0004(89)90062-5; PELHAM H, 1988, NATURE, V332, P776, DOI 10.1038/332776a0; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; RUTLEDGE T, 1992, EMBO J, V11, P3245, DOI 10.1002/j.1460-2075.1992.tb05402.x; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SMITH MH, 1986, MOL IMMUNOL, V23, P1077, DOI 10.1016/0161-5890(86)90006-4; SMITH MH, 1990, MOL IMMUNOL, V27, P169, DOI 10.1016/0161-5890(90)90112-D; STAFFORD FJ, 1991, J CELL BIOL, V115, P1225, DOI 10.1083/jcb.115.5.1225; STAMNES M A, 1992, Trends in Cell Biology, V2, P272, DOI 10.1016/0962-8924(92)90200-7; STERNBERG MJE, 1990, PROTEIN ENG, V3, P245, DOI 10.1093/protein/3.4.245; SUZUKI CK, 1991, J CELL BIOL, V114, P189, DOI 10.1083/jcb.114.2.189; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; WADA I, 1991, J BIOL CHEM, V266, P19599; WANECK GL, 1987, J EXP MED, V165, P1358, DOI 10.1084/jem.165.5.1358; WANECK GL, 1988, P NATL ACAD SCI USA, V85, P577, DOI 10.1073/pnas.85.2.577; WANECK GL, 1988, SCIENCE, V241, P697, DOI 10.1126/science.3399901; WILLIAMS DB, 1989, J IMMUNOL, V142, P2796; YOKOYAMA K, 1985, BIOCHEMISTRY-US, V24, P3002, DOI 10.1021/bi00333a029	56	80	80	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17959	17966						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349678				2022-12-27	WOS:A1993LT74300050
J	WANG, YH; BORTNER, CD; GRIFFITH, J				WANG, YH; BORTNER, CD; GRIFFITH, J			RECA BINDING TO BULGE-CONTAINING AND MISMATCH-CONTAINING DNAS - CERTAIN SINGLE-BASE MISMATCHES PROVIDE STRONG SIGNALS FOR RECA BINDING EQUAL TO MULTIPLE BASE BULGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTAINING DEOXYTRIDECANUCLEOTIDE DUPLEXES; METHYL-DIRECTED REPAIR; ESCHERICHIA-COLI; POSSIBLE MECHANISM; FLANKING SEQUENCE; SOS MUTAGENESIS; POLYMERASE-III; PROTEIN; CLEAVAGE; STRAND	Studies from several laboratories have demonstrated that RecA protein can recognize a variety of pertubations in the DNA helix. Here, using a nitrocellulose filter binding assay, it was observed that RecA bound to bulge-containing DNAs more effectively than non-bulged DNA. The degree of binding of RecA protein to bulged DNA was dependent on the conformation of the bulged bases and the kinking angles produced by the bulges as determined by the type and number of bases in the bulge. Although a single base mismatch does not kink DNA, RecA protein showed preferential binding to DNAs containing certain single base mismatches. An A.C mismatch flanked by A.T base pairs in a 28-base pair (bp) DNA facilitated the binding of RecA protein to the same high level as when the 28-bp DNA contained a 4-base cytosine bulge. Chemical probing techniques were used to examine the structure of DNA within the RecA filament. It was found that upon binding of RecA protein, the DNA helix becomes accessible over at least 14 bp, and the degree of sensitivity agrees with the binding efficiency of RecA protein.	UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill					NIGMS NIH HHS [GM-31819, GM-42342] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819, R01GM042342] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOULELA F, 1985, NUCLEIC ACIDS RES, V13, P4811, DOI 10.1093/nar/13.13.4811; BHATTACHARYYA A, 1989, J MOL BIOL, V209, P583, DOI 10.1016/0022-2836(89)90596-2; BHATTACHARYYA A, 1989, NUCLEIC ACIDS RES, V17, P6821, DOI 10.1093/nar/17.17.6821; BLAHO JA, 1987, J BIOL CHEM, V262, P6082; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURCKHARDT SE, 1988, P NATL ACAD SCI USA, V85, P1811, DOI 10.1073/pnas.85.6.1811; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P6018, DOI 10.1073/pnas.78.10.6018; COX MM, 1991, MOL MICROBIOL, V5, P1295, DOI 10.1111/j.1365-2958.1991.tb00775.x; DOHET C, 1986, P NATL ACAD SCI USA, V83, P3395, DOI 10.1073/pnas.83.10.3395; FURLONG JC, 1986, NUCLEIC ACIDS RES, V14, P3995, DOI 10.1093/nar/14.10.3995; GRIFFITH J, 1985, BIOCHEMISTRY-US, V24, P158, DOI 10.1021/bi00322a022; HSIEH CH, 1989, P NATL ACAD SCI USA, V86, P4833, DOI 10.1073/pnas.86.13.4833; KAHN R, 1981, P NATL ACAD SCI-BIOL, V78, P4786, DOI 10.1073/pnas.78.8.4786; KALNIK MW, 1989, BIOCHEMISTRY-US, V28, P294, DOI 10.1021/bi00427a040; KALNIK MW, 1989, J BIOL CHEM, V264, P3702; KENNARD O, 1987, NUCL ACIDS MOL BIOL, P25; KIM JI, 1989, J BIOL CHEM, V264, P21848; KOJIMA M, 1990, NUCLEIC ACIDS RES, V18, P2707, DOI 10.1093/nar/18.9.2707; KOWALCZYKOWSKI SC, 1987, P NATL ACAD SCI USA, V34, P3127; LEARN BA, 1989, J BACTERIOL, V171, P6473, DOI 10.1128/jb.171.12.6473-6481.1989; LU C, 1986, P NATL ACAD SCI USA, V83, P619, DOI 10.1073/pnas.83.3.619; Maxam A M, 1980, Methods Enzymol, V65, P499; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; NOHMI T, 1988, P NATL ACAD SCI USA, V85, P1816, DOI 10.1073/pnas.85.6.1816; PATEL DJ, 1987, NUCL ACIDS MOL BIOL, P70; PUGH BF, 1987, J BIOL CHEM, V262, P1326; RAJAGOPALAN M, 1992, P NATL ACAD SCI USA, V89, P10777, DOI 10.1073/pnas.89.22.10777; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; RICE JA, 1989, BIOCHEMISTRY-US, V28, P4512, DOI 10.1021/bi00436a058; ROCA AI, 1990, CRIT REV BIOCHEM MOL, V25, P415, DOI 10.3109/10409239009090617; ROSEN MA, 1992, BIOCHEMISTRY-US, V31, P4004, DOI 10.1021/bi00131a016; ROSEN MA, 1992, BIOCHEMISTRY-US, V31, P4015, DOI 10.1021/bi00131a017; ROSENBERG M, 1990, J BIOL CHEM, V265, P20641; SHANER SL, 1987, J BIOL CHEM, V262, P9211; SHANER SL, 1987, J BIOL CHEM, V262, P9220; SHI YB, 1988, NUCLEIC ACIDS RES, V16, P8945, DOI 10.1093/nar/16.18.8945; SHINAGAWA H, 1988, P NATL ACAD SCI USA, V85, P1806, DOI 10.1073/pnas.85.6.1806; SU SS, 1988, J BIOL CHEM, V263, P6829; THRESHER RJ, 1990, P NATL ACAD SCI USA, V87, P5056, DOI 10.1073/pnas.87.13.5056; VANDENHOOGEN YT, 1988, NUCLEIC ACIDS RES, V16, P2971, DOI 10.1093/nar/16.7.2971; WANG YH, 1991, BIOCHEMISTRY-US, V30, P1358, DOI 10.1021/bi00219a028; WANG YH, 1992, J BIOL CHEM, V267, P4911; WEST SC, 1981, P NATL ACAD SCI-BIOL, V78, P6149, DOI 10.1073/pnas.78.10.6149; WOODSON SA, 1988, BIOCHEMISTRY-US, V27, P3130, DOI 10.1021/bi00409a004	45	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17571	17577						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349637				2022-12-27	WOS:A1993LQ98800099
J	PARK, DG; JHON, DY; LEE, CW; LEE, KH; RHEE, SG				PARK, DG; JHON, DY; LEE, CW; LEE, KH; RHEE, SG			ACTIVATION OF PHOSPHOLIPASE-C ISOZYMES BY G-PROTEIN BETA-GAMMA SUBUNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SIGNAL TRANSDUCTION; ALPHA-SUBUNIT; BOVINE BRAIN; PURIFICATION; IDENTIFICATION; MEMBRANES; CYCLASE	The betagamma subunits of guanine nucleotide-binding proteins (G proteins) have been shown to activate unidentified phospholipase C (PLC) isozymes (Camps, M., Hou, C., Sidiropoulos, D., Stock, J. B., Jakobs, K. H., and Gierschik, P. (1992) Eur. J. Biochem. 206, 821-831; Blank, J. L., Brattain, K. A., and Exton, J. H. (1992) J. Biol. Chem. 267, 23069-23075). To identify these target PLC isozymes, we measured the effect of bovine brain G protein betagamma subunits on PLC-beta1, PLC-beta2, PLC-beta3, PLC-gamma1, and PLC-delta1 activity by reconstituting purified protein components with lipid vesicles containing [H-3]phosphatidylinositol 4,5-bisphosphate (PtdIns 4,5-P2). A nearly saturating concentration of betagamma produced 2.5-, 4-, 8.5-, and 2-fold increases in PLC-beta1, PLC-beta2, PLC-beta3, and PLC-delta1 activity, respectively, and no activation of PLC-gamma1, in the presence of 0.2 muM free Ca2+. The betagamma-dependent activation of the PLC-beta isozymes does not appear to be the result of increased affinity of the enzymes for Ca2+. The betagamma-dependent PLC activation could be reversed by addition of the GDP-bound form of the alpha subunit of G(o). The alpha subunits of G(q) class G proteins have been shown to activate PLC-beta isozymes in the order of PLC-beta1 greater-than-or-equal-to PLC-beta3 >> PLC-beta2, which differs from the order of PLC-beta3 > PLC-beta2 > PLC-beta1 for betagamma-dependent activation. Furthermore, the half-maximal concentration of betagamma (25 nM) required to activate PLC-beta3 is much higher than that of G(q) alpha subunits (0.6 nM) required to activate PLC-beta1. These results suggest that the extracellular signals that induce the dissociation of G(o) or G(i), the heterotrimeric G proteins abundant in brain, should enhance the hydrolysis of PtdIns 4,5-P2 in brain primarily through activation of PLC-beta3 (PLC-beta2 is not detectable in brain). However, signals that activate the less abundant G(q) class heterotrimers should result in the activation primarily of PLC-beta1 and PLC-beta3 by the corresponding alpha subunits.	NHLBI, BIOCHEM LAB, BLDG 3, RM 122, 9000 ROCKVILLE PIKE, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)								BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BLANK JL, 1991, J BIOL CHEM, V266, P18206; BLANK JL, 1992, J BIOL CHEM, V267, P23069; BOYER JL, 1992, J BIOL CHEM, V267, P25451; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; COCKCROFT S, 1987, TRENDS BIOCHEM SCI, V12, P75, DOI 10.1016/0968-0004(87)90035-1; DEVIVO M, 1990, ADP RIBOSYLATING TOX, P267; FAIN JN, 1990, BIOCHIM BIOPHYS ACTA, V1053, P81, DOI 10.1016/0167-4889(90)90029-D; Goo Rhee Sue, 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P35; JELSEMA CL, 1987, P NATL ACAD SCI USA, V84, P3623, DOI 10.1073/pnas.84.11.3623; JHON DY, 1993, IN PRESS J BIOL CHEM; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; LOGOTHETIS DE, 1988, P NATL ACAD SCI USA, V85, P5814, DOI 10.1073/pnas.85.16.5814; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; MARTIN TFJ, 1989, INOSITOL LIPIDS CELL, P81; MORIARTY TM, 1990, NATURE, V343, P79, DOI 10.1038/343079a0; NORTHUP JK, 1983, J BIOL CHEM, V258, P1361; PANG IH, 1990, J BIOL CHEM, V265, P18707; PREMONT RT, 1992, P NATL ACAD SCI USA, V89, P9809, DOI 10.1073/pnas.89.20.9809; RANA RS, 1990, PHYSIOL REV, V70, P115, DOI 10.1152/physrev.1990.70.1.115; RHEE SG, 1992, J BIOL CHEM, V267, P12393; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; TAYLOR SJ, 1990, J BIOL CHEM, V265, P17150; VONWEIZSACKER E, 1992, BIOCHEM BIOPH RES CO, V183, P350, DOI 10.1016/0006-291X(92)91650-F; WALDO GL, 1991, J BIOL CHEM, V266, P14217; WHITEWAY M, 1989, CELL, V56, P467, DOI 10.1016/0092-8674(89)90249-3; WU DQ, 1992, J BIOL CHEM, V267, P1811	34	271	275	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	1993	268	7					4573	4576						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP884	8383116				2022-12-27	WOS:A1993KP88400002
J	THOMAS, DC; BREWER, CB; ROTH, MG				THOMAS, DC; BREWER, CB; ROTH, MG			VESICULAR STOMATITIS-VIRUS GLYCOPROTEIN CONTAINS A DOMINANT CYTOPLASMIC BASOLATERAL SORTING SIGNAL CRITICALLY DEPENDENT UPON A TYROSINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE KIDNEY-CELLS; APICAL PLASMA-MEMBRANE; POLYMERIC IMMUNOGLOBULIN RECEPTOR; POLARIZED EPITHELIAL-CELLS; AMINO-ACID CHANGE; G-PROTEIN; MDCK CELLS; VIRAL GLYCOPROTEINS; INFLUENZA HEMAGGLUTININ; INTRACELLULAR-TRANSPORT	To investigate the contribution of the cytoplasmic domain of the vesicular stomatitis virus G glycoprotein to its basolateral expression in polarized epithelial cells, chimeric proteins containing the external and transmembrane domains of an apically targeted protein, the influenza virus hemagglutinin (HA), and either the G cytoplasmic domain or an unrelated cytoplasmic sequence, were introduced into Madin-Darby canine kidney (MDCK) cells. Addition of the cytoplasmic tail of G to a truncated HA resulted in delivery of greater than 95% of the chimeric protein to the basolateral cell surface, indicating that the G cytoplasmic domain contains a dominant basolateral sorting signal. A similar chimera, containing the cytoplasmic tail of herpes simplex I glycoprotein gC, was not sorted basolaterally. Deletion of the cytoplasmic tail from G protein itself decreased the fidelity of sorting to the basolateral surface, but not the extent to which the protein reached the plasma membrane. Mutation of cytoplasmic tyrosine 501 of G caused an identical loss of basolateral targeting, suggesting that the tyrosine, or the sequence surrounding it, is required for efficient basolateral transport of G. Mutation of tyrosine 501 had no effect on internalization of G, which was much slower than that of endocytic receptors. Thus, VSV G protein contains an efficient cytoplasmic basolateral targeting signal that is not an efficient internalization signal.	UNIV TEXAS, SW MED CTR, DEPT BIOCHEM, DALLAS, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas				Roth, Michael/0000-0002-9056-332X	NIGMS NIH HHS [GM08203, GM37547] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037547] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOMSEL M, 1991, Current Opinion in Cell Biology, V3, P647, DOI 10.1016/0955-0674(91)90036-X; BOULAN ER, 1980, CELL, V20, P45, DOI 10.1016/0092-8674(80)90233-0; BREWER CB, 1991, J CELL BIOL, V114, P413, DOI 10.1083/jcb.114.3.413; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; CAPLAN M, 1989, FUNCTIONAL EPITHELIA, P71; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; COMPTON T, 1989, P NATL ACAD SCI USA, V86, P4112, DOI 10.1073/pnas.86.11.4112; DOMS RW, 1987, J CELL BIOL, V105, P1957, DOI 10.1083/jcb.105.5.1957; DOYLE C, 1985, J CELL BIOL, V100, P704, DOI 10.1083/jcb.100.3.704; FULLER SD, 1985, EMBO J, V4, P297, DOI 10.1002/j.1460-2075.1985.tb03629.x; GONZALEZ A, 1987, P NATL ACAD SCI USA, V84, P3738, DOI 10.1073/pnas.84.11.3738; GOTTLIEB TA, 1986, J CELL BIOL, V102, P1242, DOI 10.1083/jcb.102.4.1242; GRAEVE L, 1989, J CELL BIOL, V109, P2809, DOI 10.1083/jcb.109.6.2809; GRUENBERG J, 1987, P NATL ACAD SCI USA, V84, P5758, DOI 10.1073/pnas.84.16.5758; HOPKINS CR, 1991, CELL, V66, P827, DOI 10.1016/0092-8674(91)90427-Z; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; KONDORKOCH C, 1985, CELL, V43, P297, DOI 10.1016/0092-8674(85)90035-2; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZAROVITS J, 1988, CELL, V53, P743, DOI 10.1016/0092-8674(88)90092-X; LAZAROVITS J, 1990, J BIOL CHEM, V265, P4760; LAZAROVITS J, 1988, THESIS U TEXAS SW ME; LEBIVIC A, 1991, J CELL BIOL, V115, P607, DOI 10.1083/jcb.115.3.607; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; LISANTI MP, 1989, J CELL BIOL, V109, P2117, DOI 10.1083/jcb.109.5.2117; MATLIN K, 1983, J CELL BIOL, V97, P627, DOI 10.1083/jcb.97.3.627; MATLIN KS, 1984, J CELL BIOL, V99, P2131, DOI 10.1083/jcb.99.6.2131; MCQUEEN N, 1986, P NATL ACAD SCI USA, V83, P9318, DOI 10.1073/pnas.83.24.9318; MCQUEEN NL, 1987, J BIOL CHEM, V262, P16233; MISEK DE, 1984, CELL, V39, P537, DOI 10.1016/0092-8674(84)90460-4; MOSTOV K, 1992, J CELL BIOL, V116, P577, DOI 10.1083/jcb.116.3.577; MOSTOV KE, 1986, CELL, V47, P359, DOI 10.1016/0092-8674(86)90592-1; NELSON WJ, 1989, FUNCTIONAL EPITHELIA, P71; OKAMOTO CT, 1992, J BIOL CHEM, V267, P9925; PESONEN M, 1984, J CELL BIOL, V99, P796, DOI 10.1083/jcb.99.3.796; PFEIFFER S, 1985, J CELL BIOL, V101, P470, DOI 10.1083/jcb.101.2.470; PUDDINGTON L, 1987, P NATL ACAD SCI USA, V84, P2756; RINDLER MJ, 1984, J CELL BIOL, V98, P1304, DOI 10.1083/jcb.98.4.1304; RINDLER MJ, 1985, J CELL BIOL, V100, P136, DOI 10.1083/jcb.100.1.136; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; ROMAN LM, 1986, J CELL BIOL, V103, P2607, DOI 10.1083/jcb.103.6.2607; ROTH MG, 1986, J CELL BIOL, V102, P1271, DOI 10.1083/jcb.102.4.1271; ROTH MG, 1987, J CELL BIOL, V104, P769, DOI 10.1083/jcb.104.3.769; Sambrook J, 1989, MOL CLONING LABORATO; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; SIMONS K, 1985, ANNU REV CELL BIOL, V1, P243, DOI 10.1146/annurev.cb.01.110185.001331; STEPHENS EB, 1986, EMBO J, V5, P237, DOI 10.1002/j.1460-2075.1986.tb04204.x; WANDINGERNESS A, 1990, J CELL BIOL, V111, P987, DOI 10.1083/jcb.111.3.987; YOKODE M, 1992, J CELL BIOL, V117, P39, DOI 10.1083/jcb.117.1.39; ZOLLER MJ, 1984, DNA-J MOLEC CELL BIO, V3, P479, DOI 10.1089/dna.1.1984.3.479	51	141	142	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3313	3320						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381425				2022-12-27	WOS:A1993KM16100047
J	OZAWA, K; YAMADA, K; KAZANIETZ, MG; BLUMBERG, PM; BEAVEN, MA				OZAWA, K; YAMADA, K; KAZANIETZ, MG; BLUMBERG, PM; BEAVEN, MA			DIFFERENT ISOZYMES OF PROTEIN-KINASE-C MEDIATE FEEDBACK INHIBITION OF PHOSPHOLIPASE-C AND STIMULATORY SIGNALS FOR EXOCYTOSIS IN RAT RBL-2H3 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PHORBOL ESTER BINDING; SYNERGISTIC SIGNALS; DOWN-REGULATION; 2H3 CELLS; EXPRESSION; RECEPTOR; FAMILY; SECRETION; EPSILON; RELEASE	Previous studies indicated that rat basophilic RBL-2H3 cells contained the Ca2+-dependent alpha and beta and the Ca2+-independent delta, epsilon, and zeta isoforms of protein kinase C (PKC); of these, PKCbeta and delta were the most potent transducers of signals for exocytosis in antigen-stimulated permeabilized cells. Exocytosis, nevertheless, was still dependent on an elevated free Ca2+. (Ozawa, K., Szallasi, Z., Kazanietz, M. G., Blumberg, P. M., Mischak, H., Mushinski, J. F., and Beaven, M. A. (1993) J. Biol. Chem. 268, 1749-1756). We now demonstrate that PKCalpha and epsilon, exclusively, inhibit antigen-induced hydrolysis of inositol phospholipids in the same permeabilized RBL-2H3 cells. Unlike secretion, the inhibitory actions occurred at a basal concentration (0.1 muM) of free Ca2+. The inhibitory actions of the two isozymes were potentiated by 20 nM phorbol 12-myristate 13-acetate. As indicated by the effects of the phorbol ester, the probable mechanism was reduced tyrosine phosphorylation of phospholipase C gamma1. The negative regulation of phospholipase C was apparent in intact cells, because the PKC inhibitor Ro31-7549 or down-regulation of PKC with phorbol ester enhanced antigen-induced hydrolysis of inositol phospholipids. The concentrations of the various isozymes of PKC in RBL-2H3 cells, as estimated by immunoblotting studies, were sufficient for promotion of exocytosis (i.e. beta and delta) and inhibition of phospholipid hydrolysis (i.e. alpha and epsilon).	NHLBI, CHEM PHARMACOL LAB, RM 8N114, BLDG 10, BETHESDA, MD 20892 USA; NCI, CELLULAR CARCINOGENESIS & TUMOR PROMOT LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								ALI H, 1989, J IMMUNOL, V143, P2626; ALI H, 1989, BIOCHIM BIOPHYS ACTA, V1010, P88, DOI 10.1016/0167-4889(89)90188-2; ASE K, 1988, FEBS LETT, V236, P396, DOI 10.1016/0014-5793(88)80064-4; BALDASSARE JJ, 1992, J BIOL CHEM, V267, P15585; BEAVEN MA, 1987, J CELL BIOL, V105, P1129, DOI 10.1083/jcb.105.3.1129; BEAVEN MA, 1988, PROG ALLERGY, V42, P123; BENHAMOU M, 1992, J BIOL CHEM, V267, P7310; BURNS DJ, 1991, J BIOL CHEM, V266, P18330; CUNHAMELO JR, 1989, J IMMUNOL, V143, P2617; ELLIOTT LH, 1990, BIOCHEM BIOPH RES CO, V171, P148, DOI 10.1016/0006-291X(90)91369-4; HUANG FL, 1989, J BIOL CHEM, V264, P4238; Jaken S, 1990, CURR OPIN CELL BIOL, V2, P192, DOI 10.1016/0955-0674(90)90006-Z; KILEY SC, 1991, J BIOL CHEM, V266, P23761; MAEYAMA K, 1986, J BIOL CHEM, V261, P2583; METZGER H, 1986, ANNU REV IMMUNOL, V4, P419, DOI 10.1146/annurev.iy.04.040186.002223; NISHIZUKA Y, 1989, CANCER, V63, P1892, DOI 10.1002/1097-0142(19890515)63:10<1892::AID-CNCR2820631005>3.0.CO;2-Z; OGITA K, 1990, ADV SEC MESS PHOSPH, V24, P218; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; ONO Y, 1988, J BIOL CHEM, V263, P6927; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; OSADA S, 1990, J BIOL CHEM, V265, P22434; OZAWA K, 1993, J BIOL CHEM, V268, P1749; PACHTER JA, 1992, J BIOL CHEM, V267, P9826; PARK DJ, 1991, J BIOL CHEM, V266, P24237; PARK DJ, 1992, J BIOL CHEM, V267, P1496; RHEE SG, 1992, J BIOL CHEM, V267, P12393; RYVES WJ, 1991, FEBS LETT, V288, P5, DOI 10.1016/0014-5793(91)80989-G; SCHAAP D, 1990, J BIOL CHEM, V265, P7301; TANAKA Y, 1986, J BIOCHEM-TOKYO, V99, P257, DOI 10.1093/oxfordjournals.jbchem.a135467; WAYS DK, 1992, J BIOL CHEM, V267, P4799; YAMADA K, 1992, J IMMUNOL, V149, P1031	31	167	168	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2280	2283						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8381401				2022-12-27	WOS:A1993KK81500004
J	SHIMADA, N; ISHIKAWA, N; MUNAKATA, Y; TODA, T; WATANABE, K; KIMURA, N				SHIMADA, N; ISHIKAWA, N; MUNAKATA, Y; TODA, T; WATANABE, K; KIMURA, N			A 2ND FORM (BETA-ISOFORM) OF NUCLEOSIDE DIPHOSPHATE KINASE FROM RAT - ISOLATION AND CHARACTERIZATION OF COMPLEMENTARY AND GENOMIC DNA AND EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-METASTASIS; PROTEIN; GENE; DROSOPHILA; CLONING; NM23; COMPLEX; PRODUCT; PRUNE; CELLS	Complementary and genomic clones for a second form (the beta isoform) of rat nucleoside diphosphate kinase were isolated. Structural studies revealed that nucleotide and deduced amino acid sequences of the beta isoform were quite similar to those of the alpha isoform (identities were 82 and 89%, respectively), which were delineated in our previous study (Kimura, N., Shimada, N., Nomura, K., and Watanabe, K. (1990) J. Biol. Chem. 265, 15744-15749). The gene encoding the beta isoform, covering 10 kilobases and comprising five exons, was located in tandem in the immediate vicinity (at a 3-kilobase distance) of the 5' upstream of the alpha isoform gene which was recently reported from this laboratory (Ishikawa, N., Shimada, N., Munakata, Y., Watanabe, K., and Kimura, N. (1992) J. Biol. Chem. 267, 14366-14372), suggesting their generation by gene duplication. The exon-intron junctions were exactly conserved between the two genes. Southern blot analyses showed that unidentified fragments cross-reacted with the beta isoform cDNA probe besides those containing the genuine gene, and at least two of them were identified as possible processed pseudogenes. Northern and dot blot hybridization studies demonstrated that the alpha isoform was more expressed than the beta isoform in rat tissues examined except brain, from which the isoform designation was derived. These results suggest independent expression and specific roles of these isoforms in the cell. Comparative studies between rat and human isoforms indicate that the isoforms could have differentiated before the two species evolutionally diverged.	TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,DEPT MOLEC BIOL,35-2 SAKAECHO,ITABASHI KU,TOKYO 173,JAPAN; TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,DEPT MOLEC PATHOL,ITABASHI KU,TOKYO 173,JAPAN; TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,DEPT EXPTL BIOL,ITABASHI KU,TOKYO 173,JAPAN				xu, tao/K-6631-2016					BEVILACQUA G, 1989, CANCER RES, V49, P5185; BIGGS J, 1988, GENE DEV, V2, P1333, DOI 10.1101/gad.2.10.1333; BIGGS J, 1990, CELL, V63, P933, DOI 10.1016/0092-8674(90)90496-2; DEAROLF CR, 1988, DEV BIOL, V129, P169, DOI 10.1016/0012-1606(88)90171-6; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; GILLES AM, 1991, J BIOL CHEM, V266, P8784; HAMA H, 1991, GENE, V105, P31, DOI 10.1016/0378-1119(91)90510-I; HIRAYAMA R, 1991, J NATL CANCER I, V83, P1249, DOI 10.1093/jnci/83.17.1249; ISHHOROWICZ D, 1981, NUCLEIC ACIDS RES, V9, P2989, DOI 10.1093/nar/9.13.2989; ISHIKAWA N, 1992, J BIOL CHEM, V267, P14366; ISHIKAWA N, 1990, J BIOL CHEM, V265, P19040; KIKKAWA S, 1990, J BIOL CHEM, V265, P21536; KIMURA N, 1990, BIOCHEM BIOPH RES CO, V168, P99, DOI 10.1016/0006-291X(90)91680-Q; KIMURA N, 1977, J BIOL CHEM, V252, P3829; KIMURA N, 1990, J BIOL CHEM, V265, P15744; KIMURA N, 1983, J BIOL CHEM, V258, P2609; KIMURA N, 1993, IN PRESS GTPASES BIO; LACOMBE M L, 1992, Trends in Pharmacological Sciences, V13, P46, DOI 10.1016/0165-6147(92)90020-7; LACOMBE ML, 1990, J BIOL CHEM, V265, P10012; LEONE A, 1991, CELL, V65, P25, DOI 10.1016/0092-8674(91)90404-M; MUNOZDORADO J, 1990, J BIOL CHEM, V265, P2702; NAKAYAMA T, 1992, J NATL CANCER I, V84, P1349, DOI 10.1093/jnci/84.17.1349; NICKERSON JA, 1984, J BIOL CHEM, V259, P1297; NOMURA T, 1992, ARCH BIOCHEM BIOPHYS, V297, P42, DOI 10.1016/0003-9861(92)90638-D; OKABEKADO J, 1992, BIOCHEM BIOPH RES CO, V182, P987, DOI 10.1016/0006-291X(92)91829-F; OTERO AD, 1990, BIOCHEM PHARMACOL, V39, P1399; Parks R.E., 1973, ENZYMES, V8, P307, DOI [10.1016/S1874-6047(08)60069-4, DOI 10.1016/S1874-6047(08)60069-4]; ROSENGARD AM, 1989, NATURE, V342, P177, DOI 10.1038/342177a0; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; Sambrook J, 1989, MOL CLONING LABORATO; SINGER M, 1991, GENES GENOMES, P641; STAHL JA, 1991, CANCER RES, V51, P445; STEEG PS, 1988, CANCER RES, V48, P6550; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; TENG DHF, 1991, NATURE, V353, P437, DOI 10.1038/353437a0; WALTON GM, 1975, BIOCHIM BIOPHYS ACTA, V390, P231, DOI 10.1016/0005-2787(75)90344-5	37	89	97	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2583	2589						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8381409				2022-12-27	WOS:A1993KK81500050
J	DOI, T; HIGASHINO, K; KURIHARA, Y; WADA, Y; MIYAZAKI, T; NAKAMURA, H; UESUGI, S; IMANISHI, T; KAWABE, Y; ITAKURA, H; YAZAKI, Y; MATSUMOTO, A; KODAMA, T				DOI, T; HIGASHINO, K; KURIHARA, Y; WADA, Y; MIYAZAKI, T; NAKAMURA, H; UESUGI, S; IMANISHI, T; KAWABE, Y; ITAKURA, H; YAZAKI, Y; MATSUMOTO, A; KODAMA, T			CHARGED COLLAGEN STRUCTURE MEDIATES THE RECOGNITION OF NEGATIVELY CHARGED MACROMOLECULES BY MACROPHAGE SCAVENGER RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; HAMSTER OVARY CELLS; PERITONEAL-MACROPHAGES; CHOLESTEROL DEPOSITION; MULTIPLE RECEPTORS; BINDING-SITE; ENDOCYTOSIS; EXPRESSION; DEGRADATION; PEROXIDATION	Macrophage scavenger receptors mediate the recognition of a wide range of negatively charged macromolecules including modified low density lipoproteins (LDL). Truncated bovine receptors lacking residues 330-342, which include the conserved lysine cluster of a collagen-like domain, were unable to degrade modified LDL in spite of their expression on the cell surface. Substitution of lysine 337 into alanine abolished the acetyl-LDL degradation and binding at 37-degrees-C, but did not abolish the 4-degrees-C binding. In contrast, substitution of more than 2 lysines in this region are needed to abolish the oxidized LDL degradation and 37-degrees-C binding. Based on computational modeling of this domain, we propose that a ''charged collagen'' structure containing a lysine cluster forms a positively charged groove which specifically interacts with negatively charged ligands.	NATL INST HLTH & NUTR,DIV CLIN NUTR,TOKYO 162,JAPAN; UNIV TOKYO,DEPT INTERNAL MED 3,TOKYO 113,JAPAN; CHUGAI PHARMACEUT,DRUG DEV LAB,SHIZUOKA,JAPAN	National Institute of Health & Nutrition - Japan; University of Tokyo; Chugai Pharmaceutical Co., Ltd.; Roche Holding	DOI, T (corresponding author), OSAKA UNIV,FAC PHARMACEUT SCI,1-6 YAMADA OKA,SUITA,OSAKA 565,JAPAN.		Nakamura, Haruki/O-4028-2014	Kawabe, Yoshiki/0000-0002-6465-7146				ARAI H, 1989, BIOCHEM BIOPH RES CO, V159, P1375, DOI 10.1016/0006-291X(89)92262-6; BROWN MS, 1980, J SUPRAMOL STR CELL, V13, P67, DOI 10.1002/jss.400130107; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; FRANK JS, 1989, J LIPID RES, V30, P967; FREEMAN M, 1990, P NATL ACAD SCI USA, V87, P8810, DOI 10.1073/pnas.87.22.8810; FREEMAN M, 1991, P NATL ACAD SCI USA, V88, P4931, DOI 10.1073/pnas.88.11.4931; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; HABERLAND ME, 1989, J IMMUNOL, V142, P855; HAMPTON RY, 1991, NATURE, V352, P342, DOI 10.1038/352342a0; HOOVER GA, 1988, ARTERIOSCLEROSIS, V8, P525, DOI 10.1161/01.ATV.8.5.525; KINGSLEY DM, 1984, P NATL ACAD SCI-BIOL, V81, P5454, DOI 10.1073/pnas.81.17.5454; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; KODAMA T, 1988, P NATL ACAD SCI USA, V85, P9238, DOI 10.1073/pnas.85.23.9238; MATSUMOTO A, 1990, P NATL ACAD SCI USA, V87, P9133, DOI 10.1073/pnas.87.23.9133; MATSUZAWA Y, 1988, AM J CARDIOL, V62, pB6; MORIKAMI K, 1992, IN PRESS COMP CHEM; NAITO M, 1991, AM J PATHOL, V139, P1411; NAITO M, 1992, COMPUT CHEM, V16, P243; PENMAN M, 1991, J BIOL CHEM, V266, P23985; PHILLIPS DR, 1985, NATURE, V316, P746, DOI 10.1038/316746a0; ROHRER L, 1990, NATURE, V343, P570, DOI 10.1038/343570a0; SAENGER W, 1984, PRINCIPLES NUCLEIC A, P69; SPARROW CP, 1989, J BIOL CHEM, V264, P2599; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEINBRECHER UP, 1989, J BIOL CHEM, V264, P15216; STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883; SUSSMAN DJ, 1984, MOL CELL BIOL, V4, P1641, DOI 10.1128/MCB.4.8.1641; TERASAKI T, 1989, J PHARMACOL EXP THER, V251, P351; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WILEY HS, 1982, J BIOL CHEM, V257, P4222; WRIGHT SD, 1991, CURR OPIN IMMUNOL, V3, P83, DOI 10.1016/0952-7915(91)90082-C; YAMAMOTO A, 1986, AM J CARDIOL, V57, pH29, DOI 10.1016/0002-9149(86)90434-0; YLA HS, 1991, ANN MED, V23, P561; YLA HS, 1991, J CLIN INVEST, V87, P1146; YONATH A, 1969, J MOL BIOL, V43, P461, DOI 10.1016/0022-2836(69)90352-0	36	222	236	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2126	2133						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380589				2022-12-27	WOS:A1993KH62000094
J	YUN, CHC; GURUBHAGAVATULA, S; LEVINE, SA; MONTGOMERY, JLM; BRANT, SR; COHEN, ME; CRAGOE, EJ; POUYSSEGUR, J; TSE, CM; DONOWITZ, M				YUN, CHC; GURUBHAGAVATULA, S; LEVINE, SA; MONTGOMERY, JLM; BRANT, SR; COHEN, ME; CRAGOE, EJ; POUYSSEGUR, J; TSE, CM; DONOWITZ, M			GLUCOCORTICOID STIMULATION OF ILEAL NA+ ABSORPTIVE CELL BRUSH-BORDER NA+ H+ EXCHANGE AND ASSOCIATION WITH AN INCREASE IN MESSAGE FOR NHE-3, AN EPITHELIAL NA+ H+ EXCHANGER ISOFORM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-VESICLES; ELECTROLYTE TRANSPORT; CHLORIDE TRANSPORT; MOLECULAR-CLONING; RABBIT; METHYLPREDNISOLONE; EXPRESSION; ANTIPORTER; INHIBITION; INVITRO	Methylprednisolone stimulates rabbit ileal neutral NaCl absorption; and aminoglutethimide, which decreases glucocorticoid levels, decreases NaCl absorption. Studies were carried out to determine the mechanism of these effects and to determine which members of the gene family of mammalian Na+/H+ exchangers were involved. Rabbits were treated subcutaneously with methylprednisolone (40 mg daily for 24 or 72 h), aminoglutethimide (100 mg twice daily for 72 h), or saline as a control. Ileal brush border membranes were prepared by magnesium precipitation, and brush border Na+/H+ exchange was determined by Na-22+ uptake over 3-8 s. The Na-22+ uptake experiments were performed in the presence of a voltage clamp using either valinomycin/potassium or tetramethylammonium/nitrate to eliminate potential contributions by other electrogenic transport processes. Methylprednisolone treatment approximately doubled ileal brush border Na+/H+ exchange, whereas aminoglutethimide led to a 50% decrease in Na+/H+ exchange. These effects were specifically on Na+ uptake with an acid inside pH gradient, whereas diffusive Na+ uptake (no pH gradient), glucose-dependent Na+ uptake, and glucose and Na+ equilibrium volumes were not affected. To determine if the increase in Na+/H+ exchange was associated with an increase in message expression, mRNA levels were measured by ribonuclease protection assay. Methylprednisolone stimulated the NHE-3 mRNA level by 4-6-fold at 24 h, which remained increased at 72 h. In contrast, messages for NHE-1 and NHE-2 were not affected by methylprednisolone. In summary, 1) methylprednisolone stimulation of rabbit ileal Na+ absorption is due to stimulation of ileal villus cell brush border Na+/H+ exchange; 2) basal ileal brush border Na+/H+ exchange is dependent on glucocorticoid levels; and 3) an increase in NHE-3 message, but not in NHE-1 or NHE-2 message, correlates with the stimulation of ileal brush border Na+/H+ exchange. It is likely that NHE-3 is an Na+/H+ exchanger that is involved in ileal Na+ absorption.	JOHNS HOPKINS UNIV,SCH MED,DEPT PHYSIOL,DIV GASTROENTEROL,BALTIMORE,MD 21205; CTR BIOCHIM,CNRS,F-06034 NICE,FRANCE	Johns Hopkins University; Centre National de la Recherche Scientifique (CNRS)	YUN, CHC (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT MED,DIV GASTROENTEROL,BALTIMORE,MD 21205, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026523, R29DK043778, T32DK007632] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01DK26523, R29DK43778, T32DK07632] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASCOLI M, 1983, ENDOCRINOLOGY, V113, P127, DOI 10.1210/endo-113-1-127; BECK JC, 1978, J BIOL CHEM, V253, P7158; CHARNEY AN, 1982, AM J PHYSIOL, V243, pG112, DOI 10.1152/ajpgi.1982.243.2.G112; CHARNEY AN, 1975, J CLIN INVEST, V56, P653, DOI 10.1172/JCI108135; CHARNEY AN, 1976, J CLIN INVEST, V57, P1590, DOI 10.1172/JCI108429; COHEN ME, 1991, J CLIN INVEST, V88, P855, DOI 10.1172/JCI115387; FREIBERG JM, 1982, P NATL ACAD SCI-BIOL, V79, P4932, DOI 10.1073/pnas.79.16.4932; GRAVES PE, 1979, ENDOCRINOLOGY, V105, P52, DOI 10.1210/endo-105-1-52; GREINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73; GUNTHER RD, 1984, J MEMBRANE BIOL, V78, P119, DOI 10.1007/BF01869199; HAGGERTY C, 1988, P NATL ACAD SCI USA, V88, P6797; KNICKELBEIN R, 1985, AM J PHYSIOL, V249, pG236, DOI 10.1152/ajpgi.1985.249.2.G236; KNICKELBEIN R, 1983, AM J PHYSIOL, V245, pG504, DOI 10.1152/ajpgi.1983.245.4.G504; KNICKELBEIN RG, 1990, AM J PHYSIOL, V259, pG802, DOI 10.1152/ajpgi.1990.259.5.G802; ROOD RP, 1988, J CLIN INVEST, V82, P1091, DOI 10.1172/JCI113665; SARDET C, 1990, SCIENCE, V247, P723, DOI 10.1126/science.2154036; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; SELLIN JH, 1981, J CLIN INVEST, V67, P770, DOI 10.1172/JCI110094; TAI YH, 1981, AM J PHYSIOL, V240, pG365, DOI 10.1152/ajpgi.1981.240.5.G365; TSE C M, 1991, Gastroenterology, V100, pA258; TSE CM, 1991, EMBO J, V10, P1957, DOI 10.1002/j.1460-2075.1991.tb07725.x; TSE CM, 1992, J BIOL CHEM, V267, P9340; VINCENTINI LM, 1985, P NATL ACAD SCI USA, V82, P8053	23	124	125	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					206	211						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380155				2022-12-27	WOS:A1993KE60300032
J	CAMAIONI, A; HASCALL, VC; YANAGISHITA, M; SALUSTRI, A				CAMAIONI, A; HASCALL, VC; YANAGISHITA, M; SALUSTRI, A			EFFECTS OF EXOGENOUS HYALURONIC-ACID AND SERUM ON MATRIX ORGANIZATION AND STABILITY IN THE MOUSE CUMULUS CELL-OOCYTE COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TRYPSIN INHIBITOR; MURAL GRANULOSA-CELLS; PLASMINOGEN-ACTIVATOR; EXTRACELLULAR-MATRIX; ACROSOME REACTION; GOLDEN-HAMSTER; ZONA PELLUCIDA; RAT OOCYTES; INVITRO; FERTILIZATION	Compact cumulus cell-oocyte complexes (COCs) isolated from preovulatory mouse follicles undergo expansion in vitro when high levels of hyaluronic acid (HA) are synthesized and organized into an extracellular matrix. We studied the effects of fetal bovine serum (FBS) and of exogenous HA and HA-oligomers on the expansion process. Maximum retention of HA in the COC matrix, and hence complete COC expansion, occurs when 1% FBS is continuously present during the first 18 h of culture. Irrespective of the culture time, HA synthesized when serum is absent is primarily in the medium, whereas HA synthesized when serum is present is primarily in the cell matrix. These findings support the hypothesis that the serum factor, identified as an inter-alpha-trypsin inhibitor by Chen et al. (Chen, L., Mao, S. J., and Larsen, W. J. (1992) J. Biol. Chem. 267, 12380-12386), is a structural component of the matrix. Addition of exogenous HA or of HA oligomers of decasaccharide size (GlcUA-GlcNAc)5 or larger effectively displaces endogenously synthesized HA from the matrix into the medium, thereby preventing COC expansion. Addition of exogenous chondroitin sulfate affects neither matrix organization nor COC expansion, thus indicating specificity of the binding of some structural component(s) to HA. Fully expanded, COCs disassemble when cultured longer than 18 h, a process which occurs also in vivo and which correlates with loss of oocyte fertilizability both in vivo and in vitro. This process involves release of macromolecular HA from the matrix into the medium, with loss of 50% of the HA in the first 8 h of incubation after full expansion. The release is not facilitated when HA oligomers, long enough to prevent matrix formation, are added to the culture medium after the COCs are fully expanded. This suggests that cooperative binding to HA of either the serum factor, an endogenously synthesized factor(s), or both is required to stabilize the fully expanded COC matrix.	NIDR, BONE RES BRANCH, BLDG 30, RM 106, BETHESDA, MD 20892 USA; UNIV ROMA TOR VERGATA, FAC MED, DEPT SANITA PUBBL & BIOL CELLULARE, I-00173 ROME, ITALY	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Rome Tor Vergata			Camaioni, Antonella/AAB-5294-2020; Camaioni, Antonella/AAB-5285-2020	Camaioni, Antonella/0000-0002-7059-2617; Camaioni, Antonella/0000-0002-7059-2617; SALUSTRI, ANTONIETTA/0000-0002-8731-1041				BUCCIONE R, 1990, DEV BIOL, V138, P16, DOI 10.1016/0012-1606(90)90172-F; CANIPARI R, 1987, J CELL BIOL, V105, P977, DOI 10.1083/jcb.105.2.977; CASTILLO GM, 1993, FEBS LETT, V318, P292, DOI 10.1016/0014-5793(93)80531-X; CHEN L, 1993, MOL REPROD DEV, V34, P87, DOI 10.1002/mrd.1080340114; CHEN L, 1992, J BIOL CHEM, V267, P12380; CHERR GN, 1990, DEV GROWTH DIFFER, V32, P353; CULTY M, 1990, J CELL BIOL, V111, P2765, DOI 10.1083/jcb.111.6.2765; DANDEKAR P, 1992, MOL REPROD DEV, V31, P135, DOI 10.1002/mrd.1080310208; DEFELICI M, 1982, GAMETE RES, V6, P107, DOI 10.1002/mrd.1120060203; DEKEL N, 1978, ENDOCRINOLOGY, V102, P1797, DOI 10.1210/endo-102-6-1797; DEKEL N, 1979, BIOL REPROD, V20, P191, DOI 10.1095/biolreprod20.2.191; DEKEL N, 1979, BIOL REPROD, V21, P9, DOI 10.1095/biolreprod21.1.9; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; EPPIG JJ, 1980, BIOL REPROD, V22, P629, DOI 10.1093/biolreprod/22.3.629; EPPIG JJ, 1979, J EXP ZOOL, V208, P111, DOI 10.1002/jez.1402080112; EPPIG JJ, 1979, NATURE, V281, P483, DOI 10.1038/281483a0; FUKUI Y, 1990, MOL REPROD DEV, V26, P40, DOI 10.1002/mrd.1080260107; HASCALL VC, 1974, J BIOL CHEM, V249, P4242; HERP A, 1980, CARBOHYDRATES CHEM B, V1, P1276; HUARTE J, 1985, CELL, V43, P551, DOI 10.1016/0092-8674(85)90184-9; HUTADILOK N, 1988, ANN RHEUM DIS, V47, P377, DOI 10.1136/ard.47.5.377; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; MAHIBROWN CA, 1983, GAMETE RES, V8, P1, DOI 10.1002/mrd.1120080102; MARSTON JH, 1964, J EXP ZOOL, V155, P237, DOI 10.1002/jez.1401550211; MEIZEL S, 1985, AM J ANAT, V174, P285, DOI 10.1002/aja.1001740309; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; SALUSTRI A, 1989, J BIOL CHEM, V264, P13840; SALUSTRI A, 1990, J BIOL CHEM, V265, P19517; SALUSTRI A, 1990, DEV BIOL, V138, P26, DOI 10.1016/0012-1606(90)90173-G; SALUSTRI A, 1992, DEV BIOL, V151, P541, DOI 10.1016/0012-1606(92)90192-J; TALBOT P, 1984, GAMETE RES, V10, P127, DOI 10.1002/mrd.1120100205; UCHIYAMA H, 1990, J BIOL CHEM, V265, P7753; VANDERHYDEN BC, 1989, BIOL REPROD, V40, P720, DOI 10.1095/biolreprod40.4.720; YANAGISHITA M, 1979, J BIOL CHEM, V254, P911; YANAGISHITA M, 1989, METHOD ENZYMOL, V179, P435; YONEDA M, 1990, J BIOL CHEM, V265, P5247; YUDIN AI, 1988, CELL TISSUE RES, V251, P555, DOI 10.1007/BF00214003	37	112	116	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20473	20481						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376402				2022-12-27	WOS:A1993LY01900080
J	LIN, XL; TANG, J; KOELSCH, G; MONOD, M; FOUNDLING, S				LIN, XL; TANG, J; KOELSCH, G; MONOD, M; FOUNDLING, S			RECOMBINANT CANDITROPSIN, AN EXTRACELLULAR ASPARTIC PROTEASE FROM YEAST CANDIDA-TROPICALIS - ESCHERICHIA-COLI EXPRESSION, PURIFICATION, ZYMOGEN ACTIVATION, AND ENZYMATIC-PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL CUTANEOUS CANDIDIASIS; PROTEINASE-DEFICIENT MUTANT; PROTEOLYTIC ACTIVITY; SYSTEMIC CANDIDOSIS; ACID PROTEINASE; ALBICANS; PEPSINOGEN; VIRULENCE; PATHOGENESIS; SUBSTRATE	A cDNA fragment which encodes the zymogen of canditropsin, the extracellular aspartic protease from the yeast Candida tropicalis (Togni, G., Sanglard, D., Falchetto, R., and Monod, M. (1991) FEBS Lett. 2 86, 181-185) was cloned into a T7 expression vector for the synthesis of the recombinant zymogen in Escherichia coli. Recombinant canditropsinogen (Ctg), which was expressed as inclusion bodies in the cytosol of E. coli, was refolded by dialysis from an 8 m urea solution and purified to homogeneity using chromatographies on Sephacryl S-300 and on MonoQ columns. The purified Ctg was converted into canditropsin by either acid activation or trypsin conversion. The specificity of the resulting recombinant canditropsin toward polypeptide substrates is significantly different from other aspartic proteases. Canditropsin hydrolyzes oxidized insulin B chain between Ala-Leu and many other minor cleavage sites. Canditropsin also hydrolyzes keratin and collagen, which are components of connective tissues known to be hydrolyzed by canditropsin during Candida infections. Canditropsin was strongly inhibited by the universal aspartic protease inhibitor pepstatin (K(i) = 1.75 x 10(-8) M) and inactivated by two aspartic protease inactivators, DAN and EPNP. Canditropsin is weakly inhibited by leupeptin and antipain, with an apparent K(i) of 1.74 x 10(-4) M and 1.5 x 10(-5) M, respectively.	UNIV OKLAHOMA HLTH SCI CTR, HLTH SCI CTR, DEPT BIOCHEM & MOLEC BIOL, OKLAHOMA CITY, OK 73104 USA; CHU VAUDOIS, SERV DERMATOL, MYCOL LAB, CH-1011 LAUSANNE, SWITZERLAND	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	LIN, XL (corresponding author), OKLAHOMA MED RES FDN, PROT STUDIES PROGRAM, 825 NE 13TH ST, OKLAHOMA CITY, OK 73104 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI034273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK001107] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-34273] Funding Source: Medline; NIDDK NIH HHS [DK-01107] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALJANABI J, 1972, J BIOL CHEM, V247, P4628; BIETH J, 1974, PROTEINASE INHIBITOR, P463; CAPOBIANCO JO, 1992, ANAL BIOCHEM, V204, P96, DOI 10.1016/0003-2697(92)90145-W; CHEN Z, 1991, J BIOL CHEM, V266, P11718; FUSEK M, 1990, J BIOL CHEM, V265, P1496; Herriott RM, 1938, J GEN PHYSIOL, V22, P65, DOI 10.1085/jgp.22.1.65; KONDOH Y, 1987, MICROBIOL IMMUNOL, V31, P1061, DOI 10.1111/j.1348-0421.1987.tb01338.x; KYUNG JKC, 1985, INFECT IMMUN, V49, P571, DOI 10.1128/IAI.49.3.571-575.1985; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN XL, 1989, J BIOL CHEM, V264, P4482; LIN XL, 1992, J BIOL CHEM, V267, P17257; MACDONALD F, 1983, J GEN MICROBIOL, V129, P431; MACDONALD F, 1980, JAMA-J AM MED ASSOC, V243, P2409, DOI 10.1001/jama.243.23.2409; MACDONALD F, 1980, J MED MICROBIOL, V13, P423, DOI 10.1099/00222615-13-3-423; MACRINISZYN J, 1976, J BIOL CHEM, V251, P7088; NEGI M, 1984, J INVEST DERMATOL, V83, P32, DOI 10.1111/1523-1747.ep12261656; RAY TL, 1990, CLIN RES, V38, pA687; RAY TL, 1976, J INVEST DERMATOL, V66, P29, DOI 10.1111/1523-1747.ep12478053; RAY TL, 1990, INFECT IMMUN, V58, P508, DOI 10.1128/IAI.58.2.508-514.1990; RAY TL, 1987, CLIN RES, V35, pA711; RAY TL, 1978, ARCH DERMATOL, V114, P539, DOI 10.1001/archderm.114.4.539; REMOLD H, 1968, BIOCHIM BIOPHYS ACTA, V167, P399, DOI 10.1016/0005-2744(68)90219-2; ROSS IK, 1990, J GEN MICROBIOL, V136, P687, DOI 10.1099/00221287-136-4-687; RUCHEL R, 1982, SABOURAUDIA, V20, P233; RUCHEL R, 1983, ZBL BAKT-INT J MED M, V255, P524, DOI 10.1016/S0174-3031(83)80012-2; RUCHEL R, 1988, MYCOSES, V31, P87, DOI 10.1111/j.1439-0507.1988.tb03862.x; RUCHEL R, 1986, INFECT IMMUN, V53, P411; RUCHEL R, 1981, BIOCHIM BIOPHYS ACTA, V659, P99, DOI 10.1016/0005-2744(81)90274-6; SAMARANAYAKE LP, 1983, MICROBIOS, V37, P105; SCHREIBER B, 1985, DIAGN MICR INFEC DIS, V3, P1, DOI 10.1016/0732-8893(85)90060-4; STAIB F, 1969, MYCOPATH MYCOL APPL, V37, P345, DOI 10.1007/BF02129881; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TOGNI G, 1991, FEBS LETT, V286, P181, DOI 10.1016/0014-5793(91)80969-A; Umezawa H, 1976, Methods Enzymol, V45, P678; 1985, SAS USERS GUIDE STAT	35	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20143	20147						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376373				2022-12-27	WOS:A1993LY01900035
J	PEREZCASTILLO, A; PIPAON, C; GARCIA, I; ALEMANY, S				PEREZCASTILLO, A; PIPAON, C; GARCIA, I; ALEMANY, S			NGFI-A GENE-EXPRESSION IS NECESSARY FOR T-LYMPHOCYTE PROLIFERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; FINGER-ENCODING GENE; SERUM GROWTH-FACTORS; C-FOS; PROTEIN-KINASE; CYCLOSPORINE-A; RETINOIC ACID; MESSENGER-RNA; 3T3 CELLS; ACTIVATION	NGFI-A is an immediate early gene, encoding a zinc finger protein, rapidly activated after mitogenic stimulation. NGFI-A gene expression was found to be rapidly and transiently induced after interleukin-2 (IL-2) stimulation of G1 lymphoblasts, as well as during the G0/G1 transition, when stimulated with concanavalin A (ConA). Activation of both Ca2+ and protein kinase C pathways, separately, in quiescent T lymphocytes produced a partial induction of this gene; however, both stimuli together are necessary to obtain a full response. ConA- induced activation of NGFI-A in quiescent cells was inhibited by immunosuppressors. 8-Bromo-cAMP was able to inhibit the expression of this gene in G1 lymphoblasts after IL-2 stimulation, but failed to interfere with the ConA-induced expression in quiescent T lymphocytes. Exposure of T cells to an NGFI-A antisense oligonucleotide blocked the ConA- and IL-2-induced proliferation of the cells, measured as thymidine incorporation and cell number. This inhibition provides direct evidence that the early gene NGFI-A plays a regulatory role in growth control processes of lymphocytes and that its expression is essential for cellular proliferation.	UNIV AUTONOMA MADRID,FAC MED,E-28029 MADRID,SPAIN	Autonomous University of Madrid	PEREZCASTILLO, A (corresponding author), CSIC,INST INVEST BIOMED,ARTURO DUPERIER 4,E-28029 MADRID,SPAIN.		Pipaon, Carlos/L-4922-2014; Perez-Castillo, Ana/A-9505-2015; Alemany, Susana/J-6307-2014	Pipaon, Carlos/0000-0002-3851-6710; Alemany, Susana/0000-0002-4089-7620; Perez-Castillo, Ana/0000-0002-2632-5853				ACKERMAN SL, 1991, P NATL ACAD SCI USA, V88, P7523, DOI 10.1073/pnas.88.17.7523; ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; BAKER PE, 1981, CELL IMMUNOL, V61, P52, DOI 10.1016/0008-8749(81)90353-1; BALDARI CT, 1991, J BIOL CHEM, V266, P19103; BAUGHMAN G, 1991, MOL ENDOCRINOL, V5, P637, DOI 10.1210/mend-5-5-637; BIERER BE, 1990, P NATL ACAD SCI USA, V87, P9231, DOI 10.1073/pnas.87.23.9231; CAO XM, 1990, MOL CELL BIOL, V10, P1931, DOI 10.1128/MCB.10.5.1931; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; COOKE MP, 1991, CELL, V65, P281, DOI 10.1016/0092-8674(91)90162-R; DARLAND T, 1991, ONCOGENE, V6, P1367; DUMONT FJ, 1990, J IMMUNOL, V144, P251; EASTMANREKS SB, 1986, CANCER RES, V46, P2457; EDWARDS SA, 1991, DEV BIOL, V148, P165, DOI 10.1016/0012-1606(91)90327-Y; FARRAR WL, 1987, J IMMUNOL, V139, P2075; FEDER JN, 1990, J CELL BIOL, V111, P2693, DOI 10.1083/jcb.111.6.2693; GARCIA MI, 1992, LYMPHOKINE RES, V11, P23; GEWIRTZ AM, 1989, SCIENCE, V245, P180, DOI 10.1126/science.2665077; HERSCHMAN HR, 1989, TRENDS BIOCHEM SCI, V14, P455, DOI 10.1016/0968-0004(89)90105-9; HOLT JT, 1988, MOL CELL BIOL, V8, P963, DOI 10.1128/MCB.8.2.963; JOHNSON KW, 1988, P NATL ACAD SCI USA, V85, P6072, DOI 10.1073/pnas.85.16.6072; JULIUS MH, 1973, EUR J IMMUNOL, V3, P645, DOI 10.1002/eji.1830031011; KAMMER GM, 1988, IMMUNOL TODAY, V9, P222, DOI 10.1016/0167-5699(88)91220-0; KLAUS SJ, 1992, J IMMUNOL, V149, P1867; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; LIM RW, 1987, ONCOGENE, V1, P263; LINGK DS, 1990, J IMMUNOL, V145, P449; MATTILA PS, 1990, EMBO J, V9, P4425, DOI 10.1002/j.1460-2075.1990.tb07893.x; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MULLER HJ, 1991, P NATL ACAD SCI USA, V88, P10079, DOI 10.1073/pnas.88.22.10079; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NGUYEN HQ, 1993, CELL, V72, P197, DOI 10.1016/0092-8674(93)90660-I; NOSE K, 1991, EUR J BIOCHEM, V201, P99, DOI 10.1111/j.1432-1033.1991.tb16261.x; PIPAON C, 1992, J BIOL CHEM, V267, P21, DOI 10.1016/S0021-9258(18)48449-9; PREISS A, 1985, NATURE, V313, P27, DOI 10.1038/313027a0; REDONDO JM, 1988, J BIOL CHEM, V263, P17467; REED JC, 1986, P NATL ACAD SCI USA, V83, P3982, DOI 10.1073/pnas.83.11.3982; ROSENBERG UB, 1985, NATURE, V313, P703, DOI 10.1038/313703a0; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; SEYFERT VL, 1990, SCIENCE, V250, P797, DOI 10.1126/science.2237429; SEYFERT VL, 1989, MOL CELL BIOL, V9, P2083, DOI 10.1128/MCB.9.5.2083; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; SUVA LJ, 1991, MOL CELL BIOL, V11, P2503, DOI 10.1128/MCB.11.5.2503; TOCCI MJ, 1989, J IMMUNOL, V143, P718; VARNUM BC, 1989, MOL CELL BIOL, V9, P3580, DOI 10.1128/MCB.9.8.3580; VENTURELLI D, 1990, P NATL ACAD SCI USA, V87, P5963, DOI 10.1073/pnas.87.15.5963; WEISS A, 1984, P NATL ACAD SCI-BIOL, V81, P4169, DOI 10.1073/pnas.81.13.4169; WINGETT D, 1991, J IMMUNOL, V147, P3653; WISKOCIL R, 1985, J IMMUNOL, V134, P1599	53	62	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19445	19450						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366092				2022-12-27	WOS:A1993LW81900047
J	STACK, MS; PIZZO, SV				STACK, MS; PIZZO, SV			MODULATION OF TISSUE-PLASMINOGEN ACTIVATOR-CATALYZED PLASMINOGEN ACTIVATION BY SYNTHETIC PEPTIDES DERIVED FROM THE AMINO-TERMINAL HEPARIN-BINDING DOMAIN OF FIBRONECTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL CREST CELLS; AFFINITY-CHROMATOGRAPHY; EXTRACELLULAR-MATRIX; FIBRINOLYTIC SYSTEM; PLASMA FIBRONECTIN; MIGRATION; LAMININ; GLYCOPROTEIN; COLLAGEN; INVITRO	Fibronectin is a multidomain adhesive glycoprotein found in plasma, interstitial connective tissue, and basement membrane. Diverse biological activities have been associated with the fibronectin molecule including cell adhesion, cell migration, wound healing, hemostasis, and oncogenic transformation. Binding sites for heparin, fibrin, gelatin/collagen, and cells have been localized to various structural domains of the molecule. In addition, fibronectin also binds both plasminogen and tissue plasminogen activator (t-PA) via a 55-kDa amino-terminal fragment (Moser, T. L., Enghild, J. J., Pizzo, S. V., and Stack, M. S. (1993) J. Biol. Chem. 268, 18917-18923). Although intact fibronectin does not enhance the rate of t-PA-catalyzed plasminogen activation, a mixture of proteolytically degraded fibronectin fragments stimulates the activation reaction, resulting in an 11-fold increase in the k(cat)/K(m). Based on these observations, we have synthesized a variety of peptides derived from the plasminogen/t-PA binding region of fibronectin and determined the effect of these peptides on the initial rate kinetics of plasminogen activation by t-PA as well as on plasmin and t-PA amidolytic activity. Here we report that a specific octapeptide, SRNRCNDQ-NH2, consisting of residues 196-203 of the fibronectin molecule is a potent stimulator of t-PA-catalyzed plasminogen activation, resulting in a 15-fold increase in the k(cat)/K(m) of the activation reaction.			STACK, MS (corresponding author), DUKE UNIV,MED CTR,DEPT PATHOL,BOX 3712,DURHAM,NC 27710, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031932, F32HL008382] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-08382, HL-31932] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMBROSE JF, 1950, J AM CHEM SOC, V72, P317, DOI 10.1021/ja01157a083; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; BECKMANN R, 1991, J BIOL CHEM, V266, P2227; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; CASTELLINO FJ, 1981, CHEM REV, V81, P431, DOI 10.1021/cr00045a001; CHRISTENSEN U, 1984, BIOCHEM J, V223, P413, DOI 10.1042/bj2230413; CUATRECA.P, 1968, P NATL ACAD SCI USA, V61, P636, DOI 10.1073/pnas.61.2.636; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; DUFOUR S, 1988, EMBO J, V7, P2661, DOI 10.1002/j.1460-2075.1988.tb03119.x; GARCIAPARDO A, 1983, J BIOL CHEM, V258, P2670; GILBOA N, 1985, THROMB HAEMOSTASIS, V54, P639; GONZALEZGRONOW M, 1984, BIOCHEMISTRY-US, V23, P190, DOI 10.1021/bi00297a003; GREENBERG JH, 1981, DEV BIOL, V87, P259, DOI 10.1016/0012-1606(81)90149-4; HIGHSMITH RF, 1981, J BIOL CHEM, V256, P6788; HORMANN H, 1980, H-S Z PHYSIOL CHEM, V361, P1449; Hynes RO, 1990, FIBRONECTINS; KNOX P, 1986, J CELL BIOL, V102, P2318, DOI 10.1083/jcb.102.6.2318; KNUDSEN BS, 1986, J BIOL CHEM, V261, P765; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; LIOTTA LA, 1981, THROMB RES, V21, P663, DOI 10.1016/0049-3848(81)90268-1; MANGEL WF, 1990, SCIENCE, V248, P69, DOI 10.1126/science.2108500; MOSER TL, 1993, J BIOL CHEM, V268, P18912; NEWGREEN D, 1980, CELL TISSUE RES, V211, P269; NEWGREEN DF, 1982, CELL TISSUE RES, V221, P521; OSSOWSKI L, 1978, BIOL MARKERS NEOPLAS; REICH E, 1978, BIOL MARKERS NEOPLAS, P506; RUOSLAHTI E, 1981, J BIOL CHEM, V256, P7277; SALONEN EM, 1985, J BIOL CHEM, V260, P2302; SILVERSTEIN RL, 1985, J BIOL CHEM, V260, P346; SOTTRUPJENSEN L, 1978, PROGR CHEM FIBRINOLY, V3, P191; STACK S, 1991, BIOCHEMISTRY-US, V30, P2073, DOI 10.1021/bi00222a011; STACK S, 1990, BIOCHEMISTRY-US, V29, P4966, DOI 10.1021/bi00472a029; STRICKLAND S, 1976, CELL, V9, P231, DOI 10.1016/0092-8674(76)90114-8; VAHERI A, 1978, BIOCHIM BIOPHYS ACTA, V516, P1, DOI 10.1016/0304-419X(78)90002-1; VALI Z, 1982, J BIOL CHEM, V257, P2104; VARADI A, 1981, BIOCHEM BIOPH RES CO, V103, P97, DOI 10.1016/0006-291X(81)91665-X; WOHL RC, 1980, J BIOL CHEM, V255, P2005	37	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18924	18928						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360182				2022-12-27	WOS:A1993LV65900082
J	CLARKE, DM; LOO, TW; RICE, WJ; ANDERSEN, JP; VILSEN, B; MACLENNAN, DH				CLARKE, DM; LOO, TW; RICE, WJ; ANDERSEN, JP; VILSEN, B; MACLENNAN, DH			FUNCTIONAL CONSEQUENCES OF ALTERATIONS TO HYDROPHOBIC AMINO-ACIDS LOCATED IN THE M(4) TRANSMEMBRANE SECTOR OF THE CA2+-ATPASE OF SARCOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; ADENOSINE-TRIPHOSPHATASE; MULTIPLE METALS; CA-2+-ATPASE; ATPASE; MUTATIONS; CA-2+; CELLS; TRANSPORT; PROGRAMS	Those hydrophobic residues between Ile298 and Ile315 in transmembrane segment M4 of the Ca2+-ATPase of sarcoplasmic reticulum, not previously mutated, were mutated systematically in ways that would alter their size or polarity, and functional consequences were measured. Fourteen residues in this sequence are organized as juxtapositions of large, hydrophobic (Val, Leu, Ile) and small (Ala, Gly) residues, and these were altered so that large residues were substituted for small and vice versa. Several mutants exhibited diminished Ca2+ transport, but mutants A305V and A306V lost all Ca2+ transport function. In both cases, the mutants were phosphorylated with ATP in the presence of Ca2+ and with inorganic phosphate only in the absence of Ca2+, indicating that the Ca2+-binding sites were intact. Reduced Ca2+ affinity, as measured by Ca2+ dependence of phosphorylation from ATP, was observed for mutant A305V. In both mutants, the ADP-insensitive phosphoenzyme intermediate (E2P) decayed slowly relative to the wild-type enzyme, suggesting that the E2P to E2 conformational transition was impaired, slowing the rate of the phosphatase reaction. Double mutants which reversed the order of Val304 and Ala305 and Ala306 and Ile307, resulted in the same phenotype as the single Ala mutations. These results, combined with our previous demonstration that Glu309 is a Ca2+ binding residue, that Pro312 is involved in E1P to E2P conformational changes, and that Gly310 is involved in E2P to E2 conformational changes, support the hypothesis that transmembrane segment M4 plays a key role in the Ca2+ transport function of the Ca2+-ATPase through its involvement in both the binding of Ca2+ and the subsequent conformational changes which bring about the translocation of Ca2+ to the lumen of the membrane.	UNIV TORONTO, CHARLES H BEST INST, BANTING & BEST DEPT MED RES, 112 COLL ST, TORONTO M5G 1L6, ONTARIO, CANADA; AARHUS UNIV, INST PHYSIOL, DANISH BIOMEMBRANE RES CTR, DK-8000 AARHUS, DENMARK	University of Toronto; Aarhus University			Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Andersen, Jens Peter/0000-0003-0654-4300; Vilsen, Bente/0000-0002-4727-9382; Rice, William/0000-0002-5187-255X; Loo, Tip W/0000-0003-2108-0188				ANDERSEN JP, 1992, J BIOL CHEM, V267, P2767; ANDERSEN JP, 1989, J BIOL CHEM, V264, P21018; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; CLARKE DM, 1990, J BIOL CHEM, V265, P6262; CLARKE DM, 1989, J BIOL CHEM, V264, P11246; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; CLARKE DM, 1990, J BIOL CHEM, V265, P22223; CLARKE DM, 1990, J BIOL CHEM, V265, P14088; de Meis L, 1974, Biochemistry, V13, P2057, DOI 10.1021/bi00707a009; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; INESI G, 1985, ANNU REV PHYSIOL, V47, P573, DOI 10.1146/annurev.ph.47.030185.003041; INESI G, 1985, ENZYMES BIOL MEMBR, V3, P157; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MACLENNA.DH, 1970, J BIOL CHEM, V245, P4508; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MARUYAMA K, 1989, J BIOL CHEM, V264, P13038; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; PETITHORY JR, 1988, BIOCHEMISTRY-US, V27, P5553, DOI 10.1021/bi00415a025; SERRANO R, 1988, BIOCHIM BIOPHYS ACTA, V947, P1, DOI 10.1016/0304-4157(88)90017-2; VILSEN B, 1991, J BIOL CHEM, V266, P18839; VILSEN B, 1989, J BIOL CHEM, V264, P21024; WEBER K, 1969, J BIOL CHEM, V244, P4406; WONG GG, 1985, SCIENCE, V228, P810, DOI 10.1126/science.3923623; ZUBRZYCKAGAARN E, 1984, J BIOENERG BIOMEMBR, V16, P441, DOI 10.1007/BF00743238	31	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18359	18364						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349711				2022-12-27	WOS:A1993LT74300104
J	LUTHRA, M; BALASUBRAMANIAN, D				LUTHRA, M; BALASUBRAMANIAN, D			NONENZYMATIC GLYCATION ALTERS PROTEIN-STRUCTURE AND STABILITY - A STUDY OF 2 EYE LENS CRYSTALLINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NON-ENZYMATIC GLYCOSYLATION; ALPHA-CRYSTALLIN; GAMMA-CRYSTALLINS; CROSS-LINKING; MAILLARD REACTION; BETA-CRYSTALLINS; END-PRODUCTS; CONFORMATIONAL STABILITY; TERTIARY STRUCTURE; DIABETES-MELLITUS	We have investigated the effect of nonenzymatic glycation (fructation) in vitro on the structure and stability of two proteins that are glycated in vivo as a consequence of high endogenous levels of sugar. We find that whereas fructation leads to the structural destabilization of the monomeric gamma-crystallin from the core of the eye lens, it leads to an increase in stability in the multimeric alpha-crystallin of the lens cortex. Thus, while glycated gamma-crystallin shows (a) a longer wavelength of fluorescent emission, indicating a greater exposure of its aromatic side chains to the medium; (b) a reduced secondary structural content; and (c) a more facile denaturation by thermodynamic and chemical means, alpha-crystallin displays the opposite behavior. Furthermore, alpha-crystallin shows an increased tendency toward multimeric aggregation upon fructation. We interpret these differences in the broad context of the effects of neutralization of positive charges on protein structure and stability. Fructation tends to destabilize gamma-crystallin, by effecting a significant reversal in the balance of charges in the protein, at physiological pH. Alpha-crystallin is a multimeric protein whose pl is lower than its pH of optimum stability. Fructation in this case effectively neutralizes the cationic charges and promotes conformational order. This study indicates that although glycation brings about similar changes in the covalent chemical structures of proteins, its influence on the three-dimensional structures of different proteins can be different.	CTR CELLULAR & MOLEC BIOL, UPPAL RD, HYDERABAD 500007, INDIA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)			Luthra-Guptasarma, Manni/A-7558-2011	Luthra-Guptasarma, Manni/0000-0002-2740-887X				ABRAHAM EC, 1989, MAILLARD REACTION AG, P123; AHMED N, 1991, ANAL BIOCHEM, V192, P109, DOI 10.1016/0003-2697(91)90193-W; ARAKI N, 1992, J BIOL CHEM, V267, P10211; AUGUSTEYN RC, 1988, BIOCHIM BIOPHYS ACTA, V957, P192, DOI 10.1016/0167-4838(88)90272-5; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Baynes J. W., 1989, MAILLARD REACTION AG, P43; BENEDEK GB, 1971, APPL OPTICS, V10, P459, DOI 10.1364/AO.10.000459; BETTELHEIM FA, 1983, BIOPHYS J, V41, P29, DOI 10.1016/S0006-3495(83)84402-6; BROWNLEE M, 1986, SCIENCE, V232, P1629, DOI 10.1126/science.3487117; BUNN HF, 1981, SCIENCE, V213, P222, DOI 10.1126/science.12192669; CERAMI A, 1986, J CELL BIOCHEM, V30, P111, DOI 10.1002/jcb.240300203; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; ELBE AS, 1983, J BIOL CHEM, V258, P9406; FERSHT AR, 1972, J MOL BIOL, V64, P497, DOI 10.1016/0022-2836(72)90513-X; GABBAY KH, 1972, ISRAEL J MED SCI, V8, P1557; GALLOP PM, 1981, ANAL BIOCHEM, V117, P427, DOI 10.1016/0003-2697(81)90802-2; GUPTASARMA P, 1992, BIOCHEMISTRY-US, V31, P4296, DOI 10.1021/bi00132a021; HAMLIN CR, 1975, DIABETES, V24, P902, DOI 10.2337/diabetes.24.10.902; HAYASE F, 1989, J BIOL CHEM, V264, P3758; HOENDERS HJ, 1981, MOL CELLULAR BIOL EY, P279; HONIG BH, 1986, ANNU REV BIOPHYS BIO, V15, P163; HORIUCHI S, 1991, J BIOL CHEM, V266, P7329; KOHN RR, 1987, CLIN PHARM ELDERLY, P3; KONO M, 1990, BIOCHEMISTRY-US, V29, P464, DOI 10.1021/bi00454a022; KRANTZ S, 1986, EXP CLIN ENDOCRINOL, V88, P257, DOI 10.1055/s-0029-1210605; LEE HS, 1979, J AGR FOOD CHEM, V27, P1094, DOI 10.1021/jf60225a045; LIANG J, 1981, BIOCHEM BIOPH RES CO, V102, P180, DOI 10.1016/0006-291X(81)91505-9; LIANG JN, 1984, BIOCHEM BIOPH RES CO, V123, P899; LIANG JN, 1987, INVEST OPHTH VIS SCI, V28, P790; LIANG JN, 1990, EXP EYE RES, V50, P367, DOI 10.1016/0014-4835(90)90137-J; LINDLEY PF, 1985, OCULAR LENS STRUCTUR, P123; LUTHRA M, 1991, MOL CONFORMATIONS BI, P281; MAITI M, 1988, FEBS LETT, V236, P109, DOI 10.1016/0014-5793(88)80295-3; MAKITA Z, 1992, J BIOL CHEM, V267, P5133; MANDAL K, 1985, BIOCHIM BIOPHYS ACTA, V832, P156, DOI 10.1016/0167-4838(85)90327-9; MANDAL K, 1987, J BIOL CHEM, V262, P8096; MCPHERSON JD, 1988, BIOCHEMISTRY-US, V27, P1901, DOI 10.1021/bi00406a016; MONNIER VM, 1988, DIABETES, V37, P867, DOI 10.2337/diabetes.37.7.867; MONNIER VM, 1979, J EXP MED, V150, P1098, DOI 10.1084/jem.150.5.1098; NJOROGE FG, 1989, MAILLARD REACTION AG, P85; Nozaki Y, 1972, Methods Enzymol, V26, P43; PACE C N, 1975, Critical Reviews in Biochemistry, V3, P1, DOI 10.3109/10409237509102551; PACE CN, 1990, TRENDS BIOCHEM SCI, V15, P14, DOI 10.1016/0968-0004(90)90124-T; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; PERRY RE, 1987, EXP EYE RES, V44, P269, DOI 10.1016/S0014-4835(87)80011-8; PONGOR S, 1984, P NATL ACAD SCI-BIOL, V81, P2684, DOI 10.1073/pnas.81.9.2684; RAO CM, 1991, BIOCHEM BIOPH RES CO, V176, P1351, DOI 10.1016/0006-291X(91)90435-A; RUSSO G, 1992, BIOCHEMISTRY-US, V31, P9279, DOI 10.1021/bi00153a022; SCHNIDER SL, 1981, J CLIN INVEST, V67, P1630, DOI 10.1172/JCI110198; SHARMA Y, 1989, J BIOL CHEM, V264, P12794; STEVENS VJ, 1978, P NATL ACAD SCI USA, V75, P2918, DOI 10.1073/pnas.75.6.2918; STIGTER D, 1990, BIOCHEMISTRY-US, V29, P1262, DOI 10.1021/bi00457a023; SUAREZ G, 1989, J BIOL CHEM, V264, P3674; SWAMY MS, 1991, EXP EYE RES, V52, P439, DOI 10.1016/0014-4835(91)90040-L; SWAMY MS, 1987, FASEB J, V46, P2153; SZWERGOLD BS, 1990, SCIENCE, V247, P451, DOI 10.1126/science.2300805; VANBOEKEL MAM, 1991, EXP EYE RES, V53, P89, DOI 10.1016/0014-4835(91)90149-9; VLASSARA H, 1987, J EXP MED, V166, P539, DOI 10.1084/jem.166.2.539; WADA A, 1981, NATURE, V293, P757, DOI 10.1038/293757a0; WALSH MT, 1991, J BIOL CHEM, V266, P20079; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	61	117	119	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18119	18127						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349689				2022-12-27	WOS:A1993LT74300071
J	KNEHR, M; THOMAS, H; ARAND, M; GEBEL, T; ZELLER, HD; OESCH, F				KNEHR, M; THOMAS, H; ARAND, M; GEBEL, T; ZELLER, HD; OESCH, F			ISOLATION AND CHARACTERIZATION OF A CDNA-ENCODING RAT-LIVER CYTOSOLIC EPOXIDE HYDROLASE AND ITS FUNCTIONAL EXPRESSION IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOFIBRATE-TREATED MICE; MOUSE-LIVER; PURIFICATION; HYDRATION; INDUCTION; PROTEINS; ACID; RNA; DNA; LEUKOTRIENE-A4	A cDNA of 1992 base pairs encoding the complete rat liver cytosolic epoxide hydrolase has been isolated using a polymerase chain reaction-derived DNA fragment (Arand, M., Vnehr, M., Thomas, H., Zeller, H. D., and Oesch, F. (1991) FEBS Lett. 294, 19-22) known to represent the 3'-end of the cytosolic epoxide hydrolase mRNA. Sequence analysis revealed an open reading frame of 1662 nucleotides corresponding to 554 amino acids (M(r) = 62,268). The DNA sequence obtained did not display significant homology to the sequences of microsomal epoxide hydrolase or leukotriene A4 hydrolase or to any other DNA included in the EMBL Data Bank (release 32). On Northern blotting of rat liver RNA, a single mRNA species was detected that was strongly induced on treatment of the animal with fenofibrate, a potent peroxisome proliferator. The most significant structure of the deduced protein is a modified peroxisomal targeting signal (Ser-Lys-Ile) at the carboxyl terminus that is regarded to be responsible for the unusual dual localization of the cytosolic epoxide hydrolase in peroxisomes as well as in the cytosol. In addition, a leucine zipper-like motif was identified at the amino terminus. Its possible implication for the observed dimeric structure of cytosolic epoxide hydrolase is discussed. The isolated cDNA was expressed in bacteria to yield a catalytically active enzyme. Specific activity of the crude lysate obtained exceeded that of rat liver cytosols from maximally induced animals by a factor of 8.	UNIV MAINZ, INST TOXICOL, OBERE ZAHLBACHERSTR 67, W-6500 MAINZ, GERMANY	Johannes Gutenberg University of Mainz			Arand, Michael/J-3926-2014; Oesch, Franz/AAA-8746-2020	Arand, Michael/0000-0003-2413-3177; 				ARAND M, 1991, FEBS LETT, V294, P19, DOI 10.1016/0014-5793(91)81333-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANG C, 1991, ARCH BIOCHEM BIOPHYS, V285, P276, DOI 10.1016/0003-9861(91)90360-U; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DIETZE EC, 1990, INT J BIOCHEM, V22, P461, DOI 10.1016/0020-711X(90)90258-5; ERIKSSON AM, 1991, EUR J BIOCHEM, V198, P471; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GEBEL T, 1992, FEBS LETT, V309, P37, DOI 10.1016/0014-5793(92)80734-X; GILL SS, 1974, J AGR FOOD CHEM, V22, P386, DOI 10.1021/jf60193a058; GILL SS, 1981, BIOCHEM PHARMACOL, V30, P2111, DOI 10.1016/0006-2952(81)90230-6; GILL SS, 1979, BIOCHEM BIOPH RES CO, V89, P965, DOI 10.1016/0006-291X(79)91872-2; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; GOZUKARA EM, 1981, MOL PHARMACOL, V19, P153; HALARNKAR PP, 1992, ARCH BIOCHEM BIOPHYS, V294, P586, DOI 10.1016/0003-9861(92)90729-G; KAUR S, 1986, BIOCHEM PHARMACOL, V35, P1299, DOI 10.1016/0006-2952(86)90275-3; KETTERER B, 1988, MUTAT RES, V202, P343, DOI 10.1016/0027-5107(88)90197-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KYTE J, 1982, J MOL BIOL, V157, P102; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; MCGEE J, 1985, J BIOL CHEM, V260, P2832; MEDINA JF, 1991, BIOCHEM BIOPH RES CO, V176, P1516, DOI 10.1016/0006-291X(91)90459-K; MEIJER J, 1985, EUR J BIOCHEM, V148, P421, DOI 10.1111/j.1432-1033.1985.tb08856.x; MEIJER J, 1988, ARCH TOXICOL S, V12, P283; NOUROOZZADEH J, 1992, ARCH BIOCHEM BIOPHYS, V294, P675, DOI 10.1016/0003-9861(92)90741-E; OESCH F, 1980, CANCER LETT, V9, P169, DOI 10.1016/0304-3835(80)90083-X; OESCH F, 1973, XENOBIOTICA, V3, P305, DOI 10.3109/00498257309151525; OESCH F, 1991, NATO ADV SCI I A-LIF, V202, P447; OTA K, 1980, SCIENCE, V207, P1479, DOI 10.1126/science.7361100; PACEASCIAK CR, 1989, J BIOL CHEM, V264, P9310; PATEL BN, 1986, BIOCHEM PHARMACOL, V35, P231, DOI 10.1016/0006-2952(86)90519-8; PICHARE MM, 1985, BIOCHEM BIOPH RES CO, V133, P233, DOI 10.1016/0006-291X(85)91866-2; PORTER TD, 1986, ARCH BIOCHEM BIOPHYS, V248, P121, DOI 10.1016/0003-9861(86)90408-X; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLADT L, 1986, BIOCHEM PHARMACOL, V35, P3309, DOI 10.1016/0006-2952(86)90428-4; SCHLADT L, 1987, BIOCHEM PHARMACOL, V36, P345, DOI 10.1016/0006-2952(87)90292-9; SCHLADT L, 1988, EUR J BIOCHEM, V176, P31, DOI 10.1111/j.1432-1033.1988.tb14247.x; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; THOMAS H, 1990, ENVIRON HEALTH PERSP, V88, P49, DOI 10.2307/3431050; THOMAS H, 1990, FRONTIERS BIOTRANSFO, V2, P278; WAECHTER F, 1983, FEBS LETT, V158, P225, DOI 10.1016/0014-5793(83)80583-3; WAECHTER F, 1984, BIOCHEM PHARMACOL, V33, P31, DOI 10.1016/0006-2952(84)90366-6; WANG P, 1982, BIOCHEMISTRY-US, V21, P5769, DOI 10.1021/bi00266a007; WATABE T, 1981, J BIOL CHEM, V256, P2900	45	62	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17623	17627						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349641				2022-12-27	WOS:A1993LQ98800105
J	NICHOLS, JC; VYAS, NK; QUIOCHO, FA; MATTHEWS, KS				NICHOLS, JC; VYAS, NK; QUIOCHO, FA; MATTHEWS, KS			MODEL OF LACTOSE REPRESSOR CORE BASED ON ALIGNMENT WITH SUGAR-BINDING PROTEINS IS CONCORDANT WITH GENETIC AND CHEMICAL-DATA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; COLI-B-R; LAC REPRESSOR; ESCHERICHIA-COLI; L-ARABINOSE; FUNCTIONAL SIMILARITY; TERMINAL FRAGMENT; INDUCER BINDING; D-GALACTOSE; D-RIBOSE	Using primary sequence similarity to arabinose-binding protein, D-glucose/D-galactose-binding protein, and ribose-binding protein (Vyas, N. K., Vyas, M. N., and Quiocho, F. A. (1991) J. Biol. Chem. 266, 5226-5237; Mowbray, S. L., and Cole, L. B. (1992) J. Mol. Biol. 225, 155-175), the core domain (residues 62-323) of the bacterial regulatory protein lac repressor has been aligned to these sugar-binding proteins of known structure. Although the sequence identity is not striking, there is strong overall homology based on two separate matrix scoring systems (minimum base change per codon (MBC/C) and amino acid homology per residue (AAH/R)) (mean score: MBC/C < 1.25, AAH/R > 5.50; random sequences: MBC/C = 1.45, AAH/R = 4.46). Similarly, the predicted secondary structure of the repressor exhibits excellent agreement with the known secondary structures of the sugar-binding proteins. Using this primary sequence alignment, the tertiary structure of the core domain of the lac repressor has been modeled based on the known structures of the sugar-binding proteins as templates. While the structure deduced for the repressor is hypothetical, the model generated allows a comparison between the predicted tertiary arrangement and the wealth of genetic and chemical data elucidated for the repressor. Important residues involved in operator and sugar binding and in protein assembly have been identified using genetic methods, and placement of these residues in the model is consistent with their known function. This approach, therefore, provides a means to visualize the core domain of the lac repressor that allows interpretation of genetic and chemical data for specific residues and rational design of future experiments.	RICE UNIV, DEPT BIOCHEM & CELL BIOL, HOUSTON, TX 77251 USA; RICE UNIV, WM KECK CTR COMP BIOL, HOUSTON, TX 77251 USA; BAYLOR COLL MED, DEPT BIOCHEM & STRUCT BIOL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, WM KECK CTR COMP BIOL, HOUSTON, TX 77030 USA	Rice University; Rice University; Baylor College of Medicine; Baylor College of Medicine					NIGMS NIH HHS [GM22441, GM21371] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021371, R01GM022441] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTI S, 1991, NEW BIOL, V3, P57; ANDERSON WF, 1985, BIOSYSTEMS, V18, P3, DOI 10.1016/0303-2647(85)90056-5; BACON DJ, 1986, J MOL BIOL, V191, P153, DOI 10.1016/0022-2836(86)90252-4; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BEYREUTHER K, 1975, EUR J BIOCHEM, V59, P491, DOI 10.1111/j.1432-1033.1975.tb02477.x; BEYREUTHER K, 1973, P NATL ACAD SCI USA, V70, P3576, DOI 10.1073/pnas.70.12.3576; BEYREUTHER K, 1980, OPERON, P123; BOELENS R, 1987, J MOL BIOL, V193, P213, DOI 10.1016/0022-2836(87)90638-3; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; CHAKERIAN AE, 1991, J BIOL CHEM, V266, P1371; CHAKERIAN AE, 1991, J BIOL CHEM, V266, P22206; CHANG WI, 1993, J BIOL CHEM, V268, P17613; CHEN J, 1992, J BIOL CHEM, V267, P13843; DALY TJ, 1986, BIOCHEMISTRY-US, V25, P5479, DOI 10.1021/bi00367a020; DALY TJ, 1986, BIOCHEMISTRY-US, V25, P5468, DOI 10.1021/bi00367a018; DALY TJ, 1986, BIOCHEMISTRY-US, V25, P5474, DOI 10.1021/bi00367a019; DAYHOFF MO, 1978, ATLAS PROTEIN SEQUEN, V5, P1; EISENBERG D, 1989, TRENDS BIOCHEM SCI, V14, P260, DOI 10.1016/0968-0004(89)90059-5; FARABAUGH PJ, 1978, NATURE, V274, P765, DOI 10.1038/274765a0; FILES JG, 1976, J BIOL CHEM, V251, P3386; FITCH WM, 1966, J MOL BIOL, V16, P9, DOI 10.1016/S0022-2836(66)80258-9; GARDNER JA, 1990, J BIOL CHEM, V265, P21061; GEISLER N, 1976, P NATL ACAD SCI USA, V73, P3103, DOI 10.1073/pnas.73.9.3103; GEISLER N, 1977, BIOCHEMISTRY-US, V16, P938, DOI 10.1021/bi00624a020; GILLILAND GL, 1981, J MOL BIOL, V146, P341, DOI 10.1016/0022-2836(81)90392-2; GORDON AJE, 1988, J MOL BIOL, V200, P239, DOI 10.1016/0022-2836(88)90237-9; GREER J, 1991, METHOD ENZYMOL, V202, P239; GROARKE JM, 1983, J BIOL CHEM, V258, P2952; HECHT MH, 1990, SCIENCE, V249, P884, DOI 10.1126/science.2392678; HOGG RW, 1977, J BIOL CHEM, V252, P5135; JOVIN TM, 1977, NATURE, V269, P668, DOI 10.1038/269668a0; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; KAPTEIN R, 1990, BIOCHEM PHARMACOL, V40, P89, DOI 10.1016/0006-2952(90)90183-L; KLEINA LG, 1990, J MOL BIOL, V212, P295, DOI 10.1016/0022-2836(90)90126-7; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MAHONEY WC, 1981, J BIOL CHEM, V256, P4350; MARTEL P, 1992, PROG BIOPHYS MOL BIO, V57, P129, DOI 10.1016/0079-6107(92)90023-Y; MAUZY CA, 1992, PROTEIN SCI, V1, P843, DOI 10.1002/pro.5560010702; MILLER JH, 1979, J MOL BIOL, V131, P223, DOI 10.1016/0022-2836(79)90074-3; MILLER JH, 1979, J MOL BIOL, V131, P249, DOI 10.1016/0022-2836(79)90075-5; MILLER JH, 1979, J MOL BIOL, V131, P191, DOI 10.1016/0022-2836(79)90073-1; MOWBRAY SL, 1992, J MOL BIOL, V225, P155, DOI 10.1016/0022-2836(92)91033-L; MOWBRAY SL, 1992, J MOL BIOL, V227, P418, DOI 10.1016/0022-2836(92)90898-T; MULLERHILL B, 1971, ANGEW CHEM INT EDIT, V10, P160, DOI 10.1002/anie.197101601; MULLERHILL B, 1983, NATURE, V302, P163, DOI 10.1038/302163a0; NIERMANN T, 1991, METHOD ENZYMOL, V202, P45; NORTH AK, 1989, GENE, V80, P29, DOI 10.1016/0378-1119(89)90247-3; OGATA RT, 1978, P NATL ACAD SCI USA, V75, P5851, DOI 10.1073/pnas.75.12.5851; OPPENHEIMER NJ, 1989, METHOD ENZYMOL, V176, P177; PACE HC, 1990, P NATL ACAD SCI USA, V87, P1870, DOI 10.1073/pnas.87.5.1870; PFAHL M, 1974, GENETICS, V76, P669; PTITSYN OB, 1983, BIOPOLYMERS, V22, P15, DOI 10.1002/bip.360220105; QUIOCHO FA, 1984, NATURE, V310, P381, DOI 10.1038/310381a0; SAMS CF, 1984, NATURE, V310, P429, DOI 10.1038/310429a0; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; SCHIFFER CA, 1990, PROTEINS, V8, P30, DOI 10.1002/prot.340080107; SCHMITZ A, 1976, J BIOL CHEM, V251, P3359; SCHNEIDER JM, 1984, BIOCHEMISTRY-US, V23, P2221, DOI 10.1021/bi00305a019; SCHOLLE A, 1987, MOL GEN GENET, V208, P247, DOI 10.1007/BF00330450; SPOTTS RO, 1991, J BIOL CHEM, V266, P22998; VONWILCKENBERGMANN B, 1982, P NATL ACAD SCI-BIOL, V79, P2427; VYAS NK, 1991, J BIOL CHEM, V266, P5226; VYAS NK, 1988, SCIENCE, V242, P1290, DOI 10.1126/science.3057628; VYAS NK, 1987, NATURE, V327, P635, DOI 10.1038/327635a0; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; WRIGHT PE, 1989, TRENDS BIOCHEM SCI, V14, P255, DOI 10.1016/0968-0004(89)90058-3; WYCKOFF HW, 1985, METHOD ENZYMOL, V114, pR11; [No title captured]	70	31	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17602	17612						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349639				2022-12-27	WOS:A1993LQ98800103
J	BALZARINI, J; BOHMAN, C; DECLERCQ, E				BALZARINI, J; BOHMAN, C; DECLERCQ, E			DIFFERENTIAL MECHANISM OF CYTOSTATIC EFFECT OF (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE, 9-(1,3-DIHYDROXY-2-PROPOXYMETHYL)GUANINE, AND OTHER ANTIHERPETIC DRUGS ON TUMOR-CELLS TRANSFECTED BY THE THYMIDINE KINASE GENE OF HERPES-SIMPLEX VIRUS TYPE-1 OR TYPE-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMIDYLATE SYNTHETASE; NUCLEOSIDE ANALOGS; 5-SUBSTITUTED 2'-DEOXYURIDINES; DEOXYTHYMIDINE KINASES; TARGET ENZYME; SYNTHASE; STRAINS; AGENT; 9-(2-HYDROXYETHOXYMETHYL)GUANINE; ESTABLISHMENT	After they have been transfected with the herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2) thymidine kinase (TK) gene murine mammary carcinoma (FM3A) cells become highly sensitive to the growth inhibitory properties of the antiherpetic agents (E)5-(2-bromovinyl)-2'-deoxyuridine (BVDU), 9-[(2-hydroxyethoxy)methyl]guanine (acyclovir, ACV), 9-[(1,3-dihydroxy-2-propoxy)methyl[guanine (DHPG, ganciclovir), and 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-methyluracil (FMAU). BVDU was 100-fold more potent an inhibitor of HSV TK gene-transfected tumor cell growth (50% inhibitory concentration (IC50), 0.0020-0.0047 muM) than FMAU or DHPG (IC50, 0.051-0.277 muM) and 1000-fold more potent than ACV (IC50, 0.42-4.9 muM). As a rule, the test compounds were more cytostatic to HSV-2 TK than HSV-1 TK gene-transfected FM3A cells. This may be ascribed to the higher phosphorylating capacity (V(max)/K(m)) of HSV-2 TK than HSV-1 TK and/or to the higher TK enzyme levels of the HSV-2 TK gene-transfected FM3A cells than the HSV-1 TK gene-transfected FM3A cells. Thymidylate synthase of the HSV TK gene-transfected FM3A cells appears to be the target enzyme for the cytostatic action of BVDU, but not FMAU, DHPG, or ACV. Instead, the cytostatic activity of DHPG seems to be correlated with its conversion to the triphosphate form and subsequent incorporation into the DNA of HSV TK gene-transfected FM3A cells.			BALZARINI, J (corresponding author), CATHOLIC UNIV LEUVEN,REGA INST MED RES,MINDERBROEDERSSTR 10,B-3000 LOUVAIN,BELGIUM.			De Clercq, Erik/0000-0002-2985-8890				AYUSAWA D, 1981, SOMAT CELL GENET, V7, P523, DOI 10.1007/BF01549656; AYUSAWA D, 1980, SOMAT CELL GENET, V6, P261, DOI 10.1007/BF01538800; AYUSAWA D, 1985, JPN J CANCER RES, V76, P984; BALZARINI J, 1989, METHOD FIND EXP CLIN, V11, P379; BALZARINI J, 1987, MOL PHARMACOL, V32, P410; BALZARINI J, 1984, BIOCHIM BIOPHYS ACTA, V785, P36, DOI 10.1016/0167-4838(84)90231-0; BALZARINI J, 1985, FEBS LETT, V185, P95, DOI 10.1016/0014-5793(85)80747-X; BALZARINI J, 1985, MOL PHARMACOL, V28, P581; BALZARINI J, 1982, BIOCHEM PHARMACOL, V31, P3673, DOI 10.1016/0006-2952(82)90594-9; BORRELLI E, 1988, P NATL ACAD SCI USA, V85, P7572, DOI 10.1073/pnas.85.20.7572; CHEN MS, 1978, J BIOL CHEM, V253, P1325; CHENG YC, 1981, MOL PHARMACOL, V20, P230; CHENG YC, 1983, P NATL ACAD SCI-BIOL, V80, P2767, DOI 10.1073/pnas.80.9.2767; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; De Clercq E, 1986, Verh K Acad Geneeskd Belg, V48, P261; DECLERCQ E, 1984, J ANTIMICROB CHEMOTH, V14, P85, DOI 10.1093/jac/14.suppl_A.85; DECLERCQ E, 1984, BIOCHEM PHARMACOL, V33, P2159, DOI 10.1016/0006-2952(84)90649-X; DECLERCQ E, 1980, J INFECT DIS, V141, P563, DOI 10.1093/infdis/141.5.563; DECLERCQ E, 1979, P NATL ACAD SCI USA, V76, P2947, DOI 10.1073/pnas.76.6.2947; DECLERCQ E, 1981, MOL PHARMACOL, V19, P321; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; FIELD AK, 1983, P NATL ACAD SCI-BIOL, V80, P4139, DOI 10.1073/pnas.80.13.4139; JONES AS, 1979, TETRAHEDRON LETT, V45, P4415; LOPEZ C, 1980, ANTIMICROB AGENTS CH, V17, P803, DOI 10.1128/AAC.17.5.803; MACHIDA H, 1982, ANTIMICROB AGENTS CH, V21, P358, DOI 10.1128/AAC.21.2.358; MAR EC, 1984, J GEN VIROL, V65, P47, DOI 10.1099/0022-1317-65-1-47; MAR EC, 1985, J VIROL, V53, P776, DOI 10.1128/JVI.53.3.776-780.1985; MOOLTEN FL, 1986, CANCER RES, V46, P5276; RUTH JL, 1981, MOL PHARMACOL, V20, P415; SHIMIZU K, 1986, CELL STRUCT FUNCT, V11, P295, DOI 10.1247/csf.11.295; SMEE DF, 1985, BIOCHEM PHARMACOL, V34, P1049, DOI 10.1016/0006-2952(85)90608-2; SMEE DF, 1983, ANTIMICROB AGENTS CH, V23, P676, DOI 10.1128/AAC.23.5.676; STONE R, 1992, SCIENCE, V256, P1513, DOI 10.1126/science.1317967; ZOU FC, 1984, BIOCHEM PHARMACOL, V33, P1797, DOI 10.1016/0006-2952(84)90352-6	34	127	135	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1993	268	9					6332	6337						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KT368	8384209				2022-12-27	WOS:A1993KT36800040
J	FORMISANO, P; SOHN, KJ; MIELE, C; DIFINIZIO, B; PETRUZZIELLO, A; RICCARDI, G; BEGUINOT, L; BEGUINOT, F				FORMISANO, P; SOHN, KJ; MIELE, C; DIFINIZIO, B; PETRUZZIELLO, A; RICCARDI, G; BEGUINOT, L; BEGUINOT, F			MUTATION IN A CONSERVED MOTIF NEXT TO THE INSULIN-RECEPTOR KEY AUTOPHOSPHORYLATION SITES DE-REGULATES KINASE-ACTIVITY AND IMPAIRS INSULIN ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-I; TYROSINE PROTEIN-KINASE; SKELETAL-MUSCLE CELLS; BETA-SUBUNIT; HEPATOMA-CELLS; RESIDUES 1162; PHOSPHORYLATION; REPLACEMENT; ACTIVATION; INVITRO	We have recently reported two non-insulin-dependent diabetic patients exhibiting a heterozygous point mutation (R1152-Q) next to the key tyrosine autophosphorylation sites (Y1146, Y1150, Y1151) of the insulin receptor. In the present study, we demonstrate that the Q1152 mutation alters a previously unrecognized consensus sequence in the insulin receptor family of tyrosine kinases. To define the effect of this alteration on insulin receptor function, the mutant insulin receptor (Q1152) was constructed and overexpressed in NIH-3T3 cells. In spite of normal insulin binding, ''in vivo'' and ''in vitro'' autophosphorylation as well as transphosphorylation by the wild-type receptor (WT) were deficient in Q1152 as compared with the transfected WT receptors. Insulin-stimulated kinase activity toward poly(Glu, Tyr) 4:1 and the endogenous substrates p120 and p175 were also impaired in Q1152. However, insulin-independent kinase activity of Q1152 was 2-5-fold higher than that of WT. While insulin stimulated 2-deoxyglucose uptake and glycogen synthase activity in WT-transfected cells with a sensitivity proportional to receptor number, no insulin stimulation was observed in Q1152 cells. Similar to the kinase, insulin-independent glycogen synthase activity and 2-deoxyglucose uptake were 2-fold higher in Q1152 than in either WT or parental cells. We conclude that the Q1152 mutation deregulates insulin receptor kinase and generates insulin insensitivity in cells. Alterations in this highly conserved region of the insulin receptor may contribute to non-insulin dependent diabetes mellitin pathogenesis in humans.	CNR,CTR ENDOCRINOL & ONCOL SPERIMENTALE,VIA S PANSINI 5,I-80131 NAPLES,ITALY; UNIV NAPLES 2,SCH MED,DIPARTIMENTO BIOL & PATOL CELLULARE & MOLEC LUIGI CALIFANO,NAPLES,ITALY; UNIV NAPLES 2,SCH MED,IST MED INTERNA,NAPLES,ITALY; OSPED SAN RAFFAELE,DIBIT,MOLEC ONCOL LAB,MILAN,ITALY; UNIV COPENHAGEN,INST MICROBIOL,COPENHAGEN K,DENMARK	Consiglio Nazionale delle Ricerche (CNR); Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Copenhagen			Formisano, Pietro/J-4237-2018; riccardi, gabriele/A-9269-2012; PETRUZZIELLO, ARNOLFO/O-1163-2017	Formisano, Pietro/0000-0001-7020-6870; PETRUZZIELLO, ARNOLFO/0000-0003-0353-9151				ACCILI D, 1991, J BIOL CHEM, V266, P434; AVRUCH J, 1989, MOL CELLULAR BIOL DI, P65; Battey, 1986, BASIC METHODS MOL BI; BEGUINOT F, 1989, ENDOCRINOLOGY, V125, P1599, DOI 10.1210/endo-125-3-1599; BEGUINOT F, 1988, BIOCHEMISTRY-US, V27, P3222, DOI 10.1021/bi00409a015; BEGUINOT F, 1986, ENDOCRINOLOGY, V118, P446, DOI 10.1210/endo-118-1-446; CAMA A, 1992, J BIOL CHEM, V267, P8383; COCOZZA S, 1992, DIABETES, V41, P521, DOI 10.2337/diabetes.41.4.521; CUATRECASAS P, 1972, P NATL ACAD SCI USA, V69, P318, DOI 10.1073/pnas.69.2.318; DEBANT A, 1988, P NATL ACAD SCI USA, V85, P8032, DOI 10.1073/pnas.85.21.8032; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; FLIER JS, 1989, MOL CELLULAR BIOL DI, V2, P175; FLORESRIVEROS JR, 1989, J BIOL CHEM, V264, P21557; GOLDFINE ID, 1987, ENDOCR REV, V8, P235, DOI 10.1210/edrv-8-3-235; GOREN HJ, 1987, BIOCHEMISTRY-US, V26, P2374, DOI 10.1021/bi00382a044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRANDORI C, 1989, NATURE, V338, P467, DOI 10.1038/338467a0; HAFEN E, 1987, SCIENCE, V236, P55, DOI 10.1126/science.2882603; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HELIN K, 1991, ONCOGENE, V6, P825; HERRERA R, 1986, J BIOL CHEM, V261, P1980; KASUGA M, 1982, SCIENCE, V215, P185, DOI 10.1126/science.7031900; KASUGA M, 1982, NATURE, V298, P667, DOI 10.1038/298667a0; KLEIN HH, 1986, J BIOL CHEM, V261, P4691; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANDARINO LJ, 1986, AM J PHYSIOL, V251, pE489, DOI 10.1152/ajpendo.1986.251.4.E489; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MATSUSHIME H, 1986, MOL CELL BIOL, V6, P3000, DOI 10.1128/MCB.6.8.3000; MCCLAIN DA, 1988, J BIOL CHEM, V263, P8904; MCCLAIN DA, 1989, MOL CELLULAR BIOL DI, V2, P53; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MURAKAMI MS, 1991, J BIOL CHEM, V266, P22653; NISHIDA Y, 1986, BIOCHEM BIOPH RES CO, V141, P474, DOI 10.1016/S0006-291X(86)80197-8; Potts W M, 1988, Oncogene Res, V3, P343; REESJONES RW, 1985, J BIOL CHEM, V260, P4461; ROSEN OM, 1983, P NATL ACAD SCI-BIOL, V80, P3237, DOI 10.1073/pnas.80.11.3237; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; TAVARE JM, 1988, BIOCHEM J, V252, P607, DOI 10.1042/bj2520607; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; TORNQVIST HE, 1987, J BIOL CHEM, V262, P10212; TORNQVIST HE, 1988, J BIOL CHEM, V263, P4593; TORNQVIST HE, 1988, J BIOL CHEM, V263, P350; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; VELU TJ, 1989, J CELL BIOCHEM, V39, P153, DOI 10.1002/jcb.240390207; WHITE MF, 1988, J BIOL CHEM, V263, P2969; WILDEN PA, 1990, P NATL ACAD SCI USA, V87, P3358, DOI 10.1073/pnas.87.9.3358; YU KT, 1986, J BIOL CHEM, V261, P4715; ZHANG B, 1991, J BIOL CHEM, V266, P990	51	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1993	268	7					5241	5248						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP884	8383132				2022-12-27	WOS:A1993KP88400097
J	KRIEGER, M; ACTON, S; ASHKENAS, J; PEARSON, A; PENMAN, M; RESNICK, D				KRIEGER, M; ACTON, S; ASHKENAS, J; PEARSON, A; PENMAN, M; RESNICK, D			MOLECULAR FLYPAPER, HOST DEFENSE, AND ATHEROSCLEROSIS - STRUCTURE, BINDING-PROPERTIES, AND FUNCTIONS OF MACROPHAGE SCAVENGER RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							LOW-DENSITY-LIPOPROTEIN; BOVINE SERUM-ALBUMIN; HERITABLE HYPERLIPIDEMIC RABBIT; MOUSE PERITONEAL-MACROPHAGES; HAMSTER OVARY CELLS; CHOLESTEROL DEPOSITION; RAT-LIVER; EXPRESSION; INVIVO; DEGRADATION				KRIEGER, M (corresponding author), MIT, DEPT BIOL, RM E25-236, CAMBRIDGE, MA 02139 USA.				NHLBI NIH HHS [HL41484] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041484] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABRAMS JM, 1993, DEVELOPMENT, V117, P29; ACTON S, 1993, J BIOL CHEM, V268, P3530; ARAI H, 1989, BIOCHEM BIOPH RES CO, V159, P1375, DOI 10.1016/0006-291X(89)92262-6; ARAMS JM, 1992, P NATL ACAD SCI USA, V89, P10375; ARUFFO A, 1991, J EXP MED, V174, P949, DOI 10.1084/jem.174.4.949; ASAOKA H, 1991, CIRCULATION, V84, P230; BICKEL PE, 1992, J CLIN INVEST, V90, P1450, DOI 10.1172/JCI116012; BRIAN JD, 1985, HDB PHYSL 3, V1, P447; BROWN MS, 1980, J SUPRAMOL STR CELL, V13, P67, DOI 10.1002/jss.400130107; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; BROWN MS, 1979, J CELL BIOL, V82, P597, DOI 10.1083/jcb.82.3.597; CAMPOSORTEGA JA, 1985, EMBRYONIC DEV DROSOP, P49; CAREW TE, 1987, P NATL ACAD SCI USA, V84, P7725, DOI 10.1073/pnas.84.21.7725; DRESEL HA, 1987, EMBO J, V6, P319, DOI 10.1002/j.1460-2075.1987.tb04757.x; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; EZEKOWITZ RAB, 1991, NATURE, V351, P155, DOI 10.1038/351155a0; FREEMAN M, 1990, P NATL ACAD SCI USA, V87, P8810, DOI 10.1073/pnas.87.22.8810; FREEMAN M, 1991, P NATL ACAD SCI USA, V88, P4931, DOI 10.1073/pnas.88.11.4931; GIUDICE GJ, 1992, J INVEST DERMATOL, V99, P243, DOI 10.1111/1523-1747.ep12616580; Goldstein J.L., 1989, METABOLIC BASIS INHE, P1215; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; GORDON S, 1988, J CELL SCI, P1; HABERLAND ME, 1988, SCIENCE, V241, P215, DOI 10.1126/science.2455346; HAMPTON RY, 1991, NATURE, V352, P342, DOI 10.1038/352342a0; HAVEL RJ, 1989, METABOLIC BASIS INHE, P1129; HOFF HF, 1985, ANN NY ACAD SCI, V454, P183, DOI 10.1111/j.1749-6632.1985.tb11857.x; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; KITA T, 1987, P NATL ACAD SCI USA, V84, P5928, DOI 10.1073/pnas.84.16.5928; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; KODAMA T, 1988, P NATL ACAD SCI USA, V85, P9238, DOI 10.1073/pnas.85.23.9238; KODAMA T, 1991, CIRCULATION, V84, P229; KRIEGER M, 1992, TRENDS BIOCHEM SCI, V17, P141, DOI 10.1016/0968-0004(92)90322-Z; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; MATSUMOTO A, 1990, P NATL ACAD SCI USA, V87, P9133, DOI 10.1073/pnas.87.23.9133; MOULTON KS, 1992, P NATL ACAD SCI USA, V89, P8102, DOI 10.1073/pnas.89.17.8102; NAGELKERKE JF, 1992, P NATL ACAD SCI USA, V258, P12221; NAITO M, 1991, AM J PATHOL, V139, P1411; NISHIKAWA K, 1990, J BIOL CHEM, V265, P5226; OTTNAD E, 1988, BIOCHEM J, V253, P835, DOI 10.1042/bj2530835; OTTNAD E, 1990, BIOCHEM J, V265, P689, DOI 10.1042/bj2650689; PALINSKI W, 1989, P NATL ACAD SCI USA, V86, P1372, DOI 10.1073/pnas.86.4.1372; PEARSON AM, 1993, J BIOL CHEM, V268, P3546; PENMAN M, 1991, J BIOL CHEM, V266, P23985; PITAS RE, 1985, J CELL BIOL, V100, P103, DOI 10.1083/jcb.100.1.103; PITAS RE, 1990, J BIOL CHEM, V265, P12722; REID KBM, 1979, BIOCHEM J, V179, P367, DOI 10.1042/bj1790367; RESNICK D, 1993, J BIOL CHEM, V268, P3538; ROHRER L, 1990, NATURE, V343, P570, DOI 10.1038/343570a0; SPARROW CP, 1989, J BIOL CHEM, V264, P2599; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; THIEL S, 1989, FEBS LETT, V250, P78, DOI 10.1016/0014-5793(89)80689-1; VANBERKEL TJC, 1991, J BIOL CHEM, V266, P2282; VIA D, 1992, FASEB J, V6, pA371; VIA DP, 1985, J BIOL CHEM, V260, P7379; VOSS T, 1988, J MOL BIOL, V201, P219, DOI 10.1016/0022-2836(88)90448-2; WONG H, 1983, ARTERIOSCLEROSIS, V3, pA475; YLAHERTTUALA S, 1991, J CLIN INVEST, V87, P1146, DOI 10.1172/JCI115111	58	252	261	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	1993	268	7					4569	4572						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP884	8383115				2022-12-27	WOS:A1993KP88400001
J	VOSS, T; WALLNER, E; CZERNILOFSKY, AP; FREISSMUTH, M				VOSS, T; WALLNER, E; CZERNILOFSKY, AP; FREISSMUTH, M			AMPHIPATHIC ALPHA-HELICAL STRUCTURE DOES NOT PREDICT THE ABILITY OF RECEPTOR-DERIVED SYNTHETIC PEPTIDES TO INTERACT WITH GUANINE NUCLEOTIDE-BINDING REGULATORY PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; DOPAMINE RECEPTOR; BOVINE BRAIN; MASTOPARAN; SUBUNITS; SUBTYPES; CLONING; GS; GI	In guanine nucleotide-binding regulatory protein-(G protein) coupled receptors, an amphipathic alpha-helix has been postulated to be the common structural determinant in the NH2- and COOH-terminal portions of the third intracellular loop representing the major interaction site with the G proteins. Here we assessed the ability of six peptides derived from these sites of the human dopamine D1-, D2-, and beta1-adrenergic receptors to either activate G proteins directly or to uncouple the activity of their respective receptors in a native membrane environment. In addition, the cross-reactivity was analyzed. Nonspecific effects occurring at high concentrations were differentiated from G protein-specific effects. The peptide D2N derived from the NH2-terminal part of the third intracellular loop of the dopamine D2 receptor was the only one capable of specifically reversing the action of its receptor, the dopamine-mediated inhibition of the adenylyl cyclase. Furthermore, only D2N stimulated pertussis toxin-sensitive G proteins. However, D2N as the only peptide exhibiting specific effects did not exhibit the predicted amphipathic alpha-helix observed for mastoparan (Higashijima, T., Burnier, J., and Ross, E. M. (1990) J. Biol. Chem. 265, 14176-14186) as demonstrated by circular dichroism spectroscopy. In contrast, a peptide for which a certain degree of helicality was verified spectroscopically (D1C) was neither active in GTPase and adenylyl cyclase determinations, nor did it block the receptor-mediated cyclase activation. Hence, the amphipathic alpha-helix does not represent the main structural determinant for the receptor-G protein interaction site.	UNIV VIENNA,INST PHARMACOL,A-1090 VIENNA,AUSTRIA	University of Vienna	VOSS, T (corresponding author), FA BENDER & CO,ERNST BOEHRINGER INST ARZNEIMITTELFORSCH,DEPT PROT CHEM,DR BOEHRINGER GASSE 5-11,A-1121 VIENNA,AUSTRIA.			Freissmuth, Michael/0000-0001-9398-1765				BERTIN B, 1992, J BIOL CHEM, V267, P8200; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; CHEUNG AH, 1991, FEBS LETT, V279, P277, DOI 10.1016/0014-5793(91)80167-2; CHEUNG AH, 1989, MOL PHARMACOL, V34, P132; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; DALTOSO R, 1989, EMBO J, V8, P4025, DOI 10.1002/j.1460-2075.1989.tb08585.x; DEARRY A, 1990, NATURE, V347, P72, DOI 10.1038/347072a0; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; FAERMAN CH, 1992, PROTEINS, V12, P111, DOI 10.1002/prot.340120204; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FREISSMUTH M, 1991, J BIOL CHEM, V266, P17778; FREISSMUTH M, 1989, FASEB J, V3, P2125, DOI 10.1096/fasebj.3.10.2546847; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; HAUSLEITHNER V, 1985, BIOCHEM J, V232, P501, DOI 10.1042/bj2320501; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; KUROSE H, 1991, BIOCHEMISTRY-US, V30, P3335, DOI 10.1021/bi00227a024; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MCCLUE SJ, 1992, BIOCHEM J, V284, P565, DOI 10.1042/bj2840565; MUNCH G, 1991, EUR J BIOCHEM, V198, P357, DOI 10.1111/j.1432-1033.1991.tb16023.x; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; OKAMOTO T, 1990, CELL, V62, P709, DOI 10.1016/0092-8674(90)90116-V; PALM D, 1989, FEBS LETT, V254, P89, DOI 10.1016/0014-5793(89)81015-4; Sambrook J, 1989, MOL CLONING LABORATO; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; SENOGLES SE, 1990, J BIOL CHEM, V265, P4507; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; STROSBERG AD, 1991, EUR J BIOCHEM, V196, P1, DOI 10.1111/j.1432-1033.1991.tb15778.x; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211	32	61	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1993	268	7					4637	4642						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP884	8383121				2022-12-27	WOS:A1993KP88400015
J	BAU, MY; DRAPER, RK				BAU, MY; DRAPER, RK			RICIN INTOXICATES END4 MUTANTS THAT HAVE AN ABERRANT GOLGI-COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HAMSTER OVARY CELLS; BREFELDIN-A ACTION; ADP-RIBOSYLTRANSFERASE; DIPHTHERIA-TOXIN; MDCK CELLS; PROTEIN; TEMPERATURE; APPARATUS; TRANSPORT; CHAIN	Ricin is a protein toxin that arrests protein synthesis in mammalian cells by catalytically inactivating ribosomes. To interact with ribosomes, the A chain of the toxin must enter the cytosol. Entry involves receptor-mediated endocytosis and penetration of the toxin through an intracellular membrane, but the identity of the compartment where penetration occurs is unknown. It has been suggested that the A chain penetrates from the endoplasmic reticulum, implying the existence of a pathway from endosomes to the endoplasmic reticulum, perhaps via retrograde transport through the Golgi. (For a recent review, see Pelham, H. R. B., Roberts, L. M., and Lord, J. M. (1992) Trends Cell Biol. 2, 183-185.) To investigate the role of the Golgi in the intoxication process of ricin, we studied the effect of ricin on mutants of the End4 complementation group of Chinese hamster ovary cells. End4 mutants express a temperature-sensitive block in secretion that is correlated with the disappearance of the Golgi stacks at the level of fluorescence microscopy. We found that End4 cells and wild-type cells were equally sensitive to ricin at the restrictive temperature, although the minimum lag before inhibition of protein synthesis was longer in the mutant cells. The simplest interpretation of these data is that ricin does not pass through the cis, medial, or trans stacks of the Golgi en route to the cytosol.	UNIV TEXAS,MOLEC & CELL BIOL PROGRAM,F031,POB 830688,RICHARDSON,TX 75083	University of Texas System; University of Texas Dallas								CHAUDRY GJ, 1993, J BIOL CHEM, V268, P9437; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; ENDO Y, 1987, J BIOL CHEM, V262, P8128; HUDSON TH, 1991, J BIOL CHEM, V266, P18586; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; KAO CY, 1992, J CELL BIOL, V117, P701, DOI 10.1083/jcb.117.4.701; MEKADA E, 1981, J BIOL CHEM, V256, P1225; NAKANO A, 1985, BIOCHIM BIOPHYS ACTA, V845, P324, DOI 10.1016/0167-4889(85)90195-8; NEVILLE DM, 1986, ANNU REV BIOCHEM, V55, P195, DOI 10.1146/annurev.biochem.55.1.195; Olsnes S., 1982, MOL ACTION TOXINS VI, P51; PELHAM H R B, 1992, Trends in Cell Biology, V2, P183, DOI 10.1016/0962-8924(92)90230-K; PRYDZ K, 1992, J CELL BIOL, V119, P259, DOI 10.1083/jcb.119.2.259; SANDVIG K, 1991, J CELL BIOL, V115, P971, DOI 10.1083/jcb.115.4.971; SANDVIG K, 1979, EXP CELL RES, V121, P15, DOI 10.1016/0014-4827(79)90439-7; SUGAI M, 1992, P NATL ACAD SCI USA, V89, P8903, DOI 10.1073/pnas.89.19.8903; SUGAI M, 1992, J BIOL CHEM, V267, P21297; VANDEURS B, 1988, J CELL BIOL, V106, P253, DOI 10.1083/jcb.106.2.253; WALES R, 1992, EXP CELL RES, V203, P1, DOI 10.1016/0014-4827(92)90032-4; WANG RH, 1992, SOMAT CELL MOLEC GEN, V18, P543, DOI 10.1007/BF01232650; WANG RH, 1990, J BIOL CHEM, V265, P20179; WILSON WW, 1993, J BIOL CHEM, V268, P7465; YOSHIDA T, 1991, EXP CELL RES, V192, P389, DOI 10.1016/0014-4827(91)90056-Z; YOULE RJ, 1981, CELL, V23, P551, DOI 10.1016/0092-8674(81)90151-3; ZUBER C, 1991, P NATL ACAD SCI USA, V88, P9818, DOI 10.1073/pnas.88.21.9818	25	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					19939	19942						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376356				2022-12-27	WOS:A1993LY01900007
J	FARESE, RV; STANDAERT, M; YU, BZ; HERNANDEZ, H; COOPER, DR				FARESE, RV; STANDAERT, M; YU, BZ; HERNANDEZ, H; COOPER, DR			2-HYDROXYPROPYL-BETA-CYCLODEXTRIN ENHANCES PHORBOL ESTER EFFECTS ON GLUCOSE-TRANSPORT AND OR PROTEIN-KINASE C-BETA TRANSLOCATION TO THE PLASMA-MEMBRANE IN RAT ADIPOCYTES AND SOLEUS MUSCLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED HEXOSE-TRANSPORT; FAT-CELLS; INSULIN STIMULATION; DIACYLGLYCEROL; INHIBITION; BINDING; GLUT4	In rat adipocytes and soleus muscles, 2-hydroxypropyl-beta-cyclodextrin (CD) was found to have a relatively small or no effect on basal or insulin-stimulated hexose uptake, but markedly enhanced hexose uptake effects of phorbol esters and/or diacylglycerol. In rat adipocytes, the CD-induced enhancement of hexose uptake during concurrent phorbol ester treatment was not associated with an increase in GLUT4 glucose transporter translocation to the plasma membrane, which was stimulated comparably by insulin and phorbol esters. Moreover, CD appeared to activate or facilitate the activation of glucose transporters subsequent to their translocation to the plasma membrane during on-going phorbol ester treatment. In rat adipocytes, CD also enhanced the translocation of protein kinase C (PKC)-beta to the plasma membrane during the action of phorbol esters, which alone had little or no effect on this specific PKC translocation. Although it is uncertain how CD alters the function of plasma membranes to enhance the translocation of PKC-beta to, and the activation of glucose transporters within, this subcellular fraction during phorbol ester treatment, our findings provide direct support for a two-step model in the activation of glucose transport. In addition, it seems clear that, at least in some cell types, simple phorbol ester treatment does not necessarily serve as a ubiquitous activator of all activable PKC pools and all potential PKC-mediated responses.	UNIV S FLORIDA,COLL MED,DEPT INTERNAL MED,TAMPA,FL 33612; UNIV S FLORIDA,COLL MED,DEPT BIOCHEM,TAMPA,FL 33612	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	FARESE, RV (corresponding author), JA HALEY VET HOSP,RES SERV VAR 151,13000 BRUCE DOWNS BLVD,TAMPA,FL 33612, USA.		Farese, Robert/B-3605-2015		NIDDK NIH HHS [DK38079] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038079] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHEN KS, 1991, T ASSOC AM PHYSICIAN, V104, P206; CHERQUI G, 1986, ENDOCRINOLOGY, V118, P1759, DOI 10.1210/endo-118-5-1759; CHERQUI G, 1987, ENDOCRINOLOGY, V120, P2192, DOI 10.1210/endo-120-5-2192; CORVERA S, 1991, J BIOL CHEM, V266, P9271; DRAZNIN B, 1988, BIOCHEM BIOPH RES CO, V156, P570, DOI 10.1016/S0006-291X(88)80880-5; EGAN JJ, 1990, P NATL ACAD SCI USA, V87, P1052, DOI 10.1073/pnas.87.3.1052; FARESE RV, 1992, BIOCHEM J, V288, P319, DOI 10.1042/bj2880319; ISHIZUKA T, 1990, DIABETES, V39, P181, DOI 10.2337/diabetes.39.2.181; ISHIZUKA T, 1991, DIABETES, V40, P1274, DOI 10.2337/diabetes.40.10.1274; ISHIZUKA T, 1989, FEBS LETT, V257, P337, DOI 10.1016/0014-5793(89)81565-0; KIRSCH D, 1985, BIOCHEM BIOPH RES CO, V128, P824, DOI 10.1016/0006-291X(85)90121-4; MUHLBACHER C, 1988, BIOCHEM J, V249, P865; OLEFSKY JM, 1978, BIOCHEM J, V172, P137, DOI 10.1042/bj1720137; ROBERTSON DG, 1989, J BIOL CHEM, V264, P6773; ROTH BL, 1989, J NEUROCHEM, V52, P215, DOI 10.1111/j.1471-4159.1989.tb10919.x; SALTIS J, 1991, J BIOL CHEM, V266, P261; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SMAL J, 1989, FEBS LETT, V244, P465, DOI 10.1016/0014-5793(89)80584-8; SOWELL MO, 1988, DIABETES, V37, P499, DOI 10.2337/diabetes.37.5.499; STANDAERT ML, 1990, METABOLISM, V39, P1170, DOI 10.1016/0026-0495(90)90090-Y; STANDAERT ML, 1991, FEBS LETT, V282, P139, DOI 10.1016/0014-5793(91)80463-D; STRALFORS P, 1988, NATURE, V335, P554, DOI 10.1038/335554a0; VOGT B, 1990, BIOCHEM BIOPH RES CO, V168, P1089, DOI 10.1016/0006-291X(90)91141-E; VOGT B, 1991, BIOCHEM J, V275, P597, DOI 10.1042/bj2750597; WAYS K, 1991, J BIOL CHEM, V266, P1258; WEBER TM, 1988, RECEPTOR BIOCH MET B, V12, P171; YU BZ, 1992, ENDOCRINOLOGY, V130, P3345, DOI 10.1210/en.130.6.3345	27	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					19949	19955						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376357				2022-12-27	WOS:A1993LY01900009
J	ZEIDLER, R; HOBERT, O; JOHANNES, L; FAULHAMMER, H; KRAUSS, G				ZEIDLER, R; HOBERT, O; JOHANNES, L; FAULHAMMER, H; KRAUSS, G			CHARACTERIZATION OF 2 NOVEL SINGLE-STRANDED DNA-SPECIFIC AUTONOMOUSLY REPLICATING SEQUENCE-BINDING PROTEINS FROM SACCHAROMYCES-CEREVISIAE, ONE OF WHICH IS ADENYLOSUCCINATE SYNTHETASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST CHROMOSOMAL REPLICATOR; ARS CONSENSUS SEQUENCE; DICTYOSTELIUM-DISCOIDEUM; ORIGIN; PURIFICATION; ELEMENTS	We report here the identification and characterization of two novel proteins from Saccharomyces cerevisiae that bind to the T-rich strand of the core consensus autonomously replicating sequence (ARS) in a highly specific manner. The two proteins, 40 and 45 kDa in size, can be distinguished by multiple criteria from each other and from the 65-kDa ssARS-T-binding protein identified recently in our laboratory (Schmidt, A. M. A., Herterich, S. U., and Krauss, G. (1991) EMBO J. 10, 981-985). The specificity of binding is inferred from gel shift and nuclease-footprinting experiments using single-stranded probes containing the core consensus ARS. With a 321-nucleotide single-stranded ARS1 fragment, specific protection of the A and B1 domain against DNase I digestion is observed. Partial amino acid sequencing and enzymatic assays identify the 45-kDa protein as adenylosuccinate synthetase, an enzyme necessary for the de novo synthesis of adenylate.	UNIV BAYREUTH,LEHRSTUHL BIOCHEM,D-95440 BAYREUTH,GERMANY	University of Bayreuth			Johannes, Ludger/M-9778-2017; Johannes, Ludger/W-8593-2019	Johannes, Ludger/0000-0002-2168-0004; Johannes, Ludger/0000-0002-2168-0004; Hobert, Oliver/0000-0002-7634-2854				BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; DESHPANDE AM, 1992, MOL CELL BIOL, V12, P4305, DOI 10.1128/MCB.12.10.4305; DIFFLEY JFX, 1992, NATURE, V357, P169, DOI 10.1038/357169a0; DORFMAN BZ, 1969, GENETICS, V61, P377; DORFMAN BZ, 1971, J BACTERIOL, V107, P646, DOI 10.1128/JB.107.3.646-654.1971; FANGMAN WL, 1991, ANNU REV CELL BIOL, V7, P375, DOI 10.1146/annurev.cb.07.110191.002111; GASTON K, 1992, NUCLEIC ACIDS RES, V20, P6297, DOI 10.1093/nar/20.23.6297; GUICHERIT OM, 1992, J BIOL CHEM, V266, P22582; HELD PG, 1992, BIOCHIM BIOPHYS ACTA, V1130, P235, DOI 10.1016/0167-4781(92)90435-3; HOFMANN JFX, 1991, CELL, V64, P951, DOI 10.1016/0092-8674(91)90319-T; KEARSEY S, 1984, CELL, V37, P299, DOI 10.1016/0092-8674(84)90326-X; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; MUIRHEAD KM, 1974, J BIOL CHEM, V249, P459; PALZKILL TG, 1988, CELL, V53, P441, DOI 10.1016/0092-8674(88)90164-X; POWELL SM, 1992, FEBS LETT, V303, P4, DOI 10.1016/0014-5793(92)80465-S; SCHLEICHER M, 1986, FEBS LETT, V200, P156, DOI 10.1016/0014-5793(86)80529-4; SCHMIDT AMA, 1991, EMBO J, V10, P981, DOI 10.1002/j.1460-2075.1991.tb08032.x; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; STUDIER WF, 1990, METHOD ENZYMOL, V185, P60, DOI DOI 10.1016/0076-6879(90)85008-C; TULLIUS TD, 1987, METHOD ENZYMOL, V155, P537; UMEK RM, 1989, BIOCHIM BIOPHYS ACTA, V1007, P1, DOI 10.1016/0167-4781(89)90123-1; VANHOUTEN JV, 1990, MOL CELL BIOL, V10, P3917, DOI 10.1128/MCB.10.8.3917; WIESMULLER L, 1991, J BIOL CHEM, V266, P2480; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; WOLFE SA, 1988, J BIOL CHEM, V263, P19147	27	19	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20191	20197						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376380				2022-12-27	WOS:A1993LY01900043
J	ADAM, D; KLAGES, S; BISHOP, P; MAHAJAN, S; ESCOBEDO, JA; BOLEN, JB				ADAM, D; KLAGES, S; BISHOP, P; MAHAJAN, S; ESCOBEDO, JA; BOLEN, JB			SIGNAL-TRANSDUCTION THROUGH A BIMOLECULAR RECEPTOR TYROSINE PROTEIN-KINASE COMPOSED OF A PLATELET-DERIVED GROWTH-FACTOR RECEPTOR-CD4 CHIMERA AND THE NONRECEPTOR TYROSINE PROTEIN-KINASE LCK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ANTIGEN RECEPTOR; AMINO-TERMINAL DOMAIN; CYTOPLASMIC DOMAINS; SRC FAMILY; P56LCK; CD4; ACTIVATION; PHOSPHORYLATION; ASSOCIATION; SUBSTRATE	We have generated a novel ''receptor tyrosine kinase'' by fusing the extracellular and transmembrane domain of the mouse platelet-derived growth factor receptor (PDGFR) to the cytoplasmic domain of CD4 and coexpressing the construct with the murine cytoplasmic tyrosine protein kinase p56lck. NMuMG cells, which are mouse mammary gland epithelial cells that lack endogenous platelet-derived growth factor (PDGF) receptor expression, were stably transfected with both PDGFR-CD4 and p56lck. The PDGFR-CD4 chimeric protein was expressed at the cell surface and formed a complex with p56lck. Addition of PDGF to these cells led to increased tyrosine phosphorylation of a 56-kDa protein likely to be p56lck and several unidentified cellular proteins. The enzymatic activity of p56lck was increased after treatment with PDGF, indicating that dimerization (or oligomerization) mediated by ligand binding at the cell surface is capable of inducing the activation not only of receptor tyrosine kinases but nonreceptor tyrosine kinases as well. However, the PDGFR-CD4.p56lck complex was, in contrast to the wild type PDGF receptor, not able to induce a PDGF-dependent mitogenic response or DNA synthesis in NMuMG cells. Analysis of several known substrates of the PDGFR-signaling pathway indicates an early block in the transduction of the signal generated by p56lck.	BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT MOLEC BIOL,SIGNAL TRANSDUCT LAB,PRINCETON,NJ 08543; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143	Bristol-Myers Squibb; Howard Hughes Medical Institute; University of California System; University of California San Francisco			Adam-Klages, Sabine/E-9761-2010; Adam, Dieter/E-9763-2010	Adam, Dieter/0000-0002-5668-5032				AMREIN KE, 1992, P NATL ACAD SCI USA, V89, P3343, DOI 10.1073/pnas.89.8.3343; BOLEN JB, 1992, FASEB J, V6, P3403, DOI 10.1096/fasebj.6.15.1281458; BOLEN JB, 1991, CELL GROWTH DIFFER, V2, P409; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P740; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARON L, 1992, MOL CELL BIOL, V12, P2720, DOI 10.1128/MCB.12.6.2720; EISEMAN E, 1992, NATURE, V355, P78; ELLIS C, 1991, ONCOGENE, V6, P895; ESCOBEDO JA, 1988, J BIOL CHEM, V263, P1482; ETTEHADIEH E, 1992, SCIENCE, V255, P853, DOI 10.1126/science.1311128; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; GORMAN C, 1983, SCIENCE, V221, P551, DOI 10.1126/science.6306768; HELDIN CH, 1989, TRENDS GENET, V5, P108, DOI 10.1016/0168-9525(89)90040-1; HORAK ID, 1990, NATURE, V348, P557, DOI 10.1038/348557a0; MADDON PJ, 1985, CELL, V42, P93, DOI 10.1016/S0092-8674(85)80105-7; MADDON PJ, 1986, CELL, V47, P33; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; OWENS RB, 1974, J NATL CANCER I, V52, P1375, DOI 10.1093/jnci/52.4.1375; SHAW AS, 1990, MOL CELL BIOL, V10, P1853, DOI 10.1128/MCB.10.5.1853; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; THOMPSON PA, 1991, CELL GROWTH DIFFER, V2, P609; THOMPSON PA, 1992, ONCOGENE, V7, P719; TSYGANKOV AY, 1992, J BIOL CHEM, V267, P18259; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; WEBER JR, 1992, J EXP MED, V176, P373, DOI 10.1084/jem.176.2.373; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	31	14	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19882	19888						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366126				2022-12-27	WOS:A1993LW81900107
J	BELL, GI; BURANT, CF; TAKEDA, J; GOULD, GW				BELL, GI; BURANT, CF; TAKEDA, J; GOULD, GW			STRUCTURE AND FUNCTION OF MAMMALIAN FACILITATIVE SUGAR TRANSPORTERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GLUT1 GLUCOSE TRANSPORTER; XENOPUS OOCYTES; MOLECULAR REGULATION; PLASMA-MEMBRANE; SMALL-INTESTINE; AMINO-ACID; ERYTHROCYTE; EXPRESSION; PROTEIN; TRYPTOPHAN-412		UNIV CHICAGO, DEPT BIOCHEM, CHICAGO, IL 60637 USA; UNIV CHICAGO, DEPT MOLEC BIOL, CHICAGO, IL 60637 USA; UNIV CHICAGO, DEPT MED, CHICAGO, IL 60637 USA; UNIV GLASGOW, GLASGOW G12 8QQ, SCOTLAND	University of Chicago; University of Chicago; University of Chicago; University of Glasgow	BELL, GI (corresponding author), UNIV CHICAGO, HOWARD HUGHES MED INST, 5841 S MARYLAND AVE, MC1028, CHICAGO, IL 60637 USA.		Burant, Charles/GPC-5690-2022	Burant, Charles/0000-0001-9189-5003; Gould, Gwyn/0000-0001-6571-2875	NIDDK NIH HHS [DK-20595] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		APPELMAN JR, 1989, BIOCHEMISTRY-US, V28, P8221; ASANO T, 1991, J BIOL CHEM, V266, P24632; BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; BURANT CF, 1992, J BIOL CHEM, V267, P14523; BURANT CF, 1991, RECENT PROG HORM RES, V47, P349; CAIRNS MT, 1987, BIOCHIM BIOPHYS ACTA, V905, P295, DOI 10.1016/0005-2736(87)90458-5; CARRUTHERS A, 1990, PHYSIOL REV, V70, P1135, DOI 10.1152/physrev.1990.70.4.1135; COLVILLE CA, 1993, BIOCHEM J, V290, P701, DOI 10.1042/bj2900701; CZECH MP, 1992, TRENDS BIOCHEM SCI, V17, P197, DOI 10.1016/0968-0004(92)90266-C; DAVIDSON NO, 1992, AM J PHYSIOL, V262, pC795, DOI 10.1152/ajpcell.1992.262.3.C795; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; GOULD GW, 1991, BIOCHEMISTRY-US, V30, P5139, DOI 10.1021/bi00235a004; GRIFFITH J K, 1992, Current Opinion in Cell Biology, V4, P684, DOI 10.1016/0955-0674(92)90090-Y; HASHIRAMOTO M, 1992, J BIOL CHEM, V267, P17502; HOLMAN GD, 1987, BIOCHIM BIOPHYS ACTA, V897, P395, DOI 10.1016/0005-2736(87)90437-8; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; ISHIHARA H, 1991, BIOCHEM BIOPH RES CO, V176, P922, DOI 10.1016/S0006-291X(05)80274-8; JAMES DE, 1993, J CELL SCI, V104, P607; JHUN BH, 1992, J BIOL CHEM, V267, P17710; KAHN BB, 1992, J CLIN INVEST, V89, P1367, DOI 10.1172/JCI115724; KATAGIRI H, 1991, J BIOL CHEM, V266, P7769; KATAGIRI H, 1992, J BIOL CHEM, V267, P22550; KATAGIRI H, 1993, BIOCHEM J, V291, P861, DOI 10.1042/bj2910861; KAYANO T, 1990, J BIOL CHEM, V265, P13276; KELLER K, 1989, J BIOL CHEM, V264, P18884; LACHAAL M, 1990, J BIOL CHEM, V265, P15449; LI J, 1987, BIOCHEMISTRY-US, V26, P4816, DOI 10.1021/bi00389a032; LIN JL, 1992, BIOCHEM BIOPH RES CO, V184, P865, DOI 10.1016/0006-291X(92)90670-G; MARSHALLCARLSON L, 1990, MOL CELL BIOL, V10, P1105, DOI 10.1128/MCB.10.3.1105; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; NEBERT DN, 1992, J BIOL CHEM, V267, P23829; NISHIMURA H, 1993, J BIOL CHEM, V268, P8514; OKA Y, 1990, NATURE, V345, P550, DOI 10.1038/345550a0; PESSIN JE, 1992, ANNU REV PHYSIOL, V54, P911, DOI 10.1146/annurev.ph.54.030192.004403; PESSINO A, 1991, J BIOL CHEM, V266, P20213; SIMPSON IA, 1986, ANNU REV BIOCHEM, V55, P1095; THORENS B, 1990, AM J PHYSIOL, V259, pC279; THORENS B, 1993, ANNU REV PHYSIOL, V55, P591, DOI 10.1146/annurev.ph.55.030193.003111; WADDELL ID, 1992, BIOCHEM J, V286, P173, DOI 10.1042/bj2860173; WADZINSKI BE, 1988, BIOCHEM J, V255, P983, DOI 10.1042/bj2550983; WALMSLEY AR, 1988, TRENDS BIOCHEM SCI, V13, P226, DOI 10.1016/0968-0004(88)90089-8; WRIGHT EM, 1993, ANNU REV PHYSIOL, V55, P575, DOI 10.1146/annurev.ph.55.030193.003043	43	441	450	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19161	19164						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366068				2022-12-27	WOS:A1993LW81900001
J	SUPPLY, P; WACH, A; THINESSEMPOUX, D; GOFFEAU, A				SUPPLY, P; WACH, A; THINESSEMPOUX, D; GOFFEAU, A			PROLIFERATION OF INTRACELLULAR STRUCTURES UPON OVEREXPRESSION OF THE PMA2 ATPASE IN SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE ATPASE; PROTON-TRANSLOCATING ATPASE; H+-ATPASE; SCHIZOSACCHAROMYCES-POMBE; ENDOPLASMIC-RETICULUM; VANADATE RESISTANCE; SECRETORY PATHWAY; YEAST; GENE; LOCALIZATION	The PMA2 gene is a presumed isogene of the PMA1 gene, encoding the major yeast plasma membrane H+-ATPase. When controlled by its own promoter, PMA2 in multiple copies does not complement a deficient PMA1 gene. Under the control of the PMA1 promoter, however, and expressed on a centromeric plasmid in yeast strains specially designed for stable expression, the PMA2 gene replaces the PMA1 gene to some extent, allowing growth on standard medium but not on acidic media. Plasma membranes of cells expressing only the PMA2 enzyme display low ATPase activity correlating with low amounts of PMA2 protein. This low activity is maintained throughout growth and does not increase when overexpression is favored by increased gene dosage. Immunoelectron microscopy reveals a dramatic proliferation of intracellular structures (probably endoplasmic reticulum) in which overexpressed PMA2 protein accumulates. Overexpression of PMA1 ATPase causes a similar phenomenon, but quantitative effects are lower compared to PMA2. These results indicate that the PMA2 gene encodes a functional plasma membrane H+-ATPase and suggest a specific control of the intracellular traffic of plasma membrane ATPase.	UNIV CATHOLIQUE LOUVAIN,UNITE BIOCHIM PHYSIOL,PL CROIX SUD 2-20,B-1348 LOUVAIN,BELGIUM	Universite Catholique Louvain			Supply, Philip/A-9580-2019	Supply, Philip/0000-0003-3690-3853				BEGGS JD, 1978, NATURE, V275, P104, DOI 10.1038/275104a0; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BOWMAN BJ, 1986, J MEMBRANE BIOL, V94, P83, DOI 10.1007/BF01871190; BRADA D, 1988, J BACTERIOL, V170, P2775, DOI 10.1128/jb.170.6.2775-2783.1988; CAPIEAUX E, 1989, J BIOL CHEM, V264, P7437; CHANG A, 1991, J CELL BIOL, V115, P289, DOI 10.1083/jcb.115.2.289; CID A, 1987, CURR GENET, V12, P105, DOI 10.1007/BF00434664; DUFOUR JP, 1988, METHOD ENZYMOL, V157, P528; ERASO P, 1987, FEBS LETT, V224, P193, DOI 10.1016/0014-5793(87)80446-5; GHISLAIN M, 1991, J BIOL CHEM, V266, P18276; GOFFEAU A, 1981, BIOCHIM BIOPHYS ACTA, V639, P197, DOI 10.1016/0304-4173(81)90010-0; HARLOW E, 1988, ANTIBODIES LABORATOR; HARRIS SL, 1991, J BIOL CHEM, V266, P24439; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LJUNGDAHL PO, 1992, CELL, V71, P463, DOI 10.1016/0092-8674(92)90515-E; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCUSKER JH, 1987, MOL CELL BIOL, V7, P4082, DOI 10.1128/MCB.7.11.4082; NAVARRE C, 1992, J BIOL CHEM, V267, P6425; OBERTO J, 1985, GENE, V40, P57, DOI 10.1016/0378-1119(85)90024-1; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P186, DOI 10.1016/0968-0004(87)90090-9; PORTILLO F, 1989, EUR J BIOCHEM, V186, P501, DOI 10.1111/j.1432-1033.1989.tb15235.x; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; ROTH J, 1978, J HISTOCHEM CYTOCHEM, V26, P1074, DOI 10.1177/26.12.366014; Sambrook J, 1989, MOL CLONING LABORATO; SCARBOROUGH GA, 1984, ANN NY ACAD SCI, V402, P99; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHLESSER A, 1988, J BIOL CHEM, V263, P19480; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SCHUNCK WH, 1991, EUR J CELL BIOL, V55, P336; SELDEN RF, 1989, CURRENT PROTOCOLS MO; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; SERRANO R, 1988, BIOCHIM BIOPHYS ACTA, V947, P1, DOI 10.1016/0304-4157(88)90017-2; SIKORSKI RS, 1989, GENETICS, V122, P19; SUPPLY P, 1993, J BIOL CHEM, V268, P19753; TRECO DA, 1989, CURRENT PROTOCOLS MO; ULASZEWSKI S, 1987, J BIOL CHEM, V262, P223; ULASZEWSKI S, 1987, MOL GEN GENET, V207, P38, DOI 10.1007/BF00331488; VANDYCK L, 1990, EUR J BIOCHEM, V194, P785; VANTUINEN E, 1987, J HISTOCHEM CYTOCHEM, V35, P327, DOI 10.1177/35.3.3546482; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341; WACH A, 1992, J BIOENERG BIOMEMBR, V24, P309; WRIGHT R, 1988, J CELL BIOL, V107, P101, DOI 10.1083/jcb.107.1.101	43	77	78	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19744	19752						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366114				2022-12-27	WOS:A1993LW81900089
J	ZHANG, F; SHEPS, JA; LING, V				ZHANG, F; SHEPS, JA; LING, V			COMPLEMENTATION OF TRANSPORT-DEFICIENT MUTANTS OF ESCHERICHIA-COLI ALPHA-HEMOLYSIN BY 2ND-SITE MUTATIONS IN THE TRANSPORTER HEMOLYSIN-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PASTEURELLA-HAEMOLYTICA LEUKOTOXIN; TERMINAL SECRETION SIGNAL; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; FUNCTIONAL COMPLEMENTATION; DOMAIN; EXPORT; SUBSTITUTION; DETERMINANT; MUTAGENESIS	Hemolysin B (HlyB) is a membrane-bound transport protein composed of an amino-terminal multiple membrane-spanning portion followed by a conserved ATP binding sequence. Together with the inner membrane protein HlyD and the outer membrane protein TolC, HlyB is responsible for transport of the 107-kDa toxin HlyA from the cytoplasm, across both membranes of the cell envelope of Escherichia coli, directly to the medium. We have used a mutational approach to investigate a postulated interaction between HlyA and HlyB. We have isolated transport-deficient mutants of HlyA altered in the C-terminal signal sequence and used one of these, a deletion of 29 amino acids, to select compensatory mutants in the transporter protein HlyB. Fifteen mutants located at six different sites, all mapping within the amino-terminal multiple membrane-spanning domain of HlyB, were identified. All of the mutations are clustered into three groups located close to the predicted inner face of the cytoplasmic membrane. We propose that these locations are close to sites on HlyB that interact with the C-terminal signal sequence of HlyA. This interaction is likely to involve either binding of HlyA to HlyB or activation of the transport mechanism. The compensatory mutants also display different patterns of specificity in terms of their ability to transport different HlyA mutants. The fact that point mutations are able to compensate for drastic changes in the signal sequence of HlyA suggests that substrate specificity of transporters such as HlyB may shift dramatically during evolutionary history. This could account for the diversity of substrates observed for the ABC transporter superfamily in nature.	ONTARIO CANC INST, DIV MOLEC & STRUCT BIOL, TORONTO M4X 1K9, ONTARIO, CANADA; UNIV TORONTO, DEPT MED BIOPHYS, TORONTO M5S 1A1, ONTARIO, CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto								ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; CHU CT, 1979, VIROLOGY, V98, P168, DOI 10.1016/0042-6822(79)90535-X; DELEPELAIRE P, 1990, J BIOL CHEM, V265, P17118; DEVINE SE, 1992, P NATL ACAD SCI USA, V89, P4564, DOI 10.1073/pnas.89.10.4564; FATH MJ, 1991, J BACTERIOL, V173, P7549, DOI 10.1128/jb.173.23.7549-7556.1991; GENTSCHEV I, 1992, MOL GEN GENET, V232, P40, DOI 10.1007/BF00299135; GROS P, 1991, P NATL ACAD SCI USA, V88, P7289, DOI 10.1073/pnas.88.16.7289; HIGHLANDER SK, 1990, J BACTERIOL, V172, P2343, DOI 10.1128/jb.172.5.2343-2350.1990; HOLLAND IB, 1990, BIOCHIMIE, V72, P131, DOI 10.1016/0300-9084(90)90138-7; HOWARD JC, 1993, P NATL ACAD SCI USA, V90, P3777, DOI 10.1073/pnas.90.9.3777; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; JURANKA P, 1992, J BIOL CHEM, V267, P3764; JURANKA PF, 1989, FASEB J, V3, P2583, DOI 10.1096/fasebj.3.14.2574119; KENNY B, 1991, MOL MICROBIOL, V5, P2557, DOI 10.1111/j.1365-2958.1991.tb02102.x; KENNY B, 1992, MOL MICROBIOL, V6, P1477, DOI 10.1111/j.1365-2958.1992.tb00868.x; KUCHLER K, 1989, EMBO J, V8, P3973, DOI 10.1002/j.1460-2075.1989.tb08580.x; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MACKMAN N, 1985, MOL GEN GENET, V201, P282, DOI 10.1007/BF00425672; MASURE HR, 1990, BIOCHEMISTRY-US, V29, P140, DOI 10.1021/bi00453a017; RAYMOND M, 1992, SCIENCE, V256, P232, DOI 10.1126/science.1348873; SAFA AR, 1990, P NATL ACAD SCI USA, V87, P7225, DOI 10.1073/pnas.87.18.7225; Sambrook J, 1989, MOL CLONING LABORATO; STANLEY P, 1991, MOL MICROBIOL, V5, P2391, DOI 10.1111/j.1365-2958.1991.tb02085.x; STRATHDEE CA, 1989, J BACTERIOL, V171, P916, DOI 10.1128/jb.171.2.916-928.1989; THOMAS WD, 1992, J BACTERIOL, V174, P6771, DOI 10.1128/JB.174.21.6771-6779.1992; VALVERDE MA, 1992, NATURE, V355, P830, DOI 10.1038/355830a0; WANDERSMAN C, 1990, P NATL ACAD SCI USA, V87, P4776, DOI 10.1073/pnas.87.12.4776; ZHANG F, 1993, P NATL ACAD SCI USA, V90, P4211, DOI 10.1073/pnas.90.9.4211	29	31	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19889	19895						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366127				2022-12-27	WOS:A1993LW81900108
J	GARCIACALVO, M; LEONARD, RJ; NOVICK, J; STEVENS, SP; SCHMALHOFER, W; KACZOROWSKI, GJ; GARCIA, ML				GARCIACALVO, M; LEONARD, RJ; NOVICK, J; STEVENS, SP; SCHMALHOFER, W; KACZOROWSKI, GJ; GARCIA, ML			PURIFICATION, CHARACTERIZATION, AND BIOSYNTHESIS OF MARGATOXIN, A COMPONENT OF CENTRUROIDES-MARGARITATUS VENOM THAT SELECTIVELY INHIBITS VOLTAGE-DEPENDENT POTASSIUM CHANNELS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY BINDING-SITES; HUMAN LYMPHOCYTES-T; GATED K+ CHANNELS; XENOPUS-OOCYTES; FUNCTIONAL EXPRESSION; BLOCKING PEPTIDE; 3-DIMENSIONAL STRUCTURE; CHARYBDOTOXIN BLOCKS; DIRECT ASSOCIATION; SCORPION TOXINS	A novel peptidyl inhibitor of K+ channels has been purified to homogeneity from venom of the new world scorpion Centruroides margaritatus. The primary structure of this 39-amino-acid peptide, which we term margatoxin (MgTX), was determined by amino acid compositional analysis and peptide sequencing. Margatoxin potently inhibits binding of radiolabeled charybdotoxin (ChTX) to voltage-activated channels in brain synaptic plasma membranes. Like ChTX, MgTX blocks the n-type current of human T-lymphocytes (K(v)1.3 channel), but compared to ChTX, is 20-fold more potent (half-block at approximately 50 pM), has a slower dissociation rate, and has no effect on calcium-activated channels. To demonstrate that these characteristics are due solely to the purified toxin, recombinant MgTX was expressed in Escherichia coli as part of a fusion protein. After cleavage and folding, purified recombinant MgTX displayed the same properties as native peptide. Replacement of the COOH-terminal histidine residue of MgTX with asparagine resulted in a peptide with a 10-fold reduction in potency. This was due to a faster apparent dissociation rate, suggesting that the COOH-terminal amino acid may play an important role in the binding of MgTX to the K(v)1.3 channel. MgTX displays significant sequence homology with previously identified K+ channel inhibitors (e.g. ChTX, iberiotoxin, noxiustoxin, and kaliotoxin). However, given its potency and unique selectivity, MgTX represents an especially useful tool with which to study the physiologic role of K(v)1.3 channels.	MERCK SHARP & DOHME LTD,DEPT MEMBRANE BIOCHEM & BIOPHYS,RAHWAY,NJ 07065	Merck & Company								ALDRICH RW, 1990, COLD SPRING HARB SYM, V55, P19; ARKETT SA, 1992, J PHYSIOL-LONDON, V458, P633, DOI 10.1113/jphysiol.1992.sp019438; ATTALI B, 1992, J BIOL CHEM, V267, P8650; Ausubel FM, 1988, MOL REPROD DEV; BONTEMS F, 1992, BIOCHEMISTRY-US, V31, P7756, DOI 10.1021/bi00149a003; BONTEMS F, 1991, EUR J BIOCHEM, V196, P19, DOI 10.1111/j.1432-1033.1991.tb15780.x; BONTEMS F, 1991, SCIENCE, V254, P1521, DOI 10.1126/science.1720574; BUSCH AE, 1991, BIOCHEM BIOPH RES CO, V179, P1384, DOI 10.1016/0006-291X(91)91726-S; CAHALAN M, 1992, METHOD ENZYMOL, V207, P3; CARBONE E, 1987, PFLUG ARCH EUR J PHY, V408, P423, DOI 10.1007/BF00585064; CASTLE NA, 1986, FEBS LETT, V209, P117, DOI 10.1016/0014-5793(86)81095-X; CHANDY K G, 1992, Biophysical Journal, V61, pA257; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; CREST M, 1992, J BIOL CHEM, V267, P1640; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FOLANDER K, 1990, P NATL ACAD SCI USA, V87, P2975, DOI 10.1073/pnas.87.8.2975; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; GARCIA ML, 1991, J BIOENERG BIOMEMBR, V23, P615, DOI 10.1007/BF00785814; GARCIACALVO M, 1992, BIOPHYS J, V61, P377; GIMENEZGALLEGO G, 1988, P NATL ACAD SCI USA, V85, P3329, DOI 10.1073/pnas.85.10.3329; GOH JW, 1992, BRAIN RES, V591, P165, DOI 10.1016/0006-8993(92)90992-I; GOLDIN AL, 1991, METHOD CELL BIOL, V36, P487; HAUSDORFF SF, 1991, BIOCHEMISTRY-US, V30, P3341, DOI 10.1021/bi00227a025; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HERMANN A, 1987, J GEN PHYSIOL, V90, P27, DOI 10.1085/jgp.90.1.27; Hille B., 1992, IONIC CHANNELS EXCIT; HOWELL ML, 1989, J BIOL CHEM, V264, P15268; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; IVERSON LE, 1990, J NEUROSCI, V10, P2903; JAN LY, 1992, ANNU REV PHYSIOL, V54, P535, DOI 10.1146/annurev.physiol.54.1.535; JOHNSON BA, 1992, BIOCHEMISTRY-US, V31, P8151, DOI 10.1021/bi00150a006; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KAVANAUGH MP, 1992, NEURON, V8, P493, DOI 10.1016/0896-6273(92)90277-K; KAVANAUGH MP, 1991, J BIOL CHEM, V266, P7583; KIRSCH GE, 1992, BIOPHYS J, V62, P136, DOI 10.1016/S0006-3495(92)81800-3; LAMBERT P, 1990, BIOCHEM BIOPH RES CO, V170, P684, DOI 10.1016/0006-291X(90)92145-P; LEE SC, 1992, J GEN PHYSIOL, V99, P771, DOI 10.1085/jgp.99.5.771; LEONARD RJ, 1992, P NATL ACAD SCI USA, V89, P10094, DOI 10.1073/pnas.89.21.10094; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; LIN CS, 1993, J EXP MED, V177, P637, DOI 10.1084/jem.177.3.637; LUCCHESI K, 1989, J MEMBRANE BIOL, V109, P269, DOI 10.1007/BF01870284; LUNEAU CJ, 1991, P NATL ACAD SCI USA, V88, P3932, DOI 10.1073/pnas.88.9.3932; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MACKINNON R, 1988, NEURON, V1, P997, DOI 10.1016/0896-6273(88)90156-0; MCCORMACK K, 1990, BIOCHEM BIOPH RES CO, V171, P1361, DOI 10.1016/0006-291X(90)90836-C; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; NOVICK J, 1991, BIOPHYS J, V59, P78; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; OLIVA C, 1991, Biophysical Journal, V59, p450A; OLIVA C, 1991, Society for Neuroscience Abstracts, V17, P775; PARK CS, 1992, BIOCHEMISTRY-US, V31, P7749, DOI 10.1021/bi00149a002; PARK CS, 1992, NEURON, V9, P307, DOI 10.1016/0896-6273(92)90169-E; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; PHILIPSON LH, 1991, P NATL ACAD SCI USA, V88, P53, DOI 10.1073/pnas.88.1.53; PONGS O, 1989, Pfluegers Archiv European Journal of Physiology, V414, pS71, DOI 10.1007/BF00582251; PONGS O, 1992, TRENDS PHARMACOL SCI, V13, P359, DOI 10.1016/0165-6147(92)90109-J; POSSANI LD, 1982, CARLSBERG RES COMMUN, V47, P285, DOI 10.1007/BF02907789; PRICE M, 1989, P NATL ACAD SCI USA, V86, P10171, DOI 10.1073/pnas.86.24.10171; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; SANDS SB, 1989, J GEN PHYSIOL, V93, P1061, DOI 10.1085/jgp.93.6.1061; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; SANGUINETTI MC, 1991, AM J PHYSIOL, V260, pH393, DOI 10.1152/ajpheart.1991.260.2.H393; SCHWEITZ H, 1989, BIOCHEMISTRY-US, V28, P9708, DOI 10.1021/bi00451a025; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; STOCKER M, 1990, P NATL ACAD SCI USA, V87, P8903, DOI 10.1073/pnas.87.22.8903; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SUGG EE, 1990, J BIOL CHEM, V265, P18745; SWANSON R, 1992, METHOD ENZYMOL, V207, P310; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; VALDIVIA HH, 1988, FEBS LETT, V226, P280, DOI 10.1016/0014-5793(88)81439-X; VAZQUEZ J, 1990, J BIOL CHEM, V265, P15564; VAZQUEZ J, 1989, J BIOL CHEM, V264, P20902; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WOLFF D, 1988, J MEMBRANE BIOL, V106, P243, DOI 10.1007/BF01872162; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494	81	295	313	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18866	18874						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360176				2022-12-27	WOS:A1993LV65900074
J	HATTORI, M; ARAI, H; INOUE, K				HATTORI, M; ARAI, H; INOUE, K			PURIFICATION AND CHARACTERIZATION OF BOVINE BRAIN PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLASMA; FACTOR PAF; LIPID EXTRACT; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE-A2; 1-ALKYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE; CELLS; LYSOPHOSPHOLIPASE; DIFFERENTIATION; IDENTIFICATION	Platelet-activating factor (PAF) acetylhydrolase, which removes the acetyl moiety at the sn-2 position, has been found in plasma and tissue cytosol. PAF acetylhydrolase in bovine brain cytosol was chromatographically separated into three distinct fractions, all of which exhibited pH optima in the neutral to mild alkaline region and were unaffected by EDTA. We have purified the major fraction of the enzyme to near homogeneity. The purified enzyme had a molecular mass of about 100 kDa, as estimated by gel filtration chromatography, and gave three distinct bands of 45, 30, and 29 kDa, respectively, on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. These polypeptides exclusively co-migrated with the activity throughout the purification steps. These data suggest that this set of polypeptides corresponds to the subunits of bovine brain PAF acetylhydrolase. Diisopropyl fluorophosphate completely inhibited the activity at 0.1 mM. [H-3]Diisopropyl fluorophosphate labeled only the 29-kDa polypeptide, suggesting that this polypeptide possesses an active serine residue(s). The purified enzyme displayed similar activity against PAF and oxidatively modified phosphatidylcholine, but did not hydrolyze phosphatidylcholine or phosphatidylethanolamine with two long chain acyl groups. Thus, the intracellular PAF acetylhydrolase is likely to be a new member of the calcium-independent phospholipases A2 in mammalian tissues.	UNIV TOKYO,FAC PHARMACEUT SCI,DEPT HLTH CHEM,HONGO 7-3-1,BUNKYO KU,TOKYO 113,JAPAN	University of Tokyo			Hattori, Mitsuharu/F-3859-2010	Hattori, Mitsuharu/0000-0002-0503-4969				AARSMAN AJ, 1991, EUR J BIOCHEM, V200, P187, DOI 10.1111/j.1432-1033.1991.tb21066.x; BAZEN NG, 1970, BIOCHIM BIOPHYS ACTA, V218, P1; BLANK ML, 1981, J BIOL CHEM, V256, P175; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHIEN KR, 1978, J BIOL CHEM, V253, P4809; DEMOPOULOS H, 1977, OXYGEN PHYSL FUNCTIO, P49; DOI O, 1974, BIOCHIM BIOPHYS ACTA, V369, P64; DOMINGO MT, 1988, BIOCHEM BIOPH RES CO, V151, P730, DOI 10.1016/S0006-291X(88)80341-3; EDGER AD, 1982, J NEUROCHEM, V39, P1111; FARR RS, 1980, CLIN IMMUNOL IMMUNOP, V15, P318, DOI 10.1016/0090-1229(80)90044-6; GASSAMADIAGNE A, 1989, J BIOL CHEM, V264, P9470; GLENDE EA, 1986, BIOCHEM PHARMACOL, V35, P3301, DOI 10.1016/0006-2952(86)90427-2; HANAHAN DJ, 1986, ANNU REV BIOCHEM, V55, P483, DOI 10.1146/annurev.bi.55.070186.002411; HAZEN SL, 1990, J BIOL CHEM, V265, P10622; ITABE H, 1988, BIOCHIM BIOPHYS ACTA, V962, P8; KENZORA JL, 1984, J CLIN INVEST, V74, P1193, DOI 10.1172/JCI111528; KRIEGLSTEIN J, 1986, LIFE SCI, V39, P2237; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE TC, 1982, BIOCHEM BIOPH RES CO, V105, P1303, DOI 10.1016/0006-291X(82)90928-7; NATORI Y, 1983, J BIOCHEM-TOKYO, V93, P631, DOI 10.1093/oxfordjournals.jbchem.a134219; NIJSSEN JG, 1986, BIOCHIM BIOPHYS ACTA, V876, P611, DOI 10.1016/0005-2760(86)90050-0; OFLAHERTY JT, 1981, AM J PATHOL, V103, P70; PANNETA T, 1987, BIOCHEM BIOPH RES CO, V149, P580; PATEL KD, 1992, J BIOL CHEM, V267, P15168; SHIMOJO T, 1974, J LIPID RES, V15, P525; SMILEY PL, 1991, J BIOL CHEM, V266, P11104; SNYDER F, 1985, MED RES REV, V5, P107, DOI 10.1002/med.2610050105; SPINNEWYN B, 1987, PROSTAGLANDINS, V34, P337, DOI 10.1016/0090-6980(87)90079-7; STAFFORINI DM, 1991, LIPIDS, V26, P979, DOI 10.1007/BF02536488; STAFFORINI DM, 1989, P NATL ACAD SCI USA, V86, P2393, DOI 10.1073/pnas.86.7.2393; STAFFORINI DM, 1993, J BIOL CHEM, V268, P3857; STAFFORINI DM, 1990, J BIOL CHEM, V265, P9682; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4223; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4215; STEINBRECHER UP, 1989, J LIPID RES, V30, P305; STREMLER KE, 1989, J BIOL CHEM, V264, P5331; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; TARBET EB, 1991, J BIOL CHEM, V266, P16667; TOKUMURA A, 1989, J LIPID RES, V30, P219; TOKUMURA A, 1988, BIOCHEM BIOPH RES CO, V155, P863, DOI 10.1016/S0006-291X(88)80575-8; WARDLOW ML, 1986, J IMMUNOL, V136, P3441; YANOSHITA R, 1988, J BIOCHEM-TOKYO, V103, P815, DOI 10.1093/oxfordjournals.jbchem.a122352; YASAKA T, 1982, J IMMUNOL, V128, P1939; ZHANG Y, 1988, J BIOL CHEM, V263, P9965	44	159	171	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18748	18753						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360169				2022-12-27	WOS:A1993LV65900060
J	MATARESE, V; LODISH, HF				MATARESE, V; LODISH, HF			SPECIFIC UPTAKE OF RETINOL-BINDING PROTEIN BY VARIANT F9 CELL-LINES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERATOCARCINOMA STEM-CELLS; PIGMENT EPITHELIUM; MEMBRANE-RECEPTOR; MESSENGER-RNAS; DIBUTYRYL-CAMP; CDNA CLONES; CYCLIC-AMP; VITAMIN-A; ACID; DIFFERENTIATION	Serum retinol-binding protein (RBP) specifically binds to and is internalized by F9 embryonal carcinoma cells. Monolayers of F9 cells were differentiated into a primitive endoderm stage by addition of retinoic acid. Fluorescein-derivatized or radiolabeled RBP associated with F9 cell monolayers at 37-degrees-C in a time- and concentration-dependent manner. Competition by simultaneous incubation with excess unlabeled RBP indicated that this association was specific and saturable; the apparent dissociation constant was 200-300 nM using either tracer. At 37-degrees-C, over 80% of the cell-associated RBP was internalized, and only a small fraction was bound to the cell surface; fluorescence microscopy indicated that internalized RBP was in small vesicles within the cytoplasm. Internalized RBP was subsequently degraded and released from the cell in an acid-soluble form. Parental F9 cells were heterogeneous in their ability to associate with RBP. Random subcloning identified natural variant F9 cell lines which did, or did not, express this biological activity upon retinoic acid-induced differentiation. The clonal nature of the capacity for RBP uptake suggests that this specific internalization is a heritable trait. Together, these observations provide strong evidence that RBP uptake occurs by a receptor-mediated process in F9 cells. The cycle of RBP internalization and degradation by F9 cells bearing specific RBP receptors may provide a regulable mechanism for the cellular accumulation of serum retinol.	WHITEHEAD INST BIOMED RES,9 CAMBRIDGE CTR,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)			Matarese, Valerie/ABE-1606-2020	Matarese, Valerie/0000-0003-2687-194X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041484] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-41484] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAVIK CO, 1991, J BIOL CHEM, V266, P14978; BERNSTINE EG, 1973, P NATL ACAD SCI USA, V70, P3899, DOI 10.1073/pnas.70.12.3899; COWAN SW, 1990, PROTEINS, V8, P44, DOI 10.1002/prot.340080108; CROCE CM, 1981, P NATL ACAD SCI-BIOL, V78, P5754, DOI 10.1073/pnas.78.9.5754; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; DE LUCA LM, 1991, FASEB J, V5, P2924; DETHE H, 1987, NATURE, V330, P667, DOI 10.1038/330667a0; ERIKSSON U, 1986, CANCER RES, V46, P717; FEX G, 1988, BIOCHIM BIOPHYS ACTA, V944, P249, DOI 10.1016/0005-2736(88)90438-5; FEX G, 1987, BIOCHIM BIOPHYS ACTA, V901, P255, DOI 10.1016/0005-2736(87)90122-2; GJOEN T, 1987, J BIOL CHEM, V262, P10926; GONDA TJ, 1982, MOL CELL BIOL, V2, P617, DOI 10.1128/MCB.2.6.617; GROVER A, 1983, J CELL BIOL, V96, P1690, DOI 10.1083/jcb.96.6.1690; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HELLER J, 1975, J BIOL CHEM, V250, P3613; HORWITZ J, 1973, J BIOL CHEM, V248, P6317; HU L, 1990, MOL CELL BIOL, V10, P391, DOI 10.1128/MCB.10.1.391; MARTIN CA, 1990, P NATL ACAD SCI USA, V87, P4804, DOI 10.1073/pnas.87.12.4804; NEWCOMER ME, 1984, EMBO J, V3, P1451, DOI 10.1002/j.1460-2075.1984.tb01995.x; NOY N, 1990, BIOCHEMISTRY-US, V29, P3878, DOI 10.1021/bi00468a012; PARNES JR, 1982, CELL, V29, P661, DOI 10.1016/0092-8674(82)90182-9; PFEFFER BA, 1986, INVEST OPHTH VIS SCI, V27, P1031; RASK L, 1976, J BIOL CHEM, V251, P6360; RICKLES RJ, 1989, MOL CELL BIOL, V9, P1691, DOI 10.1128/MCB.9.4.1691; RICKLES RJ, 1988, J BIOL CHEM, V263, P1563; SENOO H, 1990, J LIPID RES, V31, P1229; SHINGLETON JL, 1989, BIOCHEMISTRY-US, V28, P9641, DOI 10.1021/bi00451a015; SIVAPRASADARAO A, 1988, BIOCHEM J, V255, P561; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; STRICKLAND S, 1980, CELL, V21, P347, DOI 10.1016/0092-8674(80)90471-7; STRICKLAND S, 1981, CELL, V24, P277, DOI 10.1016/0092-8674(81)90313-5; VAHLQUIST A, 1971, EUR J BIOCHEM, V20, P160, DOI 10.1111/j.1432-1033.1971.tb01374.x; WOLF G, 1991, NUTR REV, V49, P1, DOI 10.1111/j.1753-4887.1991.tb07349.x; WOOD L, 1988, FEBS LETT, V227, P5, DOI 10.1016/0014-5793(88)81402-9	34	18	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18859	18865						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360175				2022-12-27	WOS:A1993LV65900073
J	BHATIA, MB; DELPOZO, AM; RINGE, D; YOSHIMURA, T; SODA, K; MANNING, JM				BHATIA, MB; DELPOZO, AM; RINGE, D; YOSHIMURA, T; SODA, K; MANNING, JM			ROLE REVERSAL FOR SUBSTRATES AND INHIBITORS - SLOW INACTIVATION OF D-AMINO-ACID TRANSAMINASE BY ITS NORMAL SUBSTRATES AND PROTECTION BY INHIBITORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; MITOCHONDRIAL ASPARTATE-AMINOTRANSFERASE; BINDING-SITE; RESIDUE; LYSINE; ENZYME	D-Amino acid transaminase, which catalyzes the synthesis of D-alanine and D-glutamate for the bacterial cell wall, is a candidate for the design of specific inhibitors that could be novel antimicrobial agents. Under the experimental conditions usually employed for enzyme assays, kinetic parameters for its substrates were determined for short incubation periods, when intermediates and products do not accumulate and the enzyme activity is linear with time. Such kinetic analyses indicate that the enzyme accepts MoSt D-amino acids but D-aspartate and D-glutamate are the best substrates. Under a different type of experimental conditions when the enzyme is exposed to D-alanine, intermediates, and products for periods of hours, it slowly becomes inactivated (Martinez del Pozo, A., Yoshimura, T., Bhatia, M. B., Futaki, S., and Manning, J. M. (1992) Biochemistry 31, 6018-6023). We now report that D-aspartate, D-glutamate, and L-alanine also lead to slow inactivation. Methylation or amidation of the alpha-COOH group of D-alanine prevents inactivation, indicating that decarboxylation is required for inactivation; the slow release of CO2 from substrate is demonstrated. The alpha-methyl analog of D-alanine, D-aspartate, and D-glutamate do not lead to inactivation, showing that the alpha-hydrogen of the substrate is required, i.e. that some processing is required. Lys145, which binds pyridoxal 5'-phosphate in the wild-type enzyme, is not involved in the inactivation since two active site mutant enzymes, K145Q and K145N, are also inactivated. Reactivation of the inactive enzyme at acidic pH is accompanied by the release of ammonia corresponding to 1 mol/mol of dimeric enzyme. Competitive inhibitors, amine-containing buffers, and thiols effectively impede the inactivation. This reversal in the roles of substrates and inhibitors, i.e. when a substrate can be an inactivator and an inhibitor can act as a protector, occurs during a time period not usually used to measure steady-state kinetics or initial velocities of enzyme reactions and could have physiological relevance in cells.	ROCKEFELLER UNIV,NEW YORK,NY 10021; BRANDEIS UNIV,WALTHAM,MA 02254; KYOTO UNIV,UJI,KYOTO 611,JAPAN	Rockefeller University; Brandeis University; Kyoto University			Martinez-del-Pozo, Alvaro/L-8556-2014	Martinez-del-Pozo, Alvaro/0000-0003-0043-5939	NCRR NIH HHS [507-RR-07065] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BHATIA MB, 1993, J BIOL CHEM, V268, P6932; BRAUNSTEIN AE, 1972, ENZYMES, P379; Cleland W W, 1979, Methods Enzymol, V63, P103; CRONIN CN, 1988, BIOCHEMISTRY-US, V27, P4572, DOI 10.1021/bi00412a052; DELPOZO AM, 1992, BIOCHEMISTRY-US, V31, P6018, DOI 10.1021/bi00141a009; DELPOZO AM, 1989, J BIOL CHEM, V264, P17784; DELPOZO AM, 1989, BIOCHEMISTRY-US, V28, P510, DOI 10.1021/bi00428a015; FORD GC, 1980, P NATL ACAD SCI-BIOL, V77, P2559, DOI 10.1073/pnas.77.5.2559; Fox B.W., 1976, TECHNIQUES SAMPLE PR; FUTAKI S, 1990, J BIOL CHEM, V265, P22306; HUNTLEY TE, 1967, S PYRIDOXAL ENZYMES, P81; JENKINS WT, 1966, J BIOL CHEM, V241, P5567; JOHN RA, 1980, ENZYME INHIBITORS DR, P73; JONES WM, 1985, METHOD ENZYMOL, V113, P108; LIKOS JJ, 1982, BIOCHEMISTRY-US, V21, P4377, DOI 10.1021/bi00261a029; MANNING JM, 1974, P NATL ACAD SCI USA, V71, P417, DOI 10.1073/pnas.71.2.417; MARTINEZCARRION M, 1965, J BIOL CHEM, V210, P3538; MARTINEZCARRION M, 1965, J BIOL CHEM, V210, P3547; MASON M, 1959, J BIOL CHEM, V234, P2770; MEROLA M, 1989, BIOCHEMISTRY-US, V28, P505, DOI 10.1021/bi00428a014; MICHUDA CM, 1970, J BIOL CHEM, V245, P262; Miles E.W., 1985, TRANSAMINASES, P470; MORINO Y, 1972, BIOCHEM BIOPH RES CO, V47, P498, DOI 10.1016/0006-291X(72)90742-5; MORINO Y, 1974, J BIOL CHEM, V249, P6684; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; NOVOGRODSKY A, 1964, J BIOL CHEM, V239, P879; OLEARY MH, 1977, J BIOL CHEM, V252, P7168; SANDMEIER E, 1982, J BIOL CHEM, V257, P6745; SOPER TS, 1982, J BIOL CHEM, V257, P3930; SUKHAREVA B S, 1971, Molekulyarnaya Biologiya (Moscow), V5, P302; TANIZAWA K, 1989, J BIOL CHEM, V264, P2445; TANIZAWA K, 1989, J BIOL CHEM, V264, P2450; YOSHIMURA T, 1992, BIOCHEMISTRY-US, V31, P11748, DOI 10.1021/bi00162a011	33	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17687	17694						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349653				2022-12-27	WOS:A1993LT74300011
J	WIELAND, T; NURNBERG, B; ULIBARRI, I; KALDENBERGSTASCH, S; SCHULTZ, G; JAKOBS, KH				WIELAND, T; NURNBERG, B; ULIBARRI, I; KALDENBERGSTASCH, S; SCHULTZ, G; JAKOBS, KH			GUANINE NUCLEOTIDE-SPECIFIC PHOSPHATE TRANSFER BY GUANINE-NUCLEOTIDE-BINDING REGULATORY PROTEIN BETA-SUBUNITS - CHARACTERIZATION OF THE PHOSPHORYLATED AMINO-ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE-DIPHOSPHATE KINASE; ROD OUTER SEGMENTS; FORMYL-PEPTIDE; HL-60 CELLS; SIGNAL TRANSDUCTION; HORMONAL INHIBITION; ADENYLATE-CYCLASE; GAMMA-SUBUNITS; ALPHA-SUBUNIT; RECEPTOR	One major substrate protein was phosphorylated with [gamma-P-32]GTP in membranes of human leukemia (HL-60) cells. The phosphoprotein comigrated with beta-subunits of heterotrimeric GTP-binding proteins (G proteins) in different gel systems. Upon solubilization of the phosphorylated membranes, the phosphoprotein could be immunoprecipitated by a G protein beta-subunit-specific antiserum. The beta-subunit phosphorylation was transient and was found to be specific for GTP and its analog, guanosine 5'-O-(gamma-thio)triphosphate. When phosphorylated membranes were incubated with various nucleotides, the bound phosphate was specifically removed by GDP, suggesting that the phosphate can be retransferred onto GDP. Divalent cations, preferentially Mg2+ and Mn2+, were required for both phosphorylation and dephosphorylation. The phosphorylation was stable against treatment with NaOH but sensitive to treatment with heat, HCl, and hydroxylamine. Moreover, treatment of the membranes with the histidine-modifying agent, diethyl pyrocarbonate, resulted in a loss in phosphate incorporation. The data suggest that G protein beta-subunits are involved in a guanine nucleotide-specific enzymatic activity transferring the gamma-phosphate from GTP to GDP, presumably at G protein alpha-subunits, via a phosphohistidine intermediate.	FREE UNIV BERLIN,INST PHARMAKOL,W-1000 BERLIN 33,GERMANY	Free University of Berlin	WIELAND, T (corresponding author), UNIV ESSEN GESAMTHSCH,INST PHARMAKOL,HUFELANDSTR 55,W-4300 ESSEN 1,GERMANY.		Wieland, Thomas/G-1772-2012; Wieland, Thomas/Q-1506-2019	Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261; Nurnberg, Bernd/0000-0002-5995-6555				AMIRZALTSMAN Y, 1989, MOL CELL ENDOCRINOL, V63, P175, DOI 10.1016/0303-7207(89)90094-4; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; Bitte L, 1974, Methods Enzymol, V30, P563; Bridger W. A., 1974, ENZYMES, P581; ECKSTEIN F, 1985, ANNU REV BIOCHEM, V54, P367, DOI 10.1146/annurev.bi.54.070185.002055; FAWZI AB, 1990, BIOCHEMISTRY-US, V29, P3804, DOI 10.1021/bi00467a030; FLORIO VA, 1989, J BIOL CHEM, V264, P3909; FLORIO VA, 1985, J BIOL CHEM, V260, P3477; FUNG BKK, 1983, J BIOL CHEM, V258, P495; GIERSCHIK P, 1989, J BIOL CHEM, V264, P21470; GIERSCHIK P, 1989, EUR J BIOCHEM, V183, P97, DOI 10.1111/j.1432-1033.1989.tb14901.x; GIERSCHIK P, 1990, G PROTEINS MEDIATORS, P67; GILLES AM, 1991, J BIOL CHEM, V266, P8784; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOODY RS, 1972, BIOCHIM BIOPHYS ACTA, V276, P155, DOI 10.1016/0005-2744(72)90016-2; HICKEY ME, 1972, ARCH BIOCHEM BIOPHYS, V152, P423, DOI 10.1016/0003-9861(72)90232-9; HINSCH KD, 1989, BIOCHIM BIOPHYS ACTA, V1013, P60, DOI 10.1016/0167-4889(89)90128-6; HOKIN LE, 1965, P NATL ACAD SCI USA, V54, P177, DOI 10.1073/pnas.54.1.177; JAKOBS KH, 1978, FEBS LETT, V85, P167, DOI 10.1016/0014-5793(78)81272-1; KATADA T, 1985, EUR J BIOCHEM, V151, P431, DOI 10.1111/j.1432-1033.1985.tb09120.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Miles E W, 1977, Methods Enzymol, V47, P431; OFFERMANS S, 1990, FEBS LETT, V260, P14, DOI 10.1016/0014-5793(90)80054-M; PARKS RW, 1983, ENZYMES, V8, P307; RAMDAS L, 1991, BIOCHEMISTRY-US, V30, P11637, DOI 10.1021/bi00114a005; SCHEPERS TM, 1992, J BIOL CHEM, V267, P159; SCHMIDT A, 1991, J BIOL CHEM, V266, P18025; SEIFERT R, 1988, EUR J BIOCHEM, V175, P51, DOI 10.1111/j.1432-1033.1988.tb14165.x; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SPICHER K, 1992, FEBS LETT, V307, P215, DOI 10.1016/0014-5793(92)80770-H; SPICHER K, 1991, BIOCHEM BIOPH RES CO, V175, P473, DOI 10.1016/0006-291X(91)91588-4; STRYER L, 1986, ANNU REV CELL BIOL, V2, P391, DOI 10.1146/annurev.cb.02.110186.002135; VANETTEN RL, 1977, ARCH BIOCHEM BIOPHYS, V183, P250, DOI 10.1016/0003-9861(77)90438-6; VANETTEN RL, 1974, J AM CHEM SOC, V96, P6782, DOI 10.1021/ja00828a053; WALSETH TF, 1979, BIOCHIM BIOPHYS ACTA, V562, P11, DOI 10.1016/0005-2787(79)90122-9; WATKINS PA, 1980, J BIOL CHEM, V255, P3959; WENDLAND M, 1991, J BIOL CHEM, V266, P2917; WIELAND T, 1991, EUR J BIOCHEM, V196, P707, DOI 10.1111/j.1432-1033.1991.tb15869.x; WIELAND T, 1992, J BIOL CHEM, V267, P20791; WIELAND T, 1992, EUR J BIOCHEM, V205, P1201, DOI 10.1111/j.1432-1033.1992.tb16891.x; WIELAND T, 1991, EUR J PHARM-MOLEC PH, V208, P17, DOI 10.1016/0922-4106(91)90046-K; WITKOWSKI A, 1991, J BIOL CHEM, V266, P18514; YAMAZAKI A, 1987, J BIOL CHEM, V262, P9316; YOUNT RG, 1975, ADV ENZYMOL RAMB, V43, P1	44	102	107	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18111	18118						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349688				2022-12-27	WOS:A1993LT74300070
J	SULO, P; MARTIN, NC				SULO, P; MARTIN, NC			ISOLATION AND CHARACTERIZATION OF LIP5 - A LIPOATE BIOSYNTHETIC LOCUS OF SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE CLEAVAGE SYSTEM; TRANSFER RNA-SYNTHETASE; GROUP-I INTRONS; ESCHERICHIA-COLI; LIPOIC ACID; TRANSCRIPTION TERMINATION; PYRUVATE-DEHYDROGENASE; PROTEIN-SYNTHESIS; YEAST; MITOCHONDRIAL	A number of mutants with pleiotropic effects on mitochondrial metabolism have been isolated in yeast Saccharomyces cerevisiae, and for many the biochemical function that is impaired is not yet known. We report here the isolation and characterization of the LIP5 gene involved in lipoic acid metabolism which complements the g189 mutant (Tzagoloff, A., and Dieckmann, C. L. (1990) Microbiol. Rev. 54, 211-225). DNA sequence analysis of complementing yeast genomic DNA revealed an open reading frame predicting a protein of 414 amino acids. The protein sequence deduced from the gene shares 43% identical residues with the product of the Escherichia coli lip gene, which codes an enzyme involved in lipoic acid synthesis. The LIP5 mutant is not capable of synthesizing lipoic acid but still possesses the activity necessary for attachment of lipoic acid to protein. Relative to the E. coli lip gene product, the LIP5 protein has an amino-terminal extension with characteristics of mitochondrial targeting signals. Cells carrying a disrupted copy of the LIP5 gene show slow growth on ethanol-rich media and barely detectable growth on glycerol-rich media. Unlike other strains with defects in the tricarboxylic acid cycle, LIP5 mutants undergo a high frequency of mitochondrial DNA deletions.	UNIV LOUISVILLE, DEPT BIOCHEM, LOUISVILLE, KY 40292 USA	University of Louisville			Sulo, Pavol/AAC-3981-2019	Sulo, Pavol/0000-0003-1845-9031				AKINS RA, 1987, CELL, V50, P331, DOI 10.1016/0092-8674(87)90488-0; ALI ST, 1990, MOL MICROBIOL, V4, P943, DOI 10.1111/j.1365-2958.1990.tb00667.x; BECKER DM, 1991, METHOD ENZYMOL, V194, P182; BOURGUIGNON J, 1992, EUR J BIOCHEM, V204, P865, DOI 10.1111/j.1432-1033.1992.tb16706.x; BROOKFIELD DE, 1991, FEBS LETT, V295, P13, DOI 10.1016/0014-5793(91)81373-G; CIGAN AM, 1987, GENE, V59, P1; DEMOLL E, 1983, BIOCHEM BIOPH RES CO, V110, P243, DOI 10.1016/0006-291X(83)91286-X; DICKINSON JR, 1986, MOL GEN GENET, V204, P103; DIFFLEY JFX, 1991, P NATL ACAD SCI USA, V88, P7864, DOI 10.1073/pnas.88.17.7864; Dupre S, 1983, Prog Clin Biol Res, V125, P343; FUJIWARA K, 1990, J BIOL CHEM, V265, P17463; GUARENTE L, 1987, ANNU REV GENET, V21, P425, DOI 10.1146/annurev.genet.21.1.425; HAYDEN MA, 1992, J BIOL CHEM, V267, P9512; HENIKOFF S, 1984, MOL CELL BIOL, V4, P1515, DOI 10.1128/MCB.4.8.1515; HENRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056; HERBERT A. A., 1970, Methods in Enzymology, V18A, P269, DOI 10.1016/0076-6879(71)18314-0; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HOLLINGSWORTH MJ, 1986, MOL CELL BIOL, V6, P1058, DOI 10.1128/MCB.6.4.1058; KAMPER U, 1992, MOL CELL BIOL, V12, P499; KLOET SRJ, 1984, MICROBIOL METHODS, V2, P189; KOTYLAK Z, 1977, MITOCHONDRIA 1977 GE, P183; KOVACOVA V, 1968, BIOCHIM BIOPHYS ACTA, V162, P157, DOI 10.1016/0005-2728(68)90097-2; LABOUESSE M, 1990, MOL GEN GENET, V224, P209, DOI 10.1007/BF00271554; Maniatis T, 1989, MOL CLONING; MARTIN NC, 1985, J BIOL CHEM, V260, P1479; MORALES MJ, 1989, NUCLEIC ACIDS RES, V17, P6865, DOI 10.1093/nar/17.17.6865; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; PARRY RJ, 1983, TETRAHEDRON, V39, P1215, DOI 10.1016/S0040-4020(01)91887-3; PAUL MF, 1989, EUR J BIOCHEM, V185, P163, DOI 10.1111/j.1432-1033.1989.tb15098.x; PEARSON WR, 1989, P NATL ACAD SCI USA, V86, P2444; REED LJ, 1990, J BIOL CHEM, V265, P8971; REPETTO B, 1989, MOL CELL BIOL, V9, P2695, DOI 10.1128/MCB.9.6.2695; RICHARME G, 1985, J BACTERIOL, V162, P286, DOI 10.1128/JB.162.1.286-293.1985; RUSSO P, 1991, EMBO J, V10, P563, DOI 10.1002/j.1460-2075.1991.tb07983.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHARP PM, 1991, YEAST, V7, P657, DOI 10.1002/yea.320070702; Sherman F., 1983, METHODS YEAST GENETI; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; VANDENBOOM TJ, 1991, J BACTERIOL, V173, P6411, DOI 10.1128/jb.173.20.6411-6420.1991; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WHITE RH, 1980, BIOCHEMISTRY-US, V19, P15, DOI 10.1021/bi00542a003; WU M, 1987, J BIOL CHEM, V262, P12275; YEAMAN SJ, 1989, BIOCHEM J, V257, P625, DOI 10.1042/bj2570625; ZARET KS, 1982, CELL, V28, P563, DOI 10.1016/0092-8674(82)90211-2; ZIMMER G, 1991, ARCH BIOCHEM BIOPHYS, V288, P609, DOI 10.1016/0003-9861(91)90243-C	45	65	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17634	17639						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349643				2022-12-27	WOS:A1993LQ98800107
J	YOSHIMURA, M; COOPER, DMF				YOSHIMURA, M; COOPER, DMF			TYPE-SPECIFIC STIMULATION OF ADENYLYLCYCLASE BY PROTEIN-KINASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							BETA-ADRENERGIC-RECEPTOR; PHORBOL ESTER RECEPTOR; ADENYLATE-CYCLASE; RAT-BRAIN; EXPRESSION; CLONING; PHOSPHORYLATION; INHIBITION; MECHANISMS; PATHWAYS	Ca2+-stimulable (type I), Ca2+-insensitive (type II), and Ca2+-inhibitable adenylylcyclase (type VI) were transiently expressed in the human embryonic kidney 293 cell line. Phorbol 12,13-dibutyrate (PDBu) increased cAMP synthesis by the Ca2+-insensitive type II adenylylcyclase more than 9-fold within 10 min, while the treatment had no effect on the other two types of adenylylcyclases. This stimulatory effect of PDBu on type II activity was dose-dependent and synergistic with the effect of forskolin. Another phorbol ester, phorbol 12-myristate 13-acetate (PMA), had a similar stimulatory effect on type II activity, while its inactive isomer, 4alpha-phorbol 12-myristate 13-acetate (4alpha-PMA), had no effect. Staurosporine, a potent protein kinase C (PKC) inhibitor, markedly attenuated the action of PDBu on cAMP synthesis by type II adenylylcyclase. These results are particularly significant in that they indicate that a species of adenylylcyclase that is insensitive to regulation by one arm of the phosphatidylinositide pathway, i.e. Ca2+, nevertheless can be regulated by the other arm, i.e. PKC.	UNIV COLORADO,HLTH SCI CTR,DEPT PHARMACOL,BOX C-236,4200 E 9TH AVE,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032483] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 32483] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIYAR N, 1992, CELL CALCIUM MOL PHA, V31, P180; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; ASHENDEL CL, 1985, BIOCHIM BIOPHYS ACTA, V822, P219, DOI 10.1016/0304-4157(85)90009-7; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; CALDWELL KK, 1992, CELL CALCIUM, V13, P107, DOI 10.1016/0143-4160(92)90004-C; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOI EJ, 1992, BIOCHEMISTRY-US, V31, P6492, DOI 10.1021/bi00143a019; COLVIN RA, 1991, CELL CALCIUM, V12, P19, DOI 10.1016/0143-4160(91)90081-O; COOPER DMF, 1988, J CELL BIOCHEM, V36, P417, DOI 10.1002/jcb.240360410; DIXON BS, 1988, AM J PHYSIOL, V254, pC183, DOI 10.1152/ajpcell.1988.254.1.C183; EVANS T, 1984, MOL PHARMACOL, V26, P395; FEINSTEIN PG, 1991, P NATL ACAD SCI USA, V88, P10173, DOI 10.1073/pnas.88.22.10173; FUCHS R, 1991, COMPUT APPL BIOSCI, V7, P105; GAO BN, 1991, P NATL ACAD SCI USA, V88, P10178, DOI 10.1073/pnas.88.22.10178; GARTE SJ, 1980, NATURE, V284, P171, DOI 10.1038/284171a0; HOUSLAY MD, 1991, EUR J BIOCHEM, V195, P9, DOI 10.1111/j.1432-1033.1991.tb15671.x; ISHIKAWA Y, 1992, J BIOL CHEM, V267, P13553; KATADA T, 1985, EUR J BIOCHEM, V151, P431, DOI 10.1111/j.1432-1033.1985.tb09120.x; KATSUSHIKA S, 1992, P NATL ACAD SCI USA, V89, P8774, DOI 10.1073/pnas.89.18.8774; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; MONS N, 1993, IN PRESS SYNAPSE; NAKADATE T, 1988, BIOCHEM PHARMACOL, V37, P1541, DOI 10.1016/0006-2952(88)90016-0; NARAYANAN N, 1989, ENDOCRINOLOGY, V124, P484, DOI 10.1210/endo-124-1-484; PREMONT RT, 1992, P NATL ACAD SCI USA, V89, P9809, DOI 10.1073/pnas.89.20.9809; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SIBLEY DR, 1984, BIOCHEM BIOPH RES CO, V121, P973, DOI 10.1016/0006-291X(84)90772-1; TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6; TANG WJ, 1991, J BIOL CHEM, V266, P8595; WORLEY PF, 1986, J NEUROSCI, V6, P199; YOSHIMASA T, 1987, NATURE, V327, P67, DOI 10.1038/327067a0; YOSHIMURA M, 1992, P NATL ACAD SCI USA, V89, P6716, DOI 10.1073/pnas.89.15.6716	31	180	183	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1993	268	7					4604	4607						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP884	8383119				2022-12-27	WOS:A1993KP88400010
J	KIJIMA, Y; SAITO, A; JETTON, TL; MAGNUSON, MA; FLEISCHER, S				KIJIMA, Y; SAITO, A; JETTON, TL; MAGNUSON, MA; FLEISCHER, S			DIFFERENT INTRACELLULAR-LOCALIZATION OF INOSITOL 1,4,5-TRISPHOSPHATE AND RYANODINE RECEPTORS IN CARDIOMYOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; RELEASE CHANNELS; CALCIUM-RELEASE; PLASMA-MEMBRANE; SMOOTH-MUSCLE; CA-2+ RELEASE; PROTEIN; HEART; HYDROLYSIS	The ryanodine and inositol 1,4,5-trisphosphate (IP3) receptors have previously been found to be intracellular Ca2+ release channels characterized by their large size and 4-fold symmetry. In this study, cardiomyocytes are found to have a different intracellular localization for the two receptors. At the level of light microscopy, the IP3 receptor is immunolocalized in rat ventricular cardiomyocytes at the region of the intercalated discs. By contrast, immunoreactivity of the ryanodine receptor is observed as transverse bands throughout the length of the cardiomyocyte, coincident with the triad junction at the I-bands. At the level of electron microscopy, immunogold particles directed to the IP3 receptor specifically decorate the intercalated discs of rat ventricular and atrial cardiomyocytes, preferentially at the fascia adherens. Binding of [H-3] IP3 and [H-3]ryanodine were measured in cardiac subcellular fractions. IP3 binding is enriched in a fraction containing intercalated discs. Little or no IP3 binding was detected in longitudinal sareoplasmic reticulum (SR), junctional SR, sarcolemma, mitochondria, and submitochondrial vesicles. Ryanodine binding is the highest in junctional SR. We conclude that the IP3 receptor is present in ventricular and atrial cardiomyocytes and localized at the region of the intercalated discs. These results suggest a possible role of the IP3 receptor in Ca2+ entry through intercalated discs and/or intercellular signaling between cardiomyocytes.	VANDERBILT UNIV, MED CTR, SCH MED, DEPT MOLEC PHYSIOL & BIOPHYS, NASHVILLE, TN 37232 USA	Vanderbilt University	KIJIMA, Y (corresponding author), VANDERBILT UNIV, DEPT MOLEC BIOL, NASHVILLE, TN 37235 USA.		Magnuson, Mark/AAY-7172-2021; Magnuson, Mark A/B-1335-2009	Magnuson, Mark/0000-0002-8824-6499; Magnuson, Mark A/0000-0002-8824-6499	NHLBI NIH HHS [P01-HL46681, HL32711] Funding Source: Medline; NIDDK NIH HHS [DK42612] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032711, P01HL046681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042612] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BOCK HG, 1974, METHOD ENZYMOL, V31, P374; BORGATTA L, 1991, P NATL ACAD SCI USA, V88, P2486, DOI 10.1073/pnas.88.6.2486; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN JH, 1985, CIRC RES, V57, P532, DOI 10.1161/01.RES.57.4.532; CHADWICK CC, 1990, P NATL ACAD SCI USA, V87, P2132, DOI 10.1073/pnas.87.6.2132; CHAMBERLAIN BK, 1983, J BIOL CHEM, V258, P6602; ECKEL J, 1991, J MOL CELL CARDIOL, V23, P617, DOI 10.1016/0022-2828(91)90053-O; FABIATO A, 1990, RECENT ADVANCES IN CALCIUM CHANNELS AND CALCIUM ANTAGONISTS, P35; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FLEISCHER S, 1985, P NATL ACAD SCI USA, V82, P7256, DOI 10.1073/pnas.82.21.7256; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.bb.18.060189.002001; FURUICHI T, 1990, FEBS LETT, V267, P85, DOI 10.1016/0014-5793(90)80294-S; IMAGAWA T, 1989, J BIOCHEM-TOKYO, V106, P342, DOI 10.1093/oxfordjournals.jbchem.a122855; INUI M, 1987, J BIOL CHEM, V262, P15637; INUI M, 1988, J BIOL CHEM, V263, P10843; JONES LR, 1979, J BIOL CHEM, V254, P530; KAWAMOTO RM, 1986, J CELL BIOL, V103, P1405, DOI 10.1083/jcb.103.4.1405; KENSLER RW, 1980, J CELL BIOL, V86, P755, DOI 10.1083/jcb.86.3.755; KENTISH JC, 1990, AM J PHYSIOL, V258, pH610, DOI 10.1152/ajpheart.1990.258.2.H610; KHAN AA, 1992, SCIENCE, V257, P815, DOI 10.1126/science.1323146; KIJIMA Y, 1991, J BIOL CHEM, V266, P22912; KUNO M, 1987, NATURE, V326, P301, DOI 10.1038/326301a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEISCHER S, 1974, METHOD ENZYMOL, V31, P292; MAEDA N, 1990, EMBO J, V9, P61, DOI 10.1002/j.1460-2075.1990.tb08080.x; MARKS AR, 1990, J BIOL CHEM, V265, P20719; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; PALADE P, 1983, J HISTOCHEM CYTOCHEM, V31, P971, DOI 10.1177/31.7.6189886; PALADE P, 1989, MOL PHARMACOL, V36, P664; ROTH J, 1989, METHOD CELL BIOL, V31, P513; SAITO A, 1978, J CELL BIOL, V79, P601, DOI 10.1083/jcb.79.3.601; SAITO A, 1984, J ULTRA MOL STRUCT R, V86, P277, DOI 10.1016/S0022-5320(84)90107-2; SATOH T, 1990, J CELL BIOL, V111, P615, DOI 10.1083/jcb.111.2.615; SCHOLZ J, 1988, J PHARMACOL EXP THER, V245, P327; SEVERS NJ, 1990, INT J CARDIOL, V26, P137, DOI 10.1016/0167-5273(90)90030-9; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIGNE P, 1990, J BIOL CHEM, V265, P6782; VIGNE P, 1989, FEBS LETT, V249, P143, DOI 10.1016/0014-5793(89)80611-8; VITES AM, 1992, AM J PHYSIOL, V262, pH268, DOI 10.1152/ajpheart.1992.262.1.H268; WALTON PD, 1991, J CELL BIOL, V113, P1145, DOI 10.1083/jcb.113.5.1145; WIENTZEK M, 1991, J MOL CELL CARDIOL, V23, P1149, DOI 10.1016/0022-2828(91)90204-Y	43	113	113	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3499	3506						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381433				2022-12-27	WOS:A1993KM16100074
J	YE, J; ESMON, CT; JOHNSON, AE				YE, J; ESMON, CT; JOHNSON, AE			THE CHONDROITIN SULFATE MOIETY OF THROMBOMODULIN BINDS A 2ND MOLECULE OF THROMBIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-THROMBIN; RECOMBINANT HUMAN THROMBOMODULIN; PROTEIN-C ACTIVATION; RABBIT THROMBOMODULIN; PROTEOLYTIC FORMATION; FUNCTIONAL DOMAINS; CRYSTAL-STRUCTURE; HEPARIN COFACTOR; ACTIVE-SITE; BOVINE	The role of the chondroitin sulfate moiety of thrombomodulin (TM) in the binding of thrombin to TM has been examined using fluorescent derivatives of thrombin. An anilinonaphthalene-6-sulfonic acid (ANS) dye was attached covalently to the active site histidine of thrombin via a D-Phe-Pro-Arg (FPR) linkage to form ANS-FPR-thrombin. When ANS-FPR-thrombin was titrated with TM lacking the chondroitin sulfate moiety (csf-TM), a monotonic and saturable increase in ANS emission intensity was observed that was consistent with the formation of a high affinity 1:1 thrombin-csf-TM complex. In contrast, titration of ANS-FPR-thrombin with intact TM containing the chondroitin sulfate resulted in a biphasic change in ANS-FPR-thrombin emission intensity that was consistent with each molecule of TM binding at least two molecules of ANS-FPR-thrombin with different affinities. This suggested that the second thrombin binds to TM via the chondroitin sulfate moiety. A direct interaction between thrombin and chondroitin sulfate was demonstrated by showing that chondroitin sulfate, cleaved and purified from TM, caused a saturable increase in ANS emission intensity upon addition to an ANS-FPR-thrombin sample. This spectral change was reversed by adding an excess of unmodified thrombin. The minimum K(d) for the ANS-FPR-thrombin-chondroitin sulfate complex was approximately 20 nM, consistent with chondroitin sulfate being the lower affinity binding site on TM for thrombin. The titration of chondroitin sulfate into ANS-FPR-thrombin samples in the absence and presence of a TM fragment containing the fifth and sixth growth factor-like domains (GF5-6) showed that GF5-6 did not block chondroitin sulfate binding and that a GF5-6-thrombin-chondroitin sulfate ternary complex was formed. Thus, the chondroitin sulfate binds to thrombin somewhere other than anion-binding exosite I, and in doing so, alters the structure and/or environment of the active site more than 15angstrom from the active site serine without detectably changing the conformation near Ser-195. Since excess TM and excess csf-TM increased the ANS emission intensity of ANS-FPR-thrombin to different extents (approximately 15 and approximately 80% respectively), the chondroitin sulfate also influences the environment of the active site probe even when thrombin is bound to the higher affinity site on TM (GF5-6).	UNIV OKLAHOMA, DEPT CHEM & BIOCHEM, NORMAN, OK 73019 USA; UNIV OKLAHOMA, HLTH SCI CTR, DEPT PATHOL, OKLAHOMA CITY, OK 73190 USA; UNIV OKLAHOMA, HLTH SCI CTR, DEPT BIOCHEM & MOLEC BIOL, OKLAHOMA CITY, OK 73190 USA; OKLAHOMA MED RES FDN, HOWARD HUGHES MED INST, OKLAHOMA CITY, OK 73104 USA; OKLAHOMA MED RES FDN, CARDIOVASC BIOL RES PROGRAM, OKLAHOMA CITY, OK 73104 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Howard Hughes Medical Institute; Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation			Johnson, Arthur E/G-3457-2012		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032934, R01HL029807] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL 29807, R37 HL 30430, R01 HL 32934] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERLINER LJ, 1978, THROMB RES, V12, P15, DOI 10.1016/0049-3848(78)90081-6; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BOCK PE, 1988, BIOCHEMISTRY-US, V27, P6633, DOI 10.1021/bi00417a063; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; BOURIN MC, 1989, THROMB RES, V54, P27; BOURIN MC, 1988, J BIOL CHEM, V263, P8044; BOURIN MC, 1990, J BIOL CHEM, V265, P15424; BOURIN MC, 1986, P NATL ACAD SCI USA, V83, P5924, DOI 10.1073/pnas.83.16.5924; CHURCH FC, 1989, J BIOL CHEM, V264, P18419; EHRLICH HJ, 1990, EMBO J, V9, P2367, DOI 10.1002/j.1460-2075.1990.tb07411.x; ESMON CT, 1989, J BIOL CHEM, V264, P4743; ESMON CT, 1991, ANN NY ACAD SCI, V614, P30; ESMON CT, 1987, DEV BIOL STAND, V67, P59; ESMON NL, 1982, J BIOL CHEM, V257, P859; ESMON NL, 1983, J BIOL CHEM, V258, P5548; GALVIN JB, 1987, J BIOL CHEM, V262, P2199; GRINNELL BW, 1990, ADV AP BIOT, V11, P29; GRUTTER MG, 1990, EMBO J, V9, P2361, DOI 10.1002/j.1460-2075.1990.tb07410.x; HAYASHI T, 1990, J BIOL CHEM, V265, P20156; HOFSTEENGE J, 1986, BIOCHEM J, V237, P243, DOI 10.1042/bj2370243; JACKMAN RW, 1986, P NATL ACAD SCI USA, V83, P8834, DOI 10.1073/pnas.83.23.8834; JAKUBOWSKI HV, 1986, J BIOL CHEM, V261, P3876; JAKUBOWSKI HV, 1989, J BIOL CHEM, V264, P11117; KISIEL W, 1979, J CLIN INVEST, V64, P761, DOI 10.1172/JCI109521; KISIEL W, 1976, BIOCHEMISTRY-US, V15, P4893, DOI 10.1021/bi00667a022; KOYAMA T, 1991, EUR J BIOCHEM, V198, P563, DOI 10.1111/j.1432-1033.1991.tb16051.x; KOYAMA T, 1991, BRIT J HAEMATOL, V78, P515, DOI 10.1111/j.1365-2141.1991.tb04481.x; KURACHI K, 1976, BIOCHEMISTRY-US, V15, P368, DOI 10.1021/bi00647a020; KUROSAWA S, 1988, J BIOL CHEM, V263, P5993; KUROSAWA S, 1987, J BIOL CHEM, V262, P2206; LEBONNIEC BF, 1991, J BIOL CHEM, V266, P13796; LEBONNIEC BF, 1991, P NATL ACAD SCI USA, V88, P7371, DOI 10.1073/pnas.88.16.7371; MILETICH JP, 1978, J BIOL CHEM, V253, P6908; NAWA K, 1990, BIOCHEM BIOPH RES CO, V171, P729, DOI 10.1016/0006-291X(90)91207-9; OLSON ST, 1991, J BIOL CHEM, V266, P6342; OWEN WG, 1975, BIOCHIM BIOPHYS ACTA, V405, P380, DOI 10.1016/0005-2795(75)90103-8; OWEN WG, 1974, J BIOL CHEM, V249, P594; PARKINSON JF, 1992, BIOCHEM J, V283, P151, DOI 10.1042/bj2830151; PARKINSON JF, 1990, J BIOL CHEM, V265, P12602; PARKINSON JF, 1990, BIOCHEM BIOPH RES CO, V169, P177, DOI 10.1016/0006-291X(90)91451-W; PREISSNER KT, 1990, J BIOL CHEM, V265, P4915; ROGERS SJ, 1992, J BIOL CHEM, V267, P3613; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; STUBBS MT, 1992, EUR J BIOCHEM, V206, P187, DOI 10.1111/j.1432-1033.1992.tb16916.x; SUZUKI K, 1987, EMBO J, V6, P1891, DOI 10.1002/j.1460-2075.1987.tb02448.x; THOMPSON AR, 1977, ARCH BIOCHEM BIOPHYS, V178, P356, DOI 10.1016/0003-9861(77)90204-1; TSIANG M, 1990, BIOCHEMISTRY-US, V29, P10602, DOI 10.1021/bi00499a005; WEN DZ, 1987, BIOCHEMISTRY-US, V26, P4350, DOI 10.1021/bi00388a025; WU QY, 1991, P NATL ACAD SCI USA, V88, P6775, DOI 10.1073/pnas.88.15.6775; YE J, 1991, J BIOL CHEM, V266, P23016; YE J, 1992, J BIOL CHEM, V267, P11023; ZUSHI M, 1989, J BIOL CHEM, V264, P10351	53	66	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2373	2379						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8381406				2022-12-27	WOS:A1993KK81500022
J	CONTI, A; BRANDO, C; DEBELL, KE; ALAVA, MA; HOFFMAN, T; BONVINI, E				CONTI, A; BRANDO, C; DEBELL, KE; ALAVA, MA; HOFFMAN, T; BONVINI, E			CD3-INDUCED PREFERENTIAL HYDROLYSIS OF POLYPHOSPHOINOSITIDES AND CALCIUM REGULATION OF INOSITOL PHOSPHATE-METABOLISM IN A PERMEABILIZED MURINE T-CELL CLONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-C; ANTIGEN RECEPTOR COMPLEX; HUMAN LYMPHOCYTES-T; 1,4,5-TRISPHOSPHATE 3-KINASE; PHOSPHOLIPASE-C; PHORBOL ESTERS; ACTIVATION; HETEROGENEITY; CALMODULIN; ION	Murine T helper cloned cells permeabilized with the bacterial lysin, tetanolysin, were used to investigate the role of intracellular Ca2+ in regulating myo-[2-H-3] inositol phospholipid (InsPL) hydrolysis triggered upon perturbation of the T cell receptor-CD3 complex. [Ca2+] was controlled by a calcium/magnesium/EGTA buffer. Antibody (mAb) aggregation of CD3 induced InsPL hydrolysis in the absence of added Ca2+. However, stimulated InsPL hydrolysis increased with the free [Ca2+], reaching a maximum at 100-300 nM [Ca2+]. Ca2+ increased the overall efficiency of hydrolysis without changes in EC50 of the anti-CD3 mAb. The response diminished at >300 nM [Ca2+] due to a mixed type inhibition. Ca2+ alone had no effect on inositol phosphate levels. Polyphosphoinositides were preferentially cleaved, since no accumulation of Ins(1)P/Ins(3)P was detected, indicating that direct hydrolysis of phosphatidylinositol did not occur, irrespective of the Ca2+ concentration. [Ca2+] above 300 nM shifted the relative amounts of CD3-induced inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) and inositol 1,3,4,5-tetrakisphosphate (Ins(1,3,4,5)P4) in favor of the latter. Unlabeled permeabilized cells exposed to greater-than-or-equal-to 100 nM [Ca2+] showed enhanced conversion of [H-3]Ins (1,4,5)P, to [H-3]Ins(1,3,4,5)P4. In conclusion, InsPL hydrolysis is optimally triggered by CD3 perturbation at intracellular Ca2+ levels approximating those observed in intact resting lymphocytes (100 nM). Ca2+ concentrations similar to those triggered by InsPL-derived metabolites may inhibit InsPL hydrolysis and promote Ins(1,3,4,5)P4 production, thus controlling the amounts of Ins(1,4,5)P3.	US FDA,CTR BIOL EVALUAT & RES,DIV HEMATOL,CELL BIOL LAB,BLDG 29,RM 231,8800 ROCKVILLE PIKE,BETHESDA,MD 20892	US Food & Drug Administration (FDA)								ABRAHAM RT, 1988, MOL CELL BIOL, V8, P5448, DOI 10.1128/MCB.8.12.5448; ALAVA MA, 1992, BIOCHEM J, V284, P189, DOI 10.1042/bj2840189; ALI H, 1989, BIOCHIM BIOPHYS ACTA, V1010, P88, DOI 10.1016/0167-4889(89)90188-2; ASANO Y, 1983, J EXP MED, V158, P1178, DOI 10.1084/jem.158.4.1178; BANSAL VS, 1990, ANNU REV CELL BIOL, V6, P41, DOI 10.1146/annurev.cellbio.6.1.41; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BONVINI E, 1989, J IMMUNOL, V143, P587; BONVINI E, 1991, BIOCHEM J, V275, P689, DOI 10.1042/bj2750689; BRANDO C, 1990, J CHROMATOGR-BIOMED, V529, P65, DOI 10.1016/S0378-4347(00)83808-6; BRATTSAND G, 1990, J IMMUNOL, V144, P3651; CANTRELL DA, 1989, J IMMUNOL, V143, P3653; CANTRELL DA, 1985, P NATL ACAD SCI USA, V82, P8158, DOI 10.1073/pnas.82.23.8158; DEBELL KE, 1992, J IMMUNOL, V149, P2271; GARDNER P, 1989, CELL, V59, P15, DOI 10.1016/0092-8674(89)90865-9; GOUY H, 1990, EUR J IMMUNOL, V20, P2269, DOI 10.1002/eji.1830201016; IMBODEN JB, 1987, J CLIN INVEST, V79, P1538, DOI 10.1172/JCI112986; INOKUCHI S, 1990, J BIOL CHEM, V265, P5983; IRVINE RF, 1986, NATURE, V320, P631, DOI 10.1038/320631a0; IRVINE RF, 1988, PHILOS T ROY SOC B, V320, P281, DOI 10.1098/rstb.1988.0077; JENKINS MK, 1987, P NATL ACAD SCI USA, V84, P5409, DOI 10.1073/pnas.84.15.5409; KAIBUCHI K, 1985, J BIOL CHEM, V260, P1366; KLEE CB, 1991, NEUROCHEM RES, V16, P1059, DOI 10.1007/BF00965851; KUNO M, 1987, NATURE, V326, P301, DOI 10.1038/326301a0; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LI GD, 1989, BIOCHEM J, V260, P771, DOI 10.1042/bj2600771; LUCKHOFF A, 1992, NATURE, V355, P356, DOI 10.1038/355356a0; MAJERUS PW, 1986, SCIENCE, V234, P1519, DOI 10.1126/science.3024320; MARTELL AE, 1974, CRITICAL STABILITY C, V1, P269; MINTA A, 1989, J BIOL CHEM, V264, P8171; MORRIS AJ, 1987, BIOCHEM J, V248, P489, DOI 10.1042/bj2480489; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; PECHT I, 1987, EMBO J, V6, P1935, DOI 10.1002/j.1460-2075.1987.tb02454.x; PERRIN DD, 1967, TALANTA, V14, P883; RYU SH, 1987, FASEB J, V1, P388, DOI 10.1096/fasebj.1.5.2824270; SEGEL IH, 1975, ENZYME KINETICS, P214; SILLEN DD, 1964, STABILITY CONSTANTS, P697; SMITH CD, 1986, SCIENCE, V232, P97, DOI 10.1126/science.3006254; Smythe C.J., 1978, BACTERIAL TOXINS CEL, P129; TRENN G, 1992, J IMMUNOL, V148, P1338; TRUNEH A, 1985, J IMMUNOL, V135, P2262; TRUNEH A, 1985, NATURE, V313, P318, DOI 10.1038/313318a0; VANSEVENTER GJ, 1992, IN PRESS J IMMUNOL; WARD SG, 1990, J IMMUNOL, V144, P3523; WEISS A, 1986, ANNU REV IMMUNOL, V4, P593, DOI 10.1146/annurev.iy.04.040186.003113; WEISS A, 1984, P NATL ACAD SCI-BIOL, V81, P4169, DOI 10.1073/pnas.81.13.4169; WILSOND B, 1984, J BIOL CHEM, V259, P11718; ZILBERMAN Y, 1987, EMBO J, V6, P957, DOI 10.1002/j.1460-2075.1987.tb04845.x	47	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					783	791						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8380415				2022-12-27	WOS:A1993KG07700008
J	APODACA, G; AROETI, B; TANG, K; MOSTOV, KE				APODACA, G; AROETI, B; TANG, K; MOSTOV, KE			BREFELDIN-A INHIBITS THE DELIVERY OF THE POLYMERIC IMMUNOGLOBULIN RECEPTOR TO THE BASOLATERAL SURFACE OF MDCK CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE KIDNEY-CELLS; INFLUENZA-VIRUS HEMAGGLUTININ; POLARIZED EPITHELIAL-CELLS; TRANS-GOLGI NETWORK; AMINO-ACID CHANGE; CYTOPLASMIC DOMAIN; ENDOPLASMIC-RETICULUM; SELECTIVE-INHIBITION; ORGANELLE STRUCTURE; SECRETORY PROTEINS	We have studied the effects of brefeldin A (BFA) on the polarized delivery of the polymeric immunoglobulin receptor to the basolateral surface of MDCK cells. Unlike the delivery of several other basolateral membrane and secretory proteins, the delivery of the polymeric immunoglobulin receptor from the trans-Golgi network to the cell surface was inhibited by BFA. The effect of BFA treatment was apparent at 1.0 mug/ml (36% inhibition), and maximal inhibition was observed at 10 mug/ml (70% inhibition). The delivery of the receptor from the endoplasmic reticulum to the basolateral surface was even more sensitive to the effect of BFA; delivery was inhibited 95% in cells treated with 1 mug/ml BFA. The selective action of BFA on the basolateral delivery of the polymeric immunoglobulin receptor suggests that there may be multiple pathways for delivery of proteins to the basolateral cell surface of MDCK cells.	UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM & BIOPHYS, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, INST CARDIOVASC RES, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	APODACA, G (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT ANAT, BOX 0452, SAN FRANCISCO, CA 94143 USA.		Apodaca, Gerard/HCJ-0048-2022	mostov, keith/0000-0002-8123-6247	NIAID NIH HHS [R01 AI25144] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025144] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		APODACA G, 1991, J CLIN INVEST, V87, P1877, DOI 10.1172/JCI115211; BOLL W, 1991, P NATL ACAD SCI USA, V88, P8592, DOI 10.1073/pnas.88.19.8592; BREITFELD PP, 1989, METHOD CELL BIOL, V32, P329; BREWER CB, 1991, J CELL BIOL, V114, P413, DOI 10.1083/jcb.114.3.413; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; DONALDSON JG, 1991, J CELL BIOL, V112, P579, DOI 10.1083/jcb.112.4.579; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; HUNZIKER W, 1989, J CELL BIOL, V109, P3291, DOI 10.1083/jcb.109.6.3291; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KTISTAKIS NT, 1991, J CELL BIOL, V113, P1009, DOI 10.1083/jcb.113.5.1009; LAZAROVITS J, 1988, CELL, V53, P743, DOI 10.1016/0092-8674(88)90092-X; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LOW SH, 1992, J CELL BIOL, V118, P51, DOI 10.1083/jcb.118.1.51; LOW SH, 1991, J BIOL CHEM, V266, P17729; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; MOSTOV K, 1992, J CELL BIOL, V116, P577, DOI 10.1083/jcb.116.3.577; NARULA N, 1992, J CELL BIOL, V117, P27, DOI 10.1083/jcb.117.1.27; ODA K, 1987, FEBS LETT, V214, P135, DOI 10.1016/0014-5793(87)80028-5; PRYDZ K, 1992, J CELL BIOL, V119, P259, DOI 10.1083/jcb.119.2.259; ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U; ULMER JB, 1991, EUR J CELL BIOL, V54, P38; WONG DH, 1992, J CELL BIOL, V117, P1171, DOI 10.1083/jcb.117.6.1171; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5	28	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20380	20385						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376395				2022-12-27	WOS:A1993LY01900069
J	GREENHALGH, DA; FARRENS, DL; SUBRAMANIAM, S; KHORANA, HG				GREENHALGH, DA; FARRENS, DL; SUBRAMANIAM, S; KHORANA, HG			HYDROPHOBIC AMINO-ACIDS IN THE RETINAL-BINDING POCKET OF BACTERIORHODOPSIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON TRANSLOCATION; SCHIFF-BASE; PURPLE MEMBRANE; ASPARTIC ACID-96; N-INTERMEDIATE; F-HELIX; SUBSTITUTIONS; MUTANTS; RESIDUES; PROTEIN	The hydrophobic amino acids Met-20, Val-49, Ala-53, Met-118, Gly-122, and Met-145 are believed to be among the amino acids that form the retinal-binding pocket in bacteriorhodopsin. We have now replaced the above amino acids, one at a time, and report on the effects of these replacements (M20A/E, V49A/L, A53G, M118A/E, G122C, and M145A/E) on the properties of bacteriorhodopsin. With the exception of Met-20, replacements at all of the other positions resulted in (i) altered rates of in vitro chromophore formation that ranged from 20-fold faster to 45-fold slower than wild-type bacteriorhodopsin, (ii) blue shifts in the visible spectra of up to 80 nm, and (iii) caused changes in the retinal isomer compositions of the mutant chromophores. Specific effects were also observed in the photocycles of the Met-118, Met-145, and Val-49 mutants, suggesting that these 3 amino acids have important roles in light transduction by bacteriorhodopsin. These results are discussed together with previous studies on the effects of amino acid replacements in the retinal-binding pocket of bacteriorhodopsin.	MIT,DEPT BIOL,CAMBRIDGE,MA 02139; MIT,DEPT CHEM,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)				Subramaniam, Sriram/0000-0003-4231-4115	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI011479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028289, R37GM028289] Funding Source: NIH RePORTER; NCI NIH HHS [CA-09112] Funding Source: Medline; NIAID NIH HHS [AI-11479] Funding Source: Medline; NIGMS NIH HHS [GM-28289] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHL PL, 1988, J BIOL CHEM, V263, P13594; ALTENBACH C, 1990, SCIENCE, V248, P1088, DOI 10.1126/science.2160734; BARIBEAU J, 1985, CAN J BIOCHEM CELL B, V63, P305, DOI 10.1139/o85-045; BAYLEY H, 1981, P NATL ACAD SCI-BIOL, V78, P2225, DOI 10.1073/pnas.78.4.2225; BRAIMAN MS, 1987, J BIOL CHEM, V262, P9271; BROUILLETTE CG, 1987, BIOCHEMISTRY-US, V26, P7431, DOI 10.1021/bi00397a035; BUTT HJ, 1989, EMBO J, V8, P1657, DOI 10.1002/j.1460-2075.1989.tb03556.x; DUNACH M, 1990, P NATL ACAD SCI USA, V87, P9873, DOI 10.1073/pnas.87.24.9873; FISCHER U, 1979, BIOPHYS J, V28, P211, DOI 10.1016/S0006-3495(79)85172-3; FODOR SPA, 1988, BIOCHEMISTRY-US, V27, P7097, DOI 10.1021/bi00418a064; GREENHALGH DA, 1991, P NATL ACAD SCI USA, V88, P8626, DOI 10.1073/pnas.88.19.8626; HACKETT NR, 1987, J BIOL CHEM, V262, P9277; HAUSS T, 1992, THESIS FREIE U BERLI; HOLZ M, 1989, P NATL ACAD SCI USA, V86, P2167, DOI 10.1073/pnas.86.7.2167; KHORANA HG, 1988, J BIOL CHEM, V263, P7439; KREBS MP, 1993, J BACTERIOL, V175, P1555, DOI 10.1128/JB.175.6.1555-1560.1993; KREBS MP, 1993, P NATL ACAD SCI USA, V90, P1987, DOI 10.1073/pnas.90.5.1987; MARTI T, 1991, J BIOL CHEM, V266, P6919; MARTI T, 1991, J BIOL CHEM, V266, P18674; MATHIES RA, 1991, ANNU REV BIOPHYS BIO, V20, P491, DOI 10.1146/annurev.bb.20.060191.002423; MOGI T, 1988, P NATL ACAD SCI USA, V85, P4148, DOI 10.1073/pnas.85.12.4148; MOGI T, 1987, P NATL ACAD SCI USA, V84, P5595, DOI 10.1073/pnas.84.16.5595; MOGI T, 1989, J BIOL CHEM, V264, P14192; MOGI T, 1989, J BIOL CHEM, V264, P14197; NASSAL M, 1987, J BIOL CHEM, V262, P9264; NEEDLEMAN R, 1991, J BIOL CHEM, V266, P11478; NISHIMURA S, 1985, BIOCHIM BIOPHYS ACTA, V818, P421, DOI 10.1016/0005-2736(85)90018-5; OESTERHELT D, 1973, EUR J BIOCHEM, V40, P453, DOI 10.1111/j.1432-1033.1973.tb03214.x; OTTO H, 1989, P NATL ACAD SCI USA, V86, P9228, DOI 10.1073/pnas.86.23.9228; OTTO H, 1990, P NATL ACAD SCI USA, V87, P1018, DOI 10.1073/pnas.87.3.1018; PANDE C, 1989, BIOCHEMISTRY-US, V28, P5971, DOI 10.1021/bi00440a038; ROTHSCHILD KJ, 1989, FEBS LETT, V250, P448, DOI 10.1016/0014-5793(89)80774-4; SCHERRER P, 1989, BIOCHEMISTRY-US, V28, P829, DOI 10.1021/bi00428a063; SCHRECKENBACH T, 1977, EUR J BIOCHEM, V76, P499, DOI 10.1111/j.1432-1033.1977.tb11620.x; STERN LJ, 1989, J BIOL CHEM, V264, P14202; STOECKENIUS W, 1979, BIOCHIM BIOPHYS ACTA, V505, P215, DOI 10.1016/0304-4173(79)90006-5; SUBRAMANIAM S, 1991, P NATL ACAD SCI USA, V88, P6873, DOI 10.1073/pnas.88.15.6873; SUBRAMANIAM S, 1990, P NATL ACAD SCI USA, V87, P1013, DOI 10.1073/pnas.87.3.1013; UEGAKI K, 1991, ARCH BIOCHEM BIOPHYS, V286, P107, DOI 10.1016/0003-9861(91)90014-A; VARO G, 1991, BIOCHEMISTRY-US, V30, P5008, DOI 10.1021/bi00234a024	41	61	62	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20305	20311						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376389				2022-12-27	WOS:A1993LY01900059
J	LEE, SS; KANG, C				LEE, SS; KANG, C			2 BASE-PAIRS AT -9 AND -8 DISTINGUISH BETWEEN THE BACTERIOPHAGE-T7 AND SP6-PROMOTERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T7 RNA-POLYMERASE; LATE PROMOTERS; NUCLEOTIDE-SEQUENCE; POINT MUTATIONS; GENE; SP6; TRANSCRIPTION; DNA; T3; EXPRESSION	Bacteriophage T7 and SP6 RNA polymerases and their promoters share a high degree of their primary structure homology, but each polymerase exclusively recognizes its own promoter sequence. To reveal the molecular basis of this specificity, 4 base pairs at positions -12, -10, -9, and -8 of the T7 promoter were substituted individually and multiply by SP6 promoter-specific base pairs, and 3 base pairs at -10, -9, and -8 of the SP6 promoter were replaced by T7 promoter-specific base pairs. Promoter activities of 28 sequences were measured in vitro with T7 and SP6 polymerases separately under optimal conditions at 6 mM MgCl2. Single and double substitutions at -12 and -10 do not significantly affect the T7 promoter activity, although they are almost exclusively conserved among T7 genomic promoters. Changes at -10 of SP6 promoter hardly affect the activity. However, any T7 variants that contain either or both changes at -9 and -8 show greatly reduced activity. Interestingly, the double substitution at -9 and -8 yields significant SP6 promoter activities and virtually no T7 promoter activity. Furthermore, the SP6 promoter variants with both T7-specific -9C and -8T show good T7 promoter activities, although they still show some SP6 promoter activities. However, under high salt conditions (either 20 mM MgCl2 or 100 mM NaCl plus 6 mM MgCl2), they show only slight SP6 promoter activity. No other SP6 variants show any T7 promoter activity. All these results indicate that the 2 base pairs at -9 and -8 of both the T7 and SP6 promoters are the primary (if not the only) determinants of Specificity and that the hierarchy of importance of positions for promoter activity is -8, -9 > > -10 > -12. Also, a phyLogenic relationship among the T3, T7, K11, and SP6 promoters is suggested based on dissimilarities in their sequences from -12 to -8.	KOREA ADV INST SCI & TECHNOL,DEPT LIFE SCI,373-1 KUSUNG DONG,YUSUNG GU,TAEJON 305701,SOUTH KOREA	Korea Advanced Institute of Science & Technology (KAIST)								BASU S, 1986, J MOL BIOL, V190, P425, DOI 10.1016/0022-2836(86)90013-6; BECK PJ, 1989, J MOL BIOL, V210, P687, DOI 10.1016/0022-2836(89)90102-2; BROWN JE, 1986, NUCLEIC ACIDS RES, V14, P3521, DOI 10.1093/nar/14.8.3521; BUTLER ET, 1982, J BIOL CHEM, V257, P5772; CHAKRABORTY PR, 1973, J BIOL CHEM, V248, P6637; CHAMBERL.M, 1970, NATURE, V228, P227, DOI 10.1038/228227a0; CHAPMAN KA, 1987, NUCLEIC ACIDS RES, V15, P5413, DOI 10.1093/nar/15.13.5413; CHAPMAN KA, 1988, NUCLEIC ACIDS RES, V16, P4511, DOI 10.1093/nar/16.10.4511; DIETZ A, 1986, J GEN VIROL, V67, P831, DOI 10.1099/0022-1317-67-5-831; DIETZ A, 1990, MOL GEN GENET, V221, P283, DOI 10.1007/BF00261733; DIETZ A, 1985, THESIS FREIBURG U FR; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; GOLOMB M, 1977, J VIROL, V21, P743, DOI 10.1128/JVI.21.2.743-752.1977; GUNDERSON SI, 1987, BIOCHEMISTRY-US, V26, P1539, DOI 10.1021/bi00380a007; IKEDA RA, 1986, P NATL ACAD SCI USA, V83, P3614, DOI 10.1073/pnas.83.11.3614; IKEDA RA, 1992, NUCLEIC ACIDS RES, V20, P2517, DOI 10.1093/nar/20.10.2517; JORGENSEN ED, 1991, J BIOL CHEM, V266, P645; KANG C, 1987, NUCLEIC ACIDS RES, V15, P2279, DOI 10.1093/nar/15.5.2279; KLEMENT JF, 1990, J MOL BIOL, V215, P21, DOI 10.1016/S0022-2836(05)80091-9; KOTANI H, 1987, NUCLEIC ACIDS RES, V15, P2653, DOI 10.1093/nar/15.6.2653; MCGRAW NJ, 1985, NUCLEIC ACIDS RES, V13, P6753, DOI 10.1093/nar/13.18.6753; MULLER DK, 1989, BIOCHEMISTRY-US, V28, P3306, DOI 10.1021/bi00434a028; NAM SC, 1988, J BIOL CHEM, V263, P18123; ROSA MD, 1981, J MOL BIOL, V147, P41, DOI 10.1016/0022-2836(81)90078-4; Sambrook J, 1989, MOL CLONING LAB MANU, P125; SCHNEIDER TD, 1989, NUCLEIC ACIDS RES, V17, P659, DOI 10.1093/nar/17.2.659	26	15	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19299	19304						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366080				2022-12-27	WOS:A1993LW81900025
J	LINCOLN, JE; CAMPBELL, AD; OETIKER, J; ROTTMANN, WH; OELLER, PW; SHEN, NF; THEOLOGIS, A				LINCOLN, JE; CAMPBELL, AD; OETIKER, J; ROTTMANN, WH; OELLER, PW; SHEN, NF; THEOLOGIS, A			LE-ACS4, A FRUIT RIPENING AND WOUND-INDUCED 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE GENE OF TOMATO (LYCOPERSICON-ESCULENTUM) - EXPRESSION IN ESCHERICHIA-COLI, STRUCTURAL CHARACTERIZATION, EXPRESSION CHARACTERISTICS, AND PHYLOGENETIC ANALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; ETHYLENE BIOSYNTHESIS; DIFFERENTIAL EXPRESSION; ARABIDOPSIS-THALIANA; MOLECULAR-CLONING; COMPLEMENTARY-DNA; BINDING-FACTOR; ACID SYNTHASE; 2 GENES; SEQUENCE	ACC (1-aminocyclopropane-1-carboxylic acid) synthase is the key regulatory enzyme in the biosynthetic pathway of the plant hormone ethylene and is encoded by a highly divergent multigene family in tomato (Rottmann, W. H., Peter, G. F., Oeller, P. W., Keller, J. A., Shen, N. F., Nagy, B. P., Taylor, L. P., Campbell, A. D., and Theologis, A. (1991) J. Mol. Biol. 222, 937-961). Two members of the family, LE-ACS2 and LE-ACS4, are induced during fruit ripening and upon treatment of mature green fruits with exogenous ethylene (C2H4) in a dose-dependent manner. Both genes are superinduced by wounding of pericarp tissue during various stages of ripening. The wound-induced accumulation of LE-ACS2 mRNA is more rapid and greater than that of LE-ACS4. Both mRNAs accumulate in the absence of protein synthesis, suggesting that their induction is a primary response to the inducer. The LE-ACS4 gene was isolated and structurally characterized. The function of the LE-ACS4 protein (53,509 Da, pI 5.4) was verified by expression experiments in Escherichia coli. The promoters of LE-ACS2 and LE-ACS4 contain potential cis-acting regulatory elements responsible for induction by ethylene, wounding, and anaerobiosis. In addition, elements for binding the transcriptional factors EmBP1, GBF-1, and OCSBF-1 are also present. Phylogenetic analysis of 20 ACC synthases from dicots and monocots indicate that the LE-ACS2 and LE-ACS4 proteins belong to an unique sublineage that includes an additional member of the tobacco family, NT-ACS1. The divergence of this sublineage is a relatively recent event in the evolution of ACC synthase protein.	PLANT GENE EXPRESS CTR, ALBANY, CA 94710 USA						NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035447] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-35447] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeles F.B., 1992, PLANT BIOL ETHYL, P1, DOI [DOI 10.1016/B978-0-08-091628-6.50001-1, 10.1016/b978-0-08-091628-6.50001-1, DOI 10.1016/C2009-0-03226-7]; [Anonymous], 1975, COLOR CLASSIFICATION; BAILEY BA, 1992, PLANT PHYSIOL, V100, P1615, DOI 10.1104/pp.100.3.1615; BOLLER T, 1980, NATURE, V286, P259, DOI 10.1038/286259a0; BOORSTEIN WR, 1989, METHOD ENZYMOL, V180, P347; BOTELLA JR, 1992, PLANT MOL BIOL, V20, P425, DOI 10.1007/BF00040602; BOTELLA JR, 1993, GENE, V123, P249, DOI 10.1016/0378-1119(93)90132-M; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CORDES S, 1989, PLANT CELL, V1, P1025, DOI 10.1105/tpc.1.10.1025; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DONG JG, 1991, PLANTA, V185, P38, DOI 10.1007/BF00194512; ENYEDI AJ, 1992, CELL, V70, P879, DOI 10.1016/0092-8674(92)90239-9; Felsenstein J, 1989, PHYLIP MANUAL VERSIO; GHOSH D, 1990, NUCLEIC ACIDS RES, V18, P1749, DOI 10.1093/nar/18.7.1749; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; GUILTINAN MJ, 1990, SCIENCE, V250, P267, DOI 10.1126/science.2145628; HAMILTON AJ, 1990, NATURE, V346, P284, DOI 10.1038/346284a0; HEIN J, 1991, MOL BIOL EVOL, V30, P409; HUANG PL, 1991, P NATL ACAD SCI USA, V88, P7021, DOI 10.1073/pnas.88.16.7021; KENDE H, 1989, PLANT PHYSIOL, V91, P1, DOI 10.1104/pp.91.1.1; LIANG XW, 1992, P NATL ACAD SCI USA, V89, P11046, DOI 10.1073/pnas.89.22.11046; MASON HS, 1993, PLANT CELL, V5, P241, DOI 10.1105/tpc.5.3.241; MEHTA AM, 1988, P NATL ACAD SCI USA, V85, P8810, DOI 10.1073/pnas.85.23.8810; NAKAGAWA N, 1991, PLANT CELL PHYSIOL, V32, P1153; NAKAJIMA N, 1990, PLANT CELL PHYSIOL, V31, P1021; OELLER PW, 1991, SCIENCE, V254, P437, DOI 10.1126/science.1925603; OLSON DC, 1991, P NATL ACAD SCI USA, V88, P5340, DOI 10.1073/pnas.88.12.5340; PARK KY, 1992, PLANT MOL BIOL, V18, P377, DOI 10.1007/BF00034964; ROTTMANN WH, 1991, J MOL BIOL, V222, P937, DOI 10.1016/0022-2836(91)90587-V; Sambrook J., 1989, MOL CLONING LAB MANU, P931; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO T, 1989, P NATL ACAD SCI USA, V86, P6621, DOI 10.1073/pnas.86.17.6621; SCHINDLER U, 1992, EMBO J, V11, P1275, DOI 10.1002/j.1460-2075.1992.tb05171.x; SIEBERTZ B, 1989, PLANT CELL, V1, P961, DOI 10.1105/tpc.1.10.961; SINGH K, 1990, PLANT CELL, V2, P891, DOI 10.1105/tpc.2.9.891; SMITH CJS, 1986, PLANTA, V168, P94, DOI 10.1007/BF00407014; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SU LY, 1984, HORTSCIENCE, V19, P576; THEOLOGIS A, 1985, J MOL BIOL, V183, P53, DOI 10.1016/0022-2836(85)90280-3; THEOLOGIS A, 1992, CELL, V70, P181, DOI 10.1016/0092-8674(92)90093-R; THEOLOGIS A, 1982, PLANT PHYSIOL, V69, P1031, DOI 10.1104/pp.69.5.1031; VAN DER STRAETEN D, 1990, P NATL ACAD SCI USA, V87, P4859, DOI 10.1073/pnas.87.12.4859; VAN DER STRAETEN D, 1992, P NATL ACAD SCI USA, V89, P9969, DOI 10.1073/pnas.89.20.9969; WALKER JC, 1987, P NATL ACAD SCI USA, V84, P6624, DOI 10.1073/pnas.84.19.6624; WANG RF, 1991, BIOTECHNIQUES, V11, P438; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; YIP WK, 1990, P NATL ACAD SCI USA, V87, P7930, DOI 10.1073/pnas.87.20.7930; YIP WK, 1992, P NATL ACAD SCI USA, V89, P2475, DOI 10.1073/pnas.89.6.2475; ZAREMBINSKI TI, 1993, MOL BIOL CELL, V4, P363, DOI 10.1091/mbc.4.4.363	50	144	151	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19422	19430						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366090				2022-12-27	WOS:A1993LW81900044
J	MARQUARDT, T; HEBERT, DN; HELENIUS, A				MARQUARDT, T; HEBERT, DN; HELENIUS, A			POSTTRANSLATIONAL FOLDING OF INFLUENZA HEMAGGLUTININ IN ISOLATED ENDOPLASMIC RETICULUM-DERIVED MICROSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; CHAIN BINDING-PROTEIN; VIRUS HEMAGGLUTININ; INTRACELLULAR-TRANSPORT; SECRETORY PROTEINS; BOND FORMATION; HEAT-SHOCK; MEMBRANE; GLYCOPROTEIN; GLYCOSYLATION	The folding of influenza hemagglutinin was analyzed after in vitro translation and translocation into dog pancreas microsomes. Ectodomain folding of this membrane glycoprotein involves the formation of six intra-chain disulfide bonds. After translation under reducing conditions, the folding process was initiated by the addition of oxidized glutathione or diamide. For correct folding a reduction-oxidation potential of -310 to -210 mV had to be reached in the bulk solution. At lower values, or after addition of other oxidants such as NAD or NADP, no HA disulfides formed. At more oxidizing values interchain disulfide-cross-linked aggregates were generated. Judging by their electrophoretic gel mobility and immunoreactivity, the folding intermediates observed in microsomes were indistinguishable from those previously seen in the endoplasmic reticulum of live cells. The kinetics of folding was also similar, but the efficiency being 43% was somewhat lower. The folding process was dependent on lumenal factors within the rough endoplasmic reticulum vesicles and also on some macromolecular component(s) present in the reticulocyte lysate. The results showed that dog pancreas microsomes provide a useful system for protein folding studies.	YALE UNIV, SCH MED, DEPT CELL BIOL, 333 CEDAR ST, NEW HAVEN, CT 06510 USA	Yale University								BERGMAN LW, 1979, J BIOL CHEM, V254, P8869; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BRAAKMAN I, 1992, NATURE, V356, P260, DOI 10.1038/356260a0; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; BULLEID NJ, 1988, NATURE, V335, P649, DOI 10.1038/335649a0; CONNOLLY T, 1989, J CELL BIOL, V108, P299, DOI 10.1083/jcb.108.2.299; COPELAND CS, 1986, J CELL BIOL, V103, P1179, DOI 10.1083/jcb.103.4.1179; COPELAND CS, 1988, CELL, V53, P197, DOI 10.1016/0092-8674(88)90381-9; CREIGHTON TE, 1978, PROG BIOPHYS MOL BIO, V33, P231; CREIGHTON TE, 1990, BIOCHEM J, V270, P1; DANIELS RS, 1985, CELL, V40, P431, DOI 10.1016/0092-8674(85)90157-6; DOMS RW, 1985, J BIOL CHEM, V260, P2973; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; FREEDMAN RB, 1984, TRENDS BIOCHEM SCI, V9, P438, DOI 10.1016/0968-0004(84)90152-X; GALLAGHER PJ, 1992, J VIROL, V66, P7136, DOI 10.1128/JVI.66.12.7136-7145.1992; GEORGOPOULOS C, 1992, TRENDS BIOCHEM SCI, V17, P295, DOI 10.1016/0968-0004(92)90439-G; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; HARTL FU, 1992, ANNU REV BIOPH BIOM, V21, P293, DOI 10.1146/annurev.bb.21.060192.001453; Helenius Ari, 1992, Trends in Cell Biology, V2, P227, DOI 10.1016/0962-8924(92)90309-B; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; HUBBARD TJP, 1991, PROTEIN ENG, V4, P711, DOI 10.1093/protein/4.7.711; HURTLEY SM, 1989, J CELL BIOL, V108, P2117, DOI 10.1083/jcb.108.6.2117; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; JAENICKE R, 1991, BIOCHEMISTRY-US, V30, P3147, DOI 10.1021/bi00227a001; KADERBHAI MA, 1985, EUR J BIOCHEM, V153, P167, DOI 10.1111/j.1432-1033.1985.tb09283.x; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; KLAUSNER R D, 1989, New Biologist, V1, P3; KOSOWER NS, 1987, METHOD ENZYMOL, V143, P264; LEVY F, 1991, CELL, V67, P265, DOI 10.1016/0092-8674(91)90178-2; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P619, DOI 10.1021/bi00217a005; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; MARQUARDT T, 1992, J CELL BIOL, V117, P505, DOI 10.1083/jcb.117.3.505; MAZZARELLA RA, 1990, J BIOL CHEM, V265, P1094; MAZZARELLA RA, 1987, J BIOL CHEM, V262, P8875; NOIVA R, 1992, J BIOL CHEM, V267, P3553; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PETERS T, 1982, J BIOL CHEM, V257, P8847; POUYSSEGUR J, 1977, CELL, V11, P941, DOI 10.1016/0092-8674(77)90305-1; RIBAUDO RK, 1992, J IMMUNOL, V149, P2935; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; ROTHMAN JE, 1977, NATURE, V269, P775, DOI 10.1038/269775a0; SAXENA VP, 1970, BIOCHEMISTRY-US, V9, P5015; SCHEELE G, 1982, J BIOL CHEM, V257, P2277; SCHEELE G, 1983, METHOD ENZYMOL, V96, P94; SECKLER R, 1992, FASEB J, V6, P2545, DOI 10.1096/fasebj.6.8.1592207; TATU U, 1993, EMBO J, V12, P2151, DOI 10.1002/j.1460-2075.1993.tb05863.x; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WETLAUFER DB, 1987, PROTEIN ENG, V1, P141, DOI 10.1093/protein/1.2.141; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053	53	62	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19618	19625						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366105				2022-12-27	WOS:A1993LW81900073
J	CHEN, LY; CHEN, MY; LEU, WM; TSAI, TY; LEE, YHW				CHEN, LY; CHEN, MY; LEU, WM; TSAI, TY; LEE, YHW			MUTATIONAL STUDY OF STREPTOMYCES TYROSINASE TRANSACTIVATOR MELC1 - MELC1 IS LIKELY A CHAPERONE FOR APOTYROSINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK; MOLECULAR CHAPERONES; ESCHERICHIA-COLI; PROTEINS; GENE; ANTIBIOTICUS; GLAUCESCENS; EXPRESSION; CLONING; PROMOTER	The melanin operon (melC) of Streptomyces antibioticus contains two genes, melC1 and melC2 (apotyrosinase). Our previous studies indicated that MelC1 forms a transient binary complex with the downstream apotyrosinase MelC2 to facilitate the incorporation of copper ion and the secretion of tyrosinase. In this study, we investigated the role of histidine residues in the function of MelC1 by examining a series of substitution or deletion mutants. Of eight mutants only the substitution of His-117 with Asp in the mutant M-117D rendered the complete abolishment of the intracellular tyrosinase activity in both Streptomyces and Escherichia coli. Replacement of His-102 by Leu in the mutant M-102L also caused a 64-70% reduction of tyrosinase activity in Streptomyces and E. coli. These two mutations also affected the secretion of both MelC1 and MelC2 proteins. In vitro copper activation of the purified MelC1 . MelC2 binary complex from these two mutants regained only 20-30% tyrosinase activity of the wild type. Biochemical characterization of the tyrosinases from these two mutants revealed that they were different in several aspects. The intracellular tyrosinase activity in M-117D, but not in M-102L, could be partially reactivated by copper ion or by the cell extract containing MelC1. The copper content and the specific activity of the tyrosinase purified from the culture supernatant from M-117D were only 40% of those in wild type and M-102L. Additionally, fast protein liquid chromatography analysis indicated that in these two mutants the copper activation process was defective, very likely due to the incompetent MelC1 . MelC2 binary complex formed: reduced association in M-117D and elevated association in M-102L. Furthermore, the conformation of MelC2 in the binary complex or in the mature enzyme form in wild type could be differentiated by the proteinase K digestion pattern, and so did the conformation of MelC2 found in those of M-102L, but not in M-117D mutant. Taken together, our results demonstrate that MelC1 is indispensable in the incorporation of copper ion into MelC2 apotyrosinase via a transient, competent binary complex formation, during which a conformational transition of MelC2 has occurred. This strongly suggests that MelC1 is a chaperone for the apotyrosinase MelC2.	NATL YANG MING MED COLL,INST BIOCHEM,TAIPEI 112,TAIWAN	National Yang Ming Chiao Tung University				Lee Wu, Yan-Hwa/0000-0001-7299-7354; CHEN, MEI-YU/0000-0002-5765-9178				BERNAN V, 1985, GENE, V37, P101, DOI 10.1016/0378-1119(85)90262-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAMBERS SP, 1988, GENE, V68, P139, DOI 10.1016/0378-1119(88)90606-3; Chater K. F., 1982, CURR TOP MICROBIOL I, V96, P69; CHEN LY, 1992, J BIOL CHEM, V267, P20100; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; DELLACIOPPA G, 1990, BIO-TECHNOL, V8, P634, DOI 10.1038/nbt0790-634; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; ELLIS RJ, 1990, SCIENCE, V250, P954, DOI 10.1126/science.250.4983.954; ELLIS RJ, 1989, TRENDS BIOCHEM SCI, V14, P339, DOI 10.1016/0968-0004(89)90168-0; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GEORGOPOULOS C, 1992, TRENDS BIOCHEM SCI, V17, P295, DOI 10.1016/0968-0004(92)90439-G; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; HINTERMANN G, 1985, MOL GEN GENET, V200, P422, DOI 10.1007/BF00425726; HOPWOOD DA, 1983, J GEN MICROBIOL, V129, P2257; HUBER M, 1988, BIOCHEMISTRY-US, V27, P5610, DOI 10.1021/bi00415a032; HUBER M, 1987, NUCLEIC ACIDS RES, V15, P8106, DOI 10.1093/nar/15.19.8106; KATZ E, 1983, J GEN MICROBIOL, V129, P2703; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Kuster E., 1976, ACTINOMYCETES BOUNDA, P43; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMINET AA, 1990, EMBO J, V9, P2315, DOI 10.1002/j.1460-2075.1990.tb07403.x; LEE YHW, 1988, GENE, V65, P71, DOI 10.1016/0378-1119(88)90418-0; LERCH K, 1972, EUR J BIOCHEM, V31, P427, DOI 10.1111/j.1432-1033.1972.tb02549.x; LERCH K, 1981, MET IONS BIOL SYST, V13, P143; LEU WM, 1989, GENE, V84, P267; LEU WM, 1992, J BIOL CHEM, V267, P20108; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; Maniatis T, 1980, Methods Enzymol, V65, P299; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSENG HC, 1990, GENE, V86, P123, DOI 10.1016/0378-1119(90)90124-A	35	39	41	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18710	18716						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360164				2022-12-27	WOS:A1993LV65900055
J	SHIMADA, M; SHIMANO, H; GOTODA, T; YAMAMOTO, K; KAWAMURA, M; INABA, T; YAZAKI, Y; YAMADA, N				SHIMADA, M; SHIMANO, H; GOTODA, T; YAMAMOTO, K; KAWAMURA, M; INABA, T; YAZAKI, Y; YAMADA, N			OVEREXPRESSION OF HUMAN LIPOPROTEIN-LIPASE IN TRANSGENIC MICE - RESISTANCE TO DIET-INDUCED HYPERTRIGLYCERIDEMIA AND HYPERCHOLESTEROLEMIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; MONOCYTE-DERIVED MACROPHAGES; FREE FATTY-ACIDS; BETA-ACTIN GENE; MISSENSE MUTATION; ENZYMATIC DETERMINATION; APOLIPOPROTEIN-E; HEART-DISEASE; METABOLISM; DEFICIENCY	Lipoprotein lipase (LPL) is a key enzyme in the hydrolysis of triglyceride-rich lipoproteins. To determine the role of LPL in lipoprotein metabolism, we established three transgenic mouse lines overexpressing the human LPL gene; the highest expressor line, which transcribed human LPL mRNA in the heart, skeletal muscles, and adipose tissue, was used in this study. The transgenic mice had 5- and 1.7-fold higher LPL activity in adipose tissue and post-heparin plasma, respectively. Plasma triglyceride levels in transgenic mice were 24.2% of that in control mice, and gel filtration chromatography showed that very low density lipoprotein (VLDL) triglycerides were much reduced in transgenic mice. In the chemical analysis of plasma lipoproteins isolated by ultracentrifugation, we found that LDL particles were cholesterol-rich and HDL2 cholesterol was increased 1.4-fold in transgenic mice as compared to control mice. When we injected I-125-VLDL intravenously into transgenic mice, the clearance of I-125-VLDL and the conversion of VLDL to LDL was markedly enhanced as compared to control mice. Furthermore, the clearance of chylomicrons, estimated by both the fat loading and retinyl palmitate loading tests, was significantly enhanced in transgenic mice. After sucrose feeding, no increase in VLDL was observed in transgenic mice. When fed a high cholesterol diet, the development of hypercholesterolemia was suppressed in transgenic mice. These results suggested that LPL determined not only hydrolysis of triglyceride-rich lipoproteins but also lipolytic conversion, and that overexpression of LPL acted to protect against diet-induced hypertriglyceridemia as well as hypercholesterolemia.	UNIV TOKYO, DEPT INTERNAL MED 3, TOKYO 113, JAPAN	University of Tokyo			Shimano, Hitoshi/AAI-5648-2020; Shimano, Hitoshi/V-1761-2019	Shimano, Hitoshi/0000-0002-5562-5572				ALLAIN CC, 1974, CLIN CHEM, V20, P470; AMEIS D, 1991, J CLIN INVEST, V87, P1165, DOI 10.1172/JCI115114; AUSTIN MA, 1991, ARTERIOSCLER THROMB, V11, P2, DOI 10.1161/01.ATV.11.1.2; AVIRAM M, 1988, J BIOL CHEM, V263, P15416; BARBORIAK JJ, 1979, METABOLISM, V28, P735, DOI 10.1016/0026-0495(79)90178-1; BEG OU, 1990, P NATL ACAD SCI USA, V87, P3474, DOI 10.1073/pnas.87.9.3474; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BUCOLO G, 1973, CLIN CHEM, V19, P476; CAMBIEN F, 1986, AM J EPIDEMIOL, V124, P624, DOI 10.1093/oxfordjournals.aje.a114435; CASTELLI WP, 1986, AM HEART J, V112, P432, DOI 10.1016/0002-8703(86)90296-6; CHAIT A, 1982, J CLIN INVEST, V69, P490, DOI 10.1172/JCI110473; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRYER A, 1981, INT J BIOCHEM, V13, P525, DOI 10.1016/0020-711X(81)90177-4; DICHEK HL, 1991, J BIOL CHEM, V266, P473; EISENBERG S, 1984, J LIPID RES, V25, P1017; EISENBERG S, 1976, LOW DENSITY LIPOPROT, P73; ELDER PK, 1988, MOL CELL BIOL, V8, P480, DOI 10.1128/MCB.8.1.480; EMI M, 1990, J BIOL CHEM, V265, P5910; FAUSTINELLA F, 1991, J BIOL CHEM, V266, P14418; GARFINKEL AS, 1987, PLASMA LIPOPROTEINS, P335; GOLDBERG IJ, 1988, J CLIN INVEST, V81, P561, DOI 10.1172/JCI113354; GOTODA T, 1991, J CLIN INVEST, V88, P1856, DOI 10.1172/JCI115507; GOTODA T, 1989, NUCLEIC ACIDS RES, V17, P2351, DOI 10.1093/nar/17.6.2351; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HAVEL RJ, 1960, J CLIN INVEST, V39, P1777, DOI 10.1172/JCI104202; HENDERSON HE, 1991, J CLIN INVEST, V87, P2005, DOI 10.1172/JCI115229; ISHIBASHI S, 1990, J BIOL CHEM, V265, P3040; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; KERN PA, 1991, CURR OPIN LIPIDOL, V2, P162; KHOO JC, 1981, J BIOL CHEM, V256, P7105; KIRCHGESSNER TG, 1987, J BIOL CHEM, V262, P8463; LANGLOIS S, 1989, P NATL ACAD SCI USA, V86, P948, DOI 10.1073/pnas.86.3.948; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MA YH, 1991, NEW ENGL J MED, V324, P1761, DOI 10.1056/NEJM199106203242502; MAHONEY EM, 1982, P NATL ACAD SCI-BIOL, V79, P1639, DOI 10.1073/pnas.79.5.1639; Maniatis T, 1989, MOL CLONING; MATTHEWS CME, 1957, PHYS MED BIOL, V2, P36, DOI 10.1088/0031-9155/2/1/305; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; MILLER GJ, 1975, LANCET, V1, P16; MONSALVE MV, 1990, J CLIN INVEST, V86, P728, DOI 10.1172/JCI114769; MURASE T, 1980, METABOLISM, V29, P666, DOI 10.1016/0026-0495(80)90112-2; NG SY, 1985, MOL CELL BIOL, V5, P2720, DOI 10.1128/MCB.5.10.2720; NILSSONEHLE P, 1976, J LIPID RES, V17, P536; Olivecrona T, 1990, CURR OPIN LIPIDOL, V1, P222; SAXENA U, 1990, J BIOL CHEM, V265, P12880; SCHONFELD G, 1971, J LIPID RES, V12, P614; SEHAYEK E, 1991, J CLIN INVEST, V88, P553, DOI 10.1172/JCI115339; SHIMANO H, 1992, P NATL ACAD SCI USA, V89, P1750, DOI 10.1073/pnas.89.5.1750; SHIMIZU S, 1980, ANAL BIOCHEM, V107, P193, DOI 10.1016/0003-2697(80)90511-4; TAKAYAMA M, 1977, CLIN CHIM ACTA, V79, P93, DOI 10.1016/0009-8981(77)90465-X; WEINTRAUB MS, 1987, J CLIN INVEST, V79, P1110, DOI 10.1172/JCI112926; WILLIAMS KJ, 1992, J BIOL CHEM, V267, P13284; YAMADA N, 1986, J LIPID RES, V27, P910; YOKODE M, 1990, SCIENCE, V250, P1273, DOI 10.1126/science.2244210	55	125	130	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17924	17929						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349676				2022-12-27	WOS:A1993LT74300045
J	TANASIJEVIC, MJ; MYERS, MG; THOMA, RS; CRIMMINS, DL; WHITE, MF; SACKS, DB				TANASIJEVIC, MJ; MYERS, MG; THOMA, RS; CRIMMINS, DL; WHITE, MF; SACKS, DB			PHOSPHORYLATION OF THE INSULIN-RECEPTOR SUBSTRATE IRS-1 BY CASEIN KINASE-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATES TYROSINE PHOSPHORYLATION; EPIDERMAL GROWTH-FACTOR; SERINE PHOSPHORYLATION; SKELETAL-MUSCLE; ALPHA-SUBUNIT; BETA-SUBUNIT; RAT-LIVER; PROTEIN; CALMODULIN; ACTIVATION	IRS-1, a principal substrate of the insulin receptor, is phosphorylated on serine, threonine, and tyrosine residues in a variety of tissues during insulin stimulation. Casein kinase II, an insulin-sensitive serine/threonine kinase, catalyzed the in vitro incorporation of 1 to 2 mol of phosphate/mol of recombinant rat IRS-1. Two-dimensional phosphopeptide mapping of IRS-1 phosphorylated by casein kinase II in vitro and IRS-1 immunoprecipitated from intact Chinese hamster ovary cells demonstrated multiple common phosphopeptides, suggesting that overexpressed IRS-1 is a substrate for casein kinase II in these cells. Moreover, the common phosphopeptides that appeared to be insulin-sensitive in intact cells comprised 22% of casein kinase II-catalyzed P-32 incorporation into IRS-1 in vitro. These data suggest that casein kinase II mediates a portion of the insulin-stimulated serine/threonine phosphorylation of overexpressed IRS-1 in vivo. By using phosphoamino acid analysis, strong cation exchange analysis, manual Edman degradation, and automated amino acid sequencing, Thr-502 was identified as the major casein kinase II-catalyzed phosphorylation site in rat IRS-1. Furthermore, Ser-99, an additional site labeled at low yield, appeared to be contained in an insulin-sensitive phosphopeptide. Thus, casein kinase II-catalyzed phosphorylation of IRS-1 may be a component of the intracellular insulin signalling cascade.	BRIGHAM & WOMENS HOSP, DEPT PATHOL, MRB 615, 75 FRANCIS ST, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, JOSLIN DIABET CTR, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DEPT MED, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA; WASHINGTON UNIV, SCH MED, HOWARD HUGHES MED INST, ST LOUIS, MO 63110 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Washington University (WUSTL)				Sacks, David/0000-0003-3100-0735	NIDDK NIH HHS [DK 43808, DK 43682] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043808, R01DK043682] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACKERMAN P, 1990, P NATL ACAD SCI USA, V87, P821, DOI 10.1073/pnas.87.2.821; ARAKI E, 1992, DIABETES S1, V41, pA167; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; CRIMMINS DL, 1989, ANAL BIOCHEM, V176, P255, DOI 10.1016/0003-2697(89)90305-9; CZECH MP, 1988, J BIOL CHEM, V263, P11017; DAVIS HW, 1990, BIOCHEM BIOPH RES CO, V171, P53, DOI 10.1016/0006-291X(90)91355-V; DENTON RM, 1986, ADV CYCLIC NUCL PROT, V20, P293; DOBROWOLSKA G, 1992, EUR J BIOCHEM, V204, P299, DOI 10.1111/j.1432-1033.1992.tb16637.x; DOBROWOLSKA G, 1991, BIOCHIM BIOPHYS ACTA, V1129, P139, DOI 10.1016/0167-4781(91)90230-J; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; GIRAULT JA, 1989, J BIOL CHEM, V264, P21748; GRANDE J, 1988, FEBS LETT, V232, P130, DOI 10.1016/0014-5793(88)80401-0; HATHAWAY GM, 1983, METHOD ENZYMOL, V99, P317, DOI 10.1016/0076-6879(83)99067-5; HAYSTEAD TAJ, 1988, EUR J BIOCHEM, V175, P347, DOI 10.1111/j.1432-1033.1988.tb14203.x; KARASIK A, 1988, J BIOL CHEM, V263, P11862; KLARLUND JK, 1988, J BIOL CHEM, V263, P15872; KOVACINA KS, 1990, J BIOL CHEM, V265, P12115; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUO KX, 1991, METHOD ENZYMOL, V201, P149; MAEDA R, 1991, J CLIN INVEST, V87, P1017, DOI 10.1172/JCI115060; MARIN O, 1992, FEBS LETT, V301, P111, DOI 10.1016/0014-5793(92)80221-2; MCCROSKEY MC, 1988, J CHROMATOGR, V442, P307, DOI 10.1016/S0021-9673(00)94478-9; MIRALPEIX M, 1992, BIOCHEMISTRY-US, V31, P9031, DOI 10.1021/bi00152a046; MOONEY RA, 1989, ENDOCRINOLOGY, V124, P422, DOI 10.1210/endo-124-1-422; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; NISHIYAMA M, 1992, BIOCHEM BIOPH RES CO, V183, P280, DOI 10.1016/0006-291X(92)91640-C; PALEN E, 1991, BIOCHEMISTRY-US, V30, P5586, DOI 10.1021/bi00236a035; PICCIOTTO MR, 1992, J BIOL CHEM, V267, P12742; PICTON C, 1982, FEBS LETT, V150, P191, DOI 10.1016/0014-5793(82)81332-X; PISANO MR, 1988, BIOCHEM BIOPH RES CO, V155, P1207, DOI 10.1016/S0006-291X(88)81268-3; ROTH RA, 1987, DIABETES, V36, P123, DOI 10.2337/diabetes.36.1.123; ROTHENBERG PL, 1991, J BIOL CHEM, V266, P8302; SACKS DB, 1988, J BIOL CHEM, V263, P2377; SACKS DB, 1992, BIOCHEM BIOPH RES CO, V188, P754, DOI 10.1016/0006-291X(92)91120-F; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; SACKS DB, 1992, BIOCHEM J, V286, P211, DOI 10.1042/bj2860211; SALTIEL AR, 1988, AM J PHYSIOL, V255, pC1, DOI 10.1152/ajpcell.1988.255.1.C1; SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027; SOMMERCORN J, 1987, P NATL ACAD SCI USA, V84, P8834, DOI 10.1073/pnas.84.24.8834; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; SULLIVAN S, 1991, ANAL BIOCHEM, V197, P65, DOI 10.1016/0003-2697(91)90356-X; SUMMERS MD, 1988, TEX AGR EXP STN B, V1555, P1; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUN XJ, 1992, J BIOL CHEM, V267, P22662; TAKAYAMA S, 1988, J BIOL CHEM, V263, P3440; TUAZON PT, 1991, ADV SEC MESS PHOSPH, V23, P123; VOSS H, 1991, J BIOL CHEM, V266, P13706; WALTON GM, 1985, J BIOL CHEM, V260, P4745; WHITE MF, 1987, J BIOL CHEM, V262, P9769; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; YU IJ, 1991, J CELL BIOL, V114, P1217, DOI 10.1083/jcb.114.6.1217	53	69	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18157	18166						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349691				2022-12-27	WOS:A1993LT74300076
J	THIAGALINGAM, S; GROSSMAN, L				THIAGALINGAM, S; GROSSMAN, L			THE MULTIPLE ROLES FOR ATP IN THE ESCHERICHIA-COLI UVRABC ENDONUCLEASE-CATALYZED INCISION REACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION REPAIR; BACTERIAL TRANSPORT PROTEINS; ENZYMATIC-PROPERTIES; (A)BC EXCINUCLEASE; DNA; GENE; BINDING; UVRB; PURIFICATION; COMPLEX	The biochemical properties of the Escherichia coli UvrA tandem ATPase site mutants in nucleotide excision repair have been studied. In these and earlier studies it was found that ATP binding is required for protein-protein and nucleoprotein association reactions, whereas the dissociation reactions are driven by the hydrolysis of ATP. The self-association of UvrA to form the reactive dimeric species UvrA2 is driven by nucleotide binding, but its dissociation from DNA requires ATP hydrolysis. Similarly, ATP binding drives those allosteric changes in DNA topology during UvrA2-nucleoprotein formation (Oh, E. Y., and Grossman, L. (1986) Nucleic Acids Res. 14, 8557-8571). The manifestation of the UvrB-associated cryptic ATPase requires UvrA and DNA in a helicase-catalyzed supercoiling reaction. The UvrA2B helicase activity requires ATP hydrolysis by the C-terminal ATPase site of UvrA in addition to UvrB. ATP hydrolysis by the C-terminal ATPase site of UvrA also participates in the localization of damaged sites contributing to the formation of damage-specific high affinity nucleoprotein complexes. The levels of complementation to UV survival by the ATPase site mutants of UvrA (Thiagalingam, S., and Grossman, L. (1991) J. Biol. Chem. 266, 11395-11403) correspond to its ability to self-bind and translocate in combination with the UvrB subunit in its search for damaged sites during the preincision mode of nucleotide excision.	JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT BIOCHEM,615 N WOLFE ST,BALTIMORE,MD 21205	Johns Hopkins University				Thiagalingam, Sam/0000-0001-5211-266X	NIGMS NIH HHS [GM31110, R01 GM22846] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031110, R01GM022846] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACKENDORF C, 1986, NUCLEIC ACIDS RES, V14, P2877, DOI 10.1093/nar/14.7.2877; BRAUN A, 1974, P NATL ACAD SCI USA, V71, P1833; BRAUN AG, 1981, DNA REPAIR LABORAT B, V1, P447; CARON PR, 1988, NUCLEIC ACIDS RES, V16, P9651, DOI 10.1093/nar/16.20.9651; CARON PR, 1988, NUCLEIC ACIDS RES, V16, P7855, DOI 10.1093/nar/16.16.7855; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CLAASSEN LA, 1991, J BIOL CHEM, V266, P11388; DOOLITTLE RF, 1986, NATURE, V323, P451, DOI 10.1038/323451a0; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; GROS P, 1988, MOL CELL BIOL, V8, P2770, DOI 10.1128/MCB.8.7.2770; GROSSMAN L, 1990, PHOTOCHEM PHOTOBIOL, V51, P749, DOI 10.1111/php.1990.51.6.749; HUSAIN I, 1986, J BIOL CHEM, V261, P4895; KOO HS, 1991, P NATL ACAD SCI USA, V88, P1212, DOI 10.1073/pnas.88.4.1212; MAZUR SJ, 1991, BIOCHEMISTRY-US, V30, P4432, DOI 10.1021/bi00232a009; MYLES GM, 1991, BIOCHEMISTRY-US, V30, P3824, DOI 10.1021/bi00230a004; OH EY, 1989, NUCLEIC ACIDS RES, V17, P4145, DOI 10.1093/nar/17.11.4145; OH EY, 1986, NUCLEIC ACIDS RES, V14, P8557, DOI 10.1093/nar/14.21.8557; OH EY, 1989, J BIOL CHEM, V264, P1336; OH EY, 1987, P NATL ACAD SCI USA, V84, P3638, DOI 10.1073/pnas.84.11.3638; ORREN DK, 1989, P NATL ACAD SCI USA, V86, P5237, DOI 10.1073/pnas.86.14.5237; ORREN DK, 1990, J BIOL CHEM, V265, P15796; PU WT, 1989, J BIOL CHEM, V264, P20697; RIAZUDDIN S, 1977, J BIOL CHEM, V252, P6280; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sambrook J, 1989, MOL CLONING LABORATO; SANCAR A, 1983, CELL, V33, P249, DOI 10.1016/0092-8674(83)90354-9; SEEBERG E, 1978, P NATL ACAD SCI USA, V75, P2569, DOI 10.1073/pnas.75.6.2569; SEEBERG E, 1982, P NATL ACAD SCI-BIOL, V79, P988, DOI 10.1073/pnas.79.4.988; SEELEY TW, 1990, J BIOL CHEM, V265, P7158; SEELEY TW, 1989, P NATL ACAD SCI USA, V86, P6577, DOI 10.1073/pnas.86.17.6577; SELBY CP, 1990, MUTAT RES, V236, P203, DOI 10.1016/0921-8777(90)90005-P; THIAGALINGAM S, 1991, J BIOL CHEM, V266, P11395; THOMAS DC, 1985, J BIOL CHEM, V260, P9875; VANHOUTEN B, 1990, MICROBIOL REV, V54, P18, DOI 10.1128/MMBR.54.1.18-51.1990; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; YEUNG AT, 1986, NUCLEIC ACIDS RES, V14, P2567, DOI 10.1093/nar/14.6.2567; YEUNG AT, 1986, NUCLEIC ACIDS RES, V14, P8535, DOI 10.1093/nar/14.21.8535; YEUNG AT, 1983, P NATL ACAD SCI-BIOL, V80, P6157, DOI 10.1073/pnas.80.20.6157	38	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18382	18389						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349713				2022-12-27	WOS:A1993LT74300107
J	VELARDO, MA; BRETTHAUER, RK; BOUTAUD, A; REINHOLD, B; REINHOLD, VN; CASTELLINO, FJ				VELARDO, MA; BRETTHAUER, RK; BOUTAUD, A; REINHOLD, B; REINHOLD, VN; CASTELLINO, FJ			THE PRESENCE OF UDP-N-ACETYLGLUCOSAMINE - ALPHA-3-D-MANNOSIDE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE-I ACTIVITY IN SPODOPTERA-FRUGIPERDA CELLS (IPLB-SF-21AE) AND ITS ENHANCEMENT AS A RESULT OF BACULOVIRUS INFECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; COMPLEX-TYPE OLIGOSACCHARIDES; GLYCOPROTEIN-SYNTHESIS; CHROMATOGRAPHY; EXPRESSION	A Golgi preparation from Spodoptera frugiperda (IPLB-SF-21AE) cells was incubated in the presence of the mannosidase II inhibitor, swainsonine, with the oligosaccharide, M(alpha1,3)[[M(alpha1,3)[M(al,6)]M(alpha1,6)]] M(beta1,4)Gn(beta1,4)Gn (M5Gn2), the preferred substrate for the enzyme, UDP-N-acetylglucosamine:alpha-3-D-mannoside beta1,2-N-acetylglucosaminyltransferase I (Gn-TI). This resulted in formation of the product, Gn(beta1,2)M(alpha1,3)[[M(alpha1,3)[M(alpha1,6)]M(alpha1,6)]]-M(beta1,4) Gn(beta1,4)Gn (Gn(I)M5Gn2). A significantly increased (>4-fold) rate of conversion of M5Gn2 to Gn(I)M5Gn2 occurred with insect cell-derived Golgi preparations that had been infected with a recombinant baculovirus for 66 h, a time at which significant amounts of complex-type oligosaccharides were assembled on a heterologous protein, human plasminogen, expressed in this system. Coupled with previous results (Davidson, D. J., Bretthauer, R. K., and Castellino, F. J. (1991) Biochemistry 30, 9811-9815) that demonstrated the occurrence of virally induced activation of a specific M6-mannosidase in IPLB-SF-21AE cells, it is clear that viral infection of lepidopteran insect cells makes available enzymes that provide and utilize the substrate, M5Gn2-protein. This is a key feature in the explanation of the previous original observations made by this laboratory, that lepidopteran insect cells are capable of assembly of complex-type oligosaccharides on glycoproteins.	UNIV NOTRE DAME, DEPT CHEM & BIOCHEM, NOTRE DAME, IN 46556 USA; HARVARD UNIV, SCH PUBL HLTH, DEPT NUTR, BOSTON, MA 02115 USA	University of Notre Dame; Harvard University; Harvard T.H. Chan School of Public Health					NHLBI NIH HHS [HL-19982, HL-13423] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019982, R37HL013423, R01HL013423] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLEN SD, 1984, J BIOL CHEM, V259, P6984; BASU S, 1975, J BIOL CHEM, V250, P2956; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUTTERS TD, 1981, BIOCHIM BIOPHYS ACTA, V640, P672, DOI 10.1016/0005-2736(81)90097-3; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; DAVIDSON DJ, 1991, BIOCHEMISTRY-US, V30, P6167, DOI 10.1021/bi00239a013; DAVIDSON DJ, 1990, BIOCHEMISTRY-US, V29, P5584, DOI 10.1021/bi00475a024; DAVIDSON DJ, 1991, BIOCHEMISTRY-US, V30, P6689, DOI 10.1021/bi00241a008; DAVIDSON DJ, 1991, BIOCHEMISTRY-US, V30, P9811, DOI 10.1021/bi00105a001; DAVIDSON DJ, 1993, THESIS U NOTRE DAME; HARDY MR, 1988, ANAL BIOCHEM, V170, P54, DOI 10.1016/0003-2697(88)90089-9; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; NARASIMHAN S, 1977, J BIOL CHEM, V252, P3926; ROTH J, 1992, SCIENCE, V256, P673, DOI 10.1126/science.1585182; SCHACHTER H, 1983, METHOD ENZYMOL, V98, P98; SCHACHTER H, 1989, METHOD ENZYMOL, V179, P351; SRIDHAR P, 1993, FEBS LETT, V315, P282, DOI 10.1016/0014-5793(93)81179-4; TABAS I, 1978, J BIOL CHEM, V253, P7779; YAMASHITA K, 1982, METHOD ENZYMOL, V83, P105	21	54	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17902	17907						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349674				2022-12-27	WOS:A1993LT74300042
J	LEI, KJ; WANG, C; CHAMBERLIN, ME; LIU, JL; PAN, CJ; CHOU, JY				LEI, KJ; WANG, C; CHAMBERLIN, ME; LIU, JL; PAN, CJ; CHOU, JY			CHARACTERIZATION OF 2 ALLELIC VARIANTS OF A HUMAN PREGNANCY-SPECIFIC GLYCOPROTEIN GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CARCINOEMBRYONIC ANTIGEN; DNA-BINDING; MOLECULAR-CLONING; BETA-1-GLYCOPROTEIN FAMILY; CDNA SEQUENCE; FETAL LIVER; CEA FAMILY; CACCC-BOX; PROTEINS; SP1	The pregnancy-specific glycoproteins (PSGs) of the human placenta are a group of proteins that together with the carcinoembryonic antigens comprise a subfamily within the immunoglobulin superfamily. To study the control of PSG expression, we isolated and characterized PSG genes and identified cis-acting DNA elements in the 5'-flanking gene regions essential for PSG expression. Two overlapping PSG cosmid clones, which contain two allelic variants of a PSG gene (PSG12 and PSG12psi), were isolated from an unamplified library made from a single individual. Cosmid 1 contains exons 1 (5'/L) and 2 (L/N) of the PSG12 gene located downstream of a previously identified PSG1-I gene. Cosmid 6 contains a portion of the PSG1-I gene lacking exons 1 and 2 upstream of a complete PSG12psi transcription unit. Sequence comparison indicates that exons 5'/L and L/N in PSG12 and PSG12psi are 99% identical, except that the L/N exon in the PSG12psi gene contains a stop codon. Both PSG12 and PSG12psi transcripts were detected in the human placenta, indicating that both genes are actively transcribed. However, the PSG12psi gene may represent an allelic pseudogene variant of the PSG12 gene, because all identified PSGs contain a functional N-domain. Primer extension analysis showed that the PSG12 gene starts at a cluster of sites located at -106 to -104 base pairs with respect to the translation start site. In transient transfection assays using a chloramphenicol acetyltransferase reporter gene, we demonstrated that the -835 to -34 DNA region upstream of the translation start site of PSG12 or PSG12psi contained both positive and negative elements that control PSG expression. Deletion analysis showed that nucleotides -172 to -34 in the PSG12 gene could function as a promoter. Gel retardation analysis showed that protein factors in human placental cell extract formed four complexes (I, II, IIa, and III) with the PSG12(-172/-34) DNA. Site-directed mutagenesis that prevents protein factor binding to the PSG12 promoter resulted in a marked reduction in transcription activation, locating the core enhancers at nucleotides-148 to -141 and -60 to -55. Mutagenesis studies also showed that the ACAGC repeats at nucleotides -84 to -68 in the PSG12 5'-flanking are essential for expression of the PSG12 gene in human placental cells.	NICHHD,HUMAN GENET BRANCH,BLDG 10,RM 95242,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)								BARNETT TR, 1989, J CELL BIOL, V108, P267, DOI 10.1083/jcb.108.2.267; BATZER MA, 1990, NUCLEIC ACIDS RES, V18, P6793, DOI 10.1093/nar/18.23.6793; BEAUCHEMIN N, 1987, MOL CELL BIOL, V7, P3221, DOI 10.1128/MCB.7.9.3221; BOHN H, 1971, ARCH GYNAKOL, V210, P440, DOI 10.1007/BF01628222; BURTIS KC, 1990, CELL, V61, P85, DOI 10.1016/0092-8674(90)90217-3; CHAN WY, 1988, DNA-J MOLEC CELL BIO, V7, P545, DOI 10.1089/dna.1.1988.7.545; CHAN WY, 1991, MOL CELL BIOCHEM, V106, P161; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOU JY, 1992, SEMIN REPROD ENDOCR, V10, P116, DOI 10.1055/s-2007-1018867; CHU G, 1981, GENE, V13, P197, DOI 10.1016/0378-1119(81)90008-1; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; FORDIS M, 1986, METHOD ENZYMOL, V151, P382; GUMUCIO DL, 1991, BLOOD, V78, P1853; GUNTHER CV, 1990, GENE DEV, V4, P667, DOI 10.1101/gad.4.4.667; HEILIG R, 1987, NUCLEIC ACIDS RES, V15, P9129, DOI 10.1093/nar/15.22.9129; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HINODA Y, 1988, P NATL ACAD SCI USA, V85, P6959, DOI 10.1073/pnas.85.18.6959; HO IC, 1990, SCIENCE, V250, P814, DOI 10.1126/science.2237431; KAGEYAMA R, 1989, CELL, V59, P815, DOI 10.1016/0092-8674(89)90605-3; KARIM FD, 1990, GENE DEV, V4, P1451, DOI 10.1101/gad.4.9.1451; KHAN WN, 1990, BIOCHEM BIOPH RES CO, V168, P214, DOI 10.1016/0006-291X(90)91696-P; KHAN WN, 1992, GENOMICS, V12, P780, DOI 10.1016/0888-7543(92)90309-G; KOCZAN D, 1991, NUCLEIC ACIDS RES, V19, P5591, DOI 10.1093/nar/19.20.5591; LEE JN, 1979, BRIT J OBSTET GYNAEC, V86, P888, DOI 10.1111/j.1471-0528.1979.tb10717.x; LEI KJ, 1992, J BIOL CHEM, V267, P16371; LEI KJ, 1992, MOL ENDOCRINOL, V6, P703, DOI 10.1210/me.6.5.703; LESLIE KK, 1990, P NATL ACAD SCI USA, V87, P5822, DOI 10.1073/pnas.87.15.5822; LIN TM, 1974, J CLIN INVEST, V54, P576, DOI 10.1172/JCI107794; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MACDONALD DJ, 1983, AM J OBSTET GYNECOL, V147, P430, DOI 10.1016/S0002-9378(16)32239-6; MANCUSO DJ, 1991, BIOCHEMISTRY-US, V30, P253, DOI 10.1021/bi00215a036; MANTOVANI R, 1988, NUCLEIC ACIDS RES, V16, P4299, DOI 10.1093/nar/16.10.4299; MARTIN ME, 1988, P NATL ACAD SCI USA, V85, P5839, DOI 10.1073/pnas.85.16.5839; MASSON GM, 1983, BRIT J OBSTET GYNAEC, V90, P146, DOI 10.1111/j.1471-0528.1983.tb08899.x; NEUMAIER M, 1988, J BIOL CHEM, V263, P3202; OIKAWA S, 1988, BIOCHEM BIOPH RES CO, V156, P68, DOI 10.1016/S0006-291X(88)80806-4; OIKAWA S, 1987, BIOCHEM BIOPH RES CO, V142, P511, DOI 10.1016/0006-291X(87)90304-4; OIKAWA S, 1989, BIOCHEM BIOPH RES CO, V163, P1021, DOI 10.1016/0006-291X(89)92324-3; PARMENTIER M, 1989, GENOMICS, V4, P309, DOI 10.1016/0888-7543(89)90335-2; RAO VN, 1987, SCIENCE, V237, P635, DOI 10.1126/science.3299708; ROONEY BC, 1988, GENE, V71, P439, DOI 10.1016/0378-1119(88)90061-3; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHREWE H, 1990, MOL CELL BIOL, V10, P2738, DOI 10.1128/MCB.10.6.2738; SCHULE R, 1988, NATURE, V332, P87, DOI 10.1038/332087a0; SNAPE AM, 1991, DEVELOPMENT, V113, P283; SORENSEN S, 1984, TUMOUR BIOL, V5, P275; STREYDIO C, 1990, GENOMICS, V6, P579, DOI 10.1016/0888-7543(90)90492-D; STREYDIO C, 1988, BIOCHEM BIOPH RES CO, V154, P130, DOI 10.1016/0006-291X(88)90660-2; TAMSEN L, 1983, J PERINAT MED, V11, P19, DOI 10.1515/jpme.1983.11.1.19; TATARINOV Y S, 1970, Byulleten' Eksperimental'noi Biologii i Meditsiny, V69, P66; TATARINOV YS, 1978, GYNECOL OBSTET INVES, V9, P65, DOI 10.1159/000300972; TAWARAGI Y, 1988, BIOCHEM BIOPH RES CO, V150, P89, DOI 10.1016/0006-291X(88)90490-1; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; VORLICKOVA M, 1982, NUCLEIC ACIDS RES, V10, P1071, DOI 10.1093/nar/10.3.1071; WATANABE S, 1988, BIOCHEM BIOPH RES CO, V152, P762, DOI 10.1016/S0006-291X(88)80103-7; WATANABE S, 1988, J BIOL CHEM, V263, P2049; WATSON DK, 1988, P NATL ACAD SCI USA, V85, P7862, DOI 10.1073/pnas.85.21.7862; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; WURZ H, 1981, J PERINAT MED, V9, P67, DOI 10.1515/jpme.1981.9.2.67; ZHENG QX, 1990, BIOCHEMISTRY-US, V29, P2845, DOI 10.1021/bi00463a030; ZIMMERMANN W, 1989, BIOCHEM BIOPH RES CO, V163, P1197, DOI 10.1016/0006-291X(89)91105-4	63	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17528	17538						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349632				2022-12-27	WOS:A1993LQ98800093
J	BANERJEE, A; GREGORI, L; XU, YP; CHAU, V				BANERJEE, A; GREGORI, L; XU, YP; CHAU, V			THE BACTERIALLY EXPRESSED YEAST CDC34 GENE-PRODUCT CAN UNDERGO AUTOUBIQUITINATION TO FORM A MULTIUBIQUITIN CHAIN-LINKED PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; SHORT-LIVED PROTEIN; N-END RULE; AFFINITY PURIFICATION; CELL CYCLE; DEGRADATION; RAD6; PROTEOLYSIS; RECOGNITION; HOMOLOGS	The CDC34 gene of Saccharomyces cerevisiae encodes a 295-residue ubiquitin-conjugating enzyme (E2). The function of this ubiquitin-conjugating activity remains to be defined as its in vivo substrates are presently unknown. The bacterially expressed and purified Cdc34 protein is shown here to catalyze its own ubiquitination via an intramolecular transfer of its thiol ester-linked ubiquitin to a lysine. In this process, multiple ubiquitin groups are added to Cdc34, and these ubiquitin groups were shown to be arranged predominantly in the form of a single Lys48-specific multiubiquitin chain. Analysis of the hydroxylamine-dependent cleavage of ubiquitin-Cdc34 conjugates at the single Asn-Gly sequence in Cdc34 placed the major ubiquitin linkage site within the C-terminal 215-295 residues of Cdc34. The 4 Lys residues (Lys273, Lys277, Lys293, and Lys294) in this region of CDC34 were substituted by arginine either singly or in combination to produce a set of Cdc34 mutants. Analysis of these Cdc34 mutants for autoubiquitination revealed that the multiubiquitin chain can be formed on any one of these 4 lysines although most Cdc34 conjugates contain a single multiubiquitin chain. Since the presence of a Lys48-specific multiubiquitin chain in protein conjugates is known to target acceptor proteins for degradation in the ubiquitin-mediated proteolytic pathway, the present result raises the possibility that one function of the ubiquitin-conjugating activity in CDC34 may be used to target its own degradation.	WAYNE STATE UNIV, SCH MED, DEPT PHARMACOL, 540 E CANFIELD, DETROIT, MI 48201 USA	Wayne State University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035803] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 35803] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BYERS B, 1973, COLD SPRING HARB SYM, V38, P123, DOI 10.1101/SQB.1974.038.01.016; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; DUNTEN RL, 1991, J BIOL CHEM, V266, P3260; ECKER DJ, 1987, J BIOL CHEM, V262, P14213; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; GREGORI L, 1990, J BIOL CHEM, V265, P8354; HAAS AL, 1991, J BIOL CHEM, V266, P5104; HAAS AL, 1988, J BIOL CHEM, V263, P13258; HERSHKO A, 1991, J BIOL CHEM, V266, P16376; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; HERSHKO A, 1991, TRENDS BIOCHEM SCI, V16, P265, DOI 10.1016/0968-0004(91)90101-Z; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; JOHNSON ES, 1990, NATURE, V346, P287, DOI 10.1038/346287a0; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; KOKEN MHM, 1991, P NATL ACAD SCI USA, V88, P8865, DOI 10.1073/pnas.88.20.8865; PICKART CM, 1985, J BIOL CHEM, V260, P1573; PICKART CM, 1988, J BIOL CHEM, V263, P15076; PICKART CM, 1988, UBIQUITIN, P77; RECHSTEINER M, 1987, ANNU REV CELL BIOL, V3, P1, DOI 10.1146/annurev.cb.03.110187.000245; REISS Y, 1990, J BIOL CHEM, V265, P3685; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SUNG P, 1991, EMBO J, V10, P2187, DOI 10.1002/j.1460-2075.1991.tb07754.x; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; WING SS, 1992, J BIOL CHEM, V267, P6495	31	87	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1993	268	8					5668	5675						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR822	8383676				2022-12-27	WOS:A1993KR82200048
J	HIGUCHI, M; AGGARWAL, BB				HIGUCHI, M; AGGARWAL, BB			OKADAIC ACID INDUCES DOWN-MODULATION AND SHEDDING OF TUMOR-NECROSIS-FACTOR RECEPTORS - COMPARISON WITH ANOTHER TUMOR PROMOTER, PHORBOL ESTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CYTO-TOXIC RESPONSE; FACTOR-ALPHA; MOLECULAR-CLONING; TNF RECEPTOR; CELLS; EXPRESSION; INTERLEUKIN-1; PHOSPHATASES; MECHANISM	Protein kinase C modulates the receptor for tumor necrosis factor (TNF) in wide variety of different cell types. However, there is no information about the role of phosphatases in the regulation of the TNF receptor. In this report, we investigated the effect of okadaic acid, an inhibitor of serine/threonine phosphatases, on TNF receptors in U-937 cells, a human histiocytic lymphoma cell line. In our study okadaic acid induced a dose- and time-dependent down-modulation of TNF receptors. On exposure of cells to 0.5 muM okadaic acid for 60 min at 37-degrees-C, a complete down-regulation of the receptors was observed, but no modulation occurred at 4-degrees-C. Scatchard analysis of the binding data on U-937 cells revealed that okadaic acid caused a decrease in the high affinity cell surface receptor number without a significant change in the affinity constant. The down-regulation of the TNF receptor by okadaic acid was not specific to U-937 cells, as it was also observed with several other cell types. Okadaic acid had no significant effect on the internalization of the receptor, but it did induce a shedding of the TNF receptor from its cell surface. On exposure of cells to okadaic acid, a dose- and time-dependent increase in the 40-kDa polypeptide was detected in the medium with anti-p80 antibodies by Western blot analysis. The secreted product was also found to bind TNF. The mechanism by which okadaic acid down-modulates the TNF receptor appears to be quite different from that of phorbol ester. First, okadaic acid synergistically potentiated the effect of phorbol ester. Second, the phorbol ester-mediated down-modulation could be blocked by H-7 and staurosporine, well known protein kinase C inhibitors, but these inhibitors had no effect on okadaic acid-mediated response. Third, phorbol ester-mediated down-modulation of the TNF receptor was reversible after removal of the agent, but the response mediated through okadaic acid was irreversible. Fourth, the TNF receptor was down-regulated by okadaic acid but not by phorbol ester in cells depleted of protein kinase C. Thus, overall, our results demonstrate that serine/threonine phosphatases can down-modulate and induce shedding of TNF receptors by a mechanism distinct from that of protein kinase C.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT CLIN IMMUNOL & BIOL THERAPY,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center			Aggarwal, Bharat B/G-3388-2013					AGGARWAL BB, 1987, J BIOL CHEM, V262, P10000; AGGARWAL BB, 1986, J BIOL CHEM, V261, P3652; AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345; AGGARWAL BB, 1985, NATURE, V318, P665, DOI 10.1038/318665a0; AGGARWAL BB, 1987, J BIOL CHEM, V262, P16450; AIYER RA, 1987, CRC HDB CYTOLYTIC LY, V2, P105; BAZIL V, 1991, J IMMUNOL, V147, P1567; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BROCKHAUS M, 1990, P NATL ACAD SCI USA, V87, P3127, DOI 10.1073/pnas.87.8.3127; CAO XM, 1992, J BIOL CHEM, V267, P12991; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; COLLINS MKL, 1982, J CELL PHYSIOL, V112, P42, DOI 10.1002/jcp.1041120108; COSTLOW ME, 1982, J BIOL CHEM, V257, P9330; DEAN NM, 1991, CARCINOGENESIS, V12, P665, DOI 10.1093/carcin/12.4.665; DEMBIC Z, 1990, Cytokine, V2, P231, DOI 10.1016/1043-4666(90)90022-L; DING AH, 1989, J BIOL CHEM, V264, P3924; DOWNING JR, 1989, MOL CELL BIOL, V9, P2890, DOI 10.1128/MCB.9.7.2890; ERIKSTEIN BK, 1991, EUR J IMMUNOL, V21, P1033, DOI 10.1002/eji.1830210426; GOEDDEL DV, 1989, COLD SPRING HARB SYM, V1, P597; GUY GR, 1992, J BIOL CHEM, V267, P1846; HERNANDEZSOTOMAYOR SMT, 1991, J BIOL CHEM, V266, P21281; HEYSTEAD TAJ, 1989, NATURE, V337, P78; HIGUCHI M, 1992, BIOCHEM BIOPH RES CO, V182, P638, DOI 10.1016/0006-291X(92)91780-T; HIGUCHI M, 1992, J BIOL CHEM, V267, P20892; HIGUCHI M, 1992, ANAL BIOCHEM, V204, P53, DOI 10.1016/0003-2697(92)90138-W; HOHMANN HP, 1990, J BIOL CHEM, V265, P22409; HOHMANN HP, 1989, J BIOL CHEM, V264, P14927; HOLTMANN H, 1987, J IMMUNOL, V139, P1161; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P255, DOI 10.1111/j.1432-1033.1983.tb07357.x; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; KOHNO T, 1990, P NATL ACAD SCI USA, V87, P8331, DOI 10.1073/pnas.87.21.8331; KULL FC, 1981, CANCER RES, V41, P4885; KULL FC, 1988, BIOCHEM BIOPH RES CO, V153, P402, DOI 10.1016/S0006-291X(88)81238-5; LANTZ M, 1990, J CLIN INVEST, V86, P1396, DOI 10.1172/JCI114853; LE JM, 1987, LAB INVEST, V56, P234; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; MEDCALF RL, 1992, J BIOL CHEM, V267, P12220; PANG XP, 1989, ENDOCRINOLOGY, V125, P599; PELECH SL, 1987, J BIOL CHEM, V262, P11598; PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0; POUTEU F, 1990, J EXP MED, V172, P599; POUTEU F, 1991, J BIOL CHEM, V28, P18846; RUBIN LA, 1985, J IMMUNOL, V135, P3172; RUGGIERO V, 1987, J IMMUNOL, V138, P661; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCHEURICH P, 1989, J EXP MED, V170, P947, DOI 10.1084/jem.170.3.947; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SMITH MR, 1990, J IMMUNOL, V144, P162; STAUBER GB, 1988, J BIOL CHEM, V263, P19098; STEWART AA, 1980, FEBS LETT, V119, P16, DOI 10.1016/0014-5793(80)80988-4; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; TACHIBANA K, 1981, J AM CHEM SOC, V103, P2469, DOI 10.1021/ja00399a082; THOMA B, 1990, J EXP MED, V172, P1019, DOI 10.1084/jem.172.4.1019; TIETZE C, 1980, BIOCHEM BIOPH RES CO, V93, P1, DOI 10.1016/S0006-291X(80)80237-3; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; TSUJIMOTO M, 1985, P NATL ACAD SCI USA, V82, P7626, DOI 10.1073/pnas.82.22.7626; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455	57	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1993	268	8					5624	5631						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR822	8383675				2022-12-27	WOS:A1993KR82200043
J	ZHANG, HF; YANG, YH; STEINBRECHER, UP				ZHANG, HF; YANG, YH; STEINBRECHER, UP			STRUCTURAL REQUIREMENTS FOR THE BINDING OF MODIFIED PROTEINS TO THE SCAVENGER RECEPTOR OF MACROPHAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; HUMAN MONOCYTE-MACROPHAGES; ATHEROSCLEROTIC LESIONS; LIPID-PEROXIDATION; APOLIPOPROTEIN-B; CHOLESTEROL DEPOSITION; LYSINE RESIDUES; DEGRADATION; INVIVO; RECOGNITION	Oxidized low density lipoprotein (LDL) and certain chemically modified LDL are recognized by the scavenger receptor of macrophages. All of these modifications involve charge-neutralizing derivatization of lysine amino groups. However, it remains controversial whether recognition of modified LDL by this receptor is due to the modification per se, or to other factors such as a conformational change of apoB. In this study, LDL and other proteins including bovine serum albumin, human high density lipoprotein, and murine IgG were derivatized with oxidation products generated from arachidonic acid by thermal autoxidation. Modified proteins had increased negative charge, and showed a more than 10-fold enhancement of degradation by mouse peritoneal macrophages via the scavenger receptor pathway. Modification was prevented by blocking lysine residues of the proteins by prior reductive methylation. Amino acid analysis revealed dose-dependent modification of lysine residues with no significant effects on any other amino acid. Fab fragments of monoclonal antibodies specific for adducts of oxidation products with lysine prevented the uptake of oxidation product-modified LDL and oxidized LDL by macrophages. Chromatography of oxidation product-modified LDL over Sepharose CL-4B showed that uptake by macrophages did not require LDL aggregation. These results suggest that a relatively simple domain consisting of a cluster of suitably derivatized lysine residues is sufficient for recognition by the scavenger receptor of macrophages.	UNIV BRITISH COLUMBIA,DEPT MED,2211 WESBROOK MALL,VANCOUVER V6T 1W5,BC,CANADA	University of British Columbia								ARAI H, 1989, BIOCHEM BIOPH RES CO, V159, P1375, DOI 10.1016/0006-291X(89)92262-6; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BROWN MS, 1980, J SUPRAMOL STR CELL, V13, P67, DOI 10.1002/jss.400130107; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; CAREW TE, 1987, P NATL ACAD SCI USA, V84, P7725, DOI 10.1073/pnas.84.21.7725; CHEN SH, 1986, J BIOL CHEM, V261, P2918; COULTER A, 1983, J IMMUNOL METHODS, V59, P199, DOI 10.1016/0022-1759(83)90031-5; DAVIS JM, 1982, J IMMUNOL METHODS, V50, P161, DOI 10.1016/0022-1759(82)90222-8; ESTERBAUER H, 1982, BIOCHEM J, V208, P129, DOI 10.1042/bj2080129; FOGELMAN AM, 1980, P NATL ACAD SCI-BIOL, V77, P2214, DOI 10.1073/pnas.77.4.2214; FREEMAN M, 1990, P NATL ACAD SCI USA, V87, P8810, DOI 10.1073/pnas.87.22.8810; FREEMAN M, 1991, P NATL ACAD SCI USA, V88, P4931, DOI 10.1073/pnas.88.11.4931; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; HABERLAND M, 1988, SCIENCE, V24, P215; HABERLAND ME, 1985, P NATL ACAD SCI USA, V82, P2693, DOI 10.1073/pnas.82.9.2693; HABERLAND ME, 1984, J BIOL CHEM, V259, P1305; HABERLAND ME, 1982, P NATL ACAD SCI USA, V79, P922; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HOFF HF, 1989, ARTERIOSCLEROSIS, V9, P538, DOI 10.1161/01.ATV.9.4.538; Horiuchi S, 1989, J Mol Recognit, V2, P56, DOI 10.1002/jmr.300020203; JENTOFT N, 1979, J BIOL CHEM, V254, P4359; JURGENS G, 1986, BIOCHIM BIOPHYS ACTA, V875, P103, DOI 10.1016/0005-2760(86)90016-0; KAMPS AAM, 1992, ARTERIOSCLER THROMB, V12, P1079; KODAMA T, 1988, P NATL ACAD SCI USA, V85, P9238, DOI 10.1073/pnas.85.23.9238; KODAMA T, 1992, CIRCULATION, V86, P549; KODAMA T, 1990, NATURE, V343, P532; LOUGHEED M, 1991, J BIOL CHEM, V266, P14519; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHLEY RW, 1979, J CLIN INVEST, V64, P743, DOI 10.1172/JCI109518; MATSUMOTO A, 1990, P NATL ACAD SCI USA, V87, P9133, DOI 10.1073/pnas.87.23.9133; PALINSKI W, 1989, P NATL ACAD SCI USA, V86, P1372, DOI 10.1073/pnas.86.4.1372; ROHRER L, 1990, NATURE, V343, P570, DOI 10.1038/343570a0; ROSENFELD ME, 1990, ARTERIOSCLEROSIS, V10, P336, DOI 10.1161/01.ATV.10.3.336; ROSENFELD ME, 1992, ARTERIOSCLER THROMB, V12, P985, DOI 10.1161/01.ATV.12.8.985; SMALL DM, 1988, ARTERIOSCLEROSIS, V8, P103, DOI 10.1161/01.ATV.8.2.103; SPARROW CP, 1989, J BIOL CHEM, V264, P2599; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEINBRECHER UP, 1984, J LIPID RES, V25, P1109; STEINBRECHER UP, 1987, J BIOL CHEM, V262, P3603; STEINBRECHER UP, 1987, ARTERIOSCLEROSIS, V7, P135, DOI 10.1161/01.ATV.7.2.135; STEINBRECHER UP, 1989, J BIOL CHEM, V264, P15216; STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883; VANBERKEL TJC, 1991, J BIOL CHEM, V266, P2282; VIA D, 1992, FASEB J, V6, pA371; YLAHERTTUALA S, 1990, EUR HEART J, V11, P88, DOI 10.1093/eurheartj/11.suppl_E.88; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; ZHANG H, 1993, IN PRESS CLIN CHEM E	48	103	106	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1993	268	8					5535	5542						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR822	8383674				2022-12-27	WOS:A1993KR82200031
J	POLLARD, S; DUGGAN, MJ; STEPHENSON, FA				POLLARD, S; DUGGAN, MJ; STEPHENSON, FA			FURTHER EVIDENCE FOR THE EXISTENCE OF ALPHA-SUBUNIT HETEROGENEITY WITHIN DISCRETE GAMMA-AMINOBUTYRIC ACIDA-RECEPTOR SUBPOPULATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA-A RECEPTORS; BENZODIAZEPINE RECEPTORS; CEREBRAL-CORTEX; ANTIBODIES; SEQUENCE; BRAIN; CELLS; SITE	The alpha subunit complements of natural gamma-aminobutyric acid(A) (GABA(A)) receptor subpopulations were investigated by their purification from mammalian cerebral cortex and cerebellum by immunoaffinity chromatography using antibodies raised against peptide sequences unique to the alpha1, alpha2, alpha3, and alpha6 subunits. Receptors purified from cerebral cortex by anti-Cys alpha2 414-424 and anti-Cys alpha3 454-467 antibody affinity columns in series had immunoreactivity with alpha2 and alpha3 but not alpha1 subunit-specific antibodies. Receptors purified from cerebellum by a new affinity column matrix, anti-alpha6 1-16 Cys whole antibody, or the Fab fragment thereof, enriched for alpha6 subunit immunoreactivity. A further series of experiments demonstrated the partial coexistence of this alpha6 subunit immunoreactivity with that for the alpha1 but not the alpha2 and alpha3 subunits. These results provide additional evidence for the existence of GABA(A) receptor subpopulations with heterogeneous alpha subunit complements yielding increased structural diversity of natural GABA(A) receptors. Furthermore, they substantiate previous findings implicating the presence of two alpha subunits per receptor oligomer.	UNIV LONDON,DEPT PHARMACEUT CHEM,2939 BRUNSWICK SQ,LONDON WC1N 1AX,ENGLAND	University of London; University College London; University of London School of Pharmacy								BENKE D, 1991, J BIOL CHEM, V266, P4478; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; CUATRECA.P, 1968, P NATL ACAD SCI USA, V61, P636, DOI 10.1073/pnas.61.2.636; DUGGAN MJ, 1991, J BIOL CHEM, V266, P24778; DUGGAN MJ, 1992, J NEUROCHEM, V58, P72, DOI 10.1111/j.1471-4159.1992.tb09278.x; DUGGAN MJ, 1990, J BIOL CHEM, V265, P3831; DUGGAN MJ, 1989, J NEUROCHEM, V53, P132, DOI 10.1111/j.1471-4159.1989.tb07304.x; HARLOW E, 1988, ANTIBODIES LABORATOR; KATO K, 1990, J MOL BIOL, V214, P619, DOI 10.1016/0022-2836(90)90276-R; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; LUDDENS H, 1990, NATURE, V346, P648, DOI 10.1038/346648a0; MAMALAKI C, 1989, J NEUROCHEM, V52, P124, DOI 10.1111/j.1471-4159.1989.tb10906.x; MCKERNAN RM, 1991, NEURON, V7, P667, DOI 10.1016/0896-6273(91)90379-E; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; PRITCHETT DB, 1989, SCIENCE, V245, P1389, DOI 10.1126/science.2551039; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SIGEL E, 1983, J BIOL CHEM, V258, P6965; STEPHENSON FA, 1990, J BIOL CHEM, V265, P21160; STEPHENSON FA, 1989, BIOCHEM J, V264, P199, DOI 10.1042/bj2640199; THOMPSON CL, 1992, NEUROSCI LETT, V144, P53, DOI 10.1016/0304-3940(92)90714-I; TURNER JD, 1992, SOC NEUR ABSTR, V120, P11; ZEZULA J, 1991, FEBS LETT, V284, P15, DOI 10.1016/0014-5793(91)80750-W	22	74	74	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3753	3757						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381438				2022-12-27	WOS:A1993KM16100110
J	NAGASHIMA, M; LUNDH, E; LEONARD, JC; MORSER, J; PARKINSON, JF				NAGASHIMA, M; LUNDH, E; LEONARD, JC; MORSER, J; PARKINSON, JF			ALANINE-SCANNING MUTAGENESIS OF THE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS OF HUMAN THROMBOMODULIN IDENTIFIES CRITICAL RESIDUES FOR ITS COFACTOR ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-C ACTIVATION; FACTOR-V; BINDING-SITES; THROMBIN; INACTIVATION; ANTICOAGULANT; LOCALIZATION; COAGULATION; RECEPTOR; SEQUENCE	Thrombomodulin (TM) is an endothelial cell surface-bound cofactor in thrombin-dependent formation of activated protein C, a potent anticoagulant. Cofactor activity has been localized to the carboxyl-terminal half of the six epidermal growth factor-like (EGF) domains of TM (TM(E)). To identify residues in TM(E) that are critical for activity, 77 alanine point mutants were made between Cys-333 and Cys-462 by site-directed mutagenesis (all residues except Ala, Cys, Gly, and Pro). Mutants were expressed in Escherichia coli and cofactor activity measured directly in periplasmic extracts obtained by osmotic shock. Critical residues were defined as those which when mutated had less than 25% cofactor activity of a reference TM(E). Western blots of non-reduced samples confirmed that alanine substitutions did not significantly decrease expression levels or result in the formation of multimers. In EGF4, which is essential for protein C activation by the thrombin-TM complex, critical residues were: Asp349, Glu-357, Tyr-358, and Phe-376. In EGF5-EGF6, critical residues within a proposed acidic thrombin-binding region were: Glu-408, Tyr-413, Ile-414, Leu415, Asp-416, Asp-417, Asp-423, Ile-424, Asp-425, and Glu-426. A potential Ca2+-binding site, which is comprised of residues Asp-423, Asp-425, Glu-426, Asn-439, Leu-440, and Phe-444, was also identified and overlaps the thrombin-binding region. Asp-461, in the C-loop of EGF6 previously shown to be critical for thrombin binding, was also critical. Asp-398, Asp-400, Asn-402, and Asn-429 in EGF5 were also critical. Thus, rapid alanine-scanning mutagenesis of TM(E) has identified 22 critical residues in the region comprising EGF4-6, which is essential for thrombin binding and protein C activation by the thrombin-TM complex.	BERLEX BIOSCI INC,15049 SAN PABLO AVE,POB 4099,RICHMOND,CA 94804									CLARKE JH, IN PRESS J BIOL CHEM; CUNNINGHAM BC, 1989, SCIENCE, V244, P1801; DAHLBACK B, 1990, J BIOL CHEM, V265, P18481; DITTMAN WA, 1988, J BIOL CHEM, V263, P15815; DITTMAN WA, 1990, BLOOD, V75, P329; ESMON CT, 1992, ARTERIOSCLER THROMB, V12, P135, DOI 10.1161/01.ATV.12.2.135; ESMON CT, 1982, J BIOL CHEM, V257, P7944; ESMON NL, 1983, J BIOL CHEM, V258, P2238; ESMON NL, 1982, J BIOL CHEM, V257, P859; FULCHER CA, 1984, BLOOD, V63, P486; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; HAYASHI T, 1990, J BIOL CHEM, V265, P20156; JACKMAN RW, 1986, P NATL ACAD SCI USA, V83, P8834, DOI 10.1073/pnas.83.23.8834; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEBONNIEC BF, 1991, J BIOL CHEM, V266, P13796; LEBONNIEC BF, 1991, BIOCHEMISTRY-US, V88, P7371; PARKINSON JF, 1992, BIOCHEM BIOPH RES CO, V185, P567, DOI 10.1016/0006-291X(92)91662-A; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STEARNS DJ, 1989, J BIOL CHEM, V264, P3352; SUZUKI K, 1987, EMBO J, V6, P1891, DOI 10.1002/j.1460-2075.1987.tb02448.x; SUZUKI K, 1986, BIOCHIM BIOPHYS ACTA, V882, P343, DOI 10.1016/0304-4165(86)90257-6; SUZUKI K, 1983, J BIOL CHEM, V258, P1914; SUZUKI K, 1991, J BIOL CHEM, V266, P18498; TSIANG M, 1992, J BIOL CHEM, V267, P6164; WALKER FJ, 1979, BIOCHIM BIOPHYS ACTA, V571, P333, DOI 10.1016/0005-2744(79)90103-7; WEN DZ, 1987, BIOCHEMISTRY-US, V26, P4350, DOI 10.1021/bi00388a025; YE J, 1991, J BIOL CHEM, V266, P23016; ZUSHI M, 1991, J BIOL CHEM, V266, P19886; ZUSHI M, 1989, J BIOL CHEM, V264, P10351	29	79	100	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2888	2892						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8381415				2022-12-27	WOS:A1993KK81500092
J	BAME, KJ				BAME, KJ			RELEASE OF HEPARAN-SULFATE GLYCOSAMINOGLYCANS FROM PROTEOGLYCANS IN CHINESE-HAMSTER OVARY CELLS DOES NOT REQUIRE PROTEOLYSIS OF THE CORE PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST GROWTH-FACTOR; HIGH-AFFINITY RECEPTOR; N-SULFOTRANSFERASE; INTRACELLULAR DEGRADATION; LINKAGE REGION; BIOSYNTHESIS; SURFACE; MUTANTS; ENDOGLYCOSIDASE; IDENTIFICATION	The initial steps in the catabolism of cell-associated heparan sulfate proteoglycans in Chinese hamster ovary (CHO) cells are similar to what has been observed in other cells, cell surface proteoglycans are internalized and the heparan sulfate glycosaminoglycans are released from core proteins and cleaved to small chains by intracellular heparanases. The mechanism of the release and cleavage reactions is unclear, since only intact proteoglycans and small, cleaved heparan sulfate chains are observed in pulse-chase experiments; however, it is thought that release of the glycosaminoglycans from core proteins precedes heparanase cleavage (Yanagishita, M., and Hascall, V. C. (1992) J. Biol. Chem. 267, 9451-9454). The relationship between these two steps were examined with the proteoglycan synthesis mutant pgsE-606 (Bame, K. J., and Esko, J. D. (1989) J. Biol. Chem. 264, 8059-8065), since the undersulfated heparan sulfate synthesized by the mutant is a poor substrate for heparanases. In addition to intact proteoglycans and small cleaved chains, a large glycosaminoglycan intermediate is present in pgsE-606 cells, suggesting that heparan sulfate is released from proteoglycans as large chains which are subsequently cleaved by heparanases. The catabolic intermediate in the mutant has been acted upon by heparanases, since it is smaller than the size of the heparan sulfate chains found on proteoglycans, raising the possibility that the glycosaminoglycans are first released from proteoglycans by an endoglycosidic cleavage of the chain before proteolysis of the core protein. To examine whether proteolysis of the core protein is required for endoglycosidic cleavage of the chain, heparan sulfate proteoglycans immobilized to Sepharose were incubated with CHO cell extracts in the presence of protease inhibitors. Heparan sulfate chains are released from the proteoglycans by heparanases in the cell extract, indicating that release of the glycosaminoglycans from core proteins is not a prerequisite for endoglycosidic cleavage of the chain. In addition, these studies indicate that there is a heparanase activity in CHO cells which can recognize and cleave sequences in the undersulfated heparan sulfate, but is unable to completely cleave the mutant glycosaminoglycan, suggesting that there may be multiple heparanase activities responsible for degrading the heparan sulfate chains.			BAME, KJ (corresponding author), UNIV MISSOURI,SCH BIOL SCI,DIV MOLEC BIOL & BIOCHEM,KANSAS CITY,MO 64110, USA.				NICHD NIH HHS [HD28210] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD028210] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BAME KJ, 1991, J BIOL CHEM, V266, P10287; BAME KJ, 1989, J BIOL CHEM, V264, P8059; BAME KJ, 1991, J BIOL CHEM, V266, P12461; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; BIENKOWSKI MJ, 1984, J BIOL CHEM, V259, P2989; CHIEFETZ S, 1989, J BIOL CHEM, V264, P12025; ESKO JD, 1987, J BIOL CHEM, V262, P12189; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; GALLAGHER JT, 1988, BIOCHEM J, V250, P719, DOI 10.1042/bj2500719; HOOK M, 1984, ANNU REV BIOCHEM, V53, P847; IOZZO RV, 1989, J BIOL CHEM, V262, P1888; JACOBSSON KG, 1987, BIOCHEM J, V246, P409, DOI 10.1042/bj2460409; KJELLEN L, 1985, J BIOL CHEM, V260, P8416; LEBARON RG, 1988, J CELL BIOL, V106, P945, DOI 10.1083/jcb.106.3.945; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; LINDBLOM A, 1991, BIOCHEM J, V279, P821, DOI 10.1042/bj2790821; LYON M, 1987, BIOCHEM J, V242, P493, DOI 10.1042/bj2420493; NAKAJIMA M, 1988, J CELL BIOCHEM, V36, P157, DOI 10.1002/jcb.240360207; OLDBERG A, 1980, BIOCHEMISTRY-US, V19, P5755, DOI 10.1021/bi00566a014; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cb.04.110188.001305; SAKAGUCHI K, 1991, J BIOL CHEM, V266, P7270; SAXENA U, 1990, J BIOL CHEM, V265, P12880; TURNBULL JE, 1991, BIOCHEM J, V277, P297, DOI 10.1042/bj2770297; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; YANAGISHITA M, 1985, J BIOL CHEM, V260, P1075; YANAGISHITA M, 1984, J BIOL CHEM, V259, P270; YANAGISHITA M, 1992, J BIOL CHEM, V267, P9451; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	29	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					19956	19964						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376358				2022-12-27	WOS:A1993LY01900010
J	KOBAYASHI, M; TAKAMATSU, K; SAITOH, S; NOGUCHI, T				KOBAYASHI, M; TAKAMATSU, K; SAITOH, S; NOGUCHI, T			MYRISTOYLATION OF HIPPOCALCIN IS LINKED TO ITS CALCIUM-DEPENDENT MEMBRANE ASSOCIATION PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; GUANYLATE-CYCLASE; ACYLATED PROTEINS; RECOVERIN; CLONING; PHOSPHODIESTERASE; ELECTROPHORESIS; NEUROCALCIN; INCREASES; SEQUENCE	Hippocalcin, a recently identified Ca2+-binding protein of the recoverin family exclusively expressed in the hippocampus, has a primary structure containing three putative Ca2+-binding sites (EF-hands) and a possible NH2-terminal myristoylation site. Ca-45 blots demonstrated that every three EF-hand domains, expressed as fusion proteins in Escherichia coli, bind Ca2+, indicating that hippocalcin binds 3 mol of Ca2+/mol of protein. To determine whether hippocalcin is myristoylated, hippocalcin mRNA was translated in vitro in the presence of [H-3]myristic acid. H-3 label was resistant to hydroxylamine treatment, and replacement of NH2-terminal glycine with alanine prevented H-3 label incorporation, indicating that in vitro translated hippocalcin covalently bound [H-3]myristic acid at the NH2-terminal glycine. In vitro translated hippocalcin is quantitatively myristoylated, as evidenced by an electrophoretic mobility shift of [S-35]methionine-labeled protein on two-dimensional gels. Native hippocalcin comigrated precisely with the in vitro translated hippocalcin on two-dimensional gels, suggesting that native hippocalcin is myristoylated. Native and in vitro translated hippocalcins, but not non-myristoylated mutagenic (Gly1-Ala1) hippocalcin, displayed Ca2+-dependent membrane association, indicating that myristoylation participates in its Ca2+-dependent membrane association properties. In vitro translated hippocalcin bound to phospholipid vesicles somewhat, however, phospholipid association was insufficient for its membrane association properties, suggesting that the NH2-terminal myristoyl moiety on hippocalcin interacts with lipid bilayers and facilitates interaction with other membrane proteins.	TOHO UNIV, SCH MED,DEPT PHYSIOL,5-21-16 OHMORI NISHI,OHTA KU, TOKYO 143, JAPAN									CROSS FR, 1984, MOL CELL BIOL, V4, P2697; DEICHAITE I, 1988, MOL CELL BIOL, V8, P4295, DOI 10.1128/MCB.8.10.4295; DIZHOOR AM, 1992, J BIOL CHEM, V267, P16033; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; GOULD KL, 1988, MOL CELL BIOL, V8, P3345, DOI 10.1128/MCB.8.8.3345; JAMES G, 1990, BIOCHEMISTRY-US, V29, P2623, DOI 10.1021/bi00463a001; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KAWAMURA S, 1992, BIOCHEM BIOPH RES CO, V186, P411, DOI 10.1016/S0006-291X(05)80823-X; KOBAYASHI M, 1992, BIOCHEM BIOPH RES CO, V189, P511, DOI 10.1016/0006-291X(92)91587-G; Kretsinger R H, 1979, Adv Cyclic Nucleotide Res, V11, P1; KUNO T, 1992, BIOCHEM BIOPH RES CO, V184, P1219, DOI 10.1016/S0006-291X(05)80012-9; KUTUZOV MA, 1991, FEBS LETT, V293, P21, DOI 10.1016/0014-5793(91)81143-V; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBRECHT HG, 1991, EMBO J, V10, P793, DOI 10.1002/j.1460-2075.1991.tb08011.x; LINDER ME, 1991, J BIOL CHEM, V266, P4654; MAGEE AI, 1985, EMBO J, V4, P1137, DOI 10.1002/j.1460-2075.1985.tb03751.x; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; MCGINNIS JF, 1992, FEBS LETT, V302, P172, DOI 10.1016/0014-5793(92)80433-H; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OKAZAKI K, 1992, BIOCHEM BIOPH RES CO, V185, P147, DOI 10.1016/S0006-291X(05)80968-4; POLANS AS, 1991, J CELL BIOL, V112, P981, DOI 10.1083/jcb.112.5.981; RAY S, 1992, P NATL ACAD SCI USA, V89, P5705, DOI 10.1073/pnas.89.13.5705; RESH MD, 1990, NATURE, V346, P84, DOI 10.1038/346084a0; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Smith RM, 1974, CRITICAL STABILITY C, V1-6; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAKAMATSU K, 1992, BIOCHEM BIOPH RES CO, V183, P245, DOI 10.1016/0006-291X(92)91635-4; TERASAWA M, 1992, J BIOL CHEM, V267, P19596; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; YAMAGATA K, 1990, NEURON, V4, P469, DOI 10.1016/0896-6273(90)90059-O; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	35	108	109	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18898	18904						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360179				2022-12-27	WOS:A1993LV65900078
J	ASPINALL, GO; MCDONALD, AG; PANG, H; KURJANCZYK, LA; PENNER, JL				ASPINALL, GO; MCDONALD, AG; PANG, H; KURJANCZYK, LA; PENNER, JL			AN ANTIGENIC POLYSACCHARIDE FROM CAMPYLOBACTER-COLI SEROTYPE O/30 - STRUCTURE OF A TEICHOIC ACID-LIKE ANTIGENIC POLYSACCHARIDE ASSOCIATED WITH THE LIPOPOLYSACCHARIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-SPECIFIC POLYSACCHARIDE; HEMOPHILUS-INFLUENZAE; CAPSULAR POLYSACCHARIDE; REPEATING UNIT; JEJUNI; SPECTROSCOPY	A water-soluble antigenic polysaccharide of high M(r) associated with the lipopolysaccharide has been isolated from phenol-water extraction of cells of Campylobacter coli serotype O:30. The polysaccharide and oligosaccharide degradation products formed on O-dephosphorylation and by periodate oxidation followed by reduction have been investigated by one- and two-dimensional H-1, C-13, and P-31 NMR. It is concluded that the antigenic polysaccharide has a teichoic acid-like structure with a poly-Ribitol phosphate, [5-Ribitol-1-P]n, backbone with side chains at O-2 of O-(6-deoxy-beta-D-talo-heptopyranosyl)-(1-->4)-(2-acetylamino-2-deoxy-beta-D-glucopyranosyl) units. The structure is unusual in Gram-negative bacteria and is unique in possessing 6-deoxy-D-talo-heptose as a constituent sugar. Evidence for the relationship of the antigenic polysaccharide to the lipopolysaccharide of low M(r) is discussed.	UNIV TORONTO,DEPT MOLEC & MED GENET,CARBOHYDRATE RES CTR,TORONTO M5G 1A8,ON,CANADA; UNIV TORONTO,DEPT MICROBIOL,TORONTO M5G 1A8,ON,CANADA	University of Toronto; University of Toronto	ASPINALL, GO (corresponding author), YORK UNIV,DEPT CHEM,N YORK M3J 1P3,ONTARIO,CANADA.							Archibald A R, 1966, Adv Carbohydr Chem Biochem, V21, P323; ARMSTRONG JJ, 1960, BIOCHEM J, V76, P610, DOI 10.1042/bj0760610; ASPINALL GO, 1993, EUR J BIOCHEM, V213, P1029, DOI 10.1111/j.1432-1033.1993.tb17850.x; ASPINALL GO, 1993, EUR J BIOCHEM, V213, P1017, DOI 10.1111/j.1432-1033.1993.tb17849.x; ASPINALL GO, 1992, J BACTERIOL, V174, P1324, DOI 10.1128/jb.174.4.1324-1332.1992; ASPINALL GO, 1992, CARBOHYD RES, V231, P13, DOI 10.1016/0008-6215(92)84003-B; ASPINALL GO, 1993, J BIOL CHEM, V268, P6263; AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450; BADDILEY J, 1962, BIOCHEM J, V85, P49, DOI 10.1042/bj0850049; BEER W, 1986, J BASIC MICROB, V4, P201; BEYNON LM, 1992, EUR J BIOCHEM, V210, P119, DOI 10.1111/j.1432-1033.1992.tb17398.x; BRANEFORSHELANDER P, 1976, ACTA CHEM SCAND B, V30, P276, DOI 10.3891/acta.chem.scand.30b-0276; BRANEFORSHELANDER P, 1977, CARBOHYD RES, V56, P117, DOI 10.1016/S0008-6215(00)84242-1; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; BYRD RA, 1987, CARBOHYD RES, V166, P47, DOI 10.1016/0008-6215(87)80043-5; CHIZHOV OS, 1966, ADV CARBOHYD CHEM, V21, P29; EICH G, 1982, J AM CHEM SOC, V104, P3731, DOI 10.1021/ja00377a036; JOSELEAU JP, 1981, CARBOHYD RES, V90, P339, DOI 10.1016/S0008-6215(00)85934-0; Kenne L., 1983, POLYSACCHARIDES, P287; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V96, P1156, DOI 10.1016/0006-291X(80)90073-X; LERNER L, 1987, CARBOHYD RES, V166, P35, DOI 10.1016/0008-6215(87)80042-3; LVOV VL, 1990, BIOORG KHIM+, V16, P379; LVOV VL, 1992, CARBOHYD RES, V228, P415, DOI 10.1016/0008-6215(92)84134-E; MANDATORI R, 1989, INFECT IMMUN, V57, P3506, DOI 10.1128/IAI.57.11.3506-3511.1989; MORAN AP, 1991, J BACTERIOL, V173, P618, DOI 10.1128/jb.173.2.618-626.1991; NAESS V, 1984, J GEN MICROBIOL, V130, P2783; PENNER J L, 1988, Clinical Microbiology Reviews, V1, P157; PRESTON MA, 1987, INFECT IMMUN, V55, P1806, DOI 10.1128/IAI.55.8.1806-1812.1987; PRITCHARD DG, 1988, CARBOHYD RES, V173, P255, DOI 10.1016/S0008-6215(00)90821-8; SELTMANN G, 1985, J BASIC MICROB, V25, P551, DOI 10.1002/jobm.3620250823; TSUI FP, 1988, CARBOHYD RES, V173, P65, DOI 10.1016/S0008-6215(00)90803-6; YORK WS, 1986, METHOD ENZYMOL, V118, P3	32	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18321	18329						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349707				2022-12-27	WOS:A1993LT74300099
J	BUTIKOFER, P; BRODBECK, U				BUTIKOFER, P; BRODBECK, U			PARTIAL-PURIFICATION AND CHARACTERIZATION OF A (GLYCOSYL) INOSITOL PHOSPHOLIPID-SPECIFIC PHOSPHOLIPASE-C FROM PEANUT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VARIANT SURFACE GLYCOPROTEIN; HUMAN-ERYTHROCYTE ACETYLCHOLINESTERASE; TRYPANOSOMA-BRUCEI; PLASMA-MEMBRANES; PHOSPHATIDYLINOSITOL ANCHOR; SIGNAL TRANSDUCTION; BACILLUS-CEREUS; PROTEINS; SERUM; LIVER	We have isolated a glycosyl inositol phospholipid (GIP) anchor-hydrolyzing activity from peanut seeds by a series of column chromatographic steps. The activity has a pH optimum below 6.0, requires calcium, and is inhibited by sulfhydryl reagents. It cleaves the GIP anchors of solubilized acetylcholinesterase from bovine erythrocytes and variant surface glycoprotein from Trypanosoma brucei. On the other hand, it does not act on membrane-bound GIP-anchored substrate or on inositol-acylated GIP anchor of human erythrocyte acetylcholinesterase. The only product released from [H-3]myristate-labeled variant surface glycoprotein following treatment with the activity from peanut was H-3-labeled diacylglycerol. Together, these findings identify the activity from peanut seeds as a GIP anchor-hydrolyzing phospholipase C. The enzyme has been found to hydrolyze not only protein GIP anchors but also phosphatidylinositol, whereas it shows no activity against other phospholipids. The water-soluble products of phosphatidylinositol hydrolysis by peanut phospholipase C were characterized as a mixture of inositol 1,2-cyclic phosphate and inositol phosphate.			BUTIKOFER, P (corresponding author), UNIV BERN,INST BIOCHEM & MOLEC BIOL,BUHLSTR 28,CH-3012 BERN,SWITZERLAND.							BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BRODBECK U, 1986, PROGR PROTEIN LIPID, V2, P303; BRODBECK U, 1983, MEMBRANE PROTEINS LA, P85; BRUZIK KS, 1992, BIOCHEMISTRY-US, V31, P5183, DOI 10.1021/bi00137a014; BULOW R, 1986, J BIOL CHEM, V261, P1918; BUTIKOFER P, 1989, BLOOD, V73, P1699; CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245; DAVITZ MA, 1989, J BIOL CHEM, V264, P13760; DAVITZ MA, 1987, SCIENCE, V238, P81, DOI 10.1126/science.2443973; DEALMEIDA MLC, 1983, NATURE, V302, P349, DOI 10.1038/302349a0; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4547; Ferguson MAJ, 1991, CURR OPIN STRUC BIOL, V1, P522, DOI 10.1016/S0959-440X(05)80072-7; FOUCHIER F, 1990, BIOCHEM J, V269, P321, DOI 10.1042/bj2690321; FOX JA, 1987, P NATL ACAD SCI USA, V84, P2663, DOI 10.1073/pnas.84.9.2663; FOX JA, 1986, J BIOL CHEM, V261, P5767; HANSEN SI, 1991, INT J VITAM NUTR RES, V61, P264; HELLER M, 1974, BIOCHIM BIOPHYS ACTA, V369, P397, DOI 10.1016/0005-2760(74)90153-2; HERELD D, 1986, J BIOL CHEM, V261, P3813; HOENER MC, 1990, EUR J BIOCHEM, V190, P593, DOI 10.1111/j.1432-1033.1990.tb15614.x; HOENER MC, 1992, EUR J BIOCHEM, V206, P747, DOI 10.1111/j.1432-1033.1992.tb16981.x; HUANG KS, 1990, J BIOL CHEM, V265, P17738; Ikezawa H, 1981, METHODS ENZYMOLOGY C, P731, DOI [10.1016/0076-6879(81)71086-3, DOI 10.1016/0076-6879(81)71086-3]; IRVINE RF, 1980, BIOCHEM J, V192, P279, DOI 10.1042/bj1920279; JAGER K, 1991, BIOCHIM BIOPHYS ACTA, V1074, P45, DOI 10.1016/0304-4165(91)90037-H; KIHN L, 1991, AM J CLIN PATHOL, V96, P470, DOI 10.1093/ajcp/96.4.470; KIM JW, 1989, BIOCHEM BIOPH RES CO, V163, P177, DOI 10.1016/0006-291X(89)92117-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Low M G, 1981, Methods Enzymol, V71 Pt C, P741; LOW MG, 1988, J IMMUNOL METHODS, V113, P101, DOI 10.1016/0022-1759(88)90386-9; LOW MG, 1989, BIOCHIM BIOPHYS ACTA, V988, P427, DOI 10.1016/0304-4157(89)90014-2; LOW MG, 1991, BIOCHEM J, V279, P483, DOI 10.1042/bj2790483; LOW MG, 1988, P NATL ACAD SCI USA, V85, P980, DOI 10.1073/pnas.85.4.980; MAJERUS PW, 1986, SCIENCE, V234, P1519, DOI 10.1126/science.3024320; MAYOR S, 1990, Methods (Orlando), V1, P297, DOI 10.1016/S1046-2023(05)80331-7; MCMURRAY WC, 1988, BIOCHEM J, V249, P877, DOI 10.1042/bj2490877; MELDRUM E, 1991, BIOCHIM BIOPHYS ACTA, V1092, P49, DOI 10.1016/0167-4889(91)90177-Y; PFAFFMANN H, 1987, PLANT PHYSIOL, V85, P1151, DOI 10.1104/pp.85.4.1151; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; ROBERTS WL, 1988, J BIOL CHEM, V263, P18766; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; SCALLON BJ, 1991, SCIENCE, V252, P446, DOI 10.1126/science.2017684; SILLEN LG, 1964, SPECIAL PUBLICATION, V17; SORENSEN K, 1986, EXPERIENTIA, V42, P161, DOI 10.1007/BF01952446; STIEGER S, 1991, BIOCHIMIE, V73, P1179, DOI 10.1016/0300-9084(91)90002-I; STIEGER S, 1991, EUR J BIOCHEM, V197, P67, DOI 10.1111/j.1432-1033.1991.tb15883.x; TATE BF, 1989, PLANT PHYSIOL, V91, P1275, DOI 10.1104/pp.91.4.1275; TOUTANT JP, 1989, EUR J BIOCHEM, V180, P503, DOI 10.1111/j.1432-1033.1989.tb14674.x; TUTIKOFER P, 1992, EUR J BIOCHEM, V208, P677; VERMA RS, 1992, J BIOL CHEM, V267, P4119; VOLWERK JJ, 1990, BIOCHEMISTRY-US, V29, P8056, DOI 10.1021/bi00487a010; ZAMZE SE, 1988, EUR J BIOCHEM, V176, P527, DOI 10.1111/j.1432-1033.1988.tb14310.x	54	32	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17794	17802						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349664				2022-12-27	WOS:A1993LT74300027
J	HO, MN; HIRATA, R; UMEMOTO, N; OHYA, Y; TAKATSUKI, A; STEVENS, TH; ANRAKU, Y				HO, MN; HIRATA, R; UMEMOTO, N; OHYA, Y; TAKATSUKI, A; STEVENS, TH; ANRAKU, Y			VMA13 ENCODES A 54-KDA VACUOLAR H+-ATPASE SUBUNIT REQUIRED FOR ACTIVITY BUT NOT ASSEMBLY OF THE ENZYME COMPLEX IN SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING ADENOSINE-TRIPHOSPHATASE; CATALYTIC SUBUNIT; YEAST VACUOLE; CELL-CYCLE; GENE; MEMBRANES; PROTEIN; DNA; BIOSYNTHESIS; POLYPEPTIDE	Previous purifications and characterizations of the Saccharomyces cerevisiae vacuolar proton-translocating ATPase (V-ATPase) have indicated that this enzyme is a multisubunit complex composed of at least eight subunits of 100-, 69-, 60-, 42-, 36-, 32-, 27-, and 17-kDa (Kane, P. M., Yamashiro, C. T., and Stevens, T. H. (1989) J. Biol. Chem. 264, 19236-19244). We report the cloning and characterization of an additional V-ATPase subunit, the 54-kDa subunit, which is encoded by the VMA13 gene. VMA13 was isolated by complementation of the growth phenotypes associated with the vma13 mutation, which was originally described as cls11 (Ohya, Y., Umemoto, N., Tanida, I., Ohta, A., Iida, H., and Anraku, Y. (1991) J. Biol. Chem. 266, 13971-13977). The nucleotide sequence of the VMA13 gene predicted a hydrophilic polypeptide with a calculated molecular mass of 54,415 daltons. The VMA13 54-kDa gene product resides on the vacuolar membrane and co-purified with the active V-ATPase complex. Characterization of a null vma13 mutant (DELTAvma13) revealed that the Vma13 polypeptide is essential for V-ATPase activity. However, the Vma13 polypeptide is not required for targeting of the other V-ATPase subunits (100-, 69-, 60-, 42-, 27-, or 17-kDa subunits) to the vacuolar membrane as shown by the association of these subunits with vacuolar membranes isolated from DELTAvma13 cells. The nature of the V-ATPase ''complex'' in DELTAvma13 mutant is, nevertheless, fundamentally different from the wild-type enzyme. This is evidenced by the fact that the inactive V-ATPase complex from DELTAvma13 cells is less stable than the wild-type enzyme. Taken together, these results indicate that DELTAvma13 encodes the 54-kDa subunit of the V-ATPase and that this subunit is essential for activity, but not assembly, of the enzyme complex.	UNIV TOKYO, FAC SCI, DEPT BIOL, BUNKYO KU, TOKYO 113, JAPAN; INST PHYS & CHEM RES, WAKO, SAITAMA 35101, JAPAN; UNIV OREGON, INST MOLEC BIOL, EUGENE, OR 97403 USA	University of Tokyo; RIKEN; University of Oregon			Hirata, Ryogo/C-7424-2017; Umemoto, Naoyuki/C-9712-2017	Umemoto, Naoyuki/0000-0001-5507-0848; Stevens, Tom/0000-0001-6427-6848	NIGMS NIH HHS [GM38006] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038006] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANRAKU Y, 1992, J BIOENERG BIOMEMBR, V24, P395, DOI 10.1007/BF00762532; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BAUERLE C, 1993, J BIOL CHEM, V268, P12749; BOWMAN BJ, 1992, J BIOENERG BIOMEMBR, V24, P361, DOI 10.1007/BF00762529; FORGAC M, 1992, J BIOENERG BIOMEMBR, V24, P341, DOI 10.1007/BF00762527; FORGAC M, 1989, PHYSIOL REV, V69, P765, DOI 10.1152/physrev.1989.69.3.765; FOURY F, 1990, J BIOL CHEM, V265, P18554; HIRATA R, 1993, J BIOL CHEM, V268, P961; HIRATA R, 1990, J BIOL CHEM, V265, P6726; HO MN, 1993, J BIOL CHEM, V268, P221; HOLM C, 1986, GENE, V42, P169, DOI 10.1016/0378-1119(86)90293-3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; KANE PM, 1989, J BIOL CHEM, V264, P19236; KANE PM, 1992, J BIOL CHEM, V267, P447; KANE PM, 1992, J BIOENERG BIOMEMBR, V24, P383, DOI 10.1007/BF00762531; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; NELSON H, 1989, FEBS LETT, V247, P147, DOI 10.1016/0014-5793(89)81259-1; OHYA Y, 1986, J GEN MICROBIOL, V132, P979; OHYA Y, 1991, J BIOL CHEM, V266, P13971; PARRY RV, 1989, J BIOL CHEM, V264, P20025; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PUOPOLO K, 1992, J BIOL CHEM, V267, P5171; RAYMOND CK, 1990, J CELL BIOL, V111, P877, DOI 10.1083/jcb.111.3.877; ROBERTS CJ, 1989, J CELL BIOL, V108, P1363, DOI 10.1083/jcb.108.4.1363; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; UCHIDA E, 1988, J BIOL CHEM, V263, P45; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; UMEMOTO N, 1991, J BIOL CHEM, V266, P24526; WEISMAN LS, 1987, J CELL BIOL, V105, P1539, DOI 10.1083/jcb.105.4.1539; YAMASHIRO CT, 1990, MOL CELL BIOL, V10, P3737, DOI 10.1128/MCB.10.7.3737; YOSHIHISA T, 1989, BIOCHEM BIOPH RES CO, V163, P908, DOI 10.1016/0006-291X(89)92308-5	38	136	138	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18286	18292						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349704				2022-12-27	WOS:A1993LT74300094
J	PAUL, RV; WACKYM, PS; BUDISAVLJEVIC, M; EVERETT, E; NORRIS, JS				PAUL, RV; WACKYM, PS; BUDISAVLJEVIC, M; EVERETT, E; NORRIS, JS			REGULATION OF ATRIAL-NATRIURETIC-PEPTIDE CLEARANCE RECEPTORS IN MESANGIAL CELLS BY GROWTH-FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; ANGIOTENSIN-II; ENDOTHELIAL-CELLS; PROLIFERATIVE NEPHRITIS; GUANYLATE-CYCLASE; C-RECEPTORS; CYCLIC-GMP; RAT; PDGF; EXPRESSION	Rat mesangial cells can express both 130-kDa guanylyl cyclase-coupled and 66-kDa non-coupled atrial natriuretic peptide (ANP) receptors (ANPR-A and ANPR-C, respectively). Exposure of mesangial cells, grown in 20% fetal calf serum, to 0.1% serum for 24 h increased total ANP receptor density more than 2-fold (B(max) = 87 versus 37 fmol/mg of cell protein) without changing binding affinity (K(d) = 94 versus 88 pM). Radioligand binding and cross-linking studies demonstrated that up-regulation of ANP binding after serum deprivation was entirely due to an increase in ANPR-C, with little or no change in ANPR-A. Inhibition of protein synthesis with cycloheximide blocked up-regulation after serum deprivation. Steady-state ANPR-C mRNA level was increased 15-fold by serum deprivation, as judged by Northern blotting. There was no change in ANPR-A mRNA. Platelet-derived growth factor and phorbol myristate acetate, when added to low serum medium, blocked or reversed the effect of serum deprivation on ANPR-C. We conclude that synthesis and expression of ANPR-C but not ANPR-A is suppressed by serum, platelet-derived growth factor, and phorbol myristate acetate. Suppression of ANPR-C in vivo could contribute to mesangial cell proliferative responses to growth factors.	MED UNIV S CAROLINA,DEPT BIOCHEM & MOLEC BIOL,CHARLESTON,SC 29425; MED UNIV S CAROLINA,DEPT MED,CHARLESTON,SC 29425; VET AFFAIRS MED CTR,RALPH H JOHNSON DEPT,DIV NEPHROL,CHARLESTON,SC	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center					NCI NIH HHS [R01-CA-49949] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA049949] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABELL TJ, 1989, BIOCHEM BIOPH RES CO, V160, P1392, DOI 10.1016/S0006-291X(89)80158-5; ALMEIDA FA, 1989, AM J PHYSIOL, V256, pR469, DOI 10.1152/ajpregu.1989.256.2.R469; ANANDSRIVASTAVA MB, 1992, MOL CELL BIOCHEM, V113, P83; ARONICA SM, 1991, ENDOCRINOLOGY, V128, P2045, DOI 10.1210/endo-128-4-2045; BALLERMANN BJ, 1984, AM J PHYSIOL, V247, pF110, DOI 10.1152/ajprenal.1984.247.1.F110; BERK BC, 1989, HYPERTENSION, V13, P305, DOI 10.1161/01.HYP.13.4.305; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; Brooker G, 1979, Adv Cyclic Nucleotide Res, V10, P1; CAHILL PA, 1991, BIOCHEM BIOPH RES CO, V179, P1606, DOI 10.1016/0006-291X(91)91758-5; CANAANKUHL S, 1992, ENDOCRINOLOGY, V130, P550, DOI 10.1210/en.130.1.550; CHABRIER PE, 1988, J BIOL CHEM, V263, P13199; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DORN GW, 1992, AM J PHYSIOL, V262, pC927, DOI 10.1152/ajpcell.1992.262.4.C927; FERGUSON AV, 1991, CAN J PHYSIOL PHARM, V69, P1026, DOI 10.1139/y91-153; FULLER F, 1988, J BIOL CHEM, V263, P9395; HANASAKI K, 1990, J BIOL CHEM, V265, P4871; HARVEY W, 1974, ANN RHEUM DIS, V33, P437, DOI 10.1136/ard.33.5.437; HIRATA M, 1989, BIOCHIM BIOPHYS ACTA, V1010, P346, DOI 10.1016/0167-4889(89)90060-8; IIDA H, 1991, P NATL ACAD SCI USA, V88, P6560, DOI 10.1073/pnas.88.15.6560; JOHNSON A, 1988, BIOCHEM BIOPH RES CO, V152, P893, DOI 10.1016/S0006-291X(88)80123-2; KATAFUCHI T, 1992, J BIOL CHEM, V267, P7624; KIKKAWA U, 1984, ADV CYCLIC NUCL PROT, V17, P437; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; KOH GY, 1992, J BIOL CHEM, V267, P11987; KOLLER KJ, 1991, SCIENCE, V252, P120, DOI 10.1126/science.1672777; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANIERSMITH KL, 1990, EUR J PHARMACOL, V178, P105, DOI 10.1016/0014-2999(90)94800-D; LANIERSMITH KL, 1991, ENDOCRINOLOGY, V129, P2311, DOI 10.1210/endo-129-5-2311; LEE JJ, 1987, METHOD ENZYMOL, V152, P633; LEVIN ER, 1991, AM J PHYSIOL, V261, pR453, DOI 10.1152/ajpregu.1991.261.2.R453; LONGENECKER JP, 1984, J CELL BIOL, V98, P534, DOI 10.1083/jcb.98.2.534; LOVETT D, 1983, KIDNEY INT, V23, P343; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maack T, 1988, Contrib Nephrol, V68, P58; MAACK T, 1987, SCIENCE, V238, P675, DOI 10.1126/science.2823385; NORRIS JS, 1991, MOL ENDOCRINOL, V5, P979, DOI 10.1210/mend-5-7-979; PFEILSCHIFTER J, 1991, CELL SIGNAL, V3, P413, DOI 10.1016/0898-6568(91)90072-3; RATHINAVELU A, 1991, BIOCHEM J, V276, P493, DOI 10.1042/bj2760493; Sambrook J, 1989, MOL CLONING LABORATO; SHULTZ PJ, 1988, AM J PHYSIOL, V255, pF674, DOI 10.1152/ajprenal.1988.255.4.F674; STRIKER GE, 1985, LAB INVEST, V53, P122; SUGA SI, 1992, CIRC RES, V71, P34, DOI 10.1161/01.RES.71.1.34; TSENG YCL, 1990, J CLIN ENDOCR METAB, V70, P528, DOI 10.1210/jcem-70-2-528; ULLIAN ME, 1989, J CLIN INVEST, V84, P840, DOI 10.1172/JCI114244; WILCOX JN, 1991, MOL CELL BIOL, V11, P3454, DOI 10.1128/MCB.11.7.3454; YOSHIMURA A, 1991, KIDNEY INT, V40, P470, DOI 10.1038/ki.1991.234	47	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18205	18212						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349696				2022-12-27	WOS:A1993LT74300083
J	QUEHENBERGER, O; PROSSNITZ, ER; CAVANAGH, SL; COCHRANE, CG; YE, RD				QUEHENBERGER, O; PROSSNITZ, ER; CAVANAGH, SL; COCHRANE, CG; YE, RD			MULTIPLE DOMAINS OF THE N-FORMYL PEPTIDE RECEPTOR ARE REQUIRED FOR HIGH-AFFINITY LIGAND-BINDING - CONSTRUCTION AND ANALYSIS OF CHIMERIC N-FORMYL PEPTIDE RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; BETA-ADRENERGIC-RECEPTOR; CHEMOATTRACTANT RECEPTOR; CHEMOTACTIC PEPTIDES; THYROTROPIN RECEPTOR; CDNA; IDENTIFICATION; CONFORMATION; ACTIVATION; PROTEINS	Binding of the chemotactic tripeptide fMet-Leu-Phe (fMLP) to its receptor on phagocytes activates these cells through a G protein-coupled pathway. To delineate the structural requirement of the N-formyl peptide receptor (FPR) for ligand binding and signaling, we constructed chimeric receptors between FPR and a recently identified granulocyte receptor, FPR2 (Ye, R. D., Cavanagh, S. L., Quehenberger, O., Prossnitz, E. R., and Cochrane, C. G. (1992) Biochem. Biophys. Res. Commun. 184, 582-589). FPR2 shares 69% sequence homology with the FPR; yet it binds fMLP with a low affinity (K(d) = 430 nM), as compared with the high affinity (K(d) = 1 nM) displayed by the FPR. This property of the FPR2 was utilized for mapping the FPR ligand binding domains. Seven chimeric FPR/FPR2 receptors were generated by sequential replacement of the FPR segments with the corresponding regions from FPR2. Three reciprocal FPR2/FPR chimeric receptors were also constructed by selective substitution of the FPR segments into FPR2. These chimeric receptors were stably expressed in transfected fibroblasts and analyzed for their ligand binding and transmembrane signaling properties. Replacement of the FPR domains, including the first and the third extracellular loops, resulted in 275- and 85-fold decrease in ligand binding affinity, respectively. Introduction of both domains into the FPR2 significantly increased ligand binding affinity (K(d) = 18 nM), whereas substitution of the domains containing the first or third extracellular loop alone improved ligand binding to a lesser degree (K(d) = 90 and 372 nM, respectively). In contrast, substitution of either the amino or the carboxyl-terminal regions with those of the FPR2 had little effect on ligand binding affinity. An analysis of the sequences of the two receptors revealed several key-residues in the first and the third extracellular loops of the FPR and their adjacent transmembrane domains that may be essential for binding of fMLP. We propose that multiple domains of the FPR are required for high-affinity ligand binding, with a major determinant located in the first extracellular loop and its adjacent transmembrane domains.	Scripps Res Inst, DEPT IMMUNOL, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA	Scripps Research Institute			Ye, Richard/O-5223-2016; Ye, Richard/ABF-2413-2020; Prossnitz, Eric R./B-4543-2008	Ye, Richard/0000-0002-2164-5620; Ye, Richard/0000-0002-2164-5620; Prossnitz, Eric/0000-0001-9190-8302	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046572] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33503] Funding Source: Medline; NIGMS NIH HHS [GM46572] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAO L, 1992, Genomics, V13, P437, DOI 10.1016/0888-7543(92)90265-T; BOULAY F, 1990, BIOCHEM BIOPH RES CO, V168, P1103, DOI 10.1016/0006-291X(90)91143-G; BOULAY F, 1990, BIOCHEMISTRY-US, V29, P11123, DOI 10.1021/bi00502a016; COBBOLD PH, 1987, BIOCHEM J, V248, P313, DOI 10.1042/bj2480313; Cochrane CG, 1990, CELLULAR MOL MECHANI, P83; DAHL SG, 1991, P NATL ACAD SCI USA, V88, P8111, DOI 10.1073/pnas.88.18.8111; DENTINO AR, 1991, J BIOL CHEM, V266, P18460; DIDSBURY JR, 1992, FEBS LETT, V297, P275, DOI 10.1016/0014-5793(92)80555-U; DOHLMAN HG, 1988, BIOCHEMISTRY-US, V27, P1813, DOI 10.1021/bi00406a002; EDMUNDSON AB, 1985, MOL IMMUNOL, V22, P463, DOI 10.1016/0161-5890(85)90131-2; ENGELMAN DM, 1980, P NATL ACAD SCI-BIOL, V77, P2023, DOI 10.1073/pnas.77.4.2023; FELLER DC, 1989, INT J PEPT PROT RES, V34, P229; FINDLAY JBC, 1986, BIOCHEM J, V238, P625, DOI 10.1042/bj2380625; FRASER CM, 1989, MOL PHARMACOL, V36, P840; FREER RJ, 1982, BIOCHEMISTRY-US, V21, P257, DOI 10.1021/bi00531a009; FREER RJ, 1980, BIOCHEMISTRY-US, V19, P2404, DOI 10.1021/bi00552a019; FUHLBRIGGE RC, 1988, P NATL ACAD SCI USA, V85, P5649, DOI 10.1073/pnas.85.15.5649; GAVUZZO E, 1989, INT J PEPT PROT RES, V34, P409; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HARGRAVE PA, 1992, FASEB J, V6, P2323, DOI 10.1096/fasebj.6.6.1544542; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; KOO C, 1983, J CLIN INVEST, V72, P748, DOI 10.1172/JCI111045; MALECH HL, 1985, J BIOL CHEM, V260, P2509; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MURPHY PM, 1992, J BIOL CHEM, V267, P7637; NAGAYAMA Y, 1991, P NATL ACAD SCI USA, V88, P902, DOI 10.1073/pnas.88.3.902; NAGAYAMA Y, 1991, J BIOL CHEM, V266, P14926; PEREZ HD, 1993, J BIOL CHEM, V268, P2292; PEREZ HD, 1992, GENE, V118, P303, DOI 10.1016/0378-1119(92)90208-7; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; PROSSNITZ ER, 1991, BIOCHEM BIOPH RES CO, V179, P471, DOI 10.1016/0006-291X(91)91394-R; QUEHENBERGER O, 1992, J BIOL CHEM, V267, P19757; RADEL SJ, 1991, BIOCHEM INT, V25, P745; SEMUS SF, 1988, BIOCHEM BIOPH RES CO, V157, P569, DOI 10.1016/S0006-291X(88)80287-0; SKLAR LA, 1989, J BIOL CHEM, V264, P8483; SKLAR LA, 1990, BIOCHEMISTRY-US, V29, P313, DOI 10.1021/bi00454a002; SPILBERG I, 1986, J LEUKOCYTE BIOL, V39, P545; STRADER CD, 1988, J BIOL CHEM, V263, P10267; STRADER CD, 1989, J BIOL CHEM, V264, P13572; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WANG CD, 1991, MOL PHARMACOL, V40, P168; YE RD, 1992, BIOCHEM BIOPH RES CO, V184, P582, DOI 10.1016/0006-291X(92)90629-Y; YE RD, 1993, J IMMUNOL, V150, P1383; YOKOTA Y, 1992, EMBO J, V11, P3585, DOI 10.1002/j.1460-2075.1992.tb05442.x	45	110	113	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18167	18175						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349692				2022-12-27	WOS:A1993LT74300077
J	BROSI, R; HAURI, HP; KRAMER, A				BROSI, R; HAURI, HP; KRAMER, A			SEPARATION OF SPLICING FACTOR SF3 INTO 2 COMPONENTS AND PURIFICATION OF SF3A ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; NUCLEAR RIBONUCLEOPROTEIN-PARTICLES; COMPLEX-FORMATION; CONSERVED FAMILY; U2 SNRNP; BIOCHEMICAL-CHARACTERIZATION; POLYPYRIMIDINE TRACT; PRESPLICING COMPLEX; AUXILIARY FACTOR; PROTEIN	Components required for the splicing of nuclear messenger RNA precursors in vitro have been isolated from HeLa cells. Here we describe the separation of splicing factor SF3 into two components, SF3a and SF3b. Both activities are required together with several other protein factors and U1 and U2 small nuclear ribonucleoproteins for the assembly of a presplicing complex which represents the first ATP-dependent step in the assembly of the active spliceosome. SF3a has been purified to homogeneity by a combination of ion-exchange chromatography, gel filtration, and glycerol gradient sedimentation. It consists of a complex of three polypeptides of 60, 66, and 120 kDa. The association of SF3a activity with these polypeptides has been confirmed by immunoprecipitation and depletion experiments using a monoclonal antibody directed against the 66-kDa subunit.	UNIV GENEVA, DEPT BIOL CELLULAIRE SCI 3, 30 QUAI ERNEST ANSERMET, CH-1211 GENEVA 4, SWITZERLAND; UNIV BASEL, BIOCTR, PHARMAKOL ABT, CH-4056 BASEL, SWITZERLAND	University of Geneva; University of Basel								ABOVICH N, 1990, MOL CELL BIOL, V10, P6417, DOI 10.1128/MCB.10.12.6417; AST G, 1991, EMBO J, V10, P425, DOI 10.1002/j.1460-2075.1991.tb07964.x; BEHRENS SE, 1993, MOL CELL BIOL, V13, P307, DOI 10.1128/MCB.13.1.307; BENNETT M, 1992, MOL CELL BIOL, V12, P3165, DOI 10.1128/MCB.12.7.3165; BENNETT M, 1992, GENE DEV, V6, P1986, DOI 10.1101/gad.6.10.1986; CECH TR, 1986, ANNU REV BIOCHEM, V55, P599, DOI 10.1146/annurev.biochem.55.1.599; DELANNOY P, 1991, MOL CELL BIOL, V11, P3425, DOI 10.1128/MCB.11.7.3425; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; FU XD, 1992, P NATL ACAD SCI USA, V89, P1725, DOI 10.1073/pnas.89.5.1725; GARCIABLANCO MA, 1989, GENE DEV, V3, P1874, DOI 10.1101/gad.3.12a.1874; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; GHETTI A, 1992, NUCLEIC ACIDS RES, V20, P3671, DOI 10.1093/nar/20.14.3671; GUTHRIE C, 1988, ANNU REV GENET, V22, P387, DOI 10.1146/annurev.ge.22.120188.002131; GUTHRIE C, 1991, SCIENCE, V253, P157, DOI 10.1126/science.1853200; HAURI HP, 1985, J CELL BIOL, V101, P838, DOI 10.1083/jcb.101.3.838; HEINRICHS V, 1990, SCIENCE, V247, P69, DOI 10.1126/science.2136774; KIM SH, 1992, EMBO J, V11, P2319, DOI 10.1002/j.1460-2075.1992.tb05291.x; KRAINER AR, 1990, GENE DEV, V4, P1158, DOI 10.1101/gad.4.7.1158; KRAINER AR, 1985, CELL, V42, P725, DOI 10.1016/0092-8674(85)90269-7; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; KRAMER A, 1991, EMBO J, V10, P1503, DOI 10.1002/j.1460-2075.1991.tb07670.x; KRAMER A, 1987, J BIOL CHEM, V262, P17630; KRAMER A, 1988, GENE DEV, V2, P1155, DOI 10.1101/gad.2.9.1155; KRAMER A, 1983, J BIOL CHEM, V258, P1915; KRAMER A, 1992, MOL CELL BIOL, V12, P4545; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAYEDA A, 1992, P NATL ACAD SCI USA, V89, P1301, DOI 10.1073/pnas.89.4.1301; MICHAUD S, 1991, GENE DEV, V5, P2534, DOI 10.1101/gad.5.12b.2534; Moore M. J., 1993, RNA WORLD; PINOLROMA S, 1988, GENE DEV, V2, P215, DOI 10.1101/gad.2.2.215; ROTH MB, 1991, J CELL BIOL, V115, P587, DOI 10.1083/jcb.115.3.587; RYMOND BC, 1992, MOL CELLULAR BIOL YE, V2, P143; SCHEFFNER M, 1989, CELL, V57, P955, DOI 10.1016/0092-8674(89)90334-6; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; SHARP PA, 1991, SCIENCE, V254, P663, DOI 10.1126/science.1948046; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Steitz J. A., 1988, STRUCTURE FUNCTION M, P115; STEITZ JA, 1992, SCIENCE, V257, P888, DOI 10.1126/science.1386941; STOCKER JW, 1982, RES DISCLOSURE   MAY, P154; UTANS U, 1990, EMBO J, V9, P4119, DOI 10.1002/j.1460-2075.1990.tb07634.x; UTANS U, 1992, GENE DEV, V6, P631, DOI 10.1101/gad.6.4.631; WEINER AM, 1993, CELL, V72, P161, DOI 10.1016/0092-8674(93)90654-9; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; ZAMORE PD, 1991, EMBO J, V10, P207, DOI 10.1002/j.1460-2075.1991.tb07937.x; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243	46	96	99	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17640	17646						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349644				2022-12-27	WOS:A1993LQ98800108
J	GRANT, DF; STORMS, DH; HAMMOCK, BD				GRANT, DF; STORMS, DH; HAMMOCK, BD			MOLECULAR-CLONING AND EXPRESSION OF MURINE LIVER SOLUBLE EPOXIDE HYDROLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID EPOXYGENASE; MOUSE-LIVER; EPOXYEICOSATRIENOIC ACIDS; PROTEINS; PURIFICATION; METABOLISM; ANTIBODY; RABBIT; CDNA	A clofibrate-induced mouse liver cDNA library was prepared and used to isolate the coding sequence for soluble epoxide hydrolase. A 1668-base pair (bp) clone was isolated and found to contain a 1269-bp open reading frame coding for 423 amino acids. Subsequent RNA polymerase chain reaction resulted in the isolation of 396 bp of additional 5'-sequence. Translation of the resulting 1659-bp open reading frame produced a 553-residue protein (62,527 Da) containing deduced peptide segments that matched the amino acid sequences of six peptide fragments isolated previously from CNBr digests of pure murine soluble epoxide hydrolase. Neither the DNA nor the protein sequence showed significant similarity to other currently published sequences. Structural analysis of the soluble epoxide hydrolase coding region suggested at least one potential regulatory motif. Expression of the composite cDNA in COS-7 cells resulted in a 5-10-fold increase in soluble epoxide hydrolase activity and a similar increase in soluble epoxide hydrolase protein amount compared to mock-transfected or vector control-transfected cells. Treatment of C57BL/6J mice with clofibrate led to an approximately 4-fold increase in both soluble epoxide hydrolase enzyme activity and steady-state mRNA levels.	UNIV CALIF DAVIS,DEPT ENTOMOL,DAVIS,CA 95616; UNIV CALIF DAVIS,DEPT ENVIRONM TOXICOL,DAVIS,CA 95616	University of California System; University of California Davis; University of California System; University of California Davis					NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005707, R01ES002710] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ESO2710, P30 ESO5707] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ARAND M, 1991, FEBS LETT, V294, P19, DOI 10.1016/0014-5793(91)81333-4; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CAPDEVILA JH, 1990, J BIOL CHEM, V265, P10865; CARROLL MA, 1987, EUR J PHARMACOL, V138, P281, DOI 10.1016/0014-2999(87)90445-6; CHACOS N, 1983, ARCH BIOCHEM BIOPHYS, V223, P639, DOI 10.1016/0003-9861(83)90628-8; CHANG C, 1991, ARCH BIOCHEM BIOPHYS, V285, P276, DOI 10.1016/0003-9861(91)90360-U; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DIETZE EC, 1990, INT J BIOCHEM, V22, P461, DOI 10.1016/0020-711X(90)90258-5; DIETZE EC, 1993, COMP BIOCHEM PHYS B, V104, P299, DOI 10.1016/0305-0491(93)90372-C; FINLEY BL, 1988, BIOCHEM PHARMACOL, V37, P3169, DOI 10.1016/0006-2952(88)90316-4; FITZPATRICK FA, 1989, PHARMACOL REV, V40, P229; GILL SS, 1979, BIOCHEM BIOPH RES CO, V89, P965, DOI 10.1016/0006-291X(79)91872-2; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; HASSETT C, 1989, ARCH BIOCHEM BIOPHYS, V271, P380, DOI 10.1016/0003-9861(89)90287-7; IMAI H, 1980, SCIENCE, V207, P651, DOI 10.1126/science.7352277; JANSEN R, 1989, GENE ANAL TECH, V6, P79, DOI 10.1016/0735-0651(89)90020-4; KARARA A, 1989, J BIOL CHEM, V264, P19822; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MEIJER J, 1988, CHEM-BIOL INTERACT, V64, P207, DOI 10.1016/0009-2797(88)90100-7; MOODY DE, 1992, DRUG METAB DISPOS, V20, P779; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; NASHED NT, 1985, ARCH BIOCHEM BIOPHYS, V241, P149, DOI 10.1016/0003-9861(85)90371-6; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; NUTTLEY WM, 1988, GENE, V69, P171, DOI 10.1016/0378-1119(88)90428-3; PRESTWICH GD, 1985, P NATL ACAD SCI USA, V82, P1663, DOI 10.1073/pnas.82.6.1663; RAO MS, 1991, ENVIRON HEALTH PERSP, V93, P205, DOI 10.2307/3431190; Rechsteiner M, 1990, Semin Cell Biol, V1, P433; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; SAMBROOK J, 1989, MOL CLONING LABORATO, V1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SILVA MH, 1987, COMP BIOCHEM PHYS B, V87, P95, DOI 10.1016/0305-0491(87)90475-5; SUGIYAMA S, 1987, LIFE SCI, V40, P225, DOI 10.1016/0024-3205(87)90336-5; WANG KKW, 1989, BIOCHEM J, V262, P693, DOI 10.1042/bj2620693; WIXTROM RN, 1985, BIOCH PHARM TOXICOLO, V1, P1	37	86	94	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17628	17633						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349642				2022-12-27	WOS:A1993LQ98800106
J	LUTZ, HU; STAMMLER, P; FASLER, S				LUTZ, HU; STAMMLER, P; FASLER, S			PREFERENTIAL FORMATION OF C3B-IGG COMPLEXES IN-VITRO AND IN-VIVO FROM NASCENT C3B AND NATURALLY-OCCURRING ANTI-BAND-3 ANTIBODIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; ALTERNATIVE COMPLEMENT PATHWAY; COVALENTLY BOUND C3B; NATURALLY-OCCURRING AUTOANTIBODIES; HUMAN-MONOCYTES; POLYMORPHONUCLEAR LEUKOCYTES; DEPENDENT PHAGOCYTOSIS; GEL ELECTROPHORESIS; IMMUNE-COMPLEXES; HUMAN-SERUM	Naturally occurring anti-band 3 antibodies appear to have tissue homeostatic functions in the clearance of senescent red cells and in eliciting selective phagocytosis of oxidatively stressed red cells by mediating C3b deposition under conditions that favor the alternative complement pathway (Lutz, H. U., Bussolino, F., Flepp, R., Fasler, S., Stammler, P., Kazatchkine, M. D., and Arese, P. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 7368-7372). They overcome the notoriously low affinities of naturally occurring antibodies by having affinity for C3 which renders these antibodies preferred targets of nascent C3b. Anti-band 3 antibodies preferentially formed covalently linked C3b-IgG complexes, when C3 was activated randomly by trypsin. IgG depleted of anti-band 3 antibodies had almost lost the ability to form C3b-IgG complexes. Likewise, anti-band 3 antibodies, but not anti-spectrin antibodies, preferentially formed C3b-IgG complexes on oxidatively stressed red cells in the presence of a 10(3)-fold excess of other serum IgG, when complement deposition was initiated by antibody binding in diluted serum. Moreover, anti-band 3 antibodies preferentially formed C3b-IgG complexes at a 10(5)-fold excess of other IgG on in vivo aging red cells, since C3b-IgG complexes from senescent red cells contained exclusively anti-band 3 antibodies with an affinity for C3. Thus, the low titer, low affinity naturally occurring antibody became functionally relevant by preferred generation of C3b-IgG complexes that can nucleate alternative complement pathway C3 convertases and represent the most effective opsonins (Fries, L. F., Siwik, S. A., Malbran, A., and Frank, M. M. (1987) Immunology 62, 45-51).			LUTZ, HU (corresponding author), SWISS FED INST TECHNOL, BIOCHEM LAB, CH-8092 ZURICH, SWITZERLAND.							BEPPU M, 1990, J BIOL CHEM, V265, P3226; BUSSOLINO F, 1989, J BIOL CHEM, V264, P21711; CLARK MR, 1983, BLOOD, V61, P899, DOI 10.1182/blood.V61.5.899.899; FACHI T, 1977, SCAND J IMMUNOL, V6, P241; FASLER S, 1988, ANAL BIOCHEM, V174, P593, DOI 10.1016/0003-2697(88)90061-9; FRANK MM, 1991, IMMUNOL TODAY, V12, P322, DOI 10.1016/0167-5699(91)90009-I; FREEDMAN J, 1984, TRANSFUSION, V24, P477, DOI 10.1046/j.1537-2995.1984.24685066804.x; FRIES LF, 1984, J EXP MED, V160, P1640, DOI 10.1084/jem.160.6.1640; FRIES LF, 1987, IMMUNOLOGY, V62, P45; FRIES LF, 1985, J IMMUNOL, V135, P2673; FUJITA T, 1987, J EXP MED, V166, P1221, DOI 10.1084/jem.166.5.1221; GADD KJ, 1981, BIOCHEM J, V195, P471, DOI 10.1042/bj1950471; GATTEGNO L, 1989, J LEUKOCYTE BIOL, V45, P422, DOI 10.1002/jlb.45.5.422; GEE AP, 1981, ANAL BIOCHEM, V116, P524, DOI 10.1016/0003-2697(81)90397-3; HAMMER CH, 1981, J BIOL CHEM, V256, P3995; JACOBS RJ, 1983, J IMMUNOL, V130, P2775; JOINER KA, 1985, J EXP MED, V162, P877, DOI 10.1084/jem.162.3.877; KAY MMB, 1984, P NATL ACAD SCI-BIOL, V81, P5753, DOI 10.1073/pnas.81.18.5753; KINOSHITA T, 1988, J IMMUNOL, V141, P3895; KULICS J, 1983, MOL IMMUNOL, V20, P805, DOI 10.1016/0161-5890(83)90076-7; LAW SK, 1977, P NATL ACAD SCI USA, V74, P2701, DOI 10.1073/pnas.74.7.2701; LAW SKA, 1988, J CELL SCI, P67; LUTZ HU, 1987, SCHWEIZ MED WSCHR, V117, P1821; LUTZ HU, 1988, BLOOD CELLS, V14, P175; LUTZ HU, 1992, BIOCHIM BIOPHYS ACTA, V1116, P1, DOI 10.1016/0304-4165(92)90120-J; LUTZ HU, 1989, BEITR INFUS, V24, P193; LUTZ HU, 1987, P NATL ACAD SCI USA, V84, P7368, DOI 10.1073/pnas.84.21.7368; LUTZ HU, 1984, J IMMUNOL, V133, P2610; LUTZ HU, 1982, J IMMUNOL, V128, P1695; LUTZ HU, 1990, BIOMED BIOCHIM ACTA, V49, pS224; LUTZ HU, 1983, BIOMED BIOCHIM ACTA, V42, pS117; Lutz HU, 1990, BLOOD CELL BIOCH, V1, P81; MALBRAN A, 1987, IMMUNOLOGY, V61, P15; MORGAN AC, 1982, CANCER RES, V42, P881; MUELLER TJ, 1987, J CLIN INVEST, V79, P492, DOI 10.1172/JCI112839; NEVILLE DM, 1971, J BIOL CHEM, V246, P6328; NEWMAN SL, 1979, J IMMUNOL, V123, P1839; OKADA N, 1983, IMMUNOLOGY, V50, P75; SCHENKEIN HA, 1981, J IMMUNOL, V126, P7; SCHIFFERLI JA, 1989, KIDNEY INT, V35, P993, DOI 10.1038/ki.1989.83; SCHLESINGER LS, 1991, J IMMUNOL, V147, P1983; SHOHET JM, 1991, J BIOL CHEM, V266, P18520; SORETTE MP, 1991, BLOOD, V77, P628; TACK BF, 1976, BIOCHEMISTRY-US, V15, P4513, DOI 10.1021/bi00665a028; TAKATA Y, 1984, J IMMUNOL, V132, P2531; TYLER JM, 1979, P NATL ACAD SCI USA, V76, P5192, DOI 10.1073/pnas.76.10.5192; WAYTES AT, 1991, J IMMUNOL, V146, P2694	47	59	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17418	17426						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349625				2022-12-27	WOS:A1993LQ98800079
J	SCHAAP, P; VANMENTSCOHEN, M; SOEDE, RDM; BRANDT, R; FIRTEL, RA; DOSTMANN, W; GENIESER, HG; JASTORFF, B; VANHAASTER, PJM				SCHAAP, P; VANMENTSCOHEN, M; SOEDE, RDM; BRANDT, R; FIRTEL, RA; DOSTMANN, W; GENIESER, HG; JASTORFF, B; VANHAASTER, PJM			CELL-PERMEABLE NONHYDROLYZABLE CAMP DERIVATIVES AS TOOLS FOR ANALYSIS OF SIGNALING PATHWAYS CONTROLLING GENE-REGULATION IN DICTYOSTELIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; BINDING PROTEINS; DISCOIDEUM CELLS; PRESTALK GENE; EXPRESSION; AMP; RECEPTOR; DIFFERENTIATION; ADENOSINE	A novel class of cAMP derivatives were tested for binding to surface cAMP receptors (CAR), protein kinase A (PKA), and cAMP-phosphodiesterase (PDE) and for induction of three classes of cAMP regulated genes in Dictyostelium discoideum. These derivatives carry sulfur substitutions for either the axial (Sp) or equatorial (Rp) exocyclic oxygen atoms, while further modifications were introduced to provide specificity for binding to either CAR or PKA, and/or to increase lipophilicity and render the derivatives membrane-permeable. All derivatives bind weakly to PDE and are almost not degraded during incubation with Dictyostelium cells. One cAMP derivative, 6-thioethylpurineriboside 3',5'-monophosphorothioate, Sp-isomer (Sp-6SEtcPuMPS), fulfills the criteria for selective activation of PKA in vivo. The compound enters Dictyostelium cells and reaches an intracellular concentration of 1 muM, sufficient to activate PKA, at an extracellular concentration of 30 mum, which is insufficient to activate CAR. Expression of cAMP-regulated prespore and prestalk genes and the aggregative PDE gene are effectively induced by CAR agonists and very poorly by PKA agonists. Even Sp-6SEtcPuMPS is ineffective to induce gene expression. These data not only indicate that surface cAMP receptors are the first targets for cAMP-induced gene expression, but argue against direct induction of expression of these genes by cAMP-induced PKA activation.	UNIV CALIF SAN DIEGO, CTR MOLEC GENET, DEPT BIOL, LA JOLLA, CA 92097 USA; TECH UNIV MUNICH, INST PHARMACOL & TOXICOL, W-8000 MUNICH, GERMANY; BIOLOG LIFE SCI INST, W-2800 BREMEN, GERMANY; UNIV BREMEN, INST ORGAN CHEM, W-2800 BREMEN, GERMANY; UNIV GRONINGEN, DEPT BIOCHEM, 9747 AG GRONINGEN, NETHERLANDS	University of California System; University of California San Diego; Technical University of Munich; University of Bremen; University of Groningen	SCHAAP, P (corresponding author), LEIDEN UNIV, DEPT BIOL, CELL BIOL & GENET UNIT, KAISERSTR 63, 2311 GP LEIDEN, NETHERLANDS.		Schaap, Pauline/M-5355-2019; Schaap, Pauline/A-3682-2009	Schaap, Pauline/0000-0003-4500-2555; Schaap, Pauline/0000-0003-4500-2555; Genieser, Hans-Gottfried/0000-0002-4904-5790				ADASHI EY, 1990, MOL CELL ENDOCRINOL, V72, P1, DOI 10.1016/0303-7207(90)90234-Y; ALLY S, 1989, CANCER RES, V49, P5650; ANJARD C, 1992, DEVELOPMENT, V115, P785; ASHWORTH JM, 1970, BIOCHEM J, V119, P175, DOI 10.1042/bj1190175; BOZZARO S, 1987, DEV BIOL, V123, P540, DOI 10.1016/0012-1606(87)90412-X; BRAUMANN T, 1986, BIOCHIM BIOPHYS ACTA, V871, P199, DOI 10.1016/0167-4838(86)90174-3; BRAUMANN T, 1985, J CHROMATOGR, V350, P105, DOI 10.1016/S0021-9673(01)93510-1; BUCHLER W, 1988, FEBS LETT, V228, P27, DOI 10.1016/0014-5793(88)80577-5; CAMPAGNE MMV, 1991, CANCER RES, V51, P1600; DARMON M, 1975, P NATL ACAD SCI USA, V72, P3163, DOI 10.1073/pnas.72.8.3163; DATTA S, 1988, GENE DEV, V2, P294, DOI 10.1101/gad.2.3.294; DEGUNZBURG J, 1984, BIOCHEMISTRY-US, V23, P3805, DOI 10.1021/bi00312a003; DEWIT RJW, 1982, FEBS LETT, V145, P150, DOI 10.1016/0014-5793(82)81225-8; DEWIT RJW, 1984, EUR J BIOCHEM, V142, P255; DINGERMANN T, 1989, GENE, V85, P353, DOI 10.1016/0378-1119(89)90428-9; DOSTMANN W, 1987, THESIS U BREMEN FEDE; DOSTMANN WRG, 1990, J BIOL CHEM, V265, P10484; ECKSTEIN F, 1985, ANNU REV BIOCHEM, V54, P367, DOI 10.1146/annurev.bi.54.070185.002055; FAURE M, 1990, MOL CELL BIOL, V10, P1921, DOI 10.1128/MCB.10.5.1921; FIRTEL RA, 1990, GENE DEV, V4, P18, DOI 10.1101/gad.4.1.18; GENIESER HG, 1988, TETRAHEDRON LETT, V29, P2803, DOI 10.1016/0040-4039(88)85214-6; GERISCH G, 1975, NATURE, V255, P547, DOI 10.1038/255547a0; GOMER RH, 1986, P NATL ACAD SCI USA, V83, P8624, DOI 10.1073/pnas.83.22.8624; GRANT CE, 1990, GENE, V96, P213, DOI 10.1016/0378-1119(90)90255-P; HARIBABU B, 1986, MOL CELL BIOL, V6, P2402, DOI 10.1128/MCB.6.7.2402; HARWOOD AJ, 1992, DEV BIOL, V149, P90, DOI 10.1016/0012-1606(92)90266-J; HARWOOD AJ, 1992, CELL, V69, P615, DOI 10.1016/0092-8674(92)90225-2; JASTORFF B, 1972, CHEM BER-RECL, V105, P3192, DOI 10.1002/cber.19721051007; JOHNSON RL, 1992, J BIOL CHEM, V267, P4600; KAY RR, 1989, DEVELOPMENT, V105, P753; KLEIN PS, 1988, SCIENCE, V241, P1467, DOI 10.1126/science.3047871; KONIJN TM, 1973, FEBS LETT, V34, P263, DOI 10.1016/0014-5793(73)80808-7; KUMAGAI A, 1989, CELL, V57, P265, DOI 10.1016/0092-8674(89)90964-1; LACOMBE ML, 1986, J BIOL CHEM, V261, P6811; MA PCC, 1990, MOL CELL BIOL, V10, P3297, DOI 10.1128/MCB.10.7.3297; MANN SKO, 1991, MECH DEVELOP, V35, P89, DOI 10.1016/0925-4773(91)90060-J; MANN SKO, 1988, DEV BIOL, V130, P294, DOI 10.1016/0012-1606(88)90435-6; MEHDY MC, 1985, MOL CELL BIOL, V5, P705, DOI 10.1128/MCB.5.4.705; MEHDY MC, 1983, CELL, V32, P763, DOI 10.1016/0092-8674(83)90062-4; MUTZEL R, 1987, P NATL ACAD SCI USA, V84, P6, DOI 10.1073/pnas.84.1.6; NOEGEL A, 1986, EMBO J, V5, P1473, DOI 10.1002/j.1460-2075.1986.tb04384.x; OYAMA M, 1986, P NATL ACAD SCI USA, V83, P4819, DOI 10.1073/pnas.83.13.4819; PEARS CJ, 1987, EMBO J, V6, P195, DOI 10.1002/j.1460-2075.1987.tb04738.x; PETERS DJM, 1991, P NATL ACAD SCI USA, V88, P9219, DOI 10.1073/pnas.88.20.9219; RICHARDSON DL, 1991, DEV BIOL, V144, P269, DOI 10.1016/0012-1606(91)90421-X; ROTHERMEL JD, 1983, J BIOL CHEM, V258, P2125; SAXE CL, 1991, GENE DEV, V5, P1, DOI 10.1101/gad.5.1.1; SCHAAP P, 1986, DEV BIOL, V118, P52, DOI 10.1016/0012-1606(86)90072-2; SCHAAP P, 1986, CELL, V45, P137, DOI 10.1016/0092-8674(86)90545-3; SCHAAP P, 1985, EXP CELL RES, V159, P388, DOI 10.1016/S0014-4827(85)80012-4; SCHOEN C, 1984, BIOCHIM BIOPHYS ACTA, V784, P1, DOI 10.1016/0167-4838(84)90165-1; SIMON MN, 1992, NATURE, V356, P171, DOI 10.1038/356171a0; SIMON MN, 1989, EMBO J, V8, P2039, DOI 10.1002/j.1460-2075.1989.tb03612.x; SPEK W, 1988, FEBS LETT, V228, P231, DOI 10.1016/0014-5793(88)80005-X; THEIBERT A, 1986, DEV BIOL, V114, P529, DOI 10.1016/0012-1606(86)90216-2; TSANG AS, 1986, J BIOL CHEM, V261, P753; VANHAASTERT PJM, 1984, J GEN MICROBIOL, V130, P2559; VANHAASTERT PJM, 1984, J BIOL CHEM, V259, P20; VANHAASTERT PJM, 1984, J BIOL CHEM, V259, P3321; VANHAASTERT PJM, 1983, J BIOL CHEM, V258, P9636; VANHAASTERT PJM, 1983, EUR J BIOCHEM, V131, P659; VANHAASTERT PJM, 1987, BIOPHOSPHATES THEIR, P469; VANMENTSCOHEN M, 1989, J BIOL CHEM, V264, P8717; WANG M, 1988, DEVELOPMENT, V103, P611; WEIJER CJ, 1985, J EMBRYOL EXP MORPH, V86, P19; YEH RP, 1978, DEV BIOL, V66, P361, DOI 10.1016/0012-1606(78)90245-2	66	72	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1993	268	9					6323	6331						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KT368	8384208				2022-12-27	WOS:A1993KT36800039
J	ISOGAI, Y; IIZUKA, T; MAKINO, R; IYANAGI, T; ORII, Y				ISOGAI, Y; IIZUKA, T; MAKINO, R; IYANAGI, T; ORII, Y			SUPEROXIDE-PRODUCING CYTOCHROME-B - ENZYMATIC AND ELECTRON-PARAMAGNETIC RESONANCE PROPERTIES OF CYTOCHROME-B(558) PURIFIED FROM NEUTROPHILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; RESPIRATORY BURST OXIDASE; OXIDATION-REDUCTION PROPERTIES; FERRICYTOCHROME-C; NADPH OXIDASE; PURIFICATION; MECHANISM; BINDING; CHAIN; SPECTROSCOPY	Molecular properties of superoxide (O2-)-producing cytochrome b558 purified from neutrophils were investigated focusing on the mechanism of the catalytic reaction. The purified cytochrome, which was depleted of FAD, exhibited high O2--generating activity with consumption of NADPH in the presence of microsomal NADPH-cytochrome P-450 reductase. Exogenous additions of CO, CN-, or N3- had no effect on the enzymatic activity. Potentiometric titration of the ferric-ferrous couple of the cytochrome showed that the midpoint reduction potential was -255 mV at pH 7.4. When the reaction of the reduced cytochrome with O2 was analyzed by stopped flow and rapid scanning spectrophotometry, the ferrous form was found to be converted to the ferric form at a rate constant of 9.3 x 10(6) M-1 s-1 at 10-degrees-C without showing formation of an oxygenated intermediate. EPR measurement of the ferric cytochrome at 10 K showed that the electronic spin state was in a low spin with g values of 3.2, 2.05, and 1.5. These results suggest that the heme in a six-coordinated low spin state catalyzes one electron reduction of O2 without ligation of O2 to the heme iron during the catalytic cycle.	HIMEJI INST TECHNOL,FAC SCI,HIMEJI,HYOGO 67812,JAPAN; KYOTO UNIV,FAC MED,DEPT PUBL HLTH,KYOTO 606,JAPAN	University of Hyogo; Kyoto University	ISOGAI, Y (corresponding author), RIKEN,HIROSAWA 2-1,WAKO,SAITAMA 31501,JAPAN.			Isogai, Yasuhiro/0000-0001-6905-4208				ABO A, 1991, J BIOL CHEM, V266, P23577; ABO A, 1992, J BIOL CHEM, V267, P16767; BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205; BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403; BUTLER J, 1982, J BIOL CHEM, V257, P747; CROSS AR, 1981, BIOCHEM J, V194, P599, DOI 10.1042/bj1940599; CROSS AR, 1985, BIOCHEM J, V226, P881, DOI 10.1042/bj2260881; CROSS AR, 1982, BIOCHEM J, V204, P479, DOI 10.1042/bj2040479; CROSS AR, 1991, BIOCHIM BIOPHYS ACTA, V1057, P281, DOI 10.1016/S0005-2728(05)80140-9; CURNUTTE JT, 1989, P NATL ACAD SCI USA, V86, P825, DOI 10.1073/pnas.86.3.825; DINAUER MC, 1987, NATURE, V327, P717, DOI 10.1038/327717a0; FUJII H, 1992, BIOCHIM BIOPHYS ACTA, V1136, P239, DOI 10.1016/0167-4889(92)90112-O; HURST JK, 1991, J BIOL CHEM, V266, P1627; IIZUKA T, 1985, J BIOL CHEM, V260, P2049; IIZUKA T, 1985, BIOCHEM BIOPH RES CO, V130, P621, DOI 10.1016/0006-291X(85)90462-0; ISOGAI Y, 1991, J BIOL CHEM, V266, P13481; IYANAGI T, 1984, BIOCHEMISTRY-US, V23, P1418, DOI 10.1021/bi00302a013; IYANAGI T, 1981, BIOCHEMISTRY-US, V20, P1722, DOI 10.1021/bi00510a004; KAKINUMA K, 1987, J BIOL CHEM, V262, P12316; KOZIOL J., 1971, Methods in Enzymology, V18B, P253, DOI 10.1016/S0076-6879(71)18089-5; MAKINO R, 1980, J BIOL CHEM, V255, P1883; MAKINO R, 1986, J BIOL CHEM, V261, P1144; MIKI T, 1992, J BIOL CHEM, V267, P19673; MIZUNO T, 1992, J BIOL CHEM, V267, P10215; OMURA T, 1970, J BIOCHEM-TOKYO, V67, P249, DOI 10.1093/oxfordjournals.jbchem.a129248; ORII Y, 1984, J BIOL CHEM, V259, P7187; PARKOS CA, 1988, P NATL ACAD SCI USA, V85, P3319, DOI 10.1073/pnas.85.10.3319; ROOME PW, 1983, J BIOL CHEM, V258, P2593; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SEGAL AW, 1987, NATURE, V326, P88, DOI 10.1038/326088a0; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; SEGAL AW, 1989, J CLIN INVEST, V83, P1785, DOI 10.1172/JCI114083; SUTIN N, 1972, J BIOL CHEM, V247, P6932; TANAKA T, 1990, J BIOL CHEM, V265, P18717; TEAHAN C, 1987, NATURE, V327, P720, DOI 10.1038/327720a0; UENO I, 1991, FEBS LETT, V281, P130, DOI 10.1016/0014-5793(91)80375-D; UMEI T, 1991, J BIOL CHEM, V266, P6019; VOLPP BD, 1988, SCIENCE, V242, P1295, DOI 10.1126/science.2848318; YEA CM, 1990, BIOCHEM J, V265, P95, DOI 10.1042/bj2650095; YONETANI T, 1971, J BIOL CHEM, V246, P7683	41	39	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					4025	4031						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382686				2022-12-27	WOS:A1993KN53300036
J	TAGUCHI, T; SEKO, A; KITAJIMA, K; INOUE, S; IWAMATSU, T; KHOO, KH; MORRIS, HR; DELL, A; INOUE, Y				TAGUCHI, T; SEKO, A; KITAJIMA, K; INOUE, S; IWAMATSU, T; KHOO, KH; MORRIS, HR; DELL, A; INOUE, Y			STRUCTURAL STUDIES OF A NOVEL TYPE OF TETRAANTENNARY SIALOGLYCAN UNIT IN A CARBOHYDRATE-RICH GLYCOPEPTIDE ISOLATED FROM THE FERTILIZED-EGGS OF INDIAN MEDAKA FISH, ORYZIAS-MELASTIGMA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAINBOW-TROUT EGGS; EMBRYONAL CARCINOMA-CELLS; LINKED GLYCAN CHAIN; UNFERTILIZED EGGS; FREE SIALOOLIGOSACCHARIDES; AFFINITY-CHROMATOGRAPHY; LIQUID-CHROMATOGRAPHY; METHYLATION ANALYSIS; MAGNETIC-RESONANCE; CORTICAL ALVEOLI	A novel carbohydrate-rich sialoglycopolyprotein of apparent molecular mass approximately 7000 Da was isolated from the fertilized eggs of the Medaka fish species, Oryzias melastigma. The glycoprotein was identified as a member of the L-hyosophorin family because it exhibited the following several distinctive features of L-hyosophorin molecules: (a) it contains a high proportion of carbohydrate (90% by weight), and (b) the amino acid sequence of the apopeptide was identical with that of the Oryzias latipes L-hyosophorin which has previously been demonstrated to be derived from a high molecular weight form of hyosophorin, i.e. H-hyosophorin, present in the cortical vesicles of unfertilized eggs. The apoprotein of H-hyosophorin is composed of tandem repeats of the L-hyosophorin apopeptide, i.e. it is a polyprotein. The structure of the carbohydrate portion of purified L-hyosophorin of 0. melastigma was studied by composition and methylation analysis, selective chemical (periodate-Smith degradation; hydrazinolysis-nitrous acid deamination), and enzymatic (endo-beta-galactosidase; peptide:N-glycanase) degradation, together with instrumental methods (fast atom bombardment-mass spectrometry and H-1 NMR). O. melastigma L-hyosophorin was found to contain two types of large, branched tetraantennary glycan units capped with sialic acids. The two glycans differ with respect to the branching pattern of the trimannosyl core (x = 4 or 6 in Eq. A). [GRAPHICS] The possible physiological significance of the hyosophorin family is discussed in the light of their unique structural features.	UNIV TOKYO, FAC SCI, DEPT BIOPHYS & BIOCHEM, HONGO 7, TOKYO 113, JAPAN; SHOWA UNIV, SCH PHARMACEUT SCI, TOKYO 142, JAPAN; AICHI UNIV EDUC, DEPT BIOL, KARIYA 448, JAPAN; UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED, DEPT BIOCHEM, LONDON SW7 2AZ, ENGLAND	University of Tokyo; Showa University; Aichi University Education; Imperial College London			Khoo, Kay-Hooi/E-1989-2019	Khoo, Kay-Hooi/0000-0003-2906-406X; Taguchi, Tomohiko/0000-0003-0464-6370	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AMINOFF D, 1961, BIOCHEM J, V81, P384, DOI 10.1042/bj0810384; BROCKHAUSEN I, 1989, J BIOL CHEM, V264, P11211; CHAN A L, 1991, Glycobiology, V1, P173, DOI 10.1093/glycob/1.2.173; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FUKUDA M, 1981, P NATL ACAD SCI-BIOL, V78, P6299, DOI 10.1073/pnas.78.10.6299; FUKUDA MN, 1985, J BIOL CHEM, V260, P6623; Gray W R, 1972, Methods Enzymol, V25, P121, DOI 10.1016/S0076-6879(72)25010-8; HAKOMORI S, 1982, TERATOCARCINOMA EMBR, P179; HAKOMORI SI, 1964, J BIOCHEM-TOKYO, V55, P205; HEINRIKSON RL, 1984, ANAL BIOCHEM, V136, P65, DOI 10.1016/0003-2697(84)90307-5; INOUE S, 1987, DEV BIOL, V123, P442, DOI 10.1016/0012-1606(87)90402-7; INOUE S, 1986, J BIOL CHEM, V261, P5256; INOUE S, 1989, J BIOL CHEM, V264, P18520; INOUE S, 1978, BIOCHEM BIOPH RES CO, V83, P1018, DOI 10.1016/0006-291X(78)91497-3; INOUE S, 1979, CARBOHYD RES, V74, P361, DOI 10.1016/S0008-6215(00)84795-3; INOUE S, 1980, BIOCHEM BIOPH RES CO, V93, P162, DOI 10.1016/S0006-291X(80)80260-9; ISHII K, 1989, J BIOL CHEM, V264, P1623; IWASAKI M, 1984, BIOCHEM INT, V8, P573; IWASAKI M, 1984, BIOCHEMISTRY-US, V23, P305, DOI 10.1021/bi00297a020; Iwasaki M., 1985, GLYCOCONJUGATE J, V2, P209, DOI [10.1007/BF01049269, DOI 10.1007/BF01049269]; IWASAKI M, 1992, IN PRESS J BIOL CHEM; KAMADA Y, 1987, EUR J BIOCHEM, V163, P497, DOI 10.1111/j.1432-1033.1987.tb10896.x; KITAJIMA K, 1989, DEV BIOL, V132, P544, DOI 10.1016/0012-1606(89)90249-2; KITAJIMA K, 1986, J BIOL CHEM, V261, P5262; KITAJIMA K, 1988, BIOCHEMISTRY-US, V27, P7141, DOI 10.1021/bi00418a071; KITAJIMA K, 1988, J BIOL CHEM, V263, P18269; KITAJIMA K, 1984, BIOCHEMISTRY-US, V23, P310, DOI 10.1021/bi00297a021; LEVERY SB, 1987, METHOD ENZYMOL, V138, P13, DOI 10.1016/0076-6879(87)38004-8; MORI E, 1991, BIOCHEMISTRY-US, V30, P2078, DOI 10.1021/bi00222a012; NADANO D, 1986, J BIOL CHEM, V261, P1550; NOGUCHI S, 1992, EUR J BIOCHEM, V204, P1089, DOI 10.1111/j.1432-1033.1992.tb16733.x; NOMOTO H, 1982, ARCH BIOCHEM BIOPHYS, V218, P335, DOI 10.1016/0003-9861(82)90352-6; OHYAMA Y, 1985, J BIOL CHEM, V260, P6882; PARENTE JP, 1982, J BIOL CHEM, V257, P13173; Segrest J P, 1971, Biochem Biophys Res Commun, V44, P390; RUTISHAUSER U, 1989, NEUROBIOLOGY GLYCOCO, P367; SASAKI H, 1987, J BIOL CHEM, V262, P12059; Schuel H., 1985, BIOL FERTILIZATION, V3, P1; SEKO A, 1989, J BIOL CHEM, V264, P15922; SHIMAMURA M, 1984, BIOCHEMISTRY-US, V23, P317, DOI 10.1021/bi00297a022; SHIMAMURA M, 1984, BIOCHEMISTRY-US, V22, P959; SVENNERHOLM L, 1963, METHOD ENZYMOL, V6, P459, DOI 10.1016/0076-6879(63)06206-6; THORPE SJ, 1988, DEVELOPMENT, V102, P193; UCHIDA Y, 1977, J BIOCHEM-TOKYO, V82, P1425, DOI 10.1093/oxfordjournals.jbchem.a131830; VLIEGENTHART JFG, 1983, ADV CARBOHYD CHEM BI, V41, P209, DOI 10.1016/S0065-2318(08)60059-1; YAMASHITA K, 1983, J BIOL CHEM, V258, P3099; YAMASHITA K, 1982, J BIOL CHEM, V257, P2809; YANG PF, 1992, J CELL BIOL, V116, P1487, DOI 10.1083/jcb.116.6.1487; YUREWICZ EC, 1987, J BIOL CHEM, V262, P564	50	42	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2353	2362						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8381405				2022-12-27	WOS:A1993KK81500019
J	MATTER, N; RITZ, MF; FREYERMUTH, S; ROGUE, P; MALVIYA, AN				MATTER, N; RITZ, MF; FREYERMUTH, S; ROGUE, P; MALVIYA, AN			STIMULATION OF NUCLEAR-PROTEIN KINASE-C LEADS TO PHOSPHORYLATION OF NUCLEAR INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR AND ACCELERATED CALCIUM RELEASE BY INOSITOL 1,4,5-TRISPHOSPHATE FROM ISOLATED RAT-LIVER NUCLEI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECONSTITUTED LIPID VESICLES; TRISPHOSPHATE RECEPTOR; METABOLIZING ENZYMES; SOLUBILIZATION; PURIFICATION; BRAIN; 1,3,4,5-TETRAKISPHOSPHATE; EXPRESSION; SEPARATION; BINDING	Rat liver nuclei inositol 1,4,5-trisphosphate receptor (Malviya, A. N., Rogue, P., and Vincendon, G. (1990) Proc. Natl. Acad. Sci U. S. A. 87, 9270-9274) is identified as a 220-kDa protein on Western blotting employing two types of antibodies (anti-goat and anti-rabbit) raised against purified rat brain inositol 1,4,5-trisphosphate receptor (IP3R). Nuclear IP3R does not seem identical with microsomal IP3R in rat liver. Treatment of isolated rat liver nuclei with 12-O-tetradecanoylphorbol-13-acetate stimulates native protein kinase C activity severalfold. Nuclear IP3R is phosphorylated by stimulated protein kinase C, with accelerated as well as enhanced maximum (Ca2+)-C-45 release by inositol 1,4,5-trisphosphate from isolated nuclei, without altering 1,4,5-trisphosphate binding characteristics (K(D) and B(max)). Stimulation of nuclear protein kinase C is found physiologically relevant since lamin B2, a nuclear protein, is concomitantly phosphorylated. These data deal with functional consequences of nuclear IP3R phosphorylation by native protein kinase C in isolated rat liver nuclei. It is postulated that phosphorylation of nuclear IP3R, probably dephosphorylation also, subserves a key mechanism in nuclear calcium homeostasis.	CNRS,CTR NEUROCHIM,NEUROBIOL MOLEC INTERACT CELLULAIRES LAB,5 RUE BLAISE PASCAL,F-67084 STRASBOURG,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg								BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCKLEY AR, 1988, P NATL ACAD SCI USA, V85, P8649, DOI 10.1073/pnas.85.22.8649; CHADWICK CC, 1990, P NATL ACAD SCI USA, V87, P2132, DOI 10.1073/pnas.87.6.2132; COMBETTES L, 1992, FEBS LETT, V301, P287, DOI 10.1016/0014-5793(92)80258-I; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; FERRIS CD, 1992, J BIOL CHEM, V267, P7036; FERRIS CD, 1990, P NATL ACAD SCI USA, V87, P2147, DOI 10.1073/pnas.87.6.2147; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; HINEGARDNER RT, 1971, ANAL BIOCHEM, V39, P197, DOI 10.1016/0003-2697(71)90476-3; JACOB R, 1988, NATURE, V335, P40, DOI 10.1038/335040a0; LANINI L, 1992, J BIOL CHEM, V267, P11548; MALVIYA AN, 1992, TRENDS BIOCHEM SCI, V17, P176, DOI 10.1016/0968-0004(92)90259-C; MALVIYA AN, 1990, P NATL ACAD SCI USA, V87, P9270, DOI 10.1073/pnas.87.23.9270; MASMOUDI A, 1989, J BIOL CHEM, V264, P1172; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MIYAWAKI A, 1990, NEURON, V5, P11, DOI 10.1016/0896-6273(90)90029-F; MOUREY RJ, 1990, BIOCHEM J, V272, P383, DOI 10.1042/bj2720383; NAKAGAWA T, 1991, P NATL ACAD SCI USA, V88, P6244, DOI 10.1073/pnas.88.14.6244; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; QUINTON TM, 1992, BIOCHEM BIOPH RES CO, V184, P893, DOI 10.1016/0006-291X(92)90675-B; ROGUE P, 1990, J BIOL CHEM, V265, P4161; ROSS C A, 1991, Society for Neuroscience Abstracts, V17, P18; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; THEIBERT AB, 1990, BIOCHEM J, V267, P441, DOI 10.1042/bj2670441; THEIBERT AB, 1992, J BIOL CHEM, V267, P9071; THEIBERT AB, 1992, BIOCHEM J, V267, P9071; VOLPE P, 1990, AM J PHYSIOL, V258, pC1086, DOI 10.1152/ajpcell.1990.258.6.C1086; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0	35	136	139	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					732	736						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380171				2022-12-27	WOS:A1993KE60300110
J	SCHLAME, M; HALDAR, D				SCHLAME, M; HALDAR, D			CARDIOLIPIN IS SYNTHESIZED ON THE MATRIX SIDE OF THE INNER MEMBRANE IN RAT-LIVER MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; BEEF-HEART MITOCHONDRIA; OUTER-MEMBRANE; CYTOCHROME-C; PRECURSOR PROTEIN; LIPID-COMPOSITION; PHOSPHOLIPIDS; BINDING; REQUIREMENT; CARRIER	In the mitochondrial inner membrane, cardiolipin is a specific lipid component associated with various protein complexes. The assembly of such complexes has been studied, and it seems that most protein subunits enter the inner membrane from the matrix side, but nothing is known about the path of cardiolipin. In this paper, the topography of cardiolipin biosynthesis is investigated. Cardiolipin synthase, a membrane-bound protein, could not be released by sonication or 1 M KCl. In sucrose density gradient subfractionation, cardiolipin synthase co-migrated with the inner membrane marker cytochrome oxidase. No indication was obtained for a preferential localization of this enzyme at contact sites between the outer and inner membranes. Protease digestion experiments showed that cardiolipin synthase exposed protease-susceptible domains mainly to the matrix side of the inner membrane. In intact mitochondria, the Mn2+-dependent stimulation of cardiolipin synthesis was abolished when the Mn2+ influx into the matrix was blocked by ruthenium red. 1-Decanoyl-sn-glycero-3-phosphorylcholine, a water-soluble inhibitor of cardiolipin synthase, was only effective after disintegration of mitochondria. The metabolic precursor of cardiolipin, CDP-diacylglycerol, was synthesized by an inner membrane enzyme whose protease-susceptible domains were mainly exposed to the matrix side. It is concluded that cardiolipin is synthesized in the inner leaflet of the mitochondrial inner membrane.			SCHLAME, M (corresponding author), ST JOHNS UNIV,DEPT BIOL SCI,JAMAICA,NY 11439, USA.							ARDAIL D, 1990, J BIOL CHEM, V265, P18797; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRANDT M, 1991, ARCH BIOCHEM BIOPHYS, V290, P14, DOI 10.1016/0003-9861(91)90585-7; BRINDLEY DN, 1982, PHOSPHOLIPIDS, P179; CHENEVAL D, 1985, J BIOL CHEM, V260, P3003; EBLE KS, 1990, J BIOL CHEM, V265, P19434; ENDO T, 1988, EMBO J, V7, P1153, DOI 10.1002/j.1460-2075.1988.tb02925.x; ENDO T, 1989, J BIOL CHEM, V264, P2951; FRY M, 1981, J BIOL CHEM, V256, P1874; Greenawalt J W, 1974, Methods Enzymol, V31, P310; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; Helenius A, 1979, Methods Enzymol, V56, P734; HESLER CB, 1985, J BIOL CHEM, V260, P7452; HOSTETLER KY, 1972, BIOCHIM BIOPHYS ACTA, V260, P380, DOI 10.1016/0005-2760(72)90052-5; HOSTETLER KY, 1975, BIOCHIM BIOPHYS ACTA, V380, P382, DOI 10.1016/0005-2760(75)90106-X; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; KADENBACH B, 1982, FEBS LETT, V139, P109, DOI 10.1016/0014-5793(82)80498-5; KREBS JJR, 1979, J BIOL CHEM, V254, P5308; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MULLER M, 1985, J BIOL CHEM, V260, P3839; NEUPERT W, 1990, CELL, V63, P447, DOI 10.1016/0092-8674(90)90437-J; OU WJ, 1988, J BIOCHEM-TOKYO, V103, P589, DOI 10.1093/oxfordjournals.jbchem.a122312; ROBINSON NC, 1990, BIOCHEMISTRY-US, V29, P8962, DOI 10.1021/bi00490a012; SCHLAME M, 1991, J BIOL CHEM, V266, P22398; SCHLAME M, 1991, ANAL BIOCHEM, V195, P290, DOI 10.1016/0003-2697(91)90332-N; SCHLAME M, 1992, METHOD ENZYMOL, V209, P330; SCHLAME M, 1990, BIOCHEM J, V272, P589, DOI 10.1042/bj2720589; SCHLAME M, 1990, BIOCHEM J, V265, P79, DOI 10.1042/bj2650079; SCHLAME M, 1991, EUR J BIOCHEM, V199, P459, DOI 10.1111/j.1432-1033.1991.tb16144.x; SCHLAME M, 1985, BIOMED BIOCHIM ACTA, V44, P1083; SPOONER PJR, 1991, BIOCHEMISTRY-US, V30, P3871, DOI 10.1021/bi00230a010; TABOR CW, 1955, METHOD ENZYMOL, V2, P390, DOI 10.1016/S0076-6879(55)02218-0; TAMM LK, 1991, BIOCHIM BIOPHYS ACTA, V1071, P123, DOI 10.1016/0304-4157(91)90021-N; VANCE JE, 1990, J BIOL CHEM, V265, P7248; WOJTCZAK L, 1990, BIOCHIM BIOPHYS ACTA, V1044, P284, DOI 10.1016/0005-2760(90)90315-O; YONETANI T, 1965, J BIOL CHEM, V240, P3392; YUE WH, 1991, BIOCHEMISTRY-US, V30, P2303, DOI 10.1021/bi00223a002	40	130	131	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					74	79						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380172				2022-12-27	WOS:A1993KE60300013
J	VANDERNEUT, R; PANTALONI, C; NEBOUT, I; BOCKAERT, J; AUDIGIER, Y				VANDERNEUT, R; PANTALONI, C; NEBOUT, I; BOCKAERT, J; AUDIGIER, Y			MUTAGENESIS OF THE AMINO-TERMINAL GLYCINE TO ALANINE IN GS-ALPHA SUBUNIT ALTERS BETA-GAMMA-DEPENDENT PROPERTIES AND DECREASES ADENYLYLCYCLASE ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD OUTER SEGMENTS; ADENYLATE-CYCLASE; BINDING PROTEIN; MEMBRANE ASSOCIATION; MYRISTOYLATION; TRANSDUCIN; RECONSTITUTION; ANCHORAGE; REGION	Proteolytic removal and genetic deletion of the amino-terminal domain of G protein alpha subunit have shown that this region is necessary for interaction with betagamma subunits. In the alpha subunits which undergo myristoylation, myristoylation of the amino-terminal glycine modulates the affinity of alpha subunit for the betagamma complex. To determine the role of the same glycine in nonmyristoylated alpha subunits, we substituted it for alanine in G(s)alpha and characterized the properties of the mutated chain G2A G(s)alpha. The mutant could still bind guanosine 5'-(3-O-thio)triphosphate (GTPgammaS) as revealed by its resistance to trypsin proteolysis and was able to interact with the membrane. However, G2A G(s)alpha was a poor substrate for cholera toxin-catalyzed ADP-ribosylation either in the soluble form or when membrane-associated. Addition of betagamma subunits increased the sedimentation rate of G2A G(s)alpha in sucrose gradients. Binding experiments performed on cyc- membranes reconstituted by G2A G(s)alpha showed that the GTP-induced shift of isoproterenol affinity for the beta-adrenergic receptors was reduced. On the same membranes, isoproterenol, GTPgammaS and NaF were 2-fold less effective for activating adenylylcyclase when compared to cyc- membranes reconstituted by G(s)alpha. This differential stimulation of adenylylcyclase was not due to an affinity change for the effector but to a decrease in the maximal activation. Thus the G2A substitution affected betagamma-dependent properties on reconstituted membranes such as receptor coupling and cholera toxin-catalyzed ADP-ribosylation and we propose that the decreased activation of adenylylcyclase might result from the same defect. Although not essential for association with betagamma subunits, the amino-terminal glycine of nonmyristoylated G(s)alpha might play a modulatory role in this interaction.	CNRS,INSERM,RUE CARDONILLE,F-34094 MONTPELLIER 5,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier								AUDIGIER Y, 1990, J CELL BIOL, V111, P1427, DOI 10.1083/jcb.111.4.1427; BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; BIRNBAUMER L, 1987, KIDNEY INT, V32, pS14; BLUMER KJ, 1990, P NATL ACAD SCI USA, V87, P4363, DOI 10.1073/pnas.87.11.4363; BOCKAERT J, 1985, EMBO J, V4, P1413, DOI 10.1002/j.1460-2075.1985.tb03795.x; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BUSS JE, 1987, P NATL ACAD SCI USA, V84, P7493, DOI 10.1073/pnas.84.21.7493; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; FUNG BKK, 1983, J BIOL CHEM, V258, P503; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; JONES DT, 1987, J BIOL CHEM, V262, P14241; JONES TLZ, 1990, P NATL ACAD SCI USA, V87, P568, DOI 10.1073/pnas.87.2.568; JOURNOT L, 1989, FEBS LETT, V251, P230, DOI 10.1016/0014-5793(89)81460-7; JOURNOT L, 1991, J BIOL CHEM, V266, P9009; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDER ME, 1991, J BIOL CHEM, V266, P4654; MARBACH I, 1990, J BIOL CHEM, V265, P9999; MILLER RT, 1988, NATURE, V334, P712, DOI 10.1038/334712a0; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; NAVON SE, 1987, J BIOL CHEM, V262, P15746; NEER EJ, 1988, J BIOL CHEM, V263, P8996; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; WATKINS PA, 1985, J BIOL CHEM, V260, P3478; YI F, 1991, J BIOL CHEM, V266, P3900	26	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					436	441						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380163				2022-12-27	WOS:A1993KE60300067
J	BERETTA, L; DOBRANSKY, T; SOBEL, A				BERETTA, L; DOBRANSKY, T; SOBEL, A			MULTIPLE PHOSPHORYLATION OF STATHMIN - IDENTIFICATION OF 4 SITES PHOSPHORYLATED IN INTACT-CELLS AND IN-VITRO BY CYCLIC-AMP-DEPENDENT PROTEIN-KINASE AND P34CDC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; NEURON-ENRICHED PHOSPHOPROTEIN; 2 CYTOSOLIC PROTEINS; RAPID PHOSPHORYLATION; SIGNAL TRANSDUCTION; GENE FAMILY; ACTIVATION; EXPRESSION; BRAIN; REGULATIONS	Stathmin is a ubiquitous, highly conserved phosphoprotein which most likely acts as a relay integrating various intracellular pathways regulating cell proliferation, differentiation, and functions. At least 14 molecular forms of stathmin have been identified so far, which migrate as 2 unphosphorylated and 12 increasingly phosphorylated spots (M(r) = 19,000-23,000; pI = 6.2-5.6) on two-dimensional electrophoretic gels, and whose pattern may reflect the state of activation of cells. We found that stathmin could be phosphorylated in vitro by at least three different protein kinases: cAMP-dependent protein kinase, p34cdc2, and casein kinase II. cAMP-dependent protein kinase catalyzed the phosphorylation of stathmin on serines 16 (K-R-A-S) and 63 (R-R-K-S), whereas p34cdc2 induced phosphorylation on serines 25 (I-L-S-P-R) and 38 (P-L-S-P-P-K-K-K). Interestingly, phosphorylation by both kinases together yielded all of the phosphoforms of stathmin identified so far. Two-dimensional phosphopeptide analysis allowed us to demonstrate that the same four sites were exclusively found to be phosphorylated in vivo, in brain tissue as well as in control or nerve growth factor-stimulated PC12 cells. In this latter case, the major site phosphorylated in response to nerve growth factor being serine 25, it is likely that a kinase such as a mitogen-activated protein kinase, known to be activated by growth factors, might directly phosphorylate stathmin. The phosphopeptide map analysis allowed further identification of the specific combinations among the four sites whose phosphorylation is responsible for the characteristic two-dimensional polyacrylamide gel electrophoresis migration of the resulting stathmin forms both in vitro and in vivo and revealed the existence of likely structural interactions between the sites phosphorylated. In conclusion, our results show that phosphorylation of serines 16, 25, 38, and 63 accounts for all of the major functional stathmin forms observed in vivo. The present identification of these sites will foster a better understanding of some intracellular mechanisms involved in the diverse physiological regulation of the proliferation, differentiation, and functions of cells, including the role of stathmin in these processes as a relay integrating diverse signaling pathways.	CNRS, URA 614, INSERM, U153, 17 RUE FER MOULIN, F-75005 PARIS, FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)				Laura, Beretta/0000-0002-2054-684X				ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; BERETTA L, 1989, ENDOCRINOLOGY, V125, P1358, DOI 10.1210/endo-125-3-1358; BERETTA L, 1988, ENDOCRINOLOGY, V122, P40, DOI 10.1210/endo-122-1-40; BERETTA L, 1989, J BIOL CHEM, V264, P9932; CHNEIWEISS H, 1989, J NEUROCHEM, V53, P856, DOI 10.1111/j.1471-4159.1989.tb11783.x; CHNIEWEISS H, 1992, J NEUROCHEM, V58, P282; COOPER HL, 1991, J IMMUNOL, V146, P3689; COUNTAWAY JL, 1989, J BIOL CHEM, V264, P10828; DOVE V, 1991, THESIS U PARIS; DOYE V, 1992, DIFFERENTIATION, V50, P89, DOI 10.1111/j.1432-0436.1992.tb00489.x; DOYE V, 1989, J BIOL CHEM, V264, P12134; DOYE V, 1990, J BIOL CHEM, V265, P11650; DOYE V, 1992, BIOCHEM J, V287, P549, DOI 10.1042/bj2870549; EDMAN P, 1950, ACTA CHEM SCAND, V4, P183; FEUERSTEIN N, 1985, CANCER RES, V45, P3243; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; GOTOH Y, 1990, FEBS LETT, P661; GUILLBERG M, 1990, J BIOL CHEM, V265, P17499; HAILAT N, 1990, ONCOGENE, V5, P1615; HEMMINGS HC, 1984, J BIOL CHEM, V259, P4491; KOPPEL J, 1990, J BIOL CHEM, V265, P3703; LABBE JC, 1989, EMBO J, V8, P3053, DOI 10.1002/j.1460-2075.1989.tb08456.x; LABDON JE, 1992, J BIOL CHEM, V267, P3506; LEGOUVELLO S, 1991, FEBS LETT, V287, P80, DOI 10.1016/0014-5793(91)80020-4; LEIGHTON I, 1993, IN PRESS MOL CELL BI; LOPEZBRIONES LG, 1990, EXP EYE RES, V51, P277, DOI 10.1016/0014-4835(90)90024-O; MARY D, 1989, J BIOL CHEM, V264, P14498; MAUCER A, 1991, J CELL BIOL, V115, P53; MAUCUER A, 1990, FEBS LETT, V264, P275, DOI 10.1016/0014-5793(90)80266-L; MAUCUER A, 1993, J BIOL CHEM, V268, P16420; NORTHWOOD IC, 1990, P NATL ACAD SCI USA, V87, P6107, DOI 10.1073/pnas.87.16.6107; PAMPFER S, 1992, REPROD FERT DEVELOP, V4, P205, DOI 10.1071/RD9920205; PASMANTIER R, 1986, ENDOCRINOLOGY, V19, P1229; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PEYRON JF, 1989, BIOCHEM J, V258, P505, DOI 10.1042/bj2580505; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; SCHUBART UK, 1988, J BIOL CHEM, V263, P12156; SCHUBART UK, 1989, DNA-J MOLEC CELL BIO, V8, P389, DOI 10.1089/dna.1.1989.8.389; SCHUBART UK, 1987, J BIOL CHEM, V262, P11871; SOBEL A, 1983, J BIOL CHEM, V258, P312; SOBEL A, 1989, J BIOL CHEM, V264, P3765; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; STRAHLER JR, 1992, J IMMUNOL, V149, P1191; TOUTANT M, 1987, DEV BIOL, V124, P370, DOI 10.1016/0012-1606(87)90489-1	44	157	161	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20076	20084						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376365				2022-12-27	WOS:A1993LY01900026
J	SCHWARTZ, MA; BROWN, EJ; FAZELI, B				SCHWARTZ, MA; BROWN, EJ; FAZELI, B			A 50-KDA INTEGRIN-ASSOCIATED PROTEIN IS REQUIRED FOR INTEGRIN-REGULATED CALCIUM-ENTRY IN ENDOTHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PHOSPHORYLATION; ADHESION; FAMILY	A 50-kDa integrin-associated protein (IAP), identified by its role in activation of neutrophils by extracellular matrix proteins, has recently been found to have a primary sequence that predicts five transmembrane domains, raising the possibility that the protein participates in ion transport. In endothelial cells, extracellular matrix proteins and anti-integrin antibodies have been shown to trigger an influx of [Ca2+]i via voltage-independent membrane channels. We now show that monoclonal antibodies to IAP that block neutrophil activation completely inhibited the fibronectin-stimulated rise in [Ca2+]i in endothelial cells. An antibody that binds IAP but does not block neutrophil function had no effect on endothelial cell [Ca2+]i. Inhibition of IAP function had no effect on endothelial cell adhesion, no effect on the integrin-mediated rise in intracellular pH, and no effect on the integrin-mediated increase in tyrosine phosphorylation. In addition, inhibition of IAP had no effect on the influx of Ca2+ triggered by histamine. These results demonstrate that IAP is specifically required for the integrin-regulated calcium influx and suggest that IAP itself might be an integrin-associated calcium channel.	WASHINGTON UNIV, DEPT INTERNAL MED, DIV INFECT DIS, ST LOUIS, MO 63110 USA	Washington University (WUSTL)	SCHWARTZ, MA (corresponding author), SCRIPPS RES INST, COMM VASC BIOL, LA JOLLA, CA 92037 USA.			schwartz, martin/0000-0002-2071-1243	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038330, R01GM047214] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL48728] Funding Source: Medline; NIGMS NIH HHS [R01 GM38330, R01 GM47214] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BROWN E, 1990, J CELL BIOL, V111, P2785, DOI 10.1083/jcb.111.6.2785; Damsky CH, 1991, CURR OPIN CELL BIOL, V3, P777, DOI 10.1016/0955-0674(91)90049-5; FAULL RJ, 1993, J CELL BIOL, V121, P155, DOI 10.1083/jcb.121.1.155; GRESHAM HD, 1989, J CELL BIOL, V108, P1935, DOI 10.1083/jcb.108.5.1935; GUAN JL, 1991, CELL REGUL, V2, P951, DOI 10.1091/mbc.2.11.951; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; LEAVESLEY DI, 1993, J CELL BIOL, V121, P163, DOI 10.1083/jcb.121.1.163; RYBAK MEM, 1989, J BIOL CHEM, V264, P14617; SCHWARTZ M A, 1992, Trends in Cell Biology, V2, P304, DOI 10.1016/0962-8924(92)90120-C; SCHWARTZ MA, 1993, J CELL BIOL, V120, P1003, DOI 10.1083/jcb.120.4.1003; SCHWARTZ MA, 1990, J BIOL CHEM, V265, P1327	14	147	159	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					19931	19934						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376355				2022-12-27	WOS:A1993LY01900005
J	KEIL, P; WEINZIERL, A; KIEBLER, M; DIETMEIER, K; SOLLNER, T; PFANNER, N				KEIL, P; WEINZIERL, A; KIEBLER, M; DIETMEIER, K; SOLLNER, T; PFANNER, N			BIOGENESIS OF THE MITOCHONDRIAL RECEPTOR COMPLEX - 2 RECEPTORS ARE REQUIRED FOR BINDING OF MOM38 TO THE OUTER-MEMBRANE SURFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTEIN IMPORT; YEAST MITOCHONDRIA; PRECURSOR PROTEINS; PROCESSING PROTEASE; TRANSLOCATION; INSERTION; IDENTIFICATION; RECOGNITION; VIABILITY; CARRIER	Targeting of preproteins to mitochondria is mediated by the receptor complex in the outer membrane that contains two import receptors and the general insertion pore with MOM38 (38-kDa mitochondrial outer membrane protein) as major constituent. As all components of the receptor complex have to be imported from the cytosol themselves, the specificity of their targeting is fundamental for the correct assembly of mitochondria. None of the receptors is involved in its own import; the precursor of the main receptor MOM19 is even targeted without any surface receptor but directly assembles with MOM38. We report that import of the precursor of MOM38 strictly depended on surface receptors. The import followed a new highly selective mechanism in that both receptors together were needed for the specific binding of the preprotein to the outer membrane surface, which was followed by its assembly into the receptor complex. These findings suggest that targeting of the mitochondrial targeting components involves a complex system of mutual specificity control, ensuring a selective assembly of the components into preexisting import sites.	UNIV FREIBURG, INST BIOCHEM, HERMANN HERDER STR 7, W-7800 FREIBURG, GERMANY; SLOAN KETTERING INST CANC RES, NEW YORK, NY 10021 USA; UNIV MUNICH, INST PHYSIOL CHEM, D-80336 MUNICH, GERMANY	University of Freiburg; Memorial Sloan Kettering Cancer Center; University of Munich			Pfanner, Nikolaus/AAV-7878-2021	Kiebler, Michael/0000-0002-8850-6297				ANDREWS DW, 1989, J CELL BIOL, V108, P797, DOI 10.1083/jcb.108.3.797; BAKER KP, 1990, NATURE, V348, P605, DOI 10.1038/348605a0; BAKER KP, 1991, NATURE, V349, P205, DOI 10.1038/349205a0; CHENG MY, 1990, NATURE, V348, P455, DOI 10.1038/348455a0; DOUGLAS MG, 1986, MICROBIOL REV, V50, P166, DOI 10.1128/MMBR.50.2.166-178.1986; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; HORTSCH M, 1988, BIOCHEM BIOPH RES CO, V150, P111, DOI 10.1016/0006-291X(88)90493-7; Horwich A, 1990, CURR OPIN CELL BIOL, V2, P625, DOI 10.1016/0955-0674(90)90103-L; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; KEIL P, 1993, FEBS LETT, V321, P197, DOI 10.1016/0014-5793(93)80107-6; KIEBLER M, 1990, NATURE, V348, P610, DOI 10.1038/348610a0; LI JM, 1992, BIOCHIM BIOPHYS ACTA, V1106, P233, DOI 10.1016/0005-2736(92)90001-3; MOCZKO M, 1992, FEBS LETT, V310, P265, DOI 10.1016/0014-5793(92)81345-M; PFANNER N, 1991, TRENDS BIOCHEM SCI, V16, P63, DOI 10.1016/0968-0004(91)90026-R; RAPOPORT TA, 1992, SCIENCE, V258, P931, DOI 10.1126/science.1332192; SCHNEIDER H, 1990, J BIOL CHEM, V265, P9881; SCHNEIDER H, 1991, SCIENCE, V254, P1689; SOLLNER T, 1992, NATURE, V355, P84, DOI 10.1038/355084a0; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; SOLLNER T, 1991, METHOD CELL BIOL, V34, P345; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353; WICKNER WT, 1985, SCIENCE, V230, P400, DOI 10.1126/science.4048938; WITTE C, 1988, EMBO J, V7, P1439, DOI 10.1002/j.1460-2075.1988.tb02961.x; YANG M, 1991, J BIOL CHEM, V266, P6416	25	45	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19177	19180						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366069				2022-12-27	WOS:A1993LW81900005
J	THORNTON, K; WANG, Y; WEINER, H; GORENSTEIN, DG				THORNTON, K; WANG, Y; WEINER, H; GORENSTEIN, DG			IMPORT, PROCESSING, AND 2-DIMENSIONAL NMR STRUCTURE OF A LINKER-DELETED SIGNAL PEPTIDE OF RAT-LIVER MITOCHONDRIAL ALDEHYDE DEHYDROGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; HYDROGEN-EXCHANGE KINETICS; F1-ATPASE BETA-SUBUNIT; M13 COAT PROTEIN; 12 AMINO-ACIDS; MEMBRANE-PROTEIN; SECONDARY STRUCTURE; TERMINAL DELETIONS; LEADER PEPTIDE; PRE-SEQUENCE	Previous NMR studies (Karslake, C., Piotto, M. E., Pak, Y. M., Weiner, H., and Gorenstein, D. G. (1990) Biochemistry 29, 9872-9878) had shown that a 22-amino acid signal peptide of rat liver aldehyde dehydrogenase (ALDH) when bound to a micelle had two amphiphilic alpha-helices, one located at the N terminus and the other at the C terminus. It was shown that deletion of either helix caused the precursor protein not to be imported (Wang, Y., and Weiner, H., (1993) J. Biol. Chem. 268, 4759-4765). The two helices are separated by a Arg-Gly-Pro flexible ''linker'' region, and to test the role of this linker region in the import and processing of the precursor protein, we deleted it from the ALDH signal peptide and precursor protein. The 19-amino acid signal peptide of ALDH, to which has been added 3 residues at the C terminus and from which has been deleted the 3-residue flexible linker region, has been studied by two-dimensional NMR in a dodecylphosphocholine micelle. In this membrane-like environment the peptide contains a single alpha-helical segment that extends almost the entire length of the peptide. NH exchange experiments show residues on the hydrophobic face of the peptide to exchange much more slowly than those of the hydrophilic face. Combined with the previous study, these results suggest that precursor protein import simply requires a sufficiently long amphiphilic helix (or helices) to bind stably to the membrane. The N and C helices of native ALDH are only about 6-8 residues long; this represents only about two turns of a helix, and either helix on its own does not provide enough stabilization to ensure folding and binding to the membrane. The linker-deleted ALDH peptide contains a single helix of 12-14 residues that is long enough to provide a hydrophobic surface that can stably interact with the hydrophobic interior of the membrane. The function of the C helix in the native signal peptide is therefore to enhance the stability and binding of the N-terminal signal to the membrane. Significantly, unlike native ALDH precursor protein, the linker-deleted signal peptide precursor protein could no longer be processed after import into mitochondria. As explained by modeling of the alpha-helix and the NH exchange rate data, the precursor protein requires that the first several residues of the mature protein be part of the hydrophobic membrane associated face of the helix. By removing 3 residues in the center of the helix, a phase shift of the amphiphilic helix has occurred, moving the first several residues of the mature protein toward the hydrophilic face. The proteolytic signal processing protein therefore appears unable to recognize these residues.	PURDUE UNIV,DEPT CHEM,W LAFAYETTE,IN 47907; PURDUE UNIV,DEPT BIOCHEM,W LAFAYETTE,IN 47907	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA005812, R01AA005812, R03AA008532] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA08532, AA05812] Funding Source: Medline; NIAID NIH HHS [AI27744] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BEDWELL DM, 1989, MOL CELL BIOL, V9, P1014, DOI 10.1128/MCB.9.3.1014; BEDWELL DM, 1987, MOL CELL BIOL, V7, P4038, DOI 10.1128/MCB.7.11.4038; BRAUN W, 1983, J MOL BIOL, V169, P921, DOI 10.1016/S0022-2836(83)80143-0; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; BRIGGS MS, 1985, SCIENCE, V228, P1096, DOI 10.1126/science.3158076; BRUCH MD, 1992, BIOCHIM BIOPHYS ACTA, V1159, P81, DOI 10.1016/0167-4838(92)90078-R; ENDO T, 1989, J BIOCHEM, V106, P396, DOI 10.1093/oxfordjournals.jbchem.a122864; ENGLANDER SW, 1984, Q REV BIOPHYS, V16, P521; EPAND RM, 1986, J BIOL CHEM, V261, P17; FURUYA S, 1991, EMBO J, V10, P1759, DOI 10.1002/j.1460-2075.1991.tb07700.x; GLASER SM, 1990, J BIOL CHEM, V265, P8817; HAHN U, 1985, EUR J BIOCHEM, V152, P481, DOI 10.1111/j.1432-1033.1985.tb09222.x; HALDI M, 1989, J BIOL CHEM, V264, P17107; HENRY GD, 1987, BIOCHEMISTRY-US, V26, P3619, DOI 10.1021/bi00386a055; HENRY GD, 1990, BIOCHEMISTRY-US, V29, P6303, DOI 10.1021/bi00478a027; HORWICH AL, 1986, CELL, V44, P451, DOI 10.1016/0092-8674(86)90466-6; HORWICH AL, 1985, EMBO J, V4, P1129, DOI 10.1002/j.1460-2075.1985.tb03750.x; HOYT DW, 1991, J BIOL CHEM, V266, P21693; HURT EC, 1985, EMBO J, V4, P3509, DOI 10.1002/j.1460-2075.1985.tb04110.x; HURT EC, 1987, J BIOL CHEM, V262, P1420; HURT EC, 1985, EMBO J, V4, P2061, DOI 10.1002/j.1460-2075.1985.tb03892.x; KARSLAKE C, 1990, BIOCHEMISTRY-US, V29, P9872, DOI 10.1021/bi00494a017; KUCHINKA E, 1989, BIOCHEMISTRY-US, V28, P4216, DOI 10.1021/bi00436a014; LANGRIDGE R, 1984, J MOL GRAPHICS, V2, P56, DOI 10.1016/0263-7855(84)80042-9; MCLEAN LR, 1991, BIOCHEMISTRY-US, V30, P31, DOI 10.1021/bi00215a005; MOLDAY RS, 1972, BIOCHEMISTRY-US, V11, P150, DOI 10.1021/bi00752a003; NIKONOWICZ E, 1989, BIOCHEMISTRY-US, V28, P8714, DOI 10.1021/bi00448a007; NISHI T, 1989, J BIOL CHEM, V264, P6944; ONEIL JDJ, 1989, BIOCHEMISTRY-US, V28, P699, DOI 10.1021/bi00428a043; ONO H, 1988, J BIOL CHEM, V263, P3188; PAK YK, 1990, J BIOL CHEM, V265, P14298; PFANNER N, 1988, TRENDS BIOCHEM SCI, V13, P165, DOI 10.1016/0968-0004(88)90140-5; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; PLGRIM D, 1986, MOL CELL BIOL, V7, P294; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; RODER H, 1985, BIOCHEMISTRY-US, V24, P7396, DOI 10.1021/bi00346a055; ROISE D, 1992, P NATL ACAD SCI USA, V89, P608, DOI 10.1073/pnas.89.2.608; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; ROISE D, 1988, EMBO J, V7, P649, DOI 10.1002/j.1460-2075.1988.tb02859.x; ROONGTA V, 1989, BIOCHEMISTRY-US, V28, P1048, DOI 10.1021/bi00429a019; SKERJANC IS, 1987, EMBO J, V6, P3117, DOI 10.1002/j.1460-2075.1987.tb02621.x; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; SWANSON ST, 1992, BIOCHEMISTRY-US, V31, P5746, DOI 10.1021/bi00140a009; TAMM LK, 1991, BIOCHIM BIOPHYS ACTA, V1071, P123, DOI 10.1016/0304-4157(91)90021-N; TAMM LK, 1986, BIOCHEMISTRY-US, V25, P7470, DOI 10.1021/bi00371a032; TAMM LK, 1990, FEBS LETT, V272, P29, DOI 10.1016/0014-5793(90)80441-K; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WANG TTY, 1989, ARCH BIOCHEM BIOPHYS, V272, P440, DOI 10.1016/0003-9861(89)90238-5; WANG Y, 1993, J BIOL CHEM, V268, P4759; WATSON MEE, 1984, NUCLEIC ACIDS RES, V12, P5145, DOI 10.1093/nar/12.13.5145; WEINER PK, 1981, J COMPUT CHEM, V2, P287, DOI 10.1002/jcc.540020311; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; Wuthrich K., 1986, NMR PROTEINS NUCL AC; YANG JT, 1986, METHOD ENZYMOL, V130, P208	57	68	70	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19906	19914						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366128				2022-12-27	WOS:A1993LW81900110
J	VARGA, AR; KAPLAN, S				VARGA, AR; KAPLAN, S			SYNTHESIS AND STABILITY OF REACTION-CENTER POLYPEPTIDES AND IMPLICATIONS FOR REACTION-CENTER ASSEMBLY IN RHODOBACTER-SPHAEROIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOPSEUDOMONAS-CAPSULATA; PUC OPERON; BACTERIOCHLOROPHYLL BIOSYNTHESIS; RHODOSPIRILLUM-CENTENUM; PROTEIN; EXPRESSION; COMPLEX; R-26; OXYGEN; GENES	The synthesis and stability of the H and M polypeptide subunits of the photosynthetic reaction center of Rhodobacter sphaeroides were examined. In wild-type cells, low levels of both M and H were found to be synthesized under aerobic growth conditions, with a 20-fold induction in their synthesis under anaerobic-dark growth conditions. Neither M nor H was stable in aerobic cells, but in anaerobic-dark grown cells stability increased dramatically with the t1/2 going from 4-6 min to values estimated in excess of 4 h. In the H-deficient mutant PUHA1, the synthesis and membrane partitioning of the M subunit were unaffected by the absence of the H subunit but there was a significant decrease in M polypeptide stability in the membranes of PUHA1 relative to wild-type cells. The stability of all or part of the M population in PUHA1 could be restored by providing an H-encoding plasmid in trans. It was also determined that the presence of bacteriochlorophyll in fully aerobic cells had a direct, positive effect on M and H stability, utilizing the oxygen-regulatory mutant strain T1a. Implications for the role of the H subunit and putative assembly factors in reaction center assembly are discussed.	UNIV TEXAS, HLTH SCI CTR, DEPT MICROBIOL & MOLEC GENET, HOUSTON, TX 77225 USA	University of Texas System; University of Texas Health Science Center Houston					NIGMS NIH HHS [GM15590] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P6162, DOI 10.1073/pnas.84.17.6162; BALTSCHEFFSKY M, 1978, PHOTOSYNTHETIC BACTE, P595; BIEL AJ, 1983, J BACTERIOL, V156, P686, DOI 10.1128/JB.156.2.686-694.1983; CHORY J, 1984, J BACTERIOL, V159, P540, DOI 10.1128/JB.159.2.540-554.1984; COHENBAZIRE G, 1957, J CELL COMPAR PHYSL, V49, P25, DOI 10.1002/jcp.1030490104; DAVIS J, 1988, J BACTERIOL, V170, P320, DOI 10.1128/jb.170.1.320-329.1988; DEBUS RJ, 1985, BIOCHEMISTRY-US, V24, P2488, DOI 10.1021/bi00331a015; DIERSTEIN R, 1983, FEBS LETT, V160, P281, DOI 10.1016/0014-5793(83)80983-1; DIESENHOFER J, 1985, NATURE, V318, P619; DONOHUE TJ, 1986, ENCY PLANT PHYSL, V19, P632; DONOHUE TJ, 1986, J BACTERIOL, V168, P963; FEHER G, 1989, NATURE, V339, P111, DOI 10.1038/339111a0; Feher G., 1978, PHOTOSYNTHETIC BACTE, P349; GIBSON LCD, 1992, MOL MICROBIOL, V6, P3171, DOI 10.1111/j.1365-2958.1992.tb01773.x; HUNTER CN, 1988, J GEN MICROBIOL, V134, P1491; JACKSON WJ, 1987, FEBS LETT, V215, P171, DOI 10.1016/0014-5793(87)80135-7; KAPLAN S, 1990, FEMS SYMP, V53, P105; KILEY PJ, 1988, MICROBIOL REV, V52, P50, DOI 10.1128/MMBR.52.1.50-69.1988; KILEY PJ, 1987, J BACTERIOL, V169, P742, DOI 10.1128/jb.169.2.742-750.1987; KOMIYA H, 1988, P NATL ACAD SCI USA, V85, P9012, DOI 10.1073/pnas.85.23.9012; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE JK, 1992, J BACTERIOL, V174, P1158, DOI 10.1128/jb.174.4.1158-1171.1992; LEE JK, 1989, J BACTERIOL, V171, P3391, DOI 10.1128/jb.171.6.3391-3405.1989; MA D, 1993, J BACTERIOL, V175, P2037, DOI 10.1128/JB.175.7.2037-2045.1993; MICHEL H, 1986, EMBO J, V5, P2445, DOI 10.1002/j.1460-2075.1986.tb04520.x; MULLET JE, 1990, P NATL ACAD SCI USA, V87, P4038, DOI 10.1073/pnas.87.11.4038; OKAMURA MY, 1974, BIOCHEMISTRY-US, V13, P1394, DOI 10.1021/bi00704a013; PETERS J, 1983, BIOCHEMISTRY-US, V22, P5660, DOI 10.1021/bi00293a032; SMITH L, 1978, PHOTOSYNTHETIC BACTE, P641; SOCKETT RE, 1989, J BACTERIOL, V171, P426; TAKEMOTO J, 1973, P NATL ACAD SCI USA, V70, P799, DOI 10.1073/pnas.70.3.799; TICHY HV, 1989, J BACTERIOL, V171, P4914, DOI 10.1128/jb.171.9.4914-4922.1989; VARGA AR, 1989, J BACTERIOL, V171, P5830, DOI 10.1128/jb.171.11.5830-5839.1989; WILLIAMS J C, 1986, Proteins Structure Function and Genetics, V1, P312, DOI 10.1002/prot.340010405; YEN HC, 1977, ARCH BIOCHEM BIOPHYS, V181, P411, DOI 10.1016/0003-9861(77)90246-6; YILDIZ FH, 1991, J BACTERIOL, V173, P4163, DOI 10.1128/jb.173.13.4163-4170.1991; YILDIZ FH, 1992, MOL MICROBIOL, V6, P2683, DOI 10.1111/j.1365-2958.1992.tb01445.x; ZHU YS, 1986, J BIOL CHEM, V261, P366	38	26	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19842	19850						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366122				2022-12-27	WOS:A1993LW81900102
J	YOUNG, J; KANE, LP; EXLEY, M; WILEMAN, T				YOUNG, J; KANE, LP; EXLEY, M; WILEMAN, T			REGULATION OF SELECTIVE PROTEIN-DEGRADATION IN THE ENDOPLASMIC-RETICULUM BY REDOX POTENTIAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ANTIGEN RECEPTOR; PRE-GOLGI DEGRADATION; ASIALOGLYCOPROTEIN RECEPTOR; INTRACELLULAR DEGRADATION; AUTOPHAGIC VACUOLE; TRUNCATED FORMS; IL-2 RECEPTOR; ALPHA-CHAINS; BETA-CHAINS; CD3 COMPLEX	Recent studies show that the endoplasmic reticulum (ER) contains proteases, but it is not understood how these enzymes are regulated. In this report we study the selective ER degradation of the subunits (alphabetagammadeltaepsilonzeta) of the T-cell antigen receptor (TCR). When analyzed in vivo, unassembled subunits of the TCR fail to reach the Golgi apparatus and show a differential sensitivity to degradation after synthesis. The alpha, beta, and delta subunits are degraded rapidly, while gamma, epsilon, and zeta are stable. To study the regulation of proteolysis in more detail, beta, gamma, delta, and epsilon subunits were expressed alone in fibroblasts and their selective degradation analyzed in vitro. The beta and delta chains were degraded in the complete absence of vesicular transport, indicating their degradation in the ER membrane compartment. Proteolysis was unaffected by GTPgammaS (guanosine 5'-O-(thiotriphosphate)), EDTA, or depletion of ATP. They and epsilon subunits were stable under the same in vitro conditions, indicating that the assay reconstituted selective protein degradation within the ER. Furthermore, the results showed that the gamma and epsilon subunits did not escape degradation by being transported from the ER to pre-Golgi, or cis-Golgi, membrane compartments. Structural determinants of ER degradation contained within the membrane anchor of the TCR beta subunit were only active in permeabilized cells when reducing agents were added to the assay. Surprisingly, reducing conditions disrupted the regulation of ER proteolysis and induced rapid ER degradation of the stable CD3 gamma subunit and of a control interleukin 2 receptor chimera. Taken together, the results indicated that the ER membrane compartment regulates the selective degradation of newly synthesized proteins. Importantly, the stability of proteins retained in the ER was highly sensitive to redox conditions. It is possible that the redox buffer within the ER lumen may regulate ER protein degradation in vivo.	HARVARD UNIV, BETH ISRAEL HOSP,SCH MED,DEPT MED,DIV IMMUNOL, 218 RES E,330 BROOKLINE AVE, BOSTON, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School				Kane, Lawrence/0000-0001-5198-516X; Exley, Mark/0000-0002-5088-1032				ALARCON B, 1988, J BIOL CHEM, V263, P2953; AMARA JF, 1989, J CELL BIOL, V109, P3315, DOI 10.1083/jcb.109.6.3315; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; BECKERS CJM, 1990, J BIOL CHEM, V265, P18298; BECKERS CJM, 1987, CELL, V50, P523, DOI 10.1016/0092-8674(87)90025-0; BLUMBERG RS, 1990, J BIOL CHEM, V265, P14036; BONIFACINO J S, 1991, Current Opinion in Cell Biology, V3, P592, DOI 10.1016/0955-0674(91)90028-W; BONIFACINO JS, 1991, EMBO J, V10, P2783, DOI 10.1002/j.1460-2075.1991.tb07827.x; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; BONIFACINO JS, 1988, P NATL ACAD SCI USA, V85, P6929, DOI 10.1073/pnas.85.18.6929; BONIFACINO JS, 1989, J CELL BIOL, V109, P73, DOI 10.1083/jcb.109.1.73; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; BRAAKMAN I, 1992, NATURE, V356, P260, DOI 10.1038/356260a0; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; CARSON GR, 1991, J BIOL CHEM, V266, P7883; CHEN C, 1988, J CELL BIOL, V107, P2149, DOI 10.1083/jcb.107.6.2149; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; DESILVA A, 1993, J CELL BIOL, V120, P647, DOI 10.1083/jcb.120.3.647; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935; Exley M, 1991, Semin Immunol, V3, P283; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GRAHAM KS, 1990, J BIOL CHEM, V265, P20463; HALL C, 1991, INT IMMUNOL, V3, P359, DOI 10.1093/intimm/3.4.359; HSU VW, 1991, NATURE, V352, P441, DOI 10.1038/352441a0; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; INOUE S, 1992, J BIOL CHEM, V267, P9080; INOUE S, 1991, J BIOL CHEM, V266, P13311; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KONING F, 1988, J IMMUNOL, V140, P3126; KRISSANSEN GW, 1986, EMBO J, V5, P1799, DOI 10.1002/j.1460-2075.1986.tb04429.x; LE A, 1990, J BIOL CHEM, V265, P14001; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; LODISH HF, 1992, J BIOL CHEM, V267, P12753; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; NODA T, 1992, J CELL BIOL, V119, P85, DOI 10.1083/jcb.119.1.85; PESSANO S, 1985, EMBO J, V4, P337, DOI 10.1002/j.1460-2075.1985.tb03634.x; ROITELMAN J, 1991, J BIOL CHEM, V266, P16085; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; RUBIN LA, 1985, HYBRIDOMA, V4, P91, DOI 10.1089/hyb.1985.4.91; RUSK CM, 1988, J IMMUNOL, V140, P2249; SHAW E, 1990, ADV ENZYMOL RAMB, V63, P271; SHIN J, 1993, SCIENCE, V259, P1901, DOI 10.1126/science.8456316; STAFFORD FJ, 1991, J CELL BIOL, V115, P1225, DOI 10.1083/jcb.115.5.1225; TOOZE J, 1989, J CELL BIOL, V109, P35, DOI 10.1083/jcb.109.1.35; TSAO YS, 1992, J CELL BIOL, V116, P57, DOI 10.1083/jcb.116.1.57; VALETTI C, 1991, J CELL BIOL, V115, P983, DOI 10.1083/jcb.115.4.983; WEISSMAN AM, 1989, EMBO J, V8, P3651, DOI 10.1002/j.1460-2075.1989.tb08539.x; WIKSTROM L, 1992, J BIOL CHEM, V267, P5; WIKSTROM L, 1991, J CELL BIOL, V113, P997, DOI 10.1083/jcb.113.5.997; WILEMAN T, 1990, CELL REGUL, V1, P907, DOI 10.1091/mbc.1.12.907; WILEMAN T, 1991, J BIOL CHEM, V266, P4500; WILEMAN T, 1990, INT IMMUNOL, V2, P743, DOI 10.1093/intimm/2.8.743; WILEMAN T, 1990, J CELL BIOL, V110, P973, DOI 10.1083/jcb.110.4.973; WILEMAN T, 1993, J CELL BIOL, V122, P67, DOI 10.1083/jcb.122.1.67; WILEMAN T, 1991, CELL REGUL, V2, P753, DOI 10.1091/mbc.2.9.753	59	51	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19810	19818						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366119				2022-12-27	WOS:A1993LW81900098
J	EMMERMANN, M; BRAUN, HP; ARRETZ, M; SCHMITZ, UK				EMMERMANN, M; BRAUN, HP; ARRETZ, M; SCHMITZ, UK			CHARACTERIZATION OF THE BIFUNCTIONAL CYTOCHROME-C REDUCTASE-PROCESSING PEPTIDASE COMPLEX FROM POTATO MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT; INNER MEMBRANE; RAT-LIVER; INTERMEMBRANE SPACE; YEAST MITOCHONDRIA; CORE PROTEIN; BC1 COMPLEX; SUBUNIT-II; MATRIX; PURIFICATION	In potato, cytochrome c reductase, a protein complex of the respiratory chain, exhibits processing activity toward mitochondrial precursor proteins. One of the two cooperating components of the processing peptidase was shown to be identical with subunit III of the complex. Here we report that two additional proteins of the complex (subunit I and II) share 40-50% sequence identity with the processing enhancing protein, the other component of the processing enzyme from fungi and mammals. Thus the composition and structure of the complex integrated processing peptidase seems to be different from its fungal and mammalian counterparts. Cytochrome c reductase from potato is extraordinarily stable, and separation of subunit III from the complex leads to aggregation of the remaining subcomplex and irreversible loss of processing activity. Expression of the three high molecular weight subunits of the complex allowed purification of each individual protein. Neither the individual subunits nor their combinations are active in in vitro processing assays suggesting that they may need the structural support of the complex for activity. In contrast to mitochondrial processing peptidases from other organisms, the purified potato enzyme is active in the presence of high salt (above 1 M NaCl) and works efficiently without addition of metal ions. These data indicate that potato cytochrome c reductase is a bifunctional protein complex with unique features. Possibly, there is a more general evolutionary relationship between cytochrome c reductases and mitochondrial processing peptidases than hitherto assumed.	INST GENBIOL FORSCH BERLIN GMBH,IHNESTR 63,D-14195 BERLIN,GERMANY; UNIV MUNICH,INST PHYSIOL CHEM,W-8000 MUNICH 2,GERMANY	University of Munich			Braun, Hans-Peter/E-7149-2011	Braun, Hans-Peter/0000-0002-4459-9727				ARRETZ M, 1991, BIOMED BIOCHIM ACTA, V50, P403; BEHRENS M, 1991, MOL GEN GENET, V228, P167, DOI 10.1007/BF00282462; BOHNI P, 1980, ORG EXPRESSION MITOC, P423; BOUTRY M, 1985, EMBO J, V4, P2159, DOI 10.1002/j.1460-2075.1985.tb03910.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN HP, 1992, EUR J BIOCHEM, V208, P761, DOI 10.1111/j.1432-1033.1992.tb17245.x; BRAUN HP, 1992, MOL GEN GENET, V231, P217, DOI 10.1007/BF00279794; BRAUN HP, 1992, EMBO J, V11, P3219, DOI 10.1002/j.1460-2075.1992.tb05399.x; EMMERMANN M, 1991, CURR GENET, V20, P405, DOI 10.1007/BF00317069; GENCIC S, 1991, EUR J BIOCHEM, V199, P123, DOI 10.1111/j.1432-1033.1991.tb16099.x; GEORGOPOULOS C, 1990, STRESS PROTEINS BIOL, P191; Glick B, 1991, Trends Cell Biol, V1, P99, DOI 10.1016/0962-8924(91)90037-A; GRAACK HR, 1991, BIOCHIMIE, V73, P837, DOI 10.1016/0300-9084(91)90063-7; GRIVELL LA, 1989, EUR J BIOCHEM, V182, P477, DOI 10.1111/j.1432-1033.1989.tb14854.x; HARTL FU, 1990, SCIENCE, V247, P930, DOI 10.1126/science.2406905; Hatefi Y, 1974, Methods Enzymol, V31, P770; HAWLITSCHEK G, 1988, CELL, V53, P795, DOI 10.1016/0092-8674(88)90096-7; HOSOKAWA Y, 1989, J BIOL CHEM, V264, P13483; HWANG ST, 1991, J BIOL CHEM, V266, P21083; KALOUSEK F, 1988, P NATL ACAD SCI USA, V85, P7536, DOI 10.1073/pnas.85.20.7536; KALOUSEK F, 1992, EMBO J, V11, P2803, DOI 10.1002/j.1460-2075.1992.tb05347.x; KLEIBER J, 1990, P NATL ACAD SCI USA, V87, P7978, DOI 10.1073/pnas.87.20.7978; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINKE P, 1986, METHOD ENZYMOL, V126, P201; LOTTSPEICH F, 1985, TRAC-TREND ANAL CHEM, V4, P244, DOI 10.1016/0165-9936(85)87042-4; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; OU WJ, 1989, EMBO J, V8, P2605, DOI 10.1002/j.1460-2075.1989.tb08400.x; OUDSHOORN P, 1987, EUR J BIOCHEM, V163, P97, DOI 10.1111/j.1432-1033.1987.tb10741.x; PFANNER N, 1990, ANNU REV BIOCHEM, V59, P331, DOI 10.1146/annurev.bi.59.070190.001555; PFANNER N, 1992, CELL, V68, P999, DOI 10.1016/0092-8674(92)90069-O; RASSOW J, 1991, FEBS LETT, V293, P85, DOI 10.1016/0014-5793(91)81157-4; RIESKE JS, 1967, J BIOL CHEM, V242, P4854; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAGGER H, 1986, METHOD ENZYMOL, V126, P224; SCHNEIDER A, 1991, EMBO J, V10, P247, DOI 10.1002/j.1460-2075.1991.tb07944.x; SCHULTE U, 1989, NATURE, V339, P147, DOI 10.1038/339147a0; TZAGOLOFF A, 1986, J BIOL CHEM, V261, P7163; VERNER K, 1988, SCIENCE, V241, P1307, DOI 10.1126/science.2842866; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; YANG M, 1988, EMBO J, V7, P3857, DOI 10.1002/j.1460-2075.1988.tb03271.x; YANG M, 1991, J BIOL CHEM, V266, P6416	42	68	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18936	18942						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360183				2022-12-27	WOS:A1993LV65900084
J	HOGERVORST, F; KUIKMAN, I; NOTEBOOM, E; SONNENBERG, A				HOGERVORST, F; KUIKMAN, I; NOTEBOOM, E; SONNENBERG, A			THE ROLE OF PHOSPHORYLATION IN ACTIVATION OF THE ALPHA-6A-BETA-1 LAMININ RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CELL-ADHESION; T-CELLS; PROTEIN PHOSPHATASES; INTEGRIN RECEPTORS; ENHANCES ADHESION; MOLECULAR-CLONING; FRAGMENT E8; GPIIB-IIIA; SUBUNIT; ALPHA-6-BETA-1	The phorbol ester phorbol 12-myristate 13-acetate (PMA) induces phosphorylation of serine residues in the cytoplasmic domain of the alpha6A integrin subunit, as well as activation of the alpha6Abeta1 laminin receptor. We examined whether phosphorylation correlates with the induction of high affinity binding of laminin by the alpha6Abeta1 receptor. Two potential phosphorylation sites for protein kinase C, serine 1041 and serine 1048, are present in the cytoplasmic domain of the alpha6A subunit. We introduced point mutations into the alpha6A cDNA, replacing either one or both of the serine residues with alanine. Wild-type and mutant alpha6A cDNAs were transfected into K562 cells. All alpha6A subunit mutants were expressed at levels similar to those of wild-type alpha6A and formed heterodimers with endogenous beta1. Analysis of the phosphorylation state of wild-type and mutant alpha6A subunits in resting K562 cells and after treatment with PMA showed that serine 1041, but not serine 1048, is the target residue of PMA-induced phosphorylation. Cells expressing alpha6A mutant subunits or wild-type alpha6A transfectants all bound laminin in the presence, but not in the absence of PMA; however, the extent of binding differed. Cells transfected with alpha6A containing the serine to alanine mutation showed a 2-3-fold higher binding to laminin than cells transfected with alpha6A containing serine 1041. The results indicate that phosphorylation of the alpha6A cytoplasmic domain is not required for the induction of high affinity of the alpha6Abeta1 receptor by PMA, and suggest that, in contrast, it may reduce the affinity of this integrin for ligand.	NETHERLANDS CANC INST, DIV CELL BIOL, PLESMANLAAN 121, 1066 CX AMSTERDAM, NETHERLANDS	Netherlands Cancer Institute								ARROYO AG, 1992, J CELL BIOL, V117, P659, DOI 10.1083/jcb.117.3.659; AUMAILLEY M, 1990, EXP CELL RES, V188, P55, DOI 10.1016/0014-4827(90)90277-H; BOHNSACK JF, 1992, BLOOD, V79, P1545; BURN P, 1988, P NATL ACAD SCI USA, V85, P497, DOI 10.1073/pnas.85.2.497; CHAN BMC, 1993, J CELL BIOL, V120, P537, DOI 10.1083/jcb.120.2.537; COOPER HM, 1991, J CELL BIOL, V115, P843, DOI 10.1083/jcb.115.3.843; DANILOV YN, 1989, J CELL BIOL, V108, P1925, DOI 10.1083/jcb.108.5.1925; DECURTIS I, 1991, J CELL BIOL, V113, P405, DOI 10.1083/jcb.113.2.405; DETMERS PA, 1987, J CELL BIOL, V105, P1137, DOI 10.1083/jcb.105.3.1137; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; GISMONDI A, 1992, J EXP MED, V176, P1251, DOI 10.1084/jem.176.5.1251; HEMLER ME, 1987, J BIOL CHEM, V262, P3300; HEMLER ME, 1984, J IMMUNOL, V132, P3011; HERMANOWSKIVOSATKA A, 1992, CELL, V68, P341, DOI 10.1016/0092-8674(92)90475-R; HERMANOWSKIVOSATKA A, 1988, J BIOL CHEM, V263, P17822; HIERCK BP, 1993, CELL ADHES COMMUN, V1, P33, DOI 10.3109/15419069309095680; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HOGERVORST F, 1993, J CELL BIOL, V121, P179, DOI 10.1083/jcb.121.1.179; HOGERVORST F, 1991, EUR J BIOCHEM, V199, P425, DOI 10.1111/j.1432-1033.1991.tb16140.x; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; KEIZER GD, 1987, EUR J IMMUNOL, V17, P1317, DOI 10.1002/eji.1830170915; KEMENADE EV, 1992, J CELL BIOL, V117, P461; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KIEFFER N, 1990, ANNU REV CELL BIOL, V6, P329; MARTINTHOUVENIN V, 1992, J CELL PHYSIOL, V153, P95, DOI 10.1002/jcp.1041530113; MIRON S, 1992, CELL IMMUNOL, V144, P182, DOI 10.1016/0008-8749(92)90235-H; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; SHAW LM, 1990, J CELL BIOL, V110, P2167, DOI 10.1083/jcb.110.6.2167; SHIMIZU Y, 1990, NATURE, V345, P250, DOI 10.1038/345250a0; SONNENBERG A, 1990, J CELL BIOL, V110, P2145, DOI 10.1083/jcb.110.6.2145; SONNENBERG A, 1987, J BIOL CHEM, V262, P10376; SONNENBERG A, 1991, EXP CELL RES, V197, P234, DOI 10.1016/0014-4827(91)90428-W; SONNENBERG A, 1988, NATURE, V336, P487, DOI 10.1038/336487a0; TAKADA Y, 1991, J CELL BIOL, V115, P257, DOI 10.1083/jcb.115.1.257; TAMURA RN, 1991, P NATL ACAD SCI USA, V88, P10183, DOI 10.1073/pnas.88.22.10183; TSUJI T, 1990, J BIOL CHEM, V265, P7016; VANKOOYK Y, 1991, J CELL BIOL, V112, P345, DOI 10.1083/jcb.112.2.345; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0	39	52	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18427	18430						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360143				2022-12-27	WOS:A1993LV65900008
J	WAGNER, JR; MOTCHNIK, PA; STOCKER, R; SIES, H; AMES, BN				WAGNER, JR; MOTCHNIK, PA; STOCKER, R; SIES, H; AMES, BN			THE OXIDATION OF BLOOD-PLASMA AND LOW-DENSITY-LIPOPROTEIN COMPONENTS BY CHEMICALLY GENERATED SINGLET OXYGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-PEROXIDATION; ANTIOXIDANT; CHOLESTEROL; THERMOLYSIS; TOCOPHEROLS; UBIQUINONES; MECHANISM; REDUCTION; SYSTEMS	Human blood plasma and freshly isolated LDL were exposed to singlet oxygen (O-1(2)) by thermal decomposition of synthetic endoperoxides. Exposure of blood plasma to 20 mm water-soluble O-1(2) generator resulted in the depletion of ascorbate (100%), urate (75%), ubiquinol-10 (65%), protein thiols (50%), and bilirubin (25%), whereas under these conditions the levels of alpha-tocopherol, beta-carotene, and lycopene remained unchanged. The following rates of depletion were obtained by kinetic analysis (moles depleted per 100 mol of O-1(2) consumed): protein thiols (5), urate (5), ascorbate (4), bilirubin (1), and ubiquinol-10 (0.008). In contrast, the rates of depletion using the lipid-soluble O-1(2) generator were faster for bilirubin (13-fold), protein thiols (9-fold), ubiquinol-10 (8-fold), and ascorbate (5-fold), and slower for urate (2-fold). The formation of lipid hydroperoxides, including mostly cholesteryl linoleate hydroperoxide, was observed in O-1(2)-treated plasma (0.007-0.009 mol/100 mol O-1(2)) and LDL solutions (0.086 mol/100 mol O-1(2)). Based on competition kinetics, we estimate that 98% of O-1(2) generated in the aqueous phase of plasma is quenched by components in this phase, mostly by plasma protein (63%; 6% by protein thiols), urate (9%; 5% by chemical quenching), and bilirubin (5%; 1% by chemical quenching). Ascorbate and ubiquinol-10 do not contribute to O-1(2) quenching in plasma, and their oxidation is probably mediated secondary species. The remaining O-1(2) generated in plasma (2%) diffuses into lipoprotein leading to the formation of lipid hydroperoxides with an efficiency of about 100-fold greater than that compared to aqueous generated O-1(2). The principal O-1(2) quenchers in LDL include apoB (42%), lycopene and beta-carotene (40%), and alpha-tocopherol (17%). The importance of carotenoids in the quenching of O-1(2) in lipoprotein suggest that the beneficial effects of these compounds in health may in part be due to the elimination of this species in biology and medicine.	HEART RES INST,SYDNEY,NSW 2050,AUSTRALIA; UNIV DUSSELDORF,INST PHYSIOL CHEM 1,W-4000 DUSSELDORF 1,GERMANY	University of Sydney; Heart Research Institute; Heinrich Heine University Dusseldorf	WAGNER, JR (corresponding author), UNIV CALIF BERKELEY,DIV BIOCHEM & MOLEC BIOL,BERKELEY,CA 94720, USA.		Stocker, Roland/AAV-4489-2021; Sies, Helmut/ABE-7355-2020; Sies, Helmut/B-7266-2008	Sies, Helmut/0000-0002-1000-3198; Wagner, J. Richard/0000-0002-0240-2324	NATIONAL CANCER INSTITUTE [R35CA039910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001896] Funding Source: NIH RePORTER; NCI NIH HHS [CA 39910] Funding Source: Medline; NIEHS NIH HHS [ESO1896] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AUBRY JM, 1985, J AM CHEM SOC, V107, P5844, DOI 10.1021/ja00307a002; BAGCHI D, 1992, FREE RADICAL RES COM, V17, P109, DOI 10.3109/10715769209082268; BENDICH A, 1991, MICRONUTRIENTS HLTH; CANDIDE C, 1988, PHOTOCHEM PHOTOBIOL, V48, P137, DOI 10.1111/j.1751-1097.1988.tb02798.x; DI MASCIO P, 1990, BIOCHEM SOC T, V18, P1054; DI MASCIO P, 1989, J AM CHEM SOC, V111, P2909, DOI 10.1021/ja00190a027; EGOROV SY, 1987, BIOFIZIKA+, V32, P169; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ESTERBAUER H, 1990, CHEM RES TOXICOL, V3, P77, DOI 10.1021/tx00014a001; Foote C.S, 1976, FREE RADICALS BIOL, P85, DOI DOI 10.1016/B978-0-12-566502-5.50010-X; FREI B, 1989, P NATL ACAD SCI USA, V86, P6377, DOI 10.1073/pnas.86.16.6377; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; FREI B, 1992, MOL BIOL FREE RADICA, P23; Gollnick K., 1968, ADV PHOTOCHEM, V6, P1; Health. & N.R.C.U.C.o.D.a., 1989, DIET HLTH IMPLICATIO; HENDERSON BW, 1992, PHOTOCHEM PHOTOBIOL, V1, P145; KANOFSKY JR, 1989, CHEM-BIOL INTERACT, V70, P1, DOI 10.1016/0009-2797(89)90059-8; KANOFSKY JR, 1990, PHOTOCHEM PHOTOBIOL, V51, P299, DOI 10.1111/j.1751-1097.1990.tb01714.x; KANOFSKY JR, 1988, J BIOL CHEM, V263, P9692; KESSEL D, PHOTODYNAMIC THERAPY, V1; KESSEL D, PHOTODYNAMIC THERAPY, V2; LANG JK, 1986, ANAL BIOCHEM, V157, P106, DOI 10.1016/0003-2697(86)90203-4; MATHEWSROTH MM, 1986, BIOCHIMIE, V68, P875, DOI 10.1016/S0300-9084(86)80104-3; MURPHY ME, 1990, METHOD ENZYMOL, V186, P595; Nieuwint A W, 1985, Free Radic Res Commun, V1, P1, DOI 10.3109/10715768509056532; Patai, 1983, CHEM PEROXIDES; PETERS G, 1980, BIOCHEM BIOPH RES CO, V96, P770, DOI 10.1016/0006-291X(80)91421-7; Putnam E., 1975, 3 SERUM ALBUMIN, VSecond, P133, DOI [10.1016/B978-0-12-568401-9.50010-4, DOI 10.1016/B978-0-12-568401-9.50010-4]; SAITO I, 1981, J AM CHEM SOC, V103, P188, DOI 10.1021/ja00391a035; SIES H, 1992, MUTAT RES, V275, P367, DOI 10.1016/0921-8734(92)90039-R; STEINBECK MJ, 1992, J BIOL CHEM, V267, P13425; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; STOCKER R, 1991, P NATL ACAD SCI USA, V88, P1646, DOI 10.1073/pnas.88.5.1646; SUGIOKA K, 1988, BIOCHIM BIOPHYS ACTA, V936, P377, DOI 10.1016/0005-2728(88)90014-X; TURRO NJ, 1981, J AM CHEM SOC, V103, P7218, DOI 10.1021/ja00414a029; VEVERBIZET C, 1989, PHOTOCHEM PHOTOBIOL, V50, P321, DOI 10.1111/j.1751-1097.1989.tb04165.x; WARDMAN P, 1989, J PHYS CHEM REF DATA, V18, P1637, DOI 10.1063/1.555843; YAMAMOTO Y, 1987, ANAL BIOCHEM, V160, P7, DOI 10.1016/0003-2697(87)90606-3	38	93	94	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18502	18506						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360151				2022-12-27	WOS:A1993LV65900022
J	LI, HY; ELBER, R; STRAUB, JE				LI, HY; ELBER, R; STRAUB, JE			MOLECULAR-DYNAMICS SIMULATION OF NO RECOMBINATION TO MYOGLOBIN MUTANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; CARBON-MONOXIDE; HEME-PROTEINS; HEMOGLOBIN; DIFFUSION; POCKET; LEGHEMOGLOBIN; HISTIDINE; CO	Molecular dynamics simulations on two coupled electronic surfaces are employed to investigate the geminate recombination of nitric oxide to mutants of sperm whale myoglobin. A model for the ground and the excited states is constructed based on experimental data. The crossing between the surfaces is treated using the Landau-Zener formula. The reaction probability and the recombination curves are calculated directly by histogramming the results of an ensemble of trajectories. The experimental trend is reproduced in which the picosecond recombination rate of different mutants increases in the order Phe29 > Leu29 > Val29 > Ala29. Furthermore, in accord with the experiment on significantly longer time scales an opposite trend is obtained, in which the recombination rate for Ala29 is larger than for Phe29. These results are explained by constrained diffusion of the ligand in the heme pocket. The average and the transient volume of the heme pocket is modified by the 29 mutants.	HEBREW UNIV JERUSALEM,FRITZ HABER RES CTR,DEPT PHYS CHEM,IL-91904 JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,INST LIFE SCI,IL-91904 JERUSALEM,ISRAEL; BOSTON UNIV,DEPT CHEM,BOSTON,MA 02215	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Boston University	LI, HY (corresponding author), UNIV ILLINOIS,DEPT CHEM,CHICAGO,IL 60680, USA.		Li, HY/G-3987-2010		NIGMS NIH HHS [GM41905] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041905] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI S, 1992, J BIOL CHEM, V267, P12614; AGMON N, 1983, J CHEM PHYS, V79, P2042, DOI 10.1063/1.445988; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CARVER TE, 1992, J BIOL CHEM, V267, P22022; CLINE RE, 1987, J CHEM PHYS, V86, P3836, DOI 10.1063/1.451942; ELBER R, 1990, J AM CHEM SOC, V112, P9161, DOI 10.1021/ja00181a020; FRAUENFELDER H, 1985, SCIENCE, V229, P337, DOI 10.1126/science.4012322; GIBSON QH, 1992, J BIOL CHEM, V267, P22022; GIBSON QH, 1957, PROC R SOC SER B-BIO, V147, P44, DOI 10.1098/rspb.1957.0035; HENRY ER, 1985, P NATL ACAD SCI USA, V82, P2034, DOI 10.1073/pnas.82.7.2034; IKEDASAITO M, 1993, J BIOL CHEM, V268, P6855; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KOTTALAM J, 1988, J AM CHEM SOC, V110, P7690, DOI 10.1021/ja00231a018; KUCZERA K, 1990, J MOL BIOL, V213, P351, DOI 10.1016/S0022-2836(05)80196-2; LAMBRIGHT DG, 1989, J MOL BIOL, V207, P289, DOI 10.1016/0022-2836(89)90456-7; Landau L., 1932, PHYZ SOWJETUNION, V2, P46, DOI DOI 10.1098/RSPA.1932.0165; MAXWELL JC, 1976, BIOCHEMISTRY-US, V15, P388, DOI 10.1021/bi00647a023; NOWAK W, 1991, J AM CHEM SOC, V113, P5627, DOI 10.1021/ja00015a016; OLSON JS, 1988, NATURE, V336, P265, DOI 10.1038/336265a0; PETRICH JW, 1991, BIOCHEMISTRY-US, V30, P3975, DOI 10.1021/bi00230a025; SMERDON SJ, 1991, BIOCHEMISTRY-US, V30, P6252, DOI 10.1021/bi00239a025; STRAB JE, 1993, PROTEINS, V15, P360, DOI 10.1002/prot.340150404; STRAUB JE, 1993, P NATL ACAD SCI USA, V90, P809, DOI 10.1073/pnas.90.3.809; STRAUB JE, 1987, J CHEM PHYS, V87, P6111, DOI 10.1063/1.453484; VERKHIVKER G, 1992, J AM CHEM SOC, V114, P7866, DOI 10.1021/ja00046a036; WALEH A, 1982, J AM CHEM SOC, V104, P2346, DOI 10.1021/ja00373a002; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Zener C, 1932, P R SOC LOND A-CONTA, V137, P696, DOI 10.1098/rspa.1932.0165	29	82	82	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17908	17916						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349675				2022-12-27	WOS:A1993LT74300043
J	MILLER, DK; AYALA, JM; EGGER, LA; RAJU, SM; YAMIN, TT; DING, GJF; GAFFNEY, EP; HOWARD, AD; PALYHA, OC; ROLANDO, AM; SALLEY, JP; THORNBERRY, NA; WEIDNER, JR; WILLIAMS, JH; CHAPMAN, KT; JACKSON, J; KOSTURA, MJ; LIMJUCO, G; MOLINEAUX, SM; MUMFORD, RA; CALAYCAY, JR				MILLER, DK; AYALA, JM; EGGER, LA; RAJU, SM; YAMIN, TT; DING, GJF; GAFFNEY, EP; HOWARD, AD; PALYHA, OC; ROLANDO, AM; SALLEY, JP; THORNBERRY, NA; WEIDNER, JR; WILLIAMS, JH; CHAPMAN, KT; JACKSON, J; KOSTURA, MJ; LIMJUCO, G; MOLINEAUX, SM; MUMFORD, RA; CALAYCAY, JR			PURIFICATION AND CHARACTERIZATION OF ACTIVE HUMAN INTERLEUKIN-1-BETA-CONVERTING ENZYME FROM THP.1 MONOCYTIC CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED HUMAN-MONOCYTES; INTERLEUKIN 1-BETA; CONVERTING ENZYME; PRECURSOR; PROTEASE; ARTHRITIS; IDENTIFICATION; SPECIFICITY; FIBROBLASTS; IL-1-BETA	Interleukin-1beta-converting enzyme (ICE) was purified from dialyzed cytoplasmic extracts of THP.1 human monocytic cells by a combination of DEAE-5PW and SP-5PW ion exchange and C4 reverse phase high performance liquid chromatography. Sequence information from tryptic and Asp.N peptides on the isolated 20-kDa (p20) and a 10-kDa (p10) proteins enabled the subsequent cloning of ICE (Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J., Elliston, K. O., Ayala, J. M., Casano, F. J., Chin, J., Ding, G. J.-F., Egger, L. A., Gaffney, E. P., Limjuco, G., Palyha, O. C., Raju, S. M., Rolando, A. M., Salley, J. P., Yamin, T.-T., Lee, T. D., Shively, J. E., MacCross, M., Mumford, R. A., Schmidt, J. A., and Tocci, M. J. (1992) Nature 356, 768-774) and localized the active site Cys. Immunoblots with ICE specific antibodies and NH2-terminal sequencing indicated that ICE active column fractions contained in addition to p20 and p10 an alternatively processed form of the p20 protein (p22) containing an extra 16 amino acids NH2-terminal to the p20. Furthermore, immunoblot analysis of the ion exchange column effluent showed that p20 and p22 were found together in three separate fractions distinguished by differences in p10: an intact p10 with complete ICE activity, a COOH-terminally truncated form of p10 with decreased ICE activity, and an absence of p10 with no ICE activity. These results indicate that the p10 protein is essential for ICE activity and that the ICE holoenzyme contains an intact p10 subunit paired with a p20 or p22 catalytic subunit.	MERCK RES LABS,DEPT BIOCHEM,RAHWAY,NJ 07065; MERCK RES LABS,DEPT MOLEC IMMUNOL,RAHWAY,NJ 07065; MERCK RES LABS,DEPT MED CHEM RES,RAHWAY,NJ 07065; MERCK RES LABS,DEPT BASIC MICROBIOL,RAHWAY,NJ 07065; MERCK RES LABS,DEPT CELLULAR & MOLEC PHARMACOL,RAHWAY,NJ 07065; MERCK RES LABS,DEPT ANALYT BIOCHEM,RAHWAY,NJ 07065	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company	MILLER, DK (corresponding author), MERCK RES LABS,DEPT BIOCHEM & MOLEC PATHOL,POB 2000,R80N-A32,RAHWAY,NJ 07065, USA.			Kostura, Matthew/0000-0001-7940-7492				AITHAL HN, 1988, J IMMUNOL METHODS, V112, P63, DOI 10.1016/0022-1759(88)90034-8; AMMIRATI MJ, 1992, JUL PROT SOC SAN DIE; AURON PE, 1987, J IMMUNOL, V138, P1447; BAYNE EK, 1986, J EXP MED, V163, P1267, DOI 10.1084/jem.163.5.1267; BLACK RA, 1989, FEBS LETT, V247, P386, DOI 10.1016/0014-5793(89)81376-6; BLACK RA, 1988, J BIOL CHEM, V263, P9437; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; DINARELLO CA, 1988, FASEB J, V2, P108, DOI 10.1096/fasebj.2.2.3277884; EASTGATE JA, 1988, LANCET, V2, P706; FUHLBRIGGE RC, 1988, P NATL ACAD SCI USA, V85, P5649, DOI 10.1073/pnas.85.15.5649; GIRI JG, 1985, J IMMUNOL, V134, P343; GRASSI J, 1991, IMMUNOL REV, V119, P125, DOI 10.1111/j.1600-065X.1991.tb00581.x; HAZUDA D, 1989, J BIOL CHEM, V264, P1689; HAZUDA DJ, 1988, J BIOL CHEM, V263, P8473; HILL HD, 1988, ANAL BIOCHEM, V170, P203, DOI 10.1016/0003-2697(88)90109-1; HOM JT, 1988, J IMMUNOL, V141, P834; HOWARD AD, 1991, J IMMUNOL, V147, P2964; HOWARD AD, 1993, J CELL BIOCH B, V17, P146; KNIGHT WB, 1992, IN PRESS BIOCHEMISTR, V31; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; KRONHEIM SR, 1992, ARCH BIOCHEM BIOPHYS, V296, P698, DOI 10.1016/0003-9861(92)90629-B; LIMJUCO G, 1986, P NATL ACAD SCI USA, V83, P3972, DOI 10.1073/pnas.83.11.3972; MILLER DK, 1990, NATURE, V343, P278, DOI 10.1038/343278a0; MILLER DK, 1993, FASEB J, V7, P267; MOLINEAUX SM, 1993, P NATL ACAD SCI USA, V90, P1809, DOI 10.1073/pnas.90.5.1809; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; NETT M, 1992, FASEB J, V6, pA2056; PETTIPHER ER, 1986, P NATL ACAD SCI USA, V83, P8749, DOI 10.1073/pnas.83.22.8749; SCHMIDT JA, 1990, PEPTIDE GROWTH FACTO, V1, P473; SHIVELY JE, 1987, ANAL BIOCHEM, V163, P517, DOI 10.1016/0003-2697(87)90257-0; SHIVERS BD, 1993, J CELL BIOCH B, V17, P119; SINGER II, 1988, J EXP MED, V167, P389, DOI 10.1084/jem.167.2.389; SLEATH PR, 1990, J BIOL CHEM, V265, P14526; STARNES HF, 1991, SEMIN HEMATOL, V28, P34; STEWART AE, 1992, JUL PROT SOC SAN DIE; STIMPSON SA, 1988, J IMMUNOL, V140, P2964; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; WADA H, 1991, THROMB HAEMOSTASIS, V65, P364; WEIDNER JR, 1991, IN PRESS PEPTIDES CH; YOUNG PR, 1988, J CELL BIOL, V107, P447, DOI 10.1083/jcb.107.2.447	40	107	111	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18062	18069						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349684				2022-12-27	WOS:A1993LT74300063
J	SATOH, S; NISHIMURA, H; CLARK, AE; KOZKA, IJ; VANNUCCI, SJ; SIMPSON, IA; QUON, MJ; CUSHMAN, SW; HOLMAN, GD				SATOH, S; NISHIMURA, H; CLARK, AE; KOZKA, IJ; VANNUCCI, SJ; SIMPSON, IA; QUON, MJ; CUSHMAN, SW; HOLMAN, GD			USE OF BISMANNOSE PHOTOLABEL TO ELUCIDATE INSULIN-REGULATED GLUT4 SUBCELLULAR TRAFFICKING KINETICS IN RAT ADIPOSE-CELLS - EVIDENCE THAT EXOCYTOSIS IS A CRITICAL SITE OF HORMONE ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; GLUCOSE-TRANSPORT ACTIVITY; 3T3-L1 ADIPOCYTES; PLASMA-MEMBRANE; STIMULATED TRANSLOCATION; PHORBOL ESTER; PHOSPHORYLATION STATE; HEXOSE TRANSPORTERS; SURFACE; ISOPROTERENOL	The subcellular trafficking of tracer-tagged GLUT4 between the plasma membranes and low-density microsomes of rat adipose cells has been studied. Cell-surface GLUT4 have been initially tracer-tagged in the insulin-stimulated state with the [H-3]bismannose photolabel 2-N-4-(1-azi-2,2,2-trifluoroethyl)benzoyl-1,3-bis-(D-mannos-4-yloxy)-2-propylamine. The half-time for internalization of tracer-tagged GLUT4 when insulin is removed by collagenase treatment is similar to that observed for the decrease in immunodetectable GLUT4 in the plasma membranes and the decrease in glucose transport activity in the intact cells. In contrast, internalization of tracer-tagged GLUT4 also occurs when cells are maintained in the continuous presence of insulin even though the plasma membrane level of immunodetectable GLUT4 and glucose transport activity in the intact cells are unaltered. These data show, for the first time, that insulin has little, if any, effect on the rate constant for GLUT4 endocytosis, but instead, primarily increases the rate constant for exocytosis. Tracer-tagged GLUT4 that is returned to the low-density microsomes can be restimulated with fresh insulin to recycle to the plasma membranes and to a steady-state distribution level that is the same as that observed in cells that are maintained in the continuous presence of insulin. These data suggest that the cells' entire complement of GLUT4 is involved in the recycling process. Following insulin stimulation of adipose cells initially in the basal state, the increase in immunodetectable GLUT4 in the plasma membranes precedes the increase in accessibility of GLUT4 to exofacial 2-N-4-(1-azi-2,2,2-trifluoroethyl)benzoyl-1,3-bis(D-mannos-4-yloxy)-2-propylamine photolabeling, and this in turn precedes the increase in cellular glucose transport activity. Such time course data suggest that there may be plasma membrane intermediate states in the GLUT4 trafficking pathway. The kinetic properties of GLUT4 translocation and its recycling have been interpreted in terms of a subcellular trafficking model that identifies exocytosis, possibly involving-hypothetical ''docking'' and ''fusion'' steps, as the critical site of hormone action.	NIDDKD,EXPTL DIABET METAB & NUTR SECT,BLDG 10,RM 5N102,BETHESDA,MD 20892; NIDDKD,DIABET BRANCH,RECEPTORS & HORMONE ACT SECT,BETHESDA,MD 20892; UNIV BATH,DEPT BIOCHEM,BATH BA2 7AY,AVON,ENGLAND	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Bath			Quon, Michael/B-1970-2008	Holman, Geoffrey/0000-0001-7045-1358; QUON, MICHAEL/0000-0002-5289-3707; Quon, Michael/0000-0002-9601-9915				BORNEMANN A, 1992, DIABETES, V41, P215, DOI 10.2337/diabetes.41.2.215; CALDERHEAD DM, 1990, J BIOL CHEM, V265, P13800; CLARK AE, 1991, BIOCHEM J, V278, P235, DOI 10.1042/bj2780235; CLARK AE, 1990, BIOCHEM J, V265, P13800; CUSHMAN SW, 1978, J LIPID RES, V19, P269; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; CZECH MP, 1993, J BIOL CHEM, V268, P9187; GIBBS EM, 1988, BIOCHEMISTRY-US, V27, P6681, DOI 10.1021/bi00418a006; GIBBS EM, 1986, J BIOL CHEM, V261, P6597; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; HARRISON SA, 1992, J BIOL CHEM, V267, P3783; HARRISON SA, 1991, J BIOL CHEM, V266, P19438; HOLMAN GD, 1988, BIOCHIM BIOPHYS ACTA, V946, P75, DOI 10.1016/0005-2736(88)90459-2; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; JAMES DE, 1988, NATURE, V333, P283; JOOST HG, 1987, J BIOL CHEM, V262, P11261; KAHN BB, 1991, J CLIN INVEST, V87, P561, DOI 10.1172/JCI115031; KARNIELI E, 1981, J BIOL CHEM, V256, P4772; KHUN BH, 1992, J BIOL CHEM, V267, P17710; KONO T, 1981, J BIOL CHEM, V256, P6400; KOZKA IJ, 1991, J BIOL CHEM, V266, P11726; KURODA M, 1987, J BIOL CHEM, V262, P245; MIDGLEY PJW, 1985, BIOCHIM BIOPHYS ACTA, V812, P33, DOI 10.1016/0005-2736(85)90518-8; NISHIMURA H, 1991, P NATL ACAD SCI USA, V88, P11500, DOI 10.1073/pnas.88.24.11500; NISHIMURA H, 1993, IN PRESS J BIOL CHEM; OKA Y, 1984, J BIOL CHEM, V259, P8125; PALFREYMAN RW, 1992, BIOCHEM J, V284, P275, DOI 10.1042/bj2840275; QUON MJ, 1991, J THEOR BIOL, V150, P93, DOI 10.1016/S0022-5193(05)80477-1; SIMPSON IA, 1986, ANNU REV BIOCHEM, V55, P1059, DOI 10.1146/annurev.biochem.55.1.1059; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SLOT JW, 1991, P NATL ACAD SCI USA, V88, P7815, DOI 10.1073/pnas.88.17.7815; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; SMITH RM, 1991, P NATL ACAD SCI USA, V88, P6893, DOI 10.1073/pnas.88.15.6893; SONNE O, 1988, PHYSIOL REV, V68, P1129, DOI 10.1152/physrev.1988.68.4.1129; STOORVOGEL W, 1987, J CELL BIOL, V104, P1261, DOI 10.1083/jcb.104.5.1261; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; TANNER LI, 1987, J BIOL CHEM, V262, P8975; VANNUCCI SJ, 1992, BIOCHEM J, V288, P325, DOI 10.1042/bj2880325; WEBER TM, 1988, INSULIN RECEPTOR, V2, P171; WHITESELL RR, 1979, J BIOL CHEM, V254, P5276; YANG J, 1992, BIOCHEM J, V281, P809, DOI 10.1042/bj2810809; YANG J, 1993, J BIOL CHEM, V268, P4600; YANG J, 1992, J BIOL CHEM, V267, P10393; ZORZANO A, 1989, J BIOL CHEM, V264, P12358	44	267	270	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17820	17829						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349666				2022-12-27	WOS:A1993LT74300030
J	TAGUCHI, H; OHTA, T				TAGUCHI, H; OHTA, T			HISTIDINE-296 IS ESSENTIAL FOR THE CATALYSIS IN LACTOBACILLUS-PLANTARUM D-LACTATE DEHYDROGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING SITES; ESCHERICHIA-COLI; ACTIVE-SITE; MUTAGENESIS; FRAMEWORK	Two His residues, His-205 and His-296, in Lactobacillus plantarum D-lactate dehydrogenase are highly conserved in the D-isomer-specific 2-hydroxyacid dehydrogenase family, suggesting that they are candidates for the catalytic His in the enzyme. The substitution of His-296 with Tyr by means of site-directed mutagenesis induced a drastic decrease in the reaction rate, while a His-205 to Tyr substitution induced no large change in the catalytic properties. In pyruvate reduction, the Tyr-296 enzyme showed a slightly increased K(m) below pH 6.0 but no significant pH dependence above pH 6.0, where the wild-type enzyme showed an increased K(m) value. In D-lactate oxidation, in contrast, the Tyr-296 enzyme showed a greatly increased K(m) value for D-lactate and strong pH dependence. An additional substitution of His-296 with Gln induced more complete loss of the catalytic activity. In contrast to the Tyr-296 enzyme, the Gln-296 enzyme showed a greatly increased K(m) value and a strong pH-dependent reaction rate even in pyruvate reduction. Unlike the wild-type or His-205 enzyme, both the Tyr-296 and Gln-296 enzymes showed significant resistance against diethyl pyrocarbonate. These results clearly indicate that His-296 is essential for the catalysis by D-lactate dehydrogenase, as in the case of His-195 in L-lactate dehydrogenase.			TAGUCHI, H (corresponding author), UNIV TOKYO,DEPT AGR CHEM,BUNKYO KU,TOKYO 113,JAPAN.			Taguchi, Hayao/0000-0001-5270-581X				CLARKE AR, 1989, TRENDS BIOCHEM SCI, V14, P145, DOI 10.1016/0968-0004(89)90147-3; CLARKE AR, 1989, TRENDS BIOCHEM SCI, V14, P101, DOI 10.1016/0968-0004(89)90131-X; CLARKE AR, 1988, BIOCHEMISTRY-US, V27, P1617, DOI 10.1021/bi00405a034; CLARKE AR, 1986, NATURE, V324, P699, DOI 10.1038/324699a0; DENNIS D, 1960, J BIOL CHEM, V235, P810; EVERSE J, 1973, ADV ENZYMOL RAMB, V37, P61; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; GASSER F, 1970, J GEN MICROBIOL, V62, P241, DOI 10.1099/00221287-62-2-241; GLEASON FH, 1966, SCIENCE, V152, P1272, DOI 10.1126/science.152.3726.1272; Holbrook JJ., 1975, ENZYMES, P191; KOCHHAR S, 1992, J BIOL CHEM, V267, P8499; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LONG GL, 1973, ARCH BIOCHEM BIOPHYS, V154, P711, DOI 10.1016/0003-9861(73)90026-X; LONG GL, 1968, SCIENCE, V162, P685, DOI 10.1126/science.162.3854.685; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TAGUCHI H, 1991, J BIOL CHEM, V266, P12588; TERADA I, 1990, J BIOL CHEM, V265, P6576	19	44	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18030	18034						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349682				2022-12-27	WOS:A1993LT74300059
J	FSIHI, H; KOTTWITZ, B; BREMER, E				FSIHI, H; KOTTWITZ, B; BREMER, E			SINGLE AMINO-ACID SUBSTITUTIONS AFFECTING THE SUBSTRATE-SPECIFICITY OF THE ESCHERICHIA-COLI K-12 NUCLEOSIDE-SPECIFIC TSX CHANNEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PERMEABILITY; RECEPTOR PROTEIN; PORE PROPERTIES; BINDING-SITE; MUTANTS; RESISTANCE; TRANSPORT; PORINS; GENE; MALTOPORIN	The Tsx protein from the Escherichia coli outer membrane is a channel-forming protein containing a nucleoside-specific binding site. The antibiotic albicidin enters the cell via this substrate-specific channel. Because albicidin is toxic for E. coli at a very low external substrate concentration, the Tsx channel is likely to contain a binding site for this antibiotic. To identify residues involved in the Tsx substrate-specific channel activity, we devised a selection scheme to isolate albicidin-resistant tsx mutants synthesizing Tsx proteins with defects in their nucleoside uptake function. We recovered seven distinct albicidin-resistant tsx alleles, six point mutations and a 39-base pair duplication. The mutants with a duplication of residues 21-33 of Tsx or with single amino acid substitutions of residue Gly28 (to Arg) and Ser217 (to Arg) are completely deficient in nucleoside uptake at a low substrate concentration. Substitutions of Phe27 to Leu, Gly28 to Glu, Gly239 to Asp, and Gly240 to Asp result in a Tsx protein partially defective in nucleoside transport. These mutant proteins still permit nonspecific diffusion of serine indicating that the mutations do not result in a block of the Tsx channel. Our results are discussed in terms of a model for the topological organization of the Tsx protein within the outer membrane of E. coli.	MAX PLANCK INST TERRESTR MIKROBIOL,KARL VONFRISCH STR,W-3550 MARBURG,GERMANY; UNIV CONSTANCE,DEPT BIOL,W-7750 CONSTANCE,GERMANY	Max Planck Society; University of Konstanz			FSIHI, Hafida/H-9852-2014					BENSON SA, 1988, J MOL BIOL, V203, P961, DOI 10.1016/0022-2836(88)90121-0; BENSON SA, 1985, J BACTERIOL, V161, P361, DOI 10.1128/JB.161.1.361-367.1985; BENZ R, 1988, EUR J BIOCHEM, V176, P1, DOI 10.1111/j.1432-1033.1988.tb14245.x; BENZ R, 1988, EUR J BIOCHEM, V176, P699, DOI 10.1111/j.1432-1033.1988.tb14333.x; BERMAN ML, 1984, J BACTERIOL, V159, P750, DOI 10.1128/JB.159.2.750-756.1984; BIRCH RG, 1985, J GEN MICROBIOL, V131, P1069; BIRCH RG, 1990, J GEN MICROBIOL, V136, P51, DOI 10.1099/00221287-136-1-51; BREMER E, 1990, GENE, V96, P59, DOI 10.1016/0378-1119(90)90341-N; BREMER E, 1988, J BACTERIOL, V170, P108, DOI 10.1128/jb.170.1.108-116.1988; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CHARBIT A, 1988, J MOL BIOL, V201, P487, DOI 10.1016/0022-2836(88)90630-4; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DARGENT B, 1988, J MOL BIOL, V201, P497, DOI 10.1016/0022-2836(88)90632-8; DATTA DB, 1977, J BACTERIOL, V131, P821, DOI 10.1128/JB.131.3.821-829.1977; FREUNDLIEB S, 1988, J BIOL CHEM, V263, P314; HANCOCK REW, 1975, J BACTERIOL, V121, P983, DOI 10.1128/JB.121.3.983-993.1975; HANTKE K, 1976, FEBS LETT, V70, P109, DOI 10.1016/0014-5793(76)80737-5; HENNING U, 1978, EUR J BIOCHEM, V92, P491, DOI 10.1111/j.1432-1033.1978.tb12771.x; HEUZENROEDER MW, 1981, J BACTERIOL, V147, P1113, DOI 10.1128/JB.147.3.1113-1116.1981; JEANTEUR D, 1991, MOL MICROBIOL, V5, P2153, DOI 10.1111/j.1365-2958.1991.tb02145.x; KRIEGERBRAUER HJ, 1980, ARCH MICROBIOL, V124, P233, DOI 10.1007/BF00427732; LUCKEY M, 1980, P NATL ACAD SCI-BIOL, V77, P167, DOI 10.1073/pnas.77.1.167; LUGTENBERG B, 1975, FEBS LETT, V58, P254, DOI 10.1016/0014-5793(75)80272-9; MAIER C, 1988, J BIOL CHEM, V263, P2493; MAIER C, 1990, MOL GEN GENET, V221, P491, DOI 10.1007/BF00259416; MANNING PA, 1978, MOL GEN GENET, V158, P279, DOI 10.1007/BF00267199; Miller J.H., 1972, EXPT MOL GENETICS; MISRA R, 1988, J BACTERIOL, V170, P528, DOI 10.1128/jb.170.2.528-533.1988; MUNCHPETERSEN A, 1979, J BIOL CHEM, V254, P3730; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; NIKAIDO H, 1992, MOL MICROBIOL, V6, P435, DOI 10.1111/j.1365-2958.1992.tb01487.x; NIKAIDO H, 1992, SCIENCE, V258, P936, DOI 10.1126/science.1279804; PUGSLEY AP, 1985, J GEN MICROBIOL, V131, P369; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287, DOI 10.1146/annurev.bi.55.070186.001443; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER H, 1993, J BACTERIOL, V175, P2809, DOI 10.1128/JB.175.10.2809-2817.1993; Silhavy T. J., 1984, EXPT GENE FUSIONS; SINGER M, 1989, MICROBIOL REV, V53, P1; STRUYVE M, 1991, J MOL BIOL, V218, P141, DOI 10.1016/0022-2836(91)90880-F; TRIAS J, 1989, ANTIMICROB AGENTS CH, V33, P1201, DOI 10.1128/AAC.33.8.1202; VANALPHEN W, 1978, MOL GEN GENET, V159, P75, DOI 10.1007/BF00401750; WADA KN, 1992, NUCLEIC ACIDS RES, V20, P2111, DOI 10.1093/nar/20.suppl.2111; WEISS MS, 1990, FEBS LETT, V267, P268, DOI 10.1016/0014-5793(90)80942-C	44	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17495	17503						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349629				2022-12-27	WOS:A1993LQ98800089
J	HEINECKE, JW; LI, W; DAEHNKE, HL; GOLDSTEIN, JA				HEINECKE, JW; LI, W; DAEHNKE, HL; GOLDSTEIN, JA			DITYROSINE, A SPECIFIC MARKER OF OXIDATION, IS SYNTHESIZED BY THE MYELOPEROXIDASE-HYDROGEN PEROXIDE SYSTEM OF HUMAN NEUTROPHILS AND MACROPHAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL MYRISTATE ACETATE; HYPOCHLOROUS ACID; SINGLET OXYGEN; LEUKOCYTES; SUPEROXIDE; TYROSINE; MECHANISMS; GENERATION; MEMBRANE; CATALASE	Myeloperoxidase, secreted by activated phagocytes, produces the powerful cytotoxin hypochlorous acid from H2O2 and Cl-. We show that the enzyme can also employ H2O2 to oxidize L-tyrosine to tyrosyl radical, yielding the stable cross-linked product dityrosine. Dityrosine synthesis by the myeloperoxidase-H2O2 system did not require halide and was partially inhibited by Cl-. At physiological concentrations of Cl-, L-tyrosine, and other plasma amino acids, purified myeloperoxidase utilized 26% of the H2O2 in the reaction mixture to form dityrosine. Aminotriazole, cyanide, and azide inhibited the reaction. Phorbol ester-stimulated human neutrophils and monocyte-derived macrophages similarly generated dityrosine from L-tyrosine by a pathway inhibited by catalase, aminotriazole, and azide. The requirement for H2O2 and the inhibition by heme poisons suggest that activated phagocytes synthesize dityrosine by a peroxidative mechanism. These results indicate that L-tyrosine can compete effectively with Cl- as a substrate for myeloperoxidase and raise the possibility that formation of tyrosyl radical may play a role in the phagocyte inflammatory response. Because dityrosine is protease-resistant, stable to acid hydrolysis, and intensely fluorescent, its identification in tissues may pinpoint targets where phagocytes inflict oxidative damage in vivo.	WASHINGTON UNIV,SCH MED,DEPT MED,ST LOUIS,MO 63110	Washington University (WUSTL)					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029920] Funding Source: NIH RePORTER; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P60AM020579] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00954] Funding Source: Medline; NIADDK NIH HHS [AM20579] Funding Source: Medline; NICHD NIH HHS [R01 HD29920] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALBRICH JM, 1981, P NATL ACAD SCI-BIOL, V78, P210, DOI 10.1073/pnas.78.1.210; AMADO R, 1984, METHOD ENZYMOL, V107, P377; Andersen S.O, 1966, ACTA PHYSIOL SC S263, V66, P1; BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403; BAYSE GS, 1972, BIOCHIM BIOPHYS ACTA, V284, P34; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BRITIGAN BE, 1986, J BIOL CHEM, V261, P7026; BRIZA P, 1986, J BIOL CHEM, V261, P4288; BRIZA P, 1990, GENE DEV, V4, P1775, DOI 10.1101/gad.4.10.1775; CERUTTI PA, 1988, OXY RADICALS MOL BIO; DIETS T, 1984, J BIOL CHEM, V259, P13525; DOLPHIN D, 1971, P NATL ACAD SCI USA, V68, P614, DOI 10.1073/pnas.68.3.614; FOERDER CA, 1977, P NATL ACAD SCI USA, V74, P4214, DOI 10.1073/pnas.74.10.4214; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; GOLDSMITH LA, 1989, METABOLIC BASIS INHE, P547; GROSS AJ, 1959, J BIOL CHEM, V234, P1611; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; HARRISON JE, 1978, FEBS LETT, V92, P327, DOI 10.1016/0014-5793(78)80780-7; HEINECKE JW, 1987, J BIOL CHEM, V262, P10098; HELD AM, 1978, BIOCHEM BIOPH RES CO, V81, P878, DOI 10.1016/0006-291X(78)91433-X; HICKSTEIN DD, 1987, J BIOL CHEM, V262, P5576; HUNTER EPL, 1989, FREE RADICAL BIO MED, V6, P581, DOI 10.1016/0891-5849(89)90064-6; HURST JK, 1989, CRIT REV BIOCHEM MOL, V24, P271, DOI 10.3109/10409238909082555; IBBOTT FA, 1974, CLIN CHEM, P565; JOSCHEK HI, 1966, J AM CHEM SOC, V88, P3273, DOI 10.1021/ja00966a019; Klebanoff S.J., 1978, NEUTROPHIL FUNCTION; KLEBANOFF SJ, 1984, METHOD ENZYMOL, V105, P399; KRINSKY NI, 1974, SCIENCE, V186, P363, DOI 10.1126/science.186.4161.363; LEHRER SS, 1967, BIOCHEMISTRY-US, V6, P757, DOI 10.1021/bi00855a017; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALMSTROM BG, 1982, ANNU REV BIOCHEM, V51, P21, DOI 10.1146/annurev.bi.51.070182.000321; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; MORITA Y, 1986, J BIOCHEM-TOKYO, V99, P761, DOI 10.1093/oxfordjournals.jbchem.a135535; Musso H., 1963, ANGEW CHEM INT EDIT, V2, P723, DOI DOI 10.1002/ANIE.196307231; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; RAKITA RM, 1990, BIOCHEMISTRY-US, V29, P1075, DOI 10.1021/bi00456a033; SEALY RC, 1985, J AM CHEM SOC, V107, P3401, DOI 10.1021/ja00298a001; SEGAL AW, 1989, J CLIN INVEST, V83, P1785, DOI 10.1172/JCI114083; TAUBER AI, 1977, J CLIN INVEST, V60, P374, DOI 10.1172/JCI108786; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; WEISS SJ, 1983, SCIENCE, V222, P625, DOI 10.1126/science.6635660; WEISS SJ, 1977, J CLIN INVEST, V60, P370, DOI 10.1172/JCI108785; WHITE JG, 1974, AM J PATHOL, V75, P45; WRIGHT DG, 1977, AM J PATHOL, V87, P273; ZGLICZYNSKI JM, 1968, EUR J BIOCHEM, V4, P540, DOI 10.1111/j.1432-1033.1968.tb00246.x	48	421	436	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					4069	4077						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382689				2022-12-27	WOS:A1993KN53300043
J	HALL, TR; WALLIN, R; REINHART, GD; HUTSON, SM				HALL, TR; WALLIN, R; REINHART, GD; HUTSON, SM			BRANCHED-CHAIN AMINOTRANSFERASE ISOENZYMES - PURIFICATION AND CHARACTERIZATION OF THE RAT-BRAIN ISOENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART MITOCHONDRIA; PROTEINS; TISSUES; TRANSAMINASE; MECHANISM; CULTURES; MEMBRANE; ACIDS; LIVER	This paper presents the first complete purification of the branched chain aminotransferase (EC 2.6.1.42) from rat brain cytosol (BCAT(c)). On sodium dodecyl sulfate-polyacrylamide gel electrophoresis the enzyme appeared as a single band with a molecular mass of 47 kDa; however, gel exclusion chromatography suggested that BCAT(c) is a dimer. Comparison of tryptic peptide maps of BCAT(c) and the mitochondrial form of the enzyme (BCAT(m)) indicated that they are different proteins. Experiments with protein labeling reagents, in particular sulfhydryl reagents, also suggested that there may be some distinct structural differences in BCAT(c) and BCAT(m). Nevertheless, BCAT(c) and BCAT(m) showed similar specificities for amino acid and alpha-keto acid substrates. Both enzymes transaminated branched chain amino acids, their straight chain analogs, L-alloisoleucine and glutamate. A broader range of alpha-keto acids than amino acids was accepted as substrate including alpha-ketobutyrate and the alpha-keto acid of methionine. Both enzymes exhibited ping-pong kinetics with apparent K(m) values for leucine and isoleucine of about 1 and 5 mm for valine, respectively. K(m) values for alpha-ketoglutarate ranged from about 0.6 to 3 mm depending on the amino acid substrate. Polyclonal antibodies were raised in rabbits against purified BCAT(c). BCAT(c) antiserum neutralized branched chain aminotransferase activity in rat brain cytosol but did not affect the activity in a heart mitochondrial extract. However, immunoblotting showed that BCAT(c) and BCAT(m) do share common epitopes since BCAT(m) antiserum recognized BCAT(c) on the immunoblots. The tissue distribution of BCAT(c) was examined using BCAT(c) and BCAT(m) antisera. These data showed that BCAT(c) was found in adult and fetal rat brain, cultured cells from fetal rat brain cortex, ovary, and placenta. Brain had the highest activity followed by ovary, fetal brain, and placenta. BCAT(c) was not found in fetal liver, adult rat liver, or a rat hepatoma cell line. These data provide clear evidence that BCAT(c), unlike BCAT(m), is restricted to several highly specialized tissues.	WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT BIOCHEM,MED CTR BLVD,WINSTON SALEM,NC 27157; WAKE FOREST UNIV,BOWMAN GRAY SCH MED,RHEUMATOL SECT,WINSTON SALEM,NC 27157; UNIV OKLAHOMA,DEPT CHEM & BIOCHEM,NORMAN,OK 73018	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; University of Oklahoma System; University of Oklahoma - Norman					NIDDK NIH HHS [DK34738] Funding Source: Medline; NIGMS NIH HHS [GM33216] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033216] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKI K, 1969, J BIOCHEM-TOKYO, V65, P539, DOI 10.1093/oxfordjournals.jbchem.a129047; Arnone A, 1985, TRANSAMINASES, P138; BENNETT BA, 1989, BRAIN RES, V491, P109, DOI 10.1016/0006-8993(89)90092-9; BOOTH RFG, 1978, BIOCHEM J, V176, P365, DOI 10.1042/bj1760365; CLELAND WW, 1967, ADV ENZYMOL RAMB, V29, P1; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; COOPER AJL, 1987, PHYSIOL REV, V67, P440, DOI 10.1152/physrev.1987.67.2.440; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; ELDER JH, 1977, J BIOL CHEM, V252, P6510; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; GEHRING H, 1985, TRANSAMINASES, P373; GOTO M, 1977, GANN, V68, P663; HALESTRAP AP, 1978, BIOCHEM J, V172, P377, DOI 10.1042/bj1720377; HARPER AE, 1989, ANN NY ACAD SCI, V573, P413; HUTSON SM, 1990, P NATL ACAD SCI USA, V87, P1028, DOI 10.1073/pnas.87.3.1028; HUTSON SM, 1992, J BIOL CHEM, V267, P15681; HUTSON SM, 1988, J BIOL CHEM, V263, P3618; HUTSON SM, 1993, J BIOL CHEM, V268, P3084; HUTSON SM, 1988, J NUTR, V118, P1475, DOI 10.1093/jn/118.12.1475; Ichihara A, 1985, TRANSAMINASES, P430; KADOWAKI H, 1982, BIOCHEM J, V202, P777, DOI 10.1042/bj2020777; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai J.C.K., 1989, NEUROMETHODS, P43; LOWRY M, 1980, BIOCHEM J, V190, P771, DOI 10.1042/bj1900771; MAKINO M, 1984, COMP BIOCHEM PHYS B, V77, P175, DOI 10.1016/0305-0491(84)90240-2; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; NEELY JR, 1976, CIRC RES, V38, P22; OGAWA K, 1970, J BIOCHEM-TOKYO, V68, P901, DOI 10.1093/oxfordjournals.jbchem.a129429; REIDERER BM, 1987, J NEUROSCI, V7, P864; ROTH SL, 1977, CANCER RES, V37, P1147; RUDIGER HW, 1972, BIOCHEM J, V126, P445, DOI 10.1042/bj1260445; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SPACH PI, 1991, BIOCHIM BIOPHYS ACTA, V1056, P40, DOI 10.1016/S0005-2728(05)80070-2; STERNICZUK A, 1991, EUR J BIOCHEM, V196, P143, DOI 10.1111/j.1432-1033.1991.tb15797.x; TAYLOR RT, 1966, J BIOL CHEM, V241, P4396; WALLIN R, 1990, J BIOL CHEM, V265, P6019; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	39	130	132	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3092	3098						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381418				2022-12-27	WOS:A1993KM16100015
J	HASENAUER, J; HUANG, WH; ASKARI, A				HASENAUER, J; HUANG, WH; ASKARI, A			ALLOSTERIC REGULATION OF THE ACCESS CHANNELS TO THE RB+ OCCLUSION SITES OF (NA++K+)-ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							(NA+ + K+)-ATPASE; BINDING SITES; RUBIDIUM IONS; RAPID RELEASE; NA+/K+-ATPASE; K+; NA,K-ATPASE; TRANSPORT; LIGAND; OUABAIN	Previous work on the role of occluded Rb+ (a K+ substitute) in the reaction cycle of (Na+ + K+)-ATPase has focused on the kinetics of the dissociation of the enzyme- Rb+ complex at 20-24-degrees-C. Doing experiments at 4-degrees-C, we have made the following observations on the equilibrium binding levels and the kinetics of binding and release of Rb+. 1) The plot of bound Rb+ as a function of [Rb+] showed occupancy of high affinity sites, followed by binding to sites of lower affinity. The estimated number of Rb+ sites/active site was two to three, but a higher number was not ruled out. Release of bound Rb+ was slow and not monoexponential, the major portion being in a pool with a half-life of 4-5 h. Dissociation curves were identical at different levels of site occupancy. Rb+ binding also had fast and slow phases, requiring about 24 h to reach steady state at vastly different [Rb+]. These data suggest that (a) Rb+ occlusion sites are confined within the protein matrix and connected to the medium by narrow access channels that are heterogeneous in size, and (b) channel heterogeneity is distinct from differences in occlusion site affinities. 2) ATP, at a low affinity allosteric site, had no significant effect on the maximal level of bound Rb+ at any [Rb+], but it accelerated both the fast and the slow phases of Rb+ binding and release, and it increased the ratio of fast to slow phases. Evidently, ATP activates the channels (lowers the energy barrier for access) without altering binding site affinities. 3) Na+ was a competitive inhibitor of Rb+ at the occluded sites, but it also acted at an allosteric site to activate the access channels. Rb+ and K+ also had allosteric effects: although they did not affect the access channels directly, they blocked the allosteric effect of Na+. 4) Ouabain was an access channel inhibitor. It reduced the rates of binding and release of Rb+, blocked channel activation by ATP and Na+, but seemed to have no effect on the events at the occluded sites. The existence of heterogeneous access channels to the ion transport sites and the demonstration of channel regulation by the physiological ligands of the enzyme suggest the necessity of the inclusion of such allosteric mechanisms in the reaction cycle of (Na+ + K+)-ATPase.	MED COLL OHIO,DEPT PHARMACOL,TOLEDO,OH 43699						NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-36573] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALMER E, 1992, BIOPHYS J, V61, P553; ASKARI A, 1988, J BIOL CHEM, V263, P235; ASKARI A, 1983, J BIOL CHEM, V258, P3453; Askari A, 1988, Prog Clin Biol Res, V268A, P149; BUXBAUM E, 1991, EUR J BIOCHEM, V195, P407, DOI 10.1111/j.1432-1033.1991.tb15720.x; BUXBAUM E, 1992, J THEOR BIOL, V155, P21, DOI 10.1016/S0022-5193(05)80546-6; CAPASSO JM, 1992, J BIOL CHEM, V267, P1150; ESMANN M, 1983, BIOCHIM BIOPHYS ACTA, V748, P413, DOI 10.1016/0167-4838(83)90187-5; ESMANN M, 1989, BIOCHIM BIOPHYS ACTA, V978, P209, DOI 10.1016/0005-2736(89)90117-X; ESMANN M, 1985, BIOCHIM BIOPHYS ACTA, V815, P196, DOI 10.1016/0005-2736(85)90289-5; FORBUSH B, 1987, J BIOL CHEM, V262, P11116; FORBUSH B, 1983, CURR TOP MEMBR TRANS, V19, P167; FORBUSH B, 1987, J BIOL CHEM, V262, P11104; Forbush B 3rd, 1988, Prog Clin Biol Res, V268A, P229; FROEHLICH JP, 1991, SODIUM PUMP STRUCTUR, P227; GLYNN IM, 1990, ANNU REV BIOCHEM, V59, P171, DOI 10.1146/annurev.bi.59.070190.001131; GLYNN IM, 1985, J PHYSIOL-LONDON, V368, P453, DOI 10.1113/jphysiol.1985.sp015868; GLYNN IM, 1982, J PHYSIOL-LONDON, V330, P17, DOI 10.1113/jphysiol.1982.sp014326; HAYASHI Y, 1989, BIOCHIM BIOPHYS ACTA, V983, P217, DOI 10.1016/0005-2736(89)90237-X; JENSEN J, 1983, CURR TOP MEMBR TRANS, V19, P223; JORGENSEN PL, 1982, BIOCHIM BIOPHYS ACTA, V705, P38, DOI 10.1016/0167-4838(82)90333-8; KLODOS I, 1985, SODIUM PUMP, P383; KLOTZ IM, 1984, J BIOL CHEM, V259, P60; MATSUI H, 1982, J BIOCHEM-TOKYO, V92, P193, DOI 10.1093/oxfordjournals.jbchem.a133916; MAUNSBACH AB, 1991, SODIUM PUMP STRUCTUR, P159; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Neet K E, 1980, Methods Enzymol, V64, P192; NORBY JG, 1991, SODIUM PUMP STRUCTUR, P173; OMAY HS, 1992, BIOCHIM BIOPHYS ACTA, V1104, P167, DOI 10.1016/0005-2736(92)90146-D; ROBERT CH, 1987, P NATL ACAD SCI USA, V84, P1891, DOI 10.1073/pnas.84.7.1891; ROBINSON JD, 1991, BIOCHIM BIOPHYS ACTA, V1069, P281, DOI 10.1016/0005-2736(91)90136-V; SHANI M, 1987, BIOCHIM BIOPHYS ACTA, V904, P13, DOI 10.1016/0005-2736(87)90081-2; SHANISEKLER M, 1988, J BIOL CHEM, V263, P19331; SKOU JC, 1980, BIOCHIM BIOPHYS ACTA, V601, P386, DOI 10.1016/0005-2736(80)90543-X; SKOU JC, 1983, BIOCHIM BIOPHYS ACTA, V746, P101, DOI 10.1016/0167-4838(83)90016-X; SUZUKI K, 1991, SODIUM PUMP RECENT D, P375; VASILETS LA, 1991, J BIOL CHEM, V266, P16285; YAMAGUCHI M, 1980, J BIOCHEM-TOKYO, V88, P1365, DOI 10.1093/oxfordjournals.jbchem.a133105; YODA A, 1987, J BIOL CHEM, V262, P110	39	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3289	3297						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381424				2022-12-27	WOS:A1993KM16100044
J	IGLESIAS, AA; BARRY, GF; MEYER, C; BLOKSBERG, L; NAKATA, PA; GREENE, T; LAUGHLIN, MJ; OKITA, TW; KISHORE, GM; PREISS, J				IGLESIAS, AA; BARRY, GF; MEYER, C; BLOKSBERG, L; NAKATA, PA; GREENE, T; LAUGHLIN, MJ; OKITA, TW; KISHORE, GM; PREISS, J			EXPRESSION OF THE POTATO-TUBER ADP-GLUCOSE PYROPHOSPHORYLASE IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC ACTIVATOR SITE; ADPGLUCOSE PYROPHOSPHORYLASE; BACTERIAL GLYCOGEN; SUBUNIT STRUCTURE; CLONING VEHICLES; REDUCED-ACTIVITY; BINDING-SITE; BIOSYNTHESIS; STARCH; SEQUENCE	cDNA clones encoding the putative mature forms of the large and small subunits of the potato tuber ADP-glucose pyrophosphorylase have been expressed separately and together in an Escherichia coli B mutant deficient in ADP-glucose pyrophosphorylase activity. Expression of both subunits from compatible vectors resulted in restoration of ADP-glucose pyrophosphorylase activity. Maximal enzyme activity required both subunits. The expressed ADP-glucose pyrophosphorylase was purified and characterized. The recombinant enzyme exhibited catalytic and allosteric kinetic properties very similar to the enzyme purified from potato tuber. The expressed enzyme activity was neutralized by incubation with antibodies raised against potato tuber and spinach leaf ADP-glucose pyrophosphorylases but not with anti-Escherichia coli enzyme serum. 3-Phosphoglycerate was the most efficient activator and its effect was increased by dithiothreitol. In the ADP-glucose synthesis direction, 3-phosphoglycerate activated the recombinant enzyme nearly 100-fold in the presence of dithiothreitol, with an A0.5 value of 57 muM. The recombinant ADP-glucose pyrophosphorylase was less sensitive to P(i) inhibition and more sensitive to heat denaturation than the potato tuber enzyme. Results suggest that bacterial expression of potato tuber cDNAs could be used to study the role and interaction of the subunits of the native ADP-glucose pyrophosphorylase.	MICHIGAN STATE UNIV, DEPT BIOCHEM, E LANSING, MI 48824 USA; MONSANTO CO, AGR GRP, ST LOUIS, MO 63198 USA; WASHINGTON STATE UNIV, INST BIOL CHEM, PULLMAN, WA 99164 USA	Michigan State University; Monsanto; Washington State University				Iglesias, Alberto/0000-0001-9729-7338; Nakata, Paul/0000-0002-6331-9700; Okita, Tom/0000-0002-2246-0599	NIAID NIH HHS [AI 022385] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BALL KL, 1992, J PROTEIN CHEM, V11, P231, DOI 10.1007/BF01024861; BALL S, 1991, PLANTA, V185, P17, DOI 10.1007/BF00194509; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CARLSON CA, 1976, J BIOL CHEM, V251, P7886; CARLSON CA, 1982, BIOCHEMISTRY-US, V21, P1929, DOI 10.1021/bi00537a036; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; DICKINSON DB, 1969, ARCH BIOCHEM BIOPHYS, V130, P119, DOI 10.1016/0003-9861(69)90017-4; DIXON M, 1979, ENZYMES, P332; DUJARDIN P, 1991, PLANT MOL BIOL, V16, P349, DOI 10.1007/BF00020568; FLING ME, 1985, NUCLEIC ACIDS RES, V13, P7095; Gabriel, 1971, METHOD ENZYMOL, V22, P565, DOI 10.1016/0076-6879(71)22041-3; GHOSH HP, 1966, J BIOL CHEM, V241, P4491; HAUGEN T, 1976, BIOCHEM BIOPH RES CO, V69, P346, DOI 10.1016/0006-291X(76)90528-3; IGLESIAS AA, 1992, J PROTEIN CHEM, V11, P119, DOI 10.1007/BF01025217; IGLESIAS AA, 1991, PLANT PHYSIOL, V97, P1187, DOI 10.1104/pp.97.3.1187; KAKEFUDA G, 1992, PLANT PHYSIOL, V99, P359, DOI 10.1104/pp.99.1.359; KEEGSTRA K, 1989, ANNU REV PLANT PHYS, V40, P471, DOI 10.1146/annurev.pp.40.060189.002351; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE YM, 1986, ARCH BIOCHEM BIOPHYS, V244, P585, DOI 10.1016/0003-9861(86)90627-2; MORELL M, 1988, J BIOL CHEM, V263, P633; MORELL MK, 1987, PLANT PHYSIOL, V85, P182, DOI 10.1104/pp.85.1.182; MULLERROBER BT, 1990, MOL GEN GENET, V224, P136, DOI 10.1007/BF00259460; NAKATA PA, 1991, PLANT MOL BIOL, V17, P1089, DOI 10.1007/BF00037149; NEUHAUS HE, 1989, PLANTA, V178, P110, DOI 10.1007/BF00392534; NEUHAUS HE, 1990, PLANTA, V182, P445, DOI [10.1007/BF02411398, 10.1007/BF00197565]; OKITA TW, 1990, PLANT PHYSIOL, V93, P785, DOI 10.1104/pp.93.2.785; OLINS PO, 1989, J BIOL CHEM, V264, P16973; OZAKI H, 1972, METHOD ENZYMOL, V23, P406; PARSONS TF, 1978, J BIOL CHEM, V253, P7638; PARSONS TF, 1978, J BIOL CHEM, V253, P6197; PETTERSSON G, 1989, EUR J BIOCHEM, V179, P169, DOI 10.1111/j.1432-1033.1989.tb14536.x; PLAXTON WC, 1987, PLANT PHYSIOL, V83, P105, DOI 10.1104/pp.83.1.105; PREISS J, 1991, BIOCHEM SOC T, V19, P539, DOI 10.1042/bst0190539; PREISS J, 1989, ADV MICROB PHYSIOL, V30, P183; Preiss J., 1988, BIOCH PLANTS, V14., P181; Preiss J, 1991, OXFORD SURVEYS PLANT, V7, P59; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SMITHWHITE BJ, 1992, J MOL EVOL, V34, P449, DOI 10.1007/BF00162999; SOBERON X, 1980, GENE, V9, P287, DOI 10.1016/0378-1119(90)90328-O; SOWOKINOS JR, 1982, PLANT PHYSIOL, V69, P1459, DOI 10.1104/pp.69.6.1459; SOWOKINOS JR, 1981, PLANT PHYSIOL, V68, P924, DOI 10.1104/pp.68.4.924	42	115	131	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1081	1086						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8380404				2022-12-27	WOS:A1993KG07700050
J	MADER, S; LEROY, P; CHEN, JY; CHAMBON, P				MADER, S; LEROY, P; CHEN, JY; CHAMBON, P			MULTIPLE PARAMETERS CONTROL THE SELECTIVITY OF NUCLEAR RECEPTORS FOR THEIR RESPONSE ELEMENTS - SELECTIVITY AND PROMISCUITY IN RESPONSE ELEMENT RECOGNITION BY RETINOIC ACID RECEPTORS AND RETINOID-X RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTORS; GENE PROMOTER; FUNCTIONAL-CHARACTERIZATION; GLUCOCORTICOID RECEPTOR; ESTROGEN-RECEPTOR; BETA-GENE; BINDING; MOUSE; DNA; TRANSCRIPTION	A number of nuclear receptors are capable of binding to specific DNA sequences known as response elements that correspond to two 5'-PuG(G/T)TCA motifs. We have systematically compared the selectivity of DNA sequence recognition by the estrogen receptor and the retinoic acid receptor (RAR) and retinoid X receptor (RXR), using a variety of synthetic oligonucleotides related to natural response elements. The importance of the spacing and relative orientation of the PuG(G/T)TCA motifs as well as the possible role of the flanking sequences were investigated for each receptor. We find that the three receptors have different response element preferences and that their intrinsic DNA binding properties cannot be simply ascribed to spacing or orientation rules. For example, RARs bind with similar efficiencies to response elements containing directly repeated PuGTTCA motifs separated by 2, 3, 4, or 5 base pairs, and RXRs bind to response elements in which the directly repeated motifs are separated by 1, 2, and 5 base pairs. The actual sequence of the repeated motifs and the nature of their flanking bases appear to be important parameters in determining RAR and RXR binding efficiencies. The possibility that the binding specificity of nuclear receptors can be modified by interactions with other proteins, in particular other nuclear receptors, is discussed in relation to the patterns of transcriptional activation observed with either endogenous or transiently expressed receptors on chimeric promoters containing various response elements.	FAC MED STRASBOURG,INST CHEM BIOL,INSERM,UNITE BIOL MOLEC & GEN GENET 184,CNRS,F-67085 STRASBOURG,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg								AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; BUGGE TH, 1992, EMBO J, V11, P1409, DOI 10.1002/j.1460-2075.1992.tb05186.x; DESVERGNE B, 1991, J BIOL CHEM, V266, P1008; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DEVERNEUIL H, 1990, NUCLEIC ACIDS RES, V18, P4489; DOLLE P, 1989, NATURE, V342, P702, DOI 10.1038/342702a0; DUESTER G, 1991, MOL CELL BIOL, V11, P1638, DOI 10.1128/MCB.11.3.1638; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FLINK IL, 1990, J BIOL CHEM, V265, P11233; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GRAUPNER G, 1989, NATURE, V340, P653, DOI 10.1038/340653a0; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; HAMADA K, 1989, P NATL ACAD SCI USA, V86, P8289, DOI 10.1073/pnas.86.21.8289; HOFFMANN B, 1990, MOL ENDOCRINOL, V4, P1727, DOI 10.1210/mend-4-11-1727; KATO S, 1992, CELL, V68, P731, DOI 10.1016/0092-8674(92)90148-6; KLEINHITPASS L, 1988, NUCLEIC ACIDS RES, V16, P647, DOI 10.1093/nar/16.2.647; KLIEWER A, 1992, P NATL ACAD SCI USA, V89, P1448; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; KLOCK G, 1987, NATURE, V329, P734, DOI 10.1038/329734a0; KRUST A, 1989, P NATL ACAD SCI USA, V86, P5310, DOI 10.1073/pnas.86.14.5310; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; LEROY P, 1991, EMBO J, V10, P59, DOI 10.1002/j.1460-2075.1991.tb07921.x; LEROY P, 1991, P NATL ACAD SCI USA, V88, P10138, DOI 10.1073/pnas.88.22.10138; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; MANGELSDORF DJ, 1991, CELL, V66, P555, DOI 10.1016/0092-8674(81)90018-0; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MANGELSDORF DJ, 1990, NATURE, V345, P223; MARKS MS, 1992, EMBO J, V11, P1419, DOI 10.1002/j.1460-2075.1992.tb05187.x; MARTINEZ E, 1987, EMBO J, V6, P3719, DOI 10.1002/j.1460-2075.1987.tb02706.x; MENDELSOHN C, 1992, DEV BIOL, V152, P50, DOI 10.1016/0012-1606(92)90155-A; MENDELSOHN C, 1991, DEVELOPMENT, V113, P723; MUNOZCANOVES P, 1990, J BIOL CHEM, V265, P20065; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; NICHOLSON RC, 1990, EMBO J, V9, P4443, DOI 10.1002/j.1460-2075.1990.tb07895.x; NORDEEN SK, 1990, MOL ENDOCRINOL, V4, P1866, DOI 10.1210/mend-4-12-1866; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; ROTTMAN JN, 1991, MOL CELL BIOL, V11, P3814, DOI 10.1128/MCB.11.7.3814; RUIZ MDMV, 1991, EMBO J, V10, P3829, DOI 10.1002/j.1460-2075.1991.tb04952.x; SAP J, 1990, EMBO J, V9, P887, DOI 10.1002/j.1460-2075.1990.tb08186.x; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SMITH WC, 1991, EMBO J, V10, P2223, DOI 10.1002/j.1460-2075.1991.tb07758.x; SUCOV HM, 1990, P NATL ACAD SCI USA, V87, P5392, DOI 10.1073/pnas.87.14.5392; TORA L, 1988, EMBO J, V7, P3771, DOI 10.1002/j.1460-2075.1988.tb03261.x; TORA L, 1989, EMBO J, V8, P1986; TRUSS M, 1990, P NATL ACAD SCI USA, V87, P7180, DOI 10.1073/pnas.87.18.7180; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; VASIOS G, 1991, EMBO J, V10, P1149, DOI 10.1002/j.1460-2075.1991.tb08055.x; VASIOS GW, 1989, P NATL ACAD SCI USA, V86, P9099, DOI 10.1073/pnas.86.23.9099; WIDOM RL, 1991, MOL CELL BIOL, V11, P677, DOI 10.1128/MCB.11.2.677; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZELENT A, 1991, EMBO J, V10, P71, DOI 10.1002/j.1460-2075.1991.tb07922.x; ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	59	204	206	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					591	600						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380169				2022-12-27	WOS:A1993KE60300089
J	RABINOWITZ, I; RANDI, AM; SHINDLER, KS; TULEY, EA; RUSTAGI, PK; SADLER, JE				RABINOWITZ, I; RANDI, AM; SHINDLER, KS; TULEY, EA; RUSTAGI, PK; SADLER, JE			TYPE-IIB MUTATION HIS-505 -] ASP IMPLICATES A NEW SEGMENT IN THE CONTROL OF VON-WILLEBRAND-FACTOR BINDING TO PLATELET GLYCOPROTEIN-IB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE MONOCLONAL-ANTIBODY; VON-WILLEBRAND FACTOR; MISSENSE MUTATIONS; FACTOR MULTIMERS; HEMOPHILIA-A; DISEASE; RISTOCETIN; COMPLEX; IDENTIFICATION; DOMAIN	Type IIB von Willebrand disease is characterized by increased affinity of mutant von Willebrand factor (vWF) for platelet glycoprotein Ib. Eight different missense mutations that cause this phenotype have been reported within the disulfide loop defined by Cys-509 and Cys-695 of the mature vWF subunit; this disulfide loop is required for normal binding of vWF to platelet glycoprotein Ib. A new mutation was identified in a patient with type IIB von Willebrand disease (vWD) characterized by a lifelong bleeding disorder, mild thrombocytopenia, normal levels of factor VIII, vWF antigen, and ristocetin cofactor activity but increased ristocetin-induced platelet agglutination at low concentrations of ristocetin. Exon 28 of the patient's vWF gene was amplified, cloned, and sequenced. At nucleotide 3802 (numbering the cDNA from translation initiation), a C to G transversion was identified, which changes the encoded amino acid sequence from His-505 to Asp. The corresponding mutant recombinant vWF was expressed in transiently transfected COS cells. Relative to wild type vWF, the mutant vWF exhibited markedly increased binding to platelets at low concentrations of ristocetin, confirming the association between the His-505 --> Asp substitution and the type IIB vWD phenotype. The His-505 --> Asp mutation lies outside the disulfide loop affected by other type IIB vWD mutations and implicates a new segment of vWF in the regulation of platelet glycoprotein Ib binding.	WASHINGTON UNIV,SCH MED,HOWARD HUGHES MED INST,660 S EUCLID AVE,BOX 8022,ST LOUIS,MO 63110; WASHINGTON UNIV,JEWISH HOSP ST LOUIS,SCH MED,DEPT MED,ST LOUIS,MO 63110; WASHINGTON UNIV,JEWISH HOSP ST LOUIS,SCH MED,DEPT BIOCHEM & MOLEC BIOPHYS,ST LOUIS,MO 63110; UNIV ALABAMA,DEPT MED,BIRMINGHAM,AL 35294; UNIV ALABAMA,DEPT PATHOL,BIRMINGHAM,AL 35294	Howard Hughes Medical Institute; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham			Sadler, Evan/D-8556-2011; Shindler, Kenneth/D-2095-2009	Sadler, J. Evan/0000-0001-5705-469X	NHLBI NIH HHS [HLBI 14147] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL014147] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDREWS RK, 1989, BIOCHEMISTRY-US, V28, P8326, DOI 10.1021/bi00447a010; BERNDT MC, 1992, BIOCHEMISTRY-US, V31, P11144, DOI 10.1021/bi00160a027; BRINKHOUS KM, 1980, BLOOD, V55, P517; COLLER BS, 1983, BLOOD, V61, P99; COLLER BS, 1983, J CLIN INVEST, V72, P325, DOI 10.1172/JCI110973; COONEY KA, 1991, J CLIN INVEST, V87, P1227, DOI 10.1172/JCI115123; COONEY KA, 1992, P NATL ACAD SCI USA, V89, P2869, DOI 10.1073/pnas.89.7.2869; DEMARCO L, 1985, P NATL ACAD SCI USA, V82, P7424; DEMARCO L, 1990, J CLIN INVEST, V86, P785, DOI 10.1172/JCI114775; DONNER M, 1992, BRIT J HAEMATOL, V82, P58, DOI 10.1111/j.1365-2141.1992.tb04594.x; FUJIMURA Y, 1986, J BIOL CHEM, V261, P381; HOLMBERG L, 1993, J CLIN INVEST, V91, P2169, DOI 10.1172/JCI116443; HOLMBERG L, 1986, BLOOD, V68, P668; KRONER PA, 1992, BLOOD, V79, P2048; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANCUSO DJ, 1991, BIOCHEMISTRY-US, V30, P253, DOI 10.1021/bi00215a036; MAZURIER C, 1990, BRIT J HAEMATOL, V76, P372, DOI 10.1111/j.1365-2141.1990.tb06371.x; MAZURIER C, 1988, BRIT J HAEMATOL, V69, P499, DOI 10.1111/j.1365-2141.1988.tb02406.x; MOHRI H, 1988, J BIOL CHEM, V263, P17901; NISHIO K, 1990, AM J HEMATOL, V33, P261, DOI 10.1002/ajh.2830330409; RABINOWITZ I, 1992, P NATL ACAD SCI USA, V89, P9846, DOI 10.1073/pnas.89.20.9846; RAINES G, 1990, THROMB RES, V60, P201, DOI 10.1016/0049-3848(90)90181-B; RANDI AM, 1991, J CLIN INVEST, V87, P1220, DOI 10.1172/JCI115122; RANDI AM, 1992, J BIOL CHEM, V267, P21187; RIBBA AS, 1992, J BIOL CHEM, V267, P23209; RIBBA AS, 1991, BLOOD, V78, P1738; RUGGERI ZM, 1980, NEW ENGL J MED, V302, P1047, DOI 10.1056/NEJM198005083021902; SADLER JE, 1991, J BIOL CHEM, V266, P22777; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SOUTAR AK, 1990, PROTEIN FUNCTION, P69; SUGIMOTO M, 1991, J BIOL CHEM, V266, P18172; TULEY EA, 1991, P NATL ACAD SCI USA, V88, P6377, DOI 10.1073/pnas.88.14.6377; WAGNER DD, 1991, CELL, V64, P403, DOI 10.1016/0092-8674(91)90648-I; WARE J, 1991, P NATL ACAD SCI USA, V88, P2946, DOI 10.1073/pnas.88.7.2946; WEISS HJ, 1986, BLOOD, V68, P149; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585	36	31	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20497	20501						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376405				2022-12-27	WOS:A1993LY01900083
J	BAUM, G; CHEN, YL; ARAZI, T; TAKATSUJI, H; FROMM, H				BAUM, G; CHEN, YL; ARAZI, T; TAKATSUJI, H; FROMM, H			A PLANT GLUTAMATE-DECARBOXYLASE CONTAINING A CALMODULIN-BINDING DOMAIN - CLONING, SEQUENCE, AND FUNCTIONAL-ANALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-AMINOBUTYRIC ACID; RAPHANUS-SATIVUS L; ESCHERICHIA-COLI; HEAT-SHOCK; CALCIUM; CELLS; EXPRESSION; METABOLISM; PURIFICATION; ACCUMULATION	Molecular procedures have been applied to isolate plant calmodulin-binding proteins. A petunia CDNA expression library was screened with S-35-labeled recombinant calmodulin as a probe, and a CDNA coding for a Ca2+-dependent calmodulin-binding protein was isolated. The deduced amino acid sequence of the petunia protein (500 amino acid residues, 58 kDa) has 67% overall amino acid sequence similarity to glutamate decarboxylase (GAD) from Escherichia coli (466 amino acid residues, 53 kDa). The recombinant protein expressed in E. coli cells displays GAD activity, i.e. catalyzes the conversion of glutamic acid to gamma-aminobutyric acid and binds calmodulin, whereas E. coli GAD does not bind calmodulin. The calmodulin binding domain in the petunia GAD was mapped by binding truncated forms of GAD immobilized on nitrocellulose membranes to recombinant petunia S-35-calmodulin as well as to biotinylated bovine calmodulin and by binding truncated forms of GAD to calmodulin-Sepharose columns. The calmodulin binding domain in petunia GAD is part of a carboxyl end extension that is not present in E. coli GAD. Polyclonal antibodies raised against the recombinant petunia GAD detect a single protein band from plant extracts of gel mobility identical to that of the recombinant GAD. Moreover, the plant protein binds calmodulin in vitro. This is the first report of the isolation of a GAD gene from plants and of a calmodulin-binding GAD from any organism. Our results raise the possibility that intracellular Ca2+ signals via calmodulin are involved in the regulation of gamma-aminobutyric acid synthesis in plants.	WEIZMANN INST SCI, DEPT PLANT GENET, IL-76100 REHOVOT, ISRAEL; NATL INST AGROBIOL RESOURCES, TSUKUBA, IBARAKI 305, JAPAN	Weizmann Institute of Science; National Institute of Agrobiological Sciences - Japan			FROMM, HILLEL/AAF-6783-2019	FROMM, HILLEL/0000-0003-1977-1211; Baum, Gideon/0000-0002-4167-0188				BIELESKI RL, 1966, ANAL BIOCHEM, V17, P278, DOI 10.1016/0003-2697(66)90206-5; BLUMENTHAL DK, 1985, P NATL ACAD SCI USA, V82, P3187, DOI 10.1073/pnas.82.10.3187; BORMANN J, 1988, TRENDS NEUROSCI, V11, P112, DOI 10.1016/0166-2236(88)90156-7; BRAAM J, 1992, P NATL ACAD SCI USA, V89, P3213, DOI 10.1073/pnas.89.8.3213; BRAAM J, 1990, CELL, V60, P357, DOI 10.1016/0092-8674(90)90587-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER M, 1969, THIN LAYER CHROMATOG, P730; Campbell A.K, 1983, INTRACELLULAR CALCIU; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOYLE KE, 1990, J MOL BIOL, V213, P599, DOI 10.1016/S0022-2836(05)80245-1; ERLANDER MG, 1991, NEUROCHEM RES, V16, P215, DOI 10.1007/BF00966084; FISCHER R, 1988, J BIOL CHEM, V263, P17055; FONDA ML, 1985, METHOD ENZYMOL, V113, P11; FROMM H, 1991, 1991 COLD SPRING HAR, P35; Fromm H, 1992, PLANT MOL BIOL REP, V10, P199, DOI 10.1007/BF02668347; HEPLER PK, 1985, ANNU REV PLANT PHYS, V36, P397, DOI 10.1146/annurev.pp.36.060185.002145; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; INATOMI K, 1975, BIOCHEM J, V147, P479, DOI 10.1042/bj1470479; KARLSEN AE, 1991, P NATL ACAD SCI USA, V88, P8337, DOI 10.1073/pnas.88.19.8337; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARAS B, 1992, EUR J BIOCHEM, V204, P93, DOI 10.1111/j.1432-1033.1992.tb16609.x; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; MAYER RR, 1990, PLANT PHYSIOL, V94, P796, DOI 10.1104/pp.94.2.796; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MEANS AR, 1988, RECENT PROG HORM RES, V44, P223; MINORSKY PV, 1989, PLANT CELL ENVIRON, V12, P137, DOI 10.1111/j.1365-3040.1989.tb01925.x; ONEIL KT, 1987, SCIENCE, V236, P1454, DOI 10.1126/science.3589665; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; POOVAIAH BW, 1987, CRC CR REV PLANT SCI, V6, P47, DOI 10.1080/07352688709382247; RAZ V, 1992, PLANT CELL, V4, P1123, DOI 10.1105/tpc.4.9.1123; RHODES D, 1986, PLANT PHYSIOL, V82, P890, DOI 10.1104/pp.82.4.890; ROBERTS DM, 1992, ANNU REV PLANT PHYS, V43, P375, DOI 10.1146/annurev.pp.43.060192.002111; ROBERTS JKM, 1992, PLANT PHYSIOL, V98, P480, DOI 10.1104/pp.98.2.480; ROUX SJ, 1986, PHYSIOL PLANTARUM, V66, P344, DOI 10.1111/j.1399-3054.1986.tb02430.x; ROUX SJ, 1987, CRC CR REV PLANT SCI, V5, P205, DOI 10.1080/07352688709382240; SALGANICOFF L, 1965, J NEUROCHEM, V12, P287, DOI 10.1111/j.1471-4159.1965.tb06766.x; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATYANARAYAN V, 1985, EUR J BIOCHEM, V150, P53, DOI 10.1111/j.1432-1033.1985.tb08987.x; SATYANARAYAN V, 1990, PHYTOCHEMISTRY, V29, P367, DOI DOI 10.1016/0031-9422(90)85081-P; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SNEDDEN WA, 1992, PLANT PHYSIOL, V99, P665, DOI 10.1104/pp.99.2.665; STREETER JG, 1972, PLANT PHYSIOL, V49, P579, DOI 10.1104/pp.49.4.579; STREETER JG, 1972, PLANT PHYSIOL, V49, P572, DOI 10.1104/pp.49.4.572; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TRETYN A, 1990, PHYSIOL PLANTARUM, V78, P230, DOI 10.1111/j.1399-3054.1990.tb02086.x; WALLACE W, 1984, PLANT PHYSIOL, V75, P170, DOI 10.1104/pp.75.1.170; WATILLON B, 1992, PLANT SCI, V81, P227, DOI 10.1016/0168-9452(92)90046-O	50	189	224	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19610	19617						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366104				2022-12-27	WOS:A1993LW81900072
J	DABEVA, MD; WARNER, JR				DABEVA, MD; WARNER, JR			RIBOSOMAL-PROTEIN L32 OF SACCHAROMYCES-CEREVISIAE REGULATES BOTH SPLICING AND TRANSLATION OF ITS OWN TRANSCRIPT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; EXCESS PROTEIN; YEAST; GENE; ACCUMULATION; DEGRADATION; INITIATION; EXPRESSION; UPSTREAM; ELEMENTS	Ribosomal protein L32 of Saccharomyces cerevisiae regulates the splicing of its own transcript (1, 2) apparently by interacting with a structure composed largely of the 5' exon. However, even in strains overproducing L32 mRNA, e.g. from a cDNA copy of the gene, little accumulation of L32 is observed after a brief pulse label. When the 5' leader of the RPL32 mRNA is replaced by an exogenous leader, the amount of pulse-labeled L32 increases severalfold, suggesting that L32 regulates the translation of its own mRNA, acting through sequences in the 5' region. This conclusion was confirmed by the observation that in cells carrying a chimeric gene in which the L32 leader is fused to LacZ coding sequences, the presence of a second gene that overexpresses L32 itself reduces the level of beta-galactosidase by 50%, in spite of a doubling of L32-lacZ fusion mRNA, presumably due to stabilization of the message. Mutations within the 5' leader that abolish the regulation of splicing also abolish the regulation of translation, suggesting that the regulation of translation by L32 involves a structure similar to that proposed for the regulation of splicing. In cells overproducing L32-mRNA about half the excess mRNA was found in ribonucleoproteins of <25 S, unassociated with ribosomal particles. Much of the rest was found in ribonucleoproteins of 80-120 S.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT CELL BIOL,1300 MORRIS PK AVE,BRONX,NY 10461	Yeshiva University; Albert Einstein College of Medicine					NCI NIH HHS [CA 13330] Funding Source: Medline; NIGMS NIH HHS [GM25532] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025532] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOVICH N, 1985, MOL CELL BIOL, V5, P3429, DOI 10.1128/MCB.5.12.3429; ALONI R, 1992, MOL CELL BIOL, V12, P2203, DOI 10.1128/MCB.12.5.2203; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; DABEVA MD, 1987, J BIOL CHEM, V262, P16055; DABEVA MD, 1986, P NATL ACAD SCI USA, V83, P5854, DOI 10.1073/pnas.83.16.5854; DONOVAN DM, 1986, MOL CELL BIOL, V6, P2429, DOI 10.1128/MCB.6.7.2429; ELBARADI TTAL, 1986, CURR GENET, V10, P733, DOI 10.1007/BF00405095; ENG FJ, 1991, CELL, V65, P797, DOI 10.1016/0092-8674(91)90387-E; GEYER PK, 1982, MOL CELL BIOL, V2, P685, DOI 10.1128/MCB.2.6.685; GORENSTEIN C, 1976, P NATL ACAD SCI USA, V73, P1547, DOI 10.1073/pnas.73.5.1547; HAMMOND ML, 1991, GENE DEV, V5, P1723, DOI 10.1101/gad.5.9.1723; HERRUER MH, 1987, NUCLEIC ACIDS RES, V15, P10133, DOI 10.1093/nar/15.24.10133; HERRUER MH, 1988, NUCLEIC ACIDS RES, V16, P7917, DOI 10.1093/nar/16.16.7917; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; JACOBSLORENA M, 1987, TRANSLATIONAL REGULA, P63; JINKSROBERTSON S, 1987, ESCHERICHIA COLI SAL, P1358; KASPAR RL, 1990, J BIOL CHEM, V265, P3619; KASPAR RL, 1992, J BIOL CHEM, V267, P508; KIEF DR, 1981, MOL CELL BIOL, V1, P1007, DOI 10.1128/MCB.1.11.1007; KIM CH, 1983, J MOL BIOL, V165, P79, DOI 10.1016/S0022-2836(83)80243-5; LEVY S, 1991, P NATL ACAD SCI USA, V88, P3319, DOI 10.1073/pnas.88.8.3319; MAICAS E, 1988, MOL CELL BIOL, V8, P169, DOI 10.1128/MCB.8.1.169; MAINA CV, 1988, GENE, V74, P365, DOI 10.1016/0378-1119(88)90170-9; MARIOTTINI P, 1990, MOL CELL BIOL, V10, P816, DOI 10.1128/MCB.10.2.816; MCKNIGHT GL, 1983, P NATL ACAD SCI-BIOL, V80, P4412, DOI 10.1073/pnas.80.14.4412; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; PEARSON NJ, 1982, CELL, V29, P347, DOI 10.1016/0092-8674(82)90151-9; Rose MD., 1990, METHODS YEAST GENETI; ROTENBERG MO, 1986, MOL CELL BIOL, V6, P674, DOI 10.1128/MCB.6.2.674; SCHWINDINGER WF, 1987, J BIOL CHEM, V262, P5690; STEEL LF, 1987, MOL CELL BIOL, V7, P965, DOI 10.1128/MCB.7.3.965; TSAY YF, 1988, GENE DEV, V2, P664, DOI 10.1101/gad.2.6.664; WARNER JR, 1985, MOL CELL BIOL, V5, P1512, DOI 10.1128/MCB.5.6.1512; WARNER JR, 1977, J MOL BIOL, V115, P315, DOI 10.1016/0022-2836(77)90157-7; Woolford Jr JL, 1991, MOL CELLULAR BIOL YE, P587; WOUDT LP, 1986, EMBO J, V5, P1037, DOI 10.1002/j.1460-2075.1986.tb04319.x	37	83	84	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19669	19674						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366109				2022-12-27	WOS:A1993LW81900080
J	STONE, RL; ZALKIN, H; DIXON, JE				STONE, RL; ZALKIN, H; DIXON, JE			EXPRESSION, PURIFICATION, AND KINETIC CHARACTERIZATION OF RECOMBINANT HUMAN ADENYLOSUCCINATE LYASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-T7 RNA-POLYMERASE; ESCHERICHIA-COLI; SYNTHETASE; GENES; CLONING; PROTEIN; ENZYME	Adenylosuccinate adenosine 5'-monophospate lyase (EC 4.3.2.2; ASL) catalyzes two distinct reactions in adenosine 5'-monophosphate (AMP) biosynthesis. A S413P mutation in ASL segregates with mental retardation in an affected family (Stone, R. L., Aimi, J., Barshop, B. A., Jaeken, J., Van den Berghe, G., Zalkin, H., and Dixon, J. E. (1992) Nature Genet. 1, 59-63). ASL and S413P ASL have been expressed, purified, and kinetically characterized. Lowering the Escherichia coli growth temperature to 25-degrees-C and the concentration of inducer, isopropyl-1-thio-beta,D-galactopyranoside, to 40 muM was necessary for synthesis of soluble, tetrameric enzymes. The recombinant enzymes were purified to homogeneity using anion exchange chromatography followed by chromatography on Blue 2A Sepharose. At pH 7.0 and 25-degrees-C, the k(cat) for cleavage of 5-amino-4-imidazole-N-succinocarboxamide ribotide (SAICAR) by ASL was 90 s-1 with a K(m) of 2.3 5 muM. The k(cat) for adenylosuccinate (SAMP) cleavage was 97 s-1 with a K(m) of 1.79 muM. The catalytic mechanism involved one general base catalyst (pK(a) = 6.4) and one general acid catalyst (pK(a) = 7.5). ASL follows an ordered uni-bi reaction mechanism with fumarate released first. 5-Amino-4-imidazolecarboxamide ribotide (AICAR) and AMP were competitive with SAICAR and SAMP (Ki[AICAR] = 11.3 muM; K(i)[AMP] = 9.2 muM), whereas fumarate inhibited noncompetitively (K(ii) = 2.3 mM, K(is) = 2.8 mM). The competitive inhibition by AICAR and AMP suggests a single active site that binds both SAICAR and SAMP. The kinetic constants at pH 7.0, 25-degrees-C and the k(cat)/K(m) versus pH profiles for ASL and S413P ASL were very similar. These results are consistent with S413P being a structural rather than a catalytic defect.	UNIV MICHIGAN,SCH MED,DEPT BIOL CHEM,5416 MED SCI 1,ANN ARBOR,MI 48109; PURDUE UNIV,DEPT BIOCHEM,W LAFAYETTE,IN 47907	University of Michigan System; University of Michigan; Purdue University System; Purdue University; Purdue University West Lafayette Campus					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018024, R37DK018024] Funding Source: NIH RePORTER; NIDDK NIH HHS [NIDDKD 18024] Funding Source: Medline; NIGMS NIH HHS [GM46466] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIMI J, 1990, J BIOL CHEM, V265, P9011; BARSHOP BA, 1989, BIOCHIM BIOPHYS ACTA, V999, P19, DOI 10.1016/0167-4838(89)90023-X; BECKER MA, 1986, ARTHRITIS RHEUM, V29, P880, DOI 10.1002/art.1780290710; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIDGER WA, 1968, J BIOL CHEM, V243, P644; BROX LW, 1973, CAN J BIOCHEM CELL B, V51, P1072, DOI 10.1139/o73-140; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; CASEY PJ, 1986, J BIOL CHEM, V261, P3637; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P173, DOI 10.1016/0926-6569(63)90226-8; DIXON JE, 1992, PROG NUCLEIC ACIDS R, V42, P262; GENDRON N, 1992, P NATL ACAD SCI USA, V89, P5389, DOI 10.1073/pnas.89.12.5389; JAEKEN J, 1988, EUR J PEDIATR, V148, P126, DOI 10.1007/BF00445919; JAEKEN J, 1984, LANCET, V2, P1058; JAEKEN J, 1992, J INHERITED METAB DI, V5, P416; MITSUYA H, 1986, P NATL ACAD SCI USA, V83, P1911, DOI 10.1073/pnas.83.6.1911; MOFFATT BA, 1987, CELL, V49, P221, DOI 10.1016/0092-8674(87)90563-0; NAIR V, 1992, BIOCHIM BIOPHYS ACTA, V1119, P201, DOI 10.1016/0167-4838(92)90392-Q; PARSELL DA, 1989, J BIOL CHEM, V264, P7590; PATTERSON D, 1981, P NATL ACAD SCI-BIOL, V78, P405, DOI 10.1073/pnas.78.1.405; POWELL SM, 1992, FEBS LETT, V303, P4, DOI 10.1016/0014-5793(92)80465-S; SEEGMILLER JE, 1980, DISEASES PURINE PYRI; SHEN BW, 1975, J AM CHEM SOC, V97, P1205, DOI 10.1021/ja00838a040; SPECTOR T, 1977, BIOCHIM BIOPHYS ACTA, V481, P741, DOI 10.1016/0005-2744(77)90308-4; Steczko J, 1991, Protein Expr Purif, V2, P221, DOI 10.1016/1046-5928(91)90075-T; STONE RL, 1992, NAT GENET, V1, P59, DOI 10.1038/ng0492-59; STONE RL, 1993, IN PRESS 2ND ANN MUN; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; VANDENBERGH F, 1991, ADV EXP MED BIOL, V309, P277; VANDENBERGH F, 1991, ANAL BIOCHEM, V193, P287, DOI 10.1016/0003-2697(91)90023-M	30	59	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19710	19716						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366112				2022-12-27	WOS:A1993LW81900085
J	LAURIE, SM; CAIN, CC; LIENHARD, GE; CASTLE, JD				LAURIE, SM; CAIN, CC; LIENHARD, GE; CASTLE, JD			THE GLUCOSE-TRANSPORTER GLUT4 AND SECRETORY CARRIER MEMBRANE-PROTEINS (SCAMPS) COLOCALIZE IN RAT ADIPOCYTES AND PARTIALLY SEGREGATE DURING INSULIN STIMULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-II RECEPTORS; 3T3-L1 ADIPOCYTES; TRANSFERRIN RECEPTORS; ADIPOSE-CELLS; PLASMA-MEMBRANE; TRANSLOCATION; LOCALIZATION; VESICLES; REDISTRIBUTION; BIOGENESIS	Secretory carrier membrane proteins (SCAMPs) mark the recycling system for the insulin-responsive glucose transporter, GluT4, in rat adipocytes. Anti-GluT4 and anti-SCAMP antibodies each immunoadsorb vesicles containing both antigens from a low density microsomal fraction that is enriched in both antigens. The immunoadsorbed vesicles also contain VAMPs (synaptobrevins), synaptic vesicle membrane proteins. All three antigens were colocalized in low density microsomal vesicles from both basal and insulin-stimulated adipocytes. The SCAMPs have the same electrophoretic mobility as a major polypeptides detected in GluT4 vesicles. During insulin stimulation, 40% each of GluT4 and VAMPs redistribute from low density microsomes to the plasma membrane fraction; however, <10% of the SCAMPs redistribute. Immunocytochemical staining of adipose tissue shows almost complete coincidence of SCAMPs and GluT4 in the basal state and extensive redistribution of both antigens to the cell periphery during insulin stimulation. Segregation of antigens during stimulation is not as distinct as observed by fractionation, although there are regions at the cell border where the SCAMPs appear more concentrated than GluT4. These data suggest that during insulin stimulation, in contrast to the behavior of GluT4, SCAMPs remain tightly associated with the recycling system.	UNIV VIRGINIA,MED CTR,HLTH SCI CTR,DEPT ANAT & CELL BIOL,BOX 439,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,MED CTR,INST MOLEC BIOL,CHARLOTTESVILLE,VA 22908; DARTMOUTH COLL SCH MED,DEPT BIOCHEM,HANOVER,NH 03755	University of Virginia; University of Virginia; Dartmouth College			Mastick, Cynthia/G-9841-2017	Mastick, Cynthia/0000-0003-4769-5412	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE009655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025336, R55DK025336] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE09655] Funding Source: Medline; NIDDK NIH HHS [DK25336] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		APPELL KC, 1988, J BIOL CHEM, V263, P10824; BALDINI G, 1991, J BIOL CHEM, V266, P4037; BRAND SH, 1991, J BIOL CHEM, V266, P18949; CAIN CC, 1992, J BIOL CHEM, V267, P11681; CALDERHEAD DM, 1990, J BIOL CHEM, V265, P1380; CAMERON PL, 1991, J CELL BIOL, V115, P151, DOI 10.1083/jcb.115.1.151; CLIFTOGRADY L, 1990, J CELL BIOL, V110, P1693, DOI 10.1083/jcb.110.5.1693; DAVIS RJ, 1986, J BIOL CHEM, V261, P8708; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; JHUN BH, 1992, J BIOL CHEM, V267, P17710; KITAGAWA K, 1989, BIOCHIM BIOPHYS ACTA, V1014, P83, DOI 10.1016/0167-4889(89)90244-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURIE SM, 1992, EUR J CELL BIOL, V58, P12; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; ROBINSON LJ, 1992, AM J PHYSIOL, V263, pE383, DOI 10.1152/ajpendo.1992.263.2.E383; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; RODNICK KJ, 1992, J BIOL CHEM, V267, P6278; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SLOT JW, 1990, NATURE, V346, P369, DOI 10.1038/346369a0; SLOT JW, 1991, P NATL ACAD SCI USA, V88, P7815, DOI 10.1073/pnas.88.17.7815; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; SMITH RM, 1991, P NATL ACAD SCI USA, V88, P6893, DOI 10.1073/pnas.88.15.6893; TANNER LI, 1989, J CELL BIOL, V108, P1537, DOI 10.1083/jcb.108.4.1537; TANNER LI, 1987, J BIOL CHEM, V262, P8975; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; ZORZANO A, 1989, J BIOL CHEM, V264, P12358	27	110	112	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					19110	19117						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360193				2022-12-27	WOS:A1993LV65900108
J	POTTER, DA; LARSON, CJ; ECKES, P; SCHMID, RM; NABEL, GJ; VERDINE, GL; SHARP, PA				POTTER, DA; LARSON, CJ; ECKES, P; SCHMID, RM; NABEL, GJ; VERDINE, GL; SHARP, PA			PURIFICATION OF THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I TRANSCRIPTION FACTOR-H2TF1 - THE FULL-LENGTH PRODUCT OF THE NFKB2 GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DNA-BINDING SUBUNIT; POLYACRYLAMIDE GELS; AFFINITY PURIFICATION; REGULATORY SEQUENCE; ENHANCER SEQUENCES; RNA-POLYMERASE; NUCLEAR FACTOR; P50 PRECURSOR; REL ONCOGENE	H2TF1 is a ubiquitous major histocompatibility complex (MHC) class I-specific transcription factor, which binds to the palindromic kappaB enhancer site upstream of MHC class I genes. Here we report that H2TF1 consists of a polypeptide with relative molecular mass 110,000, that corresponds to the predicted 100-kDa product (NF-kappaB2 p100) encoded by the candidate proto-oncogene nfkb2 (lyt-10). H2TF1 was purified by a novel affinity chromatography method and identified as the NF-kappaB2 p100 polypeptide by peptide sequencing as well as by reactivity with a specific antiserum. Purified H2TF1 binds the MHC kappaB site with high affinity (K(D) = 3 x 10(-11) M), in contrast with previous reports that NF-kappaB2 p100 did not bind DNA.	MIT,CTR CANC RES,CAMBRIDGE,MA 02139; MIT,DEPT BIOL,CAMBRIDGE,MA 02139; HARVARD UNIV,DEPT CHEM,CAMBRIDGE,MA 02138; UNIV MICHIGAN,MED CTR,HOWARD HUGHES MED INST,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,MED CTR,DEPT BIOL CHEM,ANN ARBOR,MI 48109	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan				Larson, Christopher J./0000-0001-8574-2246	NATIONAL CANCER INSTITUTE [P01CA042063, K08CA001562, P30CA014051] Funding Source: NIH RePORTER; NCI NIH HHS [K08 CA001562-04, K08-CA-01562-01, P01 CA042063, P30-CA14051, P01-CA42063, P30 CA014051] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BALDWIN AS, 1988, P NATL ACAD SCI USA, V85, P723, DOI 10.1073/pnas.85.3.723; BALDWIN AS, 1987, MOL CELL BIOL, V7, P305, DOI 10.1128/MCB.7.1.305; BERNARDS R, 1987, TRENDS GENET, V3, P298, DOI 10.1016/0168-9525(87)90272-1; BERNARDS R, 1991, EMBO J, V10, P1119, DOI 10.1002/j.1460-2075.1991.tb08052.x; BLANCHET O, 1992, P NATL ACAD SCI USA, V89, P3488, DOI 10.1073/pnas.89.8.3488; BLANK V, 1991, EMBO J, V10, P4159, DOI 10.1002/j.1460-2075.1991.tb04994.x; BLANK V, 1992, TRENDS BIOCHEM SCI, V17, P135, DOI 10.1016/0968-0004(92)90321-Y; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BOURS V, 1992, MOL CELL BIOL, V12, P685, DOI 10.1128/MCB.12.2.685; BOURS V, 1990, NATURE, V348, P76, DOI 10.1038/348076a0; CHODOSH LA, 1991, CURRENT PROTOCOLS MO; DAVID-WATINE B, 1990, IMMUNOL TODAY, V11, P286, DOI 10.1016/0167-5699(90)90114-O; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DUCKETT CS, 1993, MOL CELL BIOL, V13, P1315, DOI 10.1128/MCB.13.3.1315; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GILMORE TD, 1990, CELL, V62, P841, DOI 10.1016/0092-8674(90)90257-F; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; HENKEL T, 1992, CELL, V68, P1121, DOI 10.1016/0092-8674(92)90083-O; HENSELING U, 1990, MOL CELL BIOL, V10, P4100, DOI 10.1128/MCB.10.8.4100; ISRAEL A, 1989, EMBO J, V8, P3793, DOI 10.1002/j.1460-2075.1989.tb08556.x; ISRAEL A, 1987, P NATL ACAD SCI USA, V84, P2653, DOI 10.1073/pnas.84.9.2653; KADONAGA JT, 1991, METHOD ENZYMOL, V208, P10; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KIMURA A, 1986, CELL, V44, P261, DOI 10.1016/0092-8674(86)90760-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSON CJ, 1992, NUCLEIC ACIDS RES, V20, P3525, DOI 10.1093/nar/20.13.3525; LENARDO M, 1989, EMBO J, V8, P3351, DOI 10.1002/j.1460-2075.1989.tb08497.x; LOGEAT F, 1991, EMBO J, V10, P1827, DOI 10.1002/j.1460-2075.1991.tb07708.x; MEYER R, 1991, P NATL ACAD SCI USA, V88, P966, DOI 10.1073/pnas.88.3.966; MORIN PJ, 1992, NUCLEIC ACIDS RES, V20, P2453, DOI 10.1093/nar/20.10.2453; NERI A, 1991, CELL, V67, P1075, DOI 10.1016/0092-8674(91)90285-7; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; RUBEN SM, 1991, SCIENCE, V251, P1490, DOI 10.1126/science.2006423; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; SCHEPPLER JA, 1989, J IMMUNOL, V143, P2858; SCHMID RM, 1991, NATURE, V352, P733, DOI 10.1038/352733a0; SCHRIER PI, 1983, NATURE, V305, P771, DOI 10.1038/305771a0; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SINGER DS, 1990, CRIT REV IMMUNOL, V10, P235; STORMS RW, 1992, VIROLOGY, V188, P765, DOI 10.1016/0042-6822(92)90531-S; TEMPST P, 1990, ELECTROPHORESIS, V11, P537, DOI 10.1002/elps.1150110704; TENAKA K, 1988, ANNU REV IMMUNOL, V6, P359	45	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18882	18890						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360178				2022-12-27	WOS:A1993LV65900076
J	SHIBATA, K; AJIRO, K				SHIBATA, K; AJIRO, K			CELL CYCLE-DEPENDENT SUPPRESSIVE EFFECT OF HISTONE H1 ON MITOSIS-SPECIFIC H3 PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PREMATURE CHROMOSOME CONDENSATION; CHINESE-HAMSTER CELLS; STRUCTURAL-CHANGES; CHROMATIN; KINASE; PHASE; INVITRO; SITES; DNA	To analyze the mechanism by which histone H3 phosphorylation occurs specifically during mitosis, the effect of H1 on mitosis-specific H3 phosphorylation (Ser-10) was investigated in nucleosomes. Hl interaction with H1-depleted nucleosomes suppressed H3 phosphorylation including Ser-10 by approximately 50%. However, H1 interaction with DNA-free histone octamers failed to suppress H3 phosphorylation. The extent of suppression of H3 phosphorylation in nucleosomes with H1 prepared from synchronized HeLa cells was cell cycle-dependent. Binding with a highly phosphorylated mitotic H1 produced the least suppression of H3 phosphorylation, whereas binding with a lower H1 phosphorylation from G1 phase resulted in the greatest suppression. The results suggest that 1) mitotic H3 phosphorylation is suppressed with a lower level of H1 phosphorylation during interphase and 2) highly phosphorylated H1 during mitosis partially releases the suppression of mitotic H3 phosphorylation.	AICHI CANC CTR,RES INST,CELL BIOL LAB,CHIKUSA KU,NAGOYA,AICHI 464,JAPAN; NAGOYA CITY UNIV,PHARMACEUT SCI LAB,NAGOYA,AICHI 467,JAPAN	Aichi Cancer Center; Nagoya City University								AJIRO K, 1985, J BIOL CHEM, V260, P5379; AJIRO K, 1983, J BIOL CHEM, V258, P4534; AJIRO K, 1981, BIOCHEMISTRY-US, V20, P1445, DOI 10.1021/bi00509a007; AJIRO K, 1981, BIOCHEMISTRY-US, V20, P1454, DOI 10.1021/bi00509a008; ARION D, 1988, CELL, V55, P371, DOI 10.1016/0092-8674(88)90060-8; BALHORN R, 1975, BIOCHEMISTRY-US, V14, P2504, DOI 10.1021/bi00682a033; BELYAVSKY AV, 1980, J MOL BIOL, V139, P519, DOI 10.1016/0022-2836(80)90144-8; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; GURLEY LR, 1973, BIOCHEM BIOPH RES CO, V50, P744, DOI 10.1016/0006-291X(73)91307-7; GURLEY LR, 1983, ANAL BIOCHEM, V131, P465, DOI 10.1016/0003-2697(83)90200-2; GURLEY LR, 1974, J CELL BIOL, V60, P356, DOI 10.1083/jcb.60.2.356; GURLEY LR, 1975, J BIOL CHEM, V250, P3936; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; HEWISH DR, 1973, BIOCHEM BIOPH RES CO, V52, P504, DOI 10.1016/0006-291X(73)90740-7; KHARRAT A, 1991, BIOCHEMISTRY-US, V30, P10329, DOI 10.1021/bi00106a034; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKE RS, 1972, BIOCHEMISTRY-US, V11, P4817, DOI 10.1021/bi00775a027; LANGAN TA, 1989, MOL CELL BIOL, V9, P3860, DOI 10.1128/MCB.9.9.3860; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARION C, 1985, J MOL BIOL, V186, P367, DOI 10.1016/0022-2836(85)90111-1; MAZEN A, 1987, J MOL BIOL, V194, P741, DOI 10.1016/0022-2836(87)90251-8; PAULSON JR, 1982, J BIOL CHEM, V257, P6064; ROBERGE M, 1990, J CELL BIOL, V111, P1753, DOI 10.1083/jcb.111.5.1753; SHIBATA K, 1990, EUR J BIOCHEM, V192, P87, DOI 10.1111/j.1432-1033.1990.tb19199.x; SIMON RH, 1979, NUCLEIC ACIDS RES, V6, P689, DOI 10.1093/nar/6.2.689; TAYLOR SS, 1982, J BIOL CHEM, V257, P6056; Zweidler A, 1978, Methods Cell Biol, V17, P223, DOI 10.1016/S0091-679X(08)61145-0	27	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18431	18434						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360144				2022-12-27	WOS:A1993LV65900009
J	ITO, M; MATSUI, T; TANIGUCHI, T; TSUKAMOTO, T; MURAYAMA, T; ARIMA, N; NAKATA, H; CHIBA, T; CHIHARA, K				ITO, M; MATSUI, T; TANIGUCHI, T; TSUKAMOTO, T; MURAYAMA, T; ARIMA, N; NAKATA, H; CHIBA, T; CHIHARA, K			FUNCTIONAL-CHARACTERIZATION OF A HUMAN BRAIN CHOLECYSTOKININ-B RECEPTOR - A TROPHIC EFFECT OF CHOLECYSTOKININ AND GASTRIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHARMACOLOGICAL CHARACTERIZATION; CCK RECEPTORS; BINDING-SITES; CELL-LINE; EXPRESSION; TRANSFORMATION; INVOLVEMENT; STIMULATION; MITOGENESIS; SEROTONIN	We have cloned a human brain cholecystokinin (CCK)-B receptor cDNA and characterized its function by introducing it into Chinese hamster ovary (CHO) cells. The deduced amino acid sequence was highly conserved as compared with those of the gastrin receptors in Mastomys enterochromaffin-like cells (90%) and canine parietal cells (89%). Human brain CCK-B receptors possessed slightly but significantly higher affinities for CCK-8 than for gastrin I, while both ligands bound equally to Mastomys enterochromaffin-like cell-derived gastrin receptors. Both CCK-8 and gastrin I markedly augmented phosphoinositide hydrolysis and cytosolic free calcium levels in the CHO transfectants, indicating that the cloned CCK-B receptor could functionally couple with intracellular signaling molecules. Moreover, CCK-8 and gastrin I dose-dependently increased [H-3]thymidine incorporation of the CHO transfectants in serum-free medium and promoted cell growth. The CCK-B receptor mRNA was abundantly expressed in particular areas of the human brain and stomach, such as the cerebral cortex and mucosa of the gastric fundus. This is the first demonstration of trophic effects of CCK and gastrin through the normal human brain CCK-B receptor. The availability of this receptor cDNA will help to clarify the precise role of CCK in the central nervous system as well as digestive organs.	KOBE UNIV,SCH MED,DEPT MED,DIV 3,KUSUNOKI CHO,CHUO KU,KOBE 650,JAPAN; KOBE UNIV,SCH MED,DEPT MED,DIV GERONTOL,CHUO KU,KOBE 650,JAPAN	Kobe University; Kobe University			Matsui, Toshimitsu/E-8065-2010	Matsui, Toshimitsu/0000-0002-2536-7584				ALLEN LF, 1991, P NATL ACAD SCI USA, V88, P11354, DOI 10.1073/pnas.88.24.11354; ASHKENAZI A, 1989, NATURE, V340, P146, DOI 10.1038/340146a0; BHAMBI B, 1991, AM J PATHOL, V139, P1131; BOCK MG, 1989, J MED CHEM, V32, P13, DOI 10.1021/jm00121a004; CHANG RSL, 1986, P NATL ACAD SCI USA, V83, P4923, DOI 10.1073/pnas.83.13.4923; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CROSS AJ, 1988, NEUROPEPTIDES, V11, P73, DOI 10.1016/0143-4179(88)90013-3; DELVALLE J, 1992, AM J PHYSIOL, V262, pG420, DOI 10.1152/ajpgi.1992.262.3.G420; DIETL MM, 1987, SYNAPSE, V1, P169, DOI 10.1002/syn.890010205; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; GUTKIND JS, 1991, P NATL ACAD SCI USA, V88, P4703, DOI 10.1073/pnas.88.11.4703; HAYS SE, 1981, BRAIN RES, V225, P452, DOI 10.1016/0006-8993(81)90853-2; INNIS RB, 1979, P NATL ACAD SCI USA, V76, P521, DOI 10.1073/pnas.76.1.521; JENSEN RT, 1990, GASTROINTEST ENDOSC, P95; JOHNSON LR, 1982, SCAND J GASTROENTERO, V17, P89; JULIUS D, 1989, SCIENCE, V244, P1057, DOI 10.1126/science.2727693; KATSUURA G, 1991, NEUROSCI LETT, V132, P159, DOI 10.1016/0304-3940(91)90291-Z; KOPIN AS, 1992, P NATL ACAD SCI USA, V89, P3605, DOI 10.1073/pnas.89.8.3605; LAMBERT M, 1991, REGUL PEPTIDES, V32, P151, DOI 10.1016/0167-0115(91)90043-G; LARSSON H, 1986, GASTROENTEROLOGY, V90, P391, DOI 10.1016/0016-5085(86)90938-8; LIGNON MF, 1991, MOL PHARMACOL, V39, P615; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MATSUI T, 1989, P NATL ACAD SCI USA, V86, P8314, DOI 10.1073/pnas.86.21.8314; MIYOSHI R, 1991, NEUROPEPTIDES, V18, P115, DOI 10.1016/0143-4179(91)90102-O; NAKAMURA A, 1992, BIOCHEM BIOPH RES CO, V187, P1151; NEMECEK GM, 1986, P NATL ACAD SCI USA, V83, P674, DOI 10.1073/pnas.83.3.674; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; POLACEK MA, 1966, SURGERY, V60, P606; SAITO A, 1980, SCIENCE, V208, P1155, DOI 10.1126/science.6246582; SAKAMOTO C, 1984, BIOCHEM BIOPH RES CO, V124, P497, DOI 10.1016/0006-291X(84)91581-X; SEUWEN K, 1992, ADV CANCER RES, V58, P75, DOI 10.1016/S0065-230X(08)60291-2; SINGH L, 1991, P NATL ACAD SCI USA, V88, P1130, DOI 10.1073/pnas.88.4.1130; SINGH P, 1985, AM J PHYSIOL, V249, pG761, DOI 10.1152/ajpgi.1985.249.6.G761; TSUKAMOTOT, 1991, J BIOL CHEM, V266, P10143; WANK SA, 1992, P NATL ACAD SCI USA, V89, P3125, DOI 10.1073/pnas.89.7.3125; WANK SA, 1992, P NATL ACAD SCI USA, V89, P8691, DOI 10.1073/pnas.89.18.8691; WIERTELAK EP, 1992, SCIENCE, V256, P830, DOI 10.1126/science.1589765; WINSETT OE, 1982, SURG FORUM, V33, P384; WOODRUFF GN, 1991, ANNU REV PHARMACOL, V31, P469; YODER DG, 1987, PEPTIDES, V8, P103, DOI 10.1016/0196-9781(87)90171-9; ZHANG DM, 1986, PHYSIOL BEHAV, V36, P1183, DOI 10.1016/0031-9384(86)90498-1	41	105	107	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18300	18305						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349705				2022-12-27	WOS:A1993LT74300096
J	LI, SH; PELKA, H; SCHULMAN, LH				LI, SH; PELKA, H; SCHULMAN, LH			THE ANTICODON AND DISCRIMINATOR BASE ARE IMPORTANT FOR AMINOACYLATION OF ESCHERICHIA-COLI TRANSFER RNA(ASN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; SUPPRESSOR TRANSFER-RNAS; INITIATOR TRANSFER-RNA; RECOGNITION; INVIVO; IDENTITY; METHIONINE; NUCLEOTIDE	A gel shift assay that distinguishes the aminoacylated form from the deacylated form of tRNAs was used to study the requirements for aminoacylation of Escherichia coli tRNA(Asn) in vivo. tRNA(Asn) derivatives containing single base changes in their anticodons or discriminator bases were constructed, and the extent of in vivo aminoacylation was determined directly. Substitution of U35 with C35 or U36 with C36 abolished aminoacylation of the tRNA. Substitution of G34 with C34 converted tRNA(Asn) into a lysine acceptor. Thus, each of the anticodon nucleotides are important for aminoacylation of tRNA(Asn). Substitution of discriminator base G73 with A73 affected the extent of aminoacylation in vivo indicating that the discriminator base also contributes to aminoacylation of tRNA(Asn).			LI, SH (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT DEV BIOL & CANC, BRONX, NY 10461 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM016995, R37GM017151, F32GM017151, R56GM017151, R01GM017151] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM17151, GM16995-23] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANSELME J, 1989, GENE, V84, P481, DOI 10.1016/0378-1119(89)90524-6; HO YS, 1987, P NATL ACAD SCI USA, V84, P2185, DOI 10.1073/pnas.84.8.2185; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; JANEL G, 1984, EMBO J, V3, P1603, DOI 10.1002/j.1460-2075.1984.tb02017.x; LEE CP, 1992, P NATL ACAD SCI USA, V89, P9262, DOI 10.1073/pnas.89.19.9262; MCCLAIN WH, 1990, P NATL ACAD SCI USA, V87, P9260, DOI 10.1073/pnas.87.23.9260; MUENCH KH, 1966, PROCEDURES NUCLEIC A, P375; NORMANLY J, 1989, ANNU REV BIOCHEM, V58, P1029, DOI 10.1146/annurev.bi.58.070189.005121; PAK M, 1992, BIOCHEMISTRY-US, V31, P3303, DOI 10.1021/bi00128a001; PALLANCK L, 1992, J BIOL CHEM, V267, P7221; PALLANCK L, 1991, TRANSFER RNA PROTEIN; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; SCHULMAN LH, 1983, P NATL ACAD SCI-BIOL, V80, P6755, DOI 10.1073/pnas.80.22.6755; SCHULMAN LH, 1988, SCIENCE, V242, P765, DOI 10.1126/science.3055296; SCHULMAN LH, 1991, PROG NUCLEIC ACID RE, V41, P23; SHIMIZU M, 1992, J MOL EVOL, V35, P436; SUSSMAN JL, 1976, SCIENCE, V192, P853, DOI 10.1126/science.775636; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	20	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18335	18339						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349709				2022-12-27	WOS:A1993LT74300101
J	NANBERG, E; WESTERMARK, B				NANBERG, E; WESTERMARK, B			PLATELET-DERIVED GROWTH-FACTOR INCREASES THE TURNOVER OF GTP/GDP ON RAS IN PERMEABILIZED FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; TYROSINE KINASE-ACTIVITY; SWISS 3T3 CELLS; MITOGENIC SIGNAL TRANSDUCTION; GUANINE-NUCLEOTIDE EXCHANGE; FACTOR RECEPTORS; PDGF RECEPTOR; P21RAS ACTIVATION; PEPTIDE RECEPTOR; PHOSPHORYLATION	The potent mitogen platelet-derived growth factor (PDGF) induced a rapid increase in Ras.GTP in permeabilized human and murine fibroblasts. The effect was initiated by both PDGF-AA acting exclusively through PDGF alpha-receptors, and by PDGF-BB interacting with both alpha- and beta-type receptors. The dose-response curves suggest that both receptor types mediate the response. PDGF-dependent Ras activation, measured as increased formation of Ras.GTP, was rapid and reversible. At 37-degrees-C the effect had a duration of around 10 min. The PDGF-dependent increase in Ras.GTP was followed by a simultaneous increase in Ras.GDP. Under no experimental condition could a relative increase in Ras.GTP be detected. 0.5 muM GDP and 0.5 muM GTP were equally potent competing for the formation of Ras.[alpha-P-32]GTP upon PDGF stimulation. Furthermore, when the basal nucleotide exchange rate on Ras was elevated by omission of Mg2+ from the medium, PDGF had no further effect on the formation of Ras.GTP. We therefore conclude that PDGF activates Ras through a mechanism leading to an increased nucleotide exchange on Ras.			NANBERG, E (corresponding author), UNIV HOSP UPPSALA,DEPT PATHOL,S-75185 UPPSALA,SWEDEN.							BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BATTEY JF, 1991, P NATL ACAD SCI USA, V88, P395, DOI 10.1073/pnas.88.2.395; BETSHOLTZ C, 1984, J CELL PHYSIOL, V118, P203, DOI 10.1002/jcp.1041180213; BISHAYEE S, 1989, J BIOL CHEM, V264, P11699; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; CAI H, 1990, MOL CELL BIOL, V10, P5314, DOI 10.1128/MCB.10.10.5314; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CLAESSONWELSH L, 1989, P NATL ACAD SCI USA, V86, P4917, DOI 10.1073/pnas.86.13.4917; CRECHET JB, 1990, SCIENCE, V248, P866, DOI 10.1126/science.2188363; DER CJ, 1991, CANCER CELL-MON REV, V3, P331; DEVRIESSMITS AMM, 1992, NATURE, V357, P602, DOI 10.1038/357602a0; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; DURONIO V, 1992, P NATL ACAD SCI USA, V89, P1587, DOI 10.1073/pnas.89.5.1587; EK B, 1982, J BIOL CHEM, V257, P486; FELDMAN RI, 1990, J BIOL CHEM, V265, P17364; FEUERSTEIN J, 1987, J BIOL CHEM, V262, P8455; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GIBBS JB, 1990, J BIOL CHEM, V265, P20437; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HAMMACHER A, 1988, J BIOL CHEM, V263, P16493; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; HART CE, 1990, BIOCHEMISTRY-US, V29, P166, DOI 10.1021/bi00453a022; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; HELDIN CH, 1988, EMBO J, V7, P1387, DOI 10.1002/j.1460-2075.1988.tb02955.x; HELDIN CH, 1990, CELL REGUL, V1, P555, DOI 10.1091/mbc.1.8.555; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HELDIN CH, 1991, TRENDS BIOCHEM SCI, V16, P450, DOI 10.1016/0968-0004(91)90175-U; HELDIN CH, 1986, NATURE, V319, P511, DOI 10.1038/319511a0; KANAKARAJ P, 1991, BIOCHEMISTRY-US, V30, P1761, DOI 10.1021/bi00221a005; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAZLAUSKAS A, 1990, SCIENCE, V247, P1578, DOI 10.1126/science.2157284; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MARTEGANI E, 1992, EMBO J, V11, P2151, DOI 10.1002/j.1460-2075.1992.tb05274.x; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MOLLOY CJ, 1989, NATURE, V342, P711, DOI 10.1038/342711a0; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; NANBERG E, 1990, J CELL PHYSIOL, V143, P232, DOI 10.1002/jcp.1041430206; Ostman A, 1989, GROWTH FACTORS, V1, P271, DOI 10.3109/08977198908998003; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Raines E.W., 1990, PEPTIDE GROWTH FACTO, DOI [10.1007/978-3-642-49295-2_5, DOI 10.1007/978-3-642-49295-2_5]; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P2936, DOI 10.1073/pnas.80.10.2936; SATOH T, 1990, P NATL ACAD SCI USA, V87, P7926, DOI 10.1073/pnas.87.20.7926; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; ZACHARY I, 1987, BIOCHEM BIOPH RES CO, V146, P456, DOI 10.1016/0006-291X(87)90551-1; ZHANG K, 1992, SCIENCE, V257, P671, DOI 10.1126/science.1496380	59	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18187	18194						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349694				2022-12-27	WOS:A1993LT74300080
J	SUNG, SSJ; WALTERS, JA				SUNG, SSJ; WALTERS, JA			STIMULATION OF INTERLEUKIN-1-ALPHA AND INTERLEUKIN-1-BETA PRODUCTION IN HUMAN MONOCYTES BY PROTEIN PHOSPHATASE-1 AND PHOSPHATASE-2A INHIBITORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE PERITONEAL-MACROPHAGES; OKADAIC ACID; C-JUN; CELL-LINES; KINASE-C; SEQUENCE; GENE; EXPRESSION; ACTIVATION; FOS	Protein phosphatases 1 and 2A are important in regulating cellular functions by controlling the phosphorylation state of their substrates. In human monocytes, the inhibitors of these phosphatases, okadaic acid and calyculin A, were found to increase the mRNA accumulation and cytokine production of interleukin-1beta and interleukin-1alpha. The increased mRNA accumulation was found to be primarily because of the increase in the transcription rate of the interleukin-1 genes. Stimulation of interleukin-1 gene transcription may be caused by the stimulation of transcription factor activities, including those of AP-1, by these protein phosphatase inhibitors. Okadaic acid increased the synthesis of the interleukin-1beta precursor and mature forms and their secretion. This increased processing and secretion correlated with the stimulation of IL-1beta convertase mRNA accumulation. The stimulation of interleukin-1alpha production by okadaic acid was more modest than that of interleukin-1beta. However, the phosphorylation of the precursor interleukin-1alpha cytokine was increased. These results show that protein phosphatase 1 and 2A inhibitors exert multiple effects on cytokine production in human monocytes and suggest that these two phosphatases play important roles in regulating interleukin-I production.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT MICROBIOL & IMMUNOL,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,MASSEY CANC CTR,RICHMOND,VA 23298	Virginia Commonwealth University; Virginia Commonwealth University	SUNG, SSJ (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT RADIAT ONCOL,BOX 58,RICHMOND,VA 23298, USA.				NCI NIH HHS [P30-CA16059] Funding Source: Medline; NIAID NIH HHS [AI-26928] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026928] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABDULGHANI M, 1991, P NATL ACAD SCI USA, V88, P1803, DOI 10.1073/pnas.88.5.1803; BARKOUCHE O, 1992, J IMMUNOL, V148, P84; BENSI G, 1990, CELL GROWTH DIFFER, V1, P491; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BEUSCHER HU, 1990, J IMMUNOL, V144, P2179; BEUSCHER HU, 1988, J BIOL CHEM, V263, P4023; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; CAO XM, 1992, J BIOL CHEM, V267, P12991; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; CLARK BD, 1986, NUCLEIC ACIDS RES, V14, P7897, DOI 10.1093/nar/14.20.7897; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; DINARELLO CA, 1991, BLOOD, V77, P1627; FURUTANI Y, 1986, NUCLEIC ACIDS RES, V14, P3167, DOI 10.1093/nar/14.8.3167; HAAS JG, 1990, P NATL ACAD SCI USA, V87, P9563, DOI 10.1073/pnas.87.24.9563; HENTZE MW, 1991, BIOCHIM BIOPHYS ACTA, V1090, P281, DOI 10.1016/0167-4781(91)90191-N; HOGQUIST KA, 1991, J IMMUNOL, V147, P2181; JAIN J, 1992, J EXP MED, V175, P853, DOI 10.1084/jem.175.3.853; KERN JA, 1988, J CLIN INVEST, V81, P237, DOI 10.1172/JCI113301; LAIRDOFFRINGA IA, 1992, BIOESSAYS, V14, P119, DOI 10.1002/bies.950140209; LINK E, 1992, J BIOL CHEM, V267, P239; LUND LR, 1992, FEBS LETT, V298, P177, DOI 10.1016/0014-5793(92)80050-Q; MIYASAKA T, 1990, BIOCHEM BIOPH RES CO, V168, P1237, DOI 10.1016/0006-291X(90)91161-K; NAGAMINE Y, 1991, EMBO J, V10, P117, DOI 10.1002/j.1460-2075.1991.tb07927.x; PERREGAUX D, 1992, J IMMUNOL, V149, P1294; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; SAMBROOK J, 1989, MOL CLIN LABORATORY; SCHONTHAL A, 1992, NEW BIOL, V4, P16; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P959, DOI 10.1128/MCB.9.3.959; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; SUNG SSJ, 1983, J CELL PHYSIOL, V116, P21, DOI 10.1002/jcp.1041160105; SUNG SSJ, 1992, J EXP MED, V176, P897, DOI 10.1084/jem.176.3.897; SUNG SSJ, 1988, J EXP MED, V167, P937, DOI 10.1084/jem.167.3.937; SUNG SSJ, 1991, J IMMUNOL, V147, P2047; SUNG SSJ, 1985, J IMMUNOL, V135, P1981; SUNG SSJ, 1989, J IMMUNOL, V142, P1274; SUTTLES J, 1990, J IMMUNOL, V144, P175; THEVENIN C, 1990, New Biologist, V2, P793; THEVENIN C, 1991, J BIOL CHEM, V266, P9363; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0	43	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1993	268	8					5802	5809						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR822	8383677				2022-12-27	WOS:A1993KR82200067
J	GREEN, PC; TRIPATHI, RL; KEMP, RG				GREEN, PC; TRIPATHI, RL; KEMP, RG			IDENTIFICATION OF ACTIVE-SITE RESIDUES IN PYROPHOSPHATE-DEPENDENT PHOSPHOFRUCTO-1-KINASE BY SITE-DIRECTED MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPIONIBACTERIUM-FREUDENREICHII; KINETIC MECHANISM; ESCHERICHIA-COLI; PHOSPHOFRUCTOKINASE	The primary structure of pyrophosphate-dependent phosphofructokinase (PFK) from Propionibacterium freudenreichii exhibits a low but significant level of sequence identity with Escherichia coli ATP-dependent PFK, permitting the tentative assignment of residues that may be involved in catalysis. Based on these assignments, the roles in catalysis of 2 aspartyl residues (Asp151 and Asp153) and 2 lysyl residues (Lys80 and Lys85) were examined. Mutagenesis of the Asp151 to alanine and serine reduced k(cat) by a factors of 2 x 10(4) and 4 x 10(5), respectively, while showing no change in K(m) for either substrate in the forward reaction or for metal ion in the back reaction. The k(cat) for Asp153 was decreased by a factor of 700 with no change in K(m) for pyrophosphate and an increase of about 20-fold in K(m) for fructose 6-P and close to 4-fold for magnesium ion. That these changes in the mutants were not the result of global conformational changes was indicated by their identical behavior during substrate-specific elution chromatography, ion-exchange chromatography, and limited proteolysis by trypsin and subtilisin. Mutations of Lys80 and Lys85 showed no significant changes in kinetic parameters, suggesting no involvement in mechanism or substrate binding. These and other results permit preliminary modeling of the active site of pyrophosphate-dependent PFK.	UNIV HLTH SCI CHICAGO MED SCH,DEPT BIOL CHEM,3333 GREEN BAY BLVD,N CHICAGO,IL 60064	Chicago Medical School					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019912] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK19912] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERTAGNOLLI BL, 1984, BIOCHEMISTRY-US, V23, P4101, DOI 10.1021/bi00313a014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHO YK, 1988, BIOCHEMISTRY-US, V27, P3320, DOI 10.1021/bi00409a030; CHO YK, 1989, BIOCHEMISTRY-US, V28, P4155, DOI 10.1021/bi00436a005; GREEN PC, 1992, BIOCHEMISTRY-US, V31, P4815, DOI 10.1021/bi00135a011; HALKIDES CJ, 1991, BIOCHEMISTRY-US, V30, P10313, DOI 10.1021/bi00106a032; HELLINGA HW, 1987, NATURE, V327, P437, DOI 10.1038/327437a0; LADROR US, 1991, J BIOL CHEM, V266, P16550; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; OBRIEN WE, 1975, J BIOL CHEM, V250, P8690; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIRAKIHARA Y, 1988, J MOL BIOL, V204, P973, DOI 10.1016/0022-2836(88)90056-3	12	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1993	268	7					5085	5088						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP884	8383128				2022-12-27	WOS:A1993KP88400077
J	GOODMAN, LJ; KAIN, SR; FIRESTONE, GL				GOODMAN, LJ; KAIN, SR; FIRESTONE, GL			TRAFFICKING OF WILD-TYPE AND AN ENDOPROTEOLYTIC-SITE MUTANT OF THE MOUSE MAMMARY-TUMOR VIRUS GLYCOPROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT HEPATOMA-CELLS; PROTEOLYTIC CLEAVAGE SITE; ENV GENE; ENVELOPE GLYCOPROTEIN; PROTEINS; EXPRESSION; COMPARTMENTALIZATION; DNA; GLYCOSYLATION; LOCALIZATION	We have utilized a mouse mammary tumor virus (MMTV) glycoprotein gene containing a mutation in the endoproteolytic cleavage site to investigate the biological significance of processing, the structural requirements for and the events involved in the proteolytic maturation of MMTV. Using oligonucleotide-directed mutagenesis, the endoproteolytic cleavage site within the MMTV glycoprotein was mutated from Arg-Ala-Lys-Arg to Arg-Ala-Asn-Gln and both the wild-type and mutated genes were transfected and expressed in HTC rat hepatoma cells. Indirect immunofluorescence, steady state radiolabeling and pulse-chase kinetic experiments demonstrated that this mutated glycoprotein was transported to the cell surface with the same efficiency as the wild-type maturation products; however, proteolytic cleavage and fusogenic activity were almost completely abolished. Consistent with the lack of cleavage, the endoglycosidase H-resistant precursor, gp78, accumulated on the cell surface and in the extracellular environment. When HTC cells expressing the wild-type MMTV glycoprotein were treated with the Golgi mannosidase I and II inhibitors, deoxymannojirimycin and swainsonine respectively, the resulting endogycosidase H-sensitive glycoproteins were processed efficiently. Taken together, these results suggest that proteolytic processing of the MMTV glycoprotein most likely occurs in the trans Golgi or at a later step in the exocytic pathway and occurs after the formation of an endoglycosidase H-resistant, terminally sialylated intermediate. Moreover, the acquisition of endoglycosidase H-resistant oligosaccharides is not a prerequisite for recognition by the cellular proteases to generate the viral maturation products. Our evidence also suggests that the processing of the MMTV envelope glycoprotein is required for the functional exposure of the fusion domain which is involved in viral infectivity.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, 591 LSA, BERKELEY, CA 94720 USA; UNIV CALIF BERKELEY, CANC RES LAB, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley					NATIONAL CANCER INSTITUTE [F32CA009053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK042799, R01DK042799] Funding Source: NIH RePORTER; NCI NIH HHS [F32 CA09053, CA-09041] Funding Source: Medline; NIDDK NIH HHS [DK-42799] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARTHUR LO, 1982, J VIROL, V41, P414, DOI 10.1128/JVI.41.2.414-422.1982; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; BEDGOOD RM, 1992, J BIOL CHEM, V267, P7060; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BOSCH V, 1990, J VIROL, V64, P2337, DOI 10.1128/JVI.64.5.2337-2344.1990; BRAVO DA, 1991, MOL ENDOCRINOL, V5, P336, DOI 10.1210/mend-5-3-336; BRESNAHAN PA, 1990, J CELL BIOL, V111, P2851, DOI 10.1083/jcb.111.6.2851; CARDIFF RD, 1978, VIROLOGY, V85, P157, DOI 10.1016/0042-6822(78)90420-8; COREY JL, 1990, CELL REGUL, V1, P531, DOI 10.1091/mbc.1.7.531; DICKSON C, 1983, CURR TOP MICROBIOL, V106, P1; DONG JY, 1992, J VIROL, V66, P865, DOI 10.1128/JVI.66.2.865-874.1992; DUNPHY WG, 1985, CELL, V42, P13, DOI 10.1016/S0092-8674(85)80097-0; ELBEIN AD, 1991, FASEB J, V5, P3055, DOI 10.1096/fasebj.5.15.1743438; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FIRESTONE GL, 1983, J BIOL CHEM, V258, P6155; FIRESTONE GL, 1990, METHOD ENZYMOL, V182, P688; FIRESTONE GL, 1982, NATURE, V300, P221, DOI 10.1038/300221a0; FIRESTONE GL, 1988, ENDOCRINE GENES ANAL, P95; FREED EO, 1987, J VIROL, V61, P2852, DOI 10.1128/JVI.61.9.2852-2856.1987; FULLER SD, 1985, EMBO J, V4, P297, DOI 10.1002/j.1460-2075.1985.tb03629.x; HAFFAR OK, 1987, MOL CELL BIOL, V7, P1508, DOI 10.1128/MCB.7.4.1508; HAFFAR OK, 1988, J CELL BIOL, V106, P1463, DOI 10.1083/jcb.106.5.1463; HENDERSON LE, 1983, J VIROL, V48, P314, DOI 10.1128/JVI.48.1.314-319.1983; HIZI A, 1989, J VIROL, V63, P2543, DOI 10.1128/JVI.63.6.2543-2549.1989; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; JAIN SK, 1991, J BIOL CHEM, V266, P5756; JOHN NJ, 1988, P NATL ACAD SCI USA, V85, P797, DOI 10.1073/pnas.85.3.797; KAIN SR, 1992, J BIOL CHEM, V267, P8128; KIEFER MC, 1991, DNA CELL BIOL, V10, P757, DOI 10.1089/dna.1991.10.757; Klenk H D, 1980, Curr Top Microbiol Immunol, V90, P19; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KRANGEL MS, 1979, CELL, V18, P979, DOI 10.1016/0092-8674(79)90210-1; MAJORS JE, 1983, J VIROL, V47, P495, DOI 10.1128/JVI.47.3.495-504.1983; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Moore D H, 1979, Adv Cancer Res, V29, P347, DOI 10.1016/S0065-230X(08)60850-7; NAGAI K, 1987, METHOD ENZYMOL, V153, P461; NAKAYAMA K, 1992, J BIOL CHEM, V267, P5897; PEREZ LG, 1987, J VIROL, V61, P1609, DOI 10.1128/JVI.61.5.1609-1614.1987; PEREZ LG, 1987, J VIROL, V61, P2981, DOI 10.1128/JVI.61.10.2981-2988.1987; PLATT EJ, 1986, ANAL BIOCHEM, V156, P126, DOI 10.1016/0003-2697(86)90163-6; PLATT EJ, 1991, J BIOL CHEM, V266, P19384; PLATT EJ, 1991, MOL ENDOCRINOL, V5, P1696, DOI 10.1210/mend-5-11-1696; PRESPER KA, 1985, ENZYMOLOGY POST TRAN, P53; REDMOND S, 1984, VIROLOGY, V133, P393, DOI 10.1016/0042-6822(84)90405-7; REDMOND SMS, 1983, EMBO J, V2, P125, DOI 10.1002/j.1460-2075.1983.tb01393.x; RINGOLD GM, 1979, P NATL ACAD SCI USA, V76, P665, DOI 10.1073/pnas.76.2.665; SABATINI DD, 1982, J CELL BIOL, V92, P1, DOI 10.1083/jcb.92.1.1; SALMINEN A, 1992, J CELL BIOL, V116, P349, DOI 10.1083/jcb.116.2.349; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARKAR NH, 1983, VIROLOGY, V126, P279, DOI 10.1016/0042-6822(83)90479-8; TSAI WP, 1988, J VIROL, V62, P3167, DOI 10.1128/JVI.62.9.3167-3174.1988; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; WATANABE T, 1992, J BIOL CHEM, V267, P8270; WHITE BA, 1982, J BIOL CHEM, V257, P8569; White JM, 1989, CURR OPIN CELL BIOL, V1, P934, DOI 10.1016/0955-0674(89)90061-6	55	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2329	2336						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8381404				2022-12-27	WOS:A1993KK81500015
J	AKIYAMA, M; CROOKE, E; KORNBERG, A				AKIYAMA, M; CROOKE, E; KORNBERG, A			AN EXOPOLYPHOSPHATASE OF ESCHERICHIA-COLI - THE ENZYME AND ITS PPX GENE IN A POLYPHOSPHATE OPERON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPIONIBACTERIUM-SHERMANII; PURIFICATION; MECHANISM; PROTEIN; KINASE; MAP	A gene, ppx, that encodes a novel exopolyphosphatase of 513 amino acids (58,133 Da) was found down-stream of the gene for polyphosphate kinase, ppk. Transcription of the ppx gene depends on the ppk promoters, indicating a polyphosphate (polyP) operon of ppk and ppx. Exopolyphosphatase, purified to homogeneity from overproducing cells, is judged to be a dimer of 58-kDa subunits. Orthophosphate is released processively from the ends of polyP approximately 500 residues long, but chains of approximately 15 residues compete poorly with polyP as substrate; ATP is not a substrate. Mg2+ (1 mM) and a high concentration of K+ (175 mM) support optimal activity.	STANFORD UNIV,MED CTR,SCH MED,DEPT BIOCHEM,STANFORD,CA 94305	Stanford University					NIGMS NIH HHS [GM07581] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM007581, R01GM007581] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHN KH, 1990, J BIOL CHEM, V265, P11734; AKIYAMA M, 1992, J BIOL CHEM, V267, P22556; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BACHMANN BJ, 1990, MICROBIOL REV, V54, P130, DOI 10.1128/MMBR.54.2.130-197.1990; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLARK JE, 1987, ANAL BIOCHEM, V161, P280, DOI 10.1016/0003-2697(87)90452-0; DIRHEIMER G, 1968, B SOC CHIM BIOL, V50, P1933; GAREN A, 1960, BIOCHIM BIOPHYS ACTA, V38, P470, DOI 10.1016/0006-3002(60)91282-8; HAROLD FM, 1965, J BACTERIOL, V89, P1262, DOI 10.1128/JB.89.5.1262-1270.1965; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; ITO K, 1980, J BIOL CHEM, V255, P2123; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; KORNBERG A, 1956, BIOCHIM BIOPHYS ACTA, V20, P215, DOI 10.1016/0006-3002(56)90280-3; KORNBERG SR, 1957, BIOCHIM BIOPHYS ACTA, V26, P294, DOI 10.1016/0006-3002(57)90008-2; Kulaev IS, 1979, BIOCH INORGANIC POLY; MUHAMMED A, 1959, J GEN MICROBIOL, V20, P482, DOI 10.1099/00221287-20-3-482; PEPIN CA, 1987, J BIOL CHEM, V262, P5223; PICK U, 1990, FEBS LETT, V274, P15, DOI 10.1016/0014-5793(90)81318-I; REUSCH RN, 1988, P NATL ACAD SCI USA, V85, P4176, DOI 10.1073/pnas.85.12.4176; ROBINSON NA, 1987, J BIOL CHEM, V262, P5216; Sambrook J, 1989, MOL CLONING LABORATO; Stahl E., 1969, THIN LAYER CHROMATOG; SZYMONA M, 1977, ACTA BIOCHIM POL, V24, P133; Tinberg H M, 1979, Methods Enzymol, V56, P622; Torriani-Gorini A., 1987, PHOSPHATE METABOLISM; WOOD HG, 1988, ANNU REV BIOCHEM, V57, P235, DOI 10.1146/annurev.bi.57.070188.001315	26	225	229	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					633	639						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380170				2022-12-27	WOS:A1993KE60300095
J	HORUK, R; YANSURA, DG; REILLY, D; SPENCER, S; BOURELL, J; HENZEL, W; RICE, G; UNEMORI, E				HORUK, R; YANSURA, DG; REILLY, D; SPENCER, S; BOURELL, J; HENZEL, W; RICE, G; UNEMORI, E			PURIFICATION, RECEPTOR-BINDING ANALYSIS, AND BIOLOGICAL CHARACTERIZATION OF HUMAN-MELANOMA GROWTH STIMULATING ACTIVITY (MGSA) - EVIDENCE FOR A NOVEL MGSA RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL CHEMOTACTIC FACTOR; HUMAN INTERLEUKIN-8 RECEPTOR; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; INFLAMMATORY CYTOKINES; HUMAN-FIBROBLASTS; CULTURE-MEDIUM; FACTOR MDNCF; CELL-LINE; EXPRESSION	Human melanoma growth stimulating activity (MGSA) is a mitogenic factor first identified in the conditioned media of human melanoma cells. Structurally, MGSA belongs to a superfamily of proteins that includes interleukin-8 (IL-8) and platelet factor 4. These proteins are involved in inflammatory processes, and an understanding of their mechanism of action should provide insight into their pathophysiology. In this study, we report the high level expression of recombinant human MGSA in Escherichia coli. The structure was confirmed by mass spectrometry and NH2-terminal amino acid sequencing. Receptor binding studies were carried out in a human melanoma cell line, Hs294T, and in U937 cells. Direct binding experiments with I-125-MGSA in Hs294T cells have allowed us to identify a novel MGSA receptor in these cells, with a K(D) of 3.9-4.25 nM and approximately 52,960-67,758 binding sites/cell. These MGSA-binding sites were specific and could not be displaced by unlabeled IL-8. The MGSA receptor in these cells is biologically active, and the addition of ligand induces cellular proliferation in a dose-dependent manner. In U937 cells, unlabeled IL-8 and MGSA were able to completely displace radiolabeled IL-8. Scatchard analysis of the displacement binding data was consistent with binding to a single class of binding sites, and the calculated K(D) values were 2.4 +/- 0.6 nM for IL-8 and 3.2 +/- 0.80 nM for MGSA. Treatment of U937 cells with IL-8 or MGSA produced a rapid increase in Ca2+ flux; however, subsequent incubation with either ligand failed to produce any further Ca2+ flux. The IL-8 receptor in U937 cells was covalently labeled with I-125-IL-8 to reveal a protein with a molecular mass of 69 kDa.	GENENTECH INC,DEPT CELL CULTURE,S SAN FRANCISCO,CA 94080; GENENTECH INC,DEPT CELL GENET,S SAN FRANCISCO,CA 94080; GENENTECH INC,DEPT CELL BIOL,S SAN FRANCISCO,CA 94080; GENENTECH INC,DEPT DEV BIOL,S SAN FRANCISCO,CA 94080	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	HORUK, R (corresponding author), GENENTECH INC,DEPT PROT CHEM,460 POINT SAN BRUNO BLVD,S SAN FRANCISCO,CA 94080, USA.			Henzel, William/0000-0003-2940-3797				ANISOWICZ A, 1988, P NATL ACAD SCI USA, V85, P9645, DOI 10.1073/pnas.85.24.9645; BECKMANN MP, 1991, BIOCHEM BIOPH RES CO, V179, P784, DOI 10.1016/0006-291X(91)91885-G; BETTER M, 1988, SCIENCE, V240, P1041, DOI 10.1126/science.3285471; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; DERYNCK R, 1990, BIOCHEMISTRY-US, V29, P10225, DOI 10.1021/bi00496a011; GOLDS EE, 1989, BIOCHEM J, V259, P585, DOI 10.1042/bj2590585; GROB PM, 1990, J BIOL CHEM, V265, P8311; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HEBERT CA, 1990, J IMMUNOL, V145, P3033; HENZEL WJ, 1987, J CHROMATOGR, V404, P41, DOI 10.1016/S0021-9673(01)86835-7; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; IIDA N, 1990, MOL CELL BIOL, V10, P5596, DOI 10.1128/MCB.10.10.5596; LEE CH, 1983, INFECT IMMUN, V42, P264, DOI 10.1128/IAI.42.1.264-268.1983; MANDEL M, 1970, J MOL BIOL, V53, P159, DOI 10.1016/0022-2836(70)90051-3; MATSUSHIMA K, 1988, J EXP MED, V167, P1883, DOI 10.1084/jem.167.6.1883; MCPHERSON GA, 1983, COMPUT PROG BIOMED, V17, P107, DOI 10.1016/0010-468X(83)90031-4; MOSER B, 1990, J EXP MED, V171, P1797, DOI 10.1084/jem.171.5.1797; MOSER B, 1991, J BIOL CHEM, V266, P10666; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; NAGAHARI K, 1985, EMBO J, V4, P3589, DOI 10.1002/j.1460-2075.1985.tb04121.x; OBUKOWICZ MG, 1988, MOL GEN GENET, V215, P19, DOI 10.1007/BF00331297; Orencole S F, 1989, Cytokine, V1, P14, DOI 10.1016/1043-4666(89)91044-2; PABORSKY LR, 1989, BIOCHEMISTRY-US, V28, P8072, DOI 10.1021/bi00446a016; PICKEN RN, 1983, INFECT IMMUN, V42, P269, DOI 10.1128/IAI.42.1.269-275.1983; PONCZ M, 1987, BLOOD, V69, P219; RICHMOND A, 1988, EMBO J, V7, P2025, DOI 10.1002/j.1460-2075.1988.tb03042.x; RICHMOND A, 1983, CANCER RES, V43, P2106; RICHMOND A, 1986, J CELL PHYSIOL, V129, P375, DOI 10.1002/jcp.1041290316; ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126; ROSOFF PM, 1988, CELL, V54, P73, DOI 10.1016/0092-8674(88)90181-X; SAMANTA AK, 1989, J EXP MED, V169, P1185, DOI 10.1084/jem.169.3.1185; SCHOLTISSEK S, 1987, NUCLEIC ACIDS RES, V15, P3185, DOI 10.1093/nar/15.7.3185; SMITH RD, 1990, ANAL CHEM, V62, P882, DOI 10.1021/ac00208a002; THOMAS HG, 1988, MOL CELL ENDOCRINOL, V57, P69, DOI 10.1016/0303-7207(88)90033-0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UNEMORI EN, 1991, J CLIN INVEST, V88, P1656, DOI 10.1172/JCI115480; WALZ A, 1987, BIOCHEM BIOPH RES CO, V149, P755, DOI 10.1016/0006-291X(87)90432-3; WEN DZ, 1989, EMBO J, V8, P1761, DOI 10.1002/j.1460-2075.1989.tb03569.x	39	46	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					541	546						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380167				2022-12-27	WOS:A1993KE60300082
J	CORMONT, M; TANTI, JF; ZAHRAOUI, A; VANOBBERGHEN, E; TAVITIAN, A; LEMARCHANDBRUSTEL, Y				CORMONT, M; TANTI, JF; ZAHRAOUI, A; VANOBBERGHEN, E; TAVITIAN, A; LEMARCHANDBRUSTEL, Y			INSULIN AND OKADAIC ACID INDUCE RAB4 REDISTRIBUTION IN ADIPOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING-PROTEINS; RAT ADIPOSE-CELLS; GLUCOSE TRANSPORTER; PLASMA-MEMBRANE; STIMULATED TRANSLOCATION; POTENTIAL MECHANISM; APPARENT TRANSLOCATION; ENDOCYTIC PATHWAY; FUSION INVITRO; YPT1 PROTEIN	Insulin stimulation of glucose transport involves the translocation of vesicles containing the glucose transporter Glut 4 to the plasma membrane. Rab proteins, which have been implicated in the regulation of vesicular traffic, were studied in adipocytes. Rab3B, Rab3C, Rab4, and Rab8 were detected, but Rab3A was not. In the absence of insulin, Rab3B and Rab3C were cytosolic, while Rab4 and Rab8 were associated with membranes. Only Rab4 distribution was modified by insulin. In unstimulated adipocytes, most of Rab4 was found in a low density microsomal fraction, which also contained the majority of Glut 4. After insulin treatment, a 50% decrease in Rab4 content was observed, concomitantly with a departure of transporters to the plasma membrane. The dose responses for the departure of Glut 4 and Rab4 from the microsomal fractions were superimposable, half-maximal effects being obtained with 0.1 nM insulin. Rab4 was redistributed to the cytosol and its movement was reversed by insulin withdrawal. When Glut 4-containing vesicles were immunopurified with antibodies to Glut 4, Rab4 was found in the immune pellets, suggesting that Rab4 was tightly associated with the vesicles. Okadaic acid, an inhibitor of phosphatases 1 and 2A that is known to stimulate Glut 4 translocation, caused the same movement of Rab4 from low density microsomal fraction to the cytosol, while the phorbol ester 12-O-tetradecanoylphorbol-13-acetate had no effect. We suggest that insulin and okadaic acid induce a cycling of Rab4 from a vesicular fraction containing the Glut 4 transporter to the cytosol and that this cycling may participate in the insulin stimulatory action on glucose transporter translocation.	FAC MED LARIBOISIERE,INSERM,U248,F-75010 PARIS,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	CORMONT, M (corresponding author), FAC MED NICE,INSERM,U145,AVE VALOMBROSE,F-06107 NICE,FRANCE.			Tanti, Jean-Francois/0000-0003-1782-1318; CORMONT, Mireille/0000-0001-6918-2410				BAILLY E, 1991, NATURE, V350, P715, DOI 10.1038/350715a0; BALCH WE, 1990, TRENDS BIOCHEM SCI, V15, P473, DOI 10.1016/0968-0004(90)90301-Q; BALDINI G, 1991, J BIOL CHEM, V266, P4037; BALDINI G, 1992, P NATL ACAD SCI USA, V89, P5049, DOI 10.1073/pnas.89.11.5049; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BOURNE HR, 1988, CELL, V53, P669, DOI 10.1016/0092-8674(88)90081-5; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; CAIN CC, 1992, J BIOL CHEM, V267, P11681; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CORMONT M, 1991, ENDOCRINOLOGY, V129, P3343, DOI 10.1210/endo-129-6-3343; CORMONT M, 1991, DIABETES, V40, P1170, DOI 10.2337/diabetes.40.9.1170; CORMONT M, 1992, EUR J BIOCHEM, V207, P185, DOI 10.1111/j.1432-1033.1992.tb17036.x; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; DARCHEN F, 1990, P NATL ACAD SCI USA, V87, P5692, DOI 10.1073/pnas.87.15.5692; DAVIS RJ, 1986, J BIOL CHEM, V261, P8708; DEVRIESSMITS AMM, 1992, NATURE, V357, P602, DOI 10.1038/357602a0; GALLWITZ D, 1983, NATURE, V306, P704, DOI 10.1038/306704a0; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GOUD B, 1990, NATURE, V345, P553, DOI 10.1038/345553a0; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; GOULD GW, 1990, TRENDS BIOCHEM SCI, V15, P18, DOI 10.1016/0968-0004(90)90125-U; HAUBRUCK H, 1989, EMBO J, V8, P1427, DOI 10.1002/j.1460-2075.1989.tb03524.x; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; JAMES DE, 1987, J BIOL CHEM, V262, P11817; KARNIELI E, 1981, J BIOL CHEM, V256, P4772; KORN LJ, 1987, SCIENCE, V236, P840, DOI 10.1126/science.3554510; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE JC, 1990, J BIOL CHEM, V265, P2324; LAWRENCE JC, 1990, J BIOL CHEM, V265, P19768; LEMARCHANDBRUSTEL Y, 1990, ENDOCRINOLOGY, V127, P2687; MARIDONNEAUPARINI I, 1991, J CLIN INVEST, V87, P901, DOI 10.1172/JCI115096; MARIDONNEAUPARINI I, 1992, J BIOL CHEM, V267, P6396; MOLLARD GFV, 1990, P NATL ACAD SCI USA, V87, P1988; OLOFSSON B, 1988, ONCOGENE, V3, P231; PESSINO A, 1991, J BIOL CHEM, V266, P20213; REGAZZI R, 1992, EUR J BIOCHEM, V208, P729, DOI 10.1111/j.1432-1033.1992.tb17241.x; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; RUTTER GA, 1992, BIOCHEM J, V281, P431, DOI 10.1042/bj2810431; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SCHURMANN A, 1992, BIOCHEM J, V283, P795, DOI 10.1042/bj2830795; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SIMPSON IA, 1986, ANNU REV BIOCHEM, V55, P1059, DOI 10.1146/annurev.biochem.55.1.1059; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; SMITH RM, 1991, P NATL ACAD SCI USA, V88, P6893, DOI 10.1073/pnas.88.15.6893; SUZUKI K, 1980, P NATL ACAD SCI USA, V77, P2452; TANTI JF, 1991, J BIOL CHEM, V266, P2099; TUOMIKOSKI T, 1989, NATURE, V342, P942, DOI 10.1038/342942a0; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; VANDERSLUIJS P, 1991, P NATL ACAD SCI USA, V88, P6313, DOI 10.1073/pnas.88.14.6313; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; WARDZALA LJ, 1984, J BIOL CHEM, V259, P8378; WARDZALA LJ, 1981, J BIOL CHEM, V256, P7090; WOODMAN PG, 1992, J CELL BIOL, V116, P331, DOI 10.1083/jcb.116.2.331; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394; ZORZANO A, 1989, J BIOL CHEM, V264, P12358	59	162	167	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19491	19497						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366094				2022-12-27	WOS:A1993LW81900054
J	MARGALIT, H; FISCHER, N; BENSASSON, SA				MARGALIT, H; FISCHER, N; BENSASSON, SA			COMPARATIVE-ANALYSIS OF STRUCTURALLY DEFINED HEPARIN-BINDING SEQUENCES REVEALS A DISTINCT SPATIAL-DISTRIBUTION OF BASIC RESIDUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST GROWTH-FACTOR; HUMAN ANTITHROMBIN-III; HUMAN APOLIPOPROTEIN-E; PLATELET FACTOR-4; HIGH-AFFINITY; IV COLLAGEN; PEPTIDE; SITE; DOMAIN; IDENTIFICATION	Heparin, among the best studied glycosaminoglycans, is well known for its involvement in a variety of physiological processes. Many proteins, whose activities are modulated via heparin binding, were identified, and the consequences of their interaction with heparin were characterized. However, in the absence of solid structural information regarding heparin-protein complexes, the mechanism by which heparin operates at the molecular level is still obscure. The structure of such a complex is hereby explored via the identification of a common motif in heparin binding sequences. To avoid ambiguity we included in our data base only sequences that have been shown experimentally to be directly involved in heparin binding. Then, a comparison of the spatial distribution of basic residues was conducted among those peptides for which three-dimensional structures were defined. Using computer graphics techniques we were able to identify a unique distribution shared by all of these segments. Two basic amino acids (most frequently arginine) are located at about 20 angstrom apart, facing opposite directions of an alpha-helix. Other basic amino acids are dispersed between these two residues, facing one side, while nonpolar residues face the opposite side, forming an amphipathic structure. The distribution of basic amino acids in other heparin binding sequences that preserves the same spatial arrangement seems to be compatible with beta-strand structure. The 20-angstrom interval accommodates a glycosaminoglycan pentasaccharide, and the spatial distribution of the basic residues suggests an intertwinement of the heparin-protein complex. The dynamics of such an interaction may provide a clue regarding the ensuing change in protein activity.	HEBREW UNIV JERUSALEM, HADASSAH MED SCH, DEPT EXPTL MED & CANC RES, IL-91010 JERUSALEM, ISRAEL	Hebrew University of Jerusalem	MARGALIT, H (corresponding author), HEBREW UNIV JERUSALEM, HADASSAH MED SCH, DEPT MOLEC GENET, IL-91010 JERUSALEM, ISRAEL.		Margalit, Hanah/H-1651-2013					BAIRD A, 1988, P NATL ACAD SCI USA, V85, P2324, DOI 10.1073/pnas.85.7.2324; BARKALOW FJB, 1991, J BIOL CHEM, V266, P7812; BJORK I, 1982, MOL CELL BIOCHEM, V48, P161, DOI 10.1007/BF00421226; CARDIN AD, 1986, BIOCHEM BIOPH RES CO, V134, P783, DOI 10.1016/S0006-291X(86)80489-2; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CARDIN AD, 1984, ANAL BIOCHEM, V137, P368, DOI 10.1016/0003-2697(84)90099-X; CARDIN AD, 1991, METHOD ENZYMOL, V203, P556; CASTELLOT JJ, 1986, J CELL BIOL, V102, P1979, DOI 10.1083/jcb.102.5.1979; CASU B, 1989, ANN NY ACAD SCI, V556, P1; COLE GJ, 1989, NEURON, V2, P1157, DOI 10.1016/0896-6273(89)90182-7; ECKEL RH, 1989, NEW ENGL J MED, V320, P1060; FERRAN DS, 1992, BIOCHEMISTRY-US, V31, P5010, DOI 10.1021/bi00136a014; HARDIN RI, 1976, J BIOL CHEM, V251, P4273; HIRSH J, 1991, NEW ENGL J MED, V324, P1565; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; JAYE M, 1986, SCIENCE, V233, P541, DOI 10.1126/science.3523756; KALLUNKI P, 1992, J CELL BIOL, V116, P559, DOI 10.1083/jcb.116.2.559; KNAUS HG, 1990, J BIOL CHEM, V265, P11156; KOLIAKOS GG, 1989, J BIOL CHEM, V264, P2313; KOUZIKOLIAKOS K, 1989, J BIOL CHEM, V264, P17971; KUHN LA, 1990, P NATL ACAD SCI USA, V87, P8506, DOI 10.1073/pnas.87.21.8506; LEBARON RG, 1988, J CELL BIOL, V106, P945, DOI 10.1083/jcb.106.3.945; LELLOUCH AC, 1992, BIOCHEMISTRY-US, V31, P2279, DOI 10.1021/bi00123a010; LIU CS, 1987, J BIOL CHEM, V262, P17356; LOSCALZO J, 1985, ARCH BIOCHEM BIOPHYS, V240, P446, DOI 10.1016/0003-9861(85)90049-9; MARCUM JA, 1984, BIOCHEMISTRY-US, V23, P1730, DOI 10.1021/bi00303a023; PRESTRELSKI SJ, 1992, ARCH BIOCHEM BIOPHYS, V293, P314, DOI 10.1016/0003-9861(92)90401-H; RUCINSKI B, 1990, THROMB HAEMOSTASIS, V63, P493; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; SENO M, 1990, EUR J BIOCHEM, V188, P239, DOI 10.1111/j.1432-1033.1990.tb15395.x; SINAY P, 1984, CARBOHYD RES, V132, pC5, DOI 10.1016/0008-6215(84)85236-2; SMITH JW, 1990, BIOCHEMISTRY-US, V29, P8950, DOI 10.1021/bi00490a010; SOBEL M, 1992, J BIOL CHEM, V267, P8857; STCHARLES R, 1989, J BIOL CHEM, V264, P2092; SUN XJ, 1990, BIOCHEMISTRY-US, V29, P8957, DOI 10.1021/bi00490a011; SUN XJ, 1989, J BIOL CHEM, V264, P11288; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; WALZ DA, 1977, THROMB RES, V11, P893, DOI 10.1016/0049-3848(77)90117-7; WEISGRABER KH, 1986, J BIOL CHEM, V261, P2068; WILKE MS, 1990, J INVEST DERMATOL, V95, P264, DOI 10.1111/1523-1747.ep12484883; WILSON C, 1991, SCIENCE, V252, P1818; YAOI Y, 1990, BIOCHIM BIOPHYS ACTA, V1035, P139, DOI 10.1016/0304-4165(90)90108-9; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556	44	217	244	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19228	19231						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366075				2022-12-27	WOS:A1993LW81900015
J	NOIVA, R; FREEDMAN, RB; LENNARZ, WJ				NOIVA, R; FREEDMAN, RB; LENNARZ, WJ			PEPTIDE BINDING TO PROTEIN DISULFIDE-ISOMERASE OCCURS AT A SITE DISTINCT FROM THE ACTIVE-SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; DIRECTED MUTAGENESIS; ISOMERIZATION; THIOREDOXIN; GLYCOSYLATION; PURIFICATION; RESIDENT; LUMEN	Protein disulfide isomerase (PDI) is a multifunctional protein resident in the lumen of the rough endoplasmic reticulum that facilitates protein folding via disulfide bond isomerization. Previously we determined that PDI binds a variety of peptides that can be covalently attached to this protein via a photoreactive cross-linker. We have now investigated the relationship between the peptide binding site and the ability of PDI to catalyze disulfide bond isomerization. PDI has two identical sequences, -WCGHCK-, that have been demonstrated to be important in PDI-catalyzed disulfide isomerization. We have found that other proteins containing these thioredoxin-like active site sequences do not bind the photoreactive peptide probes. Moreover, although chemical modification of the 2 cysteines within the thioredoxin-like active site regions completely inhibits PDI-catalyzed disulfide isomerization, these modifications do not affect peptide binding by PDI. Both of these observations suggest that peptide binding occurs at a site other than the putative PDI active sites. To localize the site in PDI at which binding occurs, we used a radiolabeled peptide photoaffinity probe. Peptide fragments generated by cleavage of I-125-peptide-labeled PDI with cyanogen bromide yielded a single 8-kDa polypeptide fragment containing the I-125-labeled peptide site, but neither of the putative catalytic sites of PDI. An I-125-labeled tryptic peptide was generated from this cyanogen bromide fragment and determined by microsequencing to contain residues 451-476 of PDI; this 26-residue peptide is noteworthy because of its extremely high content of acidic amino acids. Based on these findings we conclude that the peptide binding site is located in the COOH-terminal domain of the protein, and it is distinct from the two active sites for PDI-catalyzed disulfide isomerization and from the region of PDI that has estrogen receptor sequence similarity.	SUNY,DEPT BIOCHEM & CELL BIOL,STONY BROOK,NY 11794; UNIV KENT,BIOL LAB,CANTERBURY CT2 7NZ,KENT,ENGLAND; UNIV S DAKOTA,SCH MED,DEPT BIOCHEM & MOLEC BIOL,VERMILLION,SD 57069	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; SUNY Maritime College; University of Kent; University of South Dakota					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033185, R37GM033185, R01GM033184] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33185, GM33184] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; BONIFACE JJ, 1990, SCIENCE, V247, P61, DOI 10.1126/science.2104678; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULLEID NJ, 1990, EMBO J, V9, P3527, DOI 10.1002/j.1460-2075.1990.tb07561.x; BURLEIGH BD, 1976, J BIOL CHEM, V251, P308; CARMICHAEL DF, 1977, J BIOL CHEM, V252, P7163; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; FREEDMAN RB, 1989, BIOCHEM SOC SYMP, V55, P167; FREEDMAN RB, 1991, CONFORMATIONS FORCES, P204; HAWKINS HC, 1991, BIOCHEM J, V275, P349, DOI 10.1042/bj2750349; HAWKINS HC, 1991, BIOCHEM J, V275, P335, DOI 10.1042/bj2750335; HAWKINS HC, 1991, BIOCHEM J, V275, P341, DOI 10.1042/bj2750341; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; KAPLAN HA, 1988, J BIOL CHEM, V263, P7814; KURUP CKR, 1966, BIOCHIM BIOPHYS ACTA, V113, P255, DOI 10.1016/S0926-6593(66)80066-8; LAMBERT N, 1983, BIOCHEM J, V213, P235, DOI 10.1042/bj2130235; MAZZARELLA RA, 1990, J BIOL CHEM, V265, P1094; MORJANA NA, 1991, BIOCHEMISTRY-US, V30, P4985, DOI 10.1021/bi00234a021; NOIVA R, 1992, J BIOL CHEM, V267, P3553; NOIVA R, 1991, P NATL ACAD SCI USA, V88, P1986, DOI 10.1073/pnas.88.5.1986; NOIVA R, 1991, J BIOL CHEM, V266, P19645; RIPPMANN F, 1991, EMBO J, V10, P1053, DOI 10.1002/j.1460-2075.1991.tb08044.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; TSIBRIS JCM, 1989, J BIOL CHEM, V264, P13967; VUORI K, 1992, J BIOL CHEM, V267, P7211; VUORI K, 1992, EMBO J, V11, P4213, DOI 10.1002/j.1460-2075.1992.tb05515.x	26	118	119	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19210	19217						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366073				2022-12-27	WOS:A1993LW81900013
J	WU, CB; KO, KT				WU, CB; KO, KT			IDENTIFICATION OF AN UNCLEAVABLE TARGETING SIGNAL IN THE 70-KILODALTON SPINACH CHLOROPLAST OUTER ENVELOPE MEMBRANE-PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSIT PEPTIDE; IMPORT; MITOCHONDRIA; TRANSPORT; POLYPEPTIDE; PRECURSORS; RNA	A cDNA clone encoding a cognate 70-kDa heat shock protein from the spinach chloroplast outer envelope (SCE70) was recently characterized (Ko, K., Bornemisza, O., Kourtz, L., Ko, Z. W., Plaxton, W. C., and Cashmore, A. R. (1992) J. Biol. Chem. 267, 2986-2993). Initial studies revealed that SCE70 is targeted to the chloroplast outer envelope membrane without further processing. To determine whether SCE70 possesses a ''targeting domain,'' we tested the targeting ability of SCE70 proteins with various carboxyl- and amino-terminal deletions. Carboxyl-terminal deletions of up to 60% of the protein had no apparent effect on the targeting ability of SCE70. Amino-terminal deletions abolished targeting to the chloroplast except when the extreme NH2-terminal 48-amino acid sequence was retained. We further assessed the chloroplast-targeting ability of the NH2-terminal 48 amino acids by fusing to the foreign protein, mouse dihydrofolate reductase (DHFR). The resulting fusion protein, SCE70-DHFR, was localized to the outer envelope membrane of isolated chloroplasts. SCE70-DHFR exhibited targeting characteristics similar to native SCE70. The targeting of SCE70-DHFR was inhibited effectively by anti-SCE70 antibodies. Immunoprecipitation and chemical cross-linking experiments revealed that SCE70-DHFR is targeted to the same complex as SCE70 in the chloroplast envelope. These results suggest that the extreme NH2 terminus of SCE70 is required for directing SCE70 to a destination in the chloroplast outer envelope membrane, possibly through assembling the polypeptide into a protein complex.	QUEENS UNIV, DEPT BIOL, KINGSTON K7L 3N6, ONTARIO, CANADA	Queens University - Canada								BAKER KP, 1990, NATURE, V348, P605, DOI 10.1038/348605a0; BARTLETT SG, 1982, METHODS CHLOROPLAST, P1081; BIGGIN MO, 1984, P NATL ACAD SCI USA, V80, P3963; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHUA NH, 1979, J CELL BIOL, V81, P461, DOI 10.1083/jcb.81.3.461; CHUA NH, 1982, METHODS CHLOROPLAST, P1063; CLINE K, 1985, J BIOL CHEM, V260, P3691; CLINE K, 1984, PLANT PHYSIOL, V75, P675, DOI 10.1104/pp.75.3.675; ERICKSON AH, 1983, METHOD ENZYMOL, V96, P38; HASE T, 1984, EMBO J, V3, P3157, DOI 10.1002/j.1460-2075.1984.tb02274.x; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; HURT EC, 1985, EMBO J, V4, P3509, DOI 10.1002/j.1460-2075.1985.tb04110.x; JOYARD J, 1983, J BIOL CHEM, V258, P1; KEEGSTRA K, 1989, CELL, V56, P247, DOI 10.1016/0092-8674(89)90898-2; KEEGSTRA K, 1986, METHOD ENZYMOL, V118, P316; KIEBLER M, 1990, NATURE, V348, P610, DOI 10.1038/348610a0; KO K, 1992, J BIOL CHEM, V267, P2986; KO K, 1989, EMBO J, V8, P3187, DOI 10.1002/j.1460-2075.1989.tb08477.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI HM, 1991, PLANT CELL, V3, P709, DOI 10.1105/tpc.3.7.709; LI HM, 1992, J BIOL CHEM, V267, P18999; LI JM, 1992, SCIENCE, V256, P1815, DOI 10.1126/science.1615327; LIPP J, 1989, J CELL BIOL, V109, P2013, DOI 10.1083/jcb.109.5.2013; MCBRIDE HM, 1992, J CELL BIOL, V119, P1451, DOI 10.1083/jcb.119.6.1451; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; NAKAI M, 1989, J BIOCHEM-TOKYO, V105, P513, DOI 10.1093/oxfordjournals.jbchem.a122698; RIEZMAN H, 1983, EMBO J, V2, P2161, DOI 10.1002/j.1460-2075.1983.tb01717.x; SALOMON M, 1990, P NATL ACAD SCI USA, V87, P5778, DOI 10.1073/pnas.87.15.5778; Sambrook J, 1989, MOL CLONING LABORATO; SANDERS SL, 1992, CELL, V69, P353, DOI 10.1016/0092-8674(92)90415-9; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHERER PE, 1990, EMBO J, V9, P4323; SCHNEIDER H, 1991, SCIENCE, V254, P1659, DOI 10.1126/science.1661031; SMEEKENS S, 1986, CELL, V46, P365, DOI 10.1016/0092-8674(86)90657-4; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353	35	24	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19384	19391						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366085				2022-12-27	WOS:A1993LW81900038
J	FOGELPETROVIC, M; SHAPPELL, NW; BERGERON, RJ; PORTER, CW				FOGELPETROVIC, M; SHAPPELL, NW; BERGERON, RJ; PORTER, CW			POLYAMINE AND POLYAMINE ANALOG REGULATION OF SPERMIDINE SPERMINE N1-ACETYLTRANSFERASE IN MALME-3M HUMAN-MELANOMA CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; S-ADENOSYLMETHIONINE DECARBOXYLASE; MESSENGER-RNA STABILITY; COLON CARCINOMA-CELLS; ORNITHINE DECARBOXYLASE; TRANSLATIONAL REGULATION; GROWTH-INHIBITION; GENE-EXPRESSION; L1210 CELLS; LUNG-CANCER	In MALME-3M human melanoma cells the polyamine analog N1,N-12-bis(ethyl)spermine (BESPM) suppresses the key polyamine biosynthetic enzymes, ornithine and S-adenosylmethionine decarboxylase, and increases the polyamine catabolizing enzyme, spermidine/spermine N1-acetyl-transferase (SSAT) by more than 200-fold. In the present study increases in SSAT activity in MALME-3M cells treated with 10 muM BESPM were found to be accompanied by a substantial (up to 45-fold) accumulation of SSAT mRNA. By Northern blot analysis three RNA transcripts were found to hybridize with the coding region of human SSAT cDNA: a minor high molecular weight (approximately 3.5 kilobases) species designated form A and two lower molecular weight species designated forms B and C (approximately 1.5 and approximately 1.3 kilobases, respectively). Form A increased uniformly during BESPM treatment and was most obvious in nuclear RNA preparations. On the basis of size similarity to the transcribing region of the gene and hybridization with the coding region of SSAT cDNA and its prevalence in nuclear mRNA preparations, form A is thought to represent precursor SSAT RNA. Form C is present in control cells and increases steadily during treatment, whereas form B increases transiently during early treatment (1-3 h). By RNase H digestion assay, form B was found to have a 200-base pair longer poly(A) tract and as such may represent a precursor to form C. Accumulation of SSAT mRNA was found to be a result of increased gene transcription and stabilization of SSAT mRNA. Nuclear run-on studies indicated a 2-4-fold increase in the transcription rate of the SSAT gene. As indicated by actinomycin D studies, the SSAT mRNA half-life increased with BESPM treatment from 17 to 64 h. The natural polyamine, spermine, also increased SSAT mRNA (5.5-fold at 24 h) and behaved similarly to BESPM in inducing the appearance of the same three transcript forms. The polyamine was much less effective than the analog at increasing enzyme activity. Lowering intracellular polyamine pools with inhibitors of biosynthesis decreased basal SSAT mRNA levels by at least 70% indicating, that the gene can be down-regulated as well as up-regulated by polyamines. These findings indicate that SSAT represents a unique example of gene expression being positively influenced at the RNA level by polyamines and their analogs.	ROSWELL PK CANC INST, GRACE CANC DRUG CTR, BUFFALO, NY 14263 USA; UNIV FLORIDA, J HILLIS MILLER HLTH CTR, DEPT MED CHEM, GAINESVILLE, FL 32610 USA	Roswell Park Cancer Institute; State University System of Florida; University of Florida					NCI NIH HHS [CA-16506, CA-51524] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA051524] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ATWATER JA, 1990, ANNU REV GENET, V24, P519; BERGERON RJ, 1986, ACCOUNTS CHEM RES, V19, P105, DOI 10.1021/ar00124a002; BERGERON RJ, 1988, J MED CHEM, V31, P1183, DOI 10.1021/jm00401a019; BERNACKI RJ, 1992, CANCER RES, V52, P2424; BRAWERMAN G, 1981, CRC CR REV BIOCH MOL, V10, P1, DOI 10.3109/10409238109114634; BROCK ML, 1983, J BIOL CHEM, V258, P5449; BROCK ML, 1983, CELL, V34, P207, DOI 10.1016/0092-8674(83)90151-4; BYERS TL, 1990, J CELL PHYSIOL, V143, P460, DOI 10.1002/jcp.1041430309; CARRAZANA EJ, 1988, MOL CELL BIOL, V8, P2267, DOI 10.1128/MCB.8.6.2267; CASERO RA, 1992, CANCER RES, V52, P5359; CASERO RA, 1990, BIOCHEM J, V270, P615, DOI 10.1042/bj2700615; CASERO RA, 1989, CANCER RES, V49, P3829; CASERO RA, 1991, J BIOL CHEM, V266, P810; CELANO P, 1989, J BIOL CHEM, V264, P8922; CELANO P, 1989, BIOCHEM BIOPH RES CO, V165, P384, DOI 10.1016/0006-291X(89)91082-6; CHANG BK, 1992, CANCER CHEMOTH PHARM, V30, P183, DOI 10.1007/BF00686309; CHELEY S, 1984, ANAL BIOCHEM, V137, P15, DOI 10.1016/0003-2697(84)90339-7; CHENG J, 1990, MOL CELL BIOL, V10, P5502, DOI 10.1128/MCB.10.10.5502; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOGELPETROVIC M, 1993, IN PRESS BIOCH BIOPH; HOLTTA E, 1986, J BIOL CHEM, V261, P9502; JONES PM, 1990, ENDOCRINOLOGY, V126, P1374, DOI 10.1210/endo-126-3-1374; KAHANA C, 1985, J BIOL CHEM, V260, P5390; KAMEJI T, 1987, J BIOL CHEM, V262, P2427; KANKINUMA Y, 1988, EUR J BIOCHEM, V176, P409; KRAMER DL, 1993, J CELL PHYSIOL, V155, P399, DOI 10.1002/jcp.1041550222; KRAMER DL, 1989, BIOCHEM J, V259, P325, DOI 10.1042/bj2590325; KROWCZYNSKA A, 1985, J MOL BIOL, V181, P231, DOI 10.1016/0022-2836(85)90087-7; LAMERS WH, 1982, P NATL ACAD SCI-BIOL, V79, P5137, DOI 10.1073/pnas.79.17.5137; LEI X, 1992, BIOCHEM BIOPH RES CO, V187, P1493, DOI 10.1016/0006-291X(92)90471-V; LIBBY PR, 1991, ARCH BIOCHEM BIOPHYS, V284, P238, DOI 10.1016/0003-9861(91)90291-P; LIBBY PR, 1989, CANCER RES, V49, P6226; Maniatis T., 1982, MOL CLONING; MATSUI I, 1982, BIOCHEM BIOPH RES CO, V106, P1155, DOI 10.1016/0006-291X(82)91233-5; MCKNIGHT GS, 1979, J BIOL CHEM, V254, P9050; MURAKAMI Y, 1985, BIOCHEM J, V226, P893, DOI 10.1042/bj2260893; Nevins J R, 1980, Methods Enzymol, V65, P768; OSTROWSKI LE, 1989, CARCINOGENESIS, V10, P1439, DOI 10.1093/carcin/10.8.1439; PEGG AE, 1990, BIOCHEM J, V267, P331, DOI 10.1042/bj2670331; PEGG AE, 1985, BIOCHEM J, V231, P285, DOI 10.1042/bj2310285; PERSSON L, 1984, BIOCHEMISTRY-US, V23, P3777, DOI 10.1021/bi00311a033; PERSSON L, 1986, FEBS LETT, V205, P175, DOI 10.1016/0014-5793(86)80892-4; PORTER CW, 1987, BIOCHEM J, V242, P433, DOI 10.1042/bj2420433; PORTER CW, 1991, CANCER RES, V51, P3715; PORTER CW, 1988, ADV ENZYME REGUL, V27, P57; PORTER CW, 1990, BIOCHEM J, V268, P207, DOI 10.1042/bj2680207; PORTER CW, 1992, FALK SYMP, V62, P301; PORTER CW, 1993, CANCER RES, V53, P581; ROSS J, 1976, J MOL BIOL, V106, P403, DOI 10.1016/0022-2836(76)90093-0; SEILER N, 1985, BIOCHEM J, V225, P219, DOI 10.1042/bj2250219; SEILER N, 1987, CAN J PHYSIOL PHARM, V65, P2024, DOI 10.1139/y87-317; SHAPPELL NW, 1992, ANTICANCER RES, V12, P1083; SHAPPELL NW, 1993, FEBS LETT, V321, P179, DOI 10.1016/0014-5793(93)80103-2; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SIERRA F, 1983, NUCLEIC ACIDS RES, V11, P7069, DOI 10.1093/nar/11.20.7069; WALLACE HM, 1987, MED SCI RES-BIOCHEM, V15, P1437; WETTERS TV, 1989, MOL CELL BIOL, V9, P5484, DOI 10.1128/MCB.9.12.5484; XIAO L, 1991, BIOCHEM BIOPH RES CO, V179, P407, DOI 10.1016/0006-291X(91)91385-P; ZEEVI M, 1982, MOL CELL BIOL, V2, P517, DOI 10.1128/MCB.2.5.517	61	87	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					19118	19125						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360194				2022-12-27	WOS:A1993LV65900109
J	ROSSI, SG; ROTUNDO, RL				ROSSI, SG; ROTUNDO, RL			LOCALIZATION OF NON-EXTRACTABLE ACETYLCHOLINESTERASE TO THE VERTEBRATE NEUROMUSCULAR-JUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASYMMETRIC ACETYLCHOLINESTERASE; MOLECULAR-FORMS; SKELETAL-MUSCLE; RAT DIAPHRAGM; BASAL LAMINA; EXTRACELLULAR-MATRIX; HEPARIN; ENDPLATE; MEMBRANE; SOLUBILIZATION	Asymmetric forms of acetylcholinesterase (AChE) are thought to be the predominant forms of this enzyme at vertebrate neuromuscular junctions where they attach to the synaptic basal lamina via a collagen-like tail. High salt and heparin-containing buffers are capable of solubilizing asymmetric AChE molecules from skeletal muscle; however, detachment of AChE specifically from synaptic basal lamina using these procedures has not been demonstrated. To determine whether AChE can be solubilized from mature neuromuscular junctions, adult quail muscle fibers were extracted with buffered detergent solutions containing either 0.05 M NaCl, 1 M NaCl, 0.5-2 mg/ml heparin, 8 M urea, or 4 M guanidine HCl, and the remaining AChE molecules were localized by indirect immunofluorescence. Analysis of extracted AChE oligomeric forms showed that low salt buffers containing heparin and high salt buffers were capable of solubilizing substantial amounts of catalytically active collagen-tailed AChE, whereas none of these buffers were capable of detaching AChE from synaptic basal lamina. In contrast, digestion with purified collagenase detached asymmetric forms from the non-extractable fraction and removed the AChE from the neuromuscular junctions. Parallel experiments using rat gastrocnemius muscle and enzyme histochemistry to detect AChE gave similar results. These studies indicate that the junctional AChE molecules are firmly attached to the extracellular matrix and that all the conventional extraction buffers used to solubilize the asymmetric collagen-tailed forms of AChE are incapable of detaching this enzyme from the synaptic basal lamina.	UNIV MIAMI,SCH MED,DEPT CELL BIOL & ANAT R124,POB 016960,MIAMI,FL 33101	University of Miami					NATIONAL INSTITUTE ON AGING [R01AG005917] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG005917] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANGLISTER L, 1991, J CELL BIOL, V115, P755, DOI 10.1083/jcb.115.3.755; ANGLISTER L, 1985, J CELL BIOL, V101, P735, DOI 10.1083/jcb.101.3.735; BARAT A, 1986, FEBS LETT, V195, P209, DOI 10.1016/0014-5793(86)80162-4; BAYNE EK, 1984, J CELL BIOL, V99, P1486, DOI 10.1083/jcb.99.4.1486; BETZ W, 1973, J PHYSIOL-LONDON, V230, P673, DOI 10.1113/jphysiol.1973.sp010211; BON S, 1978, EUR J BIOCHEM, V85, P1, DOI 10.1111/j.1432-1033.1978.tb12207.x; BRANDAN E, 1985, J CELL BIOL, V101, P985, DOI 10.1083/jcb.101.3.985; BRANDAN E, 1984, BIOCHEM J, V221, P415, DOI 10.1042/bj2210415; BRIMIJOIN S, 1982, J NEUROCHEM, V38, P588, DOI 10.1111/j.1471-4159.1982.tb08667.x; BRZIN M, 1963, J CELL BIOL, V19, P349, DOI 10.1083/jcb.19.2.349; COLLINS PL, 1982, J BIOL CHEM, V257, P13638; COUTEAUX R, 1955, INT REV CYTOL, V4, P335, DOI 10.1016/S0074-7696(08)60463-5; DONALDSON SKB, 1975, J GEN PHYSIOL, V66, P427, DOI 10.1085/jgp.66.4.427; FERNANDEZ HL, 1984, NEUROSCI LETT, V44, P187, DOI 10.1016/0304-3940(84)90079-X; FERNANDEZ HL, 1979, J NEUROBIOL, V10, P441, DOI 10.1002/neu.480100503; GUTH L, 1964, EXP NEUROL, V10, P236, DOI 10.1016/0014-4886(64)90065-2; HALL ZW, 1973, J NEUROBIOL, V4, P343, DOI 10.1002/neu.480040404; HALL ZW, 1971, NATURE-NEW BIOL, V232, P62, DOI 10.1038/newbio232062a0; INESTROSA NC, 1992, MULTIDISCIPLINARY APPROACHES TO CHOLINESTERASE FUNCTIONS, P25; INESTROSA NC, 1989, TRENDS PHARMACOL SCI, V10, P325, DOI 10.1016/0165-6147(89)90067-9; JOHNSON CD, 1975, ANAL BIOCHEM, V64, P229, DOI 10.1016/0003-2697(75)90423-6; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; KASPRZAK H, 1985, J NEUROSCI, V5, P951; KREJCI E, 1991, EMBO J, V10, P1285, DOI 10.1002/j.1460-2075.1991.tb08070.x; LOMO T, 1985, J NEUROSCI, V5, P1180; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MCMAHAN UJ, 1978, NATURE, V271, P172, DOI 10.1038/271172a0; NEWMAN JR, 1984, J PHYSIOL-LONDON, V352, P305, DOI 10.1113/jphysiol.1984.sp015292; PEREZTUR J, 1991, NEUROSCI LETT, V126, P172, DOI 10.1016/0304-3940(91)90546-6; ROTUNDO RL, 1984, J BIOL CHEM, V259, P3186; ROTUNDO RL, 1984, P NATL ACAD SCI-BIOL, V81, P479, DOI 10.1073/pnas.81.2.479; ROTUNDO RL, 1987, VERTEBRATE NEUROMUSC, P247; SANES JR, 1986, J CELL BIOL, V102, P420, DOI 10.1083/jcb.102.2.420; SILMAN I, 1979, NATURE, V280, P160, DOI 10.1038/280160a0; SILMAN I, 1987, EUR J BIOCHEM, V170, P11, DOI 10.1111/j.1432-1033.1987.tb13662.x; SKETELJ J, 1978, EXP NEUROL, V60, P624, DOI 10.1016/0014-4886(78)90016-X; SWENARCHUK LE, 1990, DEVELOPMENT, V110, P51; TAYLOR P, 1991, J BIOL CHEM, V266, P4025; TORRES JC, 1983, BIOCHEM J, V215, P201, DOI 10.1042/bj2150201; TORRES JC, 1983, FEBS LETT, V154, P265, DOI 10.1016/0014-5793(83)80162-8; TORRES JC, 1985, CELL MOL NEUROBIOL, V5, P303, DOI 10.1007/BF00711015; VIGNY M, 1983, J BIOL CHEM, V258, P8794; VIGNY M, 1976, J NEUROCHEM, V27, P1347, DOI 10.1111/j.1471-4159.1976.tb02614.x; WEINBERG CB, 1979, DEV BIOL, V68, P631, DOI 10.1016/0012-1606(79)90233-1; YOUNKIN SG, 1982, J BIOL CHEM, V257, P13630	45	32	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					19152	19159						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360197				2022-12-27	WOS:A1993LV65900113
J	SECRIST, JP; BURNS, LA; KARNITZ, L; KORETZKY, GA; ABRAHAM, RT				SECRIST, JP; BURNS, LA; KARNITZ, L; KORETZKY, GA; ABRAHAM, RT			STIMULATORY EFFECTS OF THE PROTEIN TYROSINE PHOSPHATASE INHIBITOR, PERVANADATE, ON T-CELL ACTIVATION EVENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN RECEPTOR; PHOSPHOLIPASE C-GAMMA-1; LYMPHOCYTE-T; SIGNAL TRANSDUCTION; CROSS-LINKING; GROWTH-FACTOR; PHOSPHORYLATION; KINASE; ANTIBODY; FAMILY	Ligation of the multimeric T-cell antigen receptor complex (TCR) triggers a pleiotropic cellular activation response that includes lymphokine secretion, cell-cycle progression, and ultimately, T-cell proliferation. The earliest detectable biochemical event triggered by TCR cross-linkage is the tyrosine phosphorylation of specific intracellular proteins, which, in turn, propagate receptor-mediated signals into the cytoplasm and nucleus. In this study, we have examined the effects of pervanadate, a powerful inhibitor of protein tyrosine phosphatases (PTP), on the activation state of the human leukemic T-cell line, Jurkat. Treatment of Jurkat cells with pervanadate rapidly induced a series of proximal T-cell activation events that closely resembled those induced by TCR-dependent stimuli. Moreover, pervanadate treatment, like TCR cross-linkage, stimulated interleukin-2 production in wild-type Jurkat cells, indicating that the biochemical events initiated by this TCR-independent stimulus were sufficient to induce lymphokine gene expression. Exposure of intact cells to pervanadate also stimulated the in vitro catalytic activities of both p59fyn and p56lck, src family kinases strongly implicated in TCR-mediated signaling. The stimulatory effects of pervanadate on protein tyrosine kinase-mediated signaling events were accompanied by a marked inhibition of CD45-associated PTP activity. However, the ability of pervanadate to stimulate tyrosine phosphorylation in CD45-negative Jurkat cells suggests that PTPs other than CD45 are important intracellular targets for pervanadate. These studies demonstrate that inhibition of PTP activities in Jurkat cells leads to a T-cell activation response that is remarkably similar to that induced by TCR cross-linkage.	MAYO CLIN & MAYO FDN,DEPT IMMUNOL,RM 342B,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT PHARMACOL,ROCHESTER,MN 55905; UNIV IOWA,COLL MED,DEPT INTERNAL MED,IOWA CITY,IA 52242; UNIV IOWA,COLL MED,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242	Mayo Clinic; Mayo Clinic; University of Iowa; University of Iowa			Koretzky, Gary/AAU-5381-2021		NATIONAL CANCER INSTITUTE [U19CA052995, R29CA056843, U01CA052995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047286] Funding Source: NIH RePORTER; NCI NIH HHS [CA 56843, CA 52995] Funding Source: Medline; NIGMS NIH HHS [GM 47286] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAM N, 1990, MOL CELL BIOL, V10, P5197, DOI 10.1128/MCB.10.10.5197; ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; Altman A, 1990, Adv Immunol, V48, P227, DOI 10.1016/S0065-2776(08)60756-7; AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; AUGUSTINE JA, 1991, J IMMUNOL, V146, P2889; BERGER AE, 1981, HUM IMMUNOL, V3, P231, DOI 10.1016/0198-8859(81)90020-3; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; BIJSTERBOSCH MK, 1985, CELL, V41, P999, DOI 10.1016/S0092-8674(85)80080-5; BOURGOIN S, 1992, J BIOL CHEM, V267, P11908; CHAN A, 1992, ARTHRITIS RHEUM, V35, pS61; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; COOKE MP, 1991, CELL, V65, P281, DOI 10.1016/0092-8674(91)90162-R; EAKLE KA, 1988, MOL CELL BIOL, V8, P4098, DOI 10.1128/MCB.8.10.4098; EGERTON M, 1992, EMBO J, V11, P3533, DOI 10.1002/j.1460-2075.1992.tb05436.x; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; FANTUS IG, 1989, BIOCHEMISTRY-US, V28, P8864, DOI 10.1021/bi00448a027; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; GARCIAMORALES P, 1990, P NATL ACAD SCI USA, V87, P9255, DOI 10.1073/pnas.87.23.9255; GILLILAND LK, 1992, J BIOL CHEM, V267, P13610; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; HEFFETZ D, 1990, J BIOL CHEM, V265, P2896; HO SN, 1987, J IMMUNOL METHODS, V98, P99, DOI 10.1016/0022-1759(87)90441-8; HSI ED, 1989, J BIOL CHEM, V264, P10836; HUHN RD, 1987, P NATL ACAD SCI USA, V84, P4408, DOI 10.1073/pnas.84.13.4408; JUNE CH, 1990, J IMMUNOL, V144, P1591; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; KADOTA S, 1987, BIOCHEM BIOPH RES CO, V147, P259, DOI 10.1016/S0006-291X(87)80115-8; KANNER SB, 1992, BIOCHEM SOC T, V20, P178, DOI 10.1042/bst0200178; KARNITZ L, 1992, MOL CELL BIOL, V12, P4521, DOI 10.1128/MCB.12.10.4521; KEEGAN AD, 1992, IMMUNOL TODAY, V13, P63, DOI 10.1016/0167-5699(92)90136-U; KIENER PA, 1989, J IMMUNOL, V143, P23; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KOLLER KJ, 1987, NATURE, V325, P542, DOI 10.1038/325542a0; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; LUO K, 1990, ONCOGENE, V5, P921; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; MUSTELIN T, 1990, SCIENCE, V247, P1584, DOI 10.1126/science.2138816; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; NOVOGRODSKY A, 1980, J EXP MED, V151, P755, DOI 10.1084/jem.151.3.755; NOVOGRODSKY A, 1974, EUR J IMMUNOL, V4, P646, DOI 10.1002/eji.1830041003; PARK DJ, 1991, P NATL ACAD SCI USA, V88, P5453, DOI 10.1073/pnas.88.12.5453; PEYRON JF, 1991, INT IMMUNOL, V3, P1357, DOI 10.1093/intimm/3.12.1357; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SECRIST JP, 1991, J BIOL CHEM, V266, P12135; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SULTZMAN L, 1991, MOL CELL BIOL, V11, P2018, DOI 10.1128/MCB.11.4.2018; TSYGANKOV AY, 1992, J BIOL CHEM, V267, P18259; VANWAUWE JP, 1980, J IMMUNOL, V124, P2708; VEILLETTE A, 1989, MOL CELL BIOL, V9, P4441, DOI 10.1128/MCB.9.10.4441; WATSON J, 1979, J EXP MED, V150, P1510, DOI 10.1084/jem.150.6.1510; WEBER JR, 1992, J EXP MED, V176, P373, DOI 10.1084/jem.176.2.373; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484; WISKOCIL R, 1985, J IMMUNOL, V134, P1599; ZICK Y, 1990, BIOCHEMISTRY-US, V29, P10240, DOI 10.1021/bi00496a013	60	291	294	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1993	268	8					5886	5893						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR822	8383678				2022-12-27	WOS:A1993KR82200080
J	HEINEMEYER, W; GRUHLER, A; MOHRLE, V; MAHE, Y; WOLF, DH				HEINEMEYER, W; GRUHLER, A; MOHRLE, V; MAHE, Y; WOLF, DH			PRE2, HIGHLY HOMOLOGOUS TO THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX-LINKED RING10 GENE, CODES FOR A YEAST PROTEASOME SUBUNIT NECESSARY FOR CHYMOTRYPTIC ACTIVITY AND DEGRADATION OF UBIQUITINATED PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT PROTEINASE; CLASS-II REGION; MULTICATALYTIC PROTEINASE; SACCHAROMYCES-CEREVISIAE; MACROPAIN PROTEASOME; HUMAN MHC; PARTICLES; SEQUENCE; CLONING; CELLS	We have cloned the yeast PRE2 gene by complementation of pre2 mutants, which are defective in the chymotrypsin-like activity of the 20 S proteasome (multicatalytic-multifunctional proteinase complex). The PRE2 gene, a beta-type member of the proteasomal gene family, is essential for life and codes for a 287-amino acid proteasomal subunit with a predicted molecular mass of 31.6 kDa. Missense mutations in two pre2 mutant alleles were identified. They led to enhanced sensitivity of yeast cells against stress. At the same time, pre2 mutants accumulated ubiquitinated proteins. The Pre2 protein shows striking homology to the human Ring10 protein (60% identity excluding the 70 amino-terminal residues), which is encoded in the major histocompatibility complex class II region. It represents a component of the low molecular mass polypeptide complex, previously shown to be a special type of the 20 S proteasome. The low molecular mass polypeptide complex is assumed to be involved in antigen presentation, generating peptides from cytosolic protein antigens, which are subsequently presented to cytotoxic T-lymphocytes on the cell surface. The high homology of Pre2 to Ring10 implies the hypothesis that Ring10 is a subunit of the low molecular mass polypeptide complex central in its chymotryptic activity. One might further suggest that replacement of constitutive proteasomal components by functionally related major histocompatibility complex-linked low molecular mass polypeptides, as is Ring10, adapts mammalian proteasomes for functions in the immune response.	UNIV STUTTGART,INST BIOCHEM,PFAFFENWALDRING 55,W-7000 STUTTGART 80,GERMANY	University of Stuttgart								AKI M, 1992, FEBS LETT, V301, P65, DOI 10.1016/0014-5793(92)80211-X; [Anonymous], 1991, Methods Enzymol, V194, P1; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; DeMars R, 1992, Trends Cell Biol, V2, P81, DOI 10.1016/0962-8924(92)90077-Z; DEMARTINO GN, 1991, BIOCHIM BIOPHYS ACTA, V1079, P29, DOI 10.1016/0167-4838(91)90020-Z; DRISCOLL J, 1990, J BIOL CHEM, V265, P4789; DRISCOLL J, 1992, CELL, V68, P823, DOI 10.1016/0092-8674(92)90024-7; EMORI Y, 1991, MOL CELL BIOL, V11, P344, DOI 10.1128/MCB.11.1.344; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; FRENTZEL S, 1992, FEBS LETT, V302, P121, DOI 10.1016/0014-5793(92)80420-L; FUJIWARA T, 1990, J BIOL CHEM, V265, P16604; GEORGATSOU E, 1992, FEBS LETT, V299, P29; GLYNNE R, 1991, NATURE, V353, P357, DOI 10.1038/353357a0; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; HAFFTER P, 1991, NUCLEIC ACIDS RES, V19, P5075, DOI 10.1093/nar/19.18.5075; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; HEINEMEYER W, 1990, Yeast, V6, pS342; HOUGH R, 1987, J BIOL CHEM, V262, P8303; KELLY A, 1991, NATURE, V353, P667, DOI 10.1038/353667a0; KLEINSCHMIDT JA, 1988, FEBS LETT, V239, P35, DOI 10.1016/0014-5793(88)80540-4; LEE DH, 1992, BIOCHEM BIOPH RES CO, V182, P452, DOI 10.1016/0006-291X(92)91753-D; LEE LW, 1990, BIOCHIM BIOPHYS ACTA, V1037, P178, DOI 10.1016/0167-4838(90)90165-C; LEER RJ, 1984, FEBS LETT, V175, P371, DOI 10.1016/0014-5793(84)80771-1; LILLEY KS, 1990, FEBS LETT, V262, P327, DOI 10.1016/0014-5793(90)80220-D; MARTINEZ CK, 1991, NATURE, V353, P664, DOI 10.1038/353664a0; MORITZ M, 1991, MOL CELL BIOL, V11, P5681, DOI 10.1128/MCB.11.11.5681; ORLOWSKI M, 1990, BIOCHEMISTRY-US, V29, P10289, DOI 10.1021/bi00497a001; ORTIZNAVARRETE V, 1991, NATURE, V353, P662, DOI 10.1038/353662a0; RICHTERRUOFF B, 1992, FEBS LETT, V302, P192, DOI 10.1016/0014-5793(92)80438-M; RIVETT AJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P1, DOI 10.1016/0003-9861(89)90558-4; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; Sherman F., 1986, METHODS YEAST GENETI; TANAKA K, 1992, NEW BIOL, V4, P173; TANAKA K, 1988, J BIOL CHEM, V263, P16209; ZWICKL P, 1992, BIOCHEMISTRY-US, V31, P964, DOI 10.1021/bi00119a004	36	242	244	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1993	268	7					5115	5120						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP884	8383129				2022-12-27	WOS:A1993KP88400081
J	SCHWANINGER, M; LUX, G; BLUME, R; OETJEN, E; HIDAKA, H; KNEPEL, W				SCHWANINGER, M; LUX, G; BLUME, R; OETJEN, E; HIDAKA, H; KNEPEL, W			MEMBRANE DEPOLARIZATION AND CALCIUM INFLUX INDUCE GLUCAGON GENE-TRANSCRIPTION IN PANCREATIC-ISLET CELLS THROUGH THE CYCLIC AMP-RESPONSIVE ELEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; DNA-BINDING PROTEINS; NUCLEAR FACTOR CREB; SOMATOSTATIN GENE; BETA-CELLS; INSULIN-SECRETION; PROMOTER ELEMENT; RAT SOMATOSTATIN; MAMMALIAN-CELLS; ENDOCRINE-CELLS	Glucagon-producing pancreatic islet cells generate calcium-dependent action potentials. By the control of calcium influx through voltage-gated calcium channels, calcium is a tightly regulated second messenger in these cells. It is unknown whether calcium is a signal for glucagon gene transcription. Therefore, rat glucagon reporter fusion genes were transiently transfected into pancreatic islet cell lines. High potassium-induced membrane depolarization activated glucagon gene transcription. The effects of a calcium chelator, calcium channel blockers, calmodulin antagonists, and an inhibitor of calcium/calmodulin-dependent protein kinase II (CaM kinase II) indicate that depolarization-induced glucagon gene transcription depends on calcium influx and CaM kinase II. The depolarization-responsive element was mapped to the glucagon cAMP-responsive element (CRE). The CRE-binding protein CREB was shown, by using GAL4-CREB fusion proteins, to function as a depolarization-regulated transcription factor in pancreatic islet cells. Membrane depolarization and cAMP had synergistic effects on glucagon gene transcription. These results suggest that rat glucagon gene transcription is regulated by membrane electrical activity and calcium influx in pancreatic islet cells. This signal may be transmitted via CaM kinase II and CREB to the glucagon CRE.	UNIV GOTTINGEN, DEPT BIOCHEM PHARMACOL, ROBERT KOCH STR 40, W-3400 GOTTINGEN, GERMANY; NAGOYA UNIV, SCH MED, DEPT PHARMACOL, NAGOYA, AICHI 466, JAPAN	University of Gottingen; Nagoya University				Schwaninger, Markus/0000-0002-4510-9718				ALPERT S, 1988, CELL, V53, P295, DOI 10.1016/0092-8674(88)90391-1; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COOK DL, 1991, TRENDS NEUROSCI, V14, P411, DOI 10.1016/0166-2236(91)90033-Q; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; DAY RN, 1990, MOL ENDOCRINOL, V4, P736, DOI 10.1210/mend-4-5-736; DAY RN, 1989, J BIOL CHEM, V264, P431; DEFRANCO AL, 1991, NATURE, V352, P754, DOI 10.1038/352754a0; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DIEM P, 1990, ENDOCRINOLOGY, V127, P1609, DOI 10.1210/endo-127-4-1609; DRUCKER DJ, 1988, ENDOCRINOLOGY, V123, P1861, DOI 10.1210/endo-123-4-1861; DRUCKER DJ, 1991, ENDOCRINOLOGY, V128, P394, DOI 10.1210/endo-128-1-394; EFRAT S, 1988, NEURON, V1, P605, DOI 10.1016/0896-6273(88)90110-9; EPSTEIN PN, 1989, CELL, V58, P1067, DOI 10.1016/0092-8674(89)90505-9; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; FLINT KJ, 1991, ONCOGENE, V6, P2019; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; FUKUNAGA K, 1988, J NEUROCHEM, V51, P1070, DOI 10.1111/j.1471-4159.1988.tb03070.x; GERMAN MS, 1990, J BIOL CHEM, V265, P22063; GINTY DD, 1991, J BIOL CHEM, V266, P17454; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HABENER JF, 1990, MOL ENDOCRINOL, V4, P1087, DOI 10.1210/mend-4-8-1087; HABENER JF, 1991, ENDOCRINE PANCREAS, P53; HAMAGUCHI K, 1990, DIABETES, V39, P415, DOI 10.2337/diabetes.39.4.415; HIDAKA H, 1992, ANNU REV PHARMACOL, V32, P377, DOI 10.1146/annurev.pharmtox.32.1.377; HILL RS, 1987, DIABETES, V36, P4400; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; HSU WH, 1991, J BIOL CHEM, V266, P837; INAGAKI N, 1992, P NATL ACAD SCI USA, V89, P1045, DOI 10.1073/pnas.89.3.1045; ISHIKAWA N, 1990, J PHARMACOL EXP THER, V254, P598; IVERSEN J, 1973, J CLIN INVEST, V52, P2102, DOI 10.1172/JCI107395; JAMESON JL, 1989, MOL ENDOCRINOL, V3, P763, DOI 10.1210/mend-3-5-763; Janis RA, 1987, ADV DRUG RES, V16, P309; KAPILOFF MS, 1991, P NATL ACAD SCI USA, V88, P3710, DOI 10.1073/pnas.88.9.3710; KEAHEY HH, 1989, DIABETES, V38, P188, DOI 10.2337/diabetes.38.2.188; KILBOURNE EJ, 1992, J BIOL CHEM, V267, P7563; KNEPEL W, 1990, J BIOL CHEM, V265, P8725; KNEPEL W, 1991, MOL ENDOCRINOL, V5, P1457, DOI 10.1210/mend-5-10-1457; KNEPEL W, 1990, MOL CELL BIOL, V10, P6799, DOI 10.1128/MCB.10.12.6799; KOBIERSKI LA, 1991, P NATL ACAD SCI USA, V88, P10222, DOI 10.1073/pnas.88.22.10222; LEDOUARIN NM, 1988, CELL, V53, P169, DOI 10.1016/0092-8674(88)90375-3; LEE CQ, 1990, EMBO J, V9, P4455, DOI 10.1002/j.1460-2075.1990.tb07896.x; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LUCKHOFF A, 1992, NATURE, V355, P356, DOI 10.1038/355356a0; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; NEHER E, 1992, NATURE, V355, P298, DOI 10.1038/355298a0; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; NORMAN JA, 1987, MOL PHARMACOL, V31, P535; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; OZAWA S, 1986, PHYSIOL REV, V66, P887, DOI 10.1152/physrev.1986.66.4.887; PEREZREYES E, 1990, J BIOL CHEM, V265, P20430; PHILIPPE J, 1988, MOL CELL BIOL, V8, P4877, DOI 10.1128/MCB.8.11.4877; PHILIPPE J, 1990, J BIOL CHEM, V265, P1465; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P817, DOI 10.1210/endo-117-3-817; POWERS AC, 1990, DIABETES, V39, P406, DOI 10.2337/diabetes.39.4.406; POWERS AC, 1989, J BIOL CHEM, V264, P10048; PRENTKI M, 1988, J BIOL CHEM, V263, P11044; RAJAN AS, 1989, DIABETES, V38, P874, DOI 10.2337/diabetes.38.7.874; RORSMAN P, 1988, J GEN PHYSIOL, V91, P223, DOI 10.1085/jgp.91.2.223; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; RORSMAN P, 1988, J GEN PHYSIOL, V91, P243, DOI 10.1085/jgp.91.2.243; Sambrook J, 1989, MOL CLONING LABORATO; SANTERRE RF, 1981, P NATL ACAD SCI-BIOL, V78, P4339, DOI 10.1073/pnas.78.7.4339; SATIN LS, 1988, PFLUG ARCH EUR J PHY, V411, P401, DOI 10.1007/BF00587719; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SORYSORENSON RL, 1991, DIABETES, V40, P1365; TAKAKI R, 1986, IN VITRO CELL DEV B, V22, P120; TANAKA T, 1982, MOL PHARMACOL, V22, P4008; TEITELMAN G, 1991, RECENT PROG HORM RES, V47, P259; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; UNGER RH, 1981, NEW ENGL J MED, V304, P1518, DOI 10.1056/NEJM198106183042504; VANNGUYEN T, 1990, J NEUROSCI, V10, P2825; WAEBER G, 1991, MOL ENDOCRINOL, V5, P1418, DOI 10.1210/mend-5-10-1418; WANG JL, 1990, BIOCHEM BIOPH RES CO, V166, P813, DOI 10.1016/0006-291X(90)90882-N; WATERMAN M, 1985, SCIENCE, V229, P267, DOI 10.1126/science.2990047; WEGNER M, 1992, SCIENCE, V256, P370, DOI 10.1126/science.256.5055.370; WOLLHEIM CB, 1990, BIOCHEM SOC T, V18, P111, DOI 10.1042/bst0180111; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YAN GZ, 1991, MOL ENDOCRINOL, V5, P1488, DOI 10.1210/mend-5-10-1488	85	99	100	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	1993	268	7					5168	5177						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP884	8383130				2022-12-27	WOS:A1993KP88400088
J	SHOELSON, SE; LEE, JS; LYNCH, CS; BACKER, JM; PILCH, PF				SHOELSON, SE; LEE, JS; LYNCH, CS; BACKER, JM; PILCH, PF			BPA(B25) INSULINS - PHOTOACTIVATABLE ANALOGS THAT QUANTITATIVELY CROSS-LINK, RADIOLABEL, AND ACTIVATE THE INSULIN-RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT HUMAN INSULIN; BIOLOGICAL-ACTIVITY; PLASMA-MEMBRANE; BINDING-SITE; SUBUNIT STRUCTURE; PROTEIN DESIGN; SELECTIVE H-2; SIDE-CHAIN; MAIN CHAIN; ASSIGNMENT	Benzoylphenylalanine (Bpa), a photoactivatable amino acid was incorporated into the 25 position of the insulin B-chain by a combination of chemical synthesis and enzymatic semisynthesis. Bpa(B25) insulin binds specifically to the insulin receptor with an affinity almost-equal-to 40% that of native insulin. Addition of biotin or epsilon-amino-hexanoic acid-iminobiotin at the epsilon-Lys(B29) position to form Bpa(B25),B29epsilon-biotinyl (BBpa) or Bpa(B25),B29epsilon-(Aha-iminobiotin) analogues had little adverse effect on receptor binding affinity and provided a convenient handle for affinity purification, gel shift assays, and blotting of cross-linked complexes with avidin. The analogues were readily I-125-iodinated with the majority of I-125 being incorporated at the Tyr(A14) position; the monoiodo-A14 derivative was easily separated from other forms by high performance liquid chromatography. Photolysis of a complex of the insulin receptor and either Bpa(B25) insulin or [I-125]iodo-Tyr(A14),Bpa(B25) insulin yields a covalent insulin-receptor complex. The efficiency of cross-linking with these reagents was unusually high, ranging from 60 to 100%. Furthermore, cross-linking to the insulin receptor results in kinase activation in vitro, and in intact cells insulin receptor phosphorylation and internalization were both activated. Notably, even at saturating concentrations one molecule of Bpa(B25) insulin covalently cross-linked each alpha2beta2 receptor, demonstrating that holoreceptor activation occurs with one high affinity insulin binding site occupied and, if a second insulin binds with lower affinity it must be in a different orientation. Bpa insulin analogues form a new class of photoaffinity reagents which facilitate studies relating insulin-insulin receptor structure and function.	BRIGHAM & WOMENS HOSP,DEPT MED,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; BOSTON UNIV,SCH MED,DEPT MED,BOSTON,MA 02118	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University	SHOELSON, SE (corresponding author), JOSLIN DIABET CTR,1 JOSLIN PL,BOSTON,MA 02215, USA.		Lee, Jongsoon/AAG-1674-2020	Lee, Jongsoon/0000-0002-0891-5059; Pilch, Paul/0000-0003-1997-0499	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036424, R01DK043123, P30DK036836] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK43123, DK36836, R01 DK36424] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BACKER JM, 1991, J CELL BIOL, V115, P1535, DOI 10.1083/jcb.115.6.1535; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; BONISCHNETZLER M, 1986, J BIOL CHEM, V261, P5281; BONISCHNETZLER M, 1987, J BIOL CHEM, V262, P8395; BREMS DN, 1991, J BIOL CHEM, V266, P1611; BRESLOW R, 1980, ACCOUNTS CHEM RES, V13, P170, DOI 10.1021/ar50150a002; CHOWDHRY V, 1979, ANNU REV BIOCHEM, V48, P293, DOI 10.1146/annurev.bi.48.070179.001453; CUTFIELD J, 1981, H-S Z PHYSIOL CHEM, V362, P755, DOI 10.1515/bchm2.1981.362.1.755; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DEMEYTS P, 1976, J BIOL CHEM, V251, P1877; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; FABRY M, 1992, J BIOL CHEM, V267, P8950; FUDEMGOLDIN B, 1990, METHOD ENZYMOL, V184, P167; HOFMANN K, 1980, P NATL ACAD SCI-BIOL, V77, P4666, DOI 10.1073/pnas.77.8.4666; HUA QX, 1991, BIOCHEMISTRY-US, V30, P5505, DOI 10.1021/bi00236a025; HUA QX, 1992, BIOCHEMISTRY-US, V31, P11940, DOI 10.1021/bi00162a037; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; INOUYE K, 1981, BIOPOLYMERS, V20, P1845, DOI 10.1002/bip.1981.360200909; INOUYE K, 1981, EXPERIENTIA, V37, P811, DOI 10.1007/BF01985653; INOUYE K, 1982, PEPTIDE CHEM, P277; KAUER JC, 1986, J BIOL CHEM, V261, P695; KOBAYASHI M, 1984, BIOCHEM BIOPH RES CO, V119, P49, DOI 10.1016/0006-291X(84)91616-4; KOBAYASHI M, 1982, BIOCHEM J, V206, P597, DOI 10.1042/bj2060597; LEE JS, 1993, J BIOL CHEM, V268, P4092; LIOUBIN MN, 1984, PREP BIOCHEM, V14, P303, DOI 10.1080/10826068408070637; MASSAGUE J, 1981, J BIOL CHEM, V256, P3182; MASSAGUE J, 1980, P NATL ACAD SCI-BIOL, V77, P7137, DOI 10.1073/pnas.77.12.7137; MILLER WT, 1988, P NATL ACAD SCI USA, V85, P5429, DOI 10.1073/pnas.85.15.5429; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; NAKAGAWA SH, 1987, J BIOL CHEM, V262, P12054; NAKAGAWA SH, 1986, J BIOL CHEM, V261, P7332; NAKAGAWA SH, 1989, J BIOL CHEM, V264, P272; NG DS, 1985, BIOCHEM BIOPH RES CO, V133, P154, DOI 10.1016/0006-291X(85)91854-6; ONEIL KT, 1989, J BIOL CHEM, V264, P14571; PANG DT, 1983, J BIOL CHEM, V258, P2514; PILCH PF, 1979, J BIOL CHEM, V254, P3375; PILCH PF, 1980, J BIOL CHEM, V255, P1722; PRIGENT SA, 1990, J BIOL CHEM, V265, P9970; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; SAYOUN N, 1978, P NATL ACAD SCI USA, V75, P1675; SHOELSON S, 1983, NATURE, V302, P540, DOI 10.1038/302540a0; SHOELSON S, 1983, P NATL ACAD SCI-BIOL, V80, P7390, DOI 10.1073/pnas.80.24.7390; SHOELSON SE, 1992, BIOCHEMISTRY-US, V31, P1757, DOI 10.1021/bi00121a025; SHOELSON SE, 1992, PEPTIDES CHEM BIOL, P57; SHYMKO RM, 1989, BIOCHEM BIOPH RES CO, V164, P191, DOI 10.1016/0006-291X(89)91701-4; Stewart JM, 1984, SOLID PHASE PEPTIDE; SWEET LJ, 1987, J BIOL CHEM, V262, P16730; TAGER H, 1980, P NATL ACAD SCI-BIOL, V77, P3181, DOI 10.1073/pnas.77.6.3181; TAGER H, 1979, NATURE, V281, P122, DOI 10.1038/281122a0; TAMM P, 1980, INSULIN CHEM STRUCTU; WAUGH SM, 1989, BIOCHEMISTRY-US, V28, P3448, DOI 10.1021/bi00434a045; WEDEKIND F, 1989, BIOL CHEM H-S, V370, P251, DOI 10.1515/bchm3.1989.370.1.251; WEISS MA, 1989, BIOCHEMISTRY-US, V28, P9855, DOI 10.1021/bi00451a046; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; WOLLMER A, 1981, H-S Z PHYSIOL CHEM, V362, P581, DOI 10.1515/bchm2.1981.362.1.581; YAJIMA H, 1988, TETRAHEDRON, V44, P805, DOI 10.1016/S0040-4020(01)86118-4; YEUNG CWT, 1980, BIOCHEMISTRY-US, V19, P2196, DOI 10.1021/bi00551a031; YIP CC, 1978, J BIOL CHEM, V253, P1743; YIP CC, 1992, J BIOL CHEM, V267, P13131; YIP CC, 1980, BIOCHEMISTRY-US, V19, P70, DOI 10.1021/bi00542a011; YIP CC, 1982, BIOCHEMISTRY-US, V21, P2940, DOI 10.1021/bi00541a021	63	62	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					4085	4091						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382690				2022-12-27	WOS:A1993KN53300045
J	SAWAI, T; NEGISHI, M; NISHIGAKI, N; OHNO, T; ICHIKAWA, A				SAWAI, T; NEGISHI, M; NISHIGAKI, N; OHNO, T; ICHIKAWA, A			ENHANCEMENT BY PROTEIN-KINASE-C OF PROSTACYCLIN RECEPTOR-MEDIATED ACTIVATION OF ADENYLATE-CYCLASE THROUGH A CALMODULIN MYRISTOYLATED ALANINE-RICH C-KINASE SUBSTRATE (MARCKS) SYSTEM IN IC2 MAST-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEINS; S49 LYMPHOMA-CELLS; PROSTAGLANDIN-E RECEPTOR; CYCLIC-AMP ACCUMULATION; BOVINE ADRENAL-MEDULLA; PHORBOL ESTERS; PLASMA-MEMBRANE; 87-KDA PROTEIN; PHOSPHORYLATION; PURIFICATION	The addition of 12-O-tetradecanoylphorbol-13-acetate (TPA) markedly enhanced cAMP formation induced by carbacyclin, a stable prostacyclin analogue, in cultured mast cells (IC2 cells), but did not enhance basal or NaF plus AlCl3-induced cAMP formation. On the other hand, W-7, a calmodulin (CaM) inhibitor, almost completely suppressed the enhancing activity of TPA, suggesting the involvement of CaM in the enhancement by TPA of carbacyclin-induced cAMP formation. The enhancing activity of TPA disappeared in TPA-treated cells permeabilized with saponin in the presence of Ca2+, but reconstitution with CaM in the permeable cells resulted in remarkable restoration of the action of TPA. On the other hand, TPA treatment induced the phosphorylation and translocation of myristoylated alanine-rich C kinase substrate (MARCKS) from the membrane to the cytosol. Exogenously added protein kinase C (PKC) also phosphorylated MARCKS and induced its translocation in the cells permeabilized with saponin. Whereas the addition of CaM did not enhance the carbacyclin-stimulated GTPase activity and adenylate cyclase activity in the control permeable cells, in which MARCKS bound to the membrane, CaM markedly enhanced those activities in the PKC-treated permeable cells, which lost endogenous membrane-bound MARCKS. When MARCKS was added to the PKC-treated permeable cells, MARCKS bound to the membrane and inhibited the effects of CaM. These results suggest that activation of PKC enhances the prostacyclin-activated adenylate cyclase through a CaM/MARCKS system.	KYOTO UNIV,FAC PHARMACEUT SCI,DEPT PHYSIOL CHEM,KYOTO 606,JAPAN; RIKEN,TSUKUBA LIFE SCI CTR,IBARAKI 305,JAPAN	Kyoto University; RIKEN			Nishigaki, Nobuhiro/AAZ-3584-2021; Ohno, Shigeo/B-1768-2010	Nishigaki, Nobuhiro/0000-0002-7524-1429; Ohno, Shigeo/0000-0002-1294-5269				ALBERT KA, 1987, P NATL ACAD SCI USA, V84, P7046, DOI 10.1073/pnas.84.20.7046; ASANO T, 1986, FEBS LETT, V203, P135, DOI 10.1016/0014-5793(86)80729-3; BELL JD, 1985, J BIOL CHEM, V260, P2625; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BLACKSHEAR PJ, 1986, J BIOL CHEM, V261, P1499; BOUVIER M, 1987, J BIOL CHEM, V262, P3106; CARLSON KE, 1986, MOL PHARMACOL, V30, P463; GRAFF JM, 1989, J BIOL CHEM, V264, P21818; GROSS MK, 1987, J BIOL CHEM, V262, P8672; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; HASHIMOTO H, 1990, PROSTAGLANDINS, V40, P491, DOI 10.1016/0090-6980(90)90111-8; HOLGATE ST, 1980, J IMMUNOL, V125, P1367; HOUSLAY MD, 1991, EUR J BIOCHEM, V195, P9, DOI 10.1111/j.1432-1033.1991.tb15671.x; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; INSEL PA, 1982, J BIOL CHEM, V257, P9717; ISHIZAKA T, 1984, FED PROC, V43, P2840; JOHNSON AR, 1970, J PHARMACOL EXP THER, V175, P632; KAJIYAMA Y, 1989, ARCH BIOCHEM BIOPHYS, V274, P200, DOI 10.1016/0003-9861(89)90431-1; KATADA T, 1987, J BIOL CHEM, V262, P11897; KENNEDY MS, 1979, MOL PHARMACOL, V16, P215; KIKKAWA U, 1983, J BIOL CHEM, V258, P1442; KLEE CB, 1980, ANNU REV BIOCHEM, V49, P485; KOYASU S, 1985, J IMMUNOL, V134, P3130; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEEBLUNDBERG LMF, 1985, P NATL ACAD SCI USA, V82, P5651, DOI 10.1073/pnas.82.17.5651; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANALAN AS, 1984, ADV CYCLIC NUCL PROT, V18, P227; MINOCHERHOMJEE AM, 1988, CALMODULIN, P249; MOLLNER S, 1988, EUR J BIOCHEM, V171, P265, DOI 10.1111/j.1432-1033.1988.tb13785.x; NEGISHI M, 1987, J BIOL CHEM, V262, P12077; NEGISHI M, 1988, J BIOL CHEM, V263, P6893; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; PFEUFFER E, 1985, EMBO J, V4, P3675, DOI 10.1002/j.1460-2075.1985.tb04134.x; SAGIEISENBERG R, 1989, TRENDS BIOCHEM SCI, V14, P355, DOI 10.1016/0968-0004(89)90001-7; SIBLEY DR, 1986, ARCH BIOCHEM BIOPHYS, V244, P373, DOI 10.1016/0003-9861(86)90126-8; SMIGEL MD, 1986, J BIOL CHEM, V261, P1976; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; TESHIMA Y, 1978, J CYCLIC NUCL PROT, V4, P219; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; WANG JKT, 1989, P NATL ACAD SCI USA, V86, P2253, DOI 10.1073/pnas.86.7.2253; WHITE JR, 1985, P NATL ACAD SCI USA, V82, P8193, DOI 10.1073/pnas.82.23.8193; WOLF M, 1984, BIOCHEM BIOPH RES CO, V122, P1268, DOI 10.1016/0006-291X(84)91229-4; YOSHIMASA T, 1987, NATURE, V327, P67, DOI 10.1038/327067a0	43	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1995	2000						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380584				2022-12-27	WOS:A1993KH62000076
J	DETOMASO, AW; XIE, ZJ; LIU, GQ; MERCER, RW				DETOMASO, AW; XIE, ZJ; LIU, GQ; MERCER, RW			EXPRESSION, TARGETING, AND ASSEMBLY OF FUNCTIONAL NA,K-ATPASE POLYPEPTIDES IN BACULOVIRUS-INFECTED INSECT CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT; INTRACELLULAR-TRANSPORT; (NA+; OUABAIN; BRAIN; NA+,K+-ATPASE; MATURATION; ENZYME; PUMP; ION	Deciphering the roles of the individual subunits of the heteromeric Na,K-ATPase in the structure, function, and assembly of this enzyme has been complicated because most expression systems have endogenous levels of Na,K-ATPase activity. This problem has become even more significant in light of the recent identification of multiple isoforms for both the alpha and beta subunits. The baculovirus expression system, which uses the baculovirus Autographica californica to infect insect cells, affords two distinct advantages for the expression of the Na,K-ATPase; some insect cells have little or no levels of Na,K-ATPase, and baculovirus-infected cells produce extremely high levels of foreign protein. We have made two separate recombinant baculoviruses containing the rodent alpha1 or beta1 cDNAs and used them to infect the insect cell line Sf-9. The infected Sf-9 cells produce Na,K-ATPase subunit protein on the order of 5-10 mug of protein/ml of cultured cells. The rodent alpha1 polypeptide produced in the Sf-9 cells is indistinguishable electrophoretically and antigenically from the native subunit. The expressed beta1 subunit is also antigenically identical but has a higher electrophoretic mobility due to differential glycosylation by the infected Sf-9 cell. In contrast to other systems, when expressed alone, each individual Na,K-ATPase subunit is targeted to the infected Sf-9 plasma membrane. In contrast, when infected with a virus that induces the heavy chain of murine IgG, the infected Sf-9 cell retains the polypeptide in the endoplasmic reticulum. However, when both IgG light and heavy chains are expressed, the polypeptides are properly processed and secreted. When the Na,K-ATPase alpha1 and beta1 polypeptides are simultaneously expressed, they form detergent-resistant complexes that are functional. Ouabain-sensitive ATPase activity on the order of 5 mumol P(i)/mg/h in infected Sf-9 membranes was dependent on the expression of both the alpha1 and beta1 subunits. Sodium-dependent phosphorylated intermediates were detected that were potassium- and ouabain-sensitive. No increase in ouabain-sensitive activity or phosphorylated intermediates was detected when either subunit was expressed alone. The alpha1beta1-coinfected cells were also able to transport ions, as detected in Rb-86 uptake experiments. Thus, the recombinant Na,K-ATPase expressed in insect cells is biologically active and is suitable for structural and functional analysis.	WASHINGTON UNIV, SCH MED, DEPT CELL BIOL & PHYSIOL, 660 S EUCLID AVE, ST LOUIS, MO 63110 USA; MED COLL OHIO, DEPT PHARMACOL, TOLEDO, OH 43699 USA	Washington University (WUSTL)			Mercer, Robert/F-5918-2012		NHLBI NIH HHS [HL 36573] Funding Source: Medline; NIGMS NIH HHS [GM 39746] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM039746, R01GM039746] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACKERMANN U, 1990, FEBS LETT, V269, P105, DOI 10.1016/0014-5793(90)81130-G; ACKERMANN U, 1992, J BIOL CHEM, V267, P12911; ASKARI A, 1983, J BIOL CHEM, V258, P3453; ASKARI A, 1980, BIOCHEMISTRY-US, V19, P1132, DOI 10.1021/bi00547a015; BLOUNT P, 1990, J CELL BIOL, V111, P2613, DOI 10.1083/jcb.111.6.2613; BONIFACINO JS, 1989, J CELL BIOL, V109, P73, DOI 10.1083/jcb.109.1.73; DETOMASO AW, 1992, SODIUM PUMP RECENT D, P69; ESMANN M, 1988, METHOD ENZYMOL, V156, P105; FAMBROUGH DM, 1991, SOC GEN PHY, V46, P17; GEERING K, 1991, FEBS LETT, V285, P189, DOI 10.1016/0014-5793(91)80801-9; HARLOW E, 1988, ANTIBODIES LABORATOR; HARVEY WR, 1983, AM J PHYSIOL, V244, pR163, DOI 10.1152/ajpregu.1983.244.2.R163; HASEMANN CA, 1990, P NATL ACAD SCI USA, V87, P3942, DOI 10.1073/pnas.87.10.3942; HOROWITZ B, 1990, J BIOL CHEM, V265, P4189; HUGHES RC, 1981, TRENDS BIOCHEM SCI, V6, P228, DOI 10.1016/0968-0004(81)90083-9; HUNDAL HS, 1992, J BIOL CHEM, V267, P5040; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBOVITZ RM, 1989, EMBO J, V8, P193, DOI 10.1002/j.1460-2075.1989.tb03364.x; LINGREL JB, 1990, PROG NUCLEIC ACID RE, V38, P37; LUCKOW VA, 1990, RECOMBINANT DNA TECH; MARXER A, 1989, J CELL BIOL, V109, P1057, DOI 10.1083/jcb.109.3.1057; MERCER RW, 1986, MOL CELL BIOL, V6, P3884, DOI 10.1128/MCB.6.11.3884; MERCER RW, 1989, RED BLOOD CELL MEMBR, P135; MIRCHEFF AK, 1992, AM J PHYSIOL, V262, pC470, DOI 10.1152/ajpcell.1992.262.2.C470; NOGUCHI S, 1987, FEBS LETT, V225, P27, DOI 10.1016/0014-5793(87)81125-0; Sambrook J, 1989, MOL CLONING LABORATO; SCHNEIDER JW, 1988, P NATL ACAD SCI USA, V85, P284, DOI 10.1073/pnas.85.1.284; SUMMERS MD, 1987, TEX AGR EXP STN B, V55, P1; SUZUKI CK, 1991, J CELL BIOL, V114, P189, DOI 10.1083/jcb.114.2.189; TAKEYASU K, 1988, J BIOL CHEM, V263, P4347; TAKEYASU K, 1987, J BIOL CHEM, V262, P10733; XIE ZJ, 1989, ANAL BIOCHEM, V183, P215, DOI 10.1016/0003-2697(89)90470-3; ZAMOFING D, 1988, J MEMBRANE BIOL, V104, P69, DOI 10.1007/BF01871903	33	87	90	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1470	1478						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8380413				2022-12-27	WOS:A1993KG07700105
J	KIM, JH; HILLE, R				KIM, JH; HILLE, R			REDUCTIVE HALF-REACTION OF XANTHINE-OXIDASE WITH XANTHINE - OBSERVATION OF A SPECTRAL INTERMEDIATE ATTRIBUTABLE TO THE MOLYBDENUM CENTER IN THE REACTION OF ENZYME WITH XANTHINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; RAY ABSORPTION-SPECTROSCOPY; MECHANISM; COMPLEXES; EXAFS; OXYGEN; MOLYBDOENZYMES; HYDROXYLATION; INHIBITION; KINETICS	The reductive half-reaction of xanthine oxidase with substoichiometric concentrations of xanthine and 1-methylxanthine at pH 10 and 8.5 has been examined by UV-visible stopped-flow and rapid-quench electron paramagnetic resonance (EPR) kinetic experiments. A spectral intermediate is observed in stopped-flow experiments with xanthine which exhibits a difference absorbance maximum relative to oxidized enzyme at 480 nm and which decays at the same rate as the decay of the ''very rapid'' Mo(V) EPR signal observed by freeze-quench EPR experiments both at 5 and 20-degrees-C. The intermediate is observed in experiments using enzyme that has had its flavin removed, and most likely arises from the molybdenum center. With 40 muM xanthine oxidase and 10 muM xanthine, rate constants for the appearance and decay of this intermediate at pH 10 are 11 and 1.1 s-1, respectively; at pH 8.5 the corresponding values are 20 and 2.5 s-1. Based on the correlation of the stopped-flow kinetics with the appearance and decay of the Mo(V) EPR signal designated very rapid as monitored in freeze-quench experiments, it is concluded that the spectral intermediate corresponds to the species exhibiting the very rapid EPR signal, the Mo(IV) species that gives rise to it, or a combination of the two. None of the Mo(V) EPR signals designated ''rapid'' is observed under single turnover conditions with either xanthine or 1-methylxanthine as substrate at pH 8.5, by contrast with the substantial amounts observed in both cases under conditions of excess substrate. These results call into question the prevailing view that the species giving rise to the rapid EPR signal lies downstream in the catalytic cycle from that exhibiting the very rapid signal.			KIM, JH (corresponding author), OHIO STATE UNIV,DEPT MED BIOCHEM,COLUMBUS,OH 43210, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038917] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 38917] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BLAIR DF, 1985, J AM CHEM SOC, V107, P7389, DOI 10.1021/ja00311a029; BORDAS J, 1980, BIOCHEM J, V191, P499, DOI 10.1042/bj1910499; BRAY RC, 1961, BIOCHEM J, V81, P196, DOI 10.1042/bj0810196; BRAY RC, 1978, BIOCHEM J, V171, P653, DOI 10.1042/bj1710653; BRAY RC, 1964, J BIOL CHEM, V239, P2667; BRAY RC, 1979, BIOCHEM J, V177, P357, DOI 10.1042/bj1770357; BRAY RC, 1988, Q REV BIOPHYS, V21, P299, DOI 10.1017/S0033583500004479; BRAY RC, 1985, BIOCHEM SOC T, V13, P560, DOI 10.1042/bst0130560; BRAY RC, 1961, BIOCHEM J, V81, P180; Bray RC., 1975, ENZYMES, V12, P299, DOI DOI 10.1016/S1874-6047(08)60229-2; CRAMER SP, 1981, J AM CHEM SOC, V103, P7721, DOI 10.1021/ja00416a005; CRAMER SP, 1985, J AM CHEM SOC, V107, P8164, DOI 10.1021/ja00312a059; DAVIS MD, 1982, J BIOL CHEM, V257, P4730; DAVIS MD, 1984, J BIOL CHEM, V259, P3526; DUBOURDI.M, 1970, BIOCHEM BIOPH RES CO, V38, P965, DOI 10.1016/0006-291X(70)90816-8; EDMONDSON D, 1973, J BIOL CHEM, V248, P6135; EDMONDSON DE, 1972, J BIOL CHEM, V247, P1555; ENTSCH B, 1976, J BIOL CHEM, V251, P2550; GUTTERIDGE S, 1978, BIOCHEM J, V175, P869, DOI 10.1042/bj1750869; Hille R., 1985, Metal Ions in Biology, V7, P443; HILLE R, 1991, J BIOL CHEM, V266, P5608; HILLE R, 1987, J BIOL CHEM, V262, P10914; HILLE R, 1984, J BIOL CHEM, V259, P1570; HILLE R, 1981, J BIOL CHEM, V256, P9090; HILLE R, 1989, INORG CHEM, V28, P4018, DOI 10.1021/ic00320a016; HILLE R, 1986, J BIOL CHEM, V261, P1241; HILLE R, 1991, CHEM BIOCH FLAVOENZY, P21; KOMAI H, 1969, J BIOL CHEM, V244, P1692; KREY GD, 1988, J BIOL CHEM, V263, P15436; MASSEY V, 1970, J BIOL CHEM, V245, P6595; MASSEY V, 1969, J BIOL CHEM, V244, P1682; MCGARTOLL MA, 1970, BIOCHIM BIOPHYS ACTA, V212, P523, DOI 10.1016/0005-2744(70)90264-0; MCWHIRTER RB, 1991, J BIOL CHEM, V266, P23724; MOORE JW, 1981, KINETICS MECHANISM, P290; MORPETH FF, 1984, BIOCHEMISTRY-US, V23, P1332, DOI 10.1021/bi00301a047; MORRISON M, 1963, J BIOL CHEM, V238, P2847; OERTLING WA, 1990, J BIOL CHEM, V265, P17446; OLSON JS, 1974, J BIOL CHEM, V249, P4350; OLSON JS, 1974, J BIOL CHEM, V249, P4363; PALMER G, 1964, J BIOL CHEM, V239, P2657; PICK FM, 1969, BIOCHEM J, V114, P735, DOI 10.1042/bj1140735; PORRAS AG, 1981, J BIOL CHEM, V256, P9096; Tanner SJ, 1978, BIOCHEM SOC T, V6, P1328, DOI 10.1042/bst0061328; TULLIUS TD, 1979, J AM CHEM SOC, V101, P2776, DOI 10.1021/ja00504a069; TURNER NA, 1989, BIOCHEM J, V260, P563, DOI 10.1042/bj2600563; VAROTSIS C, 1990, BIOCHEMISTRY-US, V29, P7357, DOI 10.1021/bi00484a001; WIKSTROM M, 1981, P NATL ACAD SCI-BIOL, V78, P4051, DOI 10.1073/pnas.78.7.4051; WILSON GL, 1991, J AM CHEM SOC, V113, P6803, DOI 10.1021/ja00018a014	48	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					44	51						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380164				2022-12-27	WOS:A1993KE60300009
J	TABAS, I; LI, YQ; BROCIA, RW; XU, SW; SWENSON, TL; WILLIAMS, KJ				TABAS, I; LI, YQ; BROCIA, RW; XU, SW; SWENSON, TL; WILLIAMS, KJ			LIPOPROTEIN-LIPASE AND SPHINGOMYELINASE SYNERGISTICALLY ENHANCE THE ASSOCIATION OF ATHEROGENIC LIPOPROTEINS WITH SMOOTH-MUSCLE CELLS AND EXTRACELLULAR-MATRIX - A POSSIBLE MECHANISM FOR LOW-DENSITY-LIPOPROTEIN AND LIPOPROTEIN(A) RETENTION AND MACROPHAGE FOAM CELL-FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; CHOLESTERYL ESTER ACCUMULATION; LOW-LEVEL HYPERCHOLESTEROLEMIA; MOUSE PERITONEAL-MACROPHAGES; FATTY STREAK FORMATION; ATHEROSCLEROTIC LESIONS; GROWTH-FACTOR; FAMILIAL HYPERCHOLESTEROLEMIA; NONHUMAN PRIMATE; ENDOTHELIAL-CELLS	Prominent features of atheromata include smooth muscle cells, cholesteryl ester-loaded macrophage foam cells, extracellular matrix, extracellularly trapped and aggregated lipoproteins, and various enzymes including lipoprotein lipase (LpL) and sphingomyelinase (SMase). The interplay of these factors was investigated in cell culture. Incubation of bovine aortic smooth muscle cells for 18 h at 37-degrees-C with low density lipoprotein (LDL) in the presence of LpL and SMase led to massive aggregation of LDL on the surface of the cells as viewed by phase, fluorescence (using 1,1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbocyanine perchlorate-LDL), and electron microscopy. This aggregation required both enzymes. Studies with I-125-LDL confirmed these observations: I-125-LDL cell association in the presence of LpL plus SMase was 50-100-fold greater than in the absence of the two enzymes and was 10-fold-greater than in the presence of either enzyme alone. A similar effect (68-fold enhancement) was seen with I-125-labeled lipoprotein(a) (Lp(a)), another atherogenic lipoprotein. In all cases, I-125-lipoprotein degradation was relatively low (<5% of cell-associated material). LpL/SMase-mediated association of I-125-LDL with smooth muscle cells was still observed when enzymatically inactive LpL was used. The effect was markedly diminished when the smooth muscle cells were treated with a combination of chondroitin ABC lyase and heparitinase or when mutant Chinese hamster ovary cells that lack cell-surface proteoglycans were used, indicating a specific role for cellular proteoglycans. When smooth muscle cells with I-125-LDL or I-125-Lp(a) aggregates were rinsed and then coincubated with mouse peritoneal macrophages for a further 24 h, visible aggregates disappeared, and there was marked I-125-lipoprotein degradation. Electron micrographs after 24 h of co-culture showed lipid-laden, foamy macrophages situated on top of smooth muscle cells, suggesting that the macrophages phagocytosed and metabolized the smooth muscle cell-associated LDL aggregates. Last, I-125-LDL association with smooth muscle cell extracellular matrix was also synergistically enhanced by LpL and SMase, to a level that was 19-fold greater than in the absence of the two enzymes. Thus, the interaction of LDL and Lp(a) with four atheroma components, namely, smooth muscle cells, extracellular matrix, LpL, and SMase, represents a physiologically plausible mechanism for massive, focal retention and aggregation of atherogenic lipoproteins in the arterial wall with subsequent macrophage foam cell formation.	COLUMBIA UNIV,DEPT ANAT & CELL BIOL,NEW YORK,NY 10032; MED COLL PENN,DEPT BIOCHEM,PHILADELPHIA,PA 19129; MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065	Columbia University; Drexel University; Merck & Company	TABAS, I (corresponding author), COLUMBIA UNIV,DEPT MED,630 W 168TH ST,NEW YORK,NY 10032, USA.			Williams, Kevin Jon/0000-0002-0000-2159	NHLBI NIH HHS [HL21006, HL38956, HL39703] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038956, R01HL038956, P50HL021006, R01HL039703] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; BEISIEGEL U, 1991, CURR OPIN LIPIDOL, V2, P317; BIHAIN BE, 1992, BIOCHEMISTRY-US, V31, P4628, DOI 10.1021/bi00134a013; BIHARIVARGA M, 1988, ARTERIOSCLEROSIS, V8, P851, DOI 10.1161/01.ATV.8.6.851; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; CAMEJO G, 1982, ADV LIPID RES, V19, P1; CAMEJO G, 1990, CURR OPIN LIPIDOL, V1, P431; CAMEJO G, 1991, J LIPID RES, V32, P1938; CHANG Y, 1983, J BIOL CHEM, V258, P5679; CHEN JK, 1991, IN VITRO CELL DEV B, V27, P6; CISAR LA, 1989, J BIOL CHEM, V264, P1767; COREY JE, 1977, ATHEROSCLEROSIS, V27, P201, DOI 10.1016/0021-9150(77)90057-0; DAHLEN C, 1978, CLIN GENET, V14, P36; EISENBERG S, 1992, J CLIN INVEST, V90, P2013, DOI 10.1172/JCI116081; Esko JD, 1991, CURR OPIN CELL BIOL, V3, P805, DOI 10.1016/0955-0674(91)90054-3; GARFIELD RE, 1975, LAB INVEST, V33, P418; GERRITY RG, 1981, AM J PATHOL, V103, P181; GOLDSTEIN JL, 1975, P NATL ACAD SCI USA, V72, P1092, DOI 10.1073/pnas.72.3.1092; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GREENSPAN P, 1990, BIOCHIM BIOPHYS ACTA, V1045, P94, DOI 10.1016/0005-2760(90)90208-F; GUYTON JR, 1989, AM J PATHOL, V134, P705; GUYTON JR, 1988, J HISTOCHEM CYTOCHEM, V36, P1319, DOI 10.1177/36.10.2458408; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HEINECKE JW, 1987, J BIOL CHEM, V262, P10098; HERMANN M, 1992, ARTERIOSCLER THROMB, V12, P1503, DOI 10.1161/01.ATV.12.12.1503; HOFF HF, 1990, EUR HEART J, V11, P105, DOI 10.1093/eurheartj/11.suppl_E.105; JONASSON L, 1987, J LIPID RES, V28, P437; KAUFMANN J, 1990, ATHEROSCLEROSIS, V85, P113, DOI 10.1016/0021-9150(90)90103-P; KHOO JC, 1988, ARTERIOSCLEROSIS, V8, P348, DOI 10.1161/01.ATV.8.4.348; KLAUS GG, 1973, EXP CELL RES, V79, P73, DOI 10.1016/0014-4827(73)90490-4; KLINGER MM, 1985, J BIOL CHEM, V260, P4082; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTIN BM, 1981, J IMMUNOL, V126, P1510; MASUDA J, 1990, ARTERIOSCLEROSIS, V10, P178, DOI 10.1161/01.ATV.10.2.178; MASUDA J, 1990, ARTERIOSCLEROSIS, V10, P164, DOI 10.1161/01.ATV.10.2.164; MULDER M, 1992, BIOCHEM BIOPH RES CO, V185, P582, DOI 10.1016/0006-291X(92)91664-C; MURPHYULLRICH JE, 1988, J BIOL CHEM, V263, P6400; NAVAB M, 1991, J CLIN INVEST, V88, P2039, DOI 10.1172/JCI115532; NEWMAN HAI, 1962, J BIOL CHEM, V237, P2078; NICOSIA RF, 1992, MOL BIOL CELL, V3, pA69; NIEVELSTEIN PFEM, 1990, ARTERIOSCLEROSIS, V10, P462, DOI 10.1161/01.ATV.10.3.462; NIEVELSTEIN PFEM, 1991, ARTERIOSCLER THROMB, V11, P1795, DOI 10.1161/01.ATV.11.6.1795; OKADA Y, 1986, J ELECTRON MICROSC, V35, P195; Olivecrona T., 1987, LIPOPROTEIN LIPASE, P15; OWENS RT, 1991, ARTERIOSCLER THROMB, V11, P1752, DOI 10.1161/01.ATV.11.6.1752; PITAS RE, 1981, ARTERIOSCLEROSIS, V1, P177, DOI 10.1161/01.ATV.1.3.177; PORTMAN OW, 1970, J LIPID RES, V11, P23; POSNER I, 1988, ARCH BIOCHEM BIOPHYS, V226, P306; QUINN DM, 1985, BIOCHIM BIOPHYS ACTA, V834, P267, DOI 10.1016/0005-2760(85)90165-1; ROSENFELD ME, 1990, ARTERIOSCLEROSIS, V10, P680, DOI 10.1161/01.ATV.10.5.680; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; ROSS R, 1990, ANN NY ACAD SCI, V598, P102, DOI 10.1111/j.1749-6632.1990.tb42282.x; RUMSEY SC, 1992, J CLIN INVEST, V90, P1504, DOI 10.1172/JCI116018; SAXENA U, 1992, J CLIN INVEST, V89, P373, DOI 10.1172/JCI115595; SCANU AM, 1990, J CLIN INVEST, V85, P1709, DOI 10.1172/JCI114625; SCHAFFNER T, 1980, AM J PATHOL, V100, P57; SCHWENKE DC, 1989, ARTERIOSCLEROSIS, V9, P895, DOI 10.1161/01.ATV.9.6.895; SHIMADA K, 1981, J CLIN INVEST, V68, P995, DOI 10.1172/JCI110354; SHIMOKADO K, 1985, CELL, V43, P277, DOI 10.1016/0092-8674(85)90033-9; SIMIONESCU N, 1986, AM J PATHOL, V123, P109; SINGH JP, 1988, P NATL ACAD SCI USA, V85, P6374, DOI 10.1073/pnas.85.17.6374; SIVARAM P, 1992, J BIOL CHEM, V267, P16517; SNYDER ML, 1992, J BIOL CHEM, V267, P339; STEIN O, 1984, BIOCHIM BIOPHYS ACTA, V795, P47, DOI 10.1016/0005-2760(84)90103-6; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEINBRECHER UP, 1992, ARTERIOSCLER THROMB, V12, P608, DOI 10.1161/01.ATV.12.5.608; SUITS AG, 1989, P NATL ACAD SCI USA, V86, P2713, DOI 10.1073/pnas.86.8.2713; TABAS I, 1990, J CELL BIOL, V111, P929, DOI 10.1083/jcb.111.3.929; TABAS I, 1987, J CLIN INVEST, V79, P418, DOI 10.1172/JCI112828; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631; VIJAYAGOPAL P, 1992, ARTERIOSCLER THROMB, V12, P237, DOI 10.1161/01.ATV.12.2.237; WILLIAMS KJ, 1992, J BIOL CHEM, V267, P13284; WILLIAMS KJ, 1991, J CLIN INVEST, V88, P1300, DOI 10.1172/JCI115434; WILLIAMS KJ, 1992, CIRCULATION, V86, P475; Williams KJ, 1991, CIRCULATION S2, V84, P566; WOLFBAUER G, 1986, P NATL ACAD SCI USA, V83, P7760, DOI 10.1073/pnas.83.20.7760; XU XX, 1991, J BIOL CHEM, V266, P24849; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; YANAGISHITA M, 1984, J BIOL CHEM, V259, P270; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P10143, DOI 10.1073/pnas.88.22.10143; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473	84	153	163	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20419	20432						14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376399				2022-12-27	WOS:A1993LY01900075
J	WEBER, J; WILKEMOUNTS, S; LEE, RSF; GRELL, E; SENIOR, AE				WEBER, J; WILKEMOUNTS, S; LEE, RSF; GRELL, E; SENIOR, AE			SPECIFIC PLACEMENT OF TRYPTOPHAN IN THE CATALYTIC SITES OF ESCHERICHIA-COLI F(1)-ATPASE PROVIDES A DIRECT PROBE OF NUCLEOTIDE-BINDING - MAXIMAL ATP HYDROLYSIS OCCURS WITH 3 SITES OCCUPIED	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART MITOCHONDRIAL F1-ATPASE; SYNTHASE BETA-SUBUNIT; ADENINE-NUCLEOTIDES; MUTANT STRAINS; PROTON-ATPASE; FLUORESCENCE; MUTAGENESIS; MUTATIONS; ADP; TRIPHOSPHATE	Residue betaY331 of Escherichia coli F1-ATPase is known from previous affinity labeling, mutagenesis, and lin-benzo-ADP binding experiments to interact directly with the adenine moiety of substrates bound in catalytic sites. Here we mutagenized betaY331 to tryptophan. Mutant cells grew well on succinate or limiting glucose; purified mutant F1 had k(cat)/K(m) and lin-benzo-ADP binding characteristics similar to wild type. Fluorescence from betaW331 residues exhibited a maximum at 349 nm, indicating a polar environment in unoccupied sites. ATP, ADP, or AMPPNP caused virtually complete quenching of betaW331 fluorescence, so that the fluorescence of mutant F1 with occupied catalytic sites resembled that of wild-type enzyme. Therefore the betaW331 fluorescence provided a direct probe of nucleotide binding to catalytic sites under true equilibrium conditions. We measured ATP binding and hydrolysis in parallel experiments and found that occupancy of one or two catalytic sites per F1 molecule did not yield significant rates of hydrolysis while occupancy of all three sites yielded V(max) rates. K(m)(ATP) was similar to K(d3), the K(d) for ATP binding to the third catalytic site. We also measured AMPPNP and ADP binding parameters. For ADP, the ''on'' rate at the first catalytic site was much faster (greater-than-or-equal-to 5 x 10(5) M-1 s-1) than seen previously by centrifuge column procedures, although the K(d) was not much changed. For AMPPNP, the ''on'' rate at the first site was 2 orders of magnitude less than for ADP or ATP, and the K(d) was similar to that for ADP.	MAX PLANCK INST BIOPHYS, W-6000 FRANKFURT 70, GERMANY	Max Planck Society	WEBER, J (corresponding author), UNIV ROCHESTER, MED CTR, DEPT BIOCHEM, ROCHESTER, NY 14642 USA.				NIGMS NIH HHS [GM25349] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025349, R01GM025349] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADMON A, 1987, BIOCHEMISTRY-US, V26, P3193, DOI 10.1021/bi00385a038; ALLISON WS, 1992, J BIOENERG BIOMEMBR, V24, P469, DOI 10.1007/BF00762364; ALSHAWI MK, 1992, BIOCHEMISTRY-US, V31, P878, DOI 10.1021/bi00118a033; ALSHAWI MK, 1988, J BIOL CHEM, V263, P19633; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULLOUGH DA, 1986, J BIOL CHEM, V261, P14171; CROSS RL, 1987, P NATL ACAD SCI USA, V84, P5715, DOI 10.1073/pnas.84.16.5715; CROSS RL, 1982, J BIOL CHEM, V257, P2101; Cross RL, 1992, MOL MECHANISMS BIOEN, P317; CUNNINGHAM D, 1988, J BIOL CHEM, V263, P18850; DIVITA G, 1991, BIOCHEMISTRY-US, V30, P3256, DOI 10.1021/bi00227a013; DIVITA G, 1992, BIOCHEMISTRY-US, V31, P5791, DOI 10.1021/bi00140a015; DIVITA G, 1993, BIOCHEMISTRY-US, V32, P1017, DOI 10.1021/bi00055a004; DUNCAN TM, 1992, J BIOENERG BIOMEMBR, V24, P453, DOI 10.1007/BF00762362; EFTINK MR, 1991, METHOD BIOCHEM ANAL, V35, P127; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; GARBOCZI DN, 1990, J BIOL CHEM, V265, P14632; GARIN J, 1986, BIOCHEMISTRY-US, V25, P4431, DOI 10.1021/bi00363a039; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE RSF, 1991, BIOCHEMISTRY-US, V30, P6842, DOI 10.1021/bi00242a006; LEONARD NJ, 1978, BIOCHEMISTRY-US, V17, P3677, DOI 10.1021/bi00611a001; LEONARD NJ, 1976, J AM CHEM SOC, V98, P3987, DOI 10.1021/ja00429a040; MAGGIO MB, 1988, J BIOL CHEM, V263, P4619; MILLS DA, 1991, J BIOL CHEM, V266, P7440; PARSONAGE D, 1987, J BIOL CHEM, V262, P8022; PENEFSKY HS, 1991, ADV ENZYMOL RAMB, V64, P173; RAO R, 1988, J BIOL CHEM, V263, P5569; ROGNER M, 1986, BIOCHIM BIOPHYS ACTA, V849, P121, DOI 10.1016/0005-2728(86)90103-9; SENIOR AE, 1992, J BIOENERG BIOMEMBR, V24, P479, DOI 10.1007/BF00762365; SENIOR AE, 1979, BIOCHEM J, V180, P111, DOI 10.1042/bj1800111; SENIOR AE, 1992, ARCH BIOCHEM BIOPHYS, V297, P340, DOI 10.1016/0003-9861(92)90682-M; SENIOR AE, 1984, ARCH BIOCHEM BIOPHYS, V228, P49, DOI 10.1016/0003-9861(84)90045-6; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; SENIOR AE, 1983, J MEMBRANE BIOL, V73, P105, DOI 10.1007/BF01870434; SENIOR AE, 1992, J BIOL CHEM, V267, P21471; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; THOMAS PJ, 1992, J BIOL CHEM, V267, P20331; TIEDGE H, 1982, EUR J BIOCHEM, V127, P291, DOI 10.1111/j.1432-1033.1982.tb06869.x; TIEDGE H, 1986, BIOL CHEM H-S, V367, P689, DOI 10.1515/bchm3.1986.367.2.689; VIGNAIS PV, 1985, ANNU REV BIOCHEM, V54, P977, DOI 10.1146/annurev.biochem.54.1.977; WEBER J, 1987, BIOCHIM BIOPHYS ACTA, V892, P30, DOI 10.1016/0005-2728(87)90244-1; WEBER J, 1992, J BIOL CHEM, V267, P1712; WEBER J, 1990, J BIOL CHEM, V265, P10884; WEBER J, 1992, BIOCHEMISTRY-US, V31, P5112, DOI 10.1021/bi00137a004; WISE JG, 1987, FEBS LETT, V223, P395, DOI 10.1016/0014-5793(87)80326-5; WISE JG, 1990, J BIOL CHEM, V265, P10403; WISE JG, 1983, BIOCHEM J, V215, P343, DOI 10.1042/bj2150343	49	199	201	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20126	20133						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376371				2022-12-27	WOS:A1993LY01900033
J	ALLEN, GC; KORNBERG, A				ALLEN, GC; KORNBERG, A			ASSEMBLY OF THE PRIMOSOME OF DNA-REPLICATION IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN COMPLEX; PHI-X174 DNA; FACTOR-Y; SEQUENCE; PRIA; INVITRO; MUTANTS; N'; PURIFICATION; REQUIREMENT	Assembly of the Escherichia coli primosome requires six proteins, PriA, PriB, PriC, DnaB, DnaC, and DnaT, acting at a primosome assembly site (pas) on an SSB-coated single-stranded (ss) DNA. Assembly is initiated by interactions of PriA and PriB with ssDNA and the pas. PriC, DnaB, DnaC, and DnaT then act on the PriA-PriB-DNA complex to yield the primosome. In the primosome, the dATPase (ATPase) of PriA becomes hyper-activated. In addition, the assembled primosome appears to block the pas, preventing it from activating additional PriA molecules. Either ATP alone or dATP in combination with GTP is sufficient for primosome assembly, while ATP or GTP provides for its maintenance during isolation. These nucleotide requirements can be reconciled with the need for ATP or dATP for DnaB-DnaC complex formation and hydrolysis of ATP or GTP by DnaB when it binds ssDNA. Such isolated primosomes contain a dATPase, the hallmark of PriA, and a GTPase indicative of DnaB. Further studies indicate that the isolated primosome contains the PriB replication activity in addition to PriA and DnaB.	STANFORD UNIV,MED CTR,SCH MED,BECKMAN CTR,DEPT BIOCHEM,STANFORD,CA 94305	Stanford University					NIGMS NIH HHS [GM07581] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM007581, R01GM007581] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN GC, 1991, J BIOL CHEM, V266, P11610; ALLEN GC, 1993, CELL, V74, P713, DOI 10.1016/0092-8674(93)90518-U; ARAI K, 1981, P NATL ACAD SCI-BIOL, V78, P69, DOI 10.1073/pnas.78.1.69; ARAI K, 1981, J BIOL CHEM, V256, P5273; ARAI KI, 1981, J BIOL CHEM, V256, P5252; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; KAGUNI JM, 1984, CELL, V38, P183, DOI 10.1016/0092-8674(84)90539-7; KOBORI JA, 1982, J BIOL CHEM, V257, P13770; KORNBERG A, 1992, DNA REPICATION; LARK CA, 1978, J BACTERIOL, V136, P1008, DOI 10.1128/JB.136.3.1008-1017.1978; LARK KG, 1978, CSHSQB, V43, P537; LASKEN RS, 1988, J BIOL CHEM, V263, P5512; LEE EH, 1990, P NATL ACAD SCI USA, V87, P4620, DOI 10.1073/pnas.87.12.4620; LEE EH, 1991, P NATL ACAD SCI USA, V88, P3029, DOI 10.1073/pnas.88.8.3029; LEE MS, 1989, J BIOL CHEM, V264, P14531; LEE MS, 1987, P NATL ACAD SCI USA, V84, P8345, DOI 10.1073/pnas.84.23.8345; LOW RL, 1982, J BIOL CHEM, V257, P6242; MARIANS KJ, 1992, ANNU REV BIOCHEM, V61, P673, DOI 10.1146/annurev.bi.61.070192.003325; MASAI H, 1989, J BACTERIOL, V171, P2975, DOI 10.1128/jb.171.6.2975-2980.1989; MINDEN JS, 1985, J BIOL CHEM, V260, P9316; NURSE P, 1990, P NATL ACAD SCI USA, V87, P4615, DOI 10.1073/pnas.87.12.4615; NURSE P, 1991, J BACTERIOL, V173, P6686, DOI 10.1128/jb.173.21.6686-6693.1991; SCHEKMAN R, 1975, J BIOL CHEM, V250, P5859; SHLOMAI J, 1980, P NATL ACAD SCI-BIOL, V77, P799, DOI 10.1073/pnas.77.2.799; SHLOMAI J, 1980, J BIOL CHEM, V255, P6794; STAMFORD NPJ, 1992, BIOCHIM BIOPHYS ACTA, V1132, P17, DOI 10.1016/0167-4781(92)90047-4; WAHLE E, 1989, J BIOL CHEM, V264, P2463; WECHSLER JA, 1971, MOL GEN GENET, V113, P273, DOI 10.1007/BF00339547; WEINER JH, 1976, P NATL ACAD SCI USA, V73, P752, DOI 10.1073/pnas.73.3.752; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P921, DOI 10.1073/pnas.72.3.921; WICKNER S, 1974, P NATL ACAD SCI USA, V71, P4120, DOI 10.1073/pnas.71.10.4120; ZAVITZ KH, 1991, J BIOL CHEM, V266, P13988; ZAVITZ KH, 1992, J BIOL CHEM, V267, P6933	33	58	60	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19204	19209						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366072				2022-12-27	WOS:A1993LW81900012
J	PORTER, DJT; SPECTOR, T				PORTER, DJT; SPECTOR, T			DIHYDROPYRIMIDINE DEHYDROGENASE - KINETIC MECHANISM FOR REDUCTION OF URACIL BY NADPH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA 5-FLUOROURACIL LEVELS; ANTITUMOR-ACTIVITY; PIG-LIVER; RAT-LIVER; MICE; BROMOVINYLDEOXYURIDINE; PURIFICATION; DEGRADATION; PYRIMIDINE; ADENOCARCINOMA-755	Steady-state and pre-steady-state kinetic data were used to determine the kinetic mechanism for bovine liver dihydropyrimidine dehydrogenase (DPDase). Steady-state kinetic data suggested a random rapid-equilibrium mechanism with K(m) values for NADPH and uracil of 0.12 muM and 0.8 muM, respectively, and a k(cat) of 1.6 s-1 in Tris buffer at pH 8.0 and 37-degrees-C. The dissociation constant of DPDase for NADPH at 25-degrees-C in the absence of uracil (0.09 muM) was similar to the K(m) for NADPH. DPDase also catalyzed the exchange of tritium in ([4S-H-3,4R-H-1]NADPH)H-3 with solvent protons in the absence of uracil. DPDase inactivated by 5-ethynyluracil, which covalently modifies the enzyme at the uracil binding site, catalyzed the exchange reaction at the same rate (1 s-1) as native enzyme. Thus, the interaction of NADPH with DPDase was independent of the uracil binding site. Because DPDase catalyzed the exchange of deuterium in ([4S-H-2,4R-H-1]NADPH)-H-2 with solvent protons with a rate constant of 5.4 s-1, which was significantly larger than that for tritium, the analogous rate constant for exchange of the 4-hydrogen in NADPH must be significantly larger than 5 s-1. Consequently, intermediates on the exchange pathway were kinetically competent to participate in the reduction of uracil by NADPH (k(cat) = 1.6 s-1). Pate constants for reduction of DPDase by NADPH and 5,6-dihydrouracil were several orders of magnitude greater that k(cat). The rate constants for dissociation of E.NADP+ (15 s-1) and for dissociation of E.5,6-dihydrouracil (>250 s-1) were also greater than k(cat). These results supported a random rapid-equilibrium kinetic mechanism and suggested k(cat) was an internal electron transfer between enzymic prosthetic groups.			PORTER, DJT (corresponding author), WELLCOME RES LABS,DIV EXPTL THERAPY,RES TRIANGLE PK,NC 27709, USA.							BENEFRAIM S, 1986, BRIT J CANCER, V54, P847, DOI 10.1038/bjc.1986.250; DESGRANGES C, 1986, CANCER RES, V46, P1094; DRYSDALE GR, 1959, J BIOL CHEM, V234, P2399; DRYSDALE GR, 1956, BIOCHIM BIOPHYS ACTA, V21, P397, DOI 10.1016/0006-3002(56)90037-3; FRITZSON P, 1960, J BIOL CHEM, V235, P719; FUJIMOTO S, 1990, J NUTR SCI VITAMINOL, V37, P89; GANI D, 1985, J CHEM SOC PERK T 1, P1355, DOI 10.1039/p19850001355; GHISLA S, 1974, BIOCHEMISTRY-US, V13, P589, DOI 10.1021/bi00700a029; GOEDDE HW, 1970, H-S Z PHYSIOL CHEM, V351, P945, DOI 10.1515/bchm2.1970.351.2.945; GRISOLIA S, 1957, BIOCHIM BIOPHYS ACTA, V25, P430, DOI 10.1016/0006-3002(57)90498-5; IIGO M, 1989, BIOCHEM PHARMACOL, V38, P1885; IIGO M, 1988, BIOCHEM PHARMACOL, V37, P1609; KREYSZIG E, 1963, ADV ENG MATH, P95; LU ZH, 1992, J BIOL CHEM, V267, P17102; MANDAL C, 1980, BIOCHEMISTRY-US, V19, P5819, DOI 10.1021/bi00566a025; NAGUIB FNM, 1989, BIOCHEM PHARMACOL, V38, P1471, DOI 10.1016/0006-2952(89)90187-1; NORTHROP DB, 1981, ANNU REV BIOCHEM, V50, P103, DOI 10.1146/annurev.bi.50.070181.000535; PODSCHUN B, 1989, EUR J BIOCHEM, V185, P219, DOI 10.1111/j.1432-1033.1989.tb15105.x; PODSCHUN B, 1990, J BIOL CHEM, V265, P12966; PODSCHUN B, 1992, BIOCHEM BIOPH RES CO, V182, P609, DOI 10.1016/0006-291X(92)91776-M; PORTER DJT, 1991, J BIOL CHEM, V266, P19988; PORTER DJT, 1992, J BIOL CHEM, V267, P5236; SANNO Y, 1970, J BIOL CHEM, V245, P5668; Schowen R. L, 1978, TRANSIT STATES BIOCH, P225; Segel IH, 1975, ENZYME KINETICS, P54; SHIOTANI T, 1981, J BIOL CHEM, V256, P219; SWAIN CG, 1958, J AM CHEM SOC, V80, P5885, DOI 10.1021/ja01554a077; TATSUMI K, 1987, JPN J CANCER RES, V78, P748; WASTERNACK C, 1980, PHARMACOL THERAPEUT, V8, P629, DOI 10.1016/0163-7258(80)90079-0; WEBER MM, 1957, J BIOL CHEM, V227, P27; YOU KS, 1982, METHOD ENZYMOL, V87, P101; 1961, PABST CIRCULAR OR, V18, P2	32	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19321	19327						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366081				2022-12-27	WOS:A1993LW81900028
J	ALONSOTORRE, SR; TRAUTMANN, A				ALONSOTORRE, SR; TRAUTMANN, A			CALCIUM RESPONSES ELICITED BY NUCLEOTIDES IN MACROPHAGES - INTERACTION BETWEEN 2 RECEPTOR SUBTYPES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING FACTOR; PERITONEAL MAST-CELLS; EXTRACELLULAR-ATP; PLASMA-MEMBRANE; SENSORY NEURONS; SMOOTH-MUSCLE; RAT; CHANNELS; INFLUX; LYMPHOCYTES	The responses elicited by ATP and UTP in macrophages (measured by microfluorescence and in patch-clamp) present marked differences. The release of Ca2+ from intracellular stores induced by ATP is due to the activation of P2U receptors. These receptors can be activated by ATP4- and by MgATP2-, with apparent K0.5 values of 0.65 and 6.5 muM, respectively. The release of Ca2+ due to activation of P2U receptors by either ATP or UTP is followed by the opening of ionic channels leading to an influx of Ca2+. A second pathway for Ca2+ influx results from the opening of P2Z receptor channels triggered by adenosine-5'-O(1-thiotriphosphate) or ATP but not by UTP. The form of ATP that activates P2Z receptors is ATP4- (with a K0.5 of 0.5 muM). In voltage-clamped cells, the inward current activated by ATP4- is transient, partly because it inactivates and partly because it is rapidly masked by the development of a quinine-sensitive Ca2+-dependent K+ current. In current-clamp, macrophages stimulated by UTP remain normally polarized, whereas ATP depolarizes them. This P2Z-mediated depolarization results in an inhibition of the influx of Ca2+, which explains part of the difference between the time courses of the Ca2+ responses elicited by ATP and UTP.	ECOLE NORMALE SUPER,NEUROBIOL LAB,CNRS,URA 295,46 RUE ULM,F-75231 PARIS 05,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)			Sara, Alonso de la Torre/V-4902-2017	Sara, Alonso de la Torre/0000-0001-7319-0659				Bean B P, 1990, Ion Channels, V2, P169; BEAN BP, 1990, J NEUROSCI, V10, P1; BEAN BP, 1992, TRENDS PHARMACOL SCI, V13, P87, DOI 10.1016/0165-6147(92)90032-2; BENHAM CD, 1987, NATURE, V328, P275, DOI 10.1038/328275a0; CONRAD GW, 1986, J CELL BIOL, V103, P439, DOI 10.1083/jcb.103.2.439; COWEN DS, 1989, J CLIN INVEST, V83, P1651, DOI 10.1172/JCI114064; DONNADIEU E, 1992, J BIOL CHEM, V267, P25864; DONNADIEU E, 1992, J IMMUNOL, V148, P2643; DUBYAK GR, 1988, J BIOL CHEM, V263, P18108; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FIEBER LA, 1991, J PHYSIOL-LONDON, V434, P239, DOI 10.1113/jphysiol.1991.sp018467; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; FISHMAN MC, 1981, P NATL ACAD SCI-BIOL, V78, P5245, DOI 10.1073/pnas.78.8.5245; FRIEL DD, 1988, J GEN PHYSIOL, V91, P1, DOI 10.1085/jgp.91.1.1; FRIEL DD, 1988, J PHYSIOL-LONDON, V401, P361, DOI 10.1113/jphysiol.1988.sp017167; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; GREENBERG S, 1988, J BIOL CHEM, V263, P10337; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAROOTUNIAN AT, 1989, J BIOL CHEM, V264, P19458; KRISHTAL OA, 1988, NEUROSCIENCE, V27, P995, DOI 10.1016/0306-4522(88)90203-5; MATTHEWS G, 1989, J PHYSIOL-LONDON, V418, P105, DOI 10.1113/jphysiol.1989.sp017830; MELDOLESI J, 1987, EXP CELL RES, V171, P271, DOI 10.1016/0014-4827(87)90161-3; MELDOLESI J, 1991, TRENDS PHARMACOL SCI, V12, P289, DOI 10.1016/0165-6147(91)90577-F; MERRITT JE, 1987, J BIOL CHEM, V262, P17362; MERTZ LM, 1992, J MEMBRANE BIOL, V126, P183; MULLER RU, 1972, J GEN PHYSIOL, V60, P285, DOI 10.1085/jgp.60.3.285; NAUMOV AP, 1992, FEBS LETT, V313, P285, DOI 10.1016/0014-5793(92)81210-D; PFEILSCHIFTER J, 1989, EUR J BIOCHEM, V186, P509, DOI 10.1111/j.1432-1033.1989.tb15236.x; RANDRIAMAMPITA C, 1991, CELL REGUL, V2, P513, DOI 10.1091/mbc.2.7.513; RANDRIAMAMPITA C, 1987, J CELL BIOL, V105, P761, DOI 10.1083/jcb.105.2.761; RANDRIAMAMPITA C, 1991, PFLUG ARCH EUR J PHY, V417, P633, DOI 10.1007/BF00372962; RANDRIAMAMPITA C, 1990, J BIOL CHEM, V265, P18059; RANDRIAMAMPITA C, 1989, FEBS LETT, V249, P199, DOI 10.1016/0014-5793(89)80624-6; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; TATHAM PER, 1990, J GEN PHYSIOL, V95, P459, DOI 10.1085/jgp.95.3.459; VINCENT P, 1992, J PHYSIOL-LONDON, V449, P313, DOI 10.1113/jphysiol.1992.sp019088; WILLIAMS M, 1990, NEUROTRANSMISSIONS, V6, P1; YU HX, 1991, J PHARMACOL EXP THER, V259, P1344	39	49	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18640	18647						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360160				2022-12-27	WOS:A1993LV65900045
J	WU, AL; WEMMIE, JA; EDGINGTON, NP; GOEBL, M; GUEVARA, JL; MOYEROWLEY, WS				WU, AL; WEMMIE, JA; EDGINGTON, NP; GOEBL, M; GUEVARA, JL; MOYEROWLEY, WS			YEAST BZIP PROTEINS MEDIATE PLEIOTROPIC DRUG AND METAL RESISTANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE GENE; TRANSCRIPTION FACTOR AP-1; CONFERRING RESISTANCE; ESCHERICHIA-COLI; SHUTTLE VECTORS; LEUCINE ZIPPERS; YAP1 ENCODES; DNA; BINDING; JUN	Saccharomyces cerevisiae contains a group of transcription factors related to mammalian c-Jun. This yeast Jun-family of proteins consists of GCN4, a regulator of genes involved in amino acid biosynthesis, and yAP-1, a factor conferring pleiotropic drug resistance when overexpressed. In the work described here, we show that a third member of the yeast Jun-family exists. This protein has been designated CAD1 and provides resistance to cadmium when present on a high-copy plasmid. CAD1 and yAP-1 are related in their amino-terminal DNA binding domains and can recognize the same DNA target site in vitro. Overproduction of CAD1 leads to transcriptional activation of an artificial reporter gene in DELTAyap1 cells. High level production of either CAD1 or yAP-1 causes cells to acquire a pleiotropic drug-resistant phenotype and to be able to tolerate normally toxic levels of iron chelators and zinc. Surprisingly, disruption of the CAD1 gene has no effect on the normal cellular resistance to cadmium but DELTAyap1 mutants are hypersensitive to this cytotoxic metal. The cadmium hypersensitivity of the DELTAyap1 mutant described here indicates that one major role of YAP1 in the yeast cell is to mediate resistance to this metal.	UNIV IOWA, PROGRAM MOLEC BIOL, IOWA CITY, IA 52242 USA; UNIV IOWA, DEPT PHYSIOL & BIOPHYS, IOWA CITY, IA 52242 USA; INDIANA UNIV, SCH MED, WALTHER ONCOL CTR, INDIANAPOLIS, IN 46202 USA; INDIANA UNIV, SCH MED, DEPT BIOCHEM & MOLEC BIOL, INDIANAPOLIS, IN 46202 USA	University of Iowa; University of Iowa; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Indiana University System; Indiana University-Purdue University Indianapolis			Moye-Rowley, Scott/AFL-7135-2022	Moye-Rowley, Scott/0000-0002-7163-1120; Wemmie, John/0000-0001-7531-9065				ABEL T, 1989, NATURE, V341, P24, DOI 10.1038/341024a0; ARNDT K, 1986, P NATL ACAD SCI USA, V83, P8516, DOI 10.1073/pnas.83.22.8516; BALZI E, 1987, J BIOL CHEM, V262, P16871; BALZI E, 1991, BIOCHIM BIOPHYS ACTA, V1073, P241, DOI 10.1016/0304-4165(91)90128-4; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BUSCH SJ, 1990, TRENDS GENET, V6, P36, DOI 10.1016/0168-9525(90)90071-D; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; CONKLIN DS, 1992, MOL CELL BIOL, V12, P3678, DOI 10.1128/MCB.12.9.3678; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EMR SD, 1986, J CELL BIOL, V102, P523, DOI 10.1083/jcb.102.2.523; GADD GM, 1989, SPEC PUBL SOC GEN MI, V26, P19; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; HANAHAN D, 1989, RECOMBINANT DNA METH, P267; HARSHMAN KD, 1988, CELL, V53, P321, DOI 10.1016/0092-8674(88)90393-5; HERTLE K, 1991, CURR GENET, V19, P429, DOI 10.1007/BF00312733; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HSU SIH, 1990, MOL CELL BIOL, V10, P3596, DOI 10.1128/MCB.10.7.3596; HUSSAIN M, 1991, GENE, V101, P149, DOI 10.1016/0378-1119(91)90238-7; JANUSKA AP, 1988, GENETIKA+, V24, P773; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; JUNGMANN J, 1993, NATURE, V361, P369, DOI 10.1038/361369a0; KAMIZONO A, 1989, MOL GEN GENET, V219, P161, DOI 10.1007/BF00261172; KATAOKA T, 1984, CELL, V37, P437, DOI 10.1016/0092-8674(84)90374-X; LEPPERT G, 1990, GENETICS, V125, P13; MEISTER A, 1988, J BIOL CHEM, V263, P17205; MOYE WS, 1985, J BIOL CHEM, V260, P4718; MOYEROWLEY WS, 1989, GENE DEV, V3, P283, DOI 10.1101/gad.3.3.283; MOYEROWLEY WS, 1988, COLD SPRING HARB SYM, V53, P711, DOI 10.1101/SQB.1988.053.01.081; MUTOH N, 1988, BIOCHEM BIOPH RES CO, V151, P32, DOI 10.1016/0006-291X(88)90555-4; NIES DH, 1992, PLASMID, V27, P17, DOI 10.1016/0147-619X(92)90003-S; OKUDA A, 1990, EMBO J, V9, P1131, DOI 10.1002/j.1460-2075.1990.tb08219.x; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; SCHNELL N, 1991, EUR J BIOCHEM, V200, P487, DOI 10.1111/j.1432-1033.1991.tb16209.x; SCHNELL N, 1992, CURR GENET, V21, P269, DOI 10.1007/BF00351681; SHATZMAN AR, 1987, METHOD ENZYMOL, V152, P661; Sherman F, 1979, METHODS YEAST GENETI; SHUEY DJ, 1986, J BIOL CHEM, V261, P7934; SIKORSKI RS, 1989, GENETICS, V122, P19; STRUHL K, 1985, NUCLEIC ACIDS RES, V13, P8587, DOI 10.1093/nar/13.23.8587; TATCHELL K, 1984, NATURE, V309, P523, DOI 10.1038/309523a0; THIELE DJ, 1992, NUCLEIC ACIDS RES, V20, P1183, DOI 10.1093/nar/20.6.1183; TODA T, 1991, GENE DEV, V5, P60, DOI 10.1101/gad.5.1.60; VOGT PK, 1987, P NATL ACAD SCI USA, V84, P3316, DOI 10.1073/pnas.84.10.3316	47	172	174	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18850	18858						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360174				2022-12-27	WOS:A1993LV65900072
J	LOLKEMA, JS				LOLKEMA, JS			A METHOD TO STUDY COMPLEX ENZYME-KINETICS INVOLVING NUMERICAL-ANALYSIS OF ENZYMATIC SCHEMES - THE MANNITOL PERMEASE OF ESCHERICHIA-COLI AS AN EXAMPLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PHOSPHOTRANSFERASE SYSTEM; C-TERMINAL DOMAIN; PHOSPHOENOLPYRUVATE; TRANSPORT; IIMTL; PHOSPHORYLATION; MEMBRANE; STATE; COMPLEMENTATION; OVEREXPRESSION	An analysis of complex kinetic mechanisms is proposed that consists of two steps, (i) building of an kinetic scheme from experimental data other than steady-state kinetics and (ii) numerical simulation and analysis of the kinetics of the proposed scheme in relation to the experimental kinetics. Procedures are introduced to deal with large numbers of enzymatic states and rate constants, and numerical tools are defined to support the analysis of the scheme. The approach is explored by taking the mannitol permease of Escherichia coli as an example. This enzyme catalyzes both the transport of mannitol across the cytoplasmic membrane and the phosphorylation of mannitol. The challenge is to deduce the transport properties of this dimeric enzyme from the phosphorylation kinetics. It is concluded that (i) the steady-state kinetic behavior is largely consistent with the proposed catalytic cycle of the monomeric subunit, (ii) the kinetics provide no direct support but also do not disprove a coupled translocation of the binding sites on the two monomeric subunits. The approach reveals the need for further experimentation where the implementation of experimental results in the scheme conflict with the experimental kinetics and where specific experimental characteristics do not show up in the simulations of the proposed kinetic scheme.			LOLKEMA, JS (corresponding author), UNIV GRONINGEN,DEPT MICROBIOL,KERKLAAN 30,9751 NN HAREN,NETHERLANDS.							BARTFAI T, 1972, FEBS LETT, V26, P252, DOI 10.1016/0014-5793(72)80585-4; ELFERINK MGL, 1990, J BACTERIOL, V172, P7119, DOI 10.1128/jb.172.12.7119-7125.1990; GRISAFI PL, 1989, J BACTERIOL, V171, P2719, DOI 10.1128/jb.171.5.2719-2727.1989; KHANDEKAR SS, 1989, J CELL BIOCHEM, V39, P207, DOI 10.1002/jcb.240390212; KING EL, 1956, J PHYS CHEM-US, V60, P1375, DOI 10.1021/j150544a010; LOLKEMA JS, 1990, BIOCHEMISTRY-US, V29, P10120, DOI 10.1021/bi00495a016; LOLKEMA JS, 1993, J BIOL CHEM, V268, P17844; LOLKEMA JS, 1993, BIOCHEMISTRY-US, V32, P1396, DOI 10.1021/bi00057a002; LOLKEMA JS, 1992, BIOCHEMISTRY-US, V31, P5514, DOI 10.1021/bi00139a013; LOLKEMA JS, 1991, BIOCHEMISTRY-US, V30, P6721, DOI 10.1021/bi00241a013; LOLKEMA JS, 1990, BIOCHEMISTRY-US, V29, P10659, DOI 10.1021/bi00499a012; LOLKEMA JS, 1991, BIOCHEMISTRY-US, V30, P6716, DOI 10.1021/bi00241a012; LOLKEMA JS, 1993, BIOCHEMISTRY-US, V32, P5848, DOI 10.1021/bi00073a018; LOLKEMA JS, 1992, NEW COMPR BIOCH, V21, P135; MANNERVIK B, 1973, EUR J BIOCHEM, V37, P270, DOI 10.1111/j.1432-1033.1973.tb02985.x; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; PAS HH, 1988, BIOCHEMISTRY-US, V27, P5835, DOI 10.1021/bi00416a002; PAS HH, 1988, BIOCHEMISTRY-US, V27, P5520, DOI 10.1021/bi00415a020; PAS HH, 1987, BIOCHEMISTRY-US, V26, P6689, DOI 10.1021/bi00395a019; POSTMA PW, 1985, MICROBIOL REV, V49, P232, DOI 10.1128/MMBR.49.3.232-269.1985; RAY WJ, 1983, BIOCHEMISTRY-US, V22, P4625, DOI 10.1021/bi00289a003; ROOSSIEN FF, 1984, BIOCHEMISTRY-US, V23, P4934, DOI 10.1021/bi00316a017; ROOSSIEN FF, 1986, FEBS LETT, V196, P284, DOI 10.1016/0014-5793(86)80264-2; ROOSSIEN FF, 1984, BIOCHEMISTRY-US, V23, P5682, DOI 10.1021/bi00319a003; SAIER MH, 1980, J SUPRAMOL STR CELL, V14, P281, DOI 10.1002/jss.400140303; SOLOMON E, 1973, J BACTERIOL, V172, P723; STEPHAN MM, 1986, BIOCHEMISTRY-US, V25, P8230, DOI 10.1021/bi00373a016; STEPHAN MM, 1986, BIOCHEMISTRY-US, V25, P4046, DOI 10.1021/bi00362a009; VANNULAND NAJ, 1993, FEBS LETT, V315, P11, DOI 10.1016/0014-5793(93)81122-G; VANWEEGHEL RP, 1991, BIOCHEMISTRY-US, V30, P9478, DOI 10.1021/bi00103a013; VANWEEGHEL RP, 1991, BIOCHEMISTRY-US, V30, P1774, DOI 10.1021/bi00221a007; WALZ D, 1988, CELL BIOPHYS, V12, P13, DOI 10.1007/BF02918348; WHITE DW, 1990, J BACTERIOL, V172, P1509, DOI 10.1128/jb.172.3.1509-1515.1990; 1987, TURBO PASCAL TOOLBOX, P105	34	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17850	17860						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349669				2022-12-27	WOS:A1993LT74300034
J	SATO, Y; ARAI, H; MIYATA, A; TOKITA, S; YAMAMOTO, K; TANABE, T; INOUE, K				SATO, Y; ARAI, H; MIYATA, A; TOKITA, S; YAMAMOTO, K; TANABE, T; INOUE, K			PRIMARY STRUCTURE OF ALPHA-TOCOPHEROL TRANSFER PROTEIN FROM RAT-LIVER - HOMOLOGY WITH CELLULAR RETINALDEHYDE-BINDING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-E-DEFICIENCY; GAMMA-TOCOPHEROL; HUMAN LIPOPROTEINS; BOVINE RETINA; PURIFICATION; SEQUENCES; CLONING	Alpha-tocopherol transfer protein (alphaTTP) present in rat liver cytosol specifically binds this vitamin and enhances its transfer between separate membranes. We previously reported purification of alphaTTP and showed that two isoforms exist in rat liver, of which the isoelectric points are 5.0 and 5.1, respectively (Sato, Y., Hagiwara, K., Arai, H., and Inoue, K. (1991) FEBS Lett. 288, 41-45). In the present paper, we have isolated a cDNA clone with 2194 base pairs encoding alphaTTP from a rat liver cDNA library. The amino acid sequence deduced from the cDNA contained all the sequences of the peptide fragments obtained by digestion of the purified protein with endoproteinase Lys-C. The isolated cDNA was found to encode the isoform with a pI of 5.0 on the basis of the cross-reactivity of the recombinant protein expressed in Escherichia coli with the isoform-specific monoclonal antibody. From the longest open reading frame of the cloned cDNA, one isoform of rat liver alphaTTP is predicted to be composed of 278 amino acid residues of calculated molecular weight 31,845. Both Western and Northern blot analyses revealed that alphaTTP is expressed exclusively in the liver in rats. AlphaTTP has been found to exhibit a structural homology with the cellular retinaldehyde-binding protein present only in visual tissues.	UNIV TOKYO, FAC PHARMACEUT SCI, DEPT HLTH CHEM, BUNKYO KU, TOKYO 113, JAPAN; UNIV TOKYO, FAC PHARMACEUT SCI, DIV CHEM TOXICOL & IMMUNOCHEM, TOKYO 113, JAPAN; NATL CARDIOVASC CTR, RES INST, DEPT PHARMACOL, SUITA, OSAKA 565, JAPAN	University of Tokyo; University of Tokyo; National Cerebral & Cardiovascular Center - Japan								BEHRENS WA, 1982, NUTR RES, V2, P611, DOI 10.1016/S0271-5317(82)80073-0; BEHRENS WA, 1986, J AM COLL NUTR, V5, P91; BEHRENS WA, 1982, NUTR REP INT, V25, P107; BIERI JG, 1974, AM J CLIN NUTR, V27, P980, DOI 10.1093/ajcn/27.8.980; BURCK U, 1981, NEUROPEDIATRICS, V12, P267, DOI 10.1055/s-2008-1059657; BURTON GW, 1986, ACCOUNTS CHEM RES, V19, P194, DOI 10.1021/ar00127a001; CATIGNANI GL, 1975, BIOCHEM BIOPH RES CO, V67, P66, DOI 10.1016/0006-291X(75)90283-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOW CK, 1975, AM J CLIN NUTR, V28, P756, DOI 10.1093/ajcn/28.7.756; CRABB JW, 1988, J BIOL CHEM, V263, P18678; CRABB JW, 1988, J BIOL CHEM, V263, P18688; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; DENHARDT DT, 1966, BIOCHEM BIOPH RES CO, V23, P641, DOI 10.1016/0006-291X(66)90447-5; DIPLOCK AT, 1985, FAT SOLUBLE VITAMINS, P154; Galfre G, 1981, Methods Enzymol, V73, P3; HARDING AE, 1985, NEW ENGL J MED, V313, P32, DOI 10.1056/NEJM198507043130107; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KRENDEL DA, 1987, NEUROLOGY, V37, P538, DOI 10.1212/WNL.37.3.538; KUROKI M, 1992, IMMUNOL INVEST, V21, P241, DOI 10.3109/08820139209072262; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPLANTE P, 1984, CAN J NEUROL SCI, V11, P561, DOI 10.1017/S0317167100035046; LEFF SE, 1986, ANNU REV BIOCHEM, V55, P1091, DOI 10.1146/annurev.bi.55.070186.005303; LISCOVITCH M, 1985, ANAL BIOCHEM, V151, P182, DOI 10.1016/0003-2697(85)90069-7; MIERENDORF RC, 1987, METHOD ENZYMOL, V152, P458; MOWRI H, 1981, EUR J BIOCHEM, V117, P537; MURPHY DJ, 1981, J BIOL CHEM, V256, P464; SAARI JC, 1987, J BIOL CHEM, V262, P7618; SAARI JC, 1982, BIOCHIM BIOPHYS ACTA, V716, P266, DOI 10.1016/0304-4165(82)90277-X; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO Y, 1991, FEBS LETT, V288, P41, DOI 10.1016/0014-5793(91)80999-J; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SOKOL RJ, 1988, J LAB CLIN MED, V111, P548; SUNDELIN J, 1985, J BIOL CHEM, V260, P6494; TRABER MG, 1989, ANN NY ACAD SCI, V570, P95; TRABER MG, 1989, AM J CLIN NUTR, V49, P517, DOI 10.1093/ajcn/49.3.517; TRABER MG, 1990, J CLIN INVEST, V85, P397, DOI 10.1172/JCI114452; YOKOTA T, 1987, ANN NEUROL, V22, P84, DOI 10.1002/ana.410220119; YOKOYAMA C, 1989, BIOCHEM BIOPH RES CO, V165, P888, DOI 10.1016/S0006-291X(89)80049-X; YOSHIDA H, 1992, J LIPID RES, V33, P343; [No title captured]	41	145	152	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17705	17710						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349655				2022-12-27	WOS:A1993LT74300013
J	SUAREZ, G; ORONSKY, AL; KOCH, MHLJ				SUAREZ, G; ORONSKY, AL; KOCH, MHLJ			AGE-DEPENDENT STRUCTURAL-CHANGES IN INTACT HUMAN LENSES DETECTED BY SYNCHROTRON-RADIATION X-RAY-SCATTERING - CORRELATION WITH MAILLARD REACTION PROTEIN FLUORESCENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUASIELASTIC LIGHT-SCATTERING; EYE LENS; ALPHA-CRYSTALLIN; QUATERNARY STRUCTURE; MOLECULAR-BASIS; END-PRODUCTS; AMINO-GROUPS; GLYCATION; INVIVO; TRANSPARENCY	To understand alterations in the spatial organization of the crystallins, the major determinant of lens transparency, the x-ray scattering by intact normal human lenses from individuals 6-82 years of age was measured using synchrotron radiation. The angular dependence of the integrated scattering intensity is consistent with short-range order within the crystallin assemblies. A significant change in the scattering patterns of the lenses occurs after 55 years of age, in parallel with an increase of the fluorescence of the urea-insoluble crystallin fraction. This correlation suggests a gradual derangement of the short-range order as a result of cross-linking of the crystallin subunits by advanced Maillard reaction products that are generated by the continuous reaction of sugars, such as glucose or fructose, with proteins.	EUROPEAN MOLEC BIOL LAB,HAMBURG OUTSTN,W-2000 HAMBURG 52,GERMANY; AMER CYANAMID CO,LEDERLE LABS,DIV MED RES,PEARL RIVER,NY 10965	European Molecular Biology Laboratory (EMBL)	SUAREZ, G (corresponding author), NEW YORK MED COLL,DEPT BIOCHEM & MOLEC BIOL,VALHALLA,NY 10595, USA.							ARAKI N, 1992, J BIOL CHEM, V267, P10211; AZEVEDO M, 1988, FREE RADICAL RES COM, V4, P331, DOI 10.3109/10715768809066899; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Baynes JW, 1989, MAILLARD REACTION AG; BENEDEK GB, 1987, CURR EYE RES, V6, P1421, DOI 10.3109/02713688709044506; BENEDEK GB, 1984, CIBA F SYMP, V106, P237; BENEDEK GB, 1971, APPL OPTICS, V10, P459, DOI 10.1364/AO.10.000459; Bloemendal H, 1981, MOL CELLULAR BIOL EY, P1; BOULIN C, 1986, NUCL INSTRUM METH A, V249, P399, DOI 10.1016/0168-9002(86)90694-7; BOULIN CJ, 1988, NUCL INSTRUM METH A, V269, P312, DOI 10.1016/0168-9002(88)90895-9; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; DELAYE M, 1986, C INSERM EURAGE, V147, P357; DYER DG, 1991, J BIOL CHEM, V266, P11654; EBASHI S, 1991, HDB SYNCHROTRON RAD; ELBAUM D, 1974, P NATL ACAD SCI USA, V7, P4718; GARCIACASTINEIRAS S, 1983, INVEST OPHTH VIS SCI, V24, P1181; GILLERY P, 1988, DIABETES METAB, V14, P25; Harding J.J., 1981, MOL CELLULAR BIOL EY, P327; HARDING JJ, 1989, MECH AGEING DEV, V50, P7, DOI 10.1016/0047-6374(89)90054-7; HARDING JJ, 1973, EXP EYE RES, V17, P377, DOI 10.1016/0014-4835(73)90247-9; HICKS M, 1988, BIOCHEM BIOPH RES CO, V151, P649, DOI 10.1016/S0006-291X(88)80330-9; HOENDERS HJ, 1983, J GERONTOL, V38, P278, DOI 10.1093/geronj/38.3.278; HOENDERS HJ, 1981, MOL CELLULAR BIOL EY, P279; KOCH MHJ, 1983, NUCL INSTRUM METHODS, V208, P461, DOI 10.1016/0167-5087(83)91169-9; LIBONDI T, 1986, CURR EYE RES, V5, P411, DOI 10.3109/02713688609015109; MAKITA Z, 1992, J BIOL CHEM, V267, P5133; MCPHERSON JD, 1988, BIOCHEMISTRY-US, V27, P1901, DOI 10.1021/bi00406a016; MEEK KM, 1981, J MOL BIOL, V149, P477, DOI 10.1016/0022-2836(81)90482-4; NAGARAJ RH, 1992, BIOCHIM BIOPHYS ACTA, V1116, P34, DOI 10.1016/0304-4165(92)90125-E; NAGARAJ RH, 1991, P NATL ACAD SCI USA, V88, P10257, DOI 10.1073/pnas.88.22.10257; OIMOMI M, 1988, EXP EYE RES, V46, P415, DOI 10.1016/S0014-4835(88)80029-0; PATRICK JS, 1990, J GERONTOL, V45, pB18, DOI 10.1093/geronj/45.1.B18; SAKURAI T, 1988, FEBS LETT, V236, P406, DOI 10.1016/0014-5793(88)80066-8; SATOH K, 1973, EXP EYE RES, V16, P167, DOI 10.1016/0014-4835(73)90311-4; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; SIMONELLI F, 1990, OPHTHALMIC RES, V22, P160, DOI 10.1159/000267017; SLINGSBY C, 1991, BIOCHEM SOC T, V19, P853, DOI 10.1042/bst0190853; SPECTOR A, 1975, EXP EYE RES, V21, P9, DOI 10.1016/0014-4835(75)90053-6; STADTMAN ER, 1988, J GERONTOL, V43, pB112, DOI 10.1093/geronj/43.5.B112; SUAREZ G, 1989, J BIOL CHEM, V264, P3674; SUAREZ G, 1980, ARCH BIOCHEM BIOPHYS, V205, P422, DOI 10.1016/0003-9861(80)90125-3; SUAREZ G, 1988, Investigative Ophthalmology and Visual Science, V29, P70; SUAREZ G, 1989, MAILLARD REACTION AG, P141; TARDIEU A, 1986, J MOL BIOL, V192, P711, DOI 10.1016/0022-2836(86)90023-9; THOMSON JA, 1984, J BIOL CHEM, V259, P4339; TROKEL S, 1962, INVEST OPHTH VISUAL, V1, P493; VANBOEKEL MAM, 1992, BIOCHIM BIOPHYS ACTA, V1159, P99, DOI 10.1016/0167-4838(92)90080-W; VANDENOETELAAR PJM, 1990, BIOCHEMISTRY-US, V29, P3488, DOI 10.1021/bi00466a010; VERETOUT F, 1989, J MOL BIOL, V205, P713, DOI 10.1016/0022-2836(89)90316-1; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; ZIGMAN S, 1976, EXP EYE RES, V23, P555, DOI 10.1016/0014-4835(76)90163-9	51	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17716	17721						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349657				2022-12-27	WOS:A1993LT74300015
J	TUROWSKI, PN; MCGUIRL, MA; DOOLEY, DM				TUROWSKI, PN; MCGUIRL, MA; DOOLEY, DM			INTRAMOLECULAR ELECTRON-TRANSFER RATE BETWEEN ACTIVE-SITE COPPER AND TOPA QUINONE IN PEA SEEDLING AMINE OXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MECHANISM	The equilibrium between the two substrate-reduced forms of pea seedling amine oxidase, one containing Cu(II) and reduced 3-(2,4,5-trihydroxyphenyl)-L-alanine (topa) cofactor and one containing Cu(I) and topa semiquinone, was investigated by visible spectroscopy as a function of temperature. To determine the rate of interconversion between the two species, temperature jump relaxation studies were performed on the substrate-reduced enzyme near room temperature. The yellow radical species was found to approach its equilibrium concentration with a maximum rate constant of 43,000 +/- 3,000 s-1. This rapid equilibration is attributed to intramolecular electron transfer between copper and topa. The data indicate that the Cu(I)/topa(SQ) species is a kinetically competent intermediate in the reaction of amine oxidases with substrates. Furthermore, the extremely rapid electron transfer rate (k(ET) congruent-to 20,000 s-1) suggests that the topa cofactor is in close proximity to the copper atom.	AMHERST COLL,DEPT CHEM,AMHERST,MA 01002	Amherst College			McGuirl, Michele/N-2311-2014		NIGMS NIH HHS [GM14692, GM27659] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027659, F32GM014692] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELLELLI A, 1991, J BIOL CHEM, V266, P20654; BROWN DE, 1991, J BIOL CHEM, V266, P4049; DOOLEY DM, 1991, NATURE, V349, P262, DOI 10.1038/349262a0; DOOLEY DM, 1990, J AM CHEM SOC, V112, P2782, DOI 10.1021/ja00163a047; FARVER O, 1989, P NATL ACAD SCI USA, V86, P6968, DOI 10.1073/pnas.86.18.6968; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; JACKMAN MP, 1988, J AM CHEM SOC, V110, P5880, DOI 10.1021/ja00225a046; JANES SM, 1990, SCIENCE, V248, P981, DOI 10.1126/science.2111581; KLUETZ MD, 1980, PREP BIOCHEM, V10, P615, DOI 10.1080/00327488008061757; MCCLENDON G, 1992, CHEM REV, V92, P481; MCGUIRL MA, 1991, J INORG BIOCHEM, V43, P186; McIntire W. S., 1993, COPPER CONTAINING AM, P97; MU D, 1992, J BIOL CHEM, V267, P7979; PASTERNACK RF, 1969, J AM CHEM SOC, V91, P4401, DOI 10.1021/ja01044a012; PEDERSEN JZ, 1992, BIOCHEMISTRY-US, V31, P8, DOI 10.1021/bi00116a002; STUBBE J, 1988, BIOCHEMISTRY-US, V27, P3893, DOI 10.1021/bi00411a001; THOMSON AJ, 1991, NATURE, V350, P22, DOI 10.1038/350022a0; WILLIAMS TJ, 1986, J BIOL CHEM, V261, P5949; WINKLER JR, 1992, CHEM REV, V92, P365	19	96	98	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17680	17682						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349651				2022-12-27	WOS:A1993LT74300009
J	LI, R; NORTAMO, P; VALMU, L; TOLVANEN, M; HUUSKONEN, J; KANTOR, C; GAHMBERG, CG				LI, R; NORTAMO, P; VALMU, L; TOLVANEN, M; HUUSKONEN, J; KANTOR, C; GAHMBERG, CG			A PEPTIDE FROM ICAM-2 BINDS TO THE LEUKOCYTE INTEGRIN CD11A/CD18 AND INHIBITS ENDOTHELIAL-CELL ADHESION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE DOMAINS; CRYSTAL-STRUCTURE; SOLUBLE FORM; PLASMODIUM-FALCIPARUM; MONOCLONAL-ANTIBODIES; PLATELET INTEGRIN; COUNTER-RECEPTOR; HUMAN CD4; LFA-1; MOLECULE	Numerous leukocyte functions depend on adhesive intercellular interactions. The leukocyte-specific integrins CD11a/CD18 (lymphocyte function-associated antigen-1 (LFA-1)) and CD11b/CD18 (complement type 3 receptor (Mac-1)), which bind to the intercellular adhesion molecules ICAM-1 and ICAM-2, play a key role in adhesion. Little is known about the binding in molecular detail. We have now defined a peptide region from the first immunoglobulin domain of ICAM-2 that is specifically involved in binding to CD11a/CD18. A synthetic peptide from this part of ICAM-2, covering residues 21-42, bound to purified CD11a/CD18 and inhibited the adhesion of endothelial cells to this integrin. It also inhibited the binding of B lymphoblastoid cells to endothelial cells. Leukocytes bound to the peptide coated on plastic. Several shorter peptides from the same region showed less or no activity.	UNIV HELSINKI, DEPT BIOCHEM, UNIONINKATU 35, SF-00170 HELSINKI 17, FINLAND	Finland National Institute for Health & Welfare; University of Helsinki			Gahmberg, Carl/AAE-1876-2019	Tolvanen, Martti/0000-0003-3434-7646; Gahmberg, Carl/0000-0001-9892-9296				ARNAOUT MA, 1990, BLOOD, V75, P1037; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BERENDT AR, 1992, CELL, V68, P71, DOI 10.1016/0092-8674(92)90207-S; BORCHE L, 1987, EUR J IMMUNOL, V17, P1523, DOI 10.1002/eji.1830171023; CLARK EA, 1986, HUM IMMUNOL, V16, P100, DOI 10.1016/0198-8859(86)90039-X; DAMLE NK, 1992, J IMMUNOL, V148, P665; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; DSOUZA SE, 1991, NATURE, V350, P66, DOI 10.1038/350066a0; DSOUZA SE, 1990, J BIOL CHEM, V265, P3440; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; FECONDO JV, 1991, P NATL ACAD SCI USA, V88, P2879, DOI 10.1073/pnas.88.7.2879; GAHMBERG CG, 1991, EUR J BIOCHEM, V195, P177, DOI 10.1111/j.1432-1033.1991.tb15692.x; GIRANDA VL, 1990, PROTEINS, V7, P227, DOI 10.1002/prot.340070304; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; HOGG N, 1991, CHEM IMMUNOLOGY INTE, P99; HORLEY KJ, 1989, EMBO J, V8, P2889, DOI 10.1002/j.1460-2075.1989.tb08437.x; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; MARLIN SD, 1990, NATURE, V344, P70, DOI 10.1038/344070a0; NORTAMO P, 1988, SCAND J IMMUNOL, V28, P537, DOI 10.1111/j.1365-3083.1988.tb01485.x; NORTAMO P, 1991, EUR J IMMUNOL, V21, P2629, DOI 10.1002/eji.1830211049; NORTAMO P, 1991, J IMMUNOL, V146, P2530; PATARROYO M, 1990, IMMUNOL REV, V114, P67, DOI 10.1111/j.1600-065X.1990.tb00562.x; RENKONEN R, 1992, AM J PATHOL, V140, P763; ROSS L, 1992, J BIOL CHEM, V267, P8537; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; SETH R, 1991, FEBS LETT, V282, P193, DOI 10.1016/0014-5793(91)80475-I; SIMMONS D, 1988, NATURE, V331, P624, DOI 10.1038/331624a0; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; WEGNER CD, 1990, SCIENCE, V247, P456, DOI 10.1126/science.1967851; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; YAMADA KM, 1991, J BIOL CHEM, V266, P12809; [No title captured]	44	65	68	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17513	17518						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349630				2022-12-27	WOS:A1993LQ98800091
J	MCDONALD, TV; PREMACK, BA; GARDNER, P				MCDONALD, TV; PREMACK, BA; GARDNER, P			FLASH-PHOTOLYSIS OF CAGED INOSITOL 1,4,5-TRISPHOSPHATE ACTIVATES PLASMA-MEMBRANE CALCIUM CURRENT IN HUMAN T-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL TRANSDUCTION; ANTIGEN RECEPTOR; LYMPHOCYTES-T; K+ CHANNELS; PATCH-CLAMP; TRISPHOSPHATE; CA-2+; PHOSPHATES; MECHANISM; ENTRY	Sustained elevation of intracellular Ca2+ by cell surface receptors is often dependent on influx of Ca2+ across the plasma membrane through routes not involving voltage-gated Ca2+ channels. We demonstrate that intracellular release of inositol 1,4,5-trisphosphate (InsP3), either from stimulation of transfected human muscarinic receptors or from photolytic release of caged InsP3, activates whole cell Ca2+ current in the Jurkat T cell line. Whole cell voltage clamp recordings indicate that the current is carried by a Ca2+-selective channel that resembles T-type voltage-gated Ca2+ channels in relative conductance of different cation species. Elevation of internal Ca2+ inactivates the channel, whereas internal perfusion with inositol 1,3,4,5-tetrakisphosphate (InsP4) does not affect it. Photolytic release of caged 1-(alpha-glycerophosphoryl)inositol 4,5-bisphosphate, an analog of InsP3 which activates InsP3 receptors but is not readily metabolized to InsP4, also activates the current. We conclude that generation of InsP3 is sufficient to activate Ca2+-selective channels in the plasma membrane of T cells. InsP3 may have its effect indirectly through depletion of Ca2+ stores, or directly with a plasma membrane-associated InSP3 receptor.	STANFORD UNIV, MED CTR,SCH MED,FALK CARDIOVASC RES CTR,DEPT MED, STANFORD, CA 94305 USA	Stanford University					NHLBI NIH HHS [K11-HL02397] Funding Source: Medline; NIDDK NIH HHS [R01-DK41324] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K11HL002397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041324] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BIRD GS, 1991, NATURE, V352, P162, DOI 10.1038/352162a0; BIRD GS, 1992, J BIOL CHEM, V267, P17722; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CATTERALL WA, 1991, CELL, V64, P871, DOI 10.1016/0092-8674(91)90309-M; CHOW SC, 1990, CELL CALCIUM, V11, P641, DOI 10.1016/0143-4160(90)90018-P; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; ELY JA, 1990, BIOCHEM J, V268, P333, DOI 10.1042/bj2680333; FERRIS CD, 1992, ANNU REV PHYSIOL, V54, P469, DOI 10.1146/annurev.physiol.54.1.469; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GARDNER P, 1989, J BIOL CHEM, V264, P1068; GOLDSMITH MA, 1989, J BIOL CHEM, V264, P17190; GOLDSMITH MA, 1988, SCIENCE, V240, P1029, DOI 10.1126/science.3259335; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; IMBODEN JB, 1985, J EXP MED, V161, P446, DOI 10.1084/jem.161.3.446; IRVINE RF, 1986, NATURE, V320, P631, DOI 10.1038/320631a0; IRVINE RF, 1986, BIOCHEM J, V240, P917, DOI 10.1042/bj2400917; KAPLAN JH, 1990, ANNU REV PHYSIOL, V52, P897; KHAN AA, 1992, SCIENCE, V257, P815, DOI 10.1126/science.1323146; KHAN AA, 1992, P NATL ACAD SCI USA, V89, P2849, DOI 10.1073/pnas.89.7.2849; KUNO M, 1986, NATURE, V323, P269, DOI 10.1038/323269a0; KUNO M, 1987, NATURE, V326, P301, DOI 10.1038/326301a0; LEWIS RS, 1989, CELL REGUL, V1, P99, DOI 10.1091/mbc.1.1.99; LU CY, 1989, J MEMBRANE BIOL, V109, P85, DOI 10.1007/BF01870793; LUCKHOFF A, 1992, NATURE, V355, P356, DOI 10.1038/355356a0; MASON MJ, 1991, J BIOL CHEM, V266, P20856; MATTESON DR, 1984, NATURE, V307, P468, DOI 10.1038/307468a0; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; MINKE B, 1991, PROG RETIN RES, V11, P99, DOI 10.1016/0278-4327(91)90026-X; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; MORRIS AP, 1987, NATURE, V330, P653, DOI 10.1038/330653a0; NISHIMOTO I, 1991, NEURON, V6, P547, DOI 10.1016/0896-6273(91)90057-7; OETTGEN HC, 1985, CELL, V40, P583, DOI 10.1016/0092-8674(85)90206-5; OGDEN DC, 1990, J PHYSIOL-LONDON, V422, P585, DOI 10.1113/jphysiol.1990.sp018002; PREMACK BA, 1992, IN PRESS AM J PHYSL; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; ROSS CA, 1989, NATURE, V339, P468, DOI 10.1038/339468a0; RUKNUDIN A, 1991, J CELL BIOL, V112, P125, DOI 10.1083/jcb.112.1.125; SATOH T, 1990, J CELL BIOL, V111, P615, DOI 10.1083/jcb.111.2.615; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; TSIEN RW, 1987, ANNU REV BIOPHYS BIO, V16, P265; WALKER JW, 1989, BIOCHEMISTRY-US, V28, P3272, DOI 10.1021/bi00434a023; WEISS MJ, 1984, P NATL ACAD SCI-BIOL, V81, P6836, DOI 10.1073/pnas.81.21.6836	47	110	110	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					3889	3896						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382682				2022-12-27	WOS:A1993KN53300018
J	RESNICK, D; FREEDMAN, NJ; XU, SZ; KRIEGER, M				RESNICK, D; FREEDMAN, NJ; XU, SZ; KRIEGER, M			SECRETED EXTRACELLULAR DOMAINS OF MACROPHAGE SCAVENGER RECEPTORS FORM ELONGATED TRIMERS WHICH SPECIFICALLY BIND CROCIDOLITE ASBESTOS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; HAMSTER-CELL MUTANTS; CHOLESTEROL DEPOSITION; LIGAND-BINDING; OVARY CELLS; EXPRESSION; PROTEINS; ATHEROSCLEROSIS; BIOSYNTHESIS; METABOLISM	Macrophage scavenger receptors, which have been implicated in the development of atherosclerosis and other macrophage-mediated events, are trimeric integral membrane glycoproteins whose extracellular domains have been predicted to include alpha-helical coiled-coil, collagenous and globular structures. To elucidate further the structural and functional properties of these receptors, we generated transfected Chinese hamster ovary cells which express secreted extracellular domains of the type I and type II bovine scavenger receptors and developed a solid-phase bead-binding assay to assess their ligand-binding properties. The secreted receptors exhibited the distinctive high-affinity, broad polyanionic ligand-binding specificity and the pH dependence of binding which characterize the membrane-anchored cell-surface forms of the receptors. Both the type I and type II secreted receptors were trimeric glycoproteins comprising disulfide-linked dimers and noncovalently associated monomers. Gel filtration and glycerol-gradient centrifugation established that the type II trimers were highly elongated and did not associate into higher order oligomers at the low concentrations used in these experiments. Crocilodite asbestos, which is phagocytosed by alveolar macrophages and can cause asbestosis and mesothelioma, bound efficiently to secreted type I receptors and less well to the type II receptors. This binding was specific in that it was competed by a variety of well established scavenger receptor ligands but not by negative controls. These studies have identified a new type of insoluble scavenger receptor ligand, and have raised the possibility that scavenger receptors may play a role in mediating the physiological and pathological interactions of inspired particles with alveolar macrophages.	MIT,DEPT BIOL,RM E25-236,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT)					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041484] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL41484] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACTON S, 1993, J BIOL CHEM, V268, P3530; ARQUINT M, 1987, P NATL ACAD SCI USA, V84, P600, DOI 10.1073/pnas.84.2.600; ARUFFO A, 1991, J EXP MED, V174, P949, DOI 10.1084/jem.174.4.949; AXELSSON I, 1978, J CHROMATOGR, V152, P21, DOI 10.1016/S0021-9673(00)85330-3; BICKEL PE, 1992, J CLIN INVEST, V90, P1450, DOI 10.1172/JCI116012; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DUAN DSR, 1991, J BIOL CHEM, V266, P413; FASMAN GD, 1976, PROTEINS, V3, P249; FREEMAN M, 1990, P NATL ACAD SCI USA, V87, P8810, DOI 10.1073/pnas.87.22.8810; FREEMAN M, 1991, P NATL ACAD SCI USA, V88, P4931, DOI 10.1073/pnas.88.11.4931; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; GREEN SA, 1985, J BIOL CHEM, V260, P9867; HAMPTON RY, 1991, NATURE, V352, P342, DOI 10.1038/352342a0; HINZ HJ, 1986, THERMODYNAMIC DATA B, P69; HOLIAN A, 1990, HOSP PRACT, V25, P53; JURGENS G, 1987, CHEM PHYS LIPIDS, V45, P315, DOI 10.1016/0009-3084(87)90070-3; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; KODAMA T, 1988, P NATL ACAD SCI USA, V85, P9238, DOI 10.1073/pnas.85.23.9238; KODAMA T, 1991, CIRCULATION, V84, P11229; KOZARSKY KF, 1986, J CELL BIOL, V102, P1567, DOI 10.1083/jcb.102.5.1567; KRIEGER M, 1983, CELL, V33, P413, DOI 10.1016/0092-8674(83)90423-3; KRIEGER M, 1992, TRENDS BIOCHEM SCI, V17, P141, DOI 10.1016/0968-0004(92)90322-Z; KUMAR KN, 1991, J BIOL CHEM, V266, P14947; LAX I, 1991, J BIOL CHEM, V266, P13828; LOOS M, 1983, CURR TOP MICROBIOL, V102, P1; MATSUMOTO A, 1990, P NATL ACAD SCI USA, V87, P9133, DOI 10.1073/pnas.87.23.9133; MOSSMAN BT, 1989, NEW ENGL J MED, V320, P1721, DOI 10.1056/NEJM198906293202604; NAITO M, 1991, AM J PATHOL, V139, P1411; NISHIKAWA K, 1990, J BIOL CHEM, V265, P5226; PENMAN M, 1991, J BIOL CHEM, V266, P23985; PETERSON GL, 1986, BIOCHEMISTRY-US, V25, P3189, DOI 10.1021/bi00359a017; PJEARSON A, 1993, J BIOL CHEM, V268, P3546; RAETZ CRH, 1988, COLD SPRING HARB SYM, V53, P973, DOI 10.1101/SQB.1988.053.01.112; ROHRER L, 1990, NATURE, V343, P570, DOI 10.1038/343570a0; ROM WN, 1991, AM REV RESPIR DIS, V143, P408, DOI 10.1164/ajrccm/143.2.408; Sambrook J, 1989, MOL CLONING LABORATO; Segrest JP, 1972, METHOD ENZYMOL, V28, P54, DOI DOI 10.1016/0076-6879(72)28007-7; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEINBRECHER UP, 1990, FREE RADICAL BIO MED, V9, P155, DOI 10.1016/0891-5849(90)90119-4; STUHLMANN H, 1989, MOL CELL BIOL, V9, P100, DOI 10.1128/MCB.9.1.100; SUBRAMANI S, 1981, MOL CELL BIOL, V1, P854, DOI 10.1128/MCB.1.9.854; THIEL S, 1989, FEBS LETT, V250, P78, DOI 10.1016/0014-5793(89)80689-1; VANHOLDE KE, 1985, PHYSICAL BIOCH, P95; WATSON SR, 1990, J CELL BIOL, V110, P2221, DOI 10.1083/jcb.110.6.2221	46	79	82	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3538	3545						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381434				2022-12-27	WOS:A1993KM16100080
J	CHAN, VTW; NG, SW; EDER, JP; SCHNIPPER, LE				CHAN, VTW; NG, SW; EDER, JP; SCHNIPPER, LE			MOLECULAR-CLONING AND IDENTIFICATION OF A POINT MUTATION IN THE TOPOISOMERASE-II CDNA FROM AN ETOPOSIDE-RESISTANT CHINESE-HAMSTER OVARY CELL-LINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER CHROMATID EXCHANGES; DNA CLEAVAGE; SACCHAROMYCES-CEREVISIAE; ANTINEOPLASTIC DRUGS; ESCHERICHIA-COLI; CYTO-TOXICITY; GENE; GYRASE; RELIGATION; ACID	Topoisomerase II (Trop II) is the target enzyme for many antineoplastic drugs such as epipodophyllotoxins, anthracyclines, and acridines. Cell lines with alterations in Top II are resistant to drugs that interact with the enzyme. Studies of the Top II from a Chinese hamster ovary line, Vpm(R)-5, that is resistant to VP-16 and VM-26, demonstrated that it is very similar, qualitatively and quantitatively, to its normal counterpart except that DNA cleavage by the Vpm(R)-5 enzyme is not stimulated by VP-16 or VM-26. To understand the basis for the drug-resistant phenotype, the Top II cDNAs were isolated from both Chinese hamster ovary (CHO) and Vpm(R)-5 cells by cDNA cloning with lambdagt22, and the entire cDNAs were sequenced. A mutation of G --> A at nucleotide 1478 was the only alteration observed in the Vpm(R)-5 Top II cDNA compared with the wild-type gene. The mutation in Vpm(R)-5 was confirmed by sequencing DNA fragments amplified from the genomic DNA by the polymerase chain reaction. Southern blot hybridization analysis of genomic DNA demonstrated loss of a Top II allele in Vpm(R)-5 probably occurred during the development of resistance to etoposide. The mutation in Vpm(R)-5 changes amino acid 493 from arginine to glutamine and is located adjacent to a putative ATP binding site of Top II. Mutations in an analogous region have been identified in two human leukemia cell lines by amplification of segments of Top II cDNA with Taq DNA polymerase. Taken together, these observations suggest that mutations in this region of the gyrase B domain of mammalian topoisomerase II may be capable of conferring resistance to antineoplastic agents that interact with this enzyme.	BETH ISRAEL HOSP, THORNDIKE LAB, BOSTON, MA 02215 USA; BETH ISRAEL HOSP, DEPT MED, DIV HEMATOL & ONCOL, BOSTON, MA 02215 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	CHAN, VTW (corresponding author), BETH ISRAEL HOSP, CHARLES A DANA RES INST, BOSTON, MA 02215 USA.							AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BAE YS, 1988, P NATL ACAD SCI USA, V85, P2076, DOI 10.1073/pnas.85.7.2076; BERGER NA, 1991, P NATL ACAD SCI USA, V88, P8740, DOI 10.1073/pnas.88.19.8740; BUGG BY, 1991, P NATL ACAD SCI USA, V88, P7654, DOI 10.1073/pnas.88.17.7654; CHAN VTW, 1988, ANAL BIOCHEM, V168, P16, DOI 10.1016/0003-2697(88)90004-8; CHAN VTW, 1985, NUCLEIC ACIDS RES, V13, P8083, DOI 10.1093/nar/13.22.8083; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DANKS MK, 1988, BIOCHEMISTRY-US, V27, P8861, DOI 10.1021/bi00424a026; DINARDO S, 1984, P NATL ACAD SCI-BIOL, V81, P2616, DOI 10.1073/pnas.81.9.2616; ESTEY EH, 1987, BIOCHEM BIOPH RES CO, V144, P787, DOI 10.1016/S0006-291X(87)80033-5; GLISSON B, 1986, CANCER RES, V46, P1934; GOTO T, 1984, CELL, V36, P1073, DOI 10.1016/0092-8674(84)90057-6; GUPTA RS, 1983, CANCER RES, V43, P1568; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HINDS M, 1991, CANCER RES, V51, P4729; HUANG WM, 1990, DNA TOPOLOGY ITS BIO, P409; JACKSON AP, 1991, J MOL BIOL, V217, P15, DOI 10.1016/0022-2836(91)90606-7; KMIEC EB, 1986, P NATL ACAD SCI USA, V83, P1305, DOI 10.1073/pnas.83.5.1305; LIU LF, 1983, J BIOL CHEM, V258, P5365; LYNN R, 1986, SCIENCE, V233, P647, DOI 10.1126/science.3014661; MAXWELL A, 1984, J BIOL CHEM, V259, P4472; NELSON WG, 1986, NATURE, V322, P187, DOI 10.1038/322187a0; OSHEROFF N, 1989, BIOCHEMISTRY-US, V28, P6157, DOI 10.1021/bi00441a005; PER SR, 1987, MOL PHARMACOL, V32, P17; POMMIER Y, 1988, CANCER RES, V48, P512; POMMIER Y, 1985, CANCER RES, V45, P3143; POMMIER Y, 1986, CANCER RES, V46, P3075; ROBINSON MJ, 1991, BIOCHEMISTRY-US, V30, P1807, DOI 10.1021/bi00221a012; ROBINSON MJ, 1990, BIOCHEMISTRY-US, V29, P2511, DOI 10.1021/bi00462a012; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SULLIVAN DM, 1989, BIOCHEMISTRY-US, V28, P5680, DOI 10.1021/bi00439a051; TAMURA JK, 1990, J BIOL CHEM, V265, P21342; TSAIPFLUGFELDER M, 1988, P NATL ACAD SCI USA, V85, P7177, DOI 10.1073/pnas.85.19.7177; VOELKELMEIMAN K, 1986, GENE, V42, P193, DOI 10.1016/0378-1119(86)90296-9; WALKER PR, 1991, CANCER RES, V51, P1078; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; WYCKOFF E, 1989, J MOL BIOL, V205, P1, DOI 10.1016/0022-2836(89)90361-6; YAMAGISHI J, 1986, MOL GEN GENET, V204, P367, DOI 10.1007/BF00331012	39	79	81	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2160	2165						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380592				2022-12-27	WOS:A1993KH62000099
J	OKAZAKI, O; GUENGERICH, FP				OKAZAKI, O; GUENGERICH, FP			EVIDENCE FOR SPECIFIC BASE CATALYSIS IN N-DEALKYLATION REACTIONS CATALYZED BY CYTOCHROME-P450 AND CHLOROPEROXIDASE - DIFFERENCES IN RATES OF DEPROTONATION OF AMINIUM RADICALS AS AN EXPLANATION FOR HIGH KINETIC HYDROGEN ISOTOPE EFFECTS OBSERVED WITH PEROXIDASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER MICROSOMAL CYTOCHROME-P-450; MECHANISM-BASED INACTIVATION; PROSTAGLANDIN-H SYNTHASE; MONOAMINE-OXIDASE; ELECTRON-TRANSFER; CATION RADICALS; OXIDATION; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; DEHYDROGENATION; PURIFICATION	Alkyamines are oxidized by a number of different types of enzymes, and the low oxidation potentials favor 1-electron transfer processes and aminium radicals. We studied the mechanism of N-dealkylation by hemoproteins using the prototypic substrate N,N-dimethylaniline (with isotopic substitution on the methyl groups), since there were considerable data available from kinetic deuterium isotope studies suggesting alternative mechanisms for different hemoproteins (Miwa, G. T., Walsh, J. S., Kedderis, G. L., and Hollenberg, P. F. (1983) J. Biol. Chem. 258, 14445-14449). Cytochrome P450 2B1 (P450), chloroperoxidase, and several biomimetic metalloporphyrin systems showed low kinetic hydrogen isotope effects (D(V/K)intra less-than-or-equal-to 2.0, T(V/K) less-than-or-equal-to 3.4), and hemoglobin, horseradish peroxidase, and prostaglandin H synthase yielded high isotope effects (D(V//K)intra greater-than-or-equal-to 3.5, T(V/K) greater-than-or-equal-to 8.1), in agreement with previous studies. Dinnocenzo and Banach (Dinnocenzo, J. P., and Banach, T. E. (1989) J. Am. Chem. Soc. 111, 8646-8653) have provided evidence that the pK(a) for an alpha-hydrogen of the N,N-dimethylaniline aminium radical is approximately 9 and also estimated that the pK(a) for the 4-hydrogen of a 1,4-dihydropyridine aminium radical is approximately 3.5. The oxidations of two model 1,4-dihydropyridines showed only low kinetic hydrogen isotope effects with all of the enzymes examined (D(V/K) less-than-or-equal-to 2.3, T(V/K) less-than-or-equal-to 2.8). Aminium radicals derived from aminopyrine and N,N-dimethylthioanisole accumulated only with those hemoprotein systems showing the high isotope effects with N,N-dimethylaniline. We conclude that specific base catalysis of alkyl hydrogen removal from aminium radicals by the (Fe.O)2+ complex is a feature of some hemoproteins, including P450s, and that the lack ot' such catalysis in other hemoproteins is the basis of their high kinetic hydrogen isotope effects.	VANDERBILT UNIV, MED CTR, SCH MED, DEPT BIOCHEM, NASHVILLE, TN 37232 USA; VANDERBILT UNIV, MED CTR, SCH MED, CTR MOLEC TOXICOL, NASHVILLE, TN 37232 USA	Vanderbilt University; Vanderbilt University					NATIONAL CANCER INSTITUTE [R35CA044353] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NCI NIH HHS [CA44353] Funding Source: Medline; NIEHS NIH HHS [ES00267] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ANNE A, 1992, J AM CHEM SOC, V114, P4694, DOI 10.1021/ja00038a036; ASHLEY PL, 1980, BIOCHEM BIOPH RES CO, V97, P660, DOI 10.1016/0006-291X(80)90315-0; AUGUSTO O, 1982, J BIOL CHEM, V257, P1288; BABA T, 1987, XENOBIOTICA, V17, P1029, DOI 10.3109/00498258709044201; BLANKE SR, 1988, J BIOL CHEM, V263, P18739; BOCKER RH, 1986, J MED CHEM, V29, P1596; BONDON A, 1989, J BIOL CHEM, V264, P1988; BORN JL, 1989, CHEM RES TOXICOL, V2, P57, DOI 10.1021/tx00007a010; BURKA LT, 1985, J AM CHEM SOC, V107, P2549, DOI 10.1021/ja00294a057; DEMONTELLANO PRO, 1987, ACCOUNTS CHEM RES, V20, P289; DEMONTELLANO PRO, 1992, ANNU REV PHARMACOL, V32, P89, DOI 10.1146/annurev.pharmtox.32.1.89; DINNOCENZO JP, 1989, J AM CHEM SOC, V111, P8646, DOI 10.1021/ja00205a014; FLEISCHER EB, 1971, J AM CHEM SOC, V93, P3162, DOI 10.1021/ja00742a012; FURNISS BS, 1978, VOGELS TXB PRACTICAL, P670; GRIFFIN BW, 1980, ARCH BIOCHEM BIOPHYS, V205, P543, DOI 10.1016/0003-9861(80)90137-X; GUENGERICH FP, 1988, J BIOL CHEM, V263, P8168; GUENGERICH FP, 1990, CHEM RES TOXICOL, V3, P21, DOI 10.1021/tx00013a004; GUENGERICH FP, 1984, J AM CHEM SOC, V106, P6446, DOI 10.1021/ja00333a071; GUENGERICH FP, 1980, ARCH BIOCHEM BIOPHYS, V205, P365, DOI 10.1016/0003-9861(80)90119-8; GUENGERICH FP, 1990, CRIT REV BIOCHEM MOL, V25, P97; GUENGERICH FP, 1990, FASEB J, V4, P2453, DOI 10.1096/fasebj.4.8.2185971; Guengerich FP, 1989, PRINCIPLES METHODS T, P777; GUENGERICH FP, 1992, IN PRESS ADV ELECTRO, V3; HAWKINS BK, 1992, J AM CHEM SOC, V114, P3547, DOI 10.1021/ja00035a059; HUSAIN M, 1982, BIOCHEMISTRY-US, V21, P595, DOI 10.1021/bi00532a028; KOBAYASHI S, 1987, BIOCHEMISTRY-US, V26, P5019, DOI 10.1021/bi00390a020; LEE JS, 1988, BIOCHEMISTRY-US, V27, P7703, DOI 10.1021/bi00420a020; LINDSAYSMITH JR, 1985, J CHEM SOC CHEM COMM, P64; MACDONALD TL, 1989, BIOCHEMISTRY-US, V28, P2071, DOI 10.1021/bi00431a016; MACDONALD TL, 1982, J AM CHEM SOC, V104, P2050, DOI 10.1021/ja00371a056; Marnett L. J., 1991, PEROXIDASES CHEM BIO, V1, P293; Marnett L.J., 1986, CYTOCHROME P 450 STR, P29; MARNETT LJ, 1984, MOL PHARMACOL, V26, P328; MCMAHON RE, 1969, J AM CHEM SOC, V91, P3389, DOI 10.1021/ja01040a060; MIWA GT, 1983, J BIOL CHEM, V258, P4445; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; NELSEN SF, 1986, J AM CHEM SOC, V108, P4879, DOI 10.1021/ja00276a028; NORTHROP DB, 1975, BIOCHEMISTRY-US, V14, P2644, DOI 10.1021/bi00683a013; NORTHROP DB, 1982, METHOD ENZYMOL, V87, P607; ODENWALLER R, 1990, METHOD ENZYMOL, V187, P479; OTTOBONI S, 1990, CHEM RES TOXICOL, V3, P423, DOI 10.1021/tx00017a006; OTTOBONI S, 1989, J BIOL CHEM, V264, P13684; PALMER G, 1992, J BIOL CHEM, V267, P665; PLE P, 1989, J BIOL CHEM, V264, P13983; Saltzman H., 1973, ORG SYNTH, P658; SHIMADA T, 1986, J BIOL CHEM, V261, P909; SHONO T, 1982, J AM CHEM SOC, V104, P2639, DOI 10.1021/ja00373a053; SILVERMAN RB, 1991, BIOCHEM SOC T, V19, P201, DOI 10.1042/bst0190201; WALSH CT, 1979, ENZYMATIC REACTION M; WILLIAMS DE, 1989, DRUG METAB DISPOS, V17, P387; YASUKOCHI Y, 1976, J BIOL CHEM, V251, P5337	51	95	96	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1546	1552						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380572				2022-12-27	WOS:A1993KH62000010
J	REBECCHI, MJ; EBERHARDT, R; DELANEY, T; ALI, S; BITTMAN, R				REBECCHI, MJ; EBERHARDT, R; DELANEY, T; ALI, S; BITTMAN, R			HYDROLYSIS OF SHORT ACYL CHAIN INOSITOL LIPIDS BY PHOSPHOLIPASE C-DELTA-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORCINE PANCREATIC PHOSPHOLIPASE-A2; BOVINE BRAIN CYTOSOL; INTERFACIAL ACTIVATION; BACILLUS-CEREUS; C ENZYMES; PURIFICATION; SEQUENCE; ZYMOGEN; FORMS; 4-PHOSPHATE	We investigated the relationship between substrate aggregation and activation of phosphoinositide-specific phospholipase C-delta1 (PLC-delta1), isolated from bovine brain cytosol. The inositol lipids 1,2-dibutyryl-sn-glycero-3-phosphoinositol (di-C4-PI), 1,2-dihexanoyl-sn-glycero-3-phosphoinositol (di-C6-PI), and 1,2-dioctanoyl-sn-glycero-3-phosphoinositol (di-C8-PI) were prepared from synthetic cytidine diphosphate diglyceride analogs in a reaction with myo-inositol catalyzed by yeast phosphatidylinositol synthase. All three lipids served as substrates for PLC-delta1 at concentrations significantly below their critical micelle concentration (cmc). Under these conditions, steps that might limit the reaction rate, such as membrane adsorption or penetration into the phospholipid surface, were eliminated. Below the cmc, the concentration of lipid substrate required to produce hydrolysis followed the order: di-C8-PI < di-C6-PI << di-C4-PI. Calcium was essential for hydrolysis of the short chain substrates at all lipid concentrations tested. The dependence of the reaction on calcium suggests that this ion activates PLC-delta1 at a step other than adsorption to or penetration of the membrane surface. As the concentration of di-C8-PI was raised above the cmc, the reaction velocity increased 2-3-fold. These results are consistent with the idea that micellar or bilayer aggregates of phosphoinositol are not required for PLC-catalyzed hydrolysis, although the reaction rate is enhanced by micelle formation.	CUNY QUEENS COLL,DEPT CHEM & BIOCHEM,FLUSHING,NY 11367	City University of New York (CUNY) System; Queens College NY (CUNY)	REBECCHI, MJ (corresponding author), SUNY STONY BROOK,DEPT PHYSIOL & BIOPHYS,STONY BROOK,NY 11794, USA.			Eberhardt, Robert/0000-0002-5076-7416	NHLBI NIH HHS [HL-16660] Funding Source: Medline; NIGMS NIH HHS [GM-43422] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016660, R01HL016660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043422, R29GM043422] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMSON AW, 1967, PHYSICAL CHEM SURFAC; AGRANOFF BW, 1969, BIOCH PREP, V10, P47; BANSAL VS, 1990, ANNU REV CELL BIOL, V6, P41, DOI 10.1146/annurev.cellbio.6.1.41; Bartfai T, 1979, Adv Cyclic Nucleotide Res, V10, P219; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BOYER JL, 1989, TRENDS PHARMACOL SCI, V10, P360, DOI 10.1016/0165-6147(89)90008-4; BRUZIK KS, 1992, BIOCHEMISTRY-US, V31, P5183, DOI 10.1021/bi00137a014; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CRUZRIVERA M, 1990, BIOCHIM BIOPHYS ACTA, V1042, P113, DOI 10.1016/0005-2760(90)90064-5; DEAN NM, 1987, BIOCHEM J, V242, P361, DOI 10.1042/bj2420361; DEHAAS GH, 1971, BIOCHIM BIOPHYS ACTA, V239, P252, DOI 10.1016/0005-2760(71)90171-8; Dennis EA, 1983, ENZYMES, P307; ELSAYED MY, 1985, BIOCHIM BIOPHYS ACTA, V837, P325, DOI 10.1016/0005-2760(85)90056-6; EMORI Y, 1989, J BIOL CHEM, V264, P21885; FISCHL AS, 1983, J BACTERIOL, V154, P304, DOI 10.1128/JB.154.1.304-311.1983; FUKUI T, 1988, J BIOL CHEM, V263, P17730; HARRISON SM, 1987, BIOCHIM BIOPHYS ACTA, V925, P133, DOI 10.1016/0304-4165(87)90102-4; HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7; HERRERO C, 1988, BIOCHEM J, V255, P807, DOI 10.1042/bj2550807; HILLE JDR, 1983, BIOCHEMISTRY-US, V22, P5347, DOI 10.1021/bi00292a014; HIRASAWA K, 1981, BIOCHEM J, V193, P607, DOI 10.1042/bj1930607; HOFMANN SL, 1982, J BIOL CHEM, V257, P6461; HOMMA Y, 1988, J BIOL CHEM, V263, P6592; HOUGH E, 1989, NATURE, V338, P357, DOI 10.1038/338357a0; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V1002, P127, DOI 10.1016/0005-2760(89)90281-6; KATAN M, 1988, CELL, V54, P171, DOI 10.1016/0092-8674(88)90549-1; LEE KY, 1987, P NATL ACAD SCI USA, V84, P5540, DOI 10.1073/pnas.84.16.5540; LEWIS KA, 1990, BIOCHEMISTRY-US, V29, P9962, DOI 10.1021/bi00494a029; MCDONALD LJ, 1989, BIOCHEMISTRY-US, V28, P9926, DOI 10.1021/bi00452a008; MCLAUGHLIN S, 1989, ANNU REV BIOPHYS BIO, V18, P113, DOI 10.1146/annurev.biophys.18.1.113; PETERSON A, 1991, BIOPHYS J, V59, P509; PIETERSON WA, 1974, BIOCHEMISTRY-US, V13, P1455, DOI 10.1021/bi00704a021; PREISS J, 1986, J BIOL CHEM, V261, P8597; REBECCHI MJ, 1987, J BIOL CHEM, V262, P12526; RHEE SG, 1991, TRENDS BIOCHEM SCI, V16, P297, DOI 10.1016/0968-0004(91)90122-C; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; RYU SH, 1987, J BIOL CHEM, V262, P12511; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; SEGEL IH, 1975, ENZYME KINETICS BHAV; Shinoda K., 1963, COLLOIDAL SURFACTANT; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; SUH PG, 1988, CELL, V54, P161, DOI 10.1016/0092-8674(88)90548-X; SUH PG, 1988, P NATL ACAD SCI USA, V85, P5415; Tanford C., 1973, HYDROPHOBIC EFFECT; TOUCHSTONE J C, 1981, Journal of High Resolution Chromatography and Chromatography Communications, V4, P423, DOI 10.1002/jhrc.1240040816; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2036; VANEIJK JH, 1983, EUR J BIOCHEM, V132, P183; VANOORT MG, 1985, BIOCHEMISTRY-US, V24, P7987, DOI 10.1021/bi00348a022; VERHEIJ HM, 1981, REV PHYSIOL BIOCH P, V91, P91; WAITE M, 1987, HDB LIPIDS RES, V5, P283; WELLS MA, 1974, BIOCHEMISTRY-US, V13, P2248, DOI 10.1021/bi00708a002; WILSON DB, 1984, J BIOL CHEM, V259, P1718; XU CJ, 1992, IN PRESS BIOCH BIOPH	55	44	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1735	1741						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380575				2022-12-27	WOS:A1993KH62000037
J	GREEN, TR; SHANGGUAN, XC				GREEN, TR; SHANGGUAN, XC			STOICHIOMETRY OF O2 METABOLISM AND NADPH OXIDATION OF THE CELL-FREE LATENT OXIDASE RECONSTITUTED FROM CYTOSOL AND SOLUBILIZED MEMBRANE FROM RESTING HUMAN NEUTROPHILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; CYTOCHROME B558; FATTY-ACIDS; OXIDOREDUCTASE; FLAVOPROTEIN; ACTIVATION; REDUCTION; SYSTEM; O-2	The stoichiometry of NADPH-dependent O2 consumption expressed by reconstituted latent oxidase obtained by combining cytosol and membrane fractions from resting human neutrophils with GTPgammaS and SDS in a cell-free assay was evaluated with regard to NADPH consumed and superoxide and H2O2 production. Oxidase activity monitored simultaneously by O2 uptake analysis using a Clark cell and O2 electrode for O2 consumption, and spectrally at 340 nm for NADPH oxidation, in the presence of excess superoxide dismutase and catalase, yielded an O2 uptake:NADPH consumption ratio of 0.51 +/- 0.04 (+/- 1 S.D., n = 6). In the presence of varying concentrations of ferricytochrome c in excess of 100 muM, and with exclusion of superoxide dismutase, the net rate of O2 consumption plateaued at approximately 6% of the rate seen with exclusion of ferricytochrome c from final assay mixtures. Cytosol and solubilized membrane fractions employed in these assays were devoid of endogenous superoxide trapping, or dismutase-like, activities. These results indicate that of the total O2 consumed, 94% is associated with direct univalent generation of superoxide. The remaining albeit low level of O2 consumption appears to be recovered in the form of H2O2 indicating that the cell-free oxidase reconstituted with SDS is capable of channeling electron equivalents through its redox sites in a highly controlled manner in ensuring that superoxide is its principal O2 reduction product concomitant with oxidation of NADPH.	OREGON HLTH SCI UNIV,DEPT BIOCHEM & MOLEC BIOL,PORTLAND,OR 97201	Oregon Health & Science University	GREEN, TR (corresponding author), VET ADM MED CTR,CLIN PATHOL SERV,PORTLAND,OR 97207, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027880] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-27880] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BABIOR BM, 1981, J BIOL CHEM, V256, P2321; BELLAVITE P, 1993, MOL CELL BIOL, V52, P17; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; CHIBA T, 1990, BIOCHEM BIOPH RES CO, V173, P376, DOI 10.1016/S0006-291X(05)81068-X; CROSS AR, 1985, BIOCHEM J, V226, P881, DOI 10.1042/bj2260881; CUPUY C, 1991, J BIOL CHEM, V266, P3739; CURNUTTE J T, 1990, Current Opinion in Pediatrics, V2, P907, DOI 10.1097/00008480-199010000-00010; GALLIN JI, 1990, JAMA-J AM MED ASSOC, V263, P1553; GREEN TR, 1988, J BIOL CHEM, V263, P5617; GREEN TR, 1981, BIOCHEMISTRY-US, V20, P7483, DOI 10.1021/bi00529a024; GREEN TR, 1986, J BIOL CHEM, V261, P6010; IIZUKA T, 1985, BIOCHEM BIOPH RES CO, V130, P621, DOI 10.1016/0006-291X(85)90462-0; ISOGAI Y, 1991, J BIOL CHEM, V266, P13481; KAKINUMA K, 1986, J BIOL CHEM, V261, P9426; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; LETO TL, 1990, SCIENCE, V248, P727, DOI 10.1126/science.1692159; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; MAKIN OR, 1986, J BIOL CHEM, V261, P1144; MCCORD JM, 1973, OXIDASES RELATED RED, V1, P51; NUNOI H, 1988, SCIENCE, V242, P1298, DOI 10.1126/science.2848319; ROTROSEN D, 1990, J BIOL CHEM, V265, P8745; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TANAKA T, 1987, BIOCHEM BIOPH RES CO, V144, P606, DOI 10.1016/S0006-291X(87)80009-8; TANAKA T, 1988, J BIOL CHEM, V263, P13670	24	6	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					857	861						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8380417				2022-12-27	WOS:A1993KG07700018
J	GRUBMEYER, C; SEGURA, E; DORFMAN, R				GRUBMEYER, C; SEGURA, E; DORFMAN, R			ACTIVE-SITE LYSINES IN OROTATE PHOSPHORIBOSYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; SALMONELLA-TYPHIMURIUM; ACID SEQUENCE; URA5 GENE; EXPRESSION; BINDING; CLONING	Orotate phosphoribosyltransferase (OPRTase; EC 2.4.2.10) catalyzes the formation of the nucleotide orotidine-5'-monophosphate from orotate and 5-phosphoribosyl-1-pyrophosphate (PRPP). The bacterial enzyme, unlike its mammalian homolog, is monofunctional and is a dimer of M(r) 23,000 subunits. The availability of large amounts of highly purified crystalline Salmonella typhimurium OPRTase have enabled us to begin structure/function studies on the enzyme. Like other phosphoribosyltransferases, OPRTase binds the highly charged MgPRPP complex, as well as anionic orotate, suggesting an active site containing basic residues. The S. typhimurium sequence (Scapin, G., Sacchettini, J. C., Dessen, A., Bhatia, M., and Grubmeyer, C. (1993) J. Mol. Biol. 230, 1304-1308) contains 12 lysine and 13 arginine residues, of which Lys-26, Arg-99, Lys-100, Lys-103, and Arg-156 are conserved as identities among the sequences of OPRTases from other organisms, with Lys-19 and Arg-161 replaced by the alternative basic residue in one or more sequences. The lysine modifier 2,4,6-trinitrobenzene sulfonate inactivated S. typhimurium OPRTase in a pseudo first-order process, and OMP and PRPP provided good protection against inactivation. Spectral quantitation of trinitrophenyl (TNP) group incorporation showed that inactivation was correlated with incorporation of one TNP group per subunit. Surprisingly, tryptic proteolysis followed by high performance liquid chromatography and amino acid sequence analysis revealed that four peptides, containing three distinct lysines, had been modified. Peptides modified at Lys-26, Lys-100 and Lys-103, as well as a doubly modified peptide containing TNP groups at Lys-100 and Lys-103, were identified. Inactivation kinetics showed that the 3 lysine residues were modified at equal rates. Protection studies demonstrated that Lys-26, and to a lesser extent Lys-100 and Lys-103, were protected against modification by OMP, whereas PRPP protected Lys-26, Lys-100 and Lys-103. Pyrophosphate protected Lys-100 and Lys-103. The results suggest active site locations for the sequence-conserved and TNP-modified lysine residues, with Lys-26 interacting with the ribose-5-phosphate moiety of OMP and PRPP, and Lys-100 and Lys-103 interacting with the pyrophosphate moiety of PRPP.	TEMPLE UNIV,HLTH SCI CTR,SCH MED,FELS RES INST,PHILADELPHIA,PA 19140	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	GRUBMEYER, C (corresponding author), TEMPLE UNIV,HLTH SCI CTR,SCH MED,DEPT BIOCHEM,PHILADELPHIA,PA 19140, USA.				NIGMS NIH HHS [GM-48623] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048623] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDRESEN PS, 1992, EUR J BIOCHEM, V204, P51; ASHTON RW, 1989, ARCH BIOCHEM BIOPHYS, V272, P421, DOI 10.1016/0003-9861(89)90236-1; BHATIA M, 1991, THESIS NEW YORK U NE; BHATIA MB, 1990, BIOCHEMISTRY-US, V29, P10480, DOI 10.1021/bi00498a009; BOYMARCOTTE E, 1984, MOL GEN GENET, V193, P406, DOI 10.1007/BF00382076; CHELSKY D, 1975, J BIOL CHEM, V250, P5669; DEMONTIGNY J, 1989, MOL GEN GENET, V215, P455, DOI 10.1007/BF00427043; GOITEIN RK, 1978, J BIOL CHEM, V253, P2963; HERSHEY HV, 1986, GENE, V43, P287, DOI 10.1016/0378-1119(86)90218-0; HOVEJENSEN B, 1986, J BIOL CHEM, V261, P6765; HUGHES KT, 1993, J BACTERIOL, V175, P479, DOI 10.1128/JB.175.2.479-486.1993; LIPMAN DJ, 1989, P NATL ACAD SCI USA, V86, P4412, DOI 10.1073/pnas.86.12.4412; Means G.E., 1971, CHEM MODIFICATION PR; MENTCH F, 1987, BIOCHEMISTRY-US, V26, P921, DOI 10.1021/bi00377a037; MUSICK WDL, 1981, CRC CR REV BIOCH MOL, V11, P1, DOI 10.3109/10409238109108698; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; POULSEN P, 1984, EMBO J, V3, P1783, DOI 10.1002/j.1460-2075.1984.tb02046.x; SCAPIN G, 1993, J MOL BIOL, V230, P1304, DOI 10.1006/jmbi.1993.1244; SCRUTTON MC, 1977, EUR J BIOCHEM, V76, P219, DOI 10.1111/j.1432-1033.1977.tb11587.x; SUTTLE DP, 1988, P NATL ACAD SCI USA, V85, P1754, DOI 10.1073/pnas.85.6.1754; TURCQ B, 1987, GENE, V53, P201, DOI 10.1016/0378-1119(87)90008-4; VINITSKY A, 1991, J BACTERIOL, V173, P536, DOI 10.1128/jb.173.2.536-540.1991	22	24	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20299	20304						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376388				2022-12-27	WOS:A1993LY01900058
J	MEYER, S; KRESBACH, G; HARING, P; SCHUMPPVONACH, B; CLEMETSON, KJ; HADVARY, P; STEINER, B				MEYER, S; KRESBACH, G; HARING, P; SCHUMPPVONACH, B; CLEMETSON, KJ; HADVARY, P; STEINER, B			EXPRESSION AND CHARACTERIZATION OF FUNCTIONALLY ACTIVE FRAGMENTS OF THE PLATELET GLYCOPROTEIN (GP) IB-IX COMPLEX IN MAMMALIAN-CELLS - INCORPORATION OF GP IB-ALPHA INTO THE CELL-SURFACE MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VONWILLEBRAND-FACTOR-BINDING; AMINO-ACID SEQUENCE; MONOCLONAL-ANTIBODIES; SHEAR RATE; PROTEIN; SUBENDOTHELIUM; IDENTIFICATION; ADHESION; THROMBIN; DOMAIN	The platelet glycoprotein Ib-IX complex (GP Ib-IX) is essential for the initial attachment of platelets to the wall of damaged arteries. In this study, an N-terminal fragment of human GP Ib(alpha) (residues 1-318), containing the ligand binding sites for von Willebrand factor (vWF) and thrombin, as well as the entire human GP Ib(alpha) were expressed in Chinese hamster ovary cells. The transfected cells secreted a 48- and a 110-kDa protein, respectively, into the supernatant. Both recombinant proteins were purified by immunoaffinity chromatography. The purified proteins bound soluble vWF in the presence of botrocetin as demonstrated in solid-phase binding assays. The dissociation constant (K(d)) for I-125-vWF binding to the recombinant 110-kDa protein was 1.2 +/- 0.2 nM as compared with 1.0 +/- 0.3 nM for vWF binding to purified platelet GP Ib-IX. Both recombinant proteins were also retained on thrombin-Sepharose 4B. The 48-kDa protein contained two N-linked oligosaccharide chains. A 125-kDa protein was identified in the lysate of cells transfected with the coding sequence for the entire GP Ib(alpha). Trypsin treatment of this protein generated a 110-kDa fragment, whereas the secreted 110-kDa protein remained unchanged. Post-translational removal of the C-terminal transmembrane domain of recombinant GP Ib(alpha) might have facilitated the secretion of the soluble glycocalicin-like 110-kDa fragment. In addition, flow cytometry and immunofluorescence microscopy demonstrated that the expression of GP Ib(alpha) alone is sufficient for its incorporation into the cell surface membrane. These data indicate that two soluble fragments of human GP Ib(alpha) with binding activity for vWF and thrombin can be expressed in mammalian cells and that the incorporation of GP Ib(alpha) into the surface membrane does not depend on co-expression with GP Ib(beta) and/or GP IX.	F HOFFMANN LA ROCHE & CO LTD, DIV PHARMA, PRECLIN RES, GRENZACHERSTR 124, CH-4002 BASEL, SWITZERLAND; UNIV BERN, THEODOR KOCHER INST, CH-3012 BERN, SWITZERLAND	Roche Holding; University of Bern								ANDREWS RK, 1991, J BIOL CHEM, V266, P7144; BAUMGARTNER HR, 1976, PLATELETS BIOL PATHO, P23; BERNDT MC, 1985, EUR J BIOCHEM, V151, P637, DOI 10.1111/j.1432-1033.1985.tb09152.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHOPEK MW, 1986, BIOCHEMISTRY-US, V25, P3146, DOI 10.1021/bi00359a012; CULLEN BR, 1986, CELL, V46, P973, DOI 10.1016/0092-8674(86)90696-3; FOX JEB, 1985, J BIOL CHEM, V260, P1060; FOX JEB, 1988, J BIOL CHEM, V263, P4882; FOX JEB, 1985, J BIOL CHEM, V260, P1970; FURLAN M, 1979, BIOCHIM BIOPHYS ACTA, V579, P325, DOI 10.1016/0005-2795(79)90060-6; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HANDA M, 1986, J BIOL CHEM, V261, P2579; HARING P, 1985, P NATL ACAD SCI USA, V82, P4837, DOI 10.1073/pnas.82.14.4837; HICKEY MJ, 1989, P NATL ACAD SCI USA, V86, P6773, DOI 10.1073/pnas.86.17.6773; KATAGIRI Y, 1990, THROMB HAEMOSTASIS, V63, P122; KAUFMAN RJ, 1982, J MOL BIOL, V159, P601, DOI 10.1016/0022-2836(82)90103-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOPEZ JA, 1987, P NATL ACAD SCI USA, V84, P5615, DOI 10.1073/pnas.84.16.5615; LOPEZ JA, 1988, P NATL ACAD SCI USA, V85, P2135, DOI 10.1073/pnas.85.7.2135; LOPEZ JA, 1992, J BIOL CHEM, V267, P12851; Montreuil J, 1980, Adv Carbohydr Chem Biochem, V37, P157; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MURATA M, 1991, J BIOL CHEM, V266, P15474; MURATA M, 1991, THROMB HAEMOSTASIS, V65, P771; OKUMURA T, 1976, J BIOL CHEM, V251, P5950; OKUMURA T, 1978, J BIOL CHEM, V253, P3435; PETERSEN E, 1992, THROMB HAEMOSTASIS, V68, P203; PHILLIPS DR, 1977, J BIOL CHEM, V252, P2121; RINGOLD G, 1981, Journal of Molecular and Applied Genetics, V1, P165; SAKARIASSEN KS, 1987, ANN NY ACAD SCI, V516, P52, DOI 10.1111/j.1749-6632.1987.tb33029.x; SUBRAMANI S, 1981, MOL CELL BIOL, V1, P854, DOI 10.1128/MCB.1.9.854; TAKATSUKI A, 1971, J ANTIBIOT, V24, P785, DOI 10.7164/antibiotics.24.785; TURITTO VT, 1977, ANN NY ACAD SCI, V283, P284, DOI 10.1111/j.1749-6632.1977.tb41775.x; URLAUB G, 1980, P NATL ACAD SCI-BIOL, V77, P4216, DOI 10.1073/pnas.77.7.4216; VICENTE V, 1988, J BIOL CHEM, V263, P18473; VICENTE V, 1990, J BIOL CHEM, V265, P274; WEISS HJ, 1974, AM J MED, V57, P920, DOI 10.1016/0002-9343(74)90170-3; WEISS HJ, 1978, J LAB CLIN MED, V92, P750; WENGER RH, 1988, BIOCHEM BIOPH RES CO, V156, P389, DOI 10.1016/S0006-291X(88)80853-2; WICKI AN, 1985, EUR J BIOCHEM, V153, P1, DOI 10.1111/j.1432-1033.1985.tb09259.x; WICKI AN, 1992, METHOD ENZYMOL, V215, P276	42	42	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20555	20562						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376410				2022-12-27	WOS:A1993LY01900091
J	WONG, I; AMARATUNGA, M; LOHMAN, TM				WONG, I; AMARATUNGA, M; LOHMAN, TM			HETERODIMER FORMATION BETWEEN ESCHERICHIA-COLI REP AND UVRD PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-INDUCED DIMERIZATION; HELICASE-II; GENE-PRODUCT; DUPLEX DNA; CIRCULAR DNA; REPLICATION; IDENTIFICATION; PURIFICATION; MECHANISMS; MUTATION	DNA helicases catalyze the essential process of unwinding duplex DNA to form the single-stranded DNA intermediates required for DNA metabolic processes including replication, recombination, and repair. Most cells, possibly all, encode multiple helicases that function selectively in different processes, although some helicases can complement each other in vivo. Thus, although Escherichia coli can survive mutations or deletions of either the uvrD gene (encoding Helicase II) or the rep gene (encoding Rep helicase) separately, deletion of both rep and uvrD genes is lethal (Washburn, B. K., and Kushner, S. R. (1991) J. Bacteriol. 173,2569-2575). The Rep and UvrD polypeptides share approximately 40% sequence homology, and we have previously shown that both form homodimeric species and that the Rep homodimer appears to be the functionally active helicase. We report here that these two proteins can also interact in vitro to form a heterodimer. The heterodimer appears to be energetically more stable than the Rep homodimer but less stable than the UvrD homodimer under our conditions. The observation of Rep/UvrD heterodimer formation in vitro opens up the intriguing possibility that the heterodimer may play a physiologically important role that is distinct from the role of the Rep or UvrD homodimers. Therefore, considerations of the role of either protein in DNA metabolic processes, such as replication and repair, must include a potential role for a Rep/UvrD heterodimer.	WASHINGTON UNIV, SCH MED,DEPT BIOCHEM & MOLEC BIOPHYS,BOX 8231, 660 S EUCLID AVE, ST LOUIS, MO 63110 USA	Washington University (WUSTL)					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045948] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45948, R01 GM045948] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABDELMONEM M, 1977, EUR J BIOCHEM, V79, P33, DOI 10.1111/j.1432-1033.1977.tb11780.x; ABDELMONEM M, 1983, P NATL ACAD SCI-BIOL, V80, P4659, DOI 10.1073/pnas.80.15.4659; ARTHUR HM, 1983, GENE, V25, P309, DOI 10.1016/0378-1119(83)90235-4; BRIDGES BA, 1981, MUTAT RES, V82, P229, DOI 10.1016/0027-5107(81)90152-4; CALENDAR R, 1970, VIROLOGY, V40, P72, DOI 10.1016/0042-6822(70)90380-6; CHAO KL, 1991, J MOL BIOL, V221, P1165, DOI 10.1016/0022-2836(91)80119-F; COLASANTI J, 1987, MOL GEN GENET, V209, P382, DOI 10.1007/BF00329669; DANIELS DL, 1992, SCIENCE, V257, P771, DOI 10.1126/science.1379743; DENHARDT DT, 1967, P NATL ACAD SCI USA, V57, P813, DOI 10.1073/pnas.57.3.813; GILCHRIST CA, 1987, NUCLEIC ACIDS RES, V15, P465, DOI 10.1093/nar/15.2.465; KLINKERT MQ, 1980, J BIOL CHEM, V255, P9746; KUHBN B, 1982, EUR J BIOCHEM, V125, P63; KUMURA K, 1984, J BIOL CHEM, V259, P1560; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LANE HED, 1974, J BACTERIOL, V120, P805, DOI 10.1128/JB.120.2.805-814.1974; LANE HED, 1975, J MOL BIOL, V97, P99; LI XY, 1992, CHROMOSOMA, V102, pS93, DOI 10.1007/BF02451791; LOHMAN TM, 1992, MOL MICROBIOL, V6, P5, DOI 10.1111/j.1365-2958.1992.tb00831.x; LOHMAN TM, 1988, BIOCHEMISTRY-US, V27, P2260, DOI 10.1021/bi00407a002; LOHMAN TM, 1989, J BIOL CHEM, V264, P10139; LOHMAN TM, 1993, J BIOL CHEM, V268, P2269; MATSON SW, 1991, PROG NUCLEIC ACID RE, V40, P289; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; MATSON SW, 1986, J BIOL CHEM, V261, P169; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; NAKAYAMA K, 1983, MOL GEN GENET, V192, P391, DOI 10.1007/BF00392180; ORREN DK, 1992, J BIOL CHEM, V267, P780; RUNYON GT, 1989, J BIOL CHEM, V264, P17502; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P602, DOI 10.1021/bi00053a028; SCOTT JF, 1978, J BIOL CHEM, V253, P3292; SCOTT JF, 1977, P NATL ACAD SCI USA, V74, P193, DOI 10.1073/pnas.74.1.193; SIEGEL EC, 1983, MOL GEN GENET, V191, P397, DOI 10.1007/BF00425753; THOMMES P, 1992, J BIOL CHEM, V267, P6063; THOMMES P, 1990, FEBS LETT, V268, P325, DOI 10.1016/0014-5793(90)81279-W; TSANEVA IR, 1993, P NATL ACAD SCI USA, V90, P1315, DOI 10.1073/pnas.90.4.1315; WASHBURN BK, 1991, J BACTERIOL, V173, P2569, DOI 10.1128/jb.173.8.2569-2575.1991; WONG I, 1992, J BIOL CHEM, V267, P7596; WONG I, 1992, SCIENCE, V256, P350, DOI 10.1126/science.256.5055.350; YARRANTON GT, 1979, P NATL ACAD SCI USA, V76, P1658, DOI 10.1073/pnas.76.4.1658	39	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20386	20391						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376396				2022-12-27	WOS:A1993LY01900070
J	KATZ, RW; KOENIG, RJ				KATZ, RW; KOENIG, RJ			NONBIASED IDENTIFICATION OF DNA-SEQUENCES THAT BIND THYROID-HORMONE RECEPTOR-ALPHA-1 WITH HIGH-AFFINITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID RECEPTORS; RESPONSE ELEMENTS; NUCLEAR RECEPTORS; GENE-EXPRESSION; T3 RECEPTOR; X-RECEPTOR; RXR-BETA; PROMOTER; PROTEIN; SITE	Thyroid hormone receptors are transcription factors that bind to specific DNA sequences and regulate gene expression in a ligand-dependent manner. Although thyroid hormone receptors are known to bind to the hexamer 5'-AGGTCA, it is not known if this represents the optimal binding site. Therefore, a nonbiased strategy was used to identify DNA sequences which bind thyroid hormone receptor alpha1 with high affinity. Such DNA sequences were isolated from a pool of random sequences using a strategy combining an electrophoretic mobility shift assay with the polymerase chain reaction. It was found that thyroid hormone receptor alpha1 binds with highest affinity to the octamer 5'-TAAGGTCA. Mutation of the two 5'-nucleotides decreased the affinity of thyroid hormone receptor alpha1 for this DNA sequence approximately 5-fold, and the importance of those nucleotides in receptor binding was confirmed by DNA footprinting. A single copy of the octamer sequence (but not the hexamer AGGTCA) could impart T3 responsiveness to a heterologous promoter in a transient transfection assay. The results indicate that the optimal binding site for thyroid hormone receptor alpha1 is 2 base pairs larger than previously thought, and that a single binding site can function as a response element. In addition, we speculate that the optimal binding sites for thyroid hormone, vitamin D, and retinoic acid receptors may not be identical, as had previously been thought.	UNIV MICHIGAN,MED CTR,DIV ENDOCRINOL,5560 MSRB II,1150 W MED CTR DR,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan					NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K11DE000301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044155] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE00301] Funding Source: Medline; NIDDK NIH HHS [DK44155] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ausubel FM, 1988, MOL REPROD DEV; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; BEYER HS, 1985, ENDOCRINOLOGY, V116, P2669, DOI 10.1210/endo-116-6-2669; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BRENT GA, 1992, MOL ENDOCRINOL, V6, P502, DOI 10.1210/me.6.4.502; BRENT GA, 1989, MOL ENDOCRINOL, V3, P1996, DOI 10.1210/mend-3-12-1996; CHATTERJEE VKK, 1989, P NATL ACAD SCI USA, V86, P9114, DOI 10.1073/pnas.86.23.9114; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FARSETTI A, 1992, J BIOL CHEM, V267, P15784; FLINK IL, 1990, J BIOL CHEM, V265, P11233; FORMAN BM, 1992, MOL ENDOCRINOL, V6, P429, DOI 10.1210/me.6.3.429; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; IZUMO S, 1988, NATURE, V334, P539, DOI 10.1038/334539a0; KIM HS, 1992, MOL ENDOCRINOL, V6, P1489, DOI 10.1210/me.6.9.1489; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; KOENIG RJ, 1988, P NATL ACAD SCI USA, V85, P5031, DOI 10.1073/pnas.85.14.5031; KOENIG RJ, 1987, P NATL ACAD SCI USA, V84, P5670, DOI 10.1073/pnas.84.16.5670; LARSEN PR, 1986, J BIOL CHEM, V261, P4373; LAZAR MA, 1991, MOL CELL BIOL, V11, P5005, DOI 10.1128/MCB.11.10.5005; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; MARKS MS, 1992, EMBO J, V11, P1419, DOI 10.1002/j.1460-2075.1992.tb05187.x; MITSUHASHI T, 1990, J BIOL CHEM, V265, P7395; MOORE DD, 1986, GENE AMST, V45, P107; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; ODONNELL AL, 1991, MOL ENDOCRINOL, V5, P94, DOI 10.1210/mend-5-1-94; PROST E, 1988, NUCLEIC ACIDS RES, V16, P6248, DOI 10.1093/nar/16.13.6248; PU WT, 1992, NUCLEIC ACIDS RES, V20, P771, DOI 10.1093/nar/20.4.771; ROSEN ED, 1992, J BIOL CHEM, V267, P22010; SAP J, 1990, EMBO J, V9, P887, DOI 10.1002/j.1460-2075.1990.tb08186.x; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; STRAHLE U, 1987, P NATL ACAD SCI USA, V84, P7871, DOI 10.1073/pnas.84.22.7871; TOPLISS DJ, 1983, ENDOCRINOLOGY, V112, P1868, DOI 10.1210/endo-112-5-1868; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; WILLIAMS GR, 1991, J BIOL CHEM, V266, P19636; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0; ZILZ ND, 1990, J BIOL CHEM, V265, P8136	37	97	97	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19392	19397						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366086				2022-12-27	WOS:A1993LW81900039
J	VONARNIM, AG; DENG, XW				VONARNIM, AG; DENG, XW			RING FINGER MOTIF OF ARABIDOPSIS-THALIANA COP1 DEFINES A NEW CLASS OF ZINC-BINDING DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEIC-ACID BINDING; MYC TRANSGENIC MICE; TRANSCRIPTION FACTOR; REGULATORY GENE; RAR-ALPHA; PROTEIN; EXPRESSION; SEQUENCE; ENCODES; TRANSLOCATION	The COP1 gene of Arabidopsis thaliana encodes a protein mediating the switch between the two developmental pathways utilized in light and darkness. A cysteine-rich motif identified the COP1 protein as a member of a group of regulatory proteins which share the amino acid motif Cys-X-X-Cys-loop I-Cys-X-His-X-X-Cys-X-X-Cys-loop II-Cys-X-X-Cys (ring finger). Although this new class of cysteine-rich motifs has been proposed to bind metal ions, no direct evidence supporting this has been presented. By analyzing the COP1 protein expressed in Escherichia coli, we demonstrate here that each COP1 molecule can bind up to two zinc atoms. The two zinc ions are bound with different affinities. One is tightly bound and resistant to urea and EDTA, whereas the other one is labile under those conditions. It is further shown that deletion of the ring finger motif abolishes the metal-binding capacity of COP1. We conclude that the ring finger motif constitutes a zinc-coordinating element distinct from previously characterized zinc-binding domains.	YALE UNIV, DEPT BIOL,OSBORN MEM LAB,POB 6666,165 PROSPECT ST, NEW HAVEN, CT 06511 USA	Yale University			Deng, Xing Wang/ABF-4107-2020	von Arnim, Albrecht/0000-0003-3472-3357	NIGMS NIH HHS [1R29-GM47850-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM047850] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELLINI M, 1993, EMBO J, V12, P107, DOI 10.1002/j.1460-2075.1993.tb05636.x; BERG JM, 1990, J BIOL CHEM, V265, P6513; BERG JM, 1986, SCIENCE, V232, P485, DOI 10.1126/science.2421409; BLAKE TJ, 1991, ONCOGENE, V6, P653; BRUNK BP, 1991, NUCLEIC ACIDS RES, V19, P3149, DOI 10.1093/nar/19.11.3149; DENG XW, 1992, CELL, V71, P791, DOI 10.1016/0092-8674(92)90555-Q; DENG XW, 1991, GENE DEV, V5, P1172, DOI 10.1101/gad.5.7.1172; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; FITZGERALD DW, 1991, BIOCHEMISTRY-US, V30, P5195, DOI 10.1021/bi00235a012; FREEMONT PS, 1991, CELL, V64, P483, DOI 10.1016/0092-8674(91)90229-R; FURST P, 1988, CELL, V55, P705, DOI 10.1016/0092-8674(88)90229-2; GIEDROC DP, 1986, P NATL ACAD SCI USA, V83, P8452, DOI 10.1073/pnas.83.22.8452; HANAS JS, 1983, J BIOL CHEM, V258, P4120; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; HAY RT, 1980, VIROLOGY, V104, P230, DOI 10.1016/0042-6822(80)90381-5; HUNT JB, 1984, J BIOL CHEM, V259, P4793; JONES JS, 1988, NUCLEIC ACIDS RES, V16, P7119, DOI 10.1093/nar/16.14.7119; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871; LI PM, 1991, P NATL ACAD SCI USA, V88, P9210, DOI 10.1073/pnas.88.20.9210; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; MIKI T, 1991, P NATL ACAD SCI USA, V88, P5167, DOI 10.1073/pnas.88.12.5167; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; PALMER G, 1975, ENZYMES, V12, P2; REDDY BA, 1991, NUCLEIC ACIDS RES, V19, P6330, DOI 10.1093/nar/19.22.6330; REDDY BA, 1991, DEV BIOL, V148, P107, DOI 10.1016/0012-1606(91)90321-S; TAGAWA M, 1990, J BIOL CHEM, V265, P20021; TAKAHASHI M, 1988, MOL CELL BIOL, V8, P1853, DOI 10.1128/MCB.8.4.1853; TAO P, 1990, P NATL ACAD SCI USA, V87, P2077, DOI 10.1073/pnas.87.6.2077; VALLEE BL, 1991, P NATL ACAD SCI USA, V88, P999, DOI 10.1073/pnas.88.3.999; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; VANLOHUIZEN M, 1991, NATURE, V353, P353, DOI 10.1038/353353a0; VANONI MA, 1992, BIOCHEMISTRY-US, V31, P4613, DOI 10.1021/bi00134a011	35	83	85	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19626	19631						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366106				2022-12-27	WOS:A1993LW81900074
J	LINK, E; MCMAHON, H; VONMOLLARD, GF; YAMASAKI, S; NIEMANN, H; SUDHOF, TC; JAHN, R				LINK, E; MCMAHON, H; VONMOLLARD, GF; YAMASAKI, S; NIEMANN, H; SUDHOF, TC; JAHN, R			CLEAVAGE OF CELLUBREVIN BY TETANUS TOXIN DOES NOT AFFECT FUSION OF EARLY ENDOSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RECEPTOR-MEDIATED ENDOCYTOSIS; MEMBRANE-PROTEINS; YEAST; VESICLES; POLYACRYLAMIDE; SYNAPTOBREVIN; NEUROTOXINS; TRANSPORT; BINDING; INVITRO	Tetanus toxin is a potent inhibitor of neurotransmitter release, which acts as an intracellular metalloendoprotease that selectively cleaves synaptobrevin, a major membrane protein of synaptic vesicles. Recently, synaptobrevin has been found to form an ATP-dependent complex with N-ethylmaleimide-sensitive fusion protein (NSF) and soluble NSF attachment protein, which are known to function in endosome fusion. Furthermore, a highly homologous isoform of synaptobrevin, named cellubrevin, was identified that is expressed in virtually all tissues in the endocytic pathway and is cleaved by tetanus toxin light chain in vitro, suggesting that cellubrevin may have a general function in intracellular fusion events. In the present study, we have analyzed whether cleavage of cellubrevin by tetanus toxin influences the ATP-dependent, N-ethylmaleimide-sensitive fusion of early endosomes in vitro. Our results show that endosome fusion is not affected by tetanus toxin although cellubrevin is almost completely proteolyzed, suggesting that the function of NSF in endosome fusion does not involve cellubrevin.	YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT CELL BIOL,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06510; UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235; BUNDESFORSCH ANSTALT VIRUSKRANKHEITEN TIERE,W-7400 TUBINGEN,GERMANY	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas				Jahn, Reinhard/0000-0003-1542-3498; Fischer von Mollard, Gabriele/0000-0003-3236-1401				ALKAISSI E, 1983, J IMMUNOL METHODS, V58, P127, DOI 10.1016/0022-1759(83)90269-7; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAELL WA, 1987, P NATL ACAD SCI USA, V84, P1137, DOI 10.1073/pnas.84.5.1137; BRAND SH, 1991, J BIOL CHEM, V266, P18949; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; DIAZ R, 1989, NATURE, V339, P398, DOI 10.1038/339398a0; GERST JE, 1992, P NATL ACAD SCI USA, V89, P4338, DOI 10.1073/pnas.89.10.4338; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; GRUENBERG JE, 1991, COURS MANUAL EMBO PR, P1; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINK E, 1992, BIOCHEM BIOPH RES CO, V189, P1017, DOI 10.1016/0006-291X(92)92305-H; MCMAHON H, 1993, NATURE, V364, P356; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; SATHYAMOORTHY V, 1985, J BIOL CHEM, V260, P10161; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1992, J BIOL CHEM, V267, P23479; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; TRIMBLE WS, 1991, ANNU REV NEUROSCI, V14, P93, DOI 10.1146/annurev.ne.14.030191.000521; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; WILSON DW, 1989, NATURE, V339, P355, DOI 10.1038/339355a0; [No title captured]	29	55	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18423	18426						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360142				2022-12-27	WOS:A1993LV65900007
J	URBANEK, M; RUSSELL, JE; COOKE, NE; LIEBHABER, SA				URBANEK, M; RUSSELL, JE; COOKE, NE; LIEBHABER, SA			FUNCTIONAL-CHARACTERIZATION OF THE ALTERNATIVELY SPLICED, PLACENTAL HUMAN GROWTH-HORMONE RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLACTIN RECEPTOR; MESSENGER-RNA; 20,000-DALTON VARIANT; OVERLAP EXTENSION; HUMAN-LYMPHOCYTES; GENE-EXPRESSION; BINDING-PROTEIN; XENOPUS OOCYTES; HUMAN-LIVER; CLONING	The human growth hormone family of peptide hormones is encoded by five genes, pituitary growth hormone (hGH-N), and four placentally expressed genes, growth hormone variant (hGH-V), chorionic somatomammotropin A and B (hCS-A, hCS-B), and prolactin (hPrl). As part of an effort to define the local effects of the placentally expressed members of the GH/Prl family of hormones on the placenta, we have identified an isoform (hGHRd3) of the growth hormone receptor expressed in the placental villi. hGHRd3 mRNA differs from the liver GHR mRNA by the deletion of a 66-base pair segment encoding exon 3. In this study we show that hGHRd3 mRNA encodes a stable and functional receptor. hGHRd3 mRNA is efficiently translated and processed in a rabbit reticulocyte lysate translation system as well as in an in vivo Xenopus laevis oocyte expression system. In Xenopus oocytes hGHRd3 is stably integrated into the cell membrane and binds and internalizes ligand as efficiently as hGHR. hGHRd3 binds all three of the placentally expressed members of the GH/Prl gene family (hGH-V, hCS, and Prl) as well as both the 22 and 20 kDa isoforms of the pituitary hGH-N. The results of the present study strongly support the expression of a functional hGHRd3 isoreceptor in the placenta which may serve in autocrine, paracrine, and/or endocrine activation.	UNIV PENN, DEPT GENET, RM 437A, CLIN RES BLDG, 422 CURIE BLVD, PHILADELPHIA, PA 19104 USA; UNIV PENN, DEPT MED, PHILADELPHIA, PA 19104 USA; UNIV PENN, HOWARD HUGHES MED INST, PHILADELPHIA, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania				Urbanek, Margrit/0000-0001-6994-7110				ADAMS TE, 1990, MOL CELL ENDOCRINOL, V73, P135, DOI 10.1016/0303-7207(90)90126-S; ALI S, 1992, MOL ENDOCRINOL, V6, P1242, DOI 10.1210/me.6.8.1242; BASS SH, 1991, P NATL ACAD SCI USA, V88, P4498, DOI 10.1073/pnas.88.10.4498; BAUMANN G, 1990, J CLIN ENDOCR METAB, V71, P1339, DOI 10.1210/jcem-71-5-1339; BOUTIN JM, 1988, CELL, V53, P69, DOI 10.1016/0092-8674(88)90488-6; CHIBA T, 1993, NATURE, V362, P646, DOI 10.1038/362646a0; CIOFFI JA, 1990, NUCLEIC ACIDS RES, V18, P6451, DOI 10.1093/nar/18.21.6451; CLEMENTS J, 1983, ENDOCRINOLOGY, V112, P1133, DOI 10.1210/endo-112-3-1133; CLOSSET J, 1983, BIOCHEM J, V214, P885, DOI 10.1042/bj2140885; COLEMAN A, 1984, TRANSCRIPTION TRANSL, P271; COOKE NE, 1988, J BIOL CHEM, V263, P9001; COOKE NE, 1988, J CLIN INVEST, V82, P270, DOI 10.1172/JCI113582; COOKE NE, 1991, TROP RES, V5, P61; COOKE NE, 1993, IN PRESS ENDOCRINOLO; COSMAN D, 1990, TRENDS BIOCHEM SCI, V15, P265, DOI 10.1016/0968-0004(90)90051-C; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; DAVIS JA, 1989, MOL ENDOCRINOL, V3, P674, DOI 10.1210/mend-3-4-674; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DIMATTIA GE, 1990, J BIOL CHEM, V265, P16412; DOHERTY P, 1992, NATURE, V356, P791, DOI 10.1038/356791a0; DUQUESNOY P, 1991, P NATL ACAD SCI USA, V88, P10272, DOI 10.1073/pnas.88.22.10272; EDERY M, 1989, P NATL ACAD SCI USA, V86, P2112, DOI 10.1073/pnas.86.6.2112; ESTES PA, 1992, J BIOL CHEM, V267, P14902; FOSTER CM, 1988, BIOCHEMISTRY-US, V27, P326, DOI 10.1021/bi00401a049; FRANKENNE F, 1988, J CLIN ENDOCR METAB, V69, P1069; FUH G, 1990, J BIOL CHEM, V265, P3111; GEORGE DL, 1981, HUM GENET, V57, P138; GODOWSKI PJ, 1989, P NATL ACAD SCI USA, V86, P8083, DOI 10.1073/pnas.86.20.8083; Gurdon J. B., 1986, MICROINJECTION ORGAN, P269; HAUSER SD, 1990, MOL CELL ENDOCRINOL, V72, P187, DOI 10.1016/0303-7207(90)90143-V; HILL DJ, 1992, J CLIN ENDOCR METAB, V75, P646, DOI 10.1210/jc.75.2.646; HOCQUETTE JF, 1989, ENDOCRINOLOGY, V125, P2167, DOI 10.1210/endo-125-4-2167; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; HUEZ G, 1986, MICROINJECTION ORGAN, P327; KELLY PA, 1991, ENDOCR REV, V12, P235, DOI 10.1210/edrv-12-3-235; KOSTYO JL, 1987, BIOCHIM BIOPHYS ACTA, V925, P314, DOI 10.1016/0304-4165(87)90197-8; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1988, MOL CELL BIOL, V8, P2737, DOI 10.1128/MCB.8.7.2737; LESNIAK MA, 1977, J CLIN ENDOCR METAB, V44, P838, DOI 10.1210/jcem-44-5-838; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; LIEBHABER SA, 1986, J BIOL CHEM, V261, P14301; LIEBHABER SA, 1984, J BIOL CHEM, V259, P5597; LIEBHABER SA, 1989, J CLIN INVEST, V83, P1985, DOI 10.1172/JCI114108; LINNEKIN D, 1992, BLOOD, V80, P1896; LONDON IM, 1987, ENZYMES, V18, P359; MCCARTER J, 1990, MOL CELL ENDOCRINOL, V73, P11, DOI 10.1016/0303-7207(90)90039-B; MOLDAVE K, 1985, ANNU REV BIOCHEM, V54, P1109, DOI 10.1146/annurev.biochem.54.1.1109; MOSIER HD, 1982, HORM METAB RES, V14, P440; NAKAMURA Y, 1992, SCIENCE, V257, P1138, DOI 10.1126/science.257.5073.1138; OWERBACH D, 1981, SCIENCE, V212, P815, DOI 10.1126/science.7221563; PEACOCK SL, 1988, J BIOL CHEM, V263, P7838; PELLEGRINI I, 1992, MOL ENDOCRINOL, V6, P1023, DOI 10.1210/me.6.7.1023; PHILLIPS JA, 1989, ADV HUM GENET, V18, P305; PIN JP, 1992, P NATL ACAD SCI USA, V89, P10331, DOI 10.1073/pnas.89.21.10331; RATNER L, 1987, NUCLEIC ACIDS RES, V15, P6017, DOI 10.1093/nar/15.15.6017; RAY J, 1990, J BIOL CHEM, V265, P7939; RODRIGUEZ MC, 1992, MOL ENDOCRINOL, V6, P327, DOI 10.1210/me.6.3.327; ROUPAS P, 1989, MOL CELL ENDOCRINOL, V61, P1, DOI 10.1016/0303-7207(89)90184-6; Sambrook J, 1989, MOL CLONING LABORATO; SHUI RPC, 1973, J CLIN ENDOCR METAB, V37, P334; SIGEL MB, 1981, ENDOCRINOLOGY, V108, P1600, DOI 10.1210/endo-108-4-1600; SMAL J, 1985, BIOCHEM J, V225, P283, DOI 10.1042/bj2250283; SMAL J, 1987, J BIOL CHEM, V262, P11071; SMITH WC, 1989, MOL ENDOCRINOL, V3, P984, DOI 10.1210/mend-3-6-984; SOKKA T, 1992, ENDOCRINOLOGY, V130, P1738, DOI 10.1210/en.130.3.1738; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; SPENCER EM, 1981, ENDOCRINOLOGY, V109, P1301, DOI 10.1210/endo-109-4-1301; Spencer S A, 1990, Recent Prog Horm Res, V46, P165; TAGA T, 1992, FASEB J, V6, P3387, DOI 10.1096/fasebj.6.15.1334470; URBANEK M, 1992, MOL ENDOCRINOL, V6, P279, DOI 10.1210/me.6.2.279; WALKER WH, 1991, ENDOCR REV, V12, P316, DOI 10.1210/edrv-12-4-316; WILHELMI AE, 1961, CAN J BIOCHEM PHYS, V39, P1659, DOI 10.1139/o61-183	73	74	83	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					19025	19032						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360189				2022-12-27	WOS:A1993LV65900097
J	AULAK, KS; ELDERING, E; HACK, CE; LUBBERS, YPT; HARRISON, RA; MAST, A; CICARDI, M; DAVIS, AE				AULAK, KS; ELDERING, E; HACK, CE; LUBBERS, YPT; HARRISON, RA; MAST, A; CICARDI, M; DAVIS, AE			A HINGE REGION MUTATION IN C1-INHIBITOR (ALA(436)-]THR) RESULTS IN NONSUBSTRATE-LIKE BEHAVIOR AND IN POLYMERIZATION OF THE MOLECULE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN C1 INHIBITOR; HEREDITARY ANGIONEUROTIC-EDEMA; ALPHA-1-PROTEINASE INHIBITOR; REACTIVE CENTER; CRYSTAL-STRUCTURE; ANTITHROMBIN-III; LIMITED PROTEOLYSIS; CL-INHIBITOR; CONFORMATIONAL TRANSITION; C1BAR INHIBITOR	C1-inhibitor(Mo), a dysfunctional C1-inhibitor molecule produced in two kindred with type II hereditary angioedema, has a mutation at the P10 position (Ala436 to Thr). Like most serpins with hinge region mutations (P14, P12, P10), C1-inhibitor(Mo) loses its inhibitory activity. However, unlike the other hinge region mutations, this mutant is not converted to a substrate. As shown by nondenaturing gel electrophoresis, gel filtration, sucrose density gradient ultracentrifugation, and electron microscopy, C1-inhibitor(Mo) exists in both monomeric and multimeric forms. Polymerization probably results from reactive center loop insertion into the A sheet of an adjacent molecule. Native C1-inhibitor(Mo) was shown to have a thermal stability profile intermediate to those of intact and of cleaved normal C1-inhibitor. Native C1-inhibitor(Mo) did not bind to monoclonal antibody KII, which binds only to reactive center-cleaved normal C1-inhibitor. It did, however, react with monoclonal antibody KOK12, which recognizes complexed or cleaved C1-inhibitor but not intact normal C1-inhibitor. Native C1-inhibitor(Mo), therefore, exists in a conformation similar to the complexed form of normal C1-inhibitor.	UNIV CINCINNATI,COLL PHARM,DEPT PEDIAT,CINCINNATI,OH 45229; NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,EXPTL & CLIN IMMUNOL LAB,AMSTERDAM,NETHERLANDS; MRC,MOLEC IMMUNOPATHOL UNIT,CAMBRIDGE CB2 2QH,ENGLAND; WASHINGTON UNIV,MED CTR,DIV LAB MED,ST LOUIS,MO 63110; UNIV MILAN,INST MED INTERNA,MED CLIN 111,I-20122 MILAN,ITALY	University System of Ohio; University of Cincinnati; University of Amsterdam; Washington University (WUSTL); University of Milan	AULAK, KS (corresponding author), CHILDRENS HOSP RES FDN,DIV NEPHROL,CINCINNATI,OH 45229, USA.		Levi, Marcel/AAZ-8559-2020; cicardi, marco/K-9219-2016	cicardi, marco/0000-0003-1251-225X; Harrison, Richard Alexander/0000-0002-2408-6043	NCRR NIH HHS [S10 RR05815] Funding Source: Medline; NHLBI NIH HHS [HL34779] Funding Source: Medline; NICHD NIH HHS [HD22082] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD022082, R01HD022082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR005815] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034779] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AARDEN LA, 1976, J IMMUNOL METHODS, V1, P27; AULAK KS, 1988, BIOCHEM J, V253, P615, DOI 10.1042/bj2530615; AULAK KS, 1989, THESIS U CAMBRIDGE C; AUSTIN RC, 1991, BLOOD, V77, P2185; AUSTIN RC, 1991, FEBS LETT, V280, P254, DOI 10.1016/0014-5793(91)80305-M; BAUMANN U, 1991, J MOL BIOL, V218, P595, DOI 10.1016/0022-2836(91)90704-A; BJORK I, 1992, J BIOL CHEM, V267, P1976; BOCK SC, 1986, BIOCHEMISTRY-US, V25, P4292, DOI 10.1021/bi00363a018; Bode W, 1991, CURR OPIN STRUC BIOL, V1, P45, DOI 10.1016/0959-440X(91)90010-Q; BRUCH M, 1988, J BIOL CHEM, V263, P16626; CARRELL RW, 1991, NATURE, V353, P576, DOI 10.1038/353576a0; CARRELL RW, 1987, COLD SPRING HARB SYM, V52, P527, DOI 10.1101/SQB.1987.052.01.060; CASO R, 1991, BRIT J HAEMATOL, V77, P87, DOI 10.1111/j.1365-2141.1991.tb07953.x; CICARDI M, 1987, J CLIN INVEST, V80, P1640, DOI 10.1172/JCI113252; COX DW, 1986, FEBS LETT, V205, P255, DOI 10.1016/0014-5793(86)80908-5; CUGNO M, 1990, J CLIN INVEST, V85, P1215, DOI 10.1172/JCI114555; DAVIS AE, 1992, NAT GENET, V1, P354, DOI 10.1038/ng0892-354; DAVIS AE, 1986, P NATL ACAD SCI USA, V83, P3161, DOI 10.1073/pnas.83.10.3161; DEAGOSTINI A, 1988, J CLIN INVEST, V82, P700, DOI 10.1172/JCI113650; DELARUE M, 1990, ACTA CRYSTALLOGR B, V46, P550, DOI 10.1107/S0108768190001689; ELDERING E, 1992, J BIOL CHEM, V267, P7013; ELDERING E, 1988, J BIOL CHEM, V263, P11776; ENGH RA, 1990, PROTEIN ENG, V3, P469, DOI 10.1093/protein/3.6.469; GETTINS P, 1989, J BIOL CHEM, V264, P3781; HARIS PI, 1990, BIOCHEMISTRY-US, V29, P1377, DOI 10.1021/bi00458a005; HARRISON RA, 1983, BIOCHEMISTRY-US, V22, P5001, DOI 10.1021/bi00290a019; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; IRELAND H, 1991, BRIT J HAEMATOL, V79, P70, DOI 10.1111/j.1365-2141.1991.tb08009.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LENNICK M, 1985, BIOCHEMISTRY-US, V24, P2561, DOI 10.1021/bi00331a025; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; MAST AE, 1992, BIOCHEMISTRY-US, V31, P2720, DOI 10.1021/bi00125a012; MAST AE, 1991, BIOCHEMISTRY-US, V30, P1723, DOI 10.1021/bi00220a039; NUIJENS JH, 1989, J CLIN INVEST, V84, P443, DOI 10.1172/JCI114185; NUIJENS JH, 1988, BLOOD, V72, P1841; NUIJENS JH, 1987, IMMUNOLOGY, V61, P387; ODERMATT E, 1981, FEBS LETT, V131, P283, DOI 10.1016/0014-5793(81)80385-7; PEMBERTON PA, 1989, BIOCHEM J, V258, P193, DOI 10.1042/bj2580193; PERRY DJ, 1991, FEBS LETT, V285, P248, DOI 10.1016/0014-5793(91)80809-H; REBOUL A, 1987, BIOCHEM J, V244, P117, DOI 10.1042/bj2440117; SALVESEN GS, 1985, J BIOL CHEM, V260, P2432; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHOENBERGER OL, 1989, FEBS LETT, V259, P165, DOI 10.1016/0014-5793(89)81519-4; SCHULZE AJ, 1991, EUR J BIOCHEM, V202, P1147, DOI 10.1111/j.1432-1033.1991.tb16483.x; SCHULZE AJ, 1990, EUR J BIOCHEM, V194, P51, DOI 10.1111/j.1432-1033.1990.tb19425.x; SKRIVER K, 1991, J BIOL CHEM, V266, P9216; STEIN P, 1991, J MOL BIOL, V221, P615, DOI 10.1016/0022-2836(91)80076-7; STEIN PE, 1989, BIOCHEM J, V262, P103, DOI 10.1042/bj2620103; STEIN PE, 1990, NATURE, V347, P99, DOI 10.1038/347099a0; TOSI M, 1986, GENE, V42, P265, DOI 10.1016/0378-1119(86)90230-1; WRIGHT HT, 1990, J MOL BIOL, V213, P513; XIAOMING P, 1992, THROMB HAEMOSTASIS, V65, P1212	54	105	106	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18088	18094						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349686				2022-12-27	WOS:A1993LT74300067
J	SIMON, TC; ROTH, KA; GORDON, JI				SIMON, TC; ROTH, KA; GORDON, JI			USE OF TRANSGENIC MICE TO MAP CIS-ACTING ELEMENTS IN THE LIVER FATTY-ACID-BINDING PROTEIN GENE (FABPL) THAT REGULATE ITS CELL LINEAGE-SPECIFIC, DIFFERENTIATION-DEPENDENT, AND SPATIAL PATTERNS OF EXPRESSION IN THE GUT EPITHELIUM AND IN THE LIVER ACINUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE SMALL-INTESTINE; TISSUE-SPECIFIC EXPRESSION; HORMONE FUSION GENES; NUCLEAR FACTOR-I; STEM-CELL; NUCLEOTIDE-SEQUENCE; TRANSCRIPTION FACTORS; GLUTAMINE-SYNTHETASE; ACTIVATED RECEPTOR; RAT-LIVER	Axial pattern formation is sustained in the mammalian gut epithelium despite rapid and continuous renewal of its four principal cell lineages. The mouse and rat liver fatty acid-binding protein (L-FABP) genes (Fabpl) represent an excellent model for understanding the mechanisms that determine differentiation-dependent, cell lineage-specific, and distinct regional patterns of expression along the crypt-to-villus and duodenal-to-ileal axes of the gut, as well as within the liver acinus. We have used transgenic mice to map cis-acting elements in rat Fabpl that control these patterns of gene expression. Seven transgenes were analyzed, representing sequential deletions of the 5'-nontranscribed domain of Fabpl linked to the human growth hormone (hGH) gene beginning at its nucleotide +3 (L-FABP/hGH+3). Several pedigrees of mice containing each one of the L-FABP/hGH+3 transgenes were examined at the end of their 8th and 20th weeks of postnatal life using immunocytochemical and RNA hybridization analyses. A remarkably compact sequence spanning nucleotides -132 to +21 of Fabpl is sufficient to establish and maintain a distribution of reporter mRNA and protein in villus-associated enterocytes located along the duodenal-to-ileal axis of the gut that resembles the pattern of expression of the endogenous Fabpl gene. L-FABP-132 to +21/hGH+3 is also expressed in surface and pit mucous cells of gastric units and in enterocytes located in the colonic homologs of small intestinal villi, the surface epithelial cuffs. This pattern of transgene expression in the stomach and colon recapitulates that of the intact endogenous donor rat Fabpl but not that of mouse Fabpl, which is silent in these proximal and distal segments of the gastrointestinal tract. Analysis of mice containing L-FABP-4000 to +21/hGH+3, L-FABP-1600 to +21/hGH+3, L-FABP-596 to +21/hGH+3, L-FABP-246 to +21 /hGH+3, and L-FABP-186 to +21/hGH+3 indicate that Fabpl's cephalocaudal gradient is influenced by cis-acting suppressors of cecal and colonic expression located between nucleotides -4000 and -1600 and by cis-acting activators of cecal and colonic expression located between nucleotides -597 and -351. L-FABP-132 to +21/hGH+3 is precociously activated in proliferating and nonproliferating epithelial cells located in intestinal crypts. The suppressor(s) of L-FABP accumulation in crypt epithelial cell populations are not represented between nucleotides -4000 and +21, indicating that different cis-acting sequences regulate regional and differentiation-dependent patterns of Fabpl expression. This conclusion is similar to one we recently made after using transgenic mice to map cis-acting transcriptional regulatory elements in the homologous rat intestinal fatty acid-binding protein gene (Fabpi). L-FABP/hGH+3 transgenes are inappropriately expressed in a variety of enteroendocrine cell subpopulations. At least seven functionally distinguishable cis-acting elements, distributed between nucleotides -4000 and +21, affect the number of enteroendocrine cells that support Fabpl expression. L-FABP/hGH+3 transgenes also direct a zonal pattern of hGH accumulation in the hepatocyte populations of liver acini that resembles that of Fabpl. Finally, Fabpl contains a peroxisome proliferator response element located between nucleotides -75 and -66. L-FABP-132 to +21/hGH+3 mice given chow supplemented with clofibrate, a hypolipidemic drug that induces peroxisomal proliferation, exhibit increases in transgene expression in the liver that parallel those of Fabpl, indicating that these animals represent a model for studying how fibrates regulate gene transcription.	WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,BOX 8103,660 S EUCLID AVE,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030292, R01DK030292] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK30292] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALNAFUSSI AI, 1982, VIRCHOWS ARCH B, V40, P51, DOI 10.1007/BF02932850; ARBER N, 1988, LIVER, V8, P80; BASS NM, 1985, J BIOL CHEM, V260, P1432; BASS NM, 1990, MOL CELL BIOCHEM, V98, P167; BAUMHUETER S, 1990, GENE DEV, V4, P372, DOI 10.1101/gad.4.3.372; BECK F, 1992, P ROY SOC B-BIOL SCI, V247, P83, DOI 10.1098/rspb.1992.0012; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; BJERKNES M, 1981, AM J ANAT, V160, P77, DOI 10.1002/aja.1001600107; BLUMENFELD M, 1991, DEVELOPMENT, V113, P589; BOWMAN LH, 1981, NUCLEIC ACIDS RES, V9, P4951, DOI 10.1093/nar/9.19.4951; BRINKMANN W, 1972, HISTOCHEMISTRY, V30, P335, DOI 10.1007/BF00279783; BROOKS AR, 1992, MOL CELL BIOL, V12, P1134, DOI 10.1128/MCB.12.3.1134; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; CHENG H, 1974, AM J ANAT, V141, P481, DOI 10.1002/aja.1001410404; CHENG H, 1985, ANAT REC, V211, P420, DOI 10.1002/ar.1092110408; CHENG H, 1974, AM J ANAT, V141, P503, DOI 10.1002/aja.1001410405; CHENG H, 1974, AM J ANAT, V141, P521, DOI 10.1002/aja.1001410406; CHWALINSKI S, 1988, CELL TISSUE KINET, V21, P317, DOI 10.1111/j.1365-2184.1988.tb00790.x; COHN SM, 1984, J BIOL CHEM, V259, P2456; COHN SM, 1992, J CELL BIOL, V119, P27, DOI 10.1083/jcb.119.1.27; COHN SM, 1991, P NATL ACAD SCI USA, V88, P1034, DOI 10.1073/pnas.88.3.1034; DEMMER LA, 1987, J BIOL CHEM, V262, P2458; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EVANS GS, 1992, J CELL SCI, V101, P219; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GHOSH D, 1992, NUCLEIC ACIDS RES, V20, P2091, DOI 10.1093/nar/20.suppl.2091; GHOSH D, 1990, NUCLEIC ACIDS RES, V18, P1749, DOI 10.1093/nar/18.7.1749; GORDON JI, 1983, J BIOL CHEM, V258, P3356; GORDON JI, 1992, FASEB J, V6, P3039, DOI 10.1096/fasebj.6.12.1521737; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; GREEN RP, 1992, DNA CELL BIOL, V11, P31, DOI 10.1089/dna.1992.11.31; GREEN S, 1992, BIOCHEM PHARMACOL, V43, P393, DOI 10.1016/0006-2952(92)90554-V; GRIFFITHS DFR, 1988, NATURE, V333, P461, DOI 10.1038/333461a0; HANSBROUGH JR, 1991, AM J PHYSIOL, V260, pG929, DOI 10.1152/ajpgi.1991.260.6.G929; HARDON EM, 1988, EMBO J, V7, P1711, DOI 10.1002/j.1460-2075.1988.tb03000.x; HASSOUNA N, 1984, NUCLEIC ACIDS RES, V12, P3563, DOI 10.1093/nar/12.8.3563; HAUFT SM, 1989, J BIOL CHEM, V264, P8419; HERMISTON ML, 1992, J HISTOCHEM CYTOCHEM, V40, P1283, DOI 10.1177/40.9.1506665; Hogan B, 1986, MANIPULATING MOUSE E, P1; IMMERGLUCK K, 1990, CELL, V62, P261, DOI 10.1016/0092-8674(90)90364-K; ISEKI S, 1989, CELL TISSUE RES, V257, P545, DOI 10.1007/BF00221464; ISEKI S, 1991, ANAT REC, V229, P51, DOI 10.1002/ar.1092290107; ISEKI S, 1990, ACTA ANAT, V138, P15, DOI 10.1159/000146915; Isomaki AM, 1973, ACTA PATHOL MICR A S, V240, P1; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; KARAM SM, 1993, ANAT RECORD, V236, P280, DOI 10.1002/ar.1092360203; KARAM SM, 1993, ANAT REC, V236, P314, DOI 10.1002/ar.1092360205; KARAM SM, 1993, ANAT REC, V236, P333, DOI 10.1002/ar.1092360206; KARAM SM, 1993, ANAT REC, V236, P297, DOI 10.1002/ar.1092360204; KARAM SM, 1993, ANAT REC, V236, P259, DOI 10.1002/ar.1092360202; KUO CF, 1989, J MOL BIOL, V208, P45, DOI 10.1016/0022-2836(89)90086-7; KUO FC, 1991, P NATL ACAD SCI USA, V88, P9468, DOI 10.1073/pnas.88.21.9468; KUO FC, 1991, MOL CELL BIOL, V11, P6050, DOI 10.1128/MCB.11.12.6050; LAMB P, 1991, TRENDS BIOCHEM SCI, V16, P417, DOI 10.1016/0968-0004(91)90167-T; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; LEE ER, 1982, AM J ANAT, V164, P187, DOI 10.1002/aja.1001640302; LEVIN MS, 1987, J BIOL CHEM, V262, P7118; LI E, 1986, P NATL ACAD SCI USA, V83, P5779, DOI 10.1073/pnas.83.16.5779; MCKEEL DW, 1978, ARCH PATHOL LAB MED, V102, P122; MENDEL DB, 1991, J BIOL CHEM, V266, P677; MESSIER B, 1960, AM J ANAT, V106, P247, DOI 10.1002/aja.1001060305; NABEYAMA A, 1974, AM J ANAT, V140, P147, DOI 10.1002/aja.1001400203; OBUOFORIBO AA, 1977, J ANAT, V24, P779; OLSEN J, 1991, J BIOL CHEM, V266, P18089; ORKIN SH, 1992, BLOOD, V80, P575; PAULSON KE, 1990, MOL CELL BIOL, V10, P1841, DOI 10.1128/MCB.10.5.1841; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; RAY D, 1992, MOL CELL BIOL, V12, P4297, DOI 10.1128/MCB.12.10.4297; REUTER R, 1990, DEVELOPMENT, V110, P1031; REYCAMPOS J, 1991, EMBO J, V10, P1445, DOI 10.1002/j.1460-2075.1991.tb07665.x; ROTH KA, 1990, P NATL ACAD SCI USA, V87, P6408, DOI 10.1073/pnas.87.16.6408; ROTH KA, 1992, AM J PHYSIOL, V263, pG174, DOI 10.1152/ajpgi.1992.263.2.G174; ROTH KA, 1991, J BIOL CHEM, V266, P5949; ROTH KA, 1992, AM J PHYSIOL, V263, pG186, DOI 10.1152/ajpgi.1992.263.2.G186; ROTH KA, 1990, J CELL BIOL, V110, P1791, DOI 10.1083/jcb.110.5.1791; ROTH KA, 1991, P NATL ACAD SCI USA, V88, P9407, DOI 10.1073/pnas.88.21.9407; RUBIN DC, 1992, J BIOL CHEM, V267, P15122; RUBIN DC, 1991, J CELL BIOL, V113, P1183, DOI 10.1083/jcb.113.5.1183; Sambrook J, 1989, MOL CLONING LABORATO; SCHMIDT GH, 1990, MUTAT RES, V228, P149, DOI 10.1016/0027-5107(90)90071-B; SCHMIDT GH, 1988, DEVELOPMENT, V103, P785; SCHMIDT GH, 1985, CELL, V40, P425, DOI 10.1016/0092-8674(85)90156-4; SEEBURG PH, 1982, DNA-J MOLEC CELL BIO, V1, P239, DOI 10.1089/dna.1.1982.1.239; SHIELDS HM, 1986, J LIPID RES, V27, P549; SIGAL SH, 1992, AM J PHYSIOL, V263, pG139, DOI 10.1152/ajpgi.1992.263.2.G139; STATES DJ, 1991, SEQUENCE ANAL PRIMER, P90; SUZUKI T, 1988, J HISTOCHEM CYTOCHEM, V36, P349, DOI 10.1177/36.4.3346538; SWEETSER DA, 1986, J BIOL CHEM, V261, P5553; SWEETSER DA, 1988, GENE DEV, V2, P1318, DOI 10.1101/gad.2.10.1318; SWEETSER DA, 1987, J BIOL CHEM, V262, P16060; TRABER PG, 1988, GASTROENTEROLOGY, V95, P1130, DOI 10.1016/0016-5085(88)90194-1; TRABER PG, 1992, MOL CELL BIOL, V12, P3614, DOI 10.1128/MCB.12.8.3614; TRAHAIR JF, 1989, J CELL BIOL, V109, P3231, DOI 10.1083/jcb.109.6.3231; TREMML G, 1989, EMBO J, V8, P2677, DOI 10.1002/j.1460-2075.1989.tb08408.x; TRIER JS, 1987, ANAT REC, V219, P69, DOI 10.1002/ar.1092190112; TRIPODI M, 1991, EMBO J, V10, P3177, DOI 10.1002/j.1460-2075.1991.tb04879.x; TROELSEN JT, 1992, J BIOL CHEM, V267, P20407; TSUBOUCHI S, 1979, AM J ANAT, V156, P431, DOI 10.1002/aja.1001560403; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; VACHER J, 1990, SCIENCE, V250, P1732, DOI 10.1126/science.1702902; WICE BM, 1992, J CELL BIOL, V116, P405, DOI 10.1083/jcb.116.2.405; WILLIAMS ED, 1992, AM J PATHOL, V141, P773; WINTON DJ, 1990, P ROY SOC B-BIOL SCI, V241, P13, DOI 10.1098/rspb.1990.0059; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; WRIGHT NA, 1982, CELL TISSUE KINET, V15, P595, DOI 10.1111/j.1365-2184.1982.tb01066.x; ZHANG BW, 1992, P NATL ACAD SCI USA, V89, P7541, DOI 10.1073/pnas.89.16.7541	107	121	124	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18345	18358						14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349710				2022-12-27	WOS:A1993LT74300103
J	ULLRICH, O; STENMARK, H; ALEXANDROV, K; HUBER, LA; KAIBUCHI, K; SASAKI, T; TAKAI, Y; ZERIAL, M				ULLRICH, O; STENMARK, H; ALEXANDROV, K; HUBER, LA; KAIBUCHI, K; SASAKI, T; TAKAI, Y; ZERIAL, M			RAB GDP DISSOCIATION INHIBITOR AS A GENERAL REGULATOR FOR THE MEMBRANE ASSOCIATION OF RAB PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; GDP/GTP EXCHANGE PROTEIN; CLATHRIN-COATED VESICLES; SMG P25A; MOLECULAR-CLONING; PLASMA-MEMBRANES; NUCLEAR-ENVELOPE; CYSTEINE MOTIFS; GOLGI-COMPLEX; CELLS	Rab proteins comprise a family of small GTPases that serve a regulatory role in membrane traffic. These proteins are in part cytosolic and in part associated with the membranes of specific exocytic and endocytic organelles. Smg p25A/rab3A GDI, a cytosolic protein which inhibits the dissociation of GDP from smg p25A/rab3A, Sec4p, and rab11, has also been found to prevent association of rab3A with the membrane. In this study, we have used Madin-Darby canine kidney cells permeabilized with the bacterial toxin streptolysin O to test the general activity of rab3A GDI in modulating the membrane association of various small GTP-binding proteins. Rab3A GDP dissociation inhibitor (GDI) removed from the membrane all rab proteins we have tested and inhibited the membrane binding of in vitro translated rab proteins. However, rab3A GDI had a limited effect on the membrane association of a mutant rab5 protein which contained a farnesylated cysteine motif. Finally, we found that, although rab3A GDI resides primarily in the cytosol, it is also associated with compartments of the exocytic and endocytic pathways. Since rab3A GDI can modulate the membrane association of various rab proteins, we propose to rename it rab GDI.	EUROPEAN MOLEC BIOL LAB,POSTFACH 102209,W-6900 HEIDELBERG,GERMANY; KOBE UNIV,SCH MED,DEPT BIOCHEM,KOBE 650,JAPAN	European Molecular Biology Laboratory (EMBL); Kobe University			Alexandrov, Kirill/A-5830-2013; Huber, Lukas Alfons/AAM-3499-2021; Stenmark, Harald/B-8868-2008	Alexandrov, Kirill/0000-0002-0957-6511; Huber, Lukas Alfons/0000-0003-1116-2120				ARAKI S, 1991, MOL CELL BIOL, V11, P1438, DOI 10.1128/MCB.11.3.1438; ARAKI S, 1990, J BIOL CHEM, V265, P13007; BACALLAO R, 1989, J CELL BIOL, V109, P2817, DOI 10.1083/jcb.109.6.2817; BOURNE HR, 1988, CELL, V53, P669, DOI 10.1016/0092-8674(88)90081-5; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BURKE B, 1986, CELL, V44, P639, DOI 10.1016/0092-8674(86)90273-4; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CHAVRIER P, 1990, MOL CELL BIOL, V10, P6578, DOI 10.1128/MCB.10.12.6578; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; FARNSWORTH CC, 1991, P NATL ACAD SCI USA, V88, P6196, DOI 10.1073/pnas.88.14.6196; GOKE B, 1992, AM J PHYSIOL, V262, pC493, DOI 10.1152/ajpcell.1992.262.2.C493; GOUD B, 1990, NATURE, V345, P553, DOI 10.1038/345553a0; GRAVOTTA D, 1990, J CELL BIOL, V111, P2893, DOI 10.1083/jcb.111.6.2893; GRIFFITHS G, 1989, J CELL BIOL, V108, P277, DOI 10.1083/jcb.108.2.277; HANCOCK JF, 1991, EMBO J, V10, P641, DOI 10.1002/j.1460-2075.1991.tb07992.x; KHOSRAVIFAR R, 1991, P NATL ACAD SCI USA, V88, P6264, DOI 10.1073/pnas.88.14.6264; KINSELLA BT, 1992, J BIOL CHEM, V267, P3940; KINSELLA BT, 1991, P NATL ACAD SCI USA, V88, P8934, DOI 10.1073/pnas.88.20.8934; KITA T, 1980, J CLIN INVEST, V66, P1094, DOI 10.1172/JCI109938; LENHARD JM, 1991, BIOCHEM BIOPH RES CO, V174, P197, DOI 10.1016/0006-291X(91)90505-2; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; MATSUI Y, 1990, MOL CELL BIOL, V10, P4116, DOI 10.1128/MCB.10.8.4116; MUSHA T, 1992, J BIOL CHEM, V267, P9821; NONAKA H, 1991, BIOCHEM BIOPH RES CO, V174, P556, DOI 10.1016/0006-291X(91)91453-J; PETER M, 1992, J CELL SCI, V102, P857; Pfeffer S R, 1992, Trends Cell Biol, V2, P41, DOI 10.1016/0962-8924(92)90161-F; PIMPLIKAR SW, 1993, NATURE, V362, P456, DOI 10.1038/362456a0; REGAZZI R, 1992, J BIOL CHEM, V267, P17512; SASAKI T, 1991, MOL CELL BIOL, V11, P2909, DOI 10.1128/MCB.11.5.2909; SASAKI T, 1990, J BIOL CHEM, V265, P2333; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; SEYDEL U, 1991, J BIOL CHEM, V266, P7602; STOORVOGEL W, 1987, J CELL BIOL, V104, P1261, DOI 10.1083/jcb.104.5.1261; TAKAI Y, 1992, INT REV CYTOL, V133, P187, DOI 10.1016/S0074-7696(08)61861-6; TAN A, 1992, J CELL BIOL, V116, P1357, DOI 10.1083/jcb.116.6.1357; UEDA T, 1991, BIOCHEMISTRY-US, V30, P909, DOI 10.1021/bi00218a005; VANDERSLUIJS P, 1991, P NATL ACAD SCI USA, V88, P6313, DOI 10.1073/pnas.88.14.6313; ZERIAL M, 1992, METHOD ENZYMOL, V219, P398	40	272	275	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18143	18150						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349690				2022-12-27	WOS:A1993LT74300074
J	ONODA, K; YIN, HL				ONODA, K; YIN, HL			GCAP39 IS PHOSPHORYLATED - STIMULATION BY OKADAIC ACID AND PREFERENTIAL ASSOCIATION WITH NUCLEI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASES; CELLULAR-REGULATION; CAPPING PROTEIN; CALCIUM-ION; ACTIN; GELSOLIN; CELLS; LOCALIZATION; KINETICS; FRAGMIN	gCap39 is an actin filament end-capping protein which is a member of the gelsolin family. Unlike gelsolin, gCap39 does not sever actin filaments and is a cytoplasmic as well as nuclear protein. We report here that gCap39 is phosphorylated, while gelsolin is not. gCap39 is phosphorylated on serines and threonines at multiple sites, and phospho-gCap39 is resolved by isofocusing into multiple isoforms which are more acidic than unphosphorylated gCap39. In vitro dephosphorylation eliminates the acidic isoforms. Okadaic acid, a protein phosphatase inhibitor, stimulates gCap39 phosphorylation in vivo. It preferentially increases labeling of several peptides and enhances labeling of phosphothreonines relative to phosphoserines. The phosphorylation state of gCap39 in cells is therefore regulated by a balance between kinases and okadaic acid-sensitive phosphatases, and phosphorylation sites containing threonines appear to be particularly sensitive to the phosphatases. Subcellular fractionation shows that the nuclear fraction contains 17 +/- 5% (n = 3) of total gCap39. Compared with the soluble cytoplasm, nuclear gCap39 has a 1.7 +/- 0.2 (n = 3) fold increase in the amount of P-32 label incorporation and a higher ratio of acidic/basic gCap39. We conclude that phospho-gCap39 is preferentially associated with nuclei and suggest that phosphorylation of gCap39 is functionally significant.	UNIV TEXAS, SW MED CTR, DEPT PHYSIOL, 5323 HARRY HINES BLVD, DALLAS, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NHLBI NIH HHS [HL29113] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029113] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; COOPER JA, 1988, J CELL BIOL, V106, P1229, DOI 10.1083/jcb.106.4.1229; DABIRI GA, 1992, J BIOL CHEM, V267, P16545; FURUHASHI K, 1990, J CELL BIOL, V111, P1081, DOI 10.1083/jcb.111.3.1081; FURUHASHI K, 1992, J BIOL CHEM, V267, P9326; HASEGAWA T, 1980, BIOCHEMISTRY-US, V19, P2677, DOI 10.1021/bi00553a021; HUNT T, 1989, CELL, V59, P949, DOI 10.1016/0092-8674(89)90747-2; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P255, DOI 10.1111/j.1432-1033.1983.tb07357.x; JOHNSTON PA, 1990, J BIOL CHEM, V265, P17946; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUDAIRA P, 1988, CELL, V54, P139, DOI 10.1016/0092-8674(88)90542-9; MUMBY MC, 1985, J BIOL CHEM, V260, P3763; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; ONODA K, 1992, J CELL BIOL, V115, P327; PRENDERGAST GC, 1991, EMBO J, V10, P757, DOI 10.1002/j.1460-2075.1991.tb08007.x; SMITH CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2641, DOI 10.1073/pnas.77.5.2641; SOUTHWICK FS, 1986, J BIOL CHEM, V261, P14191; THOMAS TP, 1988, CANCER RES, V48, P1910; WANG E, 1984, J CELL BIOL, V98, P761, DOI 10.1083/jcb.98.2.761; YIN HL, 1981, J CELL BIOL, V91, P901, DOI 10.1083/jcb.91.3.901; YIN HL, 1987, BIOESSAYS, V7, P176, DOI 10.1002/bies.950070409; YIN HL, 1980, P NATL ACAD SCI-BIOL, V77, P2188, DOI 10.1073/pnas.77.4.2188; YOUNG CL, 1990, BIOCHEMISTRY-US, V29, P2232, DOI 10.1021/bi00461a005; YU FX, 1990, SCIENCE, V250, P1413, DOI 10.1126/science.2255912; YU FX, 1991, J BIOL CHEM, V266, P19269	28	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					4106	4112						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382692				2022-12-27	WOS:A1993KN53300048
J	ITOH, T; KAIBUCHI, K; MASUDA, T; YAMAMOTO, T; MATSUURA, Y; MAEDA, A; SHIMIZU, K; TAKAI, Y				ITOH, T; KAIBUCHI, K; MASUDA, T; YAMAMOTO, T; MATSUURA, Y; MAEDA, A; SHIMIZU, K; TAKAI, Y			THE POSTTRANSLATIONAL PROCESSING OF RAS-P21 IS CRITICAL FOR ITS STIMULATION OF MITOGEN-ACTIVATED PROTEIN-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GTP-BINDING PROTEINS; RAS PROTEINS; SACCHAROMYCES-CEREVISIAE; EXCHANGE-REACTION; SENSITIVE METHOD; CYCLASE PATHWAY; SMG P21S; P21RAS; PURIFICATION; CDC25	The point-mutated active form of ras p21 is known to activate mitogen-activated protein (MAP) kinase/extracellular signal-regulated kinase (ERK) in intact mammalian cells and Xenopus oocytes, although the direct target molecule of ras p21 remains to be identified. To elucidate the role of the post-translational processing of ras p21 for the MAP kinase activation, we established the cell-free system in which ras p21 activated MAP kinase. The guanosine 5'-(3-O-thio)triphosphate (GTPgammaS) bound form of post-translationally processed Ki-ras 4B p21 activated MAP kinase in the cytosol fraction of Xenopus oocytes, but the GTPgammaS bound form of post-translationally unprocessed Ki-ras 4B p21 or the GDP bound form of processed or unprocessed Ki-ras 4B p21 was far less effective. The GTPgammaS bound form of processed Ki-ras 4B p21 activated recombinant ERK2 in the presence of the cytosol fraction of Xenopus oocytes, but the unprocessed protein was far less effective. These results provide a complete biochemical assay for ras p21 to activate MAP kinase in a cell-free system and indicate that all the elements downstream of ras p21 necessary for the MAP kinase activation are cytosolic and that the post-translational processing of ras p21 is important for the MAP kinase activation.	KOBE UNIV,SCH MED,DEPT BIOCHEM,KOBE 650,JAPAN; NATL INST HLTH,DEPT VET SCI,TOKYO 190,JAPAN; NATL INST PHYSIOL SCI,DEPT CELL PHYSIOL,OKAZAKI,AICHI 444,JAPAN	Kobe University; National Institute of Health Sciences - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)								AHN NG, 1991, J BIOL CHEM, V266, P4220; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BEEMON K, 1978, J VIROL, V28, P551, DOI 10.1128/JVI.28.2.551-566.1978; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; CRECHET JB, 1990, SCIENCE, V248, P866, DOI 10.1126/science.2188363; DEVRIESSMITS AMM, 1992, NATURE, V357, P602, DOI 10.1038/357602a0; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; DOWNWARD J, 1990, P NATL ACAD SCI USA, V87, P5998, DOI 10.1073/pnas.87.15.5998; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; GIBBS JB, 1990, J BIOL CHEM, V265, P20437; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; GOTOH Y, 1991, EMBO J, V10, P2661, DOI 10.1002/j.1460-2075.1991.tb07809.x; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HORIUCHI H, 1992, MOL CELL BIOL, V12, P4515, DOI 10.1128/MCB.12.10.4515; HUANG YK, 1990, P NATL ACAD SCI USA, V87, P8008, DOI 10.1073/pnas.87.20.8008; JACKSON JH, 1990, P NATL ACAD SCI USA, V87, P3042, DOI 10.1073/pnas.87.8.3042; JONES S, 1991, MOL CELL BIOL, V11, P2641, DOI 10.1128/MCB.11.5.2641; KAIBUCHI K, 1991, MOL CELL BIOL, V11, P2873, DOI 10.1128/MCB.11.5.2873; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; MARTEGANI E, 1992, EMBO J, V11, P2151, DOI 10.1002/j.1460-2075.1992.tb05274.x; MATSUDA S, 1992, EMBO J, V11, P973, DOI 10.1002/j.1460-2075.1992.tb05136.x; MCCORMICK F, 1989, CELL, V56, P5, DOI 10.1016/0092-8674(89)90976-8; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; MOLLOY CJ, 1989, NATURE, V342, P711, DOI 10.1038/342711a0; NAKIELNY S, 1992, EMBO J, V11, P2123, DOI 10.1002/j.1460-2075.1992.tb05271.x; NORI M, 1992, MOL CELL BIOL, V12, P936, DOI 10.1128/MCB.12.3.936; ROBINSON LC, 1987, SCIENCE, V235, P1218, DOI 10.1126/science.3547648; SATOH T, 1990, P NATL ACAD SCI USA, V87, P5993, DOI 10.1073/pnas.87.15.5993; SEGER R, 1992, J BIOL CHEM, V267, P14373; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; TAKAI Y, 1992, INT REV CYTOL, V133, P187, DOI 10.1016/S0074-7696(08)61861-6; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; WOLFMAN A, 1990, SCIENCE, V248, P67, DOI 10.1126/science.2181667; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; YAMAMOTO T, 1990, J BIOL CHEM, V265, P16626; YOSHIDA K, 1988, CANCER RES, V48, P5503	46	65	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3025	3028						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381417				2022-12-27	WOS:A1993KM16100003
J	SHIEH, WR; CHEN, CS				SHIEH, WR; CHEN, CS			PURIFICATION AND CHARACTERIZATION OF NOVEL 2-ARYLPROPIONYL-COA EPIMERASES FROM RAT-LIVER CYTOSOL AND MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-INFLAMMATORY DRUGS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; METABOLIC STEREOISOMERIC INVERSION; CHIRAL INVERSION; RENAL-FAILURE; IBUPROFEN; INVITRO; PROSTAGLANDINS; RACEMIZATION; MECHANISM	Investigation on the biochemical isomerization of ibuprofen led us to the successful purification of ''2-arylpropionyl-CoA epimerase'' from rat liver cytosol and mitochondria. The purified enzymes from both subcellular fractions exhibit similar physical and catalytic properties and are distinctly different from rat liver methylmalonyl-CoA epimerase. Both are monomeric proteins with an apparent molecular mass of 42 kDa and show similar contents of most amino acids. Their UV spectra gave no indication of any bound cofactors, and their enzyme activities were not affected by exposure to EDTA or metal ions (except Cu2+). These results suggest that the cytosolic and mitochondrial epimerases may be structurally related. The purified enzymes catalyze the epimerization of various 2-arylpropionyl-CoAs with some degree of stereochemical differentiation. For 2-(4-isobutylphenyl)propionyl-CoA, the equilibrium constant was estimated to be 1.5 in favor of the R-isomer. Evidence indicated that the proton exchange may be mediated by a 2-base mechanism and that a carboxylic residue in the active site may serve as a general base for proton abstraction.	UNIV RHODE ISL, COLL PHARM, DEPT PHARMACOGNOSY & ENVIRONM HLTH SCI, KINGSTON, RI 02881 USA	University of Rhode Island					NIGMS NIH HHS [GM-39236] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM039236] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS E, 1976, ADV ENZYMOL RAMB, V44, P69; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briggs GE, 1925, BIOCHEM J, V19, P338, DOI 10.1042/bj0190338; CALDWELL J, 1988, BIOCHEM PHARMACOL, V37, P105, DOI 10.1016/0006-2952(88)90762-9; CARMICHAEL J, 1985, AM J MED, V78, P992, DOI 10.1016/0002-9343(85)90223-2; CHEN CS, 1990, BIOCHIM BIOPHYS ACTA, V1033, P1, DOI 10.1016/0304-4165(90)90185-Y; CHEN CS, 1990, J LABELLED COMPD RAD, V28, P1017, DOI 10.1002/jlcr.2580280905; CHEN CS, 1991, BIOCHIM BIOPHYS ACTA, V1078, P411, DOI 10.1016/0167-4838(91)90164-U; CLIVE DM, 1984, NEW ENGL J MED, V310, P563, DOI 10.1056/NEJM198403013100905; HARTL FU, 1990, SCIENCE, V247, P930, DOI 10.1126/science.2406905; KNADLER MP, 1990, CHIRALITY, V2, P67, DOI 10.1002/chir.530020202; KNIGHTS KM, 1988, BIOCHEM PHARMACOL, V37, P3539, DOI 10.1016/0006-2952(88)90382-6; KNIHINICKI RD, 1989, BIOCHEM PHARMACOL, V38, P4389, DOI 10.1016/0006-2952(89)90647-3; KNIHINICKI RD, 1991, BIOCHEM PHARMACOL, V42, P1905, DOI 10.1016/0006-2952(91)90588-V; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE EJD, 1984, J PHARM SCI, V73, P1542, DOI 10.1002/jps.2600731112; MARASCO WA, 1987, ARCH INTERN MED, V147, P2107, DOI 10.1001/archinte.147.12.2107; NAKAMURA Y, 1981, J PHARMACOBIO-DYNAM, V4, pS1; PREBBLE JN, 1981, MITOCHONDRIA CHLOROP, P137; PROUBEK DJ, 1991, BIOCHEM PHARMACOL, V42, pR1; STABLER SP, 1985, ARCH BIOCHEM BIOPHYS, V241, P252, DOI 10.1016/0003-9861(85)90381-9; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; WALSH CT, 1979, ENZYMATIC REACTION M; WATTIAUX R, 1978, J CELL BIOL, V78, P349, DOI 10.1083/jcb.78.2.349; WHELTON A, 1990, ANN INTERN MED, V112, P568, DOI 10.7326/0003-4819-112-8-568; ZIPSER RD, 1986, AM J MED, V81, P95, DOI 10.1016/0002-9343(86)90911-3	26	80	82	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3487	3493						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381432				2022-12-27	WOS:A1993KM16100072
J	CHOCHOLA, J; FABRE, C; BELLAN, C; LUIS, J; BOURGERIE, S; ABADIE, B; CHAMPION, S; MARVALDI, J; ELBATTARI, A				CHOCHOLA, J; FABRE, C; BELLAN, C; LUIS, J; BOURGERIE, S; ABADIE, B; CHAMPION, S; MARVALDI, J; ELBATTARI, A			STRUCTURAL AND FUNCTIONAL-ANALYSIS OF THE HUMAN VASOACTIVE-INTESTINAL-PEPTIDE RECEPTOR GLYCOSYLATION - ALTERATION OF RECEPTOR FUNCTION BY WHEAT-GERM-AGGLUTININ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONCANAVALIN-A-SEPHAROSE; BETA-ADRENERGIC-RECEPTOR; AFFINITY-CHROMATOGRAPHY; LINKED OLIGOSACCHARIDES; GLYCOPROTEIN NATURE; BINDING-PROPERTIES; INSULIN-RECEPTORS; N-GLYCOSYLATION; LECTINS; PURIFICATION	The vasoactive intestinal peptide (VIP) receptor from the human melanoma cell line IGR39 has been shown to be a 60-kDa glycoprotein. Using serial lectin affinity chromatography, as well as specific glycosidases, we demonstrate that VIP receptor-linked carbohydrates are predominantly tri- or tetraantennary sialylated N-linked oligosaccharides, 27% of which are fucosylated, and some may have terminal galactose residues. Treatment of I-125-VIP receptor complexes with peptide-N-(N-acetyl-beta-D-glucosaminyl)asparagine amidase revealed the presence of at least three N-linked carbohydrate chains/receptor polypeptide. To investigate the functional role of the carbohydrate moiety, I-125-VIP binding to IGR39 cell membranes was tested in the presence of soluble lectins. Among the lectins tested, only wheat germ agglutinin (WGA) was found to markedly inhibit VIP binding in a dose-dependent manner. Binding data indicated that the presence of the lectin led to a 3-fold increase in K(d) value, from 0.15 to 0.44 nM, without any change in the number of available binding sites. The potent inhibitor of WGA binding, N,N',N''-triacetvtchitotriose, completely reversed the effect of the lectin. On the other hand, VIP binding inhibition persisted even after neuraminidase treatment, suggesting that sialic acids were not directly involved. Furthermore, WGA inhibition was not abolished although most, if not all, VIP receptor oligosaccharides were converted to high mannose type structures by treating IGR39 cells with deoxymannojirimycin. Finally, whereas the pharmacological profile of VIP receptor was virtually identical, the presence of WGA greatly reduced the VIP-stimulated cAMP in IGR39 cells, indicating that the lectin alters the ability of the receptor to interact with the adenylate cyclase system.	UNIV AIX MARSEILLE 1,INST CHIM BIOL,CNRS,URA 202,PL V HUGO,F-13331 MARSEILLE 3,FRANCE; UNIV LIMOGES,INST BIOTECHNOL,F-87060 LIMOGES,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Limoges			LUIS, José/M-3071-2013					ALLEN AK, 1973, BIOCHEM J, V131, P155, DOI 10.1042/bj1310155; AUBERT C, 1980, J NATL CANCER I, V64, P1029; BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; BARRINGTON WW, 1990, MOL PHARMACOL, V38, P177; BENOVIC JL, 1987, J RECEPTOR RES, V7, P257, DOI 10.3109/10799898709054989; BHAVANANDAN VP, 1979, J BIOL CHEM, V254, P4000; CARPENTER G, 1977, BIOCHEM BIOPH RES CO, V79, P545, DOI 10.1016/0006-291X(77)90192-9; COUVINEAU A, 1990, J BIOL CHEM, V265, P13386; COWAN EP, 1982, J BIOL CHEM, V257, P1241; CUATRECASAS P, 1973, P NATL ACAD SCI USA, V70, P485, DOI 10.1073/pnas.70.2.485; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1235; DUBE S, 1988, J BIOL CHEM, V263, P17516; ELBATTARI A, 1991, BIOCHEM J, V278, P527, DOI 10.1042/bj2780527; ELBATTARI A, 1988, J BIOL CHEM, V263, P17685; FUHRMANN U, 1984, NATURE, V307, P755, DOI 10.1038/307755a0; GALLAGHER JT, 1985, BIOCHEM J, V231, P115, DOI 10.1042/bj2310115; GOZES I, 1989, MOL NEUROBIOL, V3, P201, DOI 10.1007/BF02740606; GRIGORIADIS DE, 1989, ENDOCRINOLOGY, V125, P1877, DOI 10.1210/endo-125-4-1877; HARLOW E, 1988, ANTIBODIES LABORATOR; HEDO JA, 1981, BIOCHEMISTRY-US, V20, P3385, DOI 10.1021/bi00515a013; IRUMURA T, 1981, BIOCHEMISTRY-US, V20, P560; ISHIHARA T, 1992, NEURON, V8, P811, DOI 10.1016/0896-6273(92)90101-I; JARVIE KR, 1988, MOL PHARMACOL, V34, P91; KAWASHIMA H, 1990, GLYCOCONJUGATE J, V7, P323, DOI 10.1007/BF01073376; KLOTZ KN, 1986, BIOCHEM BIOPH RES CO, V140, P406, DOI 10.1016/0006-291X(86)91105-8; KRUSIUS T, 1976, FEBS LETT, V71, P117, DOI 10.1016/0014-5793(76)80911-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIBERT F, 1989, SCIENCE, V244, P569, DOI 10.1126/science.2541503; LIN PH, 1987, BIOCHEMISTRY-US, V26, P731, DOI 10.1021/bi00377a012; LONG Y, 1990, MOL CELL ENDOCRINOL, V73, P217, DOI 10.1016/0303-7207(90)90135-U; LUIS J, 1990, PEPTIDES, V11, P1239, DOI 10.1016/0196-9781(90)90158-2; LUIS J, 1988, BIOCHIMIE, V70, P1311, DOI 10.1016/0300-9084(88)90002-8; Maguire M E, 1977, Adv Cyclic Nucleotide Res, V8, P1; MARTIN JM, 1988, BIOCHEM J, V250, P679, DOI 10.1042/bj2500679; MCPHERSON GA, 1985, J PHARMACOL METHOD, V14, P213, DOI 10.1016/0160-5402(85)90034-8; NAGATA Y, 1974, J BIOL CHEM, V249, P3116; NOVOGRODSKY A, 1971, BIOCHIM BIOPHYS ACTA, V228, P579, DOI 10.1016/0005-2787(71)90064-5; OGATA S, 1975, J BIOCHEM, V78, P687, DOI 10.1093/oxfordjournals.jbchem.a130956; PLUMMER T H JR, 1991, Glycobiology, V1, P257, DOI 10.1093/glycob/1.3.257; PROVOW S, 1987, ENDOCRINOLOGY, V120, P2442, DOI 10.1210/endo-120-6-2442; RAUH JJ, 1986, J NEUROCHEM, V46, P23, DOI 10.1111/j.1471-4159.1986.tb12920.x; RENKONEN O, 1989, GLYCOCONJUGATE J, V6, P129, DOI 10.1007/BF01047895; RENSDOMIANO S, 1991, J BIOL CHEM, V266, P20094; RICE RH, 1975, BIOCHEMISTRY-US, V14, P4093, DOI 10.1021/bi00689a027; SANTER R, 1990, BIOCHIM BIOPHYS ACTA, V1051, P78, DOI 10.1016/0167-4889(90)90176-E; SAWUTZ DG, 1987, MOL PHARMACOL, V32, P565; SREEDHARAN SP, 1991, P NATL ACAD SCI USA, V88, P4986, DOI 10.1073/pnas.88.11.4986; STILES GL, 1984, J BIOL CHEM, V259, P8655; UKENA TE, 1976, CELL, V7, P213, DOI 10.1016/0092-8674(76)90020-9; VALE RD, 1982, J CELL BIOL, V94, P710, DOI 10.1083/jcb.94.3.710; VANKOPPEN CJ, 1990, J BIOL CHEM, V265, P20887; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	52	26	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2312	2318						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8381403				2022-12-27	WOS:A1993KK81500012
J	MULLIEZ, E; FONTECAVE, M; GAILLARD, J; REICHARD, P				MULLIEZ, E; FONTECAVE, M; GAILLARD, J; REICHARD, P			AN IRON-SULFUR CENTER AND A FREE-RADICAL IN THE ACTIVE ANAEROBIC RIBONUCLEOTIDE REDUCTASE OF ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TRIPHOSPHATE REDUCTASE; PROTEIN; ENZYME	Anaerobically grown Escherichia coli contain an oxygen-sensitive ribonucleotide reductase. The enzyme requires anaerobic activation by two E. coli fractions with S-adenosylmethionine, NADPH, dithiothreitol, and KCl. We now find that photochemically reduced deazaflavin can substitute for these two fractions and NADPH. The reductase contained roughly equimolar amounts of iron and sulfide, suggesting the presence of an Fe-S complex. The cluster is characterized by a charge transfer band at 420 nm and a low temperature EPR signal centered at g = 2.01 that is difficult to saturate at 14 K, suggested to be a (3Fe-4S)+ cluster. In five different preparations of essentially protein-pure reductase containing widely different amounts of iron, the catalytic activity correlated well with the iron content. The iron signal disappeared during reductive anaerobic activation, with the appearance of a new EPR signal at g = 2.0033 showing a temperature behavior and microwave power saturability consistent with an organic free radical. The signal disappeared after exposure of the activated enzyme to air. We suggest that activation involves generation of a specific amino acid free radical that is dependent on the reduced Fe-S cluster and S-adenosylmethionine. From other work it appears likely that the free radical is localized on glycine 681 of the polypeptide chain.	UNIV JOSEPH FOURIER, ETUD DYNAM & STRUCT SELECT LAB,CNRS,URA 332,BP 53X, F-38041 GRENOBLE, FRANCE; KAROLINSKA INST, MED NOBEL INST, DEPT BIOCHEM, S-10401 STOCKHOLM 60, SWEDEN; CEN, SESAM, DRFMC, SPECT COMPLEXES POLYMET & MET PROT LAB, F-38041 GRENOBLE, FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Karolinska Institutet; CEA								ATKIN CL, 1973, J BIOL CHEM, V248, P7464; BARRY BA, 1990, J BIOL CHEM, V265, P20139; BEINERT H, 1989, EUR J BIOCHEM, V186, P5, DOI 10.1111/j.1432-1033.1989.tb15170.x; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CONRADT H, 1984, ARCH BIOCHEM BIOPHYS, V228, P133, DOI 10.1016/0003-9861(84)90054-7; ELIASSON R, 1990, P NATL ACAD SCI USA, V87, P3314, DOI 10.1073/pnas.87.9.3314; ELIASSON R, 1992, J BIOL CHEM, V267, P25541; FISHEL LA, 1991, BIOCHEMISTRY-US, V30, P1986, DOI 10.1021/bi00221a036; FONTECAVE M, 1989, P NATL ACAD SCI USA, V86, P2147, DOI 10.1073/pnas.86.7.2147; FONTECAVE M, 1992, ADV ENZYMOL, V65, P147; HARDER J, 1992, J BIOL CHEM, V267, P25548; PETROVICH RM, 1992, BIOCHEMISTRY-US, V31, P10774, DOI 10.1021/bi00159a019; PETROVICH RM, 1991, J BIOL CHEM, V266, P7656; REICHARD P, 1983, SCIENCE, V221, P514, DOI 10.1126/science.6306767; STUBBE J, 1990, ADV ENZYMOL RAMB, V63, P349; STUBBE JA, 1989, ANNU REV BIOCHEM, V58, P257; SUN X, 1993, IN PRESS P NATL ACAD; THOMPSON AJ, 1985, METALLOPROTEINS, V1; VANONI MA, 1992, BIOCHEMISTRY-US, V31, P4613, DOI 10.1021/bi00134a011; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996	21	138	140	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2296	2299						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8381402				2022-12-27	WOS:A1993KK81500008
J	TERADA, T; KITAZUME, S; KITAJIMA, K; INOUE, S; ITO, F; TROY, FA; INOUE, Y				TERADA, T; KITAZUME, S; KITAJIMA, K; INOUE, S; ITO, F; TROY, FA; INOUE, Y			SYNTHESIS OF CMP-DEAMINONEURAMINIC ACID (CMP-KDN) USING THE CTP-CMP-3-DEOXYNONULOSONATE CYTIDYLYLTRANSFERASE FROM RAINBOW-TROUT TESTIS - IDENTIFICATION AND CHARACTERIZATION OF A CMP-KDN SYNTHETASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEAMINATED NEURAMINIC ACID; RICH GLYCOPROTEIN; VITELLINE ENVELOPE; CHAINS; POLYSIALOGLYCOPROTEIN; EGGS; PURIFICATION; ENZYMES; LIVER	The sugar nucleotide, cytidine 5'-(3-deoxy-D-glycero-D-galacto-2-nonulosonic phosphate) (CMP-KDN) is expected to serve as a donor of KDN residues in the synthesis of KDN-containing glycoconjugates. We report here the identification and characterization of CMP-KDN synthetase, a novel enzyme responsible for synthesis of CMP-KDN from KDN and CTP. The enzyme was partially purified from the testis of rainbow trout (Oncorhynchus mykiss), where KDN gangliosides were first discovered (Yu, S., Kitajima, K., Inoue. S., and Inoue, Y. (1991) J. Biol. Chem. 266, 21929-21935), and used to synthesize CMP-[C-14]KDN, which was characterized by H-1 NMR. V(max)/K(m) studies showed that KDN was a preferred nonulosonic acid substrate compared to N-acetylneuraminic acid (Neu5Ac) or N-glycolylneuraminic acid (Neu5Gc) (4.4 x 10(-3) min-1 for KDN versus 2.3 and 1.8 x 10(-3) min-1 for Neu5Ac and Neu5Gc, respectively). CMP-KDN synthetase activity was maximal at pH 9-10 and at 25-degrees-C. The presence of either Mg2+ or Mn2+ was essential for CMP-KDN synthetase activity. 25 mM Mg2+ stimulated formation of CMP-KDN more than 10- fold, yet only stimulated formation of CMP-Neu5Ac and CMP-Neu5Gc 4-fold, relative to 1 mM Mg2+. A kinetic study using mixed substrates showed that both CMP-KDN and CMP-Neu5Ac synthetase activities in the partially purified enzyme were due to the same active site of a single enzyme. In contrast, Neu5Ac and Neu5Gc were the preferred nonulosonic acid substrates for the calf brain CMP-sialic acid synthetase. Thus, mammalian CMP-sialic acid synthetases recognizes similar, yet distinctively different, substrate specificity determinants. Thus, the trout testis enzyme was considered to synthesize activated sugar nucleotides required for synthesis of both (KDN)G(M3) and (Neu5Ac)G(M3). The expression of CMP-KDN synthetase was shown to be temporally correlated with development and to parallel the developmental expression of (KDN)G(M3) in sperm.	UNIV TOKYO, FAC SCI, DEPT BIOPHYS & BIOCHEM, HONGO 7, TOKYO 113, JAPAN; SHOWA UNIV, SCH PHARMACEUT SCI, TOKYO 142, JAPAN; UNIV CALIF DAVIS, SCH MED, DEPT BIOL CHEM, DAVIS, CA 95616 USA	University of Tokyo; Showa University; University of California System; University of California Davis					NIAID NIH HHS [AI-09352] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI009352] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMINOFF D, 1961, BIOCHEM J, V81, P384, DOI 10.1042/bj0810384; AUGE C, 1988, TETRAHEDRON LETT, V29, P789, DOI 10.1016/S0040-4039(00)80210-5; AUGE C, 1992, J CHEM SOC CHEM COMM, V202, P25; BILLARD R, 1983, CELL TISSUE RES, V230, P495, DOI 10.1007/BF00216195; COATES SW, 1980, J BIOL CHEM, V255, P9225; COMB DG, 1960, J BIOL CHEM, V235, P2529; DAVID S, 1991, ADV CARBOHYD CHEM BI, V49, P175, DOI 10.1016/S0065-2318(08)60183-3; DIXON M, 1964, ENZYMES, P84; HAVERKAMP J, 1979, H-S Z PHYSIOL CHEM, V360, P159, DOI 10.1515/bchm2.1979.360.1.159; HIGA HH, 1985, J BIOL CHEM, V260, P8838; INOUE S, 1988, BIOCHEM BIOPH RES CO, V153, P172, DOI 10.1016/S0006-291X(88)81204-X; ITO F, 1991, 11TH P S GLYC, P153; IWASAKI M, 1987, BIOCHEMISTRY-US, V26, P1452, DOI 10.1021/bi00379a036; IWASAKI M, 1990, J BIOL CHEM, V265, P2596; KANAMORI A, 1989, BIOCHEM BIOPH RES CO, V164, P744, DOI 10.1016/0006-291X(89)91522-2; KANAMORI A, 1990, J BIOL CHEM, V265, P21811; Kean E. L., 1966, METHOD ENZYMOL, V8, P208; KEAN EL, 1970, J BIOL CHEM, V245, P2301; KEAN EL, 1966, J BIOL CHEM, V241, P5643; KNIREL YA, 1989, CARBOHYD RES, V188, P145, DOI 10.1016/0008-6215(89)84067-4; MERKER RI, 1991, GLYCOBIOLOGY, V1, P93; NADANO D, 1986, J BIOL CHEM, V261, P1550; NOMOTO H, 1982, ARCH BIOCHEM BIOPHYS, V218, P335, DOI 10.1016/0003-9861(82)90352-6; SAITO T, 1981, BIOCHIM BIOPHYS ACTA, V678, P257, DOI 10.1016/0304-4165(81)90215-4; SHAMES S L, 1991, Glycobiology, V1, P187, DOI 10.1093/glycob/1.2.187; SOMMERS LW, 1982, J BIOL CHEM, V257, P811; SONG Y, 1991, J BIOL CHEM, V266, P21929; STRECKER G, 1992, EUR J BIOCHEM, V207, P995, DOI 10.1111/j.1432-1033.1992.tb17135.x; STRECKER G, 1992, FEBS LETT, V298, P39, DOI 10.1016/0014-5793(92)80018-C; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; UCHIDA Y, 1977, J BIOCHEM-TOKYO, V82, P1425, DOI 10.1093/oxfordjournals.jbchem.a131830; VANDENEIJNDEN DH, 1972, H-S Z PHYSIOL CHEM, V353, P1817, DOI 10.1515/bchm2.1972.353.2.1817; VANN WF, 1987, J BIOL CHEM, V262, P17556; WARREN L, 1962, J BIOL CHEM, V237, P3527	34	61	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2640	2648						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8381411				2022-12-27	WOS:A1993KK81500058
J	DODSON, MS; LEHMAN, IR				DODSON, MS; LEHMAN, IR			THE HERPES-SIMPLEX VIRUS TYPE-I ORIGIN BINDING-PROTEIN - DNA-DEPENDENT NUCLEOSIDE TRIPHOSPHATASE-ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE T-ANTIGEN; LARGE TUMOR-ANTIGEN; REPLICATION ORIGIN; HELICASE-PRIMASE; SV40 ORIGIN; NONSTRUCTURAL PROTEINS; VIRAL ORIGIN; GENE-PRODUCT; POLYMERASE; IDENTIFICATION	A recombinant baculovirus overexpressing the herpes simplex virus type 1 (HSV-1) origin binding protein, encoded by the UL9 gene, was constructed. The purified recombinant protein has DNA-dependent nucleoside triphosphatase activity similar to the enzyme isolated from mammalian cells. Optimal nucleoside triphosphatase activity requires low salt (<50 mM), 2-3 mM Mg2+, alkaline pH (8.3-9.5), high temperature (45-degrees-C), and a single-stranded DNA coeffector containing minimal secondary structure. Enzymatic activity is subject to product inhibition, and there appears to be a single nucleotide binding site. The minimal length of single-stranded DNA that elicits enzymatic activity is 14 nucleotides, and activity increases as the length is increased. Saturation for various single-stranded DNA coeffectors is about 10 muM in nucleotide, but the maximum velocity is reduced 2-3-fold for coeffectors containing secondary structure. The HSV-1-encoded single-stranded DNA-binding protein ICP8 specifically stimulates the DNA-dependent nucleoside triphosphatase activity. The kinetics of nucleoside triphosphate hydrolysis exhibit a substantial lag period which can be shortened, but not eliminated, by reduced secondary structure in the DNA coeffector or by increased temperature.			DODSON, MS (corresponding author), STANFORD UNIV,MED CTR,SCH MED,BECKMAN CTR,DEPT BIOCHEM,STANFORD,CA 94305, USA.				NIAID NIH HHS [AI 26538] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026538] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		APOSHIAN HV, 1962, J BIOL CHEM, V237, P519; BAYLISS GJ, 1975, VIROLOGY, V68, P124, DOI 10.1016/0042-6822(75)90154-3; BOEHMER PE, 1993, J BIOL CHEM, V268, P1220; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; BOROWIEC JA, 1991, J VIROL, V65, P1228, DOI 10.1128/JVI.65.3.1228-1235.1991; BRAMHILL D, 1988, CELL, V54, P915, DOI 10.1016/0092-8674(88)90102-X; BRUCKNER RC, 1991, J BIOL CHEM, V266, P2669; BULLOCK PA, 1989, P NATL ACAD SCI USA, V86, P3944, DOI 10.1073/pnas.86.11.3944; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; CRUTE JJ, 1991, J BIOL CHEM, V266, P4484; CRUTE JJ, 1991, J BIOL CHEM, V266, P21252; CRUTE JJ, 1989, J BIOL CHEM, V264, P19266; CRUTE JJ, 1988, NUCLEIC ACIDS RES, V16, P6585, DOI 10.1093/nar/16.14.6585; CRUTE JJ, 1989, P NATL ACAD SCI USA, V86, P2186, DOI 10.1073/pnas.86.7.2186; DAVISON BL, 1979, J BIOL CHEM, V254, P9220; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P8981, DOI 10.1073/pnas.84.24.8981; DEAN FB, 1991, J BIOL CHEM, V266, P5062; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P16, DOI 10.1073/pnas.84.1.16; DEB S, 1988, J VIROL, V62, P2516, DOI 10.1128/JVI.62.7.2516-2519.1988; DEB S, 1991, J VIROL, V65, P2829, DOI 10.1128/JVI.65.6.2829-2838.1991; DODSON M, 1987, SCIENCE, V238, P964, DOI 10.1126/science.2823389; ECHOLS H, 1990, J BIOL CHEM, V265, P14697; ELIAS P, 1986, P NATL ACAD SCI USA, V83, P6322, DOI 10.1073/pnas.83.17.6322; ELIAS P, 1990, J BIOL CHEM, V265, P17167; ELIAS P, 1988, P NATL ACAD SCI USA, V85, P2959, DOI 10.1073/pnas.85.9.2959; FIERER DS, 1992, J VIROL, V66, P3986, DOI 10.1128/JVI.66.7.3986-3995.1992; GALLO ML, 1989, J VIROL, V63, P5023, DOI 10.1128/JVI.63.12.5023-5029.1989; GIACHERIO D, 1979, J BIOL CHEM, V254, P8113; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOETZ GS, 1988, J BIOL CHEM, V263, P383; GOTTLIEB J, 1990, J VIROL, V64, P5976, DOI 10.1128/JVI.64.12.5976-5987.1990; GRAY CP, 1984, J GEN VIROL, V65, P2109, DOI 10.1099/0022-1317-65-12-2109; HAZUDA DJ, 1991, J BIOL CHEM, V266, P24621; HERNANDEZ TR, 1991, J VIROL, V65, P1649, DOI 10.1128/JVI.65.3.1649-1652.1991; HERNANDEZ TR, 1991, J BIOL CHEM, V237, P11227; KNOPF KW, 1979, EUR J BIOCHEM, V98, P231, DOI 10.1111/j.1432-1033.1979.tb13181.x; KOFF A, 1988, J VIROL, V62, P4096, DOI 10.1128/JVI.62.11.4096-4103.1988; KOFF A, 1991, J VIROL, V65, P3284, DOI 10.1128/JVI.65.6.3284-3292.1991; Kornberg A., 1992, DNA REPLICATION; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LOCKSHON D, 1986, J VIROL, V58, P513, DOI 10.1128/JVI.58.2.513-521.1986; LOCKSHON D, 1988, MOL CELL BIOL, V8, P4018, DOI 10.1128/MCB.8.10.4018; LUCKOW VA, 1989, VIROLOGY, V170, P31, DOI 10.1016/0042-6822(89)90348-6; MARCY AI, 1990, NUCLEIC ACIDS RES, V18, P1207, DOI 10.1093/nar/18.5.1207; MASTRANGELO IA, 1989, NATURE, V338, P658, DOI 10.1038/338658a0; MCGEOCH DJ, 1988, J VIROL, V62, P444, DOI 10.1128/JVI.62.2.444-453.1988; ODONNELL ME, 1987, J BIOL CHEM, V262, P4260; ODONNELL ME, 1987, J BIOL CHEM, V262, P4252; OLIVO PD, 1988, P NATL ACAD SCI USA, V85, P5414, DOI 10.1073/pnas.85.15.5414; PARRIS DS, 1988, J VIROL, V62, P818, DOI 10.1128/JVI.62.3.818-825.1988; PARSONS RE, 1991, J VIROL, V65, P2798, DOI 10.1128/JVI.65.6.2798-2806.1991; POWELL KL, 1977, J VIROL, V24, P618, DOI 10.1128/JVI.24.2.618-626.1977; POWELL KL, 1981, J VIROL, V39, P894, DOI 10.1128/JVI.39.3.894-902.1981; PURIFOY DJM, 1977, NATURE, V269, P621, DOI 10.1038/269621a0; SPAETE RR, 1985, P NATL ACAD SCI USA, V82, P694, DOI 10.1073/pnas.82.3.694; STAHL H, 1986, EMBO J, V5, P1939, DOI 10.1002/j.1460-2075.1986.tb04447.x; STOW ND, 1982, EMBO J, V1, P863, DOI 10.1002/j.1460-2075.1982.tb01261.x; STOW ND, 1983, VIROLOGY, V130, P427, DOI 10.1016/0042-6822(83)90097-1; SUMMERS MD, 1987, TEXAS AGR EXP STAT B, V1555; TIJAN R, 1978, CELL, V13, P165; VLAZNY DA, 1981, P NATL ACAD SCI-BIOL, V78, P742, DOI 10.1073/pnas.78.2.742; WEIR HM, 1989, NUCLEIC ACIDS RES, V17, P1409, DOI 10.1093/nar/17.4.1409; WEIR HM, 1990, J GEN VIROL, V71, P1379, DOI 10.1099/0022-1317-71-6-1379; WELLER SK, 1985, MOL CELL BIOL, V5, P930, DOI 10.1128/MCB.5.5.930; WELLER SK, 1983, J VIROL, V45, P354, DOI 10.1128/JVI.45.1.354-366.1983; WIEKOWSKI M, 1988, J BIOL CHEM, V263, P436; WU CA, 1988, J VIROL, V62, P435, DOI 10.1128/JVI.62.2.435-443.1988	67	46	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1213	1219						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8380407				2022-12-27	WOS:A1993KG07700068
J	MAO, GD; THOMAS, PD; LOPASCHUK, GD; POZNANSKY, MJ				MAO, GD; THOMAS, PD; LOPASCHUK, GD; POZNANSKY, MJ			SUPEROXIDE-DISMUTASE (SOD)-CATALASE CONJUGATES - ROLE OF HYDROGEN-PEROXIDE AND THE FENTON REACTION IN SOD TOXICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-NEUTROPHILS; FREE-RADICALS; ALBUMIN; METABOLISM; CATALASE; HEARTS	Superoxide dismutase (SOD) has been championed as an effective antioxidant for the treatment of ischemia-reperfusion injury in a wide variety of tissues. Unfortunately a bell-shaped dose-response curve has been observed, whereby SOD at higher concentrations loses its effectiveness and may even enhance the extent of reperfusion injury. Using the xanthine/xanthine oxidase reaction to generate superoxide radicals, we have attempted to examine the role of the Fenton reaction in SOD toxicity observing that high SOD levels along with micromolar concentrations of Fe2+ greatly increased the production of the highly toxic hydroxyl radical. The production of superoxide radicals and their conversion to hydroxyl radicals were measured by using the spin-trapping agent 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) and electron spin resonance (ESR). Attempts to counter the toxicity of SOD involved the covalent conjugation of SOD to catalase in an effort to lower the available free H2O2 and thus minimize the extent of the Fenton reaction. The conjugate was tested in both the xanthine/xanthine oxidase system and a rat heart model of ischemia-reperfusion. In the xanthine/xanthine oxidase model, the combination of SOD and Fe2+ results in an enhanced production of hydroxyl radicals which is inhibited by the inclusion of catalase. In reperfused ischemic hearts, working at levels of free SOD which were either toxic or failed to give any protection against reperfusion injury, an equivalent amount of SOD conjugated to catalase resulted in an 80% return to normal mechanical function of the reperfused hearts. We attribute the toxicity of free SOD in hearts subjected to ischemia-reperfusion injury to the production of hydroxyl radicals as a result of the increased Fenton reaction. This reaction is inhibited by the presence of catalase conjugated to SOD.	UNIV ALBERTA, FAC MED, DEPT PHYSIOL & PEDIAT, EDMONTON T6G 2H7, ALBERTA, CANADA	University of Alberta								Aebi H., 1974, METHODS ENZYMATIC AN, Vsecond, P673, DOI [DOI 10.1016/B978-0-12-091302-2.50032-3, 10.1016/B978-0-12-091302-2.50032-3]; AMSTAD P, 1991, BIOCHEMISTRY-US, V30, P9305, DOI 10.1021/bi00102a024; BERNIER M, 1989, AM J PHYSIOL, V256, pH1344, DOI 10.1152/ajpheart.1989.256.5.H1344; BRITIGAN BE, 1987, J LEUKOCYTE BIOL, V41, P349, DOI 10.1002/jlb.41.4.349; DAS DK, 1990, OXYGEN RADICALS SYST, P97; ENGLER R, 1989, CIRCULATION, V79, P1137, DOI 10.1161/01.CIR.79.5.1137; FREEMAN BA, 1982, LAB INVEST, V47, P412; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; GREEN MJ, 1984, METHOD ENZYMOL, V105, P3; GREENWALD RA, 1990, FREE RADICAL BIO MED, V8, P201, DOI 10.1016/0891-5849(90)90092-W; GUTTERIDGE JMC, 1989, ACTA PAEDIATR SCAND, P78; GUTTERIDGE JMC, 1990, BIOCHEM J, V269, P169, DOI 10.1042/bj2690169; HALLEWELL RA, 1989, J BIOL CHEM, V264, P5260; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; HALLIWELL B, 1987, FASEB J, V1, P358, DOI 10.1096/fasebj.1.5.2824268; HALLIWELL B, 1985, FREE RADICAL BIO MED, P279; LOPASCHUK GD, 1986, AM J PHYSIOL, V250, pH351, DOI 10.1152/ajpheart.1986.250.3.H351; LOPASCHUK GD, 1987, CIRC RES, V61, P853, DOI 10.1161/01.RES.61.6.853; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAO GD, 1989, BIOMATER ARTIF CELL, V17, P229, DOI 10.3109/10731198909118282; MARGOLIASH E, 1960, BIOCHEM J, V74, P339, DOI 10.1042/bj0740339; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MINOTTI G, 1989, CHEM-BIOL INTERACT, V71, P1, DOI 10.1016/0009-2797(89)90087-2; OMAR BA, 1990, FREE RADICAL BIO MED, V9, P473, DOI 10.1016/0891-5849(90)90124-2; POU S, 1989, J BIOL CHEM, V264, P12299; POZNANSKY MJ, 1988, METHOD ENZYMOL, V137, P566; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; WEGLICKI WB, 1990, J MOL CELL CARDIOL, V22, P1199, DOI 10.1016/0022-2828(90)90083-E; WONG K, 1980, AGENTS ACTIONS, V10, P231, DOI 10.1007/BF02025941	29	186	201	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					416	420						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380162				2022-12-27	WOS:A1993KE60300064
J	YU, SS; LEFKOWITZ, RJ; HAUSDORFF, WP				YU, SS; LEFKOWITZ, RJ; HAUSDORFF, WP			BETA-ADRENERGIC-RECEPTOR SEQUESTRATION - A POTENTIAL MECHANISM OF RECEPTOR RESENSITIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-INDUCED DESENSITIZATION; BETA-2-ADRENERGIC RECEPTOR; ADENYLATE-CYCLASE; HOMOLOGOUS DESENSITIZATION; INDUCED INTERNALIZATION; PHOSPHORYLATION SITES; MEDIATED ENDOCYTOSIS; PHENYLARSINE OXIDE; A431 CELLS; INHIBITION	Continuous exposure of cells to hormonal agonists often causes a rapid waning of the stimulated response. This desensitization effect has been extensively studied in the beta-adrenergic receptor system, and attributed largely to the rapid phosphorylation of the receptor by two kinases. Over a similar time frame (seconds to minutes), agonists also trigger a selective loss in the capacity of receptors to bind hydrophilic but not hydrophobic ligands, a phenomenon termed sequestration. There is some evidence suggesting that sequestration represents the rapid internalization of receptors, but the functional significance of sequestration has remained unclear. Upon the removal of agonist, both desensitization and sequestration are readily reversed with similar kinetics (t1/2 approximately 3 min for both). To investigate the possibility that receptor sequestration is involved in this resensitization of the adenylyl cyclase response, we applied two distinct approaches to block receptor sequestration: by pretreating cells with sucrose and by creating a sequestration-defective beta2-adrenergic receptor by site-specific mutagenesis. Both approaches effectively disabled receptor sequestration, with little effect on adenylyl cyclase stimulation or on desensitization. However, in both cases, no recovery from desensitization was apparent even 20 min after the removal of agonist. Similarly, pretreating cells with concanavalin A almost completely blocked receptor sequestration and resensitization but only partially inhibited other receptor functions. Our results therefore suggest that sequestration of beta2-adrenergic receptors is a mechanism involved in reactivating and recycling desensitized receptors.	DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,DEPT MED CARDIOL,BOX 3821,DURHAM,NC 27710; DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,DEPT BIOCHEM,DURHAM,NC 27710	Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute			Lefkowitz, Robert/AAW-2649-2021		NHLBI NIH HHS [4R37-HL16037] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; BOX RJ, 1987, FEBS LETT, V214, P323, DOI 10.1016/0014-5793(87)80079-0; CAMPBELL PT, 1991, MOL PHARMACOL, V39, P192; DAUKAS G, 1985, J CELL BIOL, V101, P1673, DOI 10.1083/jcb.101.5.1673; DEBLASI A, 1985, J CLIN ENDOCR METAB, V61, P1081, DOI 10.1210/jcem-61-6-1081; EVA C, 1990, J PHARMACOL EXP THER, V253, P257; FELDMAN RD, 1986, MOL PHARMACOL, V30, P459; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HAUSDORFF WP, 1990, J BIOL CHEM, V265, P1388; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; HAUSDORFF WP, 1991, P NATL ACAD SCI USA, V88, P2979, DOI 10.1073/pnas.88.8.2979; HERTEL C, 1985, J BIOL CHEM, V260, P2547; KASSIS S, 1986, J BIOL CHEM, V261, P2233; KURZ JB, 1992, MOL PHARMACOL, V41, P375; KWATRA MM, 1986, J BIOL CHEM, V261, P2429; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; LOHSE MJ, 1989, P NATL ACAD SCI USA, V86, P3011, DOI 10.1073/pnas.86.9.3011; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; MAHAN LC, 1985, P NATL ACAD SCI USA, V82, P6566, DOI 10.1073/pnas.82.19.6566; NELSON RM, 1989, ANAL BIOCHEM, V180, P147, DOI 10.1016/0003-2697(89)90103-6; PERKINS JP, 1991, BETA ADRENERGIC RECE, P125; SIBLEY DR, 1986, P NATL ACAD SCI USA, V83, P9408, DOI 10.1073/pnas.83.24.9408; STADEL JM, 1983, J BIOL CHEM, V258, P3032; STAHL P, 1986, J CLIN INVEST, V77, P657, DOI 10.1172/JCI112359; STRADER CD, 1987, CELL, V49, P855, DOI 10.1016/0092-8674(87)90623-4; SU YF, 1980, J BIOL CHEM, V255, P7410; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; WALDO GL, 1983, J BIOL CHEM, V258, P3900; WANG HY, 1989, BIOCHEM J, V263, P519, DOI 10.1042/bj2630519; WANG HY, 1989, BIOCHEM J, V263, P533, DOI 10.1042/bj2630533; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174	31	382	385	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					337	341						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380158				2022-12-27	WOS:A1993KE60300052
J	BEDZYK, LA; ESCUDERO, KW; GILL, RE; GRIFFIN, KJ; FRERMAN, FE				BEDZYK, LA; ESCUDERO, KW; GILL, RE; GRIFFIN, KJ; FRERMAN, FE			CLONING, SEQUENCING, AND EXPRESSION OF THE GENES ENCODING SUBUNITS OF PARACOCCUS-DENITRIFICANS ELECTRON-TRANSFER FLAVOPROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A DEHYDROGENASE; ACIDEMIA TYPE-II; CYTOCHROME-C OXIDASE; NUCLEOTIDE-SEQUENCE; UBIQUINONE OXIDOREDUCTASE; ALPHA-SUBUNIT; COA DEHYDROGENASE; PIG-KIDNEY; PURIFICATION; CHAIN	The genes encoding the two subunits of Paracoccus denitrificans electron transfer flavoprotein (ETF) were identified by screening a genomic library constructed in pBluescript II SK+ with probes generated by amplification of genomic sequences by the polymerase chain reaction. Primers for the polymerase chain reaction were designed based on peptide sequences from purified Paracoccus ETF subunits. The genes are arranged in tandem in the genomic DNA with the deoxyadenylic acid residue in the TGA termination codon of the small subunit providing the deoxyadenylic acid residue for the ATG initiating codon of the large subunit. The deduced amino acid sequences of the ETF subunits exhibits extensive sequence identity with the human ETF subunits. The Paracoccus ETF is expressed from the pBluescript vector in Escherichia coli, yielding 30 mg of purified, catalytically active protein per liter of culture.	UNIV COLORADO, SCH MED, DEPT MICROBIOL, DENVER, CO 80262 USA; UNIV COLORADO, SCH MED, PROGRAM CELLULAR & DEV BIOL, DENVER, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	BEDZYK, LA (corresponding author), UNIV COLORADO, SCH MED, DEPT PEDIAT, DENVER, CO 80262 USA.				NICHD NIH HHS [HD04024, HD08315, T32 HD07385] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007385, P30HD004024] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARIGONI F, 1991, MOL GEN GENET, V225, P514, DOI 10.1007/BF00261695; ARSCOTT LD, 1982, FLAVINS FLAVOPROTEIN, P44; BECKMANN JD, 1981, BIOCHEM BIOPH RES CO, V102, P1290, DOI 10.1016/S0006-291X(81)80151-9; BECKMANN JD, 1985, BIOCHEMISTRY-US, V24, P3913, DOI 10.1021/bi00336a016; BECKMANN JD, 1983, J BIOL CHEM, V258, P7563; BYRON CM, 1990, BIOCHEMISTRY-US, V29, P3691, DOI 10.1021/bi00467a015; COLOMBO I, 1992, PROG CLIN BIOL RES, V375, P561; FINOCCHIARO G, 1988, J BIOL CHEM, V263, P15773; FINOCCHIARO G, 1993, EUR J BIOCHEM, V213, P1003, DOI 10.1111/j.1432-1033.1993.tb17847.x; FRENEAUX E, 1992, J CLIN INVEST, V90, P1679, DOI 10.1172/JCI116040; FRERMAN FE, 1985, P NATL ACAD SCI USA, V82, P4517, DOI 10.1073/pnas.82.13.4517; FRERMAN FE, 1987, T BIOCH SOC, V16, P416; GABELLINI N, 1986, EUR J BIOCHEM, V154, P569, DOI 10.1111/j.1432-1033.1986.tb09437.x; GOODMAN SI, 1992, PROG CLIN BIOL RES, V375, P567; GORELICK RJ, 1985, BIOCHEMISTRY-US, V24, P6830, DOI 10.1021/bi00345a015; GORELICK RJ, 1982, BIOCHEMISTRY-US, V21, P6936, DOI 10.1021/bi00269a049; HARMS N, 1987, J BACTERIOL, V169, P3969, DOI 10.1128/jb.169.9.3969-3975.1987; HUSAIN M, 1985, J BACTERIOL, V163, P709, DOI 10.1128/JB.163.2.709-715.1985; HUSAIN M, 1984, BIOCHEM J, V219, P1043, DOI 10.1042/bj2191043; IKEDA Y, 1986, J CLIN INVEST, V78, P997, DOI 10.1172/JCI112691; IZAI K, 1992, J BIOL CHEM, V267, P1027; KLEIN K, 1973, THESIS U COLOGNE; KNOTH K, 1988, NUCLEIC ACIDS RES, V16, P10932, DOI 10.1093/nar/16.22.10932; KUROWSKI B, 1987, J BIOL CHEM, V262, P13805; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOEHR JP, 1990, PEDIATR RES, V27, P311, DOI 10.1203/00006450-199003000-00024; MCKEAN MC, 1983, J BIOL CHEM, V258, P1866; MERMOD N, 1984, EMBO J, V3, P2461, DOI 10.1002/j.1460-2075.1984.tb02156.x; MILLER GL, 1956, ANAL CHEM, V61, P695; RAITIO M, 1987, EMBO J, V6, P2825, DOI 10.1002/j.1460-2075.1987.tb02579.x; RUZICKA FJ, 1977, J BIOL CHEM, V252, P8440; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARIMO SS, 1969, J BACTERIOL, V98, P368, DOI 10.1128/JB.98.2.368-374.1969; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEINRUCKE P, 1987, EUR J BIOCHEM, V167, P431, DOI 10.1111/j.1432-1033.1987.tb13356.x; STROUTHAMER AH, 1980, TRENDS BIOCHEM SCI, V5, P164; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANSPANNING RJM, 1990, J BACTERIOL, V172, P986, DOI 10.1128/jb.172.2.986-996.1990; VANSPANNING RJM, 1991, J BACTERIOL, V173, P6948, DOI 10.1128/jb.173.21.6948-6961.1991; VOGT VM, 1970, J BIOL CHEM, V245, P4760; WALLER JP, 1963, J MOL BIOL, V7, P483, DOI 10.1016/S0022-2836(63)80096-0; WATMOUGH NJ, 1992, EUR J BIOCHEM, V205, P1089, DOI 10.1111/j.1432-1033.1992.tb16877.x; XU XM, 1991, BIOCHEMISTRY-US, V30, P8678, DOI 10.1021/bi00099a027; XU XM, 1991, BIOCHEMISTRY-US, V30, P6422, DOI 10.1021/bi00240a012; YAGI T, 1986, ARCH BIOCHEM BIOPHYS, V250, P302, DOI 10.1016/0003-9861(86)90731-9	47	31	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20211	20217						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376381				2022-12-27	WOS:A1993LY01900046
J	GAMBEL, AM; MENICK, DR				GAMBEL, AM; MENICK, DR			PHOSPHORYLATION AND REACTION INTERMEDIATES OF THE PROKARYOTIC CA(2+)-ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; ADENOSINE-TRIPHOSPHATASE; ATP SYNTHESIS; TRANSPORT ATPASE; BINDING-SITES; CALCIUM-PUMP; MEMBRANE; PI; CA-2+-ATPASE; SODIUM	A P-type Ca2+-ATPase activity has been identified previously in membranes of the Gram-negative bacteria Flavobacterium odoratum. The reaction mechanism of the prokaryotic Ca2+-ATPase was examined by isolation of reaction cycle intermediates formed during reversal of the normal cycle using inorganic P(i). The eukaryotic ATPase can be directly phosphorylated by P(i) only in the absence of calcium, and half-maximal inhibition is observed at 1-2 muM calcium. The F. odoratum Ca2+-ATPase is also phosphorylated by P(i) in the absence of calcium, but in contrast to the eukaryotic pump, a 30-35-fold increase in phosphoenzyme (E-P) formation is observed when the enzyme is preincubated in millimolar calcium. Furthermore, the half-maximal activation of E-P formation is observed at approximately 100 muM calcium, similar to the value for low-affinity calcium binding in the sarcoplasmic reticulum Ca2+-ATPase. The data suggest that the prokaryotic Ca2+-ATPase forward reaction is ordered and that the prokaryotic enzyme does not appear to bind calcium at the high-affinity site until ATP binds. Thus, calcium does not inhibit phosphoenzyme formation by P(i) because the high-affinity Ca2+ binding site is not exposed on the free enzyme (E1).	MED UNIV S CAROLINA, DEPT MED, DIV CARDIOL, 171 ASHLEY AVE, CHARLESTON, SC 29425 USA; MED UNIV S CAROLINA, DEPT BIOCHEM & MOLEC BIOL, CHARLESTON, SC 29425 USA; MED UNIV S CAROLINA, CARDIAC RES INST, CHARLESTON, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044202] Funding Source: NIH RePORTER; NHLBI NIH HHS [NHLBI R01 44202] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALVES EW, 1987, EUR J BIOCHEM, V166, P647, DOI 10.1111/j.1432-1033.1987.tb13562.x; BLOSTEIN R, 1979, J BIOL CHEM, V254, P6673; CLARKE DM, 1990, J BIOL CHEM, V265, P6262; DAME JB, 1980, BIOCHEMISTRY-US, V19, P2931, DOI 10.1021/bi00554a018; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; DEMEIS L, 1988, J BIOL CHEM, V263, P157; DEMEIS L, 1991, EUR J BIOCHEM, V200, P209; DEMEIS L, 1991, J BIOL CHEM, V266, P5736; DEMEIS L, 1988, METHOD ENZYMOL, V157, P190; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; GAMBEL AM, 1992, J BIOL CHEM, V267, P15923; GLYNN IM, 1975, ANNU REV PHYSIOL, V37, P13, DOI 10.1146/annurev.ph.37.030175.000305; GUILLAIN F, 1984, BIOCHEMISTRY-US, V23, P4754, DOI 10.1021/bi00315a034; HANEL AM, 1990, BIOCHEMISTRY-US, V29, P5210, DOI 10.1021/bi00473a030; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; INESI G, 1992, ADV ENZYMOL RAMB, V65, P185; JENCKS WP, 1983, CURR TOP MEMBR TRANS, V19, P1; KNOWLES AF, 1975, J BIOL CHEM, V250, P1949; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAKINOSE M, 1971, FEBS LETT, V12, P271, DOI 10.1016/0014-5793(71)80196-5; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; MENICK DR, 1992, ANN NY ACAD SCI, V671, P427, DOI 10.1111/j.1749-6632.1992.tb43819.x; OGURUSU T, 1991, BIOCHEMISTRY-US, V30, P9966, DOI 10.1021/bi00105a022; PICKART CM, 1984, J BIOL CHEM, V259, P1629; SANDELEMOS MP, 1988, J BIOL CHEM, V263, P3795; Silhavy T. J., 1984, EXPT GENE FUSIONS; STAHL N, 1987, BIOCHEMISTRY-US, V26, P7654, DOI 10.1021/bi00398a019; SUMBILLA C, 1991, J BIOL CHEM, V266, P12682	28	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20590	20597						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376412				2022-12-27	WOS:A1993LY01900096
J	AHN, KS; SZCZESNASKORUPA, E; KEMPER, B				AHN, KS; SZCZESNASKORUPA, E; KEMPER, B			THE AMINO-TERMINAL 29-AMINO ACIDS OF CYTOCHROME-P450 2C1 ARE SUFFICIENT FOR RETENTION IN THE ENDOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-SPANNING DOMAIN; LUMINAL ER PROTEINS; GOLGI RETENTION; TRANSMEMBRANE DOMAIN; BOVINE 17-ALPHA-HYDROXYLASE; INTRACELLULAR-TRANSPORT; SIGNAL ANCHOR; CELL-SURFACE; EXPRESSION; SEQUENCE	Cytochromes P450 are inserted into and anchored to the endoplasmic reticulum (ER) membrane by a hydrophobic signal sequence at the NH2 terminus. To determine whether the NH2-terminal sequence might also have an ER retention function, the NH2-terminal 29 amino acids of cytochrome P450 2C1, with and without an additional 29 amino acids containing an N-glycosylation site, were fused either to a soluble cytoplasmic protein, Escherichia coli beta-galactosidase, or to a secreted protein, E. coli alkaline phosphatase, and the hybrid proteins were expressed in COS1 cells. Subcellular fractionation indicated that both the beta-galactosidase and alkaline phosphatase hybrid proteins cosedimented with marker enzymes for ER membranes, and localization by immunofluorescent staining was consistent with an ER location. Hybrid proteins with the NH2-terminal glycosylation site were glycosylated in COS1 cells, and the carbohydrate moiety was sensitive to endoglycosidase H digestion, providing further evidence that the proteins were retained in the ER. In vitro studies of membrane insertion of the alkaline phosphatase hybrid indicated that fusion to alkaline phosphatase did not alter the topological properties of the cytochrome P450 NH2-terminal sequence. In addition, alkaline phosphatase fused to the extracellular and transmembrane domains of epidermal growth factor receptor was transported to the plasma membrane in COS1 cells, which establishes that alkaline phosphatase as a cytoplasmic domain does not prevent,transport from the ER. These observations indicate that the large cytoplasmic domain of cytochrome P450 is not required for retention in the ER and suggest that a specific sequence or structure within the NH2-terminal 29 amino acids functions as an ER retention signal.	UNIV ILLINOIS,COLL MED,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign	AHN, KS (corresponding author), UNIV ILLINOIS,DEPT PHYSIOL & BIOPHYS,URBANA,IL 61801, USA.				NIGMS NIH HHS [GM 35897] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035897] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALSTON K, 1991, J BIOL CHEM, V266, P735; ANDERSSON M, 1985, CELL, V43, P215, DOI 10.1016/0092-8674(85)90026-1; AOKI D, 1992, P NATL ACAD SCI USA, V89, P4319, DOI 10.1073/pnas.89.10.4319; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGERT HG, 1985, CELL, V41, P987, DOI 10.1016/S0092-8674(85)80079-9; BURKE J, 1992, J BIOL CHEM, V267, P24433; CLARK BJ, 1991, J BIOL CHEM, V266, P5898; CLARK BJ, 1992, J BIOL CHEM, V267, P24568; COLLEY KJ, 1992, J BIOL CHEM, V267, P7784; DAHLLOF B, 1991, J BIOL CHEM, V266, P1804; DELEMOSCHIARANDINI C, 1987, J CELL BIOL, V104, P209, DOI 10.1083/jcb.104.2.209; FOWLER AV, 1983, J BIOL CHEM, V258, P4354; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; GUT J, 1983, J BIOL CHEM, V258, P8588; IVESSA NE, 1992, J CELL BIOL, V117, P949, DOI 10.1083/jcb.117.5.949; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KRONBACH T, 1991, BIOCHEMISTRY-US, V30, P6097, DOI 10.1021/bi00239a003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSON JR, 1991, J BIOL CHEM, V266, P7321; MACHAMER CE, 1987, J CELL BIOL, V105, P1205, DOI 10.1083/jcb.105.3.1205; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; Miller J. H, 1972, EXPT MOL GENETICS; MONIER S, 1988, J CELL BIOL, V107, P457, DOI 10.1083/jcb.107.2.457; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; NELSON DR, 1988, J BIOL CHEM, V263, P6038; NILSSON T, 1991, EMBO J, V10, P3567, DOI 10.1002/j.1460-2075.1991.tb04923.x; OHTA Y, 1992, BIOCHEMISTRY-US, V31, P12680, DOI 10.1021/bi00165a019; OMURA T, 1970, J BIOCHEM-TOKYO, V67, P249, DOI 10.1093/oxfordjournals.jbchem.a129248; ORCI L, 1993, NATURE, V362, P648, DOI 10.1038/362648a0; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; RUSSO RN, 1992, J BIOL CHEM, V267, P9241; SAKAGUCHI M, 1984, P NATL ACAD SCI-BIOL, V81, P3361, DOI 10.1073/pnas.81.11.3361; SAKAGUCHI M, 1987, EMBO J, V6, P2425, DOI 10.1002/j.1460-2075.1987.tb02521.x; SAKAKI T, 1992, J BIOL CHEM, V267, P16497; SCHIMMEL SD, 1973, P NATL ACAD SCI USA, V70, P3195, DOI 10.1073/pnas.70.11.3195; SHIN J, 1991, P NATL ACAD SCI USA, V88, P1918, DOI 10.1073/pnas.88.5.1918; SWIFT AM, 1991, J CELL BIOL, V115, P19, DOI 10.1083/jcb.115.1.19; SZCZESNASKORUPA E, 1988, P NATL ACAD SCI USA, V85, P738, DOI 10.1073/pnas.85.3.738; SZCZESNASKORUPA E, 1993, J BIOL CHEM, V268, P1757; SZCZESNASKORUPA E, 1989, J CELL BIOL, V108, P1237, DOI 10.1083/jcb.108.4.1237; TANG BL, 1992, J BIOL CHEM, V267, P7072; TEASDALE RD, 1992, J BIOL CHEM, V267, P4084; VALETTI C, 1991, J CELL BIOL, V115, P983, DOI 10.1083/jcb.115.4.983; VERTEL BM, 1989, J CELL BIOL, V109, P1827, DOI 10.1083/jcb.109.4.1827; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; YABUSAKI Y, 1988, DNA-J MOLEC CELL BIO, V7, P701, DOI 10.1089/dna.1988.7.701; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	51	65	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18726	18733						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360166				2022-12-27	WOS:A1993LV65900057
J	KJAERULFF, S; ANDERSEN, B; NIELSEN, VS; MOLLER, BL; OKKELS, JS				KJAERULFF, S; ANDERSEN, B; NIELSEN, VS; MOLLER, BL; OKKELS, JS			THE PSI-K SUBUNIT OF PHOTOSYSTEM-I FROM BARLEY (HORDEUM-VULGARE L) - EVIDENCE FOR A GENE DUPLICATION OF AN ANCESTRAL PSI-G/K GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL CROSS-LINKING; POLYACRYLAMIDE-GEL ELECTROPHORESIS; CDNA CLONE; MEMBRANE-PROTEINS; 9-KDA POLYPEPTIDE; BINDS FERREDOXIN; CENTER-A; CENTER-B; IDENTIFICATION; SPINACH	Photosystem I of barley contains a polypeptide with an apparent molecular mass of 7 kDa when isolated using the detergent n-decyl-beta-D-maltopyranoside. The 7-kDa polypeptide is lost from the PS I complex isolated using Triton X-100. The 7-kDa polypeptide and a corresponding full-length cDNA clone have been isolated. Based on high sequence similarity to an N-terminal sequence of PSI-K from spinach and to the deduced amino acid sequence of Psak from Chlamydomonas reinhardtii the 7-kDa barley polypeptide is identified as PSI-K. The cDNA clone encodes a precursor polypeptide of 131 amino acid residues with a calculated molecular mass of 13,726 Da. The transit peptide shows characteristics of polypeptides imported into the chloroplast. PSI-K has two hydrophobic regions predicted to be membrane-spanning alpha-helices. In vitro expressed prePSI-K polypeptide was imported into intact chloroplasts, whereas an in vitro expressed prePSI-K lacking 7 amino acid residues (Met-Ala-Ser-Gln-Leu-Ser-Ala) at the N-terminal end of the transit peptide failed to be imported. The mRNA encoding PSI-K increases during illumination. PsaK is located in a single locus in the genome. PSI-K has significant similarity to PSI-G. When comparing the barley PSI-K and PSI-G with the reported PSI-K sequence from Synechococcus vulcanus, the degree of similarity is equal, suggesting that an ancestral gene has been duplicated in a chloroplast progenitor but not in a cyano-bacterial.			KJAERULFF, S (corresponding author), ROYAL VET & AGR UNIV, DEPT PLANT BIOL, PLANT BIOCHEM LAB, 40 THORVALDSENSVEJ, DK-1871 FREDERIKSBERG C, DENMARK.		Møller, Birger Lindberg/H-2657-2014; Møller, Birger Lindberg/GQI-1792-2022	Møller, Birger Lindberg/0000-0002-3252-3119; Møller, Birger Lindberg/0000-0002-3252-3119				ANDERSEN B, 1992, PHYSIOL PLANTARUM, V84, P154, DOI 10.1111/j.1399-3054.1992.tb08778.x; ANDERSEN B, 1992, FEBS LETT, V311, P169, DOI 10.1016/0014-5793(92)81391-X; ANDERSEN B, 1990, CURRENT RES PHOTOSYN, V2, P671; ANDERSEN B, 1993, PIGMENT PROTEIN COMP, P383; BRYANT DA, 1992, CURRENT TOPICS PHOTO, V11, P501; CROFTS AR, 1990, CURRENT RES PHOTOSYN, V3, P263; DAHLIN C, 1991, PLANT CELL, V3, P1131, DOI 10.1105/tpc.3.10.1131; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P385; FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9; FRANZEN LG, 1989, MOL GEN GENET, V219, P137; GAVEL Y, 1991, FEBS LETT, V282, P41, DOI 10.1016/0014-5793(91)80440-E; GOLBECK JH, 1991, CURR TOP BIOENERG, V16, P83; HAGEMAN J, 1990, PLANT CELL, V2, P479, DOI 10.1105/tpc.2.5.479; HE WZ, 1992, FEBS LETT, V308, P298, DOI 10.1016/0014-5793(92)81297-Y; HIPPLER M, 1989, FEBS LETT, V250, P280, DOI 10.1016/0014-5793(89)80738-0; HOJ PB, 1987, J BIOL CHEM, V262, P12676; HOSHINA S, 1989, FEBS LETT, V258, P305, DOI 10.1016/0014-5793(89)81680-1; IKEUCHI M, 1992, PLANT CELL PHYSIOL, V33, P669; IKEUCHI M, 1990, FEBS LETT, V263, P274, DOI 10.1016/0014-5793(90)81391-Z; KEEGSTRA K, 1989, ANNU REV PLANT PHYS, V40, P471, DOI 10.1146/annurev.pp.40.060189.002351; KJAERULFF S, 1993, PLANT PHYSIOL, V101, P335; KNOETZEL J, 1992, RES PHOTOSYNTHESIS, V1; LI N, 1991, BIOCHEMISTRY-US, V30, P7863, DOI 10.1021/bi00245a028; LOCKHART PJ, 1992, FEBS LETT, V301, P127, DOI 10.1016/0014-5793(92)81231-A; MERATI G, 1987, FEBS LETT, V215, P37, DOI 10.1016/0014-5793(87)80109-6; NILSSON IM, 1990, CELL, V62, P1135, DOI 10.1016/0092-8674(90)90390-Z; OHOKA H, 1989, PLANT CELL PHYSIOL, V30, P869, DOI 10.1093/oxfordjournals.pcp.a077818; OKKELS JS, 1988, FEBS LETT, V237, P108, DOI 10.1016/0014-5793(88)80181-9; OKKELS JS, 1992, PLANT MOL BIOL, V18, P989, DOI 10.1007/BF00019215; OKKELS JS, 1991, J BIOL CHEM, V266, P6767; OKKELS JS, 1989, FEBS LETT, V250, P575, DOI 10.1016/0014-5793(89)80799-9; OKKELS JS, 1990, CURRENT RES PHOTOSYN, V2, P613; PLOUG M, 1989, ANAL BIOCHEM, V181, P33, DOI 10.1016/0003-2697(89)90390-4; RAO JKM, 1986, BIOCHIM BIOPHYS ACTA, V869, P197, DOI 10.1016/0167-4838(86)90295-5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHELLER HV, 1989, J BIOL CHEM, V264, P6929; SCHELLER HV, 1990, PHYSIOL PLANTARUM, V78, P484, DOI 10.1034/j.1399-3054.1990.780326.x; SCHELLER HV, 1990, CURRENT RES PHOTOSYN, V2, P679; SCHELLER HV, 1992, RES PHOTOSYNTHESIS, V4; SCHELLER HV, 1990, CURRENT RES PHOTOSYN, V3, P609; SCHMIDT GW, 1986, ANNU REV BIOCHEM, V55, P879; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; STEPPUHN J, 1988, FEBS LETT, V237, P218, DOI 10.1016/0014-5793(88)80205-9; STOEHR PJ, 1991, NUCLEIC ACIDS RES, V19, P2227, DOI 10.1093/nar/19.suppl.2227; WYNN RM, 1988, BIOCHEMISTRY-US, V27, P5863, DOI 10.1021/bi00416a007; WYNN RM, 1990, FEBS LETT, V262, P45, DOI 10.1016/0014-5793(90)80150-H; ZANETTI G, 1987, EUR J BIOCHEM, V169, P143, DOI 10.1111/j.1432-1033.1987.tb13591.x; ZILBER AL, 1988, PLANT PHYSIOL, V88, P810, DOI 10.1104/pp.88.3.810; ZILBER AL, 1992, PLANT PHYSIOL, V99, P901, DOI 10.1104/pp.99.3.901	51	33	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18912	18916						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360180				2022-12-27	WOS:A1993LV65900080
J	HARRISON, EH; ROJAS, CJ; GAD, MZ; KEMPNER, ES				HARRISON, EH; ROJAS, CJ; GAD, MZ; KEMPNER, ES			ANALYSIS OF MICROSOMAL CHOLESTERYL ESTER HYDROLASES BY RADIATION INACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED SUBCELLULAR MEMBRANES; RAT-LIVER MICROSOMES; DIFFERENT LABORATORIES; COA HYDROLASE; PURIFICATION; LIPASE; IDENTITY; ENZYMES	Radiation inactivation by high energy electrons, a method for determining the size of a protein without prior purification, was used to study the acid and neutral cholesteryl ester hydrolase (CEH) activities of rat liver microsomes. The same preparations were also assayed for the microsomal, ''nonspecific' carboxylesterases using o-nitrophenyl acetate as substrate. Nonspecific esterase activity surviving radiation could be fit to a single exponential function, the slope of which yielded a target size of 47 +/- 5 kDa (mean +/- S.D., n = 7). Surviving CEH activity assayed at pH 5 could also be fit to a single exponential that yielded a target size of 71 +/- 14 kDa (n = 5). In contrast, the surviving CEH activity assayed at pH 7 was more complex. The data from six experiments were described as the sum of two exponentials, indicating that most of the activity is due to an entity that is three to four times larger and a minor amount to one that is half the size of the pH 5 enzyme. The results are consistent with the suggestion that the acid and neutral microsomal CEH activities are due to distinct enzymes, which are not the ''nonspecific'' carboxylesterases. Their sizes also differ from those previously determined for lysosomal acid lipase and other lipases in the liver.	NIAMSD, PHYS BIOL LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	HARRISON, EH (corresponding author), MED COLL PENN, DEPT BIOCHEM, 2900 QUEEN LANE, PHILADELPHIA, PA 19129 USA.		Harrison, Earl H/AAN-5378-2021; Gad, Mohamed/U-6844-2019	Gad, Mohamed/0000-0003-1173-8628	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044498] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-22633] Funding Source: Medline; NIDDK NIH HHS [R01 DK044498, DK-44498] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMARCOSTESEC A, 1974, J CELL BIOL, V61, P201, DOI 10.1083/jcb.61.1.201; ANDERSON RA, 1991, J BIOL CHEM, V266, P22479; BEAUFAY H, 1974, J CELL BIOL, V61, P188, DOI 10.1083/jcb.61.1.188; BILLHEIMER JT, 1990, J BIOL CHEM, V265, P8632; CAMULLI ED, 1989, BIOCHIM BIOPHYS ACTA, V1005, P177, DOI 10.1016/0005-2760(89)90184-7; COLEMAN RA, 1983, BIOCHIM BIOPHYS ACTA, V751, P230, DOI 10.1016/0005-2760(83)90177-7; DEYKIN D, 1962, J BIOL CHEM, V237, P3649; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Fowler S.D., 1984, P329; GAD MZ, 1991, J LIPID RES, V32, P685; GOODMAN DS, 1964, J BIOL CHEM, V239, P1335; HARMON JT, 1985, METHOD ENZYMOL, V117, P65; HARRISON EH, 1988, BIOCHIM BIOPHYS ACTA, V963, P28, DOI 10.1016/0005-2760(88)90334-7; KLEMETS R, 1984, LIPIDS, V19, P692, DOI 10.1007/BF02534529; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MENTLEIN R, 1985, BIOCHEM J, V232, P479, DOI 10.1042/bj2320479; MENTLEIN R, 1987, BIOCHIM BIOPHYS ACTA, V913, P27, DOI 10.1016/0167-4838(87)90228-7; MENTLEIN R, 1980, ARCH BIOCHEM BIOPHYS, V200, P547, DOI 10.1016/0003-9861(80)90386-0; MUKHERJEE S, 1958, J BIOL CHEM, V230, P91; NILSSON A, 1976, BIOCHIM BIOPHYS ACTA, V450, P379, DOI 10.1016/0005-2760(76)90011-4; REINHART MP, 1987, J BIOL CHEM, V262, P9649; RIDDLE MC, 1975, BIOCHIM BIOPHYS ACTA, V388, P339, DOI 10.1016/0005-2760(75)90092-2; ROBBI M, 1983, EUR J BIOCHEM, V137, P293, DOI 10.1111/j.1432-1033.1983.tb07828.x; ROJAS CJ, 1991, FASEB J, V5, pA948	24	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17867	17870						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349671				2022-12-27	WOS:A1993LT74300036
J	WOTTON, D; WAYS, DK; PARKER, PJ; OWEN, MJ				WOTTON, D; WAYS, DK; PARKER, PJ; OWEN, MJ			ACTIVITY OF BOTH RAF AND RAS IS NECESSARY FOR ACTIVATION OF TRANSCRIPTION OF THE HUMAN T-CELL RECEPTOR BETA-GENE BY PROTEIN-KINASE-C, RAS PLAYS MULTIPLE ROLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN RECEPTOR; TYROSINE KINASE; FUNCTIONAL-ANALYSIS; HUMAN-LYMPHOCYTES; RESPONSE ELEMENT; CYCLOSPORINE-A; MICE LACKING; V-RAF; EXPRESSION; ENHANCER	Transcription of the T cell receptor beta gene is up-regulated during T cell activation. We have previously defined the elements within the TcR beta gene enhancer responsible for increased transcription in response to phorbol esters, which mimic part of the pathway for T cell activation. Using a reporter construct (betaE2x4) containing four copies of this inducible element, activation was achieved by the addition of phytohemagglutenin or phorbol esters. Activation was observed after 2 h of treatment, was maximal by 8 h, and could be blocked by the protein synthesis inhibitor cycloheximide. Coexpression of v-Ha-Ras-, v-Raf-, and v-Src-activated betaE2x4, and constitutively active mutants of protein kinase C also increased transcription from this construct. Calcium ionophore generated signals which synergized with both Ras and protein kinase C. Expression of a truncated Raf protein which has been shown to act in a dominant negative manner, was able to inhibit activation of betaE2x4, demonstrating that Raf plays an important role in T cell signaling. A dominant negative mutant of v-Ha-Ras inhibited all methods of activation tested, including transfection with v-Raf. Thus, Ras activity appears to be necessary at more than one point in the transduction of signals from T cell receptor to nucleus.	IMPERIAL CANC RES FUND,LYM PHOCYTE MOLEC BIOL LABS,POB 123,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND; IMPERIAL CANC RES FUND,PROT PHOSPHORYLAT LABS,LONDON WC2A 3PX,ENGLAND	Cancer Research UK; Cancer Research UK			Parker, Peter j/D-5192-2013	parker, peter/0000-0002-6218-2933; Wotton, David/0000-0002-4652-5350				ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; ALLISON JP, 1987, ANNU REV IMMUNOL, V5, P503, DOI 10.1146/annurev.iy.05.040187.002443; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; BALDARI CT, 1993, J BIOL CHEM, V268, P2693; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; CANTRELL DA, 1988, IMMUNOLOGY, V65, P393; COOKE M P, 1989, New Biologist, V1, P66; COOKE MP, 1991, CELL, V65, P281, DOI 10.1016/0092-8674(91)90162-R; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; GOTTSCHALK LR, 1990, MOL CELL BIOL, V10, P5486, DOI 10.1128/MCB.10.10.5486; GUTMAN A, 1991, MOL CELL BIOL, V11, P5381, DOI 10.1128/MCB.11.10.5381; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; HIVROZBURGAUD C, 1991, EUR J IMMUNOL, V21, P2811, DOI 10.1002/eji.1830211124; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; HSI ED, 1989, J BIOL CHEM, V264, P10836; IZQUIERDO M, 1992, MOL CELL BIOL, V12, P3305, DOI 10.1128/MCB.12.7.3305; JENKINSON EJ, 1989, T CELLS, P17; JUNE CH, 1990, J IMMUNOL, V144, P1591; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; KRIMPENFORT P, 1988, EMBO J, V7, P745, DOI 10.1002/j.1460-2075.1988.tb02871.x; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LINDSTEN T, 1988, J IMMUNOL, V141, P1769; MARAIS RM, 1989, EUR J BIOCHEM, V182, P129, DOI 10.1111/j.1432-1033.1989.tb14809.x; MATTILA PS, 1990, EMBO J, V9, P4425, DOI 10.1002/j.1460-2075.1990.tb07893.x; MEDEMA RH, 1991, MOL CELL BIOL, V11, P5963, DOI 10.1128/MCB.11.12.5963; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; OHASHI PS, 1990, NATURE, V346, P861, DOI 10.1038/346861a0; PATEL G, 1989, CELL SIGNAL, V1, P227, DOI 10.1016/0898-6568(89)90040-5; PEARS C, 1991, FEBS LETT, V284, P120, DOI 10.1016/0014-5793(91)80776-Y; PROSSER HM, 1991, EUR J IMMUNOL, V21, P161, DOI 10.1002/eji.1830210124; PROSSER HM, 1992, P NATL ACAD SCI USA, V89, P9934, DOI 10.1073/pnas.89.20.9934; QURESHI SA, 1992, J BIOL CHEM, V267, P17635; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; RAYTER SI, 1992, EMBO J, V11, P4549, DOI 10.1002/j.1460-2075.1992.tb05556.x; REED JC, 1986, P NATL ACAD SCI USA, V83, P3982, DOI 10.1073/pnas.83.11.3982; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SATOH T, 1990, P NATL ACAD SCI USA, V87, P5993, DOI 10.1073/pnas.87.15.5993; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SLEIGH MJ, 1986, ANAL BIOCHEM, V156, P251, DOI 10.1016/0003-2697(86)90180-6; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; TAKEDA J, 1990, MOL CELL BIOL, V10, P5027, DOI 10.1128/MCB.10.10.5027; TOYONAGA B, 1987, ANNU REV IMMUNOL, V5, P585, DOI 10.1146/annurev.immunol.5.1.585; TROPPMAIR J, 1992, ONCOGENE, V7, P1867; WET JR, 1987, MOL CELL BIOL, V7, P725; WOODROW MA, 1993, J IMMUNOL, V150, P3853	52	33	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17975	17982						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349679				2022-12-27	WOS:A1993LT74300052
J	BUXEDA, RJ; NICKELS, JT; CARMAN, GM				BUXEDA, RJ; NICKELS, JT; CARMAN, GM			REGULATION OF THE 45-KDA AND 55-KDA FORMS OF PHOSPHATIDYLINOSITOL 4-KINASE FROM THE YEAST SACCHAROMYCES-CEREVISIAE BY NUCLEOTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CONTAINING SPHINGOLIPIDS; INOSITOL STARVATION; CELL-PROLIFERATION; KINETIC-ANALYSIS; MIXED MICELLES; BIOSYNTHESIS; MEMBRANE; SYNTHASE; DIPHOSPHOINOSITIDE	The synthesis of phosphatidylinositol (PI) 4-phosphate and PI 4,5-bisphosphate in the yeast Saccharomyces cerevisiae is stimulated by glucose. PI 4-kinase (ATP:phosphatidylinositol 4-phosphotransferase, EC 2.7.1.67) catalyzes the committed step in the synthesis of these phosphoinositides. Previous studies have suggested that the glucose effect on phosphoinositide synthesis is mediated by cellular levels of ATP and ADP and by the RAS/cAMP pathway. Using purified preparations of the membrane-associated 45- and 55-kDa forms of PI 4-kinase, we examined the regulation of these activities by nucleotides and cAMP-dependent protein kinase. MgADP was a potent inhibitor of both forms of the enzyme. Detailed kinetic analyses of the 45- and 55-kDa enzymes using Triton X- 100/PI-mixed micelles showed that MgADP was a competitive inhibitor (K(i) = 0.14 and 0.25 mM, respectively) with respect to MgATP and a noncompetitive inhibitor (K(i) = 1.3 and 0.9 mM, respectively) with respect to PI. The K(i) values for MgADP were about 2-fold lower than the K(m) values the enzymes have for their substrate MgATP and about 2-fold lower than the cellular concentration of ADP. The 45- and 55-kDa forms of PI 4-kinase activity were regulated differentially by CTP, an important nucleotide involved in phospholipid biosynthesis. Whereas the 55-kDa PI 4-kinase was inhibited by CTP, the 45-kDa enzyme was unaffected by CTP. CTP was a mixed type of inhibitor (K(i) = 1.5 mM) with respect to MgATP and a noncompetitive inhibitor (K(i) = 4 mM) with respect to PI. The K(i) value for CTP was 4-fold higher than the K(m) value for MgATP and 7-fold higher than the cellular concentration of CTP. The 45- and 55-kDa PI 4-kinases were neither phosphorylated nor regulated by cAMP-dependent protein kinase. These results did not support the previous conclusion that PI 4-phosphate synthesis was mediated by the RAS/cAMP pathway. Our kinetic studies supported the conclusion that the glucose effect on the synthesis of PI 4-phosphate was mediated by cellular levels of ATP and ADP through the regulation of membrane-associated PI 4-kinase activity.	RUTGERS STATE UNIV,COOK COLL,NEW JERSEY AGR EXPT STN,DEPT FOOD SCI,NEW BRUNSWICK,NJ 08903	Rutgers State University New Brunswick					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035655] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-35655] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUGER KR, 1989, J BIOL CHEM, V264, P20181; BECKER GW, 1980, J BACTERIOL, V142, P747, DOI 10.1128/JB.142.3.747-754.1980; BELUNIS CJ, 1988, J BIOL CHEM, V263, P18897; BERRIDGE MJ, 1987, BIOCHIM BIOPHYS ACTA, V907, P33, DOI 10.1016/0304-419X(87)90017-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; BUXEDA RJ, 1991, J BIOL CHEM, V266, P13859; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; CARPENTER CL, 1990, BIOCHEMISTRY-US, V29, P11147, DOI 10.1021/bi00503a001; COLODZIN M, 1965, J BIOL CHEM, V240, P3771; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; DOWNES CP, 1990, EUR J BIOCHEM, V193, P1, DOI 10.1111/j.1432-1033.1990.tb19297.x; FLANAGAN CA, 1992, J BIOL CHEM, V267, P24117; FRASCOTTI G, 1990, FEBS LETT, V274, P19, DOI 10.1016/0014-5793(90)81319-J; HANSON BA, 1982, J BACTERIOL, V151, P334, DOI 10.1128/JB.151.1.334-342.1982; HANSON BA, 1984, J BACTERIOL, V159, P837, DOI 10.1128/JB.159.3.837-842.1984; HENRY SA, 1977, J BACTERIOL, V130, P472, DOI 10.1128/JB.130.1.472-484.1977; HOLLAND KM, 1988, J BACTERIOL, V170, P828, DOI 10.1128/jb.170.2.828-833.1988; KAIBUCHI K, 1986, P NATL ACAD SCI USA, V83, P8172, DOI 10.1073/pnas.83.21.8172; KATO H, 1989, J BIOL CHEM, V264, P3116; KELLEY MJ, 1987, J BIOL CHEM, V262, P14563; Kennedy E. P., 1986, LIPIDS MEMBRANES PRE, P171; KINNEY AJ, 1988, P NATL ACAD SCI USA, V85, P7962, DOI 10.1073/pnas.85.21.7962; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LESTER RL, 1968, J BIOL CHEM, V243, P4889; LOPEZ G, 1992, J NEUROCHEM, V59, P338; MCKENZIE MA, 1982, J FOOD BIOCHEM, V6, P77, DOI 10.1111/j.1745-4514.1982.tb00297.x; MICHELL RH, 1992, TRENDS BIOCHEM SCI, V17, P274, DOI 10.1016/0968-0004(92)90433-A; NICKELS JT, 1992, J BIOL CHEM, V267, P16297; NIKAWA J, 1987, J BIOL CHEM, V262, P4876; OZIERKALOGEROPOULOS O, 1991, MOL GEN GENET, V231, P7, DOI 10.1007/BF00293815; PATTON JL, 1991, J BACTERIOL, V173, P3101, DOI 10.1128/JB.173.10.3101-3108.1991; PATTON JL, 1992, ARCH BIOCHEM BIOPHYS, V292, P70, DOI 10.1016/0003-9861(92)90052-X; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; QUINLAN JJ, 1992, J BIOL CHEM, V267, P18013; Segel IH., 1975, ENZYME KINETICS, P1, DOI 10.1016/0014-5793(75)80457-1; STEINER S, 1972, J BACTERIOL, V109, P81, DOI 10.1128/JB.109.1.81-88.1972; TALWALKAR RT, 1973, BIOCHIM BIOPHYS ACTA, V306, P412, DOI 10.1016/0005-2760(73)90180-X; TALWALKAR RT, 1974, BIOCHIM BIOPHYS ACTA, V360, P306, DOI 10.1016/0005-2760(74)90060-5; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; UNO I, 1988, NATURE, V333, P188, DOI 10.1038/333188a0; VANCE DE, 1980, J BIOL CHEM, V255, P1064	42	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1993	268	9					6248	6255						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KT368	8384205				2022-12-27	WOS:A1993KT36800029
J	PELLERIN, S; LAFEUILLADE, B; SCHERRER, N; GAGNON, J; SHI, DL; CHAMBAZ, EM; FEIGE, JJ				PELLERIN, S; LAFEUILLADE, B; SCHERRER, N; GAGNON, J; SHI, DL; CHAMBAZ, EM; FEIGE, JJ			CORTICOTROPIN-INDUCED SECRETED PROTEIN, AN ACTH-INDUCED PROTEIN SECRETED BY ADRENOCORTICAL-CELLS, IS STRUCTURALLY RELATED TO THROMBOSPONDINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-BETA; ENDOTHELIAL-CELLS; PLATELET THROMBOSPONDIN; ADHESIVE GLYCOPROTEIN; ADRENAL-CORTEX; 1ST INTRON; BINDING; GENE; BOVINE; STEROIDOGENESIS	The treatment of primary cultures of bovine adrenocortical cells with nanomolar concentrations of ACTH induces a 10-fold increase in the synthesis of a secreted protein of apparent molecular mass 195 kDa on reducing SDS-polyacrylamide gels. This corticotropin-induced secreted protein (CISP) appears to be an oligomeric calcium-binding protein. Its secretion under serum-free culture conditions is sustained over 4 days in the continuous presence of ACTH. Induction of CISP secretion by ACTH is mimicked by cAMP analogs and adenylate cyclase activators. We report here the purification of CISP to apparent homogeneity with an overall yield of 43% using a combination of heparin-agarose and Mono-Q chromatographies. The NH2-terminal amino acid sequence and the sequence of several tryptic peptides revealed that CISP is structurally related to the members of the thrombospondin (TSP) family. Among these members, bovine CISP appeared to be more homologous to mouse TSP2 (85% identity in the 29 amino acid long NH2-terminal sequence) than to TSP1 (18% identity in the same region). We also observed that CISP binds Ca2+ and is an adhesive protein for bovine adrenocortical cells. Thus, CISP possesses both structural and functional properties of thrombospondins. Whether CISP represents the bovine form of TSP2 or a novel member of the expanding thrombospondin family will need to be elucidated by cloning and sequencing of a larger portion of the molecule.	CEN, DEPT BIOL MOLEC & STRUCT, INSERM, U244, F-38041 GRENOBLE, FRANCE; INST BIOL STRUCT, F-38027 GRENOBLE, FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)			Gagnon, Jean/C-3136-2008; Feige, Jean-Jacques/M-8905-2017	Gagnon, Jean/0000-0002-0177-824X; Feige, Jean-Jacques/0000-0002-1354-7692				BACONBAGULEY T, 1990, J BIOL CHEM, V265, P2317; BAENZIGER NL, 1972, J BIOL CHEM, V247, P2723; BORNSTEIN P, 1990, J BIOL CHEM, V265, P16691; BORNSTEIN P, 1991, J BIOL CHEM, V266, P12821; BORNSTEIN P, 1991, P NATL ACAD SCI USA, V88, P8636, DOI 10.1073/pnas.88.19.8636; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Chiquet-Ehrismann R, 1991, CURR OPIN CELL BIOL, V3, P800, DOI 10.1016/0955-0674(91)90053-2; COCHET C, 1988, J BIOL CHEM, V263, P5707; DAZORD A, 1983, ANN ENDOCRINOL-PARIS, V44, P15; DIXIT VM, 1986, P NATL ACAD SCI USA, V83, P5449, DOI 10.1073/pnas.83.15.5449; DONOVIEL DB, 1988, J BIOL CHEM, V263, P18590; DUPERRAY A, 1980, J STEROID BIOCHEM, V13, P1359, DOI 10.1016/0022-4731(80)90098-9; FEIGE JJ, 1982, MOL CELL ENDOCRINOL, V28, P645, DOI 10.1016/0303-7207(82)90152-6; FEIGE JJ, 1991, ENDOCR RES, V17, P267, DOI 10.1080/07435809109027201; FRAZIER WA, 1987, J CELL BIOL, V105, P625, DOI 10.1083/jcb.105.2.625; Frazier WA, 1991, CURR OPIN CELL BIOL, V3, P792, DOI 10.1016/0955-0674(91)90052-Z; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JAFFE EA, 1985, BLOOD, V65, P79; JAFFE EA, 1983, P NATL ACAD SCI-BIOL, V80, P998, DOI 10.1073/pnas.80.4.998; JIANG ZW, 1992, J CELL PHYSIOL, V153, P266, DOI 10.1002/jcp.1041530206; KOBAYASHI S, 1986, BIOCHEMISTRY-US, V25, P8418, DOI 10.1021/bi00374a014; KRUEGER RJ, 1983, J BIOL CHEM, V258, P159; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAHERTY CD, 1989, J BIOL CHEM, V264, P11222; LAHERTY CD, 1992, J BIOL CHEM, V267, P3274; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; LAWLER J, 1991, J BIOL CHEM, V266, P8039; LAWLER J, 1986, BLOOD, V67, P1197; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; MAJACK RA, 1986, P NATL ACAD SCI USA, V83, P9050, DOI 10.1073/pnas.83.23.9050; MAJACK RA, 1988, J CELL BIOL, V106, P415, DOI 10.1083/jcb.106.2.415; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; MCPHERSON J, 1981, J BIOL CHEM, V256, P1330; MOSHER DF, 1982, J CELL BIOL, V93, P343, DOI 10.1083/jcb.93.2.343; MURPHYULLRICH JE, 1992, MOL BIOL CELL, V3, P181, DOI 10.1091/mbc.3.2.181; MURPHYULLRICH JE, 1989, J CELL BIOL, V109, P1309, DOI 10.1083/jcb.109.3.1309; PHAN SH, 1989, BIOCHEM BIOPH RES CO, V163, P56, DOI 10.1016/0006-291X(89)92098-6; PON LA, 1986, J BIOL CHEM, V261, P6594; RAINEY WE, 1983, ENDOCRINOLOGY, V113, P48, DOI 10.1210/endo-113-1-48; RAUGI GJ, 1982, J CELL BIOL, V95, P351, DOI 10.1083/jcb.95.1.351; ROBERTS AB, 1988, RECENT PROG HORM RES, V44, P157; ROBERTS DD, 1987, J CELL BIOL, V104, P131, DOI 10.1083/jcb.104.1.131; SAEZ JM, 1981, ADV CYCL NUCL RES<D>, V14, P563; SAGE EH, 1991, J BIOL CHEM, V266, P14831; SANTORO SA, 1987, SEMIN THROMB HEMOST, V13, P290, DOI 10.1055/s-2007-1003504; SANTORO SA, 1987, METHOD ENZYMOL, V144, P438; Schimmer B P, 1980, Adv Cyclic Nucleotide Res, V13, P181; SHI DL, 1990, J BIOL CHEM, V265, P2881; SILVERSTEIN RL, 1986, ARTERIOSCLEROSIS, V6, P245, DOI 10.1161/01.ATV.6.3.245; SIMONIAN MH, 1981, ENDOCRINOLOGY, V108, P1769, DOI 10.1210/endo-108-5-1769; SIMPSON ER, 1988, ANNU REV PHYSIOL, V50, P427, DOI 10.1146/annurev.ph.50.030188.002235; SLAVINSKITURLEY EA, 1978, ENDOCRINOLOGY, V78, P427; TUSZYNSKI GP, 1987, SEMIN THROMB HEMOST, V13, P361, DOI 10.1055/s-2007-1003512; TUSZYNSKI GP, 1987, SCIENCE, V236, P1570, DOI 10.1126/science.2438772; VARANI J, 1988, J CLIN INVEST, V81, P1537, DOI 10.1172/JCI113486; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; YAMADA KM, 1991, J BIOL CHEM, V266, P12809	60	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					4304	4310						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382699				2022-12-27	WOS:A1993KN53300072
J	SCHUMANN, MA; GARDNER, P; RAFFIN, TA				SCHUMANN, MA; GARDNER, P; RAFFIN, TA			RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR-ALPHA INDUCES CALCIUM OSCILLATION AND CALCIUM-ACTIVATED CHLORIDE CURRENT IN HUMAN NEUTROPHILS - THE ROLE OF CALCIUM CALMODULIN-DEPENDENT PROTEIN-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHERENT HUMAN-NEUTROPHILS; CYTOSOLIC-FREE CALCIUM; RESPIRATORY BURST; ION CHANNELS; FREE CA-2+; CELLS; STIMULATION; LYMPHOCYTES; CONDUCTANCE; PLASMA	The role of calcium in the action of tumor necrosis factor (TNF) on human neutrophils is not clear. With fluorescent cytometry, using the visible wavelength calcium probe, fluo-3, and patch clamping, we investigated whether TNF induces cytosolic free Ca2+ changes and Ca2+-activated Cl- current, respectively. Bath application of 1000 units/ml recombinant human TNFalpha (rhTNFalpha) induced a rise in cytosolic free Ca2+ in 75% of fluo-3-loaded cells, 25% of which displayed irregular patterns of oscillation. Addition of rhTNFalpha activated Cl- current in 80% of tested cells; the activated current was blocked by 10 muM 5-nitro-2-3-phenylpropylamino) benzoic acid, a Cl- channel blocker. The current was similarly activated by 1 muM ionomycin, a Ca2+ ionophore. To study the mechanism by which rhTNFalpha induced Ca2+-activated Cl- current, we examined the involvement of calcium/calmodulin-dependent protein kinase (CaM kinase). With intracellular application of the Ca2+ chelator 1,2-bis(2-amino-ethane-N,N,N',N'-tetraacetate (5 mM), the calmodulin antagonist (2 muM), CaM kinase II-(290-309), or the inhibitory peptide (10 muM), CaM kinase II-(273-302), the current was no longer activated by rhTNFalpha. The intracellular application of the control peptide (10 muM), CaM kinase II-(284-302), or the protein kinase C (PKC) inhibitory, PKC-(19-36), or control, [Glu27]PKC-(19-36), peptide (5 muM) did not block the rhTNFalpha-induced Cl- current. These results show that Ca2+ changes are associated with the effects of rhTNFalpha and that CaM kinase plays a role in the mechanism underlying rhTNFalpha-induced activation of Ca2+-activated Cl- current in human neutrophils.	STANFORD UNIV,MED CTR,SCH MED,DEPT MED,DIV CARDIOL,STANFORD,CA 94305	Stanford University	SCHUMANN, MA (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT MED,DIV PULM & CRIT CARE MED,STANFORD,CA 94305, USA.				NHLBI NIH HHS [HL455330] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGGARWAL BB, 1992, TUMOR NECROSIS FACTO; BAGGIOLINI M, 1990, TRENDS BIOCHEM SCI, V15, P69, DOI 10.1016/0968-0004(90)90179-F; BAJAJ MS, 1992, INFLAMMATION, V16, P241, DOI 10.1007/BF00918813; BAULDRY SA, 1991, J IMMUNOL, V146, P1277; BERKOW RL, 1988, J LEUKOCYTE BIOL, V44, P345, DOI 10.1002/jlb.44.5.345; BLOCK ML, 1990, SCIENCE, V247, P1090, DOI 10.1126/science.2309122; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; CLIFF WH, 1990, P NATL ACAD SCI USA, V87, P4956, DOI 10.1073/pnas.87.13.4956; DIAMOND RD, 1991, J CLIN INVEST, V87, P711, DOI 10.1172/JCI115050; ELSNER J, 1992, J LEUKOCYTE BIOL, V51, P77; GRAY LS, 1986, J IMMUNOL, V136, P3032; GRINSTEIN S, 1989, PHYSIOL REV, V69, P417, DOI 10.1152/physrev.1989.69.2.417; HALLETT MB, 1990, CELL CALCIUM, V11, P655, DOI 10.1016/0143-4160(90)90020-U; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOGG JC, 1987, PHYSIOL REV, V67, P1249, DOI 10.1152/physrev.1987.67.4.1249; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HUANG CK, 1989, MEMBRANE BIOCHEM, V8, P61, DOI 10.3109/09687688909082261; JACONI MEE, 1988, J BIOL CHEM, V263, P10557; KRAUSE KH, 1990, J CLIN INVEST, V85, P491, DOI 10.1172/JCI114464; LEE KH, 1990, MOL ENDOCRINOL, V4, P1671, DOI 10.1210/mend-4-11-1671; LEHRER RI, 1988, ANN INTERN MED, V109, P127, DOI 10.7326/0003-4819-109-2-127; LEW PD, 1984, J CELL BIOL, V99, P1212, DOI 10.1083/jcb.99.4.1212; LEW PD, 1990, AM REV RESPIR DIS, V141, P5127; LYNN WS, 1989, ARCH ENVIRON HEALTH, V44, P323, DOI 10.1080/00039896.1989.9935901; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MARKS PW, 1990, J CELL BIOL, V110, P43, DOI 10.1083/jcb.110.1.43; MATTHEWS G, 1989, J PHYSIOL-LONDON, V418, P131, DOI 10.1113/jphysiol.1989.sp017831; MEAGER A, 1990, CYTOKINES; MERRITT JE, 1990, BIOCHEM J, V269, P513, DOI 10.1042/bj2690513; MEURER R, 1989, BIOCHEM BIOPH RES CO, V159, P763, DOI 10.1016/0006-291X(89)90060-0; MEYER JD, 1988, ARCH SURG-CHICAGO, V123, P1454; NASMITH PE, 1987, FEBS LETT, V221, P95, DOI 10.1016/0014-5793(87)80359-9; NISHIMOTO I, 1991, NEURON, V6, P547, DOI 10.1016/0896-6273(91)90057-7; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; PETERSEN M, 1990, IMMUNOLOGY, V70, P75; RICHTER J, 1989, J IMMUNOL, V142, P3199; RICHTER J, 1990, J LEUKOCYTE BIOL, V47, P506, DOI 10.1002/jlb.47.6.506; RICHTER J, 1990, J BIOL CHEM, V265, P14358; ROSOFF PM, 1988, J BIOL CHEM, V263, P19535; SCHUMANN MA, 1992, BIOCHEM BIOPH RES CO, V185, P531, DOI 10.1016/0006-291X(92)91657-C; SCHUTZE S, 1992, SEMIN ONCOL, V19, P16; SHE ZW, 1989, AM J PHYSIOL, V257, pL338, DOI 10.1152/ajplung.1989.257.6.L338; VONTSCHARNER V, 1986, NATURE, V324, P369, DOI 10.1038/324369a0; WAGNER JA, 1991, NATURE, V349, P793, DOI 10.1038/349793a0; WATSON ML, 1988, IMMUNOLOGY, V65, P567; WILLIAMSON JR, 1989, ANNU REV PHYSIOL, V51, P107, DOI 10.1146/annurev.ph.51.030189.000543; WORRELL RT, 1991, AM J PHYSIOL, V260, pC877, DOI 10.1152/ajpcell.1991.260.4.C877; YONEMARU M, 1989, J LAB CLIN MED, V114, P674	48	68	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2134	2140						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380590				2022-12-27	WOS:A1993KH62000095
J	NAJJAR, SM; ACCILI, D; PHILIPPE, N; JERNBERG, J; MARGOLIS, R; TAYLOR, SI				NAJJAR, SM; ACCILI, D; PHILIPPE, N; JERNBERG, J; MARGOLIS, R; TAYLOR, SI			PP120 ECTO-ATPASE, AN ENDOGENOUS SUBSTRATE OF THE INSULIN-RECEPTOR TYROSINE KINASE, IS EXPRESSED AS 2 VARIABLY SPICED ISOFORMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; PRE-MESSENGER RNA; GLYCOPROTEIN; PROTEIN; CLONING; COMMON; PHOSPHORYLATION; LOCALIZATION; ACTIVATION; ANTIGENS	The insulin receptor possesses tyrosine kinase activity which is thought to mediate the biological effects of insulin upon target cells. pp120 is a liver-specific glycoprotein of apparent molecular size of 120 kDa that is phosphorylated on tyrosine residues by the receptors for insulin, insulin-like growth factor-I, and epidermal growth factor. Previously, we demonstrated that pp120 is identical to a liver-specific ecto-ATPase. In the present study, we have cloned the rat gene encoding pp120/ecto-ATPase. The gene is contained within approximately 15 kilobases of genomic DNA, and consists of nine exons interrupted by eight introns. Using the reverse transcriptase/polymerase chain reaction, we isolated cDNA clones complementary to rat liver mRNA encoding pp120/ecto-ATPase. Sequence analysis indicated the presence of two populations of cDNA's that differ by the presence or absence of a 53-base pair (bp) fragment encoding the juxtamembrane region of the cytoplasmic domain. By cloning the corresponding region of the ecto-ATPase gene, we demonstrated that the 53-bp represents exon 7 of the gene. This 53-bp exon undergoes alternative splicing, thereby giving rise to two mRNA variants. Deletion of this 53-bp cassette exon introduces a frameshift, and results in a premature chain termination codon that truncates the cytoplasmic domain. The truncated cytoplasmic domain contains 10 rather than 71 amino acid residues. Because the short isoform of ecto-ATPase lacks the putative sites for tyrosine- and serine-specific phosphorylation, this alternative splicing may have a major effect upon the physiological function of the enzyme.	NIDDKD,DIABET BRANCH,BLDG 10,RM 85-239,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)			Najjar, Sonia M/GXW-2217-2022; Margolis, Ronald N/O-7773-2015	Margolis, Ronald N/0000-0002-8956-0455				ACCILI D, 1986, ENDOCRINOLOGY, V119, P1274, DOI 10.1210/endo-119-3-1274; AKBAR AN, 1988, J IMMUNOL, V140, P2171; BARNETT TR, 1989, J CELL BIOL, V108, P267, DOI 10.1083/jcb.108.2.267; FREIDENBERG GR, 1991, J CLIN INVEST, V87, P2222, DOI 10.1172/JCI115257; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; KADOWAKI T, 1987, J BIOL CHEM, V262, P7342; KHAN MN, 1989, J BIOL CHEM, V264, P12931; KUROKI M, 1991, BIOCHEM BIOPH RES CO, V176, P578, DOI 10.1016/S0006-291X(05)80223-2; KUROKI M, 1991, J BIOL CHEM, V266, P11810; LIAO K, 1991, J BIOL CHEM, V266, P6544; LIN SH, 1989, J BIOL CHEM, V264, P14408; LIN SH, 1990, ANN NY ACAD SCI, V603, P394; MARGOLIS RN, 1990, BIOCHEM BIOPH RES CO, V166, P562, DOI 10.1016/0006-291X(90)90845-E; MARGOLIS RN, 1988, P NATL ACAD SCI USA, V85, P7256, DOI 10.1073/pnas.85.19.7256; OIKAWA S, 1989, BIOCHEM BIOPH RES CO, V163, P1021, DOI 10.1016/0006-291X(89)92324-3; PERROTTI N, 1987, P NATL ACAD SCI USA, V84, P3137, DOI 10.1073/pnas.84.10.3137; PHILLIPS SA, 1987, FEBS LETT, V212, P141, DOI 10.1016/0014-5793(87)81573-9; REESJONES RW, 1985, J BIOL CHEM, V260, P4461; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STREULI M, 1989, EMBO J, V8, P787, DOI 10.1002/j.1460-2075.1989.tb03439.x; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; TAYLOR SI, 1991, INSULIN LIKE GROWTH, P221; TSAI AYM, 1989, MOL CELL BIOL, V9, P4550, DOI 10.1128/MCB.9.10.4550; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	27	89	90	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1201	1206						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8380406				2022-12-27	WOS:A1993KG07700066
J	CHEN, MJG; SHIH, CL; WANG, K				CHEN, MJG; SHIH, CL; WANG, K			NEBULIN AS AN ACTIN ZIPPER - A 2-MODULE NEBULIN FRAGMENT PROMOTES ACTIN NUCLEATION AND STABILIZES ACTIN-FILAMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE ACTIN; F-ACTIN; THIN-FILAMENTS; CYTOCHALASIN-D; POLYMERIZATION; PHALLOIDIN; PROTEIN; SPECTRIN; BINDING; MECHANISM	Nebulin is a family of giant muscle proteins (700-900 kDa) that interact with actin to form composite thin filaments in the skeletal muscle sarcomere. This modular protein is composed predominantly of repeating sequence modules of 31-38 residues. To understand the minimum size and number of sequence modules that are required for actin interaction, we studied the behavior of a highly soluble two-module nebulin fragment ND8 that was expressed in Escherichia coli. By fluorescence spectroscopy with pyrenyl-actin and co-sedimentation assays, we observed the following. 1) ND8 greatly accelerated actin nucleation, especially in a buffer that is suboptimal for actin nucleation. The presence of ND8 abolished the lag phase of actin polymerization and increased the net extent of steady state polymerization, thereby reducing the critical concentration of actin polymerization. 2) ND8 reduced the rate of actin depolymerization and might increase the rate of elongation. 3) Cytochalasin E, which caps both ends of actin filaments, inhibited the effect of ND8 on actin polymerization and caused the depolymerization of actin-ND8 complexes. These data suggest that ND8 interacts with actin in such a fashion that it stabilizes the actin nuclei and slows the depolymerization from the ends of actin filaments. 4) The binding stoichiometry of ND8 to F-actin, as estimated by co-sedimentation assays, is 1 to 2 mol of ND8 to 1 mol of actin with an apparent dissociation constant of 20 to 40 muM. Our data suggest that nebulin-actin interaction promotes actin nucleation and stabilizes preformed actin filaments, both of which are desirable attributes of a length-regulating template for actin filaments of the skeletal muscle. Each nebulin molecule may contain as many as 100-200 actin binding domains to form a zipper-like nebulin/actin composite filament.	UNIV TEXAS,INST CELL RES,INST BIOCHEM,DEPT CHEM & BIOCHEM,AUSTIN,TX 78712	University of Texas System; University of Texas Austin					NIDDK NIH HHS [DK 20270] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020270] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRENNER SL, 1980, J BIOL CHEM, V255, P1670; BRENNER SL, 1979, J BIOL CHEM, V254, P9982; BRYAN J, 1985, J CELL BIOL, V101, P1236, DOI 10.1083/jcb.101.4.1236; COLUCCIO LM, 1984, J CELL BIOL, V99, P529, DOI 10.1083/jcb.99.2.529; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; ESTES JE, 1981, BIOCHEMISTRY-US, V20, P708, DOI 10.1021/bi00507a006; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GODDETTE DW, 1986, J BIOL CHEM, V261, P5974; GORDON DJ, 1976, J BIOL CHEM, V251, P7474; JIN JP, 1991, J BIOL CHEM, V266, P21215; KAUFMANN S, 1991, FEBS LETT, V284, P187, DOI 10.1016/0014-5793(91)80681-R; KORN ED, 1982, PHYSIOL REV, V62, P672, DOI 10.1152/physrev.1982.62.2.672; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; KRUGER M, 1991, J CELL BIOL, V115, P97, DOI 10.1083/jcb.115.1.97; LABEIT S, 1991, FEBS LETT, V282, P313, DOI 10.1016/0014-5793(91)80503-U; LIN DC, 1979, P NATL ACAD SCI USA, V76, P2345, DOI 10.1073/pnas.76.5.2345; MARUYAMA K, 1989, J MUSCLE RES CELL M, V10, P350, DOI 10.1007/BF01758431; MUGURUMA M, 1990, BIOCHEM BIOPH RES CO, V171, P1217, DOI 10.1016/0006-291X(90)90815-5; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; PIEROBONBORMIOLI S, 1989, J MUSCLE RES CELL M, V10, P446, DOI 10.1007/BF01771820; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; STROMQVIST M, 1987, FEBS LETT, V213, P102, DOI 10.1016/0014-5793(87)81472-2; THOMPSON CJ, 1971, ARCH BIOCHEM BIOPHYS, V147, P178, DOI 10.1016/0003-9861(71)90325-0; TILLEY L, 1987, AUST J BIOL SCI, V40, P27, DOI 10.1071/BI9870027; WANG K, 1990, BIOPHYS J, V57, pA555; WANG K, 1980, P NATL ACAD SCI-BIOL, V77, P3254, DOI 10.1073/pnas.77.6.3254; WANG K, 1988, J CELL BIOL, V107, P2199, DOI 10.1083/jcb.107.6.2199	30	68	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20327	20334						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376391				2022-12-27	WOS:A1993LY01900062
J	YANG, ZH; COSTANZO, M; GOLDE, DW; KOLESNICK, RN				YANG, ZH; COSTANZO, M; GOLDE, DW; KOLESNICK, RN			TUMOR-NECROSIS-FACTOR ACTIVATION OF THE SPHINGOMYELIN PATHWAY SIGNALS NUCLEAR FACTOR-KAPPA-B TRANSLOCATION IN INTACT HL-60 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-ALPHA; CERAMIDE; RECEPTOR; BINDING; GENE; DIFFERENTIATION; ENHANCER; MECHANISMS; SEQUENCES; INDUCTION	Recent investigations suggest that tumor necrosis factor (TNF)-alpha may utilize the sphingomyelin pathway for signal transduction. Signaling in this system involves hydrolysis of sphingomyelin to ceramide by action of a neutral sphingomyelinase and stimulation of a ceramide-activated protein kinase (Dressler, K. A., Mathias, S., and Kolesnick, R. N. (1992) Science 255, 1715-1718). To clarify the role of this pathway in TNF action, the present studies assessed the effect of the sphingomyelin pathway on activation of nuclear factor kappaB (NF-kappaB), an event considered integral to the transfer of the TNF message to the cell nucleus. As shown previously, TNF (1 nm) induced a marked increase in nuclear NF-kappaB binding in human leukemia (HL-60) cells within 5 min, and elevated binding was detected for as long as 1 h. Addition of a maximally effective concentration of sphingomyelinase, 0.1 units.ml-1, induced a 50% reduction in sphingomyelin content by 5 min from a basal level of 560 pmol.10(6) cells-1 and a quantitative increase in ceramide levels from 89 pmol.10(6) cells-1. Sphingomyelinase 0.1 units.ml-1 also induced an increase in nuclear NF-kappaB binding within 5 min, an effect measurable for as long as 1 h. As little as 1 x 10(-5) units.ml-1 sphingomyelinase was effective and a maximal effect occurred with 1 x 10(-3) units.ml-1. A cell-permeable ceramide analog, C8-ceramide, which mimics biologic effects of TNF-alpha, also enhanced nuclear NF-kappaB activation within minutes. In contrast, addition of a phospholipase C or a synthetic diacylglycerol (DG) analog, 1,2-dioctanoylglycerol, failed to enhance nuclear NF-kappaB binding despite large increases in cellular DG content. Further, TNF-alpha induced elevation in ceramide content by 2 min to 185% of control but did not affect DG levels. These studies provide evidence that stimulation of the sphingomyelin pathway leads to NF-kappaB activation in HL-60 cells.	MEM SLOAN KETTERING CANC CTR,SLOAN KETTERING INST,SIGNAL TRANSDUCT LAB,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,SLOAN KETTERING INST,MOLEC & CELLULAR HEMATOL LAB,NEW YORK,NY 10021	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center					NCI NIH HHS [R01-CA-57400, R37-CA30388] Funding Source: Medline; NHLBI NIH HHS [R01-HL42107] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057400, R37CA030388] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042107] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DRESSLER KA, 1990, J BIOL CHEM, V265, P14917; DRESSLER KA, 1992, SCIENCE, V255, P1715, DOI 10.1126/science.1313189; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; GOLDKORN T, 1991, J BIOL CHEM, V266, P16092; IP YT, 1990, MOL CELL BIOL, V10, P3770, DOI 10.1128/MCB.10.7.3770; KIM MY, 1991, J BIOL CHEM, V266, P484; Kolesnick Richard, 1992, Trends in Cell Biology, V2, P232, DOI 10.1016/0962-8924(92)90310-J; KOLESNICK RN, 1987, J BIOL CHEM, V262, P9204; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LOWENTHAL JW, 1988, P NATL ACAD SCI USA, V85, P4468, DOI 10.1073/pnas.85.12.4468; LOWENTHAL JW, 1989, J IMMUNOL, V142, P3121; MATHIAS S, 1991, P NATL ACAD SCI USA, V88, P10009, DOI 10.1073/pnas.88.22.10009; MATHIAS S, 1993, SCIENCE, V259, P519, DOI 10.1126/science.8424175; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; OKAZAKI T, 1990, J BIOL CHEM, V265, P15823; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; PREISS J, 1986, J BIOL CHEM, V261, P8597; Sambrook J, 1989, MOL CLONING LABORATO; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; STYLIANOU E, 1992, J BIOL CHEM, V267, P15836; VILCEK J, 1991, J BIOL CHEM, V266, P7313; WEIGMANN K, 1992, J BIOL CHEM, V267, P17997; YOUNES A, 1992, J BIOL CHEM, V267, P842	26	186	189	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20520	20523						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376408				2022-12-27	WOS:A1993LY01900086
J	GOMEZ, S; MORGANS, C				GOMEZ, S; MORGANS, C			INTERACTION BETWEEN BAND-3 AND ANKYRIN BEGINS IN EARLY COMPARTMENTS OF THE SECRETORY PATHWAY AND IS ESSENTIAL FOR BAND-3 PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ERYTHROCYTE ANKYRIN; MEMBRANE-ASSOCIATED PROTEIN; ANION TRANSPORT PROTEIN; BLOOD-CELL MEMBRANE; CYTOPLASMIC DOMAIN; SELF-ASSOCIATION; PLASMA-MEMBRANE; BRAIN ANKYRIN; BINDING-SITES; SPECTRIN	In many cell types, membrane proteins are specifically segregated to particular areas of the cell surface. It is known that this segregation is stabilized by anchorage proteins which interact with the cytoskeleton. However, the mechanism by which the interactions with anchorage proteins occur, as well as whether they may also play a role in the process of sorting, is not known. Using differentiated murine erythroleukemic cells, we have investigated the association between band 3 (a major transmembrane anion exchanger), and ankyrin (a cytoplasmic protein that links band 3 to the cytoskeleton). Our data demonstrate that the association between band 3 and ankyrin occurs in the endoplasmic reticulum or the first Golgi compartment. These data support a model in which the band 3-ankyrin complex is inserted as a ''cassette'' at the plasma membrane into the cytoskeletal network. Biosynthetic studies on cotransfected 293 cells with cDNAs encoding band 3 and the band 3 binding fragment of ankyrin (AnK-90), suggest that ankyrin is not only responsible for the anchorage of band 3 to the cytoskeleton but is also involved in the exit of band 3 out of the endoplasmic reticulum.	STANFORD UNIV,DEPT BIOL SCI,STANFORD,CA 94305	Stanford University			Gomez, Sophie/N-9888-2017	Morgans, Catherine/0000-0002-7287-3447				ALPER SL, 1988, J BIOL CHEM, V263, P17092; BENNETT V, 1982, BIOCHIM BIOPHYS ACTA, V689, P475, DOI 10.1016/0005-2736(82)90305-4; BENNETT V, 1980, J BIOL CHEM, V255, P6424; BENNETT V, 1978, J BIOL CHEM, V253, P2292; BENNETT V, 1980, J BIOL CHEM, V255, P2540; BENNETT V, 1990, PHYSIOL REV, V70, P1029, DOI 10.1152/physrev.1990.70.4.1029; BENNETT V, 1982, NATURE, V299, P126, DOI 10.1038/299126a0; BRAELL WA, 1982, CELL, V28, P23, DOI 10.1016/0092-8674(82)90371-3; BRAELL WA, 1981, J BIOL CHEM, V256, P1337; BRANTON D, 1981, CELL, V24, P24, DOI 10.1016/0092-8674(81)90497-9; DAVIS JQ, 1984, J BIOL CHEM, V259, P3550; DAVIS JQ, 1984, J BIOL CHEM, V259, P1874; DAVIS LH, 1990, J BIOL CHEM, V265, P10589; FIEND C, 1971, P NATL ACAD SCI USA, V68, P378; GOODMAN SR, 1988, CRIT REV BIOCHEM MOL, V23, P171, DOI 10.3109/10409238809088319; GRINSTEIN S, 1978, BIOCHIM BIOPHYS ACTA, V507, P294, DOI 10.1016/0005-2736(78)90424-8; HARB J, 1983, EUR J BIOCHEM, V137, P131, DOI 10.1111/j.1432-1033.1983.tb07806.x; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; KOPITO RR, 1985, NATURE, V316, P234, DOI 10.1038/316234a0; KOPITO RR, 1989, CELL, V59, P927, DOI 10.1016/0092-8674(89)90615-6; KORDELI E, 1990, J CELL BIOL, V110, P1341, DOI 10.1083/jcb.110.4.1341; KVIST S, 1982, CELL, V29, P61, DOI 10.1016/0092-8674(82)90090-3; LAEMMLI UK, 1970, NATURE, V281, P117; LEE BS, 1991, J BIOL CHEM, V266, P11448; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; MARKS PA, 1978, ANNU REV BIOCHEM, V47, P419, DOI 10.1146/annurev.bi.47.070178.002223; MORGANS CW, 1993, IN PRESS J CELL SCI; MORROW JS, 1981, J CELL BIOL, V88, P463, DOI 10.1083/jcb.88.2.463; MORROW JS, 1980, P NATL ACAD SCI USA, V77, P6590; NELSON WJ, 1984, CELL, V39, P309; NELSON WJ, 1989, J CELL BIOL, V108, P893, DOI 10.1083/jcb.108.3.893; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; PATEL VP, 1987, J CELL BIOL, V105, P3105, DOI 10.1083/jcb.105.6.3105; RUETZ S, 1993, J CELL BIOL, V121, P37, DOI 10.1083/jcb.121.1.37; SENTENAC H, 1992, SCIENCE, V256, P63; SHAHBAKHTI F, 1986, BIOCHEMISTRY-US, V25, P5969, DOI 10.1021/bi00368a020; SHOTTON DM, 1979, J MOL BIOL, V131, P303, DOI 10.1016/0022-2836(79)90078-0; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; STECK TL, 1974, J CELL BIOL, V62, P1, DOI 10.1083/jcb.62.1.1; THEVENIN BJM, 1990, J BIOL CHEM, V265, P16166; THOMAS HA, 1989, AM J PHYSIOL, V257, pC537, DOI 10.1152/ajpcell.1989.257.3.C537; TYLER JM, 1979, P NATL ACAD SCI USA, V76, P5192, DOI 10.1073/pnas.76.10.5192; UNGEWICKELL E, 1978, EUR J BIOCHEM, V88, P379, DOI 10.1111/j.1432-1033.1978.tb12459.x; WEAVER DC, 1984, J BIOL CHEM, V259, P6170; WOODS CM, 1986, J CELL BIOL, V103, P1789, DOI 10.1083/jcb.103.5.1789	45	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19593	19597						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366103				2022-12-27	WOS:A1993LW81900069
J	CHANG, WC; LIU, YW; NING, CC; SUZUKI, H; YOSHIMOTO, T; YAMAMOTO, S				CHANG, WC; LIU, YW; NING, CC; SUZUKI, H; YOSHIMOTO, T; YAMAMOTO, S			INDUCTION OF ARACHIDONATE 12-LIPOXYGENASE MESSENGER-RNA BY EPIDERMAL GROWTH-FACTOR IN A431 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOXYGENASE PRODUCTS; MOLECULAR-CLONING; ACID; EXPRESSION; PLATELETS; IDENTIFICATION; CYCLOOXYGENASE; LOCALIZATION; LEUKOCYTES; DISTINCT	12(S)-Hydroxyeicosatetraenoic acid is biosynthesized from arachidonic acid by the microsomal fraction of human epidermoid carcinoma A431 cells, and the microsomal 12-lipoxygenase activity is enhanced by about 2-fold by epidermal growth factor (EGF) with a 10-h lag period (Chang, W. C., Ning, C. C., Lin, M. T., and Huang, J. D. (1992) J. Biol. Chem. 267, 3657-3666). The microsomal 12-lipoxygenase in A431 cells was only 3% active with linoleic acid as compared with arachidonic acid. The enzyme was immunoprecipitated by a monoclonal antibody against human platelet 12-lipoxygenase but not by that against porcine leukocyte enzyme. A 3.1-kilobase mRNA was detected in A431 cells by Northern blot analyses using cDNA probe of human platelet 12-lipoxygenase. EGF could increase the 12-lipoxygenase mRNA level by about 2-fold with a lag period of 10 h, which was well parallel with the increase in the enzyme activity. The induction of the 12-lipoxygenase mRNA by EGF was completely blocked by 35 muM cycloheximide, if present in culture medium during EGF treatment, indicating that a de novo protein biosynthesis was essential for EGF-induced 12-lipoxygenase mRNA expression. Our data provide the first evidence for the inducibility of human 12-lipoxygenase gene expression by a growth factor.	UNIV TOKUSHIMA,SCH MED,DEPT BIOCHEM,TOKUSHIMA 770,JAPAN	Tokushima University	CHANG, WC (corresponding author), NATL CHENG KUNG UNIV,COLL MED,DEPT PHARMACOL,TAINAN 70101,TAIWAN.							BAILEY JM, 1988, BIOCHEM BIOPH RES CO, V157, P1159, DOI 10.1016/S0006-291X(88)80995-1; CHANG WC, 1992, J BIOL CHEM, V267, P3657; CHANG WC, 1982, BIOCHEM J, V202, P771, DOI 10.1042/bj2020771; Chromczynski P, 1987, ANAL BIOCHEM, V162, P156; DEWITT DL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P121, DOI 10.1016/0005-2760(91)90032-D; DUNN JR, 1987, PROSTAGLANDINS CANCE, P257; FUNK CD, 1992, P NATL ACAD SCI USA, V89, P3962, DOI 10.1073/pnas.89.9.3962; FUNK CD, 1990, P NATL ACAD SCI USA, V87, P5638, DOI 10.1073/pnas.87.15.5638; GEROZISSIS K, 1985, NEUROENDOCRINOLOGY, V40, P272, DOI 10.1159/000124084; GROSSI IM, 1989, CANCER RES, V49, P1029; HADA T, 1991, BIOCHIM BIOPHYS ACTA, V1083, P89, DOI 10.1016/0005-2760(91)90128-5; HAMBERG M, 1967, J BIOL CHEM, V242, P5344; HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P3400, DOI 10.1073/pnas.71.9.3400; HANSBROUGH JR, 1990, J BIOL CHEM, V265, P1771; HEMLER ME, 1978, BIOCHEMISTRY-US, V17, P1772, DOI 10.1021/bi00602a031; HUBBARD WC, 1980, PROSTAGLANDINS, V20, P431; IZUMI T, 1990, P NATL ACAD SCI USA, V87, P7477, DOI 10.1073/pnas.87.19.7477; KURIBAYASHI K, 1988, NUCLEIC ACIDS RES S, V19, P61; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NAKAO J, 1982, ATHEROSCLEROSIS, V44, P339, DOI 10.1016/0021-9150(82)90008-9; NUGTEREN DH, 1975, BIOCHIM BIOPHYS ACTA, V380, P299, DOI 10.1016/0005-2760(75)90016-8; Sambrook J, 1989, MOL CLONING LABORATO; SETTY BNY, 1987, J BIOL CHEM, V262, P17613; SHINJO F, 1986, J BIOL CHEM, V261, P3377; TAKAHASHI Y, 1988, ARCH BIOCHEM BIOPHYS, V266, P613, DOI 10.1016/0003-9861(88)90294-9; TAKAHASHI Y, 1993, IN PRESS J BIOL CHEM; UEDA N, 1990, J BIOL CHEM, V265, P2311; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9; YAMAMOTO S, 1993, 2ND  INT C EIC OTH B, P7; YOSHIMOTO T, 1990, P NATL ACAD SCI USA, V87, P2142, DOI 10.1073/pnas.87.6.2142; YOSHIMOTO T, 1992, J BIOL CHEM, V267, P24805; YOSHIMOTO T, 1982, BIOCHIM BIOPHYS ACTA, V713, P638; YOSHIMOTO T, 1990, BIOCHEM BIOPH RES CO, V172, P1230, DOI 10.1016/0006-291X(90)91580-L	33	60	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18734	18739						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360167				2022-12-27	WOS:A1993LV65900058
J	MORBACH, S; TEBBE, S; SCHNEIDER, E				MORBACH, S; TEBBE, S; SCHNEIDER, E			THE ATP-BINDING CASSETTE (ABC) TRANSPORTER FOR MALTOSE MALTODEXTRINS OF SALMONELLA-TYPHIMURIUM - CHARACTERIZATION OF THE ATPASE ACTIVITY ASSOCIATED WITH THE PURIFIED MALK SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL PERIPLASMIC PERMEASES; ESCHERICHIA-COLI; NUCLEOTIDE-BINDING; MULTIDRUG-RESISTANCE; CYSTIC-FIBROSIS; GENE-PRODUCT; PROTEIN; RECONSTITUTION; SYSTEM; PURIFICATION	The ATPase activity associated with the purified MalK subunit of the maltose transport complex of Salmonella typhimurium, a bacterial ATP-Binding Cassette (ABC) transporter (Walter, C., Honer zu Bentrup, K., and Schneider, E. (1992) J. Biol. Chem. 267, 8863-8869), was characterized in detail. The analysis of the kinetics of ATP hydrolysis yielded a K(m) value of 70 +/- 4 muM and a V(max) of 1.3 +/- 0.3 mumol/min/mg of protein. Both GTP and CTP also served as substrates. While MalK exhibited nearly the same affinity for GTP as for ATP, the Michaelis constant for CTP as a substrate was much higher. ATP hydrolysis was strongly dependent on the presence of Mg2+ ions. Mn2+ at low concentrations, but neither Ca2+ nor Zn2+ partially substituted for Mg2+. The ATPase activity was optimal at slightly alkaline pH and was stimulated in the presence of both glycerol (7.5%) and dimethyl sulfoxide (Me2SO) (5%). ADP and the non-cleavable substrate analog ATPgammaS (adenosine 5'-O-(3-thiotriphosphate)) were identified as competitive inhibitors. The MalK-ATPase was resistant to specific inhibitors of F-, P-, and V-type ATPases, such as dicyclohexylcarbodiimide, azide, vanadate, or bafilomycin A1. In contrast, micromolar concentrations of the sulfhydryl reagent N-ethylmaleimide strongly inhibited the enzymatic activity. This inhibition was blocked in the presence of ATP. These results suggest that the intrinsic ATPase activity of purified MalK can be clearly distinguished from other ATP-hydrolyzing enzymes, e.g. ion-translocating ATPases.	UNIV OSNABRUCK, FACHBEREICH BIOL CHEM, ARBEITSGRP MIKROBIOL, BARBARASTR 11, D-49069 OSNABRUCK, GERMANY	University Osnabruck								ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; AMES GF, 1990, FEMS MICROBIOL LETT, V75, P429, DOI 10.1016/S0168-6445(05)80008-7; AMES GF, 1989, J BIOL CHEM, V264, P3998; AMES GFL, 1990, J BACTERIOL, V172, P4133, DOI 10.1128/jb.172.8.4133-4137.1990; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; BEHARRY S, 1991, BIOCHEM CELL BIOL, V69, P291, DOI 10.1139/o91-044; BISHOP L, 1989, P NATL ACAD SCI USA, V86, P6953, DOI 10.1073/pnas.86.18.6953; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; BOYD D, 1993, J BACTERIOL, V175, P553, DOI 10.1128/JB.175.2.553-556.1993; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; DAHL MK, 1989, MOL GEN GENET, V218, P199, DOI 10.1007/BF00331269; DASSA E, 1993, MOL MICROBIOL, V7, P29, DOI 10.1111/j.1365-2958.1993.tb01094.x; DAVIDSON AL, 1991, J BIOL CHEM, V266, P8946; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; DEAN DA, 1990, RES MICROBIOL, V141, P348, DOI 10.1016/0923-2508(90)90010-N; DOIGE CA, 1993, BIOCHIM BIOPHYS ACTA, V1146, P65, DOI 10.1016/0005-2736(93)90339-2; DOIGE CA, 1992, BIOCHIM BIOPHYS ACTA, V1109, P149, DOI 10.1016/0005-2736(92)90078-Z; Endicott J A, 1991, DNA Seq, V2, P89, DOI 10.3109/10425179109039677; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; FENG Y, 1992, J BIOL CHEM, V267, P5817; FROSHAUER S, 1988, J MOL BIOL, V200, P501, DOI 10.1016/0022-2836(88)90539-6; FRY DC, 1986, P NATL ACAD SCI USA, V83, P907, DOI 10.1073/pnas.83.4.907; HALEY BE, 1991, METHOD ENZYMOL, V200, P477; HENKEL RD, 1988, ANAL BIOCHEM, V169, P312, DOI 10.1016/0003-2697(88)90290-4; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HOSHINO T, 1992, J BIOL CHEM, V267, P21313; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; KAGAWA Y, 1979, J BIOENERG BIOMEMBR, V11, P39, DOI 10.1007/BF00743196; KUHNAU S, 1991, J BACTERIOL, V173, P2180; MACARA IG, 1980, TRENDS BIOCHEM SCI, V5, P92, DOI 10.1016/0968-0004(80)90256-X; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; RICHARME G, 1992, BIOCHIM BIOPHYS ACTA, V1104, P201, DOI 10.1016/0005-2736(92)90151-B; ROSEN BP, 1988, J BIOL CHEM, V263, P3067; SAKAMOTO J, 1983, J BIOCHEM, V93, P1601, DOI 10.1093/oxfordjournals.jbchem.a134299; SCHNEIDER E, 1991, MOL MICROBIOL, V5, P1375, DOI 10.1111/j.1365-2958.1991.tb00784.x; SCHNEIDER E, 1990, TRENDS BIOMEMBRANES, V1, P201; SCHWARTZ M, 1987, ESCHERICHIA COLI SAL, V2, P1482; SHUMAN HA, 1981, J BIOL CHEM, V256, P560; TREPTOW NA, 1985, J BACTERIOL, V163, P654, DOI 10.1128/JB.163.2.654-660.1985; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WALTER C, 1992, FEBS LETT, V303, P41, DOI 10.1016/0014-5793(92)80473-T; WALTER C, 1992, J BIOL CHEM, V267, P8863	46	91	94	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18617	18621						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360157				2022-12-27	WOS:A1993LV65900040
J	STRAYER, DS; YANG, SJ; JERNG, HH				STRAYER, DS; YANG, SJ; JERNG, HH			SURFACTANT PROTEIN-A-BINDING PROTEINS - CHARACTERIZATION AND STRUCTURES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-FETAL LUNG; II CELLS; PHOSPHOLIPID SECRETION; RAT LUNG; SP-B; PNEUMOCYTES; EXPRESSION; RECEPTOR; INVITRO; DEXAMETHASONE	An alveolar cell membrane protein acts as a surfactant protein A (SP-A) receptor; it binds SP-A and regulates surfactant secretion. We identified such alveolar cell membrane SP-A-binding proteins using anti-idiotype antibodies directed against the surfactant protein binding region of anti-surfactant antibodies. These monoclonal anti-idiotype antibodies, A2C and A2R, also recognize an alveolar cell membrane protein of almost-equal-to 30 kDa. A pulmonary protein of almost-equal-to 30 kDa binds SP-A. Unique cDNAs encoding this protein were identified in human (4.1-kilobase) and porcine (1.8-kilobase) lung expression libraries. Coding regions of these cDNAs cross-hybridize with each other under stringent conditions. Both cDNAs encode similar almost-equal-to 32-kDa proteins that bind SP-A. The human and porcine SP-A recognition (SPAR) proteins resemble each other, as well as other cell membrane receptors. Their projected structures are consistent with cell membrane receptors. Recombinant human and porcine SPAR proteins bind SP-A as well as the two anti-idiotype antibodies just as do native lung proteins of almost-equal-to 30 kDa. SPAR transcripts are expressed primarily in lung. The cellular distribution of these transcripts, as determined by in situ hybridization, is similar to that of SPAR protein, as determined by immunohistochemistry; both are found in cells consistent with type II pneumocytes. SPAR-producing cells resemble the alveolar cells expressing SP-B and SP-C transcripts in appearance, location, and distribution. Therefore, cDNAs for pulmonary SP-A-binding proteins from two disparate species have been isolated and sequenced, and the recombinant proteins they encode bind the same ligand. Further structural, functional, and genetic studies of these proteins may help explain how pulmonary surfactant secretion is regulated.			STRAYER, DS (corresponding author), THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT PATHOL & CELL BIOL,1020 LOCUST ST,PHILADELPHIA,PA 19107, USA.				FDA HHS [FD-R-000862] Funding Source: Medline	FDA HHS		Ausubel FM., 2006, ENZYMATIC MANIPULATI; BALLARD PL, 1991, ENDOCRINOLOGY, V128, P2916, DOI 10.1210/endo-128-6-2916; BOGGARAM V, 1989, J BIOL CHEM, V264, P11421; BROWN LAS, 1989, BIOCHIM BIOPHYS ACTA, V1001, P76, DOI 10.1016/0005-2760(89)90309-3; CHEN M, 1990, AM J PHYSIOL, V258, pL195, DOI 10.1152/ajplung.1990.258.4.L195; COTT GR, 1990, AM J PHYSIOL, V258, pL179, DOI 10.1152/ajplung.1990.258.4.L179; GOBRAN LI, 1990, AM J PHYSIOL, V258, pL45, DOI 10.1152/ajplung.1990.258.2.L45; GREENE MI, 1987, MONOGR ALLERGY, V22, P120; GRIESE M, 1991, AM J PHYSIOL, V260, pL52, DOI 10.1152/ajplung.1991.260.2.L52; GROSS I, 1990, AM J PHYSIOL, V259, pL337, DOI 10.1152/ajplung.1990.259.6.L337; GUITTENY AF, 1988, J HISTOCHEM CYTOCHEM, V36, P563, DOI 10.1177/36.6.3259249; HAWGOOD S, 1985, BIOCHEMISTRY-US, V24, P184, DOI 10.1021/bi00322a026; KUROKI Y, 1988, J BIOL CHEM, V263, P17596; KUROKI Y, 1988, P NATL ACAD SCI USA, V85, P5566, DOI 10.1073/pnas.85.15.5566; Maniatis T., 1982, MOL CLONING; MASON RJ, 1977, FED PROC, V36, P2697; MENDELSON CR, 1991, ANNU REV PHYSIOL, V53, P415, DOI 10.1146/annurev.ph.53.030191.002215; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; POSSMAYER F, 1988, AM REV RESPIR DIS, V138, P990, DOI 10.1164/ajrccm/138.4.990; PRYHUBER GS, 1990, J BIOL CHEM, V265, P20822; REVAK SD, 1988, J CLIN INVEST, V81, P826, DOI 10.1172/JCI113391; RICE WR, 1987, J APPL PHYSIOL, V63, P692, DOI 10.1152/jappl.1987.63.2.692; SHIMIZU H, 1991, BIOCHIM BIOPHYS ACTA, V1081, P53, DOI 10.1016/0005-2760(91)90249-H; SNYDER JM, 1987, ENDOCRINOLOGY, V120, P1250, DOI 10.1210/endo-120-4-1250; STRAYER DS, 1991, AM J PATHOL, V138, P1085; STRAYER DS, 1991, CLIN EXP IMMUNOL, V83, P41; STRAYER DS, 1991, VIROLOGY, V185, P585, DOI 10.1016/0042-6822(91)90529-K; STRAYER DS, 1975, J IMMUNOL, V114, P722; STRAYER DS, 1992, BIOL NEONATE, V61, P1; TABOR BL, 1991, AM J OBSTET GYNECOL, V164, P675, DOI 10.1016/S0002-9378(11)80045-1; WARBURTON D, 1991, AM J PHYSIOL, V260, pL548, DOI 10.1152/ajplung.1991.260.6.L548; WEAVER TE, 1991, AM J RESP CELL MOL, V5, P4, DOI 10.1165/ajrcmb/5.1.4; WHITSETT JA, 1987, J BIOL CHEM, V262, P7908; WISPE JR, 1990, J CLIN INVEST, V86, P1954, DOI 10.1172/JCI114929; YOUNG SL, 1991, AM J PHYSIOL, V260, pL161, DOI 10.1152/ajplung.1991.260.2.L161	35	56	57	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18679	18684						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360162				2022-12-27	WOS:A1993LV65900050
J	WONG, CI; ZHOU, ZX; SAR, M; WILSON, EM				WONG, CI; ZHOU, ZX; SAR, M; WILSON, EM			STEROID REQUIREMENT FOR ANDROGEN RECEPTOR DIMERIZATION AND DNA-BINDING - MODULATION BY INTRAMOLECULAR INTERACTIONS BETWEEN THE NH2-TERMINAL AND STEROID-BINDING DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PROGESTERONE-RECEPTOR; VITAMIN-D RECEPTOR; GLUCOCORTICOID RECEPTOR; THYROID-HORMONE; BACULOVIRUS SYSTEM; RESPONSE ELEMENTS; RETINOIC ACID; TRANSCRIPTIONAL ACTIVATION; CONFORMATIONAL-CHANGES; GEL-ELECTROPHORESIS	Infection of Spodoptera frugiperda Sf9 insect cells with recombinant human androgen receptor (AR) baculovirus results in expression of a 118-kDa phosphoprotein that displays high affinity androgen binding and androgen-dependent targeting to the nucleus. Using the DNA mobility shift assay, specific in vitro binding of full-length AR to androgen response element DNA (ARE) requires intracellular hormone exposure. The ability of a variety of steroids to induce ARE binding paralleled their transcriptional potential. Certain antihormones, cyproterone acetate and RU486, promote ARE binding, but a pure antiandrogen, hydroxyflutamide, inhibits AR binding to ARE DNA. AR dimerization requires incubation of recombinant baculovirus-infected insect cells with androgen, but only when one or both components of the dimer contain the NH2-terminal domain. Based on the intensities of ARE binding and lack of binding to an ARE half-site, it appears that, unlike the glucocorticoid receptor, AR binds DNA primarily as a dimer. Thus, full-length baculovirus-expressed AR requires intracellular hormone exposure for dimerization and ARE binding to overcome inhibition imposed by the AR NH2-terminal domain. Antihormones with agonist activity promote dimerization and ARE binding, while a pure antiandrogen blocks AR DNA binding. It is concluded that intramolecular interactions between the NH2-terminal and steroid-binding domains are regulated by the specificity of hormone binding and modulate receptor dimerization and DNA binding.	UNIV N CAROLINA,REPROD BIOL LABS,CB 7500 MACNIDER BLDG,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT BIOL,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT PEDIAT,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT CELL BIOL & ANAT,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT BIOCHEM & BIOPHYS,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill					NICHD NIH HHS [P30-HD18968, HD16910] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD018968, R01HD016910, R37HD016910] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLAN GF, 1992, J BIOL CHEM, V267, P19513; ALNEMRI ES, 1991, J BIOL CHEM, V266, P18072; ALNEMRI ES, 1991, J BIOL CHEM, V266, P3925; BENHAMOU B, 1992, SCIENCE, V255, P206, DOI 10.1126/science.1372753; CHANG CS, 1992, P NATL ACAD SCI USA, V89, P5946, DOI 10.1073/pnas.89.13.5946; CHRISTENSEN K, 1991, MOL ENDOCRINOL, V5, P1755, DOI 10.1210/mend-5-11-1755; DAHLMANWRIGHT K, 1990, J BIOL CHEM, V265, P14030; DROUIN J, 1992, MOL ENDOCRINOL, V6, P1299, DOI 10.1210/me.6.8.1299; ELASHRY D, 1989, MOL ENDOCRINOL, V3, P1545, DOI 10.1210/mend-3-10-1545; ELLISTON JF, 1992, J BIOL CHEM, V267, P5193; FAWELL SE, 1990, CELL, V60, P953, DOI 10.1016/0092-8674(90)90343-D; FORMAN B M, 1990, New Biologist, V2, P587; FORMAN BM, 1989, MOL ENDOCRINOL, V3, P1610, DOI 10.1210/mend-3-10-1610; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; GOSWAMI BB, 1991, BIOTECHNIQUES, V10, P626; GRONEMEYER H, 1991, ANNU REV GENET, V25, P89, DOI 10.1146/annurev.ge.25.120191.000513; GUIOCHONMANTEL A, 1988, NATURE, V336, P695, DOI 10.1038/336695a0; HARRIS SE, 1992, HORMONAL CARCINOGENESIS, P182; JONES N, 1990, CELL, V61, P9, DOI 10.1016/0092-8674(90)90207-U; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; KUPFER SR, 1993, J BIOL CHEM, V268, P17519; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; LUISI BF, 1992, NATURE, V352, P47; MACDONALD PN, 1991, J BIOL CHEM, V266, P18808; MEDIN JA, 1990, P NATL ACAD SCI USA, V87, P2760, DOI 10.1073/pnas.87.7.2760; MEYER ME, 1990, EMBO J, V9, P3923, DOI 10.1002/j.1460-2075.1990.tb07613.x; QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P1399, DOI 10.1210/mend-4-9-1399; RAAKA BM, 1989, MOL ENDOCRINOL, V3, P332, DOI 10.1210/mend-3-2-332; SAR M, 1990, ENDOCRINOLOGY, V127, P3180, DOI 10.1210/endo-127-6-3180; SAR M, 1985, TECHNIQUES IMMUNOCYT, V3, P43; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; SIMONS SS, 1992, MOL ENDOCRINOL, V6, P995, DOI 10.1210/me.6.7.995; SONE T, 1991, J BIOL CHEM, V266, P23296; SONE T, 1991, MOL ENDOCRINOL, V5, P1578, DOI 10.1210/mend-5-11-1578; SRINIVASAN G, 1990, MOL ENDOCRINOL, V4, P209, DOI 10.1210/mend-4-2-209; TAN JA, 1992, J BIOL CHEM, V267, P4456; TAN JA, 1988, MOL ENDOCRINOL, V2, P1276, DOI 10.1210/mend-2-12-1276; TSAI SY, 1988, CELL, V55, P361, DOI 10.1016/0092-8674(88)90059-1; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; VEGETO E, 1992, CELL, V69, P703, DOI 10.1016/0092-8674(92)90234-4; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; WEIGEL NL, 1992, MOL ENDOCRINOL, V6, P1585, DOI 10.1210/me.6.10.1585; XIE YB, 1992, J BIOL CHEM, V267, P4939; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E	47	187	190	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					19004	19012						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360187				2022-12-27	WOS:A1993LV65900094
J	FAN, BQ; CREWS, BC; TURKO, IV; CHOAY, J; ZETTLMEISSL, G; GETTINS, P				FAN, BQ; CREWS, BC; TURKO, IV; CHOAY, J; ZETTLMEISSL, G; GETTINS, P			HETEROGENEITY OF RECOMBINANT HUMAN ANTITHROMBIN-III EXPRESSED IN BABY HAMSTER-KIDNEY CELLS - EFFECT OF GLYCOSYLATION DIFFERENCES ON HEPARIN-BINDING AND STRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-THROMBIN-III; PROTEINS; BOVINE; ALPHA-1-ANTITRYPSIN; SPECTROSCOPY; RESOLUTION; AFFINITY; COFACTOR; VARIANT; CDNA	To determine the effects of differences in glycosylation on the structure and functional properties of recombinant human antithrombin (rHAT), we have characterized the properties of the recombinant protein overexpressed by baby hamster kidney cells. Three forms of rHAT, I-III, were isolated which differed in affinity for heparin. Form I had the lowest affinity and contained a high proportion of highly branched complex carbohydrate. Form II had higher affinity and contained both complex and high mannose-type chains. Form III had the highest affinity and was similar to form II in the type of carbohydrate present, but had a lower level of glycosylation, consistent with the absence of carbohydrate at one of the four glycosylation sites. H-1 NMR spectra of plasma HAT and rHAT forms I-III suggested very similar protein structures for all forms. Heparin pentasaccharide produced almost identical NMR perturbation difference spectra. The only functional difference found was in the rates of inactivation of factor Xa. Forms II and III gave second order rate constants similar to that of plasma HAT, whereas form I gave a biphasic inhibition, with the first phase having a rate about four times that of the other forms. We conclude that carbohydrate heterogeneity does not alter the structure of the HAT polypeptide or the heparin-induced conformational change, but does affect the heparin affinity and can alter the rate of proteinase inhibition.	VANDERBILT UNIV,MED CTR,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232; VANDERBILT UNIV,MED CTR,SCH MED,CTR MOLEC TOXICOL,NASHVILLE,TN 37232; BEHRINGWERKE AG,RES LABS,W-3550 MARBURG,GERMANY; CTR CHOAY,F-94256 GENTILLY,FRANCE	Vanderbilt University; Vanderbilt University					NHLBI NIH HHS [HL32595, HL49234] Funding Source: Medline; NIEHS NIH HHS [ES 00267] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049234, R01HL032595, R01HL049234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BJORK I, 1992, BIOCHEM J, V286, P793; BRENNAN SO, 1988, FEBS LETT, V237, P118, DOI 10.1016/0014-5793(88)80183-2; BRENNAN SO, 1987, FEBS LETT, V219, P431, DOI 10.1016/0014-5793(87)80266-1; BUNDI A, 1979, BIOPOLYMERS, V18, P285, DOI 10.1002/bip.1979.360180206; CHANDRA T, 1983, P NATL ACAD SCI-BIOL, V80, P1845, DOI 10.1073/pnas.80.7.1845; CRAIG PA, 1989, J BIOL CHEM, V264, P5452; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; FRANZEN LE, 1980, J BIOL CHEM, V255, P5090; GETTINS P, 1987, BIOCHEMISTRY-US, V26, P1391, DOI 10.1021/bi00379a027; GETTINS P, 1992, J BIOL CHEM, V267, P21946; GROSS KH, 1988, J MAGN RESON, V76, P87, DOI 10.1016/0022-2364(88)90203-X; HORNE A, 1992, BIOCHEMISTRY-US, V31, P2286, DOI 10.1021/bi00123a011; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; HUDZIAK RM, 1982, CELL, V31, P137, DOI 10.1016/0092-8674(82)90413-5; KALK A, 1976, J MAGN RESON, V24, P343, DOI 10.1016/0022-2364(76)90115-3; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE F, 1981, NATURE, V294, P228, DOI 10.1038/294228a0; MCKAY EJ, 1981, THROMB RES, V21, P375, DOI 10.1016/0049-3848(81)90138-9; MIZUOCHI T, 1980, ARCH BIOCHEM BIOPHYS, V203, P458, DOI 10.1016/0003-9861(80)90199-X; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; OLSON ST, 1992, J BIOL CHEM, V267, P12528; Petersen TE, 1979, PHYSL INHIBITORS BLO, P43; PETERSON CB, 1985, J BIOL CHEM, V260, P610; POWELL LM, 1992, J MOL BIOL, V224, P241, DOI 10.1016/0022-2836(92)90587-A; THALER E, 1975, BRIT J HAEMATOL, V31, P233, DOI 10.1111/j.1365-2141.1975.tb00853.x; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; VLIEGENTHART JFG, 1983, ADV CARBOHYD CHEM BI, V41, P209, DOI 10.1016/S0065-2318(08)60059-1; WASLEY LC, 1987, J BIOL CHEM, V262, P14766; ZETTLMEISSL G, 1989, J BIOL CHEM, V264, P21153; Zettlmeissl G, 1988, Behring Inst Mitt, P26; ZETTLMEISSL G, 1990, Patent No. 384122	32	53	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17588	17596						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349638				2022-12-27	WOS:A1993LQ98800101
J	ALI, N; CRAXTON, A; SHEARS, SB				ALI, N; CRAXTON, A; SHEARS, SB			HEPATIC INS(1,3,4,5)P4 3-PHOSPHATASE IS COMPARTMENTALIZED INSIDE ENDOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,3,4,5-TETRAKISPHOSPHATE 3-PHOSPHATASE; RAT-LIVER; PORCINE BRAIN; L1210 CELLS; HEXAKISPHOSPHATE; 1,3,4,5,6-PENTAKISPHOSPHATE; 1,4,5-TRISPHOSPHATE; PENTAKISPHOSPHATE; METABOLISM; 1,4,5,6-TETRAKISPHOSPHATE	In pursuit of the physiological role of inositol 1,3,4,5-tetrakisphosphate 3-phosphatase, which also attacks inositol pentakisphosphate and inositol hexakisphosphate with much higher affinity (Nogimori, K., Hughes, P. J., Glennon, M. C., Hodgson, M. E., Putney, J. W., Jr., and Shears, S. B. (1991) J. Biol. Chem. 266, 16499-16506), we have studied the subcellular distribution of the enzyme in liver. Initially, we had to overcome the problem that potent endogenous inhibitor(s) compromise the detection of this enzyme in vitro (Hodgson, M. E., and Shears, S. B. (1990) Biochem. J. 267, 831-834). We partially purified these inhibitor(s) by anion-exchange chromatography and gel filtration; inhibitory activity co-eluted with standard inositol hexakisphosphate and was depleted by treatment with phytase. Thus, subcellular fractions were pretreated with phytase before assay of 3-phosphatase activity. Our experiments revealed that the hepatic 3-phosphatase was nearly exclusively restricted to the endoplasmic reticulum, and there was little or no activity in either the cytosol, plasma membranes, mitochondria, or nuclei. Detergent treatment of microsomes indicated that there was 93 +/- 2% latency to mannose-6-phosphatase, an intraorganelle enzyme activity (Vanstapel, F., Pua, K., and Blanckaert, N. (1986) Eur. J. Biochem. 156, 73-77). Similar latencies were found for the hydrolysis of inositol 1,3,4,5-tetrakisphosphate (95 +/- 1%), inositol 1,3,4,5,6-pentakisphosphate (94 +/- 1%), and inositol hexakisphosphate (93 +/- 2%). Treatment of microsomes with either sodium carbonate or phosphatidylcholine-specific phospholipase C, to release luminal contents, led to solubilization of approximately 90% of 3-phosphatase activity. Thus, hepatic 3-phosphatase has a highly restricted access to inositol polyphosphates in vivo that needs to be accounted for in the determination of the physiological role of this enzyme.			ALI, N (corresponding author), NIEHS,CELLULAR & MOLEC PHARMACOL LAB,INOSITOL LIPID SECT,RES TRIANGLE PK,NC 27709, USA.		Shears, Stephen B/C-6335-2019	Shears, Stephen B/0000-0001-7309-8916				ALI N, 1990, BIOCHEM J, V271, P185, DOI 10.1042/bj2710185; BALLA T, 1989, J BIOL CHEM, V264, P9386; BARTLES JR, 1990, METHOD ENZYMOL, V191, P825; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BECKERS CJM, 1987, CELL, V50, P523, DOI 10.1016/0092-8674(87)90025-0; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BIRD GS, 1991, NATURE, V352, P162, DOI 10.1038/352162a0; BLANK GE, 1971, BIOCHEM BIOPH RES CO, V44, P319, DOI 10.1016/0006-291X(71)90602-4; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNK CF, 1979, ANAL BIOCHEM, V92, P497, DOI 10.1016/0003-2697(79)90690-0; CARPENTER D, 1989, BIOCHEM SOC T, V17, P3, DOI 10.1042/bst0170003; CULLEN PJ, 1989, BIOCHEM J, V259, P931, DOI 10.1042/bj2590931; CUNHAMELO JR, 1988, J BIOL CHEM, V263, P14255; DOUGHNEY C, 1988, BIOCHEM J, V251, P927, DOI 10.1042/bj2510927; ESTRADAGARCIA T, 1991, P ROY SOC B-BIOL SCI, V244, P63, DOI 10.1098/rspb.1991.0052; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GUSE AH, 1991, J BIOL CHEM, V266, P24498; HODGSON ME, 1990, BIOCHEM J, V267, P831, DOI 10.1042/bj2670831; HOER A, 1991, BIOCHEM J, V278, P219; HOER A, 1990, BIOCHEM J, V270, P715; HOER D, 1988, BIOCHEM BIOPH RES CO, V154, P668, DOI 10.1016/0006-291X(88)90191-X; HUGHES PJ, 1990, J BIOL CHEM, V265, P9869; Irvine Robin F., 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P161; JOSEPH SK, 1985, FEBS LETT, V180, P150, DOI 10.1016/0014-5793(85)81061-9; Kirk CJ., 1990, PEPTIDE HORMONE ACTI, P151; LOOMISHUSSELBEE JW, 1991, BIOCHEM J, V277, P883, DOI 10.1042/bj2770883; MATTINGLY RR, 1991, J BIOL CHEM, V266, P15144; MCCONNELL FM, 1991, BIOCHEM J, V280, P323, DOI 10.1042/bj2800323; MENNITI FS, 1990, J BIOL CHEM, V265, P11167; NOGIMORI K, 1991, J BIOL CHEM, V266, P16499; OBERDISSE E, 1990, J BIOL CHEM, V265, P726; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; Perney Teresa M., 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P311; RAZZELL WE, 1963, METHOD ENZYMOL, V6, P236, DOI 10.1016/0076-6879(63)06169-3; SCHMIDT E, 1974, METHOD ENZYMAT AN, V2, P650; SCHNEIDER WC, 1950, J BIOL CHEM, V183, P123; SHEARS SB, 1989, J BIOL CHEM, V264, P19879; Shears Stephen B., 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P63; SHEPHARD EH, 1969, BIOCHEM J, V113, P429, DOI 10.1042/bj1130429; STEPHENS L, 1988, BIOCHEM J, V249, P271, DOI 10.1042/bj2490271; STEPHENS LR, 1991, BIOCHEM J, V275, P485, DOI 10.1042/bj2750485; STEPHENS LR, 1988, BIOCHEM J, V249, P283, DOI 10.1042/bj2490283; ULLAH AHJ, 1987, PREP BIOCHEM, V17, P63, DOI 10.1080/00327488708062477; URADE R, 1992, J BIOL CHEM, V267, P15152; VALLEJO M, 1987, NATURE, V330, P656, DOI 10.1038/330656a0; VANSTAPEL F, 1986, EUR J BIOCHEM, V156, P73, DOI 10.1111/j.1432-1033.1986.tb09550.x; WIDNELL CC, 1964, BIOCHEM J, V92, P313, DOI 10.1042/bj0920313; WONG NS, 1992, BIOCHEM J, V286, P459, DOI 10.1042/bj2860459	50	64	68	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1993	268	9					6161	6167						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KT368	8384201				2022-12-27	WOS:A1993KT36800016
J	STAUDINGER, J; PERRY, M; ELLEDGE, SJ; OLSON, EN				STAUDINGER, J; PERRY, M; ELLEDGE, SJ; OLSON, EN			INTERACTIONS AMONG VERTEBRATE HELIX-LOOP-HELIX PROTEINS IN YEAST USING THE 2-HYBRID SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							DNA-BINDING DOMAIN; ESCHERICHIA-COLI; NEGATIVE REGULATOR; DROSOPHILA; GENE; MYOD; MYOGENIN; SEQUENCE; MYC; EXTRAMACROCHAETAE	The helix-loop-helix (HLH) motif is contained in a rapidly growing family of transcription factors and has been shown to mediate dimerization among heterologous HLH-containing proteins. E12 is a widely expressed HLH protein that preferentially forms heterodimers with cell type-specific HLH proteins such as MyoD, myogenin, and the achaete-scute gene products. As a first step toward screening for novel cell type-specific partners of E12, we used a modification of the two-hybrid assay for detection of protein-protein interactions in vivo to determine whether dimerization of HLH proteins with E12 can occur in yeast. Using the GAL4 DNA-binding domain fused to the E12 HLH motif and the GAL4 transcription activation domain fused to MyoD, we show that E12 and MyoD can efficiently dimerize in yeast and reconstruct a hybrid transcription factor that activates reporter genes linked to the GAL4 DNA-binding site. The GAL4 DNA-binding domain fused to E12 was used to screen a mouse T-cell cDNA library in which the cDNA was fused to the GAL4 activation domain. Several cDNA clones encoding proteins that interact with E12 were isolated, one of which corresponded to the HLH protein Id-2. Given the ability of E12 to dimerize preferentially with cell type-specific HLH proteins, this strategy should be useful for cloning novel partners for E12 from a variety of cell types.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT BIOCHEM & MOLEC BIOL,BOX 117,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT BIOCHEM,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine					NIAMS NIH HHS [AR39849, AR40339] Funding Source: Medline; NICHD NIH HHS [HD27246] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040339, R01AR039849] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALONSO MC, 1988, EMBO J, V7, P2585, DOI 10.1002/j.1460-2075.1988.tb03108.x; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; BRENNAN TJ, 1991, P NATL ACAD SCI USA, V88, P5675, DOI 10.1073/pnas.88.13.5675; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; CHAKRABORTY T, 1992, J BIOL CHEM, V267, P17498; CHAKRABORTY T, 1991, MOL CELL BIOL, V11, P3633, DOI 10.1128/MCB.11.7.3633; CHIEN CT, 1991, NATURE, V340, P245; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; ELLIS HM, 1990, CELL, V61, P27, DOI 10.1016/0092-8674(90)90212-W; FIELDS S, 1989, P NATL ACAD SCI USA, V88, P9578; GARRELL J, 1990, CELL, V61, P39, DOI 10.1016/0092-8674(90)90213-X; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HU JS, 1992, MOL CELL BIOL, V12, P1031, DOI 10.1128/MCB.12.3.1031; JAMES G, 1992, J CELL BIOL, V116, P863, DOI 10.1083/jcb.116.4.863; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NELSON C, 1990, GENE DEV, V4, P1035, DOI 10.1101/gad.4.6.1035; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; RIMM DL, 1989, GENE, V75, P323, DOI 10.1016/0378-1119(89)90278-3; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J, 1989, MOL CLONING LABORATO; SARTORELLI V, 1992, P NATL ACAD SCI USA, V89, P4047, DOI 10.1073/pnas.89.9.4047; SCALES JB, 1990, MOL CELL BIOL, V10, P1516, DOI 10.1128/MCB.10.4.1516; SUN XH, 1991, CELL, V64, P459, DOI 10.1016/0092-8674(91)90653-G; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7	35	55	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1993	268	7					4608	4611						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP884	8383120				2022-12-27	WOS:A1993KP88400011
J	BASU, A; PARK, K; ATCHISON, ML; CARTER, RS; AVADHANI, NG				BASU, A; PARK, K; ATCHISON, ML; CARTER, RS; AVADHANI, NG			IDENTIFICATION OF A TRANSCRIPTIONAL INITIATOR ELEMENT IN THE CYTOCHROME-C-OXIDASE SUBUNIT VB PROMOTER WHICH BINDS TO TRANSCRIPTION FACTORS NF-E1 (YY-1, DELTA) AND SP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; STRUCTURAL ORGANIZATION; IV GENE; DNA-BINDING; NUCLEAR FACTOR; ETS-DOMAIN; PROTEIN; SEQUENCE; EXPRESSION; ACTIVATION	We have mapped the basal promoter activity of the mouse cytochrome c oxidase (COX) subunit Vb gene to the -17 to +20 region which contains two putative ets binding sites flanking an NF-E1 site fused to an Sp1 site. A 17 nucleotide sequence flanking the major transcription start site (-8 to +9), referred to as 17Inr (initiator sequence) was able to drive CAT activity in 3T3 cells to a level comparable to the construct containing sequences -17 to +20. This suggests that the 17Inr sequence contains the initiator activity. The 17Inr contains a pyrimidine-rich sequence, commencing with a CA that corresponds to the major transcription start site. Primer extension of RNA from transfected cells demonstrated that transcription initiation with the 17Inr template occurs at a site identical to the endogenous gene. DNA-protein binding by gel mobility shift and methylation interference analyses indicated that the pyrimidine-rich sequence immediately flanking the transcription start site consists of an NF-E1 factor binding motif with an overlapping upstream Sp1 binding site. A 13-nucleotide sequence, 13Inr (-4 to +9), which retains the NF-E1 binding activity but does not bind Sp1, was able to promote chloramphenicol acetyltransferase gene expression at levels similar to the 17Inr sequence, suggesting that NF-E1 factor binding is critical for initiator function. Finally, using an in vitro transcription system from Drosophila embryos we demonstrate that NF-E1 is necessary for transcription activation of both the 17Inr and the 13Inr initiator templates. Thus NF-E1 binding appears to be important for basal promoter function of the mouse COXVb gene.	UNIV PENN,SCH VET MED,DEPT ANIM BIOL,BIOCHEM LABS,PHILADELPHIA,PA 19104	University of Pennsylvania					NATIONAL CANCER INSTITUTE [R37CA022762, R01CA022762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042415] Funding Source: NIH RePORTER; NCI NIH HHS [CA-22762] Funding Source: Medline; NIGMS NIH HHS [GM-42415] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATCHISON ML, 1989, MOL CELL BIOL, V9, P2067, DOI 10.1128/MCB.9.5.2067; ATCHISON ML, 1990, EMBO J, V9, P3109, DOI 10.1002/j.1460-2075.1990.tb07508.x; BASU A, 1991, J BIOL CHEM, V266, P15450; BHAT KS, 1989, BIOCHEMISTRY-US, V28, P763, DOI 10.1021/bi00428a052; BOYER TG, 1989, J BIOL CHEM, V264, P5177; BOYER TG, 1990, J BIOL CHEM, V265, P20524; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CARTER RS, 1992, J BIOL CHEM, V267, P23418; CARTER RS, 1991, ARCH BIOCHEM BIOPHYS, V288, P97, DOI 10.1016/0003-9861(91)90169-J; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; FARNHAM PJ, 1990, MOL CELL BIOL, V10, P1390, DOI 10.1128/MCB.10.4.1390; FARNHAM PJ, 1991, J BIOL CHEM, V266, P23288; FLANAGAN JR, 1992, MOL CELL BIOL, V12, P38, DOI 10.1128/MCB.12.1.38; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GUARENTE L, 1987, ANNU REV GENET, V21, P425, DOI 10.1146/annurev.genet.21.1.425; GUNTHER CV, 1990, GENE DEV, V4, P667, DOI 10.1101/gad.4.4.667; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; HARIHARAN N, 1989, GENE DEV, V3, P1789, DOI 10.1101/gad.3.11.1789; HARIHARAN N, 1991, P NATL ACAD SCI USA, V88, P9799, DOI 10.1073/pnas.88.21.9799; HARIHARAN N, 1989, NUCLEIC ACIDS RES, V17, P5323, DOI 10.1093/nar/17.13.5323; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; HIDGE M, 1990, MOL CELL BIOL, V10, P5510; HOEY T, 1990, CELL, V61, P1179, DOI 10.1016/0092-8674(90)90682-5; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KARIM FD, 1990, GENE DEV, V4, P1451, DOI 10.1101/gad.4.9.1451; LAMARCO KL, 1989, GENE DEV, V3, P1372, DOI 10.1101/gad.3.9.1372; LANDAU NR, 1987, MOL CELL BIOL, V7, P3237, DOI 10.1128/MCB.7.9.3237; LI K, 1990, J BIOL CHEM, V265, P20585; LOMAX MI, 1991, GENOMICS, V10, P1, DOI 10.1016/0888-7543(91)90476-U; MITCHELL MT, 1991, TRENDS GENET, V7, P1; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; OSHEAGREENFIELD A, 1992, J BIOL CHEM, V267, P1391; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; SALTZMAN AG, 1989, FASEB J, V3, P1723, DOI 10.1096/fasebj.3.6.2649403; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; SHARP PA, 1991, NATURE, V351, P16, DOI 10.1038/351016d0; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SMALE ST, 1990, P NATL ACAD SCI USA, V87, P4509, DOI 10.1073/pnas.87.12.4509; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUZUKI H, 1989, J BIOL CHEM, V264, P1368; SUZUKI H, 1991, J BIOL CHEM, V266, P2333; TAKESHIMA H, 1988, J MOL BIOL, V200, P1, DOI 10.1016/0022-2836(88)90328-2; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; TOMURA H, 1990, J BIOL CHEM, V265, P6525; TSUZUKI T, 1987, J MOL BIOL, V198, P21, DOI 10.1016/0022-2836(87)90454-2; VIRBASIUS JV, 1991, MOL CELL BIOL, V11, P5631, DOI 10.1128/MCB.11.11.5631; VIRBASIUS JV, 1990, NUCLEIC ACIDS RES, V18, P6581, DOI 10.1093/nar/18.22.6581; YAMADA M, 1990, J BIOL CHEM, V265, P7687	57	92	94	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					4188	4196						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382696				2022-12-27	WOS:A1993KN53300058
J	OTSU, K; KINSELLA, JL; HELLER, P; FROEHLICH, JP				OTSU, K; KINSELLA, JL; HELLER, P; FROEHLICH, JP			SODIUM DEPENDENCE OF THE NA+-H+ EXCHANGER IN THE PRE-STEADY STATE - IMPLICATIONS FOR THE EXCHANGE MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVILLUS MEMBRANE-VESICLES; THYMIC LYMPHOCYTES; MODIFIER SITE; AMILORIDE; ANTIPORT; TRANSPORT; INHIBITION; KINETICS; BINDING; KIDNEY	The pre-steady state time course of amiloride-sensitive Na+o uptake by the Na+-H+ exchanger in renal brush border membrane vesicles (BBMV) exhibits a burst phase at 0-degrees-C which corresponds to the initial turnover of the exchanger (Otsu, K., Kinsella, J. L., Sacktor, B. S., and Froehlich, J. P. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 4818-4822). Investigation of the Na+o dependence of the Na+-H+ exchanger between 1 and 10 mM Na+ revealed that activation of the burst phase involves at least two Na+ transport sites interacting with positive cooperativity. In this study, characterization of the Na+ transport sites contributing to the burst phase was extended to include Na+ concentrations below 1 mM. Between 0.1 and 1 mM Na+ the amplitude of the burst phase in acid-loaded BBMV (pH(i) 5.7; pH(o) 7.7) exhibited a sigmoidal dependence on [Na+]o, consistent with the presence of a second class of high affinity Na+ transport sites with cooperative binding characteristics. In contrast, steady state Na+ uptake obeyed Michaelis-Menten kinetics, similar to the behavior observed previously at higher (1-10 mm) Na+o concentrations. Treatment of the vesicles with carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone, which induced the formation of an inside-negative membrane potential, increased the burst amplitude but had no effect on the steady state uptake velocity. Experiments performed with alkaline-loaded BBMV (pH(i) 7.7; pH(o) 7.7), which permit only a single turnover of the exchanger, gave a simple hyperbolic dependence of the burst amplitude on [Na+]o (0.5-5 mM). We propose that the change in multiplicity of Na+ transport sites and membrane potential sensitivity that occurs in the transition between the pre-steady state and the steady state of Na+ uptake in acid-loaded vesicles reflects the presence of an oligomer which operates according to a ''flip-flop'' mechanism. The minimum subunit composition inferred from the biphasic [Na+]o dependence of the burst amplitude is a dimer at low (<1 mM) Na+o levels and a tetramer at high [Na+]o. Communication between the subunits producing the complex [Na+]o dependence is controlled by the intravesicular (cytoplasmic) H+ modifier site. Under alkaline conditions (pH 7.7), where this site is unoccupied, the subunits behave as independent units and cease operation after the first turnover. Occupation of the H+ modifier site activates a conformational interaction between the subunits that leads to cooperative Na+o binding, alternation of the transport sites, and repetitive cycling of the Na+-H+ exchanger.	NIA,CARDIOVASC SCI LAB,BALTIMORE,MD 21224	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)								ARONSON PS, 1981, FED PROC, V40, P2213; ARONSON PS, 1982, NATURE, V299, P161, DOI 10.1038/299161a0; ARONSON PS, 1978, J MEMBRANE BIOL, V42, P81, DOI 10.1007/BF01870395; ARONSON PS, 1985, ANNU REV PHYSIOL, V47, P545, DOI 10.1146/annurev.ph.47.030185.002553; BELIVEAU R, 1988, BIOCHEM BIOPH RES CO, V152, P484, DOI 10.1016/S0006-291X(88)80739-3; Booth A G, 1974, Biochem J, V142, P575; CHAPPELE.D, 1974, BIOCHEMISTRY-US, V13, P1788, DOI 10.1021/bi00706a002; DESIR GV, 1991, J BIOL CHEM, V266, P2267; GIEBEL J, 1989, AM J PHYSIOL, V257, pF790; GRINSTEIN S, 1984, J GEN PHYSIOL, V83, P341, DOI 10.1085/jgp.83.3.341; GRINSTEIN S, 1986, J MEMBRANE BIOL, V90, P1, DOI 10.1007/BF01869680; GRINSTEIN S, 1984, J GEN PHYSIOL, V84, P585, DOI 10.1085/jgp.84.4.585; GUTFREUND H, 1977, ENZYMES PHYSICAL PRI, P199; IVES HE, 1983, J BIOL CHEM, V258, P9710; KINSELLA JL, 1980, AM J PHYSIOL, V238, pF461, DOI 10.1152/ajprenal.1980.238.6.F461; KINSELLA JL, 1982, BIOCHIM BIOPHYS ACTA, V689, P161, DOI 10.1016/0005-2736(82)90200-0; KINSELLA JL, 1981, AM J PHYSIOL, V241, pF374, DOI 10.1152/ajprenal.1981.241.4.F374; KNICKELBEIN RG, 1990, AM J PHYSIOL, V259, pG802, DOI 10.1152/ajpgi.1990.259.5.G802; KNOTT GD, 1979, COMPUT PROG BIOMED, V10, P271, DOI 10.1016/0010-468X(79)90075-8; KURTZ I, 1989, J CLIN INVEST, V83, P616, DOI 10.1172/JCI113925; LAZDUNSKI M, 1972, CURRENT TOPICS CELLU, V6, P267; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MURER H, 1976, BIOCHEM J, V154, P597, DOI 10.1042/bj1540597; OTSU K, 1989, P NATL ACAD SCI USA, V86, P4818, DOI 10.1073/pnas.86.13.4818; OTSU K, 1986, BIOPHYS J, V49, pA553; OTSU K, 1988, BIOPHYS J, V53, pA341; OTSU K, 1992, J BIOL CHEM, V268, P8089; PARIS S, 1983, J BIOL CHEM, V258, P3503; REILLY RF, 1991, AM J PHYSIOL, V261, pF1088, DOI 10.1152/ajprenal.1991.261.6.F1088; RINDLER MJ, 1981, J BIOL CHEM, V256, P1080; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; Segel IH, 1975, ENZYME KINETICS, P346; SEIFTER JL, 1986, J CLIN INVEST, V78, P859, DOI 10.1172/JCI112671; WARNOCK DG, 1982, AM J PHYSIOL, V242, pF733, DOI 10.1152/ajprenal.1982.242.6.F733; WARNOCK DG, 1988, J BIOL CHEM, V263, P7216; WIERZBICKI W, 1990, J MEMBRANE BIOL, V117, P11, DOI 10.1007/BF01871562	36	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3184	3193						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381420				2022-12-27	WOS:A1993KM16100028
J	NEMENOFF, RA; WINITZ, S; QIAN, NX; VANPUTTEN, V; JOHNSON, GL; HEASLEY, LE				NEMENOFF, RA; WINITZ, S; QIAN, NX; VANPUTTEN, V; JOHNSON, GL; HEASLEY, LE			PHOSPHORYLATION AND ACTIVATION OF A HIGH-MOLECULAR-WEIGHT FORM OF PHOSPHOLIPASE-A2 BY P42 MICROTUBULE-ASSOCIATED PROTEIN-2 KINASE AND PROTEIN-KINASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; CYTOSOLIC PHOSPHOLIPASE-A2; TYROSINE PHOSPHORYLATION; MESANGIAL CELLS; IDENTIFICATION; PURIFICATION; INSULIN; ERKS	Phospholipase A2 (PLA2) is the enzyme regulating the release of arachidonic acid in most cell types. A high molecular mass, 85-kDa soluble form of PLA2 (cPLA2) has recently been identified, the activity of which is stably increased by stimulation of cells with hormones and growth factors. Growth factor stimulation of cells has been reported to result in increased phosphorylation of cPLA2 on serine residues, but the kinases mediating this effect have not been identified. We report here that human cPLA2 is phosphorylated in vitro by two growth factor-stimulated serine/threonine-specific kinases, p42 MAP kinase and protein kinase C (PKC). Phosphorylation of the cPLA2 enzyme by either kinase results in an increase in catalytic cPLA2-specific activity. Domains of the cPLA2 molecule have been expressed in Escherichia coli, and the fusion proteins purified. PKC and p42 MAP kinase give different patterns of phosphorylation of the recombinantly expressed cPLA2 fragments. p42 MAP kinase selectively phosphorylates the domain of cPLA2 containing a MAP kinase consensus sequence, whereas PKC phosphorylates sites in all three recombinantly expressed domains of the enzyme. Peptide mapping indicates that the site phosphorylated by p42 MAP kinase is different from those phosphorylated by PKC. The combined action of both of these kinases is likely to mediate the effects of growth factor stimulation on arachidonic acid release through the activation of cPLA2.	NATL JEWISH CTR IMMUNOL & RESP MED,DENVER,CO 80262	National Jewish Health	NEMENOFF, RA (corresponding author), UNIV COLORADO,HLTH SCI CTR,DEPT MED,DIV RENAL DIS & HYPERTENS,DENVER,CO 80262, USA.				NIDDK NIH HHS [DK37381] Funding Source: Medline; NIGMS NIH HHS [GM30324] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030324, R01GM030324] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHN NG, 1991, J BIOL CHEM, V266, P4220; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; BONVENTRE JV, 1990, J BIOL CHEM, V265, P4934; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CLARK JD, 1990, P NATL ACAD SCI USA, V87, P7708, DOI 10.1073/pnas.87.19.7708; CLARK MA, 1987, J BIOL CHEM, V262, P4402; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; DAVIS RJ, 1985, P NATL ACAD SCI USA, V82, P1974, DOI 10.1073/pnas.82.7.1974; ERIKSON E, 1986, J BIOL CHEM, V261, P350; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; GRONICH JH, 1990, BIOCHEM J, V271, P37, DOI 10.1042/bj2710037; GRONICH JH, 1988, J BIOL CHEM, V263, P16645; GUPTA SK, 1990, SCIENCE, V249, P662, DOI 10.1126/science.2166341; GUPTA SK, 1992, J BIOL CHEM, V267, P7987; HUCKLE WR, 1990, MOL CELL BIOL, V10, P6290, DOI 10.1128/MCB.10.12.6290; JELSEMA CL, 1987, P NATL ACAD SCI USA, V84, P3623, DOI 10.1073/pnas.84.11.3623; KAZLAUSKAS A, 1988, J CELL BIOL, V106, P1395, DOI 10.1083/jcb.106.4.1395; KAZLAUSKAS A, 1989, CELL, V58, P413; KYRIAKIS JM, 1990, J BIOL CHEM, V265, P17355; KYRIAKIS JM, 1991, J BIOL CHEM, V266, P10043; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LALLEMAIN G, 1991, CELL REGUL, V2, P675, DOI 10.1091/mbc.2.8.675; LIN LL, 1992, P NATL ACAD SCI USA, V89, P6147, DOI 10.1073/pnas.89.13.6147; LIN LL, 1991, J CELL BIOCH B, V15, P161; LOWNDES JM, 1991, J BIOL CHEM, V266, P14193; MARGOLIS BL, 1988, BIOCHEM J, V249, P587, DOI 10.1042/bj2490587; PIOMELLI D, 1991, P NATL ACAD SCI USA, V88, P6770, DOI 10.1073/pnas.88.15.6770; RAY LB, 1988, P NATL ACAD SCI USA, V85, P3753, DOI 10.1073/pnas.85.11.3753; SHARP JD, 1991, J BIOL CHEM, V266, P14850; WAITE M, 1985, J LIPID RES, V26, P1379	31	520	525	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1960	1964						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380583				2022-12-27	WOS:A1993KH62000071
J	STADLER, R; ZENK, MH				STADLER, R; ZENK, MH			THE PURIFICATION AND CHARACTERIZATION OF A UNIQUE CYTOCHROME-P-450 ENZYME FROM BERBERIS-STOLONIFERA PLANT-CELL CULTURES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BISBENZYLISOQUINOLINE ALKALOIDS; MICROSOMAL CYTOCHROME-P-450; BIOSYNTHESIS; CHROMATOGRAPHY; 4-HYDROXYLASE; RETICULINE; OXIDATION; PROTEINS; REVISION	A new cytochrome P-450 enzyme, isolated from Berberis stolonifera plant cell suspension cultures, has been purified to electrophoretic homogeneity. The purified hemoprotein migrated as a single band in sodium dodecyl sulfate polyacrylamide gel electrophoresis with a minimal M(r) = 46,000. The enzyme could be purified to a high specific content of P-450 (18.2 nmol/mg protein) after fast protein liquid chromatofocusing, displaying an isoelectric point of 6.05. Spectral analysis of the homogeneous enzyme showed that it is predominantly low spin in the oxidized state, with a slight red-shifted ferrous carbonyl complex that exhibits a maximum at 452 nm. The purified cytochrome P-450, successfully reconstituted with NADPH-cytochrome P-450 reductase, displayed a maximal turnover rate of 50 nmol of substrate/nmol of P-450/min. In the purified and reconstituted form, the enzyme catalyzed the oxidation of three different chiral benzyltetrahydroisoquinoline substrates, namely (S)-coclaurine, (R)-N-methylcoclaurine, and (S)-N-methylcoclaurine, leading to the formation of three distinct dimeric products, (R,S)-berbamunine, (R,S)-2'-norberbamunine, and (R,R)-guattegaumerine, that are also present in the plant cell cultures in vivo. This is the first report of a P-450 enzyme that mediates regio- and stereoselective intermolecular oxidative phenol coupling to furnish natural dimeric compounds. In this catalytic cycle cytochrome P-450 functions as an oxidant in a bisubstrate reaction without transfer of the activated oxygen atom to either of the two chiral substrates.	UNIV MUNICH, LEHRSTUHL PHARMAZEUT BIOL, W-8000 MUNICH 2, GERMANY	University of Munich								Barton D. H. R., 1957, FESTSCHRIFT A STOLL, P117; BARTON DHR, 1966, J CHEM SOC C, P2313, DOI 10.1039/j39660002313; BARTON DHR, 1966, J CHEM SOC CHEM COMM, V9, P266; BATTERSBY AR, 1967, OXIDATIVE COUPLING P, P119; BAUER W, 1989, TETRAHEDRON LETT, V30, P5257, DOI 10.1016/S0040-4039(01)93756-6; BAUER W, 1991, PHYTOCHEMISTRY, V30, P2953, DOI 10.1016/S0031-9422(00)98230-X; BAXTER I, 1965, J CHEM SOC, P3645, DOI 10.1039/jr9650003645; BENVENISTE I, 1989, BIOCHEM J, V259, P847, DOI 10.1042/bj2590847; BHAKUNI DS, 1978, J CHEM SOC PERK T 1, P380, DOI 10.1039/p19780000380; BHAKUNI DS, 1980, PHYTOCHEMISTRY, V19, P2347, DOI 10.1016/S0031-9422(00)91024-0; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASSELS BK, 1987, PHYTOCHEMISTRY, V26, P1005, DOI 10.1016/S0031-9422(00)82337-7; Coon M J, 1978, Methods Enzymol, V52, P200; DAHLIN DC, 1984, P NATL ACAD SCI-BIOL, V81, P1327, DOI 10.1073/pnas.81.5.1327; DEMONTELLANO PRO, 1989, TRENDS PHARMACOL SCI, V10, P354, DOI 10.1016/0165-6147(89)90007-2; ERNSTER L, 1962, J CELL BIOL, V15, P541, DOI 10.1083/jcb.15.3.541; GABRIAC B, 1991, ARCH BIOCHEM BIOPHYS, V288, P302, DOI 10.1016/0003-9861(91)90199-S; GOPINATH KW, 1959, CHEM BER-RECL, V92, P1657, DOI 10.1002/cber.19590920727; GUENGERICH FP, 1990, CRIT REV BIOCHEM MOL, V25, P97; GUENGERICH FP, 1991, J BIOL CHEM, V266, P10019; GUHA K P, 1979, Journal of Natural Products (Lloydia), V42, P1, DOI 10.1021/np50001a001; GUINAUDEAU H, 1984, TETRAHEDRON, V40, P1975, DOI 10.1016/S0040-4020(01)88437-4; HIGASHI K, 1985, AGR BIOL CHEM TOKYO, V49, P2399, DOI 10.1080/00021369.1985.10867084; KAMETANI T, 1970, J HETEROCYCLIC CHEM, V7, P181, DOI 10.1002/jhet.5570070127; KAMETANI T, 1969, J CHEM SOC C, P2770, DOI 10.1039/j39690002770; KAMETANI T, 1969, J CHEM SOC C, P9, DOI 10.1039/j39690000009; KASTNER M, 1987, J CHROMATOGR, V397, P153, DOI 10.1016/S0021-9673(01)84998-0; KOCHS G, 1989, ARCH BIOCHEM BIOPHYS, V273, P543, DOI 10.1016/0003-9861(89)90514-6; KRATZL K, 1951, MONATSH CHEM, V82, P568, DOI 10.1007/BF00900858; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINSMAIER EM, 1965, PHYSIOL PLANTARUM, V18, P100, DOI 10.1111/j.1399-3054.1965.tb06874.x; Marnett L.J., 1986, CYTOCHROME P 450 STR, P29; OKEEFE DP, 1989, PLANT PHYSIOL, V89, P1141, DOI 10.1104/pp.89.4.1141; OMURA T, 1964, J BIOL CHEM, V239, P2370; ROOS PH, 1990, J CHROMATOGR, V521, P251, DOI 10.1016/0021-9673(90)85050-6; RUEFFER M, 1987, TETRAHEDRON LETT, V28, P5307, DOI 10.1016/S0040-4039(00)96715-7; SCHIFF PL, 1983, J NAT PROD, V46, P1, DOI 10.1021/np50025a001; SCHIFF PL, 1987, J NAT PROD, V50, P529, DOI 10.1021/np50052a001; SCHIFF PL, 1991, J NAT PROD, V54, P645, DOI 10.1021/np50075a001; SONG WC, 1991, SCIENCE, V253, P781, DOI 10.1126/science.1876834; STADLER R, 1988, PHYTOCHEMISTRY, V27, P2557, DOI 10.1016/0031-9422(88)87027-4; STADLER R, 1989, PHYTOCHEMISTRY, V28, P1083, DOI 10.1016/0031-9422(89)80187-6; STADLER R, 1990, LIEBIGS ANN CHEM, P555; STADLER R, 1987, TETRAHEDRON LETT, V28, P1251, DOI 10.1016/S0040-4039(00)95338-3; TANAHASHI T, 1988, TETRAHEDRON LETT, V29, P5625, DOI 10.1016/S0040-4039(00)80829-1; WOGGON WD, 1988, NACHR CHEM TECH LAB, V36, P890; ZENK MH, 1989, J CHEM SOC CHEM COMM, P1725, DOI 10.1039/c39890001725	48	88	90	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					823	831						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8380416				2022-12-27	WOS:A1993KG07700014
J	WERSTUCK, GH; CAPONE, JP				WERSTUCK, GH; CAPONE, JP			AN UNUSUAL CELLULAR FACTOR POTENTIATES PROTEIN-DNA COMPLEX ASSEMBLY BETWEEN OCT-1 AND VMW65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOCORTICOID RECEPTOR-BINDING; SIMPLEX VIRUS TYPE-1; CALF THYMUS DNA; ALPHA-GENES; POU DOMAIN; TRANSCRIPTION; ACTIVATION; SEQUENCES; IDENTIFICATION; POLYPEPTIDE	The herpes simplex virus trans-activator Vmw65 interacts with the cellular factors Oct-1 and VCAF-1 to generate a multicomponent DNA binding complex that specifically recognizes conserved enhancer elements found upstream of the viral immediate-early genes, resulting in potent stimulation of their transcription. We have identified a HeLa cell factor, distinct from Oct-1 or VCAF-1, which significantly enhances the stability or formation of Vmw65-dependent complexes, as judged by mobility shift analysis using either nuclear extracts or bacterially expressed Oct-1 and Vmw65. This factor, designated SF (stimulatory factor), was partially purified from HeLa cell postnuclear extracts and has an apparent molecular weight of 1500-3000, based on ultrafiltration and size-exclusion chromatography. SF was shown to be resistant to inactivation by heat treatment, protease, nuclease, and phospholipase digestions, and extraction with organic solvents. Pretreatment of SF with beta-glucuronidase did not affect its ability to stimulate Vmw65-dependent complex formation but did reduce the electrophoretic mobility of the resulting complex. These data indicate that SF is probably a component of the Vmw65-induced complex and may be composed, at least partially, of carbohydrate.	MCMASTER UNIV,DEPT BIOCHEM,HAMILTON L8N 3Z5,ONTARIO,CANADA	McMaster University								ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; ABATE C, 1990, P NATL ACAD SCI USA, V87, P1032, DOI 10.1073/pnas.87.3.1032; APPHYS CMJ, 1989, J VIROL, V63, P2798; BATTERSON W, 1983, J VIROL, V46, P371, DOI 10.1128/JVI.46.2.371-377.1983; BAUMRUKER T, 1988, GENE DEV, V2, P1400, DOI 10.1101/gad.2.11.1400; BERGMEYER HU, 1983, METHODS ENZYMATIC AN, V2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BUSCH SJ, 1990, ONCOGENE, V5, P1549; BZIK DJ, 1986, NUCLEIC ACIDS RES, V14, P929, DOI 10.1093/nar/14.2.929; CAMPBELL MEM, 1984, J MOL BIOL, V180, P1, DOI 10.1016/0022-2836(84)90427-3; CAVANAUGH AH, 1990, BIOCHEMISTRY-US, V29, P989, DOI 10.1021/bi00456a022; CAVANAUGH AH, 1990, BIOCHEMISTRY-US, V29, P996, DOI 10.1021/bi00456a023; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GAFFNEY DF, 1985, NUCLEIC ACIDS RES, V13, P7874; GERSTER T, 1988, P NATL ACAD SCI USA, V85, P6347, DOI 10.1073/pnas.85.17.6347; GODING CR, 1989, VIROLOGY, V173, P363; HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; INGLES CJ, 1991, NATURE, V351, P588, DOI 10.1038/351588a0; KATAN M, 1990, NUCLEIC ACIDS RES, V18, P6871, DOI 10.1093/nar/18.23.6871; KRISTIE TM, 1984, P NATL ACAD SCI-BIOL, V81, P4065, DOI 10.1073/pnas.81.13.4065; KRISTIE TM, 1989, EMBO J, V8, P4229, DOI 10.1002/j.1460-2075.1989.tb08608.x; KRISTIE TM, 1990, GENE DEV, V4, P2383, DOI 10.1101/gad.4.12b.2383; KRISTIE TM, 1987, P NATL ACAD SCI USA, V84, P71, DOI 10.1073/pnas.84.1.71; LUISI B, 1992, NATURE, V356, P379, DOI 10.1038/356379a0; MACKEM S, 1982, J VIROL, V44, P939, DOI 10.1128/JVI.44.3.939-949.1982; MACKEM S, 1982, J VIROL, V44, P1145; MARSDEN HS, 1987, J VIROL, V61, P2428, DOI 10.1128/JVI.61.8.2428-2437.1987; MCKNIGHT JLC, 1987, P NATL ACAD SCI USA, V84, P7061, DOI 10.1073/pnas.84.20.7061; MURPHY S, 1992, MOL CELL BIOL, V12, P3247, DOI 10.1128/MCB.12.7.3247; OHARE P, 1988, CELL, V52, P435, DOI 10.1016/S0092-8674(88)80036-9; PIERANI A, 1990, MOL CELL BIOL, V10, P6204, DOI 10.1128/MCB.10.12.6204; PRESTON CM, 1988, CELL, V52, P425, DOI 10.1016/S0092-8674(88)80035-7; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; STERN S, 1991, GENE DEV, V5, P2555, DOI 10.1101/gad.5.12b.2555; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; TRIEZENBERG SJ, 1988, GENE DEV, V2, P730, DOI 10.1101/gad.2.6.730; ULLMAN KS, 1991, SCIENCE, V254, P558, DOI 10.1126/science.1683003; VERRIJZER CP, 1992, MOL CELL BIOL, V12, P542, DOI 10.1128/MCB.12.2.542; WERSTUCK G, 1989, J VIROL, V63, P5509, DOI 10.1128/JVI.63.12.5509-5513.1989; WHITE J, 1992, EMBO J, V11, P2229, DOI 10.1002/j.1460-2075.1992.tb05282.x; XIAO P, 1990, MOL CELL BIOL, V10, P4974, DOI 10.1128/MCB.10.9.4974; ZHU H, 1992, P NATL ACAD SCI USA, V89, P5291, DOI 10.1073/pnas.89.12.5291	44	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1272	1278						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8380410				2022-12-27	WOS:A1993KG07700076
J	KUAN, IC; JOHNSON, KA; TIEN, M				KUAN, IC; JOHNSON, KA; TIEN, M			KINETIC-ANALYSIS OF MANGANESE PEROXIDASE - THE REACTION WITH MANGANESE COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASIDIOMYCETE PHANEROCHAETE-CHRYSOSPORIUM; LIGNIN-DEGRADING BASIDIOMYCETE; DEPENDENT PEROXIDASE; SPECTRAL CHARACTERIZATION; OXIDATION; MECHANISM; ENZYME; DEGRADATION; SEQUENCE; CULTURE	Manganese peroxidase from the lignin-degrading fungus Phanerochaete chrysosporium catalyzes the H2O2-dependent oxidation of Mn2+ to Mn2+. Presteady-state methods were employed to characterize the reactions of free and chelated Mn2+ with the 2-electron and 1-electron oxidized forms of the enzyme, compounds I and II, respectively. At pH 4.5, the optimum pH for steady-state turnover, the reaction of compound I with Mn2+, either free or complexed, is too rapid to measure by stopped flow methods. The reactions of compound I with Mn2+ can only be monitored under non-optimal conditions of pH 2.5. The reaction of compound II with Mn2+ is much slower than compound I. Chelators such as oxalate, lactate, and malonate facilitated the reaction of Mn2+ with compound II. In contrast, succinate, which does not readily form a complex with Mn2+, and polyglutamate, which is polymeric, were ineffective in stimulating the reaction of Mn2+ with compound II. The 1:1 chelator-Mn2+ complex is the preferred substrate for compound II; this conclusion is based on known formation constants for the various Mn2+ complexes. Steady-state kinetics studies were performed by directly measuring the initial rate of Mn3+ formation. The k(cat) values for the formation of Mn3+-oxalate, Mn3+-lactate, and Mn3+-malonate are 308, 211, and 220 s-1, respectively. The K(m) values for Mn2+-oxalate, Mn2+-lactate, and Mn2+-malonate are 13, 41, and 18 muM, respectively. These results collectively indicate that manganese peroxidase does not readily oxidize free (hexa-aquo) Mn2+ as previously proposed (Wariishi, H., Valli, K., and Gold, M. H. (1992) J. Biol. Chem. 267, 23688-23695), but the Mn2+ has to be chelated to support steady-state turnover.	PENN STATE UNIV,DEPT MOLEC & CELL BIOL,UNIV PK,PA 16802; PENN STATE UNIV,CTR BIOMOLEC STRUCT & FUNCT,UNIV PK,PA 16802	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University					NIEHS NIH HHS [1-P42ES04922-01] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004922] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Cleland W W, 1979, Methods Enzymol, V63, P103; FORRESTER IT, 1990, APPL MICROBIOL BIOT, V33, P359, DOI 10.1007/BF00164536; GLENN JK, 1986, ARCH BIOCHEM BIOPHYS, V251, P688, DOI 10.1016/0003-9861(86)90378-4; GLENN JK, 1985, ARCH BIOCHEM BIOPHYS, V242, P329, DOI 10.1016/0003-9861(85)90217-6; GLENN JK, 1983, BIOCHEM BIOPH RES CO, V114, P1077, DOI 10.1016/0006-291X(83)90672-1; HAMMEL KE, 1991, ENZYME MICROB TECH, V13, P15, DOI 10.1016/0141-0229(91)90182-A; KARHUNEN E, 1990, ARCH BIOCHEM BIOPHYS, V279, P25, DOI 10.1016/0003-9861(90)90458-B; KIRK TK, 1986, BIOCHEM J, V236, P279, DOI 10.1042/bj2360279; KUAN IC, 1993, P NATL ACAD SCI USA, V90, P1242, DOI 10.1073/pnas.90.4.1242; LEONTEVSKII AA, 1990, BIOKHIMIYA, V55, P423; MALTSEVA OV, 1991, BIOTECHNOL APPL BIOC, V13, P291; MARTELL AE, 1977, CRITICAL STABILITY C, V3, P29; Meites L., 1963, HDB ANAL CHEM; MILLIS CD, 1989, BIOCHEMISTRY-US, V28, P8484, DOI 10.1021/bi00447a032; MINO Y, 1988, J BIOL CHEM, V263, P7029; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; ORTH AB, 1991, APPL ENVIRON MICROB, V57, P2591, DOI 10.1128/AEM.57.9.2591-2596.1991; PASZCZYNSKI A, 1985, FEMS MICROBIOL LETT, V29, P37; PEASE EA, 1989, J BIOL CHEM, V264, P13531; PERIE FH, 1991, APPL ENVIRON MICROB, V57, P2240; PUNJA ZK, 1984, CAN J BOT, V62, P2028, DOI 10.1139/b84-276; Schmidt C. J., 1981, Proceedings, American Wood-Preservers' Association, P157; SILLEN LG, 1964, SPECIAL PUBLICATION, V17, P386; TAUBE H, 1948, J AM CHEM SOC, V70, P3928, DOI 10.1021/ja01191a120; TIEN M, 1983, SCIENCE, V221, P661, DOI 10.1126/science.221.4611.661; TIEN M, 1990, APPL ENVIRON MICROB, V56, P2540, DOI 10.1128/AEM.56.8.2540-2544.1990; TRAQUAIR JA, 1987, CAN J BOT, V65, P1952, DOI 10.1139/b87-267; VONHOLDENRIEDER O, 1982, EUR J FOREST PATHOL, V12, P41; VONVOLGER C, 1982, EUR J FOREST PATHOL, V12, P59; WARIISHI H, 1988, BIOCHEMISTRY-US, V27, P5365, DOI 10.1021/bi00414a061; WARIISHI H, 1989, J BIOL CHEM, V264, P3335; WARIISHI H, 1991, BIOCHEM BIOPH RES CO, V176, P269, DOI 10.1016/0006-291X(91)90919-X; WARIISHI H, 1992, J BIOL CHEM, V267, P23688; WATERS WA, 1965, OXIDATION ORGANIC A, V5, P186	35	141	142	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20064	20070						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376363				2022-12-27	WOS:A1993LY01900024
J	MONTGOMERY, JA; DAVID, F; GARNEAU, M; BRUNENGRABER, H				MONTGOMERY, JA; DAVID, F; GARNEAU, M; BRUNENGRABER, H			METABOLISM OF 2,3-BUTANEDIOL STEREOISOMERS IN THE PERFUSED-RAT-LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATOGRAPHY MASS-SPECTROMETRY; PYRUVATE; ALCOHOLISM; ACETOIN; ACETATE; BLOOD	The identification of 2,3-butanediol in sera of alcoholics led to the hypothesis that it may be a specific marker of alcohol abuse. We have investigated the metabolism of the individual isomers of 2,3-butanediol (2R,3R-, 2S,3S-, meso-2,3-butanediol and racemic 2,3-butanediol) in perfused livers from fed rats. Rates of uptake of the isomers decrease in the order (i) 2R,3R-, (ii) meso-, (iii) 2S,3S-2,3-butanediol. We observed interconversion of isomers and oxidation to acetoin with 2R,3R- and meso- but not with 2S,3S-2,3-butanediol. In perfusions conducted in deuterium oxide, interconversion of isomers was accompanied by incorporation of deuterium. Thus, interconversion of isomers occurs via a reversible oxidation to acetoin with incorporation of hydrogen from water. In perfusions with either 2R,3R- or meso-[2-C-14]2,3-butanediol, the substrates were converted to labeled acetate, R-3-hydroxybutyrate and CO2, suggesting that 2,3-butanediol is oxidized to acetyl-CoA via acetoin.	UNIV MONTREAL,DEPT NUTR,MONTREAL H3C 3J7,QUEBEC,CANADA; CASE WESTERN RESERVE UNIV,DEPT NUTR,CLEVELAND,OH 44106	Universite de Montreal; Case Western Reserve University					NIDDK NIH HHS [DK35543] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035543] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALKONYI I, 1976, EUR J BIOCHEM, V66, P551, DOI 10.1111/j.1432-1033.1976.tb10581.x; BRUNENGRABER H, 1973, J BIOL CHEM, V248, P2656; Casazza J P, 1987, Alcohol Alcohol Suppl, V1, P607; CASAZZA JP, 1990, TRENDS BIOCHEM SCI, V15, P26, DOI 10.1016/0968-0004(90)90127-W; COOPER RH, 1974, BIOCHEM J, V143, P625, DOI 10.1042/bj1430625; CROUT DHG, 1991, J CHEM SOC PERK T 1, P1329, DOI 10.1039/p19910001329; Czok R, 1974, METHOD ENZYMAT AN, V3, P1446; DAWSON J, 1954, BIOCHEM J, V57, P177, DOI 10.1042/bj0570177; DAWSON J, 1954, BIOCHEM J, V57, P180, DOI 10.1042/bj0570180; DAWSON J, 1957, BIOCHEM J, V67, P456, DOI 10.1042/bj0670456; ECKHARDT MJ, 1986, PROG NEUROPSYCHOPHAR, V10, P135; GABRIEL MA, 1971, BIOCHEM J, V124, P793, DOI 10.1042/bj1240793; GABRIEL MA, 1972, COMP BIOCHEM PHYSIOL, V41, P493, DOI 10.1016/0305-0491(72)90112-5; GAVINO VC, 1987, J BIOL CHEM, V262, P6735; Green DE, 1942, J BIOL CHEM, V145, P69; GUTTMANN I, 1974, METHOD ENZYMAT AN, V3, P1465; Guynn R W, 1975, Methods Enzymol, V35, P302, DOI 10.1016/0076-6879(75)35168-9; HAPPOLD FC, 1952, BIOCHIM BIOPHYS ACTA, V8, P18, DOI 10.1016/0006-3002(52)90003-6; JUNI E, 1952, J BIOL CHEM, V195, P715; JUNI E, 1956, J BIOL CHEM, V218, P365; JUNI E, 1956, J BACTERIOL, V71, P425, DOI 10.1128/JB.71.4.425-432.1956; JUNI E, 1952, J BIOL CHEM, V195, P727; KNOWLES SE, 1974, BIOCHEM J, V142, P401, DOI 10.1042/bj1420401; LEMOIGNE M, 1930, COMPT REND ACAD, V191, P80; LUBIN M, 1945, J BIOL CHEM, V161, P503; MAMER OA, 1978, BIOMED MASS SPECTROM, V5, P287, DOI 10.1002/bms.1200050403; MONTGOMERY JA, 1990, ANAL BIOCHEM, V185, P71, DOI 10.1016/0003-2697(90)90256-9; MONTGOMERY JA, 1992, BIOL MASS SPECTROM, V21, P242, DOI 10.1002/bms.1200210504; NEEDHAM LL, 1982, J CHROMATOGR, V233, P9, DOI 10.1016/S0378-4347(00)81726-0; PRASS RL, 1980, J BIOL CHEM, V255, P5215; RUTSTEIN DD, 1983, LANCET, V2, P534; SCHREIBER G, 1963, BIOCHEM Z, V339, P83; SCHUCKIT MA, 1986, PROG NEURO-PSYCHOPH, V10, P191, DOI 10.1016/0278-5846(86)90073-4; SEBEK OK, 1952, ARCH BIOCHEM BIOPHYS, V40, P373, DOI 10.1016/0003-9861(52)90125-2; SISFONTES L, 1986, CLIN CHIM ACTA, V155, P117, DOI 10.1016/0009-8981(86)90272-X; SKINNER HA, 1986, BMJ-BRIT MED J, V292, P1703, DOI 10.1136/bmj.292.6537.1703; Stanier R. Y., 1944, CANADIAN JOUR RES SECT B CHEM SCI, V22, P140; Tanko B, 1940, H-S Z PHYSIOL CHEM, V264, P91, DOI 10.1515/bchm2.1940.264.3-4.91; TAYLOR MB, 1960, BIOCHIM BIOPHYS ACTA, V39, P448, DOI 10.1016/0006-3002(60)90197-9; THACKER SB, 1984, ALCOHOLISM CLIN EXP, V4, P375; UI S, 1984, J FERMENT TECHNOL, V62, P151; Veech R L, 1981, Curr Top Cell Regul, V18, P151; WALSH DA, 1976, BIOCHEM J, V157, P41, DOI 10.1042/bj1570041; Westerfeld WW, 1943, J BIOL CHEM, V148, P523; Westerfeld WW, 1942, J BIOL CHEM, V144, P657; WESTLEY JW, 1968, J ORG CHEM, V33, P3978, DOI 10.1021/jo01274a077; WOLF S, 1983, BRIT J PSYCHIAT, V142, P388, DOI 10.1192/bjp.142.4.388; [No title captured]; [No title captured]	49	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20185	20190						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376379				2022-12-27	WOS:A1993LY01900042
J	ANDERSON, MS; BULL, HG; GALLOWAY, SM; KELLY, TM; MOHAN, S; RADIKA, K; RAETZ, CRH				ANDERSON, MS; BULL, HG; GALLOWAY, SM; KELLY, TM; MOHAN, S; RADIKA, K; RAETZ, CRH			UDP-N-ACETYLGLUCOSAMINE ACYLTRANSFERASE OF ESCHERICHIA-COLI - THE 1ST STEP OF ENDOTOXIN BIOSYNTHESIS IS THERMODYNAMICALLY UNFAVORABLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; MEMBRANE PHOSPHOLIPID-SYNTHESIS; GRAM-NEGATIVE ENDOTOXIN; A DISACCHARIDE SYNTHASE; LIPID-A; SN-GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; RECONSTITUTION; PURIFICATION; SPECIFICITY; PRECURSORS	UDP-N-acetylglucosamine acyltransferase of Escherichia coli catalyzes the reaction, UDP-GlcNAc + R-3-hydroxymyristoyl-ACP --> UDP-3-O-(R-3-hydroxymyristoyl)GlcNAc + ACP. Using Matrex Gel Green A and heparin-agarose, we have purified the enzyme to near homogeneity from a strain that overproduces it 474-fold. The subunit molecular mass determined by SDS-gel electrophoresis is approximately 30 kDa, consistent with results of previous radiolabeling experiments in mini-cells. The amino-terminal sequence (Met-Ile-Asp-Lys-Ser-Ala-Phe-Val-His-Pro) and the amino acid composition of the purified protein are consistent with DNA sequencing (Coleman, J., and Raetz, C. R. H. (1988) J. Bacteriol. 170, 1268-1274). At saturating concentrations of the second substrate, the apparent K(m) values for UDP-GIcNAc and R-3-hydroxymyristoyl-ACP are 99 and 1.6 muM, respectively. There is an absolute requirement for the R-3-hydroxy moiety of the fatty acyl-ACP substrate; myristoyl-ACP binds effectively (IC50 = 2 muM) but is inactive (<).01%) as an alternate substrate. The most remarkable feature of the reaction is its unfavorable equilibrium constant, K(eq) congruent-to 0.01, which is not predicted by model S --> O acyl transfer reactions. Thus, although UDP-GlcNac acyltransferase catalyzes the first unique step of lipid A biosynthesis, it is the second enzyme (the deacetylase) that commits the substrates to this pathway. The specific activity of the deacetylase is elevated approximately 5-fold when lipid A synthesis is inhibited.	MERCK SHARP & DOHME LTD,DEPT BIOCHEM,RAHWAY,NJ 07065	Merck & Company					NIDDK NIH HHS [DK 19551] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019551] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON MS, 1985, J BIOL CHEM, V260, P5536; ANDERSON MS, 1988, BIOCHEMISTRY-US, V27, P1908, DOI 10.1021/bi00406a017; ANDERSON MS, 1987, J BIOL CHEM, V262, P5159; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; COLEMAN J, 1988, J BACTERIOL, V170, P1268, DOI 10.1128/jb.170.3.1268-1274.1988; CRONAN JE, 1987, ESCHERICHIA COLI SAL, V1, P474; CROWELL DN, 1986, J BACTERIOL, V168, P152, DOI 10.1128/jb.168.1.152-159.1986; DAS AK, 1992, J BIOL CHEM, V267, P9731; DICKER IB, 1992, MOL MICROBIOL, V6, P817, DOI 10.1111/j.1365-2958.1992.tb01532.x; DICKER IB, 1991, J BACTERIOL, V173, P334, DOI 10.1128/jb.173.1.334-344.1991; DUFFIELD RB, 1946, J AM CHEM SOC, V68, P557, DOI 10.1021/ja01208a007; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; GREEN PR, 1984, J BIOL CHEM, V259, P4688; GREEN PR, 1981, J BIOL CHEM, V256, P1151; Helenius A, 1979, Methods Enzymol, V56, P734; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; JENCKS WP, 1968, HDB BIOCH; JENCKS WP, 1969, CATALYSIS CHEM ENZYM, P589; JONES PJ, 1987, BIOCHEMISTRY-US, V26, P3493, DOI 10.1021/bi00386a037; KATI WM, 1989, SCIENCE, V243, P1591, DOI 10.1126/science.2928795; KELLY TM, 1993, J BIOL CHEM, V268, P19866; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIGHTNER VA, 1983, J BIOL CHEM, V258, P856; MAYO KH, 1985, BIOCHEMISTRY-US, V24, P7834, DOI 10.1021/bi00347a049; MENGINLECREULX D, 1989, J BACTERIOL, V171, P3282, DOI 10.1128/jb.171.6.3282-3287.1989; MENGINLECREULX D, 1983, J BACTERIOL, V154, P1284, DOI 10.1128/JB.154.3.1284-1290.1983; OKUYAMA H, 1976, J BIOL CHEM, V251, P2487; PARK JT, 1987, ESCHERICHIA COLI SAL, V1, P663; RADIKA K, 1988, J BIOL CHEM, V263, P14859; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; RAETZ CRH, 1986, ANNU REV GENET, V20, P253, DOI 10.1146/annurev.ge.20.120186.001345; RAETZ CRH, 1991, FASEB J, V5, P2652, DOI 10.1096/fasebj.5.12.1916089; ROCK CO, 1982, J BIOL CHEM, V257, P10759; SCHEIDELER MA, 1992, METHOD ENZYMOL, V209, P55; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TARR GE, 1986, MICROCHARACTERIZATIO, P155; VUORIO R, 1991, FEBS LETT, V292, P90, DOI 10.1016/0014-5793(91)80841-P; WALSH CT, 1989, J BIOL CHEM, V264, P2393; WILLIAMS.IP, 1966, J BIOL CHEM, V241, P2326; WILLIAMSON JM, 1991, J BACTERIOL, V173, P3591, DOI 10.1128/jb.173.11.3591-3596.1991	40	136	138	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19858	19865						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366124				2022-12-27	WOS:A1993LW81900104
J	KELLY, TM; STACHULA, SA; RAETZ, CRH; ANDERSON, MS				KELLY, TM; STACHULA, SA; RAETZ, CRH; ANDERSON, MS			THE FIRA GENE OF ESCHERICHIA-COLI ENCODES UDP-3-O-(R-3-HYDROXYMYRISTOYL)-GLUCOSAMINE N-ACYLTRANSFERASE - THE 3RD STEP OF ENDOTOXIN BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; LIPID-A BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; ACETYLGLUCOSAMINE ACYLTRANSFERASE; MYRISTOYL-COA; UDP-GLCNAC; ACID; MYRISTOYLTRANSFERASE; PURIFICATION; RHIZOBIUM	The possibility that the firA gene of Escherichia coli (Dicker, I. B., and Seetharam, S. (1991) Mol. Micro-biol. 6, 817-823) might function in lipid A biosynthesis was examined based on its homology to the lpxA gene, which encodes UDP-N-acetylglucosamine O-acyltransferase, the first enzyme in lipid A formation. Extracts of a temperature-sensitive firA mutant, RL-25, were assayed for their ability to acylate UDP-GlcNac, using a coupled assay. The results suggested that extracts of RL-25 might be defective in the third enzyme of this pathway, the UDP-3-O-(R-3-hydroxymyristoyl)glucosamine N-acyltransferase. Living cells of RL-25 also displayed a 5-fold decreased rate of lipid A biosynthesis at the nonpermissive temperature as judged by a P-32(i), incorporation assay. In order to examine N-acyltransferase activity directly, the substrate [alpha-P-32]UDP-3-O-(R-3-hydroxymyristoyl)-GlcN was synthesized enzymatically. N-Acyltransferase specific activity in RL-25 extracts was reduced to less than 10% of wild-type. When the wild-type firA gene was cloned into a T7-based expression vector, N-acyltransferase specific activity increased almost 360-fold relative to wild-type extracts, demonstrating that firA is the structural gene for the enzyme. The N-acyltransferase displays absolute specificity for the R-3-OH moiety of R-3-hydroxymyristoyl-ACP, as does the O-acyltransferase, consistent with the placement of R-3-hydroxymyristate in E. coli lipid A.	MERCK SHARP & DOHME LTD,DEPT BIOCHEM,RAHWAY,NJ 07065	Merck & Company								AASLAND R, 1988, J BACTERIOL, V170, P5916, DOI 10.1128/jb.170.12.5916-5918.1988; ANDERSON MS, 1985, J BIOL CHEM, V260, P5536; ANDERSON MS, 1988, BIOCHEMISTRY-US, V27, P1908, DOI 10.1021/bi00406a017; ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; ANDERSON MS, 1987, J BIOL CHEM, V262, P5159; BABINET C, 1970, 1ST INT LEP C, P37; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; BRAUN V, 1969, EUR J BIOCHEM, V10, P426, DOI 10.1111/j.1432-1033.1969.tb00707.x; BROZEK KA, 1990, J BIOL CHEM, V265, P15410; CLEMENTZ T, 1991, J BIOL CHEM, V266, P9687; COLEMAN J, 1988, J BACTERIOL, V170, P1268, DOI 10.1128/jb.170.3.1268-1274.1988; CROWELL DN, 1986, J BACTERIOL, V168, P152, DOI 10.1128/jb.168.1.152-159.1986; DICKER IB, 1992, MOL MICROBIOL, V6, P817, DOI 10.1111/j.1365-2958.1992.tb01532.x; DICKER IB, 1991, J BACTERIOL, V173, P334, DOI 10.1128/jb.173.1.334-344.1991; DURONIO RJ, 1991, J CELL BIOL, V113, P1313, DOI 10.1083/jcb.113.6.1313; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; FISHER RF, 1992, NATURE, V357, P655, DOI 10.1038/357655a0; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; GUPTA SD, 1991, J BIOL CHEM, V266, P9983; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HIRVAS L, 1990, FEBS LETT, V262, P123, DOI 10.1016/0014-5793(90)80169-J; HOLLINGSWORTH RI, 1989, J BIOL CHEM, V264, P9300; ITAYA M, 1990, P NATL ACAD SCI USA, V87, P8587, DOI 10.1073/pnas.87.21.8587; KISHIMOTO Y, 1983, ENZYMES, V16, P357; KNOLL LJ, 1992, J BIOL CHEM, V267, P5366; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LATHE R, 1977, MOL GEN GENET, V154, P53, DOI 10.1007/BF00265576; LATHE R, 1977, J BACTERIOL, V131, P1033, DOI 10.1128/JB.131.3.1033-1036.1977; LATHE R, 1977, MOL GEN GENET, V154, P43, DOI 10.1007/BF00265575; LI SJ, 1992, J BIOL CHEM, V267, P16841; MANIATIS T, 1982, MOL CLONING LABORATO, P368; MORRISON DC, 1992, BACTERIAL ENDOTOXIC, V1; QURESHI N, 1988, J BIOL CHEM, V263, P5502; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; RAETZ CRH, 1986, ANNU REV GENET, V20, P253, DOI 10.1146/annurev.ge.20.120186.001345; ROCK CO, 1980, ANAL BIOCHEM, V102, P362, DOI 10.1016/0003-2697(80)90168-2; ROCK CO, 1979, J BIOL CHEM, V254, P7116; RUDNICK DA, 1992, J BIOL CHEM, V267, P23852; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SPAINK HP, 1991, NATURE, V354, P125, DOI 10.1038/354125a0; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TOMASIEWICZ HG, 1987, J BACTERIOL, V169, P5735, DOI 10.1128/jb.169.12.5735-5744.1987; VAARA M, 1992, FEMS MICROBIOL LETT, V97, P249, DOI 10.1016/0378-1097(92)90344-N; VUORIO R, 1992, ANTIMICROB AGENTS CH, V36, P826, DOI 10.1128/AAC.36.4.826; VUORIO R, 1991, FEBS LETT, V292, P90, DOI 10.1016/0014-5793(91)80841-P; WILLIAMSON JM, 1991, J BACTERIOL, V173, P3591, DOI 10.1128/jb.173.11.3591-3596.1991; YOUNG K, 1993, FED PROC, V7, P1252; 1986, Patent No. 61205229	48	109	113	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19866	19874						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366125				2022-12-27	WOS:A1993LW81900105
J	KOSCHINSKY, ML; COTE, GP; GABEL, B; VANDERHOEK, YY				KOSCHINSKY, ML; COTE, GP; GABEL, B; VANDERHOEK, YY			IDENTIFICATION OF THE CYSTEINE RESIDUE IN APOLIPOPROTEIN(A) THAT MEDIATES EXTRACELLULAR COUPLING WITH APOLIPOPROTEIN-B-100	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LP(A) LIPOPROTEIN; HUMAN-PLASMA; PROTEIN; SEQUENCE; DISEASE; ASSAY; DNA	We have utilized a recombinant expression system in order to study the assembly of lipoprotein(a) (Lp(a)) particles. Using a 17-kringle recombinant form of apolipoprotein(a) (apo(a)) to transiently transfect human hepatoma cells, we could not detect recombinant Lp(a) (r-Lp(a)) particles intracellularly, by analysis of post-nuclear lysates. However, covalent r-Lp(a) complexes were observed in the transfected cell supernatants. Upon addition of [S-35]Cys-labeled human embryonic kidney cell supernatants transfected with 9-kringle or 17-kringle recombinant apo(a) (r-apo(a)) variants to human plasma, covalent r-Lp(a) complexes were observed, which could be immunoprecipitated using antibodies specific for either apo(a) or apolipoprotein B-100 (apoB-100); r-Lp(a) complexes containing the 17-kringle r-apo(a) were shown to be in the 1.063 g/ml < d < 1.20 g/ml range by density gradient ultracentrifugation analysis. Complexes containing the 17-kringle r-apo(a) formed rapidly within 20 min, with a slow increase observed up to 90 min. Addition of increasing amounts of plasma, as well as increasing amounts of isolated human low density lipoprotein to cell culture supernatants containing [S-35]Cys-labeled 17-kringle r-apo(a) led to enhanced r-Lp(a) complex formation. Blocking of free sulfhydryls in apo(a) with N-ethylmaleimide resulted in inhibition of r-Lp(a) complex formation in plasma, verifying the role of free sulfhydryls in Lp(a) particle assembly. Using site-directed mutagenesis, we demonstrated that Cys4057 in apo(a) is involved in disulfide linkage with apoB-100 in Lp(a) particles.			KOSCHINSKY, ML (corresponding author), QUEENS UNIV,DEPT BIOCHEM,KINGSTON K7L 3N6,ONTARIO,CANADA.			Koschinsky, Marlys/0000-0002-2643-2288				ARMSTRONG VW, 1985, J LIPID RES, V26, P1314; BERSOT TP, 1986, J CLIN INVEST, V77, P622, DOI 10.1172/JCI112345; CHIESA G, 1992, J BIOL CHEM, V267, P24369; DAHLEN GH, 1986, CIRCULATION, V74, P758, DOI 10.1161/01.CIR.74.4.758; DURRINGTON PN, 1988, LANCET, V1, P1070; FLESS GM, 1984, J BIOL CHEM, V259, P1470; GAUBATZ JW, 1983, J BIOL CHEM, V258, P4582; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GRIES A, 1987, CLIN CHIM ACTA, V164, P93, DOI 10.1016/0009-8981(87)90110-0; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; KOSCHINSKY ML, 1991, BIOCHEMISTRY-US, V30, P5044, DOI 10.1021/bi00234a029; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; RHOADS GG, 1986, JAMA-J AM MED ASSOC, V256, P2540, DOI 10.1001/jama.256.18.2540; Riordan J F, 1972, Methods Enzymol, V25, P449, DOI 10.1016/S0076-6879(72)25040-6; SCANU AM, 1990, J CLIN INVEST, V85, P1709, DOI 10.1172/JCI114625; SCANU AM, 1992, J INTERN MED, V231, P679, DOI 10.1111/j.1365-2796.1992.tb01257.x; SOMMER A, 1991, BIOCHEMISTRY-US, V30, P11245, DOI 10.1021/bi00111a008; TOMLINSON JE, 1989, J BIOL CHEM, V264, P5957; TRIEU VN, 1990, BIOCHEMISTRY-US, V29, P5919, DOI 10.1021/bi00477a006; UTERMANN G, 1983, FEBS LETT, V154, P357, DOI 10.1016/0014-5793(83)80182-3; WONG WLT, 1990, CLIN CHEM, V36, P192	25	187	190	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19819	19825						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366120				2022-12-27	WOS:A1993LW81900099
J	KWASTWELFELD, J; DEBELLE, I; WALKER, PR; WHITFIELD, JF; SIKORSKA, M				KWASTWELFELD, J; DEBELLE, I; WALKER, PR; WHITFIELD, JF; SIKORSKA, M			IDENTIFICATION OF A NEW CAMP RESPONSE ELEMENT-BINDING FACTOR BY SOUTHWESTERN BLOTTING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR CREB; LEUCINE ZIPPER PROTEINS; NUCLEAR FACTOR CREB; CYCLIC-AMP; GENE-TRANSCRIPTION; SOMATOSTATIN GENE; C-JUN; DNA; PHOSPHORYLATION; SEQUENCE	We have identified in mammalian cells a novel cyclic AMP response element (CRE)-binding protein of molecular mass 47 kDa. This protein was not recognized by either the CREB-327/341 or c-Jun antisera, and its tissue distribution did not overlap with those of the CREB and Jun families. For example, hepatoma and placental tissue did not contain the 47-kDa DNA-binding protein, but did contain the CREB isoforms. On the other hand, S49 lymphoma cells contained a high level of the 47-kDa DNA-binding protein but did not contain a 47-kDa Jun-related protein which was found in normal liver and hepatoma. This new 47-kDa factor bound to the CRE in the dephosphorylated form, and phosphorylation of the protein by the catalytic subunit of protein kinase A completely abolished its DNA-binding activity. The isoforms of the CREB-327/341 family, on the other hand, bound to DNA in the phosphorylated form, and alkaline phosphatase treatment reduced significantly their interaction with CRE sequence. This reverse effect of phosphorylation/dephosphorylation on the DNA-binding property of this new 47-kDa protein in particular distinguishes it from other known CREB factors and suggests that the protein might play a unique role in the regulation of cAMP-mediated transcription.	NATL RES COUNCIL CANADA,INST BIOL SCI,MOLEC CELL BIOL GRP,OTTAWA K1A 0R6,ONTARIO,CANADA	National Research Council Canada								ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; BERKOWITZ LA, 1990, P NATL ACAD SCI USA, V87, P5258, DOI 10.1073/pnas.87.14.5258; COLE TJ, 1992, GENOMICS, V13, P974, DOI 10.1016/0888-7543(92)90010-P; DEBELLE I, 1991, MOL CELL BIOL, V11, P2752, DOI 10.1128/MCB.11.5.2752; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HABENER JF, 1990, MOL ENDOCRINOL, V4, P1087, DOI 10.1210/mend-4-8-1087; HAI T, 1988, GENE DEV, V2, P1216, DOI 10.1101/gad.2.10.1216; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HOEFFLER JP, 1990, MOL ENDOCRINOL, V4, P920, DOI 10.1210/mend-4-6-920; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; IVASHKIV LB, 1990, MOL CELL BIOL, V10, P1609, DOI 10.1128/MCB.10.4.1609; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; JUNGMANN RA, 1992, NUCLEIC ACIDS RES, V20, P825, DOI 10.1093/nar/20.4.825; KARA CJ, 1990, MOL CELL BIOL, V10, P1347, DOI 10.1128/MCB.10.4.1347; KARPINSKI BA, 1992, P NATL ACAD SCI USA, V89, P4820, DOI 10.1073/pnas.89.11.4820; KWASTWELFELD J, 1989, J BIOL CHEM, V264, P6941; KWASTWELFELD J, 1991, CANCER RES, V51, P528; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CQ, 1990, EMBO J, V9, P4455, DOI 10.1002/j.1460-2075.1990.tb07896.x; LUCAS PC, 1992, ANNU REV BIOCHEM, V61, P1131; MACGREGOR PF, 1990, ONCOGENE, V5, P451; MACMANUS JP, 1987, METHOD ENZYMOL, V139, P156; MACMANUS JP, 1980, BIOCHIM BIOPHYS ACTA, V621, P296, DOI 10.1016/0005-2795(80)90181-6; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; MASQUILIER D, 1992, J BIOL CHEM, V267, P22460; MERINO A, 1989, J BIOL CHEM, V264, P21266; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MURO AF, 1992, J BIOL CHEM, V267, P12767; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PHILIPPE J, 1988, MOL CELL BIOL, V8, P4877, DOI 10.1128/MCB.8.11.4877; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; RUPPERT S, 1992, EMBO J, V11, P1503, DOI 10.1002/j.1460-2075.1992.tb05195.x; RYSECK RP, 1991, ONCOGENE, V6, P533; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHORT ML, 1992, NUCLEIC ACIDS RES, V19, P4290; SIKORSKA M, 1982, BIOCHIM BIOPHYS ACTA, V703, P171, DOI 10.1016/0167-4838(82)90045-0; SILVA CM, 1987, P NATL ACAD SCI USA, V84, P1744, DOI 10.1073/pnas.84.7.1744; WEAVER CA, 1984, GENE, V28, P319, DOI 10.1016/0378-1119(84)90149-5; YAMAMOTO KK, 1990, CELL, V60, P611, DOI 10.1016/0092-8674(90)90664-Z; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	46	21	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19581	19585						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366101				2022-12-27	WOS:A1993LW81900067
J	YU, BW; ICHINOSE, I; BONHAM, MA; ZAJAC-KAYE, M				YU, BW; ICHINOSE, I; BONHAM, MA; ZAJAC-KAYE, M			SOMATIC MUTATIONS IN C-MYC INTRON-I CLUSTER IN DISCRETE DOMAINS THAT DEFINE PROTEIN-BINDING SEQUENCES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOMA CELL-LINE; HEAVY-CHAIN LOCUS; BURKITT-LYMPHOMA; CHROMATIN STRUCTURE; TRANSCRIPTION INITIATION; VARIANT TRANSLOCATION; TRANS-ACTIVATION; 1ST EXON; GENE; PROMOTER	The activated c-myc allele in Burkitt's lymphoma tumor cells is associated with a clustering of somatic mutations within intron I near the exon I boundary. We have identified several discrete protein binding sites within this region of c-myc intron I designated as myc intron factor-1 (MIF-1), MIF-2, and MIF-3. In addition to our previous characterization of a 20-nucleotide binding site for MIF-1, we now have identified adjacent 20-nucleotide and 34-nucleotide binding sites for MIF-2 and MIF-3, respectively. All three elements are protected from exonuclease digestion by nuclear protein extracts, and each gives rise to a distinct migration pattern on mobility shift assays. In addition, MIF-1, 2, and 3 share a 5-nucleotide (TTATG) internal sequence, which may account for cross-competition of these binding sites in the exonuclease protection experiment. Deletion mutant analyses showed that selective removal of the MIF-3 binding site alone was sufficient to enhance chloramphenicol acetyltransferase reporter activity similar to that observed with larger deletions of myc intron I. We have demonstrated that somatic mutations in activated c-myc alleles are frequently clustered in discrete domains that define protein recognition sequences.	NCI, BIOL CHEM LAB, BLDG 37-5D02, 9000 ROCKVILLE PIKE, BETHESDA, MD 20892 USA; NCI, MED BRANCH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								AVIGAN MI, 1990, J BIOL CHEM, V265, P18538; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNELLE A, 1987, P NATL ACAD SCI USA, V84, P6673, DOI 10.1073/pnas.84.19.6673; CESARMAN E, 1987, SCIENCE, V238, P1272, DOI 10.1126/science.3685977; DAVIS LG, 1986, BASIC METHODS MOL BI, P286; DENNY CT, 1985, MOL CELL BIOL, V5, P3199, DOI 10.1128/MCB.5.11.3199; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DYSON PJ, 1985, P NATL ACAD SCI USA, V82, P1984, DOI 10.1073/pnas.82.7.1984; DYSON PJ, 1985, EMBO J, V4, P2885, DOI 10.1002/j.1460-2075.1985.tb04018.x; EICK D, 1988, ONCOGENE, V3, P397; GAZIN C, 1984, EMBO J, V3, P383, DOI 10.1002/j.1460-2075.1984.tb01816.x; GELMANN EP, 1983, NATURE, V306, P799, DOI 10.1038/306799a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GOULD SJ, 1988, ANAL BIOCHEM, V175, P5, DOI 10.1016/0003-2697(88)90353-3; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; HAY N, 1989, GENE DEV, V3, P293, DOI 10.1101/gad.3.3.293; HAY N, 1987, GENE DEV, V1, P659, DOI 10.1101/gad.1.7.659; HAYDAY AC, 1984, NATURE, V307, P334, DOI 10.1038/307334a0; HIEBERT SW, 1989, P NATL ACAD SCI USA, V86, P3594, DOI 10.1073/pnas.86.10.3594; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; LIU JM, 1991, VIROLOGY, V182, P361, DOI 10.1016/0042-6822(91)90682-2; MORSE B, 1989, MOL CELL BIOL, V9, P74, DOI 10.1128/MCB.9.1.74; MURPHY W, 1986, P NATL ACAD SCI USA, V83, P2939, DOI 10.1073/pnas.83.9.2939; NEPVEU A, 1986, EMBO J, V5, P2859, DOI 10.1002/j.1460-2075.1986.tb04580.x; NISHIKURA K, 1983, P NATL ACAD SCI-BIOL, V80, P4822, DOI 10.1073/pnas.80.15.4822; PELICCI PG, 1986, P NATL ACAD SCI USA, V83, P2984, DOI 10.1073/pnas.83.9.2984; PIETENPOL JA, 1991, P NATL ACAD SCI USA, V88, P10227, DOI 10.1073/pnas.88.22.10227; POSTEL EH, 1989, MOL CELL BIOL, V9, P5123, DOI 10.1128/MCB.9.11.5123; QUINN JP, 1987, MOL CELL BIOL, V7, P2735, DOI 10.1128/MCB.7.8.2735; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; SHOWE LC, 1987, P NATL ACAD SCI USA, V84, P2824, DOI 10.1073/pnas.84.9.2824; SHOWE LC, 1985, MOL CELL BIOL, V5, P501, DOI 10.1128/MCB.5.3.501; SIEBENLIST U, 1984, CELL, V37, P381, DOI 10.1016/0092-8674(84)90368-4; SPENCER CA, 1991, ADV CANCER RES, V56, P1; TAKIMOTO M, 1989, J BIOL CHEM, V264, P8992; TAUB R, 1984, CELL, V37, P511, DOI 10.1016/0092-8674(84)90381-7; TAUB R, 1984, CELL, V36, P339, DOI 10.1016/0092-8674(84)90227-7; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; THALMEIER K, 1989, GENE DEV, V3, P527, DOI 10.1101/gad.3.4.527; WEINTRAUB H, 1985, CELL, V42, P705, DOI 10.1016/0092-8674(85)90267-3; ZAJAC-KAYE M, 1990, J BIOL CHEM, V265, P4547; ZAJAC-KAYE M, 1988, SCIENCE, V240, P1776, DOI 10.1126/science.2454510; ZIMARINO V, 1987, NATURE, V327, P727, DOI 10.1038/327727a0	46	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19586	19592						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366102				2022-12-27	WOS:A1993LW81900068
J	BLAIS, S; LORTIE, R				BLAIS, S; LORTIE, R			DETERMINATION OF THE INTRINSIC MICHAELIS CONSTANT OF IMMOBILIZED ALPHA-CHYMOTRYPSIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME; PARAMETERS; SUPPORTS	The Michaelis constant of alpha-chymotrypsin, immobilized on a glutaraldehyde-activated silicate support, for N-glutaryl-L-phenylalanine-p-nitroanilide was determined and was found to be identical with that of the enzyme in solution. The influence of intraparticular diffusion was taken into account by immobilizing different amounts of enzyme, thus changing the magnitude of diffusional constraints and extrapolating apparent Michaelis constants, determined for each amount of immobilized enzyme, to zero diffusional constraints. The possible effect of the immobilized enzyme distribution inside the porous matrix was investigated through numerical simulations.			BLAIS, S (corresponding author), NATL RES COUNCIL CANADA,BIOTECHNOL RES INST,MONTREAL H4P 2R2,PQ,CANADA.							Beck J.V, 1977, PARAMETER ESTIMATION; CLARK DS, 1985, BIOTECHNOL BIOENG, V27, P208, DOI 10.1002/bit.260270217; CURRIE DJ, 1982, BIOMETRICS, V38, P907, DOI 10.2307/2529871; DO DD, 1986, BIOTECHNOL BIOENG, V28, P486, DOI 10.1002/bit.260280404; Engasser J.-M., 1976, APPL BIOCHEMISTR BIO, V1, P127; GELLF G, 1974, BIOTECHNOL BIOENG, V16, P315, DOI 10.1002/bit.260160303; HOOIJMANS CM, 1992, BIOTECHNOL BIOENG, V40, P16, DOI 10.1002/bit.260400104; LAVAL JM, 1991, BIOTECHNOL BIOENG, V38, P788, DOI 10.1002/bit.260380713; Levenspiel O., 1998, CHEM REACTION ENG; LORTIE R, 1992, AICHE J, V38, P1477, DOI 10.1002/aic.690380917; LORTIE R, 1990, CHEM ENG SCI, V45, P1133, DOI 10.1016/0009-2509(90)85035-C	11	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18637	18639						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360159				2022-12-27	WOS:A1993LV65900044
J	HUANG, SL; HASSELL, TC; YEH, WK				HUANG, SL; HASSELL, TC; YEH, WK			PURIFICATION AND PROPERTIES OF NADPH-DEPENDENT TYLOSIN REDUCTASE FROM STREPTOMYCES-FRADIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROLIDE ANTIBIOTIC TYLOSIN; MACROCIN O-METHYLTRANSFERASE; ADENOSYL-L-METHIONINE; KINETIC MECHANISM; BIOSYNTHESIS; BIOCONVERSION; TYLACTONE	A reductase of Streptomyces fradiae was speculated to catalyze reduction of tylosin to relomycin, an industrially undesirable product. The activity of tylosin reductase was closely related to bacterial growth, suggesting involvement of the enzyme in a primary metabolism. The reductase activity was improved significantly in vivo and in vitro. The enzyme was also partially stabilized in vitro. Using a simple five-step chromatographic procedure, the reductase was purified 480-fold to apparent homogeneity. The purified reductase had a molecular mass of 270 kDa and consisted of two different subunits of 26 and 7 kDa at 1:1 ratio. The enzyme exhibited an absorption maximum at 405 nm and was inhibited by exogenous FAD or FMN, indicating a flavin as its prosthetic group. Tylosin reductase was optimally active at pH 7.0-7.2 and 40-degrees-C with NADPH as a preferred electron donor. The K(m) of the enzyme for tylosin was 1.4 mm and that for NADPH was 0.15 mM. The V(max) for the enzymatic reaction was 917 mumol of tylosin formed/min/mg protein. The enzymatic conversion of tylosin to relomycin was coupled to that of NADPH to NADP+ at a stoichiometric ratio of 1:1. Tylosin reductase showed a broad substrate specificity toward all macrolide aldehydes (as normal and shunt metabolites of tylosin biosynthesis) tested. Thus, the enzyme may have a physiological role of macrolide detoxification for the bacterium.	ELI LILLY & CO,LILLY RES LAB,INDIANAPOLIS,IN 46285	Eli Lilly								Ackers G K, 1970, Adv Protein Chem, V24, P343, DOI 10.1016/S0065-3233(08)60245-4; ANDERSON R, 1977, J CHROMATOGR, V135, P447, DOI 10.1016/S0021-9673(00)88387-9; BALTZ RH, 1981, ANTIMICROB AGENTS CH, V20, P214, DOI 10.1128/AAC.20.2.214; BALTZ RH, 1983, J ANTIBIOT, V36, P131, DOI 10.7164/antibiotics.36.131; BAUER NJ, 1988, J BIOL CHEM, V263, P15619; BENNETT HPJ, 1980, J LIQ CHROMATOGR, V3, P1353, DOI 10.1080/01483918008062781; BLACKSHEAR PJ, 1984, METHOD ENZYMOL, V104, P237; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN YP, 1991, J BIOL CHEM, V266, P23909; COX KL, 1986, J NAT PROD, V49, P971, DOI 10.1021/np50048a002; DOTZLAF JE, 1984, ANTIMICROB AGENTS CH, V25, P216, DOI 10.1128/AAC.25.2.216; FETZNER S, 1992, J BACTERIOL, V174, P279, DOI 10.1128/jb.174.1.279-290.1992; FISHMAN SE, 1987, P NATL ACAD SCI USA, V84, P8248, DOI 10.1073/pnas.84.23.8248; KREUZMAN AJ, 1988, J BIOL CHEM, V263, P15626; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; OMURA S, 1982, BIOCHEM BIOPH RES CO, V107, P554; OMURA S, 1984, BIOCHIM BIOPHYS ACTA, V802, P141; ROGERS LJ, 1990, BIOCHEM J, V272, P775, DOI 10.1042/bj2720775; ROSENTHAL GA, 1992, P NATL ACAD SCI USA, V89, P1780, DOI 10.1073/pnas.89.5.1780; SENO ET, 1977, ANTIMICROB AGENTS CH, V11, P455, DOI 10.1128/AAC.11.3.455; SENO ET, 1986, BACTERIA, P231; YEH WK, 1984, J CHROMATOGR, V288, P157, DOI 10.1016/S0021-9673(01)93690-8	22	6	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18987	18993						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360186				2022-12-27	WOS:A1993LV65900091
J	PEI, ZH; BLASER, MJ				PEI, ZH; BLASER, MJ			PEB1, THE MAJOR CELL-BINDING FACTOR OF CAMPYLOBACTER-JEJUNI, IS A HOMOLOG OF THE BINDING-COMPONENT IN GRAM-NEGATIVE NUTRIENT TRANSPORT-SYSTEMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEIN; ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; SALMONELLA-TYPHIMURIUM; GENE; OPERON; CLONING; DNA; EXPRESSION; ENTERITIS	The protein PEB1 (28 kDa) is a common antigen and a major cell adherence molecule of Campylobacter jejuni and Campylobacter coli. We created a bank of chromosomal DNA fragments of C. jejuni strain 81-176 using lambdagt11. Screening this bank in Escherichia coli Y1090 cells with antibody raised against purified PEB1 enabled us to isolate and to purify a clone with a 2.6-kilobase insert expressing an immunoreactive protein of 28 kDa. DNA sequencing revealed that the insert contains three complete and two partial open reading frames (ORFs), designated 5' to 3' as ORFs A-E. The peb1A gene (ORF D) contains 780 bases encoding a 259-residue polypeptide having a calculated molecular mass of 28,181 Da. The peptide sequence starting at residue 27 matches that determined from amino-terminal sequencing of mature PEB1 from C. jejuni. The first 26 residues contain typical signal peptidase I and II cleavage sites. The deduced amino acid composition and pl of the recombinant mature protein are similar to those determined for purified PEB1. Gene bank searches indicated significant overall homology of peb1A and ORF C with operons for amino acid transport systems in other Gram-negative organisms. peb1A is homologous to the binding components of systems such as glnH (27.8%) and hisJ (28.9%), whereas ORF C has nearly 50% identity to glnQ and hisP. Thus, PEB1 could be involved both in binding to intestinal cells and in amino acid transport.	VANDERBILT UNIV,MED CTR,SCH MED,DEPT MED,DIV INFECT DIS,A-3310 MED CTR N,NASHVILLE,TN 37232; VANDERBILT UNIV,MED CTR,SCH MED,DEPT MICROBIOL & IMMUNOL,NASHVILLE,TN 37232; DEPT VET AFFAIRS MED CTR,NASHVILLE,TN 37212	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System				Pei, Zhiheng/0000-0001-8570-6747				ADACHI T, 1990, J BACTERIOL, V172, P511, DOI 10.1128/JB.172.1.511-513.1990; BIANCO AE, 1986, P NATL ACAD SCI USA, V83, P8713, DOI 10.1073/pnas.83.22.8713; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; BLACKMAN RK, 1986, J MOL BIOL, V188, P499, DOI 10.1016/S0022-2836(86)80001-8; BLASER MJ, 1990, J BIOL CHEM, V265, P14529; BLASER MJ, 1987, JAMA-J AM MED ASSOC, V257, P43, DOI 10.1001/jama.257.1.43; BLASER MJ, 1981, NEW ENGL J MED, V305, P1444, DOI 10.1056/NEJM198112103052404; BLASER MJ, 1985, J CLIN MICROBIOL, V21, P164, DOI 10.1128/JCM.21.2.164-167.1985; BLASER MJ, 1986, J INFECT DIS, V153, P249, DOI 10.1093/infdis/153.2.249; BRIZZARD BL, 1991, MOL GEN GENET, V231, P59, DOI 10.1007/BF00293822; CHAN VL, 1991, GENE, V101, P51, DOI 10.1016/0378-1119(91)90223-X; CHANG N, 1990, J BACTERIOL, V172, P5211, DOI 10.1128/jb.172.9.5211-5217.1990; CHOWDHURY MNH, 1984, TROP GEOGR MED, V36, P215; DAGERT M, 1979, GENE, V6, P23, DOI 10.1016/0378-1119(79)90082-9; DEVOS WM, 1990, J BIOL CHEM, V265, P22554; FAUCHERE JL, 1989, RES MICROBIOL, V140, P379, DOI 10.1016/0923-2508(89)90014-4; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GOTSCHLICH EC, 1986, J EXP MED, V164, P868, DOI 10.1084/jem.164.3.868; HARAYAMA S, 1983, J BACTERIOL, V153, P408, DOI 10.1128/JB.153.1.408-415.1983; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; HEIJNE G, 1985, J MOL BIOL, V184, P99; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HIGGINS CF, 1981, P NATL ACAD SCI-BIOL, V78, P6038, DOI 10.1073/pnas.78.10.6038; HOGG RW, 1981, J BIOL CHEM, V256, P1935; HORAZDOVSKY BF, 1987, J MOL BIOL, V197, P27, DOI 10.1016/0022-2836(87)90606-1; HUANG JZ, 1992, J BACTERIOL, V174, P1314, DOI 10.1128/jb.174.4.1314-1323.1992; ISHHOROWICZ D, 1981, NUCLEIC ACIDS RES, V9, P2985; KERVELLA M, 1993, IN PRESS INFECT IMMU; KRAFT R, 1987, NUCLEIC ACIDS RES, V15, P8568, DOI 10.1093/nar/15.20.8568; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEWIS MJ, 1990, NUCLEIC ACIDS RES, V18, P6438, DOI 10.1093/nar/18.21.6438; LIOR H, 1982, J CLIN MICROBIOL, V15, P761, DOI 10.1128/JCM.15.5.761-768.1982; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MAUCH L, 1990, MOL GEN GENET, V221, P427, DOI 10.1007/BF00259408; MCCLELLAND M, 1987, NUCLEIC ACIDS RES, V15, P5985, DOI 10.1093/nar/15.15.5985; MUTO A, 1987, P NATL ACAD SCI USA, V84, P166, DOI 10.1073/pnas.84.1.166; NICHOLSON RC, 1990, P NATL ACAD SCI USA, V87, P1159, DOI 10.1073/pnas.87.3.1159; NIELSEN JBK, 1982, J BACTERIOL, V152, P315; NOBLE M, 1989, J CELL BIOL, V109, P3367, DOI 10.1083/jcb.109.6.3367; NOHNO T, 1986, MOL GEN GENET, V205, P260, DOI 10.1007/BF00430437; OWEN RJ, 1982, FEMS MICROBIOL LETT, V12, P395; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PEI ZH, 1991, J BIOL CHEM, V266, P16363; PENNER JL, 1983, EUR J CLIN MICROBIOL, V2, P378, DOI 10.1007/BF02019474; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; ROCHESTER DE, 1986, EMBO J, V5, P451, DOI 10.1002/j.1460-2075.1986.tb04233.x; ROSENBERG M, 1979, ANNU REV GENET, V13, P319, DOI 10.1146/annurev.ge.13.120179.001535; RUSSELL RG, 1989, INFECT IMMUN, V57, P1438, DOI 10.1128/IAI.57.5.1438-1444.1989; Sambrook J, 1989, MOL CLONING LABORATO; SCRIPTURE JB, 1987, J MOL BIOL, V197, P37, DOI 10.1016/0022-2836(87)90607-3; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TAYLOR DE, 1983, ANTIMICROB AGENTS CH, V24, P930, DOI 10.1128/AAC.24.6.930; WALKER RI, 1986, MICROBIOL REV, V50, P81, DOI 10.1128/MMBR.50.1.81-94.1986; WU AC, 1986, CURR TOP MICROBIOL I, V125, P127; WU LJ, 1991, J BACTERIOL, V173, P4877, DOI 10.1128/jb.173.15.4877-4888.1991; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	57	118	130	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18717	18725						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360165				2022-12-27	WOS:A1993LV65900056
J	DOOHAN, JP; SAMUEL, CE				DOOHAN, JP; SAMUEL, CE			BIOSYNTHESIS OF REOVIRUS-SPECIFIED POLYPEPTIDES - ANALYSIS OF RIBOSOME PAUSING DURING TRANSLATION OF REOVIRUS S1 AND S4 MESSENGER-RNAS IN VIRUS-INFECTED AND VECTOR-TRANSFECTED CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CDNA CLONING; REGULATING TRANSLATION; NUCLEOTIDE-SEQUENCE; PROTEIN-SYNTHESIS; EFFICIENCY; INITIATION; SEROTYPE-1; ENCODES; GENES; LEVEL	The steady-state distribution of translating ribosomes on the reovirus s1 and s4 mRNAs was determined using a sensitive primer extension inhibition assay and cDNA clones of the reovirus S1 and S4 genes. Positions of significant ribosome pausing included the sites of initiation and termination of translation, both in vivo in reovirus-infected mouse fibroblast L cells and in vitro in rabbit reticulocyte lysates. The patterns of ribosome pausing detected in vivo and in vitro were comparable. Ribosomes were far less uniformly distributed along the polycistronic s1 mRNA than they were along the monocistronic s4 mRNA. During reovirus infection, ribosome pausing was detected at the initiation codons of the s1 mRNA sigma1 and sigma1ns open reading frames and the s4 mRNA sigma3 open reading frame, direct evidence that initiation is a slow step of translation in vivo. Quantitative analysis of reovirus mRNA translation in infected and transfected cells suggested that ribosomes paused longer at an AUG initiation codon present in strong context than one present in weak context. These results suggest that the dynamics of ribosome movement during translation of the reovirus s1 and s4 mRNAs are similar in vivo and in vitro and that the relative ribosome pause at an AUG initiation codon may be affected by the flanking nucleotide context of the AUG codon.	UNIV CALIF SANTA BARBARA,DEPT BIOL SCI,DIV MOLEC CELLULAR & DEV BIOL,SANTA BARBARA,CA 93106; UNIV CALIF SANTA BARBARA,GRAD PROGRAM BIOCHEM & MOLEC BIOL,SANTA BARBARA,CA 93106	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara					NIAID NIH HHS [AI-12520] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI012520, R01AI012520] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANTHONY DD, 1992, J BIOL CHEM, V267, P1554; ATWATER JA, 1986, BIOCHEM BIOPH RES CO, V136, P183, DOI 10.1016/0006-291X(86)90893-4; ATWATER JA, 1987, VIROLOGY, V159, P350, DOI 10.1016/0042-6822(87)90473-9; BELLI BA, 1993, VIROLOGY, V193, P16, DOI 10.1006/viro.1993.1099; BELLI BA, 1991, VIROLOGY, V185, P698, DOI 10.1016/0042-6822(91)90541-I; BELLI BA, 1991, THESIS U CALIFORNIA; BISCHOFF JR, 1989, VIROLOGY, V172, P106, DOI 10.1016/0042-6822(89)90112-8; CASHDOLLAR LW, 1985, P NATL ACAD SCI USA, V82, P24, DOI 10.1073/pnas.82.1.24; DOOHAN JP, 1992, VIROLOGY, V186, P409, DOI 10.1016/0042-6822(92)90006-B; FAJARDO JE, 1990, P NATL ACAD SCI USA, V87, P328, DOI 10.1073/pnas.87.1.328; GAILLARD RK, 1985, VIROLOGY, V147, P336, DOI 10.1016/0042-6822(85)90136-9; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; JACOBS BL, 1985, VIROLOGY, V147, P9, DOI 10.1016/0042-6822(85)90222-3; JOKLIK WK, 1984, REOVIRIDAE; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LEONE G, 1992, CELL, V71, P479, DOI 10.1016/0092-8674(92)90516-F; LEVIN KH, 1980, VIROLOGY, V106, P1, DOI 10.1016/0042-6822(80)90216-0; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MOLDAVE K, 1985, ANNU REV BIOCHEM, V54, P1109, DOI 10.1146/annurev.biochem.54.1.1109; MUNEMITSU SM, 1986, BIOCHEM BIOPH RES CO, V140, P508, DOI 10.1016/0006-291X(86)90761-8; MUNEMITSU SM, 1984, VIROLOGY, V136, P133, DOI 10.1016/0042-6822(84)90254-X; MUNEMITSU SM, 1988, VIROLOGY, V163, P643, DOI 10.1016/0042-6822(88)90309-1; RAY BK, 1983, P NATL ACAD SCI-BIOL, V80, P663, DOI 10.1073/pnas.80.3.663; RONER MR, 1989, VIROLOGY, V168, P292, DOI 10.1016/0042-6822(89)90269-9; SAMUEL CE, 1990, VIROLOGY, V176, P106, DOI 10.1016/0042-6822(90)90235-J; STEITZ JA, 1969, NATURE, V224, P957, DOI 10.1038/224957a0; WALDEN WE, 1981, J BIOL CHEM, V256, P1739; WILLIAMS MA, 1989, J VIROL, V63, P28, DOI 10.1128/JVI.63.1.28-35.1989; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; ZWEERINK HJ, 1970, VIROLOGY, V41, P501, DOI 10.1016/0042-6822(70)90171-6	34	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18313	18320						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349706				2022-12-27	WOS:A1993LT74300098
J	VANDENHAZEL, HB; KIELLANDBRANDT, MC; WINTHER, JR				VANDENHAZEL, HB; KIELLANDBRANDT, MC; WINTHER, JR			THE PROPEPTIDE IS REQUIRED FOR IN-VIVO FORMATION OF STABLE ACTIVE YEAST PROTEINASE-A AND CAN FUNCTION EVEN WHEN NOT COVALENTLY-LINKED TO THE MATURE REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CARBOXYPEPTIDASE-Y; PRO-PEPTIDE; DENATURED SUBTILISIN; SHUTTLE VECTORS; PEP4 GENE; VACUOLAR; PROTEASE; SEQUENCE; SECRETION	The PEP4-encoded aspartate protease proteinase A from Saccharomyces cerevisiae is synthesized as a zymogen (Ammerer, G., Hunter, C. P., Rothman, J. H., Saari, G. C., Valls, L. A., and Stevens, T. H. (1986) Mol. Cell. Biol. 6, 2490-2499; Woolford, C. A., Daniels, L. B., Park, F. J., Jones, E. W., van Arsdell, J. N., and Innis, M. A. (1986) Mol. Cell. Biol. 6,2500-2510). We constructed a mutant form, lacking the propeptide. This form, still containing the signal peptide, was translocated into the endoplasmic reticulum, but the mature region was subsequently completely degraded. When a plasmid encoding only the propeptide after the signal peptide was introduced into a strain producing the mature region, a subpopulation of mature region molecules was rescued from the degradation and gained activity. Increased activity was found when the mature region was co-produced with increased amounts of propeptide, whereas truncated propeptides, lacking residues at its C terminus, were less efficient in the interaction with the mature region. We propose that the mature region of proteinase A cannot fold into its stable active conformation in the absence of the propeptide and that the propeptide can promote folding of the mature region, even when the propeptide and the mature region are not covalently linked.	CARLSBERG LAB, DEPT YEAST GENET, GAMLE CARLSBERG VEJ 10, DK-2500 COPENHAGEN, DENMARK				Kielland-Brandt, Morten C./D-2563-2015; Winther, Jakob R./K-4451-2014	Winther, Jakob R./0000-0001-6995-9154; Kielland-Brandt, Morten/0000-0002-1272-3877				AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; BALDARI C, 1985, GENE, V35, P27, DOI 10.1016/0378-1119(85)90154-4; CONNER GE, 1992, J BIOL CHEM, V267, P21738; FABRE E, 1992, J BIOL CHEM, V267, P15049; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HARRISON TM, 1989, PROTEINS, V5, P259, DOI 10.1002/prot.340050402; IKEMURA H, 1987, J BIOL CHEM, V262, P7859; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JONES EW, 1991, METHOD ENZYMOL, V194, P428; KLIONSKY DJ, 1988, MOL CELL BIOL, V8, P2105, DOI 10.1128/MCB.8.5.2105; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; KOBAYASHI T, 1992, J MOL BIOL, V226, P931, DOI 10.1016/0022-2836(92)91042-N; LENNEY JF, 1974, BIOCHEM BIOPH RES CO, V60, P1378, DOI 10.1016/0006-291X(74)90350-7; MELDAL M, 1991, ANAL BIOCHEM, V195, P141, DOI 10.1016/0003-2697(91)90309-H; MELDAL M, 1993, IN PRESS INT J PEPT; NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538; OHTA Y, 1991, MOL MICROBIOL, V5, P1507, DOI 10.1111/j.1365-2958.1991.tb00797.x; REMACLE JE, 1992, MOL CELL BIOL, V12, P5516, DOI 10.1128/MCB.12.12.5516; ROTHMAN JH, 1986, P NATL ACAD SCI USA, V83, P3248, DOI 10.1073/pnas.83.10.3248; SAHEKI T, 1975, BIOCHIM BIOPHYS ACTA, V384, P203, DOI 10.1016/0005-2744(75)90109-6; Sambrook J, 1989, MOL CLONING LABORATO; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; SILEN JL, 1989, NATURE, V341, P462, DOI 10.1038/341462a0; STEVENS TH, 1986, J CELL BIOL, V102, P1551, DOI 10.1083/jcb.102.5.1551; TEICHERT U, 1989, J BIOL CHEM, V264, P16037; VALLS LA, 1990, J CELL BIOL, V111, P361, DOI 10.1083/jcb.111.2.361; VANDENHAZEL HB, 1992, EUR J BIOCHEM, V207, P277; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WIEMKEN A, 1979, ARCH MICROBIOL, V123, P23, DOI 10.1007/BF00403499; WINTHER JR, 1991, EUR J BIOCHEM, V197, P681, DOI 10.1111/j.1432-1033.1991.tb15959.x; WOOLFORD CA, 1986, MOL CELL BIOL, V6, P2500, DOI 10.1128/MCB.6.7.2500; ZHU XL, 1989, NATURE, V339, P483, DOI 10.1038/339483a0; ZUBENKO GS, 1982, GENETICS, V102, P679	35	77	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18002	18007						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349680				2022-12-27	WOS:A1993LT74300056
J	LEE, J; JAYARAM, M				LEE, J; JAYARAM, M			MECHANISM OF SITE-SPECIFIC RECOMBINATION - LOGIC OF ASSEMBLING RECOMBINASE CATALYTIC SITE FROM FRACTIONAL ACTIVE-SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEP-ARREST MUTANTS; FLP RECOMBINASE; REGIONAL SIMILARITIES; FUNCTIONAL-ANALYSIS; INTEGRASE FAMILY; STRAND TRANSFER; DNA; SUBSTRATE; TYROSINE; MUTAGENESIS	The active nucleophilic species in the strand cleavage and strand exchange steps of site-specific recombination by the Flp protein are the active site tyrosine (Tyr-343) of Flp and the 5'-hydroxyl of Flp-nicked DNA, respectively. The target phosphodiester, activated by Flp, can be cleaved by an exogenous nucleophile derived, for example, from H2O2. Flp variants that are defective in the phosphate activation step and cannot sustain Tyr-343-mediated cleavage also fail to elicit H2O2-mediated cleavage. An Flp mutant lacking Tyr-343, (Flp(Y343F)), can carry out both the strand cleavage and strand exchange reactions in the presence of a tyrosine analog. These results are consistent with a cis-activation/trans-nucleophilic attack paradigm for strand breakage and strand union. The proposed model conceptually unifies the chemistry and enzymology of the two partial reactions of recombination. The mechanism of Flp action has strong implications for phosphoryl transfer reactions in other site-specific DNA recombination systems and in RNA splicing.	UNIV TEXAS,DEPT MICROBIOL,AUSTIN,TX 78712	University of Texas System; University of Texas Austin			Lee, Jehee/AAS-3229-2021	Lee, Jehee/0000-0001-9144-3648				ABREMSKI KE, 1992, PROTEIN ENG, V5, P87, DOI 10.1093/protein/5.1.87; ARGOS P, 1986, EMBO J, V5, P433, DOI 10.1002/j.1460-2075.1986.tb04229.x; BEAUCAGE SL, 1981, TETRAHEDRON LETT, V22, P1859, DOI 10.1016/S0040-4039(01)90461-7; CAREY FA, 1977, ADV ORGANIC CHEM A, P208; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; CHEN JW, 1992, MOL CELL BIOL, V12, P3757, DOI 10.1128/MCB.12.9.3757; CHEN JW, 1992, CELL, V69, P647, DOI 10.1016/0092-8674(92)90228-5; CHEN JW, 1993, IN PRESS J BIOL CHEM; CRAIG NL, 1988, ANNU REV GENET, V22, P77; DROGE P, 1990, P NATL ACAD SCI USA, V87, P5336, DOI 10.1073/pnas.87.14.5336; EVANS BR, 1990, J BIOL CHEM, V265, P18504; FERSHT A, 1985, ENZYME STRUCTURE MEC, P426; FRIESEN H, 1992, J MOL BIOL, V225, P313, DOI 10.1016/0022-2836(92)90924-9; KIMBALL A, 1993, IN PRESS BIOCHEMISTR; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; LEE J, 1992, J MOL BIOL, V228, P1091, DOI 10.1016/0022-2836(92)90317-D; LERNER RA, 1991, SCIENCE, V252, P659, DOI 10.1126/science.2024118; Maniatis T., 1982, MOL CLONING; MIZUUCHI K, 1991, CELL, V66, P129, DOI 10.1016/0092-8674(91)90145-O; PAN GH, 1992, J BIOL CHEM, V267, P12397; PARSONS RL, 1988, MOL CELL BIOL, V8, P3303, DOI 10.1128/MCB.8.8.3303; PARSONS RL, 1990, J BIOL CHEM, V265, P4527; PRASAD PV, 1986, MOL CELL BIOL, V6, P4329, DOI 10.1128/MCB.6.12.4329; SERRE MC, 1992, J MOL BIOL, V225, P643, DOI 10.1016/0022-2836(92)90391-V; SERRE MC, 1992, J BIOL CHEM, V268, P455; STARK WM, 1989, CELL, V58, P779, DOI 10.1016/0092-8674(89)90111-6; UTATSU I, 1987, J BACTERIOL, V169, P5537, DOI 10.1128/jb.169.12.5537-5545.1987; WENTE SR, 1987, P NATL ACAD SCI USA, V84, P31, DOI 10.1073/pnas.84.1.31; WIRSCHING P, 1991, SCIENCE, V252, P680, DOI 10.1126/science.2024120	29	49	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17564	17570						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349636				2022-12-27	WOS:A1993LQ98800098
J	BOHM, S; BAKKE, M; NILSSON, M; ZANGER, UM; SPYROU, G; LUND, J				BOHM, S; BAKKE, M; NILSSON, M; ZANGER, UM; SPYROU, G; LUND, J			COOPERATING NONCONSENSUS CAMP-RESPONSIVE ELEMENTS ARE MEDIATORS OF ADRENOCORTICOTROPIN-INDUCED VL30 TRANSCRIPTION IN STEROIDOGENIC ADRENAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE ZIPPER PROTEINS; BINDING-PROTEINS; GENE-EXPRESSION; CYCLIC-AMP; MOUSE RETROTRANSPOSONS; SIGNAL TRANSDUCTION; REGULATORY REGIONS; DNA; FAMILY; C/EBP	Pituitary-derived trophic hormones regulate cell-type-specific expression of VL30 retrotransposons in tissues that are engaged in steroidogenesis. We show that adrenocorticotropic hormone and forskolin induced VL30 transcription in the steroidogenic adrenal cell line Y1 and that the transcriptional activation was cell type- and protein kinase A-dependent. Three novel cAMP-responsive elements (CREs), within the VL30 long terminal repeat, were identified and shown to activate transcription synergistically when templates bearing multiple sites were compared with templates bearing a single site. This type of regulation was evident only in forskolin-treated cells, and the response elements were found to be inactive as mediators of constititutive transcription. In vitro binding analyses indicated that a consensus CRE and the nonconsensus VL30 CREs differ with respect to binding affinity and specificity to a number of nuclear factors that were identified to be related to proteins within the CREB, Jun, and C/EBP families of transcription factors. The relatively low affinity and/or a restricted binding specificity of the VL30 CREs made it possible to detect forskolin-induced binding of CREB- and Jun-related proteins to these sequences. We suggest that cAMP-induced transcription, specific for steroidogenic cells, can be mediated by a novel type of nonconsensus CREs and that the mechanism for this type of gene regulation is distinct from that mediated through a consensus CRE. We also report the identification of a novel factor, distinct from previously characterized CRE-binding proteins, that constitutively binds to the identified CREs.	KAROLINSKA INST, DEPT MED CHEM 1, S-10401 STOCKHOLM 60, SWEDEN; DEPT MED NUTR, S-14186 HUDDINGE, SWEDEN; BIOCTR, DEPT PHARMACOL, CH-4056 BASEL, SWITZERLAND	Karolinska Institutet	BOHM, S (corresponding author), KAROLINSKA INST, CTR BIOTECHNOL, NOVUM, S-14157 HUDDINGE, SWEDEN.		Zanger, Ulrich M./A-9364-2012	Zanger, Ulrich M./0000-0002-5276-2002				BAKKER O, 1991, NUCLEIC ACIDS RES, V19, P1213, DOI 10.1093/nar/19.6.1213; BOHM S, 1990, CANCER RES, V50, P1626; BOHM S, 1991, J BIOL CHEM, V266, P24834; CAREY M, 1992, J VIROL, V66, P4803, DOI 10.1128/JVI.66.8.4803-4813.1992; CHEN RP, 1990, NATURE, V346, P583, DOI 10.1038/346583a0; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COWELL IG, 1992, MOL CELL BIOL, V12, P3070, DOI 10.1128/MCB.12.7.3070; DEUTSCH PJ, 1988, P NATL ACAD SCI USA, V85, P7922, DOI 10.1073/pnas.85.21.7922; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GROVE JR, 1989, J BIOL CHEM, V264, P19506; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HOEFFLER JP, 1989, MOL ENDOCRINOL, V3, P868, DOI 10.1210/mend-3-5-868; INOUE H, 1991, EUR J BIOCHEM, V195, P563, DOI 10.1111/j.1432-1033.1991.tb15738.x; IVASHKIV LB, 1990, MOL CELL BIOL, V10, P1609, DOI 10.1128/MCB.10.4.1609; JOHN ME, 1986, P NATL ACAD SCI USA, V83, P4715, DOI 10.1073/pnas.83.13.4715; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KAGEYAMA R, 1991, J BIOL CHEM, V266, P15525; KESHET E, 1982, J VIROL, V43, P50, DOI 10.1128/JVI.43.1.50-58.1982; KESHET E, 1991, ADV CANCER RES, V56, P215; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; LUND J, 1990, J BIOL CHEM, V265, P3304; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; Ptashne M., 1986, A GENETIC SWITCH; QUINN PG, 1990, MOL CELL BIOL, V10, P3357, DOI 10.1128/MCB.10.7.3357; ROONEY RJ, 1990, MOL CELL BIOL, V10, P5138, DOI 10.1128/MCB.10.10.5138; ROTMAN G, 1986, NUCLEIC ACIDS RES, V14, P645, DOI 10.1093/nar/14.2.645; Sambrook J, 1989, MOL CLONING LABORATO; SCHIFF R, 1991, GENE DEV, V5, P521, DOI 10.1101/gad.5.4.521; Schimmer B P, 1979, Methods Enzymol, V58, P570; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SIMPSON ER, 1988, ANNU REV PHYSIOL, V50, P427, DOI 10.1146/annurev.ph.50.030188.002235; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; THIERRY F, 1992, J VIROL, V66, P3740, DOI 10.1128/JVI.66.6.3740-3748.1992; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; Waterman M R, 1988, Prog Clin Biol Res, V274, P543; WATERMAN MR, 1990, BIOCHEM SOC T, V18, P26, DOI 10.1042/bst0180026; WEIH F, 1990, GENE DEV, V4, P1437, DOI 10.1101/gad.4.8.1437; WONG M, 1989, J BIOL CHEM, V264, P12867; YASUMURA Y, 1966, CANCER RES, V26, P529; ZIFF EB, 1990, TRENDS GENET, V6, P69, DOI 10.1016/0168-9525(90)90081-G	50	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					3952	3963						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382684				2022-12-27	WOS:A1993KN53300026
J	CLARK, RB; FRIEDMAN, J; KUNKEL, MW; JANUARY, BG; SHENOLIKAR, S				CLARK, RB; FRIEDMAN, J; KUNKEL, MW; JANUARY, BG; SHENOLIKAR, S			OKADAIC ACID INDUCES BOTH AUGMENTATION AND INHIBITION OF BETA(2)-ADRENERGIC STIMULATION OF CAMP ACCUMULATION IN S49 LYMPHOMA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP LEVELS; ADENYLATE-CYCLASE; PHORBOL ESTER; PHOSPHATASE INHIBITOR; PROTEIN PHOSPHATASES; HUMAN-PLATELETS; WILD-TYPE; RECEPTOR; DESENSITIZATION; PHOSPHORYLATION	To address the role of protein phosphatases in regulating hormonal responses in mammalian cells, we investigated the effects of okadaic acid, a potent inhibitor of protein phosphatases 1 and 2A, on epinephrine and prostaglandin E1 stimulation of cAMP accumulation and adenylyl cyclase in S49 WT and kin- lymphoma cells. Depending on the dose and time of okadaic acid pretreatment of both cell lines, there were two distinguishable effects on cAMP accumulation, an augmentation and an inhibition. The augmentation occurred rapidly (t 1/2 < 1 min), was maximal with 3 muM okadaic acid, and was observed with concentrations of okadaic acid as low as 0.3 muM. Prolonged (t1/2 of 5-15 min) pretreatment of cells with okadaic acid caused an inhibition of epinephrine-stimulated cAMP accumulation, which was characterized by a 2-3-fold increase in the EC50 for the response to epinephrine. The EC50 for the okadaic acid-mediated inhibition was similar to that for the augmentation. In assays of adenylyl cyclase in membrane fractions prepared from okadaic acid-pretreated cells the inhibitory, but not the stimulatory, effects of okadaic acid pretreatment were observed. The data demonstrate that protein phosphatases play an important role in regulating adenylyl cyclase and suggest that cAMP-dependent protein kinase is not involved in either of its actions.	DUKE UNIV,MED CTR,DEPT PHARMACOL,DURHAM,NC 27710	Duke University	CLARK, RB (corresponding author), UNIV TEXAS,HLTH SCI CTR,GRAD SCH BIOMED SCI,HOUSTON,TX 77225, USA.				NIGMS NIH HHS [GM31208] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031208] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOUSAMRA AB, 1987, J BIOL CHEM, V262, P1129; ALEXANDER D R, 1990, New Biologist, V2, P1049; BELL JD, 1986, J BIOL CHEM, V261, P2036; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BIANCHINI L, 1991, J BIOL CHEM, V266, P15406; BOARDER MR, 1988, J BIOL CHEM, V263, P15319; BROOKER G, 1979, ADV CYCLIC NUCLEOTID, V10, P2; BUTCHER RW, 1978, J CYCLIC NUCL PROT, V4, P411; CLARK RB, 1988, P NATL ACAD SCI USA, V85, P1442, DOI 10.1073/pnas.85.5.1442; CLARK RB, 1987, FASEB J, V1, P289, DOI 10.1096/fasebj.1.4.2820824; CLARK RB, 1986, ADV CYCLIC NUCL PROT, V20, P151; CLARK RB, 1991, FASEB J, V6, pA78; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COHEN P, 1989, J BIOL CHEM, V264, P21435; CORVERA S, 1991, J BIOL CHEM, V266, P9271; DANIELISSAKANI S, 1989, J BIOL CHEM, V264, P20240; FELDER CC, 1989, J BIOL CHEM, V264, P20356; GOKA TJ, 1983, J CYCLIC NUCL PROT, V9, P49; HAYSTEAD TAJ, 1990, J BIOL CHEM, V265, P16571; JAKOBS KH, 1985, EUR J BIOCHEM, V151, P425, DOI 10.1111/j.1432-1033.1985.tb09119.x; JOHNSON JA, 1986, J CYCLIC NUCL PROT, V11, P199; JOHNSON JA, 1990, MOL PHARMACOL, V38, P289; JOHNSON JA, 1991, MOL PHARMACOL, V39, P539; JOHNSON RA, 1990, MOL PHARMACOL, V37, P296; JOHNSON RA, 1991, MOL PHARMACOL, V39, P399; KISS Z, 1985, BIOCHEM J, V227, P987; LEFKOWITZ RJ, 1990, TRENDS PHARMACOL SCI, V11, P190, DOI 10.1016/0165-6147(90)90113-M; LEREA KM, 1992, BIOCHEMISTRY-US, V31, P6553, DOI 10.1021/bi00143a027; LOUNSBURY KM, 1991, J BIOL CHEM, V266, P22051; PALCZEWSKI K, 1991, TRENDS BIOCHEM SCI, V16, P387, DOI 10.1016/0968-0004(91)90157-Q; PREMONT RT, 1992, P NATL ACAD SCI USA, V89, P9809, DOI 10.1073/pnas.89.20.9809; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SHIBATA H, 1991, J BIOL CHEM, V266, P17948; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; YANG SD, 1988, J BIOL CHEM, V263, P8856	35	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3245	3250						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381422				2022-12-27	WOS:A1993KM16100037
J	KARLISH, SJD; GOLDSHLEGER, R; JORGENSEN, PL				KARLISH, SJD; GOLDSHLEGER, R; JORGENSEN, PL			LOCATION OF ASN(831) OF THE ALPHA-CHAIN OF NA/K-ATPASE AT THE CYTOPLASMIC SURFACE - IMPLICATION FOR TOPOLOGICAL MODELS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; MEMBRANE H+-ATPASE; SARCOPLASMIC-RETICULUM; PHOSPHOLIPID-VESICLES; CATALYTIC SUBUNIT; OUTER MEDULLA; CONFORMATIONAL TRANSITIONS; ADENOSINE-TRIPHOSPHATASE; TRANSMEMBRANE DOMAIN; COMPLEMENTARY-DNA	The principal objective of this work has been to determine whether Asn831 of the alpha chain of Na/K-ATPase is located at the cytoplasmic or extracellular surface. Asn831 is the N-terminal residue of a 19-kDa C-terminal tryptic fragment which, together with smaller (8-11 kDa) membrane-embedded fragments of the alpha chain and a largely intact beta chain, is produced by extensive tryptic digestion of renal Na,K-ATPase in the presence of Rb+ and absence of Ca2+ ions. In these so-called ''19-kDa membranes,'' Rb+ and Na+ occlusion capacities are normal, but ATP-dependent activities are lost. Transmembrane segments in the 19-kDa and other fragments are thought to contribute ligating residues to a cation occlusion ''cage.'' However, the arrangement of transmembrane segments of the alpha chain is uncertain, particularly in the critical C-terminal domain. Different topological models predict that the N-terminal Asn831 of the 19-kDa fragment lies at opposite surfaces, respectively. The location of Asn831 has been studied by tryptic digestion of either tight right side-out-oriented membrane vesicles isolated from renal medulla or phospholipid vesicles reconstituted with renal Na/K-ATPase, containing pumps in both right side-out and inside-out orientations. Digestion is performed in the presence of Rb+ and absence of Ca2+ ions. In native renal membrane vesicles the alpha chain is not split by trypsin. By contrast, the beta chain is partially split to a fragment of 16 kDa, beginning at the N-terminal Ala. This fragment is 4 residues longer than a 16-kDa fragment produced by digestion of purified Na/K-ATPase, a finding which shows that trypsin has full access to the extracellular surface, but not to the interior of the vesicles. In the presence of deoxycholate, which destroys the membrane permeability barrier, trypsin digests the alpha chain and the 19-kDa fragment (N-terminal Asn831) is produced. Extensive tryptic digestion of phospholipid vesicles reconstituted with the Na/K-ATPase leads to digestion of the alpha chain and appearance of intermediate fragments and then the 19-kDa fragment. About 25% of the alpha chains in the preparation are resistant to digestion. Functional studies show that the trypsin-resistant pumps are in the right side-out orientation. Observed tryptic fragments were sequenced and the following N termini were detected: Glu31, 33 kDa; Ser221, 78 kDa; Ile470, 56 kDa; Ala590, 39 kDa; and Asn831, 19 kDa. Observation of these N termini is consistent with digestion of the alpha chain of inside-out-oriented pumps at cytoplasmic sites. The results demonstrate clearly that Asn831 is located on the cytoplasmic surface of the alpha chain. Therefore, there must be two transmembrane segments between the end of the large cytoplasmic loop and Asn831, M5+M6. A model of alpha chain topology, with 10 transmembrane segments, including four in the 19-kDa fragment, appears to be a reasonable option. This is similar to the model proposed for sarcoplasmic reticulum Ca-ATPase. Nevertheless, certain eight-segment models, with only two transmembrane segments in the 19-kDa fragment, have not been excluded. Thus further experimentation is required in order to define the transmembrane folding of the C-terminal 19-kDa fragment and make a firm distinction between alternative topological models.	UNIV COPENHAGEN, AUGUST KROGH INST, BIOMEMBRANE RES CTR, DK-2100 COPENHAGEN, DENMARK	University of Copenhagen	KARLISH, SJD (corresponding author), WEIZMANN INST SCI, DEPT BIOCHEM, IL-76100 REHOVOT, ISRAEL.				PHS HHS [32286] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANTOLOVIC R, 1991, EUR J BIOCHEM, V199, P195, DOI 10.1111/j.1432-1033.1991.tb16109.x; BAYER R, 1990, BIOCHEMISTRY-US, V29, P2251, DOI 10.1021/bi00461a007; BESANCON M, 1992, ACTA PHYSIOL SCAND, V146, P77; CAPASSO JM, 1992, J BIOL CHEM, V267, P1150; CARAFOLI E, 1992, J BIOL CHEM, V267, P2115; CHIN G, 1984, J BIOL CHEM, V259, P5255; CLARKE DM, 1990, J BIOL CHEM, V265, P6262; CLARKE DM, 1990, J BIOL CHEM, V265, P17405; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; DZHANDZHUGAZYAN KN, 1985, BIOCHIM BIOPHYS ACTA, V817, P165, DOI 10.1016/0005-2736(85)90079-3; FELSENFELD DP, 1988, J BIOL CHEM, V263, P10932; FORBUSH B, 1982, J BIOL CHEM, V257, P2678; FORBUSH B, 1984, P NATL ACAD SCI-BIOL, V81, P5310, DOI 10.1073/pnas.81.17.5310; GIOTTA GJ, 1975, J BIOL CHEM, V250, P5159; GLYNN IM, 1990, ANNU REV BIOCHEM, V59, P171, DOI 10.1146/annurev.bi.59.070190.001131; GOLDSHLEGER R, 1992, P NATL ACAD SCI USA, V89, P6911, DOI 10.1073/pnas.89.15.6911; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P53, DOI 10.1016/0005-2736(74)90293-4; JORGENSEN PL, 1988, METHOD ENZYMOL, V156, P29; JORGENSEN PL, 1971, BIOCHIM BIOPHYS ACTA, V233, P381, DOI 10.1016/0005-2736(71)90335-X; JORGENSEN PL, 1982, J BIOL CHEM, V257, P7435; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; JORGENSEN PL, 1975, BIOCHIM BIOPHYS ACTA, V401, P399, DOI 10.1016/0005-2736(75)90239-4; KARLISH SJD, 1981, J PHYSIOL-LONDON, V312, P505, DOI 10.1113/jphysiol.1981.sp013641; KARLISH SJD, 1982, J PHYSIOL-LONDON, V328, P295, DOI 10.1113/jphysiol.1982.sp014265; KARLISH SJD, 1990, P NATL ACAD SCI USA, V87, P4566, DOI 10.1073/pnas.87.12.4566; KARLISH SJD, 1982, J PHYSIOL-LONDON, V328, P333, DOI 10.1113/jphysiol.1982.sp014267; KARLISH SJD, 1988, METHOD ENZYMOL, V156, P179; KARLISH SJD, 1984, BIOCHIM BIOPHYS ACTA, V776, P288, DOI 10.1016/0005-2736(84)90218-9; KAWAKAMI K, 1985, NATURE, V316, P733, DOI 10.1038/316733a0; LINGREL JB, 1990, PROG NUCLEIC ACID RE, V38, P37; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MANDALA SM, 1989, J BIOL CHEM, V264, P16276; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MATTHEWS I, 1990, J BIOL CHEM, V265, P18737; MATTHEWS I, 1989, BIOCHEM BIOPH RES CO, V161, P683, DOI 10.1016/0006-291X(89)92653-3; MCDONOUGH AA, 1990, FASEB J, V4, P1598, DOI 10.1096/fasebj.4.6.2156741; MILLER C, 1991, SCIENCE, V252, P1092, DOI 10.1126/science.252.5009.1092; MODYANOV N, 1992, ACTA PHYSIOL SCAND, V146, P49; MONK BC, 1991, J BIOL CHEM, V266, P18097; MUNSON KB, 1991, J BIOL CHEM, V266, P18976; OHTA T, 1986, FEBS LETT, V204, P297, DOI 10.1016/0014-5793(86)80832-8; OVCHINNIKOV YA, 1987, FEBS LETT, V217, P269, DOI 10.1016/0014-5793(87)80676-2; OVCHINNIKOV YA, 1988, FEBS LETT, V227, P230, DOI 10.1016/0014-5793(88)80904-9; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; RAO US, 1991, J BIOL CHEM, V266, P14740; REPHAELI A, 1986, J BIOL CHEM, V261, P6248; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SERRANO R, 1988, BIOCHIM BIOPHYS ACTA, V947, P1, DOI 10.1016/0304-4157(88)90017-2; SHULL GE, 1985, NATURE, V316, P691, DOI 10.1038/316691a0; SKRIVER E, 1983, CURR TOP MEMBR TRANS, V19, P119	50	78	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3471	3478						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381430				2022-12-27	WOS:A1993KM16100070
J	MATSUDA, S; GOTOH, Y; NISHIDA, E				MATSUDA, S; GOTOH, Y; NISHIDA, E			PHOSPHORYLATION OF XENOPUS MITOGEN-ACTIVATED PROTEIN (MAP) KINASE KINASE BY MAP KINASE KINASE KINASE AND MAP KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; SERINE THREONINE KINASES; SUBSTRATE RECOGNITION; SWISS 3T3-CELLS; IDENTIFICATION; INVITRO; FIBROBLASTS; SEQUENCE; PROGRESS; CASCADE	Xenopus 45-kDa mitogen-activated protein (MAP) kinase kinase (MAPKK) is a serine/threonine/tyrosine kinase, which activates MAP kinase (MAPK) by phosphorylating its threonine and tyrosine residues. MAPKK is active only when its threonine and/or serine residues are phosphorylated. We have identified from Xenopus eggs two protein kinases responsible for phosphorylation of MAPKK. The two kinases are separated by Sephacryl S-300 gel filtration chromatography. The higher molecular weight kinase phosphorylates MAPKK previously dephosphorylated and inactivated by phosphatase 2A treatment on mainly serine and slightly threonine residues, and reactivates the MAPKK, and is thus assumed to work as MAPKK kinase (MAPKKK) in vivo. The lower molecular weight kinase, identified as MAPK, phosphorylates the dephosphorylated MAPKK on mainly threonine and faintly serine residues, but does not reactivate the MAPKK activity. As Xenopus MAPKK contains a single phosphorylation consensus sequence (PXT388P) for MAPK in the C-terminal region, this T388 residue may be a major phosphorylation site catalyzed by MAPK. Thus, Xenopus MAPKK is phosphorylated in mature oocytes by not only an upstream kinase, MAPKKK, but also a downstream kinase, MAPK.	UNIV TOKYO, FAC SCI, DEPT BIOPHYS & BIOCHEM, TOKYO 113, JAPAN	University of Tokyo								AHN NG, 1991, J BIOL CHEM, V266, P4220; AHN NG, 1990, J BIOL CHEM, V265, P11487; ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; ANDERSON NG, 1991, BIOCHEM J, V277, P573, DOI 10.1042/bj2770573; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; GOTOH Y, 1991, NATURE, V349, P251, DOI 10.1038/349251a0; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; HATTORI S, 1992, J BIOL CHEM, V267, P20346; HOSHI M, 1988, J BIOL CHEM, V263, P5396; KOSAKO H, 1992, EMBO J, V11, P2903, DOI 10.1002/j.1460-2075.1992.tb05359.x; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LEE RM, 1992, J BIOL CHEM, V267, P1088; MATSUDA S, 1992, EMBO J, V11, P973, DOI 10.1002/j.1460-2075.1992.tb05136.x; NAKIELNY S, 1992, EMBO J, V11, P2123, DOI 10.1002/j.1460-2075.1992.tb05271.x; NISHIDA E, 1992, INT REV CYTOL, V138, P211, DOI 10.1016/S0074-7696(08)61589-2; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; POSADA J, 1991, MOL CELL BIOL, V11, P2517, DOI 10.1128/MCB.11.5.2517; POSADA J, 1992, SCIENCE, V255, P212, DOI 10.1126/science.1313186; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; SEGER R, 1992, J BIOL CHEM, V267, P14373; SHIINA N, 1992, EMBO J, V11, P3977, DOI 10.1002/j.1460-2075.1992.tb05491.x; SHIRAKABE K, 1992, J BIOL CHEM, V267, P16685; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O	36	121	121	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3277	3281						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381423				2022-12-27	WOS:A1993KM16100042
J	PAN, GH; LUETKE, K; JUBY, CD; BROUSSEAU, R; SADOWSKI, P				PAN, GH; LUETKE, K; JUBY, CD; BROUSSEAU, R; SADOWSKI, P			LIGATION OF SYNTHETIC ACTIVATED DNA SUBSTRATES BY SITE-SPECIFIC RECOMBINASES AND TOPOISOMERASE-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLP RECOMBINASE; IDENTIFICATION; MECHANISM; CLEAVAGE; PROTEIN; BINDING; TYROSINE; INVITRO; CRE	The FLP protein of the 2-mum plasmid of Saccharomyces cerevisiae is a conservative site-specific recombinase that is involved in the amplification of the plasmid. This recombination reaction proceeds via the covalent attachment of the protein to the 3'-phosphoryl group at the site of the breaks through a phosphotyrosine linkage. We have recently developed an assay that measures FLP-mediated strand ligation independent of FLP-mediated cleavage and covalent attachment to the DNA. The substrate for ligation was produced by FLP-induced cleavage of the FLP recognition site followed by digestion with Pronase and was shown to contain (at least) a tyrosine residue at the 3'-PO4 terminus adjacent to the FLP cleavage sites. We have now synthesized artificial substrates that bear a tyrosine residue on the 3'-PO4 of an appropriate oligonucleotide and find that this substrate is ligated as efficiently as the previous ligation substrates that were isolated after FLP cleavage of the substrate. Analogous substrates for other members of the integrase family of recombinases (lambda integrase protein, P1-Cre protein) as well as for mammalian topoisomerase I are also active as ligation substrates with their cognate protein. This class of activated substrates should be useful in the study of breakage and reunion reactions involving DNA.	UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO M5S 1A8,ONTARIO,CANADA; NATL RES COUNCIL CANADA,BIOTECHNOL RES INST,GENET ENGN SECT,MONTREAL H4P 2R2,QUEBEC,CANADA	University of Toronto; National Research Council Canada								ABREMSKI K, 1984, J BIOL CHEM, V259, P1509; ABREMSKI KE, 1992, PROTEIN ENG, V5, P87, DOI 10.1093/protein/5.1.87; ARGOS P, 1986, EMBO J, V5, P443; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Champoux JJ, 1990, DNA TOPOLOGY ITS BIO, P217; CHEN JW, 1992, CELL, V69, P647, DOI 10.1016/0092-8674(92)90228-5; Cox M. M., 1989, MOBILE DNA, P661; CRAIG NL, 1988, ANNU REV GENET, V22, P77; DEVARGAS LM, 1988, CELL, V54, P923, DOI 10.1016/0092-8674(88)90107-9; EVANS BR, 1990, J BIOL CHEM, V265, P18504; FRIESEN H, 1992, J MOL BIOL, V225, P313, DOI 10.1016/0022-2836(92)90924-9; GRONOSTAJSKI RM, 1985, MOL CELL BIOL, V5, P3274, DOI 10.1128/MCB.5.11.3274; HOESS RH, 1984, P NATL ACAD SCI-BIOL, V81, P1026, DOI 10.1073/pnas.81.4.1026; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maniatis T., 1982, MOL CLONING; PAN GH, 1992, J BIOL CHEM, V267, P12397; PAN H, 1991, J BIOL CHEM, V266, P11347; PARGELLIS CA, 1988, J BIOL CHEM, V263, P7678; PARSONS RL, 1988, MOL CELL BIOL, V8, P3303, DOI 10.1128/MCB.8.8.3303; RICHET E, 1988, CELL, V52, P9, DOI 10.1016/0092-8674(88)90526-0; SVEJSTRUP JQ, 1991, J MOL BIOL, V222, P669, DOI 10.1016/0022-2836(91)90503-X; SVEJSTRUP JQ, 1990, J BIOL CHEM, V265, P12529; VETTER D, 1983, P NATL ACAD SCI-BIOL, V80, P7284, DOI 10.1073/pnas.80.23.7284; WEISBERG RA, 1983, LAMBDA, V2, P221	24	28	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3683	3689						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381436				2022-12-27	WOS:A1993KM16100099
J	DRAZNIN, B; CHANG, L; LEITNER, JW; TAKATA, Y; OLEFSKY, JM				DRAZNIN, B; CHANG, L; LEITNER, JW; TAKATA, Y; OLEFSKY, JM			INSULIN ACTIVATES P21RAS AND GUANINE-NUCLEOTIDE RELEASING-FACTOR IN CELLS EXPRESSING WILD-TYPE AND MUTANT INSULIN-RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE AUTOPHOSPHORYLATION SITES; NERVE GROWTH-FACTOR; SACCHAROMYCES-CEREVISIAE; SIGNAL TRANSDUCTION; GENE-EXPRESSION; TERMINAL DOMAIN; CYCLASE PATHWAY; RAS; PROTEIN; KINASES	Insulin stimulates the formation of p21Ras-GTP in Rat-1 fibroblasts overexpressing wild type (HIRc) or mutant (DELTACT and Y/F2) insulin receptors. Maximal insulin effect was observed at 7 min in Y/F2 cells, at 10 min in DELTACT cells, and at 15 min in HIRc cells. Mutant insulin receptors which display enhanced mitogenic signaling properties stimulated p21Ras-GTP formation to a greater extent than wild type receptors. The amount of p21Ras was not affected by insulin (Western blotting). Tyrosine kinase inhibitor, Lavendustin A (10 nM), completely prevented insulin-induced activation of p21Ras in all cell lines. Insulin did not lead to GAP phosphorylation, or a change in cellular GAP activity, but did result in marked stimulation of Ras guanine nucleotide releasing factor (GRF) activity (by 48% in HIRc, 71% in DELTACT, and 120% in Y/F2 cells). These results indicated that p21Ras-GTP is an important signaling molecule in insulin's mitogenic pathway, but may not participate in metabolic signaling and that insulin's stimulatory effects on p21Ras-GTP formation are mediated through Ras GRF.	VET AFFAIRS MED CTR,DEPT MED,DENVER,CO 80220; UNIV COLORADO,HLTH SCI CTR,DENVER,CO 80262; VET AFFAIRS MED CTR,MED RES SERV,SAN DIEGO,CA 92093; VET AFFAIRS MED CTR,DEPT MED,SAN DIEGO,CA 92093; UNIV CALIF SAN DIEGO,LA JOLLA,CA 92093	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Diego	DRAZNIN, B (corresponding author), VET AFFAIRS MED CTR,MED RES SERV,ENDOCRINOL SECT 111H,1055 CLERMONT ST,DENVER,CO 80220, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033651, R37DK033651] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 33651] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDO A, 1992, J BIOL CHEM, V267, P12788; BEGUM N, 1993, J BIOL CHEM, V268, P7917; BONFINI L, 1992, SCIENCE, V255, P603, DOI 10.1126/science.1736363; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; BROTT BK, 1991, P NATL ACAD SCI USA, V88, P755, DOI 10.1073/pnas.88.3.755; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; BURSTEIN ES, 1992, P NATL ACAD SCI USA, V89, P1154, DOI 10.1073/pnas.89.4.1154; BURSTEIN ES, 1992, J BIOL CHEM, V267, P22715; CRECHET JB, 1990, SCIENCE, V248, P866, DOI 10.1126/science.2188363; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; GIBBS JB, 1990, J BIOL CHEM, V265, P20437; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; GULBINS E, 1993, SCIENCE, V260, P822, DOI 10.1126/science.8484124; HALL A, 1992, CELL, V69, P389, DOI 10.1016/0092-8674(92)90441-E; HUGHES DA, 1990, NATURE, V344, P355, DOI 10.1038/344355a0; JONES S, 1991, MOL CELL BIOL, V11, P2641, DOI 10.1128/MCB.11.5.2641; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAZLAUSKAS A, 1990, SCIENCE, V247, P1578, DOI 10.1126/science.2157284; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MAEGAWA H, 1988, J BIOL CHEM, V263, P8912; MEDEMA RH, 1991, J BIOL CHEM, V266, P21186; MEDEMA RH, 1991, MOL CELL BIOL, V11, P5963, DOI 10.1128/MCB.11.12.5963; MEDEMA RH, 1993, MOL CELL BIOL, V13, P155, DOI 10.1128/MCB.13.1.155; MYERS MG, 1991, J BIOL CHEM, V266, P10616; NAKAFUKU M, 1992, J BIOL CHEM, V267, P19448; OSTEROP APRM, 1992, J BIOL CHEM, V267, P14647; PARK S, 1992, J BIOL CHEM, V267, P11612; PORRAS A, 1992, J BIOL CHEM, V267, P21124; PRONK GJ, 1992, J BIOL CHEM, V267, P24058; ROBINSON LC, 1987, SCIENCE, V235, P1218, DOI 10.1126/science.3547648; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; SATOH T, 1992, J BIOL CHEM, V267, P24149; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; SIMON MA, 1993, CELL, V73, P169, DOI 10.1016/0092-8674(93)90169-Q; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; TAKATA Y, 1992, J BIOL CHEM, V267, P9065; THIES RS, 1989, J BIOL CHEM, V264, P12820; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WOLFMAN A, 1990, SCIENCE, V248, P67, DOI 10.1126/science.2181667; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; ZHANG K, 1992, SCIENCE, V257, P671, DOI 10.1126/science.1496380	46	54	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					19998	20001						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376360				2022-12-27	WOS:A1993LY01900015
J	HERUTH, DP; ZIRNSTEIN, GW; BRADLEY, JF; ROTHBERG, PG				HERUTH, DP; ZIRNSTEIN, GW; BRADLEY, JF; ROTHBERG, PG			SODIUM-BUTYRATE CAUSES AN INCREASE IN THE BLOCK TO TRANSCRIPTIONAL ELONGATION IN THE C-MYC GENE IN SW837 RECTAL-CARCINOMA CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-COLON-CARCINOMA; RNA POLYMERASE-II; TRANSFORMING GROWTH FACTOR-BETA-1; FAMILIAL ADENOMATOUS POLYPOSIS; HUMAN COLORECTAL-CANCER; ALKALINE-PHOSPHATASE; MESSENGER-RNA; PREMATURE TERMINATION; BURKITT-LYMPHOMA; 1ST EXON	Elevated expression of the c-myc oncogene is a frequent finding in tumors and cell lines derived from carcinomas of the colon and rectum. In a previous study we demonstrated that the differentiation agent sodium butyrate causes a rapid reduction in the expression of c-myc RNA in the rectal carcinoma cell line SW837. This effect was blocked by inhibitors of protein synthesis, suggesting that butyrate causes the induction of an activity that has a negative effect on c-myc expression In the present work we demonstrate that the rapid decrease in the level of c-myc RNA, upon treatment of SW837 cells with 2 mM butyrate, is followed by a slower decrease in the level of p53 RNA and an increase in the RNA levels for fibronectin and a placental type alkaline phosphatase. Using in vitro elongation of nascent transcripts to measure transcription and actinomycin D chase experiments to measure RNA stability, we show that the reduction in expression of c-myc RNA is due to an increase in the block to transcriptional elongation, rather than a decrease in transcriptional initiation or an increase in degradation of the RNA. We conclude that sodium butyrate induces an activity that increases the transcriptional block in SW837 cells, and that regulation of transcriptional elongation is an important mechanism for regulating c-myc expression in this cell type. A shift in relative usage of the two major promoters in the c-myc gene accompanies the reduction in expression. The potential significance of this finding with respect to transcriptional elongation is discussed. Mutations in the exon 1/intron 1 boundary region of the c-myc gene cause an increase in transcriptional elongation in Burkitt lymphoma. We sequenced this region in a series of cell lines derived from colorectal carcinomas, all of which had an elevated level of c-myc expression, to determine if a similar mutational mechanism is at work in this disease. All of the lines examined had a normal c-myc DNA sequence, suggesting that the deregulation of c-myc expression in colon cancer is not due to a cis mutation in this region.	CHILDRENS MERCY HOSP, MOLEC GENET LAB, 2401 GILLHAM RD, KANSAS CITY, MO 64108 USA; UNIV MISSOURI, SCH BIOL SCI, KANSAS CITY, MO 64108 USA	Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City					NCI NIH HHS [CA50246] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA050246] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ASTRIN SM, 1989, SEMIN ONCOL, V16, P138; AUSUBEL I, 1991, CURRENT PROTOCOLS MO; BENTLEY DL, 1988, CELL, V53, P245, DOI 10.1016/0092-8674(88)90386-8; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BERGER J, 1987, P NATL ACAD SCI USA, V84, P695, DOI 10.1073/pnas.84.3.695; BLAU CA, 1993, BLOOD, V81, P529; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; BRADLEY JF, 1993, GENE CHROMOSOME CANC, V7, P128, DOI 10.1002/gcc.2870070303; BREWER G, 1988, MOL CELL BIOL, V8, P1697, DOI 10.1128/MCB.8.4.1697; CESARMAN E, 1987, SCIENCE, V238, P1272, DOI 10.1126/science.3685977; CHAKRABARTY S, 1992, ANTICANCER RES, V12, P97; CHATTERJEE D, 1992, CANCER CHEMOTH PHARM, V30, P12, DOI 10.1007/BF00686479; CHATTERJEE D, 1989, CANCER RES, V49, P3910; CHUNG YS, 1985, CANCER RES, V45, P2976; COLLINS JF, 1992, J CLIN INVEST, V89, P1523, DOI 10.1172/JCI115744; COPPOLA JA, 1989, MOL CELL BIOL, V9, P1714, DOI 10.1128/MCB.9.4.1714; DENG G, 1992, CANCER RES, V52, P3378; DEPINHO RA, 1991, ADV CANCER RES, V57, P1; DOLCETTI R, 1988, EUR J CANCER CLIN ON, V24, P1321, DOI 10.1016/0277-5379(88)90223-4; EICK D, 1986, NUCLEIC ACIDS RES, V14, P8331, DOI 10.1093/nar/14.21.8331; ERISMAN MD, 1988, CANCER RES, V48, P1350; ERISMAN MD, 1989, P NATL ACAD SCI USA, V86, P4264, DOI 10.1073/pnas.86.11.4264; ERISMAN MD, 1988, ONCOGENE, V2, P367; ERISMAN MD, 1985, MOL CELL BIOL, V5, P1969, DOI 10.1128/MCB.5.8.1969; FINLEY GG, 1989, ONCOGENE, V4, P963; FOSS FM, 1989, ONCOGENE RES, V5, P13; FREYTAG SO, 1988, MOL CELL BIOL, V8, P1614, DOI 10.1128/MCB.8.4.1614; GAZIN C, 1984, EMBO J, V3, P383, DOI 10.1002/j.1460-2075.1984.tb01816.x; GRIEP AE, 1988, P NATL ACAD SCI USA, V85, P6806, DOI 10.1073/pnas.85.18.6806; GUILLEM JG, 1990, MOL CARCINOGEN, V3, P68, DOI 10.1002/mc.2940030204; GUM JR, 1987, J BIOL CHEM, V262, P1092; HEIKKILA R, 1987, NATURE, V328, P445, DOI 10.1038/328445a0; HEROLD KM, 1988, ONCOGENE, V3, P423; HEROLD KM, 1990, FAMILIAL ADENOMATOUS, P361; HERZ F, 1981, ARCH BIOCHEM BIOPHYS, V210, P581, DOI 10.1016/0003-9861(81)90224-1; HOLT JT, 1988, MOL CELL BIOL, V8, P963, DOI 10.1128/MCB.8.2.963; KIM YS, 1980, CANCER-AM CANCER SOC, V45, P1185, DOI 10.1002/1097-0142(19800315)45:5+<1185::AID-CNCR2820451324>3.0.CO;2-W; KORNBLIHTT AR, 1983, P NATL ACAD SCI-BIOL, V80, P3218, DOI 10.1073/pnas.80.11.3218; KRUH J, 1982, MOL CELL BIOCHEM, V42, P65; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; KRYSTAL G, 1988, MOL CELL BIOL, V8, P3373, DOI 10.1128/MCB.8.8.3373; LAIRDOFFRINGA IA, 1990, MOL CELL BIOL, V10, P6132, DOI 10.1128/MCB.10.12.6132; LAIRDOFFRINGA IA, 1989, NUCLEIC ACIDS RES, V17, P6499, DOI 10.1093/nar/17.16.6499; LAROCCA RV, 1992, ONCOLOGY, V49, P209; LINIAL M, 1985, SCIENCE, V230, P1126, DOI 10.1126/science.2999973; LINIAL M, 1993, SCIENCE, V7, P128; MA TL, 1992, MOL ENDOCRINOL, V6, P960, DOI 10.1210/me.6.6.960; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; MATLASHEWSKI G, 1984, EMBO J, V3, P3257, DOI 10.1002/j.1460-2075.1984.tb02287.x; MEULIA T, 1992, MOL CELL BIOL, V12, P4590, DOI 10.1128/MCB.12.10.4590; MICKLEY LA, 1989, J BIOL CHEM, V264, P18031; MILLER H, 1989, MOL CELL BIOL, V9, P5340, DOI 10.1128/MCB.9.12.5340; MINER JH, 1991, MOL CELL BIOL, V11, P2842, DOI 10.1128/MCB.11.5.2842; MULDER KM, 1988, INT J CANCER, V42, P64, DOI 10.1002/ijc.2910420113; MULDER KM, 1990, CANCER RES, V50, P7581; MULDER KM, 1988, BIOCHEM BIOPH RES CO, V150, P711, DOI 10.1016/0006-291X(88)90449-4; MURPHY LD, 1990, CANCER COMMUN, V2, P345, DOI 10.3727/095535490820874092; NEPVEU A, 1986, EMBO J, V5, P2859, DOI 10.1002/j.1460-2075.1986.tb04580.x; NILES RM, 1988, CANCER INVEST, V6, P39, DOI 10.3109/07357908809077027; PIETENPOL JA, 1990, P NATL ACAD SCI USA, V87, P3758, DOI 10.1073/pnas.87.10.3758; REITSMA PH, 1983, NATURE, V306, P492, DOI 10.1038/306492a0; ROBERTS S, 1992, GENE DEV, V6, P1562, DOI 10.1101/gad.6.8.1562; ROBERTS S, 1992, EMBO J, V11, P1085, DOI 10.1002/j.1460-2075.1992.tb05147.x; RODRIGUEZALFAGEME C, 1992, P NATL ACAD SCI USA, V89, P1482, DOI 10.1073/pnas.89.4.1482; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; ROTHBERG PG, 1984, MOL CELL BIOL, V4, P1096, DOI 10.1128/MCB.4.6.1096; ROTHBERG PG, 1987, SEMIN SURG ONCOL, V3, P152, DOI 10.1002/ssu.2980030305; ROTHBERG PG, 1985, BRIT J CANCER, V52, P629, DOI 10.1038/bjc.1985.237; RUBINSTEIN R, 1969, CLIN SCI, V37, P549; Sambrook J, 1989, MOL CLONING LABORATO; SEALY L, 1978, CELL, V14, P115, DOI 10.1016/0092-8674(78)90306-9; SKLAR MD, 1991, MOL CELL BIOL, V11, P3699, DOI 10.1128/MCB.11.7.3699; SPENCER CA, 1991, ADV CANCER RES, V56, P1; SPENCER CA, 1990, ONCOGENE, V5, P777; SPENCER CA, 1990, GENE DEV, V4, P75, DOI 10.1101/gad.4.1.75; STEWART J, 1986, BRIT J CANCER, V53, P1, DOI 10.1038/bjc.1986.1; STEWART TA, 1984, SCIENCE, V226, P707, DOI 10.1126/science.6494906; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; SUGGS SV, 1981, P NATL ACAD SCI-BIOL, V78, P6613, DOI 10.1073/pnas.78.11.6613; SWARTWOUT SG, 1989, MOL CELL BIOL, V9, P288, DOI 10.1128/MCB.9.1.288; TANAKA K, 1991, NATURE, V349, P340, DOI 10.1038/349340a0; TAUB R, 1984, CELL, V36, P339, DOI 10.1016/0092-8674(84)90227-7; TAYLOR CW, 1992, CANCER LETT, V62, P95, DOI 10.1016/0304-3835(92)90179-Y; TSAO D, 1983, CANCER RES, V43, P1217; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; TSUBOI K, 1987, BIOCHEM BIOPH RES CO, V146, P699, DOI 10.1016/0006-291X(87)90585-7; UNTAWALE S, 1988, ANTICANCER RES, V8, P1; WATSON PH, 1991, CANCER RES, V51, P3996; WICKSTROM EL, 1988, P NATL ACAD SCI USA, V85, P1028, DOI 10.1073/pnas.85.4.1028; WISDOM R, 1990, J BIOL CHEM, V265, P19015; WRIGHT S, 1991, P NATL ACAD SCI USA, V88, P11383, DOI 10.1073/pnas.88.24.11383; ZAJAC-KAYE M, 1988, SCIENCE, V240, P1776, DOI 10.1126/science.2454510	94	92	92	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20466	20472						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376401				2022-12-27	WOS:A1993LY01900079
J	RUAN, KH; WANG, LH; WU, KK; KULMACZ, RJ				RUAN, KH; WANG, LH; WU, KK; KULMACZ, RJ			AMINO-TERMINAL TOPOLOGY OF THROMBOXANE SYNTHASE IN THE ENDOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER CYTOCHROME-P-450; GLUTATHIONE-S-TRANSFERASE; MEMBRANE TOPOLOGY; ESCHERICHIA-COLI; MICROSOMAL CYTOCHROME-P-450; INSERTION SIGNAL; ACID-SEQUENCE; PURIFICATION; PROTEINS; ANTIBODIES	The membrane topology of the NH2-terminal portion of human thromboxane synthase (TXS), a member of the cytochrome P450 superfamily, has been investigated. By sequence alignment, the first 6 residues of the mature TXS polypeptide are likely to form a distinctive ''tail'' structure not found in many other mammalian cytochromes P450 in the endoplasmic reticulum membrane. Peptides with either the ultimate 10 or 15 residues of the NH2 terminus of TXS were synthesized and used to produce site-directed antibodies. The resulting peptide antibodies were highly specific and recognized human TXS, as shown by binding assays and Western blot analysis. Binding of the peptide antibodies to recombinant TXS in transfected COS-1 and to endogenous TXS in THP-1 cells was analyzed by immunocytochemistry. Selective permeabilization of the plasma membrane to immunoglobulin was achieved with streptolysin O; general permeabilization, including the endoplasmic reticulum membrane, was accomplished with Triton X-100. Permeabilization of the plasma membrane was sufficient to produce binding of both peptide antibodies to their epitopes, indicating that the epitopes for both of the peptide antibodies were exposed on the cytoplasmic side of the endoplasmic reticulum membrane. The results with the peptide antibodies provide direct experimental evidence supporting the topological model for membrane-bound cytochrome P450 proposed by Nelson and Strobel (Nelson, D. R., and Strobel, H. W. (1988) J. Biol. Chem. 263, 6038-6050), in which the NH2 terminus is oriented toward the cytoplasmic side of the endoplasmic reticulum membrane.	UNIV TEXAS,HLTH SCI CTR,DEPT INTERNAL MED,DIV HEMATOL,HOUSTON,TX 77225	University of Texas System; University of Texas Health Science Center Houston	RUAN, KH (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT INTERNAL MED,VASC BIOL RES CTR,HOUSTON,TX 77225, USA.		Wu, Kenneth Kun-Yu/B-1070-2010		NINDS NIH HHS [NS-23327] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS023327] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERNHARDT R, 1983, BIOCHIM BIOPHYS ACTA, V745, P140, DOI 10.1016/0167-4838(83)90042-0; BLACK SD, 1987, ADV ENZYMOL RAMB, V60, P35; BLACK SD, 1992, FASEB J, V6, P680, DOI 10.1096/fasebj.6.2.1537456; CAMPBELL AM, 1992, J BIOL CHEM, V267, P9321; DELEMOSCHIARANDINI C, 1987, J CELL BIOL, V104, P209, DOI 10.1083/jcb.104.2.209; DEWITT DL, 1990, J BIOL CHEM, V265, P5192; EDWARDS RJ, 1991, BIOCHEMISTRY-US, V30, P71, DOI 10.1021/bi00215a011; ERLANGER BF, 1959, J BIOL CHEM, V234, P1090; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; HAURAND M, 1985, J BIOL CHEM, V260, P5059; HEINEMANN FS, 1982, J BIOL CHEM, V257, P4988; KEMPER B, 1989, DRUG METAB REV, V20, P811, DOI 10.3109/03602538909103580; Kulmacz RJ, 1987, PROSTAGLANDINS RELAT, P209; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSON JR, 1991, J BIOL CHEM, V266, P7321; LARSON JR, 1991, P NATL ACAD SCI USA, V88, P9141, DOI 10.1073/pnas.88.20.9141; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MONIER S, 1988, J CELL BIOL, V107, P457, DOI 10.1083/jcb.107.2.457; MOORE WT, 1991, TECHNIQUES PROTEIN C, V2, P511; NELSON DR, 1988, J BIOL CHEM, V263, P6038; OHASHI K, 1992, J BIOL CHEM, V267, P789; OZOLS J, 1985, J BIOL CHEM, V260, P5427; RUAN KH, 1985, CLIN CHIM ACTA, V147, P167, DOI 10.1016/0009-8981(85)90078-6; SAKAGUCHI M, 1987, EMBO J, V6, P2425, DOI 10.1002/j.1460-2075.1987.tb02521.x; SANDUJA SK, 1991, BLOOD, V78, P3178; SHEN RF, 1986, J BIOL CHEM, V261, P1585; SHEN RF, 1986, J BIOL CHEM, V261, P1592; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; THOMAS PE, 1977, MOL PHARMACOL, V13, P819; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; ULLRICH V, 1984, TRENDS PHARMACOL SCI, V5, P352, DOI 10.1016/0165-6147(84)90467-X; VERGERES G, 1991, BIOCHIM BIOPHYS ACTA, V1063, P235, DOI 10.1016/0005-2736(91)90376-J; VERGERES G, 1989, BIOCHEMISTRY-US, V28, P3650, DOI 10.1021/bi00435a005; WANG LH, 1991, BIOCHEM BIOPH RES CO, V177, P286, DOI 10.1016/0006-291X(91)91980-Q; XZCZESNASKORUPA E, 1993, J BIOL CHEM, V268, P1757; YABUSAKI Y, 1988, DNA-J MOLEC CELL BIO, V7, P701, DOI 10.1089/dna.1988.7.701; YAMAMOTO S, 1987, PROSTAGLANDINS RELAT, P197; YOKOYAMA C, 1991, BIOCHEM BIOPH RES CO, V178, P1479, DOI 10.1016/0006-291X(91)91060-P	40	44	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19483	19490						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366093				2022-12-27	WOS:A1993LW81900053
J	MARSHALL, BA; REN, JM; JOHNSON, DW; GIBBS, EM; LILLQUIST, JS; SOELLER, WC; HOLLOSZY, JO; MUECKLER, M				MARSHALL, BA; REN, JM; JOHNSON, DW; GIBBS, EM; LILLQUIST, JS; SOELLER, WC; HOLLOSZY, JO; MUECKLER, M			GERMLINE MANIPULATION OF GLUCOSE-HOMEOSTASIS VIA ALTERATION OF GLUCOSE-TRANSPORTER LEVELS IN SKELETAL-MUSCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							INSULIN-RESPONSIVE TISSUES; NUCLEOTIDE-SEQUENCE; PROTEIN; GENE; CLONING; IDENTIFICATION; DISPOSAL; CELLS	Transgenic mice were constructed that overexpress the human Glut1 glucose transporter in skeletal muscle. Transcription of the human Glut1 cDNA was driven by the rat myosin light chain 2 promoter. Soleus and quadriceps muscles from transgenic mice expressed increased levels of Glut1 protein relative to muscles obtained from nontransgenic littermates, but there was no difference in the level of Glut4 protein between the two groups. Skeletal muscles isolated from the transgenic animals exhibited 3-4-fold increases in basal glucose uptake relative to muscles obtained from nontransgenic littermates. Muscles isolated from nontransgenic littermates exhibited 2-3-fold increases in glucose transport after incubation in the presence of insulin, but no insulin-stimulated increase in transport was observed in the muscles of transgenic mice. Plasma glucose levels were reduced by 18 and 30%, respectively, in fed and fasted transgenic mice relative to their nontransgenic siblings, but insulin and glucagon levels were not significantly different between the two groups. Glucose disposal following an oral glucose load was markedly enhanced in the transgenic animals, and plasma lactate and beta-OH-butyrate levels were elevated in both fed and fasted transgenic mice. These data strongly support the hypothesis that glucose transport plays a key role in whole body glucose homeostasis. They also demonstrate that the level of a glucose transporter in skeletal muscle can significantly influence the blood glucose set point and alter the levels of other fuel metabolites in the blood.	WASHINGTON UNIV, SCH MED, DEPT CELL BIOL & PHYSIOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT MED, ST LOUIS, MO 63110 USA; PFIZER CENT RES INC, GROTON, CT 06340 USA	Washington University (WUSTL); Washington University (WUSTL); Pfizer			Mueckler, Mike M/F-6115-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007120, R01DK018986, R01DK038495] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK38495, DK07120, DK18986] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLARD WJ, 1985, J BIOL CHEM, V260, P8668; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784; BURANT CF, 1991, RECENT PROG HORM RES, V47, P349; CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535; CZECH MP, 1992, TRENDS BIOCHEM SCI, V17, P197, DOI 10.1016/0968-0004(92)90266-C; ERCOLANI L, 1988, J BIOL CHEM, V263, P15335; FERRANNINI E, 1985, DIABETES, V34, P580, DOI 10.2337/diabetes.34.6.580; FUKUMOTO H, 1989, J BIOL CHEM, V264, P7776; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; HANEY PM, 1991, J CELL BIOL, V114, P689, DOI 10.1083/jcb.114.4.689; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; KAESTNER KH, 1989, P NATL ACAD SCI USA, V86, P3150, DOI 10.1073/pnas.86.9.3150; KORANYI LI, 1991, DIABETOLOGIA, V34, P763, DOI 10.1007/BF00401526; LIENHARD GE, 1992, SCI AM, V266, P86, DOI 10.1038/scientificamerican0192-86; MINGHETTI PP, 1986, J BIOL CHEM, V261, P6747; MUECKLER M, 1986, CELL, V44, P629, DOI 10.1016/0092-8674(86)90272-2; MUECKLER M, 1990, DIABETES, V39, P6, DOI 10.2337/diabetes.39.1.6; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; NUDEL U, 1984, NUCLEIC ACIDS RES, V12, P7175, DOI 10.1093/nar/12.18.7175; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; YOUNG DA, 1986, J BIOL CHEM, V261, P6049; ZIEL FH, 1988, DIABETES, V37, P885, DOI 10.2337/diabetes.37.7.885	23	116	118	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18442	18445						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360145				2022-12-27	WOS:A1993LV65900012
J	FAY, PJ; HAIDARIS, PJ; HUGGINS, CF				FAY, PJ; HAIDARIS, PJ; HUGGINS, CF			ROLE OF THE COOH-TERMINAL ACIDIC REGION OF A1-SUBUNIT IN A2-SUBUNIT RETENTION IN HUMAN FACTOR-VIIIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-C; PORCINE FACTOR-VIII; A1/A3-C1-C2 DIMER; SUBUNIT STRUCTURE; FACTOR-IXA; THROMBIN; INACTIVATION; BINDING; RECONSTITUTION; IDENTIFICATION	Factor VIIIa is a heterotrimer of A1,A2 and A3-C1-C2 subunits which is labile due to a relatively weak affinity interaction between the A2 subunit and the Me2+-linked A1/A3-C1-C2 dimer. Previously we speculated that the acidic region at the COOH terminus of the A1 subunit was involved with the A2 subunit retention. This region, delineated by factor VIII residues 337-372, was chemically synthesized. Both the peptide, designated FVIII337-372, and an IgG fraction prepared from rabbit anti-FVIII337-372 antiserum inhibited the reconstitution of factor VIIIa from A1/A3-C1-C2 dimer plus A2 subunit. A primary component of the inhibitory activity of the peptide was attributed to its acidic nature based upon similar inhibition of factor VIIIa reconstitution using a synthetic polymer of aspartic acid. Trypsin cleaved the peptide at Arg359 and the resultant two fragments were isolated. Inhibitory activity was associated with the NH2-terminal fragment which contained 10 of the 13 acidic residues present in the original peptide. The fluorescence of a dansylated FVIII337-372 was enhanced 2-fold by A2 subunit and this effect was reversed by addition of excess unmodified peptide. The inhibitory activity of FVIII337-372 was attenuated by the presence of Ca2+. Ca2+ also inhibited the reconstitution of factor VIIIa in the absence of peptide and increased the rate and extent of factor VIII(a) decay, suggesting that Ca2+ effectively shielded charges important for the intersubunit interactions. The above results support a role for this acidic region in the association of A2 subunit with A1/A3-C1-C2 dimer.	UNIV ROCHESTER,SCH MED & DENT,DEPT BIOCHEM,ROCHESTER,NY 14642; UNIV ROCHESTER,SCH MED & DENT,DEPT MICROBIOL & IMMUNOL,ROCHESTER,NY 14642	University of Rochester; University of Rochester	FAY, PJ (corresponding author), UNIV ROCHESTER,SCH MED & DENT,DEPT MED,HEMATOL UNIT,POB 610,601 ELMWOOD AVE,ROCHESTER,NY 14642, USA.			, PJ/0000-0003-2778-2500; Huggins, Christine/0000-0002-5873-1194	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030616, R01HL038199] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-30616, HL-38199] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSSON LO, 1986, P NATL ACAD SCI USA, V83, P2979, DOI 10.1073/pnas.83.9.2979; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; FASS DN, 1982, BLOOD, V59, P594; FAY PJ, 1989, J BIOL CHEM, V264, P14005; FAY PJ, 1991, J BIOL CHEM, V266, P20139; FAY PJ, 1992, J BIOL CHEM, V267, P13246; FAY PJ, 1991, J BIOL CHEM, V266, P8957; FAY PJ, 1986, BIOCHIM BIOPHYS ACTA, V871, P268, DOI 10.1016/0167-4838(86)90208-6; FAY PJ, 1988, ARCH BIOCHEM BIOPHYS, V262, P525, DOI 10.1016/0003-9861(88)90404-3; FAY PJ, 1989, BIOCHIM BIOPHYS ACTA, V994, P142, DOI 10.1016/0167-4838(89)90153-2; FOSTER PA, 1988, J CLIN INVEST, V82, P123, DOI 10.1172/JCI113559; HILLEUBANKS DC, 1989, P NATL ACAD SCI USA, V86, P6508, DOI 10.1073/pnas.86.17.6508; HULTIN MB, 1981, BLOOD, V57, P476; HULTIN MB, 1985, BLOOD, V66, P53; LAMPHEAR BJ, 1992, BLOOD, V80, P3120; LOLLAR P, 1990, J BIOL CHEM, V265, P1688; LOLLAR P, 1989, BIOCHEMISTRY-US, V28, P666, DOI 10.1021/bi00428a038; MANN KG, 1990, BLOOD, V76, P1; OBRIEN DP, 1992, BIOCHEMISTRY-US, V31, P2805, DOI 10.1021/bi00125a022; PITTMAN DD, 1992, BIOCHEMISTRY-US, V31, P3315, DOI 10.1021/bi00128a003; RICK ME, 1977, BRIT J HAEMATOL, V36, P585, DOI 10.1111/j.1365-2141.1977.tb00999.x; SCANDELLA D, 1989, BLOOD, V74, P1618; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0	26	55	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17861	17866						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349670				2022-12-27	WOS:A1993LT74300035
J	TAKIMOTO, M; TOMONAGA, T; MATUNIS, M; AVIGAN, M; KRUTZSCH, H; DREYFUSS, G; LEVENS, D				TAKIMOTO, M; TOMONAGA, T; MATUNIS, M; AVIGAN, M; KRUTZSCH, H; DREYFUSS, G; LEVENS, D			SPECIFIC BINDING OF HETEROGENEOUS RIBONUCLEOPROTEIN PARTICLE PROTEIN-K TO THE HUMAN C-MYC PROMOTER, IN-VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; TRANSCRIPTION FACTOR; GENE-TRANSCRIPTION; TRANS-ACTIVATION; BURKITT-LYMPHOMA; NUCLEAR FACTOR; 5S RNA; SEQUENCE; EXPRESSION; REGION	A homopurine/homopyrimidine-like sequence is found 1000-150 base pairs upstream of the human c-myc promoter P1. This element, termed the CT-element, has been shown to augment expression from P1, and it serves as a positive transcriptional element when coupled to a heterologous promoter in vivo and in vitro. Synthetic oligonucleotides comprising this element were used to form DNA-protein complexes in electrophoretic mobility shift assays. By using conventional and affinity methods, 61- and 34-kDa proteins were shown to be associated with these complexes. Amino acid sequence analysis and immunological methods have identified these proteins as heterogeneous ribonucleoprotein particle (hnRNP) proteins K and A1. Surprisingly, hnRNP protein K binds to the pyrimidine-rich strand of the CT-element in a sequence-specific manner as well as to the double-stranded molecule. Cotransfection of vectors encoding hnRNP protein K in the sense or anti-sense orientations with reporter plasmids driven by wild-type or mutant CT-elements demonstrates that hnRNP protein K augments gene expression in a cis-element-dependent manner. Taken together, these results suggest that hnRNP protein K may play a role in the transcriptional regulation of the human c-myc gene.	NCI, PATHOL LAB, BETHESDA, MD 20892 USA; UNIV PENN, SCH MED, DEPT BIOCHEM & BIOPHYS, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, HOWARD HUGHES MED INST, PHILADELPHIA, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania			Takimoto, Masato/D-9653-2012; Levens, David/C-9216-2009; Dreyfuss, Gideon/D-1218-2013	Levens, David/0000-0002-7616-922X; Dreyfuss, Gideon/0000-0001-8129-8774; Matunis, Michael/0000-0002-9350-6611				AVIGAN MI, 1990, J BIOL CHEM, V265, P18538; BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BOLES TC, 1987, BIOCHEMISTRY-US, V26, P367, DOI 10.1021/bi00376a006; BRUNEL F, 1991, NUCLEIC ACIDS RES, V19, P5237, DOI 10.1093/nar/19.19.5237; BURD CG, 1989, P NATL ACAD SCI USA, V86, P9788, DOI 10.1073/pnas.86.24.9788; CAVALIERI F, 1987, MOL CELL BIOL, V7, P3554, DOI 10.1128/MCB.7.10.3554; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; COONEY M, 1988, SCIENCE, V241, P456, DOI 10.1126/science.3293213; CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6; DAVIS TL, 1989, P NATL ACAD SCI USA, V86, P9682, DOI 10.1073/pnas.86.24.9682; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; DREYFUSS G, 1986, ANNU REV CELL BIOL, V2, P459, DOI 10.1146/annurev.cellbio.2.1.459; GAILLARD C, 1988, J VIROL, V62, P2380, DOI 10.1128/JVI.62.7.2380-2385.1988; GILMAN MZ, 1986, MOL CELL BIOL, V6, P4305, DOI 10.1128/MCB.6.12.4305; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; HAY N, 1989, GENE DEV, V3, P293, DOI 10.1101/gad.3.3.293; HAY N, 1987, GENE DEV, V1, P659, DOI 10.1101/gad.1.7.659; HENDERSON LE, 1979, ANAL BIOCHEM, V93, P153, DOI 10.1016/S0003-2697(79)80129-3; HERRICK G, 1976, J BIOL CHEM, V251, P2133; HIEBERT SW, 1989, P NATL ACAD SCI USA, V86, P3594, DOI 10.1073/pnas.86.10.3594; HOFFMAN EK, 1990, P NATL ACAD SCI USA, V87, P2705, DOI 10.1073/pnas.87.7.2705; HONDA BM, 1980, CELL, V22, P119, DOI 10.1016/0092-8674(80)90160-9; JEANG KT, 1988, J VIROL, V62, P4499, DOI 10.1128/JVI.62.12.4499-4509.1988; JOHNSON AC, 1988, MOL CELL BIOL, V8, P4174, DOI 10.1128/MCB.8.10.4174; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KELLY K, 1986, ANNU REV IMMUNOL, V4, P317, DOI 10.1146/annurev.immunol.4.1.317; KENAN DJ, 1991, TRENDS BIOCHEM SCI, V16, P214, DOI 10.1016/0968-0004(91)90088-D; LIPP M, 1987, MOL CELL BIOL, V7, P1393, DOI 10.1128/MCB.7.4.1393; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; PELHAM HRB, 1980, P NATL ACAD SCI-BIOL, V77, P4170, DOI 10.1073/pnas.77.7.4170; PINOLROMA S, 1989, J CELL BIOL, V109, P2575, DOI 10.1083/jcb.109.6.2575; POSTEL EH, 1989, MOL CELL BIOL, V9, P5123, DOI 10.1128/MCB.9.11.5123; PRENDERGAST GC, 1991, SCIENCE, V251, P186, DOI 10.1126/science.1987636; SIEBENLIST U, 1984, CELL, V37, P381, DOI 10.1016/0092-8674(84)90368-4; SPENCER CA, 1991, ADV CANCER RES, V56, P1; STONE KL, 1989, PRACTICAL GUIDE PROT, P33; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; TAKIMOTO M, 1989, J BIOL CHEM, V264, P8992; THALMEIER K, 1989, GENE DEV, V3, P527, DOI 10.1101/gad.3.4.527; WIEDERRECHT G, 1988, CELL, V54, P841, DOI 10.1016/S0092-8674(88)91197-X; WILKISON WO, 1990, J BIOL CHEM, V265, P477; ZAJAC-KAYE M, 1988, CURR TOP MICROBIOL, V141, P247; ZAJAC-KAYE M, 1988, SCIENCE, V240, P1776, DOI 10.1126/science.2454510	48	205	207	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18249	18258						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349701				2022-12-27	WOS:A1993LT74300089
J	STOPECK, AT; NICHOLSON, AC; MANCINI, FP; HAJJAR, DP				STOPECK, AT; NICHOLSON, AC; MANCINI, FP; HAJJAR, DP			CYTOKINE REGULATION OF LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE-TRANSCRIPTION IN HEPG2 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; COLONY-STIMULATING FACTOR; HUMAN-SKIN FIBROBLASTS; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; PHASE-I TRIAL; GROWTH-FACTOR; FACTOR-ALPHA; CHOLESTEROL-METABOLISM; PLASMA-CHOLESTEROL; INTERFERON-ALPHA	Elevated plasma levels of cytokines have been demonstrated in inflammatory, malignant, and infectious diseases. These disease states are often associated with abnormal lipid metabolism and reductions in plasma cholesterol levels. To determine if inflammatory cytokines could influence hepatic lipid metabolism, we evaluated low density lipoprotein (LDL) receptor function and gene expression in cytokine stimulated HepG2 cells, a hepatoblastoma-derived cell line which shares many functional similarities with normal hepatocytes. Tumor necrosis factor-alpha (TNF) and interleukin-1beta (IL-1) increased LDL binding to HepG2 cells in a dose-responsive manner. Other cytokines including macrophage-colony stimulating factor, granulocyte macrophage-colony stimulating factor, and gamma-interferon had no significant effects on LDL binding. Increased binding in response to TNF or IL-1 was paralleled by increased steady-state levels of LDL receptor mRNA. Evaluation of LDL receptor mRNA half-life revealed no significant change in mRNA stability between control and TNF- or IL-1-stimulated cells. A fusion gene construct consisting of 1563 base pairs of the 5'-flanking DNA of the human LDL receptor gene was coupled to a luciferase reporter gene, transfected into HepG2 cells, and promoter activity was assayed after TNF and IL-1 challenge to the cells. TNF and IL-1 increased promoter activity 200-400%, while treatment with LDL inhibited promoter activity by 70-85%. TNF or IL-1 co-incubation with LDL could not override transcriptional inhibition by LDL. Pretreatment with cycloheximide prevented induction of LDL receptor mRNA by TNF, but not by IL-1, suggesting stimulation of LDL receptor transcription by TNF requires protein synthesis. We propose that TNF and IL-1, acting via distinct signal transduction pathways, increase surface LDL receptors by increasing gene transcription. Our findings suggest that cytokine-induced hypocholesterolemia may be related to TNF and/or IL-1 stimulation of hepatic LDL receptor gene expression and function.	CORNELL UNIV,MED CTR,COLL MED,DEPT PATHOL,1300 YORK AVE,NEW YORK,NY 10021; CORNELL UNIV,MED CTR,COLL MED,DEPT BIOCHEM,NEW YORK,NY 10021	Cornell University; Cornell University					NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR000085] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K11HL002738, P01HL046403] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-00085] Funding Source: Medline; NHLBI NIH HHS [HL-46403, HL-02738] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANGELIN B, 1991, ANN MED, V23, P177, DOI 10.3109/07853899109148044; AUWERX JH, 1989, P NATL ACAD SCI USA, V86, P1133, DOI 10.1073/pnas.86.4.1133; BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CHAIT A, 1980, P NATL ACAD SCI-BIOL, V77, P4084, DOI 10.1073/pnas.77.7.4084; CHAIT A, 1978, BIOCHIM BIOPHYS ACTA, V529, P292, DOI 10.1016/0005-2760(78)90072-3; CHEN JK, 1988, IN VITRO CELL DEV B, V24, P353, DOI 10.1007/BF02628838; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5894; CUTHBERT JA, 1989, J BIOL CHEM, V264, P1298; DAVIES PF, 1982, BIOCHIM BIOPHYS ACTA, V712, P26, DOI 10.1016/0005-2760(82)90080-7; DAWSON PA, 1988, J BIOL CHEM, V263, P3372; EVANS RD, 1989, CLIN SCI, V77, P357, DOI 10.1042/cs0770357; FEINBERG B, 1988, J CLIN ONCOL, V6, P1328, DOI 10.1200/JCO.1988.6.8.1328; FEINGOLD KR, 1989, ENDOCRINOLOGY, V125, P267, DOI 10.1210/endo-125-1-267; FOA R, 1992, J CLIN ONCOL, V10, P954, DOI 10.1200/JCO.1992.10.6.954; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GRIFFITH RL, 1988, J EXP MED, V168, P1041, DOI 10.1084/jem.168.3.1041; GROVE RI, 1991, J LIPID RES, V32, P1889; GRUNFELD C, 1989, CANCER RES, V49, P2554; GRUNFELD C, 1991, AM J MED, V90, P154, DOI 10.1016/0002-9343(91)80154-E; GRUNFELD C, 1992, NEW ENGL J MED, V327, P329, DOI 10.1056/NEJM199207303270506; HABENICHT AJR, 1980, J BIOL CHEM, V255, P5134; HAMANAKA R, 1992, J BIOL CHEM, V267, P13160; HARADA K, 1990, BIOCHEM BIOPH RES CO, V172, P1022, DOI 10.1016/0006-291X(90)91548-7; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HO YK, 1980, J LIPID RES, V21, P391; JAKUBOWSKI AA, 1989, J CLIN ONCOL, V7, P298, DOI 10.1200/JCO.1989.7.3.298; JAVITT NB, 1990, FASEB J, V4, P161, DOI 10.1096/fasebj.4.2.2153592; JONASSON L, 1990, BIOCHIM BIOPHYS ACTA, V1053, P43, DOI 10.1016/0167-4889(90)90024-8; KOVANEN PT, 1987, AM HEART J, V113, P464, DOI 10.1016/0002-8703(87)90615-6; LE JM, 1987, LAB INVEST, V56, P234; LIN JX, 1987, J BIOL CHEM, V262, P11908; MACFARLANE AS, 1958, NATURE, V182, P53; MARSHALL PJ, 1985, ANAL BIOCHEM, V145, P192, DOI 10.1016/0003-2697(85)90347-1; MAZZONE T, 1990, J BIOL CHEM, V265, P5145; MOORBY CD, 1992, ATHEROSCLEROSIS, V97, P21, DOI 10.1016/0021-9150(92)90047-K; MOTOYOSHI K, 1989, LANCET, P326; NICHOLSON AC, 1992, J BIOL CHEM, V267, P25982; NIMER SD, 1988, JAMA-J AM MED ASSOC, V260, P3297, DOI 10.1001/jama.260.22.3297; OSTLUND RE, 1991, ARTERIOSCLER THROMB, V11, P1414; OWEN CH, 1991, ARTERIOSCLER THROMB, V11, P1447; RIIKONEN P, 1992, J INFECT DIS, V166, P432, DOI 10.1093/infdis/166.2.432; RUDLING MJ, 1990, P NATL ACAD SCI USA, V87, P3469, DOI 10.1073/pnas.87.9.3469; SAMMALKORPI K, 1988, METABOLISM, V37, P859, DOI 10.1016/0026-0495(88)90120-5; SCHECTMAN G, 1992, ARTERIOSCLER THROMB, V12, P1053, DOI 10.1161/01.ATV.12.9.1053; Shibata F, 1991, GROWTH FACTORS, V4, P277, DOI 10.3109/08977199109043913; SISSON SD, 1988, BLOOD, V72, P1368; SMITH JR, 1990, J BIOL CHEM, V265, P2306; STOUDEMIRE JB, 1991, BLOOD, V77, P750; STOVROFF M, 1992, J SURG RES, V46, P462; SUDHOF TC, 1987, CELL, V48, P1061, DOI 10.1016/0092-8674(87)90713-6; SUDHOF TC, 1987, J BIOL CHEM, V262, P10773; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; TAKAGI K, 1989, CAN J PHYSIOL PHARM, V67, P968, DOI 10.1139/y89-153; TORTI FM, 1985, SCIENCE, V229, P867, DOI 10.1126/science.3839597; VANZONNEVELD AJ, 1988, P NATL ACAD SCI USA, V85, P5525; VILCEK J, 1991, J BIOL CHEM, V266, P7313; WADE DP, 1988, EUR J BIOCHEM, V174, P213, DOI 10.1111/j.1432-1033.1988.tb14084.x; WADE DP, 1989, EUR J BIOCHEM, V181, P727, DOI 10.1111/j.1432-1033.1989.tb14784.x; WILSON DE, 1989, J CLIN ONCOL, V7, P1573, DOI 10.1200/JCO.1989.7.10.1573	61	131	134	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17489	17494						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349628				2022-12-27	WOS:A1993LQ98800088
J	VEILLETTE, A; DUMONT, S; FOURNEL, M				VEILLETTE, A; DUMONT, S; FOURNEL, M			CONSERVED CYSTEINE RESIDUES ARE CRITICAL FOR THE ENZYMATIC FUNCTION OF THE LYMPHOCYTE-SPECIFIC TYROSINE PROTEIN-KINASE P56LCK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL RESPONSIVENESS; SH3 DOMAINS; BINDING-ACTIVITY; HERBIMYCIN-A; PHOSPHORYLATION; GENE; CD4; OXIDATION; RECEPTOR; SITE	We have evaluated the possibility that conserved cysteine residues are critical for the enzymatic function of p56lck. Through oligonucleotide-directed mutagenesis, 5 Lck residues (cysteines 217, 224, 378, 464, and 475) were individually mutated to alanines, and the effects of these substitutions were tested in various in vitro and in vivo assays. We found that mutation of either of 2 cysteines located in the carboxyl portion of the kinase domain (cysteines 464 and 475) abolished the catalytic function of Lck. In addition, it was noted that alteration of cysteine 475 resulted in a dramatic reduction of the half-life of p56lck. These cysteine residues are highly conserved throughout the tyrosine protein kinase family, suggesting that they may play important functions in catalysis and/or substrate recognition.	MCGILL UNIV, DEPT BIOCHEM, MONTREAL H3G 1Y6, QUEBEC, CANADA; MCGILL UNIV, DEPT MED, MONTREAL H3G 1Y6, QUEBEC, CANADA; MCGILL UNIV, DEPT ONCOL, MONTREAL H3G 1Y6, QUEBEC, CANADA; MONTREAL GEN HOSP, DEPT MED, DIV MED ONCOL, MONTREAL H3G 1A4, QUEBEC, CANADA	McGill University; McGill University; McGill University; McGill University	VEILLETTE, A (corresponding author), MCGILL UNIV, MCGILL CANC CTR, RM 715B, MCINTYRE MED SCI BLDG, 3655 DRUMMOND ST, MONTREAL H3G 1Y6, QUEBEC, CANADA.							ABRAHAM N, 1990, MOL CELL BIOL, V10, P5197, DOI 10.1128/MCB.10.10.5197; ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; BOLEN JB, 1984, J BIOL CHEM, V259, P1686; BUHROW SA, 1982, J BIOL CHEM, V257, P4019; CAPPEL RE, 1988, J BIOL CHEM, V263, P12204; CARON L, 1992, MOL CELL BIOL, V12, P2720, DOI 10.1128/MCB.12.6.2720; CARTIER M, 1987, MOL CELL BIOL, V7, P1623, DOI 10.1128/MCB.7.5.1623; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; Cooper J.A, 1990, PEPT PROT PHOSPH, P85; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HURLEY TR, 1989, ONCOGENE, V4, P265; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; KANNER SB, 1992, P NATL ACAD SCI USA, V89, P300, DOI 10.1073/pnas.89.1.300; KATAMINE S, 1988, MOL CELL BIOL, V8, P259, DOI 10.1128/MCB.8.1.259; KING FJ, 1990, ONCOGENE, V5, P337; KLAUSNER RD, 1989, SCIENCE, V246, P870, DOI 10.1126/science.2683086; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; LUO KX, 1990, MOL CELL BIOL, V10, P5305, DOI 10.1128/MCB.10.10.5305; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; SEFTON BM, 1991, ONCOGENE, V6, P683; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; STANNERS CP, 1971, NATURE-NEW BIOL, V230, P52, DOI 10.1038/newbio230052a0; SUDOL M, 1993, ONCOGENE, V8, P823; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; UEHARA Y, 1989, CANCER RES, V49, P780; UEHARA Y, 1989, BIOCHEM BIOPH RES CO, V163, P803, DOI 10.1016/0006-291X(89)92293-6; Veillette A, 1991, Semin Immunol, V3, P143; VEILLETTE A, 1992, ONCOGENE, V7, P971; VEILLETTE A, 1990, ONCOGENE, V5, P1455; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 1988, ONCOGENE RES, V2, P385; VORONOVA AF, 1986, NATURE, V319, P682, DOI 10.1038/319682a0; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x	48	51	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17547	17553						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349633				2022-12-27	WOS:A1993LQ98800095
J	CLARKE, JH; LIGHT, DR; BLASKO, E; PARKINSON, JF; NAGASHIMA, M; MCLEAN, K; VILANDER, L; ANDREWS, WH; MORSER, J; GLASER, CB				CLARKE, JH; LIGHT, DR; BLASKO, E; PARKINSON, JF; NAGASHIMA, M; MCLEAN, K; VILANDER, L; ANDREWS, WH; MORSER, J; GLASER, CB			THE SHORT LOOP BETWEEN EPIDERMAL GROWTH FACTOR-LIKE DOMAIN-4 AND DOMAIN-5 IS CRITICAL FOR HUMAN THROMBOMODULIN FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT HUMAN THROMBOMODULIN; PROTEIN-C ACTIVATION; STRUCTURAL-CHANGES; FACTOR-V; THROMBIN; BINDING; COFACTOR; CELLS; SITE; INACTIVATION	Thrombomodulin (TM) is a cofactor for activation of protein C by thrombin. We showed that 80-90% of this cofactor activity is lost by oxidation of Met388, located within the short interdomain loop between epidermal growth factor-like domains 4 and 5 (Glaser, C. B., Morser, J., Clarke, J. H., Blasko, E., McLean, K., Kuhn, I., Chang, R.-J., Lin, J.-H., Vilander, L., Andrews, W. H., and Light, D. R. (1992) J. Clin. Invest. 90, 2565-2573). For each of the 3 amino acids of the loop, site-specific mutants are described in which, 1) all possible single amino acid substitutions are made, 2) deletions are made, or 3) alanine is inserted adjacent to each residue of the loop. Most substitutions within the loop (38/57) result in a >50% decrease in cofactor activity, while changes in the length of this region result in >90% loss of activity. Only the Met388 --> Leu mutant has higher cofactor activity (2-fold) than wild-type TM. A number of soluble and full-length TM analogs with the Met388 --> Leu substitution are improved thrombin cofactors, whether produced in bacteria, insect, or mammalian cells. Detailed kinetic analysis of a soluble TM analog consisting of the six EGF-like domains secreted from insect cells shows that the enhanced activity of the Met388 --> Leu mutant results from an increased catalytic efficiency (k(cat)/K(m)). This enhancement is maximal at physiological concentrations of calcium. The loss of activity following Met388 oxidation in the wild-type protein is the result of both decreased binding to thrombin (K(d) effect) and a decreased interaction of the TM.thrombin complex with protein C (K(m) effect). We demonstrate the critical role of this interdomain loop in the biological anticoagulant properties of TM.	BERLEX BIOSCI,DEPT PROT CHEM,RICHMOND,CA 94804; BERLEX BIOSCI,DEPT CARDIOVASC RES,RICHMOND,CA 94804; BERLEX BIOSCI,DEPT MOLEC BIOL,RICHMOND,CA 94804									DITTMAN WA, 1988, J BIOL CHEM, V263, P15815; ESMON CT, 1992, ARTERIOSCLER THROMB, V12, P135, DOI 10.1161/01.ATV.12.2.135; Esmon N L, 1987, Dev Biol Stand, V67, P75; ESMON NL, 1982, J BIOL CHEM, V257, P859; Fersht AR., 1977, ENZYME STRUCTURE MEC; FULCHER CA, 1984, BLOOD, V63, P486; GLASER CB, 1992, J CLIN INVEST, V90, P2565, DOI 10.1172/JCI116151; GLASER CB, 1974, BIOCHEMISTRY-US, V13, P1044, DOI 10.1021/bi00702a033; HALKIER T, 1991, MECHANISMS BLOOD COA, P295; HAYASHI T, 1990, J BIOL CHEM, V265, P20156; JOHNSON AE, 1983, J BIOL CHEM, V258, P5554; KUROSAWA S, 1988, J BIOL CHEM, V263, P5993; KUROSAWA S, 1987, J BIOL CHEM, V262, P2206; MARUYAMA I, 1985, J BIOL CHEM, V260, P5432; MONTELIONE GT, 1987, P NATL ACAD SCI USA, V84, P5226, DOI 10.1073/pnas.84.15.5226; PARKINSON JF, 1990, J BIOL CHEM, V265, P12602; PARKINSON JF, 1992, BIOCHEM BIOPH RES CO, V185, P567, DOI 10.1016/0006-291X(92)91662-A; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; SUZUKI K, 1987, EMBO J, V6, P1891, DOI 10.1002/j.1460-2075.1987.tb02448.x; SUZUKI K, 1983, J BIOL CHEM, V258, P1914; TSIANG M, 1992, J BIOL CHEM, V267, P6164; TSIANG M, 1990, BIOCHEMISTRY-US, V29, P10602, DOI 10.1021/bi00499a005; WEN DZ, 1987, BIOCHEMISTRY-US, V26, P4350, DOI 10.1021/bi00388a025; YE J, 1991, J BIOL CHEM, V266, P23016; YE J, 1992, J BIOL CHEM, V267, P11023; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3; ZUSHI M, 1991, J BIOL CHEM, V266, P19886; ZUSHI M, 1989, J BIOL CHEM, V264, P10351	28	59	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1993	268	9					6309	6315						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KT368	8384206				2022-12-27	WOS:A1993KT36800037
J	MERTENS, S; BENKE, D; MOHLER, H				MERTENS, S; BENKE, D; MOHLER, H			GABA(A) RECEPTOR POPULATIONS WITH NOVEL SUBUNIT COMBINATIONS AND DRUG-BINDING PROFILES IDENTIFIED IN BRAIN BY ALPHA-5-SUBUNIT-SPECIFIC AND DELTA-SUBUNIT-SPECIFIC IMMUNOPURIFICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; A-RECEPTOR; BENZODIAZEPINE RECEPTORS; RAT-BRAIN; ALPHA-SUBUNIT; SITES; SUBTYPES; ALPHA-1-SUBUNIT; HETEROGENEITY; LOCALIZATION	The pharmacological significance and structural basis of the gamma-aminobutyrate (GABA(A)) receptor heterogeneity was investigated in situ by an immunobiochemical analysis of receptor populations characterized by the delta- and alpha5-subunit. Using an antiserum specific for the delta-subunit, a population of GABA(A) receptors (21 +/- 2% of solubilized receptors) was immunoprecipitated from rat brain extracts which contained high affinity benzodiazepine binding sites. They were distinguished from those immunoprecipitated by the alpha1- and alpha3-subunit antisera by a 4-5-fold and 5-10-fold higher affinity for diazepam and betaCCM, respectively. Using the delta-antiserum in immunoaffinity chromatography the delta-subunit was found to be associated with the alpha1-, alpha3-, beta2/3-, and gamma2-subunits, suggesting that the latter conveys benzodiazepine receptor sensitivity also to GABA(A) receptors containing the delta-subunit. The receptor population immunoprecipitated by the alpha5-subunit antiserum (10 +/- 2% of receptors solubilized from whole brain extracts) was characterized by affinities for zolpidem, betaCCM, and CL 218872 which distinguished it from all other known receptor populations. The alpha5-subunit was associated with the alpha1-, alpha3-, beta2/3- and gamma2-subunits pointing to differential subunit combinations. Indeed, when receptor populations were immunoprecipitated by the alpha5-subunit antiserum from different brain regions, zolpidem displayed striking differences in affinity pointing to the role of subunits other than alpha5 in determining receptor affinity.	UNIV ZURICH, INST PHARMACOL, GLORIASTR 32, CH-8006 ZURICH, SWITZERLAND	University of Zurich								ARAKI T, 1992, MOL BRAIN RES, V12, P293, DOI 10.1016/0169-328X(92)90132-U; BENKE D, 1991, J RECEPTOR RES, V11, P407, DOI 10.3109/10799899109066418; BENKE D, 1991, FEBS LETT, V283, P145, DOI 10.1016/0014-5793(91)80573-L; BENKE D, 1991, J BIOL CHEM, V266, P4478; BENKE D, 1991, Molecular Neuropharmacology, V1, P103; CUTTING GR, 1991, P NATL ACAD SCI USA, V88, P2673, DOI 10.1073/pnas.88.7.2673; DUGGAN MJ, 1991, J BIOL CHEM, V266, P24778; DUGGAN MJ, 1992, J NEUROCHEM, V58, P72, DOI 10.1111/j.1471-4159.1992.tb09278.x; DUGGAN MJ, 1990, J BIOL CHEM, V265, P3831; EWERT M, 1990, J CELL BIOL, V110, P2043, DOI 10.1083/jcb.110.6.2043; FRITSCHY JM, 1992, P NATL ACAD SCI USA, V89, P6726, DOI 10.1073/pnas.89.15.6726; GUIDOTTI A, 1990, ADV BIOCHEM PSYCHOPH, V46, P73; HORSFALL AC, 1987, J IMMUNOL METHODS, V104, P43, DOI 10.1016/0022-1759(87)90485-6; KHRESTCHATISKY M, 1989, NEURON, V3, P745, DOI 10.1016/0896-6273(89)90243-2; KLEPNER CA, 1979, PHARMACOL BIOCHEM BE, V11, P457, DOI 10.1016/0091-3057(79)90125-4; KNOFLACH F, 1992, EUR J NEUROSCI, V4, P1, DOI 10.1111/j.1460-9568.1992.tb00103.x; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; MALHERBE P, 1990, FEBS LETT, V260, P261, DOI 10.1016/0014-5793(90)80118-3; MAMALAKI C, 1989, J NEUROCHEM, V52, P124, DOI 10.1111/j.1471-4159.1989.tb10906.x; MASSOTTI M, 1991, J PHARMACOL EXP THER, V256, P1154; MCKERNAN RM, 1991, NEURON, V7, P667, DOI 10.1016/0896-6273(91)90379-E; MCPHERSON GA, 1985, J PHARMACOL METHOD, V14, P213, DOI 10.1016/0160-5402(85)90034-8; MOHLER H, 1981, NATURE, V294, P763, DOI 10.1038/294763a0; MOHLER H, 1990, NEUROCHEM RES, V15, P199, DOI 10.1007/BF00972210; MOHLER H, 1984, EUR J PHARMACOL, V102, P191, DOI 10.1016/0014-2999(84)90358-3; MOHLER H, 1980, P NATL ACAD SCI-BIOL, V77, P1666, DOI 10.1073/pnas.77.3.1666; NIDDAM R, 1987, J NEUROCHEM, V49, P890, DOI 10.1111/j.1471-4159.1987.tb00977.x; NIELSEN M, 1980, NATURE, V286, P606, DOI 10.1038/286606a0; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; OLSEN RW, 1990, J CHEM NEUROANAT, V3, P59; POLLARD S, 1991, FEBS LETT, V295, P81, DOI 10.1016/0014-5793(91)81390-T; PRITCHETT DB, 1990, J NEUROCHEM, V54, P1802, DOI 10.1111/j.1471-4159.1990.tb01237.x; PRITCHETT DB, 1989, SCIENCE, V245, P1389, DOI 10.1126/science.2551039; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; PUIA G, 1991, MOL PHARMACOL, V39, P691; Richards G., 1991, SEMIN NEUROSCI, V3, P191; RICHARDS JG, 1986, NEUROLOGY NEUROBIOLO, V16, P629; RUANO D, 1992, J NEUROCHEM, V58, P485, DOI 10.1111/j.1471-4159.1992.tb09747.x; SCHOCH P, 1985, NATURE, V314, P168, DOI 10.1038/314168a0; SCHOCH P, 1983, EUR J PHARMACOL, V95, P323, DOI 10.1016/0014-2999(83)90656-8; SEEBURG PH, 1990, ADV BIOCHEM PSYCHOPH, V46, P15; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; SIEGHART W, 1980, NATURE, V286, P285, DOI 10.1038/286285a0; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; WILSONSHAW D, 1991, FEBS LETT, V284, P211, DOI 10.1016/0014-5793(91)80687-X; WISDEN W, 1992, J NEUROSCI, V12, P1040; ZEZULA J, 1991, FEBS LETT, V284, P15, DOI 10.1016/0014-5793(91)80750-W	47	173	173	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1993	268	8					5965	5973						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR822	8383681				2022-12-27	WOS:A1993KR82200090
J	WALTER, SA; PAPADOPOULOS, PG; BAKER, GM				WALTER, SA; PAPADOPOULOS, PG; BAKER, GM			FORMATION OF HIGH-SPIN CYTOCHROME-A IN ISOLATED CYTOCHROME-C-OXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRONIC STATE; HEAT-TREATMENT; SLOW FORMS; HEME; DERIVATIVES	The effect of temperature on the electronic structure of cytochromes a and a3 has been determined at two different concentrations of the solubilizing detergent, N-dodecyl beta-D-maltoside. In each case, an incubation temperature of 40-degrees-C resulted in a 20-30% increase in the 430-nm conformer of cytochrome a3 when compared with a 20-degrees-C control, but the higher detergent concentration led to additional formation of a new charge transfer band at 630 nm. Induction of this new feature was correlated with a loss of alpha-band intensity, a blue shift in the Soret absorbance, and a decrease in the Soret magnetic circular dichroism. The absorbance changes were associated with isosbestic wavelengths at 613, 581, 563, 453, and 416 nm, indicating a two-state electronic conversion. The loss of magnetic circular dichroism intensity and the lack of an isosbestic point between 630 and 655 nm were consistent with a selective effect on the electronic structure of ferricytochrome a. Comparison of these spectral changes with the model heme a studies of Carter and Palmer ( Carter, K., and Palmer, G. (1982) J. Biol. Chem. 257, 13507-13514) provides evidence for a low to high spin transition in cytochrome a in which one of the axial Fe-N bonds is either broken or sterically strained. This selective effect on cytochrome a and the associated thermal resistance of the a3-Cu(B) domain are discussed in terms of the 4-helix bundle motif that has been recently proposed for the catalytic site of cytochrome c oxidase.	NO ILLINOIS UNIV,DEPT CHEM,DE KALB,IL 60115	Northern Illinois University								BABCOCK GT, 1976, J BIOL CHEM, V251, P7907; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; BAKER GM, 1987, J BIOL CHEM, V262, P595; BAKER GM, 1987, BIOCHEMISTRY-US, V26, P3038, DOI 10.1021/bi00385a014; CARTER K, 1982, J BIOL CHEM, V257, P13507; HARTZELL CR, 1974, BIOCHIM BIOPHYS ACTA, V368, P318, DOI 10.1016/0005-2728(74)90178-9; HILL BC, 1988, BIOCHEMISTRY-US, V27, P4741, DOI 10.1021/bi00413a024; LEMMIEUX LJ, 1992, J BIOL CHEM, V267, P2105; LI PM, 1988, BIOCHEMISTRY-US, V27, P7538, DOI 10.1021/bi00419a054; MINAGAWA J, 1992, J BIOL CHEM, V267, P2096; MOODY AJ, 1991, BIOCHIM BIOPHYS ACTA, V1059, P189, DOI 10.1016/S0005-2728(05)80204-X; PALMER G, 1976, P NATL ACAD SCI USA, V73, P2206, DOI 10.1073/pnas.73.7.2206; PAPADOPOULOS PG, 1991, BIOCHEMISTRY-US, V30, P840, DOI 10.1021/bi00217a038; SARASTE M, 1990, Q REV BIOPHYS, V23, P331, DOI 10.1017/S0033583500005588; SARASTE M, 1991, BIOCHEM SOC T, V19, P608, DOI 10.1042/bst0190608; SCHOONOVER JR, 1988, BIOCHEMISTRY-US, V27, P5433, DOI 10.1021/bi00415a008; SHAPLEIGH JP, 1992, P NATL ACAD SCI USA, V89, P4786, DOI 10.1073/pnas.89.11.4786; SONE N, 1984, BIOCHEMISTRY-US, V23, P6550, DOI 10.1021/bi00321a042; TWEEDLE MF, 1978, J BIOL CHEM, V253, P8065; VANNESTE WH, 1966, BIOCHEMISTRY-US, V5, P838, DOI 10.1021/bi00867a005	20	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1993	268	7					4716	4719						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP884	8383123				2022-12-27	WOS:A1993KP88400027
J	DAVIDSON, HW; BALCH, WE				DAVIDSON, HW; BALCH, WE			DIFFERENTIAL INHIBITION OF MULTIPLE VESICULAR TRANSPORT STEPS BETWEEN THE ENDOPLASMIC-RETICULUM AND TRANS-GOLGI NETWORK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; SEMI-INTACT CELLS; YPT1 GENE-PRODUCT; PROTEIN-TRANSPORT; STOMATITIS-VIRUS; COMPLEMENTATION GROUPS; MOLECULAR-CLONING; FUSION PROTEIN; YEAST; GLYCOSYLATION	Using the glycoprotein of the tsO45 mutant of vesicular stomatitis virus (VSV-G) as a marker, we have developed a system capable of measuring vesicular transport from the endoplasmic reticulum (ER) to the trans Golgi network (TGN) in vitro. Movement from the ER to the cis Golgi compartment was assessed by the conversion of VSV-G from a totally endoglycosidase D (endo D)-resistant form to a species containing one endo D-resistant and one endo D-sensitive oligosaccharide (G(D1)). Similarly, delivery to the medial cisternae was measured by the appearance of the completely endo D-sensitive form of VSV-G (G(D2)) or by the acquisition of complete resistance to endoglycosidase H (endo H) (G(Hr)) and delivery to the TGN by the appearance of an endo H-resistant form of VSV-G which was sensitive to digestion with neuraminidase and subsequently beta-galactosidase (G(Ht)). Movement between each sequential compartment required ATP and soluble proteins (cytosol) and was inhibited by nonhydrolyzable analogues of GTP and by an antibody toward the N-ethylmaleimide-sensitive factor NSF. In contrast, fractionation of the cytosol by ammonium sulfate precipitation indicated that distinct proteins were required for movement between successive compartments. Similarly, inclusion of a mutant form of the small molecular weight GTP-binding protein rab1A inhibited movement between the ER and cis Golgi, and between the cis and medial cisternae, but did not affect transport from the medial Golgi to the TGN. Conversely, the protein kinase inhibitor staurosporine prevented movement between the medial Golgi and the TGN but did not influence transport between the ER and early Golgi compartments. This study provides the first demonstration that vesicular transport between the ER and TGN can be reconstituted in a cytosol-dependent fashion in vitro, allowing a direct analysis of the roles of individual components in multiple transport events.	SCRIPPS RES INST, DEPT MOLEC BIOL, LA JOLLA, CA 92037 USA	Scripps Research Institute	DAVIDSON, HW (corresponding author), SCRIPPS RES INST, DEPT CELL BIOL, LA JOLLA, CA 92037 USA.				NATIONAL CANCER INSTITUTE [P01CA027489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042336, R01GM033301] Funding Source: NIH RePORTER; NCI NIH HHS [CA27489] Funding Source: Medline; NIGMS NIH HHS [GM42336, GM33301] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; BALCH WE, 1990, TRENDS BIOCHEM SCI, V15, P473, DOI 10.1016/0968-0004(90)90301-Q; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BALCH WE, 1989, J BIOL CHEM, V264, P16965; BECKERS CJM, 1989, NATURE, V339, P397, DOI 10.1038/339397a0; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; BECKERS CJM, 1987, CELL, V50, P523, DOI 10.1016/0092-8674(87)90025-0; BERGMANN JE, 1989, METHOD CELL BIOL, V32, P85; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; BOURNE HR, 1988, CELL, V53, P669, DOI 10.1016/0092-8674(88)90081-5; CHAVRIER P, 1990, MOL CELL BIOL, V10, P6578, DOI 10.1128/MCB.10.12.6578; CHEGE NW, 1990, J CELL BIOL, V111, P893, DOI 10.1083/jcb.111.3.893; CLARY DO, 1990, J BIOL CHEM, V265, P10109; DAVIDSON HW, 1992, J CELL BIOL, V116, P1343, DOI 10.1083/jcb.116.6.1343; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; ETCHISON JR, 1977, VIROLOGY, V78, P375, DOI 10.1016/0042-6822(77)90115-5; FARQUHAR MG, 1985, ANNU REV CELL BIOL, V1, P447, DOI 10.1146/annurev.cb.01.110185.002311; FLAMAND A, 1970, J GEN VIROL, V8, P187, DOI 10.1099/0022-1317-8-3-187; GOTTLIEB C, 1975, J BIOL CHEM, V250, P3303; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; GOUD B, 1991, Current Opinion in Cell Biology, V3, P626, DOI 10.1016/0955-0674(91)90033-U; GRAHAM TR, 1991, J CELL BIOL, V114, P207, DOI 10.1083/jcb.114.2.207; GRIFF IC, 1992, J BIOL CHEM, V267, P12106; HART GW, 1989, ANNU REV BIOCHEM, V58, P841; HAUBRUCK H, 1989, EMBO J, V8, P1427, DOI 10.1002/j.1460-2075.1989.tb03524.x; HERMAN PK, 1991, CELL, V64, P425, DOI 10.1016/0092-8674(91)90650-N; HIRSCHBERG CB, 1987, ANNU REV BIOCHEM, V56, P63, DOI 10.1146/annurev.bi.56.070187.000431; HUBBARD SC, 1988, J BIOL CHEM, V263, P19303; HUNT LA, 1983, ARCH BIOCHEM BIOPHYS, V226, P347, DOI 10.1016/0003-9861(83)90301-6; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LUCOCQ J, 1991, J CELL SCI, V100, P753; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; MELLMAN I, 1992, CELL, V68, P829, DOI 10.1016/0092-8674(92)90027-A; MIZUOCHI T, 1984, J BIOCHEM-TOKYO, V95, P1209, DOI 10.1093/oxfordjournals.jbchem.a134711; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; OHASHI M, 1991, EXP CELL RES, V197, P168, DOI 10.1016/0014-4827(91)90419-U; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; PLUTNER H, 1992, J CELL BIOL, V119, P1097, DOI 10.1083/jcb.119.5.1097; PRYER NK, 1992, ANNU REV BIOCHEM, V61, P471; ROTH J, 1985, CELL, V43, P287, DOI 10.1016/0092-8674(85)90034-0; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; ROTHMAN JE, 1987, J BIOL CHEM, V262, P12502; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; RUOHOLA H, 1988, J CELL BIOL, V107, P1465, DOI 10.1083/jcb.107.4.1465; SCHANBAC.FL, 1970, J BIOL CHEM, V245, P5057; SCHMITT HD, 1988, CELL, V53, P635, DOI 10.1016/0092-8674(88)90579-X; SCHWANINGER R, 1991, J BIOL CHEM, V266, P13055; SCHWANINGER R, 1992, J CELL BIOL, V119, P1077, DOI 10.1083/jcb.119.5.1077; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SIMONS K, 1987, EMBO J, V6, P2241, DOI 10.1002/j.1460-2075.1987.tb02496.x; TARENTINO AL, 1974, J BIOL CHEM, V249, P811; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; TOUCHOT N, 1987, P NATL ACAD SCI USA, V84, P8210, DOI 10.1073/pnas.84.23.8210; TULSIANI DRP, 1982, J BIOL CHEM, V257, P7936; TUOMIKOSKI T, 1989, NATURE, V342, P942, DOI 10.1038/342942a0; TURCO SJ, 1982, J BIOL CHEM, V257, P8674; WALTER M, 1986, SCIENCE, V233, P649, DOI 10.1126/science.3487832; WILSON DW, 1989, NATURE, V339, P355, DOI 10.1038/339355a0; WOODMAN PG, 1992, J CELL BIOL, V116, P331, DOI 10.1083/jcb.116.2.331	61	96	97	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					4216	4226						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382697				2022-12-27	WOS:A1993KN53300061
J	KIRKNESS, EF; FRASER, CM				KIRKNESS, EF; FRASER, CM			A STRONG PROMOTER ELEMENT IS LOCATED BETWEEN ALTERNATIVE EXONS OF A GENE ENCODING THE HUMAN GAMMA-AMINOBUTYRIC ACID-TYPE-A RECEPTOR BETA-3 SUBUNIT (GABRB3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABAA RECEPTOR; TRANSCRIPTION INITIATION; MESSENGER-RNAS; MOLECULAR-BIOLOGY; REGION; EXPRESSION; DISTINCT; BINDING; PEPTIDE; CHROMOSOME-15	The gene that encodes the beta3 subunit of the gamma-aminobutyrate-Type A (GABA(A)) receptor is widely expressed in brain tissue and has been associated with imprinted genetic disorders. Here, the 5' regions of the human and rat genes were characterized and found to be highly conserved in both coding and non-coding sequences. A novel transcript of the human gene revealed the existence of an alternative exon 1 (exon 1a) that encodes a variant signal sequence. Relative levels of the alternative transcripts were found to vary between fetal and adult brain, and between different brain regions. Endogenous beta3 subunit transcripts were also detected in several immortalized cell lines, including human kidney 293 cells. Transcription of exon 1 is initiated from multiple sites within a pyrimidine-rich region of the gene. This region of the human gene also exhibits strong promoter activity and binds nuclear factors at a site which overlaps the transcriptional start sites. The promoter element was shown to bind Sp1 and at least one other unidentified nuclear factor.	NIAAA, NEUROGENET LAB, MOLEC NEUROBIOL SECT, ROCKVILLE, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)				Fraser, Claire/0000-0003-1462-2428				ABMAYR SM, 1991, CURRENT PROTOCOLS MO; BRENOWITZ M, 1991, CURRENT PROTOCOLS MO; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BUCHSTALLER A, 1991, FEBS LETT, V287, P27, DOI 10.1016/0014-5793(91)80008-Q; BURT DR, 1991, FASEB J, V5, P2916, DOI 10.1096/fasebj.5.14.1661244; CASALOTTI SO, 1986, J BIOL CHEM, V261, P5013; CHELLY J, 1990, NATURE, V344, P64, DOI 10.1038/344064a0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DENG L, 1986, BIOCHEM BIOPH RES CO, V138, P1308, DOI 10.1016/S0006-291X(86)80425-9; DOERFLER W, 1990, FEBS LETT, V268, P329, DOI 10.1016/0014-5793(90)81280-2; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; EWERT M, 1990, J CELL BIOL, V110, P2043, DOI 10.1083/jcb.110.6.2043; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; Frohman M.A., 1990, PCR PROTOCOLS GUIDE, P28; FUJITA K, 1989, ENVIRON HEALTH PERSP, V80, P127, DOI 10.2307/3430738; FUNK CD, 1989, P NATL ACAD SCI USA, V86, P2587, DOI 10.1073/pnas.86.8.2587; GAMBARANA C, 1991, NEUROSCIENCE, V45, P423, DOI 10.1016/0306-4522(91)90238-J; HALES TG, 1992, MOL PHARMACOL, V42, P197; HARIHARAN N, 1990, P NATL ACAD SCI USA, V87, P1526, DOI 10.1073/pnas.87.4.1526; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; KINGSTON RE, 1991, CURRENT PROTOCOLS MO; KIRKNESS EF, 1991, GENOMICS, V10, P985, DOI 10.1016/0888-7543(91)90189-L; KIRKNESS EF, 1989, BIOCHEM J, V259, P613, DOI 10.1042/bj2590613; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; LAFYATIS R, 1991, NUCLEIC ACIDS RES, V19, P6419, DOI 10.1093/nar/19.23.6419; LASHAM A, 1991, J NEUROCHEM, V57, P352, DOI 10.1111/j.1471-4159.1991.tb02135.x; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; LOLAIT SJ, 1989, FEBS LETT, V246, P145, DOI 10.1016/0014-5793(89)80271-6; LUO XC, 1989, P NATL ACAD SCI USA, V86, P4042, DOI 10.1073/pnas.86.11.4042; MANGIN M, 1989, P NATL ACAD SCI USA, V86, P2408, DOI 10.1073/pnas.86.7.2408; MEANS AL, 1990, MOL CELL BIOL, V10, P653, DOI 10.1128/MCB.10.2.653; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; MULLER M, 1992, EXPERIENTIA, V48, P118; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; OSHEAGREENFIELD A, 1992, J BIOL CHEM, V267, P1391; POLLARD S, 1991, FEBS LETT, V295, P81, DOI 10.1016/0014-5793(91)81390-T; PRITCHETT DB, 1988, SCIENCE, V242, P1306, DOI 10.1126/science.2848320; ROEDER RG, 1991, TRENDS BIOCHEM SCI, V16, P402, DOI 10.1016/0968-0004(91)90164-Q; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; SAITOH S, 1992, LANCET, V339, P366, DOI 10.1016/0140-6736(92)91686-3; SAITTA B, 1992, J BIOL CHEM, V267, P6188; Sambrook J, 1989, MOL CLONING LABORATO; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SOMMER B, 1990, DNA CELL BIOL, V9, P561, DOI 10.1089/dna.1990.9.561; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; WAGSTAFF J, 1991, AM J HUM GENET, V49, P330; WAGSTAFF J, 1991, GENOMICS, V11, P1071, DOI 10.1016/0888-7543(91)90034-C; WISDEN W, 1992, J NEUROSCI, V12, P1040; YMER S, 1989, EMBO J, V8, P1665, DOI 10.1002/j.1460-2075.1989.tb03557.x; ZELENT A, 1991, EMBO J, V10, P71, DOI 10.1002/j.1460-2075.1991.tb07922.x; ZHANG JH, 1991, J COMP NEUROL, V308, P586, DOI 10.1002/cne.903080407	57	92	96	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					4420	4428						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382702				2022-12-27	WOS:A1993KN53300088
J	PACAUD, P; LOIRAND, G; GREGOIRE, G; MIRONNEAU, C; MIRONNEAU, J				PACAUD, P; LOIRAND, G; GREGOIRE, G; MIRONNEAU, C; MIRONNEAU, J			NORADRENALINE-ACTIVATED HEPARIN-SENSITIVE CA2+ ENTRY AFTER DEPLETION OF INTRACELLULAR CA2+ STORE IN PORTAL-VEIN SMOOTH-MUSCLE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CALCIUM RELEASE; ACINAR-CELLS; TRISPHOSPHATE; 1,3,4,5-TETRAKISPHOSPHATE; CA-2+; THAPSIGARGIN; PHOSPHATES; METABOLISM; MECHANISM	Single portal vein smooth muscle cells were voltage-clamped using the whole cell patch-clamp technique. Intracellular free Ca2+ concentration ([Ca2+]i) was simultaneously monitored using the fluorescence from the dye indo-1. Noradrenaline (NA, 10 muM) evoked a transient increase in [Ca2+]i, due to inositol 1,4,5-trisphosphate (InsP3)-induced Ca2+ release, followed by a sustained increase in [Ca2+]i, caused by extracellular Ca2+ entry. This phase was maintained as long as NA was present and was never observed when the agonist was only briefly applied (3 s). Neither ryanodine, nor caffeine produced the Ca2+ influx whereas the complete depletion of intracellular Ca2+ pool in the absence of external Ca2+ allowed, when Ca2+ was readmitted, the activation of the Ca2+ entry which was used to replenish Ca2+ store. During NA stimulation, the Ca2+ entry was activated even if the Ca2+ pool had not been totally emptied. The Ca2+ entry pathway involved was blocked by Ni2+ and Mn2+, was not permeable to these ions, and was more sensitive to heparin than the InsP3-induced Ca2+ release. Thus, the complete depletion of Ca2+ store activates a Ca2+ influx which is modulated by NA such as in its presence, a partial depletion is enough to induce Ca2+ entry.			PACAUD, P (corresponding author), UNIV BORDEAUX 2,PHYSIOL CELLULAIRE & PHARMACOL MOLEC LAB,CNRS,URA 1489,F-33076 BORDEAUX,FRANCE.		Pacaud, Pierre/D-6392-2015; Loirand, Gervaise/K-1834-2014	Loirand, Gervaise/0000-0002-2306-3931				ALMERS W, 1985, FEBS LETT, V192, P13, DOI 10.1016/0014-5793(85)80033-8; BARON A, 1991, PFLUG ARCH EUR J PHY, V419, P553, DOI 10.1007/BF00370294; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BIRD GS, 1991, NATURE, V352, P162, DOI 10.1038/352162a0; CHANGYA L, 1989, FEBS LETT, V251, P43, DOI 10.1016/0014-5793(89)81425-5; CULLEN PJ, 1990, BIOCHEM J, V271, P549, DOI 10.1042/bj2710549; ELY JA, 1990, BIOCHEM J, V268, P333, DOI 10.1042/bj2680333; FERRIS CD, 1992, NATURE, V356, P350, DOI 10.1038/356350a0; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FERRIS CD, 1991, ANN REV PHYSL, V54, P465; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUILLEMETTE G, 1989, MOL PHARMACOL, V35, P339; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; HUANG CL, 1991, J BIOL CHEM, V266, P4045; HUGHES AR, 1988, J BIOL CHEM, V263, P10314; HWANG KS, 1987, PFLUG ARCH EUR J PHY, V408, P343, DOI 10.1007/BF00581127; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; IVORRA I, 1991, BIOCHEM J, V273, P317, DOI 10.1042/bj2730317; JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081; LOESSBERG PA, 1991, J BIOL CHEM, V266, P1363; LOIRAND G, 1992, J BIOL CHEM, V267, P4312; LOW AM, 1991, J PHARMACOL EXP THER, V258, P1105; LUCKHOFF A, 1992, NATURE, V355, P356, DOI 10.1038/355356a0; MISSIAEN L, 1992, NATURE, V357, P599, DOI 10.1038/357599a0; MORRIS AP, 1987, NATURE, V330, P653, DOI 10.1038/330653a0; MUALLEM S, 1988, AM J PHYSIOL, V255, pG229, DOI 10.1152/ajpgi.1988.255.2.G229; MUALLEM S, 1989, J BIOL CHEM, V264, P205; MURRAY RK, 1991, J PHYSIOL-LONDON, V435, P123, DOI 10.1113/jphysiol.1991.sp018501; PACAUD P, 1991, J PHYSIOL-LONDON, V441, P477, DOI 10.1113/jphysiol.1991.sp018763; PACAUD P, 1992, PFLUG ARCH EUR J PHY, V421, P125, DOI 10.1007/BF00374818; PACAUD P, 1991, BRIT J PHARMACOL, V104, P1000, DOI 10.1111/j.1476-5381.1991.tb12540.x; PACAUD P, 1992, J PHYSIOL-LONDON, V456, P541, DOI 10.1113/jphysiol.1992.sp019352; PARKER I, 1990, SCIENCE, V250, P977, DOI 10.1126/science.2237441; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; PUTNEY JW, 1987, TRENDS PHARMACOL SCI, V8, P481, DOI 10.1016/0165-6147(87)90043-5; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; SMITH PM, 1992, BIOCHEM J, V283, P27, DOI 10.1042/bj2830027; TEPIKIN AV, 1992, J BIOL CHEM, V267, P3569; VANBREEMEN C, 1989, ANNU REV PHYSIOL, V51, P315, DOI 10.1146/annurev.physiol.51.1.315	40	75	75	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					3866	3872						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382680				2022-12-27	WOS:A1993KN53300015
J	RHODES, CJ; THORNE, BA; LINCOLN, B; NIELSEN, E; HUTTON, JC; THOMAS, G				RHODES, CJ; THORNE, BA; LINCOLN, B; NIELSEN, E; HUTTON, JC; THOMAS, G			PROCESSING OF PROOPIOMELANOCORTIN BY INSULIN SECRETORY GRANULE PROINSULIN PROCESSING ENDOPEPTIDASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE PROOPIOMELANOCORTIN; PRO-OPIOMELANOCORTIN; MAMMALIAN-CELLS; ATT20 CELLS; PROHORMONE; CDNA; YEAST; KEX2; EXPRESSION; PROALBUMIN	A lysed preparation of isolated insulin secretory granules efficiently cleaved murine proopiomelanocortin (mPOMC) at physiologically important Lys-Arg processing sites. This processing was mostly attributed to an activity that co-eluted with the proinsulin processing type-II endopeptidase from anion exchange chromatography (Lys-Arg-directed; Davidson, H. W., Rhodes, C. J., and Hutton, J. C. (1988) Nature 333, 93-96). The principal peptide hormone products generated by the insulin secretory granule lysate were identified by specific radioimmunoassay and NH2-terminal microsequencing analysis of high performance liquid chromatography-separated products as alpha-melanocyte-stimulating hormone, corticotropin-like intermediate, gamma-lipotropin, beta-endorphin-(1-31), 18-kDa NH2-terminal fragment and, to a lesser extent, adrenocorticotrophin and beta-lipotropin. This processing had an acidic pH optimum (pH 5-5.5) and was Ca2+-dependent (K0.5 activation = 5-80 muM). With increasing Ca2+ concentrations there was an increase in the extent to which mPOMC was processed. The in vitro processing of mPOMC by the insulin secretory granule endopeptidase activity reported here is in excellent agreement with the in vivo processing of this prohormone by a combination of PC2 and PC3, candidates of prohormone endpeptidase, in gene transfer studies with cells that express the regulated secretory pathway (Thomas, L., Leduc, R., Thorne, B. A., Smeekens, S. S., Steiner, D. F., and Thomas, G. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 5297-5301).	NOVO NORDISK,NOVO ALLE 28800,DENMARK; OREGON HLTH SCI UNIV,VOLLUM INST,PORTLAND,OR 97201; UNIV CAMBRIDGE,ADDENBROOKES HOSP,DEPT CLIN BIOCHEM,CAMBRIDGE CB2 2QR,ENGLAND; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Oregon Health & Science University; Addenbrooke's Hospital; University of Cambridge; Harvard University; Harvard Medical School	RHODES, CJ (corresponding author), BRIGHAM & WOMENS HOSP,JOSLIN DIABET CTR,EP JOSLIN RES LAB,1 JOSLIN PL,BOSTON,MA 02115, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037274, P30DK036836] Funding Source: NIH RePORTER; NCRR NIH HHS [BRGS07RR05673] Funding Source: Medline; NIDDK NIH HHS [P30 DK036836, DK37274, DK36836, R01 DK037274] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission)		BAILYES EM, 1992, BIOCHEM J, V285, P391, DOI 10.1042/bj2850391; BAILYES EM, 1991, ENZYME, V45, P301, DOI 10.1159/000468903; BATHURST IC, 1987, SCIENCE, V235, P348, DOI 10.1126/science.3541206; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BENNETT DL, 1992, J BIOL CHEM, V267, P15229; BOND JS, 1987, ANNU REV BIOCHEM, V56, P333, DOI 10.1146/annurev.bi.56.070187.002001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN SO, 1988, FEBS LETT, V229, P167, DOI 10.1016/0014-5793(88)80819-6; CHICK WL, 1977, P NATL ACAD SCI USA, V74, P628, DOI 10.1073/pnas.74.2.628; DAVIDSON HW, 1988, NATURE, V333, P93, DOI 10.1038/333093a0; DOCHERTY K, 1982, ANNU REV PHYSIOL, V44, P625, DOI 10.1146/annurev.ph.44.030182.003205; DOCHERTY K, 1989, J BIOL CHEM, V264, P18335; DOUGLASS J, 1984, ANNU REV BIOCHEM, V53, P665; EDWARDS K, 1976, BIOCHEM BIOPH RES CO, V72, P310, DOI 10.1016/0006-291X(76)90995-5; EDWARDS R, 1990, PEPTIDE HORMONE SECR, P71; FULLER RS, 1988, ANNU REV PHYSIOL, V50, P345, DOI 10.1146/annurev.ph.50.030188.002021; Hutton JC, 1990, CURR OPIN CELL BIOL, V2, P1131, DOI 10.1016/0955-0674(90)90167-D; HUTTON JC, 1989, DIABETOLOGIA, V32, P271, DOI 10.1007/BF00265542; HUTTON JC, 1982, DIABETOLOGIA, V23, P365; IKEHARA Y, 1976, BIOCHEM BIOPH RES CO, V72, P319, DOI 10.1016/0006-291X(76)90996-7; LINDBERG I, 1991, PEPTIDE BIOSYTHESIS, P00141; LOH YP, 1984, ANNU REV NEUROSCI, V7, P189, DOI 10.1146/annurev.ne.07.030184.001201; MOORE HPH, 1983, CELL, V35, P531, DOI 10.1016/0092-8674(83)90187-3; NJUS D, 1986, BIOCHIM BIOPHYS ACTA, V853, P237, DOI 10.1016/0304-4173(87)90003-6; OLSON TS, 1988, J BIOL CHEM, V263, P7342; ORCI L, 1985, DIABETOLOGIA, V28, P528, DOI 10.1007/BF00281987; RHODES CJ, 1989, BIOCHEM J, V258, P305, DOI 10.1042/bj2580305; RHODES CJ, 1992, J BIOL CHEM, V267, P22719; RHODES CJ, 1987, J CELL BIOL, V105, P145, DOI 10.1083/jcb.105.1.145; RHODES CJ, 1989, J BIOL CHEM, V264, P14240; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHNABEL E, 1989, MOL ENDOCRINOL, V3, P1223, DOI 10.1210/mend-3-8-1223; SEIDAH NG, 1991, MOL ENDOCRINOL, V5, P111, DOI 10.1210/mend-5-1-111; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; SHENNAN KIJ, 1991, FEBS LETT, V284, P277, DOI 10.1016/0014-5793(91)80703-6; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; SMITH AI, 1988, ENDOCR REV, V9, P159, DOI 10.1210/edrv-9-1-159; STORER AC, 1976, BIOCHEM J, V159, P1; THIM L, 1986, P NATL ACAD SCI USA, V83, P6766, DOI 10.1073/pnas.83.18.6766; THOMAS G, 1988, ANNU REV PHYSIOL, V50, P323; THOMAS G, 1988, SCIENCE, V241, P226, DOI 10.1126/science.3291117; THOMAS L, 1991, P NATL ACAD SCI USA, V88, P5297, DOI 10.1073/pnas.88.12.5297; THORNE BA, 1989, J BIOL CHEM, V264, P3545; THORNE BA, 1990, J BIOL CHEM, V265, P8436; THORNE BA, 1991, J BIOL CHEM, V266, P13607; TOOZE J, 1987, J CELL BIOL, V105, P155, DOI 10.1083/jcb.105.1.155; UHLER M, 1983, J BIOL CHEM, V258, P257	49	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					4267	4275						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382698				2022-12-27	WOS:A1993KN53300067
J	WU, DQ; JIANG, HP; KATZ, A; SIMON, MI				WU, DQ; JIANG, HP; KATZ, A; SIMON, MI			IDENTIFICATION OF CRITICAL REGIONS ON PHOSPHOLIPASE-C-BETA-1 REQUIRED FOR ACTIVATION BY G-PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SUBUNITS; DIVERSITY	In order to determine which portion of phosphoinositide-specific phospholipase C (PLC)-beta1 is required for activation by Galphaq, a series of specific deletions and truncations of PLC-beta1 cDNA were prepared. After transfection of COS-7 cells with these cDNA clones, the activity and localization of the expressed proteins were determined. Specific deletions in the C-terminal end of the protein did not lead to loss of intrinsic enzymatic activity but did result in loss of the ability to be activated by Galphaq. The region required for activation was localized to the amino acid sequence corresponding to residues 903-1142 of PLC-beta1. This region was further subdivided into two sequences; one extending from residues Thr-903 to Gln-1030 that was required for particulate fraction association as well as for activation by Galphaq and the other extending from residues Gln-1030 to Leu-1142 that was required for interaction with G alpha subunits. These results were confirmed by the observation that the C-terminal portion of PLC-beta1, when co-expressed with the muscarinic acetylcholine receptor type 1 or the alpha1C-adrenergic receptor in COS-7 cells, markedly inhibited ligand-induced release of inositol phosphates. In an in vitro system, two peptides derived from the G-protein interaction region at the C terminus were found to inhibit the guanosine 5'-3-O-(thio)triphosphate-dependent activation of PLC-beta1 by Galphaq. This further localized the sites on PLC-beta1 which are involved in interaction with G-protein alpha subunits.	CALTECH, DIV BIOL, PASADENA, CA 91125 USA	California Institute of Technology			Katz, Arieh/F-5836-2012		NIGMS NIH HHS [GM34236] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034236, R01GM034236] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMATRUDA TT, 1991, P NATL ACAD SCI USA, V88, P5587, DOI 10.1073/pnas.88.13.5587; BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BRISTOL A, 1988, COLD SPRING HARB SYM, V53, P915, DOI 10.1101/SQB.1988.053.01.105; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; FOECKING MK, 1986, GENE, V45, P101, DOI 10.1016/0378-1119(86)90137-X; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; KATAN M, 1988, CELL, V54, P171, DOI 10.1016/0092-8674(88)90549-1; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; KRIZ R, 1990, CIBA F SYMP, V150, P112; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CH, 1992, J BIOL CHEM, V267, P16044; MORRISON DF, 1987, FEBS LETT, V222, P266, DOI 10.1016/0014-5793(87)80383-6; NAKAMURA F, 1991, J BIOL CHEM, V266, P12676; OSAWA S, 1990, CELL, V63, P697, DOI 10.1016/0092-8674(90)90136-3; PARK D, 1992, J BIOL CHEM, V267, P16048; RHEE SG, 1991, METHOD ENZYMOL, V197, P502; RHEE SG, 1991, TRENDS BIOCHEM SCI, V16, P297, DOI 10.1016/0968-0004(91)90122-C; RHEE SG, 1992, J BIOL CHEM, V267, P12393; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; SUH PG, 1988, CELL, V54, P161, DOI 10.1016/0092-8674(88)90548-X; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; WAHL MI, 1989, P NATL ACAD SCI USA, V86, P1568, DOI 10.1073/pnas.86.5.1568; WALDO GL, 1991, J BIOL CHEM, V266, P14217; WILKIE TM, 1991, P NATL ACAD SCI USA, V88, P10049, DOI 10.1073/pnas.88.22.10049; WU DQ, 1992, J BIOL CHEM, V267, P25798; WU DQ, 1992, J BIOL CHEM, V267, P1811	30	170	170	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3704	3709						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381437				2022-12-27	WOS:A1993KM16100102
J	SUGIMOTO, Y; NEGISHI, M; HAYASHI, Y; NAMBA, T; HONDA, A; WATABE, A; HIRATA, M; NARUMIYA, S; ICHIKAWA, A				SUGIMOTO, Y; NEGISHI, M; HAYASHI, Y; NAMBA, T; HONDA, A; WATABE, A; HIRATA, M; NARUMIYA, S; ICHIKAWA, A			2 ISOFORMS OF THE EP3 RECEPTOR WITH DIFFERENT CARBOXYL-TERMINAL DOMAINS - IDENTICAL LIGAND-BINDING PROPERTIES AND DIFFERENT COUPLING PROPERTIES WITH G(I) PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BETA-2-ADRENERGIC RECEPTOR; COLLECTING TUBULE CELLS; PERTUSSIS-TOXIN; GUANINE-NUCLEOTIDES; ADENYLATE-CYCLASE; MESSENGER-RNA; PROSTAGLANDIN-E2; EXPRESSION; NEUROTRANSMISSION; VASOPRESSIN	Functional cDNA clones for two isoforms of the mouse prostaglandin E receptor EP3 subtype derived from alternative RNA splicing were obtained. The two isoforms are only different in the sequence of the putative cytoplasmic carboxyl-terminal tail and their hydrophobicity; one isoform, named EP3alpha, has a hydrophilic tail, and the other, named EP3beta, has a hydrophobic tail. When expressed, the two receptors displayed identical ligand binding properties but different responses to guanosine 5'-O-(3-thiotriphosphate) (GTPgammaS). Without a change in the B(max) value, GTPgammaS increased K(d) for prostaglandin E2 of EP3beta and decreased that of EP3alpha. These effects were abolished by the treatment of membranes with pertussis toxin and restored by the addition of G(i2). Although both isoforms exerted inhibition of forskolin-induced cAMP accumulation, three orders lower concentrations of agonists were required for EP3alpha than EP3beta for 50% inhibition of cAMP formation. A similar difference in agonist potency was observed also for agonist-induced stimulation of GTPase activity in membranes. Thus, the two receptors with different carboxyl-terminal tails show different coupling to the G(i) protein, leading to the opposite responses to GTP in the ligand binding affinity and to different affinities of the agonist-occupied receptors to the G proteins.	KYOTO UNIV,FAC PHARMACEUT SCI,DEPT PHYSIOL CHEM,KYOTO 606,JAPAN; KYOTO UNIV,FAC MED,DEPT PHARMACOL,KYOTO 606,JAPAN	Kyoto University; Kyoto University			Hayashi, Yasunori/C-2249-2008; Hayashi, Yasunori/AAF-1408-2019; Sugimoto, Yukihiko/AAV-6470-2021	Hayashi, Yasunori/0000-0002-7560-3004; Hayashi, Yasunori/0000-0002-7560-3004; Sugimoto, Yukihiko/0000-0001-6973-932X				ARMSTRONG RA, 1990, ADV PROSTAGLANDIN TH, V21, P375; ASANO T, 1985, J BIOL CHEM, V260, P2653; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; CHEN MCY, 1988, GASTROENTEROLOGY, V94, P1121, DOI 10.1016/0016-5085(88)90002-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLEMAN RA, 1989, COMPREHENSIVE MED CH, V3, P643; DALTOSO R, 1989, EMBO J, V8, P4025, DOI 10.1002/j.1460-2075.1989.tb08585.x; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; GARCIAPEREZ A, 1984, J CLIN INVEST, V74, P63, DOI 10.1172/JCI111419; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GIROS B, 1989, NATURE, V342, P923, DOI 10.1038/342923a0; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRANDT R, 1982, MOL PHARMACOL, V22, P320; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HALUSHKA PV, 1989, ANNU REV PHARMACOL, V29, P213; HEDQVIST P, 1972, NEUROPHARMACOLOGY, V11, P177, DOI 10.1016/0028-3908(72)90090-1; HIRATA M, 1991, NATURE, V349, P617, DOI 10.1038/349617a0; KRALL JF, 1984, J ENDOCRINOL, V102, P329, DOI 10.1677/joe.0.1020329; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEFKOWITZ RJ, 1988, J BIOL CHEM, V263, P4993; LU ZD, 1988, J CELL PHYSIOL, V136, P1, DOI 10.1002/jcp.1041360102; MELIEN O, 1988, EUR J BIOCHEM, V172, P293, DOI 10.1111/j.1432-1033.1988.tb13886.x; MONCADA S, 1985, PHARMACOL BASIS THER, P660; MONSMA FJ, 1989, NATURE, V342, P926, DOI 10.1038/342926a0; MORISHITA R, 1989, BIOCHEM BIOPH RES CO, V161, P1280, DOI 10.1016/0006-291X(89)91381-8; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NAKAJIMA Y, 1992, J BIOL CHEM, V267, P2437; NAMBA T, 1992, BIOCHEM BIOPH RES CO, V184, P1197, DOI 10.1016/S0006-291X(05)80009-9; NEGISHI M, 1987, J BIOL CHEM, V262, P12077; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; OHIA SE, 1990, J PHARMACOL EXP THER, V255, P11; OIKAWA S, 1989, BIOCHEM BIOPH RES CO, V164, P39, DOI 10.1016/0006-291X(89)91679-3; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; RICHELSEN B, 1985, ENDOCRINOLOGY, V16, P1182; RICHELSEN B, 1984, J LIPID RES, V26, P127; ROBERTSON RP, 1983, ENDOCRINOLOGY, V113, P1732, DOI 10.1210/endo-113-5-1732; SAMBROOK J, 1989, MOL CLONING LABORATO, P2108; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; SONNENBURG WK, 1988, J BIOL CHEM, V263, P6155; SUGIMOTO Y, 1992, J BIOL CHEM, V267, P6463; SUSSMAN DJ, 1984, MOL CELL BIOL, V4, P1641, DOI 10.1128/MCB.4.8.1641; TORIKAI S, 1983, AM J PHYSIOL, V245, pF58, DOI 10.1152/ajprenal.1983.245.1.F58; URLAUB G, 1980, P NATL ACAD SCI-BIOL, V77, P4216, DOI 10.1073/pnas.77.7.4216; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; WATANABE T, 1986, J BIOL CHEM, V261, P3430; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032	49	219	230	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2712	2718						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8381413				2022-12-27	WOS:A1993KK81500068
J	JOSLIN, G; WITTWER, A; ADAMS, S; TOLLEFSEN, DM; AUGUST, A; PERLMUTTER, DH				JOSLIN, G; WITTWER, A; ADAMS, S; TOLLEFSEN, DM; AUGUST, A; PERLMUTTER, DH			CROSS-COMPETITION FOR BINDING OF ALPHA-1-ANTITRYPSIN (ALPHA-1 AT)-ELASTASE COMPLEXES TO THE SERPIN-ENZYME COMPLEX RECEPTOR BY OTHER SERPIN-ENZYME COMPLEXES AND BY PROTEOLYTICALLY MODIFIED ALPHA-1 AT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE PLASMINOGEN-ACTIVATOR; ENDOTHELIAL-CELL MONOLAYERS; HUMAN HEPATOMA-CELLS; ALPHA-1-PROTEINASE INHIBITOR; NEUTROPHIL CHEMOATTRACTANT; SEC RECEPTOR; HUMAN-PLASMA; ELASTASE; IDENTIFICATION; PURIFICATION	The serpin-enzyme complex (SEC) receptor recognizes a pentapeptide neo-domain of alpha1-antitrypsin (alpha1 AT)-elastase complexes and, in so doing, mediates internalization and intracellular catabolism of the macromolecular complex, mediates an increase in synthesis of alpha1 AT, and elicits neutrophil chemotactic activity. In previous studies we have shown that this pentapeptide domain is highly conserved among members of the serpin family and that binding of a synthetic peptide corresponding to this region (I-125-peptide 105Y, SIPPEVKFNKPFVYLI, based on alpha1 AT sequence 359-374) to HepG2 cells is blocked by several serpin-enzyme complexes. To determine whether the SEC receptor is the primary HepG2 cell surface binding site for these serpin-enzyme complexes, we examined the capacity for serpin-enzyme complexes to compete with each other for binding to the SEC receptor. The results indicate that binding of I-125-elastase-alpha1 AT complexes is blocked by thrombin-antithrombin III (ATIII), thrombin-heparin cofactor II, and cathepsin G-alpha1-antichymotrypsin (alpha1 ACT) complexes. Moreover, unlabeled elastase-alpha1 AT complexes compete for binding of I-125-thrombin-ATIII, I-125-thrombin-heparin cofactor II, and I-125-cathepsin G-alpha1 ACT complexes. Preformed soluble tissue plasminogen activator-plasminogen activator inhibitor 1 complexes also compete for binding of elastase-alpha1 AT complexes to the SEC receptor but do so to a less effective extent, probably because of a less favorable pentapeptide sequence for binding to the SEC receptor. Under conditions in which these serpin-enzyme complexes would be expected to bind to the SEC receptor there is an increase in synthesis of alpha1 AT but not in synthesis of ATIII or alpha1 ACT. Proteolytically modified alpha1 AT also competes for binding of I-125-elastase-alpha1 AT complexes to the SEC receptor and vice versa. The purified 51-kDa amino-terminal fragment of alpha1 AT does not compete for binding of I-125-elastase-alpha1 AT complexes, indicating that the pentapeptide neo-domain in the 4-kDa carboxyl-terminal fragment is sufficient for binding to the SEC receptor.	WASHINGTON UNIV, SCH MED, DEPT PEDIAT, 400 S KINGSHIGHWAY BLVD, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT INTERNAL MED, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT CELL BIOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT PHYSIOL, ST LOUIS, MO 63110 USA; MONSANTO CO, DEPT BIOL SCI, ST LOUIS, MO 63167 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Monsanto					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD007409] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037784, P50HL014147] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-14147, HL37784] Funding Source: Medline; NICHD NIH HHS [HD07409] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BANDA MJ, 1988, J EXP MED, V167, P1608, DOI 10.1084/jem.167.5.1608; BANDA MJ, 1988, J BIOL CHEM, V263, P4481; BARBEYMOREL C, 1991, PEDIATR RES, V29, P133, DOI 10.1203/00006450-199102000-00005; DEBOER HC, 1992, J BIOL CHEM, V267, P2264; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; JOHNSON D, 1978, J BIOL CHEM, V253, P7142; JOSLIN G, 1991, J BIOL CHEM, V266, P11282; JOSLIN G, 1991, J BIOL CHEM, V266, P21897; JOSLIN G, 1992, J CLIN INVEST, V90, P1150, DOI 10.1172/JCI115934; KURDOWSKA A, 1990, J BIOL CHEM, V265, P21023; MAST AE, 1991, BIOCHEMISTRY-US, V30, P1723, DOI 10.1021/bi00220a039; MATHESON NR, 1991, J BIOL CHEM, V266, P13489; MORTON PA, 1990, J BIOL CHEM, V265, P14093; OLSON D, 1992, J BIOL CHEM, V267, P9129; PAREKH RB, 1989, BIOCHEMISTRY-US, V28, P7644, DOI 10.1021/bi00445a021; PERLMUTTER DH, 1988, J CLIN INVEST, V81, P1774, DOI 10.1172/JCI113519; PERLMUTTER DH, 1990, J BIOL CHEM, V265, P16713; PERLMUTTER DH, 1990, P NATL ACAD SCI USA, V87, P3753, DOI 10.1073/pnas.87.10.3753; PERLMUTTER DH, 1991, HEPATOLOGY, V13, P172, DOI 10.1002/hep.1840130125; PERLMUTTER DH, 1989, ANN NY ACAD SCI, V557, P332; PERLMUTTER DH, 1989, J CLIN INVEST, V84, P138, DOI 10.1172/JCI114133; POTEMPA J, 1991, J BIOL CHEM, V266, P21482; RAMAKRISHNAN V, 1990, J BIOL CHEM, V265, P2755; ROLDAN AL, 1990, EMBO J, V9, P467, DOI 10.1002/j.1460-2075.1990.tb08132.x; RUSSELL ME, 1990, J BIOL CHEM, V265, P2569; SANZO MA, 1987, BIOCHEMISTRY-US, V26, P7443, DOI 10.1021/bi00397a037; TOLLEFSEN DM, 1982, J BIOL CHEM, V257, P2162; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; WEISS SJ, 1989, NEW ENGL J MED, V320, P365	30	66	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1886	1893						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380581				2022-12-27	WOS:A1993KH62000060
J	DALTON, MB; SWANEY, JB				DALTON, MB; SWANEY, JB			STRUCTURAL AND FUNCTIONAL DOMAINS OF APOLIPOPROTEIN-A-I WITHIN HIGH-DENSITY-LIPOPROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRADIENT GEL-ELECTROPHORESIS; LIVER PLASMA-MEMBRANES; MONOCLONAL-ANTIBODIES; AMPHIPATHIC HELIX; BINDING-PROTEINS; APOA-I; CHOLESTEROL; CONFORMATION; RAT; PHOSPHATIDYLCHOLINE	We prepared discoidal and spherical model high density lipoprotein (HDL) with apolipoprotein A-I and 1-palmitoyl-2-oleoyl phosphatidylcholine at various lipid:protein ratios and compared their reactivity with exo- and endopeptidases to that of human HDL2 and HDL3. Limited proteolysis with trypsin, Staphylococcus V8 protease, and elastase yielded a major stable peptide of 11,000-11,500 daltons under conditions which completely degraded lipid-free A-I. By Western blotting this protease-resistant fragment was shown to consist of the amino-terminal 90-100 residues of the A-I protein; the residues on the carboxyl side of this peptide are therefore protease-sensitive and appear to correlate with the putative ''hinge'' region, which is especially reactive with antibodies. The amino terminus was very resistant to digestion with a variety of aminopeptidases, whereas carboxypeptidases could remove up to 70 residues from the lipid-free A-I protein or 12-24 residues from A-I in various HDL. When these truncated forms of A-I, in combination with lipid, were used to examine binding interactions with rat hepatic plasma membranes, it was found that removal of up to 20-24 residues from the carboxyl terminus had no significant effect on binding, whereas removal of 70 residues completely eliminated specific binding to the membranes. Taken together, our data indicate that there is a protease-resistant domain constituted by the first 90 residues of A-I, which, in HDL, contain little of the class of amphipathic helix characteristic of the rest of the molecule and most likely form a structure dominated by protein-protein interactions. At the carboxyl end of the protein, there is a functional domain constituted by residues 149-219 that possesses the capacity to bind to proteins on hepatic membranes.	HAHNEMANN UNIV,DEPT BIOL CHEM,MS411,PHILADELPHIA,PA 19102	Drexel University					NHLBI NIH HHS [HL 33827] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033827] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLAIN CC, 1974, CLIN CHEM, V20, P470; ALLAN CM, 1992, J BIOL CHEM, V267, P13257; ALLANC M, 1993, BIOCHEM J, V290, P449; BLANCHE PJ, 1981, BIOCHIM BIOPHYS ACTA, V665, P408, DOI 10.1016/0005-2760(81)90253-8; BONOMO EA, 1988, J LIPID RES, V29, P380; BRASSEUR R, 1990, BIOCHIM BIOPHYS ACTA, V1043, P245, DOI 10.1016/0005-2760(90)90023-Q; BROUILLETTE CG, 1984, BIOCHEMISTRY-US, V23, P359, DOI 10.1021/bi00297a027; CASTRO GR, 1988, BIOCHEMISTRY-US, V27, P25, DOI 10.1021/bi00401a005; CHACKO GK, 1982, BIOCHIM BIOPHYS ACTA, V712, P129, DOI 10.1016/0005-2760(82)90094-7; CHEN GC, 1986, METHOD ENZYMOL, V128, P519; CHEN GC, 1991, J BIOL CHEM, V266, P12581; CHEUNG MC, 1987, J LIPID RES, V28, P913; COLLET X, 1991, J BIOL CHEM, V266, P9145; CURTISS LK, 1988, J BIOL CHEM, V263, P13779; EDELSTEIN C, 1986, METHOD ENZYMOL, V128, P151; FIELDING C J, 1981, Proceedings of the National Academy of Sciences of the United States of America, V78, P3911, DOI 10.1073/pnas.78.6.3911; Fleischer S, 1974, Methods Enzymol, V31, P6; GLOMSET JA, 1968, J LIPID RES, V9, P155; GRAHAM DL, 1987, J BIOL CHEM, V262, P7439; GWYNNE J, 1975, J BIOL CHEM, V250, P2269; HARA H, 1992, BIOCHEMISTRY-US, V31, P2040, DOI 10.1021/bi00122a021; HIDAKA H, 1992, BIOCHEM J, V284, P161, DOI 10.1042/bj2840161; HUI DY, 1981, J BIOL CHEM, V256, P5646; ISHIDA BY, 1987, J LIPID RES, V28, P778; JACKSON RL, 1972, BIOCHEM BIOPH RES CO, V49, P1444, DOI 10.1016/0006-291X(72)90501-3; JENG I, 1980, BIOCHEM BIOPH RES CO, V92, P876, DOI 10.1016/0006-291X(80)90784-6; JONAS A, 1990, J BIOL CHEM, V265, P22123; JONAS A, 1989, J BIOL CHEM, V264, P4818; JONAS A, 1986, METHOD ENZYMOL, V128, P553; KUNITAKE ST, 1985, J LIPID RES, V26, P549; KUNITAKE ST, 1990, ARTERIOSCLEROSIS, V10, P25, DOI 10.1161/01.ATV.10.1.25; KUNITAKE ST, 1990, J BIOL CHEM, V265, P20739; LEBLOND L, 1991, J BIOL CHEM, V266, P6058; LUX SE, 1972, J BIOL CHEM, V247, P2598; MARCEL YL, 1991, J BIOL CHEM, V266, P3644; MARCOVINA S, 1990, J LIPID RES, V31, P375; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MATHAI D, 1990, ARTERIOSCLEROSIS, V10, P1045, DOI 10.1161/01.ATV.10.6.1045; MCFARLANE AS, 1964, MAMMALIAN PROTEIN ME, P331; MCKNIGHT GL, 1992, J BIOL CHEM, V267, P12131; MILTHORP P, 1986, HUMAN APOLIPOPROTEIN, P103; MORRISON J, 1991, J BIOL CHEM, V266, P18780; MORRISON JR, 1992, J BIOL CHEM, V267, P13205; PITTMAN RC, 1987, J BIOL CHEM, V262, P2435; RIFICI VA, 1984, J BIOL CHEM, V259, P3814; ROHEIM PS, 1971, BIOCHIM BIOPHYS ACTA, V248, P315, DOI 10.1016/0005-2760(71)90020-8; SCANU AM, 1971, ANAL BIOCHEM, V44, P576, DOI 10.1016/0003-2697(71)90247-8; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHONFELD G, 1976, J BIOL CHEM, V251, P3921; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; SEGREST JP, 1992, J LIPID RES, V33, P141; SHORE VG, 1978, BIOCHIM BIOPHYS ACTA, V529, P319, DOI 10.1016/0005-2760(78)90075-9; SOKOLOFF L, 1974, P SOC EXP BIOL MED, V146, P1166; SRINIVAS RV, 1991, J CELL BIOCHEM, V45, P224, DOI 10.1002/jcb.240450214; SWANEY JB, 1983, J LIPID RES, V24, P245; SWANEY JB, 1976, BIOCHIM BIOPHYS ACTA, V446, P561, DOI 10.1016/0005-2795(76)90027-1; SWANEY JB, 1980, J BIOL CHEM, V255, P877; SWANEY JB, 1978, J BIOL CHEM, V253, P4069; TOZUKA M, 1989, BIOCHEM J, V261, P239, DOI 10.1042/bj2610239; VANLOO B, 1991, J LIPID RES, V32, P1253; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240	62	66	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19274	19283						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366078				2022-12-27	WOS:A1993LW81900022
J	KUBICEK, CP; MESSNER, R; GRUBER, F; MANDELS, M; KUBICEKPRANZ, EM				KUBICEK, CP; MESSNER, R; GRUBER, F; MANDELS, M; KUBICEKPRANZ, EM			TRIGGERING OF CELLULASE BIOSYNTHESIS BY CELLULOSE IN TRICHODERMA-REESEI - INVOLVEMENT OF A CONSTITUTIVE, SOPHOROSE-INDUCIBLE, GLUCOSE-INHIBITED BETA-DIGLUCOSIDE PERMEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALLS; SYSTEM; ENDOGLUCANASE; CELLOBIOSE; SECRETION; TRANSPORT; MECHANISM; GENES	We prepared [U-C-14]cellobiose by cultivating Acetobacter pasteurianus in the presence of [U-C-14]glucose and hydrolyzing the [U-C-14]cellulose formed with beta-glucosidase-free cellulase from Trichoderma reesei. This C-14-labeled cellobiose was used to investigate the presence of an uptake system for cellobiose in T. reesei. Evidence was obtained for the presence of a high affinity (K(m) for cellobiose 0.3 muM) but low activity (2.5 milliunits/mg fungal dry weight) cellobiose permease. The permease is formed constitutively, but higher levels are formed after addition of sophorose (glucosyl-beta-1,2-diglucoside), a reputed cellulase inducer. The permease appears to be specific for beta-diglucosides, as the uptake of [U-C-14]cellobiose is inhibited by sophorose, gentiobiose (glucosyl-,beta-1,3-glucoside), and cellobiose. Under these conditions, cellooligodextrines (n, 4-7; final concentration, 1 mM) are not inhibitors. Glucose, but no other monosaccharides, inhibits the permease. The hypersecretory mutant T. reesei RUT C-30 exhibits elevated permease activities, whereas in T. reesei QM 9979, a mutant strain defective in the induction of cellulases by cellulose or sophorose, strongly reduced permease activities were demonstrated. The results stress a hitherto not recognized point of control in the induction of cellulases by T. reesei at the level of uptake of cellulose oligosaccharides.	USA,NATICK RES & DEV LABS,NATICK,MA 01760		KUBICEK, CP (corresponding author), VIENNA TECH UNIV,MIKROBIELLE BIOCHEM ABT,INST BIOCHEM TECHNOL & MIKROBIOL,A-1060 VIENNA,AUSTRIA.							BISARIA VS, 1989, CRIT REV BIOTECHNOL, V9, P61, DOI 10.3109/07388558909040616; CHIRICO J, 1987, EUR J BIOCHEM, V165, P342; CLAEYSSENS M, 1990, BIOCHEM J, V270, P251, DOI 10.1042/bj2700251; DELAFUENTE G, 1962, BIOCHIM BIOPHYS ACTA, V56, P49, DOI 10.1016/0006-3002(62)90526-7; DICKSON RC, 1983, J BACTERIOL, V154, P1245, DOI 10.1128/JB.154.3.1245-1251.1983; ELGOGARY S, 1989, P NATL ACAD SCI USA, V86, P6138, DOI 10.1073/pnas.86.16.6138; FORNG ER, 1989, APPL ENVIRON MICROB, V55, P1317, DOI 10.1128/AEM.55.5.1317-1319.1989; FREER SN, 1990, J BIOL CHEM, V265, P12864; FRITSCHER C, 1990, EXP MYCOL, V14, P405, DOI 10.1016/0147-5975(90)90063-Y; GHOSH A, 1984, ARCH MICROBIOL, V140, P126, DOI 10.1007/BF00454914; HOFER F, 1989, BIOCHIM BIOPHYS ACTA, V992, P298, DOI 10.1016/0304-4165(89)90088-3; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; KENNEDY JF, 1979, STARKE, V31, P235, DOI 10.1002/star.19790310707; KOLBE J, 1990, APPL MICROBIOL BIOT, V34, P266; KUBICEK CP, 1987, J GEN MICROBIOL, V133, P1481; KUBICEK CP, 1981, EUR J APPL MICROBIOL, V13, P226, DOI 10.1007/BF00500103; KUBICEK CP, 1988, J GEN MICROBIOL, V134, P1215; KUBICEK CP, 1993, ENZYME MICROB TECH, V15, P90, DOI 10.1016/0141-0229(93)90030-6; MANDELS M, 1978, PROCESS BIOCHEM, V13, P6; MANDELS M, 1960, J BACTERIOL, V79, P816, DOI 10.1128/JB.79.6.816-826.1960; MESSNER R, 1991, ARCH MICROBIOL, V155, P601, DOI 10.1007/BF00245356; MESSNER R, 1990, ENZYME MICROB TECH, V12, P685, DOI 10.1016/0141-0229(90)90008-E; PENTTILA M, 1991, APPLIED MOL GENETICS, P85; SCHMID G, 1987, BIOTECHNOL BIOENG, V360, P571; SCHNETZ K, 1987, J BACTERIOL, V169, P2579, DOI 10.1128/jb.169.6.2579-2590.1987; STERNBERG D, 1979, J BACTERIOL, V139, P1321; UMILE C, 1986, FEMS MICROBIOL LETT, V34, P291; VAHERI M, 1979, BIOTECHNOL LETT, V1, P41, DOI 10.1007/BF01395789	28	75	83	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19364	19368						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366083				2022-12-27	WOS:A1993LW81900035
J	MCCLAIN, WH				MCCLAIN, WH			IDENTITY OF ESCHERICHIA-COLI TRANSFER RNA(CYS) DETERMINED BY NUCLEOTIDES IN 3 REGIONS OF TRANSFER-RNA TERTIARY STRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE TRANSFER-RNA; ACCEPTOR IDENTITY; SEQUENCE; GENES; SITE	The in vivo aminoacylation specificity of tRNA(Cys) was studied with mutants of opal and amber suppressor tRNAs in Escherichia coli. This specificity depends not only on nucleotides in the acceptor end and anticodon of tRNA(Cys) but also on nucleotides in the dihydrouridine stem and loop and the variable loop that interact, forming the complex core of tRNA tertiary structure.			MCCLAIN, WH (corresponding author), UNIV WISCONSIN,DEPT BACTERIOL,MADISON,WI 53706, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042123] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM42123] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CAVARELLI J, 1993, FASEB J, V7, P79, DOI 10.1096/fasebj.7.1.8422978; CELIS JE, 1973, NATURE-NEW BIOL, V244, P261, DOI 10.1038/newbio244261a0; CROTHERS DM, 1972, P NATL ACAD SCI USA, V69, P3063, DOI 10.1073/pnas.69.10.3063; FRANCKLYN C, 1992, SCIENCE, V255, P1121, DOI 10.1126/science.1546312; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; LADNER JE, 1975, P NATL ACAD SCI USA, V72, P4414, DOI 10.1073/pnas.72.11.4414; MASSON JM, 1986, GENE, V47, P179, DOI 10.1016/0378-1119(86)90061-2; MAZZARA GP, 1977, J MOL BIOL, V117, P1061, DOI 10.1016/S0022-2836(77)80013-2; MCCLAIN WH, 1990, P NATL ACAD SCI USA, V87, P9260, DOI 10.1073/pnas.87.23.9260; MCCLAIN WH, 1988, SCIENCE, V242, P1681, DOI 10.1126/science.2462282; MCCLAIN WH, 1991, P NATL ACAD SCI USA, V88, P6147, DOI 10.1073/pnas.88.14.6147; MCCLAIN WH, 1991, P NATL ACAD SCI USA, V88, P9272, DOI 10.1073/pnas.88.20.9272; MCCLAIN WH, 1988, J MOL BIOL, V202, P697, DOI 10.1016/0022-2836(88)90551-7; MCCLAIN WH, 1987, J MOL BIOL, V194, P6305; MILLER JH, 1983, J MOL BIOL, V164, P59, DOI 10.1016/0022-2836(83)90087-6; NICHOLAS HB, 1987, COMPUT APPL BIOSCI, V3, P53; NORMANLY J, 1986, P NATL ACAD SCI USA, V83, P6548, DOI 10.1073/pnas.83.17.6548; PALLANCK L, 1992, J BIOL CHEM, V267, P7221; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; SCHULMAN LH, 1988, SCIENCE, V240, P1591, DOI 10.1126/science.2454505; SMITH JD, 1973, NATURE-NEW BIOL, V243, P66; SPRINZL M, 1989, NUCLEIC ACIDS RES, V17, pR1, DOI 10.1093/nar/17.1.1; WAWROUSEK EF, 1984, J BIOL CHEM, V259, P3694; YARUS M, 1972, NATURE-NEW BIOL, V239, P106, DOI 10.1038/newbio239106a0	25	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19398	19402						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366087				2022-12-27	WOS:A1993LW81900040
J	SCHATZLE, J; BUSH, J; DHARMAWARDHANE, S; FIRTEL, RA; GOMER, RH; CARDELLI, J				SCHATZLE, J; BUSH, J; DHARMAWARDHANE, S; FIRTEL, RA; GOMER, RH; CARDELLI, J			CHARACTERIZATION OF THE SIGNAL-TRANSDUCTION PATHWAYS AND CIS-ACTING DNA-SEQUENCE RESPONSIBLE FOR THE TRANSCRIPTIONAL INDUCTION DURING GROWTH AND DEVELOPMENT OF THE LYSOSOMAL ALPHA-MANNOSIDASE GENE IN DICTYOSTELIUM-DISCOIDEUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWING-CELLS; CYCLIC-AMP; MOLECULAR-CLONING; PROTEIN-SYNTHESIS; EXPRESSION; DENSITY; RECEPTOR; MOTILITY	The lysosomal alpha-mannosidase gene in Dictyostelium discoideum is representative of a small group of genes that are expressed under two different conditions: 1) immediately upon removal of the bacterial food source from exponentially growing cells at <5 x 10(5) cells/ml (which also initiates the developmental cycle), and 2) when the concentration of a secreted glycoprotein termed the prestarvation response factor (PSF) reaches a critical threshold in cultures growing at densities >5 x 10(5) cells/ml. In this report we show that transcription of the alpha-mannosidase gene induced by starvation did not require protein synthesis in axenic wild-type strains, whereas protein synthesis was required for the transcriptional induction observed in response to PSF. Northern blot analysis was also done using mRNA from Galpha1 and Galpha2 gene disruption mutants. These genes encode subunits of heterotrimeric G proteins found at the cell surface in growing cells and cells early in development. The pattern of alpha-mannosidase gene expression was normal in these mutants as well as in mutants unable to produce the secreted glycoprotein conditioned medium factor or the cAMP receptor-1 protein. These genes have been shown to regulate the expression of many genes during early development. Promoter analysis studies identified a 145-base pair sequence element containing a TTG box which was required for alpha-mannosidase transcriptional induction under both starvation conditions and in response to PSF. The TTG box identified is an important regulatory element in the promoter of another prestarvation response gene, the discoidin Igamma gene. A ts mutant was found to misregulate the expression of both discoidin I and alpha-mannosidase expression at restrictive temperatures. Taken together these results suggest that the prestarvation response genes may be coordinately regulated possibly through the TTG box.	LOUISIANA STATE UNIV,MED CTR,DEPT MICROBIOL & IMMUNOL,1501 KINGS HIGHWAY,POB 33932,SHREVEPORT,LA 71130; UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093; RICE UNIV,DEPT BIOCHEM,HOUSTON,TX 77251	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of California System; University of California San Diego; Rice University				Gomer, Richard/0000-0003-2361-4307	NIDDK NIH HHS [DK39232-04] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039232, R29DK039232] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BISWAS S, 1984, MOL CELL BIOL, V4, P1035, DOI 10.1128/MCB.4.6.1035; BLUSCH J, 1992, NUCLEIC ACIDS RES, V20, P6235, DOI 10.1093/nar/20.23.6235; BUMANN J, 1984, J CELL BIOL, V98, P173, DOI 10.1083/jcb.98.1.173; CLARKE M, 1987, DIFFERENTIATION, V34, P79, DOI 10.1111/j.1432-0436.1987.tb00053.x; CLARKE M, 1987, METHOD CELL BIOL, V28, P157; CLARKE M, 1988, DEV GENET, V9, P315, DOI 10.1002/dvg.1020090413; CLARKE M, 1992, DEV BIOL, V152, P403, DOI 10.1016/0012-1606(92)90147-9; DEVINE JM, 1982, CELL, V28, P793, DOI 10.1016/0092-8674(82)90058-7; GOMER RH, 1985, COLD SPRING HARB SYM, V50, P801, DOI 10.1101/SQB.1985.050.01.098; GRABEL L, 1978, DEV BIOL, V64, P203, DOI 10.1016/0012-1606(78)90072-6; JAIN R, 1992, GENE DEV, V6, P390, DOI 10.1101/gad.6.3.390; KAYMAN SC, 1988, GENETICS, V118, P425; Kimmel AR, 1991, CURR OPIN GENET DEV, V1, P383, DOI 10.1016/S0959-437X(05)80304-1; KUMAGAI A, 1991, J BIOL CHEM, V266, P1220; LACOMBE ML, 1986, J BIOL CHEM, V261, P6811; LIVI GP, 1985, DEV BIOL, V110, P514, DOI 10.1016/0012-1606(85)90110-1; Loomis WF., 1975, DICTYOSTELIUM DISCOI; MANGIAROTTI G, 1982, DEV BIOL, V89, P82, DOI 10.1016/0012-1606(82)90296-2; MANN SKO, 1987, MOL CELL BIOL, V7, P458, DOI 10.1128/MCB.7.1.458; MANN SKO, 1989, P NATL ACAD SCI USA, V86, P1924, DOI 10.1073/pnas.86.6.1924; MATO JM, 1977, FEBS LETT, V79, P331, DOI 10.1016/0014-5793(77)80814-4; MEHDY MC, 1985, MOL CELL BIOL, V5, P705, DOI 10.1128/MCB.5.4.705; MILNE JL, 1991, J CELL BIOL, V112, P103, DOI 10.1083/jcb.112.1.103; OHALLORAN TJ, 1992, J CELL BIOL, V118, P1371, DOI 10.1083/jcb.118.6.1371; RATHI A, 1991, DEV GENET, V12, P82, DOI 10.1002/dvg.1020120115; SCHATZLE J, 1991, MOL CELL BIOL, V11, P3339, DOI 10.1128/MCB.11.6.3339; SCHATZLE J, 1992, J BIOL CHEM, V267, P4000; SINGLETON CK, 1988, MOL CELL BIOL, V8, P10, DOI 10.1128/MCB.8.1.10; SINGLETON CK, 1988, DEV BIOL, V129, P140, DOI 10.1016/0012-1606(88)90168-6; STEEL LF, 1987, MOL CELL BIOL, V7, P965, DOI 10.1128/MCB.7.3.965; SUN TJ, 1991, GENE DEV, V5, P572, DOI 10.1101/gad.5.4.572; VAUTI F, 1990, MOL CELL BIOL, V10, P4080, DOI 10.1128/MCB.10.8.4080; YUEN IS, 1991, DEVELOPMENT, V113, P1375	33	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19632	19639						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366107				2022-12-27	WOS:A1993LW81900075
J	CARLSTEDT, I; HERRMANN, A; KARLSSON, H; SHEEHAN, J; FRANSSON, LA; HANSSON, GC				CARLSTEDT, I; HERRMANN, A; KARLSSON, H; SHEEHAN, J; FRANSSON, LA; HANSSON, GC			CHARACTERIZATION OF 2 DIFFERENT GLYCOSYLATED DOMAINS FROM THE INSOLUBLE MUCIN COMPLEX OF RAT SMALL-INTESTINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; CERVICAL-MUCUS GLYCOPROTEINS; MOLECULAR-CLONING; GAS-CHROMATOGRAPHY; MACROMOLECULAR PROPERTIES; MUCOUS GLYCOPROTEINS; SUBMAXILLARY MUCIN; OLIGOSACCHARIDES; CONSERVATION; POLYMORPHISM	The highly glycosylated domains of rat small intestinal mucins were isolated after reduction and trypsin digestion and separated into two populations (A and B) by gel chromatography. The molecular mass values were 650 and 335 kDa, respectively, and the relative yields suggest that the two glycopeptides occur in equimolar proportions. Electron microscopy revealed linear structures with weight average lengths of 230 nm (A) and 110 nm (B) corresponding to a mass/unit length of about 3 kDa/nm. The protein cores (17-19%) contain large amounts of threonine (over 40%), serine (17-24%), and proline (18-19%). Carbohydrate and sulfate account for approximately 80 and 0.5%, respectively, and gas chromatography-mass spectrometry showed that the patterns of neutral and sialic acid-containing glycans are very similar in the two glycopeptides. Both contain a significant amount (7-10 mol %) of single GalNAc residues, the average oligosaccharide is about 4 sugar residues long, and the largest species observed are heptasaccharides. The major neutral and sialic acid-containing oligosaccharides are Fuc1-2Gal1-3GalNAcol and GlcNAc1-6(NeuGc2-Gal1-3)Ga1NAcol, respectively. Sialic acid is present as both N-acetyl- and N-glycoloyl-neuraminic acid. Repeated extractions of the tissue with guanidinium chloride left approximately 80% of the mucus glycoproteins as an insoluble glycoprotein complex whereas exposure to dithiothreitol or high speed homogenization accomplished complete solubilization. The ''subunits'' obtained after reduction with dithiothreitol are larger than glycopeptides A and B, and fragments corresponding in size to the latter are obtained after cleavage with trypsin. Most of the mucins from rat small intestine thus occurs as an insoluble glycoprotein complex composed of subunits joined with disulfide bonds. The subunits contain two highly glycosylated regions with different lengths substituted with very similar oligosaccharides.	UNIV GOTHENBURG, DEPT MED BIOCHEM, S-41390 GOTHENBURG, SWEDEN; UNIV MANCHESTER, DEPT BIOCHEM & MOLEC BIOL, MANCHESTER M13 9PT, LANCS, ENGLAND	University of Gothenburg; University of Manchester	CARLSTEDT, I (corresponding author), LUND UNIV, DEPT PHYSIOL CHEM 2, POB 94, S-22100 LUND, SWEDEN.		Hansson, Gunnar C/A-1236-2009; Hansson, Gunnar C./AAF-7324-2019	Hansson, Gunnar C/0000-0002-1900-1869; Hansson, Gunnar C./0000-0002-1900-1869	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANTONOPOULOS CA, 1964, BIOCHIM BIOPHYS ACTA, V83, P1, DOI 10.1016/0926-6526(64)90045-X; BREIMER ME, 1980, FEBS LETT, V114, P51, DOI 10.1016/0014-5793(80)80859-3; CARLSSON HE, 1978, CARBOHYD RES, V64, P181, DOI 10.1016/S0008-6215(00)83699-X; CARLSTEDT I, 1985, ESSAYS BIOCHEM, V20, P40; CARLSTEDT I, 1984, CIBA F SYMP, V109, P157, DOI 10.1002/9780470720905.ch11; CARLSTEDT I, 1983, BIOCHEM J, V213, P427, DOI 10.1042/bj2130427; CARLSTEDT I, 1983, BIOCHEM J, V211, P13, DOI 10.1042/bj2110013; CARLSTEDT I, 1982, ADV EXP MED BIOL, V144, P155; DAVIES JR, 1991, BIOCHEM J, V275, P663, DOI 10.1042/bj2750663; ECKHARDT AE, 1991, J BIOL CHEM, V266, P9678; FAHIM REF, 1987, BIOCHEM J, V243, P631, DOI 10.1042/bj2430631; GOA J, 1955, SCAND J CLIN LAB S22, V7, P19; GUM JR, 1990, BIOCHEM BIOPH RES CO, V171, P407, DOI 10.1016/0006-291X(90)91408-K; GUM JR, 1989, J BIOL CHEM, V264, P6480; GUM JR, 1991, J BIOL CHEM, V266, P22733; GUM JR, 1992, J BIOL CHEM, V267, P21375; HANSSON GC, 1990, METHOD ENZYMOL, V193, P733, DOI 10.1016/0076-6879(90)93447-S; HANSSON GC, 1991, CARBOHYD RES, V221, P179, DOI 10.1016/0008-6215(91)80055-R; HEINEGARD D, 1973, CHEM SCRIPTA, V4, P199; JOURDIAN GW, 1971, J BIOL CHEM, V246, P430; KARLSSON H, 1989, ANAL BIOCHEM, V182, P438, DOI 10.1016/0003-2697(89)90620-9; KARLSSON H, 1987, FEBS LETT, V226, P23, DOI 10.1016/0014-5793(87)80543-4; LARSON G, 1987, CARBOHYD RES, V161, P281, DOI 10.1016/S0008-6215(00)90085-5; LIGTENBERG MJL, 1990, J BIOL CHEM, V265, P5573; LOHMANDER LS, 1980, J BIOL CHEM, V255, P6084; MANTLE M, 1981, BIOCHEM J, V195, P267, DOI 10.1042/bj1950267; MARTENSSON S, 1988, SCAND J CLIN LAB INV, V48, P633, DOI 10.3109/00365518809085783; Neutra M.R., 1987, PHYSL GASTROINTESTIN, V2, P975; SHEEHAN JK, 1986, BIOCHEM J, V239, P147, DOI 10.1042/bj2390147; SHOGREN R, 1989, BIOCHEMISTRY-US, V28, P5525, DOI 10.1021/bi00439a029; SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006; SPICER AP, 1991, J BIOL CHEM, V266, P15099; THORNTON DJ, 1991, BIOCHEM J, V276, P667, DOI 10.1042/bj2760667; THORNTON DJ, 1990, BIOCHEM J, V265, P179, DOI 10.1042/bj2650179; VANHALBEEK H, 1983, BIOCHIM BIOPHYS ACTA, V747, P107, DOI 10.1016/0167-4838(83)90128-0; WANG YC, 1992, J BIOL CHEM, V267, P2728; WOLD JK, 1975, ACTA CHEM SCAND B, V29, P703, DOI 10.3891/acta.chem.scand.29b-0703; XU GQ, 1992, J BIOL CHEM, V267, P5401; YANG HJ, 1971, J BIOL CHEM, V246, P1192; 1992, COMPLEX CARBOHYDRATE	40	122	123	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18771	18781						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360170				2022-12-27	WOS:A1993LV65900063
J	GARCIA, AM; ROWELL, C; ACKERMANN, K; KOWALCZYK, JJ; LEWIS, MD				GARCIA, AM; ROWELL, C; ACKERMANN, K; KOWALCZYK, JJ; LEWIS, MD			PEPTIDOMIMETIC INHIBITORS OF RAS FARNESYLATION AND FUNCTION IN WHOLE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTEIN FARNESYLTRANSFERASE; TETRAPEPTIDE INHIBITORS; OOCYTE MATURATION; XENOPUS OOCYTES; TRANSFERASE; PRENYLATION	The ras protooncogene is involved in regulation of cell growth. Mutations that activate the protein result in uncontrolled cell growth. Ras undergoes a series of post-translational processing events, the first of which, farnesylation, is crucial for the function of the protein. Inhibitors of the farnesyltransferase enzyme are therefore potential candidates for the development of anticancer drugs. Tetrapeptides have been reported to be good inhibitors of this enzyme in vitro. We have synthesized analogs of the tetrapeptide Cys-Val-Phe-Met by replacement of the amino-terminal amide bonds. One inhibitor, B581, is permeable to the cell membrane. In the cell, it inhibits processing of two farnesylated proteins, H-ras and lamin A, but it does not inhibit processing of a geranylgeranylated protein, Rap 1A. Microinjection of B581 into frog oocytes inhibits maturation induced by activated, farnesylated H-ras but not maturation induced by activated, geranylgeranylated H-ras or by progesterone. These results demonstrate that this peptide mimic inhibits farnesylation selectively in the cell. The inhibition of farnesylation results in inhibition of H-ras function.			GARCIA, AM (corresponding author), EISAI RES INST,4 CORP DR,ANDOVER,MA 01810, USA.							BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BECK LA, 1988, J CELL BIOL, V107, P1307, DOI 10.1083/jcb.107.4.1307; BIRCHMEIER C, 1985, CELL, V43, P615, DOI 10.1016/0092-8674(85)90233-8; BROWN MS, 1992, P NATL ACAD SCI USA, V89, P8313, DOI 10.1073/pnas.89.17.8313; CHUNG DL, 1992, P NATL ACAD SCI USA, V89, P1993, DOI 10.1073/pnas.89.5.1993; COX A D, 1992, Critical Reviews in Oncogenesis, V3, P365; GIBBS JB, 1991, CELL, V65, P1, DOI 10.1016/0092-8674(91)90352-Y; GIBBS JB, 1993, J BIOL CHEM, V268, P7617; GOLDSTEIN JL, 1991, J BIOL CHEM, V266, P15575; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HARA M, 1993, P NATL ACAD SCI USA, V90, P2281, DOI 10.1073/pnas.90.6.2281; HORIUCHI H, 1991, J BIOL CHEM, V266, P16981; Kato K, 1992, Semin Cancer Biol, V3, P179; KIM R, 1990, MOL CELL BIOL, V10, P5945, DOI 10.1128/MCB.10.11.5945; LIU WC, 1992, J ANTIBIOT, V45, P454, DOI 10.7164/antibiotics.45.454; LUTZ RJ, 1992, P NATL ACAD SCI USA, V89, P3000, DOI 10.1073/pnas.89.7.3000; MIURA S, 1993, FEBS LETT, V318, P88, DOI 10.1016/0014-5793(93)81334-V; MOORES SL, 1991, J BIOL CHEM, V266, P14603; OMURA S, 1993, J ANTIBIOT, V46, P222, DOI 10.7164/antibiotics.46.222; REISS Y, 1991, P NATL ACAD SCI USA, V88, P732, DOI 10.1073/pnas.88.3.732; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; SASAKI Y, 1987, J MED CHEM, V30, P1162, DOI 10.1021/jm00390a008; SCHABER MD, 1990, J BIOL CHEM, V265, P14701; SCHAFER WR, 1989, SCIENCE, V245, P379, DOI 10.1126/science.2569235; SEABRA MC, 1991, CELL, V65, P429, DOI 10.1016/0092-8674(91)90460-G; SINENSKY M, 1993, FASEB J, V7, pA1040; SMITH LD, 1989, DEVELOPMENT, V107, P685; VANDERPYL D, 1992, J ANTIBIOT, V45, P1802	28	235	263	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18415	18418						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360140				2022-12-27	WOS:A1993LV65900005
J	NEWTON, AC; WILLIAMS, DS				NEWTON, AC; WILLIAMS, DS			RHODOPSIN IS THE MAJOR IN-SITU SUBSTRATE OF PROTEIN-KINASE-C IN ROD OUTER SEGMENTS OF PHOTORECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-DEPENDENT PHOSPHORYLATION; CALCIUM-SENSITIVE ACTIVATOR; ENDOGENOUS PHOSPHORYLATION; MEDIATED BREAKDOWN; RECEPTOR; DESENSITIZATION; PURIFICATION; RETINA; AUTOPHOSPHORYLATION; STIMULATION	Phorbol ester treatment of P-32-labeled retinas results in a light-dependent alteration in the phosphorylation state of rhodopsin. Previously we reported that phorbol myristate acetate causes an increase in the phosphorylation state of rhodopsin in retinas exposed to a brief flash of light, with the greatest increase in phosphorylation observed at lower (less-than-or-equal-to 10%) bleach levels (Newton, A. C., and Williams, D. S. (1991) J. Biol. Chem. 266, 17725-17728). Here we show that phorbol myristate acetate causes a decrease in the phosphorylation of rhodopsin after exposure to levels of illumination that result in maximal bleaching of the visual receptor. In contrast, no rhodopsin phosphorylation is detected in control or phorbol ester-treated retinas in the dark. Partial proteolysis revealed that phorbol esters alter the phosphorylation of the carboxyl-terminal domain of rhodopsin. Rhodopsin is the major protein whose phosphorylation state is affected significantly by phorbol esters in situ, although a number of rod outer segment cytosolic and membrane proteins are phosphorylated by protein kinase C in vitro. Our data indicate that a major target of protein kinase C in rod outer segments is rhodopsin.	INDIANA UNIV,SCH OPTOMETRY,CELL BIOL LAB,BLOOMINGTON,IN 47405	Indiana University System; Indiana University Bloomington	NEWTON, AC (corresponding author), INDIANA UNIV,DEPT CHEM,BLOOMINGTON,IN 47405, USA.				NEI NIH HHS [NEI EY08820] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008820] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ASHENDEL CL, 1989, RECEPTOR PHOSPHORYLA, P163; BINDER BM, 1990, J BIOL CHEM, V265, P15333; BINDER BM, 1989, J BIOL CHEM, V264, P8857; BUCZYLKO J, 1991, P NATL ACAD SCI USA, V88, P2568, DOI 10.1073/pnas.88.6.2568; COCHET C, 1984, J BIOL CHEM, V259, P2553; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; GHALAYINI A, 1984, BIOCHEM BIOPH RES CO, V124, P503, DOI 10.1016/0006-291X(84)91582-1; HARGRAVE PA, 1992, FASEB J, V6, P2323, DOI 10.1096/fasebj.6.6.1544542; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HAYASHI F, 1985, BIOCHEM BIOPH RES CO, V128, P954, DOI 10.1016/0006-291X(85)90139-1; INOUE M, 1984, JPN J OPHTHALMOL, V28, P47; KAPOOR CL, 1987, EXP EYE RES, V45, P545, DOI 10.1016/S0014-4835(87)80065-9; KAPOOR CL, 1984, BIOCHEM BIOPH RES CO, V122, P1397, DOI 10.1016/0006-291X(84)91246-4; KELLEHER DJ, 1990, J BIOL CHEM, V265, P2632; KELLEHER DJ, 1985, J CYCLIC NUCL PROT, V10, P579; KELLEHER DJ, 1986, J BIOL CHEM, V261, P4749; LAMBRECHT HG, 1991, FEBS LETT, V294, P207, DOI 10.1016/0014-5793(91)80670-X; LEE RH, 1982, BIOCHEMISTRY-US, V21, P3303, DOI 10.1021/bi00257a009; LEE RH, 1990, J BIOL CHEM, V265, P15860; MILLAR FA, 1988, BIOCHIM BIOPHYS ACTA, V970, P205, DOI 10.1016/0167-4889(88)90180-2; NEWTON AC, 1991, J BIOL CHEM, V266, P17725; NEWTON AC, 1993, ANNU REV BIOPH BIOM, V22, P1, DOI 10.1146/annurev.bb.22.060193.000245; NEWTON AC, 1993, TRENDS BIOCHEM SCI, V18, P275, DOI 10.1016/0968-0004(93)90032-I; NEWTON AC, 1993, METH NEUROSCI, V15, P261; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; PEPPERBERG DR, 1987, EXP EYE RES, V45, P141, DOI 10.1016/S0014-4835(87)80085-4; PITCHER J, 1992, BIOCHEMISTRY-US, V31, P3193, DOI 10.1021/bi00127a021; RATTO GM, 1988, J NEUROSCI, V8, P3240; RAYMOND JR, 1991, J BIOL CHEM, V266, P14747; RICHARDSON RM, 1992, J BIOL CHEM, V267, P10127; SHICHI H, 1978, J BIOL CHEM, V253, P7040; SHUSTER TA, 1984, BIOCHEMISTRY-US, V23, P515, DOI 10.1021/bi00298a018; SIBLEY DR, 1987, CELL, V48, P913, DOI 10.1016/0092-8674(87)90700-8; WEYAND I, 1990, EUR J BIOCHEM, V193, P459, DOI 10.1111/j.1432-1033.1990.tb19360.x; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; WILLIAMS DS, 1989, EXP EYE RES, V49, P439, DOI 10.1016/0014-4835(89)90052-3; WOLBRING G, 1991, EUR J BIOCHEM, V201, P601, DOI 10.1111/j.1432-1033.1991.tb16320.x	38	53	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18181	18186						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349693				2022-12-27	WOS:A1993LT74300079
J	BOEHMER, PE; DODSON, MS; LEHMAN, IR				BOEHMER, PE; DODSON, MS; LEHMAN, IR			THE HERPES-SIMPLEX VIRUS TYPE-1 ORIGIN BINDING-PROTEIN - DNA HELICASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION; POLYMERASE	The herpes simplex virus type 1 (HSV-1) origin binding protein, the product of the UL9 gene, catalyzes the unwinding of DNA in the 3'-5' direction. Helicase activity is coupled to the hydrolysis of ATP or dATP and to a lesser extent to CTP, dCTP, or UTP. It requires a divalent cation (Mg2+ > Mn2+ > Ca2+) with an optimum at 2.5 mM MgCl2. Activity is optimal at high pH (8.5-9.5) and high temperature (45-degrees-C) and is inhibited at ionic strengths > 50 mM NaCl. The helicase activity is specifically stimulated by the HSV-1-encoded single-stranded DNA-binding protein, ICP8, which increases both the rate and extent of helicase activity. Helicase action appears to be stoichiometric, requiring a DNA-dependent assembly of a multimeric UL9 protein complex. Under optimal conditions, the rate of DNA unwinding is approximately 75 base pairs/min.			BOEHMER, PE (corresponding author), STANFORD UNIV,MED CTR,SCH MED,BECKMAN CTR,DEPT BIOCHEM,STANFORD,CA 94305, USA.			Boehmer, Paul/0000-0003-4479-0529	NIAID NIH HHS [AI 26538] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026538] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BRUCKNER RC, 1991, J BIOL CHEM, V266, P2669; CRUTE JJ, 1991, J BIOL CHEM, V266, P4484; CRUTE JJ, 1989, J BIOL CHEM, V264, P19266; CRUTE JJ, 1988, NUCLEIC ACIDS RES, V16, P6585, DOI 10.1093/nar/16.14.6585; DODSON MS, 1993, J BIOL CHEM, V268, P1213; ELIAS P, 1990, J BIOL CHEM, V265, P17167; ELIAS P, 1988, P NATL ACAD SCI USA, V85, P2959, DOI 10.1073/pnas.85.9.2959; HERNANDEZ TR, 1990, J BIOL CHEM, V265, P11227; HURWITZ J, 1990, J BIOL CHEM, V265, P18043; KEIR HM, 1963, BIOCHIM BIOPHYS ACTA, V72, P263; KOFF A, 1991, J VIROL, V65, P3284, DOI 10.1128/JVI.65.6.3284-3292.1991; POWELL KL, 1977, J VIROL, V24, P618, DOI 10.1128/JVI.24.2.618-626.1977; RABKIN SD, 1991, P NATL ACAD SCI USA, V88, P10946, DOI 10.1073/pnas.88.23.10946; Sambrook J, 1989, MOL CLONING LABORATO; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	15	79	81	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1220	1225						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8380408				2022-12-27	WOS:A1993KG07700069
J	CHANG, NT; HUANG, LE; LIU, AYC				CHANG, NT; HUANG, LE; LIU, AYC			OKADAIC ACID MARKEDLY POTENTIATES THE HEAT-INDUCED HSP-70 PROMOTER ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; HUMAN HSP70 PROMOTER; CAMP RESPONSE ELEMENT; SHOCK FACTOR; DNA-BINDING; TRANSCRIPTION FACTOR; DEPENDENT PHOSPHORYLATION; PROTEIN PHOSPHATASES; DIPLOID FIBROBLASTS; ACTIVATION INVITRO	The effects of okadaic acid (OA), a potent and specific inhibitor of serine/threonine phosphatases 2A and 1, on the transient expression of a human hsp 70 promoter-linked chloramphenicol acetyltransferase gene transfected into N-18 mouse neuroblastoma cells were determined. Assays of reporter gene activity showed that nanomolar concentrations of OA markedly potentiated the heat-induced (but not the basal) expression of pHBCAT, a full-length hsp 70 promoter-driven chloramphenicol acetyltransferase gene construct. This effect of OA was dose-dependent and promoter-specific and appeared to be attributable to inhibition of protein phosphatase 2A as opposed to protein phosphatase 1. The ability of OA to potentiate the heat-induced expression of pHBCAT appeared to be a feature common to several different cell types examined. We propose that the heat-induced transcriptional activation of heat shock genes is associated with the phosphorylation of component(s) of the transcription complex and that OA enhances this phosphorylation, thereby potentiating the heat-induced hsp 70 promoter activity.			CHANG, NT (corresponding author), RUTGERS STATE UNIV,DEPT BIOL SCI,PISCATAWAY,NJ 08855, USA.			Huang, Eric/0000-0002-6444-1708; Liu, Alice Y./0000-0002-6984-1671				ARIAS JA, 1991, J BIOL CHEM, V266, P8055; ARNDT KT, 1989, CELL, V56, P527, DOI 10.1016/0092-8674(89)90576-X; CHERRY JR, 1989, CELL, V56, P409, DOI 10.1016/0092-8674(89)90244-4; CHOI HS, 1991, J BIOL CHEM, V266, P11858; CHOI HS, 1990, J BIOL CHEM, V265, P18005; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COHEN P, 1989, J BIOL CHEM, V264, P21435; CYERT MS, 1989, CELL, V57, P891, DOI 10.1016/0092-8674(89)90325-5; DENNER LA, 1990, SCIENCE, V250, P1740, DOI 10.1126/science.2176746; FOECKING MK, 1986, GENE, V45, P101, DOI 10.1016/0378-1119(86)90137-X; GALLO GJ, 1991, MOL CELL BIOL, V11, P281, DOI 10.1128/MCB.11.1.281; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GLINEUR C, 1990, GENE DEV, V4, P1663, DOI 10.1101/gad.4.10.1663; HAYSTEAD TAJ, 1990, J BIOL CHEM, V265, P16571; HENSOLD JO, 1990, MOL CELL BIOL, V10, P1600, DOI 10.1128/MCB.10.4.1600; HOEFFLER WK, 1988, CELL, V53, P907, DOI 10.1016/S0092-8674(88)90409-6; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; KIPREOS ET, 1990, SCIENCE, V248, P217, DOI 10.1126/science.2183353; KROLL DJ, 1991, J BIOL CHEM, V266, P7957; LAMPH WW, 1990, P NATL ACAD SCI USA, V87, P4320, DOI 10.1073/pnas.87.11.4320; LANDRY J, 1992, J BIOL CHEM, V267, P794; LARSON JS, 1988, NATURE, V335, P372, DOI 10.1038/335372a0; LEGAGNEUX V, 1990, EUR J BIOCHEM, V193, P121, DOI 10.1111/j.1432-1033.1990.tb19312.x; LIU AYC, 1989, BIOCHEM BIOPH RES CO, V162, P1302, DOI 10.1016/0006-291X(89)90815-2; LIU AYC, 1989, J BIOL CHEM, V264, P12037; LUM LSY, 1990, MOL CELL BIOL, V10, P6709, DOI 10.1128/MCB.10.12.6709; MANAK JR, 1990, GENE DEV, V4, P955, DOI 10.1101/gad.4.6.955; MERINO A, 1989, J BIOL CHEM, V264, P21266; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MORGAN WD, 1987, MOL CELL BIOL, V7, P1129, DOI 10.1128/MCB.7.3.1129; OBRIEN T, 1991, MOL CELL BIOL, V11, P5285, DOI 10.1128/MCB.11.10.5285; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; QUINN PG, 1990, MOL CELL BIOL, V10, P3357, DOI 10.1128/MCB.10.7.3357; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; SORGER PK, 1987, NATURE, V329, P81, DOI 10.1038/329081a0; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; STEIN GH, 1990, SCIENCE, V249, P666, DOI 10.1126/science.2166342; STEIN GH, 1991, P NATL ACAD SCI USA, V88, P11012, DOI 10.1073/pnas.88.24.11012; TAKAI A, 1987, FEBS LETT, V217, P81, DOI 10.1016/0014-5793(87)81247-4; TAYLOR WE, 1990, P NATL ACAD SCI USA, V87, P4098, DOI 10.1073/pnas.87.11.4098; WILLIAMS GT, 1989, MOL CELL BIOL, V9, P2574, DOI 10.1128/MCB.9.6.2574; WILLIAMS GT, 1990, MOL CELL BIOL, V10, P3125, DOI 10.1128/MCB.10.6.3125; WU B, 1985, MOL CELL BIOL, V5, P330, DOI 10.1128/MCB.5.2.330; WU BJ, 1986, P NATL ACAD SCI USA, V83, P629, DOI 10.1073/pnas.83.3.629	45	31	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1436	1439						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8380412				2022-12-27	WOS:A1993KG07700100
J	YANG, WN; BURKHART, W; CAVALLIUS, J; MERRICK, WC; BOSS, WF				YANG, WN; BURKHART, W; CAVALLIUS, J; MERRICK, WC; BOSS, WF			PURIFICATION AND CHARACTERIZATION OF A PHOSPHATIDYLINOSITOL 4-KINASE ACTIVATOR IN CARROT CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR EF-1-ALPHA; SEA-URCHIN EGGS; PLASMA-MEMBRANE; PHOSPHOINOSITIDE KINASES; INOSITOL TRISPHOSPHATE; RABBIT RETICULOCYTES; BINDING PROTEIN; FACTOR-I; ACTIN; POLYPHOSPHOINOSITIDES	A phosphatidylinositol 4-kinase activator (PIK-A49) has been purified from carrot cells grown in suspension culture. The activator was purified from a soluble fraction using DEAE-Sepharose CL-6B and S-Sepharose chromatography columns. PIK-A49 has a relative molecular mass of 49 kDa determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The A50 for the activation of the Triton X-100-solubilized phosphatidylinositol 4-kinase fraction was 0.1 muM. Maximal activation was 3-4-fold. The analysis of the sequences of seven peptide fragments containing a total of 142 amino acid residues indicated that PIK-A49 was 69% identical to an actin-binding protein (ABP-50) from Dictyostelium and >90% identical to elongation factor-1alpha (EF-1alpha) from carrot, tomato, and Arabidopsis. PIK-A49 bound actin and facilitated actin polymerization. Poly(U)-directed polyphenylalanine synthesis assays indicated that PIK-A49 had EF-1alpha activity. The EF-1alpha activity was enhanced by rabbit EF-1betagamma. Activation of phosphatidylinositol 4-kinase by a protein that binds actin and that has EF-1alpha activity provides additional complexity to the signal transduction mechanisms involving inositol phospholipid metabolism.	N CAROLINA STATE UNIV, DEPT BOT, POB 7612, RALEIGH, NC 27695 USA; CASE WESTERN RESERVE UNIV, SCH MED, DEPT BIOCHEM, CLEVELAND, OH 44106 USA	University of North Carolina; North Carolina State University; Case Western Reserve University								AXELOS M, 1989, MOL GEN GENET, V219, P106, DOI 10.1007/BF00261164; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BOSS WF, 1984, PROTOPLASMA, V120, P209, DOI 10.1007/BF01282601; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARPENTER CL, 1990, BIOCHEMISTRY-US, V29, P11147, DOI 10.1021/bi00503a001; CARVALHO JF, 1984, ARCH BIOCHEM BIOPHYS, V234, P591, DOI 10.1016/0003-9861(84)90309-6; CARVALHO MDD, 1984, ARCH BIOCHEM BIOPHYS, V234, P603, DOI 10.1016/0003-9861(84)90310-2; Chen Q, 1991, Symp Soc Exp Biol, V45, P159; CHEN QY, 1990, PLANT PHYSIOL, V94, P1820, DOI 10.1104/pp.94.4.1820; CHEN QY, 1991, PLANT PHYSIOL, V96, P340, DOI 10.1104/pp.96.1.340; COPPARD NJ, 1991, J CELL BIOL, V112, P237, DOI 10.1083/jcb.112.2.237; DEMMA M, 1990, J BIOL CHEM, V265, P2286; DHARMAWARDHANE S, 1991, CELL MOTIL CYTOSKEL, V20, P279, DOI 10.1002/cm.970200404; DJE MK, 1990, NUCLEIC ACIDS RES, V18, P3489, DOI 10.1093/nar/18.12.3489; GILROY S, 1990, NATURE, V346, P769, DOI 10.1038/346769a0; GROSS W, 1992, BIOCHIM BIOPHYS ACTA, V1134, P73, DOI 10.1016/0167-4889(92)90029-B; JANMEY PA, 1987, J BIOL CHEM, V262, P12228; JANMEY PA, 1989, J BIOL CHEM, V264, P4825; Kemper W M, 1979, Methods Enzymol, V60, P638; KJELDGAARD M, 1992, J MOL BIOL, V223, P721, DOI 10.1016/0022-2836(92)90986-T; KURIYAMA R, 1990, J CELL SCI, V95, P231; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Lloyd CW, 1989, CURR OPIN CELL BIOL, V1, P30, DOI 10.1016/S0955-0674(89)80033-X; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAJERUS PW, 1986, SCIENCE, V234, P1519, DOI 10.1126/science.3024320; MEMON AR, 1990, J BIOL CHEM, V265, P14817; Merrick W C, 1979, Methods Enzymol, V60, P108, DOI 10.1016/S0076-6879(79)60011-3; MISSIAEN L, 1989, BIOCHEM J, V261, P1055, DOI 10.1042/bj2611055; MORSE MJ, 1987, P NATL ACAD SCI USA, V84, P7075, DOI 10.1073/pnas.84.20.7075; OHTA K, 1990, J BIOL CHEM, V265, P3240; OKPODU CM, 1990, PLANT PHYSL BETHES S, V93, P362; PALATINI P, 1977, BIOCHIM BIOPHYS ACTA, V466, P1, DOI 10.1016/0005-2736(77)90203-6; PAYRASTRE B, 1991, J CELL BIOL, V115, P121, DOI 10.1083/jcb.115.1.121; POKALSKY AR, 1989, NUCLEIC ACIDS RES, V17, P4661, DOI 10.1093/nar/17.12.4661; RIIS B, 1990, TRENDS BIOCHEM SCI, V15, P420, DOI 10.1016/0968-0004(90)90279-K; SAHYOUN NE, 1989, J BIOL CHEM, V264, P1062; SANDELIUS AS, 1986, FEBS LETT, V201, P282, DOI 10.1016/0014-5793(86)80624-X; SOMMARIN M, 1988, BIOCHIM BIOPHYS ACTA, V958, P268, DOI 10.1016/0005-2760(88)90185-3; TAN Z, 1992, PLANT PHYSIOL, V100, P2116, DOI 10.1104/pp.100.4.2116; VOGEL S, 1986, EUR J BIOCHEM, V154, P253, DOI 10.1111/j.1432-1033.1986.tb09390.x; WALKER DH, 1990, BIOCHIM BIOPHYS ACTA, V1055, P295, DOI 10.1016/0167-4889(90)90046-G; WHEELER JJ, 1987, PLANT PHYSIOL, V85, P389, DOI 10.1104/pp.85.2.389; WISSING J, 1990, PLANT LIPID BIOCHEMISTRY, STRUCTURE AND UTILIZATION, P254; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; YONEZAWA N, 1990, J BIOL CHEM, V265, P8382	46	124	131	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					392	398						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380160				2022-12-27	WOS:A1993KE60300060
J	CHANG, CH; KOSTRUB, CF; BURTON, ZF				CHANG, CH; KOSTRUB, CF; BURTON, ZF			RAP30/74 (TRANSCRIPTION FACTOR-IIF) IS REQUIRED FOR PROMOTER ESCAPE BY RNA POLYMERASE-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 TAT PROTEIN; ESCHERICHIA-COLI SIGMA-70; GENERAL INITIATION-FACTOR; ELONGATION COMPLEXES; ACCURATE INITIATION; PREINITIATION COMPLEX; PROCESSIVITY FACTOR; TERNARY COMPLEX; DNA; INVITRO	RNA polymerase II-associating proteins (RAP30 and RAP74) are subunits of the transcription factor called variously RAP30/74, TFIIF, betagamma, and FC. This factor is required for accurate transcription by RNA polymerase II, in addition to other basal transcription factors. Using recombinant human RAP30 and RAP74, the functions of these subunits have been tested separately during the initiation and elongation phases of transcription. RAP30 is required to form a Sarkosyl-resistant complex at 0.25% Sarkosyl, so RAP30 is required for initiation. RAP74, however, stimulates transcription when added after Sarkosyl, indicating that RAP74 is dispensable for initiation. The same result is obtained using a pulse-chase protocol in which accurately initiated RNA is labeled during a short pulse, followed by a chase with excess unlabeled nucleoside triphosphates. RAP30 is required in order to label the transcript during the pulse, but RAP74 is not. RAP74 must be added during the chase, however, in order to obtain a short runoff transcript. The following conclusions can be drawn from these experiments: 1) RAP30 is an initiation factor; 2) RAP74 is not required for ATP hydrolysis in initiation, which precedes phosphodiester bond formation; 3) RAP74 is not required for template strand separation; 4) RAP74 is not required to initiate phosphodiester bond formation; and 5) RAP74 is required for very early elongation.	MICHIGAN STATE UNIV,DEPT BIOCHEM,E LANSING,MI 48824	Michigan State University					NIGMS NIH HHS [GM 40708] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040708] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENGAL E, 1991, MOL CELL BIOL, V11, P1195, DOI 10.1128/MCB.11.3.1195; BUNICK D, 1982, CELL, V29, P877, DOI 10.1016/0092-8674(82)90449-4; BURATOWSKI S, 1991, P NATL ACAD SCI USA, V88, P7509, DOI 10.1073/pnas.88.17.7509; BURTON ZF, 1988, MOL CELL BIOL, V8, P1602, DOI 10.1128/MCB.8.4.1602; BURTON ZF, 1986, EMBO J, V5, P2923, DOI 10.1002/j.1460-2075.1986.tb04588.x; CONAWAY JW, 1989, J BIOL CHEM, V264, P2357; CONAWAY JW, 1990, SCIENCE, V248, P1550, DOI 10.1126/science.2193400; CONAWAY RC, 1991, P NATL ACAD SCI USA, V88, P6205, DOI 10.1073/pnas.88.14.6205; CONAWAY RC, 1988, J BIOL CHEM, V263, P2962; CORDEN JL, 1990, TRENDS BIOCHEM SCI, V15, P383, DOI 10.1016/0968-0004(90)90236-5; CULLEN BR, 1990, CELL, V63, P655, DOI 10.1016/0092-8674(90)90129-3; DROMBOWSKI AJ, 1992, CELL, V70, P501; FINKELSTEIN A, 1992, NATURE, V355, P464, DOI 10.1038/355464a0; FLORES O, 1990, J BIOL CHEM, V265, P5629; FLORES O, 1991, P NATL ACAD SCI USA, V88, P9999, DOI 10.1073/pnas.88.22.9999; GILL SC, 1991, J MOL BIOL, V220, P307, DOI 10.1016/0022-2836(91)90015-X; GROSS CA, 1992, TRANSCRIPTIONAL REGU, P129; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; HORIKOSHI M, 1989, NATURE, V341, P299, DOI 10.1038/341299a0; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; KASSAVETIS GA, 1993, SCIENCE, V259, P944, DOI 10.1126/science.7679800; KATAJIMA S, 1990, NUCLEIC ACIDS RES, V18, P4843; KATO H, 1992, GENE DEV, V6, P655, DOI 10.1101/gad.6.4.655; KEPHART DD, 1993, NUCLEIC ACIDS RES, V21, P1319, DOI 10.1093/nar/21.5.1319; KILLEEN MT, 1992, MOL CELL BIOL, V12, P30, DOI 10.1128/MCB.12.1.30; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; LAYBOURN PJ, 1989, J BIOL CHEM, V263, P18880; LESLEY SA, 1989, BIOCHEMISTRY-US, V28, P7728, DOI 10.1021/bi00445a031; LUSE DS, 1987, J BIOL CHEM, V262, P289; MARCINIAK RA, 1990, CELL, V63, P791, DOI 10.1016/0092-8674(90)90145-5; MARCINIAK RA, 1991, EMBO J, V10, P4189, DOI 10.1002/j.1460-2075.1991.tb04997.x; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; MCCRACKEN S, 1991, SCIENCE, V253, P900, DOI 10.1126/science.1652156; PRICE DH, 1989, MOL CELL BIOL, V9, P1465, DOI 10.1128/MCB.9.4.1465; REINES D, 1992, J BIOL CHEM, V267, P15516; ROUGVIE AE, 1990, MOL CELL BIOL, V10, P6041, DOI 10.1128/MCB.10.11.6041; SAWADOGO M, 1984, J BIOL CHEM, V259, P5321; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; SOPTA M, 1985, J BIOL CHEM, V260, P353; SOPTA M, 1989, NATURE, V341, P410, DOI 10.1038/341410a0; SPENCER CA, 1990, ONCOGENE, V5, P777; USHEVA A, 1992, CELL, V69, P871, DOI 10.1016/0092-8674(92)90297-P; VONHIPPEL PH, 1992, TRANSCRIPTIONAL REGU, P179; WANG BQ, 1993, PROTEIN EXPRES PURIF, V4, P207, DOI 10.1006/prep.1993.1027; WANG DG, 1993, P NATL ACAD SCI USA, V90, P843, DOI 10.1073/pnas.90.3.843; WANG WD, 1992, SCIENCE, V255, P450, DOI 10.1126/science.1310361; WEIL PA, 1979, CELL, V18, P469; WIEST DK, 1992, J BIOL CHEM, V267, P7733; ZAWEL L, 1993, PROG NUCLEIC ACID RE, V44, P67, DOI 10.1016/S0079-6603(08)60217-2	50	43	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20482	20489						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376403				2022-12-27	WOS:A1993LY01900081
J	DEBEER, MC; DEBEER, FC; MCCUBBIN, WD; KAY, CM; KINDY, MS				DEBEER, MC; DEBEER, FC; MCCUBBIN, WD; KAY, CM; KINDY, MS			STRUCTURAL PREREQUISITES FOR SERUM AMYLOID-A FIBRIL FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; PROTEIN-SAA; GEL-ELECTROPHORESIS; ALZHEIMERS-DISEASE; GENE-EXPRESSION; BETA-PROTEIN; DEPOSITION; SECONDARY; MOUSE; CDNA	Most studies of experimental amyloid A protein (AA) amyloidosis in mice have been performed in type A mice with BALB/c as the prototype. In these mice the products of two genes, SAA1 and SAA2, are the major apo-SAA isoforms on high density lipoprotein (HDL). Of these two isoforms, that differ at nine amino acids, only apo-SAA2 is rapidly cleared and deposited as amyloid fibrils. No mouse strain has ever been shown to be completely resistant to amyloid induction. We have found the CE/J mouse strain to be exceedingly resistant to amyloidogenesis. Data indicate that this resistance is not due to a lack of apo-SAA synthesis but rather resides in the unique apo-SAA isoform in this strain. CE/J mice have a single major apo-SAA isoform (pI 6.15) the product of a single gene. This is a hybrid molecule with features of both apo-SAA1 and apo-SAA2, differing from the latter at only six amino acids. When CD studies were performed to explore the structural relationship of this isoform to apo-SAA1 and apo-SAA2, we found that when bound to heparan sulfate proteoglycan the CE/J pI 6.15 isoform fails to undergo the beta-sheet folding typical for apo-SAA2. This evidence suggests that the folding effect of heparan sulfate proteoglycan on apo-SAA2 is important in amyloid formation.	UNIV KENTUCKY,MED CTR,DEPT VET AFFAIRS MED CTR,DEPT BIOCHEM,LEXINGTON,KY 40536; UNIV KENTUCKY,MED CTR,DEPT VET AFFAIRS MED CTR,DEPT MED,LEXINGTON,KY 40536; UNIV ALBERTA,DEPT BIOCHEM,MED RES COUNCIL GRP PROT STRUCT & FUNCT,EDMONTON TBG 2H7,AB,CANADA	University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; University of Alberta					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040379] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR40379] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BAUW G, 1989, P NATL ACAD SCI USA, V86, P7701, DOI 10.1073/pnas.86.20.7701; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; CASTANO EM, 1986, BIOCHEM BIOPH RES CO, V141, P782, DOI 10.1016/S0006-291X(86)80241-8; DEBEER MC, 1992, BIOCHEM J, V283, P673, DOI 10.1042/bj2830673; DEBEER MC, 1991, BIOCHEM J, V280, P45, DOI 10.1042/bj2800045; FRASER PE, 1992, BIOCHEMISTRY-US, V31, P10716, DOI 10.1021/bi00159a011; FRASER PE, 1992, J NEUROCHEM, V59, P1531, DOI 10.1111/j.1471-4159.1992.tb08470.x; GLENNER GG, 1980, NEW ENGL J MED, V302, P1283, DOI 10.1056/NEJM198006053022305; GODENIR NL, 1985, J IMMUNOL METHODS, V83, P217, DOI 10.1016/0022-1759(85)90243-1; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HOFFMAN JS, 1982, J BIOL CHEM, V257, P510; HUSEBEKK A, 1987, SCAND J IMMUNOL, V25, P375, DOI 10.1111/j.1365-3083.1987.tb02203.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LOWELL CA, 1986, J BIOL CHEM, V261, P8442; MCADAM KPWJ, 1976, J EXP MED, V144, P1121, DOI 10.1084/jem.144.4.1121; MCCUBBIN WD, 1988, BIOCHEM J, V256, P775, DOI 10.1042/bj2560775; MEEK RL, 1986, J EXP MED, V163, P499, DOI 10.1084/jem.163.3.499; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; NARINDRASORASAK S, 1991, J BIOL CHEM, V266, P12878; NORLING B, 1988, CLIN EXP IMMUNOL, V73, P333; OKAYAMA H, 1982, MOL CELL BIOL, V2, P161, DOI 10.1128/MCB.2.2.161; PEPYS MB, 1986, AMYLOIDOSIS, P43; PROVENCHER S, 1981, J IMMUNOL, V135, P3645; ROKITA H, 1989, BRIT J EXP PATHOL, V70, P327; SAMBROCK J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIROO M, 1987, SCAND J IMMUNOL, V26, P709, DOI 10.1111/j.1365-3083.1987.tb02307.x; SNOW AD, 1988, AM J PATHOL, V133, P456; SNOW AD, 1990, LAB INVEST, V63, P601; SNOW AD, 1985, LAB INVEST, V53, P37; SNOW AD, 1987, LAB INVEST, V56, P170; SOLOMON A, 1991, AMYLOID AND AMYLOIDOSIS 1990, P193; SORENSON GD, 1966, METHODS ACHIEVEMENTS, V1, P514; Speicher D.W., 1989, TECHNIQUES PROTEIN C, P24; STONE MJ, 1990, BLOOD, V75, P531; STRACHAN AF, 1988, BIOCHEM J, V250, P203, DOI 10.1042/bj2500203; STRACHAN AF, 1989, J BIOL CHEM, V264, P18368; STRACHAN AF, 1989, BIOCHEM J, V263, P365, DOI 10.1042/bj2630365; TAYLOR BA, 1984, MOL GEN GENET, V195, P491, DOI 10.1007/BF00341452; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VORNDAM AV, 1986, ANAL BIOCHEM, V152, P221, DOI 10.1016/0003-2697(86)90401-X; WOHLGETHAN JR, 1980, LAB INVEST, V42, P663; YAMAMOTO K, 1985, P NATL ACAD SCI USA, V82, P2915, DOI 10.1073/pnas.82.9.2915; YAMAMOTO K, 1986, SCIENCE, V232, P227, DOI 10.1126/science.3456645; YI S, 1991, AMYLOID AMYLOIDOSIS, P657; YOUNG I, 1991, AMYLOID AND AMYLOIDOSIS 1990, P334	50	88	89	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20606	20612						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376413				2022-12-27	WOS:A1993LY01900098
J	DEANGELIS, PL; PAPACONSTANTINOU, J; WEIGEL, PH				DEANGELIS, PL; PAPACONSTANTINOU, J; WEIGEL, PH			MOLECULAR-CLONING, IDENTIFICATION, AND SEQUENCE OF THE HYALURONAN SYNTHASE GENE FROM GROUP-A STREPTOCOCCUS-PYOGENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GRAM-POSITIVE BACTERIA; ESCHERICHIA-COLI; ACID CAPSULE; DNA; SOLUBILIZATION; PROBE	The hyaluronan (HA) synthase of Group A Streptococci has been identified by transposon mutagenesis and deletion analysis. The genes for the HA synthase and a recently identified UDP-Glc dehydrogenase (Dougherty, B. A., and van de Rijn, I. (1993) J. Biol. Chem. 268, 7118-7124) reside on a contiguous stretch of 3.2-kilobase pair DNA that can direct HA biosynthesis in Enterococcus faecalis and Escherichia coli as well as mutant Streptococcus (DeAngelis, P. L., Papaconstantinou, J., and Weigel, P. H. (1993) J. Biol. Chem. 268,14568-14571). The synthase contains 395 residues (calculated M(r) = 45,063) and migrates on SDS-PAGE with a molecular mass of 42 kDa. E. coli K5, which synthesizes UDP-glucuronic acid for production of its endogenous capsular polysaccharide, can make HA if it contains a plasmid encoding the intact 42-kDa protein. E. coli SURE or chi1448 cells containing the same construct, however, cannot produce HA since these strains cannot make both required sugar nucleotide precursors. The HA synthase is predicted to be an integral membrane protein with four membrane-associated helices, which is consistent with the location of the enzyme activity in Streptococci. There is significant homology between the HA synthase and the Rhizobium nodC gene product, an enzyme that synthesizes chitin-like oligomers. This is the first description at the molecular level of an enzyme shown to synthesize a glycosaminoglycan.	UNIV TEXAS, MED BRANCH, DEPT HUMAN BIOL CHEM & GENET, GALVESTON, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston			Papaconstantinou, John/E-3312-2010		NIGMS NIH HHS [GM35978] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035978] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULAWA CE, 1992, MOL CELL BIOL, V12, P1764, DOI 10.1128/MCB.12.4.1764; CAPARON MG, 1991, METHOD ENZYMOL, V204, P556; CLEWELL DB, 1988, J BACTERIOL, V170, P3046, DOI 10.1128/jb.170.7.3046-3052.1988; DEANGELIS PL, 1993, J BIOL CHEM, V268, P14568; Dochez AR, 1919, J EXP MED, V30, P179, DOI 10.1084/jem.30.3.179; DOUGHERTY BA, 1993, J BIOL CHEM, V268, P7118; DOUGHERTY BA, 1992, J EXP MED, V175, P1291, DOI 10.1084/jem.175.5.1291; EHTESHAM NZ, 1991, BIOTECHNIQUES, V11, P718; GAWRONBURKE C, 1984, J BACTERIOL, V159, P214, DOI 10.1128/JB.159.1.214-221.1984; GREN EJ, 1984, BIOCHIMIE, V66, P1, DOI 10.1016/0300-9084(84)90188-3; GUPTA DS, 1982, FEMS MICROBIOL LETT, V14, P75, DOI 10.1111/j.1574-6968.1982.tb08638.x; HAKANSSON S, 1986, ACTA PATH MICRO IM B, V94, P139; Kendall FE, 1937, J BIOL CHEM, V118, P61; LANSING M, 1993, BIOCHEM J, V289, P179, DOI 10.1042/bj2890179; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; MARKOVITZ A, 1959, J BIOL CHEM, V234, P2343; MEAGHER RB, 1977, CELL, V10, P521, DOI 10.1016/0092-8674(77)90039-3; Meyer K, 1934, J BIOL CHEM, V107, P629; NG KF, 1989, J BIOL CHEM, V264, P11776; OCONNOR SP, 1987, J INFECT DIS, V156, P495, DOI 10.1093/infdis/156.3.495; PREHM P, 1986, BIOCHEM J, V235, P887, DOI 10.1042/bj2350887; Sambrook J, 1989, MOL CLONING LABORATO; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; TRISCOTT MX, 1986, J BIOL CHEM, V261, P6004; VANDERIJN I, 1992, J BIOL CHEM, V267, P24302; WESSELS MR, 1991, P NATL ACAD SCI USA, V88, P8317, DOI 10.1073/pnas.88.19.8317	28	189	216	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19181	19184						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366070				2022-12-27	WOS:A1993LW81900006
J	COVES, J; NIVIERE, V; ESCHENBRENNER, M; FONTECAVE, M				COVES, J; NIVIERE, V; ESCHENBRENNER, M; FONTECAVE, M			NADPH-SULFITE REDUCTASE FROM ESCHERICHIA-COLI - A FLAVIN REDUCTASE PARTICIPATING IN THE GENERATION OF THE FREE-RADICAL OF RIBONUCLEOTIDE REDUCTASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALMONELLA-TYPHIMURIUM; SUPEROXIDE-DISMUTASE; ENZYMATIC FORMATION; TYROSINE RESIDUE; ENTEROBACTERIA; HEMOFLAVOPROTEIN; SEQUENCE; SUBUNIT; IDENTIFICATION; OVERPRODUCTION	Protein R2, the small subunit of ribonucleotide reductase of Escherichia coli, contains an essential free radical localized to tyrosine 122 of its polypeptide chain. When this radical is scavenged by hydroxyurea, the enzyme is transformed into an inactive form, metR2. E. coli contains a NAD(P)H:flavin oxidoreductase, named Fre, absolutely required for the regeneration of the radical and the activation of metR2 into R2. Consequently, an E. coli mutant strain lacking an active fre gene is more sensitive to hydroxyurea during growth, demonstrating the physiological protective function of Fre from the loss of the radical. However, this gene is not essential, and we found that E. coli contains a second tyrosyl radical generating activity, also residing in a flavin reductase. The enzyme has been purified 200-fold to homogeneity and found to be identical to sulfite reductase. Pure sulfite reductase has the ability to catalyze the reduction of free riboflavin, FMN, or FAD by NADPH and thus, as Fre, to transfer electrons to the iron center of metR2, a key step during the activation reaction.	UNIV JOSEPH FOURIER, ETUD DYNAM & STRUCT SELECT LAB,CNRS, UNITE RECH ASSOCIEE 332,BP 53-X, F-38041 GRENOBLE, FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)				Niviere, Vincent/0000-0002-5132-457X				BARLOW T, 1983, P NATL ACAD SCI-BIOL, V80, P1492, DOI 10.1073/pnas.80.6.1492; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COVES J, 1993, EUR J BIOCHEM, V211, P635, DOI 10.1111/j.1432-1033.1993.tb17591.x; DIRUSSO CC, 1990, J BACTERIOL, V172, P6459, DOI 10.1128/jb.172.11.6459-6468.1990; ELIASSON R, 1986, P NATL ACAD SCI USA, V83, P2373, DOI 10.1073/pnas.83.8.2373; FONTECAVE M, 1989, J BIOL CHEM, V264, P9164; FONTECAVE M, 1987, J BIOL CHEM, V262, P12325; FONTECAVE M, 1987, J BIOL CHEM, V262, P12332; Fontecave M., 1992, ADV ENZYMOL RELAT AR, V65, P147; KANEHISA M, 1984, NUCLEIC ACIDS RES, V12, P203, DOI 10.1093/nar/12.1Part1.203; LARSSON A, 1986, EMBO J, V5, P2037, DOI 10.1002/j.1460-2075.1986.tb04461.x; MOORE EC, 1985, PHARMACOL THERAPEUT, V27, P167; MURPHY MJ, 1973, J BIOL CHEM, V248, P2801; OSTROWSKI J, 1989, J BIOL CHEM, V264, P15726; OSTROWSKI J, 1989, J BIOL CHEM, V264, P15796; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; ROSENKRANZ HS, 1966, BIOCHIM BIOPHYS ACTA, V114, P501, DOI 10.1016/0005-2787(66)90099-2; SIEGEL LM, 1974, J BIOL CHEM, V249, P1587; SIEGEL LM, 1973, J BIOL CHEM, V248, P251; SIEGEL LM, 1974, J BIOL CHEM, V249, P1572; SJOBERG BM, 1986, J BIOL CHEM, V261, P5658; SPYROU G, 1991, J BACTERIOL, V173, P3673, DOI 10.1128/JB.173.12.3673-3679.1991	22	58	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18604	18609						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360156				2022-12-27	WOS:A1993LV65900038
J	GOLDENRING, JR; SHEN, KR; VAUGHAN, HD; MODLIN, IM				GOLDENRING, JR; SHEN, KR; VAUGHAN, HD; MODLIN, IM			IDENTIFICATION OF A SMALL GTP-BINDING PROTEIN, RAB25, EXPRESSED IN THE GASTROINTESTINAL MUCOSA, KIDNEY, AND LUNG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							VESICULAR TRANSPORT; PARIETAL-CELLS; ACTIVATING PROTEIN; RAS; STIMULATION; CLONING; GENES	Small GTP-binding proteins have been implicated in the regulation of many dynamic cellular processes. The carboxyl termini of parietal cell small GTP-binding proteins were cloned using a 3'-rapid amplification of cDNA ends (RACE) technique with a degenerate oligonucleotide primer based on the WDTAGQE consensus GTP-binding sequence. Six out of 53 clones demonstrated a novel Rab sequence, now designated Rab25. The complete sequence was obtained using 3'-RACE and revealed a deduced amino acid sequence having 63% identity with Rab11. The deduced amino acid sequence demonstrated a carboxyl-terminal CCQNI and also a novel GTP-binding site sequence of WDTAGLE. Nevertheless, recombinant Rab25 was able to bind GTP on blot. A major 1.2 kilobase Rab25 message was detected throughout the gastrointestinal mucosa and in lung and kidney tissue. No message was detected in brain, heart, liver, or skeletal muscle. In gastric tissue, Rab25 was absent in the bowel wall; among mucosal cells, it was highly enriched in parietal cells compared to chief cells. Rab25 mRNA was also detected in several colon carcinoma lines including LIM1215 and HT-29. The results indicate that Rab25 represents a novel member of the Rab family with an epithelial distribution.	YALE UNIV,SCH MED,DEPT SURG,GASTROINTESTINAL SURG RES UNIT,NEW HAVEN,CT 06510; VET ADM MED CTR,NEW HAVEN,CT	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043405, R29DK043405, R01DK038063] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK43405, DK 38063] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; ADRIAN TE, 1989, ANAL BIOCHEM, V182, P346, DOI 10.1016/0003-2697(89)90606-4; BALCH WE, 1990, TRENDS BIOCHEM SCI, V15, P473, DOI 10.1016/0968-0004(90)90301-Q; BASSON MD, 1991, BIOCHEM J, V279, P43, DOI 10.1042/bj2790043; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; BHULLAR RP, 1987, BIOCHEM J, V245, P617, DOI 10.1042/bj2450617; BLADINI G, 1992, P NATL ACAD SCI USA, V89, P5049; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DARCHEN F, 1990, P NATL ACAD SCI USA, V87, P5692, DOI 10.1073/pnas.87.15.5692; DRIVAS GT, 1991, ONCOGENE, V6, P3; ELFERINK LA, 1992, J BIOL CHEM, V267, P5768; FROHMAN MA, 1992, AMPLIFICATIONS, V2, P11; GOLDENRING JR, 1993, GASTROENTEROLOGY, V104, pA1061; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; HAUBRUCK H, 1991, BIOCHIM BIOPHYS ACTA, V1072, P215, DOI 10.1016/0304-419X(91)90015-D; LEUTWILER LS, 1986, NUCLEIC ACIDS RES, V14, P4051, DOI 10.1093/nar/14.10.4051; LEWIS JJ, 1990, AM J PHYSIOL, V258, pG476, DOI 10.1152/ajpgi.1990.258.3.G476; LUTKE A, 1993, J CELL BIOL, V121, P553; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MARUTA H, 1991, J BIOL CHEM, V266, P11661; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; MOLLARD GFV, 1990, P NATL ACAD SCI USA, V87, P1988; Sambrook J, 1989, MOL CLONING LABORATO; SHULL GE, 1986, J BIOL CHEM, V261, P6788; SOLL AH, 1980, AM J PHYSIOL, V238, pG366, DOI 10.1152/ajpgi.1980.238.4.G366; TANG LH, 1992, BIOCHEM J, V285, P715, DOI 10.1042/bj2850715; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; WALWORTH NC, 1992, MOL CELL BIOL, V12, P2017, DOI 10.1128/MCB.12.5.2017	32	134	139	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18419	18422						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360141				2022-12-27	WOS:A1993LV65900006
J	HAGEN, FK; VANWUYCKHUYSE, B; TABAK, LA				HAGEN, FK; VANWUYCKHUYSE, B; TABAK, LA			PURIFICATION, CLONING, AND EXPRESSION OF A BOVINE UDP-GALNAC - POLYPEPTIDE N-ACETYL-GALACTOSAMINYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-GLYCOSYLATION; ACETYLGALACTOSAMINE; GLYCOPROTEINS; TRANSFERASE; HEPATOMA; LENGTH; CELLS; GOLGI; DNA	Partial amino acid sequence was obtained from UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase (polypeptide GalNAc transferase) purified from bovine colostrum. Oligonucleotide primers designed from these sequences were used to amplify and clone a polypeptide GalNAc transferase cDNA from bovine placental mRNA. The cDNA encodes an open reading frame, which is 519 amino acids in length and contains the predicted N-terminal and internal amino acid sequence derived from three Lys-C peptides obtained from the purified protein. There was no sequence homology with the UDP-GalNAc: Fucalpha1,2Galalpha1,3GalNAc transferase. To verify the authenticity of the clone, the cDNA was cloned in frame with an insulin secretion sequence and was expressed transiently in COS-7 cells. Polypeptide GalNAc transferase activity was detected in the culture medium; no activity was detected in the media of mock-transfected cells. Previous studies have shown that the polypeptide Gal-Nac transferase from bovine colostrum glycosylates threonine residues more efficiently than serine residues in the same peptide context (O'Connell, B. C., Hagen, F. K., and Tabak, L. A. (1992) J. Biol. Chem. 267, 25010-25018). We found that the cloned polypeptide GalNAc transferase glycosylates the threonine-containing peptide, PPDAATAAPLR, at a 58-ford greater rate than the serine-containing homologue, PPDAASAAPLR. The ratio of the in vitro threonine and serine glycosylation rate is identical for the cloned placental and purified colostral enzymes. It is not known if the preference for threonine over serine is merely context-dependent on the specific amino acids that flank the glycosylation site or if there are discrete threonine- and serine-specific isoforms of this transferase. Alternatively, there may be additional factors required to enhance the glycosylation of serine residues in vivo.	UNIV ROCHESTER,SCH MED & DENT,DEPT DENT RES,601 ELMWOOD AVE,BOX 611,ROCHESTER,NY 14642; UNIV ROCHESTER,SCH MED & DENT,DEPT BIOCHEM,ROCHESTER,NY 14642	University of Rochester; University of Rochester					NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008108, T32DE007202, R37DE008108] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE-08108, T32 DE-07202] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		CULLEN BR, 1987, METHOD ENZYMOL, V152, P6684; ELHAMMER A, 1986, J BIOL CHEM, V261, P5249; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GILLESPIE W, 1992, J BIOL CHEM, V267, P21004; HOMA FL, 1993, J BIOL CHEM, V268, P12609; HSUEH EC, 1986, J BIOL CHEM, V261, P4940; HUGHES RC, 1988, CARBOHYD RES, V178, P259, DOI 10.1016/0008-6215(88)80117-4; OCONNELL B, 1991, BIOCHEM BIOPH RES CO, V180, P1024, DOI 10.1016/S0006-291X(05)81168-4; OCONNELL BC, 1992, J BIOL CHEM, V267, P25010; SUGIURA M, 1982, J BIOL CHEM, V257, P9501; WANG WC, 1991, J BIOL CHEM, V266, P23185; WANG Y, 1992, J BIOL CHEM, V267, P12700; WILSON IBH, 1991, BIOCHEM J, V275, P529, DOI 10.1042/bj2750529; YAMAMOTO F, 1990, J BIOL CHEM, V265, P1146; YEO KT, 1985, J BIOL CHEM, V260, P7896	16	100	103	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18960	18965						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360184				2022-12-27	WOS:A1993LV65900087
J	MIZUNO, K; KAWASAKI, T; SHIMADA, H; SATOH, H; KOBAYASHI, E; OKUMURA, S; ARAI, Y; BABA, T				MIZUNO, K; KAWASAKI, T; SHIMADA, H; SATOH, H; KOBAYASHI, E; OKUMURA, S; ARAI, Y; BABA, T			ALTERATION OF THE STRUCTURAL-PROPERTIES OF STARCH COMPONENTS BY THE LACK OF AN ISOFORM OF STARCH BRANCHING ENZYME IN RICE SEEDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; ORYZA-SATIVA-L; AMYLOMAIZE STARCH; MULTIPLE FORMS; WAXY LOCUS; MAIZE; PURIFICATION; SEQUENCE; GENE; BIOSYNTHESIS	This study describes the effect of starch-synthesizing enzymes on biosynthesis of storage starch in rice amylose-extender mutants, which contain branched D-glucans with abnormal structures. Western blot analysis indicated that two out of five amylose-extender mutant lines lacked an isoform of starch branching enzyme, termed RBE3, although the levels of granule-bound starch synthase and a major form of branching enzyme, RBE1, were normal in these two mutants. Proteins corresponding to the 87-kDa RBE3 molecule were present in the three other amylose-extender mutants as well as in the wild type. However, the level of branching enzyme activity significantly decreased in all amylose-extender mutants, suggesting that the 87-kDa proteins in these three mutants are inactive forms of RBE3. Therefore, we conclude that formation of the abnormal branched glucans in the amylose-extender mutant of rice is due to the lack of the RBE3 activity. The cDNA clones encoding RBE3 have been identified from a normal rice seed cDNA library in lambdagt11, using a synthetic oligonucleotide as a probe. The deduced amino acid sequence of RBE3 indicates that this protein is initially synthesized as a precursor of 825 amino acids, including a 65-residue transit peptide at the NH2 terminus. The sequences of the catalytic regions in amylolytic enzymes are highly conserved in the sequence of RBE3. Thus, the branching enzyme isoform belongs to a family of the amylolytic enzymes. RBE3 also shares a noticeable degree of sequence identity with RBE1, especially at the central portion of the protein molecule. However, RBE3 possesses an approximately 70-residue extra sequence at the NH2 terminus and lacks a COOH-terminal sequence of almost 50 residues as compared with RBE1. The structural differences at both termini may explain the distinct role in starch synthesis for RBE1 and RBE3.	UNIV TSUKUBA,INST APPL BIOCHEM,TSUKUBA SCI CTR,TSUKUBA,IBARAKI 305,JAPAN; MITSUI PLANT BIOTECHNOL RES INST,IBARAKI 305,JAPAN; KYUSHU UNIV,FAC AGR,INST GENET RESOURCES,PLANT GENET LAB,HAKOZAKI,FUKUOKA 812,JAPAN	University of Tsukuba; Kyushu University								ANDERSON JM, 1989, J BIOL CHEM, V264, P12238; BABA T, 1982, CARBOHYD RES, V107, P215, DOI 10.1016/S0008-6215(00)80540-6; BABA T, 1984, AGR BIOL CHEM TOKYO, V48, P1763, DOI 10.1080/00021369.1984.10866395; BABA T, 1991, BIOCHEM BIOPH RES CO, V181, P87, DOI 10.1016/S0006-291X(05)81385-3; BABA T, 1982, PHYTOCHEMISTRY, V21, P2291, DOI 10.1016/0031-9422(82)85193-5; BABA T, 1983, CARBOHYD RES, V124, P344, DOI 10.1016/0008-6215(83)88471-7; BABA T, 1987, J JPN SOC STARCH SCI, V34, P196; BAECKER PA, 1986, J BIOL CHEM, V261, P8738; BANKS W, 1974, STARKE, V26, P289, DOI 10.1002/star.19740260902; Banks W., 1975, STARCH ITS COMPONENT, P5; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BHATTACHARYYA MK, 1990, CELL, V60, P115, DOI 10.1016/0092-8674(90)90721-P; BOROVSKY D, 1976, EUR J BIOCHEM, V62, P307, DOI 10.1111/j.1432-1033.1976.tb10162.x; BOROVSKY D, 1975, EUR J BIOCHEM, V59, P615, DOI 10.1111/j.1432-1033.1975.tb02490.x; BOYER CD, 1978, CARBOHYD RES, V61, P321, DOI 10.1016/S0008-6215(00)84492-4; BOYER CD, 1978, BIOCHEM BIOPH RES CO, V80, P169, DOI 10.1016/0006-291X(78)91119-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUISSON G, 1987, EMBO J, V6, P3909, DOI 10.1002/j.1460-2075.1987.tb02731.x; CHARBONNIERE R, 1968, STARKE, V20, P75, DOI 10.1002/star.19680200303; COLONNA P, 1984, CARBOHYD RES, V126, P233, DOI 10.1016/0008-6215(84)85381-1; DRUMMOND GS, 1972, EUR J BIOCHEM, V26, P168, DOI 10.1111/j.1432-1033.1972.tb01753.x; FULLER SA, 1991, CURRENT PROTOCOLS MO; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; HEDMAN KD, 1982, BIOCHEM GENET, V20, P483, DOI 10.1007/BF00484699; HIRANO HY, 1991, PLANT CELL PHYSIOL, V32, P989, DOI 10.1093/oxfordjournals.pcp.a078186; IKAWA Y, 1980, STARKE, V32, P145, DOI 10.1002/star.19800320502; KAWASAKI T, 1993, MOL GEN GENET, V237, P10, DOI 10.1007/BF00282778; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; MATSUURA Y, 1984, J BIOCHEM-TOKYO, V95, P697, DOI 10.1093/oxfordjournals.jbchem.a134659; MERCIER C, 1973, STARKE, V25, P78, DOI 10.1002/star.19730250303; MIZUNO K, 1992, J BIOCHEM, V112, P643, DOI 10.1093/oxfordjournals.jbchem.a123953; NAKAMURA Y, 1992, PHYSIOL PLANTARUM, V84, P329, DOI 10.1111/j.1399-3054.1992.tb04672.x; NELSON OE, 1964, SCIENCE, V145, P1194, DOI 10.1126/science.145.3637.1194; Preiss J., 1988, BIOCH PLANTS, V14., P181; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATOH H, 1981, JPN J BREED, V31, P316; SCHMIDT GW, 1986, ANNU REV BIOCHEM, V55, P879; SHIMADA H, 1993, IN PRESS THEOR APPL; SHURE M, 1983, CELL, V35, P225, DOI 10.1016/0092-8674(83)90225-8; SINGH BK, 1985, PLANT PHYSIOL, V79, P34, DOI 10.1104/pp.79.1.34; SMYTH DA, 1988, PLANT SCI, V57, P1, DOI 10.1016/0168-9452(88)90135-5; STARK DM, 1992, SCIENCE, V258, P287, DOI 10.1126/science.258.5080.287; TAKEDA Y, 1993, CARBOHYD RES, V240, P253, DOI 10.1016/0008-6215(93)84188-C; THON VJ, 1992, J BIOL CHEM, V267, P15224; VANDERLEIJ FR, 1991, THEOR APPL GENET, V82, P289, DOI 10.1007/BF02190614; YANO M, 1985, THEOR APPL GENET, V69, P253, DOI 10.1007/BF00662436	47	153	200	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					19084	19091						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360192				2022-12-27	WOS:A1993LV65900105
J	MOSER, TL; ENGHILD, JJ; PIZZO, SV; STACK, MS				MOSER, TL; ENGHILD, JJ; PIZZO, SV; STACK, MS			THE EXTRACELLULAR-MATRIX PROTEINS LAMININ AND FIBRONECTIN CONTAIN BINDING DOMAINS FOR HUMAN PLASMINOGEN AND TISSUE-PLASMINOGEN ACTIVATOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE; HUMAN-PLASMA; AFFINITY CHROMATOGRAPHY; COMPONENTS; CHAIN; GLYCOPROTEIN; PURIFICATION; KRINGLE-5; CLEAVAGE; THROMBIN	This study describes the binding of plasminogen and tissue-type plasminogen activator (t-PA) to the extracellular matrix proteins fibronectin and laminin. Plasminogen bound specifically and saturably to both fibronectin and laminin immobilized on microtiter wells, with K(d(app)) values of 115 and 18 nM, respectively. Limited proteolysis by endoproteinase V8 coupled with ligand blotting analysis showed that both plasminogen and t-PA preferentially bind to a 55-kDa fibronectin fragment and a 38-kDa laminin fragment. Amino acid sequence analysis demonstrated that the 55-kDa fragment originates with the fibronectin amino terminus whereas the laminin fragment was derived from the carboxyl-terminal globular domain of the laminin A chain. Ligand blotting experiments using isolated plasminogen domains were also used to identify distinct regions of the plasminogen molecule involved in fibronectin and laminin binding. Solution phase fibronectin binding to immobilized plasminogen was mediated primarily via lysine binding site-dependent interactions with plasminogen kringles 1-4. Lysine binding site-dependent binding of soluble laminin to immobilized plasminogen kringles 1-5 as well as an additional lysine binding site-independent interaction between mini-plasminogen and the 38-kDa laminin A chain fragment were also observed. These studies demonstrate binding of plasminogen and tissue-type plasminogen activator to specific regions of the extracellular matrix glycoproteins laminin and fibronectin and provide further insight into the mechanism of regulation of plasminogen activation by components of the extracellular matrix.	DUKE UNIV,MED CTR,DEPT PATHOL,BOX 3712,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT BIOCHEM,DURHAM,NC 27710	Duke University; Duke University				Enghild, Jan Johannes/0000-0001-9292-9172; Havener, Tammy/0000-0002-4613-0498	NHLBI NIH HHS [HL-43339, HL-08382, HL-31932] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031932, R01HL043339, F32HL008382] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; CASTELLINO FJ, 1981, CHEM REV, V81, P431, DOI 10.1021/cr00045a001; CHRISTENSEN U, 1984, BIOCHEM J, V223, P413, DOI 10.1042/bj2230413; DEPOLI P, 1989, BLOOD, V73, P976; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; GARCIAPARDO A, 1983, J BIOL CHEM, V258, P2670; GONZALEZGRONOW M, 1984, BIOCHEMISTRY-US, V23, P190, DOI 10.1021/bi00297a003; HIGHSMITH RF, 1981, J BIOL CHEM, V256, P6788; HOUMARD J, 1972, P NATL ACAD SCI USA, V69, P306; HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369; Hynes RO, 1990, FIBRONECTINS; KNUDSEN BS, 1986, J BIOL CHEM, V261, P765; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIMBIRD LE, 1986, CELL SURFACE RECEPTO; LIOTTA LA, 1981, THROMB RES, V21, P663, DOI 10.1016/0049-3848(81)90268-1; LIOTTA LA, 1981, CANCER RES, V41, P4629; MANGEL WF, 1990, SCIENCE, V248, P69, DOI 10.1126/science.2108500; MARTIN GR, 1987, ANNU REV CELL BIOL, V3, P57, DOI 10.1146/annurev.cellbio.3.1.57; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MILES L A, 1988, Fibrinolysis, V2, P61, DOI 10.1016/0268-9499(88)90369-4; NIEUWENHUIZEN W, 1983, BIOCHIM BIOPHYS ACTA, V755, P531, DOI 10.1016/0304-4165(83)90261-1; OSSOWSKI L, 1978, BIOL MARKERS NEOPLAS; RANBY M, 1982, BIOCHIM BIOPHYS ACTA, V704, P461, DOI 10.1016/0167-4838(82)90068-1; REICH R, 1988, CANCER RES, V48, P3307; RUOSLAHTI E, 1981, J BIOL CHEM, V256, P7277; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; SALONEN EM, 1985, J BIOL CHEM, V260, P2302; SASAKI M, 1988, J BIOL CHEM, V263, P16536; SILVERSTEIN RL, 1985, J BIOL CHEM, V260, P346; SOTTRUPJENSEN L, 1978, PROGR CHEM FIBRINOLY, V3, P191; STACK MS, 1992, BIOCHEM J, V284, P103, DOI 10.1042/bj2840103; STACK MS, 1993, J BIOL CHEM, V268, P18924; STACK S, 1990, BIOCHEMISTRY-US, V29, P4966, DOI 10.1021/bi00472a029; THEWES T, 1990, J BIOL CHEM, V265, P3906; THORSEN S, 1975, BIOCHIM BIOPHYS ACTA, V251, P363; VARADI A, 1981, BIOCHEM BIOPH RES CO, V103, P97, DOI 10.1016/0006-291X(81)91665-X; VUENTO M, 1979, BIOCHEM J, V183, P331, DOI 10.1042/bj1830331; YUEN SW, 1988, APPLIED BIOSYSTEMS U, V36, P1	39	85	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18917	18923						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360181				2022-12-27	WOS:A1993LV65900081
J	SACCHETTINI, JC; GORDON, JI				SACCHETTINI, JC; GORDON, JI			RAT INTESTINAL FATTY-ACID-BINDING PROTEIN - A MODEL SYSTEM FOR ANALYZING THE FORCES THAT CAN BIND FATTY-ACIDS TO PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; BOUND PALMITATE; REFINEMENT; SPECIFICITY; EXPRESSION; APOPROTEIN; RESOLUTION		WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110	Washington University (WUSTL)	SACCHETTINI, JC (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT BIOCHEM,BRONX,NY 10461, USA.				NIAID NIH HHS [AI27179] Funding Source: Medline; NIDDK NIH HHS [DK30292] Funding Source: Medline; NIGMS NIH HHS [GM45859] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI027179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030292, R37DK030292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045859] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATWOOD JL, 1991, NATURE, V349, P683, DOI 10.1038/349683a0; CHENG L, 1991, J BIOL CHEM, V266, P24404; CISTOLA DP, 1989, J BIOL CHEM, V264, P2700; COHN SM, 1992, J CELL BIOL, V119, P27, DOI 10.1083/jcb.119.1.27; COWAN SW, 1993, J MOL BIOL, V230, P1225, DOI 10.1006/jmbi.1993.1238; JAKOBY MG, 1993, BIOCHEMISTRY-US, V32, P872, DOI 10.1021/bi00054a019; JONES TA, 1988, EMBO J, V7, P1597, DOI 10.1002/j.1460-2075.1988.tb02985.x; LOWE JB, 1987, J BIOL CHEM, V262, P5931; MILLER K, 1993, IN PRESS MOL CELL BI; MULLERFAHRNOW A, 1991, EUR J BIOCHEM, V199, P271, DOI 10.1111/j.1432-1033.1991.tb16120.x; PETROU S, 1993, TRENDS BIOCHEM SCI, V18, P41, DOI 10.1016/0968-0004(93)90050-W; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; RICHIERI GV, 1992, J BIOL CHEM, V267, P23495; RUDNICK DA, 1992, P NATL ACAD SCI USA, V89, P10507, DOI 10.1073/pnas.89.21.10507; SACCHETTINI JC, 1989, J MOL BIOL, V208, P327, DOI 10.1016/0022-2836(89)90392-6; SACCHETTINI JC, 1992, J BIOL CHEM, V267, P23534; SCAPIN G, 1992, J BIOL CHEM, V267, P4253; SCAPIN G, 1990, MOL CELL BIOCHEM, V98, P81; SHA RS, 1993, J BIOL CHEM, V268, P7885; STUMP DG, 1991, J BIOL CHEM, V266, P4622; WINTER NS, 1993, J MOL BIOL, V230, P1247, DOI 10.1006/jmbi.1993.1239; XU ZH, 1993, J BIOL CHEM, V268, P7874; XU ZH, 1992, BIOCHEMISTRY-US, V31, P3484, DOI 10.1021/bi00128a024; ZANOTTI G, 1992, J BIOL CHEM, V267, P18541	24	110	113	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18399	18402						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360139				2022-12-27	WOS:A1993LV65900001
J	FAHIEN, LA; DAVIS, JW; LABOY, J				FAHIEN, LA; DAVIS, JW; LABOY, J			INTERACTIONS BETWEEN PYRUVATE-CARBOXYLASE AND OTHER MITOCHONDRIAL-ENZYMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CITRATE SYNTHASE; MALATE-DEHYDROGENASE; GLUTAMATE-DEHYDROGENASE; ALPHA-KETOGLUTARATE; COMPLEX-I; LIVER; HEART; PURIFICATION; OXALACETATE; BINDING	Although pyruvate carboxylase associated with both mitochondrial aspartate aminotransferase and malate dehydrogenase, it had a higher affinity for the aminotransferase. Furthermore, the aminotransferase enhanced dissociation of malate dehydrogenase from pyruvate carboxylase. Glutamate dehydrogenase did not associate with pyruvate carboxylase alone, but it apparently associated with the pyruvate carboxylase-aminotransferase complex, and malate dehydrogenase associated with the resulting ternary complex. Citrate synthase and other proteins tested did not associate with pyruvate carboxylase. However, citrate synthase associated with the pyruvate carboxylase-malate dehydrogenase complex. Apparently as a consequence of these heteroenzyme interactions, the rate of the pyruvate carboxylase reaction was slightly greater when coupled with malate dehydrogenase or both malate dehydrogenase and citrate synthase than when coupled with citrate synthase alone. In addition, in the presence of both coupling enzymes, the rate of conversion of pyruvate to citrate was higher than predicted on the basis of the Michaelis-Menten relationship of the two coupling enzymes. Therefore, binding of malate dehydrogenase to pyruvate carboxylase enhances pyruvate carboxylase activity. Association of citrate synthase with the malate dehydrogenase-pyruvate carboxylase binary complex does not alter activation of pyruvate carboxylase but results in citrate synthase being more reactive than free citrate synthase with oxalacetate.	CAYEY UNIV COLL PUERTO RICO,DEPT CHEM,CAYEY,PR 00633		FAHIEN, LA (corresponding author), UNIV WISCONSIN,SCH MED,DEPT PHARMACOL,MADISON,WI 53706, USA.				NCI NIH HHS [CA40445] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040445] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ATKINSON D. E., 1968, P23; DATTA A, 1985, J BIOL CHEM, V260, P5008; DSOUZA SF, 1983, J BIOL CHEM, V258, P4706; EGAN RR, 1971, BIOCHIM BIOPHYS ACTA, V250, P47, DOI 10.1016/0005-2744(71)90118-5; EMLY M, 1981, J AM CHEM SOC, V103, P628, DOI 10.1021/ja00393a022; ENGLARD S, 1959, J BIOL CHEM, V234, P1004; FAHIEN LA, 1969, ARCH BIOCHEM BIOPHYS, V130, P478, DOI 10.1016/0003-9861(69)90060-5; FAHIEN LA, 1969, ARCH BIOCHEM BIOPHYS, V130, P449, DOI 10.1016/0003-9861(69)90057-5; FAHIEN LA, 1992, J BIOL CHEM, V267, P10411; FAHIEN LA, 1983, ARCH BIOCHEM BIOPHYS, V220, P386, DOI 10.1016/0003-9861(83)90428-9; FAHIEN LA, 1989, J BIOL CHEM, V264, P12303; FAHIEN LA, 1988, J BIOL CHEM, V263, P10687; FAHIEN LA, 1969, ARCH BIOCHEM BIOPHYS, V130, P456, DOI 10.1016/0003-9861(69)90058-7; FUKUSHIMA T, 1989, J BIOL CHEM, V264, P16483; HALPER LA, 1977, ARCH BIOCHEM BIOPHYS, V184, P529, DOI 10.1016/0003-9861(77)90462-3; KUN E, 1962, ENZYMES, V7, P149; LEE YH, 1975, J BIOL CHEM, V250, P5604; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTINEZCARRION M, 1967, BIOCHEMISTRY-US, V6, P1715, DOI 10.1021/bi00858a021; MORIYAMA T, 1971, J BIOL CHEM, V246, P3217; OZA NB, 1973, ARCH BIOCHEM BIOPHYS, V154, P360, DOI 10.1016/0003-9861(73)90068-4; RIFE JE, 1980, BIOCHEMISTRY-US, V19, P2321, DOI 10.1021/bi00552a007; ROSIERS CD, 1991, J BIOL CHEM, V266, P1574; SCRUTTON MC, 1967, J BIOL CHEM, V242, P1725; SCRUTTON MC, 1969, METHOD ENZYMOL, V13, P235; SINGH M, 1970, J BIOL CHEM, V245, P4636; SMITH BC, 1992, BIOCHEM J, V284, P819, DOI 10.1042/bj2840819; SPIVEY HO, 1989, BIOESSAYS, V10, P127, DOI 10.1002/bies.950100409; Srere P. A., 1972, ENERGY METABOLISM RE, P79; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; STANLEY CJ, 1980, BIOCHEM J, V191, P147, DOI 10.1042/bj1910147; SUMEGI B, 1980, BIOCHIM BIOPHYS ACTA, V616, P158, DOI 10.1016/0005-2744(80)90134-5; SUMEGI B, 1984, J BIOL CHEM, V259, P5040; TELLER JK, 1990, J BIOL CHEM, V265, P19486; TISCHLER ME, 1977, ARCH BIOCHEM BIOPHYS, V184, P222, DOI 10.1016/0003-9861(77)90346-0; TOMPA P, 1987, J BIOL CHEM, V262, P6089; WALTER P, 1966, J BIOL CHEM, V241, P2523; Walter P, 1976, GLUCONEOGENESIS ITS, P239; WIMMER MJ, 1975, J BIOL CHEM, V250, P710; WU JY, 1970, J BIOL CHEM, V245, P3561	40	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17935	17942						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349677				2022-12-27	WOS:A1993LT74300047
J	JIN, MJ; SNIDER, MD				JIN, MJ; SNIDER, MD			ROLE OF MICROTUBULES IN TRANSFERRIN RECEPTOR TRANSPORT FROM THE CELL-SURFACE TO ENDOSOMES AND THE GOLGI-COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; ISOLATED RAT HEPATOCYTES; MEDIATED ENDOCYTOSIS; INTRACELLULAR MOVEMENT; CYTOCHALASIN-B; FUSION INVITRO; MEMBRANE; INTERNALIZATION; ORGANIZATION; FIBROBLASTS	Transferrin receptor (TfR) follows complex pathways of transport after endocytosis from the cell surface. Most TfR is transported to endosomes and returns rapidly to the cell surface. In addition, approximately 10% of the internalized receptor recycles through the Golgi complex. To examine the role of microtubules in TfR traffic, K562 cultured human leukemia cells treated with nocodazole to depolymerize microtubules were studied. Nocodazole caused a 50% increase in the level of surface TfR, which was due to a change in receptor dynamics. The endocytosis rate in treated cells was 20% of control, indicating that TfR endocytosis via clathrin-coated vesicles was slowed, whereas the recycling of internalized receptors to the cell surface was unaffected. In contrast, nocodazole had little effect on the transport of TfR from the cell surface to the Golgi complex. Thus, the fragmentation and dispersal of the Golgi complex caused by microtubule depolymerization, which does not interrupt secretory traffic through this organelle, also does not block recycling through the Golgi. The decreased TfR endocytosis via coated vesicles and the increased TfR transport to the Golgi caused by nocodazole suggest that either (i) endocytosis via coated vesicles is not the rate-limiting step in transport to the Golgi or (ii) coated vesicles are not a part of this pathway. Finally, because nocodazole inhibits traffic from endosomes to lysosomes, surface-to-Golgi transport probably does not involve a lysosomal intermediate.	CASE WESTERN RESERVE UNIV,SCH MED,DEPT BIOCHEM,CLEVELAND,OH 44106	Case Western Reserve University					NIGMS NIH HHS [GM38183] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038183] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACHLER C, 1989, J CELL BIOL, V109, P179, DOI 10.1083/jcb.109.1.179; BOMSEL M, 1990, CELL, V62, P719, DOI 10.1016/0092-8674(90)90117-W; CAIN CC, 1991, J BIOL CHEM, V266, P11746; CARON JM, 1985, J CELL BIOL, V101, P1763, DOI 10.1083/jcb.101.5.1763; CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681; COOPER MS, 1990, CELL, V61, P135, DOI 10.1016/0092-8674(90)90221-Y; DANIELSEN EM, 1983, BIOCHEM J, V216, P37, DOI 10.1042/bj2160037; DEBRABANDER M, 1988, CELL MOTIL CYTOSKEL, V9, P30, DOI 10.1002/cm.970090105; DRAPER RK, 1990, SCIENCE, V248, P1539, DOI 10.1126/science.2163108; DUNCAN JR, 1988, J CELL BIOL, V106, P617, DOI 10.1083/jcb.106.3.617; EILERS U, 1989, J CELL BIOL, V108, P13, DOI 10.1083/jcb.108.1.13; FISHMAN JB, 1987, CELL, V48, P157, DOI 10.1016/0092-8674(87)90366-7; GREEN SA, 1992, J CELL BIOL, V117, P47, DOI 10.1083/jcb.117.1.47; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; HERMAN B, 1984, J CELL BIOL, V98, P565, DOI 10.1083/jcb.98.2.565; HO WC, 1989, EUR J CELL BIOL, V48, P250; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; HUANG KM, 1993, J BIOL CHEM, V268, P9302; HUEBERS HA, 1987, PHYSIOL REV, V67, P520, DOI 10.1152/physrev.1987.67.2.520; IACOPETTA BJ, 1983, J HISTOCHEM CYTOCHEM, V31, P336, DOI 10.1177/31.2.6300220; INOUE S, 1952, BIOL BULL, V103, P316; JIN M, 1989, J BIOL CHEM, V264, P7675; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; KELLY RB, 1990, CELL, V61, P5, DOI 10.1016/0092-8674(90)90206-T; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; KOLSET SO, 1979, EXP CELL RES, V122, P159, DOI 10.1016/0014-4827(79)90570-6; KREIS TE, 1989, EUR J CELL BIOL, V49, P128; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; LUND KA, 1990, J BIOL CHEM, V265, P15713; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; MCGRAW TE, 1988, J CELL BIOL, V106, P1061, DOI 10.1083/jcb.106.4.1061; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; NAGURA H, 1979, J IMMUNOL, V123, P2359; OKA JA, 1983, BIOCHIM BIOPHYS ACTA, V763, P368, DOI 10.1016/0167-4889(83)90098-8; PAGANO RE, 1989, J CELL BIOL, V109, P2067, DOI 10.1083/jcb.109.5.2067; PHAIREWASHINGTON L, 1980, J CELL BIOL, V86, P641, DOI 10.1083/jcb.86.2.641; QUARONI A, 1979, BIOCHEM J, V182, P213, DOI 10.1042/bj1820213; RINDLER MJ, 1987, J CELL BIOL, V104, P231, DOI 10.1083/jcb.104.2.231; ROBERTSON BR, 1991, ARCH BIOCHEM BIOPHYS, V292, P190; ROGALSKI AA, 1984, J CELL BIOL, V99, P1101, DOI 10.1083/jcb.99.3.1101; ROME LH, 1979, CELL, V17, P143, DOI 10.1016/0092-8674(79)90302-7; ROTH J, 1987, BIOCHIM BIOPHYS ACTA, V906, P405, DOI 10.1016/0304-4157(87)90018-9; SALAS PJI, 1986, J CELL BIOL, V102, P1853, DOI 10.1083/jcb.102.5.1853; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SNIDER MD, 1985, J CELL BIOL, V100, P826, DOI 10.1083/jcb.100.3.826; SNIDER MD, 1986, J CELL BIOL, V103, P265, DOI 10.1083/jcb.103.1.265; SNIDER MD, 1991, INTRACELLULAR TRAFFI, P361; STULTS NL, 1989, J BIOL CHEM, V264, P19956; SWANSON J, 1987, P NATL ACAD SCI USA, V84, P1921, DOI 10.1073/pnas.84.7.1921; THYBERG J, 1980, EUR J CELL BIOL, V23, P95; THYBERG J, 1985, EXP CELL RES, V159, P1, DOI 10.1016/S0014-4827(85)80032-X; TURNER JR, 1989, J CELL BIOL, V109, P2081, DOI 10.1083/jcb.109.5.2081; VONFIGURA K, 1978, BIOCHEM J, V170, P313, DOI 10.1042/bj1700313; WILEY HS, 1981, CELL, V25, P433, DOI 10.1016/0092-8674(81)90061-1; WOLKOFF AW, 1984, J CELL BIOL, V98, P375, DOI 10.1083/jcb.98.2.375; WOODS JW, 1986, J CELL BIOL, V103, P277, DOI 10.1083/jcb.103.1.277	57	96	97	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18390	18397						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349714				2022-12-27	WOS:A1993LT74300108
J	OTTO, JC; DEWITT, DL; SMITH, WL				OTTO, JC; DEWITT, DL; SMITH, WL			N-GLYCOSYLATION OF PROSTAGLANDIN ENDOPEROXIDE SYNTHASES-1 AND SYNTHASES-2 AND THEIR ORIENTATIONS IN THE ENDOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHEEP VESICULAR GLAND; HEME-BINDING; H-SYNTHASE; COMPLEMENTARY-DNA; CYCLOOXYGENASE; SYNTHETASE; PROTEIN; SITE; OLIGOSACCHARIDES; PURIFICATION	Using site-directed mutagenesis, we have determined that Asn68, Asn144, and Asn410 of ovine prostaglandin endoperoxide (PGH) synthase-1 are N-glycosylated. A fourth consensus N-glycosylation sequence at Asn104 is not glycosylated. Glycosylation of PGH synthase-1 at Asn410 and at either Asn68 or Asn144 was required for expression of both the cyclooxygenase and the peroxidase activities of the enzyme. Inactive PGH synthase-1 glycosylation site mutant proteins do not appear to achieve their native conformations. However, the native enzyme, once in an active conformation, does not appear to require attached carbohydrate for cyclooxygenase or peroxidase activities. N-Glycosylation consensus sequences corresponding to the three glycosylation sites of ovine PGH synthase-1 are conserved in the deduced amino acid sequences of PGH synthases-2. Using site-directed mutagenesis, we determined that there is an additional site of N-glycosylation in murine PGH synthase-2 located at Asn580. This site is N-glycosylated in about 50% of PGH synthase-2 molecules, resulting in two peptide bands on SDS-polyacrylamide gel electrophoresis (72 and 74 kDa). Glycosylation of PGH synthase-2 is necessary for expression of enzyme activity, but glycosylation of PGH synthase-2 at Asn580 per se does not affect activity. Assuming that the N-glycosylation sites of PGH synthase-1 are on the luminal side of the endoplasmic reticulum (ER), and that the site of tryptic cleavage of ovine PGH synthase-1 (Arg277) is on the cytoplasmic side of the ER, we propose that both the NH2 and COOH termini of PGH synthase-1 are located in the lumen of the ER and that there are two transmembrane domains located between Asn144 and Arg277 and between Arg277 and Asn410, respectively. A similar orientation is predicted for PGH synthase-2.	MICHIGAN STATE UNIV,DEPT BIOCHEM,RM 510,BIOCHEM BLDG,E LANSING,MI 48824	Michigan State University					NHLBI NIH HHS [HL-07404] Funding Source: Medline; NIDDK NIH HHS [DK42509, DK22042] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK022042, R37DK022042, R01DK042509] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN YNP, 1987, J BIOL CHEM, V262, P16892; DEWITT DL, 1988, P NATL ACAD SCI USA, V85, P1412, DOI 10.1073/pnas.85.5.1412; DEWITT DL, 1990, J BIOL CHEM, V265, P5192; DEWITT DL, 1981, J BIOL CHEM, V256, P375; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; HOE MH, 1992, J BIOL CHEM, V267, P4916; HUNT RC, 1989, J BIOL CHEM, V264, P643; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; KUJUBU DA, 1992, J BIOL CHEM, V267, P7991; KULMACZ RJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P502, DOI 10.1016/0003-9861(89)90317-2; KULMACZ RJ, 1989, J BIOL CHEM, V264, P14136; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; MARNETT LJ, 1988, J BIOL CHEM, V263, P16532; MEADE EA, 1993, J LIPID MEDIATOR, V6, P119; MERLIE JP, 1988, J BIOL CHEM, V263, P3550; MIYAMOTO T, 1976, J BIOL CHEM, V251, P2629; MIZUNO K, 1982, PROSTAGLANDINS, V23, P743; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; MUTSAERS JHGM, 1985, EUR J BIOCHEM, V147, P569; OLSON TS, 1987, J BIOL CHEM, V262, P6816; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; RANDS E, 1990, J BIOL CHEM, V265, P10759; REGIER MK, 1993, ARCH BIOCHEM BIOPHYS, V301, P439, DOI 10.1006/abbi.1993.1168; ROBBI M, 1991, J BIOL CHEM, V266, P20498; ROLLINS TE, 1980, J BIOL CHEM, V255, P4872; ROTH GJ, 1981, J BIOL CHEM, V256, P18; ROTH GJ, 1980, J BIOL CHEM, V255, P1301; RUF HH, 1984, FEBS LETT, V165, P293, DOI 10.1016/0014-5793(84)80189-1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIMOKAWA T, 1991, J BIOL CHEM, V266, P6168; SHIMOKAWA T, 1990, J BIOL CHEM, V265, P20073; SHIMOKAWA T, 1992, J BIOL CHEM, V267, P12387; SHIMOKAWA T, 1992, BIOCHEM BIOPH RES CO, V183, P975, DOI 10.1016/S0006-291X(05)80286-4; SHIN J, 1991, P NATL ACAD SCI USA, V88, P1918, DOI 10.1073/pnas.88.5.1918; Simmons D.L., 1991, PROSTAGLANDINS LEUKO, P67; SIRIOS J, 1992, J BIOL CHEM, V267, P6382; SLIEKER LJ, 1986, J BIOL CHEM, V261, P5233; SMITH WL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P1, DOI 10.1016/0005-2760(91)90119-3; TAKETA K, 1986, J IMMUNOL METHODS, V95, P71; VANDEROUDERAA FJ, 1980, EUR J BIOCHEM, V109, P1; VANDEROUDERAA FJ, 1977, BIOCHIM BIOPHYS ACTA, V487, P315, DOI 10.1016/0005-2760(77)90008-X; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; YOKOYAMA C, 1988, FEBS LETT, V231, P347, DOI 10.1016/0014-5793(88)80847-0; YOKOYAMA C, 1989, BIOCHEM BIOPH RES CO, V165, P888, DOI 10.1016/S0006-291X(89)80049-X	48	203	207	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18234	18242						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349699				2022-12-27	WOS:A1993LT74300087
J	BEHRENDT, N; RONNE, E; DANO, K				BEHRENDT, N; RONNE, E; DANO, K			BINDING OF THE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR TO ITS CELL-SURFACE RECEPTOR IS INHIBITED BY LOW-DOSES OF SURAMIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOUND UROKINASE; GROWTH-FACTOR; U937 MONOCYTES; PRO-UROKINASE; STROMAL CELLS; DEGRADATION; INVASION; SYSTEM; ADENOCARCINOMAS; POTENTIATION	The multipotent drug suramin, which is currently being studied as an anticancer agent, was found to inhibit the interaction between the urokinase-type plasminogen activator (u-PA) and its cellular receptor. 50% inhibition of binding was obtained with a suramin concentration between 30 and 60 mug/ml when using U937 cells and a ligand concentration of 0.3 nM. This concentration of the drug is well below the serum levels found in suramin-treated patients. Inhibition of binding was also demonstrated at the molecular level, using chemical cross-linking or an enzyme-linked immunosorbent assay-type technique based on the ligand interaction. The inhibition was not caused by a mere polyanion effect since polysulfates such as heparin, heparan sulfate, and pentosan polysulfate were non-inhibitory or showed only a very weak inhibition. However, polysulfonated compounds with structures resembling suramin (i.e. trypan blue and Evans blue) did prove inhibitory. The inhibition found with suramin showed a concentration dependence consistent with a mixed competitive and noncompetitive mechanism. The off-rate of prebound ligand was accelerated by the drug. It is speculated that the present effect may contribute to the anti-invasive properties of suramin by destroying the cellular potential for localized plasminogen activation and proteolytic matrix degradation.			BEHRENDT, N (corresponding author), RIGSHOSP, FINSEN LAB, STRANDBLVD 49 862, DK-2100 COPENHAGEN, DENMARK.			Behrendt, Niels/0000-0003-1833-3922				BEHRENDT N, 1991, J BIOL CHEM, V266, P7842; BEHRENDT N, 1990, J BIOL CHEM, V265, P6453; BEHRENDT N, 1993, METHOD ENZYMOL, V223, pCH13; BETSHOLTZ C, 1986, P NATL ACAD SCI USA, V83, P6440, DOI 10.1073/pnas.83.17.6440; BLASI F, 1987, J CELL BIOL, V104, P801, DOI 10.1083/jcb.104.4.801; COFFEY RJ, 1987, J CELL PHYSIOL, V132, P143, DOI 10.1002/jcp.1041320120; CORNISHB.A, 1974, BIOCHEM J, V137, P143, DOI 10.1042/bj1370143; CUBELLIS MV, 1986, J BIOL CHEM, V261, P5819; CUBELLIS MV, 1990, EMBO J, V9, P1079, DOI 10.1002/j.1460-2075.1990.tb08213.x; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DIXON M, 1979, ENZYMES, P332; ELLIS V, 1991, J BIOL CHEM, V266, P12752; ELLIS V, 1990, J BIOL CHEM, V265, P9904; ELLIS V, 1989, J BIOL CHEM, V264, P2185; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; GRONDAHLHANSEN J, 1991, AM J PATHOL, V138, P111; GUESDON JL, 1979, J HISTOCHEM CYTOCHEM, V27, P1131, DOI 10.1177/27.8.90074; HOSANG M, 1985, J CELL BIOCHEM, V29, P265, DOI 10.1002/jcb.240290310; JENTSCH KD, 1987, J GEN VIROL, V68, P2183, DOI 10.1099/0022-1317-68-8-2183; LAROCCA RV, 1990, CANCER CELL-MON REV, V2, P106; LAROCCA RV, 1990, NEUROLOGY, V40, P954; MASUCCI MT, 1991, J BIOL CHEM, V266, P8655; NAKAJIMA M, 1991, J BIOL CHEM, V266, P9661; NIELSEN LS, 1986, J IMMUNOASSAY, V7, P209, DOI 10.1080/01971528608060467; NIELSEN LS, 1988, J BIOL CHEM, V263, P2358; OSSOWSKI L, 1988, J CELL BIOL, V107, P2437, DOI 10.1083/jcb.107.6.2437; OSSOWSKI L, 1991, J CELL BIOL, V115, P1107, DOI 10.1083/jcb.115.4.1107; PEDERSEN N, 1991, FIBRINOLYSIS, V5, P155, DOI 10.1016/0268-9499(91)90017-X; PLOUG M, 1991, J BIOL CHEM, V266, P1926; PLOW EF, 1986, J CELL BIOL, V103, P2411, DOI 10.1083/jcb.103.6.2411; POLLANEN J, 1991, ADV CANCER RES, V57, P273; PYKE C, 1991, AM J PATHOL, V138, P1059; QUAX PHA, 1991, CELL REGUL, V2, P793, DOI 10.1091/mbc.2.10.793; ROLDAN AL, 1990, EMBO J, V9, P467, DOI 10.1002/j.1460-2075.1990.tb08132.x; RONNE E, 1991, FEBS LETT, V288, P233, DOI 10.1016/0014-5793(91)81042-7; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; STEIN CA, 1989, J CLIN ONCOL, V7, P499, DOI 10.1200/JCO.1989.7.4.499; STEPHENS RW, 1989, J CELL BIOL, V108, P1987, DOI 10.1083/jcb.108.5.1987; STOPPELLI MP, 1985, P NATL ACAD SCI USA, V82, P4939, DOI 10.1073/pnas.82.15.4939; STOPPELLI MP, 1986, CELL, V45, P675, DOI 10.1016/0092-8674(86)90782-8; VASSALLI JD, 1985, J CELL BIOL, V100, P86, DOI 10.1083/jcb.100.1.86; ZABRENETZKY VS, 1990, CANCER RES, V50, P5937	42	39	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1993	268	8					5985	5989						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR822	8383683				2022-12-27	WOS:A1993KR82200093
J	FATHI, Z; CORJAY, MH; SHAPIRA, H; WADA, E; BENYA, R; JENSEN, R; VIALLET, J; SAUSVILLE, EA; BATTEY, JF				FATHI, Z; CORJAY, MH; SHAPIRA, H; WADA, E; BENYA, R; JENSEN, R; VIALLET, J; SAUSVILLE, EA; BATTEY, JF			BRS-3 - A NOVEL BOMBESIN RECEPTOR SUBTYPE SELECTIVELY EXPRESSED IN TESTIS AND LUNG-CARCINOMA CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIN-RELEASING PEPTIDE; SWISS 3T3 CELLS; BETA-2-ADRENERGIC RECEPTOR; MOLECULAR-CLONING; FUNCTIONAL-CHARACTERIZATION; PHOSPHORYLATION SITES; PROTEIN-KINASE; GROWTH-FACTOR; CDNA; DESENSITIZATION	The bombesin (BN)-like peptides mediate a diverse spectrum of biological activities and have been implicated as autocrine growth factors in the pathogenesis and progression of some human small cell lung carcinoma tumors. Previously, two mammalian BN-like peptide receptor subtypes, gastrin-releasing peptide receptor and neuromedin-B receptor, have been cloned and characterized. In this study, we have isolated and characterized human genomic and complementary DNA (cDNA) clones encoding a new BN-like peptide receptor subtype, BN receptor subtype 3 (BRS-3). Expression of BRS-3 cDNA in Xenopus oocytes encodes a functional receptor that is specifically activated by BN-like peptides. Chromosome mapping studies indicate that the BRS-3 gene is located on human chromosome X. BRS-3 mRNA expression in rat tissues is limited to secondary spermatocytes in testis. In contrast, BRS-3 mRNA is widely expressed in a panel of human cell lines from all histological types of lung carcinoma. These results suggest a role for BN-like peptides and their receptors in mammalian reproductive physiology and also indicate that BRS-3 could serve as a potential therapeutic target for human lung carcinoma.	NIDDKD, DIGEST DIS BRANCH, BETHESDA, MD 20892 USA; MONTREAL GEN HOSP, DIV ONCOL, MONTREAL H3G 1A4, QUEBEC, CANADA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); McGill University	FATHI, Z (corresponding author), NCI, DEPT CANC TREATMENT,DEV THERAPEUT PROGRAM, BIOL CHEM LAB,BLDG 37, RM 5D02, BETHESDA, MD 20892 USA.							ANASTASI A, 1971, EXPERIENTIA, V27, P166, DOI 10.1007/BF02145873; BATTEY JF, 1991, P NATL ACAD SCI USA, V88, P395, DOI 10.1073/pnas.88.2.395; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; CARNEY DN, 1987, CANCER RES, V47, P821; CLARK RB, 1989, MOL PHARMACOL, V36, P343; CORJAY MH, 1991, J BIOL CHEM, V266, P18771; DAVIS LG, 1986, BASIC METHODS MOL BI, P1; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; FINK PS, 1991, BIOTECHNIQUES, V10, P446; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; HAMBLIN MW, 1991, MOL PHARMACOL, V40, P143; HAMBLIN MW, 1992, BIOCHEM BIOPH RES CO, V184, P752, DOI 10.1016/0006-291X(92)90654-4; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; ISHIHARA T, 1991, EMBO J, V10, P1635, DOI 10.1002/j.1460-2075.1991.tb07686.x; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; LEBACQVERHEYDEN AM, 1990, HDB EXPT PHARM, V95, P71; SHAPIRA H, 1991, BIOCHEM BIOPH RES CO, V176, P79, DOI 10.1016/0006-291X(91)90892-B; SHAPIRA H, 1992, IN PRESS METHODS NEU; SPINDEL ER, 1990, MOL ENDOCRINOL, V4, P1956, DOI 10.1210/mend-4-12-1956; SPINDEL ER, 1992, IN PRESS RECENT PROG; STROSBERG AD, 1991, EUR J BIOCHEM, V196, P1, DOI 10.1111/j.1432-1033.1991.tb15778.x; TAKEDA Y, 1991, BIOCHEM BIOPH RES CO, V179, P1232, DOI 10.1016/0006-291X(91)91704-G; TREPEL JB, 1988, BIOCHEM J, V255, P403, DOI 10.1042/bj2550403; WADA E, 1991, NEURON, V6, P421, DOI 10.1016/0896-6273(91)90250-4; ZACHARY I, 1986, J CELL BIOL, V102, P2211, DOI 10.1083/jcb.102.6.2211	28	297	306	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1993	268	8					5979	5984						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR822	8383682				2022-12-27	WOS:A1993KR82200092
J	MENNITI, FS; MILLER, RN; PUTNEY, JW; SHEARS, SB				MENNITI, FS; MILLER, RN; PUTNEY, JW; SHEARS, SB			TURNOVER OF INOSITOL POLYPHOSPHATE PYROPHOSPHATES IN PANCREATOMA CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOINOSITOL 1,3,4,5,6-PENTAKISPHOSPHATE; PENTAKISPHOSPHATE; HEXAKISPHOSPHATE; METABOLISM; PHOSPHATES; 1,3,4-TRISPHOSPHATE; TETRAKISPHOSPHATES; PHOSPHORYLATION; CALCIUM	There is little information concerning the intracellular function of inositol 1,3,4,5,6-pentakis- and hexakisphosphate, despite their being the most abundant inositol polyphosphates. Current opinions that they play passive roles as antioxidants (Graf, E., Mahoney, J. R., Bryant, R. G., and Eaton, J. W. (1987) J. Biol. Chem. 259, 3620-3624) or ''housekeeping'' molecules (Berridge, M. J., and Irvine, R. F. (1989) Nature 341, 197-205) arises from belief in their metabolic lethargy. However, we have discovered that celt homogenates, incubated with 5 mm fluoride and 5 mM ATP, converted both inositol hexakisphosphate (K(m) = 2 +/-0.5 muM, V(max) = 9 +/- 2 pmol/mg of protein/min) and inositol 1,3,4,5,6-pentakisphosphate (K(m) = 13 +/- 4 muM, V(max) = 11 +/- 5 pmol/mg of protein/min) to more polar products. These reactions were also observed in intact cells treated with 0.5-20 mM fluoride, and the precursor/product relationships were confirmed by comparing the effects of fluoride on cells differentially labeled with [H-3]inositol in either short-term or pulse-chase protocols. The novel products were determined to be inositol pyrophosphates because of their relatively specific hydrolysis by tobacco pyrophosphatase and alkaline phosphatase. The pyrophosphates were metabolized rapidly by cell homogenates back to their pentakisphosphate and hexakisphosphate precursors. This endogenous pyrophosphatase activity was inhibited by up to 99% by 5 mM fluoride in vitro. In intact cells incubated with 10 mM fluoride, about 20% of the inositol 1,3,4,5,6-pentakisphosphate pool, and 50% of the inositol hexakisphosphate pool were each converted to pyrophosphate derivatives within 1 h.	NIEHS,CELLULAR & MOLEC PHARMACOL LAB,INOSITOL LIPID SECT,RES TRIANGLE PK,NC 27709; NIEHS,CALCIUM REGULAT SECT,RES TRIANGLE PK,NC 27709	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)			Shears, Stephen B/C-6335-2019; Putney, James W/F-7247-2019	Shears, Stephen B/0000-0001-7309-8916; Putney, James W/0000-0002-3379-4789; Menniti, Frank/0000-0003-2612-9534				AGRANOFF BW, 1985, INOSITOL PHOSPHOINOS, pR21; BALLA T, 1989, J BIOL CHEM, V264, P9386; BARRACO RA, 1989, EUR J PHARMACOL, V173, P75, DOI 10.1016/0014-2999(89)90010-1; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BIRD GSJ, 1991, BIOCHEM J, V273, P541, DOI 10.1042/bj2730541; BLACKMORE PF, 1985, J BIOL CHEM, V260, P4477; BRIGHTWELL R, 1968, ARCH BIOCHEM BIOPHYS, V124, P325, DOI 10.1016/0003-9861(68)90334-2; CHABRE M, 1990, TRENDS BIOCHEM SCI, V15, P6, DOI 10.1016/0968-0004(90)90117-T; CHAPPELE.D, 1974, BIOCHEMISTRY-US, V13, P1788, DOI 10.1021/bi00706a002; EUROPEFINNER GN, 1989, J CELL SCI, V93, P585; GRAF E, 1984, J BIOL CHEM, V259, P3620; HESLOP JP, 1985, J EXP BIOL, V119, P395; ISAACKS RE, 1980, AM ZOOL, V20, P115; JI H, 1989, J BIOL CHEM, V264, P20185; Maslanski J. A., 1990, METHODS INOSITIDE RE, P109; MATTINGLY RR, 1991, J BIOL CHEM, V266, P15144; MENNITI FS, 1990, J BIOL CHEM, V265, P11167; Michell A.H., 1989, INOSITOL LIPIDS CELL; OLIVER KG, 1992, J BIOL CHEM, V267, P21528; SEARGEANT LE, 1979, CAN J BIOCHEM CELL B, V57, P1000, DOI 10.1139/o79-124; SHEARS SB, 1989, J BIOL CHEM, V264, P19879; Shears Stephen B., 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P63; SHINSHI H, 1976, BIOCHEMISTRY-US, V15, P2185, DOI 10.1021/bi00655a024; STEPHENS LR, 1988, BIOCHEM J, V253, P721, DOI 10.1042/bj2530721; STEPHENS LR, 1991, BIOCHEM J, V275, P485, DOI 10.1042/bj2750485; STEWART SJ, 1987, BIOCHEM BIOPH RES CO, V145, P895, DOI 10.1016/0006-291X(87)91049-7; VALLEJO M, 1987, NATURE, V330, P656, DOI 10.1038/330656a0; WONG NS, 1988, BIOCHEM J, V252, P1	28	172	179	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					3850	3856						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382679				2022-12-27	WOS:A1993KN53300013
J	ZHOU, XM; CUNHA, MJ; EPSTEIN, J; LEVENSON, R; CANTLEY, LC; CANTLEY, LG				ZHOU, XM; CUNHA, MJ; EPSTEIN, J; LEVENSON, R; CANTLEY, LC; CANTLEY, LG			A MURINE GENOMIC DNA FRAGMENT AMPLIFIES OUABAIN-INDUCED NA,K-ATPASE ALPHA/BETA-SUBUNIT MESSENGER-RNA UP-REGULATION AND CONFERS OUABAIN RESISTANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT; MOLECULAR-CLONING; EXPRESSION; CELLS; GENE; TRANSFECTION; CDNA; IDENTIFICATION; AMPLIFICATION; ALPHA-1	Transfection of primate cells with a 6.4-kilobase murine genomic DNA fragment (called ouabain resistance gene or MOR6.5) has been shown previously to confer ouabain resistance (Levenson, R., Racaniello, V., Albritton, L., and Housman, D. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 1489-1493). The mechanism by which this sequence can transfer ouabain resistance remains unclear. In order to further investigate this mechanism, we determined the full-length nucleotide sequence of MOR6.5. Other than mouse repetitive domains, this DNA does not have significant homology with any coding sequence in GenBank. Although potential open reading frames and polyadenylation signals were found, we were unable to detect an MOR6.5 transcript in CV-1 or COS-1 cells transfected with this DNA, either at early or late times following transfection. We show that in early passages of MOR6.5 transfectants which were under ouabain-selective pressure and still contained MOR6.5 DNA sequence, mRNAs for both alpha1- and beta1-subunits of the Na,K-ATPase were amplified approximately 10-fold, compared to parental CV-1 cells. These results suggest that MOR6.5 may rescue the cells from ouabain toxicity by inducing transient up-regulation of the messages for the Na,K-ATPase. This might prolong cell survival on ouabain until mutations in the alpha1-subunit occur, which permanently reduce ouabain inhibition of the pump (Cantley, L. G., Zhou, X.-M., Cunha, M., Epstein, J., and Cantley, L. C. (1992) J. Biol. Chem. 267, 17271-17278). Possible mechanisms for the up-regulation of transcription based on sequence similarities found between MOR6.5 and the 5'-flanking regions of alpha1- and beta1-subunit genes are discussed.	YALE UNIV,DEPT CELL BIOL,NEW HAVEN,CT 06510; HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,BOSTON,MA 02115; HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,BOSTON,MA 02215	Yale University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	ZHOU, XM (corresponding author), TUFTS UNIV,SCH MED,DEPT PHYSIOL,BOSTON,MA 02111, USA.		Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653; Levenson, Robert/0000-0002-0936-8421				Battey, 1986, BASIC METHODS MOL BI; CANESSA CM, 1992, EMBO J, V11, P1681, DOI 10.1002/j.1460-2075.1992.tb05218.x; CANTLEY LG, 1992, J BIOL CHEM, V267, P17271; CECH TR, 1983, CELL, V34, P713, DOI 10.1016/0092-8674(83)90527-5; CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9; COFFIN J, 1984, RNA TUMOR VIRUSES, V2, P36; EAKLE KA, 1992, P NATL ACAD SCI USA, V89, P2834, DOI 10.1073/pnas.89.7.2834; EMANUEL JR, 1988, J BIOL CHEM, V263, P7726; EMANUEL JR, 1986, MOL CELL BIOL, V6, P2476, DOI 10.1128/MCB.6.7.2476; EMANUEL JR, 1989, MOL CELL BIOL, V9, P3744, DOI 10.1128/MCB.9.9.3744; ENGLISH LH, 1985, J BIOL CHEM, V260, P1114; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; HOROWITZ B, 1990, J BIOL CHEM, V265, P4189; HUNG MC, 1989, P NATL ACAD SCI USA, V86, P2545, DOI 10.1073/pnas.86.8.2545; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; KAPLAN PL, 1987, J VIROL, V61, P1731, DOI 10.1128/JVI.61.5.1731-1734.1987; KAWAKAMI K, 1986, NUCLEIC ACIDS RES, V14, P2833, DOI 10.1093/nar/14.7.2833; KAWAMURA M, 1991, SODIUM PUMP STRUCT M, V46, P46; KENT RB, 1987, SCIENCE, V237, P901, DOI 10.1126/science.3039660; KORMAN AJ, 1987, P NATL ACAD SCI USA, V84, P2150, DOI 10.1073/pnas.84.8.2150; LEVENSON R, 1984, P NATL ACAD SCI-BIOL, V81, P1489, DOI 10.1073/pnas.81.5.1489; LINGREL J B, 1990, Journal of General Physiology, V96, p1A; PRESSLEY TA, 1986, J BIOL CHEM, V261, P9779; PRICE EM, 1990, J BIOL CHEM, V265, P6638; RAYSON BM, 1991, J BIOL CHEM, V266, P21335; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER JW, 1987, BLOOD CELLS, V13, P299; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; SHIMOTOHNO K, 1982, NATURE, V299, P543; SHULL MM, 1990, GENOMICS, V6, P451, DOI 10.1016/0888-7543(90)90475-A; SHYJAN AW, 1989, BIOCHEMISTRY-US, V28, P4531, DOI 10.1021/bi00437a002; SORGE J, 1982, Journal of Molecular and Applied Genetics, V1, P547; TAKEYASU K, 1987, J BIOL CHEM, V262, P10733; THOMAS RE, 1981, BURGERS MED CHEM, V3, P47; YOUNG RM, 1987, J BIOL CHEM, V262, P4905	37	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					4126	4133						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382694				2022-12-27	WOS:A1993KN53300051
J	KUZNETSOV, G; BROSTROM, MA; BROSTROM, CO				KUZNETSOV, G; BROSTROM, MA; BROSTROM, CO			ROLE OF ENDOPLASMIC RETICULAR CALCIUM IN OLIGOSACCHARIDE PROCESSING OF ALPHA-1-ANTITRYPSIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED OLIGOSACCHARIDES; ALPHA-MANNOSIDASE; PROTEIN-SYNTHESIS; BINDING PROTEINS; 2ND MESSENGERS; GOLGI-COMPLEX; INTACT-CELLS; RAT-LIVER; SECRETION; MEMBRANE	Mobilization of Ca2+ from the endoplasmic reticulum (ER) suppresses translational initiation and inhibits post-translational processing and secretion of glycoproteins. This study explores the mechanism whereby ionomycin, a Ca2+ ionophore, and thapsigargin, an ER Ca2+-ATPase inhibitor, promote retention of alpha1-antitrypsin (alpha1-AT) bearing high mannose, endoglycosidase H (Endo H)-sensitive oligosaccharide side chains within the ER of HepG2 cells. Arrest occurred at the removal of mannose residues such that intermediates with Man7-9GlcNAc2 side chains accumulated with the Man8-9GlcNAc2 structures predominating. Maturation of alpha1-AT bearing Man5-6GlcNAc2 side chains was unaffected. Inhibition of alpha1-AT processing by ionomycin occurred independently of translational suppression. Forms of alpha1-AT identical to those retained with ionomycin or thapsigargin were observed upon treatment with the alpha-1,2-mannosidase inhibitor 1-deoxymannojirimycin whereas castanospermine, an inhibitor of ER alpha-glucosidase I, produced different forms of the glycoprotein. Neither inhibitor impaired transport or secretion of alpha1-AT. With brefeldin A, which causes redistribution of Golgi enzymes to the ER, alpha1-AT was retained intracellularly but acquired resistance to Endo H. With ionomycin, thapsigargin, or 1-deoxymannojirimycin-treated cells, however, brefeldin A failed to promote further processing of the glycoprotein. Possible mechanisms for the suppression of alpha1-AT processing at the alpha-1,2-mannosidase step by Ca2+-mobilizing agents are discussed. Excepting tunicamycin, traditional inhibitors of protein processing did not affect amino acid incorporation.	UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT PHARMACOL,PISCATAWAY,NJ 08854	Rutgers State University New Brunswick; Rutgers State University Medical Center					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035393] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 35393] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABDELLATIF AA, 1986, PHARMACOL REV, V38, P227; ALBERT PR, 1984, J BIOL CHEM, V259, P5350; ALBERT PR, 1986, AM J PHYSIOL, V251, pC887, DOI 10.1152/ajpcell.1986.251.6.C887; BALCH WE, 1986, J BIOL CHEM, V261, P4681; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BISCHOFF J, 1990, J BIOL CHEM, V265, P17110; BISCHOFF J, 1986, J BIOL CHEM, V261, P4766; BROSTROM CO, 1989, J BIOL CHEM, V264, P1644; BROSTROM CO, 1983, J BIOL CHEM, V258, P4390; BROSTROM CO, 1990, ANNU REV PHYSIOL, V52, P577; BROSTROM MA, 1992, NUTRITION GENE EXPRE, P117; CAMIRAND A, 1991, J BIOL CHEM, V266, P15120; CARRELL RW, 1982, NATURE, V298, P329, DOI 10.1038/298329a0; CHIN KV, 1988, INT J BIOCHEM, V20, P1313, DOI 10.1016/0020-711X(88)90236-4; DANIELSEN EM, 1990, J BIOL CHEM, V265, P14566; DESILVA AM, 1990, J CELL BIOL, V111, P857, DOI 10.1083/jcb.111.3.857; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; HARTMANN E, 1989, EMBO J, V8, P2225, DOI 10.1002/j.1460-2075.1989.tb08346.x; HICKMAN S, 1977, J BIOL CHEM, V252, P4402; HIGH S, 1991, J CELL BIOL, V113, P35, DOI 10.1083/jcb.113.1.35; KABCENELL AK, 1985, J CELL BIOL, V101, P1270, DOI 10.1083/jcb.101.4.1270; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; KOLESNICK RN, 1984, AM J PHYSIOL, V246, pE458, DOI 10.1152/ajpendo.1984.246.5.E458; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; KUZNETSOV G, 1992, J BIOL CHEM, V267, P3932; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LODISH HF, 1987, J CELL BIOL, V104, P221, DOI 10.1083/jcb.104.2.221; LODISH HF, 1992, J BIOL CHEM, V267, P12753; LODISH HF, 1984, J CELL BIOL, V98, P1720, DOI 10.1083/jcb.98.5.1720; LODISH HF, 1990, J BIOL CHEM, V265, P1893; MILNER RE, 1991, J BIOL CHEM, V266, P7155; MOORE SEH, 1990, J BIOL CHEM, V265, P13104; MOREMEN KW, 1990, GLYCOCONJUGATE J, V7, P401; NIGAM SK, 1990, J CELL BIOL, V111, P197, DOI 10.1083/jcb.111.1.197; NOIVA R, 1992, J BIOL CHEM, V267, P3553; OLDEN K, 1978, CELL, V13, P461, DOI 10.1016/0092-8674(78)90320-3; PORUCHYNSKY MS, 1991, J CELL BIOL, V114, P651, DOI 10.1083/jcb.114.4.651; PROSTKO CR, 1992, J BIOL CHEM, V267, P16751; PROUD CG, 1992, CURR TOP CELL REGUL, V32, P243; RABOUILLE C, 1992, J BIOL CHEM, V267, P11573; RIZZOLO LJ, 1988, J BIOL CHEM, V263, P9520; ROTH J, 1987, BIOCHIM BIOPHYS ACTA, V906, P405, DOI 10.1016/0304-4157(87)90018-9; SCHUTZBACH JS, 1990, J BIOL CHEM, V265, P2546; STRUCK DK, 1978, J BIOL CHEM, V253, P5332; SUZUKI CK, 1991, J CELL BIOL, V114, P189, DOI 10.1083/jcb.114.2.189; THASTRUP O, 1990, AGENTS ACTIONS, V29, P8, DOI 10.1007/BF01964706; TRIMBLE RB, 1984, ANAL BIOCHEM, V141, P515, DOI 10.1016/0003-2697(84)90080-0; TSAO YS, 1992, J CELL BIOL, V116, P57, DOI 10.1083/jcb.116.1.57; WADA I, 1991, J BIOL CHEM, V266, P19599; WILEMAN T, 1991, J BIOL CHEM, V266, P4500; WONG WL, 1993, IN PRESS BIOCH J	54	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2001	2008						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380585				2022-12-27	WOS:A1993KH62000077
J	IKEDA, K; OKAZAKI, R; INOUE, D; OGATA, E; MATSUMOTO, T				IKEDA, K; OKAZAKI, R; INOUE, D; OGATA, E; MATSUMOTO, T			TRANSCRIPTION OF THE GENE FOR PARATHYROID HORMONE-RELATED PEPTIDE FROM THE HUMAN IS ACTIVATED THROUGH A CAMP-DEPENDENT PATHWAY BY PROSTAGLANDIN-E1 IN HTLV-I-INFECTED T-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE ZIPPER STRUCTURE; AMP RESPONSE ELEMENT; NUCLEAR FACTOR CREB; PROTEIN-KINASE-C; CYCLIC-AMP; HUMORAL HYPERCALCEMIA; SOMATOSTATIN GENE; CDNA CLONES; NUCLEOTIDE-SEQUENCE; LEUKEMIA-LYMPHOMA	Human T-cell leukemia virus type I (HTLV-I) is the etiologic agent of adult T-cell leukemia (ATL), and hypercalcemia frequently associated with ATL is mediated by parathyroid hormone-related peptide (PTHRP). The present study was undertaken to clarify the role of cAMP second messenger system in the regulation of human PTHRP gene expression in ATL cells, using an HTLV-I-infected T-cell line, MT-2. Forskolin and dibutyryl cAMP (Bt2cAMP) caused a marked and transient increase in the steady-state level of PTHRP mRNA. The effects of these agents were dose-dependent, and the maximal effects were observed at 3 h. Nuclear runoff transcription assay showed that forskolin and Bt2cAMP caused an increase in the transcription rate of the human PTHRP gene. In contrast, the stability of PTHRP mRNA was only modestly increased by these agents. Forskolin and Bt2cAMP also increased the secretion of PTHRP by MT-2 cells, as determined by both a newly established immunoradiometric assay using two antibodies against human PTHRP-(1-34) and PTHRP-(50-83) and a radio-immunoassay using an antibody against human PTHRP-(109-141). Prostaglandin E1 (PGE1) caused a marked stimulation of intracellular cAMP production in MT-2 cells, whereas PGE2 and PGF2alpha had only modest effects. The ability of these PGs to stimulate cAMP production correlated well with their ability to increase PTHRP mRNA level and the secretion of PTHRP. Indomethacin did not affect the basal level of cAMP production or PTHRP mRNA, suggesting that endogenous PG was not involved in the basal production of cAMP or PTHRP. When PGE1 was given to MT-2 cells together with interleukin 2, which is another stimulator of PTHRP gene expression, PTHRP secretion was synergistically stimulated. These results suggest that the transcription of the human PTHRP gene is enhanced through a cAMP-dependent pathway by PGE1 and that PGE1, as well as interleukin 2, plays an important role in the overexpression of the human PTHRP gene in HTLV-I-infected T cells leading to the development of hypercalcemia in ATL patients.			IKEDA, K (corresponding author), UNIV TOKYO,SCH MED,DEPT INTERNAL MED 4,DIV ENDOCRINOL,3-28-6 MEJIRODAI,BUNKYO KU,TOKYO 112,JAPAN.							BAKER PE, 1981, CELL IMMUNOL, V61, P52, DOI 10.1016/0008-8749(81)90353-1; BECKNER SK, 1986, J BIOL CHEM, V261, P3043; BRAVO R, 1987, CELL, V48, P251, DOI 10.1016/0092-8674(87)90428-4; BROADUS AE, 1988, NEW ENGL J MED, V319, P556; BUNN PA, 1983, NEW ENGL J MED, V309, P257, DOI 10.1056/NEJM198308043090501; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; COMB M, 1986, NATURE, V323, P353, DOI 10.1038/323353a0; FARRAR WL, 1987, J IMMUNOL, V139, P2075; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FUKUMOTO S, 1988, ARCH INTERN MED, V148, P921, DOI 10.1001/archinte.148.4.921; FUKUMOTO S, 1989, CANCER RES, V49, P3849; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GOTO T, 1983, J IMMUNOL, V130, P1350; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; HONMA M, 1977, BIOCHEM MED METAB B, V18, P257, DOI 10.1016/0006-2944(77)90060-6; IKEDA K, 1988, J CLIN INVEST, V81, P2010, DOI 10.1172/JCI113551; IKEDA K, 1989, J BIOL CHEM, V264, P15743; IKEDA K, 1988, MOL ENDOCRINOL, V2, P1230, DOI 10.1210/mend-2-12-1230; IKEDA K, 1990, J BIOL CHEM, V265, P5398; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JOHNSON KW, 1988, P NATL ACAD SCI USA, V85, P6072, DOI 10.1073/pnas.85.16.6072; KASAHARA H, 1992, BIOMED RES-TOKYO, V13, P155, DOI 10.2220/biomedres.13.155; KLAUSNER RD, 1987, J BIOL CHEM, V262, P12654; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; MANGIN M, 1988, MOL ENDOCRINOL, V2, P1049, DOI 10.1210/mend-2-11-1049; MANGIN M, 1988, P NATL ACAD SCI USA, V85, P597, DOI 10.1073/pnas.85.2.597; MANGIN M, 1990, MOL ENDOCRINOL, V4, P851, DOI 10.1210/mend-4-6-851; MANGIN M, 1989, P NATL ACAD SCI USA, V86, P2408, DOI 10.1073/pnas.86.7.2408; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MOTOKURA T, 1988, BIOCHEM BIOPH RES CO, V154, P1182, DOI 10.1016/0006-291X(88)90265-3; MOTOKURA T, 1989, ANN INTERN MED, V111, P484, DOI 10.7326/0003-4819-111-6-484; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; REMILLARD B, 1991, J BIOL CHEM, V266, P14167; RIABOWOL KT, 1988, NATURE, V336, P83, DOI 10.1038/336083a0; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHIRAKAWA F, 1988, P NATL ACAD SCI USA, V85, P8201, DOI 10.1073/pnas.85.21.8201; SILVER BJ, 1987, P NATL ACAD SCI USA, V84, P2198, DOI 10.1073/pnas.84.8.2198; SMITH MR, 1991, J CLIN INVEST, V87, P761, DOI 10.1172/JCI115078; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; TSUKADA T, 1987, J BIOL CHEM, V262, P8743; VANSTRAATEN F, 1983, P NATL ACAD SCI-BIOL, V80, P3183; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YASUDA T, 1989, J BIOL CHEM, V264, P7720; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; YOSHIMURA T, 1990, EMBO J, V9, P2537, DOI 10.1002/j.1460-2075.1990.tb07434.x	53	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1174	1179						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8380405				2022-12-27	WOS:A1993KG07700062
J	GAO, ZH; KREBS, J; VANBERKUM, MFA; TANG, WJ; MAUNE, JF; MEANS, AR; STULL, JT; BECKINGHAM, K				GAO, ZH; KREBS, J; VANBERKUM, MFA; TANG, WJ; MAUNE, JF; MEANS, AR; STULL, JT; BECKINGHAM, K			ACTIVATION OF 4 ENZYMES BY 2 SERIES OF CALMODULIN MUTANTS WITH POINT MUTATIONS IN INDIVIDUAL CA(2+) BINDING-SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; X-RAY-SCATTERING; DROSOPHILA-MELANOGASTER CALMODULIN; CALCIUM-BINDING; CONFORMATIONAL CHANGE; CA2+-BINDING SITES; CARDIAC TROPONIN; PEPTIDE COMPLEX; TARGET ENZYMES; CENTRAL HELIX	Activation of four target enzymes by two series of calmodulin Ca2+ binding site mutants has been examined. In each mutant, the conserved bidentate glutamate of one of the Ca2+ binding sites is mutated to glutamine or lysine. The enzymes studied were smooth and skeletal muscle myosin light chain kinases, adenylylcyclase, and plasma membrane Ca2+-ATPase. For the first three enzymes, the activation patterns with the two mutant series were very similar: mutation of site 4 was most deleterious, then site 2, site 3, and site 1. This ranking was observed previously in Ca2+ binding and Ca2+-induced conformational studies of these mutants. Thus the response of these enzymes is probably determined by the extent to which each mutant's competence to interact with target binding regions has been compromised. In contrast, for Ca2+-ATPase, mutants of sites 3 and 4 were much poorer activators than those of sites 1 and 2. Events beyond calmodulin binding and related to enzyme activation probably dictate this unusual activation pattern and also the anomalously poor activation of skeletal muscle myosin light chain kinase by site 1 mutant B1Q. Site 1 mutant B1K showed wild type activation of all four enzymes suggesting that in site 1, the lysine substitution can evoke the conformational changes associated with Ca2+ binding.	RICE UNIV,DEPT BIOCHEM & CELL BIOL,POB 1892,HOUSTON,TX 77251; UNIV TEXAS,SW MED CTR,DEPT PHYSIOL,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,MOSS HEART CTR,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,DALLAS,TX 75235; SWISS FED INST TECHNOL,DEPT BIOCHEM,CH-8092 ZURICH,SWITZERLAND; BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030	Rice University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Swiss Federal Institutes of Technology Domain; ETH Zurich; Baylor College of Medicine			Krebs, Joachim/CAF-0460-2022; krebs, joachim/B-3023-2013	Tang, Wei-Jen/0000-0002-8267-8995	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM049155, R01GM049155, R37GM034497, R01GM033976, R01GM034497] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33976, GM34497, GM49155] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BECKINGHAM K, 1991, J BIOL CHEM, V266, P6027; BLUMENTHAL DK, 1985, P NATL ACAD SCI USA, V82, P3187, DOI 10.1073/pnas.82.10.3187; BLUMENTHAL DK, 1980, BIOCHEMISTRY-US, V19, P5608, DOI 10.1021/bi00565a023; BLUMENTHAL DK, 1988, MOL ASPECTS CELLULAR, V5, P341; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BZEDGA T, 1992, J BIOL CHEM, V267, P4394; COX JA, 1985, J BIOL CHEM, V260, P2527; CROUCH TH, 1981, BIOCHEMISTRY-US, V20, P6318, DOI 10.1021/bi00525a006; EDELMAN AM, 1985, J BIOL CHEM, V260, P1275; FABBIATO A, 1979, J PHYSL PARIS, V75, P463; GEORGE SE, 1990, J BIOL CHEM, V265, P9228; GUERINI D, 1987, EUR J BIOCHEM, V170, P35, DOI 10.1111/j.1432-1033.1987.tb13664.x; GUERINI D, 1984, J BIOL CHEM, V259, P5172; HAIECH J, 1991, J BIOL CHEM, V266, P3427; HEIDORN DB, 1988, BIOCHEMISTRY-US, V27, P909, DOI 10.1021/bi00403a011; HEIDORN DB, 1989, BIOCHEMISTRY-US, V28, P6757, DOI 10.1021/bi00442a032; HERRING BP, 1990, J BIOL CHEM, V265, P16588; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; JAMES P, 1988, J BIOL CHEM, V263, P2905; KATAOKA M, 1991, BIOCHEMISTRY-US, V30, P6247, DOI 10.1021/bi00239a024; KATAOKA M, 1989, P NATL ACAD SCI USA, V86, P6944, DOI 10.1073/pnas.86.18.6944; KEMP BE, 1985, J BIOL CHEM, V260, P3355; KEMP BE, 1987, J BIOL CHEM, V262, P2542; KRETSINGER RH, 1976, ANNU REV BIOCHEM, V45, P239, DOI 10.1146/annurev.bi.45.070176.001323; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; LUKAS TJ, 1986, BIOCHEMISTRY-US, V25, P1458, DOI 10.1021/bi00354a041; MATSUSHIMA N, 1989, J BIOCHEM, V105, P883, DOI 10.1093/oxfordjournals.jbchem.a122773; MAUNE JF, 1992, BIOCHEMISTRY-US, V31, P7779, DOI 10.1021/bi00149a006; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MUKHERJEA P, 1993, BIOCHEM MOL BIOL INT, V29, P555; NEWTON DL, 1984, J BIOL CHEM, V259, P4419; NIGGLI V, 1979, J BIOL CHEM, V254, P9955; NUNNALLY MH, 1985, J BIOL CHEM, V260, P1020; OLWIN BB, 1985, BIOCHEMISTRY-US, V24, P8081, DOI 10.1021/bi00348a037; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; PEARSON RB, 1982, FEBS LETT, V145, P327, DOI 10.1016/0014-5793(82)80193-2; PERRIE WT, 1970, BIOCHEM J, V119, P31, DOI 10.1042/bj1190031; PERSECHINI A, 1988, J BIOL CHEM, V263, P12175; PERSECHINI A, 1988, J CARDIOVASC PHARM, V12, pS1; SEATON BA, 1985, BIOCHEMISTRY-US, V24, P6740, DOI 10.1021/bi00345a002; SMITH VL, 1987, J MOL BIOL, V196, P471, DOI 10.1016/0022-2836(87)90025-8; SOLOMON Y, 1974, ANAL BIOCHEM, V58, P541; STAROVASNIK MA, 1992, PROTEIN SCI, V1, P245; STULL JT, 1978, J BIOL CHEM, V253, P5932; STULL JT, 1988, MOL ASPECTS CELL REG, V5, P92; TANG WJ, 1991, J BIOL CHEM, V266, P8595; TAYLOR DA, 1991, J BIOL CHEM, V266, P21375; TOROK K, 1992, BIOCHEMISTRY-US, V31, P3452, DOI 10.1021/bi00128a020; VANBERKUM MFA, 1990, J BIOL CHEM, V265, P3750; VANBERKUM MFA, 1991, J BIOL CHEM, V266, P21488; VORHERR T, 1990, BIOCHEMISTRY-US, V29, P355, DOI 10.1021/bi00454a008; WEBER PC, 1989, PROTEINS, V6, P70, DOI 10.1002/prot.340060107; YOSHINO H, 1989, J BIOL CHEM, V264, P19706; ZOT HG, 1990, J BIOL CHEM, V265, P14796	56	80	80	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20096	20104						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376368				2022-12-27	WOS:A1993LY01900029
J	KUSNER, DJ; SCHOMISCH, SJ; DUBYAK, GR				KUSNER, DJ; SCHOMISCH, SJ; DUBYAK, GR			ATP-INDUCED POTENTIATION OF G-PROTEIN-DEPENDENT PHOSPHOLIPASE-D ACTIVITY IN A CELL-FREE SYSTEM FROM U937 PROMONOCYTIC LEUKOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; TYROSINE PHOSPHORYLATION; HUMAN NEUTROPHIL; HL-60 CELLS; PHOSPHATIDIC-ACID; PHORBOL ESTER; GROWTH-FACTOR; PHOSPHATIDYLCHOLINE BREAKDOWN; NADPH OXIDASE; RECEPTOR	Although G-protein- and protein kinase-mediated pathways have been reported to activate phospholipase D (PLD) following cell stimulation, the relation between these activation pathways and the mechanistic details of lipase stimulation remain unknown. We have studied activation of PLD by GTPgammaS (guanosine 5'-O-(thiotriphosphate)), and its potentiation by ATP, in a cell-free system derived from U937 human promonocytic leukocytes. ATP, in the micromolar to millimolar range, significantly augmented GTPgammaS-stimulated PLD activity (2.6-fold) and the combination resulted in a 15-fold increase in PLD activity compared to control. ATP alone did not stimulate PLD activity. Measurement of endogenous cytosolic ATP levels and nucleotide depletion with activated charcoal demonstrated that stimulation of PLD by GTPgammaS proceeds by both ATP-dependent and -independent pathways. Nucleotide specificity data suggested that the ATP-dependent pathway involves kinase activity. The tyrosine phosphatase inhibitor vanadate augmented PLD activity stimulated by GTPgammaS/ATP by 41% (p < 0.01). Conversely, the tyrosine kinase inhibitors genistein and herbimycin A decreased PLD activity stimulated by GTPgammaS/ATP by 58 and 35%, respectively (p < 0.001 for each). Mixing experiments utilizing subcellular fractions from herbimycin A-treated cells suggested that the relevant tyrosine kinase activity is membrane-associated. Despite its role in ATP-induced potentiation, tyrosine kinase activity is neither necessary nor sufficient for activation of PLD in this system. Protein kinase C (PKC) is unlikely to play a role in potentiation by ATP as PKC activity is not stimulated under conditions of maximal PLD activation.	CASE WESTERN RESERVE UNIV,DEPT PHYSIOL & BIOPHYS,CLEVELAND,OH 44106	Case Western Reserve University				Dubyak, George/0000-0001-9720-4226	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036387] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-07470] Funding Source: Medline; NIGMS NIH HHS [GM-36387] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGWU DE, 1991, J CLIN INVEST, V88, P531, DOI 10.1172/JCI115336; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; ANTHES JC, 1991, BIOCHEM BIOPH RES CO, V175, P236, DOI 10.1016/S0006-291X(05)81225-2; BENAV P, 1989, FEBS LETT, V259, P64, DOI 10.1016/0014-5793(89)81495-4; BERNSTEIN G, 1992, CELL, V70, P411; BILLAH MM, 1989, J BIOL CHEM, V264, P9069; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; BOCCKINO SB, 1987, J BIOL CHEM, V262, P15309; BONFINI L, 1992, SCIENCE, V255, P603, DOI 10.1126/science.1736363; BONSER RW, 1989, BIOCHEM J, V264, P617, DOI 10.1042/bj2640617; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; BOULAY F, 1990, BIOCHEMISTRY-US, V29, P11123, DOI 10.1021/bi00502a016; BOURGOIN S, 1992, J BIOL CHEM, V267, P11908; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRICKELL P M, 1992, Critical Reviews in Oncogenesis, V3, P401; CARTER RH, 1991, P NATL ACAD SCI USA, V88, P2745, DOI 10.1073/pnas.88.7.2745; CASNELLIE JE, 1982, P NATL ACAD SCI-BIOL, V79, P282, DOI 10.1073/pnas.79.2.282; COCKCROFT S, 1992, BIOCHIM BIOPHYS ACTA, V1113, P135, DOI 10.1016/0304-4157(92)90036-A; DEYOUNG MB, 1991, HEART CARDIOVASCULAR, P543; DUBYAK GR, 1993, BIOCHEM J, V292, P121, DOI 10.1042/bj2920121; EINSPAHR KJ, 1991, P NATL ACAD SCI USA, V88, P6279, DOI 10.1073/pnas.88.14.6279; EXTON JH, 1990, J BIOL CHEM, V265, P1; FAULKNER L, 1992, IMMUNOLOGY, V76, P65; GENY B, 1992, BIOCHEM J, V284, P531, DOI 10.1042/bj2840531; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; HAUSDORFF WP, 1992, P NATL ACAD SCI USA, V89, P5720, DOI 10.1073/pnas.89.13.5720; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; IRVING HR, 1987, J BIOL CHEM, V262, P3440; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; KANAHO Y, 1992, J BIOL CHEM, V267, P23554; KANAHO Y, 1991, J IMMUNOL, V146, P3536; KASZKIN M, 1992, BIOCHEM J, V287, P51, DOI 10.1042/bj2870051; KATAGIRI K, 1991, J IMMUNOL, V146, P701; KESTER M, 1992, J CELL PHYSIOL, V150, P578, DOI 10.1002/jcp.1041500319; KINSKY SC, 1989, BIOCHEM BIOPH RES CO, V162, P788, DOI 10.1016/0006-291X(89)92379-6; KISS Z, 1990, J BIOL CHEM, V265, P7345; KONISHI F, 1991, BIOCHEM BIOPH RES CO, V179, P1070, DOI 10.1016/0006-291X(91)91928-6; LIAO F, 1992, P NATL ACAD SCI USA, V89, P3659, DOI 10.1073/pnas.89.8.3659; LISCOVITCH M, 1991, CELL REGUL, V2, P1011, DOI 10.1091/mbc.2.12.1011; NOTARIO V, 1989, J CELL BIOL, V109, P3129, DOI 10.1083/jcb.109.6.3129; OLSON SC, 1991, J BIOL CHEM, V266, P17236; PARK S, 1992, J BIOL CHEM, V267, P17194; PERRY DK, 1992, J IMMUNOL, V149, P2749; PEVERI P, 1992, P NATL ACAD SCI USA, V89, P2494, DOI 10.1073/pnas.89.6.2494; PIKE LJ, 1982, P NATL ACAD SCI-BIOL, V79, P1443, DOI 10.1073/pnas.79.5.1443; PIKE LJ, 1986, J BIOL CHEM, V261, P3782; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; SONG JG, 1991, MOL CELL BIOL, V11, P4903, DOI 10.1128/MCB.11.10.4903; TETTENBORN CS, 1988, BIOCHEM BIOPH RES CO, V155, P249, DOI 10.1016/S0006-291X(88)81076-3; THOMAS KM, 1991, J BIOL CHEM, V266, P14839; UINGS IJ, 1992, BIOCHEM J, V281, P597, DOI 10.1042/bj2810597; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; VANDERMEULEN J, 1990, BIOCHEM J, V271, P693, DOI 10.1042/bj2710693; XIE MS, 1991, BIOCHEM J, V278, P81, DOI 10.1042/bj2780081; XIE MS, 1991, J CLIN INVEST, V88, P45, DOI 10.1172/JCI115303	55	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					19973	19982						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376359				2022-12-27	WOS:A1993LY01900012
J	QIU, XY; YIN, ML; PADMANABHAN, KP; KRSTENANSKY, JL; TULINSKY, A				QIU, XY; YIN, ML; PADMANABHAN, KP; KRSTENANSKY, JL; TULINSKY, A			STRUCTURES OF THROMBIN COMPLEXES WITH A DESIGNED AND A NATURAL EXOSITE PEPTIDE INHIBITOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-THROMBIN; PRO-ARG CHLOROMETHYLKETONE; HIRUDIN COMPLEX; CRYSTAL-STRUCTURE; FUNCTIONAL DOMAIN; SITE	The structures of two hirudin-based fibrinogen recognition exosite peptide inhibitors with significantly different sequences complexed with alpha-thrombin at a site distinct from the active site (exosite) have been determined crystallographically at 2.2 and 2.3 angstrom resolution. One is a designed synthetic peptide with some nonconventional amino acid residues (MDL-28050), and the other is a natural COOH-terminal peptide isolated from the leech Hirudinaria manillensis (hirullin P18). The structures have been refined by restrained least squares methods to R values of 0.161 and 0.155, respectively. The first stretch of each peptide, corresponding to hirudin 55-59, associates with thrombin similar to hirudin and hirugen (hirudin 53-64). Although the remaining residues of the inhibitors interact with and bind to thrombin, the binding is accomplished through a rigid body conformational adjustment of the peptide with respect to the conformation displayed by hirudin and hirugen (40-degrees- rotation about the Ile59'CA-C bond). This causes the side groups of cyclohexylalanine 64' of MDL-28050 and Ile60' of hirullin to point in the opposite direction of the all important Tyr63' ring of hirudin and hirugen but permits the residues to penetrate and interact with the 3(10) turn hydrophobic binding pocket of thrombin. Thus, the hydrophobic interaction is accomplished in a different way by virtue of the substrate conformational readjustment. The results show that the first stretch of peptide makes concerted and efficient binding interactions with thrombin, and the peptide positions of the inhibitors are fairly specific and homologous so that the stretch appears to be related to specific recognition associated with the exosite. The relative flexibility of structure and sequence of the second stretch is a display of tolerance of imprecision by thrombin in its COOH-terminal hydrophobic association with hirudin-based inhibitors.	MICHIGAN STATE UNIV,DEPT CHEM,E LANSING,MI 48824; MARION MERRELL DOW RES INST,CINCINNATI,OH 45215	Michigan State University; Dow Chemical Company			Krstenansky, John/W-1569-2019; Krstenansky, John/L-3905-2016	Krstenansky, John/0000-0003-3773-2523	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043229] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL43229] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; BETZ A, 1991, BIOCHEMISTRY-US, V30, P9848, DOI 10.1021/bi00105a006; BETZ A, 1991, BIOCHEM J, V275, P801, DOI 10.1042/bj2750801; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; BODE W, 1992, PROTEIN SCI, V1, P426; BODE W, 1991, THROMBIN STRUCTURE F, P3; CHANG JY, 1991, BIOCHEMISTRY-US, V30, P6656, DOI 10.1021/bi00241a004; GRUTTER MG, 1990, EMBO J, V9, P2361, DOI 10.1002/j.1460-2075.1990.tb07410.x; HENDRICKSON WA, 1980, BIOMOLECULAR STRUCTU, P43; HOWARD AJ, 1987, J APPL CRYSTALLOGR, V20, P383, DOI 10.1107/S0021889887086436; JONES TA, 1982, COMPUTATIONAL CRYSTA, P303; KARSHIKOV A, 1992, PROTEIN SCI, V1, P727, DOI 10.1002/pro.5560010605; KRSTENANSKY JL, 1990, THROMB HAEMOSTASIS, V63, P208; KRSTENANSKY JL, 1991, BLOOD COAGUL FIBRIN, V2, P91, DOI 10.1097/00001721-199102000-00014; KRSTENANSKY JL, 1990, FEBS LETT, V269, P425, DOI 10.1016/0014-5793(90)81208-6; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; NI F, 1992, BIOCHEMISTRY-US, V31, P2545, DOI 10.1021/bi00124a015; PADMANABHAN K, 1993, J BIOL CHEM, V268, P17651; QIU XY, 1992, BIOCHEMISTRY-US, V31, P11689, DOI 10.1021/bi00162a004; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; SCHARF M, 1989, FEBS LETT, V255, P105, DOI 10.1016/0014-5793(89)81070-1; SKRZYPCZAKJANKUN E, 1991, J MOL BIOL, V221, P1379; STEINER V, 1990, J CHROMATOGR-BIOMED, V530, P273, DOI 10.1016/S0378-4347(00)82331-2; SZEWCZUK Z, 1992, BIOCHEMISTRY-US, V31, P9132, DOI 10.1021/bi00153a004; TULINSKY A, 1993, BLOOD COAGUL FIBRIN, V4, P305, DOI 10.1097/00001721-199304000-00012	26	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20318	20326						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376390				2022-12-27	WOS:A1993LY01900061
J	ATKINS, WM; WANG, RW; BIRD, AW; NEWTON, DJ; LU, AYH				ATKINS, WM; WANG, RW; BIRD, AW; NEWTON, DJ; LU, AYH			THE CATALYTIC MECHANISM OF GLUTATHIONE-S-TRANSFERASE (GST) - SPECTROSCOPIC DETERMINATION OF THE PK(A) OF TYR-9 IN RAT ALPHA-1-1 GST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SITE-DIRECTED MUTAGENESIS; 3-DIMENSIONAL STRUCTURE; PI; COMPLEX; RESOLUTION; BINDING; YAYA	The rat alpha1-1 glutathione S-transferase (GST) contains a single, non-essential tryptophan and only 8 tyrosines in each subunit. One of these tyrosines, Tyr-9, hydrogen bonds to the substrate glutathione and stabilizes the nucleophilic thiolate anion. Two mutant proteins that allow for the spectroscopic determination of the pK(a) of this catalytic residue have been constructed. The W21F mutant provides a fully active GST with no tryptophans, and the double mutant W21F/Y9F lacks both tryptophan and the active site tyrosine. The intrinsic fluorescence and absorbance properties of these mutants are dominated by tyrosine. Fluorescence emission, fluorescence excitation, and absorbance spectral changes of samples containing the W21F mutant at several pH values in the range 6.8-9.0 reveal a pH-dependent increase in the contribution of tyrosinate. No spectral changes are observed with the W21F/Y9F protein in this pH range. At pH 12.5, both proteins exhibit complete deprotonation of all tyrosines. The pK(a) of Tyr-9 determined from these spectroscopic changes is 8.3-8.5. The changes in absorbance at 250 and 295 nm correspond to titration of 0.95 +/- 0.29 tyrosines/subunit in the W21F protein between pH 6.9 and 9.3. Moreover, addition of the inhibitor S-hexyl-glutathione results in an apparent increase in the pK(a) of Tyr-9. Together, these results indicate that the catalytically active Tyr of GSTs has a pK(a) value that is 1.8-2.0 pK(a) units below tyrosine in solution. It is likely that this decrease in the pK(a) of Tyr-9 contributes to catalysis by altering the equilibrium position of the proton shared between Tyr-9 and GSH, and this active site residue may function as a general base catalyst in addition to a hydrogen bond donor.	UNIV WASHINGTON,SCH PHARM,DEPT MED CHEM,SEATTLE,WA 98195	University of Washington; University of Washington Seattle	ATKINS, WM (corresponding author), MERCK RES LABS,DEPT DRUG METAB,RAHWAY,NJ 07065, USA.							ARMSTRONG RN, 1991, CHEM RES TOXICOL, V4, P131, DOI 10.1021/tx00020a001; CHEN WJ, 1988, BIOCHEMISTRY-US, V27, P647, DOI 10.1021/bi00402a023; CLELAND WW, 1992, BIOCHEMISTRY-US, V31, P317, DOI 10.1021/bi00117a001; COLES B, 1990, CRIT REV BIOCHEM MOL, V25, P47, DOI 10.3109/10409239009090605; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; GRAMINSKI GF, 1989, BIOCHEMISTRY-US, V28, P3562, DOI 10.1021/bi00434a062; HUSKEY SEW, 1991, J AM CHEM SOC, V113, P2283, DOI 10.1021/ja00006a056; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; KONG KH, 1992, BIOCHEM BIOPH RES CO, V184, P194, DOI 10.1016/0006-291X(92)91177-R; LAWS WR, 1979, J BIOL CHEM, V254, P2582; LIU SX, 1992, J BIOL CHEM, V267, P4296; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; MANOHARAN TH, 1992, J MOL BIOL, V226, P319, DOI 10.1016/0022-2836(92)90949-K; MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409; NAGADA K, 1990, J BIOL CHEM, V265, P4296; PENINGTON CJ, 1992, BIOCHEMISTRY-US, V31, P2912, DOI 10.1021/bi00126a010; PICKETT CB, 1989, ANNU REV BIOCHEM, V58, P743, DOI 10.1146/annurev.bi.58.070189.003523; REINEMER P, 1992, J MOL BIOL, V227, P214, DOI 10.1016/0022-2836(92)90692-D; REINEMER P, 1991, EMBO J, V10, P1997, DOI 10.1002/j.1460-2075.1991.tb07729.x; ROBSON CN, 1987, CANCER RES, V47, P6922; Ross J.P., 1989, P1; TSUCHIDA S, 1992, CRIT REV BIOCHEM MOL, V27, P337, DOI 10.3109/10409239209082566; WANG RW, 1992, ARCH BIOCHEM BIOPHYS, V297, P86, DOI 10.1016/0003-9861(92)90644-C; WANG RW, 1989, ARCH BIOCHEM BIOPHYS, V269, P536, DOI 10.1016/0003-9861(89)90137-9; WANG RW, 1992, J BIOL CHEM, V267, P19866; WILLIS KJ, 1991, J PHYS CHEM-US, V95, P1585, DOI 10.1021/j100157a015	26	91	93	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19188	19191						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366071				2022-12-27	WOS:A1993LW81900008
J	SESHADRI, T; UZMAN, JA; OSHIMA, J; CAMPISI, J				SESHADRI, T; UZMAN, JA; OSHIMA, J; CAMPISI, J			IDENTIFICATION OF A TRANSCRIPT THAT IS DOWN-REGULATED IN SENESCENT HUMAN FIBROBLASTS - CLONING, SEQUENCE-ANALYSIS, AND REGULATION OF THE HUMAN L7 RIBOSOMAL-PROTEIN GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; REPLICATIVE SENESCENCE; GROWTH-FACTOR; CELLULAR SENESCENCE; RIBONUCLEIC-ACID; C-FOS; CELLS; EXPRESSION; DIFFERENTIATION; OVEREXPRESSION	Normal eukaryotic cells divide only a limited number of times before proliferation ceases due to cellular senescence. We previously reported that a constitutively expressed, non-cell cycle-regulated transcript of unknown identity declines severalfold when human fibroblasts become senescent. We show here, from the sequence of cDNA and genomic clones, that this transcript encodes L7, a structural protein of the large ribosomal subunit. The human L7 protein shares > 90% amino acid identity with the mouse and rat L7 proteins but is shorter than either rodent protein due to fewer basic repetitive motifs at the amino terminus. The position of the first intron is conserved between the mouse and human genes. The L7 mRNA was abundant, stable (t1/2 > 10 h), and polyadenylated in presenescent and senescent human fibroblasts; however, steady state mRNA levels were 5-10-fold lower in senescent cells, whether derived from fetal lung or neonatal foreskin. Quiescent and senescent cells synthesized protein at similar rates, yet only senescent cultures showed a decline in L7 mRNA. The mRNAs encoding five other ribosomal proteins (L5, P1, S3, S6, and S10) behaved similarly. The results suggest that the senescence-associated decline in L7 and other ribosomal protein mRNAs is unrelated to growth state or protein synthetic rate per se and support the view that senescence and quiescence are dissimilar states.	LAWRENCE BERKELEY LAB,DEPT CELL & MOLEC BIOL,1 CYCLOTRON RD,BERKELEY,CA 94720	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory					NATIONAL INSTITUTE ON AGING [R37AG009909, R01AG009909, R56AG009909] Funding Source: NIH RePORTER; NIA NIH HHS [AG09909] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BANTLE JA, 1976, ANAL BIOCHEM, V72, P413, DOI 10.1016/0003-2697(76)90549-2; BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112; CHESTER KA, 1989, BIOCHIM BIOPHYS ACTA, V1009, P297, DOI 10.1016/0167-4781(89)90119-X; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CRISTOFALO VJ, 1989, J GERONTOL, V44, P55, DOI 10.1093/geronj/44.6.55; DIPAOLO BR, 1992, EXP CELL RES, V201, P500, DOI 10.1016/0014-4827(92)90300-W; FINGERT HJ, 1993, CANC MED, P1; GEYER PK, 1982, MOL CELL BIOL, V2, P685, DOI 10.1128/MCB.2.6.685; GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hill WE., 1990, RIBOSOME STRUCTURE F; KAO HT, 1983, MOL CELL BIOL, V3, P2058, DOI 10.1128/MCB.3.11.2058; KAUFMANN Y, 1977, P NATL ACAD SCI USA, V74, P4801, DOI 10.1073/pnas.74.11.4801; KIEF DR, 1981, MOL CELL BIOL, V1, P1007, DOI 10.1128/MCB.1.11.1007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE RA, 1990, CELL REGUL, V1, P215, DOI 10.1091/mbc.1.2.215; LIN A, 1987, J BIOL CHEM, V262, P12665; LU KH, 1989, MOL CELL BIOL, V9, P3411, DOI 10.1128/MCB.9.8.3411; MARTIN GM, 1974, AM J PATHOL, V74, P137; MCCAFFREY P, 1987, J BIOL CHEM, V262, P1442; McCormick A, 1991, CURR OPIN CELL BIOL, V3, P230, DOI 10.1016/0955-0674(91)90144-N; MEYUHAS O, 1990, J BIOL CHEM, V265, P11465; Meyuhas O., 1984, RECOMBINANT DNA CELL, P243; MURANO S, 1991, MOL CELL BIOL, V11, P3905, DOI 10.1128/MCB.11.8.3905; NORWOOD TH, 1974, P NATL ACAD SCI USA, V71, P2231, DOI 10.1073/pnas.71.6.2231; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OU JH, 1987, NUCLEIC ACIDS RES, V18, P8919; PEACOCKE M, 1991, J CELL BIOCHEM, V45, P147, DOI 10.1002/jcb.240450205; PEREIRASMITH OM, 1983, SCIENCE, V221, P964, DOI 10.1126/science.6879195; PEREIRASMITH OM, 1988, P NATL ACAD SCI USA, V85, P6042, DOI 10.1073/pnas.85.16.6042; POGUEGEILE K, 1991, MOL CELL BIOL, V11, P3842, DOI 10.1128/MCB.11.8.3842; RITTLING SR, 1986, P NATL ACAD SCI USA, V83, P3316, DOI 10.1073/pnas.83.10.3316; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680; SMITH JR, 1974, J CELL BIOL, V62, P48, DOI 10.1083/jcb.62.1.48; STANNERS CP, 1979, J CELL PHYSIOL, V100, P127, DOI 10.1002/jcp.1041000113; STANULISPRAEGER BM, 1987, MECH AGEING DEV, V38, P1, DOI 10.1016/0047-6374(87)90109-6; STEIN GH, 1991, P NATL ACAD SCI USA, V88, P11012, DOI 10.1073/pnas.88.24.11012; TUSHINSKI RJ, 1982, J CELL PHYSIOL, V112, P128, DOI 10.1002/jcp.1041120119; WEST MD, 1989, EXP CELL RES, V184, P138, DOI 10.1016/0014-4827(89)90372-8; WOOL IG, 1990, RIBOSOME, P203	41	68	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18474	18480						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360149				2022-12-27	WOS:A1993LV65900017
J	DATTI, A; DENNIS, JW				DATTI, A; DENNIS, JW			REGULATION OF UDP-GLCNACGAL-BETA-1-3GALNAC-R-BETA-1-6-N-ACETYLGLUCOSAMINYLTRANSFERASE(GLCNAC TO GALNAC) IN CHINESE-HAMSTER OVARY CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; WISKOTT-ALDRICH SYNDROME; LINKED SUGAR CHAINS; CYCLIC-AMP; TRANSIENT EXPRESSION; SODIUM-BUTYRATE; GLYCOSYLATION; ACTIVATION; PHOSPHORYLATION; BIOSYNTHESIS	UDP-GlcNAc:Galbeta3GalNAc-R (GcNAc to GalNAc) beta1-6-N-acetylglucosaminyltransferase (i.e. core 2 GlcNAc-T) of the O-linked oligosaccharide pathway is developmentally regulated in human T cells, and changes in its activity have been associated with malignancies and the Wiskott-Aldrich immunodeficiency syndrome. Chinese hamster ovary (CHO) cells normally express low levels of core 2 GlcNAc-T activity (8-12 pmol/mg/h) which can be accurately measured with a two-step assay employing purified bovine beta1-4Gal-T and high specific activity UDP-[H-3]Gal to radiolabel the core 2 reaction product. CHO cells treated with 2 mM sodium butyrate for 24 h exhibited a 16-fold increase in core 2 GlcNAc-T activity, whereas several other differentiating agents including dimethyl sulfoxide, retinoic acid, phorbol ester, and cholera toxin had no effect on activity. The addition of butyrate, cholera toxin, or dimethyl sulfoxide to CHO cells slowed cell proliferation and induced changes in cell morphology characteristic of cell differentiation. Induction of core 2 GlcNAc-T by butyrate was blocked by actinomycin D and cycloheximide. Butyrate treatment also elevated cytosolic cAMP levels with a time course which paralleled, but preceded, induction of core 2 GlcNAc-T activity by approximately 8 h. The protein kinase inhibitors H-7 and H-8 blocked butyrate-dependent induction of enzyme activity, whereas the inactive analogue H1004 had no effect. Core 2 GlcNAc-T showed a change in K(m) for UDP-GlcNAc, from 0.50 mM in untreated cells to 4.54 mM in butyrate + cholera toxin treated CHO cells, but no changes in K(m) for the synthetic acceptor, Galbeta1-3GalNAcalpha-paranitrophenyl. Despite the 9-fold increase in K(m) for sugar nucleotide, V(max)/K(m) was 8.8-fold greater in treated compared with untreated cells. These observations suggest that in CHO cells induction of core 2 GlcNAc-T by butyrate treatment requires de novo gene transcription/translation, activation of protein kinase(s), and is associated with changes in the kinetic properties of the enzyme.	MT SINAI HOSP,SAMUEL LUNENFELD RES INST,TORONTO M5G 1X5,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto			Dennis, James/E-7268-2013; Datti, Alessandro/ABA-1108-2021	Datti, Alessandro/0000-0001-6824-7382				BANERJEE DK, 1987, P NATL ACAD SCI USA, V84, P6389, DOI 10.1073/pnas.84.18.6389; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; BOFFA LC, 1981, J BIOL CHEM, V256, P9612; BROCKHAUSEN I, 1991, CANCER RES, V51, P1257; BUNNELL BA, 1990, BIOCHEM BIOPH RES CO, V171, P196, DOI 10.1016/0006-291X(90)91376-4; BURNS LJ, 1988, BLOOD, V72, P1536; CUMMING D A, 1991, Glycobiology, V1, P115, DOI 10.1093/glycob/1.2.115; DANNA JA, 1980, BIOCHEMISTRY-US, V19, P2656, DOI 10.1021/bi00553a019; DATTI A, 1992, ANAL BIOCHEM, V206, P262, DOI 10.1016/0003-2697(92)90364-D; DEKORTE D, 1987, CANCER RES, V47, P1841; FLEISCHMANN RD, 1992, SOMAT CELL MOLEC GEN, V18, P103, DOI 10.1007/BF01233157; FURUKAWA K, 1990, INT IMMUNOL, V2, P105, DOI 10.1093/intimm/2.1.105; HEFFERNAN M, 1993, J BIOL CHEM, V268, P1242; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HIGGINS EA, 1991, J BIOL CHEM, V266, P6280; HSIEH P, 1983, J BIOL CHEM, V258, P2548; KAGAWA Y, 1988, J BIOL CHEM, V263, P17508; LAMPH WW, 1990, P NATL ACAD SCI USA, V87, P4320, DOI 10.1073/pnas.87.11.4320; LI AP, 1977, ARCH BIOCHEM BIOPHYS, V182, P181, DOI 10.1016/0003-9861(77)90297-1; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; MILHAUD P, 1980, J CELL PHYSIOL, V104, P163, DOI 10.1002/jcp.1041040205; NIELSON SE, 1980, P NATL ACAD SCI-BIOL, V77, P985, DOI 10.1073/pnas.77.2.985; OSHIMA T, 1991, J BIOL CHEM, V266, P13621; PAREKH RB, 1987, EMBO J, V6, P1233, DOI 10.1002/j.1460-2075.1987.tb02359.x; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; PAULSON JC, 1989, J BIOL CHEM, V264, P10931; PILLER F, 1991, J EXP MED, V173, P1501, DOI 10.1084/jem.173.6.1501; PILLER F, 1988, J BIOL CHEM, V263, P15146; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; SCHACHTER H, 1971, J BIOL CHEM, V246, P5321; SCHROTER H, 1981, EUR J BIOCHEM, V120, P21, DOI 10.1111/j.1432-1033.1981.tb05664.x; SHAH S, 1992, J BIOL CHEM, V267, P10652; SHARMA C, 1988, BIOCHEM BIOPH RES CO, V155, P615, DOI 10.1016/S0006-291X(88)80539-4; SHEARES BT, 1986, P NATL ACAD SCI USA, V83, P1993, DOI 10.1073/pnas.83.7.1993; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521; STORRIE B, 1978, J CELL PHYSIOL, V94, P69, DOI 10.1002/jcp.1040940109; TAKEUCHI M, 1988, J BIOL CHEM, V263, P3657; WANG X, 1990, Glycobiology, V1, P25, DOI 10.1093/glycob/1.1.25; WANG XC, 1989, J BIOL CHEM, V264, P1854; YOUSEFI S, 1991, J BIOL CHEM, V266, P1772	40	40	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1993	268	8					5409	5416						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR822	8383671				2022-12-27	WOS:A1993KR82200013
J	AJCHENBAUM, F; ANDO, K; DECAPRIO, JA; GRIFFIN, JD				AJCHENBAUM, F; ANDO, K; DECAPRIO, JA; GRIFFIN, JD			INDEPENDENT REGULATION OF HUMAN D-TYPE CYCLIN GENE-EXPRESSION DURING G1-PHASE IN PRIMARY HUMAN LYMPHOCYTES-T	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA SUSCEPTIBILITY GENE; CDC2 PROTEIN-KINASE; CELL-CYCLE; MESSENGER-RNA; ACTIVATION; PRODUCT; YEAST; PROLIFERATION; PHOSPHORYLATION; PROGRESSION	Cyclins and cyclin-dependent kinases are critically involved in controlling cell cycle progression in virtually all cells. The recent identification of candidate G1 cyclins in mammalian cells has been a major advance in this field, but the exact functions of these cyclins are unknown. The expression of three D-type cyclins (D1, D2, and D3) was investigated in primary human T lymphocytes as these cells were induced to leave G0, traverse G1, and enter S phase by T cell-specific mitogens. G0 phase T cells expressed low levels of cyclin D2, but not cyclin D3. Treatment of these cells with phytohemagglutinin and 12-O-tetradecanoylphorbol-13-acetate in the presence of fetal calf serum resulted in rapid induction of cyclin D2 RNA in early G1 and slower induction of cyclin D3 in late G1. Cyclin D1 was not detected in T cells under any condition tested. Treatment of T cells with hydroxyurea to arrest cells at G1/S did not block induction of either D2 or D3. However, arrest of cells in mid G1 with deferoxamine blocked D3 expression without affecting D2. Cyclosporin A blocked the induction of both cyclin D2 and D3. Polyclonal antisera were prepared in rabbits against both cyclin D2 and cyclin D3 glutathione S-transferase fusion proteins and used to examine cyclin D2 and D3 proteins in [S-35]methionine-labeled T cells. Protein levels were found to correlate closely with RNA levels for both cyclins. No detectable histone HI kinase activity could be precipitated with either cyclin. However, several cellular proteins were observed to coprecipitate with the cyclins, including several proteins that were observed to associate only with D3. These results indicate that striking differences exist in the induction and regulation of two candidate G1 cyclins in human T cells and suggest that these cyclins could participate in multiple cell cycle check-points during G0, G1, or S phase.	HARVARD UNIV, SCH MED,DANA FARBER CANC INST,DIV TUMOR IMMUNOL, 44 BINNEY ST, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DIV NEOPLAST DIS MECHANISMS, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School								ADAMS RLP, 1967, J BIOL CHEM, V242, P1314; BARNARD JA, 1990, BIOCHIM BIOPHYS ACTA, V1032, P79, DOI 10.1016/0304-419X(90)90013-Q; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DECAPRIO JA, 1992, P NATL ACAD SCI USA, V89, P1795, DOI 10.1073/pnas.89.5.1795; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; DRAETTA G, 1989, CELL, V56, P829, DOI 10.1016/0092-8674(89)90687-9; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; FURUKAWA Y, 1990, SCIENCE, V250, P805, DOI 10.1126/science.2237430; JUNE CH, 1989, J IMMUNOL, V143, P153; JUNE CH, 1990, IMMUNOL TODAY, V11, P211, DOI 10.1016/0167-5699(90)90085-N; JUNE CH, 1987, MOL CELL BIOL, V7, P4472, DOI 10.1128/MCB.7.12.4472; KAELIN WG, 1991, CELL, V64, P521, DOI 10.1016/0092-8674(91)90236-R; KOFF A, 1991, CELL, V66, P1217, DOI 10.1016/0092-8674(91)90044-Y; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; KUMAGAI N, 1988, J IMMUNOL, V140, P37; LEDERMAN HM, 1984, BLOOD, V64, P748; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; LYN B, 1991, EMBO J, V10, P857; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PINES J, 1991, COLD SPRING HARB SYM, V56, P449; PINES J, 1990, New Biologist, V2, P389; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; REED SI, 1985, P NATL ACAD SCI USA, V82, P4055, DOI 10.1073/pnas.82.12.4055; RICHARDSON HE, 1989, CELL, V59, P1127, DOI 10.1016/0092-8674(89)90768-X; ROSENTHAL ET, 1980, CELL, V20, P487, DOI 10.1016/0092-8674(80)90635-2; SHIPP MA, 1987, J IMMUNOL, V139, P2143; SIMANIS V, 1986, CELL, V45, P261, DOI 10.1016/0092-8674(86)90390-9; TERADA N, 1991, J IMMUNOL, V147, P698; TSAI LH, 1991, NATURE, V353, P174, DOI 10.1038/353174a0; WITHERS DA, 1991, MOL CELL BIOL, V11, P4846, DOI 10.1128/MCB.11.10.4846; WITTENBERG C, 1990, CELL, V62, P225, DOI 10.1016/0092-8674(90)90361-H; YUE X, 1991, CELL, V65, P691, DOI 10.1016/0092-8674(91)90100-D	41	263	271	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					4113	4119						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382693				2022-12-27	WOS:A1993KN53300049
J	MELENDY, T; STILLMAN, B				MELENDY, T; STILLMAN, B			AN INTERACTION BETWEEN REPLICATION PROTEIN-A AND SV40 T-ANTIGEN APPEARS ESSENTIAL FOR PRIMOSOME ASSEMBLY DURING SV40 DNA-REPLICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMIAN VIRUS-40 DNA; LAGGING STRAND SYNTHESIS; CELL NUCLEAR ANTIGEN; POLYMERASE-ALPHA; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; INVITRO REPLICATION; PURIFIED PROTEINS; BINDING-PROTEIN; INITIATION	Replication protein A from human cells (hRPA) is a multisubunit single-stranded DNA-binding protein (ssb) and is essential for SV40 DNA replication in vitro. The related RPA from Saccharomyces cerevisiae (scRPA) is unable to substitute for hRPA in SV40 DNA replication. To understand this species specificity, we evaluated human and yeast RPA in enzymatic assays with SV40 T antigen (TAg) and human DNA polymerase alpha/primase, the factors essential for initiation of SV40 DNA replication. Both human and yeast RPA stimulated the polymerase and (at subsaturating levels of RPA) the primase activities of human DNA polymerase alpha/primase on homopolymer DNA templates. In contrast, both human and yeast RPA inhibited synthesis by DNA polymerase alpha/primase on natural single-stranded DNA (ssDNA) templates. T antigen reversed the inhibition of DNA polymerase alpha/primase activity on hRPA-coated natural ssDNA, as previously described, but was unable to reverse the inhibition on scRPA or Escherichia coli ssb-coated templates. Therefore, the ability of an ssb to reconstitute SV40 DNA replication correlated with its ability to allow the TAg stimulation of polymerase alpha/primase in this assay. Enzyme-linked immunoassays demonstrated that hRPA interacts with TAg, as previously described; however, scRPA does not bind to TAg in this assay. These and other recent results suggest that T antigen contains a function analogous to some prokaryotic DNA replication proteins that facilitate primosome assembly on ssb-coated template DNAs.	COLD SPRING HARBOR LAB, POB 100, COLD SPRING HARBOR, NY 11724 USA	Cold Spring Harbor Laboratory				Stillman, Bruce/0000-0002-9453-4091	NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NCI NIH HHS [CA13106] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; ARAI K, 1981, P NATL ACAD SCI-BIOL, V78, P69, DOI 10.1073/pnas.78.1.69; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; BRILL SJ, 1991, GENE DEV, V5, P1589, DOI 10.1101/gad.5.9.1589; BROWN GW, 1992, P NATL ACAD SCI USA, V89, P10227, DOI 10.1073/pnas.89.21.10227; BULLOCK PA, 1989, P NATL ACAD SCI USA, V86, P3944, DOI 10.1073/pnas.86.11.3944; BULLOCK PA, 1991, MOL CELL BIOL, V11, P2350, DOI 10.1128/MCB.11.5.2350; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; COLLINS KL, 1991, MOL CELL BIOL, V11, P2108, DOI 10.1128/MCB.11.4.2108; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P16, DOI 10.1073/pnas.84.1.16; DORNREITER I, 1990, EMBO J, V9, P3329, DOI 10.1002/j.1460-2075.1990.tb07533.x; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; EKI T, 1992, J BIOL CHEM, V267, P7284; EKI T, 1991, J VIROL, V65, P4874, DOI 10.1128/JVI.65.9.4874-4881.1991; ERDILE LF, 1991, COLD SH Q B, V56, P303; ERDILE LF, 1991, J BIOL CHEM, V266, P12090; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; GANNON J V, 1990, New Biologist, V2, P84; GANNON JV, 1987, NATURE, V329, P456, DOI 10.1038/329456a0; HACKER K, 1989, J CELL BIOCHEM, V13, P87; HEYER WD, 1990, EMBO J, V9, P2321, DOI 10.1002/j.1460-2075.1990.tb07404.x; HURWITZ J, 1990, J BIOL CHEM, V265, P18043; ISHIMI Y, 1988, J BIOL CHEM, V263, P19723; KENNY MK, 1990, J BIOL CHEM, V265, P769; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; KORNBERG A, 1991, DNA REPLICATION, P286; LANFORD RE, 1988, VIROLOGY, V167, P72, DOI 10.1016/0042-6822(88)90055-4; LEBOWITZ JH, 1985, P NATL ACAD SCI USA, V82, P3988, DOI 10.1073/pnas.82.12.3988; LEE SH, 1991, J BIOL CHEM, V266, P594; LIU CC, 1981, J BIOL CHEM, V256, P2821; LIU LF, 1981, P NATL ACAD SCI-BIOL, V78, P3487, DOI 10.1073/pnas.78.6.3487; MATSUMOTO T, 1990, P NATL ACAD SCI USA, V87, P9712, DOI 10.1073/pnas.87.24.9712; MELENDY T, 1991, J BIOL CHEM, V266, P1942; MELENDY T, 1992, NUCLEIC ACIDS MOL BI, V6, P129; MURAKAMI Y, 1986, P NATL ACAD SCI USA, V83, P2869, DOI 10.1073/pnas.83.9.2869; MURAKAMI Y, 1992, P NATL ACAD SCI USA, V89, P952, DOI 10.1073/pnas.89.3.952; NOSSAL NG, 1980, J BIOL CHEM, V255, P2176; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; PRELICH G, 1988, CELL, V53, P117, DOI 10.1016/0092-8674(88)90493-X; PRIVES C, 1990, CELL, V61, P735, DOI 10.1016/0092-8674(90)90179-I; SALAHUDDIN, 1990, GENE DEV, V4, P968, DOI 10.1101/gad.4.6.968; SCHNEIDER C, 1992, DNA REPLICATION REGU; SCHOMBURG U, 1986, EUR J BIOCHEM, V160, P451, DOI 10.1111/j.1432-1033.1986.tb10061.x; SENGUPTA DJ, 1992, SCIENCE, V256, P1656, DOI 10.1126/science.256.5064.1656; SMALE ST, 1986, MOL CELL BIOL, V6, P4077, DOI 10.1128/MCB.6.11.4077; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; TSURIMOTO T, 1990, NATURE, V346, P534, DOI 10.1038/346534a0; TSURIMOTO T, 1989, EMBO J, V8, P3883, DOI 10.1002/j.1460-2075.1989.tb08567.x; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; TSURIMOTO T, 1989, MOL CELL BIOL, V9, P3839, DOI 10.1128/MCB.9.9.3839; WAHLE E, 1989, J BIOL CHEM, V264, P2469; WAHLE E, 1989, J BIOL CHEM, V264, P2463; WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513; WEINBERG DH, 1990, P NATL ACAD SCI USA, V87, P8692, DOI 10.1073/pnas.87.22.8692; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834; WOLD MS, 1989, J BIOL CHEM, V264, P2801; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523	62	192	192	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3389	3395						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381428				2022-12-27	WOS:A1993KM16100058
J	OHSAKO, S; NISHIDA, Y; RYO, H; YAMAUCHI, T				OHSAKO, S; NISHIDA, Y; RYO, H; YAMAUCHI, T			MOLECULAR CHARACTERIZATION AND EXPRESSION OF THE DROSOPHILA CA2+ CALMODULIN-DEPENDENT PROTEIN KINASE-II GENE - IDENTIFICATION OF 4 FORMS OF THE ENZYME GENERATED FROM A SINGLE GENE BY ALTERNATIVE SPLICING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; ALPHA-SUBUNIT; SUBCELLULAR-DISTRIBUTION; ESCHERICHIA-COLI; RAT FOREBRAIN; BETA-SUBUNIT; BRAIN; AUTOPHOSPHORYLATION; PURIFICATION; MELANOGASTER	Four cDNA sequences encoding Ca2+/calmodulin-dependent protein kinase II (CaM kinase II) were isolated from a Drosophila adult head cDNA library using rat CaM kinase II alpha and beta cDNA sequences under low stringency hybridization conditions. These cDNA clones encoded polypeptides of 490, 509, 516, and 530 amino acids, which are identical to one another except for amino acid insertions or deletions near the carboxyl-terminal of the putative ''link'' segment. These polypeptides showed considerable similarity to rat brain CaM kinase II with more than 70% of the amino acids being identical. The Drosophila adult head contains three major species of CaM kinase II with molecular masses of 55, 58, and 60 kDa. These cross-react with anti-rat CaM kinase II antibody. An expression study of the four cDNA sequences in mammalian cells revealed that the polypeptides of 490, 509, and 530 amino acids that had been predicted from the cDNA sequences correspond to the 55-, 58-, and 60-kDa polypeptides found in the head, respectively, and all exhibited enzymatic properties similar to those of rat brain CaM kinase II, including self-regulation. The Drosophila CaM kinase II gene was located in segment 102E-F on the fourth chromosome and consisted of at least 16 exons spanning approximately 20 kilobase pairs. Four forms of the enzyme are generated from a single gene by alternative splicing. Transcripts of CaM kinase II are expressed in great quantities in the central nervous system in the late embryonic stage of development and are more abundant in the head than in the body of the adult fly.	TOKYO METROPOLITAN INST MED SCI,DEPT CELL BIOL,2-6 MUSASHIDAI,TOKYO 113,JAPAN; AICHI CANC CTR,RES INST,EXPTL RADIOL LAB,CHIKUSA KU,NAGOYA,AICHI 464,JAPAN; OSAKA UNIV,FAC MED,DEPT RADIAT BIOL,SUITA,OSAKA 565,JAPAN	Tokyo Metropolitan Institute of Medical Science; Aichi Cancer Center; Osaka University								BENNETT MK, 1983, J BIOL CHEM, V258, P2735; BENNETT MK, 1987, P NATL ACAD SCI USA, V84, P1794, DOI 10.1073/pnas.84.7.1794; BENSON DL, 1991, J NEUROSCI, V11, P31; BRONSTEIN JM, 1988, J NEUROCHEM, V50, P1438, DOI 10.1111/j.1471-4159.1988.tb03028.x; BULLEIT RF, 1988, NEURON, V1, P63, DOI 10.1016/0896-6273(88)90210-3; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CAVENER DR, 1991, NUCLEIC ACIDS RES, V19, P3185, DOI 10.1093/nar/19.12.3185; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHO KO, 1991, NEURON, V7, P439, DOI 10.1016/0896-6273(91)90296-C; COLBRAN RJ, 1989, BIOCHEM J, V258, P313, DOI 10.1042/bj2580313; DOYLE KE, 1990, J MOL BIOL, V213, P599, DOI 10.1016/S0022-2836(05)80245-1; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; FONG YL, 1989, J BIOL CHEM, V264, P16759; FRYBERG EA, 1983, CELL, V33, P115; GOLDENRING JR, 1983, J BIOL CHEM, V258, P2632; HAGIWARA T, 1991, J BIOL CHEM, V266, P16401; HANLEY RM, 1987, SCIENCE, V237, P293, DOI 10.1126/science.3037704; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; HIROSE F, 1991, NUCLEIC ACIDS RES, V19, P4991, DOI 10.1093/nar/19.18.4991; KANASEKI T, 1991, J CELL BIOL, V115, P1049, DOI 10.1083/jcb.115.4.1049; KELLY PT, 1987, J NEUROCHEM, V49, P1927, DOI 10.1111/j.1471-4159.1987.tb02456.x; KENNEDY MB, 1981, P NATL ACAD SCI-BIOL, V78, P1293, DOI 10.1073/pnas.78.2.1293; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; KOVALICK GE, 1992, DEV BIOL, V150, P33, DOI 10.1016/0012-1606(92)90005-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN CR, 1987, P NATL ACAD SCI USA, V84, P5962, DOI 10.1073/pnas.84.16.5962; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MCGUINNESS TL, 1985, J BIOL CHEM, V260, P1696; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MOGAMI K, 1982, J BIOCHEM-TOKYO, V91, P643, DOI 10.1093/oxfordjournals.jbchem.a133736; NAIRN AC, 1985, ANNU REV BIOCHEM, V54, P931, DOI 10.1146/annurev.bi.54.070185.004435; NISHIDA Y, 1988, EMBO J, V7, P775, DOI 10.1002/j.1460-2075.1988.tb02875.x; OHSAKO S, 1991, J BIOCHEM-TOKYO, V109, P137, DOI 10.1093/oxfordjournals.jbchem.a123334; OHSAKO S, 1990, BIOCHEM BIOPH RES CO, V170, P705, DOI 10.1016/0006-291X(90)92148-S; OHTA Y, 1988, J BIOL CHEM, V263, P11540; ROSTAS JAP, 1988, J NEUROCHEM, V50, P945, DOI 10.1111/j.1471-4159.1988.tb03003.x; RUBIN GM, 1988, SCIENCE, V240, P1453, DOI 10.1126/science.3131880; SAITOH T, 1985, J CELL BIOL, V100, P835, DOI 10.1083/jcb.100.3.835; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHULMAN H, 1988, ADV SEC MESS PHOSPH, V22, P39; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; TOBIMATSU T, 1988, J BIOL CHEM, V263, P16082; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WILLMUND R, 1986, P NATL ACAD SCI USA, V83, P9789, DOI 10.1073/pnas.83.24.9789; YAMANAKA MK, 1987, NUCLEIC ACIDS RES, V15, P3335, DOI 10.1093/nar/15.8.3335; YAMAUCHI T, 1980, FEBS LETT, V116, P141, DOI 10.1016/0014-5793(80)80628-4; YAMAUCHI T, 1983, EUR J BIOCHEM, V132, P15, DOI 10.1111/j.1432-1033.1983.tb07319.x; YAMAUCHI T, 1990, FEBS LETT, V266, P55, DOI 10.1016/0014-5793(90)81505-I; YAMAUCHI T, 1989, J BIOL CHEM, V264, P19108	52	53	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2052	2062						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380587				2022-12-27	WOS:A1993KH62000084
J	TONEY, K; BATEMAN, A; GAGNON, C; BENNETT, HPJ				TONEY, K; BATEMAN, A; GAGNON, C; BENNETT, HPJ			ASPARTIMIDE FORMATION IN THE JOINING PEPTIDE SEQUENCE OF PORCINE AND MOUSE PROOPIOMELANOCORTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN CARBOXYL METHYLTRANSFERASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; L-ISOASPARTYL RESIDUES; ASPARTYL RESIDUES; ENDOPLASMIC-RETICULUM; SUCCINIMIDE FORMATION; NUCLEOTIDE-SEQUENCE; RAT PITUITARY; METHYLATION; DEAMIDATION	The joining peptide (JP) portion of pro-opiomelanocortin extracted from mouse pituitary glands has previously been shown to exist in one major and several distinct minor forms (Bennett, H. P. J. (1986) Peptides 7, 614-622). We now confirm the heterogeneous nature of JP extracted from mouse neurointermediate pituitary glands and show that similar forms of JP are also to be found in extracts of porcine pituitary glands. Three forms of porcine JP (pJP-A, pJP-B, and pJP-C) were purified from whole porcine pituitary glands using reversed-phase high performance liquid chromatography methods. The three structural variants constitute approximately 10, 75, and 15%, respectively, of the total JP observed. Mass spectrometric analysis revealed that pJP-C was 18 mass units smaller than pJP-B, which is consistent with the formation of a succinimide structure at the aspartyl 16-glycine 17 peptide bond. Such symmetrical imide structures are known to hydrolyze at physiological pH to yield a mixture of the original alpha-aspartyl peptides and isomerized isoaspartyl peptides. We were able to show that pJP-A was the isomerized isoaspartyl form by demonstrating that pJP-A but not pJP-B was a substrate for the protein carboxyl methyltransferase enzyme (L-isoaspartyl/D-aspartyl protein methyltransferase; EC 2.1.1.77) purified from bovine erythroctyes. This cytosolic enzyme is known to preferentially methylate L-isoaspartyl residues within model substrates. Control experiments in which JP was incubated in the acidic medium used to extract the pituitary tissue showed that the isoforms of pJP are not artifacts of peptide purification. Furthermore, we have isolated the isoforms of pJP at levels which are 100 times greater than would be expected for a spontaneous reaction. We conclude that the formation of the aspartimide form of JP appears to be a facilitated process, possibly occurring as a result of conformation constraints dictated by the structure of pro-opiomelanocortin, or an as yet uncharacterized post-translational event.	ROYAL VICTORIA HOSP, ENDOCRINE LAB, RM L205, 687 PINE AVE W, MONTREAL H3A 1A1, QUEBEC, CANADA; ROYAL VICTORIA HOSP, UROL RES LABS, MONTREAL H3A 1A1, QUEBEC, CANADA; MCGILL UNIV, DEPT MED, MONTREAL H3A 1A1, QUEBEC, CANADA	McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University				Bateman, Andrew/0000-0003-0597-769X				ASWAD DW, 1984, J BIOL CHEM, V259, P714; ASWAD DW, 1990, ANN NY ACAD SCI, V613, P26, DOI 10.1111/j.1749-6632.1990.tb18145.x; BATEMAN A, 1990, J BIOL CHEM, V265, P22130; BENNETT HPJ, 1989, ANAL BIOCHEM, V179, P222, DOI 10.1016/0003-2697(89)90119-X; BENNETT HPJ, 1986, PEPTIDES, V7, P615, DOI 10.1016/0196-9781(86)90036-7; BENNETT HPJ, 1986, J CHROMATOGR, V359, P383, DOI 10.1016/0021-9673(86)80092-9; BENNETT HPJ, 1981, BIOCHEMISTRY-US, V20, P4530, DOI 10.1021/bi00519a004; BENNETT HPJ, 1983, ANAL BIOCHEM, V128, P121, DOI 10.1016/0003-2697(83)90352-4; Bennett HPJ, 1991, PEPTIDE BIOSYNTHESIS, P111; BODANSZKY M, 1978, INT J PEPT PROT RES, V12, P57; BOILEAU G, 1983, NUCLEIC ACIDS RES, V11, P8063, DOI 10.1093/nar/11.22.8063; BRADBURY AF, 1982, NATURE, V298, P686, DOI 10.1038/298686a0; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; Covey T R, 1988, Rapid Commun Mass Spectrom, V2, P249, DOI 10.1002/rcm.1290021111; EIPPER BA, 1986, J BIOL CHEM, V261, P8686; GAGNON C, 1979, BIOCHEM BIOPH RES CO, V88, P847, DOI 10.1016/0006-291X(79)91486-4; GEIGER T, 1987, J BIOL CHEM, V262, P785; GERDES HH, 1989, J BIOL CHEM, V264, P12009; JOHNSON RG, 1987, ANN NY ACAD SCI, V493, P162, DOI 10.1111/j.1749-6632.1987.tb27198.x; KATOPODIS AG, 1991, BIOCHEMISTRY-US, V30, P6189, DOI 10.1021/bi00239a016; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; LOWENSON JD, 1992, J BIOL CHEM, V267, P5985; MAINS RE, 1976, J BIOL CHEM, V251, P4115; MCFADDEN PN, 1986, J BIOL CHEM, V261, P1503; MORRIS HR, 1981, BIOCHEM BIOPH RES CO, V101, P623, DOI 10.1016/0006-291X(81)91304-8; MURRAY ED, 1984, J BIOL CHEM, V259, P722; MURRAY ED, 1986, J BIOL CHEM, V261, P306; NGUYEN MH, 1987, J NEUROCHEM, V49, P38, DOI 10.1111/j.1471-4159.1987.tb03391.x; ONDETTI MA, 1968, BIOCHEMISTRY-US, V7, P4069, DOI 10.1021/bi00851a040; ORCI L, 1986, J CELL BIOL, V103, P2273, DOI 10.1083/jcb.103.6.2273; OTA IM, 1989, J BIOL CHEM, V264, P54; OTA IM, 1987, J BIOL CHEM, V262, P8522; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; REIFFEN FU, 1986, BIOCHEMISTRY-US, V25, P4402, DOI 10.1021/bi00363a034; REITMAN ML, 1981, J BIOL CHEM, V256, P1977; RINIKER B, 1972, NATURE-NEW BIOL, V235, P114, DOI 10.1038/newbio235114b0; ROOS N, 1988, SCANNING MICROSCOPY, V2, P323; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; THOMAS G, 1988, ANNU REV PHYSIOL, V50, P323; UHLER M, 1983, J BIOL CHEM, V258, P257; VERNER K, 1988, SCIENCE, V241, P1307, DOI 10.1126/science.2842866; VOORTER CEM, 1987, FEBS LETT, V221, P249, DOI 10.1016/0014-5793(87)80935-3	43	20	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1024	1031						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8380403				2022-12-27	WOS:A1993KG07700042
J	QAW, F; CALVERLEY, MJ; SCHROEDER, NJ; TRAFFORD, DJH; MAKIN, HLJ; JONES, G				QAW, F; CALVERLEY, MJ; SCHROEDER, NJ; TRAFFORD, DJH; MAKIN, HLJ; JONES, G			INVIVO METABOLISM OF THE VITAMIN-D ANALOG, DIHYDROTACHYSTEROL - EVIDENCE FOR FORMATION OF 1-ALPHA,25-DIHYDROXY-DIHYDROTACHYSTEROL AND 1-BETA,25-DIHYDROXY-DIHYDROTACHYSTEROL METABOLITES AND STUDIES OF THEIR BIOLOGICAL-ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLASMA; IDENTIFICATION; PROTEIN; 1-ALPHA-HYDROXYVITAMIN-D3; 24,25-DIHYDROXYVITAMIN-D3; 1,25-DIHYDROXYVITAMIN-D3; 25-HYDROXYVITAMIN-D3; ASSAYS; SERUM; MODEL	Dihydrotachysterol (DHT), a reduced vitamin D analog in which the A-ring has been rotated through 180-degrees is a biologically active molecule which can be used to study the structural requirements for the calcemic and cell differentiating properties of the vitamin D hormone, 1alpha,25-dihydroxyvitamin D3 (1alpha,25-(OH)2D3), as well as to investigate the specificity of the enzyme systems that catalyze the formation of this hormone. In this study we showed that dihydrotachysterol was metabolized in vivo into a significant polar metabolite observed on straight-phase high performance liquid chromatography (HPLC) which subsequently split into two peaks on reverse-phase HPLC. These two metabolites were identified by HPLC and gas chromatography-mass spectrometry techniques as 1alpha,25-(OH)2DHT and 1beta,25-(OH)2DHT. This pair of metabolites was formed from either DHT2 or DHT3. Standard 1alpha,25-(OH)2DHTs were generated in vitro from chemically synthesized 1-hydroxydihydrotachysterol precursors using a liver hepatoma cell system. Both 1alpha,25(OH)2D2 and 1alpha,25-(OH)2DHT3 showed a binding affinity to the mammalian vitamin D receptor only 50-100 less than 1alpha,25-(OH)2D3 whereas 1beta,25-(OH)2DHTs showed poor binding. On the other hand 1alpha,25-(OH)2DHT3 bound to the rat vitamin D transport protein (DBP) with stronger affinity than did 1alpha,25-(OH)2DHT3. When tested in a COS-1 cell transfection assay system using a rat osteocalcin vitamin D responsive element coupled to a growth hormone reporter gene, 1alpha,25-(OH)2DHT3 showed a biological activity only 10 times lower than 1alpha,25-(OH)2D3. It is therefore suggested that 1alpha,25-(OH)2DHT probably represents the metabolite of DHT responsible for some of its in vivo effects although we cannot rule out in vivo effects of other metabolites identified. Our studies suggest that 1alpha,25-dihydroxylated DHTs represent a promising novel group of vitamin D analogs worthy of study for cell differentiation as well as calcemic properties.	QUEENS UNIV,DEPT BIOCHEM,KINGSTON K7L 3N6,ONTARIO,CANADA; QUEENS UNIV,DEPT MED,KINGSTON K7L 3N6,ONTARIO,CANADA; LEO PHARMACEUT PROD,DEPT CLIN RES,DK-2750 BALLERUP,DENMARK; UNIV LONDON LONDON HOSP,COLL MED,DEPT CHEM PATHOL,LONDON E1 2AD,ENGLAND	Queens University - Canada; Queens University - Canada; University of London; University College London					Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABE J, 1987, FEBS LETT, V226, P58, DOI 10.1016/0014-5793(87)80550-1; ADAMS JS, 1990, J BONE MINER RES, V5, pS199; BJORKHEM I, 1985, STEROLS BILE ACIDS, P231; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOSCH R, 1985, J STEROID BIOCHEM, V22, P187, DOI 10.1016/0022-4731(85)90111-6; BOSCH R, 1985, J STEROID BIOCHEM, V23, P223, DOI 10.1016/0022-4731(85)90241-9; BOSCH R, 1987, J STEROID BIOCHEM, V27, P829, DOI 10.1016/0022-4731(87)90156-7; BOUILLON R, 1980, J STEROID BIOCHEM, V13, P1029, DOI 10.1016/0022-4731(80)90133-8; CALVERLEY MJ, 1987, TETRAHEDRON LETT, V28, P1337, DOI 10.1016/S0040-4039(00)95364-4; CALVERLEY MJ, 1987, TETRAHEDRON, V43, P4609, DOI 10.1016/S0040-4020(01)86903-9; COLDWELL RD, 1985, J CHROMATOGR, V338, P289, DOI 10.1016/0378-4347(85)80100-6; COTA JG, 1988, J ORG CHEM, V53, P6094, DOI 10.1021/jo00261a020; EISMAN JA, 1976, ARCH BIOCHEM BIOPHYS, V176, P235, DOI 10.1016/0003-9861(76)90161-2; Guo YD, 1991, J BONE MINER RES, V6, pS120; HALLICK RB, 1972, J BIOL CHEM, V247, P91; HAUSSLER MR, 1986, ANNU REV NUTR, V6, P527, DOI 10.1146/annurev.nu.06.070186.002523; HOWARD GA, 1981, J BIOL CHEM, V256, P7738; HSIEH JC, 1991, P NATL ACAD SCI USA, V88, P9315, DOI 10.1073/pnas.88.20.9315; JONES G, 1980, J CHROMATOGR, V221, P27, DOI 10.1016/S0378-4347(00)81004-X; JONES G, 1988, BIOCHEMISTRY-US, V27, P7070, DOI 10.1021/bi00418a060; JONES G, 1987, Steroids, V49, P29, DOI 10.1016/0039-128X(87)90078-X; JONES G, 1980, J CLIN ENDOCR METAB, V50, P773, DOI 10.1210/jcem-50-4-773; KELLY DR, 1979, SYNTHETIC COMMUN, V9, P295, DOI 10.1080/00397917908064155; KUMAR R, 1981, J BIOL CHEM, V256, P9389; PROCSAL DA, 1975, J BIOL CHEM, V250, P8382; QAW F, 1992, J BONE MINER RES, V7, pS161; QAW F, 1990, J BONE MINER RES, V5, pS200; RAY PD, 1961, J BIOL CHEM, V236, P3158; Sambrook J, 1989, MOL CLONING LABORATO; SHACKLETON CHL, 1980, J STEROID BIOCHEM, V12, P521, DOI 10.1016/0022-4731(80)90318-0; SONDERS RC, 1969, BIOCHEMISTRY-US, V8, P405, DOI 10.1021/bi00829a056; STRUGNELL S, 1990, BIOCHEM PHARMACOL, V40, P333, DOI 10.1016/0006-2952(90)90696-I; TAM SP, 1988, J LIPID RES, V29, P1637; TAYLOR A, 1987, J BONE MINER RES, V2, P567; TERPENING CM, 1991, MOL ENDOCRINOL, V5, P373, DOI 10.1210/mend-5-3-373; WING RM, 1974, SCIENCE, V186, P939, DOI 10.1126/science.186.4167.939; YAMADA S, 1984, J BIOL CHEM, V259, P884	37	59	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					282	292						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380156				2022-12-27	WOS:A1993KE60300044
J	GRIFFITH, DA; JARVIS, SM				GRIFFITH, DA; JARVIS, SM			HIGH-AFFINITY SODIUM-DEPENDENT NUCLEOBASE TRANSPORT IN CULTURED RENAL EPITHELIAL-CELLS (LLC-PK1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER MEMBRANE; NUCLEOSIDE TRANSPORT; HUMAN-ERYTHROCYTES; HYPOXANTHINE TRANSPORT; PURINE; NA+; PERMEATION; VESICLES; ADENINE; KIDNEY	Two distinct transporters for nucleobases have been characterized in LLC-PK1 cells. The first system accumulates hypoxanthine against a concentration gradient in the presence of sodium. The sodium-dependent uptake of hypoxanthine was saturable at 22-degrees-C with a K(m) value of 0.79 +/- 0.43 muM, a V(max) of 15 +/- 4 pmol/mg protein/60 s, and a Na+:hypoxanthine coupling stoichiometry of 1.27 +/- 0.20. Uptake of hypoxanthine was inhibited by 5-fluorouracil, uracil, thymine, and guanine (K(i) values 3-6 muM). Adenine and nucleosides were without effect. Using cell monolayers grown on a permeable filter support, Na+-dependent hypoxanthine uptake occurred preferentially from the apical surface. The second system exhibited no cation specificity and was saturable with a low affinity for hypoxanthine (K(m) of 124 +/- 22 muM) and a high V(max) of 275 +/- 38 pmol/mg protein/60 s. Adenine and guanine inhibited Na+-independent hypoxanthine uptake (K(i) values 30 +/- 15 and 18 +/- 7 muM, respectively). Other nucleobases and nucleosides exhibited little or no inhibition of equilibrative hypoxanthine influx. Dipyridamole, dilazep, and phloridzin were effective inhibitors of Na+-dependent hypoxanthine uptake but had little effect on the Na+-independent flux. This study represents the first direct demonstration of a unique high affinity Na+ nucleobase co-transporter system in cultured animal cells.	UNIV KENT,RES SCH BIOSCI,BIOL LAB,CANTERBURY CT2 7NJ,KENT,ENGLAND	University of Kent								ARONOW B, 1986, J BIOL CHEM, V261, P2014; BATECHLOR JG, 1977, BRIT J PHARMACOL, V59, pP521; BRONK JR, 1987, J PHYSIOL-LONDON, V382, P475, DOI 10.1113/jphysiol.1987.sp016379; DOMIN BA, 1988, J BIOL CHEM, V263, P9276; GRIFFITH DA, 1992, BIOCHIM BIOPHYS ACTA, V1106, P303, DOI 10.1016/0005-2736(92)90010-J; GRIFFITH DA, 1992, BIOCHEM SOC T, V20, pS244; JACOBS ES, 1990, J BIOL CHEM, V265, P22210; JARVIS SM, 1989, BIOCHIM BIOPHYS ACTA, V979, P132, DOI 10.1016/0005-2736(89)90533-6; KRAUPP M, 1991, BIOCHIM BIOPHYS ACTA, V1070, P157, DOI 10.1016/0005-2736(91)90158-5; LEE CW, 1990, AM J PHYSIOL, V258, pF1203, DOI 10.1152/ajprenal.1990.258.5.F1203; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHONY WB, 1988, J BIOL CHEM, V263, P9285; Plagemann P.G.W., 1980, CURR TOP MEMBR TRANS, P225; PLAGEMANN PGW, 1987, BIOCHIM BIOPHYS ACTA, V905, P17, DOI 10.1016/0005-2736(87)90004-6; PLAGEMANN PGW, 1990, BIOCHIM BIOPHYS ACTA, V1028, P289, DOI 10.1016/0005-2736(90)90178-Q; PLAGEMANN PGW, 1988, BIOCHIM BIOPHYS ACTA, V947, P405, DOI 10.1016/0304-4157(88)90002-0; PLAGEMANN PGW, 1986, BIOCHIM BIOPHYS ACTA, V855, P25, DOI 10.1016/0005-2736(86)90184-7; PULL I, 1972, BIOCHEM J, V126, P965, DOI 10.1042/bj1260965; SCHANKER LS, 1963, BIOCHEM PHARMACOL, V12, P1047, DOI 10.1016/0006-2952(63)90028-5; Segel I.H., 1975, ENZYME KINETICS; SEMENZA G, 1984, BIOCHIM BIOPHYS ACTA, V779, P343, DOI 10.1016/0304-4157(84)90016-9; SILVERMAN M, 1976, BIOCHIM BIOPHYS ACTA, V457, P303, DOI 10.1016/0304-4157(76)90003-4; SIROTNAK FM, 1987, CANCER METAST REV, V6, P459, DOI 10.1007/BF00047462; VIJAYALAKSHMI D, 1988, J BIOL CHEM, V263, P19419; WILLIAMS TC, 1991, BIOCHEM J, V274, P27, DOI 10.1042/bj2740027; WRIGHT SH, 1987, J MEMBRANE BIOL, V95, P37, DOI 10.1007/BF01869628; WU XC, 1992, J BIOL CHEM, V267, P8813; YOUNG JD, 1988, J BIOL CHEM, V263, P140	28	58	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20085	20090						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376366				2022-12-27	WOS:A1993LY01900027
J	ISHIHARA, M; GUO, YC; WEI, Z; YANG, ZC; SWIEDLER, SJ; ORELLANA, A; HIRSCHBERG, CB				ISHIHARA, M; GUO, YC; WEI, Z; YANG, ZC; SWIEDLER, SJ; ORELLANA, A; HIRSCHBERG, CB			REGULATION OF BIOSYNTHESIS OF THE BASIC FIBROBLAST GROWTH-FACTOR BINDING DOMAINS OF HEPARAN-SULFATE BY HEPARAN SULFATE-N-DEACETYLASE N-SULFOTRANSFERASE EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; POLYMER-MODIFICATION; RECEPTOR; PROTEOGLYCAN; METABOLISM; SYSTEM	Heparan sulfate-N-deacetylase/N-sulfotransferase catalyzes both the N-deacetylation and N-sulfation reactions that initiate the modification of the oligosaccharide backbone of heparan sulfate (HS). The glycosaminoglycan polymer appears to modulate the activity of growth factors by mediating their initial binding. To understand how the biosynthesis of these binding sites is regulated, a rat liver-derived cDNA encoding the above activities was overexpressed in a COS cell mutant (CM-15) that has reduced levels of the enzyme and binds poorly to immobilized basic fibroblast growth factor (bFGF). This resulted in increased synthesis of sulfated blocks of decasaccharide size or longer. These blocks exhibited high affinity binding to bFGF and contained a high content of 2-O-sulfated iduronate and at least five consecutive N-sulfated disaccharides. An increase in the synthesis of these high affinity blocks was not seen in transfected wild-type COS cells even though they showed a 4-fold increase of both enzyme activities, suggesting that once sufficient levels of highly sulfated blocks of saccharides with high affinity for bFGF are attained, no further synthesis of these domains occurs.	UNIV MASSACHUSETTS,MED CTR,DEPT BIOCHEM & MOLEC BIOL,WORCESTER,MA 01655	University of Massachusetts System; University of Massachusetts Worcester	ISHIHARA, M (corresponding author), GLYCOMED INC,860 ATLANTIC AVE,ALAMEDA,CA 94501, USA.		Orellana, Ariel/E-2166-2014; Orellana, Ariel/AAE-4866-2021	Orellana, Ariel/0000-0002-9243-808X; Orellana, Ariel/0000-0002-9243-808X; Hirschberg, Carlos/0000-0003-2299-7721	NIGMS NIH HHS [GM 34396] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034396] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; BAME KJ, 1991, J BIOL CHEM, V266, P10287; BAME KJ, 1991, J BIOL CHEM, V266, P12461; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CASTELLOT JJ, 1981, J CELL BIOL, V94, P574; FEDARKO NS, 1989, J CELL PHYSIOL, V139, P287, DOI 10.1002/jcp.1041390210; GAO Y, 1989, ANAL BIOCHEM, V176, P96; GOSPADARWICZ D, 1979, J CELL PHYSL, V5, P12; HABUCHI H, 1992, BIOCHEM J, V285, P805, DOI 10.1042/bj2850805; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P15744; ISHIHARA M, 1992, ANAL BIOCHEM, V206, P400, DOI 10.1016/0003-2697(92)90385-K; ISHIHARA M, 1989, J CELL PHYSIOL, V138, P467, DOI 10.1002/jcp.1041380305; ISHIHARA M, 1987, J BIOL CHEM, V262, P4708; ISHIHARA M, 1993, GLYCOBIOLOGY, V3, P83, DOI 10.1093/glycob/3.1.83; ISHIHARA M, 1993, J BIOL CHEM, V268, P4675; KJELLEN L, 1992, ADV EXP MED BIOL, V313, P107; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; Klagsbrun M, 1989, Prog Growth Factor Res, V1, P207, DOI 10.1016/0955-2235(89)90012-4; LIDHOLT K, 1992, BIOCHEM J, V287, P21, DOI 10.1042/bj2870021; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; TURNBULL JE, 1990, BIOCHEM J, V265, P715, DOI 10.1042/bj2650715; TURNBULL JE, 1991, BIOCHEM J, V273, P553, DOI 10.1042/bj2730553; WEI Z, 1993, P NATL ACAD SCI USA, V90, P3885, DOI 10.1073/pnas.90.9.3885; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	28	61	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20091	20095						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376367				2022-12-27	WOS:A1993LY01900028
J	STAUFFER, PL; ZHAO, H; LUBYPHELPS, K; MOSS, RL; STAR, RA; MUALLEM, S				STAUFFER, PL; ZHAO, H; LUBYPHELPS, K; MOSS, RL; STAR, RA; MUALLEM, S			GAP JUNCTION COMMUNICATION MODULATES [CA2+]I OSCILLATIONS AND ENZYME-SECRETION IN PANCREATIC ACINI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CA-2+; INTERCELLULAR COMMUNICATION; INOSITOL TRISPHOSPHATE; CALCIUM WAVES; AR42J CELLS; CHOLECYSTOKININ; AMYLASE; RELEASE; MOBILIZATION; ASTROCYTES	Global (all cells in an acinus) and focal (1-2 out of 10-15 cells) stimulation of pancreatic acini with bombesin or t-butyloxycarbonyl-Tyr(SO3)-Nle-Gly-Tyr-Asp-2-phenylethyl ester (CCKJ) together with modulation of gap junction (GJ) permeability by octanol and NO2- was used to study the role of GJ permeability in controlling [Ca2+]i oscillations and enzyme secretion. GJ permeability was quantitated by measuring fluorescence recovery after photobleaching. Octanol at 0.5 mM markedly reduced, whereas 15 mM NO2- increased GJ permeability. Focal application of bombesin caused synchronized oscillations in the entire acinus, whereas global stimulation resulted in asynchronous oscillations. Increasing GJ permeability with NO2- had no effect on bombesin-evoked [Ca2+]i oscillations. Octanol inhibited ongoing oscillations evoked by focal or global bombesin stimulation. However, when GJ were blocked prior to stimulation, subsequent global stimulation with bombesin induced long-lasting oscillations in all cells. Re-establishing GJ communication for as little as 37.5 s conferred GJ dependence on the order and time of [Ca2+]i spiking evoked by global bombesin stimulation. Focal and global stimulation with CCKJ gave different patterns of [Ca2+]i oscillations. However, in contrast to bombesin, inhibition of GJ with octanol had no effect on oscillations induced by global CCKJ stimulation. Increasing GJ permeability with NO2- synchronized CCKJ-stimulated oscillations by equalizing the amplitude and increasing the frequency in all cells within an acinus. These observations suggest that amplitude and frequency of [Ca2+]i oscillations can be regulated independently of each other, and that GJ permeable molecules modulate the frequency of [Ca2+]i oscillation in an agonist-specific manner. Regardless of the agonist, increasing the frequency of oscillations by modulation of GJ permeability correlated with an increased enzyme secretion.	UNIV TEXAS,SW MED CTR,DEPT PHYSL,5323 HARRY HINES BLV,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas				Luby-Phelps, Katherine/0000-0002-8378-1409	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046591, R01DK038938] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK38938, DK46591] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERS JJ, 1988, GLIA, V1, P371, DOI 10.1002/glia.440010604; BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q; BEYER EC, 1990, J MEMBRANE BIOL, V116, P187, DOI 10.1007/BF01868459; BOITANO S, 1992, SCIENCE, V258, P292, DOI 10.1126/science.1411526; BRUZZONE R, 1985, BIOCHEM J, V226, P621, DOI 10.1042/bj2260621; CHANSON M, 1989, J CELL PHYSIOL, V139, P147, DOI 10.1002/jcp.1041390121; CHANSON M, 1991, AM J PHYSIOL, V261, pG28, DOI 10.1152/ajpgi.1991.261.1.G28; CHRIST GJ, 1992, AM J PHYSIOL, V263, pC373, DOI 10.1152/ajpcell.1992.263.2.C373; COLE WC, 1985, GAP JUNCTIONS; FINDLAY I, 1983, CELL TISSUE RES, V232, P121; FINKBEINER S, 1992, NEURON, V8, P1101, DOI 10.1016/0896-6273(92)90131-V; HABARA Y, 1991, CELL CALCIUM, V12, P533, DOI 10.1016/0143-4160(91)90073-N; IWATSUKI N, 1979, PFLUG ARCH EUR J PHY, V380, P277, DOI 10.1007/BF00582906; IWATSUKI N, 1979, J PHYSIOL-LONDON, V291, P317, DOI 10.1113/jphysiol.1979.sp012815; IWATSUKI N, 1978, J CELL BIOL, V79, P533, DOI 10.1083/jcb.79.2.533; MATOZAKI T, 1990, J BIOL CHEM, V265, P6247; MEDA P, 1986, J CELL BIOL, V103, P475, DOI 10.1083/jcb.103.2.475; MEDA P, 1987, P NATL ACAD SCI USA, V84, P4901, DOI 10.1073/pnas.84.14.4901; MEDA P, 1983, J ULTRA MOL STRUCT R, V83, P69, DOI 10.1016/S0022-5320(83)90066-7; MUALLEM S, 1988, BIOCHEM J, V255, P301; MUALLEM S, 1989, ANNU REV PHYSIOL, V51, P83; NEYTON J, 1986, J EXP BIOL, V124, P93; PANDOL SJ, 1985, J BIOL CHEM, V260, P81; PETERSEN CCH, 1991, FEBS LETT, V284, P113, DOI 10.1016/0014-5793(91)80774-W; PETERSEN OH, 1992, J PHYSIOL-LONDON, V448, P1; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; SALUJA AK, 1992, J BIOL CHEM, V267, P11202; SANDBERG K, 1990, SCIENCE, V249, P298, DOI 10.1126/science.2374929; SANDERSON MJ, 1990, CELL REGUL, V1, P585, DOI 10.1091/mbc.1.8.585; SPRAY DC, 1990, AM J PHYSIOL, V258, pC195, DOI 10.1152/ajpcell.1990.258.2.C195; TSUNODA Y, 1990, AM J PHYSIOL, V258, pC147, DOI 10.1152/ajpcell.1990.258.1.C147; WADE MH, 1986, SCIENCE, V232, P525, DOI 10.1126/science.3961495; WILLEMS PHGM, 1993, CELL CALCIUM, V14, P145, DOI 10.1016/0143-4160(93)90084-J; YGUERABIDE J, 1982, BIOPHYS J, V39, P69; YULE DI, 1992, J BIOL CHEM, V267, P13830; ZHANG BX, 1992, AM J PHYSIOL, V262, pC1125, DOI 10.1152/ajpcell.1992.262.5.C1125; ZHAO H, 1990, J BIOL CHEM, V265, P20856	37	80	80	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19769	19775						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366115				2022-12-27	WOS:A1993LW81900092
J	BRESNICK, EH; FELSENFELD, G				BRESNICK, EH; FELSENFELD, G			EVIDENCE THAT THE TRANSCRIPTION FACTOR USF IS A COMPONENT OF THE HUMAN BETA-GLOBIN LOCUS-CONTROL REGION HETEROMERIC PROTEIN COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT CONTROL REGION; MAJOR LATE PROMOTER; PORPHOBILINOGEN DEAMINASE GENE; CELL GLUCOCORTICOID RECEPTOR; HIGH-LEVEL EXPRESSION; HEAT-SHOCK PROTEIN; DNA-BINDING; CHROMATIN STRUCTURE; ERYTHROID PROMOTER; ACTIVATION REGION	The human locus control region (LCR) consists of four DNase I hypersensitive sites upstream of the epsilon-globin gene and is intimately involved in globin gene transcription. We have used DNase I footprinting with K562 erythroleukemia cell extracts to identify protein components of the minimal LCR element, hypersensitive site 2. Six major regions of protection were observed, and the occupation of two regions (sites II and V) was strongly temperature-dependent. Fractionation of K562 nuclear proteins revealed a single major protein that bound tightly to site II. An E-box was necessary for high affinity binding to DNA. We used antibodies and recombinant USF protein to prove that the helix-loop-helix transcription factor USF is the only detectible component in K562 cells that binds to this site. Despite significant differences between site II and a canonical USF-binding site, the USF binding affinity was comparable for the two sites. In both cases the interaction with the E-box of either wild-type USF or a approximately 15-kDa minimal USF DNA binding polypeptide displays an unusual positive temperature dependence, consistent with the observed footprinting behavior. The results show that a relatively ubiquitous factor, not confined to erythroid cells, is an important part of the complex of proteins bound at hypersensitive site 2 of the LCR in K562 cells.	NIDDKD,MOLEC BIOL LAB,BLDG 5,RM 214,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)								ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BRESNICK EH, 1990, BIOCHEMISTRY-US, V29, P520, DOI 10.1021/bi00454a028; BRESNICK EH, 1989, J BIOL CHEM, V264, P4992; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; CARTHEW RW, 1987, GENE DEV, V1, P973, DOI 10.1101/gad.1.9.973; CATERINA JJ, 1991, P NATL ACAD SCI USA, V88, P1626, DOI 10.1073/pnas.88.5.1626; CHODOSH LA, 1987, SCIENCE, V238, P684, DOI 10.1126/science.3672119; COLLINS FS, 1984, PROG NUCLEIC ACID RE, V31, P315, DOI 10.1016/S0079-6603(08)60382-7; COLLIS P, 1990, EMBO J, V9, P233, DOI 10.1002/j.1460-2075.1990.tb08100.x; ELLIS J, 1993, EMBO J, V12, P127, DOI 10.1002/j.1460-2075.1993.tb05638.x; EVANS T, 1990, ANNU REV CELL BIOL, V6, P95, DOI 10.1146/annurev.cellbio.6.1.95; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; FORRESTER WC, 1987, NUCLEIC ACIDS RES, V15, P10159, DOI 10.1093/nar/15.24.10159; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; KIM CG, 1992, GENE DEV, V144, P481; KIRSCHBAUM BJ, 1992, MOL CELL BIOL, V12, P5094, DOI 10.1128/MCB.12.11.5094; KORNBERG RD, 1992, ANNU REV CELL BIOL, V8, P563, DOI 10.1146/annurev.cellbio.8.1.563; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LETOVSKY J, 1989, NUCLEIC ACIDS RES, V17, P2639, DOI 10.1093/nar/17.7.2639; Maniatis T., 1982, MOL CLONING; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; MENDEL DB, 1986, J BIOL CHEM, V261, P3758; Meyers RM, 1986, SCIENCE, V232FG, P613; MIGNOTTE V, 1989, NUCLEIC ACIDS RES, V17, P37, DOI 10.1093/nar/17.1.37; MIGNOTTE V, 1989, P NATL ACAD SCI USA, V86, P6548, DOI 10.1073/pnas.86.17.6548; MIYAMOTO NG, 1985, EMBO J, V4, P3563, DOI 10.1002/j.1460-2075.1985.tb04118.x; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; PHILIPSEN S, 1990, EMBO J, V9, P2159, DOI 10.1002/j.1460-2075.1990.tb07385.x; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; SANCHEZ ER, 1985, J BIOL CHEM, V260, P2398; SAWADOGO M, 1988, J BIOL CHEM, V263, P11985; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SCHERRER LC, 1990, J BIOL CHEM, V265, P21397; Sirito Mario, 1992, Gene Expression, V2, P231; TALBOT D, 1990, EMBO J, V9, P2169, DOI 10.1002/j.1460-2075.1990.tb07386.x; TALBOT D, 1991, EMBO J, V10, P1391, DOI 10.1002/j.1460-2075.1991.tb07659.x; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cellbio.6.1.679; WOLFFE AP, 1992, FASEB J, V6, P3354, DOI 10.1096/fasebj.6.15.1464369; WORKMAN JL, 1990, EMBO J, V9, P1299, DOI 10.1002/j.1460-2075.1990.tb08239.x; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; XIAO JH, 1987, GENE DEV, V1, P794, DOI 10.1101/gad.1.8.794; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; YANG HY, 1992, MOL CELL BIOL, V12, P4562, DOI 10.1128/MCB.12.10.4562	56	87	87	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18824	18834						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360172				2022-12-27	WOS:A1993LV65900069
J	GUTTRIDGE, DC; LAU, AL; CUNNINGHAM, DD				GUTTRIDGE, DC; LAU, AL; CUNNINGHAM, DD			PROTEASE NEXIN-1, A THROMBIN INHIBITOR, IS REGULATED BY INTERLEUKIN-1 AND DEXAMETHASONE IN NORMAL HUMAN FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLIA-DERIVED NEXIN; MESSENGER-RNA; PLASMINOGEN-ACTIVATOR; MURINE INTERLEUKIN-1; SERINE PROTEASES; BINDING-FACTOR; CELL-DIVISION; DIFFERENTIATION; TRANSCRIPTION; STIMULATION	Thrombin participates in several regulatory events following injury as a result of its effects on blood coagulation and cell migration, proliferation, and differentiation. Protease nexin-1 (PN-1) is a potent thrombin inhibitor in the extracellular environment. Since injury-related factors are known to regulate the synthesis and secretion of PN-1, the inhibitor may serve to modulate the actions of thrombin during injury. Here we report the molecular mechanisms that underlie this regulation. In normal human fibroblasts, interleukin-1 (IL-1) beta stimulated the synthesis and secretion of PN-1. The stimulation correlated with an increase in steady-state levels of PN-1 mRNA. Treatment of cells with both cycloheximide and IL-1 reduced the levels of PN-1 mRNA. Nuclear run-on assays indicated that IL-1 modestly increased the rate of PN-1 transcription. However, experiments with actinomycin D demonstrated that IL-1 significantly increased the half-life of the PN-1 mRNA. In contrast, dexamethasone (DXM) repressed the synthesis and secretion of PN-1 from fibroblasts. This effect correlated with a decrease in PN-1 mRNA. A sustained decrease in PN-1 mRNA was also seen when cells were treated with cycloheximide and DXM. In nuclear run-on assays, DXM functioned as a transcriptional repressor of PN-1 synthesis. Treatment of cells with actinomycin D showed that DXM did not affect mRNA stability. Thus, our experiments demonstrate that IL-1 and DXM, which function biologically in different fashions, regulate the synthesis of PN-1 by separate molecular mechanisms. While DXM directly regulates PN-1 at the level of transcription, IL-1 in the presence ot ongoing protein synthesis regulates PN-1 production predominantly in a post-transcriptional fashion by increasing the half-life of the PN-1 mRNA.	UNIV CALIF IRVINE, COLL MED, DEPT MICROBIOL & MOLEC GENET, IRVINE, CA 92717 USA	University of California System; University of California Irvine				Guttridge, Denis/0000-0002-7276-6609	NIA NIH HHS [AG10598] Funding Source: Medline; NIGMS NIH HHS [GM07134] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG010598] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AKIYAMA H, 1992, NEUROSCI LETT, V146, P152, DOI 10.1016/0304-3940(92)90065-F; ANDREASEN PA, 1987, MOL CELL BIOL, V7, P3021, DOI 10.1128/MCB.7.8.3021; BAKER JB, 1980, CELL, V21, P37, DOI 10.1016/0092-8674(80)90112-9; BARSHAVIT R, 1983, SCIENCE, V220, P728, DOI 10.1126/science.6836310; BAUER J, 1985, FEBS LETT, V190, P271, DOI 10.1016/0014-5793(85)81298-9; BERNHEIM HA, 1980, J PHYSIOL-LONDON, V301, P69, DOI 10.1113/jphysiol.1980.sp013189; CARNEY DH, 1978, J CELL PHYSIOL, V95, P13, DOI 10.1002/jcp.1040950103; CAVANAUGH KP, 1990, J NEUROCHEM, V54, P1735, DOI 10.1111/j.1471-4159.1990.tb01228.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CUPPS TR, 1982, IMMUNOL REV, V65, P133, DOI 10.1111/j.1600-065X.1982.tb00431.x; DUKOVICH M, 1986, CLIN IMMUNOL IMMUNOP, V38, P381, DOI 10.1016/0090-1229(86)90248-5; EATON DL, 1983, J CELL PHYSIOL, V117, P175, DOI 10.1002/jcp.1041170207; FARRELL DH, 1986, BIOCHEM J, V237, P907, DOI 10.1042/bj2370907; FARRELL DH, 1988, J CELL PHYSIOL, V134, P179, DOI 10.1002/jcp.1041340203; FRISCH SM, 1987, J BIOL CHEM, V262, P16300; GLENN KC, 1980, J BIOL CHEM, V255, P6609; GLOOR S, 1986, CELL, V47, P687; Gordon AH, 1985, ACUTE PHASE RESPONSE; GRAND RJA, 1989, EMBO J, V8, P2209, DOI 10.1002/j.1460-2075.1989.tb08344.x; GURWITZ D, 1988, P NATL ACAD SCI USA, V85, P3440, DOI 10.1073/pnas.85.10.3440; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; HOFFMANN MC, 1992, NEUROSCIENCE, V49, P397, DOI 10.1016/0306-4522(92)90105-B; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; KNUDSEN PJ, 1987, J IMMUNOL, V139, P4129; KUJUBU DA, 1992, J BIOL CHEM, V267, P7991; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE SW, 1988, P NATL ACAD SCI USA, V85, P1204, DOI 10.1073/pnas.85.4.1204; LINIAL M, 1985, SCIENCE, V230, P1126, DOI 10.1126/science.2999973; LOW DA, 1981, P NATL ACAD SCI-BIOL, V78, P2340, DOI 10.1073/pnas.78.4.2340; MCGROGAN M, 1988, BIO-TECHNOL, V6, P172, DOI 10.1038/nbt0288-172; MCNAMARA CA, 1993, J CLIN INVEST, V91, P94, DOI 10.1172/JCI116206; MEIER R, 1989, NATURE, V342, P548, DOI 10.1038/342548a0; NAWROTH PP, 1986, P NATL ACAD SCI USA, V83, P3460, DOI 10.1073/pnas.83.10.3460; NEIKEN NA, 1992, J CLIN INVEST, V90, P1614; NELSON RB, 1990, DEV BRAIN RES, V54, P93, DOI 10.1016/0165-3806(90)90069-B; PERRAUD F, 1987, INT J DEV NEUROSCI, V5, P181, DOI 10.1016/0736-5748(87)90028-1; PIKE BL, 1985, P NATL ACAD SCI USA, V82, P8153, DOI 10.1073/pnas.82.23.8153; POSTLETHWAITE AE, 1983, J EXP MED, V157, P801, DOI 10.1084/jem.157.2.801; ROSENBLATT DE, 1987, BRAIN RES, V415, P40, DOI 10.1016/0006-8993(87)90267-8; SCHINI VB, 1989, EUR J PHARMACOL, V165, P333, DOI 10.1016/0014-2999(89)90733-4; SCOTT RW, 1985, J BIOL CHEM, V260, P7029; SHAPIRO SD, 1991, J IMMUNOL, V146, P2724; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; STEPHENS JM, 1992, J BIOL CHEM, V267, P8336; VANNOSTRAND WE, 1988, BIOCHEMISTRY-US, V27, P2176, DOI 10.1021/bi00406a054; VAUGHAN PJ, 1993, J BIOL CHEM, V268, P3720; WAGNER SL, 1989, J BIOL CHEM, V264, P611; WEINHEIMER SP, 1987, J MOL BIOL, V195, P819, DOI 10.1016/0022-2836(87)90487-6	48	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18966	18974						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360185				2022-12-27	WOS:A1993LV65900088
J	LOLKEMA, JS; TENHOEVEDUURKENS, RH; ROBILLARD, GT				LOLKEMA, JS; TENHOEVEDUURKENS, RH; ROBILLARD, GT			STEADY-STATE KINETICS OF MANNITOL PHOSPHORYLATION CATALYZED BY ENZYME-II(MTL) OF THE ESCHERICHIA-COLI PHOSPHOENOLPYRUVATE-DEPENDENT PHOSPHOTRANSFERASE SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME-II; TRANSPORT; VESICLES; BACTERIA; PROTEIN; IIMTL	The kinetics of mannitol phosphorylation catalyzed by enzyme II(mtl) of the bacterial P-enolpyruvate-dependent phosphotransferase system are described for three different physical conditions of the enzyme, (i) embedded in the membrane of inside-out (ISO) oriented vesicles, (ii) solubilized and assayed above the critical micellular concentration (cmc) of the detergent, and (iii) solubilized and assayed below the cmc of the detergent. The kinetic characteristics of enzyme II(mtl), after solubilization of cytoplasmic membranes or after purification from these membranes are comparable. The mannitol-dependent kinetics at saturating concentration of P-HPr were biphasic both for the solubilized enzyme assayed above the cmc and for the enzyme in ISO vesicles. In contrast, the mannitol-dependent kinetics was monophasic for the solubilized enzyme assayed below the cmc. In the latter case, the maximal rate was about twice as high as observed with the two other conditions. The contribution of the high affinity phase to the maximal rate is lower for enzyme II(mtl) in ISO vesicles than for the solubilized enzyme. At limiting concentrations of P-HPr, the kinetics is not according to the expected ''ping-pong'' mechanism.	UNIV GRONINGEN,DEPT BIOCHEM,9714 AG GRONINGEN,NETHERLANDS; UNIV GRONINGEN,INST BIOSIN,9714 AG GRONINGEN,NETHERLANDS	University of Groningen; University of Groningen								BARTFAI T, 1972, FEBS LETT, V26, P252, DOI 10.1016/0014-5793(72)80585-4; ELFERINK MGL, 1979, FEBS LETT, V107, P300, DOI 10.1016/0014-5793(79)80395-6; ELFERINK MGL, 1990, J BACTERIOL, V172, P7119, DOI 10.1128/jb.172.12.7119-7125.1990; JACOBSON GR, 1983, J BIOL CHEM, V258, P748; LOLKEMA JS, 1990, BIOCHEMISTRY-US, V29, P10120, DOI 10.1021/bi00495a016; LOLKEMA JS, 1993, J BIOL CHEM, V268, P17850; LOLKEMA JS, 1985, EUR J BIOCHEM, V147, P69, DOI 10.1111/j.1432-1033.1985.tb08720.x; LOLKEMA JS, 1991, BIOCHEMISTRY-US, V30, P6721, DOI 10.1021/bi00241a013; LOLKEMA JS, 1990, BIOCHEMISTRY-US, V29, P10659, DOI 10.1021/bi00499a012; LOLKEMA JS, 1992, NEW COMPR BIOCH, V21, P135; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANNERVIK B, 1973, EUR J BIOCHEM, V37, P270, DOI 10.1111/j.1432-1033.1973.tb02985.x; POSTMA PW, 1985, MICROBIOL REV, V49, P232, DOI 10.1128/MMBR.49.3.232-269.1985; REENSTRA WW, 1980, BIOCHEMISTRY-US, V19, P1, DOI 10.1021/bi00542a001; ROBILLARD GT, 1987, BIOCHEMISTRY-US, V26, P5796, DOI 10.1021/bi00392a032; ROBILLARD GT, 1979, BIOCHEMISTRY-US, V18, P2984, DOI 10.1021/bi00581a012; ROOSSIEN FF, 1984, BIOCHEMISTRY-US, V23, P4934, DOI 10.1021/bi00316a017; SAIER MH, 1976, J BIOL CHEM, V251, P6584; VANDIJK AA, 1990, BIOCHEMISTRY-US, V29, P8164, DOI 10.1021/bi00487a026	19	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17844	17849						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349668				2022-12-27	WOS:A1993LT74300033
J	KRIEG, P; FEIL, S; FURSTENBERGER, G; BOWDEN, GT				KRIEG, P; FEIL, S; FURSTENBERGER, G; BOWDEN, GT			TUMOR-SPECIFIC OVEREXPRESSION OF A NOVEL KERATINOCYTE LIPID-BINDING PROTEIN - IDENTIFICATION AND CHARACTERIZATION OF A CLONED SEQUENCE ACTIVATED DURING MULTISTAGE CARCINOGENESIS IN MOUSE SKIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID-BINDING; TISSUE-SPECIFIC EXPRESSION; SQUAMOUS-CELL CARCINOMAS; MOLECULAR-CLONING; MESSENGER-RNA; 3-DIMENSIONAL STRUCTURE; NUCLEOTIDE-SEQUENCE; MYELIN-P2 PROTEIN; ESCHERICHIA-COLI; CDNA SEQUENCE	Differential screening of cDNA libraries from chemically induced malignant mouse skin squamous cell carcinomas (SCCs) identified sequences, including one called mall, that were up-regulated in their expression at both the benign papilloma and the malignant SCC stages during tumor development. The mall plasmid cDNA clone was used to screen lambda phage cDNA libraries made from chemically induced papillomas and SCCs. Two size classes (655 and 933 nucleotides excluding the poly(A) tail) of full-length cDNAs were isolated. The corresponding mRNAs differ in their 3'-untranslated region by 278 nucleotides as a result of utilizing two alternative polyadenylation signals. Both transcripts were expressed simultaneously, showing the same expression patterns, with the smaller one being the predominant species. Most tissues examined showed a weak expression of mall mRNA. High levels of mall transcripts could be detected in adipose and mammary tissues and tongue epithelia and predominantly in epidermis. The expression observed in epidermis was up-regulated dramatically during tumor formation. Computer-assisted sequence analysis revealed one open reading frame that encoded a protein of 135 amino acid residues with extensive homology to members of the lipid-binding protein family. Residues determining the proposed beta-clam structure of these proteins and the structure of the lipid-binding region were shown to be conserved in the mal1 gene. In vitro translation of mall RNA yielded a polypeptide of the predicted size of 15 kDa that was immunoprecipitable with an anti-rat liver fatty acid-binding protein antiserum. Based on the sequence analysis and antigenic properties of mall, we conclude that it encodes a novel member of the lipid-binding protein family.	UNIV ARIZONA,SCH MED,DEPT RADIAT ONCOL,TUCSON,AZ 85724	University of Arizona	KRIEG, P (corresponding author), DEUTSCH KREBSFORSCHUNGSZENTRUM,DEPT TUMOR CELL REGULAT,NEUENHEIMER FELD 280,W-6900 HEIDELBERG,GERMANY.							BALMAIN A, 1982, NUCLEIC ACIDS RES, V10, P4259, DOI 10.1093/nar/10.14.4259; BERNLOHR DA, 1985, BIOCHEM BIOPH RES CO, V132, P850, DOI 10.1016/0006-291X(85)91209-4; BERNLOHR DA, 1984, P NATL ACAD SCI-BIOL, V81, P5468, DOI 10.1073/pnas.81.17.5468; BOHMER FD, 1987, J BIOL CHEM, V262, P15137; BUELT MK, 1990, BIOCHEMISTRY-US, V29, P7408, DOI 10.1021/bi00484a008; BUELT MK, 1991, J BIOL CHEM, V266, P12266; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; CISTOLA DP, 1989, J BIOL CHEM, V264, P2700; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; FARBER E, 1982, CANCER COMPREHENSIVE, P485; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FEX G, 1986, INT J CANCER, V37, P217, DOI 10.1002/ijc.2910370208; FINCH J, 1991, CARCINOGENESIS, V12, P1519, DOI 10.1093/carcin/12.8.1519; FINCH JS, 1992, CELL GROWTH DIFFER, V3, P269; FURSTENBERGER G, 1986, CARCINOGENESIS, V7, P1745, DOI 10.1093/carcin/7.10.1745; Fusenig N E, 1985, Carcinog Compr Surv, V9, P293; GANTZ I, 1989, J BIOL CHEM, V264, P20248; GATES RE, 1985, CANCER, V56, P2598, DOI 10.1002/1097-0142(19851201)56:11<2598::AID-CNCR2820561111>3.0.CO;2-R; GIGUERE V, 1990, P NATL ACAD SCI USA, V87, P6233, DOI 10.1073/pnas.87.16.6233; GORDON JI, 1983, J BIOL CHEM, V258, P3356; GREEN RP, 1992, DNA CELL BIOL, V11, P31, DOI 10.1089/dna.1992.11.31; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HOLLADAY K, 1992, MOL CARCINOGEN, V5, P16, DOI 10.1002/mc.2940050106; JONES TA, 1988, EMBO J, V7, P1597, DOI 10.1002/j.1460-2075.1988.tb02985.x; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRIEG P, 1983, ANAL BIOCHEM, V134, P288, DOI 10.1016/0003-2697(83)90299-3; KRIEG P, 1988, CARCINOGENESIS, V9, P95, DOI 10.1093/carcin/9.1.95; KRIEG P, 1988, UCLA S MOL CELL BIOL, V32, P267; LI E, 1986, P NATL ACAD SCI USA, V83, P5779, DOI 10.1073/pnas.83.16.5779; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MARKS F, 1992, CELLULAR INTERACTION, P3; MATARESE V, 1989, PROG LIPID RES, V28, P245, DOI 10.1016/0163-7827(89)90001-5; MELBER K, 1986, CARCINOGENESIS, V7, P317, DOI 10.1093/carcin/7.2.317; MULLERFAHRNOW A, 1991, EUR J BIOCHEM, V199, P271, DOI 10.1111/j.1432-1033.1991.tb16120.x; NARAYANAN V, 1991, J NEUROCHEM, V57, P75, DOI 10.1111/j.1471-4159.1991.tb02101.x; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; OSTROWSKI LE, 1988, MOL CARCINOGEN, V1, P13, DOI 10.1002/mc.2940010106; OSTROWSKI LE, 1989, CARCINOGENESIS, V10, P1439, DOI 10.1093/carcin/10.8.1439; PAULUSSEN RJA, 1989, BIOCHIM BIOPHYS ACTA, V1001, P201, DOI 10.1016/0005-2760(89)90149-5; QUINTANILLA M, 1991, CARCINOGENESIS, V12, P1875, DOI 10.1093/carcin/12.10.1875; RAMSDEN M, 1985, EMBO J, V4, P1449, DOI 10.1002/j.1460-2075.1985.tb03801.x; SACCHETTINI JC, 1989, J MOL BIOL, V208, P327, DOI 10.1016/0022-2836(89)90392-6; SACCHETTINI JC, 1990, J BIOL CHEM, V265, P19199; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHERMAN DR, 1987, P NATL ACAD SCI USA, V84, P3209, DOI 10.1073/pnas.84.10.3209; STRICKLAND JE, 1988, CANCER RES, V48, P165; TWEEDIE S, 1989, NUCLEIC ACIDS RES, V17, P4374, DOI 10.1093/nar/17.11.4374; WAHLBERG P, 1989, BIOCHIM BIOPHYS ACTA, V1010, P287, DOI 10.1016/0167-4889(89)90051-7; WALZ DA, 1988, J BIOL CHEM, V263, P14189; WEI LN, 1990, DNA CELL BIOL, V9, P471, DOI 10.1089/dna.1990.9.471; YANAGITA T, 1986, CANCER, V58, P2251, DOI 10.1002/1097-0142(19861115)58:10<2251::AID-CNCR2820581015>3.0.CO;2-Y; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZAIN BS, 1977, J MOL BIOL, V115, P249, DOI 10.1016/0022-2836(77)90101-2	54	76	79	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17362	17369						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349619				2022-12-27	WOS:A1993LQ98800071
J	RAMACHANDRA, M; PADMANABHAN, R				RAMACHANDRA, M; PADMANABHAN, R			ADENOVIRUS DNA-POLYMERASE IS PHOSPHORYLATED BY A STABLY ASSOCIATED HISTONE H1 KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SV40 T-ANTIGEN; CYCLE-DEPENDENT PHOSPHORYLATION; ACTIVATED PROTEIN-KINASES; NUCLEAR FACTOR-III; ANIMAL VIRUS-DNA; CELL-CYCLE; REPLICATION INVITRO; BINDING PROTEIN; RETINOBLASTOMA PROTEIN; PRETERMINAL PROTEIN	Adenovirus DNA polymerase (AdPol) exists as a complex with the preterminal protein (pTP) and is essential for both initiation and elongation stages of viral DNA replication. Recent evidence from our laboratory indicates that AdPol is a phosphoprotein and that the major in vivo phosphorylation site, serine 67, occurs within the consensus substrate recognition sequence for cdc2 kinases. In this study, we found that a protein kinase which also exhibits histone H1 phosphorylation activity is stably associated with AdPol. AdPol forms a multimeric complex with this histone H1 kinase and pTP in HeLa cells infected with adenovirus or coinfected with recombinant vaccinia viruses encoding AdPol and pTP. The associated protein kinase and the p34cdc2 kinase phosphorylate AdPol at the same sites which are utilized in vivo, suggesting that the p34cdc2 kinase or a related kinase may be involved in the in vivo phosphorylation of AdPol. Serine 67 is also one of the major in vitro phosphorylation sites, and the substitution of alanine for serine at this position abolishes DNA replication initiation activity of AdPol.	UNIV KANSAS, MED CTR, DEPT BIOCHEM & MOLEC BIOL, 3901 RAINBOW BLVD, KANSAS CITY, KS 66160 USA	University of Kansas; University of Kansas Medical Center				Ramachandra, Murali/0000-0003-4039-1491	NATIONAL CANCER INSTITUTE [R01CA033099] Funding Source: NIH RePORTER; NCI NIH HHS [CA 33099] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIYAMA T, 1992, P NATL ACAD SCI USA, V89, P7900, DOI 10.1073/pnas.89.17.7900; BLANCO L, 1991, GENE, V100, P27, DOI 10.1016/0378-1119(91)90346-D; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; CHALLBERG MD, 1979, P NATL ACAD SCI USA, V76, P655, DOI 10.1073/pnas.76.2.655; CHEN M, 1990, J BIOL CHEM, V265, P18634; CHEN M, 1989, P NATL ACAD SCI USA, V86, P6116, DOI 10.1073/pnas.86.16.6116; CHROBOCZEK J, 1992, VIROLOGY, V186, P280, DOI 10.1016/0042-6822(92)90082-Z; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; CRIPPSWOLFMAN J, 1989, J BIOL CHEM, V264, P19478; DOBBS L, 1990, VIROLOGY, V178, P43, DOI 10.1016/0042-6822(90)90377-4; DRAETTA G, 1987, CELL, V50, P319, DOI 10.1016/0092-8674(87)90227-3; DRAETTA G, 1990, TRENDS BIOCHEM SCI, V15, P378, DOI 10.1016/0968-0004(90)90235-4; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; DUMONT DJ, 1992, VIROLOGY, V189, P111, DOI 10.1016/0042-6822(92)90686-J; DUTTA A, 1992, EMBO J, V11, P2189, DOI 10.1002/j.1460-2075.1992.tb05278.x; ELROYSTEIN O, 1992, CURRENT PROTOCOLS MO; FANNING E, 1992, J VIROL, V66, P1289, DOI 10.1128/JVI.66.3.1289-1293.1992; FIELD J, 1984, J BIOL CHEM, V259, P9487; GIORDANO A, 1991, SCIENCE, V253, P1271, DOI 10.1126/science.1653969; Green M, 1979, Methods Enzymol, V58, P425; HAY RT, 1989, BIOCHEM J, V258, P3, DOI 10.1042/bj2580003; HERRMANN CH, 1991, J VIROL, V65, P5848, DOI 10.1128/JVI.65.11.5848-5859.1991; HOSS A, 1990, J VIROL, V64, P4799; HU Q, 1992, MOL CELL BIOL, V12, P971, DOI 10.1128/MCB.12.3.971; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; JOUNG I, 1992, J VIROL, V66, P5788, DOI 10.1128/JVI.66.10.5788-5796.1992; KITAGAWA M, 1992, ONCOGENE, V7, P1067; KLEINBERGER T, 1991, P NATL ACAD SCI USA, V88, P11143, DOI 10.1073/pnas.88.24.11143; KOFF A, 1991, CELL, V66, P1217, DOI 10.1016/0092-8674(91)90044-Y; KRAISS S, 1990, ONCOGENE, V5, P845; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEES JA, 1991, EMBO J, V10, P4279, DOI 10.1002/j.1460-2075.1991.tb05006.x; LEHMAN IR, 1989, J BIOL CHEM, V264, P4265; LEOPOLD P, 1991, CELL, V66, P1207, DOI 10.1016/0092-8674(91)90043-X; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; LICHY JH, 1982, P NATL ACAD SCI-BIOL, V79, P5225, DOI 10.1073/pnas.79.17.5225; LINDENBAUM JO, 1986, J BIOL CHEM, V261, P218; MALLER JL, 1990, BIOCHEMISTRY-US, V29, P3157, DOI 10.1021/bi00465a001; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; MCCONLOGUE L, 1988, NUCLEIC ACIDS RES, V16, P9869, DOI 10.1093/nar/16.20.9869; MCVEY D, 1989, NATURE, V341, P503, DOI 10.1038/341503a0; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; MORLA AO, 1989, CELL, V58, P193, DOI 10.1016/0092-8674(89)90415-7; MUL YM, 1990, J VIROL, V64, P5510, DOI 10.1128/JVI.64.11.5510-5518.1990; MUL YM, 1989, NUCLEIC ACIDS RES, V17, P8917, DOI 10.1093/nar/17.22.8917; NAGATA K, 1982, P NATL ACAD SCI-BIOL, V79, P6438, DOI 10.1073/pnas.79.21.6438; NAGATA K, 1983, P NATL ACAD SCI-BIOL, V80, P6177, DOI 10.1073/pnas.80.20.6177; NAGATA K, 1983, P NATL ACAD SCI-BIOL, V80, P4266, DOI 10.1073/pnas.80.14.4266; NAKANO R, 1991, GENE, V105, P173, DOI 10.1016/0378-1119(91)90148-5; NASHEUER HP, 1991, J BIOL CHEM, V266, P7893; ONEILL EA, 1988, SCIENCE, V241, P1210, DOI 10.1126/science.3413485; PAGANO M, 1992, SCIENCE, V255, P1144, DOI 10.1126/science.1312258; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PARIS J, 1991, P NATL ACAD SCI USA, V88, P1039, DOI 10.1073/pnas.88.3.1039; PELECH SL, 1992, TRENDS BIOCHEM SCI, V17, P233, DOI 10.1016/S0968-0004(00)80005-5; PETER M, 1992, EUR J BIOCHEM, V205, P287, DOI 10.1111/j.1432-1033.1992.tb16779.x; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; PRIVES C, 1990, CELL, V61, P735, DOI 10.1016/0092-8674(90)90179-I; PRUIJN GJM, 1986, NATURE, V322, P656, DOI 10.1038/322656a0; PRUIJN GJM, 1987, EMBO J, V6, P3771, DOI 10.1002/j.1460-2075.1987.tb02712.x; RAMACHANDRA M, 1993, J BIOL CHEM, V268, P442; RAWLINS DR, 1984, CELL, V37, P309, DOI 10.1016/0092-8674(84)90327-1; ROSENBLATT J, 1992, P NATL ACAD SCI USA, V89, P2824, DOI 10.1073/pnas.89.7.2824; SAMIEI M, 1991, J BIOL CHEM, V266, P14889; SASAGURI Y, 1987, VIROLOGY, V160, P389, DOI 10.1016/0042-6822(87)90010-9; SCHEIDTMANN KH, 1991, J VIROL, V65, P1479, DOI 10.1128/JVI.65.3.1479-1490.1991; SCHNEIDER J, 1988, J VIROL, V62, P1598, DOI 10.1128/JVI.62.5.1598-1605.1988; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; STURZBECHER HW, 1990, ONCOGENE, V5, P795; TEMPERLEY SM, 1992, EMBO J, V11, P761, DOI 10.1002/j.1460-2075.1992.tb05109.x; THOMAS G, 1992, CELL, V68, P3, DOI 10.1016/0092-8674(92)90199-M; TSAI LH, 1991, NATURE, V353, P174, DOI 10.1038/353174a0; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; WIDES RJ, 1987, MOL CELL BIOL, V7, P864, DOI 10.1128/MCB.7.2.864; WILLIAMS RT, 1992, ONCOGENE, V7, P423; YUE X, 1991, CELL, V65, P691, DOI 10.1016/0092-8674(91)90100-D; ZHAO LJ, 1991, NEW BIOL, V3, P1074; ZHAO LJ, 1993, METHOD ENZYMOL, V217, P218; ZHAO LJ, 1988, CELL, V55, P1005, DOI 10.1016/0092-8674(88)90245-0; ZHAO LJ, 1991, GENE, V100, P147, DOI 10.1016/0378-1119(91)90360-N	83	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17448	17456						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349626				2022-12-27	WOS:A1993LQ98800083
J	SCHULTZ, C; VAJANAPHANICH, M; HAROOTUNIAN, AT; SAMMAK, PJ; BARRETT, KE; TSIEN, RY				SCHULTZ, C; VAJANAPHANICH, M; HAROOTUNIAN, AT; SAMMAK, PJ; BARRETT, KE; TSIEN, RY			ACETOXYMETHYL ESTERS OF PHOSPHATES, ENHANCEMENT OF THE PERMEABILITY AND POTENCY OF CAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; INOSITOL PHOSPHATES; INTACT-CELLS; INDICATORS; ANALOGS; METABOLISM; BUTYRATE; CALCIUM; CA-2+; ACID	Acetoxymethyl esters of alkyl or aryl phosphates can be prepared by reacting their trialkylammonium or silver salts with acetoxymethyl bromide. Because acetoxymethyl esters are rapidly cleaved intracellularly, they facilitate the delivery of organophosphates into the cytoplasm without puncturing or disruption of the plasma membrane. In addition, acylation of free hydroxyls, for example with butyryl groups, is useful both for synthetic convenience and increased hydrophobicity of the permeant derivatives. The highly polar intracellular messengers cAMP and cGMP were thus converted into uncharged membrane-permeant derivatives. Extracellularly applied N6,2'-O-dibutyryl cAMP acetoxymethyl ester (Bt2cAMP/AM) is shown to simulate intracellular cAMP in three model systems, namely dissociation of cAMP-dependent protein kinase in fibroblasts, activation of Cl- secretion of monolayers of the human colon epithelial cell line T84, and dispersion of pigment granules in angel fish melanophores. Bt2cAMP/AM is effective at concentrations two or three orders of magnitude less than those required for commonly used membrane-permeant cAMP derivatives such as Bt2cAMP, 8-Br-cAMP, and 8-pCPT-cAMP lacking the acetoxymethyl ester. This methodology should be of general utility for the intracellular delivery of phosphate-containing second messengers.	UNIV CALIF SAN DIEGO, HOWARD HUGHES MED INST, 0647, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, DEPT PHARMACOL, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego			Barrett, Kim/AAE-2794-2022; Barrett, Kim Elaine/AAE-7762-2019	Barrett, Kim Elaine/0000-0002-6704-998X; Schultz, Carsten/0000-0002-5824-2171	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027177, R37NS027177] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK28305] Funding Source: Medline; NINDS NIH HHS [NS 27177] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; BARRETT KE, 1991, TXB GASTROENTEROLOGY, P265; BEEBE SJ, 1988, METHOD ENZYMOL, V159, P118; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BUNDGAARD H, 1987, BIOREVERSIBLE CARRIE, P13; CORBIN JD, 1988, METHODS ENZYMOLOGY I, V159; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204, DOI 10.1152/ajpgi.1984.246.2.G204; DHARMSATHAPHORN K, 1985, J CLIN INVEST, V75, P462, DOI 10.1172/JCI111721; ENGELS J, 1977, J MED CHEM, V20, P907, DOI 10.1021/jm00217a008; FALBRIARD JL, 1967, BIOCHIM BIOPHYS ACTA, V148, P99, DOI 10.1016/0304-4165(67)90283-8; FREED JJ, 1989, BIOCHEM PHARMACOL, V38, P3193, DOI 10.1016/0006-2952(89)90613-8; GOY MF, 1991, TRENDS NEUROSCI, V14, P293, DOI 10.1016/0166-2236(91)90140-P; GRIPPO JF, 1987, J BIOL CHEM, V262, P4492; GRYNKIEWICZ G, 1987, POL J CHEM, V61, P443; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GURNEY AM, 1987, PHYSIOL REV, V67, P583, DOI 10.1152/physrev.1987.67.2.583; HARDIE DG, 1991, BIOCH MESSENGERS HOR, P147; HENION WF, 1967, BIOCHIM BIOPHYS ACTA, V148, P106, DOI 10.1016/0304-4165(67)90284-X; HUDSON RF, 1958, J CHEM SOC, P1356, DOI 10.1039/jr9580001356; IYER RP, 1989, TETRAHEDRON LETT, V30, P7141, DOI 10.1016/S0040-4039(01)93918-8; JANSEN ABA, 1965, J CHEM SOC, P2127, DOI 10.1039/jr9650002127; KOOISTRA T, 1987, BIOCHEM J, V247, P605, DOI 10.1042/bj2470605; MADARA JL, 1985, J CELL BIOL, V101, P2124, DOI 10.1083/jcb.101.6.2124; MCCRAY JA, 1989, ANNU REV BIOPHYS BIO, V18, P239, DOI 10.1146/annurev.biophys.18.1.239; MCROBERTS J A, 1989, P235; MEYER RB, 1980, BURGERS MED CHEM, P1201; NERBONNE JM, 1984, NATURE, V310, P74, DOI 10.1038/310074a0; POLOKOFF MA, 1988, J BIOL CHEM, V263, P11922; RATTO GM, 1988, J NEUROSCI, V8, P3240; REPHAELI A, 1991, INT J CANCER, V49, P66, DOI 10.1002/ijc.2910490113; Robison G.A., 1971, CYCLIC AMP, DOI [10.1146/annurev.bi.37.070168.001053, DOI 10.1146/ANNUREV.BI.37.070168.001053]; RYAN WL, 1972, SCIENCE, V177, P1002, DOI 10.1126/science.177.4053.1002; SAMMAK PJ, 1992, J CELL BIOL, V117, P57, DOI 10.1083/jcb.117.1.57; SAPERSTEIN R, 1989, BIOCHEMISTRY-US, V28, P5694, DOI 10.1021/bi00439a053; SASTRY JK, 1992, MOL PHARMACOL, V41, P441; Schliwa M., 1975, MICROTUBULES MICROTU, P215; SCHULTZ C, 1993, IN PRESS J BIOL CHEM, V268; SRIVASTVA DN, 1984, BIOORG CHEM, V12, P118, DOI 10.1016/0045-2068(84)90022-1; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; TSIEN RY, 1989, METHOD CELL BIOL, V30, P127; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; WALKER JW, 1988, J AM CHEM SOC, V110, P7170, DOI 10.1021/ja00229a036; WALKER JW, 1989, BIOCHEMISTRY-US, V28, P3272, DOI 10.1021/bi00434a023; YUSTA B, 1988, J NEUROCHEM, V51, P1807, DOI 10.1111/j.1471-4159.1988.tb01162.x	45	92	99	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1993	268	9					6316	6322						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KT368	8384207				2022-12-27	WOS:A1993KT36800038
J	WANG, YL; SWEITZER, TD; WEINHOLD, PA; KENT, C				WANG, YL; SWEITZER, TD; WEINHOLD, PA; KENT, C			NUCLEAR-LOCALIZATION OF SOLUBLE CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; PHOSPHOLIPASE-C TREATMENT; RAT-LIVER; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; CHOLINEPHOSPHATE CYTIDYLYLTRANSFERASE; INTRACELLULAR-LOCALIZATION; PHOSPHORYLATION; PROTEIN; PURIFICATION; STIMULATION	The soluble form of CTP:phosphocholine cytidylyltransferase, which has previously been assumed to be cytosolic, has been localized to the nucleus of several cell types. Indirect immunofluorescence microscopy indicated a nuclear location in HepG2, NIH-3T3, and L-cells. A comparison of the fluorescence pattern of wild-type CHO cells with a cytidylyltransferase-deficient mutant provided genetic evidence that cytidylyltransferase is nuclear in CHO cells. The enzyme is also predominantly nuclear in rat liver, as revealed by staining frozen sections of that tissue. When L-cells were fractionated by enucleation, over 95% of cytidylyltransferase activity was found in the nuclear fraction, providing biochemical evidence for a nuclear location in these cells. In light of the demonstration that the membrane-bound cytidylyltransferase in CHO cells is associated with the nuclear envelope (Watkins, J. D., and Kent, C. (1992) J. Biol. Chem. 267, 5686-5692), these results suggest that this enzyme is predominantly an intranuclear enzyme.	VET AFFAIRS MED CTR,ANN ARBOR,MI 48105	US Department of Veterans Affairs; Veterans Health Administration (VHA)	WANG, YL (corresponding author), UNIV MICHIGAN,MED CTR,DEPT BIOL CHEM,ANN ARBOR,MI 48109, USA.				NICHD NIH HHS [HD0281] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; BENSCH KG, 1982, J BIOL CHEM, V257, P8391; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAPITANI S, 1990, BIOCHIM BIOPHYS ACTA, V1044, P193, DOI 10.1016/0005-2760(90)90303-F; CAPRIOTTI AM, 1988, J BIOL CHEM, V263, P10029; CASOLA PG, 1980, BIOCHEM BIOPH RES CO, V96, P1209, DOI 10.1016/0006-291X(80)90080-7; CHOY PC, 1977, J BIOL CHEM, V252, P7673; CORNELL RB, 1991, BIOCHEMISTRY-US, V30, P5881, DOI 10.1021/bi00238a011; CORNELL RB, 1991, BIOCHEMISTRY-US, V30, P5873, DOI 10.1021/bi00238a010; ESKO JD, 1980, P NATL ACAD SCI-BIOL, V77, P5192, DOI 10.1073/pnas.77.9.5192; ESKO JD, 1981, J BIOL CHEM, V256, P7388; EXTON JH, 1990, J BIOL CHEM, V265, P1; FELDMAN DA, 1981, BIOCHIM BIOPHYS ACTA, V665, P53, DOI 10.1016/0005-2760(81)90231-9; FELDMAN DA, 1985, BIOCHIM BIOPHYS ACTA, V429, P429; FOLLETT EAC, 1974, EXP CELL RES, V84, P72, DOI 10.1016/0014-4827(74)90381-4; GARCIABUSTOS J, 1991, BIOCHIM BIOPHYS ACTA, V1071, P83, DOI 10.1016/0304-4157(91)90013-M; GASC JM, 1990, EXP CELL RES, V186, P362, DOI 10.1016/0014-4827(90)90317-4; HAMADA S, 1983, HISTOCHEMISTRY, V79, P219, DOI 10.1007/BF00489783; HIGGINS JA, 1987, J LIPID RES, V28, P268; KENT C, 1990, PROG LIPID RES, V29, P87, DOI 10.1016/0163-7827(90)90010-I; KREK W, 1992, J CELL BIOL, V116, P43, DOI 10.1083/jcb.116.1.43; LASKO DD, 1990, J BIOL CHEM, V265, P12618; MACDONALD JIS, 1992, IN PRESS PROTEIN EXP; MORAND JN, 1989, J BIOL CHEM, V264, P13785; PAYRASTRE B, 1992, J BIOL CHEM, V267, P5078; PESCE A, 1964, J BIOL CHEM, V239, P1753; SCHNEIDER WC, 1963, J BIOL CHEM, V238, P3572; SLEIGHT R, 1980, J BIOL CHEM, V255, P644; SLEIGHT R, 1983, J BIOL CHEM, V258, P824; STERN W, 1976, BIOCHIM BIOPHYS ACTA, V441, P280, DOI 10.1016/0005-2760(76)90171-5; TERCE F, 1988, J BIOL CHEM, V263, P3142; TIJBURG LBM, 1989, BIOCHIM BIOPHYS ACTA, V1004, P1, DOI 10.1016/0005-2760(89)90206-3; VANCE DE, 1989, PHOSPHATIDYLCHOLINE, P33; VANCE JE, 1988, J BIOL CHEM, V263, P5898; WATKINS JD, 1991, J BIOL CHEM, V266, P21113; WATKINS JD, 1992, J BIOL CHEM, V267, P5686; WATKINS JD, 1990, J BIOL CHEM, V265, P2190; WEINHOLD PA, 1986, J BIOL CHEM, V261, P5104; WEINHOLD PA, 1991, J BIOL CHEM, V266, P6093; WILGRAM GF, 1963, J BIOL CHEM, V238, P2615; WRIGHT PS, 1985, J BIOL CHEM, V260, P7919	42	126	126	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1993	268	8					5899	5904						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR822	8383679				2022-12-27	WOS:A1993KR82200082
J	MOEHRING, JM; INOCENCIO, NM; ROBERTSON, BJ; MOEHRING, TJ				MOEHRING, JM; INOCENCIO, NM; ROBERTSON, BJ; MOEHRING, TJ			EXPRESSION OF MOUSE FURIN IN A CHINESE-HAMSTER CELL RESISTANT TO PSEUDOMONAS EXOTOXIN-A AND VIRUSES COMPLEMENTS THE GENETIC LESION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROHORMONE-PROCESSING ENDOPROTEASE; NEWCASTLE-DISEASE VIRUS; MAMMALIAN-CELLS; STRUCTURAL CONSERVATION; SINDBIS VIRUS; MESSENGER-RNA; KEX2; AERUGINOSA; PROTEASE; SEQUENCE	RPE.40 is a strain of mutated CHO-K1 cells with elevated resistance to Pseudomonas exotoxin A, Sindbis virus, and Newcastle disease virus. Virus resistance is due to an inability to cleave precursor viral membrane glycoproteins and produce infectious virions. Transfection of RPE.40 cells with cDNA for mouse furin causes them to lose all resistance and become as sensitive as wild-type cells to the toxin and viruses. Transfection of RPE.40 cells with cDNA for the related yeast protease Kex2 reduces their resistance to the toxin and viruses, but does not completely eliminate it.	UNIV VERMONT, MARKEY CTR MOLEC GENET, DEPT MICROBIOL & MOLEC GENET, BURLINGTON, VT 05405 USA; UNIV VERMONT, VERMONT CANC CTR, BURLINGTON, VT 05405 USA	University of Vermont; University of Vermont					NIAID NIH HHS [AI 09100] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI009100] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABENES G, 1986, ARCH VIROL, V90, P97, DOI 10.1007/BF01314148; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; CHAMBERLAIN JP, 1979, ANAL BIOCHEM, V98, P132, DOI 10.1016/0003-2697(79)90716-4; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; FOSTER DC, 1991, BIOCHEMISTRY-US, V30, P367, DOI 10.1021/bi00216a009; FRYLING C, 1992, INFECT IMMUN, V60, P497, DOI 10.1128/IAI.60.2.497-502.1992; FULLER RS, 1988, ANNU REV PHYSIOL, V50, P345, DOI 10.1146/annurev.ph.50.030188.002021; FULLER RS, 1989, SCIENCE, V246, P482, DOI 10.1126/science.2683070; GOTOH B, 1990, EMBO J, V9, P4189, DOI 10.1002/j.1460-2075.1990.tb07643.x; GRAY GL, 1984, P NATL ACAD SCI USA, V81, P532; HATSUZAWA K, 1990, J BIOL CHEM, V265, P22075; IGLEWSKI BH, 1977, INFECT IMMUN, V15, P138, DOI 10.1128/IAI.15.1.138-144.1977; INOCENCIO NM, 1993, J VIROL, V67, P593, DOI 10.1128/JVI.67.1.593-595.1993; KIEFER MC, 1991, DNA CELL BIOL, V10, P757, DOI 10.1089/dna.1991.10.757; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; LEPPLA SH, 1978, BIOCHEM BIOPH RES CO, V81, P532, DOI 10.1016/0006-291X(78)91567-X; MOEHRING JM, 1983, INFECT IMMUN, V41, P998, DOI 10.1128/IAI.41.3.998-1009.1983; NAGAI Y, 1976, VIROLOGY, V72, P494, DOI 10.1016/0042-6822(76)90178-1; NAGAI Y, 1991, Behring Institute Mitteilungen, P35; OGATA M, 1990, J BIOL CHEM, V265, P20678; RICE CM, 1981, P NATL ACAD SCI-BIOL, V78, P2062, DOI 10.1073/pnas.78.4.2062; SEIDAH NG, 1991, MOL ENDOCRINOL, V5, P111, DOI 10.1210/mend-5-1-111; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; THOMAS G, 1988, SCIENCE, V241, P226, DOI 10.1126/science.3291117; THOMPSON MR, 1991, J BIOL CHEM, V266, P2390; WATSON DG, 1991, J VIROL, V65, P2332, DOI 10.1128/JVI.65.5.2332-2339.1991; WISE RJ, 1990, P NATL ACAD SCI USA, V87, P9378, DOI 10.1073/pnas.87.23.9378	30	110	119	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2590	2594						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8381410				2022-12-27	WOS:A1993KK81500051
J	FINKEL, T; DUC, J; FEARON, ER; DANG, CV; TOMASELLI, GF				FINKEL, T; DUC, J; FEARON, ER; DANG, CV; TOMASELLI, GF			DETECTION AND MODULATION INVIVO OF HELIX-LOOP-HELIX PROTEIN-PROTEIN INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							REQUIRES HETERO-OLIGOMERIZATION; DNA-BINDING; GENE FAMILY; FUNCTIONAL-ACTIVITY; C-MYC; MYOD; EXPRESSION; RAS; DIFFERENTIATION; FIBROBLASTS	Studies are described that allow for the in vivo detection of helix-loop-helix (HLH) protein-protein interaction. The assay used requires HLH protein-protein interaction to reconstitute a functional GAL4 transcriptional activator, which in turn activates a reporter gene placed downstream of GAL4 DNA binding sequences. Using this assay, we are able to detect intracellular heterodimerization but not homodimerization of the MyoD, E12, and Id gene products. In addition, using this system we are unable to detect stable heterodimerization between MyoD and c-Jun. We also show that expression of activated ras(H) gene product does not inhibit and may stabilize HLH protein-protein interaction. This system may be of general utility in studying the modulation of transcription factor interactions.	JOHNS HOPKINS UNIV,SCH MED,DEPT CELL BIOL & ANAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV HOSP,CTR ONCOL,DEPT MED,DIV CARDIOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV HOSP,CTR ONCOL,DEPT MED,DIV HEMATOL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine			Dang, Chi/Y-3375-2019	Dang, Chi/0000-0002-4031-2522	NCI NIH HHS [CA51497] Funding Source: Medline; NHLBI NIH HHS [K08 HL02421] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA051497, R37CA051497, R29CA051497] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL002421] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BENGAL E, 1992, CELL, V68, P507, DOI 10.1016/0092-8674(92)90187-H; BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; CHRISTY BA, 1991, P NATL ACAD SCI USA, V88, P1815, DOI 10.1073/pnas.88.5.1815; DANG CV, 1991, MOL CELL BIOL, V11, P954, DOI 10.1128/MCB.11.2.954; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; FEARON ER, 1992, P NATL ACAD SCI USA, V89, P7958, DOI 10.1073/pnas.89.17.7958; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; HEATHORN P, 1990, SCIENCE, V247, P467; HU JS, 1992, MOL CELL BIOL, V12, P1031, DOI 10.1128/MCB.12.3.1031; KONIECZNY SF, 1989, ONCOGENE, V4, P473; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LASSAR AB, 1989, CELL, V58, P659, DOI 10.1016/0092-8674(89)90101-3; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; LIN H, 1991, MOL CELL BIOL, V11, P267, DOI 10.1128/MCB.11.1.267; MINER JH, 1990, P NATL ACAD SCI USA, V87, P1089, DOI 10.1073/pnas.87.3.1089; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; OLSON EN, 1987, MOL CELL BIOL, V7, P2104, DOI 10.1128/MCB.7.6.2104; PAYNE PA, 1987, P NATL ACAD SCI USA, V84, P8956, DOI 10.1073/pnas.84.24.8956; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697; SUN XH, 1991, CELL, V64, P459, DOI 10.1016/0092-8674(91)90653-G; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; WEINTRAUB H, 1991, GENE DEV, V5, P1377, DOI 10.1101/gad.5.8.1377; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7	35	60	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					5	8						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380166				2022-12-27	WOS:A1993KE60300002
J	HEDRICK, CC; CASTELLANI, LW; WARDEN, CH; PUPPIONE, DL; LUSIS, AJ				HEDRICK, CC; CASTELLANI, LW; WARDEN, CH; PUPPIONE, DL; LUSIS, AJ			INFLUENCE OF MOUSE APOLIPOPROTEIN-A-II ON PLASMA-LIPOPROTEINS IN TRANSGENIC MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; CHOLESTEROL EFFLUX; LIPID TRANSPORT; GENETIC-CONTROL; HEPATIC LIPASE; ADIPOSE-CELLS; AII GENE; ATHEROSCLEROSIS; EXPRESSION; POLYMORPHISM	The role of apolipoprotein A-II (apoA-II) in the metabolism of high density lipoproteins (HDL) is poorly understood. Previous studies of naturally occurring variations of apoA-II in mice have, however, suggested that apoA-II expression influences HDL size and concentration. We now provide definitive evidence of this using transgenic mice overexpressing mouse apoA-II. Thus, as compared with nontransgenic littermates, transgenic mice possessing 4-fold elevations of apoA-II mRNA and 2-3-fold elevations in plasma apoA-II levels exhibited more than a 2-fold increase in HDL levels as well as about a 25% increase in average HDL diameter. Overexpression of mouse apoA-II also resulted in a substantial decrease in the levels of apolipoprotein E associated with HDL, suggesting that apoA-II can displace apoE from HDL. The apoA-II transgenic mice also exhibited a 2-4-fold increase in plasma very low density and low density lipoprotein-cholesterol levels, suggesting novel interactions among the classes of plasma lipoproteins.	UNIV CALIF LOS ANGELES,DEPT MICROBIOL & MOLEC GENET,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	HEDRICK, CC (corresponding author), UNIV CALIF LOS ANGELES,DEPT MED,DIV CARDIOL,47-123 CHS,LOS ANGELES,CA 90024, USA.		Hedrick, Catherine/D-1106-2012		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042488, R37HL042488] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-07386, HL-42488] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARBARAS R, 1986, BIOCHIM BIOPHYS ACTA, V888, P143, DOI 10.1016/0167-4889(86)90015-7; BRESLOW JL, 1989, J CLIN INVEST, V84, P373, DOI 10.1172/JCI114176; BRESLOW JL, 1989, METABOLIC BASIS INHE, V1, P1252; BREWER HB, 1972, P NATL ACAD SCI USA, V69, P1304, DOI 10.1073/pnas.69.5.1304; BURSTEIN M, 1970, J LIPID RES, V11, P583; CHEN CH, 1986, EUR J BIOCHEM, V155, P589, DOI 10.1111/j.1432-1033.1986.tb09529.x; CHEUNG MC, 1984, J BIOL CHEM, V259, P2201; COLE TG, 1988, BIOCOMMUNIQUE, V4, P4; DEEB SS, 1990, AM J HUM GENET, V46, P822; DOOLITTLE MH, 1990, J BIOL CHEM, V265, P16380; EDELSTEIN C, 1976, BIOCHEMISTRY-US, V15, P1262, DOI 10.1021/bi00651a014; Eisenberg S, 1975, Adv Lipid Res, V13, P1; FIELDING C J, 1981, Proceedings of the National Academy of Sciences of the United States of America, V78, P3911, DOI 10.1073/pnas.78.6.3911; HAVEL RJ, 1973, J CLIN INVEST, V52, P32, DOI 10.1172/JCI107171; HAYEK T, 1992, J CLIN INVEST, V90, P505, DOI 10.1172/JCI115887; JAHN CE, 1983, EUR J BIOCHEM, V131, P25, DOI 10.1111/j.1432-1033.1983.tb07227.x; JIAO S, 1990, J LIPID RES, V31, P467; Karathanasis S. K., 1992, MONOGRAPHS HUMAN GEN, P140; KIRCHGESSNER TG, 1989, J BIOL CHEM, V264, P1473; LEBOEUF RC, 1983, J BIOL CHEM, V258, P5063; LEBOEUF RC, 1990, J LIPID RES, V31, P91; LUSIS AJ, 1987, J BIOL CHEM, V262, P7594; LUSIS AJ, 1983, J BIOL CHEM, V258, P5071; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MEHRABIAN M, 1993, ARTERIOSCLER THROMB, V13, P1, DOI 10.1161/01.ATV.13.1.1; MILLER NE, 1987, AM HEART J, V113, P589, DOI 10.1016/0002-8703(87)90638-7; MOWRI H, 1990, CIRCULATION, V82, P558; OIKAWA S, 1993, BIOCHIM BIOPHYS ACTA, V1165, P327, DOI 10.1016/0005-2760(93)90144-X; ORDOVAS JM, 1989, J BIOL CHEM, V264, P16339; PAIGEN B, 1987, P NATL ACAD SCI USA, V84, P3763, DOI 10.1073/pnas.84.11.3763; RAJPUTWILLIAMS J, 1989, ATHEROSCLEROSIS, V77, P31, DOI 10.1016/0021-9150(89)90006-3; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; RUBIN EM, 1991, P NATL ACAD SCI USA, V88, P434, DOI 10.1073/pnas.88.2.434; Sambrook J, 1989, MOL CLONING LABORATO; SCHULTZ JR, 1992, J BIOL CHEM, V267, P21630; SCOTT J, 1985, LANCET, V1, P771; STEINMETZ A, 1990, J BIOL CHEM, V265, P7859; TALL AR, 1990, J CLIN INVEST, V86, P379, DOI 10.1172/JCI114722; WALSH A, 1989, J BIOL CHEM, V264, P6488; WARDEN CH, 1993, IN PRESS SCIENCE; Warnick G R, 1986, Methods Enzymol, V129, P101	42	162	162	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20676	20682						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376417				2022-12-27	WOS:A1993LY01900107
J	LEONG, JM; MORRISSEY, PE; ISBERG, RR				LEONG, JM; MORRISSEY, PE; ISBERG, RR			A 76-AMINO ACID DISULFIDE LOOP IN THE YERSINIA-PSEUDOTUBERCULOSIS INVASIN PROTEIN IS REQUIRED FOR INTEGRIN RECEPTOR RECOGNITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED-MAMMALIAN-CELLS; ARG-GLY-ASP; ESCHERICHIA-COLI; BINDING DOMAIN; ADHESION; RGD; IDENTIFICATION; BACTERIA; ENTEROCOLITICA; LOCALIZATION	The Yersinia pseudotuberculosis invasin protein is a 986-amino acid protein that promotes bacterial penetration into mammalian cells by avidly binding multiple beta1-chain integrins. A 192-amino acid carboxyl-terminal domain of invasin was previously shown to be sufficient for binding. Evidence is presented here that a 76-amino acid disulfide loop in the integrin binding domain of invasin is required for invasin-mediated cell binding and entry. Bacterial mutants that were altered at either of 2 cysteine residues in the binding domain of invasin were completely defective for entry. Purified invasin protein derivatives altered at either of these cysteines, in contrast to the wild-type invasin, did not promote either cell binding or penetration. Analysis of proteolytic products of invasin in the presence or absence of reducing agent provided evidence of an intrachain disulfide bond near the carboxyl terminus of the protein. Alkylation of invasin derivatives with [H-3]iodoacetate indicated that these 2 cysteines were normally disulfide-bonded. A treatment that resulted in the maximal reduction of the disulfide bond also resulted in maximal loss of cell attachment activity. These results indicate that the 76-amino acid disulfide loop at the carboxyl terminus of invasin is required for recognition by integrins.	TUFTS UNIV, SCH MED, HOWARD HUGHES MED INST, 136 HARRISON AVE, BOSTON, MA 02111 USA; TUFTS UNIV, SCH MED, DEPT MOLEC BIOL & MICROBIOL, BOSTON, MA 02111 USA; TUFTS NEW ENGLAND MED CTR HOSP, DEPT MED, DIV RHEUMATOL & IMMUNOL, BOSTON, MA 02111 USA	Howard Hughes Medical Institute; Tufts University; Tufts University					NIAID NIH HHS [1 RO1-AI23538] Funding Source: Medline; NIDDK NIH HHS [1 P30DK39428] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023538] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADLER M, 1991, SCIENCE, V253, P445, DOI 10.1126/science.1862345; AOTA S, 1991, J BIOL CHEM, V266, P15938; BARKER PL, 1992, J MED CHEM, V35, P2040, DOI 10.1021/jm00089a014; BOLIN I, 1982, INFECT IMMUN, V37, P506; BOVALLIUS A, 1975, CAN J MICROBIOL, V21, P1997, DOI 10.1139/m75-287; BRASAEMLE DL, 1988, BIOTECHNIQUES, V6, P418; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; FOWLER RG, 1974, MOL GEN GENET, V133, P179, DOI 10.1007/BF00267667; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; GRUTZKAU A, 1990, GUT, V31, P1011, DOI 10.1136/gut.31.9.1011; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HILL DE, 1986, SCIENCE, V234, P451, DOI 10.1126/science.3532321; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; ISBERG RR, 1988, P NATL ACAD SCI USA, V85, P6682, DOI 10.1073/pnas.85.18.6682; ISBERG RR, 1990, MOL BIOL MED, V7, P73; ISBERG RR, 1993, J BIOL CHEM, V268, P15840; ISBERG RR, 1987, CELL, V50, P769, DOI 10.1016/0092-8674(87)90335-7; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; ISBERG RR, 1985, NATURE, V317, P262, DOI 10.1038/317262a0; KUMAMOTO CA, 1983, J BACTERIOL, V154, P253, DOI 10.1128/JB.154.1.253-260.1983; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; LEONG JM, 1991, INFECT IMMUN, V59, P3424, DOI 10.1128/IAI.59.10.3424-3433.1991; LEONG JM, 1992, INFECT IMMUN, V60, P683, DOI 10.1128/IAI.60.2.683-686.1992; LEONG JM, 1990, EMBO J, V9, P1979, DOI 10.1002/j.1460-2075.1990.tb08326.x; MAINA CV, 1988, GENE, V74, P365, DOI 10.1016/0378-1119(88)90170-9; MOULDER JW, 1985, MICROBIOL REV, V49, P298, DOI 10.1128/MMBR.49.3.298-337.1985; NHIEU GTV, 1991, J BIOL CHEM, V266, P24367; ONEIL KT, 1992, PROTEINS, V14, P509, DOI 10.1002/prot.340140411; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; PLANTEFABER LC, 1989, CELL, V56, P281, DOI 10.1016/0092-8674(89)90902-1; RANKIN S, 1992, INFECT IMMUN, V60, P3909, DOI 10.1128/IAI.60.9.3909-3912.1992; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SAMANEN J, 1991, J MED CHEM, V34, P3114, DOI 10.1021/jm00114a022; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANNHIEU GT, 1993, EMBO J, V12, P1887, DOI 10.1002/j.1460-2075.1993.tb05837.x; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3	41	49	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20524	20532						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376409				2022-12-27	WOS:A1993LY01900087
J	HASHII, M; NOZAWA, Y; HIGASHIDA, H				HASHII, M; NOZAWA, Y; HIGASHIDA, H			BRADYKININ-INDUCED CYTOSOLIC CA2+ OSCILLATIONS AND INOSITOL TETRAKISPHOSPHATE-INDUCED CA2+ INFLUX IN VOLTAGE-CLAMPED RAS-TRANSFORMED NIH/3T3 FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVALENT-CATION ENTRY; HYBRID NG108-15 CELLS; CALCIUM OSCILLATIONS; ENDOTHELIAL-CELLS; MAST-CELLS; PLASMA-MEMBRANE; ACINAR-CELLS; HA-RAS; GROWTH-FACTOR; AR42J CELLS	Microspectrofluorometry (fura-2) was combined with the whole-cell patch-clamp technique to study bradykinin-activated calcium (Ca2+) influx in single control or v-Ki-ras-transformed NIH/3T3 (DT) fibroblasts. Application of bradykinin on DT cells, but not on control NIH/3T3 cells, evoked cytosolic Ca2+ oscillations in the presence of extracellular Ca2+, but not in the absence of external Ca2+. This effect of zero external Ca2+ concentration could be mimicked by holding at depolarized membrane potentials. Cytosolic Ca2+ oscillations observed at holding potentials of -20 to -80 mV were terminated by holding at -10 mV or more depolarized potentials. The frequency of Ca2+ oscillations increased with membrane hyperpolarization. Bradykinin significantly enhanced the hyperpolarization-induced increases in the intracellular free Ca2+ concentration ([Ca2+]i) upon membrane hyperpolarization only in DT cells but not in control cells. No [Ca2+]i increase upon hyperpolarization was observed in bradykinin-stimulated DT cells in the absence of external Ca2+, suggesting that bradykinin activates Ca2+ influx. [Ca2+]i, increased upon application of inositol 1,3,4,5-tetrakisphosphate (Ins(1,3,4,5)P4) into control and DT cells in an extracellular Ca2+-dependent manner, indicating that NIH/3T3 fibroblasts have an Ins(1,3,4,5)P4-gated Ca2+ influx pathway. Ins(1,3,4,5)P4, however, produced the sustained [Ca2+]i increase in DT cells, but not in control NIH/3T3 cells, suggesting that ras may lock the Ca2+ influx pathway at the activated state. Cytosolic Ca2+ oscillations, bradykinin-enhanced Ca2+ influx, and Ins(1,3,4,5)P4-induced Ca2+ influx were all similar in that activity was increased by membrane hyperpolarization. The results suggest that bradykinin-induced cytosolic Ca2+ oscillations in ras-transformed NIH/3T3 cells are maintained by bradykinin-activated continuous Ca2+ influx which may use Ins(1,3,4,5)P4 as an intracellular messenger.	KANAZAWA UNIV, NEUROINFORMAT RES INST, DEPT BIOPHYS, KANAZAWA, ISHIKAWA 920, JAPAN; GIFU UNIV, SCH MED, DEPT BIOCHEM, GIFU 500, JAPAN	Kanazawa University; Gifu University			higashida, haruhiro/L-3773-2015	higashida, haruhiro/0000-0002-1779-0606				ALONSO T, 1990, MOL CELL BIOL, V10, P3117, DOI 10.1128/MCB.10.6.3117; BAUMGARTEN LB, 1992, J BIOL CHEM, V267, P10524; BENHAM CD, 1987, NATURE, V328, P275, DOI 10.1038/328275a0; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; BERRIDGE MJ, 1991, CELL CALCIUM, V12, P63, DOI 10.1016/0143-4160(91)90009-4; BIRD GS, 1991, NATURE, V352, P162, DOI 10.1038/352162a0; BYRON KL, 1992, J BIOL CHEM, V267, P108; CHEN CF, 1988, SCIENCE, V239, P1024, DOI 10.1126/science.2449730; COLLIN C, 1990, SCIENCE, V250, P1743, DOI 10.1126/science.2176747; COLLIN C, 1990, BIOPHYS J, V58, P785, DOI 10.1016/S0006-3495(90)82421-8; DIVIRGILIO F, 1987, J BIOL CHEM, V262, P4574; DOCHERTY RJ, 1988, J PHYSIOL-LONDON, V398, P33, DOI 10.1113/jphysiol.1988.sp017027; DOWNWARD J, 1988, P NATL ACAD SCI USA, V85, P5774, DOI 10.1073/pnas.85.16.5774; ENOMOTO K, 1992, CELL CALCIUM, V13, P501, DOI 10.1016/0143-4160(92)90018-N; ESTACION M, 1990, J MEMBRANE BIOL, V113, P169, DOI 10.1007/BF01872890; FISCHER H, 1992, P NATL ACAD SCI USA, V89, P1438, DOI 10.1073/pnas.89.4.1438; FU T, 1991, FEBS LETT, V281, P263, DOI 10.1016/0014-5793(91)80407-T; FU T, 1992, BIOCHEM J, V283, P347, DOI 10.1042/bj2830347; GRAND RJA, 1991, BIOCHEM J, V279, P609, DOI 10.1042/bj2790609; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAHNEL C, 1992, EUR J NEUROSCI, V4, P361, DOI 10.1111/j.1460-9568.1992.tb00883.x; HAJJAR RJ, 1991, J BIOL CHEM, V266, P21589; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAROOTUNIAN AT, 1991, SCIENCE, V251, P75, DOI 10.1126/science.1986413; HEMMICK LM, 1992, J NEUROSCI, V12, P2007; HIGASHIDA H, 1990, P ROY SOC B-BIOL SCI, V242, P68, DOI 10.1098/rspb.1990.0105; HIGASHIDA H, 1991, BIOCHEM BIOPH RES CO, V178, P713, DOI 10.1016/0006-291X(91)90166-5; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; IRVINE RF, 1992, FASEB J, V6, P3085, DOI 10.1096/fasebj.6.12.1325932; IVORRA I, 1991, BIOCHEM J, V273, P317, DOI 10.1042/bj2730317; JACOB R, 1988, NATURE, V335, P40, DOI 10.1038/335040a0; JACOB R, 1990, J PHYSIOL-LONDON, V421, P55, DOI 10.1113/jphysiol.1990.sp017933; KUNO M, 1987, NATURE, V326, P301, DOI 10.1038/326301a0; KWAN CY, 1990, J BIOL CHEM, V265, P678; LANG F, 1991, J BIOL CHEM, V266, P4938; LANG F, 1992, PFLUG ARCH EUR J PHY, V421, P416, DOI 10.1007/BF00370251; LASKEY RE, 1990, J BIOL CHEM, V265, P2613; LLOPIS J, 1992, BIOCHEM J, V284, P243, DOI 10.1042/bj2840243; LOESSBERG PA, 1991, J BIOL CHEM, V266, P1363; LU CY, 1989, J MEMBRANE BIOL, V109, P85, DOI 10.1007/BF01870793; LUCKHOFF A, 1992, NATURE, V355, P356, DOI 10.1038/355356a0; MATTHEWS G, 1989, J PHYSIOL-LONDON, V418, P105, DOI 10.1113/jphysiol.1989.sp017830; MELDOLESI J, 1991, TRENDS PHARMACOL SCI, V12, P289, DOI 10.1016/0165-6147(91)90577-F; MERRITT JE, 1987, J BIOL CHEM, V262, P17362; MORRIS AP, 1987, NATURE, V330, P653, DOI 10.1038/330653a0; NEHER E, 1988, J PHYSIOL-LONDON, V395, P193, DOI 10.1113/jphysiol.1988.sp016914; NODA M, 1983, P NATL ACAD SCI-BIOL, V80, P5602, DOI 10.1073/pnas.80.18.5602; OBERHUBER H, 1991, J BIOL CHEM, V266, P1437; OETTGEN HC, 1985, CELL, V40, P583, DOI 10.1016/0092-8674(85)90206-5; OGURA A, 1990, J BIOL CHEM, V265, P3577; OSIPCHUK Y, 1992, NATURE, V359, P241, DOI 10.1038/359241a0; PARRIES G, 1987, P NATL ACAD SCI USA, V84, P2648, DOI 10.1073/pnas.84.9.2648; PENNER R, 1988, NATURE, V334, P499, DOI 10.1038/334499a0; POLVERINO AJ, 1990, BIOCHEM J, V271, P309, DOI 10.1042/bj2710309; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; SAGE SO, 1986, EUR J PHARMACOL, V128, P99, DOI 10.1016/0014-2999(86)90563-7; SAUVE R, 1990, PFLUG ARCH EUR J PHY, V416, P43, DOI 10.1007/BF00370220; SCHILLING WP, 1989, J BIOL CHEM, V264, P12838; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; WAKUI M, 1990, CELL, V63, P1025, DOI 10.1016/0092-8674(90)90505-9; WOLL E, 1992, PFLUG ARCH EUR J PHY, V420, P208, DOI 10.1007/BF00374992; ZHANG BX, 1992, J BIOL CHEM, V267, P15419; ZHAO H, 1990, J BIOL CHEM, V265, P20856	65	50	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19403	19410						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366088				2022-12-27	WOS:A1993LW81900041
J	HORST, M; MARES, M; ZABE, M; HUMMEL, M; WIEDERANDERS, B; KIRSCHKE, H; HASILIK, A				HORST, M; MARES, M; ZABE, M; HUMMEL, M; WIEDERANDERS, B; KIRSCHKE, H; HASILIK, A			SYNTHESIS OF PHOSPHORYLATED OLIGOSACCHARIDES IN LYSOZYME IS ENHANCED BY FUSION TO CATHEPSIN-D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; HAMSTER KIDNEY-CELLS; LYSOSOMAL-ENZYMES; LINKED OLIGOSACCHARIDES; BIOSYNTHESIS; RECOGNITION; FIBROBLASTS; DETERMINANTS; EXPRESSION; SUBUNIT	Chinese hamster ovary cells transfected with human lysozyme cDNA encoding Asn instead of Gly22 synthesize a mutant lysozyme, [Asn22]lysozyme, with about 60% of the molecules bearing carbohydrate. This carbohydrate is predominantly of the complex type and contains a varied number of lactosamine repeats. In this study we show that the glycosylation of [Asn22] lysozyme fused to human cathepsin D is altered relative to [Asn22]lysozyme alone. The fusion protein is synthesized as a 66-kDa precursor that is cleaved to enzymatically active and antigenically positive cathepsin D and lysozyme. As compared with [Asn22]lysozyme the lysozyme moiety of the fusion protein shows an increased N-glycosylation and a decreased synthesis of lactosamine repeats. Cleavage of the precursor with cathepsin L has revealed that the lysozyme portion of the secreted fusion protein bears a complex type carbohydrate. The intracellularly released lysozyme portion of the fusion protein contains trimmed oligosaccharides. In the presence of NH4Cl the lysosomal targeting of the fusion protein is inhibited. The secreted protein is then enriched in molecules bearing phosphorylated high mannose oligosaccharides in their lysozyme moiety. Our results indicate that carbohydrate processing in [Asn22]lysozyme, including the synthesis of mannose 6-phosphate residues and of lactosamine repeats, is altered by the attached cathepsin D. The phosphorylation of the carbohydrate on the lysozyme portion results in a very efficient lysosomal targeting of the concerned fusion protein molecules.	UNIV MUNSTER,INST PHYSIOL CHEM & PATHOBIOCHEM,WALDEYERSTR 15,D-48129 MUNSTER,GERMANY; MARTIN LUTHER UNIV HALLE WITTENBERG,INST BIOCHEM,D-06097 HALLE,GERMANY	University of Munster; Martin Luther University Halle Wittenberg			Mares, Michael/B-2413-2009	Mares, Michael/0000-0002-0847-5022				ARTELT P, 1988, GENE, V68, P213, DOI 10.1016/0378-1119(88)90023-6; BARANSKI TJ, 1991, J BIOL CHEM, V266, P23365; BARANSKI TJ, 1990, CELL, V63, P281, DOI 10.1016/0092-8674(90)90161-7; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BIELINSKA M, 1989, J BIOL CHEM, V264, P17113; CANTOR AB, 1992, J BIOL CHEM, V267, P23349; CANTOR AB, 1992, J BIOL CHEM, V267, P23357; CARLSSON Sr, 1990, J BIOL CHEM, V265, P20488; DAHMS NM, 1986, J BIOL CHEM, V261, P3186; DONG JM, 1989, J BIOL CHEM, V264, P7377; FAUST PL, 1985, P NATL ACAD SCI USA, V82, P4910, DOI 10.1073/pnas.82.15.4910; GRASSEL S, 1989, ANAL BIOCHEM, V180, P72, DOI 10.1016/0003-2697(89)90089-4; HASILIK A, 1980, J BIOL CHEM, V255, P4946; HASILIK A, 1981, EUR J BIOCHEM, V121, P125, DOI 10.1111/j.1432-1033.1981.tb06440.x; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HOFLACK B, 1987, J BIOL CHEM, V262, P123; HORST M, 1991, J BIOL CHEM, V266, P13914; HORST M, 1991, BIOCHEM J, V273, P355, DOI 10.1042/bj2730355; ISIDORO C, 1991, EUR J CLIN CHEM CLIN, V29, P165; ISIDORO C, 1991, BIOCHEM J, V273, P363, DOI 10.1042/bj2730363; KIRSCHKE H, 1977, EUR J BIOCHEM, V74, P293, DOI 10.1111/j.1432-1033.1977.tb11393.x; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; LAZZARINO D, 1990, J BIOL CHEM, V265, P11864; VARA JA, 1986, NUCLEIC ACIDS RES, V14, P4617, DOI 10.1093/nar/14.11.4617; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; YONEZAWA S, 1988, J BIOL CHEM, V263, P16504	29	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19690	19696						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366110				2022-12-27	WOS:A1993LW81900083
J	KATAOKA, R; SHERLOCK, J; LANIER, SM				KATAOKA, R; SHERLOCK, J; LANIER, SM			SIGNALING EVENTS INITIATED BY TRANSFORMING GROWTH FACTOR-BETA(1) THAT REQUIRE G(I-ALPHA-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING PROTEIN; ALPHA-2-ADRENERGIC RECEPTOR SUBTYPES; ISLET-ACTIVATING PROTEIN; MATRIX GENE-EXPRESSION; TGF-BETA RECEPTORS; FACTOR-II RECEPTOR; PERTUSSIS-TOXIN; CELL-PROLIFERATION; COUPLED RECEPTORS; AKR-2B CELLS	Transforming growth factor-beta1 (TGF-beta1) initiates a series of signaling events leading to diverse cell type-specific effects on proliferation and morphology. The multiple effects of TGF-beta1 are not due to selective expression of receptor subtypes, but rather probably reflect cell-specific expression of downstream components of the particular signaling system. To address this possibility and to identify specific signaling pathways activated by TGF-beta1, we attempted to restore cell responsiveness to the cytokine by introducing various intracellular signal transducers in NIH-3T3 fibroblasts, a cell line that is minimally responsive to TGF-beta1. In NIH-3T3 fibroblasts stably transfected with G(ialpha1) cDNA, TGF-beta1 induced a reversible morphological transformation that was identical to the effect of this cytokine in indicator cells such as AKR-2B fibroblasts. G(ialpha1) transfectants also exhibited mitogenic hyperresponsiveness to TGF-beta1. TGF-beta1 does not elicit these responses in control nontransfected fibroblasts or cells transfected with the guanine nucleotide-binding protein G(oalpha1). The response to TGF-beta1 in G(ialpha1) transfectants is blocked by pertussis toxin and is lost in G(ialpha1) transfectants that have spontaneously reverted and no longer express G(ialpha1). These data indicate that the expression of the guanine nucleotide-binding protein G(ialpha1), normally absent in these cells, confers cell sensitivity to TGF-beta1.	MED UNIV S CAROLINA, DEPT PHARMACOL, 171 ASHLEY AVE, CHARLESTON, SC 29425 USA	Medical University of South Carolina				Lanier, Stephen/0000-0002-2740-7607	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024821, R29NS024821] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-24821] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALEXANDROPOULOS K, 1991, J BIOL CHEM, V266, P15583; BEAUCHAMP RD, 1992, ENDOCRINOLOGY, V130, P2476, DOI 10.1210/en.130.5.2476; BLOCH DB, 1989, MOL CELL BIOL, V9, P5434, DOI 10.1128/MCB.9.12.5434; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; CANALS F, 1992, BIOCHEMISTRY-US, V31, P4493, DOI 10.1021/bi00133a016; COUPRY I, 1992, J BIOL CHEM, V267, P9852; CUI Z, 1991, J BIOL CHEM, V266, P20276; DELARCO JE, 1978, P NATL ACAD SCI USA, V75, P4001; DUZIC E, 1992, J BIOL CHEM, V267, P9844; DUZIC E, 1992, J BIOL CHEM, V267, P24045; EGHBALI M, 1991, P NATL ACAD SCI USA, V88, P795, DOI 10.1073/pnas.88.3.795; FANGER BO, 1986, BIOCHEMISTRY-US, V25, P3083, DOI 10.1021/bi00359a003; FEINSTEIN DL, 1990, FEBS LETT, V272, P7, DOI 10.1016/0014-5793(90)80437-N; GARIBAY JLR, 1991, BIOCHIM BIOPHYS ACTA, V1094, P193, DOI 10.1016/0167-4889(91)90008-L; HAUSDORFF WP, 1992, P NATL ACAD SCI USA, V89, P5720, DOI 10.1073/pnas.89.13.5720; HILDEBRANDT JD, 1986, FEBS LETT, V203, P87, DOI 10.1016/0014-5793(86)81442-9; HOWE PH, 1990, J CELL PHYSIOL, V142, P39, DOI 10.1002/jcp.1041420106; HOWE PH, 1989, BIOCHEM J, V261, P879, DOI 10.1042/bj2610879; HUFF RM, 1985, J BIOL CHEM, V260, P864; IGNOTZ RA, 1985, P NATL ACAD SCI USA, V82, P8530, DOI 10.1073/pnas.82.24.8530; ISHIKAWA O, 1990, BIOCHEM BIOPH RES CO, V169, P232, DOI 10.1016/0006-291X(90)91458-5; JONES DT, 1987, J BIOL CHEM, V262, P14241; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; KTISTAKIS NT, 1992, NATURE, V356, P344, DOI 10.1038/356344a0; LEOF EB, 1986, P NATL ACAD SCI USA, V83, P2453, DOI 10.1073/pnas.83.8.2453; LIANG M, 1991, J BIOL CHEM, V266, P13342; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASSAGUE J, 1992, CELL, V69, P1067, DOI 10.1016/0092-8674(92)90627-O; MASSAGUE J, 1990, ANN NY ACAD SCI, V593, P59; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MORRISON DK, 1990, MOL CELL BIOL, V10, P2359, DOI 10.1128/MCB.10.5.2359; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; MUDLER KM, 1992, J BIOL CHEM, V267, P5029; MURAYAMA T, 1987, J BIOL CHEM, V262, P12463; MURTHY US, 1988, BIOCHEM BIOPH RES CO, V152, P1228, DOI 10.1016/S0006-291X(88)80416-9; NAIR BG, 1990, J BIOL CHEM, V265, P21317; NISHIMOTO I, 1989, J BIOL CHEM, V264, P14029; NISHIMOTO I, 1991, J BIOL CHEM, V266, P12747; OGRADY P, 1991, J BIOL CHEM, V266, P8583; OHTSUKI M, 1992, MOL CELL BIOL, V12, P261, DOI 10.1128/MCB.12.1.261; OKAMOTO T, 1992, J BIOL CHEM, V267, P8342; PIENTA KJ, 1992, J CELL BIOCHEM, V49, P357, DOI 10.1002/jcb.240490406; POSTLETHWAITE AE, 1987, J EXP MED, V165, P251, DOI 10.1084/jem.165.1.251; POUYSSEGUR J, 1992, ANNU REV PHYSIOL, V54, P195, DOI 10.1146/annurev.ph.54.030192.001211; ROBERTS AB, 1991, CIBA F SYMP, V157, P7; ROBERTS CJ, 1988, J BIOL CHEM, V263, P4586; ROSS R, 1990, KAR INS NCS, P193; SEGARINI PR, 1989, MOL ENDOCRINOL, V3, P261, DOI 10.1210/mend-3-2-261; SEGARINI PR, 1992, J BIOL CHEM, V267, P1048; SEGARINI PR, 1991, CIBA F SYMP, V157, P29; SEYEDIN SM, 1986, J BIOL CHEM, V261, P5693; SHIPLEY GD, 1984, CANCER RES, V44, P710; SPARKS RL, 1992, J CELL PHYSIOL, V150, P568, DOI 10.1002/jcp.1041500318; SPIEGEL AM, 1992, ENDOCR REV, V13, P536, DOI 10.1210/er.13.3.536; TEITELBAUM I, 1990, J BIOL CHEM, V265, P4218; UI M, 1984, TRENDS PHARMACOL SCI, V5, P277, DOI 10.1016/0165-6147(84)90444-9; VANMEURS KP, 1987, P NATL ACAD SCI USA, V84, P3107, DOI 10.1073/pnas.84.10.3107; WAKEFIELD LM, 1987, J CELL BIOL, V105, P965, DOI 10.1083/jcb.105.2.965; WOLFGANG WJ, 1990, J NEUROSCI, V10, P1014; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S	62	47	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19851	19857						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366123				2022-12-27	WOS:A1993LW81900103
J	PARKKINEN, J; RAULO, E; MERENMIES, J; NOLO, R; KAJANDER, EO; BAUMANN, M; RAUVALA, H				PARKKINEN, J; RAULO, E; MERENMIES, J; NOLO, R; KAJANDER, EO; BAUMANN, M; RAUVALA, H			AMPHOTERIN, THE 30-KDA PROTEIN IN A FAMILY OF HMG1-TYPE POLYPEPTIDES - ENHANCED EXPRESSION IN TRANSFORMED-CELLS, LEADING-EDGE LOCALIZATION, AND INTERACTIONS WITH PLASMINOGEN ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY NEUROTROPHIC FACTOR; FIBROBLAST GROWTH-FACTOR; NEURO-BLASTOMA CELLS; HEPARIN-BINDING; NUCLEOTIDE-SEQUENCE; CHROMOSOMAL-PROTEINS; EXTRACELLULAR-MATRIX; HMG PROTEINS; T-PA; UROKINASE	Amphoterin is a heparin-binding protein that is developmentally regulated in brain and functionally involved in neurite outgrowth. Unexpectedly, amphoterin has a high mobility group 1 (HMG1)-type sequence. In the present study we have expressed amphoterin cDNA in a baculovirus vector and produced antibodies against the recombinant protein and several synthetic peptides. It was found that the amphoterin cDNA encodes the 30-kDa form of the protein isolated from tissues, whereas the co-purifying 28- and 29-kDa proteins (p28 and p29) have closely related but distinct primary structures. Partial amino acid sequencing shows several local changes in the sequences of p28 and p29 compared with amphoterin, suggesting the occurrence of a multigene family that encodes at least three different HMG1-type sequences in the rat. Studies using the probes that discern amphoterin from the other HMG1-type proteins indicate a high level expression in various transformed cell lines. Immunostaining of cells with the amphoterin-specific antibodies indicates a cytoplasmic localization that becomes remarkably enriched at the leading edges in spreading and motile cells. An extracellular localization is suggested by immunostaining of nonpermeabilized cells and by a plasminogen-dependent degradation of amphoterin in the substratum-attached material of cells. Tissue-derived and recombinant amphoterins strongly enhance the rate of plasminogen activation and promote the generation of surface-bound plasmin both by tissue-type and urokinase-type plasminogen activators. The results suggest an extracellular function for amphoterin in the leading edge of various invasive cells.	UNIV HELSINKI,INST BIOTECHNOL,POB 45,SF-00014 HELSINKI,FINLAND; UNIV KUOPIO,DEPT BIOCHEM & BIOTECHNOL,SF-70101 KUOPIO 10,FINLAND; UNIV HELSINKI,DEPT MED CHEM,SF-00100 HELSINKI 10,FINLAND	University of Helsinki; University of Eastern Finland; University of Helsinki				Baumann, Marc/0000-0002-2991-889X; Raulo, Erkki/0000-0001-9113-3770; Rauvala, Heikki/0000-0001-7809-9811				AVNUR Z, 1981, J MOL BIOL, V153, P361, DOI 10.1016/0022-2836(81)90283-7; BARON M, 1991, TRENDS BIOCHEM SCI, V16, P13, DOI 10.1016/0968-0004(91)90009-K; BAUMANN M, 1990, ANAL BIOCHEM, V190, P198, DOI 10.1016/0003-2697(90)90181-8; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; BIZIK J, 1990, CELL REGUL, V1, P895, DOI 10.1091/mbc.1.12.895; BUSTIN M, 1990, BIOCHIM BIOPHYS ACTA, V1049, P231, DOI 10.1016/0167-4781(90)90092-G; BUSTIN M, 1979, CELL, V16, P181, DOI 10.1016/0092-8674(79)90199-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; DASTON MM, 1991, J CELL BIOL, V112, P1229, DOI 10.1083/jcb.112.6.1229; ELLIS V, 1991, SEMIN THROMB HEMOST, V17, P194, DOI 10.1055/s-2007-1002609; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; GREEN GDJ, 1979, ANAL BIOCHEM, V93, P223, DOI 10.1016/S0003-2697(79)80070-6; GREEN N, 1982, CELL, V28, P477, DOI 10.1016/0092-8674(82)90202-1; IMAMURA T, 1992, J BIOL CHEM, V267, P5676; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; JENSENIUS JC, 1981, J IMMUNOL METHODS, V46, P63, DOI 10.1016/0022-1759(81)90333-1; Johns EW, 1982, HMG CHROMOSOMAL PROT; KAPLAN DJ, 1988, NUCLEIC ACIDS RES, V16, P10375, DOI 10.1093/nar/16.21.10375; KRYSTOSEK A, 1986, EXP CELL RES, V166, P31, DOI 10.1016/0014-4827(86)90506-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; MATSUURA Y, 1987, J GEN VIROL, V68, P1233, DOI 10.1099/0022-1317-68-5-1233; MERENMIES J, 1991, J BIOL CHEM, V266, P16722; MIGNATTI P, 1991, J CELL BIOCHEM, V47, P201, DOI 10.1002/jcb.240470303; MOSEVITSKY MI, 1989, EUR J BIOCHEM, V185, P303, DOI 10.1111/j.1432-1033.1989.tb15116.x; MUESCH A, 1990, TRENDS BIOCHEM SCI, V15, P86, DOI 10.1016/0968-0004(90)90186-F; NER S S, 1992, Current Biology, V2, P208, DOI 10.1016/0960-9822(92)90541-H; NEUMAN T, 1989, J NEUROSCI RES, V23, P274, DOI 10.1002/jnr.490230305; PAONESSA G, 1987, NUCLEIC ACIDS RES, V15, P9077, DOI 10.1093/nar/15.21.9077; PARKKINEN J, 1991, J BIOL CHEM, V266, P16730; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; RAULO E, 1992, J BIOL CHEM, V267, P11408; RAUVALA H, 1988, J CELL BIOL, V107, P2293, DOI 10.1083/jcb.107.6.2293; RAUVALA H, 1987, J BIOL CHEM, V262, P16625; SALMIVIRTA M, 1992, EXP CELL RES, V200, P444, DOI 10.1016/0014-4827(92)90194-D; SALONEN EM, 1985, J BIOL CHEM, V260, P2302; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIRAKAWA H, 1990, BIOCHEMISTRY-US, V29, P4419, DOI 10.1021/bi00470a022; SINGER SJ, 1986, ANNU REV CELL BIOL, V2, P337, DOI 10.1146/annurev.cb.02.110186.002005; STACK S, 1990, BIOCHEMISTRY-US, V29, P4966, DOI 10.1021/bi00472a029; STEIN PL, 1989, J BIOL CHEM, V264, P15441; STEPHENS RW, 1992, BIOCHEMISTRY-US, V31, P7572, DOI 10.1021/bi00148a019; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; STUMP DC, 1986, J BIOL CHEM, V261, P1274; SUMMERS M, 1986, TEXAS AGR EXPT STATI, V1555; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSUDA K, 1988, BIOCHEMISTRY-US, V27, P6159, DOI 10.1021/bi00416a050; VAHERI A, 1990, CELL DIFFER DEV, V32, P255, DOI 10.1016/0922-3371(90)90038-X; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; WALKER JM, 1980, FEBS LETT, V122, P264, DOI 10.1016/0014-5793(80)80453-4; WALKER JM, 1980, COMPREHENSIVE BIOC B, V19, P507; WEN L, 1989, NUCLEIC ACIDS RES, V17, P1197, DOI 10.1093/nar/17.3.1197; ZAMARRON C, 1984, J BIOL CHEM, V259, P2080	56	185	200	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19726	19738						13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366113				2022-12-27	WOS:A1993LW81900087
J	WANGE, RL; MALEK, SN; DESIDERIO, S; SAMELSON, LE				WANGE, RL; MALEK, SN; DESIDERIO, S; SAMELSON, LE			TANDEM SH2 DOMAINS OF ZAP-70 BIND TO T-CELL ANTIGEN RECEPTOR-ZETA AND CD3-EPSILON FROM ACTIVATED JURKAT T-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; SIGNAL TRANSDUCTION; PDGF RECEPTOR; CHAIN; PHOSPHORYLATION; ASSOCIATION; CD4; LYMPHOCYTES; INDUCTION; P59FYN	A proximal and critical biochemical event upon T cell antigen receptor (TCR) stimulation is the activation of a protein tyrosine kinase (PTK) pathway. ZAP-70, a PTK of the p72syk family, associates with phosphorylated TCR subunits upon TCR stimulation. Here we report that the tandem SH2 domains of ZAP-70, expressed as a fusion protein, bind to tyrosine-phosphorylated CD3epsilon and TCRzeta from activated Jurkat T cell lysates. The single N- and C-terminal SH2 domains of ZAP-70, expressed separately, do not bind these TCR subunits. In comparison to fusion proteins containing SH2 domains from other proteins, the tandem SH2 domains of ZAP-70 demonstrate a remarkably restricted repertoire of protein binding, binding only TCRzeta and CD3epsilon. ZAP-70 is also recovered in the binding assay, but this is likely to be a consequence of its interaction with multiple SH2 binding sites on the zeta-zeta and CD3epsilon-containing dimers.	JOHNS HOPKINS UNIV, SCH MED, HOWARD HUGHES MED INST, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT MOLEC BIOL & GENET, BALTIMORE, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	WANGE, RL (corresponding author), NICHHD, CELL BIOL & METAB BRANCH, BETHESDA, MD 20892 USA.			Wange, Ronald/0000-0001-9593-3572				APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; BANIYASH M, 1988, J BIOL CHEM, V263, P18225; CARPENTER CL, 1993, J BIOL CHEM, V268, P9478; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; COOKE MP, 1991, CELL, V65, P281, DOI 10.1016/0092-8674(91)90162-R; COOPER JA, 1993, MOL CELL BIOL, V13, P1737, DOI 10.1128/MCB.13.3.1737; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; GASSMANN M, 1992, EUR J IMMUNOL, V22, P283, DOI 10.1002/eji.1830220142; GLAICHENHAUS N, 1991, CELL, V64, P511, DOI 10.1016/0092-8674(91)90235-Q; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; IRVING BA, 1993, J EXP MED, V177, P1093, DOI 10.1084/jem.177.4.1093; KASHISHIAN A, 1992, EMBO J, V11, P1373, DOI 10.1002/j.1460-2075.1992.tb05182.x; KELLY JD, 1991, J BIOL CHEM, V266, P8987; KLAUSNER RD, 1991, CELL, V64, P875, DOI 10.1016/0092-8674(91)90310-U; KUPFER A, 1987, P NATL ACAD SCI USA, V84, P5888, DOI 10.1073/pnas.84.16.5888; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; O'SHEA JJ, 1992, P NATL ACAD SCI USA, V89, P10306, DOI 10.1073/pnas.89.21.10306; OVERDUIN M, 1992, P NATL ACAD SCI USA, V89, P11673, DOI 10.1073/pnas.89.24.11673; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PICCIONE E, 1993, BIOCHEMISTRY-US, V32, P3197, DOI 10.1021/bi00064a001; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; ROMEO C, 1992, CELL, V68, P889, DOI 10.1016/0092-8674(92)90032-8; SAIZAWA K, 1987, NATURE, V328, P260, DOI 10.1038/328260a0; SAMELSON LE, 1992, J BIOL CHEM, V267, P24913; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SECRIST JP, 1993, J BIOL CHEM, V268, P5886; SHOELSON SE, 1993, EMBO J, V12, P795, DOI 10.1002/j.1460-2075.1993.tb05714.x; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; TSYGANKOV AY, 1992, J BIOL CHEM, V267, P18259; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; WANGE RL, 1992, J BIOL CHEM, V267, P11685; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; WEISS A, 1989, FUNDAMENTAL IMMUNOLO, P359; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	37	262	269	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19797	19801						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366117				2022-12-27	WOS:A1993LW81900096
J	ISHII, T; YAMADA, M; SATO, H; MATSUE, M; TAKETANI, S; NAKAYAMA, K; SUGITA, Y; BANNAI, S				ISHII, T; YAMADA, M; SATO, H; MATSUE, M; TAKETANI, S; NAKAYAMA, K; SUGITA, Y; BANNAI, S			CLONING AND CHARACTERIZATION OF A 23-KDA STRESS-INDUCED MOUSE PERITONEAL MACROPHAGE PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; SALMONELLA-TYPHIMURIUM; MESSENGER-RNA; SEQUENCE; ACID; PURIFICATION; OOCYTES; ANTIGEN; DNA	Exposure of mouse peritoneal macrophages to oxidative and sulfhydryl-reactive agents in vitro enhances synthesis of a few cellular proteins that may be important in a self-defense system. A cDNA encoding a novel stress-inducible protein, designated MSP23 (macrophage 23-kDa stress protein), was cloned from a cDNA library of the macrophages by differential screening. A 1.0-kilobase mRNA transcript hybridized with the MSP23 cDNA gradually increased in macrophages upon culture in vitro. Treatment with diethylmaleate or glucose/glucose oxidase, which generates H2O2, markedly enhanced the induction of the transcript after several hours. Cadmium chloride and sodium arsenite also induced the transcript. An antiserum raised against recombinant MSP23 reacted with the 23-kDa stress-inducible protein of the macrophages. The amounts of 23-kDa protein in the cells rapidly increased during culture with diethylmaleate. The mRNA was detected in various tissues, and it was especially high in content in the liver. A search of databases revealed that six proteins of various species from bacteria to the mouse have a sequence homology to MSP23. One of the proteins is the C22 component of alkyl hydroperoxide reductase, which is induced by hydrogen peroxide in Salmonella typhimurium.	UNIV TSUKUBA,INST BIOL SCI,TSUKUBA,IBARAKI 305,JAPAN; KANSAI MED UNIV,DEPT HYG,MORIGUCHI,OSAKA 570,JAPAN	University of Tsukuba; Kansai Medical University	ISHII, T (corresponding author), UNIV TSUKUBA,INST BASIC MED SCI,DEPT BIOCHEM,TSUKUBA,IBARAKI 305,JAPAN.		Nakayama, Kazuhisa/ABF-2924-2020	Nakayama, Kazuhisa/0000-0001-7701-7183				AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BANNAI S, 1991, BIOCHIM BIOPHYS ACTA, V1092, P175, DOI 10.1016/0167-4889(91)90153-O; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTMAN MF, 1985, CELL, V41, P753, DOI 10.1016/S0092-8674(85)80056-8; GURDON JB, 1983, METHOD ENZYMOL, V101, P370; JACOBSON FS, 1989, J BIOL CHEM, V264, P1488; KREIG PA, 1984, NUCLEIC ACIDS RES, V12, P7052; MELTON DA, 1987, METHOD ENZYMOL, V152, P288; OTOOLE PW, 1991, J BACTERIOL, V173, P505, DOI 10.1128/jb.173.2.505-513.1991; SATO H, 1993, BIOCHIM BIOPHYS ACTA, V1148, P127, DOI 10.1016/0005-2736(93)90169-Z; STJOHN TP, 1979, CELL, V16, P443, DOI 10.1016/0092-8674(79)90020-5; TAKETANI S, 1990, J BIOCHEM-TOKYO, V108, P28, DOI 10.1093/oxfordjournals.jbchem.a123156; TARTAGLIA LA, 1990, J BIOL CHEM, V265, P10535; TORIAN BE, 1990, P NATL ACAD SCI USA, V87, P6358, DOI 10.1073/pnas.87.16.6358; XU XM, 1991, J BIOCHEM-TOKYO, V109, P678, DOI 10.1093/oxfordjournals.jbchem.a123440; YAMAMOTO T, 1989, GENE, V80, P337	17	179	183	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18633	18636						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360158				2022-12-27	WOS:A1993LV65900043
J	MOODY, SF; HANDMAN, E; MCCONVILLE, MJ; BACIC, A				MOODY, SF; HANDMAN, E; MCCONVILLE, MJ; BACIC, A			THE STRUCTURE OF LEISHMANIA-MAJOR AMASTIGOTE LIPOPHOSPHOGLYCAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DONOVANI LIPOPHOSPHOGLYCAN; GLYCOSYLATED-PHOSPHATIDYLINOSITOLS; DEVELOPMENTAL MODIFICATION; PROMASTIGOTES; SURFACE; EXPRESSION; BINDING; STAGE; IDENTIFICATION; COMPLEMENT	Intracellular amastigotes of Leishmania major produce 6 x 10(4) copies/cell of a lipophosphoglycan (LPG) that is structurally distinct from the LPG produced by the extracellular promastigote form of L. major, Leishmania donovani, and Leishmania mexicana (reviewed by McConville, M. J. (1991) Cell Biol. Int. Rep. 15, 779-798). L. major amastigote LPG is composed of a lysoalkyl phosphatidylinositol lipid anchor that links via a diphosphorylated hexasaccharide core to a phosphoglycan (6-100 kDa). The structures of the anchor, the core, and the phosphoglycan were determined by monosaccharide and linkage analysis, fast atom bombardment-mass spectrometry, one-dimensional H-1 NMR spectroscopy, and exoglycosidase microsequencing. The lipid anchor contains predominantly 1-O-alkylglycerols with 24:0 and 22:0 alkyl chains. The lipids are linked via a glycerol-myo-inositol-PO4 to a core glycan with the structure -PO4-6)Gal(alpha1-)Gal(alpha1-) Gal(f)(beta1-)[Glc(alpha1-PO4-)]Man(alpha1-)Man(alpha1-)GlcN(alpha1-). The chromatographic characteristics of the core glycan suggest that the saccharide components are linked similarly in amastigote and promastigote LPG. The phosphoglycan attached to the core consists of -PO4-6)Gal(beta1-4)Man(alpha1- repeats units which are either unsubstituted (70%) or substituted (30%) at the 3-position of the Gal residues with oligosaccharide side chains containing primarily Gal and some Glc. Thirteen different types of side chains were identified with the structures [Gal(beta1-3)]x, where x = 1-11, or Glc(1-3)Glc(1-3), or Glc(1-3)Gal(beta1-3), where glucose is probably in the beta-configuration. All monosaccharides in the phosphoglycan domain are in the pyranose configuration. The average number of repeat units per molecule is 36. The nonreducing terminus of the phosphoglycan chains probably terminates predominantly in the neutral disaccharide Gal(beta1-4)Man(alpha1-. Comparison of the structure of L. major amastigote LPG to L. major promastigote procyclic and metacyclic LPG forms (McConville, M. J., Turco, S. J., Furguson, M. A. J., and Sacks, D. L. (1992) Embo J. 11, 3593-3600) indicates that this molecule is developmentally modified throughout the different stages of the parasites' life cycle.	UNIV DUNDEE,DEPT BIOCHEM,DUNDEE DD1 4HN,SCOTLAND; UNIV MELBOURNE,SCH BOT,PLANT CELL BIOL RES CTR,PARKVILLE,VIC 3052,AUSTRALIA	University of Dundee; University of Melbourne	MOODY, SF (corresponding author), ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,IMMUNOPARASITOL UNIT,PARKVILLE,VIC 3050,AUSTRALIA.			Bacic, Tony/0000-0001-7483-8605	NIAID NIH HHS [AI 28962-02] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028962] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BLACKWELL JM, 1985, IMMUNOL LETT, V11, P227, DOI 10.1016/0165-2478(85)90172-5; CHANG KP, 1981, MOL BIOCHEM PARASIT, V4, P67, DOI 10.1016/0166-6851(81)90030-X; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; ELHAY M, 1990, MOL BIOCHEM PARASIT, V40, P255, DOI 10.1016/0166-6851(90)90047-P; GLASER TA, 1991, MOL BIOCHEM PARASIT, V45, P337, DOI 10.1016/0166-6851(91)90102-C; GLASER TA, 1990, EXP PARASITOL, V71, P343, DOI 10.1016/0014-4894(90)90039-F; HANDMAN E, 1986, J IMMUNOL, V137, P3608; HANDMAN E, 1984, PARASITE IMMUNOL, V6, P223, DOI 10.1111/j.1365-3024.1984.tb00795.x; HANDMAN E, 1983, MOL BIOCHEM PARASIT, V7, P111, DOI 10.1016/0166-6851(83)90039-7; HOMANS SW, 1992, BIOCHEMISTRY-US, V31, P654, DOI 10.1021/bi00118a004; ILG T, 1992, J BIOL CHEM, V267, P6831; JARDIM A, 1991, J IMMUNOL, V147, P3538; KARP CL, 1991, J IMMUNOL, V147, P680; KELLEHER M, 1992, P NATL ACAD SCI USA, V89, P6, DOI 10.1073/pnas.89.1.6; KWEIDER M, 1987, J IMMUNOL, V138, P299; MCCONVILLE MJ, 1992, J BIOL CHEM, V267, P5855; MCCONVILLE MJ, 1987, P NATL ACAD SCI USA, V84, P8941, DOI 10.1073/pnas.84.24.8941; MCCONVILLE MJ, 1991, J BIOL CHEM, V266, P15170; MCCONVILLE MJ, 1992, EMBO J, V11, P3593, DOI 10.1002/j.1460-2075.1992.tb05443.x; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P19611; MCCONVILLE MJ, 1991, CELL BIOL INT REP, V15, P779, DOI 10.1016/0309-1651(91)90033-F; MCCONVILLE MJ, 1989, J BIOL CHEM, V264, P757; MCNEELY TB, 1990, J IMMUNOL, V144, P2745; MOODY S F, 1991, Glycobiology, V1, P419, DOI 10.1093/glycob/1.4.419; MOSSER DM, 1992, J CELL BIOL, V116, P511, DOI 10.1083/jcb.116.2.511; ORLANDI PA, 1987, J BIOL CHEM, V262, P10384; PIMENTA PFP, 1992, SCIENCE, V256, P1812, DOI 10.1126/science.1615326; PIMENTA PFP, 1991, EXP PARASITOL, V72, P191, DOI 10.1016/0014-4894(91)90137-L; PUENTES SM, 1988, J EXP MED, V167, P887, DOI 10.1084/jem.167.3.887; RUSSO DM, 1992, J IMMUNOL, V148, P202; SACKS DL, 1990, MOL BIOCHEM PARASIT, V42, P225, DOI 10.1016/0166-6851(90)90165-I; SAMBROOK J, 1989, MOL CLONING, pB16; SCHNEIDER P, 1992, EXP PARASITOL, V75, P196, DOI 10.1016/0014-4894(92)90179-E; THOMAS JR, 1992, J BIOL CHEM, V267, P6829; TURCO SJ, 1991, MOL BIOCHEM PARASIT, V45, P91, DOI 10.1016/0166-6851(91)90030-A; TURCO SJ, 1989, J BIOL CHEM, V264, P6711; TURCO SJ, 1992, ANNU REV MICROBIOL, V46, P65, DOI 10.1146/annurev.mi.46.100192.000433; WALTON BC, 1989, LEISHMANIASIS, P276; ZINBO M, 1970, J AM CHEM SOC, V92, P2105, DOI 10.1021/ja00710a052	39	73	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18457	18466						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360147				2022-12-27	WOS:A1993LV65900015
J	THOMAS, JL; NASH, WE; MYERS, RP; CRANKSHAW, MW; STRICKLER, RC				THOMAS, JL; NASH, WE; MYERS, RP; CRANKSHAW, MW; STRICKLER, RC			AFFINITY RADIOLABELING IDENTIFIES PEPTIDES AND AMINO-ACIDS ASSOCIATED WITH SUBSTRATE-BINDING IN HUMAN PLACENTAL 3-BETA-HYDROXY-DELTA-5-STEROID DEHYDROGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL 3-BETA-HYDROXYSTEROID DEHYDROGENASE; 3-BETA-HYDROXY-5-ENE-STEROID DEHYDROGENASE; ACTIVE-SITE; STEROID 5->4-ENE-ISOMERASE; 17-BETA-ESTRADIOL DEHYDROGENASE; HYDROXYSTEROID DEHYDROGENASE; ISOMERASE; PURIFICATION; SEQUENCE; PROTEIN	Purified human placental 3beta-hydroxy-DELTA5-steroid dehydrogenase (3beta-HSD) was affinity radiolabeled by 2alpha-bromo[2'-C-14]acetoxyprogesterone (2alpha-BAP) in the presence or absence of 3beta-HSD substrate, pregnenolone. The substrate steroid substantially protects 3beta-HSD activity from inactivation by 2alpha-BAP. Tryptic peptides of unprotected and substrate-protected radioalkylated enzyme were purified by high pressure liquid chromatography. The amino acid sequence of each radiolabeled peptide was determined and localized within the cDNA-derived primary structure of the enzyme. According to the percent total radioactivity associated with each of four radiolabeled peaks separated by high pressure liquid chromatography, two peptides were protected by substrate from affinity radioalkylation by 2alpha-BAP. The first, 251GQFYYISDDTPHQSYDNLNYTLSK274, was produced by tryptic cleavage at Arg-250 and Lys-274 (the Arg-250 peptide) and contained radiolabeled His262. The second, 176NGGTLYTCALR186, was produced by tryptic cleavage at Lys-175 and Arg-186 (the Lys-175 peptide) and contained radiolabeled Cys183. Based on amino acid analysis to quantitate radioactivity incorporated per nmol of peptide, substrate steroid decreased the radiolabeling of His262 in the Arg-250 peptide by 3.6-fold and decreased the radiolabeling of Cys183 in the Lys-175 peptide by 3.7-fold. Three minor radiolabeled peptides (the NH2-terminal, Arg-71, and Arg-196 tryptic peptides) were also identified in the primary structure, but pregnenolone did not diminish their affinity radioalkylation. These observations indicate that the Arg-250 and Lys-175 peptides are involved in substrate binding and suggest that His262 and Cys183 are in close proximity in the three-dimensional structure of the enzyme.	WASHINGTON UNIV, SCH MED, DEPT OBSTET & GYNECOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT MOLEC BIOL & PHARMACOL, ST LOUIS, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)					NICHD NIH HHS [HD20055, R01 HD020055] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020055] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN QX, 1989, BIOCHEMISTRY-US, V28, P8856, DOI 10.1021/bi00448a026; Csapo A I, 1977, Ciba Found Symp, P159; DOODY KM, 1990, ENDOCRINOLOGY, V126, P2487, DOI 10.1210/endo-126-5-2487; FERRE F, 1975, STEROIDS, V26, P551, DOI 10.1016/0039-128X(75)90050-1; GAST MJ, 1989, AM J OBSTET GYNECOL, V161, P1726, DOI 10.1016/0002-9378(89)90958-7; ISHIIOHBA H, 1986, J STEROID BIOCHEM, V25, P555; ISHIIOHBA H, 1986, J STEROID BIOCHEM, V24, P753; LABRIE F, 1992, J STEROID BIOCHEM, V41, P421, DOI 10.1016/0960-0760(92)90368-S; LEVY MA, 1987, BIOCHEMISTRY-US, V26, P2270, DOI 10.1021/bi00382a030; MURDOCK GL, 1986, BIOCHEMISTRY-US, V25, P641, DOI 10.1021/bi00351a019; PALMER T, 1985, UNDERSTANDING ENZYME, P208; PENNING TM, 1991, J BIOL CHEM, V266, P8826; RUTHERFURD KJ, 1991, BIOCHEMISTRY-US, V30, P8108, DOI 10.1021/bi00247a003; RUTHERFURD KJ, 1991, BIOCHEMISTRY-US, V30, P8116, DOI 10.1021/bi00247a004; STRICKLER RC, 1975, J BIOL CHEM, V250, P7656; STRICKLER RC, 1993, AM J OBSTET GYNECOL, V168, P1216, DOI 10.1016/0002-9378(93)90372-P; STRICKLER RC, 1981, J BIOL CHEM, V256, P316; SWEET F, 1972, J BIOL CHEM, V247, P3424; THE VL, 1989, MOL ENDOCRINOL, V3, P1310, DOI 10.1210/mend-3-8-1310; THOMAS JL, 1988, J STEROID BIOCHEM, V31, P785, DOI 10.1016/0022-4731(88)90287-7; THOMAS JL, 1989, J STEROID BIOCHEM, V33, P209, DOI 10.1016/0022-4731(89)90296-3; THOMAS JL, 1990, J STEROID BIOCHEM, V36, P117, DOI 10.1016/0022-4731(90)90121-8; THOMAS JL, 1992, BIOCHEMISTRY-US, V31, P5522, DOI 10.1021/bi00139a014; TOPHAM CM, 1986, EUR J BIOCHEM, V155, P87, DOI 10.1111/j.1432-1033.1986.tb09461.x	25	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18507	18512						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360152				2022-12-27	WOS:A1993LV65900023
J	VERHOEVEN, AJ; LEUSEN, JHW; KESSELS, GCR; HILARIUS, PM; DEBONT, DBA; LISKAMP, RMJ				VERHOEVEN, AJ; LEUSEN, JHW; KESSELS, GCR; HILARIUS, PM; DEBONT, DBA; LISKAMP, RMJ			INHIBITION OF NEUTROPHIL NADPH OXIDASE ASSEMBLY BY A MYRISTOYLATED PSEUDOSUBSTRATE OF PROTEIN-KINASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE SYSTEM; CHRONIC GRANULOMATOUS-DISEASE; RESPIRATORY BURST OXIDASE; ADENINE-DINUCLEOTIDE PHOSPHATE; CHARGE-DEPENDENT REGULATION; 2 CYTOSOLIC COMPONENTS; POLYMORPHONUCLEAR LEUKOCYTES; SUPEROXIDE GENERATION; PARTIAL-PURIFICATION; FATTY-ACIDS	To further define the role played by protein kinase C (PKC) in the activation of the neutrophil NADPH oxidase, we have utilized a pseudosubstrate of PKC which was myristoylated at the N terminus. In electro-permeabilized neutrophils, the myristoylated pseudosubstrate Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln (myr-psiPKC) inhibited PMA-induced protein phosphorylations and activation of the NADPH oxidase, induced either by PMA or by the receptor agonist formyl-methionyl-leucyl-phenylalanine. Both the pseudosubstrate lacking the N-terminal myristate (psiPKC) and a myristoylated control peptide (Phe-Ala-Glu-Asp-Gly-Ala-Leu-Glu-Gln, myr-CP) were without effect on these responses. The myristoylated pseudosubstrate was also tested in a cell-free system, in which NADPH oxidase activation can be achieved by addition of SDS and guanosine 5'-3-O-(thio)triphosphate in a staurosporine-insensitive manner. Myr-psiPKC, but not psiPKC or myr-CP, proved to be a potent inhibitor of NADPH oxidase activity in the cell-free system, indicating that the inhibition observed in permeabilized neutrophils may have been caused by an effect other than PKC inhibition. In the presence of myr-psiPKC, translocation in the cell-free system of the cytosolic oxidase components p47-phox and p67-phox to the plasma membrane was inhibited. From these results we conclude that myristoylation profoundly increases the ability of pseudosubstrates of PKC to inhibit not only PKC-mediated phosphorylations, but also NADPH oxidase activation. The latter effect, however, is most probably not related to PKC inhibition but may indicate a critical role of the membrane surface charge in the translocation of the cytosolic oxidase components p47-phox and p67-phox.	UNIV AMSTERDAM,CLIN & EXPTL IMMUNOL LAB,1066 CX AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,DEPT PEDIAT,1105 AZ AMSTERDAM,NETHERLANDS; LEIDEN UNIV,GORLAEUS LABS,DEPT ORGAN CHEM,2300 RA LEIDEN,NETHERLANDS	University of Amsterdam; University of Amsterdam; Leiden University; Leiden University - Excl LUMC	VERHOEVEN, AJ (corresponding author), NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,PLESMANLAAN 125,1066 CX AMSTERDAM,NETHERLANDS.		Liskamp, Rob M/I-5889-2012; , Jeanette/AAG-3736-2019; Leusen, Jeanette/I-9010-2014	Liskamp, Rob M/0000-0001-8897-8975; Leusen, Jeanette/0000-0003-4982-6914				ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; AMBRUSO DR, 1991, J BIOL CHEM, V265, P19370; Atherton E., 1990, SOLID PHASE PEPTIDE; BERKOW RL, 1987, J LEUKOCYTE BIOL, V41, P441, DOI 10.1002/jlb.41.5.441; BJERRUM OW, 1989, EUR J HAEMATOL, V43, P67; BOLSCHER BGJM, 1989, J CLIN INVEST, V83, P757, DOI 10.1172/JCI113954; BROMBERG Y, 1984, CELL IMMUNOL, V88, P213, DOI 10.1016/0008-8749(84)90066-2; BURNHAM DN, 1990, J BIOL CHEM, V265, P17550; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; CURNUTTE JT, 1989, P NATL ACAD SCI USA, V86, P825, DOI 10.1073/pnas.86.3.825; CURNUTTE JT, 1987, J BIOL CHEM, V262, P5563; CURNUTTE JT, 1985, J CLIN INVEST, V75, P1740, DOI 10.1172/JCI111885; DOUSSIERE J, 1990, BIOCHEMISTRY-US, V29, P2225, DOI 10.1021/bi00461a004; EICHHOLTZ T, 1993, J BIOL CHEM, V268, P1982; EKLUND EA, 1991, J BIOL CHEM, V266, P13964; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; GERARD C, 1986, J CLIN INVEST, V77, P61, DOI 10.1172/JCI112302; GRINSTEIN S, 1988, J BIOL CHEM, V263, P1779; HEYNEMAN RA, 1984, J LEUKOCYTE BIOL, V36, P751, DOI 10.1002/jlb.36.6.751; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; IOANNIDES CG, 1990, CELL IMMUNOL, V131, P242, DOI 10.1016/0008-8749(90)90250-U; KESSELS GCR, 1991, J BIOL CHEM, V266, P23152; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KOENDERMAN L, 1989, FEBS LETT, V243, P399, DOI 10.1016/0014-5793(89)80170-X; KRAMER IM, 1988, J BIOL CHEM, V263, P2352; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LETO TL, 1990, SCIENCE, V248, P727, DOI 10.1126/science.1692159; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; LOMAX KJ, 1989, SCIENCE, V246, P987, DOI 10.1126/science.2587992; MCPHAIL LC, 1985, J CLIN INVEST, V75, P1735, DOI 10.1172/JCI111884; MIYAHARA M, 1987, BIOCHIM BIOPHYS ACTA, V929, P253, DOI 10.1016/0167-4889(87)90251-5; MIYAHARA M, 1988, BIOCHIM BIOPHYS ACTA, V971, P46, DOI 10.1016/S0005-2728(88)80007-0; MUID RE, 1991, FEBS LETT, V293, P169, DOI 10.1016/0014-5793(91)81178-B; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; OBRIAN CA, 1991, INVEST NEW DRUG, V9, P169, DOI 10.1007/BF00175084; PARK JW, 1992, J BIOL CHEM, V267, P17327; PEVERI P, 1992, P NATL ACAD SCI USA, V89, P2494, DOI 10.1073/pnas.89.6.2494; PICK E, 1989, J IMMUNOL, V143, P4180; ROSSI F, 1986, BIOCHIM BIOPHYS ACTA, V853, P65, DOI 10.1016/0304-4173(86)90005-4; SEGAL AW, 1985, NATURE, V316, P547, DOI 10.1038/316547a0; SEIFERT R, 1987, BIOCHEM BIOPH RES CO, V146, P1296, DOI 10.1016/0006-291X(87)90790-X; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; TANAKA T, 1988, J BIOL CHEM, V263, P13670; UHLINGER DJ, 1991, J BIOL CHEM, V266, P20990; VERHOEVEN AJ, 1989, BLOOD, V73, P1686; VOLPP BD, 1989, P NATL ACAD SCI USA, V86, P7195, DOI 10.1073/pnas.86.18.7195; VOLPP BD, 1988, SCIENCE, V242, P1295, DOI 10.1126/science.2848318; VOLPP BD, 1989, P NATL ACAD SCI USA, V86, P9563; WATSON F, 1991, J BIOL CHEM, V266, P7432	51	44	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18593	18598						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360154				2022-12-27	WOS:A1993LV65900036
J	FINCO, TS; BALDWIN, AS				FINCO, TS; BALDWIN, AS			KAPPA-B SITE-DEPENDENT INDUCTION OF GENE-EXPRESSION BY DIVERSE INDUCERS OF NUCLEAR FACTOR-KAPPA-B REQUIRES RAF-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTEIN-KINASE-C; HUMAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTION FACTOR; SIGNAL TRANSDUCTION; GROWTH-FACTOR; MOUSE FIBROBLASTS; ACTIVATION; RAS; PHOSPHORYLATION; ONCOGENE	The transcription factor nuclear factor kappaB (NF-kappaB) is sequestered in the cytoplasm of most cell types where it is complexed with its inhibitor (IkappaB). A large variety of agents, including growth factors, the tumor promoter phorbol 12-myristate 13-acetate, and the cytokine tumor necrosis factor alpha, initiate signal transduction pathways that converge upon the NF-kappaB.IkappaB complex, resulting in the dissociation of IkappaB and the translocation of NF-kappaB to the nucleus. It has been demonstrated that the phosphorylation of IkappaB is associated with NF-kappaB activation, although the kinase(s) responsible for this process in vivo remain unknown. Here we demonstrate that expression of activated forms of the GTP-binding protein Ras or of the serine/threonine kinase Raf-1 results in the activation of transcription specifically through kappaB sites. This activation appears to be dependent on NF-kappaB, since co-expression of IkappaBalpha eliminates both Ras- and Raf-1-induced transcription. In addition, through the use of a dominant negative form of Raf-1, we show that Raf-I is a common component utilized by multiple inducers in kappaB site-driven gene expression. These results illuminate a signal transduction pathway in which NF-kappaB/Rel family members participate and also implicate a pathway responsible for kappaB site-dependent gene expression during cell growth and in immune and inflammatory responses.	UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,CHAPEL HILL,NC 27599; UNIV N CAROLINA,CURRICULUM GENET & MOLEC BIOL,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT BIOL,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill					NCI NIH HHS [CA5215] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALEXANDROPOULOS K, 1992, CELL GROWTH DIFFER, V3, P731; ANISOWICZ A, 1987, P NATL ACAD SCI USA, V84, P7188, DOI 10.1073/pnas.84.20.7188; ANISOWICZ A, 1991, J IMMUNOL, V147, P520; ARENZANASEISDEDOS F, 1989, ONCOGENE, V4, P1359; ARIMA N, 1992, J IMMUNOL, V149, P83; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BAEUERLE PA, 1991, HORMONAL CONTROL REG, P409; BALDWIN AS, 1991, MOL CELL BIOL, V11, P4943, DOI 10.1128/MCB.11.10.4943; BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; BINTERUY B, 1991, NATURE, V351, P122; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; DUYAO MP, 1990, P NATL ACAD SCI USA, V87, P4727, DOI 10.1073/pnas.87.12.4727; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GRILLI M, 1993, INT REV CYTOL, V143, P1; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; IMLER JL, 1988, NATURE, V332, P275, DOI 10.1038/332275a0; JAMAL S, 1990, NATURE, V344, P463, DOI 10.1038/344463a0; KAIBUCHI K, 1989, J BIOL CHEM, V264, P20855; KITAJIMA I, 1992, SCIENCE, V258, P1792, DOI 10.1126/science.1299224; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; LECLAIR KP, 1992, P NATL ACAD SCI USA, V89, P8145, DOI 10.1073/pnas.89.17.8145; LEEVERS S J, 1992, Trends in Cell Biology, V2, P283, DOI 10.1016/0962-8924(92)90105-V; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; NARAYANAN R, 1992, SCIENCE, V256, P367, DOI 10.1126/science.256.5055.367; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; Nolan GP, 1992, CURR OPIN GENET DEV, V2, P211, DOI 10.1016/S0959-437X(05)80276-X; OLASHAW NE, 1992, MOL BIOL CELL, V3, P1131, DOI 10.1091/mbc.3.10.1131; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; QURESHI SA, 1991, J BIOL CHEM, V266, P20594; RAPP UR, 1991, ONCOGENE, V6, P495; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; SATOH T, 1992, J BIOL CHEM, V267, P24149; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P2424, DOI 10.1128/MCB.9.6.2424; SIEGEL JN, 1990, J BIOL CHEM, V265, P18472; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; TURNER B, 1991, P NATL ACAD SCI USA, V88, P1227, DOI 10.1073/pnas.88.4.1227; WASYLYK C, 1989, MOL CELL BIOL, V9, P2247, DOI 10.1128/MCB.9.5.2247; WILLIAMS NG, 1992, P NATL ACAD SCI USA, V89, P6924; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P	49	193	200	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17676	17679						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349650				2022-12-27	WOS:A1993LT74300008
J	HAKE, LE; HECHT, NB				HAKE, LE; HECHT, NB			UTILIZATION OF AN ALTERNATIVE TRANSCRIPTION INITIATION SITE OF SOMATIC CYTOCHROME-C IN THE MOUSE PRODUCES A TESTIS-SPECIFIC CYTOCHROME-C MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN-CONVERTING ENZYME; GENE-EXPRESSION; NUCLEAR FACTORS; MOLECULAR CHARACTERIZATION; NUCLEOTIDE-SEQUENCE; PROTAMINE-2 GENES; TRANSGENIC MICE; FACTORS BINDING; GAMMA-ACTIN; RAT TESTIS	The differential regulation of somatic and testis-specific cytochromes c during spermatogenesis in the mouse is accompanied by changes in mRNA length (Hake, L. E., Alcivar, A. A., and Hecht, N. B. (1990) Development 110, 249-257). In spermatogenic stem cells through early meiotic cells, we detect four somatic cytochrome c (cyt c(S)) mRNAs of 1.3, 1.1, and 0.7-0.5 kilobases (kb), whereas in postmeiotic cells we detect a larger cyt c(S) mRNA of 1.7 kb. Oligonucleotide-directed RNase H cleavage of cyt c(S) mRNA revealed that the 1.7-kb mRNA contains over 1 kb of 5'-untranslated region which is not present in the four shorter cyt c(S) mRNAs. RNase protection assays indicate that this additional sequence arises from the utilization of an alternative transcription initiation site of the functional cyt c(S) gene which is 1085 base pairs upstream of the initiation site for the four shorter cyt c(S) mRNAs. To analyze the promoter for the 1.7-kb mRNA, a genomic clone containing the cyt c(S) gene and 5 kb of 5'-flanking DNA was isolated. Sequence comparison of the putative promoter region with promoters of other postmeiotically expressed genes reveals several conserved regions. Utilization of this alternative initiation site may be involved in the down-regulation of cytochrome c(S) during spermatogenesis.	TUFTS UNIV, DEPT BIOL, MEDFORD, MA 02155 USA	Tufts University					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD011878] Funding Source: NIH RePORTER; NICHD NIH HHS [HD11878] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ausubel FM, 1991, CURRENT PROTOCOLS MO; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Bellve A.R., 1979, Oxford Reviews of Reproductive Biology, V1, P159; BUNICK D, 1990, P NATL ACAD SCI USA, V87, P891, DOI 10.1073/pnas.87.3.891; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; COSTA RH, 1988, P NATL ACAD SCI USA, V85, P3840, DOI 10.1073/pnas.85.11.3840; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOBNER PR, 1987, NUCLEIC ACIDS RES, V15, P199, DOI 10.1093/nar/15.1.199; ERICKSON RP, 1990, TRENDS GENET, V6, P264, DOI 10.1016/0168-9525(90)90209-O; EVANS MJ, 1988, MOL CELL BIOL, V8, P35, DOI 10.1128/MCB.8.1.35; EVANS MJ, 1989, J BIOL CHEM, V264, P14361; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; FISCHMAN K, 1990, MOL CELL BIOL, V10, P146, DOI 10.1128/MCB.10.1.146; FRITENSKY B, 1982, NUCLEIC ACIDS RES, V10, P6451; GARRETT JE, 1989, MOL CELL BIOL, V9, P4381, DOI 10.1128/MCB.9.10.4381; GOLDBERG E, 1977, SCIENCE, V196, P1010, DOI 10.1126/science.193188; HAKE LE, 1990, DEVELOPMENT, V110, P249; HECHT NB, 1993, CELL MOL BIOL TESTES; Hecht NB., 1986, EXPT APPROACHES MAMM, P151; HENNIG B, 1975, EUR J BIOCHEM, V55, P167, DOI 10.1111/j.1432-1033.1975.tb02149.x; HOWARD TE, 1990, MOL CELL BIOL, V10, P4294, DOI 10.1128/MCB.10.8.4294; HUET J, 1985, EMBO J, V4, P3539, DOI 10.1002/j.1460-2075.1985.tb04114.x; IVELL R, 1988, NUCLEIC ACIDS RES, V16, P7747, DOI 10.1093/nar/16.15.7747; JOHNSON PA, 1988, BIOCHIM BIOPHYS ACTA, V950, P45, DOI 10.1016/0167-4781(88)90071-1; JOHNSON PA, 1991, BIOL REPROD, V44, P127, DOI 10.1095/biolreprod44.1.127; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KILPATRICK DL, 1990, MOL CELL BIOL, V10, P3717, DOI 10.1128/MCB.10.7.3717; KIM E, 1989, MOL CELL BIOL, V9, P1875, DOI 10.1128/MCB.9.5.1875; KRAYEV AS, 1980, NUCLEIC ACIDS RES, V8, P1201, DOI 10.1093/nar/8.6.1201; KREMLING H, 1991, GENOMICS, V11, P828, DOI 10.1016/0888-7543(91)90005-Y; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; KUMAR RS, 1991, J BIOL CHEM, V266, P3854; LANGFORD KG, 1991, J BIOL CHEM, V266, P15559; LIMBACH KJ, 1985, NUCLEIC ACIDS RES, V13, P617, DOI 10.1093/nar/13.2.617; MAEDA H, 1987, NUCLEIC ACIDS RES, V15, P2851, DOI 10.1093/nar/15.7.2851; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MEIJER D, 1987, EMBO J, V6, P4041, DOI 10.1002/j.1460-2075.1987.tb02749.x; MIWA K, 1987, NUCLEIC ACIDS RES, V15, P8057, DOI 10.1093/nar/15.19.8057; MIWA T, 1991, MOL CELL BIOL, V11, P3296, DOI 10.1128/MCB.11.6.3296; Ochman H., 1990, PCR PROTOCOLS GUIDE, P219; OKO R, 1991, ANAT REC, V231, P63, DOI 10.1002/ar.1092310108; PROPST F, 1987, MOL CELL BIOL, V7, P1629, DOI 10.1128/MCB.7.5.1629; SCHAFFNER W, 1989, TRENDS GENET, V5, P37, DOI 10.1016/0168-9525(89)90017-6; SHAPER NL, 1990, P NATL ACAD SCI USA, V87, P791, DOI 10.1073/pnas.87.2.791; SHERMAN L, 1984, NUCLEIC ACIDS RES, V12, P9349, DOI 10.1093/nar/12.24.9349; STEWART TA, 1988, MOL CELL BIOL, V8, P1748, DOI 10.1128/MCB.8.4.1748; TERUYA JH, 1990, MOL CELL BIOL, V10, P2315, DOI 10.1128/MCB.10.5.2315; WALL L, 1988, GENE DEV, V2, P1089, DOI 10.1101/gad.2.9.1089; WATANABE K, 1991, J BIOCHEM-TOKYO, V109, P828, DOI 10.1093/oxfordjournals.jbchem.a123466; WATERS SH, 1985, MOL CELL BIOL, V5, P1649, DOI 10.1128/MCB.5.7.1649; WILLISON K, 1987, TRENDS GENET, V3, P351, DOI 10.1016/0168-9525(87)90296-4; Wolgemuth D. J., 1989, The molecular biology of fertilization., P235	53	50	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	1993	268	7					4788	4797						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP884	8383125				2022-12-27	WOS:A1993KP88400038
J	STUART, RA; MACKAY, D; ADAMCZEWSKI, J; WARREN, G				STUART, RA; MACKAY, D; ADAMCZEWSKI, J; WARREN, G			INHIBITION OF INTRA-GOLGI TRANSPORT INVITRO BY MITOTIC KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR STOMATITIS-VIRUS; SYNTHESIZED G-PROTEIN; CELL-CYCLE CONTROL; XENOPUS OOCYTES; HELA-CELLS; SUCCESSIVE COMPARTMENTS; MEIOTIC MATURATION; SECRETORY PATHWAY; SURFACE FUNCTIONS; MITOSIS	It has previously been shown that exocytic and endocytic membrane traffic are inhibited in mitotic mammalian cells. Here we have used a cell-free intra-Golgi transport assay supplemented with heterologous cytosols to mimic this effect in vitro. Cytosols with high histone kinase activity, made either from mitotic cells or by cyclin A treatment of interphase cells, inhibited intra-Golgi transport by up to 75%. Inhibition of transport was reversed by the kinase inhibitor staurosporine or by reduction in ATP levels leading to inactivation of histone kinase. The data indicate that cell cycle control of intra-Golgi transport is due to a reversible modification of cytosol, and this assay system may be used to study the molecular mechanism of mitotic transport inhibition in mammalian cells.	IMPERIAL CANC RES FUND,CELL BIOL LAB,44 LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND; IMPERIAL CANC RES FUND,CLARE HALL LABS,S MIMMS EN6 3LD,HERTS,ENGLAND	Cancer Research UK			Mackay, Deborah JG/B-2879-2015	Mackay, Deborah JG/0000-0003-3088-4401				BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BALCH WE, 1985, ARCH BIOCHEM BIOPHYS, V240, P413, DOI 10.1016/0003-9861(85)90046-3; BERLIN RD, 1980, J CELL BIOL, V85, P660, DOI 10.1083/jcb.85.3.660; BERLIN RD, 1978, CELL, V15, P327, DOI 10.1016/0092-8674(78)90002-8; CERIOTTI A, 1989, J CELL BIOL, V109, P1439, DOI 10.1083/jcb.109.4.1439; CLARKE PR, 1992, EMBO J, V11, P1751, DOI 10.1002/j.1460-2075.1992.tb05227.x; CLARY DO, 1990, J BIOL CHEM, V265, P10109; COLLINS RN, 1992, J BIOL CHEM, V267, P24906; COLMAN A, 1985, J CELL BIOL, V101, P313, DOI 10.1083/jcb.101.1.313; DAVIDSON HW, 1992, J CELL BIOL, V116, P1343, DOI 10.1083/jcb.116.6.1343; DEBRABANDER MJ, 1976, CANCER RES, V36, P905; DEVAULT A, 1992, J CELL BIOL, V118, P1109, DOI 10.1083/jcb.118.5.1109; DRAETTA G, 1990, TRENDS BIOCHEM SCI, V15, P378, DOI 10.1016/0968-0004(90)90235-4; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; FANG F, 1991, CELL, V66, P731, DOI 10.1016/0092-8674(91)90117-H; FAWCETT DW, 1965, J HISTOCHEM CYTOCHEM, V13, P75, DOI 10.1177/13.2.75; FEATHERSTONE C, 1985, J CELL BIOL, V101, P2036, DOI 10.1083/jcb.101.6.2036; FELIX MA, 1989, EMBO J, V8, P3059, DOI 10.1002/j.1460-2075.1989.tb08457.x; HESKETH TR, 1984, J CELL BIOL, V98, P2250, DOI 10.1083/jcb.98.6.2250; Hunt T, 1989, CURR OPIN CELL BIOL, V1, P268, DOI 10.1016/0955-0674(89)90099-9; HUNT T, 1992, J CELL BIOL, V116, P707, DOI 10.1083/jcb.116.3.707; KANKI JP, 1991, DEV BIOL, V146, P214, DOI 10.1016/0012-1606(91)90461-B; KREINER T, 1990, CELL REGUL, V1, P415, DOI 10.1091/mbc.1.5.415; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; LABBE JC, 1989, EMBO J, V8, P3053, DOI 10.1002/j.1460-2075.1989.tb08456.x; LEAF DS, 1990, DEV BIOL, V141, P1, DOI 10.1016/0012-1606(90)90097-3; LEFRANCOIS L, 1982, VIROLOGY, V121, P157, DOI 10.1016/0042-6822(82)90125-8; LORCA T, 1992, EMBO J, V11, P2381, DOI 10.1002/j.1460-2075.1992.tb05302.x; LUCOCQ J, 1991, J CELL SCI, V100, P753; LUCOCQ JM, 1989, J CELL BIOL, V109, P463, DOI 10.1083/jcb.109.2.463; LUCOCQ JM, 1987, J CELL BIOL, V104, P865, DOI 10.1083/jcb.104.4.865; LUCOCQ JM, 1987, EMBO J, V6, P3239, DOI 10.1002/j.1460-2075.1987.tb02641.x; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; MALLER JL, 1991, CURR OPIN CELL BIOL, V3, P265; MINSHULL J, 1990, EMBO J, V9, P2865, DOI 10.1002/j.1460-2075.1990.tb07476.x; NORBURY C, 1991, EMBO J, V10, P3321, DOI 10.1002/j.1460-2075.1991.tb04896.x; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PINES J, 1992, Current Opinion in Cell Biology, V4, P144, DOI 10.1016/0955-0674(92)90024-7; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; PYPAERT M, 1991, J CELL BIOL, V114, P1159, DOI 10.1083/jcb.114.6.1159; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; THOMAS L, 1992, J BIOL CHEM, V267, P6183; TUOMIKOSKI T, 1989, NATURE, V342, P942, DOI 10.1038/342942a0; WARREN G, 1984, EMBO J, V3, P2217, DOI 10.1002/j.1460-2075.1984.tb02119.x; WARREN G, 1983, J CELL BIOL, V97, P1623, DOI 10.1083/jcb.97.5.1623; WARREN G, 1985, TRENDS BIOCHEM SCI, V10, P439, DOI 10.1016/0968-0004(85)90027-1; WEIDMAN PJ, 1989, J CELL BIOL, V108, P1589, DOI 10.1083/jcb.108.5.1589; WOODMAN PG, 1992, J CELL BIOL, V116, P331, DOI 10.1083/jcb.116.2.331	52	44	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					4050	4054						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382687				2022-12-27	WOS:A1993KN53300040
J	TROTTA, E; DAMBROSIO, E; DELGROSSO, N; RAVAGNAN, G; CIRILLI, M; PACI, M				TROTTA, E; DAMBROSIO, E; DELGROSSO, N; RAVAGNAN, G; CIRILLI, M; PACI, M			H-1-NMR STUDY OF [D(GCGATCGC)]2 AND ITS INTERACTION WITH MINOR GROOVE BINDING 4',6-DIAMIDINO-2-PHENYLINDOLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENTIAL RESONANCE ASSIGNMENTS; NUCLEIC-ACIDS; H-1-NMR SPECTRA; NANOGRAM QUANTITIES; PROTON RESONANCES; AQUEOUS-SOLUTION; DNA; SPECTROSCOPY; DAPI; RNA	Two-dimensional NMR spectroscopy has been applied to study the solution binding of 4',6-diamidino-2-phenylindole (DAPI) to synthetic DNA duplex [d(GCGATCGC)]2. The structure of the complex at a molar ratio of 1:1 drug:duplex has been investigated. NMR results indicate that DAPI binds selectively in the minor groove of the DNA region containing only two A:T base pairs. The results disagree with conclusions drawn from footprinting experiments and show that the presence of the G3NH2 group in the minor groove does not prevent the binding. A molecular model is proposed that closely resembles the crystal structure previously published for the interaction of DAPI with the dodecamer [d(CGCGAATTCGCG)]2, containing four A:T base pairs in the binding site. In this model, DAPI lies in the minor groove, nearly isohelical, with its aromatic rings adjacent to H4' protons of T5 and C6 deoxyribose and the NH indole group oriented toward the DNA axis. The binding does not perturb the B-type conformation of the duplex, and the DNA oligomer conserves its 2-fold symmetry, indicating that fast exchange dynamics exist between the two stereochemically equivalent binding sites of the palindromic sequence. The binding constant and the exchange rate between free and bound species were also measured by NMR spectroscopy.	CNR,IST MED SPERIMENTALE,VIALE MARX 15,I-00137 ROME,ITALY; CNR,IST STRUTTURISTICA CHIM,ROME,ITALY; UNIV ROMA TOR VERGATA,DIPARTIMENTO SCI & TECNOL CHIM,I-00173 ROME,ITALY	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); University of Rome Tor Vergata			Trotta, Edoardo/AAW-4697-2020	Trotta, Edoardo/0000-0002-1417-9238				ALTONA C, 1982, RECL TRAV CHIM PAY B, V101, P413; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BOELENS R, 1985, J MAGN RESON, V62, P378, DOI 10.1016/0022-2364(85)90207-0; BOELENS R, 1990, SOFTWARE PROCESSING; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; BRUNK CF, 1979, ANAL BIOCHEM, V92, P497, DOI 10.1016/0003-2697(79)90690-0; CANTOR CR, 1970, BIOPOLYMERS, V9, P1059, DOI 10.1002/bip.1970.360090909; CAPOBIANCO ML, 1991, NUCLEIC ACIDS RES, V19, P1695, DOI 10.1093/nar/19.7.1695; CAVATORTA P, 1985, BIOPHYS CHEM, V22, P11, DOI 10.1016/0301-4622(85)80021-1; CLORE GM, 1985, FEBS LETT, V179, P187, DOI 10.1016/0014-5793(85)80516-0; DANN O, 1971, LIEBIGS ANN CHEM, V749, P68; DAVIES DB, 1978, PROG NUCL MAG RES SP, V12, P135, DOI 10.1016/0079-6565(78)80006-5; GIESSNERPRETTRE C, 1987, Q REV BIOPHYS, V20, P113, DOI 10.1017/S0033583500004169; GUTOWSKY HS, 1956, J CHEM PHYS, V25, P1228, DOI 10.1063/1.1743184; HARE DR, 1983, J MOL BIOL, V171, P319, DOI 10.1016/0022-2836(83)90096-7; HOSUR RV, 1988, MAGN RESON CHEM, V26, P927, DOI 10.1002/mrc.1260261019; HOSUR RV, 1985, MAGNETIC RESONANCE B, P243; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JEPPESEN C, 1989, EUR J BIOCHEM, V182, P437, DOI 10.1111/j.1432-1033.1989.tb14850.x; KAPUSCINSKI J, 1979, NUCLEIC ACIDS RES, V6, P3535, DOI 10.1093/nar/6.11.3535; KAPUSCINSKI J, 1977, ANAL BIOCHEM, V83, P252, DOI 10.1016/0003-2697(77)90533-4; KUBISTA M, 1987, BIOCHEMISTRY-US, V26, P4545, DOI 10.1021/bi00388a057; LANE AN, 1991, BIOCHEMISTRY-US, V30, P1372, DOI 10.1021/bi00219a030; LARSEN TA, 1989, J BIOMOL STRUCT DYN, V7, P477, DOI 10.1080/07391102.1989.10508505; LATT SA, 1976, ANNU REV BIOPHYS BIO, V5, P1, DOI 10.1146/annurev.bb.05.060176.000245; LEE GM, 1984, ANAL BIOCHEM, V137, P221, DOI 10.1016/0003-2697(84)90374-9; LOONTIENS FG, 1991, BIOCHEMISTRY-US, V30, P182, DOI 10.1021/bi00215a027; MANZINI G, 1983, NUCLEIC ACIDS RES, V11, P8861, DOI 10.1093/nar/11.24.8861; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; MUELLER L, 1987, J MAGN RESON, V72, P191, DOI 10.1016/0022-2364(87)90188-0; NAIMSKI P, 1980, ANAL BIOCHEM, V106, P471, DOI 10.1016/0003-2697(80)90550-3; PATEL DJ, 1987, Q REV BIOPHYS, V20, P35, DOI 10.1017/S0033583500004224; Perkins S. J., 1982, BIOL MAGN RESON, V4, P193; PORTUGAL J, 1987, EUR J BIOCHEM, V167, P281, DOI 10.1111/j.1432-1033.1987.tb13334.x; PORTUGAL J, 1988, BIOCHIM BIOPHYS ACTA, V949, P158, DOI 10.1016/0167-4781(88)90079-6; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; REID DG, 1983, BIOCHEMISTRY-US, V22, P2019, DOI 10.1021/bi00277a044; SCHEEK RM, 1984, BIOCHEMISTRY-US, V23, P1371, DOI 10.1021/bi00302a006; SCHEEK RM, 1983, J AM CHEM SOC, V105, P2914, DOI 10.1021/ja00347a075; SKLENAR V, 1987, J MAGN RESON, V74, P469, DOI 10.1016/0022-2364(87)90269-1; STAUFFERT I, 1990, MUTAT RES, V245, P93, DOI 10.1016/0165-7992(90)90006-6; SYKES BD, 1969, BIOCHEMISTRY-US, V8, P1110, DOI 10.1021/bi00831a043; Williamson D H, 1975, Methods Cell Biol, V12, P335; WILSON WD, 1989, J AM CHEM SOC, V111, P5008, DOI 10.1021/ja00195a080; WILSON WD, 1990, ANTI-CANCER DRUG DES, V5, P31; WILSON WD, 1990, BIOCHEMISTRY-US, V29, P8452, DOI 10.1021/bi00488a036; [No title captured]	47	47	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					3944	3951						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382683				2022-12-27	WOS:A1993KN53300025
J	WINKEL, GK; SARDET, C; POUYSSEGUR, J; IVES, HE				WINKEL, GK; SARDET, C; POUYSSEGUR, J; IVES, HE			ROLE OF CYTOPLASMIC DOMAIN OF THE NA+/H+ EXCHANGER IN HORMONAL ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; PROTEIN-KINASE-C; INTRACELLULAR PH REGULATION; EPIDERMAL GROWTH-FACTOR; INDEPENDENT ACTIVATION; OSMOTIC ACTIVATION; PHORBOL ESTERS; OKADAIC ACID; ANTIPORT; STIMULATION	The growth factor-activated Na+/H+ exchanger is regulated by numerous stimuli, including polypeptide hormones, phorbol esters, cell acidity, and cell shrinkage. To determine whether this regulation occurs at a common site on the cytoplasmic domain of the Na+/H+ exchanger, we microinjected polyclonal antibodies (RP1-c28) to the C-terminal 157 amino acids of the molecule and measured cell pH changes after application of a variety of stimuli known to activate the Na+/H+ exchanger. Microinjection of approximately 10 fg of RP1-c28 antibody, but not control IgG, into single cultured fibroblasts blocked subsequent activation of the exchanger by both endothelin and alpha-thrombin. In contrast, microinjected RP1-c28 did not prevent activation of Na+/H+ exchange by phorbol esters, consistent with the observation that both endothelin-1 and alpha-thrombin retained the ability to activate exchange activity in protein kinase C-depleted cells. Finally, activation of Na+/H+ exchange by both cell acidity and osmotic shrinkage was also unaffected by microinjected RP1-c28 antibody. These data indicate that activation of Na+/H+ exchange by endothelin-1 and alpha-thrombin is mechanistically distinct both from activation by protein kinase C and activation by physical factors and probably occurs at a separate site on the exchanger molecule.	UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,DIV NEPHROL,1065 HSE BOX 0532,SAN FRANCISCO,CA 94143; UNIV NICE,CNRS,CTR BIOCHIM,F-06108 NICE 2,FRANCE	University of California System; University of California San Francisco; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur					NHLBI NIH HHS [HL41210] Funding Source: Medline; NIDDK NIH HHS [DK 07219, DK34127] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007219, R01DK034127] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARONSON PS, 1982, NATURE, V299, P161, DOI 10.1038/299161a0; BERK BC, 1987, J BIOL CHEM, V262, P5065; BERK BC, 1987, J BIOL CHEM, V262, P5057; BIANCHINI L, 1991, J BIOL CHEM, V266, P15406; CALA PM, 1980, J GEN PHYSIOL, V76, P683, DOI 10.1085/jgp.76.6.683; CASSEL D, 1984, BIOCHEM BIOPH RES CO, V118, P675, DOI 10.1016/0006-291X(84)91356-1; CASSEL D, 1985, J CELL PHYSIOL, V122, P178, DOI 10.1002/jcp.1041220203; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; DANIEL TO, 1987, BIOCHEM BIOPH RES CO, V145, P111, DOI 10.1016/0006-291X(87)91294-0; ESCOBALES N, 1990, AM J PHYSIOL, V259, pC640, DOI 10.1152/ajpcell.1990.259.4.C640; GRINSTEIN S, 1986, BIOCHEM BIOPH RES CO, V134, P8, DOI 10.1016/0006-291X(86)90519-X; GRINSTEIN S, 1985, J GEN PHYSIOL, V85, P765, DOI 10.1085/jgp.85.5.765; GRINSTEIN S, 1986, J MEMBRANE BIOL, V90, P1, DOI 10.1007/BF01869680; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; HESKETH TR, 1985, NATURE, V313, P481, DOI 10.1038/313481a0; HUANG CL, 1987, J BIOL CHEM, V262, P14134; HUANG CL, 1991, J BIOL CHEM, V266, P4045; IVES HE, 1987, P NATL ACAD SCI USA, V84, P1950, DOI 10.1073/pnas.84.7.1950; KRAMER BK, 1991, CIRC RES, V68, P269, DOI 10.1161/01.RES.68.1.269; LALLEMAIN G, 1984, J BIOL CHEM, V259, P5809; LIN HY, 1991, P NATL ACAD SCI USA, V88, P3185, DOI 10.1073/pnas.88.8.3185; LOWE JHN, 1990, J BIOL CHEM, V265, P7188; MITSUHASHI T, 1988, J BIOL CHEM, V263, P8790; MITSUHASHI T, 1989, J CLIN INVEST, V84, P635, DOI 10.1172/JCI114209; MOOLENAAR WH, 1984, NATURE, V312, P371, DOI 10.1038/312371a0; MOOLENAAR WH, 1986, ANNU REV PHYSIOL, V48, P363; PARADISO AM, 1987, NATURE, V325, P447, DOI 10.1038/325447a0; PARIS S, 1984, J BIOL CHEM, V259, P989; POUYSSEGUR J, 1985, TRENDS BIOCHEM SCI, V10, P453, DOI 10.1016/0968-0004(85)90030-1; ROSOFF PM, 1986, J CELL BIOL, V103, P457, DOI 10.1083/jcb.103.2.457; ROSOFF PM, 1984, J BIOL CHEM, V259, P7056; SARDET C, 1990, SCIENCE, V247, P723, DOI 10.1126/science.2154036; SARDET C, 1991, J BIOL CHEM, V266, P19166; SIMONSON MS, 1989, J CLIN INVEST, V83, P708, DOI 10.1172/JCI113935; VANDYKE RW, 1988, HEPATOLOGY, V8, P960, DOI 10.1002/hep.1840080441; VARA F, 1985, BIOCHEM BIOPH RES CO, V130, P646, DOI 10.1016/0006-291X(85)90466-8; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424	37	36	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3396	3400						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381429				2022-12-27	WOS:A1993KM16100059
J	SIRES, UI; GRIFFIN, GL; BROEKELMANN, TJ; MECHAM, RP; MURPHY, G; CHUNG, AE; WELGUS, HG; SENIOR, RM				SIRES, UI; GRIFFIN, GL; BROEKELMANN, TJ; MECHAM, RP; MURPHY, G; CHUNG, AE; WELGUS, HG; SENIOR, RM			DEGRADATION OF ENTACTIN BY MATRIX METALLOPROTEINASES - SUSCEPTIBILITY TO MATRILYSIN AND IDENTIFICATION OF CLEAVAGE SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKIN FIBROBLAST COLLAGENASE; BASEMENT-MEMBRANE; DEGRADING METALLOPROTEINASE; SUBSTRATE-SPECIFICITY; IV COLLAGENASE; LAMININ; NIDOGEN; PURIFICATION; EXPRESSION; CELLS	Entactin is the basement membrane protein which bridges laminin and type IV collagen. Entactin is known to be degraded by serine proteinases, but its susceptibility to matrix metalloproteinases has not been determined. We have studied the capacity of three matrix metalloproteinases (interstitial collagenase, 92-kDa gelatinase, and matrilysin) to degrade entactin. While all three metalloenzymes cleaved entactin, matrilysin was approximately 100-fold as effective as collagenase and 600-fold as effective as 92-kDa gelatinase. The K(m) of matrilysin for entactin was 8.9 x 10(-7) M. A V(max) of 21 molecules of entactin degraded/molecule of matrilysin/min at 37-degrees-C was observed. An Arrhenius plot relating matrilysin's catalytic activity to temperature was linear from 15 to 37-degrees-C and indicated an activation energy of 10,060 calories/mol. Matrilysin produced multiple, but distinct, cleavages in entactin resulting in peptide fragments ranging from 115 to 29 kDa. The precise sites of cleavage of six fragments were determined by Edman degradation. Cleavage sites consistently occurred amino-terminal to leucine or isoleucine. These data indicate that entactin is a substrate for matrix metalloproteinases. The effectiveness of matrilysin is noteworthy, however, particularly in relation to the minimal ability of other much more well described matrix metalloproteinases to attack this substrate. Our results suggest a potentially important role for matrilysin in disruption of basement membranes by tumor or inflammatory cells.	WASHINGTON UNIV, JEWISH HOSP ST LOUIS,MED CTR,DEPT MED, DIV RESP & CRIT CARE, ST LOUIS, MO 63110 USA; ST LOUIS CHILDRENS HOSP, DEPT PEDIAT, ST LOUIS, MO 63178 USA; WASHINGTON UNIV, SCH MED, DEPT CELL BIOL & PHYSIOL, ST LOUIS, MO 63110 USA; STRANGEWAYS RES LAB, CAMBRIDGE CB1 4RN, ENGLAND; UNIV PITTSBURGH, DEPT NAKAHARA KU, PITTSBURGH, PA 15260 USA	Barnes-Jewish Hospital; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	SIRES, UI (corresponding author), WASHINGTON UNIV, JEWISH HOSP ST LOUIS,MED CTR,DEPT MED,DIV DERMATOL, 216 S KINGSHIGHWAY, ST LOUIS, MO 63110 USA.				NHLBI NIH HHS [HL-29594] Funding Source: Medline; NIAMS NIH HHS [AR-35805, AR-07284] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035805, T32AR007284] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BARICOS WH, 1988, BIOCHEM J, V254, P609, DOI 10.1042/bj2540609; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; BENDER BL, 1981, AM J PATHOL, V103, P419; BUSIEK DF, 1992, J BIOL CHEM, V267, P9087; CHAKRAVARTI S, 1990, J BIOL CHEM, V265, P10597; CHUNG AE, 1990, AM J RESP CELL MOL, V3, P275, DOI 10.1165/ajrcmb/3.4.275; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; DEAN DD, 1989, J CLIN INVEST, V84, P678, DOI 10.1172/JCI114215; DURKIN ME, 1988, J CELL BIOL, V107, P2749, DOI 10.1083/jcb.107.6.2749; DZIADEK M, 1985, DEV BIOL, V111, P372, DOI 10.1016/0012-1606(85)90491-9; DZIADEK M, 1989, AM J ANAT, V84, P298; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; GUTFREUND H, 1975, ENZYMES PHYSICAL PRI, P157; HECK LW, 1990, AM J PATHOL, V136, P1267; HIBBS MS, 1987, J CLIN INVEST, V80, P1644, DOI 10.1172/JCI113253; KING J, 1971, J MOL BIOL, V62, P465, DOI 10.1016/0022-2836(71)90148-3; MANN K, 1988, EUR J BIOCHEM, V178, P71, DOI 10.1111/j.1432-1033.1988.tb14430.x; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; MIYAZAKI K, 1990, CANCER RES, V50, P7758; MULLER D, 1988, BIOCHEM J, V253, P187, DOI 10.1042/bj2530187; MURPHY G, 1991, BIOCHEM J, V277, P277, DOI 10.1042/bj2770277; NETZELARNETT S, 1991, J BIOL CHEM, V266, P6747; PAULSSON M, 1986, EUR J BIOCHEM, V156, P467, DOI 10.1111/j.1432-1033.1986.tb09605.x; QUANTIN B, 1989, BIOCHEMISTRY-US, V28, P5327, DOI 10.1021/bi00439a004; ROSWIT WT, 1988, ARCH BIOCHEM BIOPHYS, V262, P67, DOI 10.1016/0003-9861(88)90169-5; SAARIALHOKERE UK, 1992, J CLIN INVEST, V90, P1952, DOI 10.1172/JCI116073; SALO T, 1985, J BIOL CHEM, V260, P8526; SELTZER JL, 1990, J BIOL CHEM, V265, P20409; SENIOR RM, 1991, J BIOL CHEM, V266, P7870; SENIOR RM, 1992, J CLIN INVEST, V90, P2251, DOI 10.1172/JCI116111; STRICKLIN GP, 1977, BIOCHEMISTRY-US, V16, P1607, DOI 10.1021/bi00627a013; TIMPL R, 1983, EUR J BIOCHEM, V137, P455, DOI 10.1111/j.1432-1033.1983.tb07849.x; TSAO T, 1990, J BIOL CHEM, V265, P5188; WARBURTON MJ, 1984, EXP CELL RES, V152, P240, DOI 10.1016/0014-4827(84)90249-0; WEINGARTEN H, 1986, BIOCHEM BIOPH RES CO, V139, P1184, DOI 10.1016/S0006-291X(86)80302-3; WELGUS HG, 1981, J BIOL CHEM, V256, P9511; WELGUS HG, 1981, J BIOL CHEM, V256, P9516; WELGUS HG, 1982, J BIOL CHEM, V257, P1534; WILHELM SM, 1987, P NATL ACAD SCI USA, V84, P6725, DOI 10.1073/pnas.84.19.6725; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; WOESSNER JF, 1988, J BIOL CHEM, V263, P16918	41	131	132	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2069	2074						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380588				2022-12-27	WOS:A1993KH62000086
J	BEAVIS, AD; LU, Y; GARLID, KD				BEAVIS, AD; LU, Y; GARLID, KD			ON THE REGULATION OF K+ UNIPORT IN INTACT MITOCHONDRIA BY ADENINE-NUCLEOTIDES AND NUCLEOTIDE ANALOGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; PURIFIED ION CHANNEL; PATCH CLAMP ANALYSIS; HEART-MITOCHONDRIA; INNER MEMBRANE; MG++ FLUX; POTASSIUM CHANNELS; LIGHT-SCATTERING; MATRIX VOLUME; TRANSPORT	Respiring mitochondria drive the electrophoretic uptake of K+ and other cations. In the presence of permeant acids this transport leads to mitochondrial swelling if it is not compensated by electroneutral K+/H+ exchange mediated by the K+/H+ antiporter. The mechanism of influx has yet to be established; however, evidence is accumulating that in addition to leak pathways a specific K+ channel or uniporter may be involved. We examine some of the properties of K+ uniport which are consistent with the existence of a specific ATP-regulated K+ channel. In contrast to the K+/H+ antiporter, K+ uniport shows little dependence on pH. K+ uniport is, however, very sensitive to inhibition by adenine nucleotides. The maximum percent inhibition is increased from 40 to 60% by treatment of mitochondria with N-ethylmaleimide (30 nmol/mg) which stimulates K+ uniport 3.6-fold. N-Ethylmaleimide, however, has no effect on the IC50 values which are 0.5, 2.3, and 8 muM for ADP, ATP, and AMP, respectively. GDP has no effect, while carboxyatractyloside is found to inhibit. The nucleotide analogs Cibacron blue 3GA and erythrosin B exhibit three effects on K+ uniport. Low doses partially inhibit K uniport (I50 = 0.13 muM Cibacron Blue), while higher doses stimulate (EC50 = 13 muM Cibacron Blue). Stimulation is especially apparent in N-ethylmaleimide-treated mitochondria. These analogs also antagonize inhibition by ATP. Since the EC50 values for this antagonism for these two drugs are similar, while the IC50 values for inhibition of ATP transport differ by a factor of five, we suggest that inhibition of K+ uniport by ATP is not mediated via the adenine nucleotide translocase. These data are consistent with the existence of an ATP-regulated K+ channel in the inner mitochondrial membrane.			BEAVIS, AD (corresponding author), MED COLL OHIO,DEPT PHARMACOL,POB 10008,TOLEDO,OH 43699, USA.			Garlid, Keith/0000-0002-6777-1235	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 36573] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; BEAVIS AD, 1985, J BIOL CHEM, V260, P3424; BEAVIS AD, 1992, J BIOENERG BIOMEMBR, V24, P77, DOI 10.1007/BF00769534; BERNARDI P, 1989, J BIOL CHEM, V264, P18902; BRIERLEY GP, 1984, J BIOL CHEM, V259, P4672; BRIERLEY GP, 1977, J BIOL CHEM, V252, P7932; BRIERLEY GP, 1978, ARCH BIOCHEM BIOPHYS, V190, P181, DOI 10.1016/0003-9861(78)90266-7; BRIERLEY GP, 1973, ARCH BIOCHEM BIOPHYS, V159, P742, DOI 10.1016/0003-9861(73)90515-8; COSTA G, 1991, BIOCHEM BIOPH RES CO, V175, P305, DOI 10.1016/S0006-291X(05)81235-5; DAVIDSON AM, 1987, BIOCHEM J, V246, P715, DOI 10.1042/bj2460715; DAVIES NW, 1991, J BIOENERG BIOMEMBR, V23, P509, DOI 10.1007/BF00785809; DIWAN JJ, 1986, BIOCHEM BIOPH RES CO, V135, P830, DOI 10.1016/0006-291X(86)91003-X; DIWAN JJ, 1986, J BIOENERG BIOMEMBR, V18, P123, DOI 10.1007/BF00743481; DIWAN JJ, 1977, BIOCHEM SOC T, V5, P203, DOI 10.1042/bst0050203; DIWAN JJ, 1988, BIOCHEM BIOPH RES CO, V153, P224, DOI 10.1016/S0006-291X(88)81212-9; DIWAN JJ, 1988, J BIOENERG BIOMEMBR, V20, P261, DOI 10.1007/BF00768398; DIWAN JJ, 1980, J BIOENERG BIOMEMBR, V12, P205, DOI 10.1007/BF00744684; DUNNE MJ, 1991, BIOCHIM BIOPHYS ACTA, V1071, P67, DOI 10.1016/0304-4157(91)90012-L; FEDOTCHEVA NJ, 1985, COMP BIOCHEM PHYS B, V82, P191, DOI 10.1016/0305-0491(85)90151-8; GAMBLE JL, 1957, J BIOL CHEM, V228, P955; GARLID KD, 1985, J BIOL CHEM, V260, P3434; GARLID KD, 1988, INTEGRATION MITOCHON, P257; GAUTHIER LM, 1979, BIOCHEM BIOPH RES CO, V87, P1072, DOI 10.1016/S0006-291X(79)80017-0; GUI G, 1991, J MOL CELL CARDIOL, V23, pS78; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; HALESTRAP AP, 1989, ANION CARRIERS OF MITOCHONDRIAL MEMBRANES, P337; HALESTRAP AP, 1986, BIOCHEM J, V236, P779, DOI 10.1042/bj2360779; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; HEGAZY MG, 1991, BIOPHYS J, V59, pA596; INOUE I, 1991, NATURE, V352, P244, DOI 10.1038/352244a0; JUNG DW, 1980, J BIOL CHEM, V255, P408; JUNG DW, 1977, ARCH BIOCHEM BIOPHYS, V183, P452, DOI 10.1016/0003-9861(77)90380-0; LEQUOC K, 1988, ARCH BIOCHEM BIOPHYS, V265, P249, DOI 10.1016/0003-9861(88)90125-7; Mironova G. D., 1981, Biophysics, V26, P458; NICOLLI A, 1991, J BIOL CHEM, V266, P9465; PANOV A, 1980, ARCH BIOCHEM BIOPHYS, V199, P420, DOI 10.1016/0003-9861(80)90298-2; PAUCEK P, 1992, Biophysical Journal, V61, pA378; PFAFF E, 1969, EUR J BIOCHEM, V10, P484, DOI 10.1111/j.1432-1033.1969.tb00715.x; POWERS MF, 1991, J BIOL CHEM, V266, P17250; ROTTENBERG H, 1990, BIOCHIM BIOPHYS ACTA, V1016, P87, DOI 10.1016/0005-2728(90)90010-2; SCOTT RL, 1961, J BIOL CHEM, V236, P570; WEBSTER K A, 1978, Journal of Bioenergetics and Biomembranes, V10, P23, DOI 10.1007/BF00743225; WOLDEGIORGIS G, 1992, EBEC REPORTS, V1, P89	44	94	96	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					997	1004						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8380420				2022-12-27	WOS:A1993KG07700038
J	ORR, I; MARTIN, C; ASHLEY, R; SHOSHANBARMATZ, V				ORR, I; MARTIN, C; ASHLEY, R; SHOSHANBARMATZ, V			THE INTERACTION OF FLUORESCEIN ISOTHIOCYANATE WITH THE RYANODINE RECEPTOR/CA2+ RELEASE CHANNEL OF SARCOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL TERMINAL CISTERNAE; NUCLEOTIDE-BINDING-SITES; RABBIT SKELETAL-MUSCLE; CALCIUM-RELEASE; ADENOSINE-TRIPHOSPHATASE; ADENINE-NUCLEOTIDE; CA-2+; ACTIVATION; LOCALIZATION; PURIFICATION	Fluorescein 5'-isothiocyanate (FITC) markedly inhibited ryanodine binding to rabbit skeletal muscle junctional sarcoplasmic reticulum. Half-maximal inhibition was obtained with about 20 muM and complete inhibition by 80 muM FITC. Inhibition was enhanced in the presence of high salt and at alkaline pH. The pH dependence of the inactivation of ryanodine binding suggested that FITC bound to a very reactive lysine epsilon-amino group with a pK(a) of about 7.5 or above. Kinetic analysis of the time course of inactivation of ryanodine binding by various concentrations of FITC suggested that the inactivation resulted from the modification of 2 or more amino acid residues. The inhibition of ryanodine binding by FITC was partially prevented by ATP, ADP, adenyl imidodiphosphate, and 3-O-(benzoyl)-benzoyl-ATP (Bz-ATP) but not by AMP. FITC modification of sarcoplasmic reticulum membranes inhibited the photoaffinity labeling by [alpha-P-32]Bz-ATP of the 450-kDa protein and the ryanodine receptor with half-maximal inhibition at about 100 muM. The results suggest that the inhibition of ryanodine binding is mainly due to FITC modification of sites which are not involved in ATP binding. The FITC moiety is bound to the 160-, 96-, 76-, and 60-kDa ryanodine receptor tryptic fragments, and the FITC site is apparently on the 21.5-, 18-, and 17-kDa fragments which are formed by the V8 protease. Covalent modification by FITC dramatically affected the activity of single Ca2+ release channels incorporated into planar lipid bilayers. FITC caused a marked increase in channel open probability mainly to a noisy approximately 60% subconductance state. FITC-modified channels were no longer affected by ryanodine but were still abolished by Mg2+ and ruthenium red. We suggest that FITC modifies reactive lysine residues involved in channel activation by transmembrane charge movement in the t-tubular system.	BEN GURION UNIV NEGEV,DEPT LIFE SCI,IL-84105 BEER SHEVA,ISRAEL; UNIV EDINBURGH,SCH MED,DEPT BIOCHEM,EDINBURGH EH8 9XD,SCOTLAND	Ben Gurion University; University of Edinburgh					Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ASHLEY CC, 1968, NATURE, V219, P1168, DOI 10.1038/2191168a0; ASHLEY RH, 1990, J GEN PHYSIOL, V95, P981, DOI 10.1085/jgp.95.5.981; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; EBASHI S, 1969, Quarterly Reviews of Biophysics, V2, P351; FILL M, 1989, ANN NY ACAD SCI, V560, P155, DOI 10.1111/j.1749-6632.1989.tb24092.x; FILL M, 1989, BIOPHYS J, V55, P85; FLEISCHER S, 1985, P NATL ACAD SCI USA, V82, P7256, DOI 10.1073/pnas.82.21.7256; HYMEL L, 1988, P NATL ACAD SCI USA, V85, P441, DOI 10.1073/pnas.85.2.441; INUI M, 1987, J BIOL CHEM, V262, P1740; JOBSIS FF, 1966, BIOCHEM BIOPH RES CO, V25, P246, DOI 10.1016/0006-291X(66)90588-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI FA, 1989, J BIOENERG BIOMEMBR, V21, P227, DOI 10.1007/BF00812070; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; LATTANZIO FA, 1987, J BIOL CHEM, V262, P2711; LEVY HM, 1963, J BIOL CHEM, V238, P3654; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MA J, 1988, SCIENCE, V242, P99, DOI 10.1126/science.2459777; MEISSNER G, 1986, BIOCHEMISTRY-US, V25, P236, DOI 10.1021/bi00349a033; MEISSNER G, 1987, J BIOL CHEM, V262, P3065; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; MICHALAK M, 1988, BIOCHIM BIOPHYS ACTA, V939, P587, DOI 10.1016/0005-2736(88)90106-X; MIESSNER G, 1989, J BIOL CHEM, V264, P1715; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; PESSAH IN, 1986, J BIOL CHEM, V261, P8643; PICK U, 1980, BIOCHIM BIOPHYS ACTA, V626, P255, DOI 10.1016/0005-2795(80)90216-0; PICK U, 1981, EUR J BIOCHEM, V121, P187, DOI 10.1111/j.1432-1033.1981.tb06448.x; ROUSSEAU E, 1986, BIOPHYS J, V50, P1009, DOI 10.1016/S0006-3495(86)83543-3; ROUSSEAU E, 1987, AM J PHYSIOL, V253, pC364, DOI 10.1152/ajpcell.1987.253.3.C364; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; SCHMIDT DE, 1971, BIOCHEMISTRY-US, V10, P1249; SEGEL IH, 1975, ENZYME KINETICS, P885; SHAMOO AE, 1976, J BIOL CHEM, V251, P4147; SHOSHANBARMATZ V, 1988, J BIOL CHEM, V263, P16772; SHOSHANBARMATZ V, 1992, BIOCHEM J, V285, P61, DOI 10.1042/bj2850061; SIMPSON I, 1978, ANAL BIOCHEM, V89, P304, DOI 10.1016/0003-2697(78)90755-8; SMITH JS, 1988, J GEN PHYSIOL, V92, P1, DOI 10.1085/jgp.92.1.1; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; WILLIAMS N, 1982, J BIOL CHEM, V257, P2834; WINEGRAD S, 1970, J GEN PHYSIOL, V55, P77, DOI 10.1085/jgp.55.1.77; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	40	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1376	1382						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8380411				2022-12-27	WOS:A1993KG07700092
J	DEMONT, N; DEBELLE, F; AURELLE, H; DENARIE, J; PROME, JC				DEMONT, N; DEBELLE, F; AURELLE, H; DENARIE, J; PROME, JC			ROLE OF THE RHIZOBIUM-MELILOTI-NODF AND NODE GENES IN THE BIOSYNTHESIS OF LIPO-OLIGOSACCHARIDIC NODULATION FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYMBIOTIC HOST-SPECIFICITY; NUCLEOTIDE-SEQUENCE; SIGNALS; PROTEIN; FAMILY; ACID; CONSTRUCTION; PHENOTYPES; ACTIVATION; COMMON	Rhizobia nodulation (nod) genes are involved in the synthesis of symbiotic signals, the Nod factors, which are mono-N-acylated chito-oligosaccharides. Nod factors elicit, in a specific manner, various plant responses on legume roots. In this report we address the question of the role of nodFEG genes in the synthesis of the acyl moiety of Rhizobium meliloti Nod factors. In a Nod factor-overproducing strain with the wild-type nod region, in addition to the DELTA2,9-C 16:2 and DELTA2,4,9-C16:3 acyl groups already described, DELTA9-C16:1 was also found, together with a series of C18 to C26 (omega-1)-hydroxylated fatty acids. A deletion of nodE resulted in the absence of C16:2 and C16:3 fatty acids, which were replaced by vaccenic acid (DELTA11-C18:1), but did not change the proportion of (omega-1)-hydroxylated fatty acids. A nodF deletion, non-polar with respect to nodE, resulted in the same alterations in the Nod factor N-acyl composition, showing that both nodF and nodE are required for the synthesis of the C-16 polyunsaturated chains. In contrast, nodG mutations did not result in a detectable change in the Nod factor N-acyl moiety. When a plasmid carrying the nodFE genes of Rhizobium leguminosarum bv. viciae was introduced into R. meliloti nodFE- and nodFEG-deleted strains, Nod factors with polyunsaturated C18 fatty acids (C18:2, C18:3, and C18:4) could be detected. These results provide evidence that the molecular basis of allelic variation between the R. meliloti and R. leguminosarum bv. viciae host range nodFE genes lies in the fact that the two nodFE alleles specify the synthesis of unsaturated fatty acid substituents with a different carbon length.	CNRS,PHARMACOL & TOXICOL FONDAMENTALES LAB,205 ROUTE NARBONNE,F-31077 TOULOUSE,FRANCE; INRA,CNRS,BIOL MOLEC RELAT PLANTESMICROORGANISMES LAB,F-31326 CASTANET TOLOSAN,FRANCE	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); INRAE								BHAT UR, 1991, J BACTERIOL, V173, P2155, DOI 10.1128/JB.173.7.2155-2159.1991; BIBB MJ, 1989, EMBO J, V8, P2727, DOI 10.1002/j.1460-2075.1989.tb08414.x; DEBELLE F, 1988, J BACTERIOL, V170, P5718, DOI 10.1128/jb.170.12.5718-5727.1988; DEBELLE F, 1986, NUCLEIC ACIDS RES, V14, P7453, DOI 10.1093/nar/14.18.7453; DEBELLE F, 1986, J BACTERIOL, V168, P1075, DOI 10.1128/jb.168.3.1075-1086.1986; DENARIE J, 1992, ANNU REV MICROBIOL, V46, P497, DOI 10.1146/annurev.mi.46.100192.002433; DENARIE J, 1992, MOL SIGNALS PLANT MI, P295; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; FAUCHER C, 1989, MOL PLANT MICROBE IN, V2, P291, DOI 10.1094/MPMI-2-291; FISHER RF, 1992, NATURE, V357, P655, DOI 10.1038/357655a0; GEIGER O, 1991, J BACTERIOL, V173, P2872, DOI 10.1128/JB.173.9.2872-2878.1991; HONMA MA, 1990, J BACTERIOL, V172, P901, DOI 10.1128/jb.172.2.901-911.1990; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; MACKENZIE SL, 1979, CAN J MICROBIOL, V25, P68, DOI 10.1139/m79-011; MAILLET F, 1990, MOL MICROBIOL, V4, P1975, DOI 10.1111/j.1365-2958.1990.tb02047.x; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; PRICE NPJ, 1992, MOL MICROBIOL, V6, P3575, DOI 10.1111/j.1365-2958.1992.tb01793.x; PROME JC, 1987, RAPID COMMUN MASS SP, V1, P50; ROCHE P, 1991, CELL, V67, P1131, DOI 10.1016/0092-8674(91)90290-F; ROCHE P, 1991, J BIOL CHEM, V266, P10933; SANJUAN J, 1992, P NATL ACAD SCI USA, V89, P8789, DOI 10.1073/pnas.89.18.8789; SCHULTZE M, 1992, P NATL ACAD SCI USA, V89, P192, DOI 10.1073/pnas.89.1.192; SHEARMAN CA, 1986, EMBO J, V5, P647, DOI 10.1002/j.1460-2075.1986.tb04262.x; SHELDON PS, 1990, BIOCHEM J, V271, P717; Simon R., 1983, MOL GENETICS BACTERI, V1st ed., P98; SPAINK HP, 1989, EMBO J, V8, P2811, DOI 10.1002/j.1460-2075.1989.tb08427.x; SPAINK HP, 1991, NATURE, V354, P125, DOI 10.1038/354125a0; SPAINK HP, 1992, PLANT MOL BIOL, V20, P977, DOI 10.1007/BF00027167; SURIN BP, 1989, PLANT MOL BIOL, V12, P19, DOI 10.1007/BF00017444; SWANSON JA, 1987, GENETICS, V117, P181; TRUCHET G, 1985, J BACTERIOL, V164, P1200, DOI 10.1128/JB.164.3.1200-1210.1985	31	94	98	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20134	20142						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376372				2022-12-27	WOS:A1993LY01900034
J	DENNIS, PB; MASARACCHIA, RA				DENNIS, PB; MASARACCHIA, RA			ACTIVATION OF AN S6 KINASE FROM HUMAN PLACENTA BY AUTOPHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-PROTEIN S6; SWISS 3T3 CELLS; RABBIT SKELETAL-MUSCLE; GROWTH-FACTOR; PHORBOL ESTER; CATALYTIC DOMAINS; LYMPHOID-CELLS; PHOSPHORYLATION; INSULIN; PURIFICATION	A number of protein kinases have been shown to undergo autophosphorylation, but few have demonstrated a coordinate increase or decrease in enzymatic activity as a result. Described here is a novel S6 kinase isolated from human placenta which autoactivates through autophosphorylation in vitro. This S6/H4 kinase, purified in an inactive state, exhibited a molecular mass of 60 kDa as estimated by SDS-polyacrylamide gel electrophoresis. The 60-kDa protein underwent autophosphorylation, was labeled by 8-azido-[alpha-P-32]ATP, and reacted with an antibody to the conserved APE domain of the cAMP-dependent protein kinase. The protein did not cochromatograph with p70 S6 kinase and did not cross-react with an anti-p70 kinase antibody. The synthetic peptide S6-21, histone H4, and myelin basic protein were phosphorylated by the purified S6/H4 kinase. Mild digestion of the inactive S6/H4 kinase with trypsin generated a 40-kDa fragment, as determined by SDS-polyacrylamide gel electrophoresis. The trypsin treatment was necessary, but not sufficient, to fully activate the kinase. Subsequent incubation of the trypsin-treated S6 kinase with MgATP resulted in the rapid autophosphorylation of the 40-kDa fragment along with a coordinate increase in kinase activity. The autophosphorylation of the 40-kDa protein was positively correlated with MgATP incubation time and an increase in activity toward the S6-21 peptide, histone H4, and myelin basic protein. Taken together, these data support the hypothesis that this previously uncharacterized S6 kinase belongs to a unique family of protein kinases which utilize autophosphorylation as part of their in vivo activation mechanism.	N TEXAS STATE UNIV,DEPT BIOL SCI,DIV BIOCHEM,BOX 13048,DENTON,TX 76203	University of North Texas System; University of North Texas Denton					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032350] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 32350] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLENIS J, 1985, P NATL ACAD SCI USA, V82, P7621, DOI 10.1073/pnas.82.22.7621; BRANDON SD, 1991, J BIOL CHEM, V266, P380; BROSTROM CO, 1971, P NATL ACAD SCI USA, V68, P2444, DOI 10.1073/pnas.68.10.2444; CHAN YL, 1988, J BIOL CHEM, V263, P2891; DELAHOUSSAYE BA, 1983, J BIOL CHEM, V258, P4272; DENNIS PB, 1990, BIOCHEM BIOPH RES CO, V173, P673, DOI 10.1016/S0006-291X(05)80088-9; DONAHUE MJ, 1984, J BIOL CHEM, V259, P435; ECKOLS TK, 1983, EUR J BIOCHEM, V134, P249, DOI 10.1111/j.1432-1033.1983.tb07558.x; EDELMAN AM, 1985, J BIOL CHEM, V260, P1275; ERIKSON E, 1985, P NATL ACAD SCI USA, V82, P742, DOI 10.1073/pnas.82.3.742; ERIKSON E, 1986, J BIOL CHEM, V261, P350; ERIKSON RL, 1991, J BIOL CHEM, V266, P6007; FRIEDMAN DL, 1963, BIOCHEMISTRY-US, V2, P669, DOI 10.1021/bi00904a009; GILL GN, 1977, J BIOL CHEM, V252, P6443; GLASS DB, 1978, ANAL BIOCHEM, V87, P566, DOI 10.1016/0003-2697(78)90707-8; GREGORY JS, 1989, J BIOL CHEM, V264, P18397; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; HAGEDORN CH, 1990, FEBS LETT, V264, P59, DOI 10.1016/0014-5793(90)80764-A; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HASELBACHER GK, 1979, FEBS LETT, V100, P185, DOI 10.1016/0014-5793(79)81160-6; HASSELL TC, 1988, BIOCHIM BIOPHYS ACTA, V957, P1, DOI 10.1016/0167-4838(88)90151-3; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HUANG KP, 1986, BIOCHEM BIOPH RES CO, V139, P320, DOI 10.1016/S0006-291X(86)80116-4; JENO P, 1989, J BIOL CHEM, V264, P1293; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KOZMA SC, 1990, P NATL ACAD SCI USA, V87, P7365, DOI 10.1073/pnas.87.19.7365; KREIG J, 1988, J BIOL CHEM, V263, P11473; KYRIAKIS JM, 1990, J BIOL CHEM, V265, P17355; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAVOINNE A, 1991, EUR J BIOCHEM, V199, P723, DOI 10.1111/j.1432-1033.1991.tb16176.x; LUBBEN TH, 1983, J BIOL CHEM, V258, P3992; MAGNINO PE, 1983, BIOCHEM BIOPH RES CO, V116, P675, DOI 10.1016/0006-291X(83)90578-8; MATSUDA Y, 1987, J BIOL CHEM, V262, P2832; NISHIMURA J, 1983, FEBS LETT, V156, P130, DOI 10.1016/0014-5793(83)80263-4; NOVAKHOFER I, 1984, J BIOL CHEM, V259, P5995; PELECH SL, 1986, P NATL ACAD SCI USA, V83, P5968, DOI 10.1073/pnas.83.16.5968; POTTER RL, 1979, J BIOL CHEM, V254, P2413; PRICE DJ, 1989, J BIOL CHEM, V264, P13825; PRICE DJ, 1990, P NATL ACAD SCI USA, V87, P7944, DOI 10.1073/pnas.87.20.7944; RANGELALDAO R, 1976, J BIOL CHEM, V251, P3375; RAY LB, 1987, BIOCHEMISTRY-US, V84, P12502; REDDY SAG, 1990, J BIOL CHEM, V265, P7748; REIMANN EM, 1971, J BIOL CHEM, V246, P1986; ROSEN OM, 1983, P NATL ACAD SCI-BIOL, V80, P3237, DOI 10.1073/pnas.80.11.3237; SMITH CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2641, DOI 10.1073/pnas.77.5.2641; SODERLING TR, 1990, J BIOL CHEM, V265, P1823; TABARINI D, 1987, BIOCHEM BIOPH RES CO, V144, P891, DOI 10.1016/S0006-291X(87)80048-7; THOMAS G, 1982, CELL, V30, P235, DOI 10.1016/0092-8674(82)90029-0; TREVILLYAN JM, 1985, J BIOL CHEM, V260, P3041; USHIRO H, 1980, J BIOL CHEM, V255, P8363; WALSH DA, 1971, J BIOL CHEM, V246, P1968	52	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19833	19841						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366121				2022-12-27	WOS:A1993LW81900101
J	KASHIWAGI, K; MIYAMOTO, S; NUKUI, E; KOBAYASHI, H; IGARASHI, K				KASHIWAGI, K; MIYAMOTO, S; NUKUI, E; KOBAYASHI, H; IGARASHI, K			FUNCTIONS OF POTA AND POTD PROTEINS IN SPERMIDINE-PREFERENTIAL UPTAKE SYSTEM IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPLASMIC TRANSPORT-SYSTEMS; PROTON MOTIVE FORCE; ORNITHINE DECARBOXYLASE; MEMBRANE-COMPONENTS; BINDING-PROTEIN; ATP; PUTRESCINE; GENE; DNA; IDENTIFICATION	Functions of potA and -D proteins in the spermidine-preferential uptake system, which consists of potA, -B, -C, and -D proteins, were studied. Spermidine uptake activity was lost when the gene for potA or potD protein was disrupted, and transformation of the cells with potA or potD gene recovered the uptake activity. PotD protein was found to bind spermidine with a 3.2 muM dissociation constant. Spermidine uptake by membrane vesicles prepared from Escherichia coli DR112 containing the genes for potA, -B, and -C proteins was strongly dependent on the addition of potD protein, and its optimal concentration was 5 muM when 10 muM spermidine was used as substrate. The ATP dependence of spermidine uptake was examined with the atp mutant of E. coli. The uptake was completely dependent on ATP. When the membrane potential was extinguished by carbonyl cyanide m-chlorophenylhydrazone, the uptake activity was decreased by 60% even if ATP existed. This suggests that the membrane potential is also involved in the spermidine uptake. ATP was found to bind to potA protein. In the spermidine transport-deficient mutant E. coli NH1596, valine 135 of potA protein, which is located between two consensus amino acid sequences for nucleotide binding, was replaced by methionine. Although the amount of mutated potA protein expressed in E. coli cells was the same as that of normal potA protein and the mutated protein was membrane-associated, no significant spermidine uptake was observed. The results taken together indicate that potA and -D proteins are absolutely necessary for spermidine uptake in conjunction with the two channel forming proteins (potB and -C).	CHIBA UNIV,FAC PHARMACEUT SCI,1-33 YAYOI CHO,INAGE KU,CHIBA 263,JAPAN	Chiba University				Igarashi, Kazuei/0000-0003-3751-3187				AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; ANRAKU Y, 1968, J BIOL CHEM, V243, P3116; BROSIUS J, 1984, P NATL ACAD SCI-BIOL, V81, P6929, DOI 10.1073/pnas.81.22.6929; CARRASCO N, 1984, P NATL ACAD SCI-BIOL, V81, P4672, DOI 10.1073/pnas.81.15.4672; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CUNNINGHAMRUNDLES S, 1975, J BACTERIOL, V124, P791, DOI 10.1128/JB.124.2.791-799.1975; FURLONG CE, 1987, CELLULAR MOL BIOL, P768; FURUCHI T, 1991, J BIOL CHEM, V266, P20928; GILSON E, 1982, NUCLEIC ACIDS RES, V10, P7449, DOI 10.1093/nar/10.22.7449; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; HANADA K, 1988, J BIOL CHEM, V262, P14100; HIGGINS CF, 1982, NATURE, V298, P723, DOI 10.1038/298723a0; HOBSON AC, 1984, P NATL ACAD SCI-BIOL, V81, P7333, DOI 10.1073/pnas.81.23.7333; HOUNG HS, 1986, J BACTERIOL, V168, P1040, DOI 10.1128/jb.168.2.1040-1044.1986; IGARASHI K, 1982, ARCH BIOCHEM BIOPHYS, V219, P438, DOI 10.1016/0003-9861(82)90175-8; IGARASHI K, 1975, J BIOCHEM-TOKYO, V77, P383, DOI 10.1093/oxfordjournals.jbchem.a130736; JOSHI AK, 1989, J BIOL CHEM, V264, P2126; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; KASHIWAGI K, 1990, J BIOL CHEM, V265, P8387; KASHIWAGI K, 1991, J BIOL CHEM, V266, P20922; KASHIWAGI K, 1992, P NATL ACAD SCI USA, V89, P4529, DOI 10.1073/pnas.89.10.4529; KASHIWAGI K, 1986, J BACTERIOL, V165, P972, DOI 10.1128/jb.165.3.972-977.1986; KASHIWAGI K, 1988, J BACTERIOL, V170, P3131, DOI 10.1128/jb.170.7.3131-3135.1988; KIMMICH GA, 1975, ANAL BIOCHEM, V69, P187, DOI 10.1016/0003-2697(75)90580-1; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; LINDEROTH N, 1983, BIOCHEM BIOPH RES CO, V117, P616, DOI 10.1016/0006-291X(83)91245-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING LAB MANU, P250; NEILSEN PJ, 1982, J BIOL CHEM, V257, P12316; OHYAMA T, 1992, J BACTERIOL, V174, P7743, DOI 10.1128/JB.174.23.7743-7749.1992; PEGG AE, 1988, CANCER RES, V48, P759; PISTOCCHI R, 1993, J BIOL CHEM, V268, P146; PROSSNITZ E, 1989, J BIOL CHEM, V264, P5006; Rottenberg H, 1979, Methods Enzymol, V55, P547; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHULTZHAUSER G, 1992, FEMS MICROBIOL LETT, V95, P231; SHIOZUKA K, 1990, J BIOL CHEM, V265, P18843; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WINANS SC, 1985, J BACTERIOL, V161, P1219, DOI 10.1128/JB.161.3.1219-1221.1985; YAMAGUCHI K, 1985, MOL GEN GENET, V200, P362, DOI 10.1007/BF00425718; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	47	73	79	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19358	19363						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366082				2022-12-27	WOS:A1993LW81900034
J	PLEY, HW; LINDES, DS; DELUCAFLAHERTY, C; MCKAY, DB				PLEY, HW; LINDES, DS; DELUCAFLAHERTY, C; MCKAY, DB			CRYSTALS OF A HAMMERHEAD RIBOZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-CLEAVAGE REACTION; T7 RNA-POLYMERASE; OLIGORIBONUCLEOTIDE	Hammerhead ribozyme-inhibitor complexes consisting of an RNA ''enzyme'' strand and a DNA ''inhibitor'' strand have been crystallized in four different crystal forms. The crystal form that is most attractive for structure determination diffracts to approximately 3.2 angstrom resolution; it is trigonal, space group P3(1)21 or enantiomorph, a = 92.5 angstrom, c = 185.0 angstrom.	STANFORD UNIV, MED CTR,SCH MED,DEPT CELL BIOL, BECKMAN LABS STRUCT BIOL,SHERMAN FAIRCHILD BLDG, STANFORD, CA 94305 USA	Stanford University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030606] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-30606] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BROWN RS, 1972, EUR J BIOCHEM, V31, P130, DOI 10.1111/j.1432-1033.1972.tb02509.x; DAHM SC, 1990, BIOCHIMIE, V72, P819, DOI 10.1016/0300-9084(90)90191-I; DAVANLOO P, 1984, P NATL ACAD SCI-BIOL, V81, P2035, DOI 10.1073/pnas.81.7.2035; FORSTER AC, 1987, CELL, V50, P9, DOI 10.1016/0092-8674(87)90657-X; FORSTER AC, 1987, CELL, V49, P211, DOI 10.1016/0092-8674(87)90562-9; HEUS HA, 1990, NUCLEIC ACIDS RES, V18, P1103, DOI 10.1093/nar/18.5.1103; HEUS HA, 1991, J MOL BIOL, V217, P113, DOI 10.1016/0022-2836(91)90615-D; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KIM SH, 1973, J MOL BIOL, V75, P421, DOI 10.1016/0022-2836(73)90031-4; LADNER JE, 1972, J MOL BIOL, V72, P99, DOI 10.1016/0022-2836(72)90071-X; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; NIKONOWICZ EP, 1992, NATURE, V355, P184, DOI 10.1038/355184a0; RUFFNER DE, 1990, BIOCHEMISTRY-US, V29, P10695, DOI 10.1021/bi00499a018; SHELDON CC, 1989, NUCLEIC ACIDS RES, V17, P5679, DOI 10.1093/nar/17.14.5679; UHLENBECK OC, 1987, NATURE, V328, P596, DOI 10.1038/328596a0; YANG JH, 1990, BIOCHEMISTRY-US, V29, P11156, DOI 10.1021/bi00503a002	17	31	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19656	19658						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366108				2022-12-27	WOS:A1993LW81900078
J	STATEN, NR; BYATT, JC; KRIVI, GG				STATEN, NR; BYATT, JC; KRIVI, GG			LIGAND-SPECIFIC DIMERIZATION OF THE EXTRACELLULAR DOMAIN OF THE BOVINE GROWTH-HORMONE RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACENTAL-LACTOGEN; PROLACTIN RECEPTOR; MOLECULAR-CLONING; BIOLOGICAL-ACTIVITIES; TRANSGENIC MICE; MESSENGER-RNA; DAIRY-COW; EXPRESSION; BINDING; RAT	The bovine growth hormone (bGH) receptor and its extracellular domain (bGHBP) bind two protein hormones with high affinity; bGH and bovine placental lactogen (bPL). However, each of these hormones bind with a different stoichiometry. bGH binds to the bGHBP in a 1:2 ratio while bPL binds in a 1:1 ratio. Scatchard analysis of saturation binding yields similar apparent dissociation constants (K(d)) for bGH and bPL of 1.4 x 10(-11) M and 3.0 x 10(-11) M, respectively, for the membrane receptor and 6.8 x 10(-11) M and 4.2 x 10(-11) M, respectively, for bGHBP. In competition experiments using either liver membranes or bGHBP, bGH is 2-3-fold more effective than bPL in competing for I-125-bGH-binding sites. In similar experiments using I-125-bPL, bPL is 50-fold more effective than bGH in competing for binding sites. A rat monoclonal antibody raised against bGHBP competes effectively for I-125-bGH-binding sites, but not for I-125-bPL-binding sites. Since bPL cannot dimerize the bGHBP and yet it acts in part as a somatogen in vivo, homodimerization of the growth hormone receptor is apparently not essential for some biological responses signaled through this receptor.			STATEN, NR (corresponding author), MONSANTO CO,MONSANTO CORP RES,AA3C,700 CHESTERFIELD PKWY N,CHESTERFIELD,MO 63198, USA.							Bauman D. E., 1989, 7TH P INT C PROD DIS, P306; BYATT JC, 1991, J ENDOCRINOL, V130, P11, DOI 10.1677/joe.0.1300011; BYATT JC, 1990, ENDOCRINOLOGY, V127, P1041, DOI 10.1210/endo-127-3-1041; BYATT JC, 1992, J DAIRY SCI, V75, P1216, DOI 10.3168/jds.S0022-0302(92)77870-9; BYATT JC, 1992, J ENDOCRINOL, V132, P185, DOI 10.1677/joe.0.1320185; BYATT JC, 1993, IN PRESS J ENDOCRINO; CHEN WY, 1991, J BIOL CHEM, V266, P2252; CHEN WY, 1991, MOL ENDOCRINOL, V5, P1845, DOI 10.1210/mend-5-12-1845; CHEN WY, 1990, P NATL ACAD SCI USA, V87, P5061, DOI 10.1073/pnas.87.13.5061; COLOSI P, 1989, MOL ENDOCRINOL, V3, P1462, DOI 10.1210/mend-3-9-1462; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DUELLO TM, 1986, ENDOCRINOLOGY, V119, P1351, DOI 10.1210/endo-119-3-1351; DUSANTERFOURT I, 1984, ENDOCRINOLOGY, V114, P1021, DOI 10.1210/endo-114-3-1021; ELBERG G, 1990, J BIOL CHEM, V265, P14770; EPPARD PJ, 1992, J ENDOCRINOL, V132, P47, DOI 10.1677/joe.0.1320047; FIDDES RJ, 1992, MOL CELL ENDOCRINOL, V86, P37, DOI 10.1016/0303-7207(92)90173-4; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; GALOSY SS, 1991, MOL CELL ENDOCRINOL, V78, P229, DOI 10.1016/0303-7207(91)90127-E; GERTLER A, 1992, J BIOL CHEM, V267, P12655; HARO LS, 1984, MOL CELL ENDOCRINOL, V38, P109, DOI 10.1016/0303-7207(84)90109-6; HAUSER SD, 1990, MOL CELL ENDOCRINOL, V72, P187, DOI 10.1016/0303-7207(90)90143-V; HEMPEL JD, 1981, J BIOL CHEM, V256, P889; KAHN CR, 1978, P NATL ACAD SCI USA, V75, P4209, DOI 10.1073/pnas.75.9.4209; MARTIAL JA, 1979, SCIENCE, V205, P602, DOI 10.1126/science.377496; MILLER WL, 1980, J BIOL CHEM, V255, P7521; MOORE S, 1963, METHOD ENZYMOL, V6, P819, DOI 10.1016/0076-6879(63)06257-1; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; OBUKOWICZ MG, 1992, APPL ENVIRON MICROB, V58, P1511, DOI 10.1128/AEM.58.5.1511-1523.1992; OKADA S, 1992, ENDOCRINOLOGY, V130, P2284, DOI 10.1210/en.130.4.2284; SCHECHTER Y, 1979, NATURE, V278, P835, DOI 10.1038/278835a0; SCHULER LA, 1988, BIOCHEMISTRY-US, V27, P8443, DOI 10.1021/bi00422a022; SCOTT P, 1992, MOL CELL ENDOCRINOL, V89, P47, DOI 10.1016/0303-7207(92)90210-W; SHIMOMURA K, 1988, MOL ENDOCRINOL, V2, P845, DOI 10.1210/mend-2-9-845; SPENCER SA, 1988, J BIOL CHEM, V263, P7862	35	52	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18467	18473						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360148				2022-12-27	WOS:A1993LV65900016
J	KOH, YC; BUCZKO, E; DUFAU, ML				KOH, YC; BUCZKO, E; DUFAU, ML			REQUIREMENT OF PHENYLALANINE-343 FOR THE PREFERENTIAL DELTA-4-LYASE VERSUS DELTA-5-LYASE ACTIVITY OF RAT CYP17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME P-45017-ALPHA; LYASE ACTIVITIES; TESTIS; CDNA; EXPRESSION; SEQUENCE; P45017-ALPHA; HYDROXYLASE; MUTAGENESIS; CELLS	Site-directed mutagenesis of a domain (amino acids 343-348) within the conserved region of rat CYP17 was performed to investigate species-specific differences between rat and human/bovine DELTA4-versus DELTA5-lyase activity. This domain displays substantial deviations between the rat and human/bovine/pig sequences and includes Arg346, which is known to he essential for DELTA4-lyase (Kitamura, M., Buczko, E., and Dufau, M. L. (1991) Mol. Endocrinol. 5, 1373-1380) and DELTA5-lyase activities. Analysis of the DELTA4-lyase activity of mutant rat CYP17 cDNA expressed in nonsteroidogenic COS-1 cells revealed that substitution of Phe at position 343 in the rat with Ile of the human/bovine sequence resulted in a reduction in DELTA4-lyase activity to levels in the range of the DELTA5-supported reaction. This Phe343 --> Ile mutant Cyp17 did not exhibit changes either in DELTA5-supported lyase activity or in DELTA4- and DELTA5-hydroxylase activities. Substitution of Asn344, Ser347, and His348 in rat CYP17 with the corresponding bovine amino acids Ser, Asn, and Arg did not enhance this effect. Thus, the reduced activity of the bovine CYP17 DELTA4-lyase reaction can be mimicked in part in the rat polypeptide by the substitution of Phe343 with the bovine counterpart, Ile. Unlike the bovine CYP17-catalyzed reaction, the rat Phe343 --> Ile mutant exhibited a low level lyase activity (k(cat)) that did not discriminate between DELTA4- and DELTA5-substrates. These results suggest that the presence of Phe343 enhances the DELTA4-supported lyase activity possibly through stabilization of a DELTA4-specific interaction.	NICHHD,ENDOCRINOL & REPROD RES BRANCH,MOLEC ENDOCRINOL SECT,BLDG 49,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)								CHUNG BC, 1987, P NATL ACAD SCI USA, V84, P407, DOI 10.1073/pnas.84.2.407; Dallner G, 1974, Methods Enzymol, V31, P191; FERSHT A, 1985, ENZYME STRUCTURE MEC, P109; FEVOLD HR, 1989, MOL ENDOCRINOL, V3, P968, DOI 10.1210/mend-3-6-968; HALL PF, 1985, VITAM HORM, V42, P315; JANIG GR, 1983, FEBS LETT, V159, P58, DOI 10.1016/0014-5793(83)80416-5; JOHNSON DC, 1992, BIOL REPROD, V16, P30; JONES DH, 1990, BIOTECHNIQUES, V8, P178; KITAMURA M, 1991, MOL ENDOCRINOL, V5, P1373, DOI 10.1210/mend-5-10-1373; KLYNE W, 1957, CHEM STEROIDS, P27; MCALLISTER JM, 1989, ENDOCRINOLOGY, V125, P1959, DOI 10.1210/endo-125-4-1959; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; NAMIKI M, 1988, BIOCHEM BIOPH RES CO, V157, P705, DOI 10.1016/S0006-291X(88)80307-3; NELSON DR, 1988, J BIOL CHEM, V263, P6038; NEMETHY G, 1962, J PHYS CHEM-US, V66, P1773, DOI 10.1021/j100816a004; NISHIHARA M, 1988, BIOCHEM BIOPH RES CO, V154, P151, DOI 10.1016/0006-291X(88)90663-8; PICADOLEONARD J, 1988, MOL ENDOCRINOL, V2, P1145, DOI 10.1210/mend-2-11-1145; RUOKONEN A, 1974, J STEROID BIOCHEM, V5, P33, DOI 10.1016/0022-4731(74)90025-9; SCHWARZE W, 1988, BIOCHEM BIOPH RES CO, V150, P996, DOI 10.1016/0006-291X(88)90727-9; ZUBER MX, 1986, SCIENCE, V234, P1258, DOI 10.1126/science.3535074; ZUBER MX, 1986, J BIOL CHEM, V261, P2475	21	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18267	18271						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349703				2022-12-27	WOS:A1993LT74300091
J	MCDONALD, LJ; MOSS, J				MCDONALD, LJ; MOSS, J			NITRIC OXIDE-INDEPENDENT, THIOL-ASSOCIATED ADP-RIBOSYLATION INACTIVATES ALDEHYDE DEHYDROGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; HUMAN ERYTHROCYTES; SACCHAROMYCES-CEREVISIAE; SKELETAL-MUSCLE; RAT-LIVER; RIBOSE; PROTEINS; MONO(ADP-RIBOSYLATION); INVIVO; FORMS	Nitric oxide inhibits the activity of glyceraldehyde-3-phosphate dehydrogenase and stimulates NAD-dependent automodification of a cysteine (Dimmeler, S., Lottspeich, F., and Brune, B. (1992) J. Biol. Chem. 267, 16771-16774). Another NAD-utilizing dehydrogenase that has a catalytic cysteine, aldehyde dehydrogenase (ALDH), was also inhibited by nitric oxide. Unlike glyceraldehyde-3-phosphate dehydrogenase, ALDH was modified in a nitric oxide-independent process by ADP-ribose, but not by NAD. Modification, which proceeded to >2 mol ADP-ribose.mol ALDH-1, was associated with an exponential decrease in enzyme activity to less than 10% of control. Two types of evidence suggested modification of the ALDH-active site: 1) ADP-ribose inhibited ALDH competitively (K(i) = 0.46 mM) with respect to NAD (K(m) = 0.11 mm) in brief incubations and 2) the presence of substrates protected ALDH from both modification and inhibition by ADP-ribose. The ALDH-ADP-ribose bond was sensitive to base and mercuric ion and stable to acid and neutral hydroxylamine, properties shared with the ADP-ribosylcysteine linkage synthesized enzymatically by pertussis toxin. These data demonstrate a novel means of inactivation of an NAD-dependent enzyme, namely the affinity-based modification of the enzyme NAD site by ADP-ribose, and suggest that nonenzymatic ADP-ribosylation may be responsible for modification of cysteine residues.			MCDONALD, LJ (corresponding author), NHLBI,CELLULAR METAB LAB,BLDG 10-5N-307,BETHESDA,MD 20892, USA.							BOSTIAN KA, 1978, BIOCHEM J, V173, P773, DOI 10.1042/bj1730773; DEVIJLDER JJ, 1968, BIOCHIM BIOPHYS ACTA, V167, P23, DOI 10.1016/0005-2744(68)90274-X; DIMMELER S, 1992, J BIOL CHEM, V267, P16771; DIMMELER S, 1992, EUR J BIOCHEM, V210, P305, DOI 10.1111/j.1432-1033.1992.tb17422.x; DOHERTY MD, 1962, BIOCHIM BIOPHYS ACTA, V65, P364, DOI 10.1016/0006-3002(62)91061-2; FARRES J, 1989, EUR J BIOCHEM, V180, P67, DOI 10.1111/j.1432-1033.1989.tb14616.x; FREI B, 1988, BIOCHEMISTRY-US, V27, P529, DOI 10.1021/bi00402a004; GALIONE A, 1992, TRENDS PHARMACOL SCI, V13, P304, DOI 10.1016/0165-6147(92)90096-O; GOODMAN I, 1959, SCIENCE, V130, P450, DOI 10.1126/science.130.3373.450; GUIDA L, 1992, BIOCHEM BIOPH RES CO, V188, P402, DOI 10.1016/0006-291X(92)92399-I; HILZ H, 1984, P NATL ACAD SCI-BIOL, V81, P3929, DOI 10.1073/pnas.81.13.3929; HSIA JA, 1985, J BIOL CHEM, V260, P6187; JACOBSON MK, 1990, J BIOL CHEM, V265, P10825; KOTS AY, 1992, FEBS LETT, V300, P9, DOI 10.1016/0014-5793(92)80153-8; KUN E, 1976, P NATL ACAD SCI USA, V73, P3131, DOI 10.1073/pnas.73.9.3131; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; LOWENSTEIN CJ, 1992, CELL, V70, P705, DOI 10.1016/0092-8674(92)90301-R; MARUTA H, 1991, BIOCHEMISTRY-US, V30, P5907, DOI 10.1021/bi00238a014; MCDONALD LJ, 1993, P NATL ACAD SCI USA, V90, P6238, DOI 10.1073/pnas.90.13.6238; MCDONALD LJ, 1992, BIOCHEMISTRY-US, V31, P11881, DOI 10.1021/bi00162a029; MEYER T, 1988, BIOL CHEM H-S, V369, P579, DOI 10.1515/bchm3.1988.369.2.579; MIRO A, 1989, FEBS LETT, V244, P123, DOI 10.1016/0014-5793(89)81176-7; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; MOSS J, 1992, J BIOL CHEM, V267, P10481; PAYNE DM, 1985, BIOCHEMISTRY-US, V24, P7540, DOI 10.1021/bi00347a006; PIETRUSZKO R, 1990, ENZYMOLOGY MOL BIOL, V3, P19; Price S.R., 1987, PYRIDINE NUCLEOTIDE, V2B, P513; RODRIQUEZ P, 1968, BIOCHIM BIOPHYS ACTA, V167, P201; SAIGAL D, 1991, J BACTERIOL, V173, P3199, DOI 10.1128/JB.173.10.3199-3208.1991; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; TANAKA Y, 1989, BIOCHEM BIOPH RES CO, V163, P1063, DOI 10.1016/0006-291X(89)92329-2; TANUMA S, 1990, FEBS LETT, V261, P381, DOI 10.1016/0014-5793(90)80597-C; TANUMA S, 1988, J BIOL CHEM, V263, P5485; VEDIA LM, 1992, J BIOL CHEM, V267, P24929; WEINER H, 1990, ENZYMOLOGY MOL BIOL, V3, P13; ZHANG J, 1992, P NATL ACAD SCI USA, V89, P9382, DOI 10.1073/pnas.89.20.9382; ZOLKIEWSKA A, 1992, P NATL ACAD SCI USA, V89, P11352, DOI 10.1073/pnas.89.23.11352; [No title captured]	38	41	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17878	17882						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349672				2022-12-27	WOS:A1993LT74300038
J	LUDEMANN, R; LEREA, KM; ETLINGER, JD				LUDEMANN, R; LEREA, KM; ETLINGER, JD			COPURIFICATION OF CASEIN KINASE-II WITH 20-S PROTEASOMES AND PHOSPHORYLATION OF A 30-KDA PROTEASOME SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTICATALYTIC PROTEINASE COMPLEX; MOLECULAR-WEIGHT PROTEINASE; PROTEOLYTIC COMPLEX; HUMAN-ERYTHROCYTES; 26S COMPLEX; UBIQUITIN; ATP; PURIFICATION; COMPONENT; INHIBITOR	The 20 S proteasome is a multicatalytic protease that has been implicated in several processes including ATP/ubiquitin-dependent proteolysis. However, the ATP requirement(s) related to proteasome function is undefined. We demonstrate that a protein kinase activity copurifies through multiple steps utilized to isolate latent 20 S proteasomes from human erythrocytes. The kinase phosphorylates serine residues within a single 30-kDa proteasome subunit. The activity is not sensitive to cyclic AMP or protein kinase inhibitor, indicating that it is not a cyclic AMP-dependent kinase. It is sensitive to nanomolar levels of heparin and is able to utilize both ATP and GTP as phosphodonors, similar to casein kinase II activity. Moreover, a polyclonal antibody specific for casein kinase II recognizes the alpha' subunit of casein kinase II in the 20 S preparation and specifically immunoprecipitates the proteasome-phosphorylating activity. These characteristics suggest that the proteasome kinase is similar or identical to casein kinase II. It is suggested that phosphorylation of the 30-kDa proteasome subunit by casein kinase II may be involved in regulating the activity and/or assembly of proteasome complexes.	NEW YORK MED COLL,DEPT CELL BIOL & ANAT,VALHALLA,NY 10595; SUNY HLTH SCI CTR,DEPT ANAT & CELL BIOL,BROOKLYN,NY 11203	New York Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center			Lerea, Ken/GWU-8597-2022					ARMON T, 1990, J BIOL CHEM, V265, P20723; CORBETT AH, 1992, J BIOL CHEM, V267, P20513; DRISCOLL J, 1992, P NATL ACAD SCI USA, V89, P4986, DOI 10.1073/pnas.89.11.4986; DRISCOLL J, 1990, J BIOL CHEM, V265, P4789; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; FILHOL O, 1992, J BIOL CHEM, V267, P20577; GANOTH D, 1988, J BIOL CHEM, V263, P12412; GLYNNE R, 1991, NATURE, V353, P357, DOI 10.1038/353357a0; HAASS C, 1989, EXP CELL RES, V180, P243, DOI 10.1016/0014-4827(89)90228-0; HATHAWAY GM, 1979, J BIOL CHEM, V254, P762; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; KANAYAMA HO, 1992, EUR J BIOCHEM, V206, P567, DOI 10.1111/j.1432-1033.1992.tb16961.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE LW, 1990, BIOCHIM BIOPHYS ACTA, V1037, P178, DOI 10.1016/0167-4838(90)90165-C; LEREA KM, 1992, BIOCHEMISTRY-US, V31, P6553, DOI 10.1021/bi00143a027; LI XCS, 1992, BIOCHEMISTRY-US, V31, P11963, DOI 10.1021/bi00163a001; MCGUIRE MJ, 1989, BIOCHIM BIOPHYS ACTA, V995, P181, DOI 10.1016/0167-4838(89)90078-2; MCGUIRE MJ, 1986, BIOCHIM BIOPHYS ACTA, V873, P279, DOI 10.1016/0167-4838(86)90055-5; MEGGIO F, 1982, FEBS LETT, V141, P257, DOI 10.1016/0014-5793(82)80061-6; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; MURAKAMI K, 1986, P NATL ACAD SCI USA, V83, P7588, DOI 10.1073/pnas.83.20.7588; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; ORLOWSKI M, 1990, BIOCHEMISTRY-US, V31, P6553; PEREIRA ME, 1992, J BIOL CHEM, V267, P7949; PEREIRA ME, 1990, ARCH BIOCHEM BIOPHYS, V283, P68, DOI 10.1016/0003-9861(90)90613-4; PICTON C, 1982, FEBS LETT, V150, P191, DOI 10.1016/0014-5793(82)81332-X; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; RIVETT AJ, 1993, BIOCHEM J, V291, P1; TAMURA T, 1991, BIOCHIM BIOPHYS ACTA, V1089, P95, DOI 10.1016/0167-4781(91)90090-9; TANAKA K, 1992, NEW BIOL, V4, P173; TUAZON PT, 1991, ADV SEC MESS PHOSPH, V23, P124; WEITMAN D, 1992, J BIOL CHEM, V267, P6977; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	36	83	85	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17413	17417						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349624				2022-12-27	WOS:A1993LQ98800078
J	GRAMINSKI, GF; JAYAWICKREME, CK; POTENZA, MN; LERNER, MR				GRAMINSKI, GF; JAYAWICKREME, CK; POTENZA, MN; LERNER, MR			PIGMENT DISPERSION IN FROG MELANOPHORES CAN BE INDUCED BY A PHORBOL ESTER OR STIMULATION OF A RECOMBINANT RECEPTOR THAT ACTIVATES PHOSPHOLIPASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS 3T3 CELLS; PROTEIN-KINASE-C; GASTRIN-RELEASING PEPTIDE; LUNG-CARCINOMA CELLS; BOMBESIN RECEPTOR; SIGNAL TRANSDUCTION; PITUITARY-CELLS; EARLY EVENTS; POTENT; ANTAGONISTS	Pigment dispersion in frog melanophores is classically mediated by receptors that activate protein kinase A via an elevation of intracellular cyclic AMP. Here, 12-O-tetradecanoylphorbol-13-acetate (TPA), an activator of protein kinase C, is found to induce pigment dispersion. To demonstrate that an increase in cAMP is not required for the melanosome movement, a murine bombesin receptor was expressed in the melanophores. When these cells were treated with bombesin, they accumulated intracellular inositol phosphates but not cAMP and dispersed their pigment. Four agonists, one partial agonist, and two antagonists for the bombesin receptor were compared for their ability to induce or block bombesin-induced pigment dispersion. In all cases, the degree of pigment dispersion followed simple equilibrium reactions. The resulting dose-response curves allowed for the determination of the effective concentration for half-maximal pigment dispersion (EC50) or half-maximal inhibition of bombesin-stimulated pigment dispersion (IC50) for the peptides. As the pigment dispersion assay can rapidly evaluate chemicals for their effects on receptors that activate phospholipase C via a functional assay, it has potential utility for investigations of ligand-receptor interactions and for massive drug screening.	YALE UNIV, SCH MED, DEPT INTERNAL MED, NEW HAVEN, CT 06510 USA; YALE UNIV, SCH MED, DEPT CELL BIOL, NEW HAVEN, CT 06510 USA; YALE UNIV, SCH MED, DEPT PHARMACOL, NEW HAVEN, CT 06510 USA; YALE UNIV, SCH MED, BOYER CTR MOLEC MED, HOWARD HUGHES MED INST, NEW HAVEN, CT 06510 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University								ABE K, 1969, ENDOCRINOLOGY, V84, P362, DOI 10.1210/endo-84-2-362; ABE K, 1969, ENDOCRINOLOGY, V85, P674, DOI 10.1210/endo-85-4-674; ABRAO MS, 1991, PIGM CELL RES, V4, P66, DOI 10.1111/j.1600-0749.1991.tb00317.x; BALLA T, 1986, P NATL ACAD SCI USA, V83, P9323, DOI 10.1073/pnas.83.24.9323; BATTEY J, 1991, TRENDS NEUROSCI, V14, P524, DOI 10.1016/0166-2236(91)90005-F; BATTEY JF, 1991, P NATL ACAD SCI USA, V88, P395, DOI 10.1073/pnas.88.2.395; CORJAY MH, 1991, J BIOL CHEM, V266, P18771; COY DH, 1992, PEPTIDES, V13, P775, DOI 10.1016/0196-9781(92)90186-7; COY DH, 1991, J BIOL CHEM, V266, P16441; COY DH, 1988, J BIOL CHEM, V263, P5056; DANIOLOS A, 1990, PIGM CELL RES, V3, P38, DOI 10.1111/j.1600-0749.1990.tb00260.x; DORFLINGER LJ, 1983, ENDOCRINOLOGY, V113, P1541, DOI 10.1210/endo-113-5-1541; ERUSALIMSKY JD, 1988, J BIOL CHEM, V263, P19188; FISCHER JB, 1988, J BIOL CHEM, V263, P2808; FUJII R, 1991, J EXP ZOOL, V259, P9, DOI 10.1002/jez.1402590103; HEIKKILA R, 1987, J BIOL CHEM, V262, P16456; HERSHEY AD, 1991, ANN NY ACAD SCI, V632, P63, DOI 10.1111/j.1749-6632.1991.tb33095.x; HESLOP JP, 1986, CELL, V47, P703, DOI 10.1016/0092-8674(86)90513-1; ISACKE CM, 1986, EMBO J, V5, P2889, DOI 10.1002/j.1460-2075.1986.tb04584.x; JENSEN RT, 1991, TRENDS PHARMACOL SCI, V12, P13, DOI 10.1016/0165-6147(91)90483-9; LERNER MR, 1988, P NATL ACAD SCI USA, V85, P261, DOI 10.1073/pnas.85.1.261; LOPEZRIVAS A, 1987, P NATL ACAD SCI USA, V84, P5768, DOI 10.1073/pnas.84.16.5768; LYNCH TJ, 1986, J BIOL CHEM, V261, P4212; MENNITI FS, 1990, J BIOL CHEM, V265, P11167; MORELLO L, 1991, BIOCHIM BIOPHYS ACTA, V1092, P397, DOI 10.1016/S0167-4889(97)90018-5; POTENZA MN, 1992, PIGM CELL RES, V5, P372, DOI 10.1111/j.1600-0749.1992.tb00565.x; POTENZA MN, 1992, ANAL BIOCHEM, V206, P315, DOI 10.1016/0003-2697(92)90372-E; POTENZA MN, 1991, PIGM CELL RES, V4, P186, DOI 10.1111/j.1600-0749.1991.tb00437.x; POTTER H, 1988, ANAL BIOCHEM, V174, P361, DOI 10.1016/0003-2697(88)90035-8; POTTER H, 1984, P NATL ACAD SCI-BIOL, V81, P7161, DOI 10.1073/pnas.81.22.7161; RODRIGUEZPENA A, 1986, BIOCHEM BIOPH RES CO, V140, P379, DOI 10.1016/0006-291X(86)91101-0; ROZDZIAL MM, 1986, CELL, V47, P1061, DOI 10.1016/0092-8674(86)90821-4; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P2936, DOI 10.1073/pnas.80.10.2936; ROZENGURT E, 1990, PHILOS T ROY SOC B, V327, P209, DOI 10.1098/rstb.1990.0055; ROZENGURT E, 1990, J CELL SCI, P43; Sambrook J, 1989, MOL CLONING LABORATO; SAMMAK PJ, 1992, J CELL BIOL, V117, P57, DOI 10.1083/jcb.117.1.57; SELDENRIJK R, 1979, CELL TISSUE RES, V198, P397, DOI 10.1007/BF00234185; SHARONI Y, 1990, CANCER RES, V50, P5257; SINNETTSMITH J, 1990, BIOCHEM J, V265, P485, DOI 10.1042/bj2650485; SPAETE RR, 1985, J VIROL, V56, P135, DOI 10.1128/JVI.56.1.135-143.1985; SPINDEL ER, 1990, MOL ENDOCRINOL, V4, P1956, DOI 10.1210/mend-4-12-1956; STRAUB RE, 1986, J BIOL CHEM, V261, P2712; STRAUB RE, 1990, P NATL ACAD SCI USA, V87, P9514, DOI 10.1073/pnas.87.24.9514; SULPICE JC, 1989, ANAL BIOCHEM, V179, P90, DOI 10.1016/0003-2697(89)90206-6; TAKUWA N, 1987, J BIOL CHEM, V262, P182; VONSCHRENCK T, 1990, AM J PHYSIOL, V259, pG468, DOI 10.1152/ajpgi.1990.259.3.G468; VONSCHRENCK T, 1989, AM J PHYSIOL, V256, pG747, DOI 10.1152/ajpgi.1989.256.4.G747; WADA E, 1991, NEURON, V6, P421, DOI 10.1016/0896-6273(91)90250-4; WANG LH, 1990, BIOCHEMISTRY-US, V29, P616, DOI 10.1021/bi00455a004; WANG LH, 1990, J BIOL CHEM, V265, P15695; WESTENDORF JM, 1983, J BIOL CHEM, V258, P7527; YOKOTA Y, 1989, J BIOL CHEM, V264, P17649; ZACHARY I, 1986, J CELL BIOL, V102, P2211, DOI 10.1083/jcb.102.6.2211	54	69	73	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1993	268	8					5957	5964						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR822	8383680				2022-12-27	WOS:A1993KR82200089
J	KALTHOFF, H; ROEDER, C; BROCKHAUS, M; THIELE, HG; SCHMIEGEL, W				KALTHOFF, H; ROEDER, C; BROCKHAUS, M; THIELE, HG; SCHMIEGEL, W			TUMOR-NECROSIS-FACTOR (TNF) UP-REGULATES THE EXPRESSION OF P75 BUT NOT P55 TNF RECEPTORS, AND BOTH RECEPTORS MEDIATE, INDEPENDENTLY OF EACH OTHER, UP-REGULATION OF TRANSFORMING GROWTH FACTOR-ALPHA AND EPIDERMAL GROWTH-FACTOR RECEPTOR MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-C; MONOCLONAL-ANTIBODIES; MOLECULAR-CLONING; CELLS; ACTIVATION; BINDING; TRANSCRIPTION; PURIFICATION; LYMPHOTOXIN; MODULATION	The expression and cytokine-mediated regulation of the two different receptors for tumor necrosis factor, TNF-R-75 and TNF-R-55, was investigated in human malignant epithelial cell lines. Here we show that cells treated with TNF-alpha up-regulate the TNF-R-75 mRNA and protein levels. No changes were seen regarding the level of TNF-R-55 transcripts. Phospholipase and protein kinase C inhibitors abrogated the signal transduction pathway of TNF-mediated TNF-R-75 mRNA up-regulation which proceeded in the absence of transcriptional activation. This process was also elicited by an agonistic antibody binding specifically to TNF-R-55. Ligand binding assays using specific inhibitory antibodies showed a marked shift in active binding sites from p55 to p75 without significant changes in the total binding for TNF-alpha after up-regulation of p75 TNF-R. This ligand-induced regulation of one of the corresponding receptors has so far only been detected in malignant epithelial cells and not in hematopoietic cell lines. In our search for a specific function we were able to show that p75 is the specific receptor for TNF-mediated up-regulation of transforming growth factor alpha mRNA, whereas p55 is the signal transducer for TNF-induced up-regulation of epidermal growth factor receptor mRNA. This is the first demonstration of an exclusive function of TNF-R-75 in cells of epithelial origin.	F HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES NEW TECHNOL,CH-4002 BASEL,SWITZERLAND	Roche Holding	KALTHOFF, H (corresponding author), UNIV HOSP HAMBURG,DEPT IMMUNOL,W-2000 HAMBURG,GERMANY.		Kalthoff, Holger/B-1618-2010					AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; AUSUBEL FM, 1988, CURRENT PROTOCOLS MO, P4101; BEUTLER B, 1987, NEW ENGL J MED, V316, P379; BROCKHAUS M, 1990, P NATL ACAD SCI USA, V87, P3127, DOI 10.1073/pnas.87.8.3127; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; DEMBIC Z, 1990, Cytokine, V2, P231, DOI 10.1016/1043-4666(90)90022-L; ECK MJ, 1989, J BIOL CHEM, V264, P17595; ERIKSTEIN BK, 1991, EUR J IMMUNOL, V21, P1033, DOI 10.1002/eji.1830210426; ESPEVIK T, 1990, J EXP MED, V171, P415, DOI 10.1084/jem.171.2.415; FIERS W, 1991, FEBS LETT, V285, P199, DOI 10.1016/0014-5793(91)80803-B; FREIMUTH WW, 1989, J IMMUNOL, V43, P3064; GATANAGA T, 1990, P NATL ACAD SCI USA, V87, P8781, DOI 10.1073/pnas.87.22.8781; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; HATEKEYAMA M, 1989, SCIENCE, V244, P551; HELLER RA, 1990, P NATL ACAD SCI USA, V87, P6151, DOI 10.1073/pnas.87.16.6151; HOHMANN HP, 1990, J BIOL CHEM, V265, P22409; HOHMANN HP, 1990, J BIOL CHEM, V265, P15183; HOHMANN HP, 1989, J BIOL CHEM, V264, P14927; ISHIKURA H, 1989, BLOOD, V73, P419; KALTHOFF H, 1991, ONCOGENE, V6, P1015; KALTHOFF H, 1993, IN PRESS INT S CLIN; KOHNO T, 1990, P NATL ACAD SCI USA, V87, P8331, DOI 10.1073/pnas.87.21.8331; KRONKE M, 1991, TUMOR NECROSIS FACTO, V3, P171; LINDVALL L, 1990, BIOCHEM BIOPH RES CO, V172, P557, DOI 10.1016/0006-291X(90)90709-V; LOETSCHER H, 1990, J BIOL CHEM, V265, P20131; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; MURAKAMI K, 1985, FEBS LETT, V192, P189, DOI 10.1016/0014-5793(85)80105-8; PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0; PORTEU F, 1991, J BIOL CHEM, V266, P18846; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCHMIEGEL W, 1991, GASTROENTEROLOGY, V100, P666; SCHMIEGEL W, 1990, PANCREAS, V5, P729; SCHMIEGEL WH, 1988, PANCREAS, V3, P180, DOI 10.1097/00006676-198804000-00012; SCHUETZE S, 1991, Immunobiology, V183, P264; SCHUTZE S, 1990, J IMMUNOL, V144, P2604; SCHUTZE S, 1991, J EXP MED, V174, P975, DOI 10.1084/jem.174.5.975; SHMIEGEL W, 1990, DIGESTION, V46, P531; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; VILCEK J, 1991, J BIOL CHEM, V266, P7313; ZHANG YH, 1988, P NATL ACAD SCI USA, V85, P6802, DOI 10.1073/pnas.85.18.6802	43	102	102	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2762	2766						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8381414				2022-12-27	WOS:A1993KK81500075
J	BLOMMAART, PJE; ZONNEVELD, D; MEIJER, AJ; LAMERS, WH				BLOMMAART, PJE; ZONNEVELD, D; MEIJER, AJ; LAMERS, WH			EFFECTS OF INTRACELLULAR AMINO-ACID-CONCENTRATIONS, CYCLIC-AMP, AND DEXAMETHASONE ON LYSOSOMAL PROTEOLYSIS IN PRIMARY CULTURES OF PERINATAL RAT HEPATOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DEGRADATION; CARBAMOYLPHOSPHATE SYNTHETASE; AUTOPHAGIC VACUOLE; PHOSPHOENOLPYRUVATE CARBOXYKINASE; MESSENGER-RNA; LIVER; INHIBITION; TRANSPORT; DEPRIVATION; TURNOVER	We have studied factors regulating the rate of protein degradation in cultured hepatocytes obtained from 17-day-old fetal, 7-day-old suckling, and 20-day-old weanling rats. At all three stages of development 60-70% of protein degradation was sensitive to inhibition by amino acids and 3-methyladenine, an inhibitor of macroautophagy, indicating a major role of the lysosomes in proteolysis under these conditions. A combination of dibutyryl cyclic AMP and dexamethasone strongly stimulated proteolysis in hepatocytes from weanling, but not from fetal and suckling rats. The stimulatory effect of these compounds was eliminated at high amino acid concentrations in the culture medium. Cultured perinatal hepatocytes responded to exposure to dibutyryl cyclic AMP and dexamethasone by de novo synthesis of mRNA for carbamoyl-phosphate synthase and for phosphoenolpyruvate carboxykinase, demonstrating that the developmental change in the effect of dibutyryl cyclic AMP and dexamethasone on proteolysis was due to a developmental change in the regulation of proteolysis. An analysis of the changes in intracellular amino acid concentrations in response to variations in the extracellular amino acid concentrations at all three stages of development showed that of all amino acids that could be identified, only Ile, Leu, Lys, Phe, and Tyr are implicated as possible regulators of hepatic proteolysis. Dibutyryl cyclic AMP and dexamethasone did not affect the intracellular concentrations of these amino acids, showing that hormonal regulation of proteolysis is not mediated by changes in intracellular concentrations of these amino acids. It is concluded that the lack of sensitivity of the proteolytic system to catabolic hormones in the period around birth, combined with higher circulating plasma amino acid concentrations, are mechanisms contributing to the low rate of intrahepatic proteolysis in vivo in the perinatal period and thus to the rapid growth of the liver in this period.	UNIV AMSTERDAM,ACAD MED CTR,DEPT ANAT & EMBRYOL,MEIBERGDREEF 15,1105 AZ AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,EC SLATER INST BIOCHEM RES,1105 AZ AMSTERDAM,NETHERLANDS	University of Amsterdam; University of Amsterdam			Lamers, Wouter H./D-2965-2012					BALLARD FJ, 1987, LYSOSOMES THEIR ROLE, P285; BELLEMANN P, 1981, J BIOCHEM-TOKYO, V90, P1821, DOI 10.1093/oxfordjournals.jbchem.a133661; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; BOND JS, 1987, ANNU REV BIOCHEM, V56, P333, DOI 10.1146/annurev.bi.56.070187.002001; BURGER HJ, 1989, HEPATOLOGY, V9, P22, DOI 10.1002/hep.1840090105; CARO LHP, 1989, EUR J BIOCHEM, V181, P717, DOI 10.1111/j.1432-1033.1989.tb14782.x; CARO LHP, 1988, EUR J BIOCHEM, V175, P325, DOI 10.1111/j.1432-1033.1988.tb14200.x; CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062; CIECHANOVER A, 1987, LYSOSOMES THEIR ROLE, P561; CLAYTON DF, 1983, MOL CELL BIOL, V3, P1552, DOI 10.1128/MCB.3.9.1552; CONDE RD, 1977, BIOCHEM J, V166, P115, DOI 10.1042/bj1660115; DEGROOT CJ, 1984, BIOCHEM BIOPH RES CO, V124, P882, DOI 10.1016/0006-291X(84)91040-4; DIMARCO PN, 1978, EUR J BIOCHEM, V87, P235, DOI 10.1111/j.1432-1033.1978.tb12371.x; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935; FURUNO K, 1990, EXP CELL RES, V189, P261, DOI 10.1016/0014-4827(90)90245-6; GORDON PB, 1989, BIOCHEM SOC SYMP, V55, P129; GRINDE B, 1984, EUR J BIOCHEM, V145, P623, DOI 10.1111/j.1432-1033.1984.tb08602.x; GRINDE B, 1985, EXPERIENTIA, V41, P1089, DOI 10.1007/BF01951685; HALLBRUCKER C, 1991, EUR J BIOCHEM, V197, P717, DOI 10.1111/j.1432-1033.1991.tb15963.x; HOPGOOD MF, 1977, BIOCHEM J, V164, P399, DOI 10.1042/bj1640399; HOPGOOD MF, 1981, BIOCHEM J, V196, P33, DOI 10.1042/bj1960033; ISOM H, 1987, J CELL BIOL, V105, P2877, DOI 10.1083/jcb.105.6.2877; JOHNSON JD, 1986, PEDIATR RES, V20, P1252, DOI 10.1203/00006450-198612000-00013; KILBERG MS, 1986, TRENDS BIOCHEM SCI, V11, P183, DOI 10.1016/0968-0004(86)90138-6; KLAIPONGPAN A, 1977, BIOCHEM J, V168, P271, DOI 10.1042/bj1680271; KOVACS AL, 1981, EXP CELL RES, V133, P431, DOI 10.1016/0014-4827(81)90336-0; LAMERS WH, 1985, IN VITRO CELL DEV B, V21, P606, DOI 10.1007/BF02623291; LAMERS WH, 1984, DEV BIOL, V105, P500, DOI 10.1016/0012-1606(84)90307-5; LEONI S, 1987, J CELL PHYSIOL, V130, P103, DOI 10.1002/jcp.1041300115; LEVERVE XM, 1987, FEBS LETT, V219, P455, DOI 10.1016/0014-5793(87)80271-5; MCEVOYBOWE E, 1987, BIOL NEONATE, V52, P135, DOI 10.1159/000242702; MCGIVAN JD, 1977, FEBS LETT, V80, P380, DOI 10.1016/0014-5793(77)80481-X; MEIJER AJ, 1990, PHYSIOL REV, V70, P701, DOI 10.1152/physrev.1990.70.3.701; MITCH WE, 1984, BIOCHEM J, V222, P579, DOI 10.1042/bj2220579; MORTIMOR.GE, 1970, J BIOL CHEM, V245, P2375; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; MORTIMORE GE, 1988, J BIOL CHEM, V263, P19545; MORTIMORE GE, 1990, INT J BIOCHEM, V22, P1075, DOI 10.1016/0020-711X(90)90104-B; MORTIMORE GE, 1991, J BIOL CHEM, V266, P1021; MORTIMORE GE, 1989, DIABETES METAB REV, V5, P49, DOI 10.1002/dmr.5610050105; NEFF NT, 1979, J CELL PHYSIOL, V101, P439, DOI 10.1002/jcp.1041010311; PASKIN N, 1977, BIOCHIM BIOPHYS ACTA, V474, P1, DOI 10.1016/0005-2787(77)90208-8; PEAVY DE, 1990, BIOCHEM J, V267, P671, DOI 10.1042/bj2670671; PLOMP PJAM, 1987, EUR J BIOCHEM, V164, P197, DOI 10.1111/j.1432-1033.1987.tb11011.x; RABKIN R, 1991, J LAB CLIN MED, V117, P505; REMESAR X, 1980, ARCH INT PHYSIOL BIO, V88, P443, DOI 10.3109/13813458009092918; RENNIE MJ, 1986, LANCET, V2, P1008; SCHWORER CM, 1979, P NATL ACAD SCI USA, V76, P3169, DOI 10.1073/pnas.76.7.3169; SCORNIK OA, 1982, BIOCH DEV FETUS NEON, P865; SCORNIK OA, 1987, LYSOSOMES THEIR ROLE, P445; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; SEGLEN PO, 1980, BIOCHIM BIOPHYS ACTA, V630, P103, DOI 10.1016/0304-4165(80)90141-5; SEGLEN PO, 1987, LYSOSOMES THEIR ROLE, P371; SHOTWELL MA, 1983, BIOCHIM BIOPHYS ACTA, V737, P267, DOI 10.1016/0304-4157(83)90003-5; SOMMERCORN JM, 1981, J BIOL CHEM, V256, P4816; STOLL B, 1991, HEPATOLOGY, V13, P247, DOI 10.1002/hep.1840130208; TANAKA K, 1983, J BIOCHEM-TOKYO, V94, P1339, DOI 10.1093/oxfordjournals.jbchem.a134479; TISCHLER ME, 1982, J BIOL CHEM, V257, P1613; VANROON MA, 1987, EUR J BIOCHEM, V165, P229; VANROON MA, 1988, EUR J BIOCHEM, V178, P191; Williamson J.R., 1969, METHOD ENZYMOL, V13, P434, DOI 10.1016/0076-687913072-4	63	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1610	1617						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380574				2022-12-27	WOS:A1993KH62000020
J	BRUSH, GS; BESSMAN, MJ				BRUSH, GS; BESSMAN, MJ			CHEMICAL MODIFICATION OF BACTERIOPHAGE-T4 DEOXYNUCLEOTIDE KINASE - EVIDENCE OF A SINGLE CATALYTIC REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; DNA-POLYMERASE-I; ESCHERICHIA-COLI; ADENYLATE KINASE; THYMIDYLATE KINASE; BINDING-SITE; GENE; ENCODES; IDENTIFICATION; PURIFICATION	The mechanism underlying the unusual specificity of bacteriophage T4 deoxynucleotide kinase, which catalyzes the phosphorylation of 5-hydroxymethyldeoxycytidylate, dTMP, and dGMP, has been investigated by chemical modification of the protein. Pyridoxal 5'-phosphate inactivates deoxynucleotide kinase by modifying a single lysine out of the 17 per monomer. Lysine 10 has been tentatively identified as the site of modification, although the possibility of mutually exclusive reactive residues has not been eliminated. Diethylpyrocarbonate also inactivates the enzyme, suggesting that histidine plays a role in catalytic function. With either reagent, the three activities are lost at equal rates, supporting the contention that one active site is responsible for the exclusive phosphorylation of three dissimilar deoxynucleotides. These studies also identify two distant regions of the primary sequence that are likely to be closely associated in the active region of the folded protein.	JOHNS HOPKINS UNIV,MCCOLLUM PRATT INST,BALTIMORE,MD 21218; JOHNS HOPKINS UNIV,DEPT BIOL,BALTIMORE,MD 21218	Johns Hopkins University; Johns Hopkins University					NIGMS NIH HHS [GM-18649] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASU A, 1987, BIOCHEMISTRY-US, V26, P1704, DOI 10.1021/bi00380a032; BASU S, 1988, BIOCHEMISTRY-US, V27, P6710, DOI 10.1021/bi00418a011; BELL JF, 1988, PROTEINS ENZYMES, P140; BELLO LJ, 1963, J BIOL CHEM, V238, P1777; BERGER A, 1989, EUR J BIOCHEM, V184, P433, DOI 10.1111/j.1432-1033.1989.tb15035.x; BESSMAN MJ, 1974, J MOL BIOL, V88, P409, DOI 10.1016/0022-2836(74)90491-4; BESSMAN MJ, 1958, P NATL ACAD SCI USA, V44, P633, DOI 10.1073/pnas.44.7.633; BHATNAGAR SK, 1991, J BIOL CHEM, V266, P9050; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROIDA J, 1985, J MOL BIOL, V185, P545, DOI 10.1016/0022-2836(85)90071-3; BRUSH GS, 1990, J BACTERIOL, V172, P2935, DOI 10.1128/jb.172.6.2935-2939.1990; CHIN DT, 1988, J BIOL CHEM, V263, P11718; DARBY G, 1986, J GEN VIROL, V67, P753, DOI 10.1099/0022-1317-67-4-753; DUCKWORTH DH, 1967, J BIOL CHEM, V242, P2877; FLAKS JG, 1957, BIOCHIM BIOPHYS ACTA, V25, P667, DOI 10.1016/0006-3002(57)90553-X; FRY DC, 1985, BIOCHEMISTRY-US, V24, P4680, DOI 10.1021/bi00338a030; HEIL A, 1974, EUR J BIOCHEM, V43, P131, DOI 10.1111/j.1432-1033.1974.tb03393.x; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; JOACHIMIAK A, 1983, P NATL ACAD SCI-BIOL, V80, P668, DOI 10.1073/pnas.80.3.668; JONG AYS, 1984, J BIOL CHEM, V259, P1052; KARPEISKY MY, 1986, VITAMIN B6 PYRIDOX B, P71; KORNBERG A, 1951, J BIOL CHEM, V193, P481; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; LEHMAN IR, 1958, J BIOL CHEM, V233, P163; LIEBERMAN I, 1955, J BIOL CHEM, V215, P429; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Miles E W, 1977, Methods Enzymol, V47, P431; MILMAN G, 1987, METHOD ENZYMOL, V153, P482; PAI EF, 1977, J MOL BIOL, V114, P37, DOI 10.1016/0022-2836(77)90281-9; PLESS RC, 1981, BIOCHEMISTRY-US, V20, P6235, DOI 10.1021/bi00524a051; REINSTEIN J, 1988, BIOCHEMISTRY-US, V27, P4712, DOI 10.1021/bi00413a020; SAKIYAMA S, 1973, J BIOL CHEM, V248, P3150; SCHULZ GE, 1974, NATURE, V250, P120, DOI 10.1038/250120a0; SEGEL IH, 1975, ENZYME KINETICS, P109; SMITH GL, 1989, NUCLEIC ACIDS RES, V17, P7581, DOI 10.1093/nar/17.19.7581; SOBER HA, 1970, HDB BIOCH, pG95; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WITTENBERG J, 1953, J BIOL CHEM, V202, P431	39	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1603	1609						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380573				2022-12-27	WOS:A1993KH62000019
J	PILZ, RB				PILZ, RB			IMPAIRED ERYTHROID-SPECIFIC GENE-EXPRESSION IN CAMP-DEPENDENT PROTEIN KINASE-DEFICIENT MURINE ERYTHROLEUKEMIA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORPHOBILINOGEN DEAMINASE GENE; HEME PATHWAY ENZYMES; MESSENGER-RNA; C-MYC; STRUCTURAL ORGANIZATION; ORNITHINE DECARBOXYLASE; HYPERSENSITIVE SITES; CDNA CLONES; DIFFERENTIATION; GLOBIN	Murine erythroleukemia cells rendered deficient in cAMP-dependent protein kinase (A-kinase) activity by gene transfection are severely impaired in hexamethylene bisacetamide (HMBA)-induced differentiation (Pilz, R. B., Eigenthaler, M., and Boss, G. R. (1992) J. Biol. Chem. 267,16161-16167). We now demonstrate that the A-kinase-deficient cells produce hemoglobin normally in response to exogenous hemin and that the heme precursor delta-aminolevulinate (delta-ALA) significantly increases HMBA-induced synthesis of heme and globin chains in these cells; these data suggest that impaired heme synthesis is at least partially responsible for the cells' deficient hemoglobin synthesis. HMBA-induced expression of the erythroid-specific delta-ALA synthetase, porphobilinogen deaminase, and beta-globin mRNAs was less in A-kinase-deficient cells than in parental cells and was reduced in proportion to the cells' residual A-kinase activity; relative transcription rates of these genes were reduced concordantly. Impaired expression of these three erythroid-specific genes was a feature of many independently-derived A-kinase-deficient clones, and normal expression was found in transfectants with normal A-kinase activity. The A-kinase-deficient cells did not exhibit a generalized defect in gene regulation since mRNA expression and transcription rates of H- and L-ferritin, c-myc, c-myb, and several housekeeping enzymes were similar in HMBA-treated parental and A-kinase-deficient cells. Our data suggest that A-kinase may be involved in regulating genes with erythroid-specific promoters and provide further evidence for heme as a regulator of globin chain synthesis.			PILZ, RB (corresponding author), UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093, USA.				NCI NIH HHS [K08 CA01548] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA001548] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAHAM NG, 1991, INT J CELL CLONING, V9, P185, DOI 10.1002/stem.5530090304; ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; BATTISTINI A, 1991, BLOOD, V78, P2098, DOI 10.1182/blood.V78.8.2098.bloodjournal7882098; BATTISTINI A, 1991, J BIOL CHEM, V266, P528; BEAUMONT C, 1984, EXP CELL RES, V154, P474, DOI 10.1016/0014-4827(84)90171-X; BEAUMONT C, 1987, J BIOL CHEM, V262, P10619; BEAUMONT C, 1989, J BIOL CHEM, V264, P14829; BEEBE SJ, 1986, ENZYMES, V17, P43; BOYD D, 1985, J BIOL CHEM, V260, P1755; BRENNER DA, 1991, P NATL ACAD SCI USA, V88, P849, DOI 10.1073/pnas.88.3.849; BROWN AJP, 1983, P NATL ACAD SCI-BIOL, V80, P1265, DOI 10.1073/pnas.80.5.1265; CASTLE S, 1985, BIOCHEM BIOPH RES CO, V132, P688, DOI 10.1016/0006-291X(85)91187-8; CELANO P, 1989, BIOTECHNIQUES, V7, P137; CHRETIEN S, 1988, P NATL ACAD SCI USA, V85, P6, DOI 10.1073/pnas.85.1.6; CLARKE MF, 1988, MOL CELL BIOL, V8, P884, DOI 10.1128/MCB.8.2.884; CONDER LH, 1991, BIOCHEM J, V275, P321, DOI 10.1042/bj2750321; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; Drabkin DL, 1942, J BIOL CHEM, V142, P855; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; EVANS T, 1990, ANNU REV CELL BIOL, V6, P95, DOI 10.1146/annurev.cellbio.6.1.95; FADIGAN A, 1987, BIOCHEM J, V243, P419, DOI 10.1042/bj2430419; FRASER PJ, 1987, GENE DEV, V1, P855, DOI 10.1101/gad.1.8.855; FREGIEN N, 1986, GENE, V48, P1, DOI 10.1016/0378-1119(86)90346-X; FUJITA H, 1991, BIOCHIM BIOPHYS ACTA, V1090, P311, DOI 10.1016/0167-4781(91)90195-R; FUJITA H, 1991, J BIOL CHEM, V266, P17494; GANGULY S, 1985, J BIOL CHEM, V260, P2167; GANGULY S, 1988, J BIOL CHEM, V263, P3216; GRANDCHAMP B, 1985, J BIOL CHEM, V260, P9630; GRANICK JL, 1978, J BIOL CHEM, V253, P5402; GUPTA M, 1985, J BIOL CHEM, V260, P2941; HARPOLD MM, 1979, CELL, V17, P1025, DOI 10.1016/0092-8674(79)90341-6; KURAMOCHI S, 1990, EUR J BIOCHEM, V193, P163, DOI 10.1111/j.1432-1033.1990.tb19318.x; LO SC, 1978, CELL, V15, P447, DOI 10.1016/0092-8674(78)90014-4; LO SC, 1981, CANCER RES, V41, P864; LOHMANN SM, 1984, ADV CYCLIC NUCL PROT, V18, P63; MACLEOD K, 1991, MOL CELL BIOL, V11, P4324, DOI 10.1128/MCB.11.9.4324; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; MARKS PA, 1978, ANNU REV BIOCHEM, V47, P419, DOI 10.1146/annurev.bi.47.070178.002223; MASONGARCIA M, 1991, FASEB J, V5, P2958, DOI 10.1096/fasebj.5.14.1752362; MIGNOTTE V, 1989, P NATL ACAD SCI USA, V86, P6548, DOI 10.1073/pnas.86.17.6548; MUSTI AM, 1993, J CELL BIOCH, V185; PADMANABAN G, 1989, TRENDS BIOCHEM SCI, V14, P492, DOI 10.1016/0968-0004(89)90182-5; PILZ RB, 1992, J BIOL CHEM, V267, P16161; PILZ RB, 1990, J BIOL CHEM, V265, P8880; PORCHER C, 1991, J BIOL CHEM, V266, P10562; PROCHOWNIK EV, 1989, BLOOD, V73, P782; PROFOUSJUCHELKA HR, 1983, MOL CELL BIOL, V3, P229, DOI 10.1128/MCB.3.2.229; RIFKIND RA, 1987, BLOOD CELLS, V13, P277; ROSS J, 1976, CELL, V8, P513, DOI 10.1016/0092-8674(76)90219-1; ROUGEON F, 1977, GENE, V1, P229, DOI 10.1016/0378-1119(77)90047-6; RUTHERFORD T, 1979, P NATL ACAD SCI USA, V76, P833, DOI 10.1073/pnas.76.2.833; RUTHERFORD TR, 1979, CELL, V16, P415, DOI 10.1016/0092-8674(79)90017-5; SASSA S, 1976, J EXP MED, V143, P305, DOI 10.1084/jem.143.2.305; SCHOENHAUT DS, 1989, NUCLEIC ACIDS RES, V17, P7013, DOI 10.1093/nar/17.17.7013; SCHOENHAUT DS, 1986, GENE, V48, P55, DOI 10.1016/0378-1119(86)90351-3; TAKETANI S, 1990, J BIOL CHEM, V265, P19377; TODOKORO K, 1986, BIOCHEM BIOPH RES CO, V135, P1112, DOI 10.1016/0006-291X(86)91043-0; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; WATSON RJ, 1988, MOL CELL BIOL, V8, P3938, DOI 10.1128/MCB.8.9.3938; WU YJ, 1991, J BIOL CHEM, V266, P17566	60	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20252	20258						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376386				2022-12-27	WOS:A1993LY01900052
J	SUBBAIAH, PV; LIU, M				SUBBAIAH, PV; LIU, M			ROLE OF SPHINGOMYELIN IN THE REGULATION OF CHOLESTEROL ESTERIFICATION IN THE PLASMA-LIPOPROTEINS - INHIBITION OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE REACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; LYSOLECITHIN ACYLTRANSFERASE; MEMBRANE SPHINGOMYELIN; SERUM-LIPOPROTEINS; PARTICLE-SIZE; SPECIFICITY; EXCHANGE; PHOSPHATIDYLCHOLINES; ABETALIPOPROTEINEMIA	In order to determine whether sphingomyelin (SPH) affects the rate of cholesterol esterification by plasma lecithin-cholesterol acyltransferase (LCAT), we studied the effects of its incorporation in to defined proteoliposome substrates containing phosphatidyl choline (PC), unesterified cholesterol, and apoprotein A-I, on the activity of purified LCAT. Cholesterol esterification was inhibited by up to 90% in the presence of SPH, and this inhibition was reversed by treatment with bacterial sphingomyelinase. The inhibition could be overcome by increasing the concentration of PC, but not unesterified cholesterol or apoprotein A-I, in the substrate. The effect of SPH was not related to the alterations in the size of the substrate particle and was not dependent on the type of acyl donor or apoprotein activator employed. The lysolecithin acyltransferase and phospholipase reactions carried out by LCAT were also inhibited by SPH. Kinetic studies suggested that: 1) LCAT binds better to substrate vesicles which contain SPH; 2) SPH competes with PC in binding to the active site of the enzyme; and 3) SPH is a more powerful competitive inhibitor than a diether analog of PC. The ability of various lipoproteins to act as substrates for purified LCAT varied inversely with the SPH/PC ratio. Treatment of the lipoproteins with sphingomyelinase activated the LCAT reaction, the percent activation being directly proportional to the SPH concentration in the native lipoprotein. Enrichment of high density lipoproteins with SPH inhibited cholesterol esterification in them by 50%, and this inhibition could be reversed by the degradation of SPH. These results show that SPH is a physiological inhibitor of cholesterol esterification in the plasma, by virtue of its competition with PC, the acyl donor for the reaction.	RUSH MED COLL,DEPT BIOCHEM,CHICAGO,IL 60612	Rush University	SUBBAIAH, PV (corresponding author), RUSH MED COLL,DEPT MED,1653 W CONGRESS PKWY,CHICAGO,IL 60612, USA.		Subbaiah, Papasani/U-1104-2019					ARON L, 1978, J BIOL CHEM, V253, P7220; BARENHOLZ Y, 1984, PHYSL MEMBRANE FLUID, P131; BARTER PJ, 1985, ATHEROSCLEROSIS, V58, P97, DOI 10.1016/0021-9150(85)90058-9; BENTEJAC M, 1988, BIOCHIM BIOPHYS ACTA, V959, P349, DOI 10.1016/0005-2760(88)90209-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHEN CH, 1982, BIOCHEM BIOPH RES CO, V107, P1091, DOI 10.1016/0006-291X(82)90633-7; CHEN CH, 1982, J LIPID RES, V23, P680; CHUNG J, 1982, ATHEROSCLEROSIS, V45, P33, DOI 10.1016/0021-9150(82)90169-1; COOPER RA, 1971, J LAB CLIN MED, V78, P323; DEMEL RA, 1982, BIOCHIM BIOPHYS ACTA, V713, P629, DOI 10.1016/0005-2760(82)90323-X; DOBIASOVA M, 1983, ADV LIPID RES, V20, P107; DOLPHIN PJ, 1987, ATHEROMA LISBON, V13, P16; FRANCONE OL, 1991, BIOCHEMISTRY-US, V30, P10074, DOI 10.1021/bi00106a002; Glomset J A, 1979, Prog Biochem Pharmacol, V15, P41; GUPTA AK, 1992, J LIPID RES, V33, P1741; GUPTA AK, 1991, J LIPID RES, V32, P125; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; JONAS A, 1984, BIOCHIM BIOPHYS ACTA, V794, P361, DOI 10.1016/0005-2760(84)90002-X; KAN CC, 1991, BIOCHEMISTRY-US, V30, P7759, DOI 10.1021/bi00245a013; KOSTNER G, 1974, CLIN SCI MOL MED, V46, P457, DOI 10.1042/cs0460457; LACKO AG, 1992, LIPIDS, V27, P266, DOI 10.1007/BF02536473; LANE JT, 1991, J LAB CLIN MED, V118, P120; LEE SM, 1991, MECH AGEING DEV, V61, P85, DOI 10.1016/0047-6374(91)90008-N; LIU M, 1992, J BIOL CHEM, V267, P5139; LIU M, 1993, BIOCHIM BIOPHYS ACTA, V1168, P144, DOI 10.1016/0005-2760(93)90118-S; LUNDKATZ S, 1988, BIOCHEMISTRY-US, V27, P3416, DOI 10.1021/bi00409a044; MARINETTI GV, 1962, J LIPID RES, V3, P1; MASSEY JB, 1985, J BIOL CHEM, V260, P1719; MATZ CE, 1982, J BIOL CHEM, V257, P4535; MORTON RE, 1988, J BIOL CHEM, V263, P12235; MYHER JJ, 1989, LIPIDS, V24, P408, DOI 10.1007/BF02535148; PHILLIPS GB, 1967, J LIPID RES, V8, P676; PHILLIPS MC, 1987, BIOCHIM BIOPHYS ACTA, V906, P223, DOI 10.1016/0304-4157(87)90013-X; POWNALL HJ, 1985, J BIOL CHEM, V260, P2146; REDGRAVE TG, 1992, BIOCHIM BIOPHYS ACTA, V1126, P65, DOI 10.1016/0005-2760(92)90218-K; SCANU AM, 1974, J CLIN INVEST, V53, P440, DOI 10.1172/JCI107578; SLOTTE JP, 1989, BIOCHIM BIOPHYS ACTA, V985, P90, DOI 10.1016/0005-2736(89)90108-9; SLOTTE JP, 1988, BIOCHEM J, V250, P653, DOI 10.1042/bj2500653; SLOTTE JP, 1990, J LIPID RES, V31, P2235; STOKKE KT, 1971, SCAND J CLIN LAB INV, V27, P21, DOI 10.3109/00365517109080184; SUBBAIAH PV, 1989, ATHEROSCLEROSIS, V79, P157, DOI 10.1016/0021-9150(89)90120-2; SUBBAIAH PV, 1980, J BIOL CHEM, V255, P9275; SUBBAIAH PV, 1992, BIOCHIM BIOPHYS ACTA, V1128, P83, DOI 10.1016/0005-2760(92)90261-S; SUBBAIAH PV, 1988, BIOCHIM BIOPHYS ACTA, V963, P445, DOI 10.1016/0005-2760(88)90313-X; SUBBAIAH PV, 1989, CIRCULATION, V80, P355; VERGER R, 1976, ANNU REV BIOPHYS BIO, V5, P77, DOI 10.1146/annurev.bb.05.060176.000453; XU XX, 1991, J BIOL CHEM, V266, P24849; YOKOYAMA S, 1980, J BIOL CHEM, V255, P7333; ZORCH NL, 1987, BIOCHIM BIOPHYS ACTA, V919, P181	49	95	96	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20156	20163						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376375				2022-12-27	WOS:A1993LY01900037
J	GIRBES, T; CITORES, L; IGLESIAS, R; FERRERAS, JM; MUNOZ, R; ROJO, MA; ARIAS, FJ; GARCIA, JR; MENDEZ, E; CALONGE, M				GIRBES, T; CITORES, L; IGLESIAS, R; FERRERAS, JM; MUNOZ, R; ROJO, MA; ARIAS, FJ; GARCIA, JR; MENDEZ, E; CALONGE, M			EBULIN-1, A NONTOXIC NOVEL TYPE-2 RIBOSOME-INACTIVATING PROTEIN FROM SAMBUCUS-EBULUS L LEAVES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; N-GLYCOSIDASE ACTIVITY; A-CHAIN; ANTIVIRAL PROTEIN; ESCHERICHIA-COLI; INFECTED-CELLS; ABRIN-A; RICIN; RNA; REPLICATION	A novel type 2 ribosome-inactivating protein (RIP) that we named ebulin 1 has been isolated from leaves of Sambucus ebulus L. (Caprifoliaceae). In vitro ebulin 1 strongly inhibited protein synthesis by rabbit reticulocyte lysates, rat brain, and rat liver cell-free systems but did not affect in vitro plant nor bacterial protein synthesis. Ebulin 1 is composed of two subunits, a catalytic A subunit (M(r) 26,000) and a D-galactose-binding lectin B subunit (M(r) 30,000). Amino-terminal amino acid sequence homology revealed the novelty that the ebulin 1 A-chain shares a high degree of homology not with the A-chain of other type 2 RIPs but rather with the Cucurbitaceae type 1 RIP briodin S and the anti-human immunodeficiency virus type I proteins trichosanthin and TAP 29. Upon treatment with acid aniline the rRNA from ebulin 1-treated rabbit reticulocyte ribosomes released the RNA fragment which is diagnostic of RIP catalytic action. Ebulin 1 was nontoxic to mice up to 2 mg/kg of body weight and did not inhibit protein synthesis in cultured NHC human epithelial cells which are highly sensitive to ricin.	UNIV VALLADOLID, INST OFTALMOBIOL, E-47005 VALLADOLID, SPAIN; CTR RAMON Y CAJAL, SERV ENDOCRINOL, E-28034 MADRID, SPAIN	Universidad de Valladolid	GIRBES, T (corresponding author), UNIV VALLADOLID, FAC CIENCIAS, DEPT BIOQUIM & BIOL MOLEC, E-47005 VALLADOLID, SPAIN.		Ferreras, José M/K-6446-2017; CITORES, LUCIA/G-7273-2017; Calonge, Margarita/K-2839-2014; Arias, Francisco Javier/A-2640-2012; Rojo, Maria Angeles/I-6728-2016; Iglesias, Rosario/G-7311-2017; Girbes, Tomas/C-6753-2013	Ferreras, José M/0000-0003-4816-5878; CITORES, LUCIA/0000-0003-3784-5042; Calonge, Margarita/0000-0001-8178-4836; Arias, Francisco Javier/0000-0001-8584-3768; Rojo, Maria Angeles/0000-0002-7809-3150; Iglesias, Rosario/0000-0002-5021-1733; Girbes, Tomas/0000-0003-1452-5935; Munoz, Raquel/0000-0001-9861-0349				ARAKI T, 1987, BIOCHIM BIOPHYS ACTA, V911, P191, DOI 10.1016/0167-4838(87)90008-2; ARIAS FJ, 1992, PLANTA, V186, P532, DOI 10.1007/BF00198033; ARIAS FJ, 1992, J EXP BOT, V43, P729, DOI 10.1093/jxb/43.5.729; ARON GM, 1980, ANTIMICROB AGENTS CH, V17, P1032, DOI 10.1128/AAC.17.6.1032; BARBIERI L, 1982, CANCER SURV, V1, P489; BOLOGNESI A, 1990, BIOCHIM BIOPHYS ACTA, V1087, P293, DOI 10.1016/0167-4781(90)90002-J; BYERS VS, 1990, AIDS, V4, P1189, DOI 10.1097/00002030-199012000-00002; CALONGE M, 1990, Investigative Ophthalmology and Visual Science, V31, P465; COLLINS EJ, 1990, J BIOL CHEM, V265, P8665; ENDO Y, 1987, J BIOL CHEM, V262, P8128; FOATOMASI L, 1982, ARCH VIROL, V71, P323, DOI 10.1007/BF01315062; FUNATSU G, 1988, AGR BIOL CHEM TOKYO, V52, P1095; GIRBES T, 1976, EUR J BIOCHEM, V67, P257, DOI 10.1111/j.1432-1033.1976.tb10657.x; HABUKA N, 1990, J BIOL CHEM, V265, P10988; HARTLEY MR, 1991, FEBS LETT, V290, P65, DOI 10.1016/0014-5793(91)81227-Y; IGLESIAS R, 1993, FEBS LETT, V318, P189, DOI 10.1016/0014-5793(93)80019-Q; ISLAM MR, 1990, AGR BIOL CHEM TOKYO, V54, P2967, DOI 10.1080/00021369.1990.10870410; KAHN JO, 1990, AIDS, V4, P1197, DOI 10.1097/00002030-199012000-00003; KAKU H, 1990, ARCH BIOCHEM BIOPHYS, V277, P255, DOI 10.1016/0003-9861(90)90576-K; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMB FI, 1985, EUR J BIOCHEM, V148, P265, DOI 10.1111/j.1432-1033.1985.tb08834.x; Lambert J M, 1988, Cancer Treat Res, V37, P175; LEEHUANG S, 1990, FEBS LETT, V272, P12, DOI 10.1016/0014-5793(90)80438-O; LEEHUANG S, 1991, P NATL ACAD SCI USA, V88, P6570, DOI 10.1073/pnas.88.15.6570; LORD JM, 1987, PLANT PHYSIOL, V85, P1, DOI 10.1104/pp.85.1.1; MACH L, 1991, BIOCHEM J, V278, P667, DOI 10.1042/bj2780667; MCGRATH MS, 1989, P NATL ACAD SCI USA, V86, P2844, DOI 10.1073/pnas.86.8.2844; MERINO MJ, 1990, J EXP BOT, V41, P67, DOI 10.1093/jxb/41.1.67; MISCHAK R P, 1990, Molecular Biotherapy, V2, P104; MONTECUCCHI PC, 1989, INT J PEPT PROT RES, V33, P263; MUNOZ R, 1990, BRAIN RES, V517, P330, DOI 10.1016/0006-8993(90)91045-I; OLSNES S, 1989, IMMUNOL TODAY, V10, P291; OLSNES S, 1982, MOL ASPECTS CELLULAR, V2, P51; PELHAM H R B, 1992, Trends in Cell Biology, V2, P183, DOI 10.1016/0962-8924(92)90230-K; SALLUSTIO S, 1990, J BIOL CHEM, V265, P582; Sambrook J, 1989, MOL CLONING LAB MANU, pE3; SANDVIG K, 1982, J BIOL CHEM, V257, P7495; STIRPE F, 1989, BIOCHEM J, V262, P1001; STIRPE F, 1988, NUCLEIC ACIDS RES, V16, P1349, DOI 10.1093/nar/16.4.1349; STIRPE F, 1986, FEBS LETT, V195, P1, DOI 10.1016/0014-5793(86)80118-1; STIRPE F, 1992, BIO-TECHNOL, V10, P405, DOI 10.1038/nbt0492-405; TILL MA, 1988, SCIENCE, V242, P1166, DOI 10.1126/science.2847316; Vallera D A, 1988, Cancer Treat Res, V37, P141; VANDEURS B, 1986, J CELL BIOL, V102, P37, DOI 10.1083/jcb.102.1.37; ZARLING JM, 1990, NATURE, V347, P92, DOI 10.1038/347092a0	45	107	109	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18195	18199						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349695				2022-12-27	WOS:A1993LT74300081
J	HUGHES, PE; MORGAN, G; ROONEY, EK; BROWNLEE, GG; HANDFORD, P				HUGHES, PE; MORGAN, G; ROONEY, EK; BROWNLEE, GG; HANDFORD, P			TYROSINE-69 OF THE 1ST EPIDERMAL GROWTH FACTOR-LIKE DOMAIN OF HUMAN FACTOR-IX IS ESSENTIAL FOR CLOTTING ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CARBOXYGLUTAMIC ACID; BETA-HYDROXYASPARTIC ACID; AFFINITY CALCIUM-BINDING; DEPENDENT PROTEIN-S; EGF-LIKE DOMAINS; CA2+ BINDING; FACTOR-X; STRUCTURAL REQUIREMENTS; MONOCLONAL-ANTIBODIES; BLOOD-COAGULATION	Epidermal growth factor (EGF)-like domains are present in many extracellular proteins including clotting factor IX. Those EGF-like domains with the consensus amino acid residues Asp/Asn, Asp/Asn, Asp/Asn, Tyr/Phe (where denotes a beta-hydroxylated residue) bind calcium. Previous NMR studies of the isolated first EGF-like domain of human factor IX suggested that the first 3 consensus residues Asp-47, Asp-49, and Asp-64 were direct ligands for calcium. We now show from mutagenesis studies that Tyr-69 is not a direct ligand for calcium but is essential for the clotting activity of intact factor IX, specifically for the factor VIIIa-dependent activation of factor X. Surprisingly, Tyr-69 is not required for beta-hydroxylation of Asp-64.	UNIV OXFORD,DEPT BIOCHEM,OXFORD OX1 3QU,ENGLAND	University of Oxford	HUGHES, PE (corresponding author), UNIV OXFORD,SIR WILLIAM DUNN SCH PATHOL,OXFORD OX1 3RE,ENGLAND.							ANSON DS, 1984, EMBO J, V3, P1053, DOI 10.1002/j.1460-2075.1984.tb01926.x; ASTERMARK J, 1991, J BIOL CHEM, V266, P2430; AUSTEN DEG, 1975, LABORATORY MANUAL BL; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brownlee G, 1988, REC ADV HAEMATOL, V5, P251; DAHLBACK B, 1990, J BIOL CHEM, V265, P18481; FERNLUND P, 1983, J BIOL CHEM, V258, P2509; FRAZIER D, 1989, BLOOD, V74, P971; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; HANDFORD PA, 1991, PROTEIN ENG, V4, P319, DOI 10.1093/protein/4.3.319; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; HUANG LH, 1989, BIOCHEM BIOPH RES CO, V160, P133, DOI 10.1016/0006-291X(89)91631-8; JAENICKE R, 1989, PROTEIN STRUCTURE PR, P208; JIA S, 1992, J BIOL CHEM, V267, P14322; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LIN SW, 1990, J BIOL CHEM, V265, P144; MAYHEW M, 1992, PROTEIN ENG, V5, P489, DOI 10.1093/protein/5.6.489; MCCORD DM, 1990, J BIOL CHEM, V265, P10250; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; MORITA T, 1985, BIOCHEM BIOPH RES CO, V130, P841, DOI 10.1016/0006-291X(85)90493-0; NAGASHIMA M, 1993, J BIOL CHEM, V268, P2888; OHLIN AK, 1988, J BIOL CHEM, V263, P7411; PERSSON E, 1989, J BIOL CHEM, V264, P16897; PERSSON E, 1991, J BIOL CHEM, V266, P2444; REES DJG, 1988, EMBO J, V7, P2053, DOI 10.1002/j.1460-2075.1988.tb03045.x; SELANDERSUMNERH.M, 1992, J BIOL CHEM, V267; STENFLO J, 1987, P NATL ACAD SCI USA, V84, P368, DOI 10.1073/pnas.84.2.368; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266; YOSHIOKA A, 1985, BRIT J HAEMATOL, V59, P265, DOI 10.1111/j.1365-2141.1985.tb02993.x	30	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17727	17733						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349658				2022-12-27	WOS:A1993LT74300017
J	KRAMER, W; GIRBIG, F; GUTJAHR, U; KOWALEWSKI, S; JOUVENAL, K; MULLER, G; TRIPIER, D; WESS, G				KRAMER, W; GIRBIG, F; GUTJAHR, U; KOWALEWSKI, S; JOUVENAL, K; MULLER, G; TRIPIER, D; WESS, G			INTESTINAL BILE-ACID ABSORPTION - NA+-DEPENDENT BILE-ACID TRANSPORT ACTIVITY IN RABBIT SMALL-INTESTINE CORRELATES WITH THE COEXPRESSION OF AN INTEGRAL 93-KDA AND A PERIPHERAL 14-KDA BILE ACID-BINDING MEMBRANE-PROTEIN ALONG THE DUODENUM-ILEUM AXIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER MEMBRANE; BETA-LACTAM ANTIBIOTICS; RAT SMALL-INTESTINE; POLYACRYLAMIDE GELS; SALT TRANSPORT; FILM DETECTION; ILEAL CYTOSOL; IDENTIFICATION; SYSTEM; TAUROCHOLATE	The anatomical localization of the Na+/bile acid cotransport system from rabbit small intestine was determined using brush border membrane vesicles prepared from eight different segments of the small intestine. Na+-dependent transport activity for bile acids, both for [H-3]taurocholate and [H-3]cholate, was found in the distal segment 8 only representing the terminal 12% of the small intestine. In contrast, the Na+-dependent D-glucose transporter and the H+-dependent oligopeptide transporter were found over the whole length of rabbit small intestine in all segments. Photoaffinity labeling with 7,7-azo- and 3,3-azo-derivatives of taurocholate with subsequent fluorographic detection of labeled polypeptides after one- and two-dimensional gel electrophoresis showed that an integral membrane polypeptide of M(r) 87,000 is present in the entire small intestine, whereas an integral membrane protein of M(r) 93,000 together with a peripheral membrane protein of M(r) 14,000 are exclusively expressed in the distal small intestine correlating with Na+-dependent bile acid transport activity. Photoaffinity labeling with the cationic bile acid derivative 1-(7,7-azo-3alpha,12alpha-dihydroxy-5beta[3beta-H-3]cholan-24-oyl)-1,2-diaminoethane hydrochloride and 7,7-azo-3alpha,12beta-dihydroxy-5beta[12alpha-H-3]cholan-24-oic acid did not result in a specific labeling of the above mentioned proteins, demonstrating their specificity for physiological bile acids. Photoaffinity labeling of the 93- and 14-kDa bile acid-binding proteins was strongly Na+-dependent. Significant labeling of the 93- and 14-kDa proteins occurred only in the presence of Na+ ions with maximal labeling above 100 mM [Na+] showing a parallel [Na+] dependence to transport activity. Inactivation of Na+-dependent [H-3]taurocholate uptake by treatment of ileal brush border membrane vesicles with 4-nitrobenzo-2-oxa-1,3-diazol chloride led to a parallel decrease in the extent of photoaffinity labeling of both the 93- and 14-kDa protein. Sequence analysis of the membrane-bound 14-kDa bile acid-binding protein surprisingly revealed its identity with gastrotropin, a hydrophobic ligand-binding protein exclusively found in the cytosol from ileocytes and thought to be involved in the intracellular transport of bile acids from the brush border membrane to the basolateral pole of the ileocyte. In conclusion, the present studies suggest that both an integral 93- and a peripheral 14-kDa membrane protein, identified as gastrotropin, and both exclusively expressed in the terminal ileum, are essential components of the Na+/bile acid cotransport system in rabbit terminal ileum.			KRAMER, W (corresponding author), HOECHST AG, SBU METAB, D-65926 FRANKFURT, GERMANY.			Muller, Gunter/0000-0001-6178-8215				ABBERGER H, 1981, BILE ACIDS LIPIDS, P233; ABBERGER H, 1983, BILE ACIDS CHOLESTER, P77; ALLAN VJ, 1986, J CELL BIOL, V103, P2229, DOI 10.1083/jcb.103.6.2229; ANWER MS, 1986, HOPPESEYLERS Z PHYSL, V375, P1477; ARION WJ, 1989, METHOD ENZYMOL, V174, P58; BARNARD JA, 1987, GASTROENTEROLOGY, V93, P925, DOI 10.1016/0016-5085(87)90553-1; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURCKHARDT G, 1983, J BIOL CHEM, V258, P3618; BURCKHARDT G, 1987, BIOCHEM BIOPH RES CO, V143, P1018, DOI 10.1016/0006-291X(87)90353-6; BUSCHER HP, 1986, RECEPTOR MEDIATED UP, P189; CHAMBERLAIN JP, 1979, ANAL BIOCHEM, V98, P132, DOI 10.1016/0003-2697(79)90716-4; DEFIZE J, 1988, ENDOCRINOLOGY, V123, P2578, DOI 10.1210/endo-123-5-2578; ECKERSKORN C, 1989, CHROMATOGRAPHIA, V28, P92, DOI 10.1007/BF02290390; EGGERT M, 1991, FEBS LETT, V292, P205, DOI 10.1016/0014-5793(91)80868-4; EINARRSON K, 1991, CURR OPIN LIPIDOL, V2, P190; FIRPI A, 1975, J LIPID RES, V16, P379; FRICKER G, 1987, BIOL CHEM H-S, V368, P1143, DOI 10.1515/bchm3.1987.368.2.1143; GANTZ I, 1989, J BIOL CHEM, V264, P20248; HAASE W, 1978, BIOCHEM J, V172, P57, DOI 10.1042/bj1720057; Hofmann A F, 1976, Adv Intern Med, V21, P501; HOPFER U, 1973, J BIOL CHEM, V248, P25; KEELAN M, 1985, CAN J PHYSIOL PHARM, V63, P1528, DOI 10.1139/y85-251; KRAMER W, 1992, EUR J BIOCHEM, V204, P923, DOI 10.1111/j.1432-1033.1992.tb16713.x; KRAMER W, 1992, J BIOL CHEM, V267, P18598; KRAMER W, 1982, EUR J BIOCHEM, V129, P13, DOI 10.1111/j.1432-1033.1982.tb07015.x; KRAMER W, 1992, BIOCHIM BIOPHYS ACTA, V1111, P93, DOI 10.1016/0005-2736(92)90278-T; KRAMER W, 1987, BIOCHIM BIOPHYS ACTA, V905, P65, DOI 10.1016/0005-2736(87)90009-5; KRAMER W, 1988, BIOCHEM PHARMACOL, V37, P2427, DOI 10.1016/0006-2952(88)90370-X; KRAMER W, 1989, J LIPID RES, V30, P1281; KRAMER W, 1983, J LIPID RES, V24, P910; KRAMER W, 1983, J BIOL CHEM, V258, P3623; KRAMER W, 1982, H-S Z PHYSIOL CHEM, V363, P901; KRAMER W, 1980, H-S Z PHYSIOL CHEM, V361, P1307; KRAMER W, 1988, BIOCHIM BIOPHYS ACTA, V943, P288, DOI 10.1016/0005-2736(88)90560-3; KRAMER W, 1979, EUR J BIOCHEM, V102, P1, DOI 10.1111/j.1432-1033.1979.tb06257.x; KRAMER W, 1981, THESIS U FREIBURG, P1; LACK L, 1979, ENVIRON HEALTH PERSP, V33, P79, DOI 10.2307/3429075; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; LEWIS MC, 1990, AM J PHYSIOL, V259, pG233, DOI 10.1152/ajpgi.1990.259.2.G233; LIN MC, 1988, J MEMBRANE BIOL, V106, P1, DOI 10.1007/BF01871762; LIN MC, 1991, BIOCHIM BIOPHYS ACTA, V1078, P329, DOI 10.1016/0167-4838(91)90152-P; LIN MC, 1990, J BIOL CHEM, V265, P14986; LINDEN M, 1982, BIOCHEM J, V208, P77, DOI 10.1042/bj2080077; LOUVARD D, 1975, BIOCHIM BIOPHYS ACTA, V375, P236, DOI 10.1016/0005-2736(75)90192-3; MARUHN D, 1976, CLIN CHIM ACTA, V73, P453, DOI 10.1016/0009-8981(76)90147-9; Matern S, 1979, Rev Physiol Biochem Pharmacol, V85, P125, DOI 10.1007/BFb0036117; MCCLINTOCK C, 1983, AM J PHYSIOL, V244, pG507, DOI 10.1152/ajpgi.1983.244.5.G507; MURER H, 1976, BIOCHIM BIOPHYS ACTA, V433, P509, DOI 10.1016/0005-2736(76)90277-7; PIND S, 1987, BIOCHIM BIOPHYS ACTA, V901, P78, DOI 10.1016/0005-2736(87)90258-6; PIPER RC, 1992, J CELL BIOL, V117, P729, DOI 10.1083/jcb.117.4.729; SACCHETTINI JC, 1990, J BIOL CHEM, V265, P19199; SCHMASSMANN A, 1990, GASTROENTEROLOGY, V99, P1092, DOI 10.1016/0016-5085(90)90630-J; SCHWARZ LR, 1975, EUR J BIOCHEM, V55, P617, DOI 10.1111/j.1432-1033.1975.tb02199.x; SHULL GE, 1985, NATURE, V316, P691, DOI 10.1038/316691a0; TAJIMA S, 1986, J CELL BIOL, V103, P1167, DOI 10.1083/jcb.103.4.1167; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VLAHCEVIC ZR, 1990, HEPATOLOGY TXB LIVER, P341; VODENLICH AD, 1991, BIOCHEM BIOPH RES CO, V177, P1147, DOI 10.1016/0006-291X(91)90659-U; VONDIPPE P, 1983, J BIOL CHEM, V258, P8896; WALZ DA, 1988, J BIOL CHEM, V263, P14189; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WIDER MD, 1984, ENDOCRINOLOGY, V115, P1484, DOI 10.1210/endo-115-4-1484; WIELAND T, 1984, P NATL ACAD SCI-BIOL, V81, P5232, DOI 10.1073/pnas.81.16.5232; WILSON FA, 1981, AM J PHYSIOL, V241, pG83, DOI 10.1152/ajpgi.1981.241.2.G83; YAKYMYSHYN LM, 1982, BIOCHIM BIOPHYS ACTA, V690, P269, DOI 10.1016/0005-2736(82)90331-5; ZIEGLER K, 1989, BIOCHIM BIOPHYS ACTA, V980, P161, DOI 10.1016/0005-2736(89)90395-7	68	124	125	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18035	18046						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349683				2022-12-27	WOS:A1993LT74300060
J	TAKADA, T; IIDA, K; MOSS, J				TAKADA, T; IIDA, K; MOSS, J			CLONING AND SITE-DIRECTED MUTAGENESIS OF HUMAN ADP-RIBOSYLARGININE HYDROLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGATION-INDEPENDENT CLONING; GLUTATHIONE-S-TRANSFERASE; TURKEY ERYTHROCYTES; SKELETAL-MUSCLE; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; PROTEIN; RIBOSYLTRANSFERASE; PURIFICATION; NAD	Mono-ADP-ribosylation of arginine is a reversible modification of proteins with NAD:arginine ADP-ribosyltransferases and ADP-ribosylarginine hydrolases catalyzing the opposing reactions in the cycle. ADP-ribosylarginine hydrolases differ in their dithiothreitol (DTT) requirements. Rat and mouse hydrolases require DTT for maximal activity, but calf, guinea pig, and human hydrolases are DTT-independent. To define the molecular basis for these differences, brain ADP-ribosylarginine hydrolases were cloned. Deduced amino acid sequences of mouse and rat hydrolases were 94% identical with 5 conserved cysteines. The human hydrolase sequence was 83% identical to that of rat but contained only 4 cysteines with cysteine 108 in rat corresponding to serine 103 in human. To investigate the role of rat cysteine 108, human and rat wild-type hydrolases and mutants, in which serine 103 in human was replaced by cysteine (S103C) and cysteine 108 in rat was replaced by serine (C108S), were expressed in Escherichia coli. Affinity-purified anti-rat brain hydrolase antibodies reacted with recombinant wild-type rat hydrolase, but only weakly with the C108S mutant. They did not react with human wild-type or the S103C mutant. Human hydrolase and rat C108S were DTT-independent; human S103C was, however, DTT-dependent. These data clearly show that cysteine 108 in rat hydrolase plays a critical role in DTT dependence and may be important in immunoreactivity.			TAKADA, T (corresponding author), NHLBI,CELLULAR METAB LAB,BETHESDA,MD 20892, USA.							AKTORIES K, 1990, ADP RIBOSYLATING TOX, P97; CHANG YC, 1986, BIOCHEM BIOPH RES CO, V139, P932, DOI 10.1016/S0006-291X(86)80267-4; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLIER RJ, 1990, ADP RIBOSYLATING TOX, P3, DOI DOI 10.1126/SCIENCE.250.4982.841-A; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; HAUN RS, 1992, BIOTECHNIQUES, V13, P515; HAUN RS, 1992, GENE, V112, P37, DOI 10.1016/0378-1119(92)90300-E; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; JACOBSON MK, 1990, J BIOL CHEM, V265, P10825; LEE FJS, 1992, BIOTECHNIQUES, V13, P844; LOWERY RG, 1990, ADP RIBOSYLATING TOX, P459; MOSS J, 1979, J BIOL CHEM, V254, P8891; MOSS J, 1988, BIOCHEMISTRY-US, V27, P5819, DOI 10.1021/bi00415a063; MOSS J, 1980, J BIOL CHEM, V255, P5838; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; MOSS J, 1986, BIOCHEMISTRY-US, V25, P5408, DOI 10.1021/bi00367a010; MOSS J, 1992, J BIOL CHEM, V267, P10481; MOSS J, 1985, P NATL ACAD SCI USA, V82, P5603, DOI 10.1073/pnas.82.17.5603; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; OKAZAKI IJ, 1993, FASEB J, V7, pA1042; PAYNE DM, 1985, BIOCHEMISTRY-US, V24, P7540, DOI 10.1021/bi00347a006; PETERSON JE, 1990, J BIOL CHEM, V265, P17062; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMITH KP, 1985, BIOCHEM BIOPH RES CO, V126, P136, DOI 10.1016/0006-291X(85)90582-0; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; TANIGAWA Y, 1984, J BIOL CHEM, V259, P2022; TANUMA S, 1990, FEBS LETT, V261, P381, DOI 10.1016/0014-5793(90)80597-C; TANUMA S, 1988, J BIOL CHEM, V263, P5485; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEST RE, 1986, BIOCHEMISTRY-US, V25, P8057, DOI 10.1021/bi00372a039; Williamson K., 1990, ADP RIBOSYLATING TOX, P493; YOST DA, 1983, J BIOL CHEM, V258, P4926; ZOLKIEWSKA A, 1992, P NATL ACAD SCI USA, V89, P11352, DOI 10.1073/pnas.89.23.11352	34	48	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17837	17843						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349667				2022-12-27	WOS:A1993LT74300032
J	UHLINHANSEN, L; YANAGISHITA, M				UHLINHANSEN, L; YANAGISHITA, M			DIFFERENTIAL EFFECT OF BREFELDIN-A ON THE BIOSYNTHESIS OF HEPARAN-SULFATE AND CHONDROITIN DERMATAN SULFATE PROTEOGLYCANS IN RAT OVARIAN GRANULOSA-CELLS IN CULTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LINKAGE REGION; ENDOPLASMIC-RETICULUM; SHARK CARTILAGE; GOLGI PROTEINS; TRANSPORT; ER	The subcellular localization of the enzymes involved in the glycosylation of proteoglycans was studied in rat ovarian granulosa cells by interfering with the normal traffic in the Golgi apparatus using brefeldin A. Cell cultures were metabolically labeled with [S-35] sulfate and [H-3]glucosamine, and the radiolabeled macromolecules were analyzed by ion-exchange and gel chromatography in combination with chondroitinase or heparitinase treatment. In the absence of brefeldin A, the cells synthesized both dermatan sulfate proteoglycans (DSPGs) and heparan sulfate proteoglycans (HSPGs) which were isolated from the culture medium, the plasma membrane, and intracellular compartments. However, in the presence of brefeldin A, the synthesized proteoglycans were almost exclusively HSPGs and were found only in the intracellular compartment. Analyses of HSPGs synthesized in the presence of brefeldin A indicated that: (i) the HS chains are synthesized on the same core protein as for the normal HSPGs; (ii) the chains are two to three times the normal molecular size; and (iii) a significant proportion of the HS chains are normally sulfated. Brefeldin A induces a disassembly of the proximal part of the Golgi complex, resulting in a redistribution of cis-, medial-, and trans-Golgi resident enzymes back to the endoplasmic reticulum (ER), and blocks the transport of proteins to the trans-Golgi network. Our results indicate that the complete set of enzymes involved in the biosynthesis of HS chains are localized in the ER/proximal part of the Golgi complex, whereas the enzymes involved in the elongation/sulfation of DS chains are exclusively located in the trans-Golgi network. Furthermore, our results indicate that the enzymes involved in the biosynthesis of HS chains are specific to HS core proteins, since no DS core proteins were substituted with HS chains in the presence of brefeldin A.	NIDR,BONE RES BRANCH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)								CARLSON DM, 1968, J BIOL CHEM, V243, P616; CHEGE NW, 1990, J CELL BIOL, V111, P893, DOI 10.1083/jcb.111.3.893; DEWAARD P, 1992, J BIOL CHEM, V267, P6036; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; FRANSSON LA, 1992, BIOCHIM BIOPHYS ACTA, V1137, P287, DOI 10.1016/0167-4889(92)90149-6; HIRSCHBERG CB, 1987, ANNU REV BIOCHEM, V56, P63, DOI 10.1146/annurev.bi.56.070187.000431; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIDHOLT K, 1988, BIOCHEM J, V254, P571, DOI 10.1042/bj2540571; Lindahl U., 1989, HEPARIN, P159; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Roden L., 1980, BIOCH GLYCOPROTEINS, P267; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; SPIRO RC, 1991, J CELL BIOL, V115, P1463, DOI 10.1083/jcb.115.5.1463; SUGAHARA K, 1992, J BIOL CHEM, V267, P6027; SUGUMARAN G, 1992, J BIOL CHEM, V267, P8802; YANAGISHITA M, 1989, J BIOL CHEM, V264, P17551; YANAGISHITA M, 1979, J BIOL CHEM, V254, P2355; YANAGISHITA M, 1987, METHOD ENZYMOL, V138, P279; YANAGISHITA M, 1984, J BIOL CHEM, V259, P270; YANAGISHITA M, 1983, J BIOL CHEM, V258, P2847; YANAGISHITA M, 1984, J BIOL CHEM, V259, P260	25	54	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17370	17376						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349620				2022-12-27	WOS:A1993LQ98800072
J	MA, XJ; SAITOH, N; CURTIS, PJ				MA, XJ; SAITOH, N; CURTIS, PJ			PURIFICATION AND CHARACTERIZATION OF A NUCLEAR DNA-BINDING FACTOR COMPLEX CONTAINING TOPOISOMERASE-II AND CHROMOSOME SCAFFOLD PROTEIN-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP ANCHORAGE; GLOBIN GENES; SV40 DNA; DIFFERENTIATION; REPLICATION; YEAST; EXPRESSION; ENZYMES; SITES; CELLS	In a search for factors that influence the process of erythroid differentiation at the molecular level, we have identified UB2, a nuclear protein factor that was originally observed for its ability to bind to a very specific and highly conserved sequence motif present in human, mouse, rabbit, and chicken beta-globin genes, as well as carbonic anhydrase I, c-myb, and the immunoglobulin heavy chain enhancer region. It was also observed for its appearance in undifferentiated but not differentiated mouse erythroleukemia cells. Purification of UB2 by DEAE-cellulose chromatography and repeated passages through a DNA affinity column, revealed a complex pattern with three major components of 170, 116, and 48 kDa, respectively. The 170-kDa protein was identified as topoisomerase (topo) II by Western blot analysis, catalytic assays, and antibody interference with UB2 binding. The complex topo II in UB2, however, has a more stringent sequence requirement for DNA binding than does topo II. The 116-kDa protein has been determined to be a proteolytic product of topo II. The chromosome scaffold protein 2 (135 kDa) copurified with UB2, and anti-scaffold protein 2 serum inhibited UB2 binding to DNA.	WISTAR INST,3601 SPRUCE ST,PHILADELPHIA,PA 19104; JOHNS HOPKINS UNIV,SCH MED,DEPT CELL BIOL & ANAT,BALTIMORE,MD 21205	The Wistar Institute; Johns Hopkins University					NIGMS NIH HHS [GM30985] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030985] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI Y, 1989, EMBO J, V8, P3997, DOI 10.1002/j.1460-2075.1989.tb08582.x; ADACHI Y, 1991, CELL, V64, P137, DOI 10.1016/0092-8674(91)90215-K; BERRIOS M, 1985, P NATL ACAD SCI USA, V82, P4145; CASTORA FJ, 1983, BIOCHIM BIOPHYS ACTA, V740, P417, DOI 10.1016/0167-4781(83)90090-8; CHAMBON P, 1966, BIOCHEM BIOPH RES CO, V25, P638, DOI 10.1016/0006-291X(66)90502-X; CHUNG TDY, 1989, P NATL ACAD SCI USA, V86, P9431, DOI 10.1073/pnas.86.23.9431; COCKERILL PN, 1987, J BIOL CHEM, V262, P5394; COCKERILL PN, 1986, CELL, V44, P273, DOI 10.1016/0092-8674(86)90761-0; DINARDO S, 1984, P NATL ACAD SCI-BIOL, V81, P2616, DOI 10.1073/pnas.81.9.2616; DRAKE FH, 1989, BIOCHEMISTRY-US, V28, P8154, DOI 10.1021/bi00446a029; EARNSHAW WC, 1985, J CELL BIOL, V100, P1706, DOI 10.1083/jcb.100.5.1706; EARNSHAW WC, 1985, J CELL BIOL, V100, P1716, DOI 10.1083/jcb.100.5.1716; EKI T, 1991, J BIOL CHEM, V266, P3087; ENGLUND PT, 1982, ANNU REV BIOCHEM, V51, P695, DOI 10.1146/annurev.bi.51.070182.003403; FRAZER P, 1987, GENE DEV, V1, P855; FUJIMURA S, 1967, BIOCHIM BIOPHYS ACTA, V145, P247, DOI 10.1016/0005-2787(67)90043-3; GALE KC, 1992, J BIOL CHEM, V267, P12090; GASSER SM, 1986, EMBO J, V5, P511, DOI 10.1002/j.1460-2075.1986.tb04240.x; GOTO T, 1984, CELL, V36, P1073, DOI 10.1016/0092-8674(84)90057-6; HARLAND RM, 1983, NATURE, V302, P38, DOI 10.1038/302038a0; HAYAISHI O, 1977, ANNU REV BIOCHEM, V46, P95, DOI 10.1146/annurev.bi.46.070177.000523; HOLM C, 1985, CELL, V41, P553, DOI 10.1016/S0092-8674(85)80028-3; INOUYE S, 1987, SYNTHESIS APPLICATIO, P181; JARMAN AP, 1988, EMBO J, V7, P3337, DOI 10.1002/j.1460-2075.1988.tb03205.x; JAZWINSKI SM, 1984, J BIOL CHEM, V259, P6852; KAGUNI JM, 1984, CELL, V38, P183, DOI 10.1016/0092-8674(84)90539-7; KAS E, 1992, EMBO J, V11, P705, DOI 10.1002/j.1460-2075.1992.tb05103.x; KIRSCH IR, 1986, J CELL BIOCHEM, V32, P11, DOI 10.1002/jcb.240320103; LACHMAN HM, 1984, NATURE, V310, P592, DOI 10.1038/310592a0; Laemmli U. K., 1978, COLD SPRING HARB SYM, V42, P109; LEWIS CD, 1982, CELL, V29, P171, DOI 10.1016/0092-8674(82)90101-5; LIU LF, 1983, CRC CR REV BIOCH MOL, V15, P1, DOI 10.3109/10409238309102799; LUCHNIK AN, 1982, EMBO J, V39, P223; MA XJ, 1991, DIFFERENTIATION, V47, P135, DOI 10.1111/j.1432-0436.1991.tb00231.x; MARKS PA, 1978, ANNU REV BIOCHEM, V47, P419, DOI 10.1146/annurev.bi.47.070178.002223; MATTERN MR, 1979, BIOCHIM BIOPHYS ACTA, V563, P306, DOI 10.1016/0005-2787(79)90049-2; MATTERN MR, 1982, BIOCHIM BIOPHYS ACTA, V697, P6, DOI 10.1016/0167-4781(82)90038-0; MAXWELL A, 1986, ADV PROTEIN CHEM, V38, P69, DOI 10.1016/S0065-3233(08)60526-4; NEGRI C, 1992, EXP CELL RES, V200, P452, DOI 10.1016/0014-4827(92)90195-E; NISHIO A, 1982, BIOCHEM BIOPH RES CO, V106, P1448, DOI 10.1016/0006-291X(82)91276-1; NISHIZUK.Y, 1967, J BIOL CHEM, V242, P3164; NOGUCHI H, 1983, CELL, V32, P443, DOI 10.1016/0092-8674(83)90464-6; ORD MG, 1977, BIOCHEM J, V161, P583, DOI 10.1042/bj1610583; ORR E, 1979, MOL GEN GENET, V177, P103, DOI 10.1007/BF00267259; OTAKE H, 1969, J BIOCHEM-TOKYO, V65, P145; RAMSAY RG, 1986, P NATL ACAD SCI USA, V83, P6849, DOI 10.1073/pnas.83.18.6849; SANDER M, 1985, NUCLEIC ACIDS RES, V13, P1057, DOI 10.1093/nar/13.4.1057; SHLOMAI J, 1983, NUCLEIC ACIDS RES, V11, P4019, DOI 10.1093/nar/11.12.4019; SINDEN RR, 1987, J CHEM EDUC, V64, P294, DOI 10.1021/ed064p294; SPECK WT, 1982, MUTAT RES, V104, P125, DOI 10.1016/0165-7992(82)90132-4; SUNDIN O, 1981, CELL, V25, P659, DOI 10.1016/0092-8674(81)90173-2; THOMPSON RJ, 1985, NUCLEIC ACIDS RES, V13, P873, DOI 10.1093/nar/13.3.873; UDVARDY A, 1985, CELL, V40, P933, DOI 10.1016/0092-8674(85)90353-8; UEMURA T, 1984, EMBO J, V3, P1737, DOI 10.1002/j.1460-2075.1984.tb02040.x; VOSBERG HP, 1985, CURR TOP MICROBIOL, V114, P19; WANG JC, 1987, BIOCHIM BIOPHYS ACTA, V909, P1, DOI 10.1016/0167-4781(87)90040-6; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665	57	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1993	268	9					6182	6188						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KT368	8384202				2022-12-27	WOS:A1993KT36800019
J	BIALEK, G; GROSSE, F				BIALEK, G; GROSSE, F			AN ERROR-CORRECTING PROOFREADING EXONUCLEASE-POLYMERASE THAT COPURIFIES WITH DNA-POLYMERASE-ALPHA-PRIMASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; REPLICATION FACTOR-C; CALF THYMUS; SACCHAROMYCES-CEREVISIAE; 3'->5' EXONUCLEASE; DROSOPHILA-MELANOGASTER; AUXILIARY PROTEIN; DELTA; PURIFICATION; EPSILON	A DNA polymerase with a 3'- to 5'-exonuclease that copurified with polymerase-primase from calf thymus was purified and extensively characterized. Its exonuclease degraded single-stranded DNA from 3' to 5' in a strictly distributive manner. On synthetic template-primer junctions, 3'-terminal mispairs were excised with a 10- to 20-fold preference over correctly paired nucleotides. In comparison to the 3'- to 5'-exonuclease the DNA polymerase activity was rather low. The ratio of nucleotides incorporated to nucleotides excised was in the order of 1 to 3 nucleotide insertions per excision, suggesting that net forward DNA synthesis is not the primary role of this DNA polymerase. DNA synthesis was performed with a low processivity in the presence and absence of PCNA. Both the polymerase and exonuclease activities were inhibited to a comparable extent by AMP. Thus, the exonuclease-polymerase might represent a novel DNA polymerase that we tentatively designate as DNA polymerase zeta. Possible benefits of DNA polymerase zeta in the process of error correction and the apparent dichotomy of an built-in proofreading activity for the processive DNA polymerases gamma, delta, and epsilon and an obviously external proofreading function for the less processive animal cell DNA polymerases alpha and beta are discussed.	GERMAN PRIMATE CTR, DEPT VIROL & IMMUNOL, W-3400 GOTTINGEN, GERMANY	Deutsches Primatenzentrum (DPZ)								BAMBARA RA, 1991, BIOCHIM BIOPHYS ACTA, V1088, P11, DOI 10.1016/0167-4781(91)90147-E; BIALEK G, 1989, EMBO J, V8, P1833, DOI 10.1002/j.1460-2075.1989.tb03578.x; BIALEK G, 1992, J BIOL CHEM, V267, P2915; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKE RG, 1991, J BIOL CHEM, V266, P3005; Burgers P M, 1989, Prog Nucleic Acid Res Mol Biol, V37, P235; BURGERS PMJ, 1990, EUR J BIOCHEM, V191, P617, DOI 10.1111/j.1432-1033.1990.tb19165.x; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; BYRNES JJ, 1977, BIOCHEMISTRY-US, V16, P3740, DOI 10.1021/bi00636a002; CHEN M, 1992, P NATL ACAD SCI USA, V89, P2516, DOI 10.1073/pnas.89.7.2516; CHEN YC, 1979, J BIOL CHEM, V254, P1678; COTTERILL SM, 1987, P NATL ACAD SCI USA, V84, P5635, DOI 10.1073/pnas.84.16.5635; CRUTE JJ, 1986, BIOCHEMISTRY-US, V25, P26, DOI 10.1021/bi00349a005; DENG GR, 1983, METHOD ENZYMOL, V100, P96; GOSCIN LP, 1982, BIOCHEMISTRY-US, V21, P2513, DOI 10.1021/bi00539a034; GOULIAN M, 1990, J BIOL CHEM, V265, P16402; GROSSE F, 1981, BIOCHEMISTRY-US, V20, P5470, DOI 10.1021/bi00522a019; GROSSE F, 1983, EMBO J, V2, P1515, DOI 10.1002/j.1460-2075.1983.tb01616.x; HOHN KT, 1987, BIOCHEMISTRY-US, V26, P2870, DOI 10.1021/bi00384a031; HUBSCHER U, 1992, TRENDS BIOCHEM SCI, V17, P55, DOI 10.1016/0968-0004(92)90499-Y; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Kornberg A., 1991, DNA REPLICATION; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE MYWT, 1987, BIOCHEMISTRY-US, V26, P1076, DOI 10.1021/bi00378a014; LEE MYWT, 1984, BIOCHEMISTRY-US, V23, P1906, DOI 10.1021/bi00304a003; LEE MYWT, 1985, NUCLEIC ACIDS RES, V13, P8623, DOI 10.1093/nar/13.23.8623; LEE SH, 1991, J BIOL CHEM, V266, P22707; LEE SH, 1990, P NATL ACAD SCI USA, V87, P5672, DOI 10.1073/pnas.87.15.5672; LEHMAN IR, 1989, J BIOL CHEM, V264, P4265; LINN S, 1991, CELL, V66, P185, DOI 10.1016/0092-8674(91)90608-2; Maniatis T., 1982, MOL CLONING; MORRISON A, 1990, CELL, V62, P1143, DOI 10.1016/0092-8674(90)90391-Q; NASHEUER HP, 1987, BIOCHEMISTRY-US, V26, P8458, DOI 10.1021/bi00399a064; NICKEL W, 1992, J BIOL CHEM, V267, P848; OTTIGER H, 1987, NUCLEIC ACIDS RES, V15, P4789, DOI 10.1093/nar/15.12.4789; OTTIGER HP, 1984, P NATL ACAD SCI-BIOL, V81, P3993, DOI 10.1073/pnas.81.13.3993; PERRINO FW, 1990, BIOCHEMISTRY-US, V29, P5226, DOI 10.1021/bi00474a002; PERRINO FW, 1989, P NATL ACAD SCI USA, V86, P3085, DOI 10.1073/pnas.86.9.3085; PERRINO FW, 1989, J BIOL CHEM, V264, P2898; PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; RADMAN M, 1978, NATL CANCER I MONOGR, V50, P121; RECKMANN B, 1983, NUCLEIC ACIDS RES, V11, P7251, DOI 10.1093/nar/11.20.7251; REYLAND ME, 1988, J BIOL CHEM, V263, P6518; SABATINO RD, 1990, CANCER RES, V50, P5340; SABATINO RD, 1988, BIOCHEMISTRY-US, V27, P2266, DOI 10.1021/bi00407a003; SCHOMBURG U, 1986, EUR J BIOCHEM, V160, P451, DOI 10.1111/j.1432-1033.1986.tb10061.x; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SKARNES W, 1986, J BIOL CHEM, V261, P6629; SYVAOJA J, 1990, P NATL ACAD SCI USA, V87, P6664, DOI 10.1073/pnas.87.17.6664; TAN CK, 1986, J BIOL CHEM, V261, P2310; THOMAS DC, 1991, BIOCHEMISTRY-US, V30, P11751, DOI 10.1021/bi00115a003; TSURIMOTO T, 1989, EMBO J, V8, P3883, DOI 10.1002/j.1460-2075.1989.tb08567.x; WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513; WRIGHT GE, 1990, PHARMACOL THERAPEUT, V47, P447, DOI 10.1016/0163-7258(90)90066-B; YODER BL, 1991, J BIOL CHEM, V266, P22689	56	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1993	268	8					6024	6033						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR822	8383685				2022-12-27	WOS:A1993KR82200098
J	EYTAN, E; ARMON, T; HELLER, H; BECK, S; HERSHKO, A				EYTAN, E; ARMON, T; HELLER, H; BECK, S; HERSHKO, A			UBIQUITIN-C-TERMINAL HYDROLASE ACTIVITY ASSOCIATED WITH THE 26-S PROTEASE COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTICATALYTIC PROTEINASE COMPLEX; DEPENDENT PROTEOLYSIS; GENE SYNTHESIS; 26S COMPLEX; ATP; RESOLUTION; SYSTEM; DEGRADATION; BREAKDOWN; IDENTIFICATION	In the ubiquitin (Ub) system for protein degradation, proteins ligated to Ub are degraded by an ATP-dependent 26 S protease complex. During or after proteolysis, free Ub is regenerated, but the mechanisms of Ub release remained unknown. It was previously observed that free Ub is released from a Ub-histone conjugate by an ATP-dependent activity present in partially purified preparations of 26 S complex, but the relationship of this activity to protein breakdown was not established. We now show that purified preparations of 26 S complex release free Ub from conjugates that are good substrates for proteolysis, such as conjugates of lysozyme with reductively methylated Ub. The activity that releases free Ub co-migrates with the 26 S protease complex in glycerol density gradient centrifugation, indicating that the responsible Ub C-terminal hydrolase is an integral part of the 26 S complex. Complex-associated hydrolase can also act on adducts in which a single Ub unit is attached to protein, such as a bacterially expressed construct in which the C terminus of Ub is fused to the alpha-NH2 group of a fragment of Ub that contains 60% of its N-terminal region. In all cases, Ub release is insensitive to Ub-aldehyde (an inhibitor of some Ub C-terminal hydrolases) and is stimulated by MgATP. ATP cannot be replaced by beta,gamma-nonhydrolyzable analogs, but it can be substituted by CTP and GTP. The nucleotide specificity of Ub release by the 26 S complex is similar to that observed previously for conjugate proteolysis and nucleotide hydrolysis. It thus seems that the activity of the Ub C-terminal hydrolase associated with the 26 S complex is tightly coupled to the proteolytic action of the complex, and it may have a role in the release of Ub from linkage to amino groups of the protein substrate at the final stages of the Ub proteolytic pathway.	TECHNION ISRAEL INST TECHNOL,B RAPPAPORT FAC MED,DEPT BIOCHEM,IL-31086 HAIFA,ISRAEL; TECHNION ISRAEL INST TECHNOL,RAPPAPORT INST RES MED SCI,IL-31086 HAIFA,ISRAEL	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology					NIDDK NIH HHS [DK25614] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025614] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGELL N, 1988, P NATL ACAD SCI USA, V85, P3693, DOI 10.1073/pnas.85.11.3693; ARMON T, 1990, J BIOL CHEM, V265, P20723; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; DEWALD DB, 1986, ANAL BIOCHEM, V154, P502, DOI 10.1016/0003-2697(86)90022-9; DRISCOLL J, 1992, P NATL ACAD SCI USA, V89, P4986, DOI 10.1073/pnas.89.11.4986; DRISCOLL J, 1990, J BIOL CHEM, V265, P4789; ECKER DJ, 1987, J BIOL CHEM, V262, P14213; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; GANOTH D, 1988, J BIOL CHEM, V263, P12412; HAAS AL, 1981, P NATL ACAD SCI-BIOL, V78, P6845, DOI 10.1073/pnas.78.11.6845; HADARI T, 1992, J BIOL CHEM, V267, P719; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P1619, DOI 10.1073/pnas.81.6.1619; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HOUGH R, 1986, J BIOL CHEM, V261, P2400; HOUGH R, 1987, J BIOL CHEM, V262, P8303; HUNTER AJ, 1985, ANAL BIOCHEM, V150, P394, DOI 10.1016/0003-2697(85)90527-5; JONNALAGADDA S, 1989, J BIOL CHEM, V264, P10637; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAYER AN, 1989, BIOCHEMISTRY-US, V28, P166, DOI 10.1021/bi00427a024; MONIA BP, 1989, J BIOL CHEM, V264, P4093; ORLOWSKI M, 1990, BIOCHEMISTRY-US, V29, P10289, DOI 10.1021/bi00497a001; PICKART CM, 1985, J BIOL CHEM, V260, P7903; PICKART CM, 1986, J BIOL CHEM, V261, P210; REDMAN KL, 1989, NATURE, V338, P438, DOI 10.1038/338438a0; Rose I. A., 1988, UBIQUITIN, P135; ROSE IA, 1987, P NATL ACAD SCI USA, V84, P1477, DOI 10.1073/pnas.84.6.1477; ROSE IA, 1988, UBIQUITIN SYSTEM, P111; WILKINSON KD, 1986, BIOCHEMISTRY-US, V25, P6644, DOI 10.1021/bi00369a047	33	115	122	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1993	268	7					4668	4674						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP884	8383122				2022-12-27	WOS:A1993KP88400020
J	HU, ZW; SHI, XY; SAKAUE, M; HOFFMAN, BB				HU, ZW; SHI, XY; SAKAUE, M; HOFFMAN, BB			PROLONGED ACTIVATION OF PROTEIN-KINASE-C INDUCES TRANSCRIPTION AND EXPRESSION OF THE ALPHA-1B ADRENERGIC-RECEPTOR GENE IN DDT1 MF-2 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; CARDIAC MYOCYTE HYPERTROPHY; PHORBOL ESTER; GROWTH-FACTOR; ALPHA-1-ADRENERGIC STIMULATION; BETA-2-ADRENERGIC RECEPTORS; INOSITOL PHOSPHATES; SIGNAL TRANSDUCTION; ANGIOTENSIN-II; RAT-HEART	Protein kinase C (PKC) regulates many cellular functions; we have examined the role of PKC in the regulation of the alpha1B adrenergic receptor gene. Exposure of DDT1 MF-2 cells to phorbol 12-myristate 13-acetate (PMA) (10 nM) increased values of alpha1B receptor mRNA with peak changes found at 4 h (3.2-fold increase). Increased values of alpha1B receptor mRNA occurred at PMA concentrations as low as 10 pM with a maximal response at 100 nm. Also, PMA induced a time-dependent increase in the number of alpha1B receptors. Stimulation of cells with phenylephrine led to an increase in IP3 production after 3, 6, and 12 h of treatment with PMA. Induction of the alpha1B receptor mRNA was suppressed by the PKC inhibitors H7 (1-(5-isoquinolinylsulsulfonyl)2-methylpiperazine) and saurosporine; the inactive phorbol ester 4alpha-phorbol didecanoate and calcium ionophores A23187 and Bay K8644 did not increase alpha1B receptor mRNA. The half-life of the alpha1B receptor mRNA was unchanged by PMA. Nuclear runoff assays demonstrated that PMA produced a marked increase in the transcription rate of alpha1B receptor gene. These results suggest that the induction of alpha1B adrenergic receptor expression is mediated by a PKC-dependent mechanism that occurs at the level of transcription.	VET ADM MED CTR, GRECC 182B, 3801 MIRANDA AVE, PALO ALTO, CA 94304 USA; STANFORD UNIV, MED CTR, SCH MED, DEPT MED, STANFORD, CA 94305 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Stanford University					NHLBI NIH HHS [HL41315] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041315] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLEN LF, 1991, P NATL ACAD SCI USA, V88, P11354, DOI 10.1073/pnas.88.24.11354; BAUCH HJ, 1987, EXP PATHOL-JENA, V31, P193, DOI 10.1016/S0232-1513(87)80001-4; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BERRY N, 1990, P NATL ACAD SCI USA, V87, P2294, DOI 10.1073/pnas.87.6.2294; BJORGE JD, 1987, J BIOL CHEM, V262, P6615; BOUVIER M, 1987, J BIOL CHEM, V262, P3106; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLUCCI WS, 1988, BIOCHEM BIOPH RES CO, V159, P924; COWLEN MS, 1987, J PHARMACOL EXP THER, V243, P527; COWLEN MS, 1988, MOL PHARMACOL, V34, P340; DEAN NM, 1989, ANAL BIOCHEM, V183, P199, DOI 10.1016/0003-2697(89)90468-5; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; EXTON JH, 1990, J BIOL CHEM, V265, P1; FARAGO A, 1990, FEBS LETT, V268, P350, DOI 10.1016/0014-5793(90)81284-U; FOLKOW B, 1982, PHYSIOL REV, V62, P347, DOI 10.1152/physrev.1982.62.2.347; GREENBERG ME, 1989, CURRENT PROTOCOLS MO; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HENRICH CJ, 1988, J MOL CELL CARDIOL, V20, P1081, DOI 10.1016/0022-2828(88)90588-3; HEPLER JR, 1988, J BIOL CHEM, V263, P7610; HOUSLAY MD, 1991, EUR J BIOCHEM, V196, P9; IKEDA U, 1991, AM J PHYSIOL, V260, pH953, DOI 10.1152/ajpheart.1991.260.3.H953; JACOBSON A, 1987, METHOD ENZYMOL, V152, P254; KIKKAWA U, 1986, ANNU REV CELL BIOL, V2, P149, DOI 10.1146/annurev.cb.02.110186.001053; KUO TH, 1991, J BIOL CHEM, V266, P2520; LAKS MM, 1973, CHEST, V64, P75, DOI 10.1378/chest.64.1.75; LEEBLUNDBERG LMF, 1987, J BIOL CHEM, V262, P3098; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; MAJESKY MW, 1990, J BIOL CHEM, V265, P1082; MINNEMAN KP, 1988, PHARMACOL REV, V40, P87; MOALIC JM, 1989, J HYPERTENS, V7, P195; MORRIS GM, 1991, J BIOL CHEM, V266, P2233; OGITA K, 1990, ADV SEC MESS PHOSPH, V24, P218; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; RODGERS JR, 1985, METHOD ENZYMOL, V109, P572; ROSENBAUM JS, 1987, BIOCHEM PHARMACOL, V36, P4335, DOI 10.1016/0006-2952(87)90681-2; RUFFOLO RR, 1991, PHARMACOL REV, V43, P475; SAKAUE M, 1991, J CLIN INVEST, V88, P385, DOI 10.1172/JCI115315; SHEARMAN MS, 1989, PHARMACOL REV, V41, P211; SIMPSON PC, 1989, J MOL CELL CARDIOL, V21, P79, DOI 10.1016/0022-2828(89)90774-8; TAYLOR SH, 1990, AM HEART J, V119, P655, DOI 10.1016/S0002-8703(05)80289-3; TSUDA T, 1990, J BIOL CHEM, V265, P1165; VANKLEEF EM, 1992, CIRC RES, V70, P1122, DOI 10.1161/01.RES.70.6.1122; VOGT PK, 1989, TRENDS BIOCHEM SCI, V14, P172, DOI 10.1016/0968-0004(89)90268-5; WEINSTEIN IB, 1990, ADV SEC MESS PHOSPH, V24, P307; YOSHIMASA T, 1988, MOL BIOL BRAIN ENDOC, P123	46	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3610	3615						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381435				2022-12-27	WOS:A1993KM16100089
J	TIHANYI, K; BOURBONNIERE, M; HOUDE, A; RANCOURT, C; WEBER, JM				TIHANYI, K; BOURBONNIERE, M; HOUDE, A; RANCOURT, C; WEBER, JM			ISOLATION AND PROPERTIES OF ADENOVIRUS TYPE-2 PROTEINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; POLYACRYLAMIDE GELS; PURIFICATION; CLEAVAGE; CYSTEINE; CELLS	We have cloned and expressed the human adenovirus type 2 proteinase gene in Escherichia coli. The expressed proteinase was isolated by a four-step chromatographic procedure. Purity and identity of the recombinant protein was established by two-dimensional gel electrophoresis, N-terminal sequencing, and specific antisera. The pure enzyme did not contain disulfide bridges, and it consisted of one subunit with a pI of 10.2. It did not show any sign of autocleavage. Labeled iodoacetate bound the pure enzyme while labeled diisopropyl fluorophosphate did not. The protease readily cleaved the viral pVII protein, ovalbumin, fibrin, and actin but had no effect on synthetic penta-, octa-, or nonapeptides carrying the consensus sequence for cleavage. The inhibitory profile of the isolated proteinase and the affinity labeling clearly indicate that the human adenovirus type 2 proteinase is a cysteine rather than a serine proteinase as previously believed. The most likely candidate for an active site residue is one of the two conserved cysteines, Cys-104 or Cys-122.	UNIV SHERBROOKE, FAC MED, DEPT MICROBIOL, SHERBROOKE J1H 5N4, QUEBEC, CANADA	University of Sherbrooke								ANDERSON CW, 1990, VIROLOGY, V177, P259, DOI 10.1016/0042-6822(90)90479-B; ANDERSON CW, 1973, J VIROL, V12, P241, DOI 10.1128/JVI.12.2.241-252.1973; ASHALL F, 1990, MOL BIOCHEM PARASIT, V38, P77, DOI 10.1016/0166-6851(90)90207-3; Beynon R.J., 1989, PROTEOLYTIC ENZYMES, P241; BHATTI AR, 1979, J BIOL CHEM, V254, P2265; BOUDIN ML, 1980, VIROLOGY, V101, P144, DOI 10.1016/0042-6822(80)90491-2; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CAI F, 1992, BIOCHIM BIOPHYS ACTA, V1129, P339, DOI 10.1016/0167-4781(92)90514-Z; CHAIKEN IM, 1969, J BIOL CHEM, V244, P4247; CHATTERJEE PK, 1987, P NATL ACAD SCI USA, V84, P714, DOI 10.1073/pnas.84.3.714; COLEMAN P, 1979, BIOCHIM BIOPHYS ACTA, V569, P41, DOI 10.1016/0005-2744(79)90079-2; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FAHEY RC, 1977, J MOL EVOL, V10, P155, DOI 10.1007/BF01751808; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GOULD NR, 1965, BIOCHEMISTRY-US, V4, P90, DOI 10.1021/bi00877a016; HANNAN C, 1983, INTERVIROLOGY, V19, P213, DOI 10.1159/000149363; HOUDE A, 1990, GENE, V88, P269, DOI 10.1016/0378-1119(90)90042-P; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUACES AL, 1988, BIOCHEM J, V250, P903, DOI 10.1042/bj2500903; MARSTON FAO, 1986, BIOCHEM J, V240, P1, DOI 10.1042/bj2400001; MARSTON FAO, 1984, BIO-TECHNOL, V2, P800, DOI 10.1038/nbt0984-800; MIRZA A, 1980, INTERVIROLOGY, V13, P307, DOI 10.1159/000149139; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PARKER CW, 1990, METHOD ENZYMOL, V182, P721; POLLOCK MR, 1962, NATURE, V194, P446, DOI 10.1038/194446a0; REISFELD RA, 1962, NATURE, V195, P281, DOI 10.1038/195281a0; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; ROBERTS NA, 1990, SCIENCE, V248, P358, DOI 10.1126/science.2183354; ROSENTHAL PJ, 1987, J EXP MED, V166, P816, DOI 10.1084/jem.166.3.816; SCHONER RG, 1985, BIO-TECHNOL, V3, P151, DOI 10.1038/nbt0285-151; TREMBLAY ML, 1983, BIOCHIM BIOPHYS ACTA, V743, P239, DOI 10.1016/0167-4838(83)90220-0; TUGGLE CK, 1985, J BACTERIOL, V162, P448, DOI 10.1128/JB.162.1.448-450.1985; WEBER J, 1976, J VIROL, V17, P462, DOI 10.1128/JVI.17.2.462-471.1976; WEBER JM, 1988, J VIROL, V62, P1741, DOI 10.1128/JVI.62.5.1741-1745.1988; WEBSTER A, 1989, J GEN VIROL, V70, P3215, DOI 10.1099/0022-1317-70-12-3215; WHITAKER JR, 1969, BIOCHEMISTRY-US, V8, P4591, DOI 10.1021/bi00839a054; WHITAKER JR, 1968, ARCH BIOCHEM BIOPHYS, V124, P70, DOI 10.1016/0003-9861(68)90304-4; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	38	42	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1780	1785						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380578				2022-12-27	WOS:A1993KH62000044
J	CASTLE, AM; CASTLE, JD				CASTLE, AM; CASTLE, JD			NOVEL SECRETORY PROLINE-RICH PROTEOGLYCANS FROM RAT PAROTID - CLONING AND CHARACTERIZATION BY EXPRESSION IN ATT-20 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN MESSENGER-RNAS; PITUITARY-TUMOR CELLS; MULTIGENE FAMILIES; GLYCOPROTEIN-SYNTHESIS; ZYMOGEN GRANULES; GLANDS; ISOPROTERENOL; SEQUENCE; ADRENOCORTICOTROPIN; IDENTIFICATION	We have isolated two cDNAs that encode backbones of proline-rich proteoglycans identified previously in parotids of isoproterenol-treated rats (Blair, A. E., Castle, A. M., and Castle, J. D. (1991) Am. J. Physiol. 30, C897-C905). The sequences and domain structure of these cDNAs are characteristic of acidic proline-rich proteins, and potential glycosaminoglycan attachment sites are present within the acidic N-terminal domain. When the cDNAs were individually expressed in a mouse pituitary cell line, AtT-20, the expressed proteins were modified to sulfated proteoglycans. As in parotid acinar cells, only a fraction of the larger backbone (M(r) = 38,000) is modified by glycosaminoglycan addition; however, most of the smaller backbone (M(r) = 30,000) appears modified. Both proteoglycans expressed in AtT-20 cells contain heparan sulfate and chondroitin sulfate, whereas the proteoglycan in parotid contained chondroitin sulfate exclusively. Both proteoglycans are targeted to the regulated secretory pathway in AtT-20 cells where they are stored more efficiently than a parotid basic proline-rich protein.	UNIV VIRGINIA,HLTH SCI CTR,INST MOLEC BIOL,CHARLOTTESVILLE,VA 22908	University of Virginia	CASTLE, AM (corresponding author), UNIV VIRGINIA,HLTH SCI CTR,DEPT ANAT & CELL BIOL,CHARLOTTESVILLE,VA 22908, USA.				NIDCR NIH HHS [DE08491] Funding Source: Medline	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ANN DK, 1987, J BIOL CHEM, V262, P899; ANN DK, 1988, J BIOL CHEM, V263, P10887; ARVAN P, 1986, J CELL BIOL, V103, P1257, DOI 10.1083/jcb.103.4.1257; BLAIR EA, 1991, AM J PHYSIOL, V261, pC897, DOI 10.1152/ajpcell.1991.261.5.C897; BLOOM GD, 1979, MED BIOL, V57, P224; BOURDON MA, 1987, P NATL ACAD SCI USA, V84, P3194, DOI 10.1073/pnas.84.10.3194; BRUGGE JS, 1977, NATURE, V269, P346, DOI 10.1038/269346a0; BURGESS TL, 1984, J CELL BIOL, V99, P2223, DOI 10.1083/jcb.99.6.2223; CAMERON RS, 1986, J CELL BIOL, V103, P1299, DOI 10.1083/jcb.103.4.1299; CARLSON DM, 1988, BIOCHIMIE, V70, P1689, DOI 10.1016/0300-9084(88)90304-5; CASTLE AM, 1992, J BIOL CHEM, V267, P13093; CHU WN, 1990, MOL ENDOCRINOL, V4, P1905, DOI 10.1210/mend-4-12-1905; CLEMENTS S, 1985, J BIOL CHEM, V260, P3471; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; HAMPSON IN, 1984, BIOCHEM J, V221, P697, DOI 10.1042/bj2210697; KIANG WL, 1982, J BIOL CHEM, V257, P1651; LEWIS RG, 1973, BIOCHEM J, V134, P455, DOI 10.1042/bj1340455; MAINS RE, 1981, J CELL BIOL, V89, P21, DOI 10.1083/jcb.89.1.21; MAY V, 1986, ENDOCRINOLOGY, V118, P1284, DOI 10.1210/endo-118-4-1284; MEHANSHO H, 1985, J BIOL CHEM, V260, P4418; MEHANSHO H, 1983, J BIOL CHEM, V258, P6616; MOORE HP, 1983, J CELL BIOL, V97, P810, DOI 10.1083/jcb.97.3.810; MUENZER J, 1979, J BIOL CHEM, V254, P5629; MUENZER J, 1979, J BIOL CHEM, V255, P5623; NEUFELD G, 1988, J CELL BIOL, V106, P1385, DOI 10.1083/jcb.106.4.1385; RAZIN E, 1982, J BIOL CHEM, V257, P7229; REGGIO H, 1978, J CELL BIOL, V78, P951, DOI 10.1083/jcb.78.3.951; REGGIO HA, 1978, J CELL BIOL, V77, P288, DOI 10.1083/jcb.77.2.288; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SLABY F, 1980, MOL CELL ENDOCRINOL, V18, P33, DOI 10.1016/0303-7207(80)90005-2; STEVENS RL, 1982, J BIOL CHEM, V257, P253; STEVENS RL, 1986, MAST CELL DIFFERENTI, P183; UVNAS B, 1974, FED PROC, V33, P2172; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WALKER JH, 1983, J NEUROCHEM, V41, P209, DOI 10.1111/j.1471-4159.1983.tb11829.x; ZANINI A, 1980, SYNTHESIS RELEASE AD, P105; ZIEMER MA, 1984, J BIOL CHEM, V259, P475; ZIEMER MA, 1982, J BIOL CHEM, V257, P1176	38	14	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20490	20496						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376404				2022-12-27	WOS:A1993LY01900082
J	CLARK, WA				CLARK, WA			EVIDENCE FOR POSTTRANSLATIONAL KINETIC COMPARTMENTATION OF PROTEIN-TURNOVER POOLS IN ISOLATED ADULT CARDIAC MYOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN HEAVY-CHAIN; THYROID-HORMONE; SKELETAL-MUSCLE; MESSENGER-RNA; HEART-CELLS; GROWTH; MYOFILAMENTS; DEGRADATION; HYPERTROPHY; CAPACITY	The kinetics of protein metabolism were evaluated in isolated adult feline cardiomyocytes maintained in long term cell culture. The results of these studies suggested that, rather than individual proteins entering a kinetically homogeneous pool, most newly synthesized proteins were segregated into different kinetic compartments with different probabilities of being degraded. Evidence for this conclusion was developed from two types of experiment. The first line of evidence was derived from the kinetics of labeled amino acid incorporation into protein when labeling was conducted over very short or long periods (4 h to 32 days). The observed rates of isotope incorporation over different periods did not fit the expected pattern for a homogeneous pool. A close approximation of observed rates of label incorporation over both short and long labeling intervals could, however, be fit to results predicted using a two-compartment model. When the results of long term equilibration labeling studies were also evaluated relative to short and long term labeling ratios, then it was also possible to identify a unique set of parameters for a two-compartment model which could account for label incorporation in both types of experiment. From this analysis it was estimated that the fast kinetic compartment represented a steady-state level of 10% of total cellular protein with a mean half-life of 21.9 h (k(s) = 75.9% d-1). The slow kinetic compartment comprised the remaining 90% of protein with a mean t1/2 equal to 15.6 days (k(s) = 4.4% d-1). Both the observed and predicted equilibration rate of this two compartment mixture was best fit by a single exponential function with an equilibration rate of 5.48% d-1. Based on this outcome, it was also predicted that mixing of nascent and long lived proteins could be followed using a protocol of long and short term labeling in different isotopes followed by a chase period without label. By tracking the isotope ratios in total proteins and SDS-polyacrylamide gel electrophoresis separated proteins, as well as in counts released into the culture medium during the chase period it was determined that nascent proteins were preferentially degraded for a period of at least 48 h following synthesis. Up to 20% of nascent proteins in both the total protein compartment as well as individual proteins, such as myosin heavy chain, were preferentially degraded prior to achieving a state of homogeneous mixing with long lived proteins. These results suggest that in adult cardiac myocytes the regulation of protein balance functions not only at the transcriptional level, but also involves post-translational segregation of nascent peptides into different kinetic compartments in which there are nearly 20-fold differences in half-life.	NORTHWESTERN UNIV,SCH MED,FEINBERG CARDIOVASC RES INST,CHICAGO,IL 60611	Northwestern University	CLARK, WA (corresponding author), NORTHWESTERN UNIV,SCH MED,DEPT MED,DIV CARDIOL,303 E CHICAGO AVE,CHICAGO,IL 60611, USA.							AIRHART J, 1979, ANAL BIOCHEM, V96, P45, DOI 10.1016/0003-2697(79)90552-9; ARIAS IM, 1969, J BIOL CHEM, V244, P3303; BUCHANAN DL, 1961, ARCH BIOCHEM BIOPHYS, V94, P489, DOI 10.1016/0003-9861(61)90077-7; CARTER WJ, 1985, J MOL CELL CARDIOL, V17, P897, DOI 10.1016/S0022-2828(85)80103-6; CLARK WA, 1981, J BIOL CHEM, V256, P4863; CLARK WA, 1991, AM J PHYSIOL, V261, pC530, DOI 10.1152/ajpcell.1991.261.3.C530; CLARK WA, 1992, AM J PHYSIOL, V264, pH573; DENNIS PP, 1974, MOL GEN GENET, V134, P39, DOI 10.1007/BF00332811; ETLINGER JD, 1975, NATURE, V255, P259, DOI 10.1038/255259a0; EVERETT AW, 1979, J MOL CELL CARDIOL, V11, P1253, DOI 10.1016/0022-2828(79)90005-1; EVERETT AW, 1981, BIOCHEM J, V194, P365, DOI 10.1042/bj1940365; EVERETT AW, 1983, J BIOL CHEM, V258, P2421; EVERETT AW, 1983, ANAL BIOCHEM, V130, P102, DOI 10.1016/0003-2697(83)90655-3; GARLICK PJ, 1976, BIOCHEM J, V156, P657, DOI 10.1042/bj1560657; GOLDFINE SM, 1991, J MUSCLE RES CELL M, V12, P161, DOI 10.1007/BF01774035; GOLDFINE SM, 1989, CELLULAR MOL BIOL MU, P271; HARE JF, 1991, P NATL ACAD SCI USA, V88, P5902, DOI 10.1073/pnas.88.13.5902; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; ISAACS WB, 1987, P NATL ACAD SCI USA, V84, P6174, DOI 10.1073/pnas.84.17.6174; JARDETZKY CD, 1958, ARCH BIOCHEM BIOPHYS, V73, P435, DOI 10.1016/0003-9861(58)90288-1; KOCH AL, 1962, J THEOR BIOL, V3, P283, DOI 10.1016/S0022-5193(62)80018-6; MANN DL, 1989, CIRC RES, V64, P1079, DOI 10.1161/01.RES.64.6.1079; MARTIN AF, 1977, J BIOL CHEM, V252, P3422; MCDERMOTT PJ, 1989, CIRC RES, V64, P542, DOI 10.1161/01.RES.64.3.542; MCKEE EE, 1978, J BIOL CHEM, V253, P1030; MEIDELL RS, 1986, AM J PHYSIOL, V251, P1076; MORGAN HE, 1986, FED PROC, V45, P2563; MORGAN HE, 1971, J BIOL CHEM, V246, P2152; MORGAN HE, 1979, HDB PHYSL CARDIOVA 2, V1, P845; MORITZ M, 1990, J CELL BIOL, V111, P2261, DOI 10.1083/jcb.111.6.2261; NAGAI R, 1987, CIRC RES, V60, P692, DOI 10.1161/01.RES.60.5.692; PARMACEK MS, 1986, AM J PHYSIOL, V251, pC727, DOI 10.1152/ajpcell.1986.251.5.C727; POOLE B, 1971, J BIOL CHEM, V116, P6587; SAMAREL AM, 1981, ANAL BIOCHEM, V118, P155, DOI 10.1016/0003-2697(81)90172-X; SAMAREL AM, 1991, FASEB J, V5, P2020, DOI 10.1096/fasebj.5.7.2010055; VANDERWESTHUYZEN DR, 1981, J BIOL CHEM, V256, P1791; VANVENROOIJ WJ, 1974, EUR J BIOCHEM, V50, P297; Waterlow J. C., 1978, PROTEIN TURNOVER MAM; ZAK R, 1974, CIRC RES, V35, P17; ZAK R, 1979, PHYSIOL REV, V59, P407, DOI 10.1152/physrev.1979.59.2.407; Zilversmit DB, 1943, J GEN PHYSIOL, V26, P325, DOI 10.1085/jgp.26.3.325; ZILVERSMIT DB, 1960, AM J MED, V29, P832, DOI 10.1016/0002-9343(60)90117-0	42	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20243	20251						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376385				2022-12-27	WOS:A1993LY01900051
J	JIANG, H; SHAH, S; HILT, DC				JIANG, H; SHAH, S; HILT, DC			ORGANIZATION, SEQUENCE, AND EXPRESSION OF THE MURINE S100-BETA GENE - TRANSCRIPTIONAL REGULATION BY CELL-TYPE-SPECIFIC CIS-ACTING REGULATORY ELEMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-C; NEURITE EXTENSION FACTOR; S-100 PROTEIN; BOVINE BRAIN; S100 PROTEIN; DEFINED MEDIUM; MESSENGER-RNA; GLIAL-CELLS; PLASMID DNA; RAT-BRAIN	The organization, sequence, and transcriptional regulation of expression of the murine S100beta gene are reported. The gene is approximately 9 kilobase pairs in length and is composed of three exons and two introns. The deduced murine S100beta protein sequence differs from the human S100beta protein by only 1 amino acid. The murine S100beta gene contains a TATA box (AATAA) and a reverse CCAAT box (ATTGG) located at 30 nucleotides and 92 nucleotides upstream of the cap site, respectively. A 149-base pair DNA fragment (-157/-9) spanning the TATA box and the reverse CCAAT box functions as a promoter. The murine S100beta promoter drives a 4-fold higher level of transcription in glial (C6) than in non-glial (3T3) cells, suggesting the existence of a potential cell type-specific regulatory element within the promoter region. The 5'-flanking region suppresses transcription from the homologous S100beta as well as the heterologous SV40 promoters in an orientation-independent fashion. However, the 5'-flanking region exhibits cell type specificity when suppressing the S100beta promoter-dependent transcription, indicating its involvement in the cell type-specific expression of S100beta gene. In order to map cell type-specific regulatory elements, transcription analyses of various deletions of the 5'-region were carried out in C6 and 3T3 cells. Two cell type-specific negative regulatory elements, one active in non-glial cells and another active in glial cells, were mapped to the regions -1552/-1234 and -1234/-551, respectively. A strong negative regulatory element and a relatively weak negative element were located in the regions -551/-157 and -1669/-1552, respectively. The murine S100beta gene is under complex transcriptional regulation involving tonic negative control exerted by combination of multiple cis-acting regulatory elements including cell type-specific elements.	UNIV MARYLAND,SCH MED,DEPT NEUROL,GRAD PROGRAM MOLEC & CELL BIOL,RM 12-045,BRESSLER RES BLDG,BALTIMORE,MD 21201; UNIV MARYLAND,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21201; UNIV MARYLAND,SCH MED,CTR MED BIOTECHNOL,BALTIMORE,MD 21201; VET ADM MED CTR,BALTIMORE,MD 21201	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA)								ALLORE RJ, 1990, J BIOL CHEM, V265, P15537; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; AUSEBEL FM, 1991, CURRENT PROTOCOLS MO; BAGGIN M, 1983, P NATL ACAD SCI USA, V80, P3963; BANIAHMAD A, 1987, EMBO J, V6, P2297, DOI 10.1002/j.1460-2075.1987.tb02504.x; BAUDIER J, 1982, FEBS LETT, V147, P165, DOI 10.1016/0014-5793(82)81033-8; BAUDIER J, 1989, J BIOL CHEM, V264, P1824; BERGER S, 1987, METHOD ENZYMOL, V154, P1; BERNDT JA, 1992, J BIOL CHEM, V267, P14730; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DONATO R, 1988, J BIOL CHEM, V263, P106; DUNN R, 1987, J BIOL CHEM, V262, P3562; ENDO T, 1983, FEBS LETT, V161, P235, DOI 10.1016/0014-5793(83)81015-1; FAN K, 1982, BRAIN RES, V237, P498, DOI 10.1016/0006-8993(82)90462-0; FARRELL FX, 1990, MOL CELL BIOL, V10, P2349, DOI 10.1128/MCB.10.5.2349; FERRARI S, 1987, J BIOL CHEM, V262, P8325; FREEMAN MR, 1989, EXP CELL RES, V182, P370, DOI 10.1016/0014-4827(89)90242-5; GARGER SJ, 1983, BIOCHEM BIOPH RES CO, V117, P835, DOI 10.1016/0006-291X(83)91672-8; GERKE V, 1985, EMBO J, V4, P2917, DOI 10.1002/j.1460-2075.1985.tb04023.x; HAGIWARA M, 1988, J BIOL CHEM, V263, P6438; HAY N, 1987, GENE DEV, V1, P659, DOI 10.1101/gad.1.7.659; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HILT DC, 1991, NOVEL CALCIUM BINDIN, P65; HILT DC, 1988, ICSU SHORT REP, V9, P133; HORNBECK P, 1989, MOL CELL BIOL, V9, P3727, DOI 10.1128/MCB.9.9.3727; ISOBE T, 1977, BIOCHIM BIOPHYS ACTA, V494, P222, DOI 10.1016/0005-2795(77)90150-7; ISOBE T, 1978, EUR J BIOCHEM, V89, P379, DOI 10.1111/j.1432-1033.1978.tb12539.x; KAZUO T, 1982, J NEUROL SCI, V56, P57; KLIGMAN D, 1987, DEV BRAIN RES, V33, P296, DOI 10.1016/0165-3806(87)90163-5; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; KLIGMAN D, 1985, P NATL ACAD SCI USA, V82, P7136, DOI 10.1073/pnas.82.20.7136; KLIGMAN D, 1982, BRAIN RES, V250, P93, DOI 10.1016/0006-8993(82)90955-6; KUWANO R, 1984, NUCLEIC ACIDS RES, V12, P7455, DOI 10.1093/nar/12.19.7455; LABOURDETTE G, 1977, EUR J BIOCHEM, V81, P591, DOI 10.1111/j.1432-1033.1977.tb11986.x; LEWIS D, 1986, BRAIN RES, V383, P159, DOI 10.1016/0006-8993(86)90016-8; MACGREGOR GR, 1987, SOMAT CELL MOLEC GEN, V13, P253, DOI 10.1007/BF01535207; MAEDA T, 1991, MOL BRAIN RES, V10, P193, DOI 10.1016/0169-328X(91)90061-2; MARKS A, 1990, EXP CELL RES, V187, P59, DOI 10.1016/0014-4827(90)90116-R; Miller J.H., 1972, EXPT MOL GENETICS; MIURA M, 1990, J NEUROCHEM, V55, P1180, DOI 10.1111/j.1471-4159.1990.tb03123.x; MOORE B, 1984, S100 PROTEIN NEURONA, P137; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; PATEL J, 1983, J NEUROCHEM, V41, P1040, DOI 10.1111/j.1471-4159.1983.tb09048.x; PATEL J, 1987, J BIOL CHEM, V262, P16686; PONDER KP, 1991, HUM GENE THER, V2, P41, DOI 10.1089/hum.1991.2.1-41; QI DF, 1984, J NEUROCHEM, V43, P256, DOI 10.1111/j.1471-4159.1984.tb06704.x; SALIER JP, 1990, J BIOL CHEM, V265, P7062; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAVAGNER P, 1990, J BIOL CHEM, V265, P6669; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; SORENSEN K, 1986, EXPERIENTIA, V42, P161, DOI 10.1007/BF01952446; TAMURA T, 1988, NUCLEIC ACIDS RES, V16, P11441, DOI 10.1093/nar/16.24.11441; VANELDIK LJ, 1988, J BIOL CHEM, V263, P7830; WANG TC, 1990, J BIOL CHEM, V265, P8908; WINNINGHAMMAJOR F, 1989, J CELL BIOL, V109, P3063, DOI 10.1083/jcb.109.6.3063; ZIMMER DB, 1987, AM J PHYSIOL, V252, pC285, DOI 10.1152/ajpcell.1987.252.3.C285	57	37	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20502	20511						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376406				2022-12-27	WOS:A1993LY01900084
J	JOSEPH, CK; BYUN, HS; BITTMAN, R; KOLESNICK, RN				JOSEPH, CK; BYUN, HS; BITTMAN, R; KOLESNICK, RN			SUBSTRATE RECOGNITION BY CERAMIDE-ACTIVATED PROTEIN-KINASE - EVIDENCE THAT KINASE-ACTIVITY IS PROLINE-DIRECTED	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; NECROSIS-FACTOR-ALPHA; PHOSPHORYLATION; MECHANISM; CELLS; AUTOPHOSPHORYLATION; THREONINE-669; DETERMINANTS; TYROSINE; P34CDC2	Signal transduction for tumor necrosis factor-a and interleukin-1 involves sphingomyelin hydrolysis to ceramide and stimulation of a ceramide-activated serine/threonine protein kinase (Mathias, S., Younes, A., Kan, C., Orlow, I., Joseph, C., and Kolesnick, R. (1993) Science 259, 519-522). Kinase activity is detected by phosphorylation of a 19-amino acid peptide derived from the sequence surrounding Thr669 of the epidermal growth factor receptor. Thr669 is contained within a -Pro-Leu-Thr-Pro- motif, which conforms to a known recognition sequence for the proline-directed class of serine/threonine protein kinases. The present studies used peptides with single-site amino acid substitutions within this sequence to assess substrate recognition by ceramide-activated protein kinase. Substitution of alanine for the C-terminal but not the N-terminal proline reduced kinase activity by 80%. Similarly, substitution of basic residues for the leucine residue reduced kinase activity by 90%. Substitution of acidic residues for leucine, or its removal, also markedly reduced kinase activity. Surprisingly, addition of a leucine residue between threonine and the C-terminal proline enhanced kinase activity 3-4 fold. The V(max(app)) of the enzyme toward the control peptide containing -Pro-Leu-Thr-Pro-(200 +/- 11 pmol of peptide phosphorylated/mixing of membrane protein) was enhanced 2.3-fold by ceramide. However, ceramide had no effect on the K(m) (2.0 +/- 0.4 mM). Membranes containing ceramide-activated protein kinase showed minimal activity toward peptides derived from substrates for casein kinase II, S6 kinase, protein kinase C, and cAMP-dependent protein kinase, but possessed substantial activity toward a calmodulin kinase substrate. However, activities toward these substrates were not enhanced by ceramide. These results suggest that ceramide-activated protein kinase may be a member of the proline-directed class of protein kinases and display specificity for -Leu-Thr-Pro- as a minimal substrate recognition motif.	MEM SLOAN KETTERING CANC CTR,SIGNAL TRANSDUCT LAB,1275 YORK AVE,NEW YORK,NY 10021; CUNY QUEENS COLL,DEPT CHEM & BIOCHEM,FLUSHING,NY 11367	Memorial Sloan Kettering Cancer Center; City University of New York (CUNY) System; Queens College NY (CUNY)					NATIONAL CANCER INSTITUTE [R01CA042385, R01CA057400] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016660, R37HL016660] Funding Source: NIH RePORTER; NCI NIH HHS [CA-42385, CA-57400-01S1] Funding Source: Medline; NHLBI NIH HHS [HL-16660] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COUNTAWAY JL, 1989, J BIOL CHEM, V264, P10828; DRESSLER KA, 1992, SCIENCE, V255, P1715, DOI 10.1126/science.1313189; GOLDKORN T, 1991, J BIOL CHEM, V266, P16092; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; HALL FL, 1991, J BIOL CHEM, V266, P17430; HASHIMOTO Y, 1987, J BIOL CHEM, V262, P8051; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KUENZEL EA, 1987, P NATL ACAD SCI USA, V84, P8834; MARSHAK DR, 1991, J CELL BIOCHEM, V45, P391, DOI 10.1002/jcb.240450413; MATHIAS S, 1991, P NATL ACAD SCI USA, V88, P10009, DOI 10.1073/pnas.88.22.10009; MATHIAS S, 1993, SCIENCE, V259, P519, DOI 10.1126/science.8424175; NORTHWOOD IC, 1991, J BIOL CHEM, V266, P15266; PELECH SL, 1987, J BIOL CHEM, V262, P11598; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; WHITEHOUSE S, 1983, J BIOL CHEM, V258, P3693; YASUDA I, 1990, BIOCHEM BIOPH RES CO, V166, P1220, DOI 10.1016/0006-291X(90)90996-Z	19	112	114	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20002	20006						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376361				2022-12-27	WOS:A1993LY01900016
J	PINEDA, T; CHURCHICH, JE				PINEDA, T; CHURCHICH, JE			REVERSIBLE UNFOLDING OF PYRIDOXAL KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; BINDING; ATP	The unfolding of brain pyridoxal kinase by guanidinium HCl has been investigated at equilibrium. The overall process was reversible as judged from the complete recovery of catalytic activity after removal of guanidinium HCl. Unfolding of pyridoxal kinase was monitored by circular dichroism and fluorescence spectroscopy. The steepness of the spectroscopic changes between 0.2 and 1.5 M guanidinium HCl, and the lack of any discernible plateau suggests that unfolding of the monomer is a cooperative process. A compact intermediate on the unfolding pathway of pyridoxal kinase could not be detected by the method of denaturant gel filtration. The fluorescent analogs of the substrates ATP and pyridoxal were used to assess differences in stability among the domains of the protein. Based on fluorescence and steady emission anisotropy results, it is postulated that the nucleotide domain is more stable than the pyridoxal domain of the kinase.			PINEDA, T (corresponding author), UNIV TENNESSEE, DEPT BIOCHEM, KNOXVILLE, TN 37916 USA.		Pineda, Teresa/K-1239-2014	Pineda, Teresa/0000-0002-1504-903X				BALDWIN RL, 1991, CHEMTRACTS BIOCH MOL, V2, P379; BENNETT WS, 1978, P NATL ACAD SCI USA, V75, P4848, DOI 10.1073/pnas.75.10.4848; BLACKSHEAR PJ, 1984, METHOD ENZYMOL, V104, P237; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHRISTENSEN H, 1991, EUR BIOPHYS J, V19, P221, DOI 10.1007/BF00183530; CHURCHICH JE, 1981, J BIOL CHEM, V256, P780; COPTON LA, 1986, ANAL BIOCHEM, V185, P155; DOMINICI P, 1988, J BIOL CHEM, V263, P14712; JAENICKE R, 1987, PROG BIOPHYS MOL BIO, V49, P117, DOI 10.1016/0079-6107(87)90011-3; KERRY JA, 1986, EUR J BIOCHEM, V158, P581, DOI 10.1111/j.1432-1033.1986.tb09794.x; KWOK F, 1991, EUR J BIOCHEM, V199, P157, DOI 10.1111/j.1432-1033.1991.tb16104.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCCORMICK D, 1961, J BIOL CHEM, V236, P2076; MEISTER A, 1990, ANN NY ACAD SCI, V585, P13, DOI 10.1111/j.1749-6632.1990.tb28038.x; MISSIAKAS D, 1990, BIOCHEMISTRY-US, V29, P8683, DOI 10.1021/bi00489a025; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Ptitsyn O.B., 1991, CONFORMATIONS FORCES, P155; PTITSYN OB, 1991, FEBS LETT, V285, P176, DOI 10.1016/0014-5793(91)80799-9; SHORTLE D, 1992, Q REV BIOPHYS, V25, P205, DOI 10.1017/S0033583500004674; SNELL EE, 1990, ANN NY ACAD SCI, V585, P1, DOI 10.1111/j.1749-6632.1990.tb28037.x; TIMASHEFF SN, 1992, BIOCHEMISTRY-US, V31, P9857, DOI 10.1021/bi00156a001; Wetlaufer D B, 1981, Adv Protein Chem, V34, P61, DOI 10.1016/S0065-3233(08)60518-5; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97; WOLKERS WF, 1991, J BIOL CHEM, V266, P20761	24	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20218	20222						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376382				2022-12-27	WOS:A1993LY01900047
J	RAO, Y; WU, XF; YIP, P; GARIEPY, J; SIU, CH				RAO, Y; WU, XF; YIP, P; GARIEPY, J; SIU, CH			STRUCTURAL CHARACTERIZATION OF A HOMOPHILIC BINDING-SITE IN THE NEURAL CELL-ADHESION MOLECULE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE DOMAINS; MONOCLONAL-ANTIBODY EPITOPES; MEMBRANE-SPANNING REGION; N-CAM; DICTYOSTELIUM-DISCOIDEUM; CHICK-EMBRYO; NEURITE OUTGROWTH; FUNCTIONAL DETERMINANTS; INTERCELLULAR-ADHESION; NUCLEOTIDE-SEQUENCE	We have previously used synthetic peptides to identify a homophilic binding site between Lys-243 and Glu-252 (KYSFNYDGSE) in the third immunoglobulin-like domain of the chick neural cell adhesion molecule (NCAM). In this report, we show that the deletion of this decapeptide sequence from chick NCAM or the scrambling of the first 5 amino acid residues led to the abolition of the homophilic binding activity of NCAM, thus confirming the role of this sequence in NCAM-NCAM binding. To investigate the involvement of individual residues of this decapeptide in NCAM binding, competition experiments were carried out using peptide analogues with various amino acid substitutions. Substitution of both Lys-243 and Asp-249 with Ala or of the 3 aromatic residues with Ala led to a total loss of activity, highlighting the importance of these residues in NCAM binding. Site-directed mutagenesis was then employed to substitute individual amino acids within the decapeptide sequence with Ala. The homophilic binding activity of mutant NCAMs transiently expressed in COS-1 cells was determined using the NCAM-Covasphere binding assay. Substitution of the charged residues with alanine decreased NCAM binding activity, implicating electrostatic interactions in NCAM binding activity. Substitution of the aromatic residues Tyr-244 and Phe-246 with Ala abolished NCAM binding activity, suggesting that hydrophobic and/or aromatic interactions may play an important role in NCAM homophilic binding. Substitution of amino acids in the predicted beta-strand portion of the decapeptide with Pro, which would tend to disrupt beta-strand conformation, led to a substantial loss of activity. Thus, NCAM-NCAM binding may also depend on the beta-backbone structure of this site. These results are consistent with the involvement of multiple amino acids within the decapeptide sequence in NCAM homophilic interaction.	UNIV TORONTO, DEPT BIOCHEM, TORONTO M5G 1L6, ONTARIO, CANADA; UNIV TORONTO, DEPT MED BIOPHYS, TORONTO M5G 1L6, ONTARIO, CANADA	University of Toronto; University of Toronto	RAO, Y (corresponding author), UNIV TORONTO, BANTING & BEST DEPT MED RES, TORONTO M5G 1L6, ONTARIO, CANADA.							ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; BARBAS JA, 1988, EMBO J, V7, P625, DOI 10.1002/j.1460-2075.1988.tb02856.x; BARTHELS D, 1987, EMBO J, V6, P907, DOI 10.1002/j.1460-2075.1987.tb04837.x; BARTON CH, 1988, DEVELOPMENT, V104, P165; BECKER JW, 1989, P NATL ACAD SCI USA, V86, P1088, DOI 10.1073/pnas.86.3.1088; BHAR TN, 1990, NATURE, V347, P483; BIXBY JL, 1987, P NATL ACAD SCI USA, V84, P2555, DOI 10.1073/pnas.84.8.2555; BIXBY JL, 1985, DEV BIOL, V119, P353; BLOCH RJ, 1992, J CELL BIOL, V116, P449, DOI 10.1083/jcb.116.2.449; BRACKENBURY R, 1977, J BIOL CHEM, V252, P6835; BURLEY SK, 1985, ACCOUNTS CHEM RES, V20, P401; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; COLE GJ, 1989, NEURON, V2, P1157, DOI 10.1016/0896-6273(89)90182-7; COLE GJ, 1986, J CELL BIOL, V102, P403, DOI 10.1083/jcb.102.2.403; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; EDELMAN GM, 1991, ANNU REV BIOCHEM, V60, P155, DOI 10.1146/annurev.bi.60.070191.001103; EDELMAN GM, 1988, BIOCHEMISTRY-US, V27, P3533, DOI 10.1021/bi00410a001; EDELMAN GM, 1987, P NATL ACAD SCI USA, V84, P8502, DOI 10.1073/pnas.84.23.8502; Erickson B. W., 1976, PROTEINS, VII, P255; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; FRELINGER AL, 1986, J CELL BIOL, V103, P1729, DOI 10.1083/jcb.103.5.1729; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GRUMET M, 1993, J CELL BIOL, V120, P815, DOI 10.1083/jcb.120.3.815; GRUMET M, 1988, J CELL BIOL, V106, P487, DOI 10.1083/jcb.106.2.487; HALL AK, 1987, J CELL BIOL, V104, P1579, DOI 10.1083/jcb.104.6.1579; HE HT, 1986, EMBO J, V5, P2489, DOI 10.1002/j.1460-2075.1986.tb04526.x; HEMPERLY JJ, 1986, P NATL ACAD SCI USA, V83, P9822, DOI 10.1073/pnas.83.24.9822; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; HOFFMAN S, 1982, J BIOL CHEM, V257, P7720; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; KADMON G, 1990, J CELL BIOL, V110, P209, DOI 10.1083/jcb.110.1.209; KADMON G, 1990, J CELL BIOL, V110, P193, DOI 10.1083/jcb.110.1.193; KAMBOJ RK, 1989, CELL, V59, P615, DOI 10.1016/0092-8674(89)90007-X; KAMBOJ RK, 1988, J CELL BIOL, V107, P1835, DOI 10.1083/jcb.107.5.1835; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LERNER RA, 1981, P NATL ACAD SCI-BIOL, V78, P3403, DOI 10.1073/pnas.78.6.3403; MATSUNAGA T, 1987, SCAND J IMMUNOL, V25, P485, DOI 10.1111/j.1365-3083.1987.tb02220.x; MAURO VP, 1992, J CELL BIOL, V119, P191, DOI 10.1083/jcb.119.1.191; MIURA M, 1992, J BIOL CHEM, V267, P10752; MURRAY BA, 1986, J CELL BIOL, V102, P189, DOI 10.1083/jcb.102.1.189; MURRAY BA, 1992, J CELL BIOL, V117, P1311, DOI 10.1083/jcb.117.6.1311; NEUGEBAUER KM, 1988, J CELL BIOL, V107, P1177, DOI 10.1083/jcb.107.3.1177; PIZZEY JA, 1989, J CELL BIOL, V109, P3465, DOI 10.1083/jcb.109.6.3465; RAO Y, 1992, J CELL BIOL, V118, P937, DOI 10.1083/jcb.118.4.937; REYES AA, 1990, CELL REGUL, V1, P567, DOI 10.1091/mbc.1.8.567; RUTISHAUSER U, 1982, P NATL ACAD SCI-BIOL, V79, P685, DOI 10.1073/pnas.79.2.685; RUTISHAUSER U, 1976, P NATL ACAD SCI USA, V73, P577, DOI 10.1073/pnas.73.2.577; RUTISHAUSER U, 1978, J CELL BIOL, V79, P382, DOI 10.1083/jcb.79.2.382; RUTISHAUSER U, 1988, PHYSIOL REV, V68, P819, DOI 10.1152/physrev.1988.68.3.819; RUTISHAUSER U, 1983, J CELL BIOL, V97, P145, DOI 10.1083/jcb.97.1.145; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTONI MJ, 1988, J NEUROSCI RES, V20, P304, DOI 10.1002/jnr.490200304; SILVER J, 1984, DEV BIOL, V106, P485, DOI 10.1016/0012-1606(84)90248-3; SIU CH, 1990, DEV GENET, V11, P377, DOI 10.1002/dvg.1020110509; SIU CH, 1987, J CELL BIOL, V105, P2523, DOI 10.1083/jcb.105.6.2523; STANFIELD RL, 1990, SCIENCE, V248, P712, DOI 10.1126/science.2333521; Stewart JM, 1984, SOLID PHASE PEPTIDE; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TANAKA H, 1991, NEURON, V7, P535, DOI 10.1016/0896-6273(91)90366-8; THIERY JP, 1977, J BIOL CHEM, V252, P6841; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDENPOL AN, 1986, J CELL BIOL, V102, P2281, DOI 10.1083/jcb.102.6.2281; Walsh F. S., 1991, SEMIN NEUROSCI, V3, P271; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; WATANABE M, 1986, J CELL BIOL, V103, P1721, DOI 10.1083/jcb.103.5.1721; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	74	50	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20630	20638						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376414				2022-12-27	WOS:A1993LY01900101
J	MORGAN, SE; KELLEY, MR; PIEPER, RO				MORGAN, SE; KELLEY, MR; PIEPER, RO			THE ROLE OF THE CARBOXYL-TERMINAL TAIL IN HUMAN O6-METHYLGUANINE DNA METHYLTRANSFERASE SUBSTRATE-SPECIFICITY AND TEMPERATURE SENSITIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ADA GENE; ESCHERICHIA-COLI; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; ALKYLATING-AGENTS; RAT-LIVER; REPAIR METHYLTRANSFERASE; ACTIVE-SITE; PROTEIN; SEQUENCE; O-6-METHYLGUANINE	The human O6-methylguanine DNA methyltransferase (MGMT) repairs O6-methylguanine (O6-MG) in DNA at a much lower rate than the Escherichia coli Ada protein, and only MGMT repairs the altered base, O6-benzylguanine (O6-BG). The diversity in DNA repair properties between MGMT and Ada may be a result of divergent amino acid sequences outside their common proline-cysteine-histidine-arginine-valine (PCHRV) acceptor site. One notable sequence difference is an MGMT 28-amino acid carboxyl-terminal tail which is highly conserved among all mammalian alkyltransferases. The role of this tail sequence in substrate specificity was assessed by expressing full-length MGMT and Ada proteins, and mutant MGMT proteins lacking either 10 or 28 amino acids from the carboxyl terminus, as GST fusion proteins in alkyltransferase-deficient E. coli cells, and comparing rates of repair of O6-MG containing DNA and O6-BG by these fusion proteins at 4-degrees-C and 37-degrees-C. The MGMT carboxyl-terminal tail was not required for repair of O6-MG in DNA at 37-degrees-C although the deletion of this tail sequence reversibly inhibited the ability of MGMT to repair O6-MG in DNA at 4-degrees-C. Therefore, the absence of this region affects the ability of the protein to repair O6-MG in DNA at lower temperatures. Furthermore, removal of the tail sequence from MGMT decreased the rate of O6-BG repair 5-fold. We conclude that the 28-amino acid carboxyl-terminal MGMT tail, while not required for activity, modulates the rate of MGMT repair at reduced temperatures and plays a role in substrate specificity.	LOYOLA UNIV,STRITCH SCH MED,DEPT MOLEC & CELLULAR BIOCHEM,MAYWOOD,IL 60153; LOYOLA UNIV,STRITCH SCH MED,PROGRAM MOLEC BIOL,MAYWOOD,IL 60153	Loyola University Chicago; Loyola University Chicago	MORGAN, SE (corresponding author), LOYOLA UNIV,STRITCH SCH MED,DEPT MED,DIV HEMATOL ONCOL,MAYWOOD,IL 60153, USA.			Kelley, Mark/0000-0002-6120-9532				ALBER T, 1988, SCIENCE, V239, P631, DOI 10.1126/science.3277275; BHATTACHARYYA D, 1990, EUR J BIOCHEM, V193, P337, DOI 10.1111/j.1432-1033.1990.tb19343.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DEMPLE B, 1985, P NATL ACAD SCI USA, V82, P2688, DOI 10.1073/pnas.82.9.2688; DEMPLE B, 1983, TRENDS BIOCHEM SCI, V8, P137, DOI 10.1016/0968-0004(83)90238-4; DEMPLE B, 1986, NUCLEIC ACIDS RES, V14, P5576; DEMPLE B, 1990, SELF METHYLATION SUI; DOLAN ME, 1991, CARCINOGENESIS, V12, P2305, DOI 10.1093/carcin/12.12.2305; DOLAN ME, 1990, P NATL ACAD SCI USA, V87, P5368, DOI 10.1073/pnas.87.14.5368; Futscher B W, 1989, Cancer Commun, V1, P65; GRAVES RJ, 1989, CARCINOGENESIS, V10, P661, DOI 10.1093/carcin/10.4.661; HAYAKAWA H, 1990, J MOL BIOL, V213, P739, DOI 10.1016/S0022-2836(05)80260-8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; LIM WA, 1991, J MOL BIOL, V219, P359, DOI 10.1016/0022-2836(91)90570-V; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; LING-LING C, 1992, Carcinogenesis (Oxford), V13, P837, DOI 10.1093/carcin/13.5.837; MEHTA JR, 1981, P NATL ACAD SCI-BIOL, V78, P6766, DOI 10.1073/pnas.78.11.6766; MORRIS KN, 1992, P NATL ACAD SCI USA, V89, P4869, DOI 10.1073/pnas.89.11.4869; NAKABEPPU Y, 1986, P NATL ACAD SCI USA, V83, P6297, DOI 10.1073/pnas.83.17.6297; PEGG AE, 1982, P NATL ACAD SCI-BIOL, V79, P5162, DOI 10.1073/pnas.79.17.5162; PEGG AE, 1984, CANCER RES, V44, P3806; PEGG AE, 1990, CANCER RES, V50, P6119; POTTER PM, 1987, NUCLEIC ACIDS RES, V15, P9177, DOI 10.1093/nar/15.22.9177; POTTER PM, 1991, CARCINOGENESIS, V12, P727, DOI 10.1093/carcin/12.4.727; REBECK GW, 1991, J BACTERIOL, V173, P2068, DOI 10.1128/jb.173.6.2068-2076.1991; RYDBERG B, 1990, NUCLEIC ACIDS RES, V18, P17, DOI 10.1093/nar/18.1.17; SANTIBANEZKOREF M, 1992, MOL CARCINOGEN, V5, P161, DOI 10.1002/mc.2940050212; Strauss B, 1975, MOL MECHANISMS REPAI, P13; TANO K, 1989, J BACTERIOL, V171, P1535, DOI 10.1128/jb.171.3.1535-1543.1989; TANO K, 1990, P NATL ACAD SCI USA, V87, P686, DOI 10.1073/pnas.87.2.686; WU RS, 1987, CANCER RES, V47, P6229; XIAO W, 1991, EMBO J, V10, P2179, DOI 10.1002/j.1460-2075.1991.tb07753.x	32	17	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19802	19809						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366118				2022-12-27	WOS:A1993LW81900097
J	CARLSON, RW; JUAN, SJ; BHAT, UR; GLUSHKA, J; SPAINK, HP; WIJFJES, AHM; VANBRUSSEL, AAN; STOKKERMANS, TJW; PETERS, NK; STACEY, G				CARLSON, RW; JUAN, SJ; BHAT, UR; GLUSHKA, J; SPAINK, HP; WIJFJES, AHM; VANBRUSSEL, AAN; STOKKERMANS, TJW; PETERS, NK; STACEY, G			THE STRUCTURES AND BIOLOGICAL-ACTIVITIES OF THE LIPO-OLIGOSACCHARIDE NODULATION SIGNALS PRODUCED BY TYPE-I AND TYPE-2 STRAINS OF BRADYRHIZOBIUM-JAPONICUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACIDS; HOST-RANGE; RHIZOBIUM-MELILOTI; GENE-EXPRESSION; ROTATING-FRAME; NOD-GENES; SPECTROSCOPY; NMR; CHROMATOGRAPHY; SPECIFICITY	Bradyrhizobium japonicum produces lipo-oligosaccharide signal molecules that induce deformation of root hairs and meristematic activity on soybeans. R japonicum USDA135 (a Type I strain) produces modified chitin pentasaccharide molecules with either a terminal N-C-16:0- or N-C18:1-glucosamine with and without an O-acetyl group at C-6 and with 2-O-methylfucose linked to C-6 of the reducing N-acetylglucosamine. An additional molecule has N-C-16:1-glucosamine and no O-acetyl group. All of these molecules cause root hair deformation on Vicia sativa and Glycine soja. The C18:1-containing molecules were tested and found to induce meristem formation on G. soja. USDA61 (a Type II strain) produces eight additional molecules. Five have a carbamoyl group on the terminal N-acylglucosamine. Six have chitin tetrasaccharide backbones. Three have a terminal N-acyl-N-methylglucosaminosyl residue. In four molecules, the reducing-end N-acetylglucosamine is glycosidically linked to glycerol and has a branching fucosyl, rather than a 2-O-methylfucosyl, residue. One molecule has a terminal N-acylglucosamine that has both acetyl and carbamoyl groups (one each).	UNIV TENNESSEE,DEPT MICROBIOL,KNOXVILLE,TN 37996; UNIV TENNESSEE,CTR LEGUME RES,KNOXVILLE,TN 37996; LEIDEN UNIV,INST MOLEC PLANT SCI,LEIDEN 2311 VJ,NETHERLANDS; OHIO STATE UNIV,OHIO STATE BIOTECHNOL CTR,COLUMBUS,OH 43210	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Leiden University; Leiden University - Excl LUMC; University System of Ohio; Ohio State University	CARLSON, RW (corresponding author), UNIV GEORGIA,COMPLEX CARBOHYDRATE RES CTR,220 RIVERBEND RD,ATHENS,GA 30602, USA.		Spaink, Herman P./S-3586-2017	Spaink, Herman P./0000-0003-4128-9501; Peters, Norman/0000-0003-0795-1362; Sanjuan, Juan/0000-0002-6404-8754	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039583] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM39583] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANFALVI Z, 1988, MOL GEN GENET, V214, P420, DOI 10.1007/BF00330475; BARBOUR WM, 1992, BIOL NITROGEN FIXATI, P293; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BERGERSEN F, 1961, AUST J BIOL SCI, V14, P349, DOI 10.1071/BI9610349; BHAT UR, 1992, GLYCOBIOLOGY, V2, P535, DOI 10.1093/glycob/2.6.535; BLAKENEY AB, 1983, CARBOHYD RES, V113, P291, DOI 10.1016/0008-6215(83)88244-5; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BODENHAUSEN G, 1977, J MAGN RESON, V27, P511, DOI 10.1016/0022-2364(77)90016-6; BOTHNERBY AA, 1984, J AM CHEM SOC, V106, P811, DOI 10.1021/ja00315a069; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; CALVERT HE, 1984, CAN J BOT, V62, P2375, DOI 10.1139/b84-324; DAVIS DG, 1985, J AM CHEM SOC, V107, P2820, DOI 10.1021/ja00295a052; DEMARY M, 1977, NOUV J CHIM, V2, P373; DENARIE J, 1992, ANNU REV MICROBIOL, V46, P497, DOI 10.1146/annurev.mi.46.100192.002433; DENARIE J, 1992, MOL SIGNALS PLANT MI, P295; DESHMANE N, 1989, J BACTERIOL, V171, P3324, DOI 10.1128/jb.171.6.3324-3330.1989; ELKAN GH, 1992, CAN J MICROBIOL, V38, P446, DOI 10.1139/m92-075; FISHER RF, 1992, NATURE, V357, P655, DOI 10.1038/357655a0; GOTTFERT M, 1990, P NATL ACAD SCI USA, V87, P2630; GRIESINGER C, 1987, J MAGN RESON, V75, P261, DOI 10.1016/0022-2364(87)90035-7; Kijne J.W., 1992, BIOL NITROGEN FIXATI, P349; KOSSLAK RM, 1987, P NATL ACAD SCI USA, V84, P7428, DOI 10.1073/pnas.84.21.7428; KRISHNAN HB, 1992, MOL MICROBIOL, V6, P3321, DOI 10.1111/j.1365-2958.1992.tb02200.x; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; MERGAERT P, 1993, P NATL ACAD SCI USA, V90, P1551, DOI 10.1073/pnas.90.4.1551; MORRIS GA, 1978, J MAGN RESON, V29, P433, DOI 10.1016/0022-2364(78)90003-3; NIEUWKOOP AJ, 1987, J BACTERIOL, V169, P2631, DOI 10.1128/jb.169.6.2631-2638.1987; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; PRICE NPJ, 1992, MOL MICROBIOL, V6, P3575, DOI 10.1111/j.1365-2958.1992.tb01793.x; ROCHE P, 1991, J BIOL CHEM, V266, P10933; RUAN XA, 1992, J BACTERIOL, V174, P3467, DOI 10.1128/JB.174.11.3467-3473.1992; SADOWSKY MJ, 1991, P NATL ACAD SCI USA, V88, P637, DOI 10.1073/pnas.88.2.637; SANJUAN J, 1992, P NATL ACAD SCI USA, V89, P8789, DOI 10.1073/pnas.89.18.8789; SCHLAMAN HRM, 1992, J BACTERIOL, V174, P5177, DOI 10.1128/JB.174.16.5177-5182.1992; SCHULTZE M, 1992, P NATL ACAD SCI USA, V89, P192, DOI 10.1073/pnas.89.1.192; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; SMIT G, 1992, J BIOL CHEM, V267, P310; SPAINK HP, 1992, MOL PLANT MICROBE IN, V5, P72, DOI 10.1094/MPMI-5-072; SPAINK HP, 1991, NATURE, V354, P125, DOI 10.1038/354125a0; STACEY G, 1991, MOL PLANT MICROBE IN, V4, P332, DOI 10.1094/MPMI-4-332; STOKKERMANS TJW, 1992, MOL PLANT MICROBE IN, V5, P504, DOI 10.1094/MPMI-5-504; TRUCHET G, 1989, PROTOPLASMA, V149, P82, DOI 10.1007/BF01322980; TURGEON BG, 1982, CAN J BOT, V60, P152, DOI 10.1139/b82-018; WOLLENWEBER HW, 1990, J MICROBIOL METH, V11, P195, DOI 10.1016/0167-7012(90)90056-C; York WS, 1985, METHOD ENZYMOL, P3, DOI DOI 10.1016/0076-6879(86)18062-1; YRUELA I, 1990, J CHROMATOGR SCI, V28, P421, DOI 10.1093/chromsci/28.8.421	47	132	135	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18372	18381						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349712				2022-12-27	WOS:A1993LT74300106
J	CHESSLER, SD; BYERS, PH				CHESSLER, SD; BYERS, PH			BIP BINDS TYPE-I PROCOLLAGEN PRO-ALPHA-CHAINS WITH MUTATIONS IN THE CARBOXYL-TERMINAL PROPEPTIDE SYNTHESIZED BY CELLS FROM PATIENTS WITH OSTEOGENESIS IMPERFECTA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-REGULATED PROTEINS; HAMSTER OVARY CELLS; ENDOPLASMIC-RETICULUM; FRAMESHIFT MUTATION; COLLAGEN-SYNTHESIS; ASCORBIC-ACID; EXPRESSION; ACCUMULATION; ASSOCIATION; INDUCTION	Of 20 fibroblast cell strains from patients with osteogenesis imperfecta (OI), a disease caused by mutations in the genes encoding type I procollagen, three had increased synthesis of BiP (GRP78), an hsp70-related, endoplasmic reticulum-resident protein. All three strains carry unique mutations in proalpha1(I) chains which impair type I procollagen chain association. Immunoprecipitation and pulse-chase experiments show that BiP (immunoglobulin heavy chain-binding protein) stably binds proalpha1(I) chains in these three cell strains after a brief lag. Ascorbate, which increases procollagen synthesis, increases BiP synthesis and content in these three strains and not in the others. In one of these three strains, BiP content is constitutively elevated prior to ascorbate treatment, and BiP is less inducible. This strain also has relatively high levels of synthesis and content of GRP94, another endoplasmic reticulum-resident stress protein. Pretreating each of the three cell strains to increase their BiP content reduces subsequent ascorbate-mediated BiP induction. BiP synthesis in the 17 other OI strains examined, which had a variety of type I procollagen mutations, was normal. These results suggest that BiP is induced by and binds procollagen with specific types of mutations: ones in the carboxyl-terminal propeptide that interfere with chain association. The recognition by BiP of such procollagen in OI cell strains shows that BiP plays a role in the physiological response to the production of some disease-producing abnormal proteins.	UNIV WASHINGTON,DEPT PATHOL,SM-30,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,CTR INHERITED DIS,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle				Byers, Peter H./0000-0001-7786-7030	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557, R01AR041223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR41223, AR21557] Funding Source: Medline; NIGMS NIH HHS [GM07266] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASSUK JA, 1989, MATRIX, V9, P244, DOI 10.1016/S0934-8832(89)80057-5; BATEMAN JF, 1989, J BIOL CHEM, V264, P10960; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BONADIO J, 1985, J BIOL CHEM, V260, P1734; BYERS PH, 1990, PROTEIN FOLDING : DECIPHERING THE SECOND HALF OF THE GENETIC CODE, P241; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; CHAN D, 1990, BIOCHEM J, V269, P175, DOI 10.1042/bj2690175; CHANG SC, 1989, MOL CELL BIOL, V9, P2153, DOI 10.1128/MCB.9.5.2153; CHESSLER SD, 1992, J BIOL CHEM, V267, P7751; CHESSLER SD, 1993, J BIOL CHEM, V268, P18218; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRESTEIL D, 1990, FEBS LETT, V267, P277, DOI 10.1016/0014-5793(90)80944-E; DION AS, 1987, J MOL BIOL, V193, P127, DOI 10.1016/0022-2836(87)90632-2; DOEGE KJ, 1986, J BIOL CHEM, V261, P8924; DORNER AJ, 1988, MOL CELL BIOL, V8, P4063, DOI 10.1128/MCB.8.10.4063; DORNER AJ, 1989, J BIOL CHEM, V264, P20602; DORNER AJ, 1992, EMBO J, V11, P1563, DOI 10.1002/j.1460-2075.1992.tb05201.x; ENDO T, 1991, MOL ENDOCRINOL, V5, P905, DOI 10.1210/mend-5-7-905; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; Gething M J, 1990, Semin Cell Biol, V1, P65; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GRAHAM KS, 1990, J BIOL CHEM, V265, P20463; HAMOS JE, 1991, NEUROLOGY, V41, P345, DOI 10.1212/WNL.41.3.345; HURTLEY SM, 1989, J CELL BIOL, V108, P2117, DOI 10.1083/jcb.108.6.2117; KASSENBROCK CK, 1989, EMBO J, V8, P1461, DOI 10.1002/j.1460-2075.1989.tb03529.x; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; KNITTLER MR, 1992, EMBO J, V11, P1573, DOI 10.1002/j.1460-2075.1992.tb05202.x; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE AS, 1984, J BIOL CHEM, V259, P4616; LENNY N, 1991, J BIOL CHEM, V266, P20532; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; MURAD S, 1983, J INVEST DERMATOL, V81, P158, DOI 10.1111/1523-1747.ep12543573; MYLLYLA R, 1991, J BIOL CHEM, V266, P2805; OLDEN K, 1979, P NATL ACAD SCI USA, V76, P791, DOI 10.1073/pnas.76.2.791; PIHLAJANIEMI T, 1984, J BIOL CHEM, V259, P2941; PINNELL SR, 1987, ARCH DERMATOL, V123, P1684, DOI 10.1001/archderm.123.12.1684; RESENDEZ E, 1985, MOL CELL BIOL, V5, P1212, DOI 10.1128/MCB.5.6.1212; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; Sambrook J, 1989, MOL CLONING LABORATO; SCHWARZ RI, 1987, ANN NY ACAD SCI, V498, P172, DOI 10.1111/j.1749-6632.1987.tb23760.x; SUZUKI CK, 1991, J CELL BIOL, V114, P189, DOI 10.1083/jcb.114.2.189; WATOWICH SS, 1991, J VIROL, V65, P3590, DOI 10.1128/JVI.65.7.3590-3597.1991	45	136	139	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18226	18233						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349698				2022-12-27	WOS:A1993LT74300086
J	LIM, LC; FANG, LH; SWENDEMAN, SL; SHEFFERY, M				LIM, LC; FANG, LH; SWENDEMAN, SL; SHEFFERY, M			CHARACTERIZATION OF THE MOLECULARLY CLONED MURINE ALPHA-GLOBIN TRANSCRIPTION FACTOR CP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROID CELL-PROTEINS; FIREFLY LUCIFERASE GENE; BINDING-PROTEINS; ESCHERICHIA-COLI; MAMMALIAN-CELLS; RNA-POLYMERASE; EXPRESSION; PROMOTER; SYSTEM; IDENTIFICATION	We recently cloned human and murine cDNAs that encode CP2, a transcription factor that interacts with the murine alpha-globin promoter. In this report, we exploited our ability to express CP2 in bacteria and eukaryotic cells to further investigate factor activities in vitro and in vivo. CP2 expressed in bacteria was significantly enriched and used in a series of DNase I footprinting and electrophoretic gel shift assays. The results suggest that CP2 binds a hyphenated recognition sequence motif that spans one DNA helix turn. In addition, the enriched bacterial protein activated transcription of alpha-globin promoter templates approximately 3- to 4-fold in vitro. We then tested the effect of elevating CP2 levels 2.5- to 5.5-fold in vivo using both transient and stable transformation assays. When a reporter construct comprised of the intact murine alpha-globin promoter driving the bacterial chloramphenicol acetyltransferase (CAT) gene was introduced into these overexpressing cells, we observed a 3- to 6-fold increase in CAT activity when compared to cells expressing normal levels of CP2. These results define the CP2 factor binding site in more detail and help characterize the activities of the factor in vivo.	CORNELL UNIV,MEMORIAL SLOAN KETTERING CANC CTR,MOLEC BIOL PROGRAM,NEW YORK,NY 10021; CORNELL UNIV,MEM SLOAN KETTERING CANC CTR,GRAD SCH MED SCI,NEW YORK,NY 10021	Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center					NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037513] Funding Source: NIH RePORTER; NCI NIH HHS [NCI-P30-CA-08748] Funding Source: Medline; NIDDK NIH HHS [DK-37513] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARNHART KM, 1989, MOL CELL BIOL, V9, P2606, DOI 10.1128/MCB.9.6.2606; BARNHART KM, 1988, MOL CELL BIOL, V8, P3215, DOI 10.1128/MCB.8.8.3215; BERGMAN Y, 1984, P NATL ACAD SCI-BIOL, V81, P7041, DOI 10.1073/pnas.81.22.7041; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRASIER AR, 1989, BIOTECHNIQUES, V7, P1116; BRAY SJ, 1989, GENE DEV, V3, P1130, DOI 10.1101/gad.3.8.1130; BRAY SJ, 1991, GENE DEV, V5, P1672, DOI 10.1101/gad.5.9.1672; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; COLBEREGARAPIN F, 1981, J MOL BIOL, V150, P1, DOI 10.1016/0022-2836(81)90321-1; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; FACKNER FG, 1984, NATURE, V310, P71; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HATAMOCHI A, 1986, J BIOL CHEM, V261, P1310; KIM CG, 1990, MOL CELL BIOL, V10, P5958, DOI 10.1128/MCB.10.11.5958; KIM CG, 1988, MOL CELL BIOL, V8, P4270, DOI 10.1128/MCB.8.10.4270; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; LIM LC, 1992, MOL CELL BIOL, V12, P828, DOI 10.1128/MCB.12.2.828; LIN SW, 1987, BIOCHEMISTRY-US, V26, P5267, DOI 10.1021/bi00391a009; Maxam A M, 1980, Methods Enzymol, V65, P499; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; OIKARINEN J, 1987, J BIOL CHEM, V262, P11064; OW DW, 1986, SCIENCE, V234, P856, DOI 10.1126/science.234.4778.856; PARSLOW TG, 1984, P NATL ACAD SCI-BIOL, V81, P2650, DOI 10.1073/pnas.81.9.2650; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; Sambrook J, 1989, MOL CLONING LABORATO; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; STRAUSS F, 1984, CELL, V37, P889, DOI 10.1016/0092-8674(84)90424-0; TOLUNAY HE, 1984, MOL CELL BIOL, V4, P17, DOI 10.1128/MCB.4.1.17; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; ULRICH MJ, 1990, BLOOD, V75, P990; VANHUIJSDUIJNEN RH, 1990, EMBO J, V9, P3119, DOI 10.1002/j.1460-2075.1990.tb07509.x; VAULONT S, 1989, MOL CELL BIOL, V9, P4409, DOI 10.1128/MCB.9.10.4409; ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5	38	59	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18008	18017						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349681				2022-12-27	WOS:A1993LT74300057
J	SLABAUGH, MB; DAVIS, RE; ROSEMAN, NA; MATHEWS, CK				SLABAUGH, MB; DAVIS, RE; ROSEMAN, NA; MATHEWS, CK			VACCINIA VIRUS RIBONUCLEOTIDE REDUCTASE EXPRESSION AND ISOLATION OF THE RECOMBINANT LARGE SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DIPHOSPHATE REDUCTASE; ALLOSTERIC REGULATION; CALF THYMUS; INHIBITION; ENZYME; SEQUENCE; CELLS; HYDROXYUREA; BACTERIOPHAGE-T4	The vaccinia virus gene encoding the 87-kDa protein that comprises the large subunit of ribonucleotide reductase (vvR1) was cloned into a bacterial expression vector under the control of an inducible promoter. Culture of Escherichia coli cells harboring the recombinant plasmid under standard induction conditions (0.4 mM isopropyl beta-D-thiogalactopyranoside, 37-degrees-C) resulted in synthesis of a completely insoluble product. Production of soluble vvR1 was achieved by growing bacteria at low temperature (15-degrees-C) during the induction period, initiating induction at low cell density, and using a low concentration (0.05 mM) of the inducer isopropyl beta-D-thiogalactopyranoside. Hydroxyurea, an inhibitor of ribonucleotide reductase, increased production of soluble vvR1 in a dose-dependent manner. Recombinant vvR1 was purified from a high salt extract of the E. coli lysate in four steps, the last utilizing an affinity column consisting of the carboxyl-terminal seven amino acids of the vvR2 protein linked to an insoluble resin. Using purified recombinant vvR2 to reconstitute active enzyme, we determined that maximizing the rate of CDP reduction required pH 8.0-8.8, 50 mM dithiothreitol, and 2 mM ATP. Specific activity of purified vvR1 was 122 nmol/min/mg. Limited proteolysis of the vvR1 protein revealed protease-resistant fragments approximately 30 and 58 kDa in size. To our knowledge, this study represents the first expression, solubilization, and isolation of a recombinant ''eukaryotic'' form of ribonucleotide reductase large subunit.	OREGON STATE UNIV, DEPT BIOCHEM & BIOPHYS, CORVALLIS, OR 97331 USA	Oregon State University								ABERG A, 1989, J BIOL CHEM, V264, P12249; AHN BY, 1992, P NATL ACAD SCI USA, V89, P7060, DOI 10.1073/pnas.89.15.7060; AVERETT DR, 1983, J BIOL CHEM, V258, P9831; BERGLUND O, 1972, J BIOL CHEM, V247, P7276; BIANCHI V, 1986, J BIOL CHEM, V261, P6037; BJORKLUND S, 1990, BIOCHEMISTRY-US, V29, P5452; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN NC, 1969, J MOL BIOL, V46, P25, DOI 10.1016/0022-2836(69)90055-2; BROWN NC, 1969, J MOL BIOL, V46, P39, DOI 10.1016/0022-2836(69)90056-4; BROWN NC, 1969, EUR J BIOCHEM, V9, P561, DOI 10.1111/j.1432-1033.1969.tb00646.x; CARAS IW, 1985, J BIOL CHEM, V260, P7015; CHILD SJ, 1990, VIROLOGY, V174, P625, DOI 10.1016/0042-6822(90)90119-C; CLIMENT I, 1991, BIOCHEMISTRY-US, V30, P5164, DOI 10.1021/bi00235a008; COHEN EA, 1986, NATURE, V321, P441, DOI 10.1038/321441a0; CUNHA CV, 1992, VIROLOGY, V187, P73, DOI 10.1016/0042-6822(92)90296-2; DAVIS RE, 1993, P NATL ACAD SCI USA, V90, P745, DOI 10.1073/pnas.90.2.745; DUTIA BM, 1986, NATURE, V321, P439, DOI 10.1038/321439a0; EHRENBERG A, 1972, J BIOL CHEM, V247, P3485; ENGSTROM Y, 1988, EMBO J, V7, P1615, DOI 10.1002/j.1460-2075.1988.tb02987.x; ENGSTROM Y, 1979, BIOCHEMISTRY-US, V18, P2941, DOI 10.1021/bi00581a004; ERIKSSON S, 1979, BIOCHEMISTRY-US, V18, P2948, DOI 10.1021/bi00581a005; ERIKSSON S, 1989, ALLOSTERIC ENZYMES, P189; FONTECAVE M, 1992, ADV ENZYMOL RAMB, V65, P147; FURLONG J, 1991, VIROLOGY, V182, P846, DOI 10.1016/0042-6822(91)90627-N; GOLDSTEIN DJ, 1988, VIROLOGY, V166, P41, DOI 10.1016/0042-6822(88)90144-4; HOWELL ML, 1992, J BIOL CHEM, V267, P1705; HOWELL ML, 1993, J BIOL CHEM, V268, P7155; JOHNSON GP, 1991, VIROLOGY, V181, P378, DOI 10.1016/0042-6822(91)90508-9; KUCERA R, 1982, ARCH BIOCHEM BIOPHYS, V214, P114, DOI 10.1016/0003-9861(82)90013-3; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAO SS, 1989, P NATL ACAD SCI USA, V86, P1485, DOI 10.1073/pnas.86.5.1485; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; NEUHARD J, 1967, BIOCHIM BIOPHYS ACTA, V145, P1, DOI 10.1016/0005-2787(67)90647-8; SCHMITT JFC, 1988, J VIROL, V62, P1889, DOI 10.1128/JVI.62.6.1889-1897.1988; SLABAUGH M, 1988, J VIROL, V62, P519, DOI 10.1128/JVI.62.2.519-527.1988; SLABAUGH MB, 1991, J VIROL, V65, P2290, DOI 10.1128/JVI.65.5.2290-2298.1991; SLABAUGH MB, 1984, J VIROL, V52, P507, DOI 10.1128/JVI.52.2.507-514.1984; SLABAUGH MB, 1984, J VIROL, V52, P501, DOI 10.1128/JVI.52.2.501-506.1984; STUBBE J, 1990, ADV ENZYMOL RAMB, V63, P349; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TENGELSEN LA, 1988, VIROLOGY, V164, P121, DOI 10.1016/0042-6822(88)90627-7; THELANDER L, 1986, MOL CELL BIOL, V6, P3433, DOI 10.1128/MCB.6.10.3433; THELANDER L, 1980, J BIOL CHEM, V255, P7426; WALTERS RA, 1976, BIOCHEM BIOPH RES CO, V69, P212, DOI 10.1016/S0006-291X(76)80294-X; WASTERNACK C, 1991, BIOCHEM INT, V23, P151; YANG FD, 1990, FEBS LETT, V272, P61, DOI 10.1016/0014-5793(90)80449-S	47	20	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17803	17810						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349665				2022-12-27	WOS:A1993LT74300028
J	KOKUBO, T; TAKADA, R; YAMASHITA, S; GONG, DW; ROEDER, RG; HORIKOSHI, M; NAKATANI, Y				KOKUBO, T; TAKADA, R; YAMASHITA, S; GONG, DW; ROEDER, RG; HORIKOSHI, M; NAKATANI, Y			IDENTIFICATION OF TFIID COMPONENTS REQUIRED FOR TRANSCRIPTIONAL ACTIVATION BY UPSTREAM STIMULATORY FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; TATA BOX-BINDING; PREINITIATION COMPLEX; PROMOTER INTERACTIONS; PROTEIN; DOMAIN; INITIATION; REGION; GENE; DNA	A TATA box-binding initiation factor, TFIID, plays a central role in the transcriptional regulation by activators. Using anti-TFIIDtau (a TATA box-binding component of native TFIID) immunoaffinity chromatography, nine polypeptides (230, 110, 85, 62, 58, 42, 28, 22, and 21 kDa) were identified as native Drosophila TFIID components that are tightly associated with TFIIDtau. To verify the functional activity of the purified TFIID complex, template DNA and other transcription factors were reconstituted with purified TFIID bound to the antibody-Sepharose matrix. Immobilized TFIID mediated not only basal transcription but transcriptional activation by upstream stimulatory factor (USF). On the other hand, recombinant TFIIDtau immobilized on the same antibody-Sepharose matrix could not mediate activation by USF. These results suggest that one or more of these additional polypeptides are required as functional TFIID subunits for activator-dependent transcription in conjunction with TFIIDtau. As further evidence of the relevance of the Drosophila TFIID components identified in this analysis, including the previously unrecognized p230 (Dynlacht, B. D., Hoey, T., and Tjian, R. (1991) Cell 66, 563-576), protein blot analysis showed that TFIIDtau interacts specifically and exclusively with p230. This suggests that p230 is an integral subunit of TFIID and that it may play a major role in tethering other subunits to TFIIDtau.	NIMH,DIV BIOMETRY & EPIDEMIOL,BLDG PK 5,RM 415,ROCKVILLE,MD 20857; ROCKEFELLER UNIV,BIOCHEM & MOLEC BIOL LAB,NEW YORK,NY 10021; UNIV TOKYO,INST APPL MICROBIOL,BUNKYO KU,TOKYO 113,JAPAN	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Rockefeller University; University of Tokyo				Takada, Ritsuko/0000-0002-1615-056X	NCI NIH HHS [CA42567] Funding Source: Medline; NIAID NIH HHS [AI27397] Funding Source: Medline; NIGMS NIH HHS [GM45258] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA042567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI027397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM045258] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CORMACK BP, 1991, CELL, V65, P341, DOI 10.1016/0092-8674(91)90167-W; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; GILL G, 1991, CELL, V65, P333, DOI 10.1016/0092-8674(91)90166-V; HOEY T, 1990, CELL, V61, P1179, DOI 10.1016/0092-8674(90)90682-5; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; HORIKOSHI M, 1988, CELL, V54, P665, DOI 10.1016/S0092-8674(88)80011-4; HORIKOSHI M, 1988, CELL, V54, P1033, DOI 10.1016/0092-8674(88)90118-3; HORIKOSHI N, 1991, P NATL ACAD SCI USA, V88, P5124, DOI 10.1073/pnas.88.12.5124; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; LEE WS, 1991, CELL, V67, P365, DOI 10.1016/0092-8674(91)90188-5; LIEBERMAN PM, 1991, GENE DEV, V5, P2441, DOI 10.1101/gad.5.12b.2441; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MUHICH ML, 1990, P NATL ACAD SCI USA, V87, P9148, DOI 10.1073/pnas.87.23.9148; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; NAKATANI Y, 1990, NATURE, V348, P86, DOI 10.1038/348086a0; PARKER CS, 1984, CELL, V36, P357, DOI 10.1016/0092-8674(84)90229-0; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; POON D, 1991, MOL CELL BIOL, V11, P4809, DOI 10.1128/MCB.11.10.4809; REINBERG D, 1987, J BIOL CHEM, V262, P3322; ROEDER RG, 1991, TRENDS BIOCHEM SCI, V16, P402, DOI 10.1016/0968-0004(91)90164-Q; SAMUELS M, 1982, J BIOL CHEM, V257, P4419; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SOELLER WC, 1988, GENE DEV, V2, P68, DOI 10.1101/gad.2.1.68; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; TAKADA R, 1992, P NATL ACAD SCI USA, V89, P11809, DOI 10.1073/pnas.89.24.11809; TIMMERS HTM, 1991, GENE DEV, V5, P1946, DOI 10.1101/gad.5.11.1946; YAMASHITA S, 1992, P NATL ACAD SCI USA, V89, P2839, DOI 10.1073/pnas.89.7.2839	28	46	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17554	17558						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349634				2022-12-27	WOS:A1993LQ98800096
J	COONEY, AJ; LENG, XH; TSAI, SY; OMALLEY, BW; TSAI, MJ				COONEY, AJ; LENG, XH; TSAI, SY; OMALLEY, BW; TSAI, MJ			MULTIPLE MECHANISMS OF CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR-DEPENDENT REPRESSION OF TRANSACTIVATION BY THE VITAMIN-D, THYROID-HORMONE, AND RETINOIC ACID RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-ERBA FUNCTIONS; RESPONSIVE ELEMENT; GENE-EXPRESSION; II GENE; SUPERFAMILY; BINDING; PROTEIN; DNA; IDENTIFICATION; MEMBER	The chicken ovalbumin upstream promoter transcription factor (COUP-TF) is a member of the steroid/thyroid hormone receptor superfamily about which little is known of its functional role in the cell. However, it is able to repress hormonal induction of target genes by vitamin D3 receptor (VDR), thyroid hormone receptor (TR), and retinoic acid receptor (RAR). We have shown previously that COUP-TF can bind a wide variety of A/GGGTCA repeats. This promiscuous recognition of response elements correlates with the ability of COUP-TF I to repress other receptors that bind to A/GGGTCA repeats with different spacings between the half-sites. Here we show that repression of transactivation by these receptors is a general phenomenon for the COUP-TF subfamily, as inhibition is also observed with COUP-TF II. This repression is also dose-dependent on COUP-TF. Inhibition of VDR, TR, and RAR activities also occurs through natural physiological response elements found in the osteocalcin, myosin heavy chain, and betaRAR promoters, respectively. In search of the mechanisms of repression by COUP-TF we show that it does not involve the formation of detectable functionally inactive heterodimers between COUP-TF and VDR, TR, and RAR. Instead, we show that the mechanism of repression could occur at three different levels: (a) active silencing of transcription and dual competition for; (b) occupancy of DNA binding sites; and (c), heterodimer formation with retinoid X receptor, the coregulator of VDR, TR, and RAR. The silencing activity was localized to the putative ligand binding domain of COUP-TF. We postulate that COUP-TF may play a master role in regulating transactivation by VDR, TR, and RAR.	BAYLOR COLL MED,DEPT CELL BIOL,1 BAYLOR PLAZA,HOUSTON,TX 77030	Baylor College of Medicine					NICHD NIH HHS [HD17379, HD08188] Funding Source: Medline; NIDDK NIH HHS [DK45641] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017379, R37HD017379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK045641, R01DK045641] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLAN GF, 1992, J BIOL CHEM, V267, P19513; BAGCHI MK, 1987, MOL CELL BIOL, V7, P4151, DOI 10.1128/MCB.7.12.4151; BANIAHMAD A, 1992, P NATL ACAD SCI USA, V89, P10633, DOI 10.1073/pnas.89.22.10633; BANIAHMAD A, 1992, EMBO J, V11, P1015, DOI 10.1002/j.1460-2075.1992.tb05140.x; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUGGE TH, 1992, EMBO J, V11, P1409, DOI 10.1002/j.1460-2075.1992.tb05186.x; CAREY M, 1989, J MOL BIOL, V209, P423, DOI 10.1016/0022-2836(89)90007-7; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DENNER LA, 1990, SCIENCE, V250, P1740, DOI 10.1126/science.2176746; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; GRAUPNER G, 1989, NATURE, V340, P653, DOI 10.1038/340653a0; HAMADA K, 1989, P NATL ACAD SCI USA, V86, P8289, DOI 10.1073/pnas.86.21.8289; HERMANN T, 1992, MOL ENDOCRINOL, V6, P1153, DOI 10.1210/me.6.7.1153; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; HWUNG YP, 1988, MOL CELL BIOL, V8, P2070, DOI 10.1128/MCB.8.5.2070; HWUNG YP, 1988, J BIOL CHEM, V263, P13470; ING NH, 1992, J BIOL CHEM, V267, P17617; KARIN M, 1990, New Biologist, V2, P126; KLIEWER SA, 1992, P NATL ACAD SCI USA, V89, P1448, DOI 10.1073/pnas.89.4.1448; KOENIG RJ, 1988, P NATL ACAD SCI USA, V85, P5031, DOI 10.1073/pnas.85.14.5031; LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; LIAO J, 1990, P NATL ACAD SCI USA, V87, P9751, DOI 10.1073/pnas.87.24.9751; MANGELSDORF DJ, 1991, CELL, V66, P555, DOI 10.1016/0092-8674(81)90018-0; MARKS MS, 1992, EMBO J, V11, P1419, DOI 10.1002/j.1460-2075.1992.tb05187.x; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MLODZIK M, 1990, CELL, V60, P211, DOI 10.1016/0092-8674(90)90737-Y; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; OMALLEY B, 1990, MOL ENDOCRINOL, V4, P363, DOI 10.1210/mend-4-3-363; OZONO K, 1990, J BIOL CHEM, V265, P21881; POWER RF, 1991, SCIENCE, V252, P1546, DOI 10.1126/science.2047861; POWER RF, 1991, SCIENCE, V254, P1636, DOI 10.1126/science.1749936; SAGAMI I, 1986, MOL CELL BIOL, V6, P4259, DOI 10.1128/MCB.6.12.4259; STRAHLE U, 1987, P NATL ACAD SCI USA, V84, P7871, DOI 10.1073/pnas.84.22.7871; THOMPSON CC, 1989, P NATL ACAD SCI USA, V86, P3494, DOI 10.1073/pnas.86.10.3494; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; WAHLSTROM GM, 1992, MOL ENDOCRINOL, V6, P1013, DOI 10.1210/me.6.7.1013; Wang Lee-Ho, 1991, Gene Expression, V1, P207; WANG LH, 1987, J BIOL CHEM, V262, P16080; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; WIDOM RL, 1992, MOL CELL BIOL, V12, P3380, DOI 10.1128/MCB.12.8.3380; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	56	233	234	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					4152	4160						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382695				2022-12-27	WOS:A1993KN53300054
J	HILT, W; ENENKEL, C; GRUHLER, A; SINGER, T; WOLF, DH				HILT, W; ENENKEL, C; GRUHLER, A; SINGER, T; WOLF, DH			THE PRE4 GENE CODES FOR A SUBUNIT OF THE YEAST PROTEASOME NECESSARY FOR PEPTIDYLGLUTAMYL-PEPTIDE-HYDROLYZING ACTIVITY - MUTATIONS LINK THE PROTEASOME TO STRESS-DEPENDENT AND UBIQUITIN-DEPENDENT PROTEOLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTICATALYTIC PROTEINASE COMPLEX; MOLECULAR-WEIGHT PROTEASES; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC CELLS; CYLINDER PARTICLES; INTRACELLULAR PROTEOLYSIS; RABBIT RETICULOCYTES; CYSTEINE PROTEINASE; MAMMALIAN-CELLS; XENOPUS-LAEVIS	Proteinase yscE, the yeast proteasome, is a member of the nonlysosomal, high molecular mass (almost-equal-to 700 kDa) multifunctional proteinase complexes that are highly conserved from yeast to man. We have isolated mutants defective in one of the three proteolytic activities of the enzyme complex, i.e. in cleavage of peptide bonds after acidic amino acids. Using one of these mutants (pre4-1), we cloned the PRE4 gene and uncovered an open reading frame with 266 amino acids coding for a predicted protein of 29.4 kDa. The protein proved to be a subunit of proteinase yscE. The Pre4 amino acid sequence shows strong homology to the beta-subunit of the Xenopus laevis proteasome. Chromosomal deletion of the PRE4 gene is lethal. The pre4-1 mutant allele was cloned and sequenced. The mutant protein is shortened by 15 amino acids at the carboxyl terminus. Mutations (pre1-1, pre2-2) in the chymotrypsin-like activity of proteinase yscE uncovered the enzyme to be involved in ubiquitin-linked and stress-dependent proteolytic pathways. In contrast to these mutants, pre4-1 mutants did not exhibit any apparent stress-dependent phenotypes. However, pre1-1 pre4-1 double mutants showed enhanced canavanine sensitivity and increased accumulation of ubiquitin protein conjugates, as compared with pre1-1 single mutants.	UNIV STUTTGART, INST BIOCHEM, PFAFFENWALDRING 55, W-7000 STUTTGART 80, GERMANY	University of Stuttgart								ACHSTETTER T, 1984, J BIOL CHEM, V259, P3344; Achstetter T, 1985, Yeast, V1, P139, DOI 10.1002/yea.320010203; ACHSTETTER T, 1984, J BIOL CHEM, V259, P3334; ARRIGO AP, 1988, NATURE, V331, P190; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BALZI E, 1989, GENE, V83, P271; CIECHANOVER A, 1989, TRENDS BIOCHEM SCI, V14, P483, DOI 10.1016/0968-0004(89)90180-1; DAHLMANN B, 1983, FEBS LETT, V160, P243, DOI 10.1016/0014-5793(83)80975-2; DAHLMANN B, 1989, FEBS LETT, V251, P125, DOI 10.1016/0014-5793(89)81441-3; DeMars R, 1992, Trends Cell Biol, V2, P81, DOI 10.1016/0962-8924(92)90077-Z; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; DRISCOLL J, 1990, J BIOL CHEM, V265, P4789; DRISCOLL J, 1992, CELL, V68, P823, DOI 10.1016/0092-8674(92)90024-7; EMORI Y, 1991, MOL CELL BIOL, V11, P344, DOI 10.1128/MCB.11.1.344; EMTER O, 1984, FEBS LETT, V166, P321, DOI 10.1016/0014-5793(84)80104-0; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; FALKENBURG PE, 1988, NATURE, V331, P192; FINLEY D, 1985, TRENDS BIOCHEM SCI, V10, P343, DOI 10.1016/0968-0004(85)90108-2; FUJIWARA T, 1990, J BIOL CHEM, V265, P16604; FULLER RS, 1988, ANNU REV PHYSIOL, V50, P345, DOI 10.1146/annurev.ph.50.030188.002021; GARCIABUSTOS J, 1991, BIOCHIM BIOPHYS ACTA, V1071, P83, DOI 10.1016/0304-4157(91)90013-M; GEORGATSOU E, 1992, FEBS LETT, V299, P39, DOI 10.1016/0014-5793(92)80095-X; HAFFTER P, 1991, NUCLEIC ACIDS RES, V19, P5075, DOI 10.1093/nar/19.18.5075; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; HEINEMEYER W, 1991, BIOCHEM SOC T, V19, P724, DOI 10.1042/bst0190724; HEINEMEYER W, 1993, IN PRESS J BIOL CHEM; HERSHKO A, 1988, J BIOL CHEM, V263, P15237; HERSHKO A, 1991, TRENDS BIOCHEM SCI, V16, P265, DOI 10.1016/0968-0004(91)90101-Z; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; HILT W, 1992, MOL MICROBIOL, V6, P2437; HIRSCH HH, 1992, EUR J BIOCHEM, V203, P641, DOI 10.1111/j.1432-1033.1992.tb16594.x; Hirsch HH., 1989, MOL CELL BIOL YEASTS, P134; HOUGH R, 1987, J BIOL CHEM, V262, P8303; JENTSCH S, 1990, TRENDS BIOCHEM SCI, V15, P195, DOI 10.1016/0968-0004(90)90161-4; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; JONES EW, 1991, J BIOL CHEM, V266, P7963; JONES EW, 1984, ANNU REV GENET, V18, P233, DOI 10.1146/annurev.ge.18.120184.001313; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KLEBE RJ, 1983, GENE, V25, P333, DOI 10.1016/0378-1119(83)90238-X; KLEINSCHMIDT JA, 1988, FEBS LETT, V239, P35, DOI 10.1016/0014-5793(88)80540-4; KLEINSCHMIDT JA, 1983, EUR J CELL BIOL, V32, P143; KLOETZEL PM, 1987, MOL BIOL REP, V12, P223, DOI 10.1007/BF00356912; KUEHN L, 1989, BIOCHIM BIOPHYS ACTA, V991, P263, DOI 10.1016/0304-4165(89)90114-1; KUEHN L, 1992, ARCH BIOCHEM BIOPHYS, V295, P55, DOI 10.1016/0003-9861(92)90487-H; LEE DH, 1992, BIOCHEM BIOPH RES CO, V182, P452, DOI 10.1016/0006-291X(92)91753-D; MATTHEWS W, 1989, P NATL ACAD SCI USA, V86, P2597, DOI 10.1073/pnas.86.8.2597; MCGUIRE MJ, 1988, BIOCHIM BIOPHYS ACTA, V967, P195, DOI 10.1016/0304-4165(88)90009-8; MCGUIRE MJ, 1986, BIOCHIM BIOPHYS ACTA, V873, P279, DOI 10.1016/0167-4838(86)90055-5; ORLOWSKI M, 1990, BIOCHEMISTRY-US, V29, P10289, DOI 10.1021/bi00497a001; ORLOWSKI M, 1989, BIOCHEMISTRY-US, V28, P9270, DOI 10.1021/bi00450a006; RECHSTEINER M, 1987, ANNU REV CELL BIOL, V3, P1, DOI 10.1146/annurev.cb.03.110187.000245; RENDUELES PS, 1988, FEMS MICROBIOL LETT, V54, P17; RICHTERRUOFF B, 1992, FEBS LETT, V302, P192, DOI 10.1016/0014-5793(92)80438-M; Rivett AJ, 1990, CURR OPIN CELL BIOL, V2, P1143, DOI 10.1016/0955-0674(90)90168-E; RIVETT AJ, 1985, J BIOL CHEM, V260, P2600; RIVETT AJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P1, DOI 10.1016/0003-9861(89)90558-4; ROSE MD, 1987, CELL, V48, P1047, DOI 10.1016/0092-8674(87)90712-4; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHERER S, 1979, P NATL ACAD SCI USA, V76, P4951, DOI 10.1073/pnas.76.10.4951; SCHERRER K, 1990, MOL BIOL REP, V14, P1, DOI 10.1007/BF00422709; SCHMID HP, 1984, EMBO J, V3, P29, DOI 10.1002/j.1460-2075.1984.tb01757.x; SEELIG A, 1991, BIOCHEM J, V280, P225, DOI 10.1042/bj2800225; SENGSTAG C, 1987, NUCLEIC ACIDS RES, V15, P233, DOI 10.1093/nar/15.1.233; SHERMAN F, 1986, METHODS YEAST GENETI, P1; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; SIMEON A, 1992, FEBS LETT, V301, P231, DOI 10.1016/0014-5793(92)81254-J; SOMMER T, 1992, EXPERIENTIA, V48, P172, DOI 10.1007/BF01923510; STRUHL K, 1979, P NATL ACAD SCI USA, V76, P1035, DOI 10.1073/pnas.76.3.1035; TANAKA K, 1988, FEBS LETT, V236, P159, DOI 10.1016/0014-5793(88)80306-5; TANAKA K, 1990, FEBS LETT, V271, P41, DOI 10.1016/0014-5793(90)80367-R; TANAKA K, 1988, J BIOL CHEM, V263, P16209; TEICHERT U, 1989, J BIOL CHEM, V264, P16037; VANRIEL MCHM, 1991, FEBS LETT, V291, P37, DOI 10.1016/0014-5793(91)81098-S; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; WAGNER JC, 1992, EUR J BIOCHEM, V203, P571, DOI 10.1111/j.1432-1033.1992.tb16585.x; WAXMAN L, 1987, J BIOL CHEM, V262, P2451; WILK S, 1980, J NEUROCHEM, V35, P1172, DOI 10.1111/j.1471-4159.1980.tb07873.x; WOLF DH, 1975, J BACTERIOL, V123, P1150, DOI 10.1128/JB.123.3.1150-1156.1975; WOLF DH, 1982, TRENDS BIOCHEM SCI, V7, P35, DOI 10.1016/0968-0004(82)90063-9; ZWICKL P, 1992, BIOCHEMISTRY-US, V31, P964, DOI 10.1021/bi00119a004	83	134	135	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3479	3486						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381431				2022-12-27	WOS:A1993KM16100071
J	ROESLER, WJ; MCFIE, PJ; PUTTICK, DM				ROESLER, WJ; MCFIE, PJ; PUTTICK, DM			EVIDENCE FOR THE INVOLVEMENT OF AT LEAST 2 DISTINCT TRANSCRIPTION FACTORS, ONE OF WHICH IS LIVER-ENRICHED, FOR THE ACTIVATION OF THE PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE PROMOTER BY CAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING-PROTEIN; AMP RESPONSE ELEMENT; CYCLIC-AMP; SV40 ENHANCER; SOMATOSTATIN GENE; REGULATORY REGION; NUCLEAR-PROTEIN; ALPHA-SUBUNIT; GTP GENE; INDUCTION	A detailed analysis of the promoter sequence requirements for the cAMP induction of transcription of the gene for phosphoenolpyruvate carboxykinase (GTP) (EC 4.1.1.32) was undertaken. It was determined that the cAMP-responsive unit of this promoter consisted of two independently weak or inactive components; the typical cAMP response element (CRE) sequence located at position -85 and a region of the promoter extending from -300 to -230 which contained multiple binding sites for liver-enriched nuclear proteins. A previous study had indicated that multiple binding sites are critical for the activity of this latter region (Liu, J., Park, E. A., Gurney, A. L., Roesler, W. J., and Hanson, R. W. (1991) J. Biol. Chem. 266, 19095-19102). In the present study, we extend this observation by demonstrating that the activity of this region can be effectively substituted for by three copies of just one subsite present in that region. This would suggest that the binding of three molecules of a single liver-enriched factor is what forms this component of the cAMP response unit. The other component of the cAMP response unit, the CRE, has been shown previously to be bound by these same liver-enriched factors as well as by cAMP response element binding protein, leading to some debate as to the identity of the protein mediating the cAMP response through this element. By two different experimental approaches, we show that neither CCAAT/enhancer binding protein nor D-site binding protein is the likely mediator of the cAMP response through the CRE, while cAMP response element binding protein is a possible candidate.			ROESLER, WJ (corresponding author), UNIV SASKATCHEWAN,DEPT BIOCHEM,SASKATOON S7N 0W0,SASKATCHEWAN,CANADA.							BOKAR JA, 1988, J BIOL CHEM, V263, P19740; DEUTSCH PJ, 1987, J BIOL CHEM, V262, P12169; FISCH TM, 1989, GENE DEV, V3, P198, DOI 10.1101/gad.3.2.198; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; FRIEDMAN AD, 1989, GENE DEV, V3, P1314, DOI 10.1101/gad.3.9.1314; FROMENTAL C, 1988, CELL, V54, P943, DOI 10.1016/0092-8674(88)90109-2; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HABENER JF, 1990, MOL ENDOCRINOL, V4, P1087, DOI 10.1210/mend-4-8-1087; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAMB P, 1991, TRENDS BIOCHEM SCI, V16, P417, DOI 10.1016/0968-0004(91)90167-T; LAMERS WH, 1982, P NATL ACAD SCI-BIOL, V79, P5137, DOI 10.1073/pnas.79.17.5137; LIU JS, 1991, J BIOL CHEM, V266, P19095; LIU JS, 1990, BIOTECHNIQUES, V9, P738; MCGRANE MM, 1990, J REPROD FERTIL, P17; MCGRANE MM, 1988, J BIOL CHEM, V263, P11443; MELLON PL, 1989, P NATL ACAD SCI USA, V86, P4887, DOI 10.1073/pnas.86.13.4887; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MUELLER CR, 1990, CELL, V61, P279, DOI 10.1016/0092-8674(90)90808-R; NIELSEN DA, 1989, ANAL BIOCHEM, V179, P19, DOI 10.1016/0003-2697(89)90193-0; ONDEK B, 1987, EMBO J, V6, P1017, DOI 10.1002/j.1460-2075.1987.tb04854.x; PARK EA, 1990, MOL CELL BIOL, V10, P6264, DOI 10.1128/MCB.10.12.6264; PEERS B, 1991, J BIOL CHEM, V266, P18127; REHFUSS RP, 1991, J BIOL CHEM, V266, P18431; ROESLER WJ, 1989, J BIOL CHEM, V264, P9657; ROESLER WJ, 1992, J BIOL CHEM, V267, P21235; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; Sambrook J, 1989, MOL CLONING LABORATO; SCHIRM S, 1987, GENE DEV, V1, P65, DOI 10.1101/gad.1.1.65; SHORT JM, 1986, J BIOL CHEM, V261, P9721; SILVER BJ, 1987, P NATL ACAD SCI USA, V84, P2198, DOI 10.1073/pnas.84.8.2198; TRUS M, 1990, MOL CELL BIOL, V10, P2418, DOI 10.1128/MCB.10.5.2418; VANOOIJ C, 1992, MOL CELL BIOL, V12, P3023, DOI 10.1128/MCB.12.7.3023; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; YAMAMOTO KK, 1990, CELL, V60, P611, DOI 10.1016/0092-8674(90)90664-Z	36	43	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3791	3796						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381439				2022-12-27	WOS:A1993KM16100115
J	NUSSENZVEIG, DR; HEINFLINK, M; GERSHENGORN, MC				NUSSENZVEIG, DR; HEINFLINK, M; GERSHENGORN, MC			AGONIST-STIMULATED INTERNALIZATION OF THE THYROTROPIN-RELEASING-HORMONE RECEPTOR IS DEPENDENT ON 2 DOMAINS IN THE RECEPTOR CARBOXYL TERMINUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BETA-2-ADRENERGIC RECEPTOR; PHOSPHOINOSITIDE HYDROLYSIS; PITUITARY-CELLS; DOWN-REGULATION; SEQUESTRATION; TRH; DESENSITIZATION; MECHANISM; MUTATION; OOCYTES	The thyrotropin-releasing hormone (TRH)-TRH receptor (TRHR) complex undergoes rapid transformation in cells to an acid-resistant form which appears to represent internalized agonist-receptor complex. Since residues in the carboxyl terminus of other G protein-coupled receptors appear to be involved in internalization, we studied the role of this domain in the TRHR. A mutant TRHR, C335Stop, missing the last 59 residues including 2 cysteine residues, undergoes minimal transformation to an acid-resistant form even though it binds agonist with equal affinity and activates inositol phosphate second messenger formation as effectively as wild type TRHR. Two distinct domains within the carboxyl terminus between residues 335 and 368 were shown to affect transformation equally. First, a domain between residues 360 and 367 was identified because a TRHR with codon 360 mutated to a stop codon attained a steady-state level of internalized receptor that was approximately 50% of wild type TRHR, whereas a mutant with codon 368 changed to a stop was internalized to the same extent as wild type TRHR. Second, the need for a proximal Cys residue(s), Cys-335 or Cys-337, was shown by mutating these residues to Ser or Gly. We conclude that rapid internalization of the TRHR is dependent on two dissimilar domains within the receptor carboxyl terminus.	CORNELL UNIV, MED CTR,NEW YORK HOSP,COLL MED,DEPT MED, DIV MOLEC MED, NEW YORK, NY 10021 USA	Cornell University; NewYork-Presbyterian Hospital					NIDDK NIH HHS [DK43046] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BUCK F, 1991, BIOCHEM BIOPH RES CO, V178, P1421, DOI 10.1016/0006-291X(91)91052-E; CAMPBELL PT, 1991, MOL PHARMACOL, V39, P192; CHEUNG AH, 1989, MOL PHARMACOL, V35, P132; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; DRUMMOND AH, 1989, ANN NY ACAD SCI, V553, P197; GERSHENGORN MC, 1986, ENDOCRINOLOGY, V119, P833, DOI 10.1210/endo-119-2-833; GERSHENGORN MC, 1991, ENDOCRINOLOGY, V128, P1204, DOI 10.1210/endo-128-2-1204; GOURDJI D, 1976, NEUROENDOCRINOLOGY, V20, P201, DOI 10.1159/000122484; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HERTEL C, 1990, J BIOL CHEM, V265, P17988; HINKLE PM, 1980, ENDOCRINOLOGY, V106, P1000, DOI 10.1210/endo-106-3-1000; HINKLE PM, 1989, ANN NY ACAD SCI, V553, P176; HINKLE PM, 1982, J BIOL CHEM, V257, P5462; IMAI A, 1987, METHOD ENZYMOL, V141, P100; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; ORON Y, 1987, SCIENCE, V238, P1406, DOI 10.1126/science.2825350; OVCHINNIKOV YA, 1988, FEBS LETT, V230, P1, DOI 10.1016/0014-5793(88)80628-8; PERLMAN JH, 1992, J BIOL CHEM, V267, P24413; RAMSDELL JS, 1986, J BIOL CHEM, V261, P5301; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; RODRIGUEZ MC, 1992, MOL ENDOCRINOL, V6, P327, DOI 10.1210/me.6.3.327; Sambrook J, 1989, MOL CLONING LABORATO; STRADER CD, 1987, CELL, V49, P855, DOI 10.1016/0092-8674(87)90623-4; STRAUB RE, 1990, P NATL ACAD SCI USA, V87, P9514, DOI 10.1073/pnas.87.24.9514; THOMPSON AK, 1991, J BIOL CHEM, V266, P23856; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VALE W, 1971, ENDOCRINOLOGY, V89, P1485, DOI 10.1210/endo-89-6-1485; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; WARREN G, 1988, TRENDS BIOCHEM SCI, V13, P462, DOI 10.1016/0968-0004(88)90229-0	33	133	134	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2389	2392						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8381407				2022-12-27	WOS:A1993KK81500024
J	HOOK, VYH; PURVIANCE, RT; AZARYAN, AV; HUBBARD, G; KRIEGER, TJ				HOOK, VYH; PURVIANCE, RT; AZARYAN, AV; HUBBARD, G; KRIEGER, TJ			PURIFICATION AND CHARACTERIZATION OF ALPHA-1-ANTICHYMOTRYPSIN-LIKE PROTEASE INHIBITOR THAT REGULATES PROHORMONE THIOL PROTEASE INVOLVED IN ENKEPHALIN PRECURSOR PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOBE SECRETORY VESICLES; CENTRAL NERVOUS-SYSTEM; HUMAN ADRENAL-MEDULLA; ALZHEIMERS-DISEASE; CONVERTING ENZYME; SUBSTANCE-P; RAT-BRAIN; BOVINE PITUITARY; BETA-PROTEIN; MONOCLONAL-ANTIBODIES	Evidence is presented showing that alpha1-antichymotrypsin (ACT) inhibits a novel prohormone thiol protease (PTP) involved in processing the enkephalin precursor. Colocalization of ACT immunoreactivity with PTP within isolated secretory vesicles of bovine adrenal medulla and pituitary indicated that endogenous ACT could regulate PTP in vivo. The endogenous 60 kDa bovine ACT (bACT)-like protein was purified from pituitary by chromatography on DEAE-Sepharose, chromatofocusing, butyl-Sepharose, and Sephacryl S-200. Characterization showed that the bACT-like protein was a potent inhibitor of PTP (K(i,app) value of 2.2 nM) as well as an effective inhibitor of chymotrypsin (K(i,app) value of 2.3 nM). Furthermore, the bACT-like protein formed sodium dodecyl sulfate-stable complexes with chymotrypsin, which is typical of serpin protease inhibitors. Importantly, PTP formed sodium dodecyl sulfate-stable complexes with human ACT, suggesting that PTP's cleavage specificity may resemble the reactive center of ACT. PTP cleavage of enkephalin-containing peptides at the NH2-terminal side of paired basic residues (Lys-Arg, Arg-Arg, Lys-Lys), flanking the COOH terminus of (Met)enkephalin (Tyr-Gly-Gly-Phe-Met), indicates methionine at the P1 position. PTP cleavage of peptide-methylcoumarin amide and peptide-p-nitroanilide substrates demonstrated specificity for paired basic and monobasic residues, as well as a role for methionine in PTP's cleavage site. These results showing PTP's ability for processing at a methionine residue which resembles the P1 specificity of ACT are compatible with inhibition of PTP by ACT. These findings are the first demonstration of the involvement of a protease inhibitor in neuropeptide precursor processing. The known developmental regulation of ACT in brain and significant amounts of ACT in amyloid plaques of Alzheimer's disease suggest a possible role for PTP in the maturation of peptidergic neurons.			HOOK, VYH (corresponding author), UNIFORMED SERV UNIV HLTH SCI, DEPT BIOCHEM, 4301 JONES BRIDGE RD, BETHESDA, MD 20814 USA.							ABRAHAM CR, 1990, NEUROBIOL AGING, V11, P123, DOI 10.1016/0197-4580(90)90045-2; ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; ARMSTRONG DM, 1989, NEUROSCIENCE, V31, P663, DOI 10.1016/0306-4522(89)90431-4; BARRETT AJ, 1980, MAMMALIAN PROTEASES, P267; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BENNETT DL, 1992, J BIOL CHEM, V267, P15229; BIETH JG, 1980, CLIN RES PROC, V16, P183; BIRCH NP, 1986, J BIOL CHEM, V261, P2213; BRESNAHAN PA, 1990, J CELL BIOL, V111, P2851, DOI 10.1083/jcb.111.6.2851; CARMICHAEL SW, 1985, SCI AM, V253, P40, DOI 10.1038/scientificamerican0885-40; CARRELL R, 1985, TRENDS BIOCHEM SCI, V10, P20, DOI 10.1016/0968-0004(85)90011-8; DAVIE EW, 1975, PROTEASES BIOL CONTR, P65; DEVI L, 1984, P NATL ACAD SCI-BIOL, V81, P1892, DOI 10.1073/pnas.81.6.1892; DOCHERTY K, 1982, ANNU REV PHYSIOL, V44, P625, DOI 10.1146/annurev.ph.44.030182.003205; ESTIVARIZ FE, 1992, J BIOL CHEM, V267, P7456; FLEMINGER G, 1983, P NATL ACAD SCI-BIOL, V80, P6418, DOI 10.1073/pnas.80.20.6418; FRITZ H, 1983, ARZNEIMITTELFORSCH, V33-1, P479; GAINER H, 1985, NEUROENDOCRINOLOGY, V40, P171, DOI 10.1159/000124070; GLUSCHANKOF P, 1987, J BIOL CHEM, V262, P9615; HENDERSON PJ, 1972, BIOCHEM J, V127, P321, DOI 10.1042/bj1270321; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; JUSTICE DL, 1987, J CELL BIOCHEM, V34, P227, DOI 10.1002/jcb.240340402; KIEFER MC, 1991, DNA CELL BIOL, V10, P757, DOI 10.1089/dna.1991.10.757; KILPATRICK DL, 1981, P NATL ACAD SCI-BIOL, V78, P3265, DOI 10.1073/pnas.78.5.3265; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KRAUSE JE, 1987, P NATL ACAD SCI USA, V84, P881, DOI 10.1073/pnas.84.3.881; KRIEGER TJ, 1991, J BIOL CHEM, V266, P8376; KRIEGER TJ, 1992, J NEUROCHEM, V59, P26, DOI 10.1111/j.1471-4159.1992.tb08871.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LISTON D, 1984, SCIENCE, V225, P734, DOI 10.1126/science.6547780; LOH YP, 1985, J BIOL CHEM, V260, P7194; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUNDBERG JM, 1979, P NATL ACAD SCI USA, V76, P4079, DOI 10.1073/pnas.76.8.4079; MERCHENTHALER I, 1986, NEUROSCIENCE, V17, P325, DOI 10.1016/0306-4522(86)90250-2; NAWA H, 1983, NATURE, V306, P32, DOI 10.1038/306032a0; PARISH DC, 1986, J BIOL CHEM, V261, P4392; PICKEL VM, 1982, J COMP NEUROL, V210, P411, DOI 10.1002/cne.902100407; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; ROKAEUS A, 1986, P NATL ACAD SCI USA, V83, P6287, DOI 10.1073/pnas.83.17.6287; ROZEMULLER JM, 1991, ACTA NEUROPATHOL, V82, P200, DOI 10.1007/BF00294446; RUBIN H, 1990, J BIOL CHEM, V265, P1199; RUSSELL JT, 1981, ANAL BIOCHEM, V113, P229, DOI 10.1016/0003-2697(81)90071-3; SARIA A, 1980, NEUROSCI LETT, V20, P195, DOI 10.1016/0304-3940(80)90145-7; SCHULTZBERG M, 1978, ACTA PHYSIOL SCAND, V103, P475, DOI 10.1111/j.1748-1716.1978.tb06243.x; SEIDAH NG, 1992, MOL ENDOCRINOL, V6, P1559, DOI 10.1210/me.6.10.1559; SEIDAH NG, 1991, MOL ENDOCRINOL, V5, P111, DOI 10.1210/mend-5-1-111; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; SHEN FS, 1989, J BIOL CHEM, V264, P15600; SILBERRING J, 1992, J BIOL CHEM, V267, P21324; SINHA S, 1990, J BIOL CHEM, V265, P8983; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; SMEEKENS SP, 1992, P NATL ACAD SCI USA, V89, P8822, DOI 10.1073/pnas.89.18.8822; SPRUCE BA, 1990, EMBO J, V9, P1787, DOI 10.1002/j.1460-2075.1990.tb08303.x; SPRUCE BA, 1988, J BIOL CHEM, V263, P19788; STERN AS, 1980, BIOSYNTHESIS MODIFIC, P99; STRUBLE RG, 1987, J NEUROPATH EXP NEUR, V46, P567, DOI 10.1097/00005072-198709000-00006; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; THOMAS L, 1991, P NATL ACAD SCI USA, V88, P5297, DOI 10.1073/pnas.88.12.5297; TOOMIM CS, 1992, BIOCHEM BIOPH RES CO, V183, P449, DOI 10.1016/0006-291X(92)90502-C; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; VANDENOUWELAND AMW, 1990, NUCLEIC ACIDS RES, V18, P664, DOI 10.1093/nar/18.3.664; VANNOSTRAND WE, 1990, J BIOL CHEM, V265, P9591; VANNOSTRAND WE, 1989, NATURE, V341, P546; VIERECK JC, 1992, J BIOL CHEM, V267, P19475; WASCHEK JA, 1987, ANN NY ACAD SCI, V493, P308, DOI 10.1111/j.1749-6632.1987.tb27215.x; WILLIAMS RG, 1983, NEUROSCIENCE, V9, P563, DOI 10.1016/0306-4522(83)90175-6; WISE RJ, 1990, P NATL ACAD SCI USA, V87, P9378, DOI 10.1073/pnas.87.23.9378	69	38	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20570	20577						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376411				2022-12-27	WOS:A1993LY01900093
J	LAWEN, A; TRABER, R				LAWEN, A; TRABER, R			SUBSTRATE SPECIFICITIES OF CYCLOSPORINE SYNTHETASE AND PEPTOLIDE SDZ 214-103 SYNTHETASE - COMPARISON OF THE SUBSTRATE SPECIFICITIES OF THE RELATED MULTIFUNCTIONAL POLYPEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDOMAIN PEPTIDE SYNTHETASE; CYSTEINYL-VALINE SYNTHETASE; EHRLICH ASCITES-CARCINOMA; LOW-DOSE CYCLOSPORIN; MULTIENZYME POLYPEPTIDE; BIOSYNTHETIC GENES; IMMUNOSUPPRESSIVE ACTIVITY; DAUNORUBICIN RESISTANCE; SEVERE PSORIASIS; ANALOGS	The recently discovered multifunctional polypeptide cyclosporin synthetase is capable of synthesizing the cyclic undecapeptide cyclosporin A in a batch reaction. Substrates are the unmethylated constitutive amino acids of cyclosporin A. Exchange of one or more of these by various amino acids gives a picture of the substrate specificity of the enzyme in vitro, which is different from the known picture obtained by in vivo studies. The uncommon amino acid butenylmethyl-threonine in position 1 of the cyclosporin ring can be exchanged by an unexpected large spectrum of different amino acids, showing a great flexibility of this site. Position 2, on the other hand, which shows the greatest variability in vivo, has an only slightly lower specificity in vitro. Position 3 has a very high degree of specificity; positions 4, 6, 7, 9, and 10 have marginally less. The variability of positions 5 and 11 is moderate, whereas position 8 shows only low substrate specificity in vitro. In general, most sites of SDZ 214-103 synthetase appear to be more specific than those of cyclosporin synthetase. Site 11 has nearly identical substrate specificity compared with that of cyclosporin synthetase. The D-2-hydroxy acid position (position 8) can be occupied by a large spectrum of substrates varying from D-lactic acid to D-2-hydroxyisocaproic acid. Within the limits of the present data, the addition of further functional groups to the D-2-hydroxy acid moiety are apparently not tolerated by the enzyme.	TECH UNIV BERLIN,OETKERHAUS,INST BIOCHEM & MOLEK BIOL,D-12205 BERLIN,GERMANY; SANDOZ PHARMA LTD,PRECLIN RES,CH-4002 BASEL,SWITZERLAND	Technical University of Berlin; Novartis; Sandoz			Lawen, Alfons/A-6598-2008	Lawen, Alfons/0000-0001-6553-9945				ANDREAE M, 1988, EUR J CELL BIOL, V47, P181; BOREL JF, 1986, PROG ALLERGY, V38, P9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COQUE JJR, 1991, MOL MICROBIOL, V5, P1125, DOI 10.1111/j.1365-2958.1991.tb01885.x; DIEZ B, 1990, J BIOL CHEM, V265, P16358; DREYFUSS M, 1976, EUR J APPL MICROBIOL, V3, P125, DOI 10.1007/BF00928431; DREYFUSS MM, 1988, Patent No. 296123; ELLIS CN, 1986, JAMA-J AM MED ASSOC, V256, P3110, DOI 10.1001/jama.256.22.3110; GAVERIAUX C, 1989, BRIT J CANCER, V60, P867, DOI 10.1038/bjc.1989.381; GRIFFITHS CEM, 1986, BRIT MED J, V293, P731, DOI 10.1136/bmj.293.6549.731; GUTIERREZ S, 1991, J BACTERIOL, V173, P2354; HEULE F, 1988, TRANSPLANT P, V20, P32; KAHAN BD, 1984, CYCLOSPORIN BIOL ACT; KLEINKAUF H, 1988, CRIT REV BIOTECHNOL, V8, P1, DOI 10.3109/07388558809150536; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWEN A, 1991, J BIOL CHEM, V266, P15567; LAWEN A, 1989, J ANTIBIOT, V42, P1283, DOI 10.7164/antibiotics.42.1283; LAWEN A, 1990, J BIOL CHEM, V265, P11355; LAWEN A, 1992, BIOCHIMIE, V74, P511, DOI 10.1016/0300-9084(92)90092-S; MACCABE AP, 1990, EMBO J, V9, P279, DOI 10.1002/j.1460-2075.1990.tb08106.x; MEADOR J, 1987, CANCER RES, V47, P6216; PETCHER TJ, 1976, HELV CHIM ACTA, V59, P1480, DOI 10.1002/hlca.19760590509; SCHINDLER R, 1985, CYCLOSPORIN AUTOIMMU; SCHMIDT B, 1992, FEBS LETT, V307, P355, DOI 10.1016/0014-5793(92)80712-P; SCOTTCRAIG JS, 1992, J BIOL CHEM, V267, P26044; SLATER LM, 1986, BRIT J CANCER, V54, P235, DOI 10.1038/bjc.1986.167; SLATER LM, 1986, J CLIN INVEST, V77, P1405, DOI 10.1172/JCI112450; THOMMENSCOTT K, 1981, AGENTS ACTIONS, V11, P770, DOI 10.1007/BF01978803; Timsit J, 1988, Rev Infirm, V38, P27; TRABER R, 1989, J ANTIBIOT, V42, P591, DOI 10.7164/antibiotics.42.591; TRABER R, 1987, HELV CHIM ACTA, V70, P13, DOI 10.1002/hlca.19870700103; TURGAY K, 1992, MOL MICROBIOL, V6, P529, DOI 10.1111/j.1365-2958.1992.tb01498.x; TWENTYMAN PR, 1987, BRIT J CANCER, V56, P55, DOI 10.1038/bjc.1987.153; VANJOOST T, 1988, BRIT J DERMATOL, V118, P183; VANJOOST T, 1986, BRIT J DERMATOL, V114, P615; VONDUNGEN A, 1976, EUR J BIOCHEM, V66, P623; WENGER RM, 1985, ANGEW CHEM INT EDIT, V24, P77, DOI 10.1002/anie.198500773; ZHANG JY, 1992, BIOCHEM J, V283, P691, DOI 10.1042/bj2830691	38	43	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20452	20465						14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376400				2022-12-27	WOS:A1993LY01900078
J	GAO, E; ALCORN, JL; MENDELSON, CR				GAO, E; ALCORN, JL; MENDELSON, CR			IDENTIFICATION OF ENHANCERS IN THE 5'-FLANKING REGION OF THE RABBIT SURFACTANT PROTEIN A (SP-A) GENE AND CHARACTERIZATION OF THEIR BINDING-PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY SURFACTANT; DNA-BINDING; FETAL LUNG; CYCLIC-AMP; INSITU HYBRIDIZATION; SOMATOSTATIN GENE; TRANSCRIPTIONAL REGULATION; RESPONSE ELEMENT; MESSENGER-RNA; SEQUENCE	The gene encoding surfactant protein A (SP-A) is expressed in type II pneumonocytes and is developmentally and hormonally regulated in fetal lung. In the present study, rabbit lung nuclear proteins were found to bind to two genomic elements within the 5'-flanking region of the rabbit SP-A gene, termed distal binding element (DBE; -986 to -977 base pairs) and proximal binding element (PBE; -87 to -70 base pairs). Binding activity was enriched in type II pneumonocytes as compared with whole lung tissue. Although binding activity was undetectable in nuclear proteins from rabbit liver and kidney, low levels of binding activity were detected in nuclear proteins from cardiac and skeletal muscle. DNase I footprinting indicated that lung nuclear proteins protected the palindromic sequence CCCACGTGGG in the DBE. The underlined core sequence is an E box motif; a similar sequence (CCCTCGTG) is present within the PBE. Both elements competed for binding to the same size species of nuclear proteins of M(r) almost-equal-to 69,000, 45,000, and 22,000. In type II cells transfected with fusion genes containing SP-A 5'-flanking DNA linked to the human growth hormone structural gene, mutagenesis of the DBE or PBE resulted in a marked reduction of basal and cyclic AMP-stimulated fusion gene expression. These findings suggest that the DBE and PBE act as enhancers that interact with the same or related trans-acting proteins and serve an important role in type II cell-specific, cyclic AMP-mediated regulation of SP-A gene expression.	UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,5323 HARRY HINES BLVD,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT OBSTET GYNECOL,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas				Mendelson, Carole Ruth/0000-0003-1696-9791	NICHD NIH HHS [HD-13912-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD013912] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALCORN JL, 1993, IN PRESS MOL ENDOCRI, V7; AUTEN RL, 1990, AM J RESP CELL MOL, V3, P491, DOI 10.1165/ajrcmb/3.5.491; AVERY ME, 1959, AMA J DIS CHILD, V97, P517, DOI 10.1001/archpedi.1959.02070010519001; BALLARD PL, 1989, ENDOCR REV, V10, P165, DOI 10.1210/edrv-10-2-165; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BOGGARAM V, 1988, J BIOL CHEM, V263, P19060; BOGGARAM V, 1988, J BIOL CHEM, V263, P2939; BOGGARAM V, 1989, J BIOL CHEM, V264, P11421; BOSHART M, 1991, CELL, V66, P849, DOI 10.1016/0092-8674(91)90432-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANTOR CR, 1980, BIOPHYS CHEM, V2, P605; CHEN Q, 1992, AM J PHYSIOL, V6, pL662; CHODOSH LA, 1986, MOL CELL BIOL, V6, P4723, DOI 10.1128/MCB.6.12.4723; CHURCH GM, 1985, NATURE, V313, P798, DOI 10.1038/313798a0; CLEMENTS JA, 1976, BIOCH BASIS PULMONAR, P363; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DELEGEANE AM, 1987, MOL CELL BIOL, V7, P3994, DOI 10.1128/MCB.7.11.3994; FLOROS J, 1986, J BIOL CHEM, V261, P9029; Gluzman Y., 1982, EUKARYOTIC VIRAL VEC, P187; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; HAWGOOD S, 1987, P NATL ACAD SCI USA, V84, P66, DOI 10.1073/pnas.84.1.66; HAWGOOD S, 1985, BIOCHEMISTRY-US, V24, P184, DOI 10.1021/bi00322a026; HEBERLEIN U, 1988, NATURE, V331, P410, DOI 10.1038/331410a0; HENNIGHAUSEN L, 1987, METHOD ENZYMOL, V152, P721; HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528; HU JS, 1992, MOL CELL BIOL, V12, P1031, DOI 10.1128/MCB.12.3.1031; JAMESON JL, 1988, J BIOL CHEM, V263, P9879; KING RJ, 1981, BIOCHIM BIOPHYS ACTA, V647, P159, DOI 10.1016/0005-2736(81)90242-X; KING RJ, 1983, J BIOL CHEM, V258, P672; KING RJ, 1973, AM J PHYSIOL, V224, P788, DOI 10.1152/ajplegacy.1973.224.4.788; KUROKI Y, 1988, P NATL ACAD SCI USA, V85, P5566, DOI 10.1073/pnas.85.15.5566; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LUCHER B, 1990, GENE DEV, V4, P2025; Maxam A M, 1980, Methods Enzymol, V65, P499; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; MENDELSON CR, 1991, ANNU REV PHYSIOL, V53, P415, DOI 10.1146/annurev.ph.53.030191.002215; MENDELSON CR, 1989, TRENDS ENDOCRIN MET, V1, P20, DOI 10.1016/1043-2760(89)90025-8; MENDELSON CR, 1986, J BIOL CHEM, V261, P9938; MISKIMINS WK, 1985, P NATL ACAD SCI USA, V82, P6741, DOI 10.1073/pnas.82.20.6741; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NG VL, 1983, BIOCHIM BIOPHYS ACTA, V754, P218, DOI 10.1016/0005-2760(83)90164-9; PHELPS DS, 1988, AM REV RESPIR DIS, V137, P939, DOI 10.1164/ajrccm/137.4.939; PHELPS DS, 1984, BIOCHIM BIOPHYS ACTA, V791, P226, DOI 10.1016/0167-4838(84)90013-X; PHELPS DS, 1991, EXP LUNG RES, V17, P985, DOI 10.3109/01902149109064330; POSSMAYER F, 1988, AM REV RESPIR DIS, V138, P990, DOI 10.1164/ajrccm/138.4.990; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; SMITH ME, 1991, J CELL BIOL, V109, P129; SNYDER JM, 1981, DEV BIOL, V85, P128; SUN XH, 1991, CELL, V64, P459, DOI 10.1016/0092-8674(91)90653-G; SUZUKI Y, 1989, AM REV RESPIR DIS, V140, P75, DOI 10.1164/ajrccm/140.1.75; VALLEJO M, 1992, J BIOL CHEM, V267, P12876; VALLEJO M, 1992, J BIOL CHEM, V267, P12868; WOHLFORDLENANE CL, 1992, AM J RESP CELL MOL, V7, P335, DOI 10.1165/ajrcmb/7.3.335; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	63	37	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19697	19709						13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366111				2022-12-27	WOS:A1993LW81900084
J	MOLKENTIN, JD; MARKHAM, BE				MOLKENTIN, JD; MARKHAM, BE			MYOCYTE-SPECIFIC ENHANCER-BINDING FACTOR (MEF-2) REGULATES ALPHA-CARDIAC MYOSIN HEAVY-CHAIN GENE-EXPRESSION IN-VITRO AND IN-VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-SPECIFIC EXPRESSION; CREATINE-KINASE GENE; NUCLEAR MATRIX; TRANSCRIPTION FACTORS; RAT-HEART; PROTEIN; CELLS; DNA; IDENTIFICATION; ELEMENTS	A myocyte-specific enhancer-binding factor (MEF-2) DNA binding site was identified in the rat alpha-myosin heavy chain (MHC) gene adjacent to the E-box binding site for alpha-MHC binding factor-2 (BF-2). Mutation of the MEF-2 site, within the context of the full-length promoter, reduced activity by 85 and 80% in neonatal cardiomyocytes and the adult heart, respectively. Mutation of the BF-2 site reduced activity approximately 70% in both models. A MEF-2/BF-2 double mutant gave significantly less activity than the BF-2 mutant but not the MEF-2 mutant, suggesting the possibility that BF-2 and MEF-2 interact. Mutations in MEF-2, which decreased functional activity, also abolished MEF-2 DNA binding activity. MEF-2 DNA binding activity was present in the developing heart, reached a peak in the late fetal and early neonatal stages, and then declined to low levels in the adult heart. The adult levels were sufficient to support alpha-MHC gene expression. MEF-2 activity was increased 2-3-fold in the adult heart subjected to a pressure or volume overload. Two working models are proposed as possible explanations of the antithetic relationship between MEF-2 levels and alpha-MHC gene expression.	MED COLL WISCONSIN, DEPT PHYSIOL, CARDIOVASC RES CTR, 8701 WATERTOWN PLANK RD, MILWAUKEE, WI 53226 USA; MED COLL WISCONSIN, GRAD PROGRAM MOLEC & CELLULAR BIOL, MILWAUKEE, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin				Molkentin, Jeffery/0000-0002-3558-6529	NHLBI NIH HHS [HL43662] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043662] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADOLPH EA, 1993, J BIOL CHEM, V268, P5349; ANVERSA P, 1975, LAB INVEST, V33, P125; BIDWELL JP, 1993, P NATL ACAD SCI USA, V90, P3162, DOI 10.1073/pnas.90.8.3162; BOULIKAS T, 1992, J CELL BIOCHEM, V50, P111, DOI 10.1002/jcb.240500202; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURT JM, 1982, J MEMBRANE BIOL, V68, P227, DOI 10.1007/BF01872267; CHASSAGNE C, 1993, CIRC RES, V72, P857, DOI 10.1161/01.RES.72.4.857; CSERJESI P, 1991, MOL CELL BIOL, V11, P4854, DOI 10.1128/MCB.11.10.4854; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DWORETZKY SI, 1992, P NATL ACAD SCI USA, V89, P4178, DOI 10.1073/pnas.89.9.4178; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; GULICK J, 1991, J BIOL CHEM, V266, P9180; GUPTA MP, 1991, J BIOL CHEM, V266, P12813; GUSTAFSON TA, 1987, P NATL ACAD SCI USA, V84, P3122, DOI 10.1073/pnas.84.10.3122; GUSTAFSON TA, 1987, J BIOL CHEM, V262, P13316; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; HIRZEL HO, 1985, CIRC RES, V57, P729, DOI 10.1161/01.RES.57.5.729; HORLICK RA, 1989, MOL CELL BIOL, V9, P2396, DOI 10.1128/MCB.9.6.2396; IZUMO S, 1987, J CLIN INVEST, V79, P970, DOI 10.1172/JCI112908; KUMARASIRI MH, 1986, J BIOL CHEM, V261, P2844; LANDERS J P, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P19; LEE KJ, 1992, J BIOL CHEM, V267, P15875; LIN H, 1990, CIRCULATION, V82, P2217, DOI 10.1161/01.CIR.82.6.2217; LOMBARD JH, 1989, HYPERTENSION, V13, P128, DOI 10.1161/01.HYP.13.2.128; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; MAHDAVI V, 1984, P NATL ACAD SCI-BIOL, V81, P2626, DOI 10.1073/pnas.81.9.2626; MAR JH, 1990, MOL CELL BIOL, V10, P4271, DOI 10.1128/MCB.10.8.4271; MARKHAM BE, 1990, J BIOL CHEM, V265, P6489; MOLKENTIN JD, 1993, J BIOL CHEM, V268, P2602; MULVAGH SL, 1987, BIOCHEM BIOPH RES CO, V147, P627, DOI 10.1016/0006-291X(87)90977-6; NADALGINARD B, 1989, J CLIN INVEST, V84, P1693, DOI 10.1172/JCI114351; NAVANKASATTUSAS S, 1992, MOL CELL BIOL, V12, P1469, DOI 10.1128/MCB.12.4.1469; OJAMAA K, 1991, BIOCHEM BIOPH RES CO, V179, P1269, DOI 10.1016/0006-291X(91)91710-T; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; PARMACEK MS, 1992, MOL CELL BIOL, V12, P1967, DOI 10.1128/MCB.12.5.1967; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; ROSENTHAL N, 1987, METHOD ENZYMOL, V152, P704; RUSCH NJ, 1992, HYPERTENSION, V19, P301, DOI 10.1161/01.HYP.19.4.301; SARTORELLI V, 1990, GENE DEV, V4, P1811, DOI 10.1101/gad.4.10.1811; SCHWARTZ K, 1986, CIRC RES, V59, P551, DOI 10.1161/01.RES.59.5.551; SEIDMAN CE, 1988, P NATL ACAD SCI USA, V85, P4104, DOI 10.1073/pnas.85.11.4104; SHEER D, 1984, J PHARMACOL EXP THER, V229, P872; SIMPSON PC, 1989, J MOL CELL CARDIOL, V21, P79, DOI 10.1016/0022-2828(89)90774-8; STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896; STURM R, 1987, GENE DEV, V1, P1147, DOI 10.1101/gad.1.10.1147; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783; ZHU H, 1991, MOL CELL BIOL, V11, P2273, DOI 10.1128/MCB.11.4.2273	49	114	118	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19512	19520						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366095				2022-12-27	WOS:A1993LW81900057
J	MUROI, M; MUROI, Y; YAMAMOTO, K; SUZUKI, T				MUROI, M; MUROI, Y; YAMAMOTO, K; SUZUKI, T			INFLUENCE OF 3' HALF-SITE SEQUENCE OF NF-KAPPA-B MOTIFS ON THE BINDING OF LIPOPOLYSACCHARIDE-ACTIVATABLE MACROPHAGE NF-KAPPA-B PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; STIMULATING FACTOR GENE; TRANSCRIPTION FACTOR; DNA-BINDING; T-CELLS; II GENE; EXPRESSION; REL; PROMOTER; SUBUNIT	Lipopolysaccharide treatment of mouse macrophage-like J774 cells was found to result in the activation of three different nuclear proteins which specifically bind to oligonucleotide containing the NF-kappaB motif of the human immunodeficiency virus (HIV) gene. These are designated as NF-kappaB1, -kappaB2, and -kappaB3, according to their electrophoretic mobilities (fast, intermediate, and slow, respectively). Immunological and UV cross-linking studies showed that NF-kappaB1 consists of only p50 subunit, whereas both NF-kappaB2 and -kappaB3 contain NF-kappaB p65 subunit and c-Rel. In addition, NF-kappaB2 was also found to contain p50 subunit of NF-kappaB. The binding of three types of NF-kappaB proteins to HIV NF-kappaB motif was effectively inhibited by other NF-kappaB motifs, whose 3' half-site nucleotide sequences are T/A-T-T/C-CC (HIV, interleukin-6, interferon (INF)-beta, H2-K(b), I-Ealpha(d), and TNF-alpha2 (nucleotide position -510)) and much less effectively by NF-kappaB motifs with 3' half-site sequences of TGCCC (TNF-alpha3, nucleotide position -610), ATCTC (G-CSF), TATTC (FcgammaR), or TCCTT (TNF-alpha1, nucleotide position -850). Our data also suggested that NF-kappaB1 and -kappaB2 which contain p50 subunit of NF-kappaB bind with the higher preference for NF-kappaB motif of H2-K(b) gene promoter than that of INF-beta, whereas NF-kappaB3 which does not contain p50 subunit appears to preferentially bind to NF-kappaB sites of IFN-beta.	UNIV KANSAS, MED CTR, DEPT MICROBIOL MOLEC GENET & IMMUNOL, 3901 RAINBOW BLVD, KANSAS CITY, KS 66160 USA; KANAZAWA UNIV, CANC RES INST, DEPT MOLEC PATHOL, KANAZAWA, ISHIKAWA 920, JAPAN	University of Kansas; University of Kansas Medical Center; Kanazawa University					NATIONAL CANCER INSTITUTE [R01CA035977, P01CA054474, R55CA055274] Funding Source: NIH RePORTER; NCI NIH HHS [R55 CA55274, R01 CA35977, P01 CA54474] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARIMA N, 1991, J VIROL, V65, P6892, DOI 10.1128/JVI.65.12.6892-6899.1991; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BALDWIN AS, 1988, P NATL ACAD SCI USA, V85, P723, DOI 10.1073/pnas.85.3.723; BLANAR MA, 1989, MOL CELL BIOL, V9, P844, DOI 10.1128/MCB.9.2.844; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DIRKS W, 1989, J INTERFERON RES, V9, P125, DOI 10.1089/jir.1989.9.125; DROUET C, 1991, J IMMUNOL, V147, P1694; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; GILMORE TD, 1992, CANCER SURV, V15, P69; HANSEN SK, 1992, EMBO J, V11, P205, DOI 10.1002/j.1460-2075.1992.tb05043.x; HENKEL T, 1992, CELL, V68, P1121, DOI 10.1016/0092-8674(92)90083-O; HOGARTH PM, 1991, J IMMUNOL, V146, P369; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KOCHEL T, 1991, ONCOGENE, V6, P615; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; MOLITOR JA, 1990, P NATL ACAD SCI USA, V87, P10028, DOI 10.1073/pnas.87.24.10028; MUROI M, 1993, CELL SIGNAL, V5, P289, DOI 10.1016/0898-6568(93)90019-I; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; NAKAYAMA K, 1992, MOL CELL BIOL, V12, P1736, DOI 10.1128/MCB.12.4.1736; NISHIZAWA M, 1990, MOL CELL BIOL, V10, P2002, DOI 10.1128/MCB.10.5.2002; RALPH P, 1975, J IMMUNOL, V114, P898; SCHRECK R, 1990, MOL CELL BIOL, V10, P1281, DOI 10.1128/MCB.10.3.1281; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P2424, DOI 10.1128/MCB.9.6.2424; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P959, DOI 10.1128/MCB.9.3.959; TANNENBAUM CS, 1988, J IMMUNOL, V140, P3640; TANNENBAUM CS, 1989, J IMMUNOL, V142, P1274; YU SF, 1990, J LEUKOCYTE BIOL, V48, P412, DOI 10.1002/jlb.48.5.412; ZABEL U, 1991, J BIOL CHEM, V266, P252	34	40	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19534	19539						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366097				2022-12-27	WOS:A1993LW81900060
J	ZHANG, YH; ZHANG, GY; MOLLAT, P; CARLES, C; RIVA, M; FROBERT, Y; MALASSINE, A; ROSTENE, W; THANG, DC; BELTCHEV, B; TAVITIAN, A; THANG, MN				ZHANG, YH; ZHANG, GY; MOLLAT, P; CARLES, C; RIVA, M; FROBERT, Y; MALASSINE, A; ROSTENE, W; THANG, DC; BELTCHEV, B; TAVITIAN, A; THANG, MN			PURIFICATION, CHARACTERIZATION, AND CELLULAR-LOCALIZATION OF THE 100-KDA HUMAN PLACENTAL GTPASE-ACTIVATING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAS P21 GTPASE; GENE TRANSCRIPTS; BOVINE BRAIN; SH3 DOMAINS; GAP; ENCODES; DIFFERENTIATION; EXPRESSION; CLONING; CELLS	Human placenta contains, in addition to the ubiquitous p120-GTPase-activating protein (GAP), another isoform of 100 kDa, which is specific to this organ. We have established a method for purifying this placental p100-GAP to near homogeneity. The purified p100-GAP allowed the preparation of polyclonal and monoclonal anti Ras-GAP antibodies. Two monoclonal antibodies were selected for a two-site enzyme immunoassay. This simple and accurate assay in turn facilitated the detection of the GAPs during purification. The purified p100-GAP has a specific activity identical to and catalytic properties similar to those of native p120-GAP. Sequence analysis of p100-GAP revealed almost total identity to the known corresponding sequences predicted by the cDNA. The purified p100-GAP kept its activity for 1 year when stored at -80-degrees-C. Our immunometric assay showed GAP to be present in human placental extracts at the exceptional abundance of about 0.1% of the total protein content. Quantitative assays showed p100-GAP to be up to 10 times more abundant than p120-GAP. Use of our antibodies allowed the specific localization of placental GAPs to cytotrophoblasts and in the syncytiotrophoblast barrier. Hence p100-GAP is shown to be found only in trophoblasts. The large quantity of p100-GAP in trophoblasts suggests that it may play a regulatory role in the proliferation or the differentiation of this cell type.	INSERM,U245,F-75012 PARIS,FRANCE; CTR ETUD SACLAY,SERV BIOCHIM & GENET MOLEC,GIF SUR YVETTE,FRANCE; CTR ETUD SACLAY,SERV PHARMACOL & IMMUNOL,GIF SUR YVETTE,FRANCE; CNRS,UNITE RECH ASSOCIES 290,F-86022 POITIERS,FRANCE; INSERM,U339,F-75012 PARIS,FRANCE; INSERM,U248,F-75010 PARIS,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)			Rostene, William/F-2754-2017	ROSTENE, WILLIAM/0000-0003-0409-5361				ALALAWI N, 1993, MOL CELL BIOL, V13, P2497, DOI 10.1128/MCB.13.4.2497; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BURSTEIN ES, 1991, J BIOL CHEM, V266, P2689; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; DIEKMANN D, 1991, NATURE, V351, P400, DOI 10.1038/351400a0; DUCHESNE M, 1993, SCIENCE, V259, P525, DOI 10.1126/science.7678707; EMKEY R, 1991, J BIOL CHEM, V266, P9703; GIBBS JB, 1988, P NATL ACAD SCI USA, V85, P5026, DOI 10.1073/pnas.85.14.5026; HALENBECK R, 1990, J BIOL CHEM, V265, P21922; HART MJ, 1991, J BIOL CHEM, V266, P20840; HSIEH CL, 1989, SOMAT CELL MOLEC GEN, V15, P579, DOI 10.1007/BF01534919; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; MALASSINE A, 1990, PLACENTA, V11, P191, DOI 10.1016/S0143-4004(05)80180-8; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MARTIN GA, 1992, SCIENCE, V255, P192, DOI 10.1126/science.1553544; MOLLAT P, 1992, BIO-TECHNOL, V10, P1151, DOI 10.1038/nbt1092-1151; MORII N, 1991, J BIOL CHEM, V266, P7646; NICE EC, 1992, J BIOL CHEM, V267, P1546; NISHI T, 1991, ONCOGENE, V6, P1555; POLAKIS PG, 1991, P NATL ACAD SCI USA, V88, P239, DOI 10.1073/pnas.88.1.239; SCHMON B, 1991, J CLIN ENDOCR METAB, V73, P888, DOI 10.1210/jcem-73-4-888; SUZUKI Y, 1991, BIOCHEM BIOPH RES CO, V181, P955, DOI 10.1016/0006-291X(91)92029-J; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; ZHANG GY, 1993, AIDS RES HUM RETROV, V9, P189, DOI 10.1089/aid.1993.9.189; ZHANG GY, 1990, THESIS U PARIS 7, P160	32	20	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18875	18881						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360177				2022-12-27	WOS:A1993LV65900075
J	SANCHEZ, VE; CARLSON, GM				SANCHEZ, VE; CARLSON, GM			ISOLATION OF AN AUTOINHIBITORY REGION FROM THE REGULATORY BETA-SUBUNIT OF PHOSPHORYLASE-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT-SKELETAL-MUSCLE; DEPENDENT PROTEIN-KINASE; ACTIVE GAMMA-SUBUNIT; CATALYTIC SUBUNIT; ALPHA-SUBUNIT; KINETIC MECHANISM; CDNA CLONING; B KINASE; CALMODULIN; ACTIVATION	An equimolar mixture of the regulatory alpha- and beta-subunits of phosphorylase kinase has been shown to inhibit its catalytic gamma-subunit (Paudel, H. K., and Carlson, G. M. (1987) J. Biol. Chem. 262, 11912-11915). The possible presence of an autoinhibitory sequence within those regulatory subunits has been evaluated by peptide isolation and characterization following chemical and proteolytic cleavage of an isolated equimolar mixture of those subunits; the peptides generated were tested for their ability to inhibit the activity of a complex of the gamma-subunit and calmodulin. An isolated inhibitory fragment, hereafter referred to as I-peptide, was sequenced and found to correspond to residues 420-436 of the beta-subunit (KRNPGSQKRFPSNCGRD). This sequence showed homology with the kinase's natural substrate, phosphorylase b. A synthetic peptide based on this sequence was constructed and used to study the mechanism of inhibition. Kinetic analysis of the inhibition of the gamma-subunit-calmodulin complex by the I-peptide revealed a competitive pattern versus the homologous substrate phosphorylase b and an uncompetitive pattern versus MgATP, suggesting an ordered binding of substrates, with the nucleotide binding first. In addition to its ability to inhibit, the I-peptide was also a substrate for the gamma-subunit-calmodulin complex, with a relatively good K(m) but poor V(max). The parallel inhibition of free gamma-subunit and the gamma-subunit-calmodulin complex by progressively increasing concentrations of I-peptide provided further evidence that the peptide inhibits by interacting directly with the catalytic subunit and not with the stimulatory calmodulin molecule. The results of this study are consistent with previous findings from this laboratory showing that the conformation of the beta-subunit changes following activation of phosphorylase kinase through a variety of mechanisms.	UNIV TENNESSEE,CTR HLTH SCI,COLL MED,DEPT BIOCHEM,800 MADISON AVE,MEMPHIS,TN 38163	University of Tennessee System; University of Tennessee Health Science Center					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032953] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 32953] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLEN G, 1981, SEQUENCING PROTEINS, P62; CARLSON GM, 1976, 4TH INT S MET INT EN, P50; CHAN KFJ, 1982, J BIOL CHEM, V257, P5939; CHENG A, 1988, J BIOL CHEM, V263, P5534; CHENG A, 1985, J BIOL CHEM, V260, P2535; Cleland W W, 1979, Methods Enzymol, V63, P103; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P173, DOI 10.1016/0926-6569(63)90226-8; COHEN P, 1980, FEBS LETT, V119, P301, DOI 10.1016/0014-5793(80)80277-8; COHEN P, 1973, FEBS LETT, V34, P43, DOI 10.1016/0014-5793(73)80699-4; COHEN P, 1973, EUR J BIOCHEM, V34, P1, DOI 10.1111/j.1432-1033.1973.tb02721.x; COHEN P, 1978, FEBS LETT, V92, P287, DOI 10.1016/0014-5793(78)80772-8; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; DASGUPTA M, 1989, J BIOL CHEM, V264, P17156; FARRAR YJK, 1991, BIOCHEMISTRY-US, V30, P10274, DOI 10.1021/bi00106a027; FISCHER EDMOND H., 1958, JOUR BIOL CHEM, V231, P65; FITZGERALD TJ, 1984, J BIOL CHEM, V259, P3266; GRAND RJA, 1981, EUR J BIOCHEM, V113, P359, DOI 10.1111/j.1432-1033.1981.tb05074.x; GRANDORI C, 1989, NATURE, V338, P467, DOI 10.1038/338467a0; Gros E., 1967, METHOD ENZYMOL, V11, P238; Hanks SK, 1991, CURR OPIN STRUC BIOL, V1, P369, DOI 10.1016/0959-440X(91)90035-R; HARDIE G, 1988, NATURE, V335, P592, DOI 10.1038/335592a0; HARRIS WR, 1990, J BIOL CHEM, V265, P11740; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; HAYAKAWA T, 1973, BIOCHEMISTRY-US, V12, P574, DOI 10.1021/bi00728a002; HOUMARD J, 1972, P NATL ACAD SCI USA, V69, P3506, DOI 10.1073/pnas.69.12.3506; KASTENSCHMIDT LL, 1968, BIOCHEMISTRY-US, V7, P3590, DOI 10.1021/bi00850a037; KEE SM, 1986, J BIOL CHEM, V261, P4732; KEMP BE, 1991, BIOCHIM BIOPHYS ACTA, V1094, P67, DOI 10.1016/0167-4889(91)90027-U; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KILIMANN MW, 1988, P NATL ACAD SCI USA, V85, P9381, DOI 10.1073/pnas.85.24.9381; KING MM, 1983, J BIOL CHEM, V258, P9925; KLINMAN JP, 1985, J AM CHEM SOC, V107, P1058, DOI 10.1021/ja00290a052; Krebs E G, 1968, Adv Enzyme Regul, V6, P245, DOI 10.1016/0065-2571(68)90016-2; LAMBOOY PK, 1982, ARCH BIOCHEM BIOPHYS, V213, P551, DOI 10.1016/0003-9861(82)90583-5; NEWSHOLME P, 1992, J BIOL CHEM, V267, P810; PAUDEL HK, 1988, ARCH BIOCHEM BIOPHYS, V264, P641, DOI 10.1016/0003-9861(88)90330-X; PAUDEL HK, 1991, J BIOL CHEM, V266, P16524; PAUDEL HK, 1987, J BIOL CHEM, V262, P11912; Pickett-Gies CA., 1986, ENZYMES, V17, P395; RAMACHANDRAN C, 1987, J BIOL CHEM, V262, P3210; REIMANN EM, 1984, BIOCHEMISTRY-US, V23, P4185, DOI 10.1021/bi00313a027; SALERNO A, 1990, J BIOL CHEM, V265, P18079; SANCHEZ VE, 1990, FASEB J, V5, pA800; SKUSTER JR, 1980, J BIOL CHEM, V255, P2203; SODERLING TR, 1990, J BIOL CHEM, V265, P1823; TABATABAI LB, 1978, J BIOL CHEM, V253, P2196; TANFORD C, 1952, J AM CHEM SOC, V74, P2509, DOI 10.1021/ja01130a017; TREMPE MR, 1987, J BIOL CHEM, V262, P4333; VIRIYA J, 1979, BIOCHEM BIOPH RES CO, V87, P17, DOI 10.1016/0006-291X(79)91641-3; WALSH DA, 1971, J BIOL CHEM, V246, P1968; ZANDER NF, 1988, P NATL ACAD SCI USA, V85, P2929, DOI 10.1073/pnas.85.9.2929	51	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17889	17895						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349673				2022-12-27	WOS:A1993LT74300040
J	SHARMA, S; HAMMEN, PK; ANDERSON, JW; LEUNG, A; GEORGES, F; HENGSTENBERG, W; KLEVIT, RE; WAYGOOD, EB				SHARMA, S; HAMMEN, PK; ANDERSON, JW; LEUNG, A; GEORGES, F; HENGSTENBERG, W; KLEVIT, RE; WAYGOOD, EB			DEAMIDATION OF HPR, A PHOSPHOCARRIER PROTEIN OF THE PHOSPHOENOLPYRUVATE - SUGAR PHOSPHOTRANSFERASE SYSTEM, INVOLVES ASPARAGINE 38 (HPR-1) AND ASPARAGINE 12 (HPR-2) IN ISOASPARTYL ACID FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE-CONTAINING PROTEIN; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; TERTIARY STRUCTURE; BACILLUS-SUBTILIS; NONENZYMATIC DEAMIDATION; NMR-SPECTROSCOPY; ACTIVE-SITE; ENZYME-I; SEQUENCE	Histidine-containing protein, HPr, of the phosphoenolpyruvate: sugar phosphotransferase system in Escherichia coli, when incubated at elevated temperatures forms many species of protein. The two major species are HPr-1 and HPr-2, which have been shown to lack one or two amides, respectively (Anderson, B., Weigel, N., Kundig, W., and Roseman, S. (1971) J. Biol. Chem. 246, 7023-7033). The formation of HPr-1 and HPr-2 is shown to be pH-dependent and does not occur readily below pH 6. Investigation of the identities and properties of the two residues that deamidate involved creation of site-directed mutants at the 6 glutamine and 2 asparagine residues of HPr; description of their deamidation species by isoelectric focusing; determination of their relative antibody binding properties; assay of their phosphoacceptor and phosphodonor activities; characterization of tryptic and VS-protease peptides; obtaining two-dimensional nuclear magnetic resonance spectra of HPr, HPr-1, and several mutants. It was determined that the sequential deamidation of Asn-38 and Asn-12 yields HPr-1 and HPr-2. Both residues exist as Asn-Gly pairs, and both deamidations probably form isoaspartyl acid. HPr from Bacillus subtilis and Staphylococcus carnosus which also have Asn-Gly at residues 38 and 39 form HPr-1 species presumably by deamidation. HPr from Streptococcus faecalis which does not have Asn-38 does not form a HPr-1 species. The E. coli mutant HPrs, N12D and Q51E, residues that may be involved in the active site, had impaired phosphohydrolysis properties and decreased phosphoenolpyruvate:sugar phosphotransferase system activity.	UNIV SASKATCHEWAN,DEPT BIOCHEM,SASKATOON S7N 0W0,SASKATCHEWAN,CANADA; UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195; NATL RES COUNCIL CANADA,INST PLANT BIOTECHNOL,SASKATOON S7N 0W9,SASKATCHEWAN,CANADA; RUHR UNIV BOCHUM,DEPT MICROBIOL,W-4630 BOCHUM,GERMANY	University of Saskatchewan; University of Washington; University of Washington Seattle; National Research Council Canada; Ruhr University Bochum					NIDDK NIH HHS [DK-35187] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R23DK035187, R01DK035187] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON B, 1971, J BIOL CHEM, V246, P7023; ANDERSON JW, 1991, BIOCHEMISTRY-US, V30, P9601, DOI 10.1021/bi00104a006; ANDERSON JW, 1993, J BIOL CHEM, V268, P12325; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BENESKI DA, 1982, J BIOL CHEM, V257, P4492; BORNSTEIN P, 1970, J BIOL CHEM, V245, P4854; CHAZIN WJ, 1989, BIOCHEMISTRY-US, V28, P8646, DOI 10.1021/bi00447a055; CLARKE S, 1985, ANNU REV BIOCHEM, V54, P479, DOI 10.1146/annurev.bi.54.070185.002403; DERUESE H, 1985, GENE AMST, V35, P199; DEUTSCHER J, 1986, BIOCHEMISTRY-US, V25, P6543, DOI 10.1021/bi00369a031; EISERMANN R, 1991, EUR J BIOCHEM, V197, P9, DOI 10.1111/j.1432-1033.1991.tb15875.x; ELKABBANI OAL, 1987, J BIOL CHEM, V262, P12926; GEIGER T, 1987, J BIOL CHEM, V262, P785; GONZYTREBOUL G, 1989, MOL MICROBIOL, V3, P103, DOI 10.1111/j.1365-2958.1989.tb00109.x; GREISINGER C, 1988, J AM CHEM SOC, V110, P7870; GRUBL G, 1990, J BACTERIOL, V172, P5871; HAMMEN PK, 1991, BIOCHEMISTRY-US, V30, P11842, DOI 10.1021/bi00115a014; HEINRIKSON RL, 1984, ANAL BIOCHEM, V136, P65, DOI 10.1016/0003-2697(84)90307-5; HERZBERG O, 1992, P NATL ACAD SCI USA, V89, P2499, DOI 10.1073/pnas.89.6.2499; JIA Z, 1992, THESIS U SASKATCHEWA; JIA Z, 1993, NATURE, V361, P95; KALBITZER HR, 1991, BIOCHEMISTRY-US, V30, P11186, DOI 10.1021/bi00110a024; KALBITZER HR, 1982, BIOCHEMISTRY-US, V21, P2879, DOI 10.1021/bi00541a012; KLEVIT RE, 1986, BIOCHEMISTRY-US, V25, P7774, DOI 10.1021/bi00371a073; KLEVIT RE, 1988, STRUCTURE EXPRESSION, V1, P119; KOSSIAKOFF AA, 1988, SCIENCE, V240, P191, DOI 10.1126/science.3353715; KUNDIG W, 1964, P NATL ACAD SCI USA, V52, P1067, DOI 10.1073/pnas.52.4.1067; LENGELER JW, 1989, FEMS MICROBIOL REV, V63, P81; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; MATTOO RL, 1983, CAN J BIOCHEM CELL B, V61, P29, DOI 10.1139/o83-005; MUELLER N, 1986, Journal of the American Chemical Society, V108, P6482, DOI 10.1021/ja00281a006; POWERS DA, 1984, J BIOL CHEM, V259, P5212; REIZER J, 1989, EMBO J, V8, P2110; Robinson A B, 1974, Curr Top Cell Regul, V8, P247; SHARMA S, 1991, P NATL ACAD SCI USA, V88, P4877, DOI 10.1073/pnas.88.11.4877; SHARMA S, 1992, THESIS U SASKATCHEWA; SPANGLER BD, 1989, BIOCHEMISTRY-US, V28, P1333, DOI 10.1021/bi00429a059; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; VANULAND NAJ, 1992, EUR J BIOCHEM, V203, P483; WADDELL WJ, 1956, J LAB CLIN MED, V48, P311; WAYGOOD EB, 1987, J BACTERIOL, V169, P2810, DOI 10.1128/jb.169.6.2810-2818.1987; WAYGOOD EB, 1980, CAN J BIOCHEM CELL B, V58, P40, DOI 10.1139/o80-006; WAYGOOD EB, 1985, BIOCHEMISTRY-US, V24, P6938, DOI 10.1021/bi00345a028; WAYGOOD EB, 1979, ANAL BIOCHEM, V95, P293, DOI 10.1016/0003-2697(79)90219-7; WEARNE SJ, 1989, PROTEINS, V5, P8, DOI 10.1002/prot.340050103; WEIGEL N, 1982, J BIOL CHEM, V257, P4499; WITTEKIND M, 1990, BIOCHEMISTRY-US, V29, P7191, DOI 10.1021/bi00483a006; WITTEKIND M, 1992, PROTEIN SCI, V1, P1363, DOI 10.1002/pro.5560011016; WRIGHT HT, 1991, PROTEIN ENG, V4, P283, DOI 10.1093/protein/4.3.283; WRIGHT HT, 1991, CRIT REV BIOCHEM MOL, V26, P1, DOI 10.1080/10409230490440532	51	39	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17695	17704						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349654				2022-12-27	WOS:A1993LT74300012
J	HU, SZ; KINCAID, JR				HU, SZ; KINCAID, JR			HEME ACTIVE-SITE STRUCTURAL CHARACTERIZATION OF CHLOROPEROXIDASE BY RESONANCE RAMAN-SPECTROSCOPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C PEROXIDASE; ELECTRON-PARAMAGNETIC RESONANCE; PORPHYRIN FORCE-FIELD; CRYSTAL-STRUCTURE; NICKEL OCTAETHYLPORPHYRIN; HORSERADISH-PEROXIDASE; BENDING VIBRATIONS; PSEUDOMONAS-PUTIDA; THIOLATE LIGATION; ISOTOPE SHIFT	Resonance Raman spectra are reported for the nitric oxide adducts of ferric and ferrous chloroperoxidase and carbon monoxide adducts of ferrous chloroperoxidase. The stretching, nu(Fe-NO), and bending, delta(FeNO), modes are detected at 538 and 558 cm-1, respectively, for the ferric nitrosylchloroperoxidase. These two bands shift to 534 and 546 cm-1, respectively, upon substitution by (NO)-N-15-O-16. The nu(Fe-NO) mode of the nitric oxide adduct of ferrous chloroperoxidase is located at 542 cm-1, which shifts to 528 (NO)-N-15-N-16, 540 (NO)-N-14-O-18, and 524 (NO)-N-15-O-18 cm-1 as the mass of the bound nitric oxide increases by 1 atomic unit. Two distinct states of the carbon monoxide adduct of chloroperoxidase, the acidic and alkaline forms, are found to undergo a reversible pH-induced transition. The nu(Fe-CO) mode shifts from 484 to 492 cm-1 and the delta(FeCO) mode at 562 cm-1 disappears as the pH is reduced from 6.0 to 3.3. In addition, two low frequency modes at 382 and 420 cm-1, assignable to the delta(CbC1C2) bending of propionate and vinyl groups, respectively, also show pH sensitivity. The results suggest a peroxidase-like heme active-site environment for chloroperoxidase and indicate a facile conformational change of heme groups accompanying the acid-base transition.	MARQUETTE UNIV,DEPT CHEM,MILWAUKEE,WI 53233	Marquette University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035153] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK35153] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABE M, 1978, J CHEM PHYS, V69, P4526, DOI 10.1063/1.436450; BANGCHAROENPAURPONG O, 1986, BIOCHEMISTRY-US, V25, P2374, DOI 10.1021/bi00357a011; BENKO B, 1983, P NATL ACAD SCI USA, V80, P7042, DOI 10.1073/pnas.80.22.7042; BLANKE SR, 1990, J BIOL CHEM, V265, P12454; CHAMPION PM, 1976, BIOCHIM BIOPHYS ACTA, V446, P486, DOI 10.1016/0005-2795(76)90015-5; CHAMPION PM, 1978, J AM CHEM SOC, V100, P3743, DOI 10.1021/ja00480a015; CHAMPION PM, 1982, J AM CHEM SOC, V104, P5469, DOI 10.1021/ja00384a037; CHAMPION PM, 1973, BIOCHEMISTRY-US, V12, P426, DOI 10.1021/bi00727a011; CHAMPION PM, 1975, BIOCHEMISTRY-US, V14, P4159, DOI 10.1021/bi00690a002; CHOI S, 1982, J AM CHEM SOC, V104, P4345, DOI 10.1021/ja00380a006; CRAMER SP, 1978, J AM CHEM SOC, V100, P7282, DOI 10.1021/ja00491a027; DAWSON JH, 1988, SCIENCE, V240, P433, DOI 10.1126/science.3358128; DAWSON JH, 1987, CHEM REV, V87, P1255, DOI 10.1021/cr00081a015; DUGAD LB, 1992, BIOCHEMISTRY-US, V31, P1651, DOI 10.1021/bi00121a011; EDWARDS SL, 1990, J BIOL CHEM, V265, P2588; EGAWA T, 1992, FEBS LETT, V305, P206, DOI 10.1016/0014-5793(92)80668-7; EVANGELISTAKIRKUP R, 1986, BIOCHEMISTRY-US, V25, P4420, DOI 10.1021/bi00363a037; HOLLENBERG PF, 1973, J BIOL CHEM, V248, P2630; HOLLENBERG PF, 1980, J BIOL CHEM, V255, P4801; HU S, 1991, J AM CHEM SOC, V113, P4816; HU SZ, 1991, J AM CHEM SOC, V113, P9760, DOI 10.1021/ja00026a008; HU SZ, 1991, J AM CHEM SOC, V113, P2843, DOI 10.1021/ja00008a007; LEE HC, 1988, J BIOL CHEM, V263, P16118; LI XY, 1990, J PHYS CHEM-US, V94, P47, DOI 10.1021/j100364a008; LI XY, 1989, J AM CHEM SOC, V111, P7012, DOI 10.1021/ja00200a018; MORRIS DR, 1966, J BIOL CHEM, V241, P1763; OZAKI Y, 1978, BIOCHEMISTRY-US, V17, P5826, DOI 10.1021/bi00619a033; OZAKI Y, 1976, J BIOCHEM-TOKYO, V80, P1447, DOI 10.1093/oxfordjournals.jbchem.a131420; POULOS TL, 1987, BIOCHEMISTRY-US, V26, P8165, DOI 10.1021/bi00399a022; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; POULOS TL, 1985, J BIOL CHEM, V260, P6122; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; RAAG R, 1990, BIOCHEMISTRY-US, V29, P8119, DOI 10.1021/bi00487a019; RAAG R, 1989, BIOCHEMISTRY-US, V28, P917, DOI 10.1021/bi00428a077; RAAG R, 1991, BIOCHEMISTRY-US, V30, P2674, DOI 10.1021/bi00224a016; RAAG R, 1989, BIOCHEMISTRY-US, V28, P7586, DOI 10.1021/bi00445a013; RAJENDRAN G, 1986, INORG CHEM, V25, P876, DOI 10.1021/ic00226a032; REMBA RD, 1979, BIOCHEMISTRY-US, V18, P2280, DOI 10.1021/bi00578a023; SAMOKYSZYN VM, 1991, BIOCHEMISTRY-US, V30, P11646, DOI 10.1021/bi00114a006; SMULEVICH G, 1991, BIOCHEMISTRY-US, V30, P9546, DOI 10.1021/bi00103a023; SMULEVICH G, 1986, BIOCHEMISTRY-US, V25, P4426, DOI 10.1021/bi00363a038; SONO M, 1986, BIOCHEMISTRY-US, V25, P347, DOI 10.1021/bi00350a011; SONO M, 1991, BIOCHIM BIOPHYS ACTA, V1078, P351, DOI 10.1016/0167-4838(91)90156-T; SPIRO TG, 1988, BIOL APPLICATIONS RA, V3; THOMAS JA, 1970, J BIOL CHEM, V245, P3129; TSUBAKI M, 1982, BIOCHEMISTRY-US, V21, P1132, DOI 10.1021/bi00535a004; UCHIDA K, 1988, J BIOCHEM-TOKYO, V103, P979, DOI 10.1093/oxfordjournals.jbchem.a122397; UNO T, 1987, J BIOL CHEM, V262, P4549; UNO T, 1985, J BIOL CHEM, V260, P2023; VANETTEN RL, 1981, J AM CHEM SOC, V103, P5633, DOI 10.1021/ja00409a002	50	41	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1993	268	9					6189	6193						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KT368	8384203				2022-12-27	WOS:A1993KT36800020
J	FELDMAN, DA; WEINHOLD, PA				FELDMAN, DA; WEINHOLD, PA			IDENTIFICATION OF A PROTEIN COMPLEX BETWEEN CHOLINE-PHOSPHATE CYTIDYLYLTRANSFERASE AND A 112-KDA PROTEIN IN RAT-LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; CHINESE-HAMSTER OVARY; HEP G2 CELLS; PHOSPHOLIPASE-C TREATMENT; FATTY-ACIDS; PHOSPHATIDYLCHOLINE SYNTHESIS; HELA-CELLS; PHOSPHORYLCHOLINE CYTIDYLYLTRANSFERASE; IMMUNOREACTIVE CONTENT; ENDOPLASMIC-RETICULUM	Antisera raised against purified cytidylyltransferase (CT) immunoprecipitated CT activity from liver cytosol and detected the M(r) 45,000 subunit of CT on Western blots. Antisera detected a M(r) 112,000 protein on Western blots of liver cytosol. This protein was not detected in purified CT and was not detected by preimmune serum. The 112-kDa antibodies, isolated by affinity chromatography, did not immunoprecipitate CT activity. Antiserum raised against an N-terminal sequence of CT and antibodies raised against an internal sequence of CT immunoprecipitated CT activity but did not detect the 112-kDa protein. These results showed that the 112-kDa protein was not a form of CT. We concluded that the antiserum probably contained anti-idiotypic antibodies that recognized CT binding sites on the 112-kDa protein. Purified CT that was conjugated to horseradish peroxidase bound to crude 112-kDa protein immobilized on nitrocellulose. The binding was competitively reduced by purified CT and by affinity-purified antibodies to the 112-kDa protein. CT and 112-kDa protein coeluted from DEAE-Sepharose. When the putative 112-kDa protein-CT complex was chromatographed on a second DEAE-Sepharose column or on a Bio-Gel A-1.5m column, CT activity and 112-kDa protein were eluted together. Chromatography of the complex on hydroxylapatite dissociated most of the complex, producing CT free of the 112-kDa protein. We conclude that the 112-kDa protein is a CT-binding protein. The formation and/or dissociation of this complex may be important in the regulation of CT.	VET AFFAIRS MED CTR, 2215 FULLER RD, ANN ARBOR, MI 48105 USA; UNIV MICHIGAN, SCH MED, DEPT BIOL CHEM, ANN ARBOR, MI 48105 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Michigan System; University of Michigan					NICHD NIH HHS [HD 02871] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD002871] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AEBERHARD EE, 1986, BIOCHIM BIOPHYS ACTA, V875, P6, DOI 10.1016/0005-2760(86)90004-4; ANDERSON KE, 1985, BIOCHIM BIOPHYS ACTA, V835, P360, DOI 10.1016/0005-2760(85)90292-9; BINION SB, 1982, J EXP MED, V156, P860, DOI 10.1084/jem.156.3.860; CHANDER A, 1988, BIOCHIM BIOPHYS ACTA, V958, P343, DOI 10.1016/0005-2760(88)90219-6; CHU AJ, 1985, BIOCHIM BIOPHYS ACTA, V834, P346, DOI 10.1016/0005-2760(85)90008-6; CORNELL R, 1987, BIOCHIM BIOPHYS ACTA, V919, P26, DOI 10.1016/0005-2760(87)90214-1; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; FELDMAN DA, 1990, BIOCHIM BIOPHYS ACTA, V1045, P49, DOI 10.1016/0005-2760(90)90202-9; FELDMAN DA, 1987, J BIOL CHEM, V262, P9075; GAULTON GN, 1986, ANNU REV IMMUNOL, V4, P253, DOI 10.1146/annurev.iy.04.040186.001345; HATCH GM, 1991, BIOCHIM BIOPHYS ACTA, V1081, P25, DOI 10.1016/0005-2760(91)90245-D; JAMIL H, 1990, J BIOL CHEM, V265, P4332; JAMIL H, 1992, J BIOL CHEM, V267, P1752; KENT C, 1990, PROG LIPID RES, V29, P87, DOI 10.1016/0163-7827(90)90010-I; KOHLER H, 1989, METHOD ENZYMOL, V178, P3; KOLESNICK RN, 1990, J BIOL CHEM, V265, P10900; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAKINEN KK, 1982, ANAL BIOCHEM, V126, P100, DOI 10.1016/0003-2697(82)90114-2; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MOCK T, 1986, BIOCHEM CELL BIOL, V64, P413, DOI 10.1139/o86-058; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V795, P433, DOI 10.1016/0005-2760(84)90169-3; PELECH SL, 1983, J BIOL CHEM, V258, P6782; ROONEY SA, 1990, BIOCHIM BIOPHYS ACTA, V1044, P385, DOI 10.1016/0005-2760(90)90085-C; ROONEY SA, 1986, BIOCHIM BIOPHYS ACTA, V888, P208, DOI 10.1016/0167-4889(86)90023-6; SHECHTER Y, 1984, J BIOL CHEM, V259, P6411; SLEIGHT R, 1983, J BIOL CHEM, V258, P831; SLEIGHT R, 1983, J BIOL CHEM, V258, P836; TERCE F, 1992, BIOCHEM J, V282, P333, DOI 10.1042/bj2820333; TIJBURG LBM, 1989, BIOCHIM BIOPHYS ACTA, V1004, P1, DOI 10.1016/0005-2760(89)90206-3; UTAL AK, 1991, J BIOL CHEM, V266, P24084; VANCE DE, 1989, PHOSPHATIDYLCHOLINE, P225; WATKINS JD, 1991, J BIOL CHEM, V266, P21113; WATKINS JD, 1992, J BIOL CHEM, V267, P5686; WATKINS JD, 1990, J BIOL CHEM, V265, P2190; WEINHOLD PA, 1992, METHOD ENZYMOL, V209, P248; WEINHOLD PA, 1984, J BIOL CHEM, V259, P315; WEINHOLD PA, 1986, J BIOL CHEM, V261, P5104; WEINHOLD PA, 1991, J BIOL CHEM, V266, P6093; WEINHOLD PA, 1989, BIOCHIM BIOPHYS ACTA, V1006, P299, DOI 10.1016/0005-2760(89)90017-9	39	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3127	3135						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381419				2022-12-27	WOS:A1993KM16100020
J	FUJIKI, M; VERNER, K				FUJIKI, M; VERNER, K			COUPLING OF CYTOSOLIC PROTEIN-SYNTHESIS AND MITOCHONDRIAL PROTEIN IMPORT IN YEAST - EVIDENCE FOR COTRANSLATIONAL IMPORT INVIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOUND CYTOPLASMIC POLYSOMES; ACCUMULATE MASSIVE AMOUNTS; POST-TRANSLATIONAL IMPORT; ENERGY-DEPENDENT UPTAKE; DIHYDROFOLATE-REDUCTASE; SACCHAROMYCES-CEREVISIAE; PRECURSOR POLYPEPTIDES; INVITRO SYSTEM; TRANSLOCATION; CELLS	We have utilized a homologous cell-free mitochondrial protein import system derived from the yeast Saccharomyces cerevisiae, in addition to performing a series of in vivo experiments in yeast, to investigate the coupling between cytosolic protein synthesis and protein transport into mitochondria. We found that the import of bulk mitochondrial proteins was inhibited in both the homologous in vitro reaction and in vivo upon arrest of cytosolic protein synthesis with the addition of cycloheximide. Tight coupling of synthesis and import was also demonstrated in vivo for the beta subunit of the mitochondrial F1-ATPase. We also investigated the effect of the antifolate methotrexate on the import of a fusion protein consisting of the mitochondrial targeting signal of yeast cytochrome oxidase subunit IV fused to mouse dihydrofolate reductase (the COXIV-DHFR fusion protein). Methotrexate has previously been shown to inhibit posttranslational import of COXIV-DHFR by preventing the DHFR moiety from unfolding. However, we found that antifolate addition had no inhibitory effect on the import of COXIV-DHFR in vivo, suggesting that its import into mitochondria in yeast cells occurs cotranslationally. Further, when we treated yeast with the proton ionophore carbonyl cyanide m-chlorophenylhydrazone to collapse the mitochondrial membrane potential and induce the accumulation of extramitochondrial precursor pools, we found that the ability to be imported by a strictly posttranslational mechanism upon reestablishing the membrane potential varied from one precursor to another, suggesting that cotranslational import may be mandatory for the import of some proteins in vivo. In summary, our findings are entirely consistent with the notion that import of proteins into yeast mitochondria occurs cotranslationally under normal conditions in vivo.			FUJIKI, M (corresponding author), PENN STATE UNIV,MILTON S HERSHEY MED CTR,COLL MED,DEPT CELLULAR & MOLEC PHYSIOL,HERSHEY,PA 17033, USA.							ACHSTETTER T, 1984, J BIOL CHEM, V259, P3334; ADES IZ, 1980, J BIOL CHEM, V255, P9925; ADES IZ, 1980, J BIOL CHEM, V255, P9918; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; CHEN WJ, 1987, J BIOL CHEM, V262, P15605; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; DAUM G, 1982, J BIOL CHEM, V257, P3028; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; DOUGLAS MG, 1986, MICROBIOL REV, V50, P166, DOI 10.1128/MMBR.50.2.166-178.1986; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; FUJIKI M, 1991, J BIOL CHEM, V266, P6841; GASSER SM, 1982, J BIOL CHEM, V257, P3034; GLICK B, 1991, ANNU REV GENET, V25, P21; HANN BC, 1991, CELL, V67, P131, DOI 10.1016/0092-8674(91)90577-L; HURT EC, 1985, EMBO J, V4, P2061, DOI 10.1002/j.1460-2075.1985.tb03892.x; HURT EC, 1984, FEBS LETT, V178, P306, DOI 10.1016/0014-5793(84)80622-5; KELLEMS RE, 1975, J CELL BIOL, V65, P1, DOI 10.1083/jcb.65.1.1; MACCECCHINI ML, 1979, P NATL ACAD SCI USA, V76, P343, DOI 10.1073/pnas.76.1.343; MARTIN J, 1991, J BIOL CHEM, V266, P18051; MIYAJIMA A, 1984, MOL CELL BIOL, V4, P407, DOI 10.1128/MCB.4.3.407; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; NELSON N, 1979, P NATL ACAD SCI USA, V76, P4365, DOI 10.1073/pnas.76.9.4365; ONO H, 1990, ARCH BIOCHEM BIOPHYS, V280, P299, DOI 10.1016/0003-9861(90)90333-T; ONO H, 1990, ARCH BIOCHEM BIOPHYS, V277, P368, DOI 10.1016/0003-9861(90)90592-M; PFANNER N, 1990, ANNU REV BIOCHEM, V59, P331, DOI 10.1146/annurev.bi.59.070190.001555; REID GA, 1982, J BIOL CHEM, V257, P3056; REID GA, 1982, J BIOL CHEM, V257, P3062; SUISSA M, 1982, J BIOL CHEM, V257, P3048; VERNER K, 1992, MOL MICROBIOL, V6, P1723, DOI 10.1111/j.1365-2958.1992.tb01344.x; VERNER K, 1988, SCIENCE, V241, P1307, DOI 10.1126/science.2842866; VERNER K, 1989, J BIOL CHEM, V264, P3877; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; WIENHUES U, 1991, J CELL BIOL, V115, P1601, DOI 10.1083/jcb.115.6.1601	33	87	93	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1914	1920						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380582				2022-12-27	WOS:A1993KH62000064
J	RAHMAN, S; CARLILE, G; EVANS, WH				RAHMAN, S; CARLILE, G; EVANS, WH			ASSEMBLY OF HEPATIC GAP-JUNCTIONS - TOPOGRAPHY AND DISTRIBUTION OF CONNEXIN-32 IN INTRACELLULAR AND PLASMA-MEMBRANES DETERMINED USING SEQUENCE-SPECIFIC ANTIBODIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; POLYPEPTIDE; TOPOLOGY; INTACT	The subcellular distribution in rat liver and the topography in intracellular and plasma membranes of connexin 32, a major protein component of gap junctions, was studied using sequence-specific anti-peptide antibodies generated to extracellular and intracellular domains of the protein. The distribution of connexin 32 in liver analyzed using SDS-polyacrylamide gel electrophoresis and Western blotting showed the relative protein levels in the subcellular fractions to be: lateral plasma membranes > Golgi membranes > sinus-oidal plasma membranes > lysosomes. Low amounts of connexin 32 were detected in microsomes, endosomes, and bile canalicular plasma membranes. Six highly conserved cysteine residues are located in the amino acid sequences comprising the two extracellular loops of all connexins thus far isolated, and these loops are positioned to extend the channel in the lipid bilayers across the intercellular region of the gap junction. In the present work, the intramolecular disulfide bonds linking the extracellular loops in gap junctions were shown to be present in connexins located in plasma membranes, Golgi, and a microsomal fraction, and it was concluded that the disulfide linkages were formed in the endoplasmic reticulum. In addition, immature configurations of connexin 32, probably occurring during membrane insertion, were detected in liver microsomal fractions. The results contribute to charting of the biogenetic routes followed by connexins in hepatocytes and the general mechanisms of gap junction assembly.			RAHMAN, S (corresponding author), NATL INST MED RES, PROT STRUCT LAB, MILL HILL, LONDON NW7 1AA, ENGLAND.							BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q; GOODENOUGH DA, 1988, J CELL BIOL, V107, P1817, DOI 10.1083/jcb.107.5.1817; HAEFLIGER JA, 1992, J BIOL CHEM, V267, P2057; HERTZBERG EL, 1988, J BIOL CHEM, V263, P19105; LOEWENSTEIN WR, 1985, BIOCHEM SOC SYMP, P43; MILKS LC, 1988, EMBO J, V7, P2967, DOI 10.1002/j.1460-2075.1988.tb03159.x; PAUL DL, 1986, J CELL BIOL, V103, P123, DOI 10.1083/jcb.103.1.123; RAHMAN S, 1991, J CELL SCI, V100, P567; SAEZ JC, 1986, P NATL ACAD SCI USA, V83, P2473, DOI 10.1073/pnas.83.8.2473; STAGG RB, 1990, ENDOCR REV, V11, P302, DOI 10.1210/edrv-11-2-302; TURIN L, 1977, NATURE, V270, P56, DOI 10.1038/270056a0; UNWIN PNT, 1984, NATURE, V307, P609, DOI 10.1038/307609a0; WILLECKE K, 1991, EUR J CELL BIOL, V56, P1; YANCEY SB, 1989, J CELL BIOL, V108, P2241, DOI 10.1083/jcb.108.6.2241; ZIMMER DB, 1987, J BIOL CHEM, V262, P7751	15	82	82	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1260	1265						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8380409				2022-12-27	WOS:A1993KG07700074
J	JABLONSKI, PE; LU, WP; RAGSDALE, SW; FERRY, JG				JABLONSKI, PE; LU, WP; RAGSDALE, SW; FERRY, JG			CHARACTERIZATION OF THE METAL CENTERS OF THE CORRINOID IRON-SULFUR COMPONENT OF THE CO DEHYDROGENASE ENZYME COMPLEX FROM METHANOSARCINA-THERMOPHILA BY EPR SPECTROSCOPY AND SPECTROELECTROCHEMISTRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL COENZYME-A; DEPENDENT METHIONINE SYNTHASE; ELECTRON-PARAMAGNETIC-RES; CARBON-MONOXIDE; CLOSTRIDIUM-THERMOACETICUM; ACETATE; PURIFICATION; PROTEIN; METHANOGENESIS; METHANOBACTERIUM	The multienzyme carbon monoxide dehydrogenase complex from Methanosarcina thermophila contains at least two protein components: a CO-oxidizing nickel/iron-sulfur (Ni/Fe-S) component and a cobalt-containing corrinoid/iron-sulfur component (Co/Fe-S). The CO dehydrogenase complex has been shown to synthesize acetyl-CoA from CoA, CH3I, and CO as well as to cleave acetyl-CoA into its methyl, carbonyl, and CoA components as the first step in the catabolism of acetyl-CoA to methane and CO2. Presumed to serve as an acceptor of the methyl group of acetyl-CoA en route to methane, the Co/Fe-S component contains iron, acid-labile sulfur, and a corrinoid cofactor (factor III) that is the site of methylation. Using EPR spectroscopy and spectroelectrochemistry, we characterized the cobalt and Fe-S centers of the Co/Fe-S component. The redox and EPR properties of the metal centers in the isolated Co/Fe-S component are similar to those of the Co/Fe-S component in the CO dehydrogenase enzyme complex, a result that indicates that any protein-protein interaction between components in the complex has little influence on the properties of the metal centers. The corrinoid is maintained in the base-off state with a formal equilibrium reduction potential (E'0) at pH 7.8 of -486 mV for the Co2+/1+ couple that facilitates reduction of the Co2+ state by approximately 12 kcal/mol relative to base-on cobamides. The Co/Fe-S component also contains a [4Fe-4S]2+/1+ cluster with an E'0 at pH 7.8 of -502 mV, which is nearly isopotential with the Co2+/1+ couple of the cobamide.	UNIV NEBRASKA,DEPT BIOCHEM,EAST CAMPUS,LINCOLN,NE 68583; VIRGINIA POLYTECH INST & STATE UNIV,DEPT ANAEROB MICROBIOL,BLACKSBURG,VA 24061	University of Nebraska System; University of Nebraska Lincoln; Virginia Polytechnic Institute & State University								ABBANAT DR, 1990, J BACTERIOL, V172, P7145, DOI 10.1128/jb.172.12.7145-7150.1990; ABBANAT DR, 1991, P NATL ACAD SCI USA, V88, P3272, DOI 10.1073/pnas.88.8.3272; ACETI DJ, 1988, J BIOL CHEM, V263, P15444; ALTMAN TE, 1981, THESIS U ILLINOIS UR; BANERJEE RV, 1990, BIOCHEMISTRY-US, V29, P11101, DOI 10.1021/bi00502a013; BANERJEE RV, 1990, BIOCHEMISTRY-US, V29, P1129, DOI 10.1021/bi00457a005; BANERJEE RV, 1990, FASEB J, V4, P1450, DOI 10.1096/fasebj.4.5.2407589; BOBIK TA, 1987, BIOCHEM BIOPH RES CO, V149, P455, DOI 10.1016/0006-291X(87)90389-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAO XJ, 1991, J BACTERIOL, V173, P5439, DOI 10.1128/jb.173.17.5439-5448.1991; DULIBA EP, 1983, THESIS U ILLINOIS UR; FISCHER R, 1989, ARCH MICROBIOL, V151, P459, DOI 10.1007/BF00416607; FUJII K, 1977, ARCH BIOCHEM BIOPHYS, V178, P662, DOI 10.1016/0003-9861(77)90238-7; GRAHAME DA, 1991, J BIOL CHEM, V266, P22227; HARDER SR, 1989, ANAL BIOCHEM, V181, P283, DOI 10.1016/0003-2697(89)90244-3; HARDER SR, 1989, BIOCHEMISTRY-US, V28, P9080, DOI 10.1021/bi00449a019; HEDDERICH R, 1989, FEBS LETT, V255, P67, DOI 10.1016/0014-5793(89)81062-2; HU SI, 1984, J BIOL CHEM, V259, P8892; JABLONSKI PE, 1991, J BACTERIOL, V173, P2481, DOI 10.1128/jb.173.8.2481-2487.1991; KUHN EP, 1990, APPL ENVIRON MICROB, V56, P2630, DOI 10.1128/AEM.56.9.2630-2637.1990; LEXA D, 1977, J AM CHEM SOC, V99, P2786, DOI 10.1021/ja00450a061; LOVLEY DR, 1984, J BACTERIOL, V160, P521, DOI 10.1128/JB.160.2.521-525.1984; LUNDIE LL, 1989, J BIOL CHEM, V264, P18392; MAURICE AM, 1982, THESIS U ILLINOIS UR; Nilges M. J., 1979, THESIS U ILLINOIS UR; ORMEJOHNSON WH, 1973, IRON SULFUR PROTEINS, V2, P194; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; Pilbrow J. R., 1982, B12, V1, P431; PILBROW JR, 1973, MOL PHYS, V25, P1073, DOI 10.1080/00268977300100941; Pratt J. M., 1982, B12, V1, P325; RAGSDALE SW, 1987, J BIOL CHEM, V262, P14289; RAGSDALE SW, 1991, CRIT REV BIOCHEM MOL, V26, P261, DOI 10.3109/10409239109114070; RUPP H, 1978, BIOCHIM BIOPHYS ACTA, V537, P255, DOI 10.1016/0005-2795(78)90509-3; SALMON RT, 1980, J ELECTROANAL CHEM, V112, P253, DOI 10.1016/S0022-0728(80)80407-4; SCHULZ H, 1988, EUR J BIOCHEM, V171, P589, DOI 10.1111/j.1432-1033.1988.tb13829.x; SOWERS KR, 1984, CURR MICROBIOL, V11, P227, DOI 10.1007/BF01567165; TERLESKY KC, 1987, J BIOL CHEM, V262, P15392; TERLESKY KC, 1986, J BACTERIOL, V168, P1053, DOI 10.1128/jb.168.3.1053-1058.1986; WEAST RC, 1986, CRC HDB CHEM PHYSICS; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576	40	47	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					325	329						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380157				2022-12-27	WOS:A1993KE60300050
J	MORI, S; HELDIN, CH; CLAESSONWELSH, L				MORI, S; HELDIN, CH; CLAESSONWELSH, L			LIGAND-INDUCED UBIQUITINATION OF THE PLATELET-DERIVED GROWTH-FACTOR BETA-RECEPTOR PLAYS A NEGATIVE REGULATORY ROLE IN ITS MITOGENIC SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-TYPE RECEPTOR; PDGF RECEPTOR; PROTEIN LIGASE; MULTIUBIQUITIN CHAIN; MEDIATED ENDOCYTOSIS; HUMAN-FIBROBLASTS; CDNA CLONING; DEGRADATION; BINDING; INTERNALIZATION	We have recently reported that the platelet-derived growth factor beta-receptor undergoes polyubiquitination as a consequence of ligand binding and that a mutant beta-receptor lacking the carboxyl-terminal 98 amino acid residues of the receptor (CT98 mutant) does not undergo this posttranslational modification (Mori, S., Heldin, C.-H., and Claesson-Welsh, L. (1992) J. Biol. Chem. 267, 6429-6434). In this paper, we report that a mutant beta-receptor in which the carboxyl-terminally located Tyr-1009 and Tyr-1021, which are potential autophosphorylation sites, were simultaneously changed to phenylalanine residues by site-directed mutagenesis (Y1009F/Y1021F mutant) showed only 15% efficiency in ligand-induced ubiquitination compared with the wild-type receptor. Ligand-stimulated degradation of the receptor-bound ligand, as well as of the receptor itself, was partially impaired in the cells expressing the ubiquitination-deficient receptor mutants (CT98 and Y1009F/Y1021F). Furthermore, the ubiquitination-deficient receptors possessed an amplified mitogenic activity, as judged by a [H-3]thymidine incorporation assay. These data suggest that ligand-induced ubiquitination plays a negative regulatory role in mitogenic signaling of the platelet-derived growth factor beta-receptor, possibly by promoting the efficient degradation of the ligand-activated receptor.			MORI, S (corresponding author), BIOMED CTR,LUDWIG INST CANC RES,HUSARGATAN 3,BOX 595,S-75124 UPPSALA,SWEDEN.			Claesson-Welsh, Lena/0000-0003-4275-2000				BISHAYEE S, 1989, J BIOL CHEM, V264, P11699; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; BOWENPOPE DF, 1985, METHOD ENZYMOL, V109, P69; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; CIECHANOVER A, 1981, P NATL ACAD SCI-BIOL, V78, P761, DOI 10.1073/pnas.78.2.761; CLAESSONWELSH L, 1989, P NATL ACAD SCI USA, V86, P4917, DOI 10.1073/pnas.86.13.4917; CLAESSONWELSH L, 1988, MOL CELL BIOL, V8, P3476, DOI 10.1128/MCB.8.8.3476; CLAESSONWELSH L, 1989, J BIOL CHEM, V264, P1742; CUADRADO A, 1990, MOL CELL BIOL, V10, P6069, DOI 10.1128/MCB.10.11.6069; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; GOLDSTEIN G, 1975, P NATL ACAD SCI USA, V72, P11, DOI 10.1073/pnas.72.1.11; GREGORI L, 1990, J BIOL CHEM, V265, P8354; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1988, J BIOL CHEM, V263, P13268; HAMMACHER A, 1989, EMBO J, V8, P2489, DOI 10.1002/j.1460-2075.1989.tb08385.x; HELDIN CH, 1990, CELL REGUL, V1, P555, DOI 10.1091/mbc.1.8.555; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HELDIN CH, 1982, J BIOL CHEM, V257, P4216; HERSHKO A, 1986, J BIOL CHEM, V261, P1992; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HERSHKO A, 1991, TRENDS BIOCHEM SCI, V16, P265, DOI 10.1016/0968-0004(91)90101-Z; JENTSCH S, 1990, TRENDS BIOCHEM SCI, V15, P195, DOI 10.1016/0968-0004(90)90161-4; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MCKEEHAN WL, 1976, P NATL ACAD SCI USA, V73, P2023, DOI 10.1073/pnas.73.6.2023; MIYAZONO K, 1987, J BIOL CHEM, V262, P4098; MORI S, 1991, J BIOL CHEM, V266, P21158; MORI S, 1992, J BIOL CHEM, V267, P6429; NILSSON J, 1983, P NATL ACAD SCI-BIOL, V80, P5592, DOI 10.1073/pnas.80.18.5592; Ostman A, 1989, GROWTH FACTORS, V1, P271, DOI 10.3109/08977198908998003; PICKART CM, 1988, J BIOL CHEM, V263, P15076; RAINES EW, 1990, HDB EXPT PHARM 1, V95, P173; RECHSTEINER M, 1991, CELL, V66, P615, DOI 10.1016/0092-8674(91)90104-7; REISS Y, 1988, J BIOL CHEM, V263, P2693; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; RONNSTRAND L, 1992, EMBO J, V11, P3977; ROSENFELD ME, 1984, J CELL PHYSIOL, V121, P263, DOI 10.1002/jcp.1041210202; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; SORKIN A, 1991, J CELL BIOL, V112, P469, DOI 10.1083/jcb.112.3.469; WEIMA SM, 1990, EXP CELL RES, V186, P324, DOI 10.1016/0014-4827(90)90312-X; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; WESTERMARK B, 1990, P NATL ACAD SCI USA, V87, P128, DOI 10.1073/pnas.87.1.128; WILEY HS, 1982, J BIOL CHEM, V257, P4222; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	47	87	88	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					577	583						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380168				2022-12-27	WOS:A1993KE60300087
J	CHEVESICH, J; CHAUDHURI, J; MAITRA, U				CHEVESICH, J; CHAUDHURI, J; MAITRA, U			CHARACTERIZATION OF MAMMALIAN TRANSLATION INITIATION FACTOR-5 (EIF-5) DEMONSTRATION THAT EIF-5 IS A PHOSPHOPROTEIN AND IS PRESENT IN CELLS AS A SINGLE MOLECULAR-FORM OF APPARENT-M(R) 58,000	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS INITIATION; RABBIT RETICULOCYTES; POLYACRYLAMIDE GELS; SEQUENCE-ANALYSIS; IMMUNIZED HENS; MESSENGER-RNA; CHICKEN EGG; PURIFICATION; ANTIBODIES; BINDING	Eukaryotic translation initiation factor 5 (eIF-5) promotes the hydrolysis of GTP bound to the 40 S initiation complex (40 S.mRNA.Met-tRNA(f).eIF-2.GTP). Using assays that measure (a) the release of P-32(i) from [gamma-P-32]GTP bound to the 40 S initiation complex and (b) the eIF-5-dependent formation of an 80 S initiation complex from a preformed 40 S initiation complex containing bound [S-35]Met-tRNA(f), we devised a novel and rapid procedure for purifying eIF-5 from rabbit reticulocyte lysates in high yield. Highly purified eIF-5 is a monomeric protein with a M(r) of about 58,000. However, in partially purified preparations, 58-kDa eIF-5 is associated with other cellular protein(s) and sediments in glycerol gradient centrifugation as a protein of M(r) almost-equal-to 160,000. Chicken antibodies to native eIF-5 were isolated from egg yolks of laying hens immunized with rabbit reticulocyte eIF-5. S-35-labeled eIF-5, isolated from rat anterior pituitary GH3 cells using affinity-purified anti-eIF-5 antibodies, also has an apparent M(r) of 58,000. eIF-5 immunoprecipitated from extracts of P-32-labeled GH3 cells was phosphorylated on serine residues. Phosphopeptide mapping revealed two major sites of phosphorylation, which are distinct from rabbit reticulocyte eIF-5 sites phosphorylated in vitro by casein kinase II. These results demonstrate that eIF-5 is a phosphoprotein that is present in cells as a single molecular form of apparent molecular weight 58,000.	YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT DEV BIOL & CANC, DIV BIOL, BRONX, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine					NCI NIH HHS [P30CA13330] Funding Source: Medline; NIGMS NIH HHS [GM15399] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015399] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; ALLEN ML, 1992, J BIOL CHEM, V267, P23232; BENNE R, 1978, J BIOL CHEM, V253, P3070; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNING KS, 1987, J BIOL CHEM, V262, P11228; CARROLL SB, 1983, J BIOL CHEM, V258, P24; CHAKRABARTI A, 1991, J BIOL CHEM, V266, P14039; CHAKRAVARTI D, 1993, J BIOL CHEM, V268, P10524; CHAKRAVARTI D, 1993, J BIOL CHEM, V268, P5754; CONWAY TW, 1964, P NATL ACAD SCI USA, V52, P1462, DOI 10.1073/pnas.52.6.1462; DAS K, 1993, P NATL ACAD SCI USA, V90, P3058, DOI 10.1073/pnas.90.7.3058; DUBNOFF JS, 1972, J BIOL CHEM, V247, P2884; DUNCAN R, 1985, J BIOL CHEM, V260, P5493; ERNST H, 1987, J BIOL CHEM, V262, P1206; GASSMANN M, 1990, FASEB J, V4, P2528, DOI 10.1096/fasebj.4.8.1970792; GHOSH S, 1989, J BIOL CHEM, V264, P5134; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; JOSHIBARVE S, 1990, J BIOL CHEM, V265, P2979; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; KOZAK M, 1983, MICROBIOL REV, V47, P1; LINDER P, 1989, P NATL ACAD SCI USA, V86, P2286, DOI 10.1073/pnas.86.7.2286; LOSCH U, 1986, J VET MED B, V33, P609; MERRICK WC, 1975, J BIOL CHEM, V250, P5556; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; MEYER LJ, 1981, J BIOL CHEM, V256, P351; NIELSEN PJ, 1988, EMBO J, V7, P2097, DOI 10.1002/j.1460-2075.1988.tb03049.x; OLMSTED JB, 1981, J BIOL CHEM, V256, P1955; PAIN VM, 1986, BIOCHEM J, V235, P625, DOI 10.1042/bj2350625; PATTERSON R, 1962, J GEN PHYSIOL, V45, P501, DOI 10.1085/jgp.45.3.501; PETERSON DT, 1979, J BIOL CHEM, V254, P7730; POLSON A, 1980, IMMUNOL COMMUN, V9, P495, DOI 10.3109/08820138009066011; RAYCHAUDHURI P, 1987, J BIOL CHEM, V262, P14222; RAYCHAUDHURI P, 1985, J BIOL CHEM, V260, P2132; RAYCHAUDHURI P, 1985, J BIOL CHEM, V260, P2140; ROSE ME, 1974, EUR J IMMUNOL, V4, P521, DOI 10.1002/eji.1830040715; SCHREIER MH, 1977, J MOL BIOL, V116, P727, DOI 10.1016/0022-2836(77)90268-6; STONE KL, 1989, PRACTICAL GUIDE TO PROTEIN AND PEPTIDE PURIFICATION FOR MICROSEQUENCING, P31; TEMPST P, 1990, ELECTROPHORESIS, V11, P537, DOI 10.1002/elps.1150110704; TRACHSEL H, 1978, P NATL ACAD SCI USA, V75, P204, DOI 10.1073/pnas.75.1.204	42	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20659	20667						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376415				2022-12-27	WOS:A1993LY01900105
J	PARK, SK; KIM, KI; WOO, KM; SEOL, JH; TANAKA, K; ICHIHARA, A; HA, DB; CHUNG, CH				PARK, SK; KIM, KI; WOO, KM; SEOL, JH; TANAKA, K; ICHIHARA, A; HA, DB; CHUNG, CH			SITE-DIRECTED MUTAGENESIS OF THE DUAL TRANSLATIONAL INITIATION SITES OF THE CLPB GENE OF ESCHERICHIA-COLI AND CHARACTERIZATION OF ITS GENE-PRODUCTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; HEAT-SHOCK PROTEIN; ION GENE; REGULATORY SUBUNIT; ACTIVATED ATPASE; LA; COMPONENT; BINDING; PROTEOLYSIS; EXPRESSION	The heat shock protein ClpB in Escherichia coli is a protein-activated ATPase and consists of two proteins with sizes of 93 and 79 kDa. By polymerase chain reaction-aided site-directed mutagenesis, both the proteins have been shown to be encoded by the same reading frame of the clpB gene, the 93-kDa protein (ClpB93) from the 5'-end AUG translational initiation site and the 79-kDa protein (ClpB79) from the 149th codon (an internal GUG start site). Both the purified ClpB93 and ClpB79 proteins behave as tetrameric complexes with a very similar size of about 350 kDa upon gel filtration on a Superose-6 column. Both appear to be exclusively localized to the cytosol of E. coli. Both show inherent ATPase activities and have an identical K(m) of 1.1 mM for ATP. The ATPase activity of ClpB93 is as markedly stimulated by proteins, including casein and insulin, as that of wild-type ClpB, but the same proteins show little or no effect on ClpB79. Because ClpB79 lacks the 148 N-terminal sequence of ClpB93 but retains the two consensus sequences for adenine nucleotide binding, the N-terminal portion appears to contain a site(s) or domain(s) responsible for protein binding. Furthermore, ClpB79 is capable of inhibiting the casein-activated ATPase activity of ClpB93 in a dose-dependent manner but without any effect on its inherent ATPase activity. In addition, ClpB93 mixed with differing amounts of ClpB79 behave as tetrameric molecules, although its protein-activated ATPase activity is gradually reduced. These results suggest that tetramer formation between ClpB93 and ClpB79 may be responsible for the inhibition of the activity.	SEOUL NATL UNIV,COLL NAT SCI,DEPT MOLEC BIOL,SEOUL 151742,SOUTH KOREA; UNIV TOKUSHIMA,INST ENZYME RES,TOKUSHIMA 770,JAPAN	Seoul National University (SNU); Tokushima University			KIM, KEUN IL/D-2959-2011					Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHARETTE MF, 1981, P NATL ACAD SCI-BIOL, V78, P4728, DOI 10.1073/pnas.78.8.4728; CHIN DT, 1988, J BIOL CHEM, V263, P11718; CHUNG CH, 1981, P NATL ACAD SCI-BIOL, V78, P4931, DOI 10.1073/pnas.78.8.4931; GILLMAN EC, 1991, MOL CELL BIOL, V11, P2382, DOI 10.1128/MCB.11.5.2382; GOFF SA, 1984, P NATL ACAD SCI-BIOL, V81, P6647, DOI 10.1073/pnas.81.21.6647; GOFF SA, 1985, CELL, V41, P587, DOI 10.1016/S0092-8674(85)80031-3; GOTTESMAN S, 1989, ANNU REV GENET, V23, P163, DOI 10.1146/annurev.ge.23.120189.001115; GOTTESMAN S, 1990, J BIOL CHEM, V265, P7886; GOTTESMAN S, 1990, P NATL ACAD SCI USA, V87, P3513, DOI 10.1073/pnas.87.9.3513; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HWANG BJ, 1988, J BIOL CHEM, V263, P8727; HWANG BJ, 1987, P NATL ACAD SCI USA, V84, P5550, DOI 10.1073/pnas.84.16.5550; KATAYAMAFUJIMURA Y, 1987, J BIOL CHEM, V262, P4477; KITAGAWA M, 1991, J BACTERIOL, V173, P4247, DOI 10.1128/JB.173.14.4247-4253.1991; KROH HE, 1990, J BACTERIOL, V172, P6026, DOI 10.1128/jb.172.10.6026-6034.1990; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MENON AS, 1987, J BIOL CHEM, V262, P14921; NOSSAL NG, 1966, J BIOL CHEM, V241, P3055; PHILLIPS TA, 1984, J BACTERIOL, V159, P283, DOI 10.1128/JB.159.1.283-287.1984; PONTIS E, 1991, BIOCHEM BIOPH RES CO, V180, P1222, DOI 10.1016/S0006-291X(05)81326-9; SQUIRES C, 1992, J BACTERIOL, V174, P1081, DOI 10.1128/jb.174.4.1081-1085.1992; SQUIRES CL, 1991, J BACTERIOL, V173, P4254, DOI 10.1128/JB.173.14.4254-4262.1991; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WAXMAN L, 1982, P NATL ACAD SCI-BIOL, V79, P4883, DOI 10.1073/pnas.79.16.4883; WOO KM, 1992, J BIOL CHEM, V267, P20429	28	64	67	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20170	20174						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376377				2022-12-27	WOS:A1993LY01900039
J	REN, JS; STUART, DI; ACHARYA, KR				REN, JS; STUART, DI; ACHARYA, KR			ALPHA-LACTALBUMIN POSSESSES A DISTINCT ZINC-BINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-ION BINDING; CALCIUM-BINDING; CRYSTAL-STRUCTURE; 1.7-A RESOLUTION; DISULFIDE-BOND; LYSOZYME; CRYSTALLIZATION; PROTEINS; LOOP; MILK	It has been proposed that the binding of Zn2+ to alpha-lactalbumin switches the conformation to one akin to a state intermediate in the folding of the protein. However, the high resolution x-ray crystal structure of human alpha-lactalbumin-Zn2+ complex at 1.7-angstrom resolution (pH 7.6) does not reveal any significant change in conformation from the native state. The Zn2+ ion binds specifically in the ''cleft'' of alpha-lactalbumin (the region which forms the active site of the homologous protein lysozyme). This may suggest a possible role for Zn2+ binding in lactose synthase complex. The coordination of the Zn2+ ion involves a symmetry-related molecule in the crystal, the crystal contacts being stabilized by a SO42- ion bound at the interface between three molecules.	UNIV BATH,DEPT BIOCHEM,CLAVERTON DOWN,BATH BA2 7AY,AVON,ENGLAND; LAB MOLEC BIOPHYS,OXFORD OX1 3QU,ENGLAND; OXFORD CTR MOLEC SCI,NEW CHEM LAB,OXFORD OX1 3QT,ENGLAND	University of Bath; University of Oxford; University of Oxford			Ren, Jingshan/AAT-7729-2021	Ren, Jingshan/0000-0003-4015-1404; Acharya, K. Ravi/0000-0002-3009-4058; Stuart, David/0000-0002-3426-4210				ACHARYA KR, 1989, J MOL BIOL, V208, P99, DOI 10.1016/0022-2836(89)90091-0; ACHARYA KR, 1991, J MOL BIOL, V221, P571; ARAMINI JM, 1992, BIOCHEMISTRY-US, V31, P6761, DOI 10.1021/bi00144a016; ASCHAFFENBURG R, 1957, OCC PAP R ANTHR I, V18, P50; BLAKE CCF, 1967, PROC R SOC SER B-BIO, V167, P378, DOI 10.1098/rspb.1967.0035; BREW K, 1967, BIOCHEM J, V102, P258, DOI 10.1042/bj1020258; BRUNGER AT, 1990, XPLOR VERSION 2 1 MA; CHAKRABARTI P, 1990, PROTEIN ENG, V4, P49, DOI 10.1093/protein/4.1.49; CHRISTIANSON DW, 1991, ADV PROTEIN CHEM, V42, P281; Dobson CM, 1991, CURR OPIN STRUC BIOL, V1, P22, DOI 10.1016/0959-440X(91)90006-F; EBERHARD M, 1991, EUR J BIOCHEM, V202, P1333, DOI 10.1111/j.1432-1033.1991.tb16508.x; EINSPAHR H, 1984, MET IONS BIOL SYST, V17, P51; FENNA RE, 1982, J MOL BIOL, V161, P211, DOI 10.1016/0022-2836(82)90288-1; FITZGERALD PM, 1988, J APPL CRYSTALLOGR, V21, P274; FUJINAGA M, 1987, J APPL CRYSTALLOGR, V20, P517, DOI 10.1107/S0021889887086102; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P3; GODOVAC-ZIMMERMANN J, 1990, BIOL CHEM H-S, V371, P649, DOI 10.1515/bchm3.1990.371.2.649; GODOVAC-ZIMMERMANN J, 1988, BIOL CHEM H-S, V369, P1109, DOI 10.1515/bchm3.1988.369.2.1109; HALL L, 1982, NUCLEIC ACIDS RES, V10, P3503, DOI 10.1093/nar/10.11.3503; HARATA K, 1992, J BIOL CHEM, V267, P1419; HOWARD AJ, 1987, J APPL CRYSTALLOGR, V20, P383, DOI 10.1107/S0021889887086436; JORI G, 1971, BIOCHIM BIOPHYS ACTA, V236, P749, DOI 10.1016/0005-2795(71)90260-1; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; KRONMAN MJ, 1981, J BIOL CHEM, V256, P8582; KRONMAN MJ, 1989, CRIT REV BIOCHEM MOL, V24, P565, DOI 10.3109/10409238909080054; KUWAJIMA K, 1990, BIOCHEMISTRY-US, V29, P8240, DOI 10.1021/bi00488a007; MCPHALEN CA, 1991, ADV PROTEIN CHEM, V42, P77; MCPHERSON A, 1982, PREPARATION ANAL PRO, P82; MUSCI G, 1985, BIOCHEMISTRY-US, V24, P3852, DOI 10.1021/bi00336a006; MUSCI G, 1986, BIOCHEMISTRY-US, V25, P4887, DOI 10.1021/bi00365a024; MUSCI G, 1985, BIOCHEMISTRY-US, V24, P6945, DOI 10.1021/bi00345a029; NITTA K, 1988, BIOL CHEM H-S, V369, P671, DOI 10.1515/bchm3.1988.369.2.671; NITTA K, 1987, FEBS LETT, V223, P405, DOI 10.1016/0014-5793(87)80328-9; PERMYAKOV EA, 1988, BIOPHYS CHEM, V32, P37, DOI 10.1016/0301-4622(88)85031-2; PERMYAKOV EA, 1991, J PROTEIN CHEM, V10, P577, DOI 10.1007/BF01025709; PHILLIPS DC, 1966, SCI AM, V215, P78, DOI 10.1038/scientificamerican1166-78; PRESTRELSKI SJ, 1991, BIOCHEMISTRY-US, V30, P8797, DOI 10.1021/bi00100a010; RAO KR, 1989, BIOCHEM BIOPH RES CO, V163, P1390, DOI 10.1016/0006-291X(89)91133-9; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; STUART DI, 1986, NATURE, V324, P84, DOI 10.1038/324084a0; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; ZENG J, 1990, J BIOL CHEM, V265, P14886	42	89	91	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19292	19298						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366079				2022-12-27	WOS:A1993LW81900024
J	GOLDSMITH, JO; KUO, LC				GOLDSMITH, JO; KUO, LC			UTILIZATION OF CONFORMATIONAL FLEXIBILITY IN ENZYME ACTION-LINKAGE BETWEEN BINDING, ISOMERIZATION, AND CATALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ORNITHINE TRANSCARBAMOYLASE; SITE-DIRECTED MUTAGENESIS; TRANSFER RNA-SYNTHETASE; STATE KINETIC-ANALYSIS; ESCHERICHIA-COLI; CARBAMOYLTRANSFERASE; SPECIFICITY; EFFICIENT; ENERGY; LOOP	An intimate relationship between protein conformational changes and catalysis has often been suggested. The present study employs ligand-induced ultraviolet difference spectra and kinetic parameters determined for Escherichia coli ornithine transcarbamoylase and its site-specific mutants to evaluate the linkage between binding, isomerization, and reaction rate. For the wild-type enzyme, the lead substrate carbamoyl phosphate introduces a large difference absorbance in the enzyme upon binding (DELTAepsilon(max) is similar to 1,800 M-1 cm-1; Miller, A. W., and Kuo, L. C. (1990) J. Biol. Chem. 265, 15023-15027). The spectrum is the same in lineshape as that produced by the bisubstrate analog N-(phosphonacetyl)-L-ornithine and is 80% as intense. Both substrate and analog cause gross protein conformational rearrangements as evident by swift and severe cracking of enzyme crystals in their presence. For the mutants, the difference spectra actuated by the substrate are the same in lineshape as that of the wild type but vary in intensity. A wide range of substrate affinity and steady-state kinetic constants are also observed for the mutants. When the binding energy of carbamoyl phosphate and the activation energy for transcarbamoylation are calculated for the wild-type and mutant enzymes, they are found to be inversely correlated to the intensity of protein difference absorbance elicited by the lead substrate. Together with analyses of steady-state kinetic parameters derived for various plausible reaction schemes, the experimental data suggest that carbamoyl phosphate induces the committed isomerization in ornithine transcarbamoylase for transition state binding. Our results provide a unique demonstration that an induced-fit isomerization, triggered by binding, either controls or contributes significantly to the rate of an enzyme-catalyzed reaction.	MERCK SHARP & DOHME LTD,DEPT BIOL CHEM,W POINT,PA 19486; STANFORD UNIV,DEPT CHEM,STANFORD,CA 94305	Merck & Company; Stanford University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K04DK001721, R01DK038089] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK38089, DK01721] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON CM, 1979, SCIENCE, V204, P375, DOI 10.1126/science.220706; ANDREWS LJ, 1972, BIOCHEMISTRY-US, V11, P1875, DOI 10.1021/bi00760a023; DICKERSON RE, 1983, HEMOGLOBIN STRUCTURE, P117; EISENSTEIN E, 1986, J BIOL CHEM, V261, P6192; ESTELL DA, 1986, SCIENCE, V233, P659, DOI 10.1126/science.233.4764.659; FERSHT A, 1985, ENZYME STRUCTURE MEC, P311; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1581, DOI 10.1021/bi00405a028; Fischer E., 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; HALDANE JBS, 1965, ENZYMES, P179; Herskovits TT, 1967, METHOD ENZYMOL, V11, P748; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; JOSEPH D, 1990, SCIENCE, V249, P1425, DOI 10.1126/science.2402636; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; KUO LC, 1989, BIOCHEMISTRY-US, V28, P4522, DOI 10.1021/bi00436a060; KUO LC, 1985, BIOCHEMISTRY-US, V24, P4754, DOI 10.1021/bi00339a007; KUO LC, 1989, J BIOL CHEM, V264, P16246; KUO LC, 1990, J MOL BIOL, V211, P271, DOI 10.1016/0022-2836(90)90026-I; KUO LC, 1988, BIOCHEMISTRY-US, V27, P8823, DOI 10.1021/bi00424a021; KUO LC, 1989, SCIENCE, V245, P522, DOI 10.1126/science.2667139; LEGRAIN C, 1976, EUR J BIOCHEM, V63, P289, DOI 10.1111/j.1432-1033.1976.tb10230.x; MILLER AW, 1990, J BIOL CHEM, V265, P15023; NORRIS K, 1983, NUCLEIC ACIDS RES, V11, P5103, DOI 10.1093/nar/11.15.5103; PAULING L, 1948, NATURE, V161, P707, DOI 10.1038/161707a0; Pauling L., 1946, CHEM ENG NEWS, V24, P1375, DOI [10.1021/cen-v024n010.p1375, DOI 10.1021/CEN-V024N010.P1375]; REICHARD P, 1957, ACTA CHEM SCAND, V11, P523, DOI 10.3891/acta.chem.scand.11-0523; Segel I. H., 1975, ENZYME KINETICS, P560; WARGNIES B, 1978, EUR J BIOCHEM, V89, P203, DOI 10.1111/j.1432-1033.1978.tb20914.x; WELLS TNC, 1986, BIOCHEMISTRY-US, V25, P1881, DOI 10.1021/bi00356a007; ZOLLER MJ, 1982, NUCLEIC ACIDS RES, V10, P6487, DOI 10.1093/nar/10.20.6487	29	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18481	18484						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360150				2022-12-27	WOS:A1993LV65900018
J	KOIKEDA, S; ANDO, K; KAJI, H; INOUE, T; MURAO, S; TAKEUCHI, K; SAMEJIMA, T				KOIKEDA, S; ANDO, K; KAJI, H; INOUE, T; MURAO, S; TAKEUCHI, K; SAMEJIMA, T			MOLECULAR-CLONING OF THE GENE FOR BILIRUBIN OXIDASE FROM MYROTHECIUM-VERRUCARIA AND ITS EXPRESSION IN YEAST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; COLIPHAGE LAMBDA-DNA; SACCHAROMYCES-CEREVISIAE; ASCORBATE OXIDASE; ASPERGILLUS-NIDULANS; HUMAN CERULOPLASMIN; ENZYMATIC REMOVAL; NEUROSPORA-CRASSA; SECRETED PROTEINS; CDNA SEQUENCE	Myrothecium verrucaria bilirubin oxidase (EC 1.3.3.5) is an enzyme catalyzing the oxidation of bilirubin to biliverdin and other substrates. We have purified bilirubin oxidase from the medium of M. verrucaria and determined its partial amino acid sequence and isolated cDNA fragment amplified by polymerase chain reaction using oligonucleotide primers designed on the basis of the partial amino acid sequence. The gene for bilirubin oxidase has been cloned from a genomic library using the cDNA fragment as a probe. The gene encodes a precursor of bilirubin oxidase consisting of 572 amino acid residues, which comprises the prepro-region of 38 amino acid residues and the mature enzyme of 534 amino acid residues containing one cysteine. Five introns were found within the coding region. Sequence comparison of bilirubin oxidase with other blue copper proteins (laccase, ascorbate oxidase, human ceruloplasmin, plastocyanin, and azurin) revealed the presence of four domains corresponding to potential copper ligands. We have expressed this bilirubin oxidase gene in Saccharomyces cerevisiae under the repressible acid phosphatase promotor and found an active recombinant bilirubin oxidase, establishing the functional identity of the gene.	KUMAMOTO INST TECHNOL,DEPT APPL MICROBIAL TECHNOL,KUMAMOTO 860,JAPAN; AOYAMA GAKUIN UNIV,FAC SCI & ENGN,DEPT CHEM,SETAGAYA KU,TOKYO 157,JAPAN	Aoyama Gakuin University	KOIKEDA, S (corresponding author), AMANO PHARMACEUT CO LTD,TSUKUBA RES LABS,22 MIYUKIGAOKA,TSUKUBA,IBARAKI 305,JAPAN.		Kaji, Hiroyuki/L-7122-2018	Kaji, Hiroyuki/0000-0002-0910-9999				ARAMAYO R, 1990, NUCLEIC ACIDS RES, V18, P3415, DOI 10.1093/nar/18.11.3415; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BRESNAHAN PA, 1990, J CELL BIOL, V111, P2851, DOI 10.1083/jcb.111.6.2851; BRODERSEN R, 1969, EUR J BIOCHEM, V10, P468, DOI 10.1111/j.1432-1033.1969.tb00712.x; BUSSEY H, 1988, YEAST, V4, P17, DOI 10.1002/yea.320040103; CALMELS TPG, 1991, J BIOTECHNOL, V17, P51, DOI 10.1016/0168-1656(91)90026-R; CARDENASVAZQUEZ R, 1986, BIOCHEM J, V236, P625, DOI 10.1042/bj2360625; DAVIDOW LS, 1987, J BACTERIOL, V169, P4621, DOI 10.1128/jb.169.10.4621-4629.1987; DOUMAS BT, 1987, CLIN CHEM, V33, P1349; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FELENBOK B, 1988, GENE, V73, P385, DOI 10.1016/0378-1119(88)90503-3; FREDERICK KR, 1990, J BIOL CHEM, V265, P3793; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FULLER RS, 1989, P NATL ACAD SCI USA, V86, P1434, DOI 10.1073/pnas.86.5.1434; GERMANN UA, 1988, J BIOL CHEM, V263, P885; GERMANN UA, 1986, P NATL ACAD SCI USA, V83, P8854, DOI 10.1073/pnas.83.23.8854; GOLDBERG DA, 1980, P NATL ACAD SCI-BIOL, V77, P5794, DOI 10.1073/pnas.77.10.5794; GOLDFINCH ME, 1988, ANN CLIN BIOCHEM, V25, P73, DOI 10.1177/000456328802500110; GOTOH Y, 1989, J BIOCHEM-TOKYO, V106, P621, DOI 10.1093/oxfordjournals.jbchem.a122906; Gray H. B., 1981, COPPER PROTEINS, V3, P1; HATSUZAWA K, 1990, J BIOL CHEM, V265, P22075; INNIS MA, 1985, SCIENCE, V228, P21, DOI 10.1126/science.228.4695.21; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KIMURA M, 1990, P SOC EXP BIOL MED, V195, P64; KIMURA M, 1988, P SOC EXP BIOL MED, V188, P364; KNOTH K, 1988, NUCLEIC ACIDS RES, V16, P10932, DOI 10.1093/nar/16.22.10932; KOSAKA A, 1987, CLIN BIOCHEM, V20, P451, DOI 10.1016/0009-9120(87)90014-2; KOSCHINSKY ML, 1986, P NATL ACAD SCI USA, V83, P5086, DOI 10.1073/pnas.83.14.5086; KRAMER RA, 1980, P NATL ACAD SCI-BIOL, V77, P6541, DOI 10.1073/pnas.77.11.6541; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAVIN A, 1985, SCIENCE, V230, P543, DOI 10.1126/science.4048947; LEE CC, 1988, SCIENCE, V239, P1288, DOI 10.1126/science.3344434; MALMSTROM BG, 1982, ANNU REV BIOCHEM, V51, P21, DOI 10.1146/annurev.bi.51.070182.000321; Maniatis T., 1982, MOL CLONING; MARTEN MR, 1989, BIOTECHNOL BIOENG, V34, P1133, DOI 10.1002/bit.260340903; MARTINKUS K, 1980, ARCH BIOCHEM BIOPHYS, V199, P465, DOI 10.1016/0003-9861(80)90303-3; MASSERSCHMIDT A, 1989, J MOL BIOL, V206, P513; MESSERSCHMIDT A, 1990, EUR J BIOCHEM, V187, P341, DOI 10.1111/j.1432-1033.1990.tb15311.x; MULLON CJP, 1987, CLIN CHEM, V33, P1822; MURAO S, 1982, AGR BIOL CHEM TOKYO, V46, P2031, DOI 10.1080/00021369.1982.10865379; MURAO S, 1981, AGR BIOL CHEM TOKYO, V45, P2383, DOI 10.1080/00021369.1981.10864896; NORRIS GE, 1983, J MOL BIOL, V165, P501, DOI 10.1016/S0022-2836(83)80216-2; OHKAWA J, 1989, P NATL ACAD SCI USA, V86, P1239, DOI 10.1073/pnas.86.4.1239; OTSUJI S, 1988, CLIN BIOCHEM, V21, P33, DOI 10.1016/S0009-9120(88)80109-7; PERRY B, 1986, CLIN CHEM, V32, P329; REMICK DG, 1990, AM J PATHOL, V136, P49; RENE CV, 1986, BIOCHEM J, V236, P625; ROSENBERG SM, 1985, GENE, V39, P313, DOI 10.1016/0378-1119(85)90330-0; ROSENBERG SM, 1985, GENE, V38, P165, DOI 10.1016/0378-1119(85)90215-X; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SOLOMON EI, 1980, J AM CHEM SOC, V102, P168, DOI 10.1021/ja00521a029; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUGI K, 1989, BIOCHIM BIOPHYS ACTA, V991, P405, DOI 10.1016/0304-4165(89)90065-2; TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P390, DOI 10.1073/pnas.81.2.390; TANAKA N, 1982, AGR BIOL CHEM TOKYO, V46, P2499, DOI 10.1080/00021369.1982.10865459; TANAKA N, 1985, AGR BIOL CHEM TOKYO, V49, P843, DOI 10.1080/00021369.1985.10866807; TANAKA N, 1983, AGR BIOL CHEM TOKYO, V47, P1627, DOI 10.1080/00021369.1983.10865827; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; VANDENOUWELAND AMW, 1990, NUCLEIC ACIDS RES, V18, P664, DOI 10.1093/nar/18.3.664; VANSOMEREN MK, 1992, MOL GEN GENET, V234, P113; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WARREN JS, 1989, J CLIN INVEST, V84, P1873, DOI 10.1172/JCI114374; YOKOSUKA O, 1987, BIOCHIM BIOPHYS ACTA, V923, P268, DOI 10.1016/0304-4165(87)90013-4	64	55	62	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18801	18809						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360171				2022-12-27	WOS:A1993LV65900066
J	MUSZBEK, L; LAPOSATA, M				MUSZBEK, L; LAPOSATA, M			COVALENT MODIFICATION OF PROTEINS BY ARACHIDONATE AND EICOSAPENTAENOATE IN PLATELETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID ACYLATION; N-MYRISTOYLTRANSFERASE; MYRISTOYL-COA; PROSTAGLANDIN BIOSYNTHESIS; EUKARYOTIC PROTEINS; CELLULAR PROTEINS; BINDING; INTERMEDIATE(S); IDENTIFICATION; SPECIFICITY	The posttranslational modification of proteins by fatty acids has been shown to involve long chain-saturated fatty acids, predominantly palmitate. In the present study, we demonstrated by metabolic labeling of human platelets with [H-3]arachidonate and [H-3]eicosapentaenoate that these polyunsaturated fatty acids can also become covalently linked to proteins. The extent of binding of arachidonate to proteins was somewhat less than that of palmitate. Arachidonate binding to platelet proteins was not significantly influenced by the inhibition of cyclooxygenase and lipoxygenase. This finding and the high performance liquid chromatography analysis of radiolabeled products removed from proteins by selective cleavage techniques established that arachidonate, and not its metabolic products, was the protein-linked radiolabeled moiety in [H-3] arachidonate-labeled platelets. A 7.5-fold higher concentration of unlabeled palmitate competed to a small extent with [H-3]arachidonate for protein labeling. Both arachidonate and eicosapentaenoate were bound to proteins almost exclusively through ester linkages. It was further demonstrated that 61 and 66% of total protein-linked arachidonate and eicosapentaenoate, respectively, were bound via thioester bonds. In contrast, 91% of the binding of palmitate to proteins occurred via thioester linkages. As demonstrated by SDS-polyacrylamide gel electrophoresis and fluorography, the patterns of palmitoylated and arachidonoylated proteins were similar but not identical, with selected proteins only palmitoylated or only arachidonoylated. [H-3]Eicosapentaenate labeled the same set of proteins as [H-3]arachidonate. The fluorographic pattern of H-3-arachidonoylated proteins was not changed by cyclooxygenase and lipoxygenase inhibitors. The binding of a polyunsaturated fatty acid to a protein in place of a saturated fatty acid could significantly influence the hydrophobic interactions of the protein and, thereby, have important functional implications.	MASSACHUSETTS GEN HOSP,DEPT PATHOL,CLIN LABS,RM 249,GRAY BLDG,FRUIT ST,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043159] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 43159] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON MW, 1979, BIOCHIM BIOPHYS ACTA, V573, P40, DOI 10.1016/0005-2760(79)90171-1; BERGER M, 1984, J BIOL CHEM, V259, P7245; BOLANOWSKI MA, 1984, J BIOL CHEM, V259, P4934; CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245; ELING TE, 1977, LIFE SCI, V21, P245, DOI 10.1016/0024-3205(77)90308-3; GLOVER CJ, 1988, BIOCHEM J, V250, P485, DOI 10.1042/bj2500485; GRAND RJA, 1989, BIOCHEM J, V258, P625, DOI 10.1042/bj2580625; HALLAQ Y, 1993, LIPIDS, V28, P355, DOI 10.1007/BF02536323; HUANG EM, 1989, BIOCHIM BIOPHYS ACTA, V1011, P134, DOI 10.1016/0167-4889(89)90200-0; JAMES G, 1990, BIOCHEMISTRY-US, V29, P2623, DOI 10.1021/bi00463a001; JEMMERSON R, 1987, BIOCHEMISTRY-US, V26, P5703, DOI 10.1021/bi00392a019; KAUFMAN JF, 1984, J BIOL CHEM, V259, P7230; LECOMTE M, 1990, J BIOL CHEM, V265, P5178; LEPAGE G, 1988, J LIPID RES, V29, P227; LOW MG, 1987, BIOCHEM J, V244, P1; MAGEE AI, 1990, J CELL SCI, V97, P581; MUSZBEK L, 1989, BLOOD, V74, P1339; MUSZBEK L, 1989, J BIOL CHEM, V264, P9716; MUSZBEK L, 1993, J BIOL CHEM, V268, P8251; NEUFELD EJ, 1983, J CLIN INVEST, V72, P219; OLSON EN, 1988, PROG LIPID RES, V27, P177, DOI 10.1016/0163-7827(88)90012-4; OLSON EN, 1985, J BIOL CHEM, V260, P3784; SEEHAFER JG, 1988, BIOCHIM BIOPHYS ACTA, V952, P92, DOI 10.1016/0167-4838(88)90105-7; SEFTON BM, 1987, J CELL BIOL, V104, P1449, DOI 10.1083/jcb.104.6.1449; SEKIYA K, 1982, BIOCHEM BIOPH RES CO, V105, P1090, DOI 10.1016/0006-291X(82)91081-6; TOWLER D, 1986, P NATL ACAD SCI USA, V83, P2812, DOI 10.1073/pnas.83.9.2812; TOWLER D, 1986, BIOCHEMISTRY-US, V25, P878, DOI 10.1021/bi00352a021; TOWLER DA, 1987, P NATL ACAD SCI USA, V84, P2708, DOI 10.1073/pnas.84.9.2708; TOWLER DA, 1988, J BIOL CHEM, V263, P1784; TOWLER DA, 1987, J BIOL CHEM, V262, P1030; WILSON AGE, 1979, PROSTAGLANDINS, V18, P409, DOI 10.1016/S0090-6980(79)80060-X	31	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18243	18248						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349700				2022-12-27	WOS:A1993LT74300088
J	PHILPOTT, CC; HAILE, D; ROUAULT, TA; KLAUSNER, RD				PHILPOTT, CC; HAILE, D; ROUAULT, TA; KLAUSNER, RD			MODIFICATION OF A FREE FE-S CLUSTER CYSTEINE RESIDUE IN THE ACTIVE IRON-RESPONSIVE ELEMENT-BINDING PROTEIN PREVENTS RNA-BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SULFUR CLUSTER; ACONITASE ACTIVITY; IRE-BP; INVITRO; MECHANISM; CRYSTAL	The iron-responsive element-binding protein (IRE-BP) binds to specific RNA stem-loop structures called iron-responsive elements (IREs), which mediate the post-transcriptional regulation of a variety of genes involved in iron metabolism. The IRE-BP is cytosolic aconitase, and a [4Fe-4S] cubane cluster is required for aconitase activity but is associated with loss of IRE binding affinity. Chemical modification of the IRE-BP can abrogate RNA binding and the 3 cysteines predicted to coordinate the Fe-S cluster in the IRE-BP could be targets for modification. We report the expression of recombinant IRE-BP in which the three putative cluster cysteines (Cys-437, Cys-503, and Cys-506) have been mutated to serine residues. Replacement of any or all of these cysteine residues results in a complete loss of aconitase activity. While all of the mutants bind RNA, substitution of Cys-437 specifically renders the IRE-BP resistant to inactivation by low concentrations of N-ethylmaleimide or diamide. These results identify Cys-437 as the target of in vitro regulation of RNA binding in the IRE-BP and suggest that, in the RNA-binding form of the protein, Cys-437 is free and therefore available for modifications that inhibit RNA binding.	NICHHD,CELL BIOL & METAB BRANCH,BLDG 18T,RM 101,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)								BEINERT H, 1990, FASEB J, V4, P2483, DOI 10.1096/fasebj.4.8.2185975; BEINERT H, 1989, EUR J BIOCHEM, V186, P5, DOI 10.1111/j.1432-1033.1989.tb15170.x; CASEY JL, 1988, P NATL ACAD SCI USA, V85, P1787, DOI 10.1073/pnas.85.6.1787; CONSTABLE A, 1992, P NATL ACAD SCI USA, V89, P4554, DOI 10.1073/pnas.89.10.4554; EMERYGOODMAN A, 1993, NUCLEIC ACIDS RES, V21, P1457, DOI 10.1093/nar/21.6.1457; HAILE DJ, 1989, MOL CELL BIOL, V9, P5055, DOI 10.1128/MCB.9.11.5055; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P7536, DOI 10.1073/pnas.89.16.7536; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; HENTZE MW, 1989, SCIENCE, V244, P357, DOI 10.1126/science.2711187; HENTZE MW, 1991, NUCLEIC ACIDS RES, V19, P1739, DOI 10.1093/nar/19.8.1739; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; KAPTAIN S, 1991, P NATL ACAD SCI USA, V88, P10109, DOI 10.1073/pnas.88.22.10109; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; KENNEDY MC, 1988, J BIOL CHEM, V263, P8190; KLAUSNER RD, 1993, MOL BIOL CELL, V4, P1; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; KOSOWER NS, 1987, METHOD ENZYMOL, V143, P264; LAUBLE H, 1992, BIOCHEMISTRY-US, V31, P2735, DOI 10.1021/bi00125a014; MCBRIDE AA, 1992, P NATL ACAD SCI USA, V89, P7531, DOI 10.1073/pnas.89.16.7531; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; ROBBINS AH, 1989, P NATL ACAD SCI USA, V86, P3639, DOI 10.1073/pnas.86.10.3639; ROBBINS AH, 1989, PROTEINS, V5, P289, DOI 10.1002/prot.340050406; ROSE IA, 1967, J BIOL CHEM, V242, P1870; ROUAULT TA, 1992, BIOMETALS, V5, P131, DOI 10.1007/BF01061319; ROUAULT TA, 1991, CELL, V64, P881, DOI 10.1016/0092-8674(91)90312-M; TANG CK, 1992, J BIOL CHEM, V267, P24466	27	93	92	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17655	17658						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349646				2022-12-27	WOS:A1993LT74300002
J	YUAN, CJ; HUANG, CYF; GRAVES, DJ				YUAN, CJ; HUANG, CYF; GRAVES, DJ			PHOSPHORYLASE-KINASE, A METAL ION-DEPENDENT DUAL-SPECIFICITY KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTEIN-KINASE; KINETIC MECHANISM; CATALYTIC SUBUNIT; TYROSINE KINASE; MAP KINASE; PURIFICATION; IDENTIFICATION; ACTIVATION	Phosphorylase kinase is shown to be a dual specificity kinase. The specificity of phosphorylation is determined by divalent cation. Mg2+ causes seryl phosphorylation of phosphorylase b, but Mn2+ activates tyrosine phosphorylation of angiotensin II. In contrast to seryl phosphorylation, the tyrosine kinase activity of holoenzyme is not regulated by Ca2+. Preincubation of the holoenzyme with Ca2+, Mg2+, and ATP that causes autophosphorylation activates tyrosine kinase activity. The tyrosyl kinase activity is a property of the gamma subunit. Addition of varying amounts of Mn2+ to a truncated form of the gamma subunit of phosphorylase kinase containing MgATP inhibits serine kinase but activates tyrosine kinase activity. This result along with an oxidative reaction caused by Cu2+ and site-directed mutagenesis of the putative catalytic base inhibiting both serine and tyrosine kinase activity suggest that one active site is involved in both activities. Kinetic studies with Mn2+ and ATP show that K(m) for nucleotide is not changed with a seryl or tyrosyl substrate. The V(m) values are different, and the value for tyrosyl phosphorylation is similar to other tyrosyl kinases. We propose two conformations for the active site; one favors seryl phosphorylation, and the second tyrosyl phosphorylation is caused by the binding of divalent cation at a second metal ion binding site.	IOWA STATE UNIV SCI & TECHNOL, DEPT BIOCHEM & BIOPHYS, AMES, IA 50011 USA	Iowa State University				Huang, Chi-Ying F/0000-0003-4898-4937	NIGMS NIH HHS [GM-09587] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM009587] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS PD, 1992, J BIOL CHEM, V267, P13135; BOLLEN M, 1987, ARCH BIOCHEM BIOPHYS, V254, P437, DOI 10.1016/0003-9861(87)90122-6; CARLSON GM, 1976, J BIOL CHEM, V251, P7480; CHAN KFJ, 1984, CALCIUM CELL FUNCTIO, V5, P1; CLERCH LB, 1972, BIOCHIM BIOPHYS ACTA, V268, P645; COHEN P, 1973, EUR J BIOCHEM, V34, P1, DOI 10.1111/j.1432-1033.1973.tb02721.x; COLEMAN TR, 1993, CELL, V72, P919, DOI 10.1016/0092-8674(93)90580-J; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; FISCHER EDMOND H., 1958, JOUR BIOL CHEM, V231, P65; GEORGOUSSI Z, 1986, BIOCHEMISTRY-US, V25, P3867, DOI 10.1021/bi00361a019; HALLENBECK PC, 1983, J BIOL CHEM, V258, P3493; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HUANG CYF, 1993, IN PRESS MOL CELL BI; HUANG TS, 1974, FEBS LETT, V42, P249, DOI 10.1016/0014-5793(74)80738-6; KASTENSCHMIDT LL, 1968, BIOCHEMISTRY-US, V7, P3590, DOI 10.1021/bi00850a037; KEE SM, 1987, J BIOL CHEM, V262, P9448; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; KONG CT, 1988, BIOCHEMISTRY-US, V27, P4795, DOI 10.1021/bi00413a032; KOSAKO H, 1992, EMBO J, V11, P2903, DOI 10.1002/j.1460-2075.1992.tb05359.x; LANDGRAF W, 1991, J BIOL CHEM, V266, P16305; LINDBERG RA, 1992, TRENDS BIOCHEM SCI, V17, P114, DOI 10.1016/0968-0004(92)90248-8; OLAH GA, 1993, BIOCHEMISTRY-US, V32, P3649, DOI 10.1021/bi00065a018; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; PICKETTGIES CA, 1986, ENZYMES, V17, P396; QAMAR R, 1992, BIOCHEMISTRY-US, V31, P9986, DOI 10.1021/bi00156a018; REIMANN EM, 1971, J BIOL CHEM, V246, P1986; SEEFELDT LC, 1993, PROTEIN SCI, V2, P93; SEGER R, 1992, J BIOL CHEM, V267, P14373; SWARUP G, 1984, ADV ENZYME REGUL, V22, P267, DOI 10.1016/0065-2571(84)90018-9; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VICARIO PP, 1988, ARCH BIOCHEM BIOPHYS, V261, P336, DOI 10.1016/0003-9861(88)90349-9; WANG JH, 1976, J BIOL CHEM, V251, P4521; WEI YF, 1991, METHOD ENZYMOL, V200, P388; YUAN CI, 1993, FASEB J, V7, pA1161; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	36	40	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17683	17686						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349652				2022-12-27	WOS:A1993LT74300010
J	ALI, S; DAVIS, MG; BECKER, MW; DORN, GW				ALI, S; DAVIS, MG; BECKER, MW; DORN, GW			THROMBOXANE-A(2) STIMULATES VASCULAR SMOOTH-MUSCLE HYPERTROPHY BY UP-REGULATING THE SYNTHESIS AND RELEASE OF ENDOGENOUS BASIC FIBROBLAST GROWTH-FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELL PROLIFERATION; C-INDEPENDENT PATHWAYS; ANGIOTENSIN-II; MESSENGER-RNA; TYROSINE PHOSPHORYLATION; SIGNAL TRANSDUCTION; NUCLEOTIDE-SEQUENCE; ARTERIAL INJURY; FACTOR-BETA; A-CHAIN	We have shown previously that thromboxane A2 stimulates hypertrophy of cultured rat aortic smooth muscle cells defined as protooncogene expression and protein synthesis without DNA synthesis or cellular proliferation (Dorn, G. W., II, Becker, M. W., Davis, M. G. (1992) J. Biol. Chem. 267, 24897-24905). Since endogenous growth modulators could possibly regulate vascular smooth muscle growth to this vasoconstrictor, we tested the hypothesis that thromboxane-stimulated vascular smooth muscle hypertrophy was due to increased expression of endogenously produced basic fibroblast growth factor (bFGF). The thromboxane mimetic (15S)-hydroxy-11alpha,9alpha-(epoxymethano)prosta-5Z,13E-dienoic acid (U46619) (1 muM) increased cultured rat aorta derived smooth muscle cell immunoreactive bFGF content by 331 +/- 40% over untreated controls after 24 h. Co-incubation of vascular smooth muscle cells with a specific antisense oligodeoxynucleotide (AS) against codon 60 of bFGF coding sequence reduced thromboxane-stimulated bFGF expression by 72 +/- 5% and prevented thromboxane-stimulated hypertrophy (nonsense oligonucleotide had no effects). Addition of exogenous bFGF (20 ng/ml) restored growth to AS-treated/thromboxane-stimulated vascular smooth muscle cells. Furthermore, addition to the culture medium of neutralizing antibody against bFGF inhibited U46619-stimulated vascular smooth muscle hypertrophy by 69 +/- 17%, whereas nonimmune IgG had no effect. Since protein tyrosine phosphorylation is a cell signal associated with growth, thromboxane-stimulated tyrosine phosphorylation was also examined. Exposure to 1 muM U46619 for 10 min increased vascular smooth muscle immunoreactive phosphotyrosine content of 130-144-, 86-, 80-, 75-, and 58-kDa proteins. The tyrosine kinase inhibitor herbimycin A (5 muM) prevented thromboxane-stimulated tyrosine phosphorylation, but not thromboxane-stimulated hypertrophy, suggesting that tyrosine phosphorylation was not required for thromboxane-stimulated vascular smooth muscle growth. These results indicate that increased expression and release of endogenous bFGF, but not direct tyrosine phosphorylation, mediates the hypertrophic vascular smooth muscle response to thromboxane.	UNIV CINCINNATI, COLL MED, DEPT MED CARDIOL, CINCINNATI, OH 45267 USA; UNIV CINCINNATI, COLL MED, DEPT PHARMACOL & CELL BIOPHYS, CINCINNATI, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati				Becker, Michael/0000-0001-9890-8815				ABRAHAM JA, 1986, SCIENCE, V233, P545, DOI 10.1126/science.2425435; ABRAHAM JA, 1986, EMBO J, V5, P2523, DOI 10.1002/j.1460-2075.1986.tb04530.x; ANTONIADES HN, 1991, P NATL ACAD SCI USA, V88, P565, DOI 10.1073/pnas.88.2.565; BAIRD A, 1986, BIOCHEM BIOPH RES CO, V138, P476, DOI 10.1016/0006-291X(86)90305-0; BERK BC, 1989, HYPERTENSION, V13, P305, DOI 10.1161/01.HYP.13.4.305; BERK BC, 1990, J BIOL CHEM, V265, P17334; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CARPENTER G, 1978, NATURE, V276, P409, DOI 10.1038/276409a0; DORN GW, 1992, J BIOL CHEM, V267, P24897; DORN GW, 1993, J PHARMACOL EXP THER, V265, P447; DORN GW, 1992, AM J PHYSIOL, V262, pC927, DOI 10.1152/ajpcell.1992.262.4.C927; FORCE T, 1991, J BIOL CHEM, V266, P6650; FRATERSCHRODER M, 1986, BIOCHEM BIOPH RES CO, V137, P295, DOI 10.1016/0006-291X(86)91209-X; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; GIBBONS GH, 1992, J CLIN INVEST, V90, P456, DOI 10.1172/JCI115881; GLOBUS RK, 1988, ENDOCRINOLOGY, V123, P98, DOI 10.1210/endo-123-1-98; HANASAKI K, 1990, BIOCHEM PHARMACOL, V40, P2535, DOI 10.1016/0006-2952(90)90096-4; HUANG CL, 1987, NATURE, V329, P849, DOI 10.1038/329849a0; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDNER V, 1991, CIRC RES, V68, P106, DOI 10.1161/01.RES.68.1.106; LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739; MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393; MAJESKY MW, 1990, J CELL BIOL, V111, P2149, DOI 10.1083/jcb.111.5.2149; MONCADA S, 1978, PHARMACOL REV, V30, P293; MORRISON RS, 1991, J BIOL CHEM, V266, P728; NAFTILAN AJ, 1989, J CLIN INVEST, V83, P1419, DOI 10.1172/JCI114032; NAFTILAN AJ, 1989, HYPERTENSION, V13, P706, DOI 10.1161/01.HYP.13.6.706; NAGATA T, 1992, AM J PHYSIOL, V263, pH1331, DOI 10.1152/ajpheart.1992.263.5.H1331; NAKAHARA K, 1992, BIOCHEM BIOPH RES CO, V184, P811, DOI 10.1016/0006-291X(92)90662-5; NEMECEK GM, 1986, P NATL ACAD SCI USA, V83, P674, DOI 10.1073/pnas.83.3.674; NIKOL S, 1992, J CLIN INVEST, V90, P1582, DOI 10.1172/JCI116027; PLOUET J, 1989, J CELL PHYSIOL, V141, P392, DOI 10.1002/jcp.1041410221; POWIS G, 1991, CLIN BIOCHEM, V24, P385, DOI 10.1016/S0009-9120(05)80014-1; SATO Y, 1991, BIOCHEM BIOPH RES CO, V174, P1260, DOI 10.1016/0006-291X(91)91557-S; SPEIR E, 1991, J CELL PHYSIOL, V147, P362, DOI 10.1002/jcp.1041470223; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; TAMAOKI T, 1991, METHOD ENZYMOL, V201, P340; TAUBMAN MB, 1989, J BIOL CHEM, V264, P526; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WEISS RH, 1992, J BIOL CHEM, V267, P5608; WILCOX JN, 1988, J CLIN INVEST, V82, P1134, DOI 10.1172/JCI113671	43	64	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17397	17403						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349623				2022-12-27	WOS:A1993LQ98800076
J	KUPFER, SR; MARSCHKE, KB; WILSON, EM; FRENCH, FS				KUPFER, SR; MARSCHKE, KB; WILSON, EM; FRENCH, FS			RECEPTOR ACCESSORY FACTOR ENHANCES SPECIFIC DNA-BINDING OF ANDROGEN AND GLUCOCORTICOID RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; MAMMARY-TUMOR VIRUS; RESPONSE ELEMENTS; TRANSCRIPTIONAL ACTIVATION; NUCLEAR-PROTEIN; RETINOIC ACID; PROGESTERONE-RECEPTOR; RNA-POLYMERASE; FOS JUN; C-JUN	Protein-protein interactions are common among transcriptional activators and may have important consequences for gene regulation. Using the mobility shift assay, we have identified a factor that enhances specific DNA binding of truncated rat androgen (AR) and glucocorticoid (GR) receptors by 25- and 6-fold, respectively, through the formation of heteromeric complexes. This factor, designated receptor accessory factor, or RAF, also potentiates DNA binding of full-length human GR. RAF is temperature and trypsin sensitive and is present in a variety of cultured mammalian cells. By gel filtration RAF has a predicted molecular mass of 130 kDa. RAF enhancement of AR-DNA binding is optimal with androgen response element DNA. RAF appears to interact directly with AR because 1) deoxycholate, which interferes with protein-protein but not protein-DNA interactions, prevents RAF.AR.DNA complex formation, 2) RAF activity is recovered from an androgen response element DNA affinity column only in the presence of AR, and 3) RAF increases the size of an AR.DNA complex by gel filtration. Mutagenesis of truncated AR fragments indicates that a region in the NH2-terminal domain is required for RAF to enhance AR-DNA binding. The interaction of RAF with AR and GR suggests that RAF might influence the ability of these nuclear receptors to activate transcription.	UNIV N CAROLINA,SCH MED,DEPT PEDIAT,CHAPEL HILL,NC 27599; UNIV N CAROLINA,SCH MED,DEPT BIOCHEM BIOPHYS,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	KUPFER, SR (corresponding author), UNIV N CAROLINA,SCH MED,REPROD BIOL LABS,CB 7500 MACNIDER BLDG,CHAPEL HILL,NC 27599, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD004466, R37HD016910, K08HD000963, R01HD016910, R37HD004466] Funding Source: NIH RePORTER; NICHD NIH HHS [P30-HD04466, K08-HD00963, HD16910] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; Andrews P, 1970, Methods Biochem Anal, V18, P1, DOI 10.1002/9780470110362.ch1; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BURNSIDE J, 1990, J BIOL CHEM, V265, P2500; CARSONJURICA MA, 1990, ENDOCR REV, V11, P201, DOI 10.1210/edrv-11-2-201; CATO ACB, 1988, J CELL BIOL, V106, P2119, DOI 10.1083/jcb.106.6.2119; CAVANAUGH AH, 1990, BIOCHEMISTRY-US, V29, P989, DOI 10.1021/bi00456a022; CHANDLER VL, 1983, CELL, V33, P489, DOI 10.1016/0092-8674(83)90430-0; CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211; DARBRE P, 1986, MOL CELL BIOL, V6, P2847, DOI 10.1128/MCB.6.8.2847; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; EDWARDS DP, 1989, MOL ENDOCRINOL, V3, P381, DOI 10.1210/mend-3-2-381; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FAWELL SE, 1990, CELL, V60, P953, DOI 10.1016/0092-8674(90)90343-D; FORMAN BM, 1990, MOL ENDOCRINOL, V4, P1293, DOI 10.1210/mend-4-9-1293; FREEDMAN LP, 1988, NATURE, V334, P543, DOI 10.1038/334543a0; GODOWSKI PJ, 1988, SCIENCE, V241, P812, DOI 10.1126/science.3043662; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HENDRY WJ, 1987, ENDOCRINOLOGY, V120, P629, DOI 10.1210/endo-120-2-629; HERMANN T, 1992, MOL ENDOCRINOL, V6, P1153, DOI 10.1210/me.6.7.1153; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; ING NH, 1992, J BIOL CHEM, V267, P17617; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KLEINHITPASS L, 1986, CELL, V46, P1053, DOI 10.1016/0092-8674(86)90705-1; LAMB P, 1991, TRENDS BIOCHEM SCI, V16, P417, DOI 10.1016/0968-0004(91)90167-T; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LAZAR MA, 1990, MOL ENDOCRINOL, V4, P1627, DOI 10.1210/mend-4-11-1627; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; LUBAHN DB, 1988, SCIENCE, V240, P237; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; MURRAY MB, 1989, MOL ENDOCRINOL, V3, P1434, DOI 10.1210/mend-3-9-1434; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; ODONNELL AL, 1991, MOL ENDOCRINOL, V5, P94, DOI 10.1210/mend-5-1-94; ONATE SA, 1991, MOL ENDOCRINOL, V5, P1993, DOI 10.1210/mend-5-12-1993; ONATE SA, 1992, 74TH ANN M END SOC, V74, P118; QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P1399, DOI 10.1210/mend-4-9-1399; REINBERG D, 1987, J BIOL CHEM, V262, P3322; ROSS TK, 1992, P NATL ACAD SCI USA, V89, P256, DOI 10.1073/pnas.89.1.256; SCHERRER LC, 1990, J BIOL CHEM, V265, P21397; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; SMITH DF, 1990, MOL ENDOCRINOL, V4, P1704, DOI 10.1210/mend-4-11-1704; SONE T, 1991, MOL ENDOCRINOL, V5, P1578, DOI 10.1210/mend-5-11-1578; SRINIVASAN G, 1990, MOL ENDOCRINOL, V4, P209, DOI 10.1210/mend-4-2-209; STRAHLE U, 1987, P NATL ACAD SCI USA, V84, P7871, DOI 10.1073/pnas.84.22.7871; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TAI PKK, 1986, BIOCHEMISTRY-US, V25, P5269, DOI 10.1021/bi00366a043; TAN JA, 1992, J BIOL CHEM, V267, P4456; TAN JA, 1988, MOL ENDOCRINOL, V2, P1276, DOI 10.1210/mend-2-12-1276; TSAI SY, 1987, CELL, V50, P701, DOI 10.1016/0092-8674(87)90328-X; TSAI SY, 1988, CELL, V55, P361, DOI 10.1016/0092-8674(88)90059-1; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; YOSHINAGA SK, 1992, SCIENCE, V258, P1598, DOI 10.1126/science.1360703; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E	58	71	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17519	17527						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349631				2022-12-27	WOS:A1993LQ98800092
J	TAGLICHT, D; PADAN, E; SCHULDINER, S				TAGLICHT, D; PADAN, E; SCHULDINER, S			PROTON-SODIUM STOICHIOMETRY OF NHAA, AN ELECTROGENIC ANTIPORTER FROM ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; NA+-H+ ANTIPORT; MEMBRANE-VESICLES; PH HOMEOSTASIS; TRANSPORT; ANT; PROTEOLIPOSOMES; PURIFICATION; BACTERIA; GRADIENT	The H+:Na+ exchange stoichiometry of NhaA, a sodium-proton antiporter coded by the nhaA gene of Escherichia coli, has been determined using purified NhaA protein reconstituted into sodium-loaded proteoliposomes. One approach involved measuring, in parallel experiments, the Na+ efflux and H+ influx from such proteoliposomes and calculating the stoichiometry from the ratio of these fluxes. A second approach was based on measuring the membrane potential generated by NhaA at various sodium gradients and assuming complete coupling and thermodynamic equilibrium between the membrane potential and the ion gradients. The results from both methods agree with a stoichiometry of 2 H+ exchanged for each Na+. This value is independent of pH between pH 7.2 and 8.1. These results support the suggestion that a change in the catalytic rate of NhaA rather than its stoichiometry is crucial for its role in regulation of intracellular pH in alkaline environments.	HEBREW UNIV JERUSALEM,ALEXANDER SILBERMAN INST LIFE SCI,DIV MICROBIAL & MOLEC ECOL,IL-91904 JERUSALEM,ISRAEL	Hebrew University of Jerusalem			Schuldiner, Shimon/F-7628-2012	Schuldiner, Shimon/0000-0002-4874-6237				ADMON A, 1985, J MEMBRANE BIOL, V86, P45, DOI 10.1007/BF01871609; BAKKER EP, 1990, FEMS MICROBIOL LETT, V75, P319, DOI 10.1111/j.1574-6968.1990.tb04105.x; BASSILANA M, 1984, BIOCHEMISTRY-US, V23, P1015, DOI 10.1021/bi00300a033; BASSILANA M, 1984, BIOCHEMISTRY-US, V23, P5288, DOI 10.1021/bi00317a029; BECK JC, 1979, ARCH BIOCHEM BIOPHYS, V194, P208, DOI 10.1016/0003-9861(79)90611-8; BOOTH IR, 1985, MICROBIOL REV, V49, P395; BORON WF, 1983, J MEMBRANE BIOL, V72, P1, DOI 10.1007/BF01870311; CASTLE AM, 1986, J BIOL CHEM, V261, P3288; CASTLE AM, 1986, J BIOL CHEM, V261, P7797; GARLID KD, 1991, J BIOL CHEM, V266, P6518; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; HAUSSINGER D, 1988, PH HOMEOSTASIS MECHA; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P1207, DOI 10.1021/bi00600a011; KARPEL R, 1988, J BIOL CHEM, V263, P10408; MACNAB RM, 1987, BIOPHYS J, V52, P637, DOI 10.1016/S0006-3495(87)83255-1; MINTA A, 1989, J BIOL CHEM, V264, P19449; PADAN E, 1989, J BIOL CHEM, V264, P20297; PADAN E, 1981, BIOCHIM BIOPHYS ACTA, V650, P1151; PAN JW, 1990, J BIOL CHEM, V265, P9247; PINNER E, 1992, J BIOL CHEM, V267, P11064; PINNER E, 1993, IN PRESS J BIOL CHEM; POUYSSEGUR J, 1988, NAPLUS HPLUS EXCHANG, P337; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; SHAHAK Y, 1982, FEBS LETT, V150, P27, DOI 10.1016/0014-5793(82)81298-2; SLONCZEWSKI JL, 1981, P NATL ACAD SCI-BIOL, V78, P6271, DOI 10.1073/pnas.78.10.6271; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; WEST IC, 1974, BIOCHEM J, V144, P87, DOI 10.1042/bj1440087	28	135	135	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1993	268	8					5382	5387						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR822	8383669				2022-12-27	WOS:A1993KR82200010
J	WANG, YL; MACDONALD, JIS; KENT, C				WANG, YL; MACDONALD, JIS; KENT, C			REGULATION OF CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE IN HELA-CELLS - EFFECT OF OLEATE ON PHOSPHORYLATION AND INTRACELLULAR-LOCALIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHINESE-HAMSTER OVARY; CHOLINE-PHOSPHATE CYTIDYLYLTRANSFERASE; PHOSPHOLIPASE-C TREATMENT; HEP G2 CELLS; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; FATTY-ACIDS; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; RAT-LIVER; II CELLS	The mechanism by which oleate induced the translocation of CTP:phosphocholine cytidylyltransferase from the soluble to particulate fraction was studied in HeLa cells. Addition of 0.5 mM oleate caused a 10-fold stimulation of [methyl-H-3]choline incorporation into phosphatidylcholine. The stimulation of phosphatidylcholine synthesis was correlated with a decrease in phosphocholine and an increase in CDP-choline, indicating that cytidylyltransferase is regulatory under these conditions. The stimulation of cytidylyltransferase activity upon oleate treatment was concomitant with the translocation of this enzyme from the soluble to particulate fraction. Immunoblot analysis revealed the soluble form as multiple slowly migrating bands, and the particulate form as a faster migrating, single band. The slowly migrating form could be converted to the fast migrating form by phosphatase treatment, suggesting that the mobility difference was due to phosphorylation. In vivo P-32 labeling showed that the soluble cytidylyltransferase was highly phosphorylated and the particulate form was much less phosphorylated. The kinetics of the translocation showed that the conversion of the majority of cytidylyltransferase from the soluble to the particulate form occurred within about 15 min following addition of oleate and that the translocation showed a good correlation with dephosphorylation. In contrast, the relocation of cytidylyltransferase from the particulate to the soluble fraction after the removal of oleate occurred within 1 min, and extensive phosphorylation was not required for cytidylyltransferase to leave the membrane. The relocated, soluble cytidylyltransferase was phosphorylated at a much slower rate than that at which the enzyme left the membrane. Immunolocalization showed that the cytidylyltransferase translocated to the nuclear envelope instead of the endoplasmic reticulum. These results indicate that activation of cytidylyltransferase by dephosphorylation and translocation to the nuclear envelope may be a general mechanism occurring in many cell types. Moreover, in HeLa cells, multiple mechanism exist for regulating cytidylyltransferase activity.	UNIV MICHIGAN,DEPT BIOL CHEM,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan					NICHD NIH HHS [HD 10580] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD010580] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BLANK ML, 1988, J BIOL CHEM, V263, P5656; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURKHARDT R, 1988, BIOCHEM J, V254, P495, DOI 10.1042/bj2540495; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; COHEN PTW, 1988, GENE, V69, P131, DOI 10.1016/0378-1119(88)90385-X; COHEN PTW, 1989, BIOCHEM J, V260, P931, DOI 10.1042/bj2600931; COOK HW, 1989, J BIOL CHEM, V264, P2746; CORNELL R, 1987, BIOCHIM BIOPHYS ACTA, V919, P26, DOI 10.1016/0005-2760(87)90214-1; DAWSON DB, 1987, BIOCHIM BIOPHYS ACTA, V923, P389; EXTON JH, 1990, J BIOL CHEM, V265, P1; HATCH GM, 1991, BIOCHIM BIOPHYS ACTA, V1081, P25, DOI 10.1016/0005-2760(91)90245-D; HIGGINS JA, 1987, J LIPID RES, V28, P268; JAMIL H, 1990, J BIOL CHEM, V265, P4332; JAMIL H, 1992, J BIOL CHEM, V267, P1752; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; KENT C, 1990, PROG LIPID RES, V29, P87, DOI 10.1016/0163-7827(90)90010-I; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MORAND JN, 1989, J BIOL CHEM, V264, P13785; Nigg EA, 1989, CURR OPIN CELL BIOL, V1, P435, DOI 10.1016/0955-0674(89)90002-1; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V795, P433, DOI 10.1016/0005-2760(84)90169-3; PELECH SL, 1983, J BIOL CHEM, V258, P6782; PESCE A, 1964, J BIOL CHEM, V239, P1753; SLACK BE, 1991, J BIOL CHEM, V266, P24503; SLEIGHT R, 1980, J BIOL CHEM, V255, P644; SLEIGHT R, 1983, J BIOL CHEM, V258, P831; SLEIGHT R, 1983, J BIOL CHEM, V258, P836; SLEIGHT R, 1983, J BIOL CHEM, V258, P824; TERCE F, 1992, BIOCHEM J, V282, P333, DOI 10.1042/bj2820333; TERCE F, 1988, J BIOL CHEM, V263, P3142; TERCE F, 1991, BIOCHIM BIOPHYS ACTA, V1084, P69, DOI 10.1016/0005-2760(91)90057-O; UTAL AK, 1991, J BIOL CHEM, V266, P24084; VANCE JE, 1988, J BIOL CHEM, V263, P5898; WATKINS JD, 1991, J BIOL CHEM, V266, P21113; WATKINS JD, 1992, J BIOL CHEM, V267, P5686; WATKINS JD, 1990, J BIOL CHEM, V265, P2190; WEINHOLD PA, 1984, J BIOL CHEM, V259, P315; WEINHOLD PA, 1991, J BIOL CHEM, V266, P6093; WEINHOLD PA, 1989, BIOCHIM BIOPHYS ACTA, V1006, P299, DOI 10.1016/0005-2760(89)90017-9; WRIGHT PS, 1985, J BIOL CHEM, V260, P7919; YAO ZM, 1990, J BIOL CHEM, V265, P4326; YAVIN E, 1976, J BIOL CHEM, V251, P1392	42	100	100	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1993	268	8					5512	5518						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR822	8383672				2022-12-27	WOS:A1993KR82200027
J	LEE, HS; GHOSEDASTIDAR, J; WINAWER, S; FRIEDMAN, E				LEE, HS; GHOSEDASTIDAR, J; WINAWER, S; FRIEDMAN, E			SIGNAL TRANSDUCTION THROUGH EXTRACELLULAR SIGNAL-REGULATED KINASE-LIKE PP57 BLOCKED IN DIFFERENTIATED CELLS HAVING LOW PROTEIN KINASE-C-BETA ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; PHORBOL ESTER; MITOGEN; DIACYLGLYCEROL; ACTIVATION; INSULIN; ERKS; AUTOPHOSPHORYLATION; EXPRESSION; ISOZYMES	pp57 is a cytoplasmic kinase which is related antigenically and functionally to the extracellular signal regulated kinase or the mitogen-activated kinase family of signal transduction proteins. Two undifferentiated colon carcinoma cell lines responded to the diacylglycerol diolein by growth and a rapid 3-4-fold increase in tyrosine phosphorylation of pp57, and smaller increases in threonine and serine phosphorylation. By enhancing tyrosine phosphorylation of pp57, diolein increased pp57 kinase activity on myelin basic protein. Two enterocytic differentiated colon carcinoma cell lines, when treated with diolein, exhibited neither increased pp57 tyrosine phosphorylation nor increased growth. Both enterocytic lines exhibited 30% of the total PKC activity, 10-20% of the abundance of PKCbeta as detected by Western blotting with anti-peptide antisera, and 10-20% of the PKCbeta activity, by immune complex kinase reactions, that was expressed in the undifferentiated cell lines. The abundance of three other PKC isozymes, alpha, epsilon, and zeta appeared unchanged in the undifferentiated and enterocytic lines, reflecting their common parental cell line origin. The association between loss of PKCbeta activity and blocked signaling through pp57 in each of two cell lines suggests that PKCbeta is part of a signal transduction system activating pp57.	MEM SLOAN KETTERING CANC CTR,GI TUMOR BIOL LAB,1275 YORK AVE,BOX 244,NEW YORK,NY 10021	Memorial Sloan Kettering Cancer Center					NCI NIH HHS [CA50645] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALESSANDRINI A, 1992, P NATL ACAD SCI USA, V89, P8200, DOI 10.1073/pnas.89.17.8200; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BELL RM, 1991, J BIOL CHEM, V266, P4661; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; CHOI PM, 1990, MOL CELL BIOL, V10, P4650, DOI 10.1128/MCB.10.9.4650; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; COOPER JA, 1981, MOL CELL BIOL, V1, P741; FRIEDMAN E, 1989, CANCER RES, V49, P544; GANONG BR, 1984, BIOCHEMISTRY-US, V23, P4977, DOI 10.1021/bi00316a023; GILMORE T, 1983, NATURE, V306, P487, DOI 10.1038/306487a0; HAFEZ MM, 1990, CELL GROWTH DIFFER, V1, P617; HAFEZ MM, 1992, CELL GROWTH DIFFER, V3, P753; HOMAN EC, 1991, J BIOL CHEM, V266, P5676; KAZLAUSKAS A, 1988, J CELL BIOL, V106, P1395, DOI 10.1083/jcb.106.4.1395; KOLESNICK RN, 1990, J BIOL CHEM, V265, P10900; KYRIAKIS JM, 1990, J BIOL CHEM, V265, P17355; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LALLEMAIN G, 1991, MOL CELL BIOL, V11, P1002, DOI 10.1128/MCB.11.2.1002; LEE H, 1993, IN PRESS J BIOL CHEM; LESUFFLEUR T, 1991, J CELL BIOL, V115, P1409, DOI 10.1083/jcb.115.5.1409; LIN TH, 1992, J BIOL CHEM, V267, P1335; MAKOWSKE M, 1988, J BIOL CHEM, V263, P3402; MARIAN B, 1989, CANCER RES, V49, P4231; MELLONI E, 1989, J BIOL CHEM, V264, P18414; MOROTOMI M, 1990, CANCER RES, V50, P3595; OTTE AP, 1992, CELL, V68, P1021, DOI 10.1016/0092-8674(92)90074-M; PFEFFER LM, 1990, P NATL ACAD SCI USA, V87, P6537, DOI 10.1073/pnas.87.17.6537; POWELL CT, 1992, P NATL ACAD SCI USA, V89, P147, DOI 10.1073/pnas.89.1.147; RAY LB, 1988, J BIOL CHEM, V263, P12721; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; TOBE K, 1991, J BIOL CHEM, V266, P24793; WU J, 1991, P NATL ACAD SCI USA, V88, P9508, DOI 10.1073/pnas.88.21.9508; YAN ZF, 1992, ONCOGENE, V7, P801	36	49	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1993	268	7					5255	5263						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP884	8383133				2022-12-27	WOS:A1993KP88400099
J	ROSENWALD, AG; PAGANO, RE				ROSENWALD, AG; PAGANO, RE			INHIBITION OF GLYCOPROTEIN TRAFFIC THROUGH THE SECRETORY PATHWAY BY CERAMIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							NECROSIS-FACTOR-ALPHA; GOLGI-APPARATUS; CELL-DIFFERENTIATION; CULTURED FIBROBLASTS; SPHINGOMYELIN TURNOVER; PLASMA-MEMBRANE; RAT-LIVER; METABOLISM; ANALOG; SPHINGOLIPIDS	Incubation of vesicular stomatitis virus-infected cells with short-chain, cell-permeable ceramide (Cer) analogs decreased the rate of viral glycoprotein transport through the Golgi complex and reduced the number of infectious virions released from cells in a concentration-dependent manner. These effects appeared to be caused directly by Cer, rather than by one of its metabolites. Cer treatment also disrupted the Golgi apparatus within 1 h, although cells treated for up to 24 h with Cer remained viable. Our results suggest that endogenous Cer may modulate secretory protein traffic and that exogenously added Cer analogs may be useful as antiviral agents.	CARNEGIE INST WASHINGTON,DEPT EMBRYOL,115 W UNIV PKWY,BALTIMORE,MD 21210	Carnegie Institution for Science					NIGMS NIH HHS [R37 GM22942] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM022942] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		COSTE H, 1985, BIOCHIM BIOPHYS ACTA, V814, P1, DOI 10.1016/0005-2736(85)90412-2; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; DRESSLER KA, 1992, SCIENCE, V255, P1715, DOI 10.1126/science.1313189; DUNPHY WG, 1985, CELL, V42, P13, DOI 10.1016/S0092-8674(85)80097-0; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; JECKEL D, 1990, FEBS LETT, V261, P155, DOI 10.1016/0014-5793(90)80659-7; KALEN A, 1992, BIOCHIM BIOPHYS ACTA, V1125, P90, DOI 10.1016/0005-2760(92)90160-W; KIM MY, 1991, J BIOL CHEM, V266, P484; Kolesnick Richard, 1992, Trends in Cell Biology, V2, P232, DOI 10.1016/0962-8924(92)90310-J; KOLESNICK RN, 1991, PROG LIPID RES, V30, P1, DOI 10.1016/0163-7827(91)90005-P; KOVAL M, 1991, BIOCHIM BIOPHYS ACTA, V1082, P113, DOI 10.1016/0005-2760(91)90184-J; KOVAL M, 1989, J CELL BIOL, V108, P2169, DOI 10.1083/jcb.108.6.2169; LARSEN D, 1982, THESIS J HOPKINS U B; LIPSKY NG, 1983, P NATL ACAD SCI-BIOL, V80, P2608, DOI 10.1073/pnas.80.9.2608; LIPSKY NG, 1985, SCIENCE, V228, P745, DOI 10.1126/science.2581316; LIPSKY NG, 1985, J CELL BIOL, V100, P27, DOI 10.1083/jcb.100.1.27; LUCOCQ J, 1991, J CELL SCI, V100, P753; MATHIAS S, 1991, P NATL ACAD SCI USA, V88, P10009, DOI 10.1073/pnas.88.22.10009; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; OKAZAKI T, 1990, J BIOL CHEM, V265, P15823; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; PAGANO RE, 1989, J CELL BIOL, V109, P2067, DOI 10.1083/jcb.109.5.2067; PAGANO RE, 1990, BIOCHEM SOC T, V18, P361, DOI 10.1042/bst0180361; PAGANO RE, 1988, BIOCHEMISTRY-US, V27, P4439, DOI 10.1021/bi00412a034; ROSENWALD AG, 1992, BIOCHEMISTRY-US, V31, P3581, DOI 10.1021/bi00129a005; ROSENWALD AG, 1993, IN PRESS ADV LIPID R; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0	30	90	92	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1993	268	7					4577	4579						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP884	8383117				2022-12-27	WOS:A1993KP88400003
J	WANG, Y; WEINER, H				WANG, Y; WEINER, H			THE PRESEQUENCE OF RAT-LIVER ALDEHYDE DEHYDROGENASE REQUIRES THE PRESENCE OF AN ALPHA-HELIX AT ITS N-TERMINAL REGION WHICH IS STABILIZED BY THE HELIX AT ITS C-TERMINI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORTED MITOCHONDRIAL PROTEIN; OUTER-MEMBRANE PROTEIN; 12 AMINO-ACIDS; LEADER PEPTIDE; SIGNAL PEPTIDE; ORNITHINE TRANSCARBAMYLASE; TARGETING SEQUENCES; PRE-SEQUENCE; YEAST; PRECURSOR	Previous nuclear magnetic resonance data showed that the conformation of the signal peptide of rat liver mitochondrial aldehyde dehydrogenase in a micelle environment contained a N-helix and a C-helix which were separated by a flexible hinge region (Karslake, C., Piotto, M. E., Pak, Y. K., Weiner, H. and Gorenstein, D. (1990) Biochemistry 29, 9872-9878). Deletion of either helix from the presequence caused complete loss of the precursor import. Switching the positions of the two helices had little effect on import but decreased processing efficiency. Import was not affected by replacing the C-helix with the N-terminal helix of the presequence of cytochrome c oxidase subunit IV, however, it was decreased by replacing the C-helix with the C-terminal random coil of the oxidase's presequence. Circular dichroism studies on the synthesized signal peptides indicated that a helix in the C-segment of aldehyde dehydrogenase signal peptide was needed to stabilize the N-helix. It is concluded that a stable helix in the N-terminal region is necessary for a functional mitochondrial presequence. This helix could be obtained from its own sequence, or from the interaction with other portions of the presequence.	PURDUE UNIV,DEPT BIOCHEM,1153 BIOCHEM BLDG,W LAFAYETTE,IN 47907	Purdue University System; Purdue University; Purdue University West Lafayette Campus					NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA008512, R03AA008532] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA00028, AA08532, AA08512] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BEDWELL DM, 1989, MOL CELL BIOL, V9, P1014, DOI 10.1128/MCB.9.3.1014; BIBUS CR, 1988, J BIOL CHEM, V263, P13097; BRUCH MD, 1990, J BIOL CHEM, V265, P3851; CHANG CT, 1978, ANAL BIOCHEM, V91, P12; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; DYSON HJ, 1988, J MOL BIOL, V201, P201, DOI 10.1016/0022-2836(88)90447-0; ENDO T, 1989, J BIOCHEM, V106, P396, DOI 10.1093/oxfordjournals.jbchem.a122864; EPAND RM, 1986, J BIOL CHEM, V261, P17; FARRES J, 1989, EUR J BIOCHEM, V180, P67, DOI 10.1111/j.1432-1033.1989.tb14616.x; GLICK B, 1991, ANNU REV GENET, V25, P21; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; HALDI M, 1989, J BIOL CHEM, V264, P17107; HORWICH AL, 1986, CELL, V44, P451, DOI 10.1016/0092-8674(86)90466-6; HORWICH AL, 1985, EMBO J, V4, P1129, DOI 10.1002/j.1460-2075.1985.tb03750.x; HOYT DW, 1991, J BIOL CHEM, V266, P21693; HURT EC, 1985, EMBO J, V4, P3509, DOI 10.1002/j.1460-2075.1985.tb04110.x; HURT EC, 1987, J BIOL CHEM, V262, P1420; HURT EC, 1985, EMBO J, V4, P2061, DOI 10.1002/j.1460-2075.1985.tb03892.x; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; KARSLAKE C, 1990, BIOCHEMISTRY-US, V29, P9872, DOI 10.1021/bi00494a017; KLEIBER J, 1990, P NATL ACAD SCI USA, V87, P7978, DOI 10.1073/pnas.87.20.7978; KRAUS JP, 1988, P NATL ACAD SCI USA, V85, P8905, DOI 10.1073/pnas.85.23.8905; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEMIRE BD, 1989, J BIOL CHEM, V264, P20206; NELSON J W, 1986, Proteins Structure Function and Genetics, V1, P211, DOI 10.1002/prot.340010303; NISHI T, 1989, J BIOL CHEM, V264, P6044; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; PABO CO, 1982, NATURE, V298, P443, DOI 10.1038/298443a0; PAK YK, 1990, J BIOL CHEM, V265, P14298; PILGRIM D, 1986, MOL CELL BIOL, V7, P294; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; ROISE D, 1988, EMBO J, V7, P649, DOI 10.1002/j.1460-2075.1988.tb02859.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER H, 1990, J BIOL CHEM, V265, P9881; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; TAMM LK, 1990, FEBS LETT, V272, P29, DOI 10.1016/0014-5793(90)80441-K; VASSAROTTI A, 1987, J BIOL CHEM, V262, P411; VESTWEBER D, 1989, NATURE, V341, P205, DOI 10.1038/341205a0; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WANG TTY, 1989, ARCH BIOCHEM BIOPHYS, V272, P440, DOI 10.1016/0003-9861(89)90238-5	42	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1993	268	7					4759	4765						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP884	8383124				2022-12-27	WOS:A1993KP88400034
J	BOYER, CS; MOORE, GA; MOLDEUS, P				BOYER, CS; MOORE, GA; MOLDEUS, P			SUBMITOCHONDRIAL LOCALIZATION OF THE NAD+ GLYCOHYDROLASE - IMPLICATIONS FOR THE ROLE OF PYRIDINE-NUCLEOTIDE HYDROLYSIS IN MITOCHONDRIAL CALCIUM FLUXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; ADP-RIBOSYLATION; CA-2+ RELEASE; MEMBRANE; INNER; METABOLISM; INHIBITION; PROOXIDANTS; TRANSFERASE; STATE	The submitochondrial location of the NAD+ glycohydrolase (NADase) and its role in mitochondrial ADP-ribosyl transfer reactions were investigated in isolated rat liver mitochondria. The NADase catalyzes the hydrolysis of NAD+ to ADP-ribose and nicotinamide. Hydrolysis of intramitochondrial NAD+ has been suggested to be the first step in a nonenzymatic mono(ADP-ribosylation) by free ADP-ribose of an inner membrane-associated acceptor peptide and that this protein is involved in regulating calcium efflux from mitochondria during exposure to oxidants. The results of the present study indicate that mitochondrial NADase activity lies outside the matrix space, however. This was determined by assessing the rates of hydrolysis of externally added NAD+ by intact mitochondria and comparing these rates with those obtained when the mitochondria were permeabilized with detergent. No significant difference was observed in the rate of NAD+ hydrolysis when detergent was added indicating that NAD+ hydrolysis by mitochondria does not necessitate its access to the matrix space. The submitochondrial location of the NADase was investigated further by digitonin titration of isolated mitochondria. Digitonin titration of the mitochondria released NADase activity with the outer membrane marker, monoamine oxidase. The digitonin titration data also suggest that the outer membrane is the exclusive location of the NADase. The incorporation of radioactive label derived from [H-3]NAD+ into submitochondrial particles proceeds at comparable rates in the absence or presence of NADase activity, indicating that the production of free ADP-ribose is not necessary for intramitochondrial ADP-ribosyl transfer reactions. Thus the conclusions of this study suggest that due to the submitochondrial location of the NADase, it does not participate in intramitochondrial pyridine nucleotide hydrolysis or nonenzymatic mono(ADP-ribosylation) during oxidative stress in mitochondria.	NATL CHEM INSPECTORAT,DEPT SCI RES & DOCUMENTAT,S-17127 SOLNA,SWEDEN		BOYER, CS (corresponding author), KAROLINSKA INST,DEPT TOXICOL,POB 60400,S-10401 STOCKHOLM 60,SWEDEN.							BARRIO JR, 1972, P NATL ACAD SCI USA, V69, P2039, DOI 10.1073/pnas.69.8.2039; BELLOMO G, 1982, J BIOL CHEM, V257, P1558; BOQUIST L, 1984, BIOCH INT, V9, P597; BOYER CS, 1991, DRUG METAB DISPOS, V19, P81; BRDICZKA D, 1974, H-S Z PHYSIOL CHEM, V355, P731, DOI 10.1515/bchm2.1974.355.1.731; BURGESS GM, 1983, J BIOL CHEM, V258, P5336; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; CAYAMA E, 1973, J BIOL CHEM, V248, P6479; CROMPTON M, 1988, BIOCHEM J, V255, P357; FAGIAN MM, 1990, J BIOL CHEM, V265, P19955; FREI B, 1988, BIOCHEMISTRY-US, V27, P529, DOI 10.1021/bi00402a004; FREI B, 1986, FEBS LETT, V198, P99, DOI 10.1016/0014-5793(86)81192-9; FREI B, 1985, EUR J BIOCHEM, V149, P633, DOI 10.1111/j.1432-1033.1985.tb08971.x; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GRAF M, 1985, BIOCHEM BIOPH RES CO, V129, P18, DOI 10.1016/0006-291X(85)91396-8; HILZ H, 1984, P NATL ACAD SCI-BIOL, V81, P3929, DOI 10.1073/pnas.81.13.3929; HOFFSTETTER W, 1981, EUR J BIOCHEM, V117, P361; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; JONES DP, 1981, J CHROMATOGR, V225, P446, DOI 10.1016/S0378-4347(00)80293-5; Kun E, 1979, Methods Enzymol, V55, P115; KUN E, 1975, P NATL ACAD SCI USA, V72, P1436, DOI 10.1073/pnas.72.4.1436; LEHNINGER AL, 1978, P NATL ACAD SCI USA, V75, P1690, DOI 10.1073/pnas.75.4.1690; LOTSCHER HR, 1980, J BIOL CHEM, V255, P9325; LOTSCHER HR, 1979, P NATL ACAD SCI USA, V76, P4340, DOI 10.1073/pnas.76.9.4340; MASMOUDI A, 1987, BIOCHEMISTRY-US, V26, P1965, DOI 10.1021/bi00381a027; MCCREANOR GM, 1983, BIOCHIM BIOPHYS ACTA, V759, P222, DOI 10.1016/0304-4165(83)90316-1; MOSER B, 1983, ARCH BIOCHEM BIOPHYS, V224, P358, DOI 10.1016/0003-9861(83)90220-5; NICOTERA P, 1992, ANNU REV PHARMACOL, V32, P449, DOI 10.1146/annurev.pa.32.040192.002313; PASCOE GA, 1989, FREE RADICAL BIO MED, V6, P209, DOI 10.1016/0891-5849(89)90118-4; Pedersen P L, 1978, Methods Cell Biol, V20, P411, DOI 10.1016/S0091-679X(08)62030-0; PHILLIPS AH, 1962, J BIOL CHEM, V237, P2652; RICHTER C, 1990, BIOCHEM J, V269, P735, DOI 10.1042/bj2690735; RICHTER C, 1987, BIOCHEM BIOPH RES CO, V143, P609, DOI 10.1016/0006-291X(87)91397-0; RICHTER C, 1990, BIOCHEM PHARMACOL, V40, P779, DOI 10.1016/0006-2952(90)90315-C; RICHTER C, 1990, FREE RADICAL RES COM, V8, P329, DOI 10.3109/10715769009053366; RICHTER C, 1988, FREE RADICAL BIO MED, V4, P365, DOI 10.1016/0891-5849(88)90088-3; RICHTER C, 1983, P NATL ACAD SCI-BIOL, V80, P3188, DOI 10.1073/pnas.80.11.3188; RICHTER C, 1987, ADP RIBOSYLATION PRO, P209; ROTTENBERG H, 1990, BIOCHIM BIOPHYS ACTA, V1016, P77, DOI 10.1016/0005-2728(90)90009-S; RYLE CM, 1984, BIOCHEM J, V222, P553, DOI 10.1042/bj2220553; SCHMIDT B, 1984, EUR J BIOCHEM, V144, P581, DOI 10.1111/j.1432-1033.1984.tb08505.x; SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158; WEIS M, 1992, J BIOL CHEM, V267, P804; ZAMMIT VA, 1985, BIOCHEM J, V230, P389, DOI 10.1042/bj2300389	44	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					4016	4020						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382685				2022-12-27	WOS:A1993KN53300034
J	CORY, AH; SHIBLEY, IA; CHALOVICH, JM; CORY, JG				CORY, AH; SHIBLEY, IA; CHALOVICH, JM; CORY, JG			DEOXYGUANOSINE-RESISTANT LEUKEMIA-L1210 CELLS - LOSS OF SPECIFIC DEOXYRIBONUCLEOSIDE KINASE-ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYCYTIDINE KINASE; RIBONUCLEOTIDE REDUCTASE; CYTO-TOXICITY; CALF THYMUS; LYMPHOBLASTS; SUBSTRATE; INHIBITORS; METABOLISM; DEFICIENT; ENZYME	A mouse leukemia L1210 cell line was selected for resistance to deoxyguanosine. The deoxyguanosine-resistant cells (dGuo-R) were 126-fold less sensitive to deoxyguanosine than the wild-type cells. The IC50 values for araC and araG were increased, but only 10-12-fold in the dGuo-R cells when compared with the wild-type cells. The dGuo-R cell line showed an increased level of resistance to 2-fluoro-2'-deoxyadenosine and 2-fluoroadenine arabinoside (11-14-fold), but essentially no increase in resistance to deoxyadenosine or adenine arabinoside. Deoxyribonucleoside kinase activity was decreased only slightly (19%) when deoxycytidine was utilized as substrate; when cytosine arabinoside or deoxyguanosine was used as the substrate, the kinase activity in the extracts from the dGuo-R cells was only 10% of the enzyme activity in the extracts from the wild-type cells. The determination of the kinetic parameters, K(m) and V(max) indicated that there were marked decreases in the V(max), values for deoxyguanosine and cytosine arabinoside as substrates, but not for deoxycytidine as substrate; the K(m) values for deoxycytidine and cytosine arabinoside were increased in the extracts from the dGuo-R cells. By use of high-performance liquid chromatography, the kinase activities in the extracts from the wild-type and resistant cells could be resolved. There was the specific loss of kinase activity toward cytosine arabinoside and deoxyguanosine as substrates. These data indicate that the dGuo-R cells have decreased levels of a specific deoxyribonucleoside kinase activity.	E CAROLINA UNIV, SCH MED, DEPT BIOCHEM, BRODY MED SCI BLDG, GREENVILLE, NC 27858 USA	University of North Carolina; East Carolina University				Chalovich, Joseph/0000-0002-1243-4055	NCI NIH HHS [CA-42070, CA-27398] Funding Source: Medline; NIAMS NIH HHS [R01 AR035216] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035216] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BHALLA K, 1984, CANCER RES, V44, P5029; BOHMAN C, 1988, BIOCHEMISTRY-US, V27, P4258, DOI 10.1021/bi00412a009; CARTER GL, 1989, ADV ENZYME REGUL, V29, P123, DOI 10.1016/0065-2571(89)90097-6; CHOTTINER EG, 1991, P NATL ACAD SCI USA, V88, P1531, DOI 10.1073/pnas.88.4.1531; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; CORY JG, 1988, CANCER RES, V48, P839; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; DOW LW, 1980, CANCER RES, V40, P1405; ERIKSSON S, 1979, BIOCHEMISTRY-US, V18, P2948, DOI 10.1021/bi00581a005; HABTEYESUS A, 1991, BIOCHEM PHARMACOL, V42, P1829, DOI 10.1016/0006-2952(91)90522-7; HERSHFIELD MS, 1982, J BIOL CHEM, V257, P6380; KAZMERS IS, 1981, SCIENCE, V214, P1137, DOI 10.1126/science.6795718; KRENITSKY TA, 1976, J BIOL CHEM, V251, P4055; LEWIS RA, 1989, BIOCHEM PHARMACOL, V38, P2001, DOI 10.1016/0006-2952(89)90500-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEYERS MB, 1976, ARCH BIOCHEM BIOPHYS, V177, P10, DOI 10.1016/0003-9861(76)90409-4; MOMPARLER RL, 1968, J BIOL CHEM, V243, P4298; OWENS JK, 1992, CANCER RES, V52, P2389; RICHEL DJ, 1990, CANCER RES, V50, P6515; SHEWACH DS, 1985, CANCER RES, V45, P1008; VERHOEF V, 1981, CANCER RES, V41, P4478	21	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					405	409						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380161				2022-12-27	WOS:A1993KE60300062
J	ASANO, T; MORISHITA, R; MATSUDA, T; FUKADA, Y; YOSHIZAWA, T; KATO, K				ASANO, T; MORISHITA, R; MATSUDA, T; FUKADA, Y; YOSHIZAWA, T; KATO, K			PURIFICATION OF 4 FORMS OF THE BETA-GAMMA-SUBUNIT COMPLEX OF G-PROTEINS CONTAINING DIFFERENT GAMMA-SUBUNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING PROTEINS; AMINO-ACID SEQUENCE; GTP-BINDING; BOVINE BRAIN; ADENYLATE-CYCLASE; ALPHA-SUBUNITS; REGIONAL DISTRIBUTION; MOLECULAR-CLONING; 3RD FORM; TRANSDUCIN	To investigate the physiological significance of the diversity of gamma subunits of G proteins, we purified four forms of betagamma of G proteins from bovine brain (betagamma-B1, betagamma-B2, betagamma-B3), and spleen (betagamma-B1) by the sequential chromatography on columns of DEAE-Sephacel, Ultrogel AcA 34, heptylamine-Sepharose, phenyl-5PW, and DEAE-5PW. Electrophoretic analyses showed that each betagamma mainly contained the 36-kDa beta and a distinct but homogeneous gamma. These betagamma complexes were subjected directly to proteolytic digestion and subsequent amino acid sequence analyses of their fragments. It was revealed that betagamma-B1, -B2, and -B3 were identical to beta1gamma7 (with a low level of beta2gamma7), beta1gamma2 and beta1gamma3, respectively, while betagamma-S1 was composed of beta1 and an unidentified form of gamma. Then we examined the functional differences among these betagamma complexes and the betagamma of transducin (betagamma-T, beta1gamma1). Few differences were observed among all betagamma complexes to enhance pertussis toxin-catalyzed ADP-ribosylation of the alpha subunits of G(o) and G(t). The four forms of betagamma complexes purified from brain and spleen showed indistinguishable inhibitory effects on the release of GDP from G(o)alpha, but betagamma-T was much less effective. Brain and spleen betagamma complexes were equally effective in inhibiting calmodulin-stimulated adenylyl-cyclase activity, but betagamma-T had a very weak inhibitory effect. Five forms of betagamma facilitated metarhodopsin II-c catalyzed binding of GTPgammaS to G(t)alpha in a concentration-dependent manner with the following rank order of effectiveness: betagamma-S1 > betagamma-T > betagamma-B1 > betagamma-B2 > betagamma-B3. Because the betagamma complexes used in this study mostly contained the same beta subunit, the functional differences must be dependent on the gamma subunits. Thus, it seems likely that the receptor, the alpha subunits, and the effector are able to distinguish between the various gamma subunits.	KYOTO UNIV,FAC SCI,DEPT BIOPHYS,KYOTO 60601,JAPAN; OSAKA SANGYO UNIV,FAC ENGN,DEPT INFORMAT SYST ENGN,DAITO,OSAKA 574,JAPAN	Kyoto University	ASANO, T (corresponding author), AICHI PREFECTURAL COLONY,INST DEV RES,DEPT BIOCHEM,KASUGAI,AICHI 48003,JAPAN.		吉孝, 深田/G-5090-2014					ASANO T, 1988, J BIOCHEM-TOKYO, V103, P950, DOI 10.1093/oxfordjournals.jbchem.a122392; ASANO T, 1987, J NEUROCHEM, V48, P1617, DOI 10.1111/j.1471-4159.1987.tb05710.x; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; CALI JJ, 1992, J BIOL CHEM, V267, P24023; CODINA J, 1986, FEBS LETT, V207, P187, DOI 10.1016/0014-5793(86)81486-7; FAWZI AB, 1991, J BIOL CHEM, V266, P12194; FISHER KJ, 1992, MOL CELL BIOL, V12, P1585, DOI 10.1128/MCB.12.4.1585; FONG HKW, 1987, P NATL ACAD SCI USA, V84, P3792, DOI 10.1073/pnas.84.11.3792; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; FUKADA Y, 1989, J BIOL CHEM, V264, P5937; FUKADA Y, 1990, NATURE, V346, P658, DOI 10.1038/346658a0; GAO B, 1987, J BIOL CHEM, V262, P17254; GAO B, 1987, P NATL ACAD SCI USA, V84, P6122, DOI 10.1073/pnas.84.17.6122; GAUTAM N, 1990, P NATL ACAD SCI USA, V87, P7973, DOI 10.1073/pnas.87.20.7973; GAUTAM N, 1989, SCIENCE, V244, P971, DOI 10.1126/science.2499046; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRAF R, 1992, EUR J BIOCHEM, V210, P609, DOI 10.1111/j.1432-1033.1992.tb17461.x; HAGA K, 1992, J BIOL CHEM, V267, P2222; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; HURLEY JB, 1984, P NATL ACAD SCI-BIOL, V81, P6948, DOI 10.1073/pnas.81.22.6948; INIGUEZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; KATADA T, 1986, J BIOL CHEM, V261, P8182; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; KOBAYASHI I, 1990, EUR J BIOCHEM, V191, P499, DOI 10.1111/j.1432-1033.1990.tb19149.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE RH, 1992, J BIOL CHEM, V267, P24776; LEVINE MA, 1990, P NATL ACAD SCI USA, V87, P2329, DOI 10.1073/pnas.87.6.2329; LOGOTHETIS DE, 1988, P NATL ACAD SCI USA, V85, P5814, DOI 10.1073/pnas.85.16.5814; MORISHITA R, 1992, EUR J BIOCHEM, V210, P1061, DOI 10.1111/j.1432-1033.1992.tb17512.x; MORISHITA R, IN PRESS BIOCH BIOPH; NEER EJ, 1988, NATURE, V333, P129, DOI 10.1038/333129a0; NORTHUP JK, 1982, J BIOL CHEM, V257, P1416; OVCHINNIKOV YA, 1985, FEBS LETT, V179, P107, DOI 10.1016/0014-5793(85)80201-5; PANG IH, 1990, J BIOL CHEM, V265, P18707; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; ROBISHAW JD, 1989, J BIOL CHEM, V264, P15758; SANO M, 1985, BRAIN RES, V345, P337, DOI 10.1016/0006-8993(85)91012-1; SASAKI I, 1982, J BIOCHEM-TOKYO, V91, P211, DOI 10.1093/oxfordjournals.jbchem.a133678; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; SUGIMOTO K, 1985, FEBS LETT, V191, P235, DOI 10.1016/0014-5793(85)80015-6; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; Weizsacker E. V., 1992, BIOCHEM BIOPH RES CO, V183, P350; YAMANE HK, 1990, P NATL ACAD SCI USA, V87, P5868, DOI 10.1073/pnas.87.15.5868; YATSUNAMI K, 1985, P NATL ACAD SCI USA, V82, P1936, DOI 10.1073/pnas.82.7.1936; YAZAWA M, 1980, J BIOCHEM, V87, P1313, DOI 10.1093/oxfordjournals.jbchem.a132869	48	46	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20512	20519						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376407				2022-12-27	WOS:A1993LY01900085
J	MITRAKI, A; DANNER, M; KING, J; SECKLER, R				MITRAKI, A; DANNER, M; KING, J; SECKLER, R			TEMPERATURE-SENSITIVE MUTATIONS AND 2ND-SITE SUPPRESSOR SUBSTITUTIONS AFFECT FOLDING OF THE P22 TAILSPIKE PROTEIN IN-VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAIL SPIKE ENDORHAMNOSIDASE; GLOBAL SUPPRESSORS; PHAGE-P22; PATHWAY; MUTANTS; CHAINS; SITES	One of the central problems in protein folding is how amino acid sequences within polypeptide chains direct polypeptide chain folding and avoid off-pathway aggregation both in intracellular environments and in the test tube. The tailspike protein of phage P22 is a model system for which genetic analysis has permitted mutational dissection of the role of amino acid positions in the polypeptide chain in directing its in vivo folding. Two classes of mutations that affect intracellular folding and aggregation have been characterized; temperature-sensitive folding (tsf) mutants and second-site suppressors of tsf mutants. Here we report the effects of these mutations on the in vitro refolding and aggregation pathway of the purified proteins. The tsf mutations reduced refolding yields at high temperature and increased aggregation, while second-site suppressors enhanced refolding and inhibited aggregation in the test tube. For both types of mutations, the strength of the effects observed in vitro correlated with their in vivo phenotypes. The results confirm that the mutations act intrinsically on the folding pathway of the tailspike polypeptide and not through accessory proteins.	UNIV REGENSBURG,INST BIOPHYS & PHYS BIOCHEM,UNIV STR 31,D-93053 REGENSBURG,GERMANY; MIT,DEPT BIOL,CAMBRIDGE,MA 02139	University of Regensburg; Massachusetts Institute of Technology (MIT)			MITRAKI, Anna/A-6034-2014	MITRAKI, Anna/0000-0001-5072-1939	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM017980, R37GM017980] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 17980] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BERGET PB, 1980, J VIROL, V34, P234, DOI 10.1128/JVI.34.1.234-243.1980; BRUNSCHIER R, 1993, J BIOL CHEM, V268, P2767; CHEN BL, 1991, BIOCHEMISTRY-US, V30, P6260, DOI 10.1021/bi00239a026; CLELAND JL, 1990, BIOCHEMISTRY-US, V29, P11072, DOI 10.1021/bi00502a009; CREIGHTON TE, 1978, PROG BIOPHYS MOL BIO, V33, P231; FANE B, 1991, J BIOL CHEM, V266, P11640; FUCHS A, 1991, BIOCHEMISTRY-US, V30, P6598, DOI 10.1021/bi00240a032; GEORGOPOULOS C, 1992, TRENDS BIOCHEM SCI, V17, P295, DOI 10.1016/0968-0004(92)90439-G; GOLDENBERG D, 1982, P NATL ACAD SCI-BIOL, V79, P3403, DOI 10.1073/pnas.79.11.3403; GOLDENBERG DP, 1981, J MOL BIOL, V145, P633, DOI 10.1016/0022-2836(81)90307-7; GOLDENBERG DP, 1983, P NATL ACAD SCI-BIOL, V80, P7060, DOI 10.1073/pnas.80.23.7060; GOLDENBERG DP, 1982, J BIOL CHEM, V257, P7864; HAASEPETTINGELL CA, 1988, J BIOL CHEM, V263, P4977; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; ISRAEL JV, 1967, P NATL ACAD SCI USA, V57, P284, DOI 10.1073/pnas.57.2.284; JAENICKE R, 1987, PROG BIOPHYS MOL BIO, V49, P117, DOI 10.1016/0079-6107(87)90011-3; KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331; KING J, 1990, PROTEIN FOLDING : DECIPHERING THE SECOND HALF OF THE GENETIC CODE, P225; King J, 1986, Methods Enzymol, V131, P250; LEE SC, 1991, J BIOL CHEM, V266, P23191; LONDON J, 1974, EUR J BIOCHEM, V47, P409, DOI 10.1111/j.1432-1033.1974.tb03707.x; MITRAKI A, 1991, SCIENCE, V253, P54, DOI 10.1126/science.1648264; MITRAKI A, 1992, FEBS LETT, V307, P20, DOI 10.1016/0014-5793(92)80894-M; MITRAKI A, 1987, EUR J BIOCHEM, V163, P29, DOI 10.1111/j.1432-1033.1987.tb10732.x; MULKERRIN MG, 1989, BIOCHEMISTRY-US, V28, P6556, DOI 10.1021/bi00442a005; SECKLER R, 1989, J BIOL CHEM, V264, P11750; SMITH DH, 1981, J MOL BIOL, V145, P653, DOI 10.1016/0022-2836(81)90308-9; STURTEVANT JM, 1989, J BIOL CHEM, V264, P10693; THOMAS GJ, 1990, BIOCHEMISTRY-US, V29, P4181, DOI 10.1021/bi00469a022; VILLAFANE R, 1988, J MOL BIOL, V204, P607, DOI 10.1016/0022-2836(88)90359-2; YU MH, 1988, J BIOL CHEM, V263, P1424; YU MH, 1984, P NATL ACAD SCI-BIOL, V81, P6584, DOI 10.1073/pnas.81.21.6584	33	70	70	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20071	20075						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376364				2022-12-27	WOS:A1993LY01900025
J	ENGLANDER, EW; WOLFFE, AP; HOWARD, BH				ENGLANDER, EW; WOLFFE, AP; HOWARD, BH			NUCLEOSOME INTERACTIONS WITH A HUMAN ALU ELEMENT - TRANSCRIPTIONAL REPRESSION AND EFFECTS OF TEMPLATE METHYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-III; TUMOR VIRUS PROMOTER; CPG BINDING-PROTEIN; DNA METHYLATION; INHIBITS TRANSCRIPTION; REGULATORY NUCLEOSOME; CHROMATIN STRUCTURE; GENE-EXPRESSION; SEQUENCE; ORGANIZATION	Alu interspersed repetitive elements possess internal RNA polymerase III promoters which are strongly transcribed in vitro, yet these elements are nearly silent in somatic cells. To examine whether repression by chromatin proteins could contribute to the low level of Alu expression, a conserved Alu element from the fourth intron of the human alpha-fetoprotein gene was reconstituted with purified octamer or tetramer particles. Analysis of reconstitutes revealed that this Alu element directed translational and rotational positioning of octamers as well as tetramers. In vitro transcription experiments with reconstituted templates demonstrated that RNA polymerase III-dependent transcription of the Alu element was profoundly repressed by positioned octamer particles. Furthermore, complete CpG methylation of this template enhanced the capacity of tetramers to repress transcription.	NICHHD, MOLEC GROWTH REGULAT LAB, BLDG 6, RM 416, BETHESDA, MD 20892 USA; NICHHD, MOLEC EMBRYOL LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)								ALMOUZNI G, 1991, MOL CELL BIOL, V11, P655, DOI 10.1128/MCB.11.2.655; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; BESSER D, 1990, FEBS LETT, V269, P358, DOI 10.1016/0014-5793(90)81193-R; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; BOYES J, 1992, EMBO J, V11, P327, DOI 10.1002/j.1460-2075.1992.tb05055.x; BRESNICK EH, 1992, NUCLEIC ACIDS RES, V20, P865, DOI 10.1093/nar/20.4.865; BUSCHHAUSEN G, 1987, P NATL ACAD SCI USA, V84, P1177, DOI 10.1073/pnas.84.5.1177; CALLADINE CR, 1984, J MOL BIOL, V178, P773, DOI 10.1016/0022-2836(84)90251-1; CALLADINE CR, 1986, J MOL BIOL, V192, P907, DOI 10.1016/0022-2836(86)90036-7; CAMERINIOTERO RD, 1976, CELL, V8, P333, DOI 10.1016/0092-8674(76)90145-8; CAREY MF, 1988, P NATL ACAD SCI USA, V85, P7059, DOI 10.1073/pnas.85.19.7059; CHIPEV CC, 1992, MOL CELL BIOL, V12, P45, DOI 10.1128/MCB.12.1.45; CLARK DJ, 1991, EMBO J, V10, P3419, DOI 10.1002/j.1460-2075.1991.tb04906.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOERFLER W, 1990, FEBS LETT, V268, P329, DOI 10.1016/0014-5793(90)81280-2; DONG F, 1991, P NATL ACAD SCI USA, V88, P10596, DOI 10.1073/pnas.88.23.10596; DREW HR, 1987, J MOL BIOL, V197, P485, DOI 10.1016/0022-2836(87)90560-2; DUNCAN C, 1979, P NATL ACAD SCI USA, V76, P5095, DOI 10.1073/pnas.76.10.5095; DURRIN LK, 1992, MOL CELL BIOL, V12, P1621, DOI 10.1128/MCB.12.4.1621; FELSENFELD G, 1982, COLD SPRING HARB SYM, V47, P577; FITZGERALD PC, 1985, J BIOL CHEM, V260, P5318; FOX KR, 1986, BIOCHEM J, V234, P213, DOI 10.1042/bj2340213; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P3087, DOI 10.1093/nar/11.10.3087; GEIDUSCHEK EP, 1988, ANNU REV BIOCHEM, V57, P873, DOI 10.1146/annurev.bi.57.070188.004301; GIBBS PEM, 1987, BIOCHEMISTRY-US, V26, P1332, DOI 10.1021/bi00379a020; HANSEN JC, 1992, TRENDS BIOCHEM SCI, V17, P187, DOI 10.1016/0968-0004(92)90264-A; HAYES JJ, 1991, P NATL ACAD SCI USA, V88, P6829, DOI 10.1073/pnas.88.15.6829; HAYES JJ, 1992, P NATL ACAD SCI USA, V89, P1229, DOI 10.1073/pnas.89.4.1229; HWU HR, 1986, P NATL ACAD SCI USA, V83, P3875, DOI 10.1073/pnas.83.11.3875; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; JUTTERMANN R, 1991, J VIROL, V65, P1735; KARIYA Y, 1987, GENE, V53, P1, DOI 10.1016/0378-1119(87)90087-4; KOCHANEK S, 1993, EMBO J, V12, P1141, DOI 10.1002/j.1460-2075.1993.tb05755.x; KOVESDI I, 1987, P NATL ACAD SCI USA, V84, P2180, DOI 10.1073/pnas.84.8.2180; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; LIU WM, 1993, NUCLEIC ACIDS RES, V21, P1351, DOI 10.1093/nar/21.6.1351; MACLEOD D, 1983, NATURE, V306, P200, DOI 10.1038/306200a0; MATERA AG, 1990, MOL CELL BIOL, V10, P5424, DOI 10.1128/MCB.10.10.5424; MEERSSEMAN G, 1992, EMBO J, V11, P2951, DOI 10.1002/j.1460-2075.1992.tb05365.x; MORSE RH, 1989, EMBO J, V8, P2343, DOI 10.1002/j.1460-2075.1989.tb08362.x; PAULSON KE, 1986, NUCLEIC ACIDS RES, V14, P6145, DOI 10.1093/nar/14.15.6145; PEREZSTABLE C, 1984, P NATL ACAD SCI-BIOL, V81, P5291, DOI 10.1073/pnas.81.17.5291; PEREZSTABLE C, 1986, MOL CELL BIOL, V6, P2041, DOI 10.1128/MCB.6.6.2041; PINA B, 1990, J MOL BIOL, V216, P975, DOI 10.1016/S0022-2836(99)80015-1; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; PINA B, 1990, NUCLEIC ACIDS RES, V18, P6981, DOI 10.1093/nar/18.23.6981; PRUNELL A, 1982, EMBO J, V1, P173, DOI 10.1002/j.1460-2075.1982.tb01143.x; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; RENBAUM P, 1990, NUCLEIC ACIDS RES, V18, P1145, DOI 10.1093/nar/18.5.1145; ROTH SY, 1992, GENE DEV, V6, P411, DOI 10.1101/gad.6.3.411; SAKAMOTO K, 1991, J BIOL CHEM, V266, P3031; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Schmid C, 1992, CURR OPIN GENET DEV, V2, P874, DOI 10.1016/S0959-437X(05)80110-8; SCHMID CW, 1991, NUCLEIC ACIDS RES, V19, P5613, DOI 10.1093/nar/19.20.5613; SHRADER TE, 1989, P NATL ACAD SCI USA, V86, P7418, DOI 10.1073/pnas.86.19.7418; SHRADER TE, 1990, J MOL BIOL, V216, P69, DOI 10.1016/S0022-2836(05)80061-0; SIMON RH, 1979, NUCLEIC ACIDS RES, V6, P689, DOI 10.1093/nar/6.2.689; SIMPSON RT, 1991, PROG NUCLEIC ACID RE, V40, P143; TREMETHICK D, 1990, J BIOL CHEM, V265, P5014; ULLU E, 1984, EMBO J, V3, P3303, DOI 10.1002/j.1460-2075.1984.tb02294.x; VANHOLDE KE, 1992, J BIOL CHEM, V267, P2837; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; WOLFFE AP, 1991, J CELL SCI, V99, P201; WOLFFE AP, 1988, SCIENCE, V241, P1626, DOI 10.1126/science.3420414; WOLFFE AP, 1987, CELL, V51, P732, DOI 10.1016/0092-8674(87)90096-1	66	94	95	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19565	19573						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366099				2022-12-27	WOS:A1993LW81900065
J	TOZAWA, K; MIYAUCHI, M; YOSHIDA, M				TOZAWA, K; MIYAUCHI, M; YOSHIDA, M			STRUCTURE OF THE ALPHA-SUBUNIT OF F(1)-ATPASE PROBED BY LIMITED PROTEOLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE BINDING-SITES; ADENOSINE-TRIPHOSPHATE SYNTHASE; HEART MITOCHONDRIAL F1-ATPASE; THERMOPHILIC BACTERIUM PS3; COLI F1 ATPASE; ESCHERICHIA-COLI; BETA-SUBUNIT; CATALYTIC SITE; GLUTAMIC-ACID; H+-ATPASE	The structure of the isolated alpha subunit of F1-ATPase from the thermophilic Bacillus strain PS3 was probed using limited proteolysis by four different proteases, and the following results were obtained. 1) Distribution of 21 protease-cleaved sites is similar to that of the beta subunit of F1-ATPase (Tozawa, K., Odaka, M., Date, T., and Yoshida, M. (1992) J. Biol. Chem. 267, 16484-16490), thus providing experimental evidence for similar folding topology of the two subunits, and the locations of 11 water-exposed loop regions in the tertiary structure are predicted. 2) Most proteolytic peptides remain associated to maintain the gross structure of the alpha subunit and can reassociate each other after denaturing urea treatment. 3) However, the carboxyl-terminal peptides comprising approximately 80 residues (C1 peptides) are released from other peptide(s) during proteolysis, and those comprising approximately 105 residues (C2 peptides) are released during native polyacrylamide gel electrophoresis after proteolysis. 4) Inclusion of Mg-ATP in the native electrophoretic system prevents the release of the C2 peptide. Addition of Mg-ATP to the proteolysis mixtures results in an increase of the C2 peptide population and a decrease of the C1 peptide population. Thus, Mg-ATP induces a conformational change at the regions of C1 and C2 peptides of the a subunit. 5) Except for the trypsin-treated one, protease-treated alpha subunits are reconstitutable with the native beta subunit into the form of alpha3beta3 complexes, which show significantly higher ATPase activities than the intact alpha3beta3 complex. This activation is attributable to the cleavage of a peptide bond that produces C2 peptides. The carboxyl-terminal region of the alpha subunit is likely to be involved in the regulation of ATPase activity in F1-ATPase.	TOKYO INST TECHNOL, RESOURCES UTILIZAT RES LAB, R-1, NAGATSUTA 4259, YOKOHAMA, KANAGAWA 227, JAPAN	Tokyo Institute of Technology								ADMON A, 1987, BIOCHEMISTRY-US, V26, P3193, DOI 10.1021/bi00385a038; ALSHAWI MK, 1990, J BIOL CHEM, V265, P5595; ANDRALOJC PJ, 1992, FEBS LETT, V310, P187, DOI 10.1016/0014-5793(92)81326-H; BENNER SA, 1991, ADV ENZYME REGUL, V31, P121, DOI 10.1016/0065-2571(91)90012-B; BENNER SA, 1992, NATURE, V359, P781, DOI 10.1038/359781a0; BIANCHET M, 1991, J BIOL CHEM, V266, P21197; BOYER PD, 1987, BIOCHEMISTRY-US, V26, P8503, DOI 10.1021/bi00400a001; BULLOUGH DA, 1986, J BIOL CHEM, V261, P14171; BULLOUGH DA, 1989, J BIOL CHEM, V264, P9155; CROSS RL, 1987, P NATL ACAD SCI USA, V84, P5715, DOI 10.1073/pnas.84.16.5715; DALLMANN HG, 1992, J BIOL CHEM, V267, P18953; DUNN SD, 1980, J BIOL CHEM, V255, P6891; FUTAI M, 1989, ANNU REV BIOCHEM, V58, P111; GARIN J, 1986, BIOCHEMISTRY-US, V25, P4431, DOI 10.1021/bi00363a039; GAVILANESRUIZ M, 1988, BIOCHEMISTRY-US, V27, P603, DOI 10.1021/bi00402a016; GOGARTEN JP, 1989, P NATL ACAD SCI USA, V86, P6661, DOI 10.1073/pnas.86.17.6661; HARADA M, 1991, BIOCHIM BIOPHYS ACTA, V1056, P279, DOI 10.1016/S0005-2728(05)80059-3; HIGASHIFUJIME S, 1992, J BIOCHEM-TOKYO, V112, P568, DOI 10.1093/oxfordjournals.jbchem.a123940; HISABORI T, 1986, J BIOCHEM-TOKYO, V100, P663, DOI 10.1093/oxfordjournals.jbchem.a121758; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MENDELHARTVIG J, 1991, BIOCHEMISTRY-US, V30, P1278, DOI 10.1021/bi00219a017; MIKI J, 1992, ARCH BIOCHEM BIOPHYS, V294, P373, DOI 10.1016/0003-9861(92)90698-V; MIKI JJ, 1990, J BIOL CHEM, V265, P21567; MIWA K, 1989, P NATL ACAD SCI USA, V86, P6484, DOI 10.1073/pnas.86.17.6484; OHTA S, 1988, BIOCHIM BIOPHYS ACTA, V933, P141, DOI 10.1016/0005-2728(88)90064-3; OHTA S, 1980, J BIOCHEM-TOKYO, V87, P1609, DOI 10.1093/oxfordjournals.jbchem.a132904; OHTSUBO M, 1987, BIOCHEM BIOPH RES CO, V146, P705, DOI 10.1016/0006-291X(87)90586-9; PENEFSKY HS, 1991, ADV ENZYMOL RAMB, V64, P173; RAO R, 1988, J BIOL CHEM, V263, P5640; SENDA M, 1983, ARCH BIOCHEM BIOPHYS, V220, P398, DOI 10.1016/0003-9861(83)90429-0; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; SHIRAKIHARA Y, 1991, J BIOCHEM-TOKYO, V109, P466, DOI 10.1093/oxfordjournals.jbchem.a123405; TOZAWA K, 1992, J BIOL CHEM, V267, P16484; TSUTSUMI S, 1991, BIOCHIM BIOPHYS ACTA, V1098, P13, DOI 10.1016/0005-2728(91)90003-7; WALKER JE, 1990, PHILOS T ROY SOC B, V326, P367, DOI 10.1098/rstb.1990.0018; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WALKER JE, 1985, J MOL BIOL, V184, P677, DOI 10.1016/0022-2836(85)90313-4; WISE JG, 1987, FEBS LETT, V223, P395, DOI 10.1016/0014-5793(87)80326-5; XUE ZX, 1987, FEBS LETT, V223, P391, DOI 10.1016/0014-5793(87)80325-3; YOHDA M, 1988, BIOCHIM BIOPHYS ACTA, V933, P156, DOI 10.1016/0005-2728(88)90065-5; YOSHIDA M, 1979, J BIOL CHEM, V254, P9525; YOSHIDA M, 1981, J BIOL CHEM, V256, P148; YOSHIDA M, 1977, J BIOL CHEM, V252, P3480; ZHUO SQ, 1992, J BIOL CHEM, V267, P12916	44	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					19044	19054						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360191				2022-12-27	WOS:A1993LV65900100
J	MARUO, K; AKAIKE, T; INADA, Y; OHKUBO, I; ONO, T; MAEDA, H				MARUO, K; AKAIKE, T; INADA, Y; OHKUBO, I; ONO, T; MAEDA, H			EFFECT OF MICROBIAL AND MITE PROTEASES ON LOW AND HIGH-MOLECULAR-WEIGHT KININOGENS - GENERATION OF KININ AND INACTIVATION OF THIOL PROTEASE INHIBITORY ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR-PERMEABILITY REACTION; HOUSE DUST MITE; HAGEMAN-FACTOR; HUMAN-PLASMA; NASAL SECRETIONS; SERRATIA-MARCESCENS; ASTHMATIC SUBJECTS; TISSUE KALLIKREIN; RHINOVIRUS COLDS; SERINE PROTEASE	Kinin release from guinea pig plasma high molecular weight kininogen (HMWK) induced by various microbial and mite proteases has been demonstrated previously (Molla, A., Yamamoto, T., Akaike, T., Miyoshi, S., and Maeda, H. (1989) J. Biol. Chem. 264, 10589-10594; Maruo, K., Akaike, T., Matsumura, Y., Kohmoto, S., Inada, Y., Ono, T., Arao, T., and Maeda, H. (1991) Biochim. Biophys. Acta 1074, 62-68). In this paper, we describe the effects of various microbial and mite proteases on low molecular weight kininogen (LMWK) and HMWK from human plasma. A protease from the house dust mite Dermatophagoides farinae (Df-protease) directly liberated kinin from both LMWK and HMWK to a significant degree. The K(m), k(cat), and k(cat)/K(m) values for kinin generation from LMWK were 3.24 muM, 0.61 s-1, and 1.9 x 10(5) M-1.s-1, respectively, and those for kinin generation from HMWK were 0.56 muM, 0.12 s-1, and 2.1 x 10(5) M-1.s-1, respectively; k(cat)/K(m) values for Df-protease were comparable with that for glandular kallikrein. In contrast, microbial proteases showed only weak kinin-releasing activity from both human plasma kininogens. Four of ten different microbial proteases liberated kinin from LMWK, and only serratial 56-kDa protease released kinin from HMWK. Furthermore, Df-protease markedly inactivated the thiol protease inhibitory activity of LMWK and HMWK, whereas all microbial proteases (as well as the endogenous protease trypsin) did not affect this inhibitory activity of both kininogens from human plasma.	KUMAMOTO UNIV, SCH MED, DEPT MICROBIOL, KUMAMOTO 860, JAPAN; KUMAMOTO UNIV, SCH MED, DEPT DERMATOL, KUMAMOTO 860, JAPAN; TOIN YOKOHAMA UNIV, DEPT MAT SCI, YOKOHAMA 227, JAPAN; SHIGA UNIV MED SCI, DEPT MED BIOCHEM, OTSU, SHIGA 52021, JAPAN	Kumamoto University; Kumamoto University; Shiga University of Medical Science			Maeda, Hiroshi/N-4471-2016					BARNETT JKC, 1990, AM REV RESPIR DIS, V142, P162, DOI 10.1164/ajrccm/142.1.162; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; CHRISTIANSEN SC, 1987, J CLIN INVEST, V79, P188, DOI 10.1172/JCI112782; COLMAN RW, 1974, NEW ENGL J MED, V291, P509, DOI 10.1056/NEJM197409052911008; GAIROLA CG, 1989, J LAB CLIN MED, V114, P419; HAN YN, 1978, J BIOCHEM, V83, P223, DOI 10.1093/oxfordjournals.jbchem.a131895; HOLDER IA, 1992, AGENT ACTION SUPPL, V38, P329; HOLDER IA, 1989, INFECT IMMUN, V57, P3345, DOI 10.1128/IAI.57.11.3345-3348.1989; ISHIGURO H, 1987, BIOCHEMISTRY-US, V26, P7021, DOI 10.1021/bi00396a025; JAMESON GW, 1973, BIOCHEM J, V131, P107, DOI 10.1042/bj1310107; KAMATA R, 1985, INFECT IMMUN, V48, P747, DOI 10.1128/IAI.48.3.747-753.1985; KATO H, 1981, METHOD ENZYMOL, V80, P172; KITAMURA N, 1985, J BIOL CHEM, V260, P8610; KOHMOTO S, 1991, J CLIN BIOCHEM NUTR, V10, P15; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAEDA H, 1989, CLIN CHIM ACTA, V185, P357, DOI 10.1016/0009-8981(89)90226-X; MAEDA H, 1988, J BIOL CHEM, V263, P16051; MAEDA H, 1992, AGENT ACTION SUPPL, V38, P362; MARUO K, 1991, BIOCHIM BIOPHYS ACTA, V1074, P62, DOI 10.1016/0304-4165(91)90040-N; MATSUMOTO K, 1984, J BACTERIOL, V157, P225, DOI 10.1128/JB.157.1.225-232.1984; MATSUMOTO K, 1984, J BIOCH, V96, P736; MATSUMURA Y, 1990, AGENTS ACTIONS, V29, P172, DOI 10.1007/BF01966443; MIYAMOTO T, 1968, J ALLERGY, V42, P14, DOI 10.1016/0021-8707(68)90128-7; MOLLA A, 1988, INFECT IMMUN, V56, P916, DOI 10.1128/IAI.56.4.916-920.1988; MOLLA A, 1989, J BIOL CHEM, V264, P10589; MULLERESTERL W, 1985, FEBS LETT, V182, P310, DOI 10.1016/0014-5793(85)80322-7; MULLERESTERL W, 1985, EUR J BIOCHEM, V149, P15, DOI 10.1111/j.1432-1033.1985.tb08886.x; NACLERIO RM, 1988, J INFECT DIS, V157, P133, DOI 10.1093/infdis/157.1.133; ODA T, 1986, J IMMUNOL METHODS, V88, P175; OHKUBO I, 1984, BIOCHEMISTRY-US, V23, P5691, DOI 10.1021/bi00319a005; POLOSA R, 1990, AM REV RESPIR DIS, V142, P1367, DOI 10.1164/ajrccm/142.6_Pt_1.1367; PROUD D, 1990, J INFECT DIS, V161, P120, DOI 10.1093/infdis/161.1.120; PROUD D, 1983, J CLIN INVEST, V72, P1678, DOI 10.1172/JCI111127; PROUD D, 1987, J IMMUNOL, V138, P428; SALVESEN G, 1986, BIOCHEM J, V234, P429, DOI 10.1042/bj2340429; SCHMAIER AH, 1986, J CLIN INVEST, V77, P1565, DOI 10.1172/JCI112472; SEMBA U, 1992, BIOCHIM BIOPHYS ACTA, V1159, P113, DOI 10.1016/0167-4838(92)90014-5; STEWART GA, 1989, LANCET, V2, P154, DOI 10.1016/S0140-6736(89)90203-1; TAKAGAKI Y, 1985, J BIOL CHEM, V260, P8601; TAKAHASHI K, 1990, INT ARCH ALLER A IMM, V91, P80, DOI 10.1159/000235094; VOOHORST R, 1967, J ALLERGY, V39, P35; YAMAMOTO T, 1987, BIOCHIM BIOPHYS ACTA, V914, P259, DOI 10.1016/0167-4838(87)90285-8; YAMAMOTO T, 1990, BIOCHIM BIOPHYS ACTA, V1038, P231, DOI 10.1016/0167-4838(90)90210-7	43	48	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17711	17715						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349656				2022-12-27	WOS:A1993LT74300014
J	CHANG, WI; OLSON, JS; MATTHEWS, KS				CHANG, WI; OLSON, JS; MATTHEWS, KS			LYSINE-84 IS AT THE SUBUNIT INTERFACE OF LAC REPRESSOR PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABINOSE-BINDING PROTEIN; AMINO-TERMINAL FRAGMENT; TRYPSIN-RESISTANT CORE; LACTOSE REPRESSOR; ESCHERICHIA-COLI; DNA-BINDING; PERIPLASMIC PROTEINS; OPERATOR INTERACTION; ACID REPLACEMENTS; INDUCER BINDING	Mutations have been generated at the Lys84 site of the lac repressor to explore its predicted role in inducer binding and/or subunit interaction. Four single mutations, Lys84 --> Ala, Lys84 --> Leu, Lys84 --> Arg, and Lys84 --> Glu, have been generated by site-specific mutagenesis. In addition, the mutation Tyr282 --> Asp, which results in a monomeric repressor, has been coupled with these four single mutants to generate the four corresponding double mutants. Unchanged inducer binding affinities in all Lys84 mutants except Lys84 --> Arg suggest that Lys84 does not contribute energy to inducer binding and is not found in the inducer-binding site as previously proposed (Sams, C. F., Vyas, N. K., Quiocho, F. A., and Matthews, K. S. (1984) Nature 310, 429-430). Interestingly, the double mutants with hydrophobic side chains at the Lys84 site are tetramers, while those with charged side chains remain monomers. This result agrees with the recent model of the lac repressor (Nichols, J. C., Vyas, N. K., Quiocho, F. A., and Matthews, K. S. (1993) J. BioL Chem. 268, 17602-17612), in which Lys84 is mapped by sequence alignment to the same face of the subunit as Tyr282. More detailed inducer binding, operator binding, and immunoblotting studies show that all the mutations at Lys84 have quaternary structures that deviate from wild-type protein, providing supportive evidence for the model placing this residue on the surface of the monomer subunit. Substitution of Lys84 by Ala or Leu results in 100-200-fold decreased association and dissociation rate constants for inducer binding and biphasic character. This decrease can be rescued at least partially in the respective double mutants at elevated pH, at which wild-type repressor shows a 10-fold decrease in affinity and cooperativity in inducer binding. In all substitutions with Ala or Leu, immunoblotting patterns with monoclonal antibody, an assay sensitive to alterations in quaternary structure, are distinct from wild-type repressor. Although substitution with Arg at position 84 yields a protein with 10-fold lower inducer binding affinity, the mutant shows decreased pH dependence of inducer binding. Substitution at this site with Glu results in cooperativity at neutral pH with no change in inducer binding at elevated pH. In addition, operator binding affinity of this mutant is affected by elevated pH, a phenomenon not observed in wild-type repressor. These changes in inducer and operator binding properties appear to be related to the altered quaternary structure of these mutants at Lys84.	RICE UNIV,DEPT BIOCHEM & CELL BIOL,HOUSTON,TX 77251; RICE UNIV,WM KECK CTR COMP BIOL,HOUSTON,TX 77251	Rice University; Rice University				Olson, John/0000-0002-0760-5403	NHLBI NIH HHS [HL 47020] Funding Source: Medline; NIGMS NIH HHS [GM 35649, GM 22441] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022441, R01GM035649] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BETZ JL, 1986, GENE, V42, P283, DOI 10.1016/0378-1119(86)90232-5; BOELENS R, 1987, J MOL BIOL, V193, P213, DOI 10.1016/0022-2836(87)90638-3; BOURGEOIS S, 1971, METHODS ENZYMOLOGY D, V21, P491; CHAKERIAN AE, 1987, BIOCHEMISTRY-US, V26, P7250, DOI 10.1021/bi00397a009; CHAKERIAN AE, 1992, MOL MICROBIOL, V6, P963, DOI 10.1111/j.1365-2958.1992.tb02162.x; CHAKERIAN AE, 1991, J BIOL CHEM, V266, P22206; CHEN J, 1992, J BIOL CHEM, V267, P13843; CHEN J, 1991, GENE, V111, P145; CHOU PY, 1975, J MOL BIOL, V96, P29, DOI 10.1016/0022-2836(75)90180-1; CHOU WY, 1989, J BIOL CHEM, V264, P6171; DALY TJ, 1986, BIOCHEMISTRY-US, V25, P5479, DOI 10.1021/bi00367a020; DALY TJ, 1986, BIOCHEMISTRY-US, V25, P5468, DOI 10.1021/bi00367a018; DALY TJ, 1986, BIOCHEMISTRY-US, V25, P5474, DOI 10.1021/bi00367a019; DENTE L, 1983, NUCLEIC ACIDS RES, V11, P1645, DOI 10.1093/nar/11.6.1645; DEUSCHLE U, 1986, P NATL ACAD SCI USA, V83, P4134, DOI 10.1073/pnas.83.12.4134; DUNAWAY M, 1980, J BIOL CHEM, V255, P115; FILES JG, 1976, J BIOL CHEM, V251, P3386; FRIEDMAN BE, 1977, J MOL BIOL, V111, P27; GEISLER N, 1977, BIOCHEMISTRY-US, V16, P938, DOI 10.1021/bi00624a020; GEISLER N, 1976, P NATL ACAD SCI USA, V73, P3101; GILLILAND GL, 1981, J MOL BIOL, V146, P341, DOI 10.1016/0022-2836(81)90392-2; GORDON AJE, 1988, J MOL BIOL, V200, P239, DOI 10.1016/0022-2836(88)90237-9; HAMADA F, 1973, J BIOCHEM, V73, P1299, DOI 10.1093/oxfordjournals.jbchem.a130204; HOROWITZ H, 1982, NUCLEIC ACIDS RES, V10, P5447, DOI 10.1093/nar/10.18.5447; HUSTON JS, 1974, BIOCHEM BIOPH RES CO, V61, P391; JOVIN TM, 1977, NATURE, V269, P668, DOI 10.1038/269668a0; KANIA J, 1977, EUR J BIOCHEM, V79, P381, DOI 10.1111/j.1432-1033.1977.tb11819.x; KAPTEIN R, 1990, BIOCHEM PHARMACOL, V40, P89, DOI 10.1016/0006-2952(90)90183-L; KLEINA LG, 1990, J MOL BIOL, V212, P295, DOI 10.1016/0022-2836(90)90126-7; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MATTHEWS KS, 1987, DNA PROTEIN INTERACT, P13; MILLER DM, 1983, J BIOL CHEM, V258, P3665; Miller J. H., 1980, OPERON; MILLER JH, 1979, J MOL BIOL, V131, P223, DOI 10.1016/0022-2836(79)90074-3; MILLER JH, 1984, J MOL BIOL, V180, P205, DOI 10.1016/0022-2836(84)90438-8; MILLER JH, 1979, J MOL BIOL, V131, P249, DOI 10.1016/0022-2836(79)90075-5; MILLER JH, 1979, J MOL BIOL, V131, P191, DOI 10.1016/0022-2836(79)90073-1; MOWBRAY SL, 1992, J MOL BIOL, V225, P155, DOI 10.1016/0022-2836(92)91033-L; MULLERHILL B, 1971, ANGEW CHEM INT EDIT, V10, P160, DOI 10.1002/anie.197101601; MULLERHILL B, 1983, NATURE, V302, P163, DOI 10.1038/302163a0; NICHOLS JC, 1993, J BIOL CHEM, V268, P17602; NICK H, 1982, P NATL ACAD SCI-BIOL, V79, P218, DOI 10.1073/pnas.79.2.218; OGATA RT, 1978, P NATL ACAD SCI USA, V75, P5851, DOI 10.1073/pnas.75.12.5851; OGORMAN RB, 1980, J BIOL CHEM, V255, P107; OGORMAN RB, 1980, J BIOL CHEM, V255, P100; OHSHIMA Y, 1972, BIOCHEM BIOPH RES CO, V47, P1444, DOI 10.1016/0006-291X(72)90234-3; PFAHL M, 1974, GENETICS, V76, P669; PLATT T, 1973, J BIOL CHEM, V248, P110; QUIOCHO FA, 1984, NATURE, V310, P381, DOI 10.1038/310381a0; RIGGS AD, 1968, J MOL BIOL, V34, P365, DOI 10.1016/0022-2836(68)90261-1; ROSENBERG JM, 1977, NUCLEIC ACIDS RES, V4, P567, DOI 10.1093/nar/4.3.567; SAMS CF, 1988, BIOCHEMISTRY-US, V27, P2277, DOI 10.1021/bi00407a005; SAMS CF, 1985, J BIOL CHEM, V260, P1185; SAMS CF, 1984, NATURE, V310, P429, DOI 10.1038/310429a0; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SCHMEISSNER U, 1977, J MOL BIOL, V109, P303, DOI 10.1016/S0022-2836(77)80036-3; SCHMITZ A, 1976, J BIOL CHEM, V251, P3359; SCHMITZ A, 1979, NUCLEIC ACIDS RES, V6, P111, DOI 10.1093/nar/6.1.111; STRANEY SB, 1987, CELL, V51, P699, DOI 10.1016/0092-8674(87)90093-6; VYAS NK, 1991, J BIOL CHEM, V266, P5226; VYAS NK, 1988, SCIENCE, V242, P1290, DOI 10.1126/science.3057628; WU FYH, 1976, J MOL BIOL, V100, P459, DOI 10.1016/S0022-2836(76)80040-X	62	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17613	17622						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349640				2022-12-27	WOS:A1993LQ98800104
J	DING, JB; BADWEY, JA				DING, JB; BADWEY, JA			NEUTROPHILS STIMULATED WITH A CHEMOTACTIC PEPTIDE OR A PHORBOL ESTER EXHIBIT DIFFERENT ALTERATIONS IN THE ACTIVITIES OF A BATTERY OF PROTEIN-KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM DODECYL-SULFATE; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; OKADAIC ACID; SYNERGISTIC STIMULATION; SUPEROXIDE RELEASE; RABBIT NEUTROPHILS; POLYACRYLAMIDE-GEL; RESPIRATORY BURST; SENSITIVE METHOD; PHOSPHORYLATION	Protein kinases in neutrophils that undergo changes in activity during cell stimulation have been investigated by two recently described procedures. These methods are based on the ability of renatured kinases to undergo autophosphorylation or to phosphorylate protein substrates fixed in gels. Using these techniques, we report that neutrophils contain a battery of protein kinases with molecular masses of 65-61 kDa (termed ''group A kinases'') that are rapidly activated upon stimulation of the cells with the chemotactic peptide N-fMet-Leu-Phe (fMLP). Activity was maximal within 30 s with this stimulus and returned to the basal level seen in unstimulated cells within 3 min. In contrast, stimulation of neutrophils with 4beta-phorbol 12-myristate 13-acetate resulted in a diminution of these kinase activities. Treatment of neutrophils with antagonists of type 1 and 2A protein phosphatases (calyculin A, okadaic acid) inhibited the activation of the group A kinases by fMLP, whereas norokadanone, an analog of okadaic acid that is a poor inhibitor of protein phosphatases, had no effect. Exposure of neutrophils to calyculin A alone resulted in the activation of several additional protein kinases with molecular masses different from the group A kinases. These data indicate that the signal transduction pathways of neutrophils are likely to be far more complicated than previously appreciated and involve a number of uncharacterized protein kinases.	BOSTON BIOMED RES INST,DEPT CELL & MOLEC BIOL,20 STANIFORD ST,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115	Boston Biomedical Research Institute; Harvard University; Harvard Medical School					NIAID NIH HHS [AI28342, AI23323] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028342, R01AI023323] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Badwey J A, 1986, Methods Enzymol, V132, P365; BADWEY JA, 1989, BIOCHEM BIOPH RES CO, V158, P1029, DOI 10.1016/0006-291X(89)92825-8; BADWEY JA, 1988, J BIOL CHEM, V263, P2779; BADWEY JA, 1989, J BIOL CHEM, V264, P20676; BEEMON K, 1978, J VIROL, V28, P551, DOI 10.1128/JVI.28.2.551-566.1978; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; CHATILA TA, 1989, J CELL BIOL, V109, P3435, DOI 10.1083/jcb.109.6.3435; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COUTURIER A, 1984, BIOCHEM BIOPH RES CO, V121, P448, DOI 10.1016/0006-291X(84)90203-1; COX CC, 1986, J IMMUNOL, V136, P4611; DING JB, 1992, J BIOL CHEM, V267, P6442; DOWNEY GP, 1992, J CELL BIOL, V116, P695, DOI 10.1083/jcb.116.3.695; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; ERIKSON RL, 1991, J BIOL CHEM, V266, P6007; FERRELL JE, 1989, J BIOL CHEM, V264, P20723; GAUTIER J, 1989, NATURE, V339, P626, DOI 10.1038/339626a0; GEAHLEN RL, 1986, ANAL BIOCHEM, V153, P151, DOI 10.1016/0003-2697(86)90074-6; GOMEZCAMBRONERO J, 1992, P NATL ACAD SCI USA, V89, P7551, DOI 10.1073/pnas.89.16.7551; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; HAYSTEAD TAJ, 1990, J BIOL CHEM, V265, P16571; HEYWORTH PG, 1989, J BIOL CHEM, V264, P14935; HEYWORTH PG, 1990, J BIOENERG BIOMEMBR, V22, P1, DOI 10.1007/BF00762842; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HUANG CK, 1988, J BIOL CHEM, V263, P13144; ISHIHARA H, 1989, J PHARMACOL EXP THER, V250, P388; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; KAIBUCHI K, 1983, J BIOL CHEM, V258, P6701; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; LACKS SA, 1980, J BIOL CHEM, V255, P7467; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI P, 1991, CELL, V64, P479, DOI 10.1016/0092-8674(91)90228-Q; MAJUMDAR S, 1991, J BIOL CHEM, V266, P9285; MELLONI E, 1986, J BIOL CHEM, V261, P4101; NISHIWAKI S, 1990, CARCINOGENESIS, V11, P1837, DOI 10.1093/carcin/11.10.1837; OKAMURA N, 1988, J BIOL CHEM, V263, P6777; SHAAFI RI, 1988, PROG ALLERGY, V42, P1; SIESS W, 1988, BIOCHEM J, V255, P309; SMOLEN JE, 1980, J CLIN INVEST, V65, P1077, DOI 10.1172/JCI109760; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; TUSZYNSKI GP, 1987, PLATELET RESPONSES M, V2, P187; TYAGI SR, 1991, J BIOL CHEM, V266, P3498; WHITE JR, 1984, J BIOL CHEM, V259, P8605; WHITE JR, 1983, J BIOL CHEM, V258, P4041	45	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1993	268	7					5234	5240						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP884	8383131				2022-12-27	WOS:A1993KP88400096
J	TANG, CL; HENRY, HL				TANG, CL; HENRY, HL			OVEREXPRESSION IN ESCHERICHIA-COLI AND AFFINITY PURIFICATION OF CHICK KIDNEY FERREDOXIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; AMINO-ACID SEQUENCE; RECOMBINANT PROTEINS; MITOCHONDRIAL FERREDOXIN; LIVER-MITOCHONDRIA; BOVINE ADRENODOXIN; CHROMATOGRAPHY; CYTOCHROME-P-450; PHOSPHORYLATION; HYDROXYLATION	Vertebrate ferredoxins are 12-14-kDa iron-sulfur proteins, some of which transfer electrons to mitochondrial cytochrome P450s. The function of many of these cytochrome P450s is to catalyze stereospecific hydroxylation of endogenous steroids. As part of our interest in the kidney mitochondrial 1alpha-hydroxylation of 25-hydroxyvitamin D3, we have constructed an expression plasmid coding for a fusion protein containing the chick kidney ferredoxin. We subcloned chick kidney ferredoxin cDNA, obtained from our vitamin D-deficient chick kidney library by polymerase chain reaction (Brandt, M. E., Gabrik, A. H., and Vickery, L. E. (1991) Gene (Amst.) 97, 113-117) into Qiagen's pQE9, which contains an N-terminal 6xHis tag (peptide sequence for 6 adjacent histidines present in the recombinant proteins). The coding sequence was preceded by a factor Xa cleavage site. The resulting plasmid, pQTcFdx, was overexpressed in Escherichia coli, and the soluble fusion protein was purified from the cell lysate in one step by Ni(II)-nitrilotriacetic acid-agarose chromatography. We obtained 7-10 mg of greater than 99% homogeneous fusion protein from a 1-liter culture and 4-6 mg of mature ferredoxin cleaved by factor Xa. The fusion protein possessed an absorption spectrum and an electron paramagnetic resonance spectrum quantitatively indistinguishable from those published for ferredoxin purified from adrenal glands and placenta or expressed in E. coli with another vector. The fusion protein was active in supporting the 1alpha-hydroxylation of 25-hydroxyvitamin D3 in a reconstitution assay of a solubilized, partially purified preparation of cytochrome P450 from vitamin D-deficient chick kidney. We conclude that the procedure described here is an efficient way to produce and purify vertebrate ferredoxin; the [2Fe-2S] cofactor is assembled in vivo and effectively incorporated into the fusion protein in E. coli; slight alterations at the N terminus do not alter incorporation of the [2Fe-2S] cofactor or the biological activity of ferredoxin, and post-translational modifications, such as phosphorylation, are not an absolute requirement for ferredoxin electron transporting activity. The recombinant ferredoxin can be used for physical studies and other structure-function studies.	UNIV CALIF RIVERSIDE,DEPT BIOCHEM,RIVERSIDE,CA 92521	University of California System; University of California Riverside								ATSUTA Y, 1978, J BIOL CHEM, V253, P4653; Beinert H., 1965, NONHEME IRON PROTEIN, P23; BLANCHARD RK, 1991, VITAMIN D, P269; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRNADT ME, 1991, GENE AMST, V97, P113; BUSH GL, 1991, J BIOL CHEM, V266, P13811; COGHLAN VM, 1989, P NATL ACAD SCI USA, V86, P835, DOI 10.1073/pnas.86.3.835; COGHLAN VM, 1988, ARCH BIOCHEM BIOPHYS, V264, P376, DOI 10.1016/0003-9861(88)90302-5; COGHLAN VM, 1992, J BIOL CHEM, V267, P8932; CUNNINGHAM NS, 1986, BIOCHIM BIOPHYS ACTA, V881, P480, DOI 10.1016/0304-4165(86)90042-5; DRISCOLL WJ, 1986, J BIOL CHEM, V261, P4122; FRASER DR, 1970, NATURE, V228, P764, DOI 10.1038/228764a0; GERMINO J, 1984, P NATL ACAD SCI-BIOL, V81, P4692, DOI 10.1073/pnas.81.15.4692; HARRIS TJR, 1983, GENET ENG, V4, P130; HEMDAN ES, 1989, P NATL ACAD SCI USA, V86, P1811, DOI 10.1073/pnas.86.6.1811; HENRY HL, 1984, ANNU REV NUTR, V4, P493, DOI 10.1146/annurev.nu.04.070184.002425; HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321; INGLEDEW WJ, 1984, MICROBIOL REV, V48, P222, DOI 10.1128/MMBR.48.3.222-271.1984; KAGIMOTO K, 1988, BIOCHEM BIOPH RES CO, V155, P379, DOI 10.1016/S0006-291X(88)81096-9; KIMURA T, 1968, J BIOCHEM-TOKYO, V63, P716, DOI 10.1093/oxfordjournals.jbchem.a128836; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MONNIER N, 1987, EUR J BIOCHEM, V169, P147, DOI 10.1111/j.1432-1033.1987.tb13592.x; NEMANI R, 1989, J BIOL CHEM, V264, P15361; OFTEBRO H, 1979, J BIOL CHEM, V254, P4331; OFTEBRO H, 1981, J LIPID RES, V22, P1254; OMDAHL JL, 1992, ARCH BIOCHEM BIOPHYS, V293, P213, DOI 10.1016/0003-9861(92)90387-C; PALMER G, 1967, BIOCHEMISTRY-US, V6, P1658, DOI 10.1021/bi00858a012; PEDERSEN JI, 1977, BIOCHEM BIOPH RES CO, V76, P666, DOI 10.1016/0006-291X(77)91552-2; PEDERSEN JI, 1976, J BIOL CHEM, V251, P3933; PONCHON G, 1969, J CLIN INVEST, V48, P1273, DOI 10.1172/JCI106093; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; SAMBROOK J, 1989, MOL CLONING LAB MANU, pF6; Sambrook J, 1989, MOL CLONING LABORATO; SASSENFELD HM, 1984, BIO-TECHNOL, V2, P76, DOI 10.1038/nbt0184-76; SHUBHRA M, 1988, ARCH BIOCHEM BIOPHYS, V264, P383; SIEGEL N, 1986, J BIOL CHEM, V261, P6998; SIMPSON ER, 1978, ARCH BIOCHEM BIOPHYS, V190, P800, DOI 10.1016/0003-9861(78)90340-5; SMITH MC, 1988, J BIOL CHEM, V263, P7211; SUHARA K, 1972, BIOCHIM BIOPHYS ACTA, V263, P272, DOI 10.1016/0005-2795(72)90079-7; TANAKA M, 1973, J BIOL CHEM, V248, P1141; ULLMANN A, 1984, GENE, V29, P27, DOI 10.1016/0378-1119(84)90162-8; VOSTERS AF, 1992, PROTEIN EXPRES PURIF, V3, P18, DOI 10.1016/1046-5928(92)90051-W; WATARI H, 1966, BIOCHEM BIOPH RES CO, V24, P106, DOI 10.1016/0006-291X(66)90417-7; QIAEXPRESSIONIST, P32	44	11	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1993	268	7					5069	5076						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP884	8383127				2022-12-27	WOS:A1993KP88400075
J	KELLY, KL; RUDERMAN, NB				KELLY, KL; RUDERMAN, NB			INSULIN-STIMULATED PHOSPHATIDYLINOSITOL 3-KINASE - ASSOCIATION WITH A 185-KDA TYROSINE-PHOSPHORYLATED PROTEIN (IRS-1) AND LOCALIZATION IN A LOW-DENSITY MEMBRANE VESICLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTORS; ISOLATED FAT-CELLS; GLUCOSE-TRANSPORTER; RAT ADIPOCYTES; BOVINE BRAIN; PHOSPHOINOSITIDE METABOLISM; SACCHAROMYCES-CEREVISIAE; SIGNAL TRANSDUCTION; 3T3-L1 ADIPOCYTES; PLASMA-MEMBRANE	Insulin stimulates the appearance of anti-tyrosine(P)-immunoprecipitable phosphatidylinositol 3-kinase (PI 3-kinase) activity in adipocytes, predominantly in an intracellular membrane fraction (Kelly, K. L., Ruderman, N. B., and Chen, K. S. (1992) J. Biol. Chem. 267, 3423-3428). Neither the mechanism underlying this activation nor the precise subcellular compartment in which it occurs is known. To address these questions, studies were performed using isolated rat adipocytes and subcellular fractions of these cells. In intact cells, insulin stimulated the rapid appearance of phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate in P-32-labeled adipocytes without changing the labeling of phosphatidylinositol 3-phosphate, phosphatidylinositol 4-phosphate, or phosphatidylinositol 4,5-bisphosphate. This effect was accompanied by the tyrosyl phosphorylation of a 185-kDa protein, tentatively identified as IRS-1, with which PI 3-kinase became associated. The majority of the p85, the regulatory subunit of PI 3-kinase, in untreated adipocytes was present in the cytosol; however, neither the activity of PI 3-kinase nor the total amount of p85 in this fraction was modified in response to insulin. In contrast, insulin increased the association of p85 with IRS-1, the tyrosyl phosphorylation of the IRS-1 associated with p85, and the total activity of PI 3-kinase in the plasma membranes and low density membranes. After insulin treatment, similar amounts of p85 were bound to IRS-1 in the low density and plasma membrane fractions; however, tyrosyl-phosphorylated IRS-1 and PI 3-kinase activity were an order of magnitude greater in the low density membranes. The complex of tyrosyl-phosphorylated IRS-1.p85 that formed in response to insulin was localized to a very low density vesicle subpopulation that could be distinguished from vesicles containing the GLUT-4 glucose transporter and the insulin receptor. These data suggest that the activation of PI 3-kinase by insulin in the adipocyte involves the formation of a complex between IRS-1 and PI 3-kinase in a very low density membrane fraction that is not enriched in GLUT-4 or insulin receptors. They also suggest that PI 3-kinase activation correlates more closely with the extent of tyrosyl phosphorylation of the IRS-1 complexed to PI 3-kinase than it does to the amount of p85 bound to IRS-1.	BOSTON UNIV,SCH MED,DEPT PHYSIOL,BOSTON,MA 02118	Boston University	KELLY, KL (corresponding author), BOSTON UNIV,SCH MED,EVANS DEPT MED,DIABET & METAB UNIT,E-211,88 E NEWTON ST,BOSTON,MA 02118, USA.			Ruderman, Neil/0000-0002-6589-6587	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042621] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32HL07224] Funding Source: Medline; NIDDK NIH HHS [DK42621] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AUGER KR, 1989, J BIOL CHEM, V264, P20181; AUGERT G, 1988, J BIOL CHEM, V263, P3600; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; COHEN B, 1990, MOL CELL BIOL, V10, P2909, DOI 10.1128/MCB.10.6.2909; COHEN B, 1990, P NATL ACAD SCI USA, V265, P40458; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; DELVECCHIO RL, 1989, BIOCHIM BIOPHYS ACTA, V986, P41, DOI 10.1016/0005-2736(89)90270-8; ENDEMANN G, 1990, J BIOL CHEM, V265, P396; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; ESCOBEDO JA, 1991, MOL CELL BIOL, V11, P1125, DOI 10.1128/MCB.11.2.1125; GIBBS EM, 1986, J BIOL CHEM, V261, P6597; HADARI YR, 1992, J BIOL CHEM, V267, P17483; HAYASHI H, 1991, BIOCHEM J, V280, P769, DOI 10.1042/bj2800769; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; HU P, 1992, MOL CELL BIOL, V12, P981, DOI 10.1128/MCB.12.3.981; JAMES DE, 1988, BIOCHEM J, V256, P725, DOI 10.1042/bj2560725; JAMES DE, 1987, J BIOL CHEM, V262, P11817; JERGIL B, 1983, J BIOL CHEM, V258, P7968; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; KASUGA M, 1982, NATURE, V298, P667, DOI 10.1038/298667a0; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; KELLER SR, 1991, J BIOL CHEM, V266, P12817; KELLY KL, 1987, J BIOL CHEM, V262, P15285; KELLY KL, 1992, J BIOL CHEM, V267, P3423; KELLY KL, 1989, J BIOL CHEM, V264, P1274; KLIPPEL A, 1992, MOL CELL BIOL, V12, P1451, DOI 10.1128/MCB.12.4.1451; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPS DL, 1989, J BIOL CHEM, V264, P19911; LIPS DL, 1989, J BIOL CHEM, V264, P8759; MCGLADE CJ, 1992, MOL CELL BIOL, V12, P991, DOI 10.1128/MCB.12.3.991; MCKEEL DW, 1970, J CELL BIOL, V44, P417, DOI 10.1083/jcb.44.2.417; MOONEY RA, 1989, ENDOCRINOLOGY, V124, P422, DOI 10.1210/endo-124-1-422; MORGAN SJ, 1990, EUR J BIOCHEM, V191, P761, DOI 10.1111/j.1432-1033.1990.tb19185.x; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; PENNINGTON SR, 1985, J BIOL CHEM, V260, P1039; PETRUZZELLI LM, 1982, P NATL ACAD SCI-BIOL, V79, P6792, DOI 10.1073/pnas.79.22.6792; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; ROTHENBERG PL, 1991, J BIOL CHEM, V266, P8302; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; SERUNIAN LA, 1989, J BIOL CHEM, V264, P17809; SHIBASAKI F, 1991, J BIOL CHEM, V266, P8108; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; SOLTOFF SP, 1992, J BIOL CHEM, V267, P17472; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUSA M, 1992, J BIOL CHEM, V267, P22951; TORNQVIST HE, 1987, J BIOL CHEM, V262, P10212; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; WHITE MF, 1988, J BIOL CHEM, V263, P2969; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; YOAKIM M, 1992, J VIROL, V66, P5485, DOI 10.1128/JVI.66.9.5485-5491.1992	57	210	211	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					4391	4398						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382701				2022-12-27	WOS:A1993KN53300084
J	BEGUM, N; LEITNER, W; REUSCH, JEB; SUSSMAN, KE; DRAZNIN, B				BEGUM, N; LEITNER, W; REUSCH, JEB; SUSSMAN, KE; DRAZNIN, B			GLUT-4 PHOSPHORYLATION AND ITS INTRINSIC ACTIVITY - MECHANISM OF CA2+-INDUCED INHIBITION OF INSULIN-STIMULATED GLUCOSE-TRANSPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; CYTOSOLIC FREE CALCIUM; GLYCOGEN-BINDING SUBUNIT; DEPENDENT PROTEIN-KINASE; RAT ADIPOCYTES; CATALYTIC SUBUNIT; PLASMA-MEMBRANE; PHOSPHATASE-1G; RESISTANCE; ATP	In this study, we examined the influence of high levels of cytosolic calcium on phosphorylation status and function of GLUT-4 in isolated rat adipocytes. Intracellular calcium was elevated by exposing adipocytes to either extracellular ATP (1.6 mM) or thapsigargin (100 nM). Both agents increased cytosolic calcium 2-3-fold. While basal glucose uptake was unaffected, both ATP and thapsigargin reduced insulin-stimulated glucose transport by 40-70% (p < 0.05). Neither ATP nor thapsigargin affected GLUT-4 content or its translocation from the low density microsomes to the plasma membrane (PM). In contrast, GLUT-4 immunoprecipitated from the PM of adipocytes exposed to either ATP or thapsigargin was phosphorylated to a greater extent than the GLUT-4 isolated from control cells. ATP and thapsigargin also abolished insulin-stimulated dephosphorylation of GLUT-4. At the same time, GLUT-4 intrinsic activity was significantly reduced in adipocytes with high levels of cytosolic calcium (p < 0.05). Preincubation of adipocytes with cAMP antagonist, RpcAMP (10(-4) M), and calcium channel blocker, nitrendipine (30 muM), improved the ability of insulin to dephosphorylate GLUT-4 and restored insulin-stimulated GLUT-4 intrinsic activity. We conclude that elevated levels of cytosolic calcium interfere with insulin's ability to dephosphorylate GLUT-4, thus reducing its intrinsic activity.	VET ADM MED CTR,DEPT MED,ENDOCRINOL SECT 111H,1055 CLERMONT ST,DENVER,CO 80220; VET AFFAIRS MED CTR,RES SERV,DENVER,CO 80220; UNIV COLORADO,HLTH SCI CTR,DENVER,CO 80262	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver				Reusch, Jane/0000-0001-8620-1003				ALEMANY S, 1986, EUR J BIOCHEM, V156, P101, DOI 10.1111/j.1432-1033.1986.tb09554.x; BEGUM N, 1992, J CLIN INVEST, V90, P1254, DOI 10.1172/JCI115988; BEGUM N, 1991, CELL CALCIUM, V12, P423, DOI 10.1016/0143-4160(91)90068-P; BEGUM N, 1992, J BIOL CHEM, V267, P5959; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COEVERA S, 1991, J BIOL CHEM, V266, P9271; COHEN P, 1988, PROC R SOC SER B-BIO, V234, P115, DOI 10.1098/rspb.1988.0040; COHEN P, 1989, J BIOL CHEM, V264, P21435; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4158; DENT P, 1990, FEBS LETT, V259, P281, DOI 10.1016/0014-5793(90)80027-G; DENT P, 1990, NATURE, V348, P302, DOI 10.1038/348302a0; DRAZNIN B, 1989, ENDOCRINOLOGY, V125, P2341, DOI 10.1210/endo-125-5-2341; DRAZNIN B, 1988, J CLIN INVEST, V82, P1848, DOI 10.1172/JCI113801; DRAZNIN B, 1987, J BIOL CHEM, V262, P14385; GINTY DD, 1991, J BIOL CHEM, V266, P17454; HUBBARD MJ, 1989, EUR J BIOCHEM, V186, P711, DOI 10.1111/j.1432-1033.1989.tb15264.x; HUBBARD MJ, 1989, EUR J BIOCHEM, V180, P457, DOI 10.1111/j.1432-1033.1989.tb14668.x; HUBBARD MJ, 1989, EUR J BIOCHEM, V186, P701, DOI 10.1111/j.1432-1033.1989.tb15263.x; JAMES DE, 1989, P NATL ACAD SCI USA, V86, P8368, DOI 10.1073/pnas.86.21.8368; LAWRENCE JC, 1990, J BIOL CHEM, V265, P2324; LAWRENCE JC, 1990, J BIOL CHEM, V265, P19768; LIN SH, 1985, J BIOL CHEM, V260, P7850; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MASON MJ, 1991, J BIOL CHEM, V266, P20856; MOLLER DE, 1991, NEW ENGL J MED, V325, P938; NAGELKERKE JF, 1989, BIOCHEM J, V263, P347, DOI 10.1042/bj2630347; REUSCH JEB, 1991, ENDOCRINOLOGY, V129, P3269, DOI 10.1210/endo-129-6-3269; REUSCH JEB, 1993, J BIOL CHEM, V268, P3348; RODBELL M, 1964, J BIOL CHEM, V239, P375; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SIMPSON IA, 1986, ANNU REV BIOCHEM, V55, P1059, DOI 10.1146/annurev.biochem.55.1.1059; SMITH PK, 1985, ANAL BIOCHEM, V150, P2324; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; VOLKER TT, 1985, ANAL BIOCHEM, V144, P347, DOI 10.1016/0003-2697(85)90127-7; Weber T. M., 1988, INSULIN RECEPTORS B, P171	35	104	104	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3352	3356						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381427				2022-12-27	WOS:A1993KM16100053
J	EDMONDSON, DG; OLSON, EN				EDMONDSON, DG; OLSON, EN			HELIX-LOOP-HELIX PROTEINS AS REGULATORS OF MUSCLE-SPECIFIC TRANSCRIPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ENHANCER-BINDING-FACTOR; DNA-BINDING; GENE FAMILY; MYOD1; MYOGENIN; ACTIVATION; EXPRESSION; DIFFERENTIATION; CELLS; FIBROBLASTS		UNIV TEXAS,MD ANDERSON CANC CTR,DEPT BIOCHEM & MOLEC BIOL,BOX 117,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center				Edmondson, Diane/0000-0003-3702-9715	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039849, R01AR040339] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 40339, AR-39849] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ANTHONYCAHILL SJ, 1992, SCIENCE, V255, P979, DOI 10.1126/science.1312255; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BENGAL E, 1992, CELL, V68, P507, DOI 10.1016/0092-8674(92)90187-H; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; BRAUN T, 1990, NATURE, V346, P633; BRENNAN TJ, 1991, P NATL ACAD SCI USA, V88, P3822, DOI 10.1073/pnas.88.9.3822; BRENNAN TJ, 1990, J CELL BIOL, V110, P929, DOI 10.1083/jcb.110.4.929; BRENNAN TJ, 1991, P NATL ACAD SCI USA, V88, P5675, DOI 10.1073/pnas.88.13.5675; CHAKRABORTY T, 1991, MOL CELL BIOL, V11, P3633, DOI 10.1128/MCB.11.7.3633; CHEN L, 1992, SCIENCE, V256, P240, DOI 10.1126/science.1314423; CRESCENZI M, 1990, P NATL ACAD SCI USA, V87, P8442, DOI 10.1073/pnas.87.21.8442; CSERJESI P, 1991, MOL CELL BIOL, V11, P4854, DOI 10.1128/MCB.11.10.4854; CSERJESI P, 1992, DEVELOPMENT, V115, P1087; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Emerson CP, 1990, CURR OPIN CELL BIOL, V2, P1065, DOI 10.1016/0955-0674(90)90157-A; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; Kingston RE, 1989, CURR OPIN CELL BIOL, V1, P1081, DOI 10.1016/S0955-0674(89)80054-7; LASSAR AB, 1989, CELL, V58, P659, DOI 10.1016/0092-8674(89)90101-3; LI L, 1992, GENE DEV, V6, P676, DOI 10.1101/gad.6.4.676; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; LI L, 1992, MOL CELL BIOL, V12, P4478, DOI 10.1128/MCB.12.10.4478; MARTIN JF, 1992, J BIOL CHEM, V267, P10956; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; SARTORELLI V, 1990, GENE DEV, V4, P1811, DOI 10.1101/gad.4.10.1811; SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0; SCHAFER BW, 1990, NATURE, V344, P454, DOI 10.1038/344454a0; SCHWARZ JJ, 1992, MOL CELL BIOL, V12, P266, DOI 10.1128/MCB.12.1.266; SORRENTINO V, 1990, NATURE, V345, P813, DOI 10.1038/345813a0; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; VENUTI JM, 1991, P NATL ACAD SCI USA, V88, P6219, DOI 10.1073/pnas.88.14.6219; VINSON CR, 1992, NEW BIOL, V4, P396; VORONOVA A, 1990, P NATL ACAD SCI USA, V87, P4722, DOI 10.1073/pnas.87.12.4722; WEINTRAUB H, 1991, GENE DEV, V5, P1377, DOI 10.1101/gad.5.8.1377; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783; YUTZEY KE, 1990, MOL CELL BIOL, V10, P3934, DOI 10.1128/MCB.10.8.3934	48	262	271	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					755	758						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8380414				2022-12-27	WOS:A1993KG07700001
J	GUIGLIARELLI, B; GUILLAUSSIER, J; MORE, C; SETIF, P; BOTTIN, H; BERTRAND, P				GUIGLIARELLI, B; GUILLAUSSIER, J; MORE, C; SETIF, P; BOTTIN, H; BERTRAND, P			STRUCTURAL ORGANIZATION OF THE IRON-SULFUR CENTERS IN SYNECHOCYSTIS-6803 PHOTOSYSTEM-I - EPR STUDY OF ORIENTED THYLAKOID MEMBRANES AND ANALYSIS OF THE MAGNETIC-INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RES; CENTER-X; THERMOPHILIC CYANOBACTERIUM; SPINACH-CHLOROPLASTS; P700 CHLOROPHYLL; 2FE-2S CLUSTER; HIGHER-PLANTS; G-STRAIN; CENTER-A; CENTER-B	The structural properties of the iron-sulfur centers of photosystem I (PSI) from the cyanobacterium Synechocystis 6803 have been investigated by EPR spectrometry. The stoichiometry of centers A, B, and X, determined by EPR intensity measurements, gives direct evidence for center X being a [4Fe-4S] center in the native system and for the core reaction center protein being a dimer. The directions of the magnetic axes of centers A, B, and X were accurately determined by EPR experiments carried out on membrane fragments oriented on thin Mylar films. These directions are very similar to those previously reported for plants and algae. To get a detailed description of the relative arrangement of A and B, the magnetic interactions between these centers have been analyzed through numerical simulations of X-band and Q-band EPR spectra. The relative orientation of the magnetic axes deduced from these simulations is fully consistent with that given by oriented multilayer experiments. Numerical simulations of X-band and Q-band EPR spectra given by spinach PSI lead to a very similar set of structural parameters, which demonstrates that the functional unit of PSI is highly conserved in all photosynthetic organisms. Moreover, the results of these studies indicate that the A-B direction is close to the membrane normal, which supports a sequential electron transfer mechanism between the iron-sulfur centers in PSI.	CENS,DEPT BIOL,SERV BIOENERGET,CNRS,URA 1290,F-91191 GIF SUR YVETTE,FRANCE	Centre National de la Recherche Scientifique (CNRS)	GUIGLIARELLI, B (corresponding author), UNIV AIX MARSEILLE 1,CTR ST JEROME,ELECTRON MILIEUX CONDENSES LAB,CNRS,URA 784,F-13397 MARSEILLE 4,FRANCE.							AASA R, 1981, BIOCHIM BIOPHYS ACTA, V637, P118, DOI 10.1016/0005-2728(81)90216-4; ANDREASSON LE, 1988, ANNU REV PLANT PHYS, V39, P379, DOI 10.1146/annurev.arplant.39.1.379; BEINERT H, 1983, ARCH BIOCHEM BIOPHYS, V222, P333, DOI 10.1016/0003-9861(83)90531-3; BENGIS C, 1977, J BIOL CHEM, V252, P4564; BERTRAND P, 1988, BIOCHIM BIOPHYS ACTA, V933, P393, DOI 10.1016/0005-2728(88)90048-5; BIGGINS J, 1988, BIOCHEMISTRY-US, V27, P1494, DOI 10.1021/bi00405a015; BLAISIE JK, 1978, BIOCHIM BIOPHYS ACTA, V501, P33; BLUM H, 1978, J MAGN RESON, V30, P385, DOI 10.1016/0022-2364(78)90108-7; BLUM H, 1978, BIOCHIM BIOPHYS ACTA, V502, P1, DOI 10.1016/0005-2728(78)90125-1; BRETTEL K, 1989, BIOCHIM BIOPHYS ACTA, V976, P246, DOI 10.1016/S0005-2728(89)80237-3; BRUCE BD, 1988, J BIOL CHEM, V263, P7302; CHAMOROVSKY SK, 1982, PHOTOBIOCH PHOTOBIOP, V4, P195; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; DISMUKES GC, 1978, BIOCHIM BIOPHYS ACTA, V504, P431, DOI 10.1016/0005-2728(78)90065-8; EVANS MCW, 1982, IRON SULFUR PROTEINS, V3, P249; FISH LE, 1986, J BIOL CHEM, V261, P8134; FISH LE, 1985, J BIOL CHEM, V260, P1413; FU WG, 1991, FEBS LETT, V284, P165, DOI 10.1016/0014-5793(91)80676-T; GERSONDE K, 1974, EUR J BIOCHEM, V43, P307, DOI 10.1111/j.1432-1033.1974.tb03414.x; GOLBECK JH, 1987, BIOCHIM BIOPHYS ACTA, V891, P94, DOI 10.1016/0005-2728(87)90087-9; GOLBECK JH, 1988, FEBS LETT, V228, P268, DOI 10.1016/0014-5793(88)80013-9; GOLBECK JH, 1987, BIOCHIM BIOPHYS ACTA, V893, P149, DOI 10.1016/0005-2728(87)90034-X; GOLBECK JH, 1987, BIOCHIM BIOPHYS ACTA, V895, P167, DOI 10.1016/S0304-4173(87)80002-2; GREEN BR, 1988, PHOTOSYNTH RES, V15, P3, DOI 10.1007/BF00054985; GUIGLIARELLI B, 1989, J BIOL CHEM, V264, P6025; GUILLAUSSIER J, 1991, THESIS U PROVENCE MA; HAGEN WR, 1985, J MAGN RESON, V61, P233, DOI 10.1016/0022-2364(85)90078-2; HAGEN WR, 1985, FEBS LETT, V189, P250, DOI 10.1016/0014-5793(85)81033-4; HOOTKINS R, 1983, BIOCHIM BIOPHYS ACTA, V723, P16, DOI 10.1016/0005-2728(83)90004-X; KOIKE H, 1989, FEBS LETT, V253, P257, DOI 10.1016/0014-5793(89)80971-8; KOMENDA J, 1989, J PHOTOCH PHOTOBIO B, V3, P575, DOI 10.1016/1011-1344(89)80081-8; KURTZ DM, 1979, J BIOL CHEM, V254, P4967; LAGOUTTE B, 1984, FEBS LETT, V174, P24, DOI 10.1016/0014-5793(84)81070-4; LAGOUTTE B, 1989, PHOTOCHEM PHOTOBIOL, V49, P833, DOI 10.1111/j.1751-1097.1989.tb05580.x; LINDAHL PA, 1985, J BIOL CHEM, V260, P1160; LUNDELL DJ, 1985, J BIOL CHEM, V260, P646; MCDERMOTT AE, 1989, BIOCHEMISTRY-US, V28, P8056, DOI 10.1021/bi00446a013; MEHARI T, 1991, BIOCHIM BIOPHYS ACTA, V1056, P139, DOI 10.1016/S0005-2728(05)80280-4; MORE C, 1987, J MAGN RESON, V73, P13, DOI 10.1016/0022-2364(87)90221-6; MOULIS JM, 1984, J BIOL CHEM, V259, P1396; NOODLEMAN L, 1991, INORG CHEM, V30, P246, DOI 10.1021/ic00002a019; OHOKA H, 1988, FEBS LETT, V234, P291, DOI 10.1016/0014-5793(88)80101-7; OHOKA H, 1988, J BIOCHEM-TOKYO, V103, P962, DOI 10.1093/oxfordjournals.jbchem.a122394; PALMER G, 1966, BIOCHEM BIOPH RES CO, V23, P357, DOI 10.1016/0006-291X(66)90733-9; PARRETT KG, 1990, BIOCHIM BIOPHYS ACTA, V1015, P341, DOI 10.1016/0005-2728(90)90039-7; PETROULEAS V, 1989, BIOCHEMISTRY-US, V28, P8980, DOI 10.1021/bi00449a004; PICAUD A, 1982, Photosynthesis Research, V3, P203, DOI 10.1007/BF00032257; PRINCE RC, 1980, BIOCHIM BIOPHYS ACTA, V592, P323, DOI 10.1016/0005-2728(80)90193-0; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; ROGNER M, 1990, BIOCHIM BIOPHYS ACTA, V1015, P415, DOI 10.1016/0005-2728(90)90074-E; SALERNO JC, 1985, BIOCHEM SOC T, V13, P611, DOI 10.1042/bst0130611; SCHAFHEUTLE ME, 1990, BIOCHEMISTRY-US, V29, P1216, DOI 10.1021/bi00457a018; SCHELLER HV, 1989, J BIOL CHEM, V264, P6929; STEIF P, 1980, PHOTOSYNTH RES, V1, P17; WYNN RM, 1988, FEBS LETT, V229, P293, DOI 10.1016/0014-5793(88)81143-8	55	57	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					900	908						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8380418				2022-12-27	WOS:A1993KG07700025
J	MING, Z; LAMBERT, H; LANDRY, J				MING, Z; LAMBERT, H; LANDRY, J			TRANSIENT ACTIVATION OF A DISTINCT SERINE PROTEIN-KINASE IS RESPONSIBLE FOR 27-KDA HEAT-SHOCK PROTEIN-PHOSPHORYLATION IN MITOGEN-STIMULATED AND HEAT-SHOCKED CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; CHINESE-HAMSTER-CELLS; SWISS MOUSE 3T3-CELLS; ALPHA-B-CRYSTALLIN; GROWTH-FACTORS; SUBSTRATE RECOGNITION; S6 PHOSPHORYLATION; MOLECULAR-WEIGHT; STRESS PROTEINS; DNA-SYNTHESIS	We have investigated the phosphorylation of HSP27, a 27-kDa heat shock protein which is involved in cellular thermoresistance and is also an early target of phosphorylation during heat shock and cell stimulation by a variety of growth and differentiation factors. HSP27 is transiently phosphorylated after shifting Chinese hamster cells from their normal temperature of 37 to 44-degrees-C. The phosphorylation correlated in time with the transient activation of specific HSP27 protein kinase activities. HSP27 kinase was also induced to maximal levels within 5-15 min following stimulation of quiescent cells with heat shock, serum, thrombin, or basic fibroblast growth factor. Extracts from quiescent cells stimulated by heat shock or serum were analyzed after sequential chromatography on cation exchange and hydroxylapatite columns. In both cases, a single and identical peak of HSP27 kinase activity was obtained, suggesting that the same protein kinase was induced. The HSP27 kinase efficiently phosphorylated recombinant Chinese hamster HSP27 or the synthetic peptide RALNRQLSSGV containing the major in vivo phosphorylation site of rodent HSP27. The kinase was inactive toward the ribosomal S6 protein, the peptide RRLSSLRA from S6 protein, or the mutant HSP27 proteins with in vivo phosphorylation sites altered to glycine. The partially purified HSP27 kinase had no kinase C, kinase A, or S6 kinase activities; conversely, HSP27 was not a good substrate for these kinases. HSP27 kinase was rapidly inactivated in the presence of acid phosphatase, suggesting that its activity was regulated by phosphorylation. It is suggested that this heat shock- and serum-induced HSP27 kinase is a novel serine kinase which is linked to a major signal transduction cascade.	UNIV LAVAL, HOTEL DIEU QUEBEC, CTR RECH CANCEROL, 11 COTE PALAIS, QUEBEC CITY G1R 2J6, PQ, CANADA	Laval University								ARRIGO AP, 1988, MOL CELL BIOL, V8, P5059, DOI 10.1128/MCB.8.12.5059; ARRIGO AP, 1990, MOL CELL BIOL, V10, P1276, DOI 10.1128/MCB.10.3.1276; ARRIGO AP, 1991, HEAT SHOCK DEV, P106; Atherton E., 1990, SOLID PHASE PEPTIDE; BALLOU LM, 1988, J BIOL CHEM, V263, P1188; CALDERWOOD SK, 1987, J CELL PHYSIOL, V130, P369, DOI 10.1002/jcp.1041300309; CALDERWOOD SK, 1989, J CELL PHYSIOL, V141, P325, DOI 10.1002/jcp.1041410214; CHAMBARD JC, 1983, J BIOL CHEM, V258, P1706; CHEN RH, 1990, MOL CELL BIOL, V10, P3204, DOI 10.1128/MCB.10.6.3204; CIOCCA DR, 1983, CANCER RES, V43, P1204; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; CRETE P, 1990, RADIAT RES, V121, P320, DOI 10.2307/3577783; DARBON JM, 1990, BIOCHEM BIOPH RES CO, V168, P527, DOI 10.1016/0006-291X(90)92353-2; DRUMMOND IAS, 1986, MOL CELL BIOL, V6, P1767, DOI 10.1128/MCB.6.5.1767; ERIKSON E, 1988, SEC MESS PHOSPHOPROT, V12, P135; ERIKSON RL, 1991, J BIOL CHEM, V266, P6007; FLOTOW H, 1992, J BIOL CHEM, V267, P3074; FUQUA SAW, 1989, CANCER RES, V49, P4126; GAESTEL M, 1991, J BIOL CHEM, V266, P14721; GLASS DB, 1978, ANAL BIOCHEM, V87, P566, DOI 10.1016/0003-2697(78)90707-8; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; GROSE JH, 1991, ADV PROSTAG THROMB L, V21, P145; GUESDON F, 1991, J IMMUNOL, V147, P3402; HICKEY E, 1986, NUCLEIC ACIDS RES, V14, P4127, DOI 10.1093/nar/14.10.4127; HUOT J, 1991, CANCER RES, V51, P5245; JURIVICH DA, 1991, J CELL PHYSIOL, V148, P252, DOI 10.1002/jcp.1041480210; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KLEMENZ R, 1991, MOL CELL BIOL, V11, P803, DOI 10.1128/MCB.11.2.803; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; KRIEG J, 1988, METHOD ENZYMOL, V164, P575; KRIEG J, 1988, J BIOL CHEM, V263, P11473; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; LALLEMAIN G, 1991, CELL REGUL, V2, P675, DOI 10.1091/mbc.2.8.675; LAMB NJC, 1989, J CELL BIOL, V108, P2409, DOI 10.1083/jcb.108.6.2409; LANDRY J, 1992, J BIOL CHEM, V267, P794; LANDRY J, 1991, J CELL PHYSIOL, V147, P93, DOI 10.1002/jcp.1041470113; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; LEGAGNEUX V, 1990, EUR J BIOCHEM, V193, P121, DOI 10.1111/j.1432-1033.1990.tb19312.x; MATSUDA Y, 1987, J BIOL CHEM, V262, P2832; MICHISHITA M, 1991, BIOCHEM BIOPH RES CO, V176, P979, DOI 10.1016/0006-291X(91)90378-K; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; NAIRN AC, 1990, ADV SEC MESS PHOSPH, V24, P202; RAY LB, 1988, J BIOL CHEM, V263, P12721; ROBAYE B, 1989, BIOCHEM BIOPH RES CO, V163, P301, DOI 10.1016/0006-291X(89)92135-9; SAKLATVALA J, 1991, BIOCHEM J, V277, P635, DOI 10.1042/bj2770635; SHIBANUMA M, 1991, CELL GROWTH DIFFER, V2, P583; STRAHLER JR, 1991, BIOCHEM BIOPH RES CO, V175, P134, DOI 10.1016/S0006-291X(05)81211-2; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; TETU B, 1992, CANCER RES, V52, P2325; THOR A, 1991, J NATL CANCER I, V83, P170, DOI 10.1093/jnci/83.3.170; VANWIJK R, 1984, EXP CELL RES, V153, P522, DOI 10.1016/0014-4827(84)90619-0; VITEK MP, 1984, J MOL BIOL, V178, P173, DOI 10.1016/0022-2836(84)90138-4; WELCH WJ, 1985, J BIOL CHEM, V260, P3058	54	71	72	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					35	43						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380159				2022-12-27	WOS:A1993KE60300008
J	DAWRA, RK; SALUJA, AK; RUNZI, M; STEER, ML				DAWRA, RK; SALUJA, AK; RUNZI, M; STEER, ML			INOSITOL TRISPHOSPHATE-INDEPENDENT AGONIST-STIMULATED CALCIUM INFLUX IN RAT PANCREATIC ACINAR-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC FREE CALCIUM; INTRACELLULAR CA-2+; HUMAN-NEUTROPHILS; CA2+ ENTRY; CHOLECYSTOKININ; 1,4,5-TRISPHOSPHATE; POOL; MOBILIZATION; ACTIVATION; RECEPTORS	CCK-JMV-180 is a cholecystokinin analog that stimulates digestive enzyme secretion from pancreatic acinar cells but does not cause either generation of inositol 1,4,5-trisphosphate or depletion of the inositol 1,4,5-trisphosphate-sensitive intracellular Ca2+ storage pool. We report that CCK-JMV-180 can accelerate Ca2+ influx into fura-2-loaded dispersed rat pancreatic acini and single acinar cells. Furthermore, CCK-JMV-180 accelerates Ca2+ influx into cells microinjected with the inositol 1,4,5-trisphosphate receptor antagonist heparin and into acini loaded with the Ca2+-chelating agent BAPTA (1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid). These results indicate that agonist-stimulated Ca2+ influx can occur (a) without depletion of the inositol 1,4,5-trisphosphate-sensitive intracellular Ca2+ storage pool, (b) without a rise in cytoplasmic free Ca2+ concentrations, and (c) after blockade of inositol 1,4,5-trisphosphate receptors. They suggest that depletion of an inositol 1,4,5-trisphosphate-independent intracellular Ca2+ storage pool and/or generation of a non-inositol 1,4,5-trisphosphate second messenger by CCK-JMV-180 may be a sufficient signal for acceleration of Ca2+ influx into rat pancreatic acinar cells.	BETH ISRAEL HOSP, DEPT SURG, 330 BROOKLINE AVE, BOSTON, MA 02215 USA; HARVARD UNIV, SCH MED, HARVARD DIGEST DIS CTR, CHARLES A DANA RES LABS, BOSTON, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School					PHS HHS [31396, 46331] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BIRD GS, 1991, NATURE, V352, P162, DOI 10.1038/352162a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; GALAS MC, 1988, AM J PHYSIOL, V254, pG176, DOI 10.1152/ajpgi.1988.254.2.G176; GHOSH TK, 1988, J BIOL CHEM, V263, P11075; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HUANG CL, 1991, J BIOL CHEM, V266, P4045; IRVINE RF, 1989, BIOCHEM SOC T, V17, P6, DOI 10.1042/bst0170006; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; KOMORI S, 1990, J PHYSIOL-LONDON, V427, P395, DOI 10.1113/jphysiol.1990.sp018178; LU CY, 1989, J MEMBRANE BIOL, V109, P85, DOI 10.1007/BF01870793; MATOZAKI T, 1990, J BIOL CHEM, V265, P6247; MATTHEWS G, 1989, J PHYSIOL-LONDON, V418, P105, DOI 10.1113/jphysiol.1989.sp017830; MERRITT JE, 1989, J BIOL CHEM, V264, P1522; MERRITT JE, 1987, J BIOL CHEM, V262, P17362; MORRIS AP, 1987, NATURE, V330, P653, DOI 10.1038/330653a0; MUALLEM S, 1988, AM J PHYSIOL, V255, pG229, DOI 10.1152/ajpgi.1988.255.2.G229; MUALLEM S, 1990, J BIOL CHEM, V265, P2011; PITTET D, 1989, J BIOL CHEM, V264, P7251; POZZAN T, 1983, SCIENCE, V221, P1413, DOI 10.1126/science.6310757; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; ROWLEY WH, 1990, AM J PHYSIOL, V259, pG655, DOI 10.1152/ajpgi.1990.259.4.G655; SALUJA A, 1986, AM J PHYSIOL, V250, pC413, DOI 10.1152/ajpcell.1986.250.3.C413; SALUJA AK, 1992, J BIOL CHEM, V267, P11202; SALUJA AK, 1989, BIOCHEM BIOPH RES CO, V264, P1522; VONTSCHARNER V, 1986, NATURE, V324, P369, DOI 10.1038/324369a0; YUE DI, 1992, J BIOL CHEM, V267, P13830	27	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20237	20242						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376384				2022-12-27	WOS:A1993LY01900050
J	LI, J; BROYLES, SS				LI, J; BROYLES, SS			THE DNA-DEPENDENT ATPASE ACTIVITY OF VACCINIA VIRUS EARLY GENE-TRANSCRIPTION FACTOR IS ESSENTIAL FOR ITS TRANSCRIPTION ACTIVATION FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE; MUTATIONAL ANALYSIS; BINDING PROTEINS; ADENYLATE KINASE; ESCHERICHIA-COLI; MESSENGER-RNA; EXPRESSION; SITE; PURIFICATION; HELICASE	Vaccinia virus early transcription factor (VETF) activates the transcription of early gene templates by the viral RNA polymerase. VETF is a heterodimeric protein that binds to transcription promoters and has an associated DNA-dependent ATPase activity. The small subunit of VETF has sequences resembling two motifs commonly found in ATPases: an A-type ATP binding motif and a DEAH box. To investigate the functional role of the ATPase activity, we have analyzed the effect of mutations in each of the putative ATPase motifs. Recombinant VETF was expressed in HeLa cells using a vaccinia virus/T7 RNA polymerase system. Simultaneous expression of both subunits of VETF was required to obtain soluble protein with promoter binding, DNA-dependent ATPase, and transcription activation functions. The mutants with altered ATPase motifs retained promoter binding activity but had no detectable ATPase activity and no ability to activate transcription. The DEAH box mutant was shown to dominantly repress transcription activation by wild-type VETF. These results indicate that the DNA-dependent ATPase activity of VETF is essential for its transcription activation function.			LI, J (corresponding author), PURDUE UNIV, DEPT BIOCHEM, W LAFAYETTE, IN 47907 USA.				NIAID NIH HHS [AI 28432-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028432] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BALDICK CJ, 1992, J VIROL, V66, P4710, DOI 10.1128/JVI.66.8.4710-4719.1992; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROYLES SS, 1988, J BIOL CHEM, V263, P10754; BROYLES SS, 1988, J BIOL CHEM, V263, P10761; BROYLES SS, 1991, J BIOL CHEM, V266, P15539; BROYLES SS, 1987, J VIROL, V61, P1738, DOI 10.1128/JVI.61.5.1738-1742.1987; COMPANY M, 1991, NATURE, V349, P487, DOI 10.1038/349487a0; CONWAY TW, 1964, P NATL ACAD SCI USA, V52, P1462, DOI 10.1073/pnas.52.6.1462; CUI JS, 1993, J BIOL CHEM, V268, P5040; DOMBROSKI AJ, 1990, J BACTERIOL, V172, P2477, DOI 10.1128/jb.172.5.2477-2484.1990; EVANS PR, 1979, NATURE, V279, P500, DOI 10.1038/279500a0; FOULKES NS, 1992, CELL, V68, P411, DOI 10.1016/0092-8674(92)90178-F; FRY DC, 1986, P NATL ACAD SCI USA, V83, P907, DOI 10.1073/pnas.83.4.907; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GERSHOWITZ A, 1978, J VIROL, V27, P399, DOI 10.1128/JVI.27.2.399-408.1978; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAGLER J, 1992, P NATL ACAD SCI USA, V89, P10099, DOI 10.1073/pnas.89.21.10099; HIRSCHMANN P, 1990, J VIROL, V64, P6063, DOI 10.1128/JVI.64.12.6063-6069.1990; JANKNECHT R, 1991, P NATL ACAD SCI USA, V88, P8972, DOI 10.1073/pnas.88.20.8972; KORANGY F, 1992, J BIOL CHEM, V267, P1733; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; LI J, 1993, J BIOL CHEM, V268, P2773; LLOYD A, 1991, NATURE, V352, P632, DOI 10.1038/352635a0; MOSS B, 1991, J BIOL CHEM, V266, P1355; MOSS B, 1990, ANNU REV BIOCHEM, V59, P661, DOI 10.1146/annurev.biochem.59.1.661; PAI EF, 1977, J MOL BIOL, V114, P37, DOI 10.1016/0022-2836(77)90281-9; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; ROZEN F, 1989, MOL CELL BIOL, V9, P4061, DOI 10.1128/MCB.9.9.4061; SANCAR A, 1993, SCIENCE, V259, P1415, DOI 10.1126/science.8451638; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; VOS JC, 1991, CELL, V65, P105, DOI 10.1016/0092-8674(91)90412-R; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WATANABE Y, 1974, FEBS LETT, V41, P331, DOI 10.1016/0014-5793(74)81241-X; WEISS DS, 1991, CELL, V67, P155, DOI 10.1016/0092-8674(91)90579-N	41	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20016	20021						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376362				2022-12-27	WOS:A1993LY01900018
J	SULLIVAN, WP; TOFT, DO				SULLIVAN, WP; TOFT, DO			MUTATIONAL ANALYSIS OF HSP90 BINDING TO THE PROGESTERONE-RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEIN; REGULATED EIF-2-ALPHA KINASE; VIRUS TRANSFORMING PROTEIN; STEROID-RECEPTORS; GLUCOCORTICOID RECEPTOR; NUCLEOTIDE-SEQUENCE; PURIFICATION; CDNA; COMPLEXES; CYTOSOL	The 90-kDa heat shock protein, hsp90, is known to associate with steroid receptors that are in the inactive state. While the biochemical function of hsp90 is unclear, this association is believed to be significant because dissociation of hsp90 occurs when receptors are activated by hormone. Complexes between hsp90 and the progesterone receptor can be formed in vitro in rabbit reticulocyte lysate. This has been shown to be an ATP-dependent process, and dissociation of the complex occurs when progesterone is added to the system. We now show that hsp90 synthesized by in vitro translation in reticulocyte lysate can form complexes with progesterone receptor that are sensitive to hormone. This system was used to analyze several mutant forms of hsp90. A series of NH2-terminal deletions showed that amino acids 1-380 can be removed from hsp90 without substantial loss of receptor binding activity. However, several deletions in the COOH-terminal half of hsp90 resulted in a partial or complete loss of this activity. Two regions, amino acids 381-441 and 601-677, appear to be particularly important for receptor binding. These studies describe a convenient and reliable method for the initial screening of hsp90 mutants, and they provide important clues to the identification of domains on hsp90 that interact with other proteins.	MAYO CLIN & MAYO GRAD SCH MED,DEPT BIOCHEM & MOLEC BIOL,ROCHESTER,MN 55905	Mayo Clinic					NICHD NIH HHS [HD 09140] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD009140] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARDWELL JCA, 1987, P NATL ACAD SCI USA, V84, P5177, DOI 10.1073/pnas.84.15.5177; BINART N, 1989, J STEROID BIOCHEM, V34, P369, DOI 10.1016/0022-4731(89)90110-6; BINART N, 1989, BIOCHEM BIOPH RES CO, V159, P140, DOI 10.1016/0006-291X(89)92415-7; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; BRUGGE J, 1983, MOL CELL BIOL, V3, P9, DOI 10.1128/MCB.3.1.9; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; CATELLI MG, 1985, EMBO J, V4, P3131, DOI 10.1002/j.1460-2075.1985.tb04055.x; CSERMELY P, 1991, J BIOL CHEM, V266, P4943; HICKEY E, 1989, MOL CELL BIOL, V9, P2615, DOI 10.1128/MCB.9.6.2615; HOFFMANN T, 1988, GENE, V74, P491, DOI 10.1016/0378-1119(88)90182-5; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; HUTCHISON KA, 1992, J BIOL CHEM, V267, P14047; IANNOTTI AM, 1988, ARCH BIOCHEM BIOPHYS, V264, P54, DOI 10.1016/0003-9861(88)90569-3; ITOH H, 1990, ARCH BIOCHEM BIOPHYS, V282, P290, DOI 10.1016/0003-9861(90)90119-J; IWASAKI M, 1989, BIOCHIM BIOPHYS ACTA, V992, P1, DOI 10.1016/0304-4165(89)90043-3; KANG HS, 1991, J BIOL CHEM, V266, P5643; KOST SL, 1989, MOL CELL BIOL, V9, P3829, DOI 10.1128/MCB.9.9.3829; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEESMILLER SP, 1989, J BIOL CHEM, V264, P2431; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; MATTS RL, 1989, J BIOL CHEM, V264, P15542; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; MOORE SK, 1987, GENE, V56, P29, DOI 10.1016/0378-1119(87)90155-7; MOORE SK, 1989, J BIOL CHEM, V264, P5343; NADEAU K, 1993, J BIOL CHEM, V268, P1479; NISHIDA E, 1986, J BIOL CHEM, V261, P6033; PERDEW GH, 1991, J BIOL CHEM, V266, P6708; PRATT WB, 1990, MOL CELL ENDOCRINOL, V74, pC69, DOI 10.1016/0303-7207(90)90198-H; REBBE NF, 1987, GENE, V53, P235, DOI 10.1016/0378-1119(87)90012-6; RIEHL RM, 1985, BIOCHEMISTRY-US, V24, P6586, DOI 10.1021/bi00344a042; ROSE DW, 1987, BIOCHEMISTRY-US, V26, P6583, DOI 10.1021/bi00395a003; ROSE DW, 1989, J BIOL CHEM, V264, P6239; SANCHEZ ER, 1990, BIOCHEMISTRY-US, V29, P5145, DOI 10.1021/bi00473a021; SANCHEZ ER, 1988, MOL ENDOCRINOL, V2, P756, DOI 10.1210/mend-2-8-756; SANCHEZ ER, 1985, J BIOL CHEM, V260, P2398; SCHERRER LC, 1990, J BIOL CHEM, V265, P21397; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; SCHUH S, 1985, J BIOL CHEM, V260, P4292; SCHWARTZ JA, 1993, FEBS LETT, V315, P109, DOI 10.1016/0014-5793(93)81144-O; SCHWARTZ JA, 1991, MED HYPOTHESES, V35, P140, DOI 10.1016/0306-9877(91)90037-Y; SHAKNOVICH R, 1992, MOL CELL BIOL, V12, P5059, DOI 10.1128/MCB.12.11.5059; SMITH DF, 1992, J BIOL CHEM, V267, P1350; SMITH DF, 1990, MOL ENDOCRINOL, V4, P1704, DOI 10.1210/mend-4-11-1704; SMITH DF, 1990, J BIOL CHEM, V265, P3996; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; SULLIVAN WP, 1986, ENDOCRINOLOGY, V119, P1549, DOI 10.1210/endo-119-4-1549	47	60	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20373	20379						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376394				2022-12-27	WOS:A1993LY01900068
J	YAN, ZF; HINKLE, PM				YAN, ZF; HINKLE, PM			SATURABLE, STEREOSPECIFIC TRANSPORT OF 3,5,3'-TRIIODO-L-THYRONINE AND L-THYROXINE INTO GH4C1 PITUITARY-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE TRANSPORT; ISOLATED HEPATOCYTES; INHIBITION; SYSTEM; 3,3',5-TRIIODO-L-THYRONINE; RECEPTORS; CULTURE; PROTEIN; BINDING	The mechanism of uptake of the thyroid hormones, 3,5,3'-triiodo-L-thyronine (L-T3) and L-thyroxine (L-T4), was studied in rat pituitary GH4C1 cells. The major portion (approximately 65%) of L-T3 transport was stereospecific and saturable. Transport of L-T3 was 8-10 times more rapid than transport of D-T3. [I-125]L-T3 transport was saturable at muM concentrations; a Lineweaver-Burk plot was linear with K(m) = 0.4 muM and V(max) = 4 pmol/min/10(6) cells. Unlabeled analogs competed with [I-125]L-T3 uptake in the order L-T3 greater-than-or-equal-to L-T4 >> 3,3',5'-triiodo-L-thyronine (reverse-T3), D-T3, D-T4, and L-thyronine. L-T3 and L-T4 also both effectively inhibited [I-125]L-T4 transport. Uptake of [I-125]L-T3 was inhibited 40-55% by large neutral amino acids and 77% by 80 muM beta-2-aminobicyclo-(2,2, l)-heptane-2-carboxylic acid, an inhibitor selective for the L system of amino acid uptake. Conversely, L-T3 inhibited the transport of [H-3]leucine by pituitary cells (IC50 = 2 muM), but D-T3 and 3,5,3'-triiodothyroacetic acid (Triac) did not. L-Leucine was transported much more efficiently (V(max) = 0.65 mumol/min/10(6) cells) than L-T3 by GH4C1 cells. The results show that L-T3 and L-T4 share the same stereospecific transport pathway in pituitary cells, that the transport mechanism is saturable at supraphysiological thyroid hormone concentrations, and that the L system is partially responsible for L-T3 transport.	UNIV ROCHESTER, SCH MED & DENT, DEPT PHARMACOL, ROCHESTER, NY 14642 USA; UNIV ROCHESTER, SCH MED & DENT, CTR CANC, ROCHESTER, NY 14642 USA	University of Rochester; University of Rochester					NATIONAL CANCER INSTITUTE [P30CA011198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019974, R01DK032847] Funding Source: NIH RePORTER; NCI NIH HHS [CA 11198] Funding Source: Medline; NIDDK NIH HHS [DK 19974, DK 32847] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BLONDEAU JP, 1988, J BIOL CHEM, V263, P2685; CENTANNI M, 1989, ENDOCRINOLOGY, V124, P2443, DOI 10.1210/endo-124-5-2443; CHENG SY, 1980, P NATL ACAD SCI-BIOL, V77, P3425, DOI 10.1073/pnas.77.6.3425; CHRISTENSEN HN, 1989, METHOD ENZYMOL, V173, P576; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FREAKE HC, 1986, MOL CELL ENDOCRINOL, V44, P25, DOI 10.1016/0303-7207(86)90102-4; GONCALVES E, 1990, MOL CELL ENDOCRINOL, V69, P157, DOI 10.1016/0303-7207(90)90009-W; GONG QH, 1988, NUCLEIC ACIDS RES, V16, P1203, DOI 10.1093/nar/16.3.1203; HAIGLER HT, 1980, J BIOL CHEM, V255, P1239; HALPERN J, 1982, ENDOCRINOLOGY, V110, P1070, DOI 10.1210/endo-110-3-1070; HASUMURA S, 1985, BIOCHEM BIOPH RES CO, V133, P837, DOI 10.1016/0006-291X(85)91210-0; HINKLE PM, 1986, CYTOSKELETON, P229; HORIUCHI R, 1982, J BIOL CHEM, V257, P3139; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; KASTELLAKIS A, 1989, MOL CELL ENDOCRINOL, V67, P231; KRENNING E, 1981, BIOCHIM BIOPHYS ACTA, V676, P314, DOI 10.1016/0304-4165(81)90165-3; LAKSHMANAN M, 1990, ENDOCRINOLOGY, V126, P3245, DOI 10.1210/endo-126-6-3245; LARSEN PR, 1989, ADV EXP MED BIOL, V261, P11; LEIN A, 1961, AM J PHYSIOL, V200, P1029, DOI 10.1152/ajplegacy.1961.200.5.1029; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MOORADIAN AD, 1985, ENDOCRINOLOGY, V117, P2449, DOI 10.1210/endo-117-6-2449; OSTY J, 1988, ENDOCRINOLOGY, V123, P2303, DOI 10.1210/endo-123-5-2303; PARDRIDGE WM, 1981, ENDOCR REV, V2, P103, DOI 10.1210/edrv-2-1-103; PASTAN IH, 1981, ANNU REV PHYSIOL, V43, P239, DOI 10.1146/annurev.ph.43.030181.001323; PERRONE MH, 1978, J BIOL CHEM, V253, P5168; RAO GS, 1983, J ENDOCRINOL, V97, P277, DOI 10.1677/joe.0.0970277; SAMUELS HH, 1973, SCIENCE, V181, P1253, DOI 10.1126/science.181.4106.1253; SAMUELS HH, 1988, J CLIN INVEST, V81, P957, DOI 10.1172/JCI113449; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; TASHJIAN AH, 1968, ENDOCRINOLOGY, V82, P342, DOI 10.1210/endo-82-2-342; TSAI JS, 1974, BIOCHEM BIOPH RES CO, V59, P420, DOI 10.1016/S0006-291X(74)80223-8	31	28	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20179	20184						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376378				2022-12-27	WOS:A1993LY01900041
J	DANG, YL; MARTIN, NC				DANG, YL; MARTIN, NC			YEAST MITOCHONDRIAL RNASE-P - SEQUENCE OF THE RPM2 GENE AND DEMONSTRATION THAT ITS PRODUCT IS A PROTEIN SUBUNIT OF THE ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-I INTRONS; SACCHAROMYCES-CEREVISIAE; RIBONUCLEASE-P; ESCHERICHIA-COLI; NUCLEAR GENE; TRANSCRIPTION TERMINATION; RIBONUCLEOPROTEIN ENZYME; NUCLEOTIDE-SEQUENCE; SPLICING REQUIRES; MESSENGER-RNA	We report here the sequence of the RPM2 gene which codes for the 105-kDa protein previously purified from the mitochondria of Saccharomyces cerevisiae and shown by genetic techniques to be required for mitochondrial RNase P activity. The sequence predicts a primary translation product of 1202 residues with a molecular mass of 139 kDa and no obvious sequence similarity to any known protein in the data bases. There are 122 amino-terminal amino acids predicted by the gene that are not found in the purified protein, some of which may play a role in mitochondrial targeting of the protein. Antibodies raised against a trpE-105-kDa fusion protein recognize a 105-kDa protein in wild-type cells but not in cells carrying a disruption of the RMP2 gene. Immune, but not preimmune serum, immunoprecipitates the RNase P RNA and the mitochondrial RNase P activity. Thus, the 105-kDa protein forms a complex with RNase P RNA and is required for RNase P activity as predicted for a bona fide subunit of the enzyme.	UNIV LOUISVILLE, DEPT BIOCHEM, LOUISVILLE, KY 40292 USA	University of Louisville					FIC NIH HHS [1 F06TW01901] Funding Source: Medline; NIGMS NIH HHS [5R01GM27597] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [F06TW001901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027597] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKABOSHI E, 1980, BIOCHEM BIOPH RES CO, V96, P831, DOI 10.1016/0006-291X(80)91430-8; AKINS RA, 1987, CELL, V50, P331, DOI 10.1016/0092-8674(87)90488-0; ASHER E B, 1989, Molecular and General Genetics, V215, P517, DOI 10.1007/BF00427051; BARTKIEWICZ M, 1989, GENE DEV, V3, P488, DOI 10.1101/gad.3.4.488; BROWN JW, 1992, NUCLEIC ACIDS RES, V20, P1451, DOI 10.1093/nar/20.7.1451; BROWN JW, 1991, J BACTERIOL, V173, P3855, DOI 10.1128/JB.173.12.3855-3863.1991; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHERNIACK AD, 1990, CELL, V62, P745, DOI 10.1016/0092-8674(90)90119-Y; CIGAN AM, 1987, GENE, V59, P1; DANG H, 1990, NUCLEIC ACIDS RES, V18, P6895, DOI 10.1093/nar/18.23.6895; DAVIS SC, 1992, J BIOL CHEM, V267, P5508; DORIA M, 1991, NUCLEIC ACIDS RES, V19, P2315, DOI 10.1093/nar/19.9.2315; EMORI Y, 1991, MOL CELL BIOL, V11, P344, DOI 10.1128/MCB.11.1.344; FEARON K, 1988, MOL CELL BIOL, V8, P3636, DOI 10.1128/MCB.8.9.3636; FEARON K, 1992, J BIOL CHEM, V267, P5162; FUJITA MQ, 1990, GENE, V93, P73, DOI 10.1016/0378-1119(90)90138-H; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; GRIBSKOV M, 1988, COMPUT APPL BIOSCI, V4, P61; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; HAAS ES, 1991, SCIENCE, V254, P853, DOI 10.1126/science.1719634; HANSEN FG, 1985, GENE, V38, P85, DOI 10.1016/0378-1119(85)90206-9; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; HENIKOFF S, 1984, MOL CELL BIOL, V4, P1515, DOI 10.1128/MCB.4.8.1515; HERBERT CJ, 1988, EMBO J, V7, P473, DOI 10.1002/j.1460-2075.1988.tb02835.x; HOLLINGSWORTH MJ, 1986, MOL CELL BIOL, V6, P1058, DOI 10.1128/MCB.6.4.1058; JAMES BD, 1988, CELL, V52, P19, DOI 10.1016/0092-8674(88)90527-2; KAMPER U, 1992, MOL CELL BIOL, V12, P499; KANG W, 1991, J BACTERIOL, V173, P4013, DOI 10.1128/jb.173.13.4013-4020.1991; KITAKAWA M, 1990, NUCLEIC ACIDS RES, V18, P1521, DOI 10.1093/nar/18.6.1521; KOERNER TJ, 1991, METHOD ENZYMOL, V194, P477; KOLE R, 1980, CELL, V19, P881, DOI 10.1016/0092-8674(80)90079-3; KRUPP G, 1986, EMBO J, V5, P1697, DOI 10.1002/j.1460-2075.1986.tb04413.x; LABOUESSE M, 1990, MOL GEN GENET, V224, P209, DOI 10.1007/BF00271554; LEE JY, 1989, MOL CELL BIOL, V9, P2536, DOI 10.1128/MCB.9.6.2536; LISOWSKY T, 1990, MOL GEN GENET, V220, P186; LUMELSKY N, 1988, J MOL BIOL, V202, P443, DOI 10.1016/0022-2836(88)90277-X; MAMULA MJ, 1989, P NATL ACAD SCI USA, V86, P8717, DOI 10.1073/pnas.86.22.8717; MILLER DL, 1983, CELL, V34, P911, DOI 10.1016/0092-8674(83)90548-2; MORALES MJ, 1989, NUCLEIC ACIDS RES, V17, P6865, DOI 10.1093/nar/17.17.6865; MORALES MJ, 1992, P NATL ACAD SCI USA, V89, P9875, DOI 10.1073/pnas.89.20.9875; MORALES MJ, 1989, NUCLEIC ACIDS RES, V17, P6965; MORSE DP, 1992, GENE, V117, P61, DOI 10.1016/0378-1119(92)90490-G; OGASAWARA N, 1985, EMBO J, V4, P3345, DOI 10.1002/j.1460-2075.1985.tb04087.x; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PEL HJ, 1992, NUCLEIC ACIDS RES, V20, P6339, DOI 10.1093/nar/20.23.6339; REICH C, 1988, SCIENCE, V239, P178, DOI 10.1126/science.3122322; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SERAPHIN B, 1988, EMBO J, V7, P1455, DOI 10.1002/j.1460-2075.1988.tb02963.x; SERAPHIN B, 1989, NATURE, V337, P84, DOI 10.1038/337084a0; SHARP PM, 1991, YEAST, V7, P657, DOI 10.1002/yea.320070702; SHU HH, 1991, MOL CELL BIOL, V11, P1662, DOI 10.1128/MCB.11.3.1662; SKOVGAARD O, 1990, GENE, V93, P27, DOI 10.1016/0378-1119(90)90131-A; Tzagoloff A, 1990, Prog Nucleic Acid Res Mol Biol, V39, P129, DOI 10.1016/S0079-6603(08)60625-X; VALENCIK ML, 1989, EMBO J, V8, P3899, DOI 10.1002/j.1460-2075.1989.tb08569.x; VAMBUTAS A, 1991, EUR J BIOCHEM, V201, P643, DOI 10.1111/j.1432-1033.1991.tb16325.x; VERDIER JM, 1990, YEAST, V6, P271, DOI 10.1002/yea.320060402; WIESENBERGER G, 1992, J BIOL CHEM, V267, P6963; WISE C, 1991, NUCLEIC ACIDS RES, V19, P4773, DOI 10.1093/nar/19.17.4773; WISE CA, 1991, J BIOL CHEM, V266, P19154; ZARET KS, 1982, CELL, V28, P563, DOI 10.1016/0092-8674(82)90211-2	60	60	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19791	19796						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366116				2022-12-27	WOS:A1993LW81900095
J	BALASTA, ML; CARBERRY, SE; FRIEDLAND, DE; PEREZ, RA; GOSS, DJ				BALASTA, ML; CARBERRY, SE; FRIEDLAND, DE; PEREZ, RA; GOSS, DJ			CHARACTERIZATION OF THE ATP-DEPENDENT BINDING OF WHEAT-GERM PROTEIN-SYNTHESIS INITIATION FACTOR-EIF-(ISO)4F AND FACTOR-EIF-4A TO MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP ANALOGS; FACTOR-4F; SEQUENCE; HELICASE	The ATP-dependent binding of wheat germ protein synthesis initiation factors eIF-(iso)4F and eIF-4A to an oligoribonucleotide has been investigated by direct fluorescence titration techniques. In addition, the effect of ATP on the interaction between another cap-binding initiation factor, eIF-4F, and eIF-4A was studied using the same methods. Comparison of the equilibrium association constants (K(eq)) indicate that 1) hydrolyzable ATP affects the affinity of eIF-(iso)4F for eIF-4A, regardless of whether or not mRNA was previously bound to the eIF-(iso)4F; in contrast, ATP had no effect on the eIF-(iso)4F/oligoribonucleotide interaction; 2) in the presence of ATP, the binding of the binary eIF-(iso)4F.eIF-4A complex to the oligoribonucleotide is of similar affinity as the binding of the oligoribonucleotide to the eIF-(iso)4F alone; the stoichiometry of this ternary eIF-(iso)4F.eIF-4A-mRNA complex was found to be 1:1:1; and 3) a similar ATP effect is observed for the eIF-4F/eIF-4A interaction as for the eIF-(iso)4F.eIF-4A complex.	CUNY HUNTER COLL, DEPT CHEM, NEW YORK, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY)								ABRAMSON RD, 1988, J BIOL CHEM, V263, P5462; ALLEN ML, 1992, J BIOL CHEM, V267, P23232; BROWNING KS, 1989, J BIOL CHEM, V264, P8491; BROWNING KS, 1985, FED PROC, V44, P1224; CARBERRY SE, 1989, BIOCHEMISTRY-US, V28, P8078, DOI 10.1021/bi00446a017; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P1624, DOI 10.1021/bi00220a026; CARBERRY SE, 1990, BIOCHEMISTRY-US, V29, P3337, DOI 10.1021/bi00465a027; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P4542, DOI 10.1021/bi00232a025; CARBERRY SE, 1992, BIOCHEMISTRY-US, V31, P1427, DOI 10.1021/bi00120a020; DEELLIS D, 1991, THESIS NEW YORK MED; DRAPER DE, 1988, METHOD ENZYMOL, V164, P221; Eadie GS, 1942, J BIOL CHEM, V146, P85; FERSHT A, 1977, ENZYME STRUCTURE MEC, P171; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Lakowicz J.R., 1983, PRINCIPLES FLUORESCE, P44; LAX S, 1985, P NATL ACAD SCI USA, V82, P330, DOI 10.1073/pnas.82.2.330; LAX SR, 1986, METHOD ENZYMOL, V118, P109; LAX SR, 1986, J BIOL CHEM, V261, P5632; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; METZ AM, 1992, NUCLEIC ACIDS RES, V20, P4096, DOI 10.1093/nar/20.15.4096; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; RHOADS RE, 1993, J BIOL CHEM, V268, P3017; RICHARDSON RW, 1989, J BIOL CHEM, V264, P4725; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; SEAL SN, 1983, P NATL ACAD SCI-BIOL, V80, P6562, DOI 10.1073/pnas.80.21.6562; SECRIST JA, 1972, BIOCHEMISTRY-US, V11, P3499, DOI 10.1021/bi00769a001	26	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18599	18603						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360155				2022-12-27	WOS:A1993LV65900037
J	KUPPUSWAMY, D; DALTON, M; PIKE, LJ				KUPPUSWAMY, D; DALTON, M; PIKE, LJ			SERINE-1002 IS A SITE OF IN-VIVO AND IN-VITRO PHOSPHORYLATION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-INDUCED INTERNALIZATION; PROTEIN KINASE-C; MYELIN BASIC-PROTEIN; EGF RECEPTOR; TYROSINE KINASE; INDEPENDENT MECHANISMS; SELF-PHOSPHORYLATION; CARBOXYL TERMINUS; THREONINE; CELLS	We have shown previously that treatment of A431 cells with epidermal growth factor (EGF) induces desensitization of the EGF receptor. We now show that this desensitization is associated with an increase in the phosphorylation of the receptor on Ser-1002. Using a synthetic peptide corresponding to the sequence surrounding Ser-1002, p34cdc was identified as a kinase capable of phosphorylating this serine residue. Purified Xenopus p34cdc2 was found to phosphorylate the synthetic peptide on the serine residue corresponding to Ser-1002. This kinase also phosphorylated purified EGF receptor in vitro on Ser-1002. Phosphorylation of the EGF receptor by p34cdc2 was associated with a decrease in its tyrosine protein kinase activity. These data indicate that the EGF receptor may be a target for phosphorylation by a cyclin-dependent kinase in vivo and imply that receptor function may be regulated in a cell cycle-dependent fashion.			KUPPUSWAMY, D (corresponding author), WASHINGTON UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT BIOCHEM & MOLEC BIOPHYS,ST LOUIS,MO 63110, USA.							AHN NG, 1991, J BIOL CHEM, V266, P4220; ALVAREZ E, 1991, CELL, V266, P15277; AROIAN RV, 1990, NATURE, V348, P693, DOI 10.1038/348693a0; BANDARA LR, 1991, NATURE, V352, P249, DOI 10.1038/352249a0; BARGMANN CI, 1986, NATURE, V319, P223; BONISCHNETZLER M, 1987, P NATL ACAD SCI USA, V84, P7832, DOI 10.1073/pnas.84.22.7832; CHANG CP, 1991, J BIOL CHEM, V266, P23467; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; COCHET C, 1988, J BIOL CHEM, V263, P3290; COCHET C, 1984, J BIOL CHEM, V259, P2553; COHEN S, 1982, P NATL ACAD SCI-BIOL, V79, P6237, DOI 10.1073/pnas.79.20.6237; COHEN S, 1980, J BIOL CHEM, V255, P4834; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; COUNTAWAY JL, 1989, J BIOL CHEM, V264, P10828; COUNTAWAY JL, 1990, J BIOL CHEM, V265, P3407; CUNNINGHAM TW, 1989, J BIOL CHEM, V264, P15351; DAVIS RJ, 1985, P NATL ACAD SCI USA, V82, P1974, DOI 10.1073/pnas.82.7.1974; DAVIS RJ, 1988, J BIOL CHEM, V263, P9462; DECKER SJ, 1990, J BIOL CHEM, V265, P7009; DOWNWARD J, 1985, J BIOL CHEM, V260, P4538; FRIEDMAN BA, 1984, P NATL ACAD SCI-BIOL, V81, P3034, DOI 10.1073/pnas.81.10.3034; HALL FL, 1991, J BIOL CHEM, V266, P17430; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HEISERMANN GJ, 1988, J BIOL CHEM, V263, P13152; HEISERMANN GJ, 1990, J BIOL CHEM, V265, P12820; HSU SC, 1992, EMBO J, V11, P3457, DOI 10.1002/j.1460-2075.1992.tb05425.x; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; KUPPUSWAMY D, 1989, J BIOL CHEM, V264, P3357; KUPPUSWAMY D, 1991, CELL SIGNAL, V3, P107, DOI 10.1016/0898-6568(91)90017-O; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LIN CR, 1986, CELL, V44, P839, DOI 10.1016/0092-8674(86)90006-1; LUND KA, 1990, J BIOL CHEM, V265, P20517; NORTHWOOD IC, 1991, J BIOL CHEM, V266, P15266; PLOWMAN GD, 1990, P NATL ACAD SCI USA, V87, P4905, DOI 10.1073/pnas.87.13.4905; PYPAERT M, 1991, J CELL BIOL, V114, P1159, DOI 10.1083/jcb.114.6.1159; SANGHERA JS, 1990, FEBS LETT, V273, P223, DOI 10.1016/0014-5793(90)81090-B; SAVAGE CR, 1972, J BIOL CHEM, V247, P7609; SULLIVAN S, 1991, ANAL BIOCHEM, V197, P65, DOI 10.1016/0003-2697(91)90356-X; TAKISHIMA K, 1988, BIOCHEM BIOPH RES CO, V157, P740, DOI 10.1016/S0006-291X(88)80312-7; TAKISHIMA K, 1991, P NATL ACAD SCI USA, V88, P2520, DOI 10.1073/pnas.88.6.2520; THEROUX SJ, 1992, J BIOL CHEM, V267, P16620; USHIRO H, 1980, J BIOL CHEM, V255, P8363; WALTON GM, 1990, J BIOL CHEM, V265, P1750; WARREN G, 1989, NATURE, V342, P857, DOI 10.1038/342857a0; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034	49	29	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					19134	19142						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360196				2022-12-27	WOS:A1993LV65900111
J	SOEDA, S; HIRAIWA, M; OBRIEN, JS; KISHIMOTO, Y				SOEDA, S; HIRAIWA, M; OBRIEN, JS; KISHIMOTO, Y			BINDING OF CEREBROSIDES AND SULFATIDES TO SAPOSINS-A-D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSIDASE ACTIVATOR PROTEIN; PURIFICATION; BRAIN; GLUCOCEREBROSIDASE; SPLEEN	Saposins are a family of four small glycoproteins, all of which are derived from prosaposin, and are involved in the lysosomal hydrolysis of various sphingolipids. Results from this investigation demonstrate that saposins A-D bind to galactosyl- and glucosylceramide. The binding was highly dependent on the solution pH; maximum binding of glucosylceramide to all saposins occurred at pH 7. Maximum binding of galactosylceramide to saposins B and D occurred at a more basic pH (8.5). The binding of glucosylceramide to saposins was significantly inhibited by Mg2+, Ca2+, or Zn2+. Although maximum binding of sulfatide to saposins A, C, and D occurred at acidic pH, the binding to saposin B was maximum at pH 8.5. Saposin A also bound sphingomyelin or phosphatidylcholine at neutral pH. No significant binding was evident between these lipids and saposins B-D at any pH value. The existence of saposin-lipid complexes was further confirmed in selected samples by gel filtration, isoelectric focusing, and a TLC binding assay. We have also shown that galactosylceramide bound to saposins A-D was efficiently transported to a rat brain microsomal fraction. This result suggests that saposins and possibly their precursor, prosaposin, may be involved in membrane biogenesis such as the assembly of myelin and plasma membranes.	UNIV CALIF SAN DIEGO,CTR MOLEC GENET 0634J,9500 GILMAN DR,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,DEPT NEUROSCI,LA JOLLA,CA 92093	University of California System; University of California San Diego; University of California System; University of California San Diego					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS013559] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-08682, NS-13559] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE A, 1985, J BIOL CHEM, V260, P1231; BERENT SL, 1981, ARCH BIOCHEM BIOPHYS, V208, P248, DOI 10.1016/0003-9861(81)90147-8; BERENT SL, 1981, BIOCHIM BIOPHYS ACTA, V664, P572, DOI 10.1016/0005-2760(81)90134-X; BOHLEY P, 1992, EXPERIENTIA, V48, P151, DOI 10.1007/BF01923508; CABACUNGAN JC, 1982, ANAL BIOCHEM, V124, P272, DOI 10.1016/0003-2697(82)90038-0; Dittmer J, 1969, METHOD ENZYMOL, V14, P482, DOI [DOI 10.1016/S0076-6879(69)14055-0, 10.1016/S0076-6879(69)14055-0]; FLUHARTY AL, 1992, BIOCHEM MED METAB B, V47, P86, DOI 10.1016/0885-4505(92)90010-V; HERSCHKO.N, 1968, J NEUROCHEM, V15, P1181, DOI 10.1111/j.1471-4159.1968.tb06835.x; HERSCHKOWITZ N, 1969, J NEUROCHEM, V16, P1049, DOI 10.1111/j.1471-4159.1969.tb05949.x; HIRAIWA M, 1992, P NATL ACAD SCI USA, V89, P11254, DOI 10.1073/pnas.89.23.11254; JUNGALWALA FB, 1974, J LIPID RES, V15, P114; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; LI SC, 1976, J BIOL CHEM, V251, P1159; LOWRY OH, 1951, J BIOL CHEM, V193, P265; METZ RJ, 1982, J BIOL CHEM, V257, P2901; MORIMOTO S, 1989, P NATL ACAD SCI USA, V86, P3389, DOI 10.1073/pnas.86.9.3389; NARIMATSU S, 1986, BIOCHIM BIOPHYS ACTA, V877, P334; NONAKA G, 1979, J NEUROCHEM, V33, P23, DOI 10.1111/j.1471-4159.1979.tb11701.x; OBRIEN JS, 1988, SCIENCE, V241, P1098, DOI 10.1126/science.2842863; OBRIEN JS, 1991, FASEB J, V5, P301, DOI 10.1096/fasebj.5.3.2001789; PETERS SP, 1977, J BIOL CHEM, V252, P563; PLEASURE DE, 1972, J NEUROCHEM, V19, P283, DOI 10.1111/j.1471-4159.1972.tb01338.x; SANO A, 1989, BIOCHEM BIOPH RES CO, V165, P1191, DOI 10.1016/0006-291X(89)92728-9; VOGEL A, 1991, EUR J BIOCHEM, V200, P591, DOI 10.1111/j.1432-1033.1991.tb16222.x; WENGER DA, 1984, MOL BASIS LYSOSOMAL, P1; YAHARA S, 1980, BIOCHIM BIOPHYS ACTA, V619, P177, DOI 10.1016/0005-2760(80)90066-1	26	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18519	18523						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360153				2022-12-27	WOS:A1993LV65900025
J	DLUZ, SM; HIGASHIYAMA, S; DAMM, D; ABRAHAM, JA; KLAGSBRUN, M				DLUZ, SM; HIGASHIYAMA, S; DAMM, D; ABRAHAM, JA; KLAGSBRUN, M			HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH-FACTOR EXPRESSION IN CULTURED FETAL HUMAN VASCULAR SMOOTH-MUSCLE CELLS - INDUCTION OF MESSENGER-RNA LEVELS AND SECRETION OF ACTIVE MITOGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; ARTERIAL INJURY; FACTOR PDGF; GENE; EGF; PROLIFERATION; PROTEIN; RECEPTOR; ALPHA; ATHEROSCLEROSIS	Heparin-binding EGF-like growth factor (HB-EGF) is a recently identified potent mitogen for smooth muscle cells (SMC). To explore whether SMC can also synthesize HB-EGF, cultured fetal human vascular SMC (FHVSMC) were analyzed for the production of HB-EGF mRNA and active growth factor. It was found that in FHVSMC, HB-EGF has the characteristics of an early response gene in that (i) the addition of fresh 10% fetal calf serum to serum-starved FHVSMC led to a rapid and transient rise in HB-EGF mRNA levels with a maximal induction of 12-14-fold occurring within 2-4 h, (ii) the phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA) also elevated HB-EGF mRNA levels rapidly and transiently with a maximal induction of 7-8-fold occurring at 2-4 h, and (iii) cyclohexamide at 40 mug/ml markedly increased basal, serum-, and TPA-induced HB-EGF mRNA levels. In addition, HB-EGF mRNA levels were increased 7-11-fold by addition of either HB-EGF itself, platelet-derived growth factor, or basic fibroblast growth factor, all potent SMC mitogens. Besides synthesizing HB-EGF mRNA, FHVSMC were found to release into conditioned medium a bioactive HB-EGF-like protein that cross-reacted with anti-HB-EGF antibody.	CHILDRENS HOSP MED CTR, DEPT SURG RES, 300 LONGWOOD AVE, BOSTON, MA 02115 USA; CHILDRENS HOSP MED CTR, DEPT BIOL CHEM & MOLEC PHARMACOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA; SCIOS NOVA INC, MT VIEW, CA 94043 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Scios					NATIONAL CANCER INSTITUTE [R01CA037392, R37CA037392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047397] Funding Source: NIH RePORTER; NCI NIH HHS [CA 37392] Funding Source: Medline; NIGMS NIH HHS [GM 47397] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAM JA, 1993, BIOCHEM BIOPH RES CO, V190, P125, DOI 10.1006/bbrc.1993.1020; ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; ANKLESARIA P, 1990, P NATL ACAD SCI USA, V87, P3289, DOI 10.1073/pnas.87.9.3289; BESNER G, 1990, CELL REGUL, V1, P811, DOI 10.1091/mbc.1.11.811; BRACHMANN R, 1989, CELL, V56, P691, DOI 10.1016/0092-8674(89)90591-6; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; GOSPODAROWICZ D, 1988, EUR J CELL BIOL, V46, P144; HERMAN IM, 1985, J CELL BIOL, V101, P43, DOI 10.1083/jcb.101.1.43; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; IBERG N, 1989, J BIOL CHEM, V264, P19951; JOHNSTON RF, 1990, ELECTROPHORESIS, V11, P355, DOI 10.1002/elps.1150110503; KLAGSBRUN M, 1989, ARTERIOSCLEROSIS, V9, P269, DOI 10.1161/01.ATV.9.3.269; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LIBBY P, 1988, NEW ENGL J MED, V318, P1493, DOI 10.1056/NEJM198806093182303; LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739; MAJACK RA, 1990, J CELL BIOL, V111, P239, DOI 10.1083/jcb.111.1.239; MAJESKY MW, 1990, J CELL BIOL, V111, P2149, DOI 10.1083/jcb.111.5.2149; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; OLSON NE, 1992, AM J PATHOL, V140, P1017; POWELL PP, 1991, MOL BRAIN RES, V11, P71, DOI 10.1016/0169-328X(91)90023-Q; RAINES EW, 1989, SCIENCE, V243, P393, DOI 10.1126/science.2783498; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; SEJERSEN T, 1986, P NATL ACAD SCI USA, V83, P6844, DOI 10.1073/pnas.83.18.6844; SIMMONS DL, 1992, MOL CELL BIOL, V12, P4164, DOI 10.1128/MCB.12.9.4164; SJOLUND M, 1988, J CELL BIOL, V106, P403, DOI 10.1083/jcb.106.2.403; TEMIZER DH, 1992, J BIOL CHEM, V267, P24892; VALENTE AJ, 1988, J CELL PHYSIOL, V136, P479, DOI 10.1002/jcp.1041360312; VLODAVSKY I, 1987, J CELL PHYSIOL, V131, P402, DOI 10.1002/jcp.1041310312; WALKER LN, 1986, P NATL ACAD SCI USA, V83, P7311, DOI 10.1073/pnas.83.19.7311; Weich HA, 1990, GROWTH FACTORS, V2, P313, DOI 10.3109/08977199009078019; WINKLES JA, 1987, P NATL ACAD SCI USA, V84, P7124, DOI 10.1073/pnas.84.20.7124; WONG ST, 1989, CELL, V56, P495, DOI 10.1016/0092-8674(89)90252-3; YOSHIZUMI M, 1992, J BIOL CHEM, V267, P9467	38	132	133	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18330	18334						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349708				2022-12-27	WOS:A1993LT74300100
J	KAO, JY; GOLJER, I; PHAN, TA; BOLTON, PH				KAO, JY; GOLJER, I; PHAN, TA; BOLTON, PH			CHARACTERIZATION OF THE EFFECTS OF A THYMINE GLYCOL RESIDUE ON THE STRUCTURE, DYNAMICS, AND STABILITY OF DUPLEX DNA BY NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDEHYDIC ABASIC SITES; IONIZING-RADIATION; RESONANCE SPECTROSCOPY; MAGNETIC-RESONANCE; THYMIDINE GLYCOL; ESCHERICHIA-COLI; OXIDATIVE DAMAGE; NUCLEIC-ACIDS; POLYMERASE-I; LESIONS	A duplex DNA containing a single thymine glycol (5,6-dihydroxy-5,6-dihydrothymidine) has been studied by NMR and other methods. Oxidative stress, ionizing radiation, and other causes can induce the oxidation of thymine to thymine glycol. The presence of thymine glycol is known to have significant biological consequences, and there are repair enzymes for thymine glycol in a wide range of organisms. These studies have been carried out on the DNA duplex of d(C1G2C3A4G5Tg6C7A8G9C10C11) paired with d(G22C21G20T19C18A17G16T15C14G13G12), with Tg indicating thymine glycol. The presence of thymine glycol lowers the thermal stability of duplex DNA. The NMR results indicate that thymine glycol induces a large, localized structural change in duplex DNA with the thymine glycol base being extrahelical as well as the opposing base on the complementary strand. This structural information is consistent with the biological consequences of thymine glycol in DNA.	WESLEYAN UNIV, DEPT CHEM, MIDDLETOWN, CT 06459 USA	Wesleyan University					NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002781, P41RR002301] Funding Source: NIH RePORTER; NCRR NIH HHS [RR02781, RR02301] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BASU AK, 1989, P NATL ACAD SCI USA, V86, P7677, DOI 10.1073/pnas.86.20.7677; CADET J, 1977, TETRAHEDRON, V33, P1603, DOI 10.1016/0040-4020(77)80169-5; CADET J, 1979, BIOCHIM BIOPHYS ACTA, V563, P206, DOI 10.1016/0005-2787(79)90021-2; CADET J, 1986, BIOCHIMIE, V68, P813, DOI 10.1016/S0300-9084(86)80097-9; CATHCART R, 1984, P NATL ACAD SCI-BIOL, V81, P5633, DOI 10.1073/pnas.81.18.5633; CLARK JM, 1986, NUCLEIC ACIDS RES, V14, P737, DOI 10.1093/nar/14.2.737; CLORE GM, 1989, CRIT REV BIOCHEM MOL, V24, P479, DOI 10.3109/10409238909086962; CULLIS PM, 1987, NATURE, V330, P773, DOI 10.1038/330773a0; DEMPLE B, 1982, NUCLEIC ACIDS RES, V10, P3781, DOI 10.1093/nar/10.12.3781; DEMPLE B, 1982, J BIOL CHEM, V257, P2848; DEMPLE B, 1991, OXIDATIVE STRESS, V2, P119; EKERT B, 1959, NATURE, V184, pBA58, DOI 10.1038/184058a0b; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; FREIDBERG EC, 1985, DNA REPAIR; FRIEDBERG EC, 1988, MICROBIOL REV, V52, P70, DOI 10.1128/MMBR.52.1.70-102.1988; GEORGE AM, 1987, PROG BIOPHYS MOL BIO, V50, P121, DOI 10.1016/0079-6107(87)90012-5; GOLJER I, 1992, BIOCHEMISTRY-US, V31, P11614, DOI 10.1021/bi00161a047; HARE D, 1986, BIOCHEMISTRY-US, V25, P7456, DOI 10.1021/bi00371a030; HAYES RC, 1988, J MOL BIOL, V201, P239, DOI 10.1016/0022-2836(88)90135-0; HAYES RC, 1986, NUCLEIC ACIDS RES, V14, P1045, DOI 10.1093/nar/14.2.1045; HRUSKA FE, 1987, CAN J CHEM, V65, P2618, DOI 10.1139/v87-432; IDE H, 1985, NUCLEIC ACIDS RES, V13, P8035, DOI 10.1093/nar/13.22.8035; IIDA S, 1970, BIOCHIM BIOPHYS ACTA, V213, P1, DOI 10.1016/0005-2787(70)90002-X; JOSHUATOR L, 1988, NATURE, V334, P82, DOI 10.1038/334082a0; KALNIK MW, 1989, BIOCHEMISTRY-US, V28, P294, DOI 10.1021/bi00427a040; LETT JT, 1990, PROG NUCLEIC ACID RE, V309, P305; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; MAZUMDER A, 1991, BIOCHEMISTRY-US, V30, P1119, DOI 10.1021/bi00218a033; MAZUMDER A, 1989, J AM CHEM SOC, V111, P8209; MILLER M, 1988, NATURE, V334, P85, DOI 10.1038/334085a0; MORDEN KM, 1990, BIOCHEMISTRY-US, V29, P8835, DOI 10.1021/bi00489a047; MORDEN KM, 1983, BIOCHEMISTRY-US, V22, P5557, DOI 10.1021/bi00293a016; NIKONOWICZ E, 1989, BIOCHEMISTRY-US, V28, P8714, DOI 10.1021/bi00448a007; NINKOWSKI EP, 1990, BIOCHEMISTRY-US, V29, P4193; ROUET P, 1985, CANCER RES, V45, P6113; SYMONS MCR, 1987, J CHEM SOC FARAD T 1, V83, P1, DOI 10.1039/f19878300001; TEEBOR GW, 1988, INT J RADIAT BIOL, V54, P131, DOI 10.1080/09553008814551591; TEOULE R, 1987, INT J RADIAT BIOL, V51, P573, DOI 10.1080/09553008414552111; VAISHNAV Y, 1991, J BIOMOL STRUCT DYN, V8, P935, DOI 10.1080/07391102.1991.10507858; VANDENHOOGEN YT, 1988, NUCLEIC ACIDS RES, V16, P2971, DOI 10.1093/nar/16.7.2971; Von Sonntag C, 1987, CHEM BASIS RAD BIOL; VONSONNTAG C, 1990, METHOD ENZYMOL, V186, P511; WAGNER JR, 1990, METHOD ENZYMOL, V186, P502; WALLACE SS, 1988, ENVIRON MOL MUTAGEN, V12, P431, DOI 10.1002/em.2860120411; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; WITHKA JM, 1991, BIOCHEMISTRY-US, V30, P9931, DOI 10.1021/bi00105a017; Wuthrich K., 1986, NMR PROTEINS NUCL AC	47	89	89	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17787	17793						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349663				2022-12-27	WOS:A1993LT74300026
J	BOUCHER, PD; RUCH, RJ; HINES, RN				BOUCHER, PD; RUCH, RJ; HINES, RN			SPECIFIC NUCLEAR-PROTEIN BINDING TO A NEGATIVE REGULATORY ELEMENT ON THE HUMAN CYP1A1 GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROCARBON HYDROXYLASE-ACTIVITY; LUNG-CANCER; CYTOCHROME-P450IA1 GENE; TRANSCRIPTION FACTOR; FUNCTIONAL-ANALYSIS; OMEGA-HYDROXYLASE; DIOXIN RECEPTOR; HUMAN-PLACENTA; BREAST-CANCER; AH RECEPTOR	Employing reporter gene/CYP1A1 chimeric plasmids, we previously identified a 275-base pair (bp) cis-element (-833 to -558; NRE275) that down-regulated the CYP1A1 promoter. In the present study, this negative regulatory activity was further localized to two subfragments of 105 bp (-833 to -728; NRE105) and 170 bp (-728 to -558; NRE,70), each of which exhibited activity with a heterologous promoter/enhancer. Co-transfection studies demonstrated a dependence on cellular trans-acting factors present at limiting concentrations. Electrophoretic mobility shift assays revealed the presence of protein(s) that specifically bound to NRE275, NRE105, and NRE170. Based upon competition studies, the protein(s) that bound to NRE105 appeared to recognize sites similar to those recognized by the NRE170-binding proteins. DNase I footprint analysis of NRE105 demonstrated nuclear protein binding to a 21-bp palindrome (-794 to -774). Protection was also observed along conserved guanine/cytosine-rich sequences that flank the palindrome, but in a strand-specific manner. Guanine residues involved in protein binding were identified by methylation interference experiments. Based on transient expression assays with each of the three NRE105 components, all three appear to be necessary for complete negative regulatory activity. However, it is clear the palindrome is the most important sequence with the guanine/cytosine-rich elements playing an ancillary role.	WAYNE STATE UNIV, SCH MED, DEPT PHARMACOL, 540 E CANFIELD, DETROIT, MI 48201 USA	Wayne State University				Hines, Ronald/0000-0002-3094-4200	NATIONAL CANCER INSTITUTE [T32CA009531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003832] Funding Source: NIH RePORTER; NCI NIH HHS [CA09531] Funding Source: Medline; NIEHS NIH HHS [ES03832, ES05530] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; BALDWIN AS, 1988, CURRENT PROTOCOLS MO; BEATO M, 1991, FASEB J, V5, P2044, DOI 10.1096/fasebj.5.7.2010057; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BRENOWITZ M, 1986, CURRENT PROTOCOLS MO; CHODOSH LA, 1988, CURRENT PROTOCOLS MO; CRABB DW, 1987, ANAL BIOCHEM, V163, P88, DOI 10.1016/0003-2697(87)90096-0; DENISON MS, 1988, J BIOL CHEM, V263, P17221; FISHER JM, 1990, J BIOL CHEM, V265, P9676; FUJINO T, 1984, CANCER RES, V44, P3916; FUJISAWASEHARA A, 1987, NUCLEIC ACIDS RES, V15, P4179, DOI 10.1093/nar/15.10.4179; GIACHELLI CM, 1991, J BIOL CHEM, V266, P3981; GONZALEZ FJ, 1985, NUCLEIC ACIDS RES, V13, P7269, DOI 10.1093/nar/13.20.7269; GUENGERICH FP, 1989, ANNU REV PHARMACOL, V29, P241; GUENGERICH FP, 1987, MAMMALIAN CYTOCHROME, P1; HAHN S, 1989, P NATL ACAD SCI USA, V86, P5718, DOI 10.1073/pnas.86.15.5718; HAYASHI S, 1991, J BIOCHEM-TOKYO, V110, P407, DOI 10.1093/oxfordjournals.jbchem.a123594; HINES RN, 1988, CARCINOGENESIS, V9, P1599, DOI 10.1093/carcin/9.9.1599; HINES RN, 1991, TOXICOLOGIST, V11, P176; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; HUANG MTF, 1990, MOL CELL BIOL, V10, P1805, DOI 10.1128/MCB.10.4.1805; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; Jefcoate C.R., 1986, CYTOCHROME P 450 STR, P387; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; KADLUBAR FF, 1987, MAMMALIAN CYTOCHROME, V2, P81; KAWAJIRI K, 1990, FEBS LETT, V263, P131, DOI 10.1016/0014-5793(90)80721-T; KELLERMANN G, 1973, NEW ENGL J MED, V289, P934, DOI 10.1056/NEJM197311012891802; KIKUTA Y, 1990, J BIOCHEM, V107, P280, DOI 10.1093/oxfordjournals.jbchem.a123039; KIMURA S, 1987, EMBO J, V6, P1929, DOI 10.1002/j.1460-2075.1987.tb02453.x; KIMURA S, 1987, Journal of Experimental Pathology (New York), V3, P61; KINGSTON RE, 1992, CURRENT PROTOCOLS MO; KOURI RE, 1982, CANCER RES, V42, P5030; KOURI RE, 1977, ORIGINS HUMAN CANCER, P811; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MAXWELL IH, 1989, BIOTECHNIQUES, V7, P276; MCLEMORE TL, 1990, J NATL CANCER I, V82, P1333, DOI 10.1093/jnci/82.16.1333; MCLEMORE TL, 1989, J NATL CANCER I, V81, P1787, DOI 10.1093/jnci/81.23.1787; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MUERHOFF AS, 1990, METHOD ENZYMOL, V187, P253; MURRAY GI, 1991, BRIT J CANCER, V63, P1021, DOI 10.1038/bjc.1991.222; NARDELLI J, 1991, NATURE, V349, P175, DOI 10.1038/349175a0; NEBERT DW, 1991, DNA CELL BIOL, V10, P1, DOI 10.1089/dna.1991.10.1; PELKONEN O, 1982, PHARMACOL REV, V34, P189; PETERSEN DD, 1991, AM J HUM GENET, V48, P720; PONCE E, 1991, BIOCHEMISTRY-US, V30, P2961, DOI 10.1021/bi00225a033; POTHIER F, 1992, DNA CELL BIOL, V11, P83, DOI 10.1089/dna.1992.11.83; PUGA A, 1990, DNA CELL BIOL, V9, P425, DOI 10.1089/dna.1990.9.425; PYYKKO K, 1991, BRIT J CANCER, V63, P596, DOI 10.1038/bjc.1991.138; RAYCHAUDHURI B, 1990, MOL ENDOCRINOL, V4, P1773, DOI 10.1210/mend-4-12-1773; RENKAWITZ R, 1990, TRENDS GENET, V6, P192, DOI 10.1016/0168-9525(90)90176-7; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; SAATCIOGLU F, 1990, MOL CELL BIOL, V10, P6408, DOI 10.1128/MCB.10.12.6408; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SONG BJ, 1985, SCIENCE, V228, P490, DOI 10.1126/science.2580351; WATERMAN MR, 1990, BIOCHEM SOC T, V18, P26, DOI 10.1042/bst0180026; WATSON AJ, 1992, MOL CELL BIOL, V12, P2115, DOI 10.1128/MCB.12.5.2115; WEIHER H, 1984, NUCLEIC ACIDS RES, V12, P2901, DOI 10.1093/nar/12.6.2901; WHITLOCK JP, 1986, ANNU REV PHARMACOL, V26, P333; WILHELMSSON A, 1990, EMBO J, V9, P69, DOI 10.1002/j.1460-2075.1990.tb08081.x	62	75	75	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17384	17391						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349622				2022-12-27	WOS:A1993LQ98800074
J	CANTIELLO, HF; PRAT, AG; BONVENTRE, JV; CUNNINGHAM, CC; HARTWIG, JH; AUSIELLO, DA				CANTIELLO, HF; PRAT, AG; BONVENTRE, JV; CUNNINGHAM, CC; HARTWIG, JH; AUSIELLO, DA			ACTIN-BINDING PROTEIN CONTRIBUTES TO CELL-VOLUME REGULATORY ION CHANNEL ACTIVATION IN MELANOMA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							POTASSIUM CONDUCTANCE; APICAL MEMBRANE; BARIUM; CYTOSKELETON; INHIBITION; EPITHELIUM; TUBULES	The cell volume regulatory response to a hypotonic stimulus is frequently initiated by activation of K+ and Cl- channels. We have characterized the hypotonic cell volume regulatory response of human melanoma cells devoid of actin-binding protein (ABP) and their genetically rescued counterpart transfected with the cDNA for ABP. ABP-deficient cells were unable to volume-regulate or activate K+ channels when exposed to a hypotonic stimulus. Genetic rescue with ABP resulted in recovery of both the cell volume regulatory response and the osmotically linked K+ channel activation. These data are consistent with a functional interaction between the actin cytoskeleton and osmotically sensitive ion transport.	MASSACHUSETTS GEN HOSP,RENAL UNIT,BOSTON,MA 02114; BRIGHAM & WOMENS HOSP,DIV EXPTL MED,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02129	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School								CANTIELLO HF, 1990, J BIOL CHEM, V265, P21624; CANTIELLO HF, 1991, AM J PHYSIOL, V261, pC882, DOI 10.1152/ajpcell.1991.261.5.C882; CHRISTENSEN O, 1987, NATURE, V330, P66, DOI 10.1038/330066a0; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; FALKE LC, 1989, J GEN PHYSIOL, V94, pA34; FOSKETT JK, 1985, AM J PHYSIOL, V248, pC27, DOI 10.1152/ajpcell.1985.248.1.C27; FOX JEB, 1985, J BIOL CHEM, V260, P1970; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Hartwig JH, 1991, CURR OPIN CELL BIOL, V3, P87, DOI 10.1016/0955-0674(91)90170-4; KAWAHARA K, 1985, J MEMBRANE BIOL, V88, P283, DOI 10.1007/BF01871092; LEWIS SA, 1990, NEWS PHYSIOL SCI, V5, P112; LINSHAW MA, 1991, AM J PHYSIOL, V261, pF60, DOI 10.1152/ajprenal.1991.261.1.F60; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; MELMED RN, 1981, J CELL BIOL, V90, P761, DOI 10.1083/jcb.90.3.761; NAGEL W, 1979, BIOCHIM BIOPHYS ACTA, V552, P346, DOI 10.1016/0005-2736(79)90289-X; OHTA Y, 1991, CELL, V67, P1; OKADA Y, 1989, NEWS PHYSIOL SCI, V4, P238; ONIEL RG, 1988, J MEMBRANE BIOL, V91, P469; PLANELLES G, 1981, N-S ARCH PHARMACOL, V318, P135; REUSS L, 1988, RENAL PHYSIOL BIOCH, V11, P187; SACKIN H, 1989, P NATL ACAD SCI USA, V86, P1731, DOI 10.1073/pnas.86.5.1731; SCHULTZ SG, 1989, NEWS PHYSIOL SCI, V4, P169; UBL J, 1988, J MEMBRANE BIOL, V104, P223, DOI 10.1007/BF01872324; VANDRIESSCHE W, 1980, J MEMBRANE BIOL, V56, P31, DOI 10.1007/BF01869349; WELLING PA, 1985, AM J PHYSIOL, V249, pF20, DOI 10.1152/ajprenal.1985.249.1.F20; WELSH MJ, 1983, AM J PHYSIOL, V244, pF639, DOI 10.1152/ajprenal.1983.244.6.F639; ZIYADEH FN, 1992, AM J PHYSIOL, V262, pF468, DOI 10.1152/ajprenal.1992.262.3.F468	27	132	136	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1993	268	7					4596	4599						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP884	8383118				2022-12-27	WOS:A1993KP88400008
J	GREGORY, JD; SERPERSU, EH				GREGORY, JD; SERPERSU, EH			ARRANGEMENT OF SUBSTRATES AT THE ACTIVE-SITE OF YEAST PHOSPHOGLYCERATE KINASE - EFFECT OF SULFATE ION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMIUM(III) ADENOSINE 5'-TRIPHOSPHATE; 3-PHOSPHOGLYCERATE KINASE; MAGNETIC-RESONANCE; BINDING-SITE; STAPHYLOCOCCAL NUCLEASE; DIRECTED MUTAGENESIS; ENZYME; RELAXATION; 5'-DIPHOSPHATE; COMPLEXES	Beta-gamma-bidentate CrATP, a stable exchange-inert metal-nucleotide analog, was used as a probe of the conformation of the substrates at the active site of yeast phosphoglycerate kinase (PGK). The paramagnetic effects of Cr3+ on the longitudinal relaxation rates (1/T1p) of the H-1, P-31, and C-13 nuclei of 3-phospho-D-glycerate (3PGA) were examined to determine the distances between enzyme-bound CrATP and the nuclei of 3PGA in the ternary PGK.CrATP.3PGA complex. Kinetic studies indicated that K(i(CrATP)) was dependent on the concentration of 3PGA that was abolished in the presence of activator sulfate ion. Similarly, NMR studies showed that the environment of CrATP bound at the active site was altered by the presence of sulfate ion. The determined metal-to-nucleus distances show the close proximity of the substrates at the active site of PGK, which is consistent with a hinge-bending mechanism of the enzyme for bringing the two substrates together. Additionally, the presence of an activating concentration of sulfate was observed to cause significant changes in both the relative Cr3+-to-3PGA distances and the overall conformation of 3PGA when compared to the findings in the absence of sulfate. This is consistent with the active site being in a ''less closed'' configuration when sulfate is present. Under both conditions, models can be constructed that allow for direct transfer of a phosphoryl group between the bound substrates.	UNIV TENNESSEE,DEPT BIOCHEM,M407 WALTERS SCI BLDG,KNOXVILLE,TN 37996	University of Tennessee System; University of Tennessee Knoxville					NCRR NIH HHS [RR02231] Funding Source: Medline; NIGMS NIH HHS [R29 GM422661] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002231] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BANKS RD, 1979, NATURE, V279, P773, DOI 10.1038/279773a0; BEISENHERZ G, 1955, METHOD ENZYMOL, V1, P391, DOI 10.1016/0076-6879(55)01063-X; BLAKE CCF, 1981, PHILOS T ROY SOC B, V293, P93, DOI 10.1098/rstb.1981.0063; Bucher T, 1942, NATURWISSENSCHAFTEN, V30, P756, DOI 10.1007/BF01488658; CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630; DUNAWAYMARIANO D, 1980, BIOCHEMISTRY-US, V19, P1496, DOI 10.1021/bi00548a037; DUNAWAYMARIANO D, 1980, BIOCHEMISTRY-US, V19, P1506, DOI 10.1021/bi00548a038; FAIRBROTHER WJ, 1989, EUR J BIOCHEM, V183, P57, DOI 10.1111/j.1432-1033.1989.tb14896.x; FREEMAN R, 1971, J CHEM PHYS, V54, P3367, DOI 10.1063/1.1675352; FRY DC, 1985, BIOCHEMISTRY-US, V24, P4680, DOI 10.1021/bi00338a030; GREGORY JD, 1991, FASEB J, V5, pA1149; GUPTA RK, 1976, J BIOL CHEM, V251, P2421; HARLOS K, 1992, PROTEINS, V12, P133, DOI 10.1002/prot.340120207; JAFFE EK, 1982, J BIOL CHEM, V257, P7650; JOAO HC, 1992, EUR J BIOCHEM, V205, P93, DOI 10.1111/j.1432-1033.1992.tb16755.x; KHAMIS MM, 1981, BIOCHIM BIOPHYS ACTA, V657, P190, DOI 10.1016/0005-2744(81)90142-X; KULBE KD, 1982, METHOD ENZYMOL, V90, P115; MANDL I, 1957, METHOD ENZYMOL, V3, P208, DOI 10.1016/S0076-6879(57)03374-1; MAS MT, 1987, BIOCHEMISTRY-US, V26, P5369, DOI 10.1021/bi00391a023; Mildvan A S, 1972, Methods Enzymol, V26, P654; MINARD P, 1990, PROTEIN ENG, V3, P515, DOI 10.1093/protein/3.6.515; MOORE JM, 1985, BIOCHEMISTRY-US, V24, P5328, DOI 10.1021/bi00341a009; PICKOVER CA, 1979, J BIOL CHEM, V254, P1323; RAO BDN, 1978, J BIOL CHEM, V253, P8056; RAY BD, 1988, BIOCHEMISTRY-US, V27, P5579, DOI 10.1021/bi00415a028; RAY BD, 1988, BIOCHEMISTRY-US, V27, P5574, DOI 10.1021/bi00415a027; REED GH, 1970, J BIOL CHEM, V245, P6547; ROUSTAN C, 1980, BIOCHEMISTRY-US, V19, P5168, DOI 10.1021/bi00564a003; SCHIERBECK B, 1979, BIOCHIM BIOPHYS ACTA, V568, P195, DOI 10.1016/0005-2744(79)90286-9; SCOPES RK, 1971, BIOCHEM J, V122, P89, DOI 10.1042/bj1220089; SCOPES RK, 1978, EUR J BIOCHEM, V85, P503, DOI 10.1111/j.1432-1033.1978.tb12266.x; SCOPES RK, 1978, EUR J BIOCHEM, V91, P119, DOI 10.1111/j.1432-1033.1978.tb20944.x; SERPERSU EH, 1987, BIOCHEMISTRY-US, V26, P1289, DOI 10.1021/bi00379a014; SERPERSU EH, 1988, BIOCHEMISTRY-US, V27, P8034, DOI 10.1021/bi00421a010; SERPERSU EH, 1992, J INORG BIOCHEM, V48, P203, DOI 10.1016/0162-0134(92)84031-H; SHERMAN MA, 1991, PROTEIN ENG, V4, P935, DOI 10.1093/protein/4.8.935; TANSWELL P, 1976, EUR J BIOCHEM, V63, P249, DOI 10.1111/j.1432-1033.1976.tb10227.x; WATSON HC, 1982, EMBO J, V1, P1635, DOI 10.1002/j.1460-2075.1982.tb01366.x; WEBB MR, 1980, J BIOL CHEM, V255, P1775; WIKSELL E, 1987, J BIOL CHEM, V262, P14472; WOLKERS WF, 1991, J BIOL CHEM, V266, P20761; WROBEL JA, 1978, EUR J BIOCHEM, V85, P345, DOI 10.1111/j.1432-1033.1978.tb12245.x; [No title captured]	43	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					3880	3888						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382681				2022-12-27	WOS:A1993KN53300017
J	SASAKI, Y; ZHANG, XF; NISHIYAMA, M; AVRUCH, J; WANDS, JR				SASAKI, Y; ZHANG, XF; NISHIYAMA, M; AVRUCH, J; WANDS, JR			EXPRESSION AND PHOSPHORYLATION OF INSULIN-RECEPTOR SUBSTRATE-1 DURING RAT-LIVER REGENERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							EPIDERMAL GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; SIGNAL TRANSDUCTION; KINASE; AUTOPHOSPHORYLATION; ACTIVATION; ONCOGENES; PROTEINS; BLOOD	Insulin has been shown to be important for normal liver regeneration to occur. The mechanisms whereby insulin may exert its effects on hepatocyte growth, however, are still unknown. The rat and human insulin receptor substrate 1 (IRS-1) is a specific target molecule for the insulin receptor beta subunit kinase and will bind to signal transducing molecules containing Src homology 2 domains through its multiple tyrosyl phosphorylation (TP) sites. This investigation examined how IRS-1 may be involved in insulin action during hepatocyte growth induced by two-thirds partial hepatectomy. The TP of IRS-1 was strikingly enhanced prior to the major wave of hepatocyte DNA synthesis at 24 h; IRS-1 protein and mRNA expression increased in parallel to a lesser extent after partial hepatectomy. TP of insulin receptor beta subunit, which enhances its kinase activity toward IRS-1, was increased in association with TP of IRS-1. Finally, phosphatidylinositol 3-kinase, one of signal transducing molecules containing Src homology 2 domains, was associated with IRS-1 following TP in vivo. These observations suggest that IRS-1 protein may play an important role in transmitting the insulin signal to intracellular regulators involved in hepatocyte growth.	MASSACHUSETTS GEN HOSP,CTR CANC,MOLEC HEPATOL LAB,149 13TH ST,7TH FLOOR,BOSTON,MA 02129; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DIABET UNIT,BOSTON,MA 02129	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital					NCI NIH HHS [CA-35711] Funding Source: Medline; NIAAA NIH HHS [AA-08169, AA-02666] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA035711, R37CA035711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA002666, R01AA008169, R37AA002666] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		AVRUCH J, 1982, J BIOL CHEM, V257, P5162; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BERGERON JJM, 1985, ANNU REV PHYSIOL, V47, P383; BUCHER NLR, 1973, CANCER RES, V33, P3189; BUCHER NLR, 1978, CIBA F S, V55, P95; Bucher NRL, 1971, REGENERATION LIVER K, P17; BURGESS JW, 1992, J BIOL CHEM, V267, P10077; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; DOHERTY JJ, 1990, J CELL BIOL, V110, P35, DOI 10.1083/jcb.110.1.35; EBINA Y, 1987, P NATL ACAD SCI USA, V84, P704, DOI 10.1073/pnas.84.3.704; FAURE R, 1992, J BIOL CHEM, V267, P11215; FISHER EH, 1991, SCIENCE, V253, P401; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; GRISHAM JW, 1962, CANCER RES, V22, P842; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; HARLOW E, 1988, ANTIBODIES LAB MANUA, P53; Higgins GM, 1931, ARCH PATHOL, V12, P186; KADOWAKI T, 1987, J BIOL CHEM, V262, P7342; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KWOK YC, 1986, ARCH BIOCHEM BIOPHYS, V244, P102, DOI 10.1016/0003-9861(86)90098-6; Leffert H. L., 1978, CIBA F S, V55, P61; MCGLADE CJ, 1992, MOL CELL BIOL, V12, P991, DOI 10.1128/MCB.12.3.991; MEYEROVITCH J, 1991, J CLIN INVEST, V87, P1286, DOI 10.1172/JCI115131; NISHIYAMA M, 1992, BIOCHEM BIOPH RES CO, V183, P280, DOI 10.1016/0006-291X(92)91640-C; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; Sambrook J, 1989, MOL CLONING LABORATO; STARZL TE, 1973, SURG GYNECOL OBSTET, V137, P179; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WANDS JR, 1979, GASTROENTEROLOGY, V77, P526; WHITE MF, 1988, J BIOL CHEM, V263, P2969; YOUNGER LR, 1966, CANCER RES, V26, P1408	33	59	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					3805	3808						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382678				2022-12-27	WOS:A1993KN53300003
J	ERICKSON, JW; CERIONE, RA				ERICKSON, JW; CERIONE, RA			REGULATION OF THE CGMP PHOSPHODIESTERASE IN BOVINE ROD OUTER SEGMENTS - USE OF RESONANCE ENERGY-TRANSFER TO DISTINGUISH BETWEEN ASSOCIATIVE AND DISSOCIATIVE ACTIVATION MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP PHOSPHODIESTERASE; NUCLEOTIDE-BINDING-PROTEIN; INHIBITORY GAMMA-SUBUNIT; ALPHA-SUBUNIT; RETINAL RODS; TRANSDUCIN; ANTIBODIES; PARAMETERS	Resonance energy transfer was used to monitor the interactions of the gamma subunit of the cyclic GMP phosphodiesterase (gamma(PDE)) With the alpha and beta subunits, which together comprise the catalytic core of the enzyme (alphabeta(PDE)). An iodoacetamidofluorescein (IAF)-labeled alphabeta(PDE) (IAF-PDE(t)) served as the acceptor species in these experiments while a coumarin maleimide-modified gamma(PDE) (CPM-gamma(PDE)) served as the fluorescent donor. Trypsin treatment of an IAF-labeled, intact phosphodiesterase (PDE) complex resulted in the selective proteolysis of the gamma(PDE); and full activation of enzyme activity. The binding of IAF-PDE(t) to the CPM-gamma(PDE) was monitored directly by measuring the quenching (25-35%) of the CPM fluorescence emission or by measuring the changes in the rate cGMP hydrolysis by IAF-PDE(t) using the pH electrode method. Both methods yielded titration curves which were well fitted using a single affinity constant (K(d) approximately 1-2 nM). Under conditions where added CPM-gamma(PDE) resulted in complete inhibition of the IAF-PDE(t) activity and, conversely, a maximal quenching of the CPM-gamma(PDE) fluorescence by added IAF-PDE(t), the subsequent addition of guanosine 5'-O-(thiotriphosphate) bound form of the alpha subunit of transducin (alpha(T)GTPgammaS) restored approximately 50% of the enzyme activity while restoring <30% of the CPM-gamma(PDE) fluorescence emission. Based on these results, we suggest that a portion of the observed PDE activation by alpha(T)GTPgammaS occurs via an associated complex of alpha(T)GTPgammaS and the enzyme.			ERICKSON, JW (corresponding author), CORNELL UNIV,DEPT PHARMACOL,ITHACA,NY 14853, USA.				NATIONAL EYE INSTITUTE [R01EY006429, F32EY006204] Funding Source: NIH RePORTER; NEI NIH HHS [EY06429, EY06204] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARSHAVSKY VY, 1992, NATURE, V357, P416, DOI 10.1038/357416a0; BEAVO JA, 1990, TRENDS PHARMACOL SCI, V11, P150, DOI 10.1016/0165-6147(90)90066-H; BENNETT N, 1989, BIOCHEMISTRY-US, V28, P7418, DOI 10.1021/bi00444a040; BROWN RL, 1992, BIOCHEMISTRY-US, V31, P5918, DOI 10.1021/bi00140a031; DETERRE P, 1988, P NATL ACAD SCI USA, V85, P2424, DOI 10.1073/pnas.85.8.2424; ERICKSON JW, 1991, BIOCHEMISTRY-US, V30, P7112, DOI 10.1021/bi00243a011; FUNG BKK, 1989, BIOCHEMISTRY-US, V28, P3133, DOI 10.1021/bi00434a003; GIERSCHIK P, 1984, FEBS LETT, V172, P321, DOI 10.1016/0014-5793(84)81149-7; GRISWOLDPRENNER I, 1989, BIOCHEMISTRY-US, V28, P6145, DOI 10.1021/bi00441a003; HINGORANI VN, 1987, BIOCHEMISTRY-US, V26, P1633, DOI 10.1021/bi00380a022; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; KROLL S, 1989, J BIOL CHEM, V264, P4490; OPPERT B, 1991, J BIOL CHEM, V266, P16607; PHILLIPS WJ, 1988, J BIOL CHEM, V263, P15498; PHILLIPS WJ, 1989, J BIOL CHEM, V264, P16679; PINES M, 1985, P NATL ACAD SCI USA, V82, P4095, DOI 10.1073/pnas.82.12.4095; SITARAMAYYA A, 1986, BIOCHEMISTRY-US, V25, P651, DOI 10.1021/bi00351a021; WENSEL T G, 1986, Proteins Structure Function and Genetics, V1, P90, DOI 10.1002/prot.340010114; WENSEL TG, 1990, BIOCHEMISTRY-US, V29, P2155, DOI 10.1021/bi00460a028; WHALEN MM, 1990, BIOCHEM J, V265, P655, DOI 10.1042/bj2650655; YEE R, 1978, J BIOL CHEM, V253, P8902	21	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3328	3333						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381426				2022-12-27	WOS:A1993KM16100049
J	GUY, GR; CAIRNS, J; NG, SB; TAN, YH				GUY, GR; CAIRNS, J; NG, SB; TAN, YH			INACTIVATION OF A REDOX-SENSITIVE PROTEIN PHOSPHATASE DURING THE EARLY EVENTS OF TUMOR-NECROSIS-FACTOR INTERLEUKIN-1 SIGNAL TRANSDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEIN; MAMMALIAN STRESS PROTEINS; GROWTH-RELATED PROTEIN; EHRLICH ASCITES TUMOR; OKADAIC ACID; HUMAN-FIBROBLASTS; HEME OXYGENASE; PHOSPHORYLATION; EXPRESSION; IDENTIFICATION	Isoforms of heat shock protein (Hsp) 27 were used as intracellular markers to study tumor necrosis factor/interleukin-1 (TNF/IL-1) regulation of protein phosphatases in primary human fibroblasts. These isoforms were rapidly phosphorylated to varying degrees when fibroblasts were treated with either TNF, IL-1, okadaic acid, calyculin A, ARS, epidermal growth factor, fibroblast growth factor, H2O2, buthionine sulfoximine, N-ethylmaleimide, diethylmaleimide, or iodoacetate. However, inhibitors of protein kinases A and C, tyrosyl protein kinases, and general protein kinases had no effect on the enhanced phosphorylation of these isoforms in TNF, IL-1, okadaic acid, or calyculin A-stimulated cells, suggesting that the activation of protein kinases by itself is insufficient to produce these changes. Isoforms of P-32-labeled Hsp27 were dephosphorylated during cold-chases with excess phosphate in the absence but not in the presence of TNF/IL-1 or inhibitors of protein phosphatases suggesting that inactivation of protein phosphatase(s) plays a role in TNF/IL-1 signal transduction. Assays of phosphatase activity of cytosolic fractions from TNF or okadaic acid treated human fibroblasts showed an inactivation of protein phosphatase activity against the P-32-labeled Hsp27 protein substrates. In vitro assays of partially purified phosphatase activity from primary human fibroblasts with Hsp27 substrate also showed the protein phosphatase activity to be inhibited by ARS. Like okadaic acid, ARS mimics TNF in inducing specific patterns of cellular protein phosphorylation. Taken together these findings are consistent with the hypothesis that a SH-dependent protein phosphatase is inactivated during the early events of TNF/IL-1 signal transduction, hence inhibitors of protein phosphatases and SH modifying compounds can mimic the early effects of TNF/IL-1 on cells.	NATL UNIV SINGAPORE,INST MOLEC & CELL BIOL,10 KENT RIDGE CRESCENT,SINGAPORE 0511,SINGAPORE	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore								BENNDORF R, 1988, BIOCHEM INT, V17, P225; BERNDT N, 1987, FEBS LETT, V223, P430; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BRAUTIGAN DL, 1981, COLD SPRING HARBOR C, V8, P459; BUCKLEY BJ, 1991, J BIOL CHEM, V266, P16659; CAO XM, 1992, J BIOL CHEM, V267, P1345; CAO XM, 1992, J BIOL CHEM, V267, P12991; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COHEN P, 1989, J BIOL CHEM, V264, P21435; FISCHER EH, 1981, METABOLIC INTERCONVE, P59; FUQUA SAW, 1989, CANCER RES, V49, P4126; GAESTEL M, 1991, J BIOL CHEM, V266, P14721; GAESTEL M, 1989, EUR J BIOCHEM, V179, P209, DOI 10.1111/j.1432-1033.1989.tb14542.x; GODING JW, 1986, MONOCLONAL ANTIBODIE, P264; GUAN KL, 1991, J BIOL CHEM, V266, P17026; GUESDON F, 1991, J IMMUNOL, V147, P3402; GUY GR, 1991, J BIOL CHEM, V266, P14343; GUY GR, 1992, J BIOL CHEM, V267, P1846; HICKEY E, 1986, NUCLEIC ACIDS RES, V14, P4127, DOI 10.1093/nar/14.10.4127; HICKEY ED, 1982, BIOCHEMISTRY-US, V21, P1513, DOI 10.1021/bi00536a008; HONKANEN RE, 1991, J BIOL CHEM, V266, P6614; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; KIM YJ, 1983, BIOCHEM BIOPH RES CO, V117, P682, DOI 10.1016/0006-291X(83)91651-0; KIM YJ, 1984, MOL CELL BIOL, V4, P468, DOI 10.1128/MCB.4.3.468; LANDRY J, 1992, J BIOL CHEM, V267, P794; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; LE JM, 1987, LAB INVEST, V56, P234; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; MEIER B, 1989, BIOCHEM J, V263, P539, DOI 10.1042/bj2630539; MEIER B, 1990, BIOL CHEM H-S, V371, P1021, DOI 10.1515/bchm3.1990.371.2.1021; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; PAULI D, 1990, J CELL BIOL, V111, P817, DOI 10.1083/jcb.111.3.817; REGAZZI R, 1988, BIOCHEM BIOPH RES CO, V152, P62, DOI 10.1016/S0006-291X(88)80680-6; SAKLATVALA J, 1991, BIOCHEM J, V277, P635, DOI 10.1042/bj2770635; SCHONTHAL A, 1991, ONCOGENE, V6, P423; SCHUTZE S, 1989, J BIOL CHEM, V264, P3562; SIMONS SS, 1990, J BIOL CHEM, V265, P1938; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; STEVENS LJ, 1989, GLUTATHONE CHEM BI B, V3, P240; THEVENIN C, 1990, New Biologist, V2, P793; WELCH WJ, 1985, J BIOL CHEM, V260, P3058; ZAHLER WL, 1968, J BIOL CHEM, V243, P716	45	118	121	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2141	2148						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380591				2022-12-27	WOS:A1993KH62000096
J	MA, YC; FUNK, M; DUNHAM, WR; KOMUNIECKI, R				MA, YC; FUNK, M; DUNHAM, WR; KOMUNIECKI, R			PURIFICATION AND CHARACTERIZATION OF ELECTRON-TRANSFER FLAVOPROTEIN RHODOQUINONE OXIDOREDUCTASE FROM ANAEROBIC MITOCHONDRIA OF THE ADULT PARASITIC NEMATODE, ASCARIS-SUUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA DEHYDROGENASE; UBIQUINONE OXIDOREDUCTASE; BETA-OXIDATION; TRANSFER COMPLEXES; RESPIRATORY-CHAIN; ENERGY GENERATION; REDUCTION; SUBSTRATE; BINDING	Electron-transfer flavoprotein:rhodoquinone oxidoreductase (ETF-RO) was purified to homogeneity from anaerobic mitochondria of the parasitic nematode, Ascaris suum. The enzyme has a subunit molecular mass of 64.5 kDa and is similar in many respects to the electron-transfer flavoprotein:ubiquinone oxidoreductase (ETF-UO) characterized in mammalian tissues. EPR spectroscopy of the purified enzyme revealed signals at g = 2.076, 1.936, and 1.883, arising from an iron-sulfur center, as well as signals attributable to a flavin semiquinone. Potentiometric titration on the enzyme with dithionite yielded an oxidation-reduction midpoint potential (E(m)) for the iron-sulfur center of +25 mV at pH 7.4. The reduction of flavin occurred in two distinct steps, with a flavin semiquinone radical detected as an intermediate. The E(m) values for the two steps in the complete reduction of flavin were +15 mV and -9 mV, respectively. Physiologically, the ascarid ETF-RO accepts electrons from a low potential quinone, rhodoquinone, and functions in a direction opposite to that of the ETF-UO. Incubations of A. suum submitochondrial particles with NADH, 2-methylcrotonyl-CoA, purified A. suum electron-transfer flavoprotein and 2-methyl branched-chain enoyl-CoA reductase resulted in significant 2-methylbutyryl-CoA formation, which was inhibited by both rotenone and antisera to the purified ETF-RO. Quinone extraction of the submitochondrial particles with dry pentane resulted in almost the complete loss of 2-MBCoA formation by the system. However, the reincorporation of rhodoquinone, but not ubiquinone, restored over 50% of the NADH-dependent 2-MBCoA formation.	UNIV TOLEDO, DEPT BIOL, TOLEDO, OH 43606 USA; UNIV TOLEDO, DEPT CHEM, TOLEDO, OH 43606 USA; UNIV MICHIGAN, DEPT BIOPHYS, ANN ARBOR, MI 48109 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University of Michigan System; University of Michigan					PHS HHS [A1 18427] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BARRETT J, 1973, COMP BIOCHEM PHYSIOL, V44, P331, DOI 10.1016/0300-9629(73)90486-6; Beinert H, 1978, Methods Enzymol, V54, P111; Beinert H, 1978, Methods Enzymol, V54, P435; CAMPBELL T, 1989, MOL BIOCHEM PARASIT, V33, P1, DOI 10.1016/0166-6851(89)90036-4; FRERMAN FE, 1987, BIOCHIM BIOPHYS ACTA, V893, P161, DOI 10.1016/0005-2728(87)90035-1; GOODMAN SI, 1992, PROG CLIN BIOL RES, V375, P567; GREEN DE, 1954, J BIOL CHEM, V206, P1; GUSTAFSON WG, 1986, J BIOL CHEM, V261, P7733; HAUGE JG, 1956, J AM CHEM SOC, V78, P5266, DOI 10.1021/ja01601a032; KAWAGUCHI A, 1981, J BIOCHEM-TOKYO, V89, P337, DOI 10.1093/oxfordjournals.jbchem.a133207; KING TE, 1967, METHOD ENZYMOL, V10, P634; KITA K, 1990, HIGHLIGHTS IN UBIQUINONE RESEARCH, P174; KITA K, 1988, BIOCHIM BIOPHYS ACTA, V935, P130, DOI 10.1016/0005-2728(88)90210-1; KITA K, 1992, PARASITOL TODAY, V8, P155, DOI 10.1016/0169-4758(92)90009-Q; KOMUNIECKI R, 1987, MOL BIOCHEM PARASIT, V24, P147, DOI 10.1016/0166-6851(87)90101-0; KOMUNIECKI R, 1985, J BIOL CHEM, V260, P4770; KOMUNIECKI R, 1989, BIOCHIM BIOPHYS ACTA, V975, P127, DOI 10.1016/S0005-2728(89)80210-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENN ND, 1990, BIOCHEMISTRY-US, V29, P3709, DOI 10.1021/bi00467a017; LOWRY OH, 1951, J BIOL CHEM, V193, P265; PAULSEN KE, 1992, BIOCHEMISTRY-US, V31, P11755, DOI 10.1021/bi00162a012; RAMSAY RR, 1987, BIOCHEM J, V241, P883, DOI 10.1042/bj2410883; RIOUX A, 1984, J COMP PHYSIOL, V154, P349, DOI 10.1007/BF00684441; RUFF V, 1988, MOL BIOCHEM PARASIT, V29, P1, DOI 10.1016/0166-6851(88)90113-2; RUZICKA FJ, 1977, J BIOL CHEM, V252, P8440; SATO M, 1969, J BIOCHEM-TOKYO, V65, P861, DOI 10.1093/oxfordjournals.jbchem.a129090; SATO M, 1972, BIOCHEM BIOPH RES CO, V46, P578, DOI 10.1016/S0006-291X(72)80178-5; SAZ HJ, 1971, COMP BIOCHEM PHYSIOL, V39, P627, DOI 10.1016/0305-0491(71)90207-0; SAZ HJ, 1960, J BIOL CHEM, V235, P914; SAZ HJ, 1981, ANNU REV PHYSIOL, V43, P323, DOI 10.1146/annurev.ph.43.030181.001543; SHEER DG, 1991, BIOTECHNIQUES, V11, P526; SIEGEL LM, 1978, METHOD ENZYMOL, V63, P419; SIMS SM, 1992, MOL BIOCHEM PARASIT, V53, P135, DOI 10.1016/0166-6851(92)90016-D; STANKOVICH MT, 1987, BIOCHEMISTRY-US, V26, P2627, DOI 10.1021/bi00383a033; SUAREZDEMATA Z, 1977, J BIOL CHEM, V252, P4215; WAN YP, 1981, METHOD ENZYMOL, V57, P591; WARD CW, 1970, J PARASITOL, V56, P1009, DOI 10.2307/3277526; WILSON DF, 1970, BIOCHEM BIOPH RES CO, V41, P1273, DOI 10.1016/0006-291X(70)90225-1	38	32	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20360	20365						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376393				2022-12-27	WOS:A1993LY01900066
J	FERREIRA, FD; HOFFMANNSOMMERGRUBER, K; BREITENEDER, H; PETTENBURGER, K; EBNER, C; SOMMERGRUBER, W; STEINER, R; BOHLE, B; SPERR, WR; VALENT, P; KUNGL, AJ; BREITENBACH, M; KRAFT, D; SCHEINER, O				FERREIRA, FD; HOFFMANNSOMMERGRUBER, K; BREITENEDER, H; PETTENBURGER, K; EBNER, C; SOMMERGRUBER, W; STEINER, R; BOHLE, B; SPERR, WR; VALENT, P; KUNGL, AJ; BREITENBACH, M; KRAFT, D; SCHEINER, O			PURIFICATION AND CHARACTERIZATION OF RECOMBINANT BET-UPSILON-I, THE MAJOR BIRCH POLLEN ALLERGEN - IMMUNOLOGICAL EQUIVALENCE TO NATURAL BET-UPSILON-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE GELS; GENE-PRODUCTS; PROTEINS; IGE; BINDING; METHIONINE; ANTIBODIES; PEPTIDES; DEAMIDATION; ASPARAGINYL	Pollen from trees of the order Fagales (e.g. birch, alder, hazel, oak, and hornbeam) are a major cause of Type I allergies observed in early spring. Previously, we reported the cloning and sequencing of Bet v I, the major birch pollen allergen, which showed high sequence similarities to a family of plant pathogen-activated genes (Breiteneder, H., Pettenburger, K., Bito, A., Valenta, R., Kraft, D., Rumpold, H., Scheiner, O., and Breitenbach, M. (1989) EMBO J. 8, 1935-1938). Here, we present the results on the expression, purification, and characterization of recombinant Bet v I produced in Escherichia coli as fusion and non-fusion protein, respectively. The purified recombinant proteins were analyzed to verify purity and structural integrity, and their immunological properties were compared to those of Bet v I isolated from birch pollen (natural Bet v 1). Immunoblot analyses showed that the recombinant proteins are specifically recognized by monoclonal antibodies raised against natural Bet v I as well as by IgE from birch pollen-allergic patients. However, enzyme-linked immunosorbent assays revealed a decreased IgE-binding activity of the recombinant fusion Bet v I compared to the non-fusion and natural Bet v I proteins, which probably results from conformational changes due to the fusion tail. Recombinant non-fusion Bet v I was equivalent to natural Bet v I with respect to IgE-binding properties, the ability to induce in vitro proliferation of allergen-specific T-cell clones, and the ability to release histamine from basophils derived from birch pollen-allergic patients.	UNIV VIENNA,INST ALLGEMEINE & EXPTL PATHOL,WAHRINGER GURTEL 18-20,A-1090 VIENNA,AUSTRIA; ERNST BOHRINGER INST ARZNEIMITTELFORSCH,A-1120 VIENNA,AUSTRIA; UNIV VIENNA,AKH,MED ABT,A-1090 VIENNA,AUSTRIA; SALZBURG UNIV,INST GENET & ALLGEMEINE BIOL,A-5020 SALZBURG,AUSTRIA; MAX PLANCK INST BIOCHEM,W-8033 MARTINSRIED,GERMANY	University of Vienna; University of Vienna; Salzburg University; Max Planck Society			Ferreira, Fatima/AAB-4321-2019; Ferreira, Fatima/E-4889-2011; Gamperl, Susi/V-2715-2019; Valent, Peter/B-8533-2016	Ferreira, Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335; Gamperl, Susi/0000-0003-0456-5095; Valent, Peter/0000-0003-0456-5095; Test, Testtest/0000-0002-7778-5219; Hoffmann-Sommergruber, Karin/0000-0002-8830-058X; Bohle, Barbara/0000-0002-5105-7985; Sperr, Wolfgang/0000-0003-3288-8027				BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BENBASSAT A, 1987, J BACTERIOL, V169, P751, DOI 10.1128/jb.169.2.751-757.1987; BISCHOFF R, 1992, ELECTROPHORESIS, V13, P214, DOI 10.1002/elps.1150130144; BOND JF, 1991, J IMMUNOL, V146, P3380; BREITENEDER H, 1992, J ALLERGY CLIN IMMUN, V90, P909, DOI 10.1016/0091-6749(92)90463-C; BREITENEDER H, 1993, EUR J BIOCHEM, V212, P355, DOI 10.1111/j.1432-1033.1993.tb17669.x; BREITENEDER H, 1989, EMBO J, V8, P1935, DOI 10.1002/j.1460-2075.1989.tb03597.x; CESKA M, 1972, J ALLERGY CLIN IMMUN, V49, P1, DOI 10.1016/0091-6749(72)90117-0; CHUA KY, 1991, CLIN EXP ALLERGY, V21, P161, DOI 10.1111/j.1365-2222.1991.tb00825.x; EBNER C, 1993, J IMMUNOL, V150, P1047; ERIKSSON NE, 1987, ALLERGY, V42, P205, DOI 10.1111/j.1398-9995.1987.tb02201.x; EVANS PA, 1987, NATURE, V329, P266, DOI 10.1038/329266a0; FOX RO, 1986, NATURE, V320, P192, DOI 10.1038/320192a0; GEIGER T, 1987, J BIOL CHEM, V262, P785; GLATTER O, 1991, PART PART SYST CHAR, V8, P274, DOI 10.1002/ppsc.19910080150; GREENE WK, 1991, J IMMUNOL, V147, P3768; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; HIRSCHWEHR R, 1992, J ALLERGY CLIN IMMUN, V90, P927, DOI 10.1016/0091-6749(92)90465-E; INANUE ER, 1987, SCIENCE, V236, P551; IPSEN H, 1983, J ALLERGY CLIN IMMUN, V72, P150, DOI 10.1016/0091-6749(83)90523-7; IPSEN H, 1989, EPITOPES ATOPIC ALLE, P3; ISHIZAKI T, 1987, ANN ALLERGY, V58, P265; JACOBS S, 1959, NATURE, V183, P262, DOI 10.1038/183262a0; JAROLIM E, 1989, ALLERGY, V44, P385, DOI 10.1111/j.1398-9995.1989.tb04169.x; JAROLIM E, 1989, INT ARCH ALLER A IMM, V90, P54, DOI 10.1159/000235000; JILEK A, 1993, MOLECULAR BIOLOGY AND IMMUNOLOGY OF ALLERGENS, P39; KAPLAN AP, 1985, ALLERGY CPH; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSEN JN, 1992, MOL IMMUNOL, V29, P703, DOI 10.1016/0161-5890(92)90180-6; LICHTENSTEIN LM, 1964, J EXP MED, V120, P507, DOI 10.1084/jem.120.4.507; LOMBARDERO M, 1990, J IMMUNOL, V144, P1353; LURA R, 1988, BIOCHEMISTRY-US, V27, P7671, DOI 10.1021/bi00420a015; MILLER CG, 1987, P NATL ACAD SCI USA, V84, P2718, DOI 10.1073/pnas.84.9.2718; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; OLSEN E, 1992, INT ARCH ALLERGY IMM, V98, P343, DOI 10.1159/000236209; OLSEN JR, 1986, J IMMUNOL, V136, P2109; PARRONCHI P, 1991, P NATL ACAD SCI USA, V88, P4538, DOI 10.1073/pnas.88.10.4538; ROHAC M, 1991, MOL IMMUNOL, V28, P897, DOI 10.1016/0161-5890(91)90054-N; Sambrook J, 1989, MOL CLONING LABORATO; SCHEINER O, 1992, ADVANCES IN ALLERGOLOGY AND CLINICAL IMMUNOLOGY, P115; SCHNABLEGGER H, 1991, APPL OPTICS, V30, P4889, DOI 10.1364/AO.30.004889; SCHWARTZ RH, 1985, ANNU REV IMMUNOL, V3, P237, DOI 10.1146/annurev.iy.03.040185.001321; STREBEL K, 1986, J VIROL, V57, P983, DOI 10.1128/JVI.57.3.983-991.1986; SUHRBIER A, 1991, J IMMUNOL, V147, P2507; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UHLEN M, 1992, Current Opinion in Biotechnology, V3, P363, DOI 10.1016/0958-1669(92)90164-E; VALENT P, 1989, P NATL ACAD SCI USA, V86, P5542, DOI 10.1073/pnas.86.14.5542; VALENTA R, 1992, INT ARCH ALLERGY IMM, V97, P287, DOI 10.1159/000236135; VERCELLI D, 1989, J CLIN IMMUNOL, V9, P75, DOI 10.1007/BF00916934; Wuthrich B, 1991, ALLERGY CLIN IMMUNOL, V3, P41; YANG M, 1991, J ALLERGY CLIN IMMUN, V87, P1096, DOI 10.1016/0091-6749(91)92155-T	51	119	120	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19574	19580						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366100				2022-12-27	WOS:A1993LW81900066
J	LOBELLO, M; PARKER, MW; DESIDERI, A; POLTICELLI, F; FALCONI, M; DELBOCCIO, G; PENNELLI, A; FEDERICI, G; RICCI, G				LOBELLO, M; PARKER, MW; DESIDERI, A; POLTICELLI, F; FALCONI, M; DELBOCCIO, G; PENNELLI, A; FEDERICI, G; RICCI, G			PECULIAR SPECTROSCOPIC AND KINETIC-PROPERTIES OF CYS-47 IN HUMAN PLACENTAL GLUTATHIONE TRANSFERASE - EVIDENCE FOR AN ATYPICAL THIOLATE ION-PAIR NEAR THE ACTIVE-SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-TRANSFERASE; CLASS-PI; DIRECTED MUTAGENESIS; CATALYTIC MECHANISM; 3-DIMENSIONAL STRUCTURE; SULFHYDRYL-GROUP; RESIDUES; IDENTIFICATION; CYSTEINE; COMPLEX	Cys-47, the most reactive cysteine in the homodimeric glutathione transferase (EC 2.5.1.18) from human placenta (class Pi), displays peculiar acid base and spectroscopic properties. The thiolate form of this residue is characterized by a sharp UV absorption spectrum centered at 229 nm with an epsilon = 7,500 M-1 cm-1. The dependence of the apparent extinction coefficient on pH indicates that the sulfhydryl group of Cys-47 has a pK(a) value of 4.2. Moreover the dependence of the reactivity of Cys-47 toward bromopyruvate and iodoacetamide with pH resembles that found for the functional sulfhydryls of thiol proteases, which have very low pK(a) values and exist mainly as a mercaptide-imidazole ion pair. The apparent pK(a) value for Cys-47, calculated by this kinetic approach, is in good agreement with that determined spectroscopically. X-ray crystallographic data indicate that the protonated amino group of Lys-54, 4.9 angstrom from the sulfur atom, is probably involved in the deprotonation of Cys-47. Calculation of the electrostatic potential on the sulfur atom of Cys-47 gives a theoretical pK(a) value of 3.5 for the sulfhydryl group. The simulated neutralization of Lys-54 shifts the pK(a) value of Cys-47 to a normal value of 9.5. These findings suggest that at physiological pH values, Cys-47 exists as the thiolate ion stabilized by an ion pair formation with the protonated amino group of Lys-54, and this probably accounts for its high reactivity.	UNIV ROMA TOR VERGATA,DEPT BIOL,I-00173 ROME,ITALY; UNIV CHIETI,INST BIOL SCI,I-66100 CHIETI,ITALY; ST VINCENTS INST MED RES,FITZROY,VIC 3065,AUSTRALIA; UNIV MESSINA,DEPT ORGAN & BIOL CHEM,I-98166 MESSINA,ITALY	University of Rome Tor Vergata; G d'Annunzio University of Chieti-Pescara; St. Vincent's Institute of Medical Research; University of Messina			Polticelli, Fabio/A-4573-2009; Parker, Michael W/F-9069-2013; Falconi, Massimo/K-2194-2016	Polticelli, Fabio/0000-0002-7657-2019; Parker, Michael W/0000-0002-3101-1138; Falconi, Massimo/0000-0001-9654-7243; desideri, alessandro/0000-0003-1541-4217; Ricci, Giorgio/0000-0002-7108-2846; FALCONI, MATTIA/0000-0002-3990-4758	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BEDNAR RA, 1990, BIOCHEMISTRY-US, V29, P3684, DOI 10.1021/bi00467a014; BENESCH RE, 1955, J AM CHEM SOC, V77, P5877, DOI 10.1021/ja01627a030; CACCURI AM, 1992, ARCH BIOCHEM BIOPHYS, V297, P119, DOI 10.1016/0003-9861(92)90648-G; CHEN WJ, 1988, BIOCHEMISTRY-US, V27, P647, DOI 10.1021/bi00402a023; DESIDERI A, 1991, J BIOL CHEM, V266, P2063; DONOVAN JW, 1964, BIOCHEMISTRY-US, V3, P67, DOI 10.1021/bi00889a012; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; GRAMINSKI GF, 1989, BIOCHEMISTRY-US, V28, P3652; Habig W H, 1981, Methods Enzymol, V77, P398; HALASZ P, 1977, EUR J BIOCHEM, V79, P491, DOI 10.1111/j.1432-1033.1977.tb11832.x; HATAYAMA I, 1990, NUCLEIC ACIDS RES, V18, P4606, DOI 10.1093/nar/18.15.4606; HERMANN P, 1961, CHEM BER-RECL, V94, P442, DOI 10.1002/cber.19610940223; IRVING RJ, 1964, ACTA CHEM SCAND, V18, P769, DOI 10.3891/acta.chem.scand.18-0769; JAKOBY WB, 1980, ENZYMATIC BASIS DETO, V2, P63; JOCELYN PC, 1972, BIOCH SH GROUP, P49; KOLM RH, 1992, BIOCHEM J, V285, P537, DOI 10.1042/bj2850537; KONG KH, 1992, BIOCHEM BIOPH RES CO, V184, P194, DOI 10.1016/0006-291X(92)91177-R; KONG KH, 1991, BIOCHEM BIOPH RES CO, V181, P748, DOI 10.1016/0006-291X(91)91254-A; KONG KH, 1992, BIOCHEM BIOPH RES CO, V182, P1122, DOI 10.1016/0006-291X(92)91848-K; LIU SX, 1992, J BIOL CHEM, V267, P4296; LOBELLO M, 1990, FEBS LETT, V263, P389, DOI 10.1016/0014-5793(90)81421-J; MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202; MANOHARAN TH, 1992, J MOL BIOL, V226, P319, DOI 10.1016/0022-2836(92)90949-K; MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409; NISHIHIRA J, 1992, BIOCHEM BIOPH RES CO, V185, P1069, DOI 10.1016/0006-291X(92)91735-9; PARKER MW, 1990, J MOL BIOL, V213, P221, DOI 10.1016/S0022-2836(05)80183-4; POLGAR L, 1973, EUR J BIOCHEM, V33, P104, DOI 10.1111/j.1432-1033.1973.tb02660.x; POLGAR L, 1974, FEBS LETT, V38, P187, DOI 10.1016/0014-5793(74)80110-9; POLGAR L, 1975, EUR J BIOCHEM, V51, P63, DOI 10.1111/j.1432-1033.1975.tb03907.x; REINEMER P, 1992, J MOL BIOL, V227, P214, DOI 10.1016/0022-2836(92)90692-D; REINEMER P, 1991, EMBO J, V10, P1997, DOI 10.1002/j.1460-2075.1991.tb07729.x; RICCI G, 1991, J BIOL CHEM, V266, P21409; RICCI G, 1989, J BIOL CHEM, V264, P5462; SAHLMAN L, 1989, J BIOL CHEM, V264, P8033; SHARP KA, 1990, ANNU REV BIOPHYS BIO, V19, P301, DOI 10.1146/annurev.bb.19.060190.001505; STENBERG G, 1991, FEBS LETT, V293, P153, DOI 10.1016/0014-5793(91)81174-7; STENBERG G, 1991, BIOCHEM J, V274, P549, DOI 10.1042/bj2740549; TAMAI K, 1990, BIOCHEM BIOPH RES CO, V167, P331, DOI 10.1016/0006-291X(90)91769-O; TAMAI K, 1991, BIOCHEM BIOPH RES CO, V179, P790, DOI 10.1016/0006-291X(91)91886-H; TANFORD C, 1962, ADV PROTEIN CHEM, V17, P69; WANG RW, 1992, ARCH BIOCHEM BIOPHYS, V297, P86, DOI 10.1016/0003-9861(92)90644-C; WANG RW, 1991, ARCH BIOCHEM BIOPHYS, V286, P5874; WIDERSTEIN M, 1992, BIOCHEM J, V285, P377, DOI 10.1042/bj2850377; ZHANG PH, 1991, J BIOL CHEM, V266, P19475; 1992, DELPHI VER 22	45	67	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					19033	19038						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360190				2022-12-27	WOS:A1993LV65900098
J	CAPUTO, A; GARNER, RS; WINKLER, U; HUDIG, D; BLEACKLEY, RC				CAPUTO, A; GARNER, RS; WINKLER, U; HUDIG, D; BLEACKLEY, RC			ACTIVATION OF RECOMBINANT MURINE CYTOTOXIC-CELL PROTEINASE-1 REQUIRES DELETION OF AN AMINO-TERMINAL DIPEPTIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TOXIC LYMPHOCYTES-T; HUMAN NEUTROPHIL ELASTASE; MEDIATED CYTO-TOXICITY; SERINE PROTEASE; CATHEPSIN-G; MAST-CELL; CLONING; PURIFICATION; SPECIFICITY; INHIBITION	Murine cytotoxic cell proteinase-1 (granzyme B) is a member of a family of novel serine proteinases that have been implicated to participate in destruction of target cells by cytotoxic T lymphocytes. Comparison of the sequence of the cDNA with the sequence of the protein isolated from cytoplasmic granules of cytotoxic T lymphocytes suggested that this protein may be synthesized as a preproenzyme containing an amino-terminal activation dipeptide. Here we show that this activation dipeptide regulates the activity of the enzyme in hydrolysis of its preferred substrate tert-butyloxycarbonyl-Ala-Ala-Asp-thiobenzyl ester. Lysates of COS cells transfected with a vector expressing the unmodified cytotoxic cell proteinase-1 cDNA were unable to hydrolyze this substrate, whereas lysates of cells transfected with a construct in which the activation dipeptide codons had been deleted were able to hydrolyze the substrate. In each case Western blotting of the lysates revealed a form of the proteinase with an apparent molecular weight of 27,000. We conclude that the activation dipeptide regulates activity of the enzyme. This is the first report of production of an enzymatically active recombinant cytotoxic T cell serine proteinase. The strategy for successful expression of an activated form of cytotoxic cell proteinase-1 may be applicable to other members of this proteinase family.	UNIV ALBERTA,DEPT BIOCHEM,EDMONTON T6G 2H7,ALBERTA,CANADA; UNIV NEVADA,DEPT MICROBIOL,RENO,NV 89557; UNIV NEVADA,GRAD PROGRAM MOLEC BIOL,RENO,NV 89557	University of Alberta; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno								Ausubel FM, 1988, MOL REPROD DEV; BENFEY PN, 1987, J BIOL CHEM, V262, P5377; BLEACKLEY RC, 1988, FEBS LETT, V234, P153, DOI 10.1016/0014-5793(88)81323-1; Bollag D.M., 1991, PROTEIN METHODS; BRUNET JF, 1987, J IMMUNOL, V138, P4102; CHANG TW, 1980, J IMMUNOL, V124, P1028; DAHLMANN B, 1985, BIOCHEM J, V228, P161, DOI 10.1042/bj2280161; GERSHENFELD HK, 1988, P NATL ACAD SCI USA, V85, P1184, DOI 10.1073/pnas.85.4.1184; GERSHENFELD HK, 1986, SCIENCE, V232, P854, DOI 10.1126/science.2422755; HOWARD AD, 1991, J IMMUNOL, V147, P2964; HUDIG D, 1984, J IMMUNOL, V133, P2647; HUDIG D, 1981, J IMMUNOL, V126, P1569; JENNE DE, 1989, BIOCHEMISTRY-US, V28, P7953, DOI 10.1021/bi00445a060; KAKUDO S, 1992, J BIOL CHEM, V267, P23782; LOBE CG, 1989, NUCLEIC ACIDS RES, V17, P5765, DOI 10.1093/nar/17.14.5765; LOBE CG, 1986, SCIENCE, V232, P858, DOI 10.1126/science.3518058; LOBE CG, 1986, P NATL ACAD SCI USA, V83, P1448, DOI 10.1073/pnas.83.5.1448; MASSON D, 1987, CELL, V49, P679, DOI 10.1016/0092-8674(87)90544-7; MCGUIRE MJ, 1993, J BIOL CHEM, V268, P2458; MURPHY MEP, 1988, PROTEINS, V4, P190, DOI 10.1002/prot.340040306; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; ODAKE S, 1991, BIOCHEMISTRY-US, V30, P2217, DOI 10.1021/bi00222a027; OKANO K, 1990, BIOCHEM BIOPH RES CO, V167, P1326, DOI 10.1016/0006-291X(90)90668-D; POE M, 1991, J BIOL CHEM, V266, P98; REDELMAN D, 1983, CELL IMMUNOL, V81, P9, DOI 10.1016/0008-8749(83)90206-X; REDELMAN D, 1980, J IMMUNOL, V124, P870; REDMOND MJ, 1987, J IMMUNOL, V139, P3184; SALVESEN G, 1987, BIOCHEMISTRY-US, V26, P2289, DOI 10.1021/bi00382a032; SALVESEN G, 1991, BIOMED BIOCHIM ACTA, V50, P665; Sambrook J, 1989, MOL CLONING LABORATO; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; SHIVER JW, 1992, CELL, V71, P315, DOI 10.1016/0092-8674(92)90359-K; TAKAHASHI H, 1988, J BIOL CHEM, V263, P14739; TALENTO A, 1992, J IMMUNOL, V149, P4039; WILK S, 1983, J NEUROCHEM, V40, P842, DOI 10.1111/j.1471-4159.1983.tb08056.x; WOODBURY RG, 1978, BIOCHEMISTRY-US, V17, P811, DOI 10.1021/bi00598a010	36	70	75	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17672	17675						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349649				2022-12-27	WOS:A1993LT74300007
J	GREENLUND, AC; SCHREIBER, RD; GOEDDEL, DV; PENNICA, D				GREENLUND, AC; SCHREIBER, RD; GOEDDEL, DV; PENNICA, D			INTERFERON-GAMMA INDUCES RECEPTOR DIMERIZATION IN SOLUTION AND ON CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR RECEPTOR; GROWTH-FACTOR RECEPTORS; HIGH-AFFINITY RECEPTOR; IFN-GAMMA; EXTRACELLULAR DOMAIN; SIGNAL TRANSDUCTION; ACCESSORY FACTOR; LIGAND-BINDING; CROSS-LINKING; EXPRESSION	The extracellular domain (ECD) of the human interferon-gamma (IFNgamma) receptor was stably expressed in Chinese hamster ovary cells and purified to homogeneity. Scatchard analysis of I-125-IFNgamma binding to ECD preparations revealed the formation of a ligand-receptor complex which displayed a K(a) of 6.4 +/- 0.9 x 10(8) M-1. Two types of complexes were identified by sucrose density gradient ultracentrifugation. The stoichiometry of the major ECD-ligand complex was determined by high performance liquid chromatography gel filtration. When IFNgamma was incubated with a 2-fold molar excess of ECD, a 190-kDa complex was isolated that contained 2 mol of ECD per 1 mol of IFNgamma. IFNgamma also induced dimerization of IFNgamma receptors expressed at the cell surface as detected by chemically cross-linking receptor bound ligand and analyzing cell lysates by SDS-polyacrylamide gel electrophoresis and immunoblotting. Finally, labeled forms of ECD bound to cells preincubated at 4-degrees-C with excess amounts of IFNgamma indicating that the ligand could associate with more than one receptor molecule in the absence of chemical cross-linking agents. These results demonstrate that IFNgamma effects dimerization of its receptor under physiologic conditions and suggest that IFNgamma receptor dimerization may be an important event in inducing IFNgamma-dependent biologic responses.	WASHINGTON UNIV,SCH MED,DEPT PATHOL,BOX 8118,660 S EUCLID AVE,ST LOUIS,MO 63110; GENENTECH INC,DEPT MOLEC BIOL,S SAN FRANCISCO,CA 94080	Washington University (WUSTL); Roche Holding; Genentech			Schreiber, Robert/Q-7550-2019; Schreiber, Robert D/A-1276-2013	Schreiber, Robert D/0000-0001-6311-0432	NATIONAL CANCER INSTITUTE [R01CA043059, R37CA043059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI024854] Funding Source: NIH RePORTER; NCI NIH HHS [CA43059] Funding Source: Medline; NIAID NIH HHS [AI24854] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGUET M, 1987, J EXP MED, V165, P988, DOI 10.1084/jem.165.4.988; AGUET M, 1988, CELL, V55, P273, DOI 10.1016/0092-8674(88)90050-5; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BASU MT, 1988, P NATL ACAD SCI USA, V85, P6282, DOI 10.1073/pnas.85.17.6282; Bebbington CR, 1987, DNA CLONING PRACTICA, VIII, P163; CALDERON J, 1988, P NATL ACAD SCI USA, V85, P4837, DOI 10.1073/pnas.85.13.4837; CELADA A, 1985, J CLIN INVEST, V76, P2196, DOI 10.1172/JCI112228; COCHET C, 1988, J BIOL CHEM, V263, P3290; COFANO F, 1990, J BIOL CHEM, V265, P4064; DIGHE AS, 1993, J BIOL CHEM, V268, P10645; EALICK SE, 1991, SCIENCE, V252, P698, DOI 10.1126/science.1902591; FARRAR MA, 1991, J BIOL CHEM, V266, P19626; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; FARRAR MA, 1992, P NATL ACAD SCI USA, V89, P11706, DOI 10.1073/pnas.89.24.11706; FINBLOOM DS, 1991, J BIOL CHEM, V266, P22545; FINBLOOM DS, 1989, J IMMUNOL, V142, P2314; FOUNTOULAKIS M, 1989, J IMMUNOL, V143, P3266; FOUNTOULAKIS M, 1990, J BIOL CHEM, V265, P19758; FOUNTOULAKIS M, 1992, EUR J BIOCHEM, V208, P781, DOI 10.1111/j.1432-1033.1992.tb17248.x; GIBBS VC, 1991, MOL CELL BIOL, V11, P5860, DOI 10.1128/MCB.11.12.5860; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; GRAY PW, 1989, P NATL ACAD SCI USA, V86, P8497, DOI 10.1073/pnas.86.21.8497; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HEMMI S, 1989, P NATL ACAD SCI USA, V86, P9901, DOI 10.1073/pnas.86.24.9901; HEMMI S, 1992, P NATL ACAD SCI USA, V89, P2737, DOI 10.1073/pnas.89.7.2737; HERSHEY GKK, 1989, J BIOL CHEM, V264, P11981; HIBINO Y, 1992, J BIOL CHEM, V267, P3741; HIBINO Y, 1991, J BIOL CHEM, V266, P6948; JUNG V, 1987, P NATL ACAD SCI USA, V84, P4151, DOI 10.1073/pnas.84.12.4151; KASHLES O, 1991, MOL CELL BIOL, V11, P1454, DOI 10.1128/MCB.11.3.1454; KUMAR CS, 1989, J BIOL CHEM, V264, P17939; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGER JA, 1988, IMMUNOL TODAY, V9, P393, DOI 10.1016/0167-5699(88)91241-8; LUNN CA, 1992, J BIOL CHEM, V267, P17920; MUNRO S, 1989, P NATL ACAD SCI USA, V86, P9248, DOI 10.1073/pnas.86.23.9248; PENNICA D, 1993, BIOCHEMISTRY-US, V32, P3131, DOI 10.1021/bi00063a027; PENNICA D, 1992, J BIOL CHEM, V267, P21172; PENNICA D, 1992, BIOCHEMISTRY-US, V31, P1134, DOI 10.1021/bi00119a023; RAZIUDDIN A, 1984, P NATL ACAD SCI-BIOL, V81, P5504, DOI 10.1073/pnas.81.17.5504; SARKAR FH, 1984, P NATL ACAD SCI-BIOL, V81, P5160, DOI 10.1073/pnas.81.16.5160; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SHEEHAN KCF, 1988, J IMMUNOL, V140, P4231; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4; STEPHENS PE, 1989, NUCLEIC ACIDS RES, V17, P7110, DOI 10.1093/nar/17.17.7110; TRINCHIERI G, 1985, IMMUNOL TODAY, V6, P131, DOI 10.1016/0167-5699(85)90080-5; UENO H, 1991, SCIENCE, V252, P844, DOI 10.1126/science.1851331; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANLOON APGM, 1991, J LEUKOCYTE BIOL, V49, P462, DOI 10.1002/jlb.49.5.462; VILCEK J, 1985, LYMPHOKINES, V11, P1	49	95	97	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18103	18110						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349687				2022-12-27	WOS:A1993LT74300069
J	PANZETER, PL; ZWEIFEL, B; MALANGA, M; WASER, SH; RICHARD, MC; ALTHAUS, FR				PANZETER, PL; ZWEIFEL, B; MALANGA, M; WASER, SH; RICHARD, MC; ALTHAUS, FR			TARGETING OF HISTONE TAILS BY POLY(ADP-RIBOSE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SYSTEMIC LUPUS-ERYTHEMATOSUS; ADP-RIBOSYLATION; DNA; CHROMATIN; DOMAIN; POLYMERASE; ANTIBODIES; PROTEINS; MODULATION; TERMINUS	After Zn2+ finger-mediated binding to a DNA break, poly(ADP-ribose) polymerase becomes automodified with long polymers of ADP-ribose. These nucleic acid-like polymers may facilitate DNA repair by noncovalently interacting with neighboring proteins. Using a novel screening technique, we have identified histones as the predominant poly(ADP-ribose)-binding species in human keratinocytes, rat hepatocytes, frog eggs, and yeast. Polymer binding is confined specifically to the histone domains responsible for DNA condensation, i.e. histone tails. Our results indicate that polymers of ADP-ribose are targeted to sites of DNA strand breaks by poly(ADP-ribose) polymerase and subsequently function to alter chromatin conformation through noncovalent interactions with histone tails.	UNIV ZURICH,TIERSPITAL,INST PHARMACOL & TOXICOL,WINTERTHURERSTR 260,CH-8057 ZURICH,SWITZERLAND	University of Zurich								ADAMIETZ P, 1984, J BIOL CHEM, V259, P6841; ALMOUZNI G, 1988, EMBO J, V7, P4355, DOI 10.1002/j.1460-2075.1988.tb03334.x; Althaus F R, 1987, Mol Biol Biochem Biophys, V37, P1; ALTHAUS FR, 1992, J CELL SCI, V102, P663; BEREZNEY R, 1975, SCIENCE, V189, P291, DOI 10.1126/science.1145202; BOHM L, 1984, BIOSCIENCE REP, V4, P365, DOI 10.1007/BF01122502; BUSTIN M, 1982, SCIENCE, V215, P1245, DOI 10.1126/science.6460317; CLEAVER JE, 1991, MUTAT RES, V257, P1, DOI 10.1016/0165-1110(91)90016-O; DEMURCIA G, 1986, J BIOL CHEM, V261, P7011; DEMURCIA G, 1988, BIOCHEM CELL BIOL, V66, P626, DOI 10.1139/o88-072; DILWORTH SM, 1987, CELL, V51, P1009, DOI 10.1016/0092-8674(87)90587-3; GARCIARAMIREZ M, 1992, J BIOL CHEM, V267, P19587; GOHILL J, 1987, MOL IMMUNOL, V24, P275, DOI 10.1016/0161-5890(87)90146-5; GRADWOHL G, 1990, P NATL ACAD SCI USA, V87, P2990, DOI 10.1073/pnas.87.8.2990; HARDIN JA, 1983, P NATL ACAD SCI-BIOL, V80, P7410, DOI 10.1073/pnas.80.24.7410; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOHR D, 1988, YEAST PRACTICAL APPR, P133; MARDIAN JKW, 1978, BIOCHEMISTRY-US, V17, P3825, DOI 10.1021/bi00611a023; PANZETER PL, 1992, BIOCHEMISTRY-US, V31, P1379, DOI 10.1021/bi00120a014; PANZETER PL, 1992, ANAL BIOCHEM, V207, P157, DOI 10.1016/0003-2697(92)90517-B; PANZETER PL, 1992, BIOCHEM BIOPH RES CO, V184, P544, DOI 10.1016/0006-291X(92)91229-J; PARK JK, 1991, CELL MOL BIOL, V37, P739; REALINI CA, 1992, J BIOL CHEM, V267, P18858; RODRIGUEZ AT, 1991, BIOPHYS CHEM, V39, P145, DOI 10.1016/0301-4622(91)85016-J; SATO MS, 1992, NATURE, V256, P356; SCOVASSI AI, 1986, EUR J BIOCHEM, V159, P77, DOI 10.1111/j.1432-1033.1986.tb09835.x; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.biochem.54.1.73; WALLIS JW, 1983, CELL, V35, P711, DOI 10.1016/0092-8674(83)90104-6; WOOD MJ, 1991, J BIOL CHEM, V266, P5696; [No title captured]	30	56	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17662	17664						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349647				2022-12-27	WOS:A1993LT74300004
J	CAZAUBON, SM; PARKER, PJ				CAZAUBON, SM; PARKER, PJ			IDENTIFICATION OF THE PHOSPHORYLATED REGION RESPONSIBLE FOR THE PERMISSIVE ACTIVATION OF PROTEIN-KINASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTERS; PURIFICATION; QUANTITATION; BOVINE; CELLS; BRAIN; ALPHA; GAMMA	Protein kinase C (PKC) appears to require phosphorylation in order to function as an effector-dependent kinase (Pears, C., Stabel, S., Cazaubon, S., and Parker, P. J. (1992) Biochem. J. 283, 515-518). By site-directed mutagenesis of the PKCalpha cDNA, it has been shown that a region including 3 threonine residues (Thr-494, Thr-495, and Thr-497), present in the catalytic domain, is involved in controlling PKC activity. Substitution of these 3 threonine residues by alanine residues leads to the expression, in COS-1 cells, of an unphosphorylated protein with an apparent molecular mass of 76 kDa, similar to that determined for the primary translation product. The biochemical characterization of this PKCalpha mutant reveals that it is a functional phorbol ester-binding protein but retains no kinase activity. Coexpression of this PKCalpha mutant and wild type PKCbeta demonstrates that the mutant has a dominant effect upon PKCbeta phosphorylation. The location of this region and its phosphorylation in relation to PKC function are discussed.	IMPERIAL CANC RES FUND,POB 123,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND	Cancer Research UK			Parker, Peter j/D-5192-2013	parker, peter/0000-0002-6218-2933				BORNER C, 1988, P NATL ACAD SCI USA, V85, P2110, DOI 10.1073/pnas.85.7.2110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAZAUBON S, 1990, EUR J BIOCHEM, V194, P799, DOI 10.1111/j.1432-1033.1990.tb19472.x; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; DEKKER LV, 1992, FEBS LETT, V312, P195, DOI 10.1016/0014-5793(92)80934-9; FARAGO A, 1990, FEBS LETT, V268, P350, DOI 10.1016/0014-5793(90)81284-U; FRY MJ, 1985, EMBO J, V4, P3173, DOI 10.1002/j.1460-2075.1985.tb04061.x; GOULD KL, 1991, EMBO J, V10, P3297, DOI 10.1002/j.1460-2075.1991.tb04894.x; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; KIKKAWA U, 1986, ANNU REV CELL BIOL, V2, P149, DOI 10.1146/annurev.cb.02.110186.001053; KIKKAWA U, 1982, J BIOL CHEM, V257, P13341; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARAIS RM, 1989, EUR J BIOCHEM, V182, P129, DOI 10.1111/j.1432-1033.1989.tb14809.x; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; ORNELLANA SA, 1992, P NATL ACAD SCI USA, V89, P4726; PARKER PJ, 1989, MOL CELL ENDOCRINOL, V65, P1, DOI 10.1016/0303-7207(89)90159-7; PARKER PJ, 1986, SCIENCE, V233, P853, DOI 10.1126/science.3755547; PARKER PJ, 1987, ADV PROT PHOSPHATASE, V4, P363; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PEARS C, 1992, BIOCHEM J, V283, P515, DOI 10.1042/bj2830515; STABEL S, 1987, J CELL PHYSIOL, V130, P111, DOI 10.1002/jcp.1041300116	22	82	83	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17559	17563						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349635				2022-12-27	WOS:A1993LQ98800097
J	KLECZKOWSKI, LA; VILLAND, P; PREISS, J; OLSEN, OA				KLECZKOWSKI, LA; VILLAND, P; PREISS, J; OLSEN, OA			KINETIC MECHANISM AND REGULATION OF ADP-GLUCOSE PYROPHOSPHORYLASE FROM BARLEY (HORDEUM-VULGARE) LEAVES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADPGLUCOSE PYROPHOSPHORYLASE; MOLECULAR CHARACTERIZATION; SUBUNIT STRUCTURE; MAIZE ENDOSPERM; LEAF; ORTHOPHOSPHATE; PURIFICATION; PROTEINS	Barley (Hordeum vulgare, cv. Bomi) leaf ADP-glucose pyrophosphorylase (AGP) was purified to near-homogeneity, using ammonium sulfate fractionation and heat treatment as well as ion exchange, hydrophobic, and dye-ligand chromatography. The enzyme was found to be composed of two subunit types of 51 and 54 kDa, which were recognized by the respective rabbit antibodies against the small and/or large subunit of spinach leaf AGP. Substrate kinetics and product inhibition studies, carried out in the direction of ADP-glucose synthesis, suggested a sequential Iso Ordered Bi Bi kinetic mechanism for the enzyme. In addition, inhibition patterns with CrATP, a dead-end inhibitor of ATP-utilizing enzymes, were consistent with ATP (synthesis reaction) and ADP-glucose (pyrophosphorolysis reaction) binding first to different free forms of the enzyme. The AGP was potently activated by 3-phosphoglycerate (PGA) (K(alpha) of 5 muM) and inhibited by orthophosphate (P(i)), with the ratio of the two effectors playing a major role in modulating AGP activity. At low [PGA]/[P(i)] ratios, P(i) could reverse the activating effect of PGA. However, at the [PGA]/[P(i)] ratios of 1.4, or higher, some activating effect of P(i) in the presence of PGA was observed. PGA decreased the K(m) values for all substrates of AGP (in both the synthesis and pyrophosphorolysis directions). Properties of the barley leaf AGP are compared to those of AGP from barley seed endosperm, which is insensitive to PGA/P(i) regulation.	MICHIGAN STATE UNIV,DEPT BIOCHEM,E LANSING,MI 48824	Michigan State University	KLECZKOWSKI, LA (corresponding author), NLVF,PLANT MOLEC BIOL LAB,N-1432 AS,NORWAY.			Kleczkowski, Leszek A./0000-0001-8685-9665				ANDERSON JM, 1991, GENE, V97, P199, DOI 10.1016/0378-1119(91)90052-D; BALL S, 1991, PLANTA, V185, P17, DOI 10.1007/BF00194509; BLOOMFIELD V, 1962, J AM CHEM SOC, V84, P4375, DOI 10.1021/ja00882a002; CHARNG YY, 1992, PLANT MOL BIOL, V20, P37, DOI 10.1007/BF00029147; DEPAMPHILIS ML, 1973, BIOCHEMISTRY-US, V12, P3714, DOI 10.1021/bi00743a022; FUCHS RL, 1979, BIOCHIM BIOPHYS ACTA, V566, P40, DOI 10.1016/0005-2744(79)90246-8; GHOSH HP, 1966, J BIOL CHEM, V241, P4491; HAUGEN TH, 1979, J BIOL CHEM, V254, P127; HELDT HW, 1977, PLANT PHYSIOL, V59, P1146, DOI 10.1104/pp.59.6.1146; IGLESIAS AA, 1991, PLANT PHYSIOL, V97, P1187, DOI 10.1104/pp.97.3.1187; KLECZKOWSKI LA, IN PRESS PLANT PHYSL, V101; KLECZKOWSKI LA, 1991, Z NATURFORSCH, V460, P605; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KRISHNAN HB, 1986, PLANT PHYSIOL, V81, P642, DOI 10.1104/pp.81.2.642; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MORELL M, 1988, J BIOL CHEM, V263, P633; MORELL MK, 1987, PLANT PHYSIOL, V85, P182, DOI 10.1104/pp.85.1.182; NAKAMURA Y, 1992, PHYSIOL PLANTARUM, V84, P336, DOI 10.1034/j.1399-3054.1992.840303.x; OKITA TW, 1990, PLANT PHYSIOL, V93, P785, DOI 10.1104/pp.93.2.785; OLIVE MR, 1989, PLANT MOL BIOL, V12, P525, DOI 10.1007/BF00036967; PAULE MR, 1971, J BIOL CHEM, V246, P4602; PLAXTON WC, 1987, PLANT PHYSIOL, V83, P105, DOI 10.1104/pp.83.1.105; PREISS J, 1990, PLANT PHYSIOL, V92, P881, DOI 10.1104/pp.92.4.881; Preiss J, 1991, OXFORD SURVEYS PLANT, V7, P59; SANWAL GG, 1968, PLANT PHYSIOL, V43, P417, DOI 10.1104/pp.43.3.417; Segel I.H., 1975, ENZYME KINETICS; SHAW JR, 1992, PLANT PHYSIOL, V98, P1214, DOI 10.1104/pp.98.3.1214; SINGH BK, 1984, PLANT PHYSIOL, V74, P711, DOI 10.1104/pp.74.3.711; SMITHWHITE BJ, 1992, J MOL EVOL, V34, P449, DOI 10.1007/BF00162999; SOWOKINOS JR, 1982, PLANT PHYSIOL, V69, P1459, DOI 10.1104/pp.69.6.1459; SOWOKINOS JR, 1981, PLANT PHYSIOL, V68, P924, DOI 10.1104/pp.68.4.924; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSAI CY, 1970, PLANT PHYSIOL, V46, P299, DOI 10.1104/pp.46.2.299; TSUBOI KK, 1969, J BIOL CHEM, V244, P1008; VILLAND P, 1992, PLANT MOL BIOL, V19, P381, DOI 10.1007/BF00023385; VILLAND P, 1992, PLANT PHYSIOL, V100, P1617, DOI 10.1104/pp.100.3.1617; ZEWE V, 1965, BIOCHEMISTRY-US, V4, P782, DOI 10.1021/bi00880a024	37	64	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1993	268	9					6228	6233						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KT368	8384204				2022-12-27	WOS:A1993KT36800026
J	DIIANNI, CL; DRIER, DA; DECKMAN, IC; MCCANN, PJ; LIU, FY; ROIZMAN, B; COLONNO, RJ; CORDINGLEY, MG				DIIANNI, CL; DRIER, DA; DECKMAN, IC; MCCANN, PJ; LIU, FY; ROIZMAN, B; COLONNO, RJ; CORDINGLEY, MG			IDENTIFICATION OF THE HERPES-SIMPLEX VIRUS-1 PROTEASE CLEAVAGE SITES BY DIRECT SEQUENCE-ANALYSIS OF AUTOPROTEOLYTIC CLEAVAGE PRODUCTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSID ASSEMBLY PROTEIN; COMPLETE DNA-SEQUENCE; GENE; ABUNDANT; VIRION; DOMAIN	Herpes simplex virus type-1 (HSV-1) encodes a protease responsible for proteolytic processing of the virus assembly protein, ICP35 (infected cell protein 35). The coding region of ICP35 is contained within the gene that encodes the protease, and ICP35 shares amino acid identity with the carboxyl-terminal 329 amino acids of the protease. The HSV-1 protease was expressed in Escherichia coli as a fusion protein containing a unique epitope and the protein A Fc binding domain at its carboxyl terminus. The fusion protease underwent autoproteolytic cleavage at two distinct sites. The size of the cleavage products containing the carboxyl-terminal epitope mapped one cleavage site near the carboxyl terminus of the protease corresponding to the proteolytic processing site of ICP35, and the second site proximal to the amino terminus consistent with previous data. The carboxyl-terminal autoproteolytic cleavage products were partially purified on an IgG affinity column by virtue of the protein A Fe binding domain and subjected to direct amino-terminal sequence analysis. Protein sequencing revealed that cleavage occurs between the Ala and Ser residues at amino acids 610/611 and 247/248 of the HSV-1 protease. The flanking sequences share homology with each other and are highly conserved in homologous proteases of other herpes viruses.	UNIV CHICAGO,MARJORIE B KOVLER VIRAL ONCOL LABS,CHICAGO,IL 60637	University of Chicago	DIIANNI, CL (corresponding author), BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT VIROL,PRINCETON,NJ 08543, USA.			McCann, Patrick/0000-0001-5297-0437				DAVISON AJ, 1986, J GEN VIROL, V67, P1759, DOI 10.1099/0022-1317-67-9-1759; DECKMAN IC, 1992, J VIROL, V66, P7362, DOI 10.1128/JVI.66.12.7362-7367.1992; GIBSON W, 1990, J VIROL, V64, P1241, DOI 10.1128/JVI.64.3.1241-1249.1990; GIBSON W, 1972, J VIROL, V10, P1044, DOI 10.1128/JVI.10.5.1044-1052.1972; GIBSON W, 1974, J VIROL, V13, P155, DOI 10.1128/JVI.13.1.155-165.1974; GRIFFIN AM, 1990, NUCLEIC ACIDS RES, V18, P3664, DOI 10.1093/nar/18.12.3664; IRMIERE A, 1985, J VIROL, V56, P277, DOI 10.1128/JVI.56.1.277-283.1985; LIU FY, 1991, J VIROL, V65, P5149, DOI 10.1128/JVI.65.10.5149-5156.1991; LIU FY, 1991, J VIROL, V65, P206, DOI 10.1128/JVI.65.1.206-212.1991; LIU FY, 1992, P NATL ACAD SCI USA, V89, P2076, DOI 10.1073/pnas.89.6.2076; MCGEOCH DJ, 1988, J GEN VIROL, V69, P1531, DOI 10.1099/0022-1317-69-7-1531; MOOS M, 1988, J BIOL CHEM, V263, P6005; PERDUE ML, 1974, VIROLOGY, V59, P201, DOI 10.1016/0042-6822(74)90216-5; PRESTON VG, 1983, J VIROL, V45, P1056, DOI 10.1128/JVI.45.3.1056-1064.1983; SCHENK P, 1991, NATURE-NEW BIOL, V242, P70; SHOWE MK, 1973, NATURE-NEW BIOL, V242, P70, DOI 10.1038/newbio242070a0; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; WELCH AR, 1991, P NATL ACAD SCI USA, V88, P10792, DOI 10.1073/pnas.88.23.10792	18	42	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2048	2051						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380586				2022-12-27	WOS:A1993KH62000083
J	BROWN, WC; DUNCAN, JA; CAMPBELL, JL				BROWN, WC; DUNCAN, JA; CAMPBELL, JL			PURIFICATION AND CHARACTERIZATION OF THE SACCHAROMYCES-CEREVISIAE DNA POLYMERASE-DELTA OVERPRODUCED IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; 5' EXONUCLEASE ACTIVITY; CALF THYMUS; REPLICATION INVITRO; CATALYTIC SUBUNIT; AUXILIARY PROTEIN; CDC2 GENE; ALPHA; EXPRESSION; ELONGATION	In order to further define the enzymatic properties of yeast DNA polymerase delta, the Saccharomyces cerevisiae POL3 gene, whose expression is highly toxic to bacteria in most cloning vectors, was cloned into a new T7 expression vector (W. C. Brown and J. L. Campbell, submitted for publication) which allowed efficient overexpression in bacteria. Fifteen mg of polymerase were obtained from 3 g of cells. Since the protein is produced in insoluble form, to obtain active polymerase, inclusion bodies were solubilized with urea. DNA polymerase delta (124 kDa) was purified in the presence of urea and then renatured by dialysis against buffers containing decreasing concentrations of urea. Optimal protein concentration for refolding was 5 mug/ml. By several criteria the enzyme obtained is comparable with that from yeast: specific activity, electrophoretic mobility, template preference, sensitivity to inhibitors, and processivity. The electrophoretic mobility suggests that, unlike DNA polymerase alpha, polymerase delta is not posttranslationally modified in yeast. Polyclonal antibody was raised against the full-length DNA polymerase delta from bacteria and shown to cross-react with the protein purified from yeast on protein blots. The renatured protein also exhibits an exonucleolytic activity. Further examination of this nuclease determined it to be a 3' to 5' exonuclease with the characteristics of a proofreading activity. The presence of this nuclease in the highly purified bacterial polymerase provides biochemical confirmation of earlier genetic evidence (Simon, M., Giot, L., and Faye, G. (1991) EMBO J. 10, 2165-2170) that suggested that DNA polymerase delta's core catalytic subunit contains an intrinsic 3' to 5' exonuclease.	CALTECH,BRAUN LABS,147-75CH,PASADENA,CA 91125	California Institute of Technology					NCI NIH HHS [CA-08692] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA008692] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAUER GA, 1988, P NATL ACAD SCI USA, V85, P7506, DOI 10.1073/pnas.85.20.7506; BAUER GA, 1990, NUCLEIC ACIDS RES, V18, P261, DOI 10.1093/nar/18.2.261; BOULET A, 1989, EMBO J, V8, P1849, DOI 10.1002/j.1460-2075.1989.tb03580.x; BROWN WC, 1993, IN PRESS GENE; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; BUDD ME, 1989, J BIOL CHEM, V264, P6557; BURGERS PMJ, 1988, J BIOL CHEM, V263, P925; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; BURGERS PMJ, 1908, J BIOL CHEM, V263, P925; BYRNES JJ, 1976, BIOCHEMISTRY-US, V15, P2817, DOI 10.1021/bi00658a018; CHEN H, 1991, NUCLEIC ACIDS RES, V18, P6231; COPELAND WC, 1991, J BIOL CHEM, V266, P22739; FRANKEL S, 1991, P NATL ACAD SCI USA, V88, P1192, DOI 10.1073/pnas.88.4.1192; FRORATH B, 1991, BIOTECHNIQUES, V11, P364; HARLOW E, 1988, ANTIBODIES LABORATOR; HSI KL, 1990, NUCLEIC ACIDS RES, V18, P6231, DOI 10.1093/nar/18.21.6231; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; KUNKEL TA, 1987, P NATL ACAD SCI USA, V84, P4865, DOI 10.1073/pnas.84.14.4865; LEE SH, 1988, P NATL ACAD SCI USA, V85, P9469, DOI 10.1073/pnas.85.24.9469; LEE SH, 1991, J BIOL CHEM, V266, P22707; LEE SH, 1990, P NATL ACAD SCI USA, V87, P5672, DOI 10.1073/pnas.87.15.5672; MORRISON A, 1990, CELL, V62, P1143, DOI 10.1016/0092-8674(90)90391-Q; MORRISON A, 1991, NUCLEIC ACIDS RES, V20, P375; NASHEUER HP, 1991, J BIOL CHEM, V266, P7893; NG L, 1991, J BIOL CHEM, V266, P11699; PIGNEDE G, 1991, J MOL BIOL, V222, P209, DOI 10.1016/0022-2836(91)90207-M; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; ROYCHOUDHURY B, 1979, NUCLEIC ACIDS RES, V3, P101; SIMON M, 1991, EMBO J, V10, P2165, DOI 10.1002/j.1460-2075.1991.tb07751.x; SITNEY KC, 1989, CELL, V56, P599, DOI 10.1016/0092-8674(89)90582-5; TAN CK, 1986, J BIOL CHEM, V261, P2310; TSURIMOTO T, 1989, MOL CELL BIOL, V9, P609, DOI 10.1128/MCB.9.2.609; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; ZHANG J, 1991, BIOCHEMISTRY-US, V30, P11742, DOI 10.1021/bi00115a002	35	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					982	990						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8380419				2022-12-27	WOS:A1993KG07700036
J	BINDOFF, LA; HOWELL, N; POULTON, J; MCCULLOUGH, DA; MORTEN, KJ; LIGHTOWLERS, RN; TURNBULL, DM; WEBER, K				BINDOFF, LA; HOWELL, N; POULTON, J; MCCULLOUGH, DA; MORTEN, KJ; LIGHTOWLERS, RN; TURNBULL, DM; WEBER, K			ABNORMAL RNA PROCESSING ASSOCIATED WITH A NOVEL TRANSFER-RNA MUTATION IN MITOCHONDRIAL-DNA - A POTENTIAL DISEASE MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY OPTIC NEUROPATHY; STROKE-LIKE EPISODES; RESPIRATORY-CHAIN; TRANSFER RNALEU(UUR); GENE ORGANIZATION; PROTEIN-SYNTHESIS; TRANSCRIPTION TERMINATION; LACTIC-ACIDOSIS; MELAS SUBGROUP; POINT MUTATION	A patient with a mitochondrial myopathy and biochemically proven profound complex I deficiency has a new mutation in mtDNA. This A-to-G transition at position 3302, involving the aminoacyl stem of tRNA(Leu(UUR)), is associated with abnormal mitochondrial RNA processing. Northern analysis demonstrates marked accumulation of a polycistronic RNA precursor containing sequence for 16 S rRNA, tRNA(Leu(UUR)), and ND1. Comparison of skeletal muscle and skin fibroblasts suggests that the processing error may be quantitatively less severe in this tissue, and biochemical analysis shows that fibroblasts do not express a biochemical defect despite containing the mutation. Important qualitative differences in the processing of this RNA precursor were found when comparing muscle and skin fibroblasts. In muscle, processing appears to occur first at the 5'-end of the tRNA, generating 16 S rRNA plus a tRNA + ND1 intermediate. In fibroblasts, processing occurs at the 3'-end of the tRNA, generating a 16 S rRNA + tRNA intermediate. We suggest that the mutation at position 3302 induces abnormal mitochondrial RNA processing that is linked to the biochemical defect (profound loss of complex I activity), either by qualitative or quantitative abnormalities in the ND1 message. The restriction to skeletal muscle of both the processing error and the biochemical defect suggests that the observed tissue differences in RNA processing play a protective role in skin fibroblasts.	UNIV TEXAS,MED BRANCH,DEPT RADIAT THERAPY,DIV BIOL,GALVESTON,TX 77550; BIOCHEM DEPT,GENET LAB,OXFORD OX1 3QU,ENGLAND	University of Texas System; University of Texas Medical Branch Galveston; University of Oxford	BINDOFF, LA (corresponding author), UNIV NEWCASTLE UPON TYNE,SCH MED,DIV CLIN NEUROSCI,FRAMLINGTON PL,NEWCASTLE TYNE NE2 4HH,ENGLAND.		Poulton, Joanna/AAB-4828-2021; Maniura, Katharina/N-2955-2016; MORTEN, Karl/GXM-6291-2022	Maniura, Katharina/0000-0001-7895-3563; Poulton, Joanna/0000-0002-2460-5587; Bindoff, Laurence/0000-0003-0988-276X; Morten, Karl/0000-0001-6926-6550	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD008315] Funding Source: NIH RePORTER; NICHD NIH HHS [P01-HD-08315] Funding Source: Medline; Wellcome Trust Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; ATTARDI G, 1990, BIOCHEM SOC T, V18, P509, DOI 10.1042/bst0180509; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BINDOFF LA, 1990, BAILLIERE CLIN ENDOC, V4, P583, DOI 10.1016/S0950-351X(05)80069-2; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221; CHOMYN A, 1987, CYTOCHROME SYSTEMS M, P145; CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408; CLAYTON DA, 1984, ANNU REV BIOCHEM, V53, P573; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; DOERSEN CJ, 1985, J BIOL CHEM, V260, P5942; EARLEY FGP, 1987, FEBS LETT, V219, P108, DOI 10.1016/0014-5793(87)81200-0; GARESSE R, 1988, GENETICS, V118, P649; GOTO Y, 1992, ANN NEUROL, V31, P672, DOI 10.1002/ana.410310617; GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7; HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HOWELL N, 1991, AM J HUM GENET, V49, P939; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; LOWERSON SA, 1992, ANAL BIOCHEM, V205, P372, DOI 10.1016/0003-2697(92)90453-E; MANAM S, 1987, J BIOL CHEM, V262, P10272; Maniatis T., 1982, MOL CLONING; MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9; ROE BA, 1985, J BIOL CHEM, V260, P9759; SCHON EA, 1992, BIOCHIM BIOPHYS ACTA, V1101, P206, DOI 10.1016/S0005-2728(05)80021-0; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SPRINZL M, 1989, NUCLEIC ACIDS RES, V17, pR1, DOI 10.1093/nar/17.1.1; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WATMOUGH NJ, 1990, J CLIN INVEST, V85, P177, DOI 10.1172/JCI114409; WILKINSON M, 1988, NUCLEIC ACIDS RES, V16, P10933, DOI 10.1093/nar/16.22.10933; YOON KL, 1991, BIOCHEM BIOPH RES CO, V176, P1112, DOI 10.1016/0006-291X(91)90399-R; ZASLOFF M, 1982, NATURE, V295, P533, DOI 10.1038/295533a0; ZENNARO E, 1989, NUCLEIC ACIDS RES, V17, P5751, DOI 10.1093/nar/17.14.5751; ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D	38	162	162	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19559	19564						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366098				2022-12-27	WOS:A1993LW81900064
J	ORELLANO, EG; CALCATERRA, NB; CARRILLO, N; CECCARELLI, EA				ORELLANO, EG; CALCATERRA, NB; CARRILLO, N; CECCARELLI, EA			PROBING THE ROLE OF THE CARBOXYL-TERMINAL REGION OF FERREDOXIN-NADP+ REDUCTASE BY SITE-DIRECTED MUTAGENESIS AND DELETION ANALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; ESCHERICHIA-COLI; SPINACH FERREDOXIN; BINDING-SITE; OXIDOREDUCTASE; PROTEIN; EXPRESSION; CDNA; GENE	The carboxyl-terminal region of plant ferredoxin-NADP+ reductases is formed by an invariant alpha-helix/loop/beta-strand, culminating in a conserved tyrosine that displays extensive interaction with the prosthetic group FAD. We have investigated the potential role of the terminal region in reductase function, by introducing mutations and deletions on pea ferredoxin-NADP+ reductase overexpressed in Escherichia coli. Replacement of the terminal tyrosine by tryptophan, phenylalanine, serine, and glycine resulted in a 2.2-, 2.0-, 22-, and 302-fold reduction, respectively, in k(cat) for the diaphorase reaction, whereas elimination of the tyrosine caused a 846-fold decrease in k(cat). K(m) values were largely unaffected by the substitutions. Similar results were obtained when the mutants were assayed for cytochrome c reduction, indicating that aromaticity is the most important factor to the function of the tyrosine in catalysis. The presence of the phenol ring at the carboxyl-terminal position of wild-type reductase is important, but not an absolute requirement for enzyme function or FAD assembly. Deletion of the alpha-helix/beta-strand region prevented reductase proper folding in the bacterial host, while shortening of the terminal region by splicing 3 amino acids at the beginning of the alpha-helix produced a moderately soluble reductase, devoid of FAD and enzymatic activity.	UNIV NACL ROSARIO,FAC CIENCIAS BIOQUIM & FARMACEUT,DEPT CIENCIAS BIOL,RA-2000 ROSARIO,ARGENTINA	National University of Rosario			Calcaterra, Nora/AAP-7469-2021; Ceccarelli, Eduardo A./V-2600-2019; Ceccarelli, Eduardo A./M-8699-2014	Ceccarelli, Eduardo A./0000-0001-5776-3306; Ceccarelli, Eduardo A./0000-0001-5776-3306				ALIVERTI A, 1990, EUR J BIOCHEM, V191, P551, DOI 10.1111/j.1432-1033.1990.tb19156.x; ALIVERTI A, 1991, J BIOL CHEM, V266, P17760; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDREWS SC, 1992, FEBS LETT, V302, P247, DOI 10.1016/0014-5793(92)80452-M; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; CARRILLO N, 1992, J BIOL CHEM, V267, P15537; CARRILLO N, 1985, EUR J BIOCHEM, V150, P469, DOI 10.1111/j.1432-1033.1985.tb09045.x; Carrillo N, 1987, TOPICS PHOTOSYNTHESI, V8, P527; CECCARELLI EA, 1991, J BIOL CHEM, V266, P14283; FILLAT MF, 1990, NUCLEIC ACIDS RES, V18, P7161, DOI 10.1093/nar/18.23.7161; JANSEN T, 1988, CURR GENET, V13, P517, DOI 10.1007/BF02427758; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; KARPLUS PA, 1984, BIOCHEMISTRY-US, V23, P6576, DOI 10.1021/bi00321a046; KUKI M, 1988, J BIOL CHEM, V263, P17437; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maniatis T, 1989, DECONTAMINATION DILU; MICHALOWSKI CB, 1989, PLANT PHYSIOL, V89, P817, DOI 10.1104/pp.89.3.817; NEWMAN BJ, 1988, PLANT MOL BIOL, V10, P511, DOI 10.1007/BF00033606; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLUCHTER WM, 1992, BIOCHEMISTRY-US, V31, P3092, DOI 10.1021/bi00127a009; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; SERRANO L, 1991, J MOL BIOL, V218, P465, DOI 10.1016/0022-2836(91)90725-L; SHERIFF S, 1981, J MOL BIOL, V145, P441, DOI 10.1016/0022-2836(81)90214-X; SHIN M, 1965, J BIOL CHEM, V240, P1405; Shin M, 1971, METHOD ENZYMOL, V23, P440; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; YAO Y, 1984, J BIOCHEM-TOKYO, V95, P1513, DOI 10.1093/oxfordjournals.jbchem.a134759; ZANETTI G, 1976, BIOCHIM BIOPHYS ACTA, V445, P14, DOI 10.1016/0005-2744(76)90157-1; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468	32	42	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19267	19273						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366077				2022-12-27	WOS:A1993LW81900021
J	CIZMECISMITH, G; STAHL, RC; SHOWALTER, LJ; CAREY, DJ				CIZMECISMITH, G; STAHL, RC; SHOWALTER, LJ; CAREY, DJ			DIFFERENTIAL EXPRESSION OF TRANSMEMBRANE PROTEOGLYCANS IN VASCULAR SMOOTH-MUSCLE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; MAMMARY EPITHELIAL-CELLS; FIBROBLAST GROWTH-FACTOR; SURFACE PROTEOGLYCAN; MOLECULAR-CLONING; MESSENGER-RNA; CORE PROTEINS; SYNDECAN; ANGIOTENSIN; HYPERTROPHY	Rat aortic vascular smooth muscle (VSM) cells synthesize the transmembrane proteoglycan syndecan (Cizmeci-Smith, G., Asundi, V., Stahl, R. C., Teichman, L. J., Chernousov, M., Cowan, K., and Carey, D. J. (1992) J. Biol. Chem. 267, 15729-15736). The present work demonstrated that VSM cells synthesize the related transmembrane proteoglycan fibroglycan and that increased expression of these two proteoglycans is stimulated under different conditions. Fibroglycan synthesis by cultured rat aortic VSM cells was demonstrated by Northern blot analysis with a rat fibroglycan cDNA probe and immunoblot analysis with anti-rat fibroglycan antibodies. Effects of growth factors and vasoactive substances on syndecan and fibroglycan expression were examined by Northern blot analysis. Syndecan mRNA levels increased in response to stimulation of VSM cells with serum, platelet-derived growth factor, or angiotensin II. VSM cells stimulated with platelet-derived growth factor contained more syndecan core protein and processed syndecan than control cells. Fibroglycan mRNA levels either decreased or remained unchanged in response to these agents. Fibroglycan mRNA levels increased following transforming growth factor-beta stimulation, while syndecan mRNA levels decreased. Other agents, including basic fibroblast growth factor, endothelin, and carbacyclin did not alter the expression of either proteoglycan. Syndecan and fibroglycan mRNA levels also varied as a function of cell density. These data demonstrate that syndecan and fibroglycan expression are regulated differently in VSM cells and lend support to the hypothesis that these proteoglycans carry out distinct physiological functions.			CIZMECISMITH, G (corresponding author), GEISINGER,SIGFRIED & JANET WEIS CTR RES,26-13 100 ACAD AVE,DANVILLE,PA 18722, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021925] Funding Source: NIH RePORTER; NINDS NIH HHS [NS21925] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERNFIELD M, 1991, ANN NY ACAD SCI, V638, P182, DOI 10.1111/j.1749-6632.1991.tb49029.x; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; CAREY DJ, 1990, J CELL BIOL, V111, P2053, DOI 10.1083/jcb.111.5.2053; CAREY DJ, 1991, ANNU REV PHYSIOL, V53, P161, DOI 10.1146/annurev.physiol.53.1.161; CAREY DJ, 1992, J CELL BIOL, V117, P191, DOI 10.1083/jcb.117.1.191; CIZMECISMITH G, 1992, J BIOL CHEM, V267, P15729; CORJAY MH, 1989, J BIOL CHEM, V264, P10501; ELENIUS K, 1992, J BIOL CHEM, V267, P6435; ELENIUS K, 1991, J CELL BIOL, V114, P585, DOI 10.1083/jcb.114.3.585; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; GOULD SE, 1992, P NATL ACAD SCI USA, V89, P3271, DOI 10.1073/pnas.89.8.3271; HAMATI HF, 1989, J CELL BIOL, V108, P2495, DOI 10.1083/jcb.108.6.2495; HAYASHI K, 1987, J HISTOCHEM CYTOCHEM, V35, P1079, DOI 10.1177/35.10.2957423; HILALDANDAN R, 1992, J BIOL CHEM, V267, P10620; HUANG MN, 1990, BIOTECHNIQUES, V9, P134; ITOH H, 1990, HYPERTENSION, V16, P325; KAI J, 1989, BIOCHEM BIOPH RES CO, V176, P1601; KIEFER MC, 1990, P NATL ACAD SCI USA, V87, P6985, DOI 10.1073/pnas.87.18.6985; KODA JE, 1985, J BIOL CHEM, V260, P8157; KOJIMA T, 1992, J BIOL CHEM, V267, P4870; MARYNEN P, 1989, J BIOL CHEM, V264, P7017; NAFTILAN AJ, 1989, HYPERTENSION, V13, P706, DOI 10.1161/01.HYP.13.6.706; PIERCE A, 1992, J BIOL CHEM, V267, P3894; RAPRAEGER A, 1989, J CELL BIOL, V109, P2509, DOI 10.1083/jcb.109.5.2509; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; SALMIVIRTA M, 1991, J BIOL CHEM, V266, P7733; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAUNDERS S, 1988, J CELL BIOL, V106, P423, DOI 10.1083/jcb.106.2.423; SAUNDERS S, 1989, J CELL BIOL, V108, P1547, DOI 10.1083/jcb.108.4.1547; SCHELLING P, 1991, J HYPERTENS, V9, P3; SCHMIDT A, 1992, J BIOL CHEM, V267, P19242; SHARIFI BG, 1992, J BIOL CHEM, V267, P23910; SUN X, 1989, J CELL BIOL, V108, P1547; THYBERG J, 1990, ARTERIOSCLEROSIS, V10, P966, DOI 10.1161/01.ATV.10.6.966; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; YEAMAN C, 1992, MOL BIOL CELL, V3, pA64	39	54	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18740	18747						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360168				2022-12-27	WOS:A1993LV65900059
J	COLLO, G; STARR, L; QUARANTA, V				COLLO, G; STARR, L; QUARANTA, V			A NEW ISOFORM OF THE LAMININ RECEPTOR INTEGRIN-ALPHA-7-BETA-1 IS DEVELOPMENTALLY-REGULATED IN SKELETAL-MUSCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAIN; CELL-ADHESION; MESSENGER-RNA; INTEGRIN; EXPRESSION; MYOBLASTS; SUBUNIT; MYOGENESIS; MOLECULES; SURFACE	Within the integrin family, there are two groups of receptors that bind laminin. One of these groups comprises the heterodimers alpha3beta1, alpha6beta1, and alpha7beta1, all of which bind the E8 fragment of laminin, and whose alpha subunits show significant homology at the amino acid sequence level. Alpha3 and alpha6 exist as isoforms with distinct cytoplasmic domains (termed A and B), suggesting that they may couple laminin adhesion to distinct cellular responses. We report the identification of a new alpha7 mRNA which encodes an alpha7 protein isoform with an alternative cytoplasmic domain. Based on homology with alpha3 and alpha6 isoforms, this new isoform is classified as alpha7A and the previously published one as alpha7B. This result extends the similarity between alpha3, alpha6, and alpha7 laminin receptor subunits and suggests a common ancestral gene. The alpha7beta1 laminin receptor was proposed to be involved in myogenic differentiation. However, alpha7 isoforms were not investigated in that context. We detected the alpha7B isoform mRNA in all tissues and cell types tested, including myocardial and skeletal muscle. In contrast, the alpha7A isoform was detectable exclusively in skeletal muscle, not in myocardial muscle or cells or any other tissues or cell lines tested. Furthermore, the differentiating skeletal muscle cell line C2C12 expressed only alpha7B at the replicating myoblast stage and acquired alpha7A expression upon induction of differentiation and fusion. Splicing of alpha7B mRNA in C2C12 occurred shortly after myogenin expression and could be an indicator of progression through the program of skeletal muscle differentiation.	Scripps Res Inst, DEPT CELL BIOL, 10666 N TORREY PINES RD, NX-7, LA JOLLA, CA 92037 USA	Scripps Research Institute			Quaranta, Vito/G-6512-2016	Quaranta, Vito/0000-0001-7491-8672; COLLO, Ginetta/0000-0003-1888-5049	NCI NIH HHS [CA47858] Funding Source: Medline; NIGMS NIH HHS [GM46902] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA047858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046902] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBELDA SM, 1990, FASEB J, V4, P2868, DOI 10.1096/fasebj.4.11.2199285; ALTRUDA F, 1990, GENE, V95, P261, DOI 10.1016/0378-1119(90)90369-3; BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143; EKBLOM P, 1986, ANNU REV CELL BIOL, V2, P27, DOI 10.1146/annurev.cb.02.110186.000331; FOSTER RF, 1987, DEV BIOL, V122, P11, DOI 10.1016/0012-1606(87)90327-7; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; Innis M. A., 1990, PCR PROTOCOL GUIDE M; KAUFMAN SJ, 1988, P NATL ACAD SCI USA, V85, P9606, DOI 10.1073/pnas.85.24.9606; KAUFMAN SJ, 1985, J CELL BIOL, V100, P1977, DOI 10.1083/jcb.100.6.1977; KAUFMAN SJ, 1991, DEV BIOL, V146, P228, DOI 10.1016/0012-1606(91)90462-C; KRAMER RH, 1991, CELL REGUL, V2, P805, DOI 10.1091/mbc.2.10.805; LANGUINO LR, 1992, J BIOL CHEM, V267, P7116; MILLAR JBA, 1992, EMBO J, V11, P4933, DOI 10.1002/j.1460-2075.1992.tb05600.x; OCALAN M, 1988, DEV BIOL, V125, P158, DOI 10.1016/0012-1606(88)90068-1; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; SONG WK, 1992, J CELL BIOL, V115, P843; STARR L, 1992, BIOTECHNIQUES, V13, P612; SUZUKI S, 1990, EMBO J, V9, P757, DOI 10.1002/j.1460-2075.1990.tb08170.x; TAMURA RN, 1990, J CELL BIOL, V111, P1593, DOI 10.1083/jcb.111.4.1593; TAMURA RN, 1991, P NATL ACAD SCI USA, V88, P10183, DOI 10.1073/pnas.88.22.10183; VANKUPPEVELT THMSM, 1989, P NATL ACAD SCI USA, V86, P5415; VONDERMARK H, 1991, J BIOL CHEM, V266, P23593; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0	26	134	136	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					19019	19024						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360188				2022-12-27	WOS:A1993LV65900096
J	HORTENSTEINER, S; VOGT, E; HAGENBUCH, B; MEIER, PJ; AMRHEIN, N; MARTINOIA, E				HORTENSTEINER, S; VOGT, E; HAGENBUCH, B; MEIER, PJ; AMRHEIN, N; MARTINOIA, E			DIRECT ENERGIZATION OF BILE-ACID TRANSPORT INTO PLANT VACUOLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CANALICULAR MEMBRANE-VESICLES; RAT-LIVER; ATP; TAUROCHOLATE; MALATE; SALT	Bile acids were shown to be transported into barley mesophyll vacuoles. Uptake of the cholate conjugates taurocholate and glycocholate is strictly ATP-dependent. Uptake of taurocholate is a saturable process (K(m) = 40 muM) and is inhibited by vanadate but not by bafilomycin, a specific inhibitor of the vacuolar H+-ATPase. Together with the observation that the non-hydrolyzable ATP analog AMPPNP (5'-adenylyl beta,gamma-imidodiphosphate) does not stimulate, but rather inhibits, the ATP-dependent uptake of taurocholate, and that a 3-fold accumulation of the bile acid is observed in the presence of bafilomycin, these results suggest that taurocholate is transported into the vacuole by a primary active process as is the case for its canalicular secretion in rat liver (Nishida, T., Gatmaitan, Z., Che, M., and Arias, I. M. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 6590-6594). Taurocholate uptake is inhibited by other bile acids and is slightly stimulated by glutathione S-conjugates. The different responses of the glutathione S-conjugate (Martinoia, E., Grill, E., Tommasini, R., Kreuz, K., and Amrhein, N. (1993) Nature 364, 247-249) and the taurocholate transporters, respectively, to substrates, oligomycin, GTP, and UTP suggest the presence of at least two ATPases specifically involved in the transport of conjugates across the tonoplast. As cholate and its conjugates have so far not been reported to occur in plants, the physiological function of the novel transport ATPase described here is presently unknown.	SWISS FED INST TECHNOL,INST PLANT SCI,SONNEGGSTR 5,CH-8092 ZURICH,SWITZERLAND; UNIV HOSP ZURICH,DEPT MED,DIV CLIN PHARMACOL,CH-8091 ZURICH,SWITZERLAND	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital			Martinoia, Enrico/AAH-8712-2021; Hagenbuch, Bruno/M-5294-2016	Hagenbuch, Bruno/0000-0002-2938-8630				ADACHI Y, 1991, HEPATOLOGY, V14, P655, DOI 10.1016/0270-9139(91)90053-X; AKERBOOM TPM, 1991, J BIOL CHEM, V266, P13147; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V; KITAMURA T, 1990, P NATL ACAD SCI USA, V87, P3557, DOI 10.1073/pnas.87.9.3557; KOBAYASHI K, 1990, J BIOL CHEM, V265, P7737; KRAUTLER B, 1991, ANGEW CHEM INT EDIT, V30, P1315, DOI 10.1002/anie.199113151; LUCKNER M, 1990, SECONDARY METABOLISM, P452; MARTINOIA E, 1985, BIOCHIM BIOPHYS ACTA, V806, P311, DOI 10.1016/0005-2728(85)90110-0; MARTINOIA E, 1993, NATURE, V364, P247, DOI 10.1038/364247a0; MARTINOIA E, 1992, BOT ACTA, V105, P232, DOI 10.1111/j.1438-8677.1992.tb00293.x; MATILE P, 1978, ANNU REV PLANT PHYS, V29, P193, DOI 10.1146/annurev.pp.29.060178.001205; MATILE P, 1988, P NATL ACAD SCI USA, V85, P9592; MULLER M, 1991, J BIOL CHEM, V266, P18920; NISHIDA T, 1991, P NATL ACAD SCI USA, V88, P6590, DOI 10.1073/pnas.88.15.6590; REA PA, 1987, PHYSIOL PLANTARUM, V71, P131, DOI 10.1111/j.1399-3054.1987.tb04630.x; RENTSCH D, 1991, PLANTA, V184, P532, DOI 10.1007/BF00197903; SERRANO R, 1989, ANNU REV PLANT PHYS, V40, P61; STIEGER B, 1992, BIOCHEM J, V284, P67, DOI 10.1042/bj2840067	19	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18446	18449						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360146				2022-12-27	WOS:A1993LV65900013
J	MONTESANORODITIS, L; MCWILLIAMS, R; GLITZ, DG; OLAH, TV; PERRAULT, AR; COOPERMAN, BS				MONTESANORODITIS, L; MCWILLIAMS, R; GLITZ, DG; OLAH, TV; PERRAULT, AR; COOPERMAN, BS			PLACEMENT OF DINITROPHENYL-MODIFIED RIBOSOMAL-PROTEINS IN TOTALLY RECONSTITUTED ESCHERICHIA-COLI 30-S SUBUNITS - LOCALIZATION OF PROTEIN-S6, PROTEIN-S13, PROTEIN-S16, AND PROTEIN-S18 BY IMMUNE ELECTRON-MICROSCOPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA BINDING; 3' MAJOR DOMAIN; MESSENGER-RNA; 16S-RIBOSOMAL RNA; CROSS-LINKING; PAIR S13-S19; IDENTIFICATION; ANTIBODY; SITE; S19	Purified Escherichia coli ribosomal proteins S6, S13, S16, and S18 were dinitrophenylated at their amino termini and/or at one or more internal lysine residues. Each dinitrophenyl protein was then separately incorporated into reconstituted small ribosomal subunits. Modified proteins were localized on the 30 S subunit surface by electron microscopy of reconstituted subunits complexed with antibodies to dinitrophenol (DNP). DNP protein S13 was placed on the subunit head above the platform and on the surface that faces the large subunit. DNP-S18 was localized to the subunit platform below the tip and in a region associated with binding to 50 S subunits. DNP proteins S6 and S16 were both localized near the junction of the subunit body and platform; DNP-S6 was available to antibody in 70 S ribosomes and was placed on the cytoplasm-facing side of the subunit in an area that overlaps the platform and body of the particle. DNP-S16 in 70 S ribosomes was not bound by antibody. It was localized to the 30 S body near its junction with the platform and on the surface facing the 50 S particle. The results complement and clarify data obtained using other approaches.	UNIV CALIF LOS ANGELES, SCH MED, DEPT BIOL CHEM, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH MED, INST MOLEC BIOL, LOS ANGELES, CA 90024 USA; UNIV PENN, DEPT CHEM, PHILADELPHIA, PA 19104 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Pennsylvania					NIGMS NIH HHS [GM-32769] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032769] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABDURASHIDOVA GG, 1986, EUR J BIOCHEM, V159, P103, DOI 10.1111/j.1432-1033.1986.tb09838.x; Amils R, 1979, Methods Enzymol, V59, P449; BOLLEN A, 1975, J BIOL CHEM, V250, P4310; BRIMACOMBE R, 1988, J MOL BIOL, V199, P115, DOI 10.1016/0022-2836(88)90383-X; BROCKMOLLER J, 1988, BIOCHEMISTRY-US, V27, P3372, DOI 10.1021/bi00409a038; BROUDE NE, 1983, EUR J BIOCHEM, V132, P139, DOI 10.1111/j.1432-1033.1983.tb07338.x; BUCK MA, 1991, BIOCHIMIE, V73, P769, DOI 10.1016/0300-9084(91)90056-7; CAPEL MS, 1988, J MOL BIOL, V200, P65, DOI 10.1016/0022-2836(88)90334-8; CAPEL MS, 1987, SCIENCE, V238, P1403, DOI 10.1126/science.3317832; COVER JA, 1981, BIOCHEMISTRY-US, V20, P2843, DOI 10.1021/bi00513a021; DOHME F, 1976, J MOL BIOL, V107, P585, DOI 10.1016/S0022-2836(76)80085-X; FISER I, 1975, FEBS LETT, V56, P226, DOI 10.1016/0014-5793(75)81097-0; FRANK J, 1991, J CELL BIOL, V115, P597, DOI 10.1083/jcb.115.3.597; GIMAUTDINOVA OI, 1981, NUCLEIC ACIDS RES, V9, P3465, DOI 10.1093/nar/9.14.3465; GLITZ DG, 1988, METHOD ENZYMOL, V164, P493; GRAIFER DM, 1989, BIOCHIM BIOPHYS ACTA, V1008, P146, DOI 10.1016/0167-4781(80)90002-0; GRANT PG, 1983, J BIOL CHEM, V258, P1305; HEROLD M, 1987, J BIOL CHEM, V262, P8826; KAHAN L, 1981, J MOL BIOL, V145, P193, DOI 10.1016/0022-2836(81)90340-5; KERLAVAGE AR, 1986, BIOCHEMISTRY-US, V25, P8002, DOI 10.1021/bi00372a032; LAKE JA, 1976, J MOL BIOL, V105, P131, DOI 10.1016/0022-2836(76)90200-X; LAKE JA, 1975, J MOL BIOL, V99, P631, DOI 10.1016/S0022-2836(75)80177-X; LAKE JA, 1978, ADV TECHNIQUES BIOL, V2, P173; LAMBERT JM, 1981, J MOL BIOL, V149, P451, DOI 10.1016/0022-2836(81)90481-2; LAMBERT JM, 1983, BIOCHEMISTRY-US, V22, P3913, DOI 10.1021/bi00285a029; LIETZKE R, 1988, METHOD ENZYMOL, V164, P278; LIN FL, 1984, J MOL BIOL, V172, P41, DOI 10.1016/0022-2836(84)90413-3; LITTLECHILD J, 1987, BIOCHIM BIOPHYS ACTA, V913, P245, DOI 10.1016/0167-4838(87)90336-0; LUHRMANN R, 1976, EUR J BIOCHEM, V66, P1, DOI 10.1111/j.1432-1033.1976.tb10419.x; NAG B, 1987, J BIOL CHEM, V262, P9681; NOLLER HF, 1990, RIBOSOME, P73; NOLLER HF, 1991, ANNU REV BIOCHEM, V60, P191, DOI 10.1146/annurev.biochem.60.1.191; OAKES MI, 1990, J MOL BIOL, V211, P897, DOI 10.1016/0022-2836(90)90082-W; OAKES MI, 1986, P NATL ACAD SCI USA, V83, P275, DOI 10.1073/pnas.83.2.275; OLAH TV, 1988, J BIOL CHEM, V263, P4795; OLAH TV, 1993, J BIOL CHEM, V268, P18696; OLSON HM, 1988, J BIOL CHEM, V263, P4801; OLSON HM, 1986, J BIOL CHEM, V261, P6924; OLSON HM, 1988, J BIOL CHEM, V263, P15196; POHL T, 1988, J BIOL CHEM, V263, P4293; POWERS T, 1988, J MOL BIOL, V200, P309, DOI 10.1016/0022-2836(88)90243-4; POWERS T, 1988, J MOL BIOL, V201, P697, DOI 10.1016/0022-2836(88)90468-8; RAMAKRISHNAN VR, 1981, J MOL BIOL, V153, P739, DOI 10.1016/0022-2836(81)90416-2; RUMMEL DP, 1973, NATURE-NEW BIOL, V245, P72, DOI 10.1038/newbio245072a0; SCHULZE H, 1982, EMBO J, V1, P609, DOI 10.1002/j.1460-2075.1982.tb01216.x; SEDELNIKOVA SE, 1991, J MOL BIOL, V220, P549, DOI 10.1016/0022-2836(91)90098-Q; STERN S, 1988, J MOL BIOL, V201, P683, DOI 10.1016/0022-2836(88)90467-6; STERN S, 1988, J MOL BIOL, V200, P291, DOI 10.1016/0022-2836(88)90241-0; STOFFLER G, 1982, J BIOL CHEM, V257, P4203; STOFFLERMEILICKE M, 1987, BIOCHIMIE, V69, P1049, DOI 10.1016/0300-9084(87)90005-8; STOFFLERMEILICKE M, 1990, RIBOSOME, P123; SVENSSON P, 1988, J MOL BIOL, V200, P301, DOI 10.1016/0022-2836(88)90242-2; SYU WJ, 1992, J PROTEIN CHEM, V11, P225, DOI 10.1007/BF01024860; TISCHENDORF GW, 1975, P NATL ACAD SCI USA, V72, P4820, DOI 10.1073/pnas.72.12.4820; TRAUB P, 1969, J MOL BIOL, V40, P391, DOI 10.1016/0022-2836(69)90161-2; Traub P, 1971, METHOD ENZYMOL, V20, P391; WITTMANN HG, 1983, ANNU REV BIOCHEM, V52, P35, DOI 10.1146/annurev.bi.52.070183.000343; WITTMANN HG, 1986, STRUCTURE FUNCTION G, P1; Wittmann-Liebold Brigitte, 1986, STRUCTURE FUNCTION G, P326; WOWER J, 1991, BIOCHIMIE, V73, P961, DOI 10.1016/0300-9084(91)90137-P; YAGUCHI M, 1978, EUR J BIOCHEM, V92, P243, DOI 10.1111/j.1432-1033.1978.tb12742.x	61	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18701	18709						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360163				2022-12-27	WOS:A1993LV65900054
J	TOESCU, EC; LAWRIE, AM; GALLACHER, DV; PETERSEN, OH				TOESCU, EC; LAWRIE, AM; GALLACHER, DV; PETERSEN, OH			THE PATTERN OF AGONIST-EVOKED CYTOSOLIC CA2+ OSCILLATIONS DEPENDS ON THE RESTING INTRACELLULAR CA2+ CONCENTRATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC ACINAR-CELLS; INOSITOL TRISPHOSPHATE; CALCIUM OSCILLATIONS; CA-2+ RELEASE; INHIBITION; RECEPTOR; 1,4,5-TRISPHOSPHATE; MECHANISM; RAT; CHOLECYSTOKININ	The agonists acetylcholine (ACh) and cholecystokinin (CCK) have been shown to evoke markedly different patterns of cytosolic Ca2+ oscillations in the same isolated pancreatic acinar cells. ACh induces high frequency sinusoidal oscillations (spiking) associated with activation of Ca2+ influx. CCK evokes longer lasting discrete transients separated by long intervals, and these low frequency transients persist for many minutes in the absence of extracellular Ca2+. Using digital imaging of fura-2 fluorescence, we have now monitored the free cytoplasmic Ca2+ concentration ([Ca2+]i) simultaneously in many individual cells from the same population. In the resting condition [Ca2+]i ranged from about 50 to 300 nm. When the resting [Ca2+]i was below 150 nM, ACh (50-100 nM) invariably evoked typical high frequency spiking. In the majority of cells which had a resting [Ca2+]i higher than 150 nM, ACh also evoked low frequency transients. Although initiated by ACh, these transients displayed the temporal and functional characteristics of the CCK-evoked transients. Removal of extracellular Ca2+ for a few minutes had no effect on this type of oscillation, whereas such a procedure reversibly abolished the ACh-evoked high frequency response. For the response evoked by 10-30 pM CCK, there was a positive correlation between the Ca2+ signal amplitude and the resting [Ca2+]i. Because CCK could never induce high frequency spiking there is some receptor specificity in dictating the time course of Ca2+ oscillations, but the resting [Ca2+]i is a major determinant of the Ca2+ signal pattern.			TOESCU, EC (corresponding author), MRC,SECRETORY CONTROL RES GRP,PHYSIOL LAB,POB 147,CROWN ST,LIVERPOOL L69 3BX,ENGLAND.		Petersen, Ole H/E-8708-2010	Petersen, Ole/0000-0002-6998-0380				ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; COBBOLD PH, 1991, CELL CALCIUM, V12, P87, DOI 10.1016/0143-4160(91)90011-3; DANOFF SK, 1988, BIOCHEM J, V254, P701, DOI 10.1042/bj2540701; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; FORSTER ER, 1992, EXP PHYSIOL, V77, P693, DOI 10.1113/expphysiol.1992.sp003635; GLENNON MC, 1992, J BIOL CHEM, V267, P25568; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAJJAR RJ, 1991, J BIOL CHEM, V266, P21589; HIRAMATSU Y, 1992, J MEMBRANE BIOL, V129, P277; IINO M, 1992, NATURE, V360, P76, DOI 10.1038/360076a0; LEVY S, 1993, J GEN PHYSIOL, V101, P67, DOI 10.1085/jgp.101.1.67; MIGNERY GA, 1992, J BIOL CHEM, V267, P7450; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OSIPCHUK YV, 1990, EMBO J, V9, P697, DOI 10.1002/j.1460-2075.1990.tb08162.x; PARKER I, 1990, P NATL ACAD SCI USA, V87, P260, DOI 10.1073/pnas.87.1.260; PETERSEN CCH, 1991, EMBO J, V10, P527, DOI 10.1002/j.1460-2075.1991.tb07979.x; PETERSEN OH, 1990, J MEMBRANE BIOL, V118, P93, DOI 10.1007/BF01868467; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; SPEKSNIJDER JE, 1989, P NATL ACAD SCI USA, V86, P6607, DOI 10.1073/pnas.86.17.6607; STREB H, 1985, J BIOL CHEM, V260, P7309; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; TEPIKIN AV, 1992, BIOCHIM BIOPHYS ACTA, V1137, P197, DOI 10.1016/0167-4889(92)90202-M; TOESCU EC, 1992, EMBO J, V11, P1623, DOI 10.1002/j.1460-2075.1992.tb05208.x; WAKUI M, 1989, NATURE, V339, P317, DOI 10.1038/339317a0; WAKUI M, 1990, FEBS LETT, V263, P206, DOI 10.1016/0014-5793(90)81374-W; WOODS NM, 1987, CELL CALCIUM, V8, P79, DOI 10.1016/0143-4160(87)90038-8; YULE DI, 1988, FEBS LETT, V239, P358, DOI 10.1016/0014-5793(88)80951-7; YULE DI, 1991, CELL CALCIUM, V12, P145, DOI 10.1016/0143-4160(91)90016-8; YULE DI, 1992, J BIOL CHEM, V267, P13830; ZHANG BX, 1992, J BIOL CHEM, V267, P24387; ZHAO H, 1990, J BIOL CHEM, V265, P21419	36	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18654	18658						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360161				2022-12-27	WOS:A1993LV65900047
J	DBAIBO, GS; OBEID, LM; HANNUN, YA				DBAIBO, GS; OBEID, LM; HANNUN, YA			TUMOR NECROSIS FACTOR-KAPPA (TNF-ALPHA) SIGNAL-TRANSDUCTION THROUGH CERAMIDE - DISSOCIATION OF GROWTH-INHIBITORY EFFECTS OF TNF-ALPHA FROM ACTIVATION OF NUCLEAR FACTOR-KAPPA-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; HUMAN-IMMUNODEFICIENCY-VIRUS; ARACHIDONIC-ACID RELEASE; CELL-DIFFERENTIATION; HL-60 CELLS; SPHINGOMYELIN TURNOVER; INDEPENDENT ACTIVATION; BINDING PROTEINS; PHOSPHOLIPASE-C; TRANSCRIPTION	Tumor necrosis factor-alpha (TNF-alpha) exerts pleiotropic biologic effects. Although TNF-alpha appears to activate a number of signal transduction pathways, the role of second messengers in mediating the different effects of TNF-alpha are not well defined. In this study, we investigated the role of ceramide as an intracellular mediator of TNF-alpha action. In Jurkat T cells, TNF-alpha caused early activation of the sphingomyelin cycle with peak hydrolysis of sphingomyelin observed at 30 min following addition of TNF-alpha. In this cell line, TNF-alpha caused potent activation of nuclear factor-kappaB (NF-kappaB) and exerted potent cytostatic/cytocidal activity. C2-ceramide mimicked the effects of TNF-alpha on cell growth in a dose-dependent manner, but C2-ceramide was unable to induce activation of NF-kappaB under multiple conditions investigated. C2-ceramide, however, enhanced activation of NF-kappaB in response to TNF-alpha with peak effects observed at a concentration of C2-ceramide of 5 muM. Thus, ceramide functions as a selective mediator of the cytostatic/cytotoxic effects of TNF-alpha and plays a positive feedback role in activation of NF-kappaB. TNF-alpha signaling, therefore, involves multiple second-messenger pathways that function independently or coordinately to transduce distinct functions of TNF-alpha.	DUKE UNIV, MED CTR, DEPT MED, BOX 3355, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT MINERAL & PETROL, DURHAM, NC 27710 USA	Duke University			Dbaibo, Ghassan S./X-2978-2019	obeid, lina/0000-0002-0734-0847	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043825, R37GM043825] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-43825] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATKINSON YH, 1990, IMMUNOLOGY, V70, P82; BEUTLER B, 1988, BIOCHEMISTRY-US, V27, P7575, DOI 10.1021/bi00420a001; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; BRETT J, 1989, J EXP MED, V169, P1977, DOI 10.1084/jem.169.6.1977; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; CLARK MA, 1988, BIOCHEM J, V250, P125, DOI 10.1042/bj2500125; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DRESSLER KA, 1992, SCIENCE, V255, P1715, DOI 10.1126/science.1313189; DUYAO MP, 1990, P NATL ACAD SCI USA, V87, P4727, DOI 10.1073/pnas.87.12.4727; FEUILLARD J, 1991, CYTOKINE, V3, P257, DOI 10.1016/1043-4666(91)90025-9; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GODFREY RW, 1987, BIOCHEM BIOPH RES CO, V142, P235, DOI 10.1016/0006-291X(87)90476-1; Grunfeld C, 1990, Adv Intern Med, V35, P45; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; HALIDAY EM, 1991, EMBO J, V10, P109, DOI 10.1002/j.1460-2075.1991.tb07926.x; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HOHMANN HP, 1991, MOL CELL BIOL, V11, P2315, DOI 10.1128/MCB.11.4.2315; IMAMURA K, 1988, J BIOL CHEM, V263, P10247; KIM MY, 1991, J BIOL CHEM, V266, P484; KRONKE M, 1987, P NATL ACAD SCI USA, V84, P469, DOI 10.1073/pnas.84.2.469; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Loetscher H, 1991, Oxf Surv Eukaryot Genes, V7, P119; LOWENTHAL JW, 1989, J IMMUNOL, V142, P3121; MARINO MW, 1989, P NATL ACAD SCI USA, V86, P8417, DOI 10.1073/pnas.86.21.8417; MCCACHREN SS, 1988, BIOCHEM BIOPH RES CO, V151, P574, DOI 10.1016/0006-291X(88)90633-X; MEICHLE A, 1990, J BIOL CHEM, V265, P8339; MERRILL AH, 1991, J BIOENERG BIOMEMBR, V23, P83; MOLITOR JA, 1990, P NATL ACAD SCI USA, V87, P10028, DOI 10.1073/pnas.87.24.10028; NEALE ML, 1988, IMMUNOLOGY, V64, P81; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; OKAZAKI T, 1990, J BIOL CHEM, V265, P15823; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; PATESTOS N P, 1992, Biochemical Society Transactions, V20, p80S; RAPUANO BE, 1991, BIOCHIM BIOPHYS ACTA, V1091, P374, DOI 10.1016/0167-4889(91)90203-A; RENAN MJ, 1989, CANCER LETT, V47, P1, DOI 10.1016/0304-3835(89)90170-5; RUBEN SM, 1991, SCIENCE, V251, P1490, DOI 10.1126/science.2006423; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SCHUTZE S, 1990, J IMMUNOL, V144, P2604; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P2424, DOI 10.1128/MCB.9.6.2424; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; VILCEK J, 1991, J BIOL CHEM, V266, P7313; WU WG, 1991, J BIOL CHEM, V266, P13602; YANAGA F, 1992, J BIOL CHEM, V267, P5114	47	219	223	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17762	17766						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349660				2022-12-27	WOS:A1993LT74300022
J	DIRUGGIERO, J; ROBB, FT; JAGUS, R; KLUMP, HH; BORGES, KM; KESSEL, M; MAI, XH; ADAMS, MWW				DIRUGGIERO, J; ROBB, FT; JAGUS, R; KLUMP, HH; BORGES, KM; KESSEL, M; MAI, XH; ADAMS, MWW			CHARACTERIZATION, CLONING, AND IN-VITRO EXPRESSION OF THE EXTREMELY THERMOSTABLE GLUTAMATE-DEHYDROGENASE FROM THE HYPERTHERMOPHILIC ARCHAEON, ES4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARCHAEBACTERIUM PYROCOCCUS-FURIOSUS; STABLE RNA GENES; ESCHERICHIA-COLI; SULFOLOBUS-SOLFATARICUS; TATA BOX; PROTEIN; SEQUENCE; PURIFICATION; ENZYME; 100-DEGREES-C	Glutamate dehydrogenase (GDH) from the hyperthermophilic Archaeon ES4 (optimal growth temperature 98-degrees-C and maximum growth temperature 110-degrees-C) was purified to homogeneity. The purified native enzyme had an M(r) of 270,000 +/- 5,000 and was shown by gel filtration and SDS-polyacrylamide gel electrophoresis to be a hexamer with identical subunits of M(r) =46,000 +/- 3,000. The hexameric subunit composition was also evident from electron micrographs, which show a triangular antiprism structure very similar to that of bovine GDH. The enzyme is exceptionally thermostable, with a half-time of inactivation of 3.5 h at 105-degrees-C. Differential scanning calorimetry revealed a t(m) for denaturation of 113-degrees-C, and a t(m) for activation at 60-degrees-C. Antigenic cross-reaction with ES4 GDH was observed with the purified GDH from the thermophilic Archaea, Pyrococcus furiosus and Thermococcus litoralis as well as with bovine and yeast GDHs. The genome of ES4 was shown to contain a single copy of the gdhA gene, and this was cloned and sequenced. The deduced amino acid sequence of the GDH from ES4 corresponded to the NH2-terminal amino acid sequence obtained from the pure protein. From the nucleotide sequence the ES4 protein is composed of 420 residues. It has a relatively high hydrophobicity and a low number of sulfur-containing residues compared with mesophilic GDHs. Relatively high homology (52%) exists between the deduced amino acid sequence of ES4 GDH and Clostridium difficile GDH. Of the two distinct families of GDH sequences known, ES4 GDH belongs to the same family as vertebrates, C. difficile, and other Archaea. The gdhA gene of ES4 was expressed in vitro in a rabbit reticulocyte cell-free Lysate, thus providing a system for structural studies of the mechanisms of thermostability in hyper-thermophilic proteins.	UNIV MARYLAND, CTR MARINE BIOTECHNOL, BALTIMORE, MD 21202 USA; UNIV MARYLAND, DEPT MICROBIOL, COLL PK, MD 20742 USA; UNIV CAPE TOWN, DEPT BIOCHEM, RONDEBOSCH 7700, SOUTH AFRICA; UNIV GEORGIA, DEPT BIOCHEM, ATHENS, GA 30602 USA; UNIV GEORGIA, CTR METALLOENZYME STUDIES, ATHENS, GA 30602 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park; University of Cape Town; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia				Adams, Michael/0000-0002-9796-5014; Robb, Frank/0000-0001-5833-6496				AHERN TJ, 1985, SCIENCE, V228, P1280, DOI 10.1126/science.4001942; AONO S, 1989, J BACTERIOL, V171, P3433, DOI 10.1128/jb.171.6.3433-3439.1989; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BENACHENHOU N, 1991, MOL GEN GENET, V230, P345, DOI 10.1007/BF00280290; BENACHENHOULAHFA N, 1993, J MOL EVOL, V36, P335; BLAKE PR, 1991, BIOCHEMISTRY-US, V30, P10885, DOI 10.1021/bi00109a012; BLAKE PR, 1992, PROTEIN SCI, V1, P1508, DOI 10.1002/pro.5560011112; BLUMENTALS II, 1990, APPL ENVIRON MICROB, V56, P1255, DOI 10.1128/AEM.56.5.1255-1262.1990; BROWN JW, 1989, CRIT REV MICROBIOL, V16, P287, DOI 10.3109/10408418909105479; BROWN SH, 1989, APPL ENVIRON MICROB, V55, P2086, DOI 10.1128/AEM.55.8.2086-2088.1989; BRYANT FO, 1989, J BIOL CHEM, V264, P5070; CONSALVI V, 1991, EUR J BIOCHEM, V202, P1189, DOI 10.1111/j.1432-1033.1991.tb16489.x; COSTANTINO HR, 1990, J BACTERIOL, V172, P3654, DOI 10.1128/jb.172.7.3654-3660.1990; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; EGGEN R, 1990, FEMS MICROBIOL LETT, V71, P17; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; GEORGE DG, 1990, METHOD ENZYMOL, V183, P333; HEIN J, 1990, METHOD ENZYMOL, V183, P626; HENSEL R, 1991, ARCHAEBACTERIA BIOCH, P7; JAGUS R, 1987, METHOD ENZYMOL, V152, P267; JOSEPHS R, 1971, J MOL BIOL, V55, P147, DOI 10.1016/0022-2836(71)90188-4; KLUMP H, 1992, J BIOL CHEM, V267, P22681; LYERLY DM, 1991, J CLIN MICROBIOL, V29, P2639, DOI 10.1128/JCM.29.11.2639-2642.1991; MA K, 1993, IN PRESS J BACTERIOL; MARAS B, 1992, EUR J BIOCHEM, V203, P81, DOI 10.1111/j.1432-1033.1992.tb19831.x; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MATTAJ IW, 1982, FEBS LETT, V147, P21, DOI 10.1016/0014-5793(82)81003-X; McCord Adams Marilyn, 1991, PROTOCOLS ARCHAEBACT, P1; MOSS B, 1990, NATURE, V348, P91, DOI 10.1038/348091a0; MUKUND S, 1990, J BIOL CHEM, V265, P11508; PHIPPS BM, 1993, NATURE, V361, P475, DOI 10.1038/361475a0; PIHL TD, 1991, J BACTERIOL, V173, P1839, DOI 10.1128/jb.173.6.1839-1844.1991; PLEDGER RJ, 1991, J GEN MICROBIOL, V137, P203, DOI 10.1099/00221287-137-1-203; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; REITER WD, 1990, P NATL ACAD SCI USA, V87, P9509, DOI 10.1073/pnas.87.24.9509; RIVERA MC, 1992, SCIENCE, V257, P74, DOI 10.1126/science.1621096; ROBB FT, 1992, BIOCHIM BIOPHYS ACTA, V1120, P267, DOI 10.1016/0167-4838(92)90247-B; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHINKINGER MF, 1991, BIOCHIM BIOPHYS ACTA, V1073, P142, DOI 10.1016/0304-4165(91)90194-L; STETTER KO, 1990, FEMS MICROBIOL LETT, V75, P117, DOI 10.1111/j.1574-6968.1990.tb04089.x; TAGUCHI H, 1991, J BIOL CHEM, V266, P22411; TELLER JK, 1992, EUR J BIOCHEM, V206, P151, DOI 10.1111/j.1432-1033.1992.tb16912.x; THOMM M, 1988, NUCLEIC ACIDS RES, V16, P151, DOI 10.1093/nar/16.1.151; TRENT JD, 1991, NATURE, V354, P490, DOI 10.1038/354490a0; WICH G, 1986, NUCLEIC ACIDS RES, V14, P2459, DOI 10.1093/nar/14.6.2459; WIERENGA RK, 1985, BIOCHEMISTRY-US, V24, P1346, DOI 10.1021/bi00327a012; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; ZHANG SP, 1991, GENE, V105, P61, DOI 10.1016/0378-1119(91)90514-C; ZWICKL P, 1990, J BACTERIOL, V172, P4329, DOI 10.1128/jb.172.8.4329-4338.1990	50	66	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17767	17774						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349661				2022-12-27	WOS:A1993LT74300023
J	LEEDS, JM; BROWN, PJ; MCGEEHAN, GM; BROWN, FK; WISEMAN, JS				LEEDS, JM; BROWN, PJ; MCGEEHAN, GM; BROWN, FK; WISEMAN, JS			ISOTOPE EFFECTS AND ALTERNATIVE SUBSTRATE REACTIVITIES FOR TRYPTOPHAN 2,3-DIOXYGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDOLEAMINE 2,3-DIOXYGENASE; GENERAL ACID; SUPEROXIDE ANION; ENZYME; EQUILIBRIUM; MECHANISM; BINDING; INTERMEDIATE; ACTIVATION; OXIDATION	Tryptophan 2,3-dioxygenase (EC 1.13.1.12) is a hemoprotein which catalyzes the first step in the oxidative degradation of tryptophan. The reaction is believed to proceed by addition of O2 across the 2,3-bond of the indole ring, followed by decomposition of the resultant dioxetane to give N-formylkynurenine. A primary D2O isotope effect of 4.4 on V(max)/K(m) was observed at the pH optimum, pH 7.0. This implies that abstraction of the indole proton is at least partially rate-determining. An inverse secondary isotope effect of 0.96 was observed for L-[2-H-3]tryptophan at this pH. The secondary isotope effect signals the formation of the C-O bond at C-2. As the rate of proton abstraction increased with increasing pH, the D2O isotope effect decreased to 1.2 at pH 8.5 and the secondary isotope effect increased to 0.92. The rate-determining steps therefore change with increasing pH, and bond formation at C-2 becomes more rate-limiting. The secondary isotope effect did not change significantly with varying O2 concentration so that substrate binding is primarily ordered with O2 binding first. The specificity of the enzyme towards substituted tryptophans shows that substitution of the phenyl ring of the indole is sterically unfavorable. Steric hindrance is highest at the 4- and 7-positions, while the 5- and 6-positions are less sensitive. 6-Fluoro-L-tryptophan was more reactive than tryptophan, and the increased reactivity can be explained by an electronic effect that enhances of the rate of C-O bond formation at C-2.	GLAXO RES INST, RES TRIANGLE PK, NC 27709 USA	GlaxoSmithKline				Brown, Peter/0000-0002-8454-0367				ABELES RH, 1960, J BIOL CHEM, V235, P853; ABELES RH, 1960, J BIOL CHEM, V235; Benson S.W, 1976, THERMOCHEMICAL KINET; CIVEN M, 1960, J BIOL CHEM, V235, P1716; CRAMER CJ, 1992, SCIENCE, V256, P213, DOI 10.1126/science.256.5054.213; DEFELIPPIS MR, 1989, BIOCHEMISTRY-US, V28, P4847, DOI 10.1021/bi00437a049; DOLMAN D, 1967, CAN J CHEMISTRY, V45, P911, DOI 10.1139/v67-155; FOX JP, 1974, J AM CHEM SOC, V96, P1436, DOI 10.1021/ja00812a029; GERLT JA, 1992, J AM CHEM SOC, V114, P5928, DOI 10.1021/ja00041a004; ISHIMURA Y, 1970, J BIOL CHEM, V245, P3593; JENCKS WP, 1980, ACCOUNTS CHEM RES, V13, P161, DOI 10.1021/ar50150a001; Klinman J P, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P415; KLINMAN JP, 1980, J BIOL CHEM, V255, P1648; KOIKE K, 1971, BIOCHEMISTRY-US, V10, P3378, DOI 10.1021/bi00794a010; MAEZONO K, 1990, BIOCHEM BIOPH RES CO, V170, P176, DOI 10.1016/0006-291X(90)91256-R; MAKINO R, 1980, J BIOL CHEM, V255, P1883; Makino R, 1980, BIOCH MED ASPECTS TR, P179; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; NAKAGAWA M, 1977, J AM CHEM SOC, V99, P4424, DOI 10.1021/ja00455a035; NAKAGAWA M, 1977, P NATL ACAD SCI USA, V74, P4730, DOI 10.1073/pnas.74.11.4730; NGUYEN NT, 1986, BIOELECTROCH BIOENER, V15, P257, DOI 10.1016/0302-4598(86)80032-0; OZAKI Y, 1986, BIOCHEM BIOPH RES CO, V137, P1106, DOI 10.1016/0006-291X(86)90339-6; PHILLIPS RS, 1986, J AM CHEM SOC, V108, P2023, DOI 10.1021/ja00268a049; RICHARDSON WH, 1989, J ORG CHEM, V54, P4677, DOI 10.1021/jo00280a041; SAWYER DT, 1981, ACCOUNTS CHEM RES, V14, P393, DOI 10.1021/ar00072a005; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; SCHUTZ G, 1972, J BIOL CHEM, V247, P5333; SCHUTZ G, 1972, J BIOL CHEM, V247, P5327; SHEU C, 1990, J AM CHEM SOC, V112, P1936, DOI 10.1021/ja00161a045; SONO M, 1986, BIOCHEMISTRY-US, V25, P6089, DOI 10.1021/bi00368a038; SONO M, 1980, J BIOL CHEM, V255, P1339; SONO M, 1989, J BIOL CHEM, V264, P1616; TAKIKAWA O, 1988, J BIOL CHEM, V263, P2041; TANIGUCHI T, 1979, J BIOL CHEM, V254, P3288; TSANG PKS, 1990, INORG CHEM, V29, P2848, DOI 10.1021/ic00340a025; YAGIL G, 1967, TETRAHEDRON, V23, P2855, DOI 10.1016/0040-4020(67)85151-2; YASUI H, 1986, P NATL ACAD SCI USA, V83, P6622, DOI 10.1073/pnas.83.17.6622; YIM JJ, 1987, J CHROMATOGR-BIOMED, V419, P296, DOI 10.1016/0378-4347(87)80290-6	38	53	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17781	17786						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349662				2022-12-27	WOS:A1993LT74300025
J	CHAMOVITZ, D; SANDMANN, G; HIRSCHBERG, J				CHAMOVITZ, D; SANDMANN, G; HIRSCHBERG, J			MOLECULAR AND BIOCHEMICAL-CHARACTERIZATION OF HERBICIDE-RESISTANT MUTANTS OF CYANOBACTERIA REVEALS THAT PHYTOENE DESATURATION IS A RATE-LIMITING STEP IN CAROTENOID BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; DEHYDROGENASE GENE; CHLOROPLAST GENOME; NORFLURAZON; EXPRESSION; CLONING; PROTEINS; MEMBRANE; SUBUNIT; ENZYME	Mutant strains of the cyanobacterium Synechococcus sp. PCC 7942 that are resistant to the herbicides norflurazon and fluridone were analyzed. These herbicides inhibit phytoene desaturase, a key enzyme in the carotenoid biosynthetic pathway. In three mutants the phenotype was related to specific point mutations in pds, the gene encoding phytoene desaturase. Since the resistance was manifested in a cell-free carotenogenic assay, it is evident that the predicted amino acid changes in the target protein alter the enzyme-herbicide interactions. In addition, the mutations also reduced the in vitro activity of phytoene desaturase. Increased levels of the substrate phytoene, accompanied by a reduction in colored carotenoids, were detected in cells of each of the mutant strains. A correlation was established between the degree of increase in the steady-state levels of phytoene and the extent of reduction in total carotenoid content in the cells. These two phenomena in turn are correlated with the rate of enzymatic activity of phytoene desaturase that was measured in vitro. Hence we deduce that phytoene desaturation is a rate-limiting step in carotenogenesis in cyanobacteria. Support for this conclusion is obtained from analysis of cells of an additional mutant strain, which overexpress phytoene desaturase due to a deletion mutation in the promoter region of pds. Cells of this mutant contained more colored carotenoids than the wild-type and were resistant to herbicides that inhibit phytoene desaturase.	HEBREW UNIV JERUSALEM, DEPT GENET, IL-91904 JERUSALEM, ISRAEL; UNIV CONSTANCE, LEHRSTUHL PHYSIOL & BIOCHEM PFLANZEN, W-7750 CONSTANCE, GERMANY	Hebrew University of Jerusalem; University of Konstanz			Chamovitz, Daniel/S-5021-2019	Chamovitz, Daniel/0000-0002-2815-2909				BARTLEY GE, 1991, P NATL ACAD SCI USA, V88, P6532, DOI 10.1073/pnas.88.15.6532; Cercla-Olmedo E., 1987, PHYCOMYCES, P337; CHAMOVITZ D, 1990, Z NATURFORSCH C, V45, P482; CHAMOVITZ D, 1991, PLANT MOL BIOL, V16, P967, DOI 10.1007/BF00016069; DENNIS ES, 1985, NUCLEIC ACIDS RES, V13, P727, DOI 10.1093/nar/13.3.727; GED C, 1988, BIOCHEMISTRY-US, V27, P6929, DOI 10.1021/bi00418a039; GOODWIN TW, 1980, BIOCH CAROTENOIDS, V1, P29; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; HIRSCHBERG J, 1987, Z NATURFORSCH C, V42, P758; KITA K, 1990, BIOCHEM BIOPH RES CO, V166, P101, DOI 10.1016/0006-291X(90)91916-G; KLEUDGEN HK, 1979, PESTIC BIOCHEM PHYS, V12, P231, DOI 10.1016/0048-3575(79)90106-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDEN H, 1991, Z NATURFORSCH C, V46, P1045; LINDEN H, 1990, PESTIC BIOCHEM PHYS, V36, P46, DOI 10.1016/0048-3575(90)90019-X; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MARTINEZFEREZ IM, 1992, PLANT MOL BIOL, V18, P981, DOI 10.1007/BF00019213; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; MORAN R, 1982, PLANT PHYSIOL, V69, P1376, DOI 10.1104/pp.69.6.1376; OHAD N, 1992, PLANT CELL, V4, P273, DOI 10.1105/tpc.4.3.273; PECKER I, 1992, P NATL ACAD SCI USA, V89, P4962, DOI 10.1073/pnas.89.11.4962; PECKER I, 1993, RES PHOTOSYNTHESIS, V3, P11; ROE BA, 1985, J BIOL CHEM, V260, P9759; Sambrook J, 1989, MOL CLONING LABORATO; SANDMANN G, 1989, Z NATURFORSCH C, V44, P787; SANDMANN G, 1988, METHOD ENZYMOL, V167, P329; Sandmann G., 1989, Target sites of herbicide action., P25; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; TAMAKI T, 1989, J BIOCHEM-TOKYO, V106, P541, DOI 10.1093/oxfordjournals.jbchem.a122889; TRICK M, 1988, PLANT MOL BIOL, V11, P147, DOI 10.1007/BF00015667; VALLE F, 1984, GENE, V27, P193, DOI 10.1016/0378-1119(84)90140-9; WARBURTON N, 1983, NUCLEIC ACIDS RES, V11, P5837, DOI 10.1093/nar/11.17.5837; XIE Y, 1990, GENE, V87, P185, DOI 10.1016/0378-1119(90)90300-G; XU XM, 1991, J BIOCHEM-TOKYO, V109, P678, DOI 10.1093/oxfordjournals.jbchem.a123440	33	208	231	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17348	17353						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349618				2022-12-27	WOS:A1993LQ98800069
J	FUKITA, Y; MIZUTA, TR; SHIROZU, M; OZAWA, K; SHIMIZU, A; HONJO, T				FUKITA, Y; MIZUTA, TR; SHIROZU, M; OZAWA, K; SHIMIZU, A; HONJO, T			THE HUMAN S-MU-BP-2, A DNA-BINDING PROTEIN-SPECIFIC TO THE SINGLE-STRANDED GUANINE-RICH SEQUENCE RELATED TO THE IMMUNOGLOBULIN-MU CHAIN SWITCH REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERVARIABLE MINISATELLITE DNA; REPETITIVE SEQUENCES; NUCLEAR-PROTEIN; GENE; RECOMBINATION; RNA; IDENTIFICATION; REPLICATION; ELEMENT; DIFFERENTIATION	We have cloned the cDNA encoding the human homologue of Smubp-2, which binds to single-stranded DNA with 5'-phosphorylated guanine-rich sequences related to the immunoglobulin mu chain switch (S(mu)) region. The deduced amino acid sequences of the mouse and human Smubp-2 are 76.5% homologous and contain motifs conserved among helicases. We have identified a domain essential for DNA binding at residues 638-786. The binding domain is less conserved (63% homologous) than the putative catalytic domain of N-terminal half containing most of the helicase motifs (85% homologous). The human and mouse SmuAbp-2 have similar, although slightly different, binding specificities. Although the mouse Smubp-2 preferentially binds to the mouse S(mu) motif (GGGGT), the human Smubp-2 binds equally well to the human (GGGCT) and mouse S(mu) motifs. The human Smubp-2 gene was mapped to chromosome 11 q13.2-q13.4 by in situ hybridization.	KYOTO UNIV, FAC MED, DEPT MED CHEM, SAKYO KU, KYOTO 60601, JAPAN; KYOTO UNIV, CTR MOLEC BIOL & GENET, SAKYO KU, KYOTO 60601, JAPAN; INST PHYS & CHEM RES, TSUKUBA LIFE SCI CTR, GENE BANK, TSUKUBA, IBARAKI 305, JAPAN	Kyoto University; Kyoto University; RIKEN			Honjo, Tasuku/N-4470-2016					BERGEMANN AD, 1992, MOL CELL BIOL, V12, P1257, DOI 10.1128/MCB.12.3.1257; BRUNEL F, 1991, NUCLEIC ACIDS RES, V19, P5237, DOI 10.1093/nar/19.19.5237; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLICK A, 1991, NUCLEIC ACIDS RES, V19, P6399, DOI 10.1093/nar/19.23.6399; COOKSON WOCM, 1989, LANCET, V1, P1292; EDELMANN W, 1989, CELL, V57, P937, DOI 10.1016/0092-8674(89)90332-2; FEAVERS IM, 1989, J BIOL CHEM, V264, P9114; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOURCADEPERONNET F, 1992, J VIROL, V66, P1682, DOI 10.1128/JVI.66.3.1682-1687.1992; GAILLARD C, 1988, J VIROL, V62, P2380, DOI 10.1128/JVI.62.7.2380-2385.1988; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; GRAY JT, 1991, CELL, V67, P807, DOI 10.1016/0092-8674(91)90075-A; GUALBERTO A, 1992, GENE DEV, V6, P815, DOI 10.1101/gad.6.5.815; HODGMAN TC, 1988, NATURE, V333, P578, DOI 10.1038/333578a0; HODGMAN TC, 1988, NATURE, V333, P22, DOI 10.1038/333022b0; Honjo T., 1989, Immunoglobulin genes., P123; ILLGES H, 1992, MOL IMMUNOL, V29, P1265, DOI 10.1016/0161-5890(92)90063-4; KATAMINE S, 1984, NATURE, V309, P369, DOI 10.1038/309369a0; KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8; KERR D, 1991, J BIOL CHEM, V266, P15876; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBO RV, 1984, SCIENCE, V225, P57, DOI 10.1126/science.6587566; MAINA CV, 1988, GENE, V74, P365, DOI 10.1016/0378-1119(88)90170-9; MARSH DG, 1992, NAT GENET, V2, P252, DOI 10.1038/ng1292-252; MILLS FC, 1990, NUCLEIC ACIDS RES, V18, P7305, DOI 10.1093/nar/18.24.7305; MIZUTA TR, 1993, NUCLEIC ACIDS RES, V21, P1761, DOI 10.1093/nar/21.8.1761; NAKAJIMAIIJIMA S, 1985, P NATL ACAD SCI USA, V82, P6133, DOI 10.1073/pnas.82.18.6133; NIKAIDO T, 1981, NATURE, V292, P845, DOI 10.1038/292845a0; NIKAIDO T, 1982, J BIOL CHEM, V257, P7322; OZAWA K, 1992, GENOMICS, V12, P214, DOI 10.1016/0888-7543(92)90368-3; PAN WT, 1990, J BIOL CHEM, V265, P7022; RAJAVASHISTH TB, 1989, SCIENCE, V245, P640, DOI 10.1126/science.2562787; Sambrook J, 1989, MOL CLONING LABORATO; SCHMIDT AMA, 1991, EMBO J, V10, P981, DOI 10.1002/j.1460-2075.1991.tb08032.x; SCHULTZ CL, 1991, INT IMMUNOL, V3, P109, DOI 10.1093/intimm/3.2.109; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1; SMITH GR, 1983, CELL, V34, P709, DOI 10.1016/0092-8674(83)90525-1; TANIGAMI A, 1992, GENOMICS, V13, P21, DOI 10.1016/0888-7543(92)90196-Y; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TRAUT W, 1988, MOL CELL BIOL, V8, P903, DOI 10.1128/MCB.8.2.903; VENNSTROM B, 1982, CELL, V28, P135, DOI 10.1016/0092-8674(82)90383-X; VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801; WAHLS WP, 1990, CELL, V60, P95, DOI 10.1016/0092-8674(90)90719-U; WAHLS WP, 1991, NUCLEIC ACIDS RES, V19, P3269, DOI 10.1093/nar/19.12.3269; WALSH K, 1992, J BIOL CHEM, V267, P13714; WATERS SH, 1989, MOL CELL BIOL, V9, P5594, DOI 10.1128/MCB.9.12.5594; WILKISON WO, 1990, J BIOL CHEM, V265, P477; WILLIAMS M, 1991, GENE DEV, V5, P2353, DOI 10.1101/gad.5.12a.2353; WUERFFEL RA, 1990, MOL CELL BIOL, V10, P1714, DOI 10.1128/MCB.10.4.1714; YAMAZAKI H, 1992, J BIOL CHEM, V267, P12311; YOSHIDA MC, 1988, P NATL ACAD SCI USA, V85, P4861, DOI 10.1073/pnas.85.13.4861; ZABEL BU, 1983, P NATL ACAD SCI-BIOL, V80, P6932, DOI 10.1073/pnas.80.22.6932	54	75	77	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17463	17470						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349627				2022-12-27	WOS:A1993LQ98800085
J	BOIE, Y; ADAM, M; RUSHMORE, TH; KENNEDY, BP				BOIE, Y; ADAM, M; RUSHMORE, TH; KENNEDY, BP			ENANTIOSELECTIVE ACTIVATION OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA OXIDASE; RESPONSIVE ELEMENT; ENZYME-ACTIVITIES; RAT-LIVER; INDUCTION; ACID; GENE; MECHANISMS; DNA; HEPATOCARCINOGENESIS	A cell-based transactivation assay was established using the mouse full-length peroxisome proliferator-activated receptor (PPAR) cDNA sequence and the positive peroxisome proliferator-responsive regulatory element (-578 to -553) of the rat acyl-CoA oxidase gene promoter. Activation of the reporter plasmid was dependent on co-transfection of the full-length PPAR cDNA, and the response was greatly stimulated, up to 100-fold, by peroxisome proliferators such as Wy-14,643 ([4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid), nafenopin (2-methyl-2[p-(1,2,3,4-tetra-hydro-1-naphtyl)phenoxy]-propionic acid), and clofibric acid (2-([p]-chlorophenoxy)-2-methylpropionic acid). Activation of the reporter plasmid promoter by the full-length PPAR cDNA also occurred at peroxisomal proliferator concentrations 40 times lower than that required for similar stimulation by a glucocorticoid-PPAR chimeric receptor. By using the stereoisomers of MK-571 ((+/)-3-(((3-(2-(7-chloro-2-quinolinyl)ethenyl)-phenyl)((3-(dimethylamino)-3-oxopropyl)-thio)methyl)-thio)propanoic acid), a potent leukotriene D4 receptor antagonist, we could show enantioselective activation of PPAR. The use of this compound in mice results in peroxisome proliferation; however, nearly all of the peroxisome proliferating activity can be attributed to the S enantiomer. Our results show a similar enantiomeric discrimination in PPAR activation of the reporter plasmid promoter, where again most of the activity can be attributed to the S enantiomer. The equivalent activities of these stereoisomers both in vivo and in the PPAR transactivation assay strongly implicate PPAR as a major component of the peroxisome proliferating mechanism in rodents.	MERCK FROSST CANADA INC,MERCK FROSST CTR THERAPEUT RES,DEPT MOLEC BIOL,POB 1005,POINTE CLAIRE H9R 4P8,PQ,CANADA	Merck & Company								CHEN CA, 1988, BIOTECHNIQUES, V6, P632; CHINJE E, 1991, BIOCHEM PHARMACOL, V41, P769, DOI 10.1016/0006-2952(91)90079-K; COHEN AJ, 1981, FOOD COSMET TOXICOL, V19, P585, DOI 10.1016/0015-6264(81)90509-5; CONWAY JG, 1989, DRUG METAB REV, V21, P65, DOI 10.3109/03602538909029956; ESBENSHADE TA, 1990, BIOCHEM PHARMACOL, V40, P1263, DOI 10.1016/0006-2952(90)90392-X; GAUTHIER JY, 1990, J MED CHEM, V33, P2841, DOI 10.1021/jm00172a025; GREEN S, 1992, BIOCHEM PHARMACOL, V43, P393, DOI 10.1016/0006-2952(92)90554-V; GROSSMAN SJ, 1992, TOXICOL APPL PHARM, V116, P217, DOI 10.1016/0041-008X(92)90301-8; HAWKINS JM, 1987, DRUG METAB REV, V18, P441, DOI 10.3109/03602538708994130; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; KENNEDY BP, 1991, J BIOL CHEM, V266, P8511; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LAKE BG, 1987, TOXICOL IND HEALTH, V3, P165, DOI 10.1177/074823378700300212; LEHMANN PA, 1986, TRENDS PHARMACOL SCI, V7, P281, DOI 10.1016/0165-6147(86)90353-6; LEIGHTON F, 1975, J CELL BIOL, V67, P281, DOI 10.1083/jcb.67.2.281; LOCK EA, 1989, ANNU REV PHARMACOL, V29, P145; LUNDGREN B, 1987, EUR J BIOCHEM, V163, P423, DOI 10.1111/j.1432-1033.1987.tb10815.x; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MIYAZAWA S, 1987, J BIOL CHEM, V262, P8131; MOODY DE, 1976, J CELL BIOL, V71, P768, DOI 10.1083/jcb.71.3.768; NEMALI MR, 1989, TOXICOL APPL PHARM, V97, P72, DOI 10.1016/0041-008X(89)90056-2; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V175, P866, DOI 10.1016/0006-291X(91)91645-S; RAO MS, 1989, DRUG METAB REV, V21, P103, DOI 10.3109/03602538909029957; REDDY JK, 1983, CRC CR REV TOXICOL, V12, P1, DOI 10.3109/10408448309029317; REDDY JK, 1986, TRENDS PHARMACOL SCI, V7, P438, DOI 10.1016/0165-6147(86)90416-5; REDDY JK, 1980, NATURE, V283, P397, DOI 10.1038/283397a0; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; STRAHLE U, 1988, EMBO J, V7, P3389, DOI 10.1002/j.1460-2075.1988.tb03212.x; TSAI SY, 1989, CELL, V57, P443, DOI 10.1016/0092-8674(89)90919-7; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x	32	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1993	268	8					5530	5534						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR822	8383673				2022-12-27	WOS:A1993KR82200030
J	ANTONNY, B; SUKUMAR, M; BIGAY, J; CHABRE, M; HIGASHIJIMA, T				ANTONNY, B; SUKUMAR, M; BIGAY, J; CHABRE, M; HIGASHIJIMA, T			THE MECHANISM OF ALUMINUM-INDEPENDENT G-PROTEIN ACTIVATION BY FLUORIDE AND MAGNESIUM - P-31 NMR-SPECTROSCOPY AND FLUORESCENCE KINETIC-STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE-BINDING; ADENYLATE-CYCLASE; GAMMA-PHOSPHATE; REGULATORY COMPONENT; STRUCTURAL ANALOGS; BETA-GAMMA; F-ACTIN; TRANSDUCIN; SUBUNITS; SITE	With magnesium present, fluoride and aluminum ions activate heterotrimeric G-proteins by forming AlF(x) complexes that mimic the gamma phosphate of a GTP. We report compelling evidence for a newly proposed process of G-protein activation by fluoride and magnesium, without Al3+. With millimolar Mg2+ and F-, G(s) and G(t) activate adenylylcyclase and cGMP-phosphodiesterase, respectively. In P-31 NMR, addition of magnesium to G(i1)alphaGDP or G(t)alphaGDP solutions containing fluoride, but no Al3+, modifies the chemical shift of the GDP beta phosphorus, suggesting that magnesium interacts with the beta phosphate. Titration of this effect indicates that two Mg2+ are bound per Galpha. Biphasic activation kinetics, monitored by Galpha tryptophan fluorescence, suggests the rapid binding of one Mg2+ to GalphaGDP and the slow association of another Mg2+, in correlation with fluoride binding and Galpha activation. The deactivation rate upon fluoride dilution shows a second order dependence with respect to the residual F- concentration, suggesting the sequential release of at least three F-/Galpha. Thus, in millimolar Mg2+ and F-, and without Al3+, two Mg2+ and three F- bind sequentially to GalphaGDP and induce the switch to an active Galpha(GDP-MgF3)Mg state, which is structurally analogous to Ga(GDP-AlF(x))Mg and to Galpha(GTP)Mg.	CNRS, INST PHARMACOL MOLEC & CELLULAIRE, 660 ROUTE LUCIOLES, F-06560 VALBONNE, FRANCE; UNIV TEXAS, SW MED CTR, DEPT PHARMACOL, DALLAS, TX 75235 USA	Centre National de la Recherche Scientifique (CNRS); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas			Antonny, Bruno/ABH-7434-2020	Antonny, Bruno/0000-0002-9166-8668; Joelle, BIGAY/0000-0002-7487-3416	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040676] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 40676] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTONNY B, 1992, J BIOL CHEM, V267, P6710; ANTONNY B, 1990, FEBS LETT, V268, P277, DOI 10.1016/0014-5793(90)81027-L; BIGAY J, 1987, EMBO J, V6, P2907, DOI 10.1002/j.1460-2075.1987.tb02594.x; BIGAY J, 1985, FEBS LETT, V191, P181, DOI 10.1016/0014-5793(85)80004-1; CARLIER MF, 1988, BIOCHEMISTRY-US, V27, P3555, DOI 10.1021/bi00410a005; CHABRE M, 1990, TRENDS BIOCHEM SCI, V15, P6, DOI 10.1016/0968-0004(90)90117-T; COMBEAU C, 1988, J BIOL CHEM, V263, P17429; COMBEAU C, 1989, J BIOL CHEM, V264, P19017; DETERRE P, 1984, FEBS LETT, V178, P228, DOI 10.1016/0014-5793(84)80606-7; DUPUIS A, 1989, FEBS LETT, V255, P47, DOI 10.1016/0014-5793(89)81058-0; FERGUSON KM, 1986, J BIOL CHEM, V261, P7393; HIGASHIJIMA T, 1991, J BIOL CHEM, V266, P3396; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P752; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; ITOH H, 1991, J BIOL CHEM, V266, P16226; LINDER ME, 1991, J BIOL CHEM, V266, P4654; LUNARDI J, 1988, P NATL ACAD SCI USA, V85, P8958, DOI 10.1073/pnas.85.23.8958; MARTIN RB, 1988, MET IONS BIOL SYST, V24, P1; MURPHY AJ, 1992, J BIOL CHEM, V267, P5229; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; STERNWEIS PC, 1981, J BIOL CHEM, V256, P1517; SUKUMAR M, 1992, J BIOL CHEM, V267, P21421; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; YAMANAKA G, 1985, BIOCHEMISTRY-US, V24, P8094, DOI 10.1021/bi00348a039; YEE R, 1978, J BIOL CHEM, V253, P8902	27	59	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2393	2402						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8381408				2022-12-27	WOS:A1993KK81500025
J	LOHMAN, TM				LOHMAN, TM			HELICASE-CATALYZED DNA UNWINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ESCHERICHIA-COLI REP; II UVRD PROTEIN; ATP HYDROLYSIS; GENE-PRODUCT; REPLICATION PROTEIN; BINDING-PROTEIN; STRANDED DNA; T-ANTIGEN; ENZYME; MECHANISM				LOHMAN, TM (corresponding author), WASHINGTON UNIV, SCH MED, DEPT BIOCHEM & MOLEC BIOPHYS, ST LOUIS, MO 63110 USA.				NIGMS NIH HHS [R01 GM045948, GM-45948, GM-30498] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030498, R01GM045948] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABDELMONEM M, 1976, EUR J BIOCHEM, V65, P441, DOI 10.1111/j.1432-1033.1976.tb10359.x; ABDELMONEM M, 1983, P NATL ACAD SCI-BIOL, V80, P4659, DOI 10.1073/pnas.80.15.4659; ARAI K, 1981, J BIOL CHEM, V256, P5260; ARAI K, 1981, J BIOL CHEM, V256, P5247; ARAI K, 1981, J BIOL CHEM, V256, P5253; ARAI N, 1981, J BIOL CHEM, V256, P5287; ARAI N, 1981, J BIOL CHEM, V256, P5294; BOEHMER PE, 1992, J BIOL CHEM, V267, P4981; BROWN WC, 1989, J BIOL CHEM, V264, P6748; BRUCKNER RC, 1991, J BIOL CHEM, V266, P2669; CHAO KL, 1991, J MOL BIOL, V221, P1165, DOI 10.1016/0022-2836(91)80119-F; CHAO KL, 1990, J BIOL CHEM, V265, P1067; COLASANTI J, 1987, MOL GEN GENET, V209, P382, DOI 10.1007/BF00329669; DANIELS DL, 1992, SCIENCE, V257, P771, DOI 10.1126/science.1379743; DAS RH, 1980, J BIOL CHEM, V255, P8069; DODSON MS, 1991, P NATL ACAD SCI USA, V88, P1105, DOI 10.1073/pnas.88.4.1105; DYKSTRA CC, 1984, COLD SPRING HARB SYM, V49, P463, DOI 10.1101/SQB.1984.049.01.052; FINGER LR, 1982, J MOL BIOL, V156, P203, DOI 10.1016/0022-2836(82)90467-3; GANESAN S, 1992, IN PRESS J MOL BIOL; GEIDER K, 1981, ANNU REV BIOCHEM, V50, P233, DOI 10.1146/annurev.bi.50.070181.001313; GEISELMANN J, 1992, PROTEIN SCI, V1, P850, DOI 10.1002/pro.5560010703; GEORGIGEISBERGER P, 1990, EUR J BIOCHEM, V192, P689, DOI 10.1111/j.1432-1033.1990.tb19277.x; GILCHRIST CA, 1987, NUCLEIC ACIDS RES, V15, P465, DOI 10.1093/nar/15.2.465; GORBALENYA AE, 1988, FEBS LETT, V235, P16, DOI 10.1016/0014-5793(88)81226-2; HILL TL, 1981, P NATL ACAD SCI-BIOL, V78, P4796, DOI 10.1073/pnas.78.8.4796; HODGMAN TC, 1988, NATURE, V333, P22, DOI 10.1038/333022b0; JENCKS WP, 1989, J BIOL CHEM, V264, P18855; KORNBERG A, 1978, J BIOL CHEM, V253, P3298; KORNBERG A, 1992, DNA REPLICATION, pCH11; LAHUE EE, 1988, J BIOL CHEM, V263, P3208; LANE D, 1988, NATURE, V334, P478, DOI 10.1038/334478a0; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; LIU CC, 1981, J BIOL CHEM, V256, P2813; LOHMAN TM, 1992, MOL MICROBIOL, V6, P5, DOI 10.1111/j.1365-2958.1992.tb00831.x; LOHMAN TM, 1989, J BIOL CHEM, V264, P10139; MASTRANGELO IA, 1989, NATURE, V338, P658, DOI 10.1038/338658a0; MATSON SW, 1991, PROG NUCLEIC ACID RE, V40, P289; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; MATSON SW, 1986, J BIOL CHEM, V261, P169; MATSON SW, 1983, J BIOL CHEM, V258, P4017; NAKAYAMA N, 1984, J BIOL CHEM, V259, P88; OH EY, 1989, J BIOL CHEM, V264, P1336; PATEL SS, 1992, J BIOL CHEM, V267, P15013; REHAKRANTZ LJ, 1978, J BIOL CHEM, V253, P4043; RICHARDSON CC, 1987, UCLA S MOL CELL BIOL, V47, P151; RICHARDSON RW, 1990, UCLA S MOL CELL BIOL, V47, P247; ROMAN LJ, 1992, J BIOL CHEM, V267, P4207; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2873, DOI 10.1021/bi00433a019; RUNYON GT, 1989, J BIOL CHEM, V264, P17502; RUNYON GT, 1990, P NATL ACAD SCI USA, V87, P6383, DOI 10.1073/pnas.87.16.6383; RUNYON GT, 1993, IN PRESS BIOCHEMISTR, V33; SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x; SENGUPTA DJ, 1992, SCIENCE, V256, P1656, DOI 10.1126/science.256.5064.1656; SEO YS, 1991, J BIOL CHEM, V266, P13161; SIMMONS RM, 1976, NATURE, V263, P615, DOI 10.1038/263615b0; TAYLOR AF, 1985, J MOL BIOL, V185, P431, DOI 10.1016/0022-2836(85)90414-0; THOMMES P, 1992, CHROMOSOMA, V101, P467, DOI 10.1007/BF00352468; VENKATESAN M, 1982, J BIOL CHEM, V257, P2426; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WASHBURN BK, 1991, J BACTERIOL, V173, P2569, DOI 10.1128/jb.173.8.2569-2575.1991; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; WIEKOWSKI M, 1988, J BIOL CHEM, V263, P436; WONG I, 1992, J BIOL CHEM, V267, P7596; WONG I, 1992, SCIENCE, V256, P350, DOI 10.1126/science.256.5055.350; YARRANTON GT, 1979, J BIOL CHEM, V254, P2002; YARRANTON GT, 1979, P NATL ACAD SCI USA, V76, P1658, DOI 10.1073/pnas.76.4.1658	66	182	183	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2269	2272						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8381400				2022-12-27	WOS:A1993KK81500001
J	VENEMA, RC; KUO, JF				VENEMA, RC; KUO, JF			PROTEIN KINASE-C-MEDIATED PHOSPHORYLATION OF TROPONIN-I AND C-PROTEIN IN ISOLATED MYOCARDIAL-CELLS IS ASSOCIATED WITH INHIBITION OF MYOFIBRILLAR ACTOMYOSIN MGATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE CARDIAC TROPONIN; MYOSIN LIGHT-CHAINS; ISOLATED RABBIT HEARTS; DEVELOPING RAT-HEART; PHORBOL ESTER; SARCOPLASMIC-RETICULUM; SUBCELLULAR-DISTRIBUTION; SMOOTH-MUSCLE; MYOCYTES; STIMULATION	Phosphorylation of cardiac myofibrillar proteins by protein kinase C (PKC) in isolated adult rat cardiomyocytes has been compared with that mediated by the cAMP-dependent protein kinase (PKA). PKA activation by beta-adrenoreceptor (isoproterenol) stimulation results in stoichiometric phosphorylation of troponin I (TnI) and C-protein. PKC activation by either 12-O-tetradecanoylphorbol-13-acetate (TPA) or by alpha-adrenoreceptor (phenylephrine plus propranolol) stimulation results in phosphorylation of the same two proteins to similar extents. Two-dimensional phosphopeptide mapping shows that the same sites in TnI are modified by PKC in vitro and in TPA- or alpha-agonist-stimulated cells. These sites are distinct from those phosphorylated in isoproterenol-stimulated cells or by PKA in vitro. Phosphopeptide mapping analysis of C-protein shows that PKC and PKA phosphorylate identical residues in this protein in vitro and in situ. TPA-stimulated phosphorylation in myocytes is associated with a reduction in maximal activity of myofibrillar Ca2+-dependent actomyosin MgATPase. Isoproterenol-stimulated phosphorylation has no effect on maximal activity but reduces the Ca2+ sensitivity of the MgATPase. These data demonstrate that TnI and C-protein are phosphorylated in myocardial cells by both PKA and PKC, resulting in different functional consequences in each case.			VENEMA, RC (corresponding author), EMORY UNIV,SCH MED,DEPT PHARMACOL,DIV CARDIOL,PO DRAWER LL,ATLANTA,GA 30322, USA.				NATIONAL CANCER INSTITUTE [R01CA036777] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL015696, F32HL008615, R37HL015696] Funding Source: NIH RePORTER; NCI NIH HHS [CA-36777] Funding Source: Medline; NHLBI NIH HHS [HL-15696, F32 HL08615] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN JH, 1985, CIRC RES, V57, P532, DOI 10.1161/01.RES.57.4.532; CAPOGROSSI MC, 1991, CIRC RES, V69, P540, DOI 10.1161/01.RES.69.2.540; CAPOGROSSI MC, 1990, CIRC RES, V66, P1143, DOI 10.1161/01.RES.66.4.1143; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHISHOLM AAK, 1988, BIOCHIM BIOPHYS ACTA, V971, P163, DOI 10.1016/0167-4889(88)90188-7; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; DOSEMECI A, 1988, CIRC RES, V62, P347, DOI 10.1161/01.RES.62.2.347; EDES I, 1990, CIRC RES, V67, P394, DOI 10.1161/01.RES.67.2.394; ENGLAND PJ, 1976, ANAL BIOCHEM, V75, P429, DOI 10.1016/0003-2697(76)90096-8; ENGLAND PJ, 1984, J MOL CELL CARDIOL, V16, P591, DOI 10.1016/S0022-2828(84)80623-9; GALLIS B, 1983, J BIOL CHEM, V258, P3089; GARVEY JL, 1988, BIOCHEM J, V249, P709, DOI 10.1042/bj2490709; GEVERS W, 1984, J MOL CELL CARDIOL, V6, P587; GIRARD PR, 1986, J BIOL CHEM, V261, P370; HARTZELL HC, 1984, J BIOL CHEM, V259, P5587; HARTZELL HC, 1982, J BIOL CHEM, V257, P2111; HENRICH CJ, 1988, J MOL CELL CARDIOL, V20, P1081, DOI 10.1016/0022-2828(88)90588-3; HOLROYDE MJ, 1979, BIOCHIM BIOPHYS ACTA, V587, P628, DOI 10.1016/0304-4165(79)90014-X; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; KAKU T, 1991, AM J PHYSIOL, V260, pC635, DOI 10.1152/ajpcell.1991.260.3.C635; KATOH N, 1983, BIOCHEM J, V209, P189, DOI 10.1042/bj2090189; KIKKAWA U, 1989, ANNU REV BIOCHEM, V58, P31, DOI 10.1146/annurev.bi.58.070189.000335; KRANIAS EG, 1985, BIOCHEM J, V226, P113, DOI 10.1042/bj2260113; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; LEATHERMAN GF, 1987, AM J PHYSIOL, V253, pH205, DOI 10.1152/ajpheart.1987.253.1.H205; LIM MS, 1985, BIOCHEM BIOPH RES CO, V132, P1187, DOI 10.1016/0006-291X(85)91932-1; LIU JD, 1989, BIOCHEM BIOPH RES CO, V162, P1105, DOI 10.1016/0006-291X(89)90787-0; MEIER KE, 1991, J BIOL CHEM, V266, P1914; MIYAMOTO E, 1973, J BIOL CHEM, V248, P179; MOCHLYROSEN D, 1990, CELL REGUL, V1, P693, DOI 10.1091/mbc.1.9.693; MUMBY MC, 1987, J BIOL CHEM, V262, P6257; MURPHY AM, 1990, PEDIATR RES, V28, P46, DOI 10.1203/00006450-199007000-00011; MURPHY AM, 1991, BIOCHEMISTRY-US, V30, P707, DOI 10.1021/bi00217a018; NOIMAN ES, 1980, J BIOL CHEM, V255, P1067; NOLAND TA, 1989, J BIOL CHEM, V264, P20778; NOLAND TA, 1991, J BIOL CHEM, V266, P4974; ONORATO JJ, 1981, J BIOL CHEM, V256, P697; RAY KP, 1976, FEBS LETT, V70, P11, DOI 10.1016/0014-5793(76)80716-8; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; ROCKSON SG, 1981, J CLIN INVEST, V67, P319, DOI 10.1172/JCI110038; ROGERS TB, 1990, J BIOL CHEM, V265, P4302; SAGGIN L, 1988, J BIOL CHEM, V263, P18488; SEI CA, 1991, J BIOL CHEM, V266, P15910; SELLERS JR, 1987, ENZYMES, P381; SHABB JB, 1991, HEART CARDIOVASCULAR, P1539; SOLARO RJ, 1976, NATURE, V262, P615, DOI 10.1038/262615a0; SOLARO RJ, 1986, PROTEIN PHOSPHORYLAT; SOLARO RJ, 1989, PHYSL PATHOPHYSIOLOG, P291; STULL JT, 1977, J BIOL CHEM, V252, P851; STULL JT, 1981, COLD SPRING HARBOR C, V8, P823; SWIDEREK K, 1990, EUR J BIOCHEM, V190, P575, DOI 10.1111/j.1432-1033.1990.tb15612.x; TADA M, 1975, J BIOL CHEM, V250, P2640; TALOSI L, 1992, CIRC RES, V70, P670, DOI 10.1161/01.RES.70.4.670; VENEMA RC, 1991, J BIOL CHEM, V266, P5298; WATANABE AM, 1977, CIRC RES, V40, P596, DOI 10.1161/01.RES.40.6.596	56	161	163	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2705	2711						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8381412				2022-12-27	WOS:A1993KK81500067
J	BOERNER, RJ; BIXBY, KA; NGUYEN, AP; NOREN, GH; DEBUS, RJ; BARRY, BA				BOERNER, RJ; BIXBY, KA; NGUYEN, AP; NOREN, GH; DEBUS, RJ; BARRY, BA			REMOVAL OF STABLE TYROSINE RADICAL D+ AFFECTS THE STRUCTURE OR REDOX PROPERTIES OF TYROSINE-Z IN MANGANESE-DEPLETED PHOTOSYSTEM-II PARTICLES FROM SYNECHOCYSTIS 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING SYSTEM; HISTIDINE OXIDATION; ELECTRON-TRANSFER; D1 POLYPEPTIDE; ENZYME; DONOR; COMPLEX; CENTERS; CLUSTER; SIGNAL	Photosystem II contains two redox-active tyrosines, D and Z. To understand the function of the dark stable tyrosine radical, D+, we have characterized two site-directed mutations at the D tyrosine residue in the transformable cyanobacterium, Synechocystis sp. PCC 6803, through the use of purified photosystem II particles (Noren, G. H., Boerner, R. J., and Barry, B. A. (1991) Biochemistry 30, 3943-3950). In manganese-depleted mutant particles, a light-induced EPR signal is observed. This signal contains a stable component, due to a chlorophyll radical, and an unstable component. The lineshape of the unstable, oxidized component, which we call M+, is obtained by subtraction; it has a lineshape different from tyrosine Z+/D+ and a g value of 2.004. Up to one M+ spin per reaction center can be photooxidized. The characteristic light-induced EPR signal ascribed to Z+ is not detected; under the same conditions, Z+ is detected in control preparations. The M+ radical lineshape is similar to the light-induced photosystem II radical identified in a site-directed mutant in the D1 polypeptide (YF161D1) (Noren, G. H., and Barry, B. A. (1992) Biochemistry 31, 33353342). Optical measurements on manganese-depleted photosystem II particles from control and D2 mutant preparations show that charge recombination kinetics between Q(A)- and an oxidized redox-active component are similar, to within a factor of two, in all three preparations. We conclude that lack of the stable tyrosine D+ alters the structure or redox properties of tyrosine Z in manganese-depleted preparations.	UNIV CALIF RIVERSIDE, DEPT BIOCHEM, RIVERSIDE, CA 92521 USA; UNIV MINNESOTA, DEPT BIOCHEM, ST PAUL, MN 55108 USA	University of California System; University of California Riverside; University of Minnesota System; University of Minnesota Twin Cities					NIGMS NIH HHS [GM43273, GM43496] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043273, R01GM043496] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAKHVERDIEV SI, 1992, FEBS LETT, V297, P51, DOI 10.1016/0014-5793(92)80325-B; BABCOCK GT, 1975, BIOCHIM BIOPHYS ACTA, V376, P315, DOI 10.1016/0005-2728(75)90024-9; BABCOCK GT, 1983, BIOCHIM BIOPHYS ACTA, V723, P276, DOI 10.1016/0005-2728(83)90127-5; BABCOCK GT, 1990, CURRENT RES PHOTOSYN, V1, P239; BARRY BA, 1987, P NATL ACAD SCI USA, V84, P7099, DOI 10.1073/pnas.84.20.7099; BARRY BA, 1988, CHEM SCRIPTA, V28A, P117; BARRY BA, 1990, PROGR PHOTOSYNTHESIS, V1, P483; BARRY BA, 1993, IN PRESS PHOTOCHEM P; BOERNER RJ, 1992, BIOCHEMISTRY-US, V31, P6660, DOI 10.1021/bi00144a005; BOUSSAC A, 1989, BIOCHEMISTRY-US, V28, P8984, DOI 10.1021/bi00449a005; BOUSSAC A, 1990, NATURE, V347, P303, DOI 10.1038/347303a0; CRAMER WA, 1986, PHOTOSYNTH RES, V10, P393, DOI 10.1007/BF00118305; DEBUS RJ, 1988, BIOCHEMISTRY-US, V27, P9071, DOI 10.1021/bi00426a001; DEBUS RJ, 1988, P NATL ACAD SCI USA, V85, P427, DOI 10.1073/pnas.85.2.427; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; DEFELIPPIS MR, 1989, BIOCHEMISTRY-US, V28, P4847, DOI 10.1021/bi00437a049; ELHAI J, 1988, GENE, V68, P119, DOI 10.1016/0378-1119(88)90605-1; GERKEN S, 1988, FEBS LETT, V237, P69, DOI 10.1016/0014-5793(88)80174-1; HARRIMAN A, 1987, J PHYS CHEM-US, V91, P6102, DOI 10.1021/j100308a011; HOGANSON CW, 1988, BIOCHEMISTRY-US, V27, P5848, DOI 10.1021/bi00416a005; INNES JB, 1989, BIOCHEMISTRY-US, V28, P1116, DOI 10.1021/bi00429a028; KLEINFELD D, 1984, BIOCHIM BIOPHYS ACTA, V766, P126, DOI 10.1016/0005-2728(84)90224-X; KLEINFELD D, 1984, THESIS U CALIFORNIA; MACDONALD GM, 1992, BIOCHEMISTRY-US, V31, P9848, DOI 10.1021/bi00155a043; METZ JG, 1989, BIOCHEMISTRY-US, V28, P6960, DOI 10.1021/bi00443a028; MILLER AF, 1991, BIOCHIM BIOPHYS ACTA, V1056, P1, DOI 10.1016/S0005-2728(05)80067-2; NOREN GH, 1991, BIOCHEMISTRY-US, V30, P3943, DOI 10.1021/bi00230a020; NOREN GH, 1992, BIOCHEMISTRY-US, V31, P3335, DOI 10.1021/bi00128a005; ONO T, 1990, BIOCHIM BIOPHYS ACTA, V1020, P269, DOI 10.1016/0005-2728(90)90157-Y; ONO T, 1991, BIOCHEMISTRY-US, V30, P6183, DOI 10.1021/bi00239a015; ONO T, 1991, FEBS LETT, V278, P183, DOI 10.1016/0014-5793(91)80112-G; RUTHERFORD AW, 1992, PHOTOSYSTEMS STRUCTU, V11, P179; SCHATZ GH, 1985, BIOCHIM BIOPHYS ACTA, V810, P283, DOI 10.1016/0005-2728(85)90212-9; SEALY RC, 1985, J AM CHEM SOC, V107, P3401, DOI 10.1021/ja00298a001; SIVARAJA M, 1989, BIOCHEMISTRY-US, V28, P9459, DOI 10.1021/bi00450a032; VANGORKOM HJ, 1974, BIOCHIM BIOPHYS ACTA, V347, P439, DOI 10.1016/0005-2728(74)90081-4; VERMAAS WFJ, 1988, P NATL ACAD SCI USA, V85, P8477, DOI 10.1073/pnas.85.22.8477; WERTZ JE, 1986, ELECTRON SPIN RESONA; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; WILLIAMS JGK, 1987, PROGR PHOTOSYNTHESIS, V4, P809	40	45	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1817	1823						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380579				2022-12-27	WOS:A1993KH62000050
J	MATSUNOYAGI, A; HATEFI, Y				MATSUNOYAGI, A; HATEFI, Y			STUDIES ON THE MECHANISM OF OXIDATIVE-PHOSPHORYLATION - DIFFERENT EFFECTS OF F0 INHIBITORS ON UNISITE AND MULTISITE ATP HYDROLYSIS BY BOVINE SUBMITOCHONDRIAL PARTICLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE-TRIPHOSPHATASE; ESCHERICHIA-COLI; CATALYTIC SITE; RESPIRATORY-CHAIN; BEEF-HEART; DICYCLOHEXYLCARBODIIMIDE; COMPLEX; F1-ATPASE; SYNTHASE; TURNOVER	Bovine submitochondrial particles prepared in the presence of GTP (G-SMP), as well as G-SMP washed in 150 mM KCl, catalyzed unisite ATP hydrolysis with a first order rate constant of 0.12 s-1. This rate constant remained unchanged at ATP concentrations < 0.06 muM but increased sharply at higher ATP concentrations, presumably because of ATP binding to other catalytic or regulatory sites. Pretreatment of the particles with oligomycin greatly inhibited unisite ATP binding, in agreement with previous findings. Pretreatment of the particles with N,N'-dicyclohexylcarbodiimide had a slight effect on unisite ATP binding, whereas pretreatment with the inhibitors venturicidin and tributyl(or triphenyl)tin chloride had no effect. Titration of unisite ATPase activity with increasing concentrations of oligomycin or efrapeptin resulted in sigmoidal inhibition curves, as though more than a single inhibition site was being titrated by each inhibitor. Venturicidin and organotin compounds had little effect on the ATPase activity of SMP at [ATP] less-than-or-equal-to [F1] and did not cause 100% inhibition at [ATP] >> [F1]. By analogy to our previous studies on the inhibition of the ubiquinol-cytochrome c reductase complex by antimycin (Hatefi, Y., and Yagi, T. (1982) Biochemistry 24, 6614-6618), it is proposed that venturicidin and organotin compounds freeze the structure of the F0 sector of the ATP synthase complex in such a manner that prevents the subunit molecular motions required for rapid proton flux but allows a slow proton flux generated by ATPase activity at low ATP concentrations.	SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, LA JOLLA, CA 92037 USA	Scripps Research Institute					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK008126, R01DK008126] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK08126] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALSHAWI MK, 1989, J BIOL CHEM, V264, P15376; AZZI A, 1973, J BIOL CHEM, V248, P5520; BERDEN JA, 1991, BIOCHIM BIOPHYS ACTA, V1057, P151, DOI 10.1016/S0005-2728(05)80099-4; BOYER PD, 1987, BIOCHEMISTRY-US, V26, P8503, DOI 10.1021/bi00400a001; COX GB, 1984, BIOCHIM BIOPHYS ACTA, V768, P201, DOI 10.1016/0304-4173(84)90016-8; CROSS RL, 1978, J BIOL CHEM, V253, P4865; CUNNINGHAM D, 1988, J BIOL CHEM, V263, P18850; FILLINGAME RH, 1990, BACTERIA TREATISE ST, V12, P345; FROMME P, 1990, BIOCHIM BIOPHYS ACTA, V1020, P187, DOI 10.1016/0005-2728(90)90050-E; GRESSER MJ, 1982, J BIOL CHEM, V257, P2030; HATEFI Y, 1982, BIOCHEMISTRY-US, V24, P6614; Hatefi Y., 1992, ADENINE NUCLEOTIDES, P33; HEKMAN C, 1991, ARCH BIOCHEM BIOPHYS, V284, P90, DOI 10.1016/0003-9861(91)90268-N; ISSARTEL JP, 1992, EXPERIENTIA, V48, P351, DOI 10.1007/BF01923429; KIEHL R, 1980, BIOCHEMISTRY-US, V19, P541, DOI 10.1021/bi00544a023; KOPECKY J, 1981, FEBS LETT, V131, P208, DOI 10.1016/0014-5793(81)80369-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUNDIN A, 1976, ANAL BIOCHEM, V75, P611, DOI 10.1016/0003-2697(76)90116-0; MATSUNOYAGI A, 1990, J BIOL CHEM, V265, P20308; MATSUNOYAGI A, 1990, J BIOL CHEM, V265, P82; MATSUNOYAGI A, 1988, J BIOENERG BIOMEMBR, V20, P481, DOI 10.1007/BF00762205; MATSUNOYAGI A, 1986, J BIOL CHEM, V261, P14031; MATSUNOYAGI A, 1988, BIOCHEMISTRY-US, V27, P335, DOI 10.1021/bi00401a050; MATSUNOYAGI A, 1985, P NATL ACAD SCI USA, V82, P7550, DOI 10.1073/pnas.82.22.7550; MCCARTY RE, 1987, TRENDS BIOCHEM SCI, V12, P234, DOI 10.1016/0968-0004(87)90116-2; MILGROM YM, 1987, FEBS LETT, V212, P63, DOI 10.1016/0014-5793(87)81557-0; MUNEYUKI E, 1991, BIOCHIM BIOPHYS ACTA, V1058, P304, DOI 10.1016/S0005-2728(05)80251-8; PENEFSKY HS, 1985, J BIOL CHEM, V260, P3728; PENEFSKY HS, 1985, P NATL ACAD SCI USA, V82, P1589, DOI 10.1073/pnas.82.6.1589; RIESKE JS, 1976, BIOCHIM BIOPHYS ACTA, V456, P195, DOI 10.1016/0304-4173(76)90012-4; RIESKE JS, 1967, J BIOL CHEM, V242, P4854; SEBALD W, 1979, EUR J BIOCHEM, V93, P587, DOI 10.1111/j.1432-1033.1979.tb12859.x; Stiggall D L, 1979, Methods Enzymol, V55, P308; TOMMASINO M, 1985, BIOCHEMISTRY-US, V24, P3972; WALKER JE, 1991, BIOCHEMISTRY-US, V30, P5369, DOI 10.1021/bi00236a007; WONG SY, 1984, BIOCHEMISTRY-US, V23, P5004, DOI 10.1021/bi00316a027; [No title captured]	37	48	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1539	1545						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380571				2022-12-27	WOS:A1993KH62000009
J	FUKUNAGA, K; KOBAYASHI, T; TAMURA, S; MIYAMOTO, E				FUKUNAGA, K; KOBAYASHI, T; TAMURA, S; MIYAMOTO, E			DEPHOSPHORYLATION OF AUTOPHOSPHORYLATED CA2+/CALMODULIN-DEPENDENT PROTEIN KINASE-II BY PROTEIN PHOSPHATASE-2C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-DEPENDENT KINASE; RAT-BRAIN; CA-2+-INDEPENDENT ACTIVITY; HIPPOCAMPAL SLICES; CA-2+ CALMODULIN; IDENTIFICATION; GENERATION; ACTIVATION; BINDING; SITES	It has been demonstrated that okadaic acid-insensitive protein phosphatases are involved in dephosphorylation of autophosphorylated Ca2+/calmodulin-dependent protein kinase II (CaM kinase II) in rat cerebellar granule cells (Fukunaga, K., Rich, D. P., and Soderling, T. R. (1989) J. Biol. Chem. 264, 21830-21836). In the present study, recombinant rat protein phosphatase 2C (PrP-2C) expressed in Escherichia coli could dephosphorylate both Thr286/287 and Thr305/306 phosphorylation sites of CaM kinase II, which are responsible for the generation of Ca2+-independent activity and the inhibition of the total activity, respectively. The dephosphorylation of Thr286/287 and Thr305/306 was accomplished within 15 min at 0-degrees-C totally dependent on Mg2+. Phosphopeptide mapping of the CNBr-cleaved P-32-labeled CaM kinase II revealed that PrP-2C was relatively specific for dephosphorylation of Thr286/287 and Thr305/306 in the autophosphorylated CaM kinase II. These results suggest that PrP-2C has a role in the regulation of the Ca2+-independent activity of CaM kinase II in the neural cells.	TOHOKU UNIV, TB & CANC RES INST, DEPT BIOCHEM, SENDAI, MIYAGI 980, JAPAN	Tohoku University	FUKUNAGA, K (corresponding author), KUMAMOTO UNIV, SCH MED, DEPT PHARMACOL, KUMAMOTO 860, JAPAN.							ABE H, 1992, MOL BRAIN RES, V13, P283, DOI 10.1016/0169-328X(92)90211-S; BINSTOCK JF, 1979, BIOCHEM BIOPH RES CO, V87, P1226; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Colbran R J, 1990, Curr Top Cell Regul, V31, P181; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; FUKUNAGA K, 1984, BIOMED RES-TOKYO, V5, P165, DOI 10.2220/biomedres.5.165; FUKUNAGA K, 1982, J NEUROCHEM, V39, P1607, DOI 10.1111/j.1471-4159.1982.tb07994.x; FUKUNAGA K, 1990, Molecular and Cellular Neuroscience, V1, P133; FUKUNAGA K, 1989, J BIOL CHEM, V264, P21830; GOTO S, 1985, J NEUROCHEM, V45, P276, DOI 10.1111/j.1471-4159.1985.tb05504.x; HASHIMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P418, DOI 10.1016/0003-9861(87)90048-8; HASHIMOTO Y, 1987, J BIOL CHEM, V262, P8051; HESCHELER J, 1988, PFLUG ARCH EUR J PHY, V412, P248, DOI 10.1007/BF00582504; HIRAGA A, 1981, EUR J BIOCHEM, V119, P503, DOI 10.1111/j.1432-1033.1981.tb05636.x; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P297, DOI 10.1111/j.1432-1033.1983.tb07362.x; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; KWIATKOWSKI AP, 1988, J BIOL CHEM, V263, P6484; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; LOU LL, 1989, J NEUROSCI, V9, P2020; MCGOWAN CH, 1987, EUR J BIOCHEM, V166, P713, DOI 10.1111/j.1432-1033.1987.tb13570.x; MILLER SG, 1988, NEURON, V1, P593, DOI 10.1016/0896-6273(88)90109-2; MOLLOY SS, 1991, P NATL ACAD SCI USA, V88, P4756, DOI 10.1073/pnas.88.11.4756; NAIRN AC, 1985, ANNU REV BIOCHEM, V54, P931, DOI 10.1146/annurev.bi.54.070185.004435; OCORR KA, 1991, NEURON, V6, P907, DOI 10.1016/0896-6273(91)90231-N; PATO MD, 1983, J BIOL CHEM, V258, P7055; PATTON BL, 1990, J BIOL CHEM, V265, P11204; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; SAITOH Y, 1986, BIOMED RES-TOKYO, V7, P399; SAITOH Y, 1987, J NEUROCHEM, V49, P1286, DOI 10.1111/j.1471-4159.1987.tb10022.x; SCHULMAN H, 1988, ADV SEC MESS PHOSPH, V22, P39; SCHWORER CM, 1988, J BIOL CHEM, V263, P13486; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; SHIELDS SM, 1985, J NEUROSCI, V5, P3414; TAMURA S, 1978, BIOCHIM BIOPHYS ACTA, V524, P349, DOI 10.1016/0005-2744(78)90171-7; TAMURA S, 1989, BIOCHEM BIOPH RES CO, V163, P131, DOI 10.1016/0006-291X(89)92109-8; TAMURA S, 1989, P NATL ACAD SCI USA, V86, P1796, DOI 10.1073/pnas.86.6.1796; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337	38	91	92	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					133	137						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380154				2022-12-27	WOS:A1993KE60300021
J	NAKANISHI, H; BREWER, KA; EXTON, JH				NAKANISHI, H; BREWER, KA; EXTON, JH			ACTIVATION OF THE ZETA-ISOZYME OF PROTEIN-KINASE-C BY PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HUMAN-PLATELETS; RAT-LIVER; PHOSPHOINOSITIDES; PHOSPHOLIPIDS; PURIFICATION; NEUTROPHILS; 3-KINASE; THROMBIN; PATHWAY	The regulation of the Ca2+- and phorbol ester-insensitive zeta isozyme of protein kinase C (PKCzeta) by phospholipids was studied. Phosphatidylserine (PS) stimulated the activity to the same extent as proteolysis by calpain. However, the PS stimulation was abolished by phosphatidylethanolamine (PE) or phosphatidylcholine. Phosphatidylinositol-3,4,5-P3 (PIP3) produced a large stimulation of PKCzeta in the absence or presence of PS plus PE that was equal to that seen with PS alone. In the presence of PS plus PE, PIP3 was half-maximally effective at 50 nM. Phosphatidylinositol-3,4-P2 also fully activated PKCzeta, but higher concentrations (0.5 muM) were required. High concentrations (0.5-2 muM) of phosphatidylinositol-3-P2 phosphatidylinositol-4-P, and phosphatidylinositol-4,5-P2 produced only partial (11-30%) activation of the enzyme. In contrast, when tested with ''conventional'' PKC purified from rat brain, none of the inositol phospholipids produced more than one-third of the stimulation seen with PS plus Ca2+ plus phorbol ester, and there was little difference between the efficacy of PIP3 and that of the other phospholipids. PIP3 produced a marked stimulation of the autophosphorylation of PKCzeta, indicating that it interacted with the enzyme directly. These results suggest that PKCzeta may be a target for PIP3 and thus may be involved in the signaling mechanism(s) for growth factors and oncogenes that increase phosphatidylinositol 3-kinase activity.	VANDERBILT UNIV, MED CTR, SCH MED, HOWARD HUGHES MED INST, NASHVILLE, TN 37232 USA; VANDERBILT UNIV, MED CTR, SCH MED, DEPT MOLEC PHYSIOL & BIOPHYS, NASHVILLE, TN 37232 USA	Howard Hughes Medical Institute; Vanderbilt University; Vanderbilt University				Nakanishi, Hiroyuki/0000-0002-9765-0266				AHN NG, 1991, J BIOL CHEM, V266, P4220; CARPENTER CL, 1990, BIOCHEMISTRY-US, V29, P11147, DOI 10.1021/bi00503a001; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; CHAUHAN A, 1991, ARCH BIOCHEM BIOPHYS, V287, P283, DOI 10.1016/0003-9861(91)90480-7; CHAUHAN VPS, 1988, BIOCHEM BIOPH RES CO, V155, P18, DOI 10.1016/S0006-291X(88)81043-X; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; COLBEAU A, 1971, BIOCHIM BIOPHYS ACTA, V249, P462, DOI 10.1016/0005-2736(71)90123-4; CONRICODE KM, 1992, J BIOL CHEM, V267, P7199; CUNNINGHAM TW, 1990, J BIOL CHEM, V265, P21676; DOD BJ, 1968, BIOCHIM BIOPHYS ACTA, V150, P397, DOI 10.1016/0005-2736(68)90138-7; DOWNES CP, 1991, CELL SIGNAL, V3, P501, DOI 10.1016/0898-6568(91)90027-R; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; HADARI YR, 1992, J BIOL CHEM, V267, P17483; HIGGINS JA, 1978, BIOCHEM J, V174, P563, DOI 10.1042/bj1740563; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; JACKSON TR, 1992, J BIOL CHEM, V267, P16627; KASHISHIAN A, 1992, EMBO J, V11, P1373, DOI 10.1002/j.1460-2075.1992.tb05182.x; KAZLAUSKAS A, 1992, MOL CELL BIOL, V12, P2534, DOI 10.1128/MCB.12.6.2534; KAZLAUSKAS A, 1991, CELL REGUL, V2, P413, DOI 10.1091/mbc.2.6.413; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KUCERA GL, 1990, J BIOL CHEM, V265, P5345; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LEE MH, 1991, BIOCHEMISTRY-US, V30, P1041, DOI 10.1021/bi00218a023; NAKANISHI H, 1992, J BIOL CHEM, V267, P16347; NAKIELNY S, 1992, EMBO J, V11, P2123, DOI 10.1002/j.1460-2075.1992.tb05271.x; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; RAY TK, 1969, J BIOL CHEM, V244, P5528; REEDIJK M, 1992, EMBO J, V11, P1365, DOI 10.1002/j.1460-2075.1992.tb05181.x; SCHACHT J, 1978, J LIPID RES, V19, P1063; SERUNIAN LA, 1991, METHOD ENZYMOL, V198, P78; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; TRAYNORKAPLAN AE, 1989, J BIOL CHEM, V264, P15668; VARTICOVSKI L, 1991, MOL CELL BIOL, V11, P1107, DOI 10.1128/MCB.11.2.1107; WAYS DK, 1992, J BIOL CHEM, V267, P4799; WETSEL WC, 1992, J CELL BIOL, V117, P121, DOI 10.1083/jcb.117.1.121; WILSON DB, 1985, J BIOL CHEM, V260, P1046	39	969	978	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					13	16						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380153				2022-12-27	WOS:A1993KE60300004
J	ODA, Y; YOSHIDA, M; KANAYA, S				ODA, Y; YOSHIDA, M; KANAYA, S			ROLE OF HISTIDINE-124 IN THE CATALYTIC FUNCTION OF RIBONUCLEASE-III FROM ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; AMINO-ACID-RESIDUES; RNASE-H; DOMAIN; MUTAGENESIS; MUTATIONS; GENE	The role of the conserved histidine residue (His124) in the catalytic function of Escherichia coli ribonuclease HI was probed by the use of the pH titration experiments with H-1 NMR and site-directed mutagenesis. His124 is located close to the catalytic triad formed by the three carboxylates. The C2H proton resonance of His124, as well as those of four other His residues, in the enzyme were assigned by comparing the H-1 NMR spectrum of the wild-type enzyme to the spectra of the five mutant enzymes, each of which lacked a different His residue. From the analysis of the pH titration shifts of these resonances, the pK(a) values of all His residues were determined. The pK(a) value of His124 was 7.1, which is slightly higher than, but close to, the normal value of the imidazole group. This result suggests that His124 is located in an acidic environment but does not interact directly with a carboxyl group in the solution structure. Three mutant enzymes, in which His124 was replaced by Lys, Gln, or Glu were constructed. The kinetic parameters of these mutant enzymes were determined by using the M13 DNA/RNA hybrid as a substrate. Substitution of Lys, Gln, or Glu for His124 dramatically lowered the V(max) value by 30-100-fold, without significantly affecting the K(m) value, as compared to those of the wild-type enzyme. In addition, any mutation impaired the in vivo function of the enzyme. These results indicate that His124 is involved in the catalytic function of the enzyme. We propose that His24 changes its conformation in the catalytic reaction and enhances the catalytic efficiency by removing a proton from a catalytically essential carboxylate.	PROT ENGN RES INST,SUITA,OSAKA 565,JAPAN; KYOWA HAKKO KOGYO CO LTD,TOKYO RES LABS,MACHIDA,TOKYO 194,JAPAN	Kyowa Kirin Ltd								ARNOLD E, 1992, NATURE, V357, P85, DOI 10.1038/357085a0; CROUCH R J, 1990, New Biologist, V2, P771; Crouch R. J., 1982, NUCLEASES, P211; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; DOOLITTLE RF, 1989, Q REV BIOL, V64, P1, DOI 10.1086/416128; FERSHT AR, 1985, ENZYME STRUCTURE MEC, P156; INAGAKI F, 1981, J BIOCHEM-TOKYO, V89, P1185; ITAYA M, 1991, MOL GEN GENET, V227, P438, DOI 10.1007/BF00273935; ITAYA M, 1990, P NATL ACAD SCI USA, V87, P8587, DOI 10.1073/pnas.87.21.8587; JARDETZKY O, 1981, NMR MOL BIOL, P281; JOU RW, 1991, J AM CHEM SOC, V113, P6685, DOI 10.1021/ja00017a056; KANAYA S, 1989, J BIOL CHEM, V264, P11546; KANAYA S, 1983, J BIOL CHEM, V258, P1276; KANAYA S, 1991, J BIOL CHEM, V266, P6038; KANAYA S, 1991, EUR J BIOCHEM, V198, P437, DOI 10.1111/j.1432-1033.1991.tb16033.x; KANAYA S, 1990, J BIOL CHEM, V265, P4615; KANAYA S, 1991, J BIOL CHEM, V266, P11621; KATAYANAGI K, 1992, J MOL BIOL, V223, P1029, DOI 10.1016/0022-2836(92)90260-Q; KATAYANAGI K, 1990, NATURE, V347, P306, DOI 10.1038/347306a0; KIMURA S, 1992, J BIOL CHEM, V267, P21535; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; NAIR SK, 1991, J AM CHEM SOC, V113, P9455, DOI 10.1021/ja00025a005; NAKAMURA H, 1991, P NATL ACAD SCI USA, V88, P11535, DOI 10.1073/pnas.88.24.11535; ODA Y, 1991, Journal of Biomolecular NMR, V1, P247, DOI 10.1007/BF01875518; ODA Y, 1992, J BIOMOL NMR, V2, P137, DOI 10.1007/BF01875525; SANCHO J, 1992, BIOCHEMISTRY-US, V31, P2253, DOI 10.1021/bi00123a006; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHATZ O, 1989, FEBS LETT, V257, P311, DOI 10.1016/0014-5793(89)81559-5; TISDALE M, 1991, J GEN VIROL, V72, P59, DOI 10.1099/0022-1317-72-1-59; WINTERSBERGER U, 1990, PHARMACOL THERAPEUT, V48, P259, DOI 10.1016/0163-7258(90)90083-E; YAMAZAKI T, 1991, BIOCHEMISTRY-US, V30, P6036, DOI 10.1021/bi00238a030; YANG W, 1990, SCIENCE, V249, P1398, DOI 10.1126/science.2169648	32	83	83	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					88	92						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380173				2022-12-27	WOS:A1993KE60300015
J	MISCHAK, H; PIERCE, JH; GOODNIGHT, J; KAZANIETZ, MG; BLUMBERG, PM; MUSHINSKI, JF				MISCHAK, H; PIERCE, JH; GOODNIGHT, J; KAZANIETZ, MG; BLUMBERG, PM; MUSHINSKI, JF			PHORBOL ESTER-INDUCED MYELOID DIFFERENTIATION IS MEDIATED BY PROTEIN KINASE-C-ALPHA AND KINASE-C-DELTA AND NOT BY PROTEIN KINASE-C-BETA-II, KINASE-C-DELTA, KINASE-C-ZETA, AND KINASE-C-ETA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA-CELL LINE; HEMATOPOIETIC-CELLS; RAT-BRAIN; EXPRESSION; HL-60; FAMILY; ACTIVATION; NPKC; PROLIFERATION; FIBROBLASTS	It is generally accepted that the multiple, similar protein kinase C (PKC) isozymes are responsible for different specialized physiological processes, but evidence that directly assigns specific functions to specific isozymes is scarce. To test whether specific PKC isozymes are involved in myeloid differentiation, we have studied the effect of overexpression of PKC-alpha, -betaII, -delta, -epsilon, -zeta and -eta in 32D, a mouse myeloid progenitor cell line that does not differentiate in response to 12-O-tetradecanoylphorbol-13-acetate (TPA). No significant morphological or phenotypic changes could be observed in unstimulated cells that overexpress any of these isozymes. However, the cell lines that overexpressed PKC-alpha or -delta had acquired the ability to become mature macrophages 2-6 h after TPA stimulation. The overexpression of PKC-betaII, -epsilon, -zeta, or -eta, in contrast, did not permit TPA-induced differentiation. These results indicate that only these two members of the PKC gene family can participate in TPA-induced myeloid differentiation.	NCI, GENET LAB, BLDG 37, RM 2B26, BETHESDA, MD 20892 USA; NCI, CELLULAR & MOLEC BIOL LAB, BETHESDA, MD 20892 USA; NCI, CELLULAR CARCINOGENESIS & TUMOR PROMOT, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Mischak, Harald/E-8685-2011	Mischak, Harald/0000-0003-0323-0306				AIHARA H, 1991, P NATL ACAD SCI USA, V88, P11062, DOI 10.1073/pnas.88.24.11062; BORNER C, 1992, J BIOL CHEM, V267, P12892; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; COLLINS SJ, 1987, BLOOD, V70, P1233; DLUGOSZ AA, 1992, MOL CARCINOGEN, V5, P286, DOI 10.1002/mc.2940050409; GOODNIGHT J, 1992, GENE, V122, P305, DOI 10.1016/0378-1119(92)90219-F; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; HASHIMOTO K, 1990, FEBS LETT, V263, P31, DOI 10.1016/0014-5793(90)80698-I; ISHIZUKA T, 1992, BIOCHEM BIOPH RES CO, V183, P814, DOI 10.1016/0006-291X(92)90556-Z; KAZANIETZ MG, 1992, J BIOL CHEM, V267, P20878; KAZANIETZ MG, 1993, IN PRESS MOL PHARM; KNOPF JL, 1986, CELL, V46, P491, DOI 10.1016/0092-8674(86)90874-3; KOIDE H, 1992, P NATL ACAD SCI USA, V89, P1149, DOI 10.1073/pnas.89.4.1149; KRAFT AS, 1990, ONCOGENE, V5, P1243; MCCLINTON D, 1990, MOL CELL BIOL, V10, P705, DOI 10.1128/MCB.10.2.705; MCSWINEKENNICK RL, 1991, J BIOL CHEM, V266, P15135; MEGIDISH T, 1989, NATURE, V342, P807, DOI 10.1038/342807a0; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; MISCHAK H, 1991, J IMMUNOL, V147, P3981; MISCHAK H, 1991, BIOCHEMISTRY-US, V30, P7925, DOI 10.1021/bi00246a008; MULLIGAN RC, 1981, P NATL ACAD SCI-BIOL, V78, P2072, DOI 10.1073/pnas.78.4.2072; NISHIKAWA M, 1990, CANCER RES, V50, P621; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OHNO S, 1991, ADV ENZYME REGUL, V31, P287, DOI 10.1016/0065-2571(91)90018-H; ONO Y, 1988, J BIOL CHEM, V263, P6927; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; OSADA S, 1992, MOL CELL BIOL, V12, P3930, DOI 10.1128/MCB.12.9.3930; OSADA S, 1990, J BIOL CHEM, V265, P22434; OSSERMAN EF, 1966, J EXP MED, V124, P921, DOI 10.1084/jem.124.5.921; OTTE AP, 1992, CELL, V68, P1021, DOI 10.1016/0092-8674(92)90074-M; OZAWA K, 1993, J BIOL CHEM, V268, P1749; PIERCE JH, 1990, P NATL ACAD SCI USA, V87, P5613, DOI 10.1073/pnas.87.15.5613; SCHAAP D, 1989, FEBS LETT, V243, P351, DOI 10.1016/0014-5793(89)80160-7; SPOSI NM, 1989, MOL CELL BIOL, V9, P2284, DOI 10.1128/MCB.9.5.2284; TONETTI DA, 1992, CELL GROWTH DIFFER, V3, P739; WATANABE T, 1992, P NATL ACAD SCI USA, V89, P10159, DOI 10.1073/pnas.89.21.10159; WAYS DK, 1987, CANCER RES, V47, P3344	37	269	277	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20110	20115						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376369				2022-12-27	WOS:A1993LY01900031
J	BABU, A; RAO, VG; SU, H; GULATI, J				BABU, A; RAO, VG; SU, H; GULATI, J			CRITICAL MINIMUM LENGTH OF THE CENTRAL HELIX IN TROPONIN-C FOR THE CA2+ SWITCH IN MUSCULAR-CONTRACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-FIBERS; BIOLOGICAL-ACTIVITY; CALCIUM-ION; EF-HAND; SKELETAL; CALMODULIN; MUTANTS; REGION; FORCE	In the troponin C (TnC) dumbbell, the NH2- and COOH-terminal lobes are well delineated, but the role of the central helix and especially the function of its long length remain doubtful. To study this, we used a cDNA construct encoding rabbit fast-twitch muscle TnC, comprising multiple restriction sequences to facilitate mutagenesis (Babu, A., Su, H., Ryu, Y. & Gulati, J. (1992) J. Biol. Chem. 267, 15469-15474). Systematically, we have deleted 3-12 amino acid residues from the central helix and examined their effects in maximally activated skinned muscle fibers. Limiting the deletions to 7 amino acid residues manifested little change in maximal force development (Sheng, Z., Francois, J. M., Hitchcock, S. E. & Potter, J. D. (1991) J. Biol. Chem. 266, 5711-5715). However, with further deletions, we now find that contractility was inhibited pari passu; by 12 deletions, the inhibition was complete. The critical minimum length for the central helix is thereby estimated as 27 angstrom The Ca2+ binding capacity (4 mol of Ca2+/mol of protein) as well as the structural characteristics (alpha-helicity by CD measurements and the fluorescence emitted by Tyr-109) indicated a well preserved global conformation of the short mutant. However, surprisingly, two of these short mutants filled each TnC slot under highly specific superloading conditions: one short molecule was taken up in EGTA solution, and the second molecule was captured and retained with Ca2+. They also rescued the contractile switch, evidently in a bimolecular reaction. Another short variant (putative skeletal fast muscle TnC-I-II), in which the NH2-terminal Ca2+-binding sites were incapacitated, failed to respond to superloading, indicating that sites III and IV could not substitute for sites I and II. The results suggest that a critical role of the central helix linker in TnC is to keep the two lobes optimally apart, evidently in proximity of their respective target sites on troponin I in the fiber.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT PHYSIOL & BIOPHYS,BRONX,NY 10461	Yeshiva University; Albert Einstein College of Medicine	BABU, A (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MED,DIV CARDIOL,MOLEC PHYSIOL LAB,BRONX,NY 10461, USA.			Akella, Aravind/0000-0002-3396-7598	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL037412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR033736] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 37412] Funding Source: Medline; NIAMS NIH HHS [AR 33736] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BABU A, 1986, FEBS LETT, V203, P20, DOI 10.1016/0014-5793(86)81428-4; BABU A, 1988, J BIOL CHEM, V263, P15485; BABU A, 1987, J BIOL CHEM, V262, P5815; BABU A, 1992, J BIOL CHEM, V267, P15469; COLLINS JH, 1976, SOC EXP BIOL S, V30, P303; Creighton T. E., 1993, PROTEINS STRUCTURES; DOBROWOLSKI Z, 1991, J BIOL CHEM, V266, P5703; GRABAREK Z, 1981, J BIOL CHEM, V256, P3121; GRABAREK Z, 1992, J MUSCLE RES CELL M, V13, P383, DOI 10.1007/BF01738034; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GULATI J, 1990, FEBS LETT, V263, P340, DOI 10.1016/0014-5793(90)81409-H; GULATI J, 1989, FEBS LETT, V248, P5, DOI 10.1016/0014-5793(89)80420-X; GULATI J, 1993, J BIOL CHEM, V268, P11685; GULATI J, 1991, J PHYSIOL-LONDON, V441, P305, DOI 10.1113/jphysiol.1991.sp018753; GULATI J, 1992, J BIOL CHEM, V267, P25073; GULATI J, 1978, J GEN PHYSIOL, V72, P701, DOI 10.1085/jgp.72.5.701; GULATI J, 1976, P NATL ACAD SCI USA, V73, P4693, DOI 10.1073/pnas.73.12.4693; GULATI J, 1993, MODULATION CARDIAC C, P215; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; KAWASAKI Y, 1972, BIOCHEM BIOPH RES CO, V49, P898, DOI 10.1016/0006-291X(72)90297-5; LESZYK J, 1990, BIOCHEMISTRY-US, V29, P299, DOI 10.1021/bi00453a041; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MURRAY AC, 1972, BIOCHEMISTRY-US, V11, P2622, DOI 10.1021/bi00764a012; SHENG Z, 1991, J BIOL CHEM, V266, P5711; SHENG ZL, 1990, J BIOL CHEM, V265, P21554; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; WEEKS RA, 1978, BIOCHEM J, V173, P449, DOI 10.1042/bj1730449	27	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19232	19238						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366076				2022-12-27	WOS:A1993LW81900016
J	SHEN, WC; SELVAKUMAR, D; STANFORD, DR; HOPPER, AK				SHEN, WC; SELVAKUMAR, D; STANFORD, DR; HOPPER, AK			THE SACCHAROMYCES-CEREVISIAE LOS1 GENE INVOLVED IN PRE-TRANSFER-RNA SPLICING ENCODES A NUCLEAR-PROTEIN THAT BEHAVES AS A COMPONENT OF THE NUCLEAR MATRIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR TRANSFER-RNAS; PORE COMPLEX; MESSENGER-RNA; SUBNUCLEAR LOCALIZATION; INTERVENING SEQUENCES; YEAST MUTANT; DNA; ENDONUCLEASE; BINDING; LIGASE	Mutations of the Saccharomyces cerevisiae LOS1 gene cause the accumulation of end matured intron-containing pre-tRNAs at elevated temperatures. In an effort to decipher the role of the LOS1 protein in pre-tRNA splicing, we have analyzed the LOS1 gene and its protein product. The LOS1 gene is located on the left arm of chromosome XI and the order of genes in this area of the chromosome is .... URA1 ... SAC1 TRP3 UBA1 STE6 LOS1....FAS1..... The LOS1 open reading frame encodes a putative protein of 1100 amino acids that shows no significant homology to other genes. The LOS1 open reading frame was tagged with the influenza virus hemagglutinin epitope recognized by the 12CA5 antibody. The 12CA5 antibody recognizes an epitope-tagged protein of the size predicted by the LOS1 open reading frame. Using this antibody for indirect immunofluorescence and cell fractionation studies we show that the LOS1 protein is located in nuclei. Los1p cannot be extracted from nuclei by treatment with nucleases, salts, or Triton X-100. This insolubility suggests that Los1p is a component of the nucleoskelton. We propose that LOS1 mutations may affect pre-tRNA processing via alteration of the nuclear matrix.	PENN STATE UNIV, MILTON S HERSHEY MED CTR, DEPT BIOL CHEM, HERSHEY, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health								ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARIS JP, 1988, J CELL BIOL, V107, P17, DOI 10.1083/jcb.107.1.17; BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2241, DOI 10.1093/nar/19.suppl.2241; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAM RJ, 1985, P NATL ACAD SCI USA, V82, P43, DOI 10.1073/pnas.82.1.43; CARTER KC, 1991, J CELL BIOCHEM, V47, P124, DOI 10.1002/jcb.240470205; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; CIGAN AM, 1987, GENE, V59, P1; CLARK MW, 1987, J CELL BIOL, V105, P1515, DOI 10.1083/jcb.105.4.1515; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; DAVIS LI, 1990, CELL, V61, P965, DOI 10.1016/0092-8674(90)90062-J; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; DEMARINI DJ, 1992, MOL CELL BIOL, V12, P2154, DOI 10.1128/MCB.12.5.2154; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; GARCIABUSTOS J, 1991, BIOCHIM BIOPHYS ACTA, V1071, P83, DOI 10.1016/0304-4157(91)90013-M; Gerace L, 1982, Cold Spring Harb Symp Quant Biol, V46 Pt 2, P967; GERACE L, 1986, TRENDS BIOCHEM SCI, V11, P443, DOI 10.1016/0968-0004(86)90243-4; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; GREER CL, 1983, CELL, V32, P537, DOI 10.1016/0092-8674(83)90473-7; HESKETH JE, 1991, BIOCHEM J, V277, P1; HO CK, 1990, EMBO J, V9, P1245, DOI 10.1002/j.1460-2075.1990.tb08232.x; HOPPER AK, 1978, CELL, V14, P211, DOI 10.1016/0092-8674(78)90108-3; HOPPER AK, 1990, J CELL BIOL, V111, P309, DOI 10.1083/jcb.111.2.309; HOPPER AK, 1980, CELL, V19, P741, DOI 10.1016/S0092-8674(80)80050-X; Hopper AK, 1992, MOL CELLULAR BIOL YE, P99; HURT DJ, 1987, MOL CELL BIOL, V7, P1208, DOI 10.1128/MCB.7.3.1208; HURT EC, 1988, EUR J CELL BIOL, V46, P554; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JEFFRIES TW, 1981, CARBOHYD RES, V95, P87, DOI 10.1016/S0008-6215(00)85298-2; JONES EW, 1991, METHOD ENZYMOL, V194, P428; KENAN DJ, 1991, TRENDS BIOCHEM SCI, V16, P214, DOI 10.1016/0968-0004(91)90088-D; KOLODZIEJ P, 1989, MOL CELL BIOL, V9, P5387, DOI 10.1128/MCB.9.12.5387; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LI JM, 1989, J CELL BIOL, V109, P1411, DOI 10.1083/jcb.109.4.1411; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; MCCRAITH SM, 1991, J BIOL CHEM, V266, P11986; MCCRAITH SM, 1990, MOL CELL BIOL, V10, P1049, DOI 10.1128/MCB.10.3.1049; MIRZAYAN C, 1992, J CELL BIOL, V116, P1319, DOI 10.1083/jcb.116.6.1319; MORTIMER RK, 1992, YEAST, V8, P817, DOI 10.1002/yea.320081002; MYLIN LM, 1990, MOL CELL BIOL, V10, P4623, DOI 10.1128/MCB.10.9.4623; NAKAYASU H, 1991, P NATL ACAD SCI USA, V88, P10312, DOI 10.1073/pnas.88.22.10312; OCONNOR JP, 1992, MOL CELL BIOL, V12, P3843, DOI 10.1128/MCB.12.9.3843; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PEEBLES CL, 1983, CELL, V32, P525, DOI 10.1016/0092-8674(83)90472-5; PEEBLES CL, 1979, CELL, V18, P27, DOI 10.1016/0092-8674(79)90350-7; PHIZICKY EM, 1992, J BIOL CHEM, V267, P4577; PHIZICKY EM, 1986, J BIOL CHEM, V261, P2978; RAUHUT R, 1990, J BIOL CHEM, V265, P18180; RILES L, 1993, GENETICS, V134, P81; ROSE AM, 1992, MOL CELL BIOL, V12, P5652, DOI 10.1128/MCB.12.12.5652; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x; SCOTT JH, 1980, J BACTERIOL, V142, P414, DOI 10.1128/JB.142.2.414-423.1980; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SINGER VL, 1990, GENE DEV, V4, P636, DOI 10.1101/gad.4.4.636; SLUSHER LB, 1991, P NATL ACAD SCI USA, V88, P9789, DOI 10.1073/pnas.88.21.9789; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; VALLEE BL, 1991, P NATL ACAD SCI USA, V88, P999, DOI 10.1073/pnas.88.3.999; VANZYL WH, 1989, GENETICS, V123, P55; WANG SS, 1992, MOL CELL BIOL, V12, P2633, DOI 10.1128/MCB.12.6.2633; WANG SS, 1988, MOL CELL BIOL, V8, P5140, DOI 10.1128/MCB.8.12.5140; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; WINEY M, 1988, GENETICS, V118, P609; WORMAN HJ, 1988, P NATL ACAD SCI USA, V85, P8531, DOI 10.1073/pnas.85.22.8531	69	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19436	19444						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366091				2022-12-27	WOS:A1993LW81900046
J	JOHNSON, GR; PRIGENT, SA; GULLICK, WJ; STROMBERG, K				JOHNSON, GR; PRIGENT, SA; GULLICK, WJ; STROMBERG, K			CHARACTERIZATION OF HIGH AND LOW-MOLECULAR-WEIGHT FORMS OF AMPHIREGULIN THAT DIFFER IN GLYCOSYLATION AND PEPTIDE CORE LENGTH - EVIDENCE THAT THE NH2-TERMINAL REGION IS NOT CRITICAL FOR BIOACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; ASPARAGINE-LINKED OLIGOSACCHARIDES; N-GLYCOSIDASE-F; FIBROBLAST GROWTH; CELL-SURFACE; FACTOR-ALPHA; EXTRACELLULAR-MATRIX; COLORECTAL TUMORS; OVARIAN-CARCINOMA; EPITHELIAL-CELLS	Human amphiregulin (AR) is a polypeptide growth regulator which acts by binding to and activating the epidermal growth factor (EGF) receptor tyrosine kinase. AR consists of an EGF-like domain and an NH2-terminal extension which contains potential glycosylation sites and nuclear localization signals. Two high molecular weight species which had molecular masses of approximately 16.5 kDa (HMW-AR1 and HMW-AR2) and a approximately 9.5-kDa low molecular weight form (LMW-AR) were isolated from the conditioned medium of phorbol 12-myristate 13-acetate-treated MCF-7 human breast carcinoma cells by sequential heparin affinity, immunoaffinity, and reverse phase-high performance liquid chromatography. HMW-AR1 and HMW-AR2 were found to possess complex or hybrid type N-linked oligosaccharide structures that contained sialic acid. Additionally, HMW-AR1 and HMW-AR2 contained the disaccharide, Galbeta(1-->3)GalNAc, linked to Ser/Thr residues. No carbohydrate moieties were detected in LMW-AR. Mapping of the peptide cores of these molecules using antipeptide antibodies revealed that HMW-AR1 and HMW-AR2 were intact molecules, whereas LMW-AR contained the EGF-like domain, but possessed a truncated NH2-terminal extension. LMW-AR, HMW-AR1, and HMW-AR2 were all found to be potent stimulators of DNA synthesis in MCF-10A human mammary epithelial cells. These results suggest that the NH2-terminal region of the AR molecule is not critical to the ability of AR to activate the EGF receptor tyrosine kinase.	HAMMERSMITH HOSP,IMPERIAL CANC RES FUND,ONCOL GRP,LONDON W12 0HS,ENGLAND	Cancer Research UK; Imperial College London	JOHNSON, GR (corresponding author), US FDA,DIV CYTOKINE BIOL,CELL BIOL LAB,HFM 511,BLDG 29A,8800 ROCKVILLE PIKE,BETHESDA,MD 20892, USA.							BELL GI, 1986, NUCLEIC ACIDS RES, V14, P8427, DOI 10.1093/nar/14.21.8427; BOSENBERG MW, 1992, CELL, V71, P1157, DOI 10.1016/S0092-8674(05)80064-9; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; CIARDIELLO F, 1991, P NATL ACAD SCI USA, V88, P7792, DOI 10.1073/pnas.88.17.7792; COOK PW, 1991, MOL CELL BIOL, V11, P2547, DOI 10.1128/MCB.11.5.2547; COOK PW, 1992, CANCER RES, V52, P3224; Culouscou JM, 1992, GROWTH FACTORS, V7, DOI 10.3109/08977199209046924; DELARCO JE, 1978, P NATL ACAD SCI USA, V75, P4001; DERYNCK R, 1984, CELL, V38, P287, DOI 10.1016/0092-8674(84)90550-6; ENDO Y, 1976, J BIOCHEM-TOKYO, V80, P1; FLAUMENHAFT R, 1989, J CELL PHYSIOL, V140, P75, DOI 10.1002/jcp.1041400110; GULLICK WJ, 1986, CANCER RES, V46, P285; GULLICK WJ, 1985, EMBO J, V4, P2869, DOI 10.1002/j.1460-2075.1985.tb04016.x; HASELBECK A, 1990, GLYCOCONJUGATE J, V7, P63, DOI 10.1007/BF01050403; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; JOHNSON GR, 1992, J CELL BIOL, V118, P741, DOI 10.1083/jcb.118.3.741; JOHNSON GR, 1991, BIOCHEM BIOPH RES CO, V180, P481, DOI 10.1016/S0006-291X(05)81090-3; JOHNSON GR, 1993, J BIOL CHEM, V268, P2924; KIMURA H, 1990, NATURE, V348, P257, DOI 10.1038/348257a0; Klagsbrun M, 1990, CURR OPIN CELL BIOL, V2, P857, DOI 10.1016/0955-0674(90)90084-R; KNIEP B, 1990, ANAL BIOCHEM, V188, P5, DOI 10.1016/0003-2697(90)90519-F; KOBATA A, 1979, ANAL BIOCHEM, V100, P1, DOI 10.1016/0003-2697(79)90102-7; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI SW, 1992, J CELL PHYSIOL, V153, P103, DOI 10.1002/jcp.1041530114; Modrell B, 1992, GROWTH FACTORS, V7, P305, DOI 10.3109/08977199209046413; OSHANNESSY DJ, 1987, ANAL BIOCHEM, V163, P204, DOI 10.1016/0003-2697(87)90114-X; PLOWMAN GD, 1990, MOL CELL BIOL, V10, P1969, DOI 10.1128/MCB.10.5.1969; PLUMMER TH, 1984, J BIOL CHEM, V259, P700; PRESTA M, 1989, J CELL PHYSIOL, V140, P68, DOI 10.1002/jcp.1041400109; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; SAEKI T, 1992, CANCER RES, V52, P3467; SARIOLA H, 1988, CELL, V54, P235, DOI 10.1016/0092-8674(88)90556-9; SCHACHTER H, 1980, BIOCH GLYCOPROTEINS; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; SHOYAB M, 1988, P NATL ACAD SCI USA, V85, P6528, DOI 10.1073/pnas.85.17.6528; SOULE HD, 1990, CANCER RES, V50, P6075; STROMBERG K, 1992, CANCER RES, V52, P341; STROOBANT P, 1985, CELL, V42, P383, DOI 10.1016/S0092-8674(85)80133-1; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; TEIXIDO J, 1990, J BIOL CHEM, V265, P6410; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRIMBLE RB, 1984, ANAL BIOCHEM, V141, P515, DOI 10.1016/0003-2697(84)90080-0; UMEMOTO J, 1977, J BIOL CHEM, V252, P8609; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	49	34	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					18835	18843						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360173				2022-12-27	WOS:A1993LV65900070
J	CHESSLER, SD; WALLIS, GA; BYERS, PH				CHESSLER, SD; WALLIS, GA; BYERS, PH			MUTATIONS IN THE CARBOXYL-TERMINAL PROPEPTIDE OF THE PRO-ALPHA-1(I) CHAIN OF TYPE-I COLLAGEN RESULT IN DEFECTIVE CHAIN ASSOCIATION AND PRODUCE LETHAL OSTEOGENESIS IMPERFECTA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELICAL DOMAIN; FRAMESHIFT MUTATION; PROCOLLAGEN; GENE; SUBSTITUTION; CLONING; GLYCINE; PROTEIN; CDNA; ORGANIZATION	Fibroblast cell strains from three infants with perinatal lethal osteogenesis imperfecta (OI) carry unique mutations in COL1A1 (the gene encoding the proalpha1(I) chain of type I procollagen) that impair chain association. The three mutations are: substitution of arginine for leucine at position 170 in the carboxyl-terminal propeptide, substitution of histidine for aspartic acid at position 59 of the propeptide, and a 6-base pair deletion that results in loss of 2 amino acid residues, glutamic acid and tyrosine, at positions 119 and 120 of the propeptide. In each cell strain the rate of association of the abnormal chain into molecules is slowed and formation of interchain disulfide bonds is impaired. The substitution at residue 59 alters the most highly conserved region of the propeptide and has a much greater effect on the incorporation of proalpha2(I) chains into disulfide-bonded trimers than the other two mutations. The molecules that contain the abnormal chains are extensively overmodified by post-translational modifying enzymes, yet have a normal thermal stability. These findings extend the range of lethal mutations in the type I collagen genes and help to identify regions of the carboxyl-terminal propeptide that may be important for chain-chain recognition and molecular assembly.	UNIV WASHINGTON, DEPT PATHOL, SM-30, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT MED, SEATTLE, WA 98195 USA; UNIV WASHINGTON, CTR INHERITED DIS, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle				Byers, Peter H./0000-0001-7786-7030	NIAMS NIH HHS [AR41223, AR21557] Funding Source: Medline; NIGMS NIH HHS [GM07266] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557, R01AR041223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALAKOKKO L, 1989, BIOCHEM J, V260, P509, DOI 10.1042/bj2600509; BATEMAN JF, 1989, J BIOL CHEM, V264, P10960; BERNARD M, 1988, J BIOL CHEM, V263, P17159; BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P5213, DOI 10.1021/bi00291a023; BONADIO J, 1985, J BIOL CHEM, V260, P1734; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; BYERS PH, 1990, PROTEIN FOLDING : DECIPHERING THE SECOND HALF OF THE GENETIC CODE, P241; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; CHESSLER SD, 1992, J BIOL CHEM, V267, P7751; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; COHN DH, 1988, J BIOL CHEM, V263, P14605; COLE WG, 1990, J MED GENET, V27, P545, DOI 10.1136/jmg.27.9.545; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; DEAK SB, 1985, COLLAGEN REL RES, V5, P305; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DEWET W, 1987, J BIOL CHEM, V262, P16032; DICKSON LA, 1984, P NATL ACAD SCI-BIOL, V81, P4524, DOI 10.1073/pnas.81.14.4524; DION AS, 1987, J MOL BIOL, V193, P127, DOI 10.1016/0022-2836(87)90632-2; DOEGE KJ, 1986, J BIOL CHEM, V261, P8924; ELIMA K, 1987, NUCLEIC ACIDS RES, V15, P9499, DOI 10.1093/nar/15.22.9499; Fisher L. W., 1989, CONNECT TISSUE RES, V21, P43; FISHER LW, 1987, J BIOL CHEM, V262, P13457; KIMURA T, 1989, J BIOL CHEM, V264, P13910; KOIVU J, 1987, FEBS LETT, V212, P229, DOI 10.1016/0014-5793(87)81350-9; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MESSING J, 1981, NUCLEIC ACIDS RES, V9, P309, DOI 10.1093/nar/9.2.309; MYERS JC, 1985, J BIOL CHEM, V260, P1216; PIHLAJANIEMI T, 1984, J BIOL CHEM, V259, P2941; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STARMAN BJ, 1989, J CLIN INVEST, V84, P1206, DOI 10.1172/JCI114286; SYKES B, 1985, BIOESSAYS, V3, P112, DOI 10.1002/bies.950030306; TAKAHARA K, 1991, J BIOL CHEM, V266, P13124; WALLIS GA, 1990, J BIOL CHEM, V265, P18628; WILLING MC, 1990, J CLIN INVEST, V85, P282, DOI 10.1172/JCI114424	39	69	71	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18218	18225						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349697				2022-12-27	WOS:A1993LT74300085
J	KLOEK, AP; YANG, J; MATHEWS, FS; GOLDBERG, DE				KLOEK, AP; YANG, J; MATHEWS, FS; GOLDBERG, DE			EXPRESSION, CHARACTERIZATION, AND CRYSTALLIZATION OF OXYGEN-AVID ASCARIS HEMOGLOBIN DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SUUM	The Ascaris perienteric hemoglobin is 10(4) times more oxygen-avid than mammalian hemoglobins. Inspection of its primary structure fails to explain this extraordinary association with oxygen. The Ascaris hemoglobin gene encodes a 40-kDa, two-domain globin; the two domains (D1 and D2) are 63% identical, and each is capable of binding a single heme. The native protein is an octamer. At the end of D2 is a highly charged carboxyl-terminal extension containing four direct repeats of HKEE. We have expressed the two domains separately in E. coli. Both individual domains are extremely oxygen-avid. D2, with attached COOH-terminal tail, is capable of multimerization, whereas D1 remains a monomer. Recombinant D1 readily forms diffractable, red, prismatic crystals. We conclude that: 1) the basis of the hemoglobin's oxygen avidity rests in an isolated heme pocket and does not involve inter-domain interactions and 2) multimerization is mediated through sequences in the second domain, most probably via the charged COOH-terminal tail.	WASHINGTON UNIV, SCH MED,DEPT MOLEC BIOL,BOX 8230,660 S EUCLID AVE, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT MED, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT BIOCHEM & MOLEC BIOPHYS, ST LOUIS, MO 63110 USA; JEWISH HOSP ST LOUIS, ST LOUIS, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Barnes-Jewish Hospital					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007172] Funding Source: NIH RePORTER; PHS HHS [20530] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bunn HF, 1986, HEMOGLOBIN MOL GENET; CARTER CW, 1979, J BIOL CHEM, V254, P2219; DARAWSHE S, 1987, BIOCHEM J, V242, P689, DOI 10.1042/bj2420689; DARAWSHE S, 1991, EUR J BIOCHEM, V201, P169, DOI 10.1111/j.1432-1033.1991.tb16270.x; DAVENPORT HE, 1949, PROC R SOC SER B-BIO, V136, P271, DOI 10.1098/rspb.1949.0025; DAVENPORT HE, 1949, PROC R SOC SER B-BIO, V136, P255, DOI 10.1098/rspb.1949.0024; DEBAERE I, 1992, P NATL ACAD SCI USA, V89, P4638, DOI 10.1073/pnas.89.10.4638; Dickerson R.E., 1983, HEMOGLOBIN STRUCTURE; GIBSON QH, 1965, PROC R SOC SER B-BIO, V163, P206, DOI 10.1098/rspb.1965.0067; HAMLIN R, 1985, METHOD ENZYMOL, V114, P416; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCPHERSON A, 1982, PREPARATION ANAL PRO, P96; OKAZAKI T, 1965, BIOCHIM BIOPHYS ACTA, V111, P503, DOI 10.1016/0304-4165(65)90060-7; OKAZAKI T, 1965, BIOCHIM BIOPHYS ACTA, V111, P496, DOI 10.1016/0304-4165(65)90059-0; Rossmann M. G., 1972, MOL REPLACEMENT METH; SHERMAN DR, 1992, P NATL ACAD SCI USA, V89, P11696, DOI 10.1073/pnas.89.24.11696; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; VAINSHTEIN BK, 1975, NATURE, V254, P163, DOI 10.1038/254163a0	18	39	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17669	17671						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349648				2022-12-27	WOS:A1993LT74300006
J	VANHOUTE, L; VANOERS, A; VANDEWETERING, M; DOOIJES, D; KAPTEIN, R; CLEVERS, H				VANHOUTE, L; VANOERS, A; VANDEWETERING, M; DOOIJES, D; KAPTEIN, R; CLEVERS, H			THE SEQUENCE-SPECIFIC HIGH-MOBILITY GROUP-1 BOX OF TCF-1 ADOPTS A PREDOMINANTLY ALPHA-HELICAL CONFORMATION IN SOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEX-DETERMINING REGION; DNA-BINDING PROPERTIES; TRANSCRIPTION FACTOR; HMG BOX; REGULATORY PROTEINS; SECONDARY-STRUCTURE; MINOR GROOVE; FACTOR-I; MOTIF; GENE	The High Mobility Group (HMG) 1 box is a protein motif that mediates DNA binding in a novel family of transcription-regulating proteins. Several members of this family, including the lymphoid-specific proteins TCF-1 and LEF-1 and the mammalian sex-determining factor SRY, carry a single HMG box with affinity for the minor groove of the heptamer motif AACAAAG or variations thereof. To initiate studies on the structural characteristics of the TCF-1 HMG box, we have expressed the 87-amino acid HMG box in milligram quantities in Escherichia coli and purified the soluble peptide to >95% homogeneity. The peptide bound DNA with the same specificity as the complete protein and was capable of inducing DNA bending. Circular dichroism (CD) analysis revealed the TCF-1 HMG box to adopt an approximately 60% alpha-helix/40% random coil conformation in solution. In the presence of an equimolar amount of double-stranded DNA containing the cognate motif, the CD spectrum changed significantly, implying the induction of a structural modification upon DNA/protein association.	UNIV HOSP UTRECHT,DEPT IMMUNOL,3508 GA UTRECHT,NETHERLANDS; UNIV UTRECHT,BIJVOET CTR BIOMOLEC RES,DEPT NUCL MAGNET RESONANCE SPECT,3584 CH UTRECHT,NETHERLANDS	Utrecht University; Utrecht University Medical Center; Utrecht University								BIANCHI ME, 1992, EMBO J, V11, P1055, DOI 10.1002/j.1460-2075.1992.tb05144.x; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; DEJONGH HHJ, 1990, BIOCHIM BIOPHYS ACTA, V1029, P104; DENNY P, 1992, EMBO J, V11, P3705, DOI 10.1002/j.1460-2075.1992.tb05455.x; FERRARI S, 1992, EMBO J, V11, P4497, DOI 10.1002/j.1460-2075.1992.tb05551.x; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GIESE K, 1991, GENE DEV, V5, P2567, DOI 10.1101/gad.5.12b.2567; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GILLEN MF, 1975, CAN J CHEM, V53, P2351, DOI 10.1139/v75-329; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; KELLY M, 1988, EMBO J, V7, P1537, DOI 10.1002/j.1460-2075.1988.tb02973.x; KIM J, 1989, GENE, V85, P15, DOI 10.1016/0378-1119(89)90459-9; KLUG A, 1987, TRENDS BIOCHEM SCI, V12, P464, DOI 10.1016/0968-0004(87)90231-3; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEVINE M, 1988, CELL, V55, P537, DOI 10.1016/0092-8674(88)90209-7; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NASRIN N, 1991, NATURE, V354, P317, DOI 10.1038/354317a0; NER S S, 1992, Current Biology, V2, P208, DOI 10.1016/0960-9822(92)90541-H; OOSTERWEGEL M, 1991, J EXP MED, V173, P1133, DOI 10.1084/jem.173.5.1133; OOSTERWEGEL MA, 1991, INT IMMUNOL, V3, P1189, DOI 10.1093/intimm/3.11.1189; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; STABEN C, 1990, P NATL ACAD SCI USA, V87, P4917, DOI 10.1073/pnas.87.13.4917; STARR DB, 1991, CELL, V67, P1231, DOI 10.1016/0092-8674(91)90299-E; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; TALANIAN RV, 1990, SCIENCE, V249, P769, DOI 10.1126/science.2389142; VANDEWETERING M, 1992, EMBO J, V11, P3039, DOI 10.1002/j.1460-2075.1992.tb05374.x; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656	34	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					18083	18087						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349685				2022-12-27	WOS:A1993LT74300066
J	PALCZEWSKI, K; BUCZYLKO, J; LEBIODA, L; CRABB, JW; POLANS, AS				PALCZEWSKI, K; BUCZYLKO, J; LEBIODA, L; CRABB, JW; POLANS, AS			IDENTIFICATION OF THE N-TERMINAL REGION IN RHODOPSIN KINASE INVOLVED IN ITS INTERACTION WITH RHODOPSIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; RETINALDEHYDE-BINDING PROTEIN; ADRENERGIC-RECEPTOR KINASE; ROD OUTER SEGMENTS; PHOSPHODIESTERASE ACTIVATION; CATALYTIC SUBUNIT; PHOTOEXCITED RHODOPSIN; CGMP PHOSPHODIESTERASE; CRYSTAL-STRUCTURE; DISK MEMBRANES	Upon illumination rhodopsin kinase (RK) phosphorylates the visual pigment, rhodopsin, in a reaction that is thought to terminate in part the biochemical events that follow photon absorption. In this paper, RK was studied to assign functional regions to the primary structure of the enzyme. Peptides derived from the sequence of RK were used to prepare site-specific antipeptide antibodies against: 1) the N-terminal region located between residues 17 and 34, which contains an autophosphorylation site; 2) the Lys/Arg-rich region corresponding to residues 216-237 near the catalytic domain; 3) the region located between residues 483 and 497, which encompasses the major autophosphorylation sites; and 4) the C-terminal region located between residues 539 and 556, close to the isoprenylation site of RK. Antibodies also were raised against purified RK. Application of the antibodies directed against the N-terminal domain blocks RK activity toward Rho*, but has no affect on the phosphorylation of a synthetic peptide substrate. Additionally, a significant portion of the inhibitory effect seen with an antibody directed against whole RK could be reversed by the peptide derived from the N-terminal region. We conclude that the N-terminal region of RK contains a sequence involved in the recognition of photolyzed Rho. Furthermore, the inhibition of RK activity eliminates the effect of ATP during the inactivation of cGMP phosphodiesterase, implying that RK is a necessary component of a cascade of reactions involved in the quenching of phototransduction. Light microscopic immunocytochemistry using these antibodies revealed that RK was localized to the rod and cone outer segments of human and bovine retinas.	UNIV WASHINGTON, DEPT PHARMACOL, SEATTLE, WA 98195 USA; GOOD SAMARITAN HOSP, RS DOW NEUROL SCI INST, PORTLAND, OR 97209 USA; UNIV S CAROLINA, DEPT CHEM, COLUMBIA, SC 29208 USA; W ALTON JONES CELL SCI CTR, PROT CHEM FACIL, LAKE PLACID, NY 12946 USA	University of Washington; University of Washington Seattle; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	PALCZEWSKI, K (corresponding author), UNIV WASHINGTON, DEPT OPHTHALMOL, SEATTLE, WA 98195 USA.				NATIONAL CANCER INSTITUTE [P01CA037589] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY008061, R29EY008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038639] Funding Source: NIH RePORTER; NCI NIH HHS [CA 37589] Funding Source: Medline; NEI NIH HHS [EY08061] Funding Source: Medline; NIDDK NIH HHS [DK38639] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANANT JS, 1992, J BIOL CHEM, V267, P687; ANANT JS, 1992, BIOCHEM BIOPH RES CO, V183, P468, DOI 10.1016/0006-291X(92)90505-F; BENOVIC JL, 1991, J BIOL CHEM, V266, P14939; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCZYLKO J, 1991, P NATL ACAD SCI USA, V88, P2568, DOI 10.1073/pnas.88.6.2568; CASSILL JA, 1991, P NATL ACAD SCI USA, V88, P11067, DOI 10.1073/pnas.88.24.11067; CHARLTON LA, 1992, J BIOL CHEM, V267, P8840; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; CRABB JW, 1988, J BIOL CHEM, V263, P18678; CRABB JW, 1991, J BIOL CHEM, V266, P16674; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FOWLES C, 1988, FEBS LETT, V238, P56, DOI 10.1016/0014-5793(88)80224-2; FUKADA Y, 1990, BIOCHEMISTRY-US, V29, P10102, DOI 10.1021/bi00495a013; FUKADA Y, 1990, NATURE, V346, P658, DOI 10.1038/346658a0; HAGA K, 1992, J BIOL CHEM, V267, P2222; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; HURLEY JB, 1992, J BIOENERG BIOMEMBR, V24, P219, DOI 10.1007/BF00762680; INGLESE J, 1992, J BIOL CHEM, V267, P1422; KAPLAN MW, 1993, IN PRESS METHODS NEU; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KUHN H, 1978, BIOCHEMISTRY-US, V17, P4389; KUHN H, 1984, PROG RETIN RES, V3, P1123; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGNADO L, 1992, NEURON, V8, P995, DOI 10.1016/0896-6273(92)90122-T; LEBIODA L, 1990, FEBS LETT, V266, P102, DOI 10.1016/0014-5793(90)81517-R; LIEBMAN PA, 1980, NATURE, V287, P734, DOI 10.1038/287734a0; LIEBMAN PA, 1982, METHOD ENZYMOL, V81, P532; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; LORENZ W, 1991, P NATL ACAD SCI USA, V88, P8715, DOI 10.1073/pnas.88.19.8715; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MILLER JL, 1986, BIOCHEMISTRY-US, V25, P4983, DOI 10.1021/bi00366a002; PALCZEWSKI K, 1989, BIOCHEMISTRY-US, V28, P8764, DOI 10.1021/bi00448a013; PALCZEWSKI K, 1988, J BIOL CHEM, V263, P14067; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P18649; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; PALCZEWSKI K, 1992, NEURON, V8, P117, DOI 10.1016/0896-6273(92)90113-R; PALCZEWSKI K, 1988, BIOCHEMISTRY-US, V27, P2306, DOI 10.1021/bi00407a010; PALCZEWSKI K, 1991, TRENDS BIOCHEM SCI, V16, P387, DOI 10.1016/0968-0004(91)90157-Q; PALCZEWSKI K, 1992, J BIOL CHEM, V267, P18991; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; POLANS AS, 1991, J CELL BIOL, V112, P981, DOI 10.1083/jcb.112.5.981; SACK JS, 1988, J MOL GRAPHICS, V6, P224, DOI 10.1016/S0263-7855(98)80040-4; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; SITARAMAYYA A, 1983, J BIOL CHEM, V258, P1205; SOVITZKY A, 1964, ANAL CHEM, V36, P1627; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; WALTER AE, 1986, INVEST OPHTH VIS SCI, V27, P1609; WEST KA, 1992, CURRENT RES PROTEIN, P37; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; ZUCKERMAN R, 1986, FEBS LETT, V207, P35, DOI 10.1016/0014-5793(86)80008-4	54	128	131	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1993	268	8					6004	6013						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR822	8383684				2022-12-27	WOS:A1993KR82200096
J	LOIS, AF; WEINSTEIN, M; DITTA, GS; HELINSKI, DR				LOIS, AF; WEINSTEIN, M; DITTA, GS; HELINSKI, DR			AUTOPHOSPHORYLATION AND PHOSPHATASE-ACTIVITIES OF THE OXYGEN-SENSING PROTEIN FIXL OF RHIZOBIUM-MELILOTI ARE COORDINATELY REGULATED BY OXYGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; TRANSCRIPTIONAL ACTIVATOR; AGROBACTERIUM-TUMEFACIENS; BACTERIAL CHEMOTAXIS; VIRG PROTEIN; GENES; PHOSPHORYLATION; EXPRESSION; SENSOR; KINASE	The FixL and FixJ proteins of Rhizobium meliloti control the expression of other nif and fix genes in response to oxygen levels. FixL is a hemoprotein kinase that senses oxygen availability and responds to the absence of oxygen by activation of its autophosphorylating activity followed by transfer of the phosphate to FixJ. FixJ in turn activates the nifA and fixK promoters. In vitro studies reported here with a soluble truncated version of FixL (FixL*) indicate that, while low oxygen tension specifically increases the autophosphorylating activity of FixL*, the ability of phospho-FixL* to act as a phosphate donor to FixJ is not affected by the presence or absence of oxygen. FixL* is also shown to possess a phosphatase activity that is repressed under anaerobic conditions only when the protein is in the phosphorylated form. A fixL mutant that induces a higher level of nifA promoter activity in the presence of fixJ in vivo displayed both an increased autophosphorylating activity and a decreased phosphatase activity in vitro. These data provide evidence for a role for both autophosphorylation and phosphatase activities of FixL in the mechanism by which oxygen tension within the alfalfa nodule induces expression of bacterial nitrogen fixation genes during symbiosis.	UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,CTR MOLEC GENET,LA JOLLA,CA 92093	University of California System; University of California San Diego; University of California System; University of California San Diego					PHS HHS [5 RO1 6M 44400/02] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALBRIGHT LM, 1989, ANNU REV GENET, V23, P311, DOI 10.1146/annurev.ge.23.120189.001523; APPLEBY CA, 1984, ANNU REV PLANT PHYS, V35, P443, DOI 10.1146/annurev.pp.35.060184.002303; BALDWIN TO, 1984, BIOCHEMISTRY-US, V23, P3663, DOI 10.1021/bi00311a014; BATUT J, 1989, EMBO J, V8, P1279, DOI 10.1002/j.1460-2075.1989.tb03502.x; CARTER P, 1985, NUCLEIC ACIDS RES, V13, P4431, DOI 10.1093/nar/13.12.4431; CORBIN D, 1982, J BACTERIOL, V149, P221, DOI 10.1128/JB.149.1.221-228.1982; DAVID M, 1988, CELL, V54, P671, DOI 10.1016/S0092-8674(88)80012-6; DEPHILIP P, 1990, J BACTERIOL, V172, P4255, DOI 10.1128/jb.172.8.4255-4262.1990; DITTA G, 1987, J BACTERIOL, V169, P3217, DOI 10.1128/jb.169.7.3217-3223.1987; EARL CD, 1987, J BACTERIOL, V169, P1127, DOI 10.1128/jb.169.3.1127-1136.1987; FORST S, 1989, P NATL ACAD SCI USA, V86, P6052, DOI 10.1073/pnas.86.16.6052; GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0; GUARENTE L, 1980, CELL, V20, P543, DOI 10.1016/0092-8674(80)90640-6; HESS JF, 1988, NATURE, V336, P139, DOI 10.1038/336139a0; IGO MM, 1989, GENE DEV, V3, P598, DOI 10.1101/gad.3.5.598; IGO MM, 1989, GENE DEV, V3, P1725, DOI 10.1101/gad.3.11.1725; JIN SG, 1990, J BACTERIOL, V172, P4945, DOI 10.1128/jb.172.9.4945-4950.1990; KEENER J, 1988, P NATL ACAD SCI USA, V85, P4976, DOI 10.1073/pnas.85.14.4976; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOIS AF, 1992, IN PRESS J BACTERIOL; MCMALLY DF, 1991, P NATL ACAD SCI USA, V88, P6269; MONSON EK, 1992, P NATL ACAD SCI USA, V89, P4280, DOI 10.1073/pnas.89.10.4280; Ninfa A J, 1991, Genet Eng (N Y), V13, P39; NINFA AJ, 1987, CELL, V50, P1039, DOI 10.1016/0092-8674(87)90170-X; NINFA AJ, 1986, P NATL ACAD SCI USA, V83, P5909, DOI 10.1073/pnas.83.16.5909; NINFA EG, 1991, J BIOL CHEM, V266, P9764; ROITSCH T, 1990, J BACTERIOL, V172, P6054, DOI 10.1128/jb.172.10.6054-6060.1990; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; VANDEWIEL C, 1990, EMBO J, V9, P1; Vincent JM, 1970, INT BIOL PROGRAM HDB, V15; VIRTS EL, 1988, P NATL ACAD SCI USA, V85, P3062, DOI 10.1073/pnas.85.9.3062; WEINSTEIN M, 1992, MOL MICROBIOL, V6, P2041, DOI 10.1111/j.1365-2958.1992.tb01377.x; WEISS V, 1988, P NATL ACAD SCI USA, V85, P8919, DOI 10.1073/pnas.85.23.8919; [No title captured]	34	107	108	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					4370	4375						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382700				2022-12-27	WOS:A1993KN53300081
J	YIM, MB; CHOCK, PB; STADTMAN, ER				YIM, MB; CHOCK, PB; STADTMAN, ER			ENZYME FUNCTION OF COPPER, ZINC SUPEROXIDE-DISMUTASE AS A FREE-RADICAL GENERATOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-SPIN-RESONANCE; HYDROGEN-PEROXIDE; HYDROXYL RADICALS; GLUTATHIONE-PEROXIDASE; PULSE-RADIOLYSIS; CATION RADICALS; INACTIVATION; KINETICS; PARAQUAT; TRAPS	The peroxidative activity-of Cu,Zn-containing superoxide dismutase (Cu,Zn-SOD) was studied by using a chromogen, 2,2'-azinobis-(3-ethylbenzthiazoline-6-sulfonate) (ABTS) which reacts with .OH radicals to form ABTS+., and the spin traps, N-tert-butyl-alpha-phenylnitrone (PBN) and 5,5-dimethyl-1-pyrroline N-oxide (DMPO). The formation of ABTS+. in this study required both active Cu,Zn-SOD and H2O2 and followed first order kinetics with respect to SOD and H2O2. However, it showed a binding isotherm with ABTS that yielded a dissociation constant of ABTS-enzyme as K(d) = 7.1 +/- 0.5 muM. The K(d) values for DMPO and PBN were obtained as 0.63 and 11 mM, respectively, by competition reactions. A radical scavenger, formate anion, inhibits the formation of ABTS+., whereas ethanol does not. The results together indicate that DMPO and anionic scavengers have easy access inside the positively charged active channel of Cu,Zn-SOD and are thus in a position to intercept the newly formed .OH radicals. PBN and ethanol, however, stay outside of the channel and are not able to compete with ABTS for .OH radicals. We trapped free radicals, which were produced in the presence of free radical scavengers, with PBN. The formation curve of PBN-hydroxyethyl radical adduct observed in the presence of ethanol indicated that the enzyme became inactivated in a relatively short period. In contrast, in the presence of anionic scavenger formate, formyl radicals were produced catalytically, and the enzyme activity was protected by the formate against H2O2 inactivation. Thus Cu,Zn-SOD behaves as an enzyme that catalyzes the formation of free radicals using anionic scavengers and H2O2 as substrates.			YIM, MB (corresponding author), NHLBI, BIOCHEM LAB, BLDG 3, RM 202, BETHESDA, MD 20892 USA.							[Anonymous], 1971, METHODS ENZYMOLOGY; BLECH DM, 1983, ARCH BIOCHEM BIOPHYS, V224, P579, DOI 10.1016/0003-9861(83)90245-X; BORDERS CL, 1985, ARCH BIOCHEM BIOPHYS, V241, P472, DOI 10.1016/0003-9861(85)90572-7; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; BRAY RC, 1974, BIOCHEM J, V139, P43, DOI 10.1042/bj1390043; BRITIGAN BE, 1990, J BIOL CHEM, V265, P17533; BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; CUDD A, 1982, J BIOL CHEM, V257, P1443; DAQUINO M, 1989, BIOCHEM BIOPH RES CO, V161, P1199, DOI 10.1016/0006-291X(89)91369-7; DEFREITAS DM, 1984, BIOCHEMISTRY-US, V23, P2079, DOI 10.1021/bi00304a031; EMMONS WD, 1957, J AM CHEM SOC, V79, P5739, DOI 10.1021/ja01578a043; FEE JA, 1986, J BIOL CHEM, V261, P3000; FINKELSTEIN E, 1980, J AM CHEM SOC, V102, P4994, DOI 10.1021/ja00535a029; FINKELSTEIN E, 1980, ARCH BIOCHEM BIOPHYS, V200, P1, DOI 10.1016/0003-9861(80)90323-9; GALLATI H, 1979, J CLIN CHEM CLIN BIO, V17, P1; GETZOFF ED, 1983, NATURE, V306, P287, DOI 10.1038/306287a0; GREENSTOCK CL, 1982, CAN J CHEM, V60, P1560, DOI 10.1139/v82-503; HARBOUR JR, 1974, CAN J CHEM, V52, P3549, DOI 10.1139/v74-527; HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5299, DOI 10.1021/bi00695a011; HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5294, DOI 10.1021/bi00695a010; HUNIG S, 1964, LIEBIGS ANN CHEM, V676, P32; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; JANZEN EG, 1978, CAN J CHEM, V56, P2237, DOI 10.1139/v78-368; JANZEN EG, 1971, ACCOUNTS CHEM RES, V4, P31, DOI 10.1021/ar50037a005; KELNER MJ, 1990, J BIOL CHEM, V265, P10872; KLUG D, 1972, J BIOL CHEM, V247, P4839; KOPPENOL WH, 1981, OXYGEN OXYRADICALS C, P617; KOTAKE Y, 1991, J AM CHEM SOC, V113, P9503, DOI 10.1021/ja00025a013; KRALL J, 1988, J BIOL CHEM, V263, P1910; KRALL J, 1991, ARCH BIOCHEM BIOPHYS, V286, P311, DOI 10.1016/0003-9861(91)90045-K; LOPEZ J, 1984, B CHEM SOC JPN, V57, P673, DOI 10.1246/bcsj.57.673; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MOREHOUSE KM, 1988, J BIOL CHEM, V263, P1204; MOTTLEY C, 1986, BIOCHEM BIOPH RES CO, V141, P622, DOI 10.1016/S0006-291X(86)80218-2; NETA P, 1980, J PHYS CHEM-US, V84, P532, DOI 10.1021/j100442a017; NETA P, 1988, CHEM KINETICS SMALL, P187; OKADA K, 1983, J HETEROCYCLIC CHEM, V20, P723, DOI 10.1002/jhet.5570200343; RIGO A, 1977, BIOCHEM BIOPH RES CO, V79, P776, DOI 10.1016/0006-291X(77)91179-2; RUSH JD, 1988, J AM CHEM SOC, V110, P4957, DOI 10.1021/ja00223a013; SAPRIN AN, 1977, ARCH BIOCHEM BIOPHYS, V180, P480, DOI 10.1016/0003-9861(77)90063-7; SINET PM, 1981, ARCH BIOCHEM BIOPHYS, V212, P411, DOI 10.1016/0003-9861(81)90382-9; SRIDHAR R, 1984, OXYGEN RADICALS CHEM, P101; SYMONYAN MA, 1972, FEBS LETT, V28, P22, DOI 10.1016/0014-5793(72)80667-7; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; THOMAS JK, 1965, T FARADAY SOC, V61, P702, DOI 10.1039/tf9656100702; TROUSSON P, 1985, J PHYS CHEM-US, V89, P1954, DOI 10.1021/j100256a028; TURRENS JF, 1991, FREE RADICAL RES COM, V12-3, P681, DOI 10.3109/10715769109145847; VANCAMP HL, 1982, BIOCHIM BIOPHYS ACTA, V704, P75, DOI 10.1016/0167-4838(82)90134-0; WITTENKELLER L, 1991, J AM CHEM SOC, V113, P7872, DOI 10.1021/ja00021a008; WOLFENDEN BS, 1982, J CHEM SOC PERK T 2, P805, DOI 10.1039/p29820000805; YIM MB, 1990, P NATL ACAD SCI USA, V87, P5006, DOI 10.1073/pnas.87.13.5006; YIM MB, 1990, P NATL ACAD SCI USA, V87, P394, DOI 10.1073/pnas.87.1.394; ZIPPLIES MF, 1986, J AM CHEM SOC, V108, P4433, DOI 10.1021/ja00275a033	54	225	231	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					4099	4105						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382691				2022-12-27	WOS:A1993KN53300047
J	TANAKA, H; DONG, Y; MCGUIRE, J; OKRET, S; POELLINGER, L; MAKINO, I; GUSTAFSSON, JA				TANAKA, H; DONG, Y; MCGUIRE, J; OKRET, S; POELLINGER, L; MAKINO, I; GUSTAFSSON, JA			THE GLUCOCORTICOID RECEPTOR AND A PUTATIVE REPRESSOR PROTEIN COORDINATELY MODULATE GLUCOCORTICOID RESPONSIVENESS OF THE MOUSE MAMMARY-TUMOR VIRUS PROMOTER IN THE RAT HEPATOMA-CELL LINE M1.19	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE AMINOTRANSFERASE GENE; STEROID-HORMONE RECEPTORS; TRANSCRIPTION FACTOR; DOWN-REGULATION; DNA-BINDING; NEGATIVE REGULATION; RESPONSE ELEMENTS; MAMMALIAN-CELLS; MMTV PROMOTER; C-JUN	Signal transduction by glucocorticoid hormones is mediated by the intracellular glucocorticoid receptor protein. The mechanisms determining cell type- or tissue-specific differences in hormone responsiveness remain, however, unclear. To address this issue we have used two different rat hepatoma cell tines, 762 and 6.10.2, respectively, in which mouse mammary tumor virus has been stably integrated. Nuclear extracts from both of these cell lines contained a factor that bound to a sequence motif extending from -163 to -147 in the mouse mammary tumor virus promoter and that appeared to repress hormonal induction of viral mRNA expression. Transient transfection experiments indicated that the cellular levels of this putative repressor did not affect basal promoter activity; this factor appeared rather to determine cellular sensitivity to glucocorticoids. Moreover, in these experiments the relative levels of the glucocorticoid receptor appeared to be the main determinant of maximum inducibility of virus expression by hormone. Taken together, these data indicate that the differential expression patterns of receptor versus the putative repressor protein may determine the level of hormonal responsiveness of target genes in glucocorticoid-sensitive tissues.	KAROLINSKA INST,HUDDINGE UNIV HOSP,DEPT MED NUTR,NOVUM F60,S-14186 HUDDINGE,SWEDEN	Karolinska Institutet	TANAKA, H (corresponding author), ASAHIKAWA MED COLL,DEPT INTERNAL MED 2,NISHIKAGURA-4-5-3,ASAHIKAWA 078,JAPAN.							AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; ALKSNIS M, 1991, J BIOL CHEM, V266, P10078; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; BAUMANN H, 1990, J BIOL CHEM, V265, P22275; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BOSHART M, 1991, CELL, V66, P849, DOI 10.1016/0092-8674(91)90432-X; BOSHART M, 1990, CELL, V61, P905, DOI 10.1016/0092-8674(90)90201-O; BRUGGEMEIER U, 1990, EMBO J, V9, P2233, DOI 10.1002/j.1460-2075.1990.tb07393.x; BRUGGEMEIER U, 1991, CELL, V64, P565, DOI 10.1016/0092-8674(91)90240-Y; BUGGE TH, 1992, EMBO J, V11, P1409, DOI 10.1002/j.1460-2075.1992.tb05186.x; BURNSTEIN KL, 1990, J BIOL CHEM, V265, P7284; CHATTERJEE VKK, 1991, MOL ENDOCRINOL, V5, P100, DOI 10.1210/mend-5-1-100; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORDINGLEY MG, 1987, CELL, V48, P261, DOI 10.1016/0092-8674(87)90429-6; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DONG Y, 1990, J BIOL CHEM, V265, P7526; DONG Y, 1988, MOL ENDOCRINOL, V2, P1256, DOI 10.1210/mend-2-12-1256; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FAUCI AS, 1976, ANN INTERN MED, V84, P304, DOI 10.7326/0003-4819-84-3-304; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; GLASS CK, 1990, CELL, V63, P729, DOI 10.1016/0092-8674(90)90139-6; GROVE JR, 1980, CELL, V21, P47, DOI 10.1016/0092-8674(80)90113-0; GUSTAFSSON JA, 1987, ENDOCR REV, V8, P185, DOI 10.1210/edrv-8-2-185; HOECK W, 1989, J BIOL CHEM, V264, P14396; IIDA S, 1990, J CLIN ENDOCR METAB, V70, P729, DOI 10.1210/jcem-70-3-729; JANTZEN HM, 1987, CELL, V49, P29, DOI 10.1016/0092-8674(87)90752-5; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; KONIG H, 1992, EMBO J, V11, P2241, DOI 10.1002/j.1460-2075.1992.tb05283.x; LECLERC S, 1991, J BIOL CHEM, V266, P8711; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; LUCIBELLO FC, 1990, EMBO J, V9, P2827, DOI 10.1002/j.1460-2075.1990.tb07471.x; MARKS MS, 1992, EMBO J, V11, P1419, DOI 10.1002/j.1460-2075.1992.tb05187.x; MEULIA T, 1990, J MOL BIOL, V216, P859, DOI 10.1016/S0022-2836(99)80006-0; MEYER EM, 1992, J BIOL CHEM, V267, P10882; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MULLER M, 1991, BIOCHIM BIOPHYS ACTA, V1088, P171, DOI 10.1016/0167-4781(91)90052-N; PEPIN MC, 1991, MOL CELL BIOL, V11, P1647, DOI 10.1128/MCB.11.3.1647; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; PRATT WB, 1989, CANCER RES, V49, pS2222; PTASHNE M, 1988, NATURE, V322, P656; RINGOLD GM, 1977, CELL, V10, P11, DOI 10.1016/0092-8674(77)90134-9; Sambrook J, 1989, MOL CLONING LABORATO; SASSONECORSI P, 1988, P NATL ACAD SCI USA, V85, P7192, DOI 10.1073/pnas.85.19.7192; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; STRAHLE U, 1988, EMBO J, V7, P3389, DOI 10.1002/j.1460-2075.1988.tb03212.x; TANAKA H, 1991, CLIN CHEM, V37, P1715; TANAKA H, 1991, P NATL ACAD SCI USA, V88, P5393, DOI 10.1073/pnas.88.12.5393; VANDERBILT JN, 1987, MOL ENDOCRINOL, V1, P68, DOI 10.1210/mend-1-1-68; WESTIN G, 1987, NUCLEIC ACIDS RES, V15, P6787, DOI 10.1093/nar/15.17.6787; WRANGE O, 1986, J BIOL CHEM, V261, P1770; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	57	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1854	1859						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380580				2022-12-27	WOS:A1993KH62000056
J	ALVES, C; VONDIPPE, P; AMOUI, M; LEVY, D				ALVES, C; VONDIPPE, P; AMOUI, M; LEVY, D			BILE-ACID TRANSPORT INTO HEPATOCYTE SMOOTH ENDOPLASMIC-RETICULUM VESICLES IS MEDIATED BY MICROSOMAL EPOXIDE HYDROLASE, A MEMBRANE-PROTEIN EXHIBITING 2 DISTINCT TOPOLOGICAL ORIENTATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER PLASMA-MEMBRANE; PERFUSED-RAT-LIVER; APOLIPOPROTEIN-B; CHEMICAL CARCINOGENESIS; TAUROCHOLATE TRANSPORT; TOPOGENIC SEQUENCE; GOLGI-APPARATUS; SYSTEM; TRANSLOCATION; MECHANISMS	Bile acids, such as taurocholate, have been shown to be transported into hepatocyte smooth endoplasmic reticulum (SER) vesicles. This process is Na+-independent, electrogenic, inhibitable by 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid and taurochenodeoxycholate, with a K(m) of 352 muM and a V(max) of 29.6 nmol/mg protein/min. The observed transport is mediated by the bifunctional protein, microsomal epoxide hydrolase (mEH) which can also mediate bile acid transport into hepatocytes across the sinusoidal plasma membrane (von Dippe, P., Amoui, M., Alves, C., and Levy, D. (1993) Am. J. Physiol. 264, G528-G534). mEH was isolated from SER membranes by immunoprecipitation with monoclonal antibody (mAb) 25D-1 which recognizes this protein on the surface of intact hepatocytes. The SER-derived protein exhibited an apparent molecular weight, isoelectric point, N-terminal amino acid sequence, and mEH-specific activity that were indistinguishable from the plasma membrane form of the enzyme. Proteoliposome reconstitution of the SER taurocholate transport system indicated that mEH was absolutely required for the expression of transport capacity. The interaction of mAb 25D-1 with mEH on intact right-side-out SER vesicles demonstrated that the epitope found on the surface of hepatocytes was also found on the cytoplasmic surface of these vesicles (80%) and in the lumen (20%) suggesting the presence of two forms of this protein in the SER, the latter form being sorted to the cell surface. The existence of two orientations of this protein in the SER was confirmed by the sensitivity to tryptic digestion, where 75% of the mAb epitope was accessible to the enzyme. The loss of the 25D-1 epitope correlated with loss of taurocholate transport capacity. The role of mEH in the transport process and the orientation of the transporting isoform was further established by demonstrating that mAb 25A-3, which also reacts with mEH on the hepatocyte surface, was able to directly inhibit taurocholate transport in the SER vesicle system. These and previous results thus establish that isoforms of mEH can mediate taurocholate transport at the sinusoidal plasma membrane and in SER vesicles and that this bifunctional protein can exist in two orientations in the SER membrane. The association of bile acids with the SER suggests a possible role of intracellular vesicles in the transhepatocellular movement of bile acids from the sinusoidal to the canalicular compartment.	UNIV SO CALIF,SCH MED,DEPT BIOCHEM,LOS ANGELES,CA 90033	University of Southern California					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025836] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 25836] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AARONSON NN, 1974, METHOD ENZYMOL, V31, P90; ABRAHAM EH, 1993, P NATL ACAD SCI USA, V90, P312, DOI 10.1073/pnas.90.1.312; ADACHI Y, 1991, HEPATOLOGY, V14, P655, DOI 10.1016/0270-9139(91)90053-X; ANANTHANARAYANAN M, 1988, J BIOL CHEM, V263, P8338; ARION WJ, 1976, J BIOL CHEM, V251, P4901; Bock H O, 1974, Methods Enzymol, V32, P374; BOCK KW, 1991, CRIT REV BIOCHEM MOL, V26, P129, DOI 10.3109/10409239109081125; Carey M.C., 1988, LIVER BIOL PATHOBIOL, V2nd, P573; CARIAPPA R, 1990, J BIOL CHEM, V265, P1470; CHUCK SL, 1992, CELL, V68, P9, DOI 10.1016/0092-8674(92)90202-N; CHUCK SL, 1990, NATURE, V346, P382, DOI 10.1038/346382a0; CLAIRMONT CA, 1992, J BIOL CHEM, V267, P3983; COLES B, 1990, CRIT REV BIOCHEM MOL, V25, P47, DOI 10.3109/10409239009090605; CRAWFORD JM, 1991, AM J PHYSIOL, V260, pG119, DOI 10.1152/ajpgi.1991.260.1.G119; CRAWFORD JM, 1988, J LIPID RES, V29, P141; DAVIS RA, 1990, J BIOL CHEM, V265, P10005; ERIKSSON LC, 1978, PHARMACOL THER PT A, V2, P281, DOI 10.1016/0362-5478(78)90019-0; GUENGERICH FP, 1990, CRIT REV BIOCHEM MOL, V25, P97; HAGENBUCH B, 1991, P NATL ACAD SCI USA, V88, P10629, DOI 10.1073/pnas.88.23.10629; HAUSER SC, 1988, BIOCHIM BIOPHYS ACTA, V967, P149, DOI 10.1016/0304-4165(88)90004-9; HAYAKAWA T, 1990, AM J PHYSIOL, V259, pG727, DOI 10.1152/ajpgi.1990.259.5.G727; HAYAKAWA T, 1990, GASTROENTEROLOGY, V99, P216, DOI 10.1016/0016-5085(90)91251-Z; KANG HS, 1991, J BIOL CHEM, V266, P5643; KHANG JT, 1991, J BIOL CHEM, V266, P18224; KNOWLES RG, 1977, BIOCHEM J, V163, P381, DOI 10.1042/bj1630381; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMRI Y, 1988, J CLIN INVEST, V82, P1173, DOI 10.1172/JCI113714; LEDERKREMER GZ, 1991, J BIOL CHEM, V266, P1237; LINGAPPA VR, 1991, CELL, V65, P527, DOI 10.1016/0092-8674(91)90081-9; LOPEZ CD, 1990, SCIENCE, V248, P226, DOI 10.1126/science.1970195; LOPEZ LC, 1991, J BIOL CHEM, V266, P15984; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEIER PJ, 1984, J BIOL CHEM, V259, P614; NATHANSON MH, 1991, HEPATOLOGY, V14, P551, DOI 10.1002/hep.1840140324; NISHIDA T, 1991, P NATL ACAD SCI USA, V88, P6590, DOI 10.1073/pnas.88.15.6590; PENNING TM, 1990, CARCINOGENESIS, V11, P1203, DOI 10.1093/carcin/11.7.1203; PEREZ M, 1985, J BIOL CHEM, V260, P4671; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; SIMION FA, 1984, J BIOL CHEM, V259, P814; SIMON FR, 1977, J CLIN INVEST, V59, P849, DOI 10.1172/JCI108707; SIPPEL CJ, 1993, J BIOL CHEM, V268, P2083; SKACH WR, 1993, J BIOL CHEM, V268, P6903; SMITHGALL TE, 1986, J BIOL CHEM, V261, P6184; STEIGER B, 1992, BIOCHEM J, V284, P67; STOLZ A, 1989, ANNU REV PHYSIOL, V51, P161, DOI 10.1146/annurev.ph.51.030189.001113; SUCHY FJ, 1983, AM J PHYSIOL, V245, pG681, DOI 10.1152/ajpgi.1983.245.5.G681; TAKIKAWA H, 1990, J BIOL CHEM, V265, P2132; THOMAS H, 1990, FRONTIERS BIOTRANSFO, V2, P278; TULSIANI DRP, 1982, J BIOL CHEM, V257, P3660; VALLEE RB, 1990, ANNU REV BIOCHEM, V59, P909, DOI 10.1146/annurev.biochem.59.1.909; VENSTAPEL F, 1988, J CLIN INVEST, V82, P1113; VONDIPPE P, 1993, AM J PHYSIOL, V264, pG528, DOI 10.1152/ajpgi.1993.264.3.G528; VONDIPPE P, 1990, J BIOL CHEM, V265, P14812; VONDIPPE P, 1983, J BIOL CHEM, V258, P8896; VONDIPPE P, 1983, J BIOL CHEM, V258, P8890; WADDELL ID, 1992, BIOCHEM J, V286, P173, DOI 10.1042/bj2860173; WU DF, 1992, HEPATOLOGY, V15, P515, DOI 10.1002/hep.1840150326; YEH GC, 1992, CANCER RES, V52, P6692; ZIMMERLI B, 1989, J PHARMACOL EXP THER, V250, P301	59	58	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20148	20155						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376374				2022-12-27	WOS:A1993LY01900036
J	ISHIKAWA, T; ALIOSMAN, F				ISHIKAWA, T; ALIOSMAN, F			GLUTATHIONE-ASSOCIATED CIS-DIAMMINEDICHLOROPLATINUM(II) METABOLISM AND ATP-DEPENDENT EFFLUX FROM LEUKEMIA-CELLS - MOLECULAR CHARACTERIZATION OF GLUTATHIONE-PLATINUM COMPLEX AND ITS BIOLOGICAL SIGNIFICANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN OVARIAN-CARCINOMA; INTERSTRAND CROSS-LINKING; PROTEIN-SYNTHESIS; TUMOR-CELLS; BILIARY-EXCRETION; DRUG-RESISTANT; CYTO-TOXICITY; L1210 CELLS; DNA; CISPLATIN	Accumulating evidence suggests a critical role of intracellular glutathione in tumor cell resistance to alkylating agents. The present study provides evidence for the direct interaction between cis-diamminedichloroplatinum(II) (cisplatin) and glutathione (GSH) both in a cell-free system, as well as in L1210 murine leukemia cells. We have isolated the reaction product and identified it by a combination of high performance liquid chromatography and atomic absorption spectroscopy. Stoichiometric analysis showed a 2:1 molar ratio of GSH/cisplatin for the reaction. The molecular mass assessed by mass spectroscopy was 809 Da, corresponding to a GS-platinum chelate complex, bis-(glutathionato)platinum. The GS-platinum complex was detected in L1210 leukemia cells incubated with 20 muM cisplatin. The intracellular content of the GS-platinum complex reached a maximal level after 12 h, corresponding to about 60% of the intracellular platinum content. Thus, formation of the GS-platinum complex is considered a significant part of the cellular metabolism of cisplatin. The GS-platinum was found to inhibit cell-free protein synthesis in a rabbit reticulocyte lysate system using both chloramphenicol acetyltransferase mRNA and poly(A) mRNA from HL-60 human promyelocytic leukemia cells (IC50 = 190 muM the GS-platinum complex). Elimination of the GS-platinum complex from tumor cells may represent an important mechanism which reduces the intracellular accumulation of the platinum complex. Using plasma membrane vesicles prepared from L1210 cells, the transport of the GS-platinum complex across the plasma membrane was found to be an ATP-dependent process (apparent K(m) values: 49 muM, ATP; 110 muM, GS-platinum complex). The ATP-dependent transport of the GS-platinum complex was inhibited by vanadate (IC50 = 35 muM) as well as by S-(2,4-dinitrophenyl)-glutathione, leukotriene C4, and GSSG, but not by doxorubicin, daunorubicin, or verapamil. The ATP-dependent glutathione S-conjugate export pump, ''GS-X pump'' (Ishikawa, T. (1992) Trends Biochem. Sci. 17, 463-468), is suggested to play a role in the elimination of the GS-platinum complex from tumor cells.			ISHIKAWA, T (corresponding author), UNIV TEXAS,MD ANDERSON CANC CTR,DEPT EXPTL PEDIAT,POB 169,1515 HOLCOMBE BLVD,HOUSTON,TX 77030, USA.							ALIOSMAN F, 1989, CANCER RES, V49, P5258; ALIOSMAN F, 1990, CANCER RES, V50, P6976; ALIOSMAN F, 1989, CANCER RES, V49, P5954; ANDREWS PA, 1986, MOL PHARMACOL, V30, P643; ANDREWS PA, 1988, CANCER RES, V48, P68; ARRICK BA, 1984, CANCER RES, V44, P4224; BAKKA A, 1981, TOXICOL APPL PHARM, V61, P215, DOI 10.1016/0041-008X(81)90411-7; BORCH RF, 1987, METABOLISM ACTION AN, P163; BORNSEN KO, 1990, CHIMIA, V44, P412; BRAUER SL, 1991, J AM CHEM SOC, V113, P3001, DOI 10.1021/ja00008a031; CAFFREY PB, 1992, CANCER RES, V52, P4812; COHEN GL, 1979, SCIENCE, V203, P1014, DOI 10.1126/science.370979; CROOK TR, 1986, CANCER RES, V46, P5035; DEDON PC, 1987, BIOCHEM PHARMACOL, V36, P1955, DOI 10.1016/0006-2952(87)90494-1; Dolphin D., 1990, GLUTATHIONE CHEM BIO, V3; DULIK DM, 1986, BIOCHEM PHARMACOL, V35, P3405, DOI 10.1016/0006-2952(86)90444-2; EASTMAN A, 1990, CANCER CELL-MON REV, V2, P275; EASTMAN A, 1988, BIOCHEMISTRY-US, V27, P4730, DOI 10.1021/bi00413a022; EASTMAN A, 1987, CHEM-BIOL INTERACT, V61, P241, DOI 10.1016/0009-2797(87)90004-4; EASTMAN A, 1983, BIOCHEMISTRY-US, V22, P3927, DOI 10.1021/bi00285a031; ERNST V, 1978, P NATL ACAD SCI USA, V75, P4110, DOI 10.1073/pnas.75.9.4110; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; GREGUS Z, 1986, TOXICOL APPL PHARM, V85, P24, DOI 10.1016/0041-008X(86)90384-4; GURTOO HL, 1981, CANCER RES, V41, P3584; GYURASICS A, 1991, BIOCHEM PHARMACOL, V42, P465, DOI 10.1016/0006-2952(91)90306-P; HAMILTON TC, 1985, BIOCHEM PHARMACOL, V34, P2583, DOI 10.1016/0006-2952(85)90551-9; IGWE OJ, 1986, BIOCHEM PHARMACOL, V35, P2987, DOI 10.1016/0006-2952(86)90375-8; ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V; ISHIKAWA T, 1990, TRENDS BIOCHEM SCI, V15, P219, DOI 10.1016/0968-0004(90)90032-7; ISHIKAWA T, 1989, J BIOL CHEM, V264, P17343; ISHIKAWA T, 1986, J BIOL CHEM, V261, P1576; ISHIKAWA T, 1993, IN PRESS STRUCTURE F; KAUFFMAN FC, 1987, FASEB J, V46, P2434; KOSOWER NS, 1971, BIOCHEM BIOPH RES CO, V45, P816, DOI 10.1016/0006-291X(71)90490-6; KOSOWER NS, 1972, BIOCHIM BIOPHYS ACTA, V272, P623, DOI 10.1016/0005-2787(72)90518-7; KRAKER AJ, 1988, CANCER RES, V48, P9; KUCHAN MJ, 1992, CANCER RES, V52, P1091; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MEISTER A, 1991, PHARMACOL THERAPEUT, V51, P155, DOI 10.1016/0163-7258(91)90076-X; ODENHEIMER B, 1982, INORG CHIM A-BIOINOR, V66, pL41, DOI 10.1016/S0020-1693(00)85769-2; Prestayko AW, 1980, CISPLATIN CURRENT ST; REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9; RICHON VM, 1987, CANCER RES, V47, P2056; ROBERTS JJ, 1972, NATURE, V235, P282, DOI 10.1038/235282a0; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; ROSENBERG B, 1985, CANCER, V55, P2303, DOI 10.1002/1097-0142(19850515)55:10<2303::AID-CNCR2820551002>3.0.CO;2-L; SHARMA RP, 1983, BIOCHEM PHARMACOL, V32, P2665, DOI 10.1016/0006-2952(83)90073-4; SIDDIK ZH, 1987, ANAL BIOCHEM, V163, P21, DOI 10.1016/0003-2697(87)90087-X; SIES H, 1989, GLUTATHIONE CONJUGAT; SOMFAIRELLE S, 1984, CANCER TREAT REV, V11, P43, DOI 10.1016/0305-7372(84)90042-2; SUZUKAKE K, 1982, BIOCHEM PHARMACOL, V31, P121; VERNIE LN, 1974, BIOCHEMISTRY-US, V13, P337, DOI 10.1021/bi00699a018; VERNIE LN, 1979, BIOCHEM J, V180, P213, DOI 10.1042/bj1800213; ZIEGLER DM, 1985, ANNU REV BIOCHEM, V54, P305, DOI 10.1146/annurev.bi.54.070185.001513; ZWELLING LA, 1981, CANCER RES, V41, P640	57	507	510	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20116	20125						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376370				2022-12-27	WOS:A1993LY01900032
J	LOWEY, S; WALLER, GS; TRYBUS, KM				LOWEY, S; WALLER, GS; TRYBUS, KM			FUNCTION OF SKELETAL-MUSCLE MYOSIN HEAVY AND LIGHT-CHAIN ISOFORMS BY AN IN-VITRO MOTILITY ASSAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBFRAGMENT-1 ISOENZYMES; MONOCLONAL-ANTIBODIES; ACTIN; ISOZYMES; VELOCITY; HOMODIMERS; SEQUENCE; FIBERS; FAMILY	The functional significance of the large number of myosin isoforms in skeletal muscles is poorly understood. Myosin molecules that have the same heavy chain, but differ in their essential or alkali light chains, have the same actin-activated ATPase activity. Similarly, the many heavy chain isoforms that appear during the course of muscle development do not show any significant differences in enzymatic activity. By means of an in vitro motility assay, we have measured the analogue of unloaded shortening velocity for myosin isoforms in a reconstituted actomyosin system. We find that both light and heavy chain isoforms translocate actin filaments at distinct velocities. These results support the hypothesis that myosin isoforms are the primary determinant for the range of shortening velocities adopted by a muscle in response to changing functional demands.			LOWEY, S (corresponding author), BRANDEIS UNIV, ROSENSTIEL BASIC MED SCI RES CTR, WALTHAM, MA 02254 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR017350, R01AR017350] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR17350] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BARNARD E A, 1982, Journal of Physiology (Cambridge), V331, P333, DOI 10.1113/jphysiol.1982.sp014375; CHALOVICH JM, 1984, BIOCHEMISTRY-US, V23, P4885, DOI 10.1021/bi00316a011; DECHESNE CA, 1987, J CELL BIOL, V105, P3031, DOI 10.1083/jcb.105.6.3031; FRANK G, 1974, EUR J BIOCHEM, V44, P317; GORDON DA, 1992, J MUSCLE RES CELL M, V13, P654, DOI 10.1007/BF01738255; GREASER ML, 1988, J PHYSIOL-LONDON, V406, P85, DOI 10.1113/jphysiol.1988.sp017370; KLEINBAUM DG, 1988, APPLIED REGRESSION A, P362; LOWEY S, 1991, J CELL BIOL, V113, P303, DOI 10.1083/jcb.113.2.303; LOWEY S, 1979, NATURE, V282, P522, DOI 10.1038/282522a0; LOWEY S, 1983, J MUSCLE RES CELL M, V4, P695, DOI 10.1007/BF00712161; MAITA T, 1987, P NATL ACAD SCI USA, V84, P416, DOI 10.1073/pnas.84.2.416; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MCNALLY EM, 1989, J MOL BIOL, V210, P665, DOI 10.1016/0022-2836(89)90141-1; MILLIGAN RA, 1990, NATURE, V348, P217, DOI 10.1038/348217a0; MOLINA MI, 1987, J BIOL CHEM, V262, P6478; NGUYEN HT, 1982, P NATL ACAD SCI-BIOL, V79, P5230, DOI 10.1073/pnas.79.17.5230; PASTRALANDIS SC, 1983, J MOL BIOL, V170, P403, DOI 10.1016/S0022-2836(83)80155-7; Pette D, 1990, Rev Physiol Biochem Pharmacol, V116, P1; POPE B, 1981, EUR J BIOCHEM, V117, P201; PRINCE HP, 1981, EUR J BIOCHEM, V121, P213, DOI 10.1111/j.1432-1033.1981.tb06451.x; REISER PJ, 1988, DEV BIOL, V129, P400, DOI 10.1016/0012-1606(88)90387-9; REISLER E, 1986, BIOCHEMISTRY-US, V25, P326, DOI 10.1021/bi00350a007; ROBBINS J, 1986, J BIOL CHEM, V261, P6606; SILBERSTEIN L, 1981, J MOL BIOL, V148, P153, DOI 10.1016/0022-2836(81)90510-6; SWEENEY HL, 1988, J BIOL CHEM, V263, P9034; TOYOSHIMA YY, 1987, NATURE, V328, P536, DOI 10.1038/328536a0; WAGNER PD, 1979, EUR J BIOCHEM, V99, P385, DOI 10.1111/j.1432-1033.1979.tb13267.x; WARSHAW DM, 1990, J CELL BIOL, V111, P453, DOI 10.1083/jcb.111.2.453; WHITE HD, 1982, METHOD ENZYMOL, V85, P698; WINKELMANN DA, 1983, CELL, V34, P295, DOI 10.1016/0092-8674(83)90160-5; WINKELMANN DA, 1986, J MOL BIOL, V188, P595, DOI 10.1016/S0022-2836(86)80009-2; WORK SS, 1992, ANAL BIOCHEM, V202, P275, DOI 10.1016/0003-2697(92)90106-H; [No title captured]	33	139	141	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20414	20418						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376398				2022-12-27	WOS:A1993LY01900074
J	TAKAMI, M				TAKAMI, M			CATABOLISM OF HEME MOIETY OF HEMOGLOBIN . HAPTOGLOBIN IN RAT-LIVER CELLS IN-VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE S-TRANSFERASES; BINDING; PURIFICATION; MEMBRANE	After intravenous administration of [H-3]-heme, C-14 globin]hemoglobin-haptoglobin or [Fe-59-heme]hemo-globin-haptoglobin to rats, the radioactive materials extracted from the liver homogenate or its subcellular fractions were subjected to a gel filtration column. In addition to the 82-kDa component, we found three metabolites of heme moiety of the complex in the subcellular fractions. Intact hemoglobin . haptoglobin complex with H-3, C-14, and Fe-59 radioactivities, an 82-kDa component with H-3, C-14, and Fe-59 radioactivities, a 40-kDa component with H-3 and Fe-59 radioactivities, a lower molecular weight component with H-3 and Fe-59 radioactivities, and a component with H-3 and Fe-59 radioactivities bound to the microsome, which are referred to as peaks A, B, C, D, and E, respectively. Using a differential centrifugation technique, most of peak B was found in the mitochondria-lysosomal fraction. Peaks C and D were in the 82,500 x g supernatant fraction, while peak D was also found in the mitochondria-lysosomal fraction. The molecular weight of peak C was approximately 40 kDa, and the H-3 radioactivity of peak C was eluted at the same fraction as glutathione S-transferases using both gel filtration and ion exchange chromatography. Peak E that was solubilized from the microsomes was found at the microsomal heme protein fraction on gel filtration chromatogram. Some of the H-3 radioactivity in the microsomes was partially co-purified with cytochrome b5 fraction. These results indicate that there are at least four metabolites of heme moiety of hemoglobin . haptoglobin complex in rat liver cells during its catabolism and suggest that some of the heme derived from catabolized hemoglobin . haptoglobin complex binds to glutathione S-transferases in the cytosol and is incorporated into apoheme proteins in the microsomes or at least apocytochrome b5.	TOKYO MED & DENT UNIV, INST MED RES, DEPT BIOCHEM GENET, TOKYO 113, JAPAN	Tokyo Medical & Dental University (TMDU)								ALIN P, 1985, ANAL BIOCHEM, V146, P313, DOI 10.1016/0003-2697(85)90545-7; BOYER TD, 1983, BIOCHEM PHARMACOL, V32, P29, DOI 10.1016/0006-2952(83)90647-0; DAVIES DM, 1982, BIOCHEM J, V202, P211, DOI 10.1042/bj2020211; Drabkin DL, 1935, J BIOL CHEM, V112, P51; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HAMAGUCHI H, 1969, AM J HUM GENET, V21, P440; HARVEY JW, 1982, BLOOD, V60, P1227; HIGA Y, 1981, J BIOL CHEM, V256, P2322; KETTERER B, 1976, BIOCHIM BIOPHYS ACTA, V428, P683, DOI 10.1016/0304-4165(76)90198-7; KETTERER B, 1988, GLUTATHIONE CONJUGAT, P94; KINO K, 1980, J BIOL CHEM, V255, P9616; KINO K, 1982, J BIOL CHEM, V257, P4828; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAINES MD, 1977, BIOCHEMISTRY-US, V16, P419, DOI 10.1021/bi00622a012; OMURA T, 1964, J BIOL CHEM, V239, P2370; OMURA T, 1970, J BIOCHEM-TOKYO, V67, P249, DOI 10.1093/oxfordjournals.jbchem.a129248; OSHIRO S, 1988, J BIOL CHEM, V263, P16032; SAWANT PL, 1964, BIOCHIM BIOPHYS ACTA, V85, P82, DOI 10.1016/0926-6569(64)90169-5; SEKI K, 1979, P JPN ACAD B-PHYS, V55, P502, DOI 10.2183/pjab.55.502; SENIO M, 1985, J BIOL CHEM, V260, P9191; SMITH KM, 1975, PORPHYRINS METALLOPO, P832; STEIN S, 1971, J BIOL CHEM, V246, P5287; TIPPING E, 1976, BIOCHEM J, V157, P461, DOI 10.1042/bj1570461; VANDERJAGT DL, 1985, J BIOL CHEM, V260, P1603; ZILBER IK, 1989, J CELL BIOCHEM, V41, P113	25	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1993	268	27					20335	20342						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LY019	8376392				2022-12-27	WOS:A1993LY01900063
J	BENOVIC, JL; GOMEZ, J				BENOVIC, JL; GOMEZ, J			MOLECULAR-CLONING AND EXPRESSION OF GRK6 - A NEW MEMBER OF THE G-PROTEIN-COUPLED RECEPTOR KINASE FAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-DEPENDENT PHOSPHORYLATION; CHROMOSOMAL LOCALIZATION; RHODOPSIN KINASE; AGONIST; DESENSITIZATION; TRANSLOCATION; IDENTIFICATION; PURIFICATION; INHIBITORS; SITES	G protein-coupled receptor kinases (GRK), such as the beta-adrenergic receptor kinase (betaARK) and rhodopsin kinase, specifically phosphorylate the activated form of G protein-coupled receptors. To identify additional members of the GRK family, we screened a human heart cDNA library by low stringency hybridization using the catalytic domains of two betaARK isoforms. Here we report the isolation of a cDNA that encodes a 576-amino-acid protein kinase, termed GRK6, that has significant homology with GRK5 (70.1% amino acid identity), IT11 (68.5%), rhodopsin kinase (47.1%), and betaARK (37.4%). RNA blot analysis of GRK6 with selected human tissues reveals two distinct mRNAs of 3 and 2.4 kilobases with a distribution very similar to that of betaARK (i.e. brain, skeletal muscle > pancreas > heart, lung, kidney, placenta > liver). GRK6, overexpressed in Sf9 insect cells using the baculovirus system, was able to phosphorylate both the beta2-adrenergic receptor and rhodopsin in a stimulus-dependent fashion, although it was significantly less active then betaARK on these substrates. These data extend the family of GRKs and suggest that GRK6 may have a substrate specificity quite distinct from betaARK and rhodopsin kinase.			BENOVIC, JL (corresponding author), THOMAS JEFFERSON UNIV, JEFFERSON CANC INST, DEPT PHARMACOL, 233 S 10TH ST, PHILADELPHIA, PA 19107 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044944] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL45964] Funding Source: Medline; NIGMS NIH HHS [GM44944] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambrose Christine, 1992, Human Molecular Genetics, V1, P697, DOI 10.1093/hmg/1.9.697; BENOVIC JL, 1991, J BIOL CHEM, V266, P14939; BENOVIC JL, 1987, J BIOL CHEM, V262, P9026; BENOVIC JL, 1991, FEBS LETT, V283, P122, DOI 10.1016/0014-5793(91)80568-N; BENOVIC JL, 1987, J BIOL CHEM, V262, P17251; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; CASSILL JA, 1991, P NATL ACAD SCI USA, V88, P11067, DOI 10.1073/pnas.88.24.11067; CHUANG TT, 1992, J BIOL CHEM, V267, P6886; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; GOMEZ J, 1992, MOL BIOL RECEPTORS T, P1; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HARGRAVE PA, 1992, MOL BIOL RECEPTORS T, P49; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; INGLESE J, 1992, J BIOL CHEM, V267, P1422; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; KIM CM, 1993, IN PRESS RECEPTOR; KOZAK M, 1983, MICROBIOL REV, V47, P1; KUHN H, 1973, BIOCHEMISTRY-US, V12, P2495; KUNAPULI P, 1993, P NATL ACAD SCI USA, V90, P5588, DOI 10.1073/pnas.90.12.5588; KWATRA MM, 1993, J BIOL CHEM, V268, P9161; KWATRA MM, 1989, BIOCHEMISTRY-US, V28, P4543, DOI 10.1021/bi00437a005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIGGETT SB, 1992, J BIOL CHEM, V267, P4740; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; LORENZ W, 1991, P NATL ACAD SCI USA, V88, P8715, DOI 10.1073/pnas.88.19.8715; MAYOR F, 1987, J BIOL CHEM, V262, P6468; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; PALCZEWSKI K, 1993, J BIOL CHEM, V268, P6004; PALCZEWSKI K, 1991, TRENDS BIOCHEM SCI, V16, P387, DOI 10.1016/0968-0004(91)90157-Q; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; RICHARDSON RM, 1993, J BIOL CHEM, V268, P13650; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLEICHER S, 1993, P NATL ACAD SCI USA, V90, P1420, DOI 10.1073/pnas.90.4.1420; SHICHI H, 1978, J BIOL CHEM, V253, P7040; STRASSER RH, 1986, P NATL ACAD SCI USA, V83, P6362, DOI 10.1073/pnas.83.17.6362; SUMMERS MD, 1987, TEXAS AGR EXPT STATI, V1555, P1; WARTELL RM, 1980, GENE, V9, P307, DOI 10.1016/0378-1119(90)90329-P; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; YAMAMOTO K, 1983, BIOPHYS STRUCT MECH, V9, P259, DOI 10.1007/BF00535661	43	124	133	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19521	19527						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366096				2022-12-27	WOS:A1993LW81900058
J	MONERA, OD; ZHOU, NE; KAY, CM; HODGES, RS				MONERA, OD; ZHOU, NE; KAY, CM; HODGES, RS			COMPARISON OF ANTIPARALLEL AND PARALLEL 2-STRANDED ALPHA-HELICAL COILED-COILS - DESIGN, SYNTHESIS, AND CHARACTERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE ZIPPER; MODEL PROTEINS; TROPOMYOSIN; STABILITY; SEQUENCES; REGISTER; DOMAIN; CHAINS; FOS; JUN	An antiparallel coiled-coil has been designed and characterized as a model for studying protein folding and assembly. This heterostranded antiparallel coiled-coil was formed by an interchain disulfide bond between cysteine residues at position 2 of one chain and at position 33 of the other chain. Each peptide chain has 35 residues which are composed of five heptad repeats of the sequence K-L-E-A-L-E-G with a single Leu --> Ala substitution at position 16. Two homostranded parallel coiled-coils were also formed as co-products of the oxidation reaction to form the interchain disulfide bond. The CD spectra of the parallel and antiparallel peptides were very similar and their high molar ellipticities at 220 nm did not increase in the presence of 50% trifluoroethanol. These data suggest that, like the parallel peptides, the antiparallel peptide also exists in a coiled-coil structure. Urea and guanidine hydrochloride denaturation studies, in conjunction with molecular modeling studies, suggest that there are no physical restrictions to the packing of hydrophobic residues in an antiparallel coiled-coil. However, interchain electrostatic interactions can have positive or negative contributions to the overall stability of the disulfide-bridged coiled-coil. In addition, interchain electrostatic interactions appear to play a major role in protein folding by controlling the parallel or antiparallel alignment of the alpha-helical polypeptide chains. This study is also for the first time providing us with a new understanding of the information that can be obtained from urea and guanidine hydrochloride denaturation studies of proteins concerning the contributions of hydrophobic and electrostatic interactions on stability.	UNIV ALBERTA,DEPT BIOCHEM,EDMONTON T6G 2G7,ALBERTA,CANADA; UNIV ALBERTA,PROT ENGN NETWORK CTR EXCELLENCE,EDMONTON T6G 2G7,ALBERTA,CANADA	University of Alberta; University of Alberta								BANNER DW, 1987, J MOL BIOL, V196, P657, DOI 10.1016/0022-2836(87)90039-8; BOWIE JU, 1989, BIOCHEMISTRY-US, V28, P7139, DOI 10.1021/bi00444a001; CASPAR DLD, 1969, J MOL BIOL, V41, P87, DOI 10.1016/0022-2836(69)90128-4; CHAKERIAN AE, 1991, J BIOL CHEM, V266, P1371; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P293; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; DEFRANCESCO R, 1991, BIOCHEMISTRY-US, V30, P143, DOI 10.1021/bi00215a021; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; GREENE RF, 1974, J BIOL CHEM, V249, P5388; HODGES R S, 1990, Peptide Research, V3, P123; HODGES R S, 1988, Peptide Research, V1, P19; Hodges R. S., 1972, COLD SPRING HARB SYM, V37, P299; HODGES RS, 1981, J BIOL CHEM, V256, P1214; HU JC, 1990, SCIENCE, V250, P1400, DOI 10.1126/science.2147779; JOHNSON P, 1975, BIOCHEM BIOPH RES CO, V64, P1316, DOI 10.1016/0006-291X(75)90836-0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LAU SYM, 1984, J BIOL CHEM, V259, P3253; LEHRER SS, 1975, P NATL ACAD SCI USA, V72, P3377, DOI 10.1073/pnas.72.9.3377; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872; PARRY DAD, 1981, J MOL BIOL, V153, P459, DOI 10.1016/0022-2836(81)90290-4; PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7; REDDY BA, 1992, TRENDS BIOCHEM SCI, V17, P344, DOI 10.1016/0968-0004(92)90308-V; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; SODEK J, 1972, P NATL ACAD SCI USA, V69, P3800, DOI 10.1073/pnas.69.12.3800; STEWART M, 1975, FEBS LETT, V53, P5, DOI 10.1016/0014-5793(75)80668-5; STONE D, 1975, 9 P FEBS M BUD, V31, P125; ZHOU NE, 1992, BIOPOLYMERS, V32, P419, DOI 10.1002/bip.360320419; ZHOU NE, 1992, J BIOL CHEM, V267, P2664; ZHOU NE, 1993, BIOCHEMISTRY-US, V32, P3178, DOI 10.1021/bi00063a033; ZHOU NE, 1992, BIOCHEMISTRY-US, V31, P5739, DOI 10.1021/bi00140a008; ZHU BY, 1993, PROTEIN SCI, V2, P383; ZHU BY, 1992, INT J PEPT PROT RES, V40, P171	37	174	179	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1993	268	26					19218	19227						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LW819	8366074				2022-12-27	WOS:A1993LW81900014
J	KARNE, S; JAYAWICKREME, CK; LERNER, MR				KARNE, S; JAYAWICKREME, CK; LERNER, MR			CLONING AND CHARACTERIZATION OF AN ENDOTHELIN-3 SPECIFIC RECEPTOR (ET(C) RECEPTOR) FROM XENOPUS-LAEVIS DERMAL MELANOPHORES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; PROTEIN-COUPLED RECEPTORS; VASCULAR SMOOTH-MUSCLE; SIGNAL TRANSDUCTION; PHOSPHOLIPASE-C; NA+/H+ EXCHANGE; LIGAND-BINDING; CELLS; EXPRESSION; RAT	We report here the presence of a receptor specific for endothelin-3 (termed ET(C) receptor or ET(C)R) on Xenopus laevis dermal melanophores. Activation of ET(C)R causes the dispersion of the pigment granules within the melanophores. The EC50 for ET-3 to induce the pigment dispersion is 24 +/- 7 nm, compared to greater than 10 muM for both ET-1 and -2. This effect desensitizes in a manner that is dependent on both time and the concentration of ET-3 used to stimulate the cells. A cDNA encoding for ET(C)R was isolated by a polymerase chain reaction-mediated DNA amplification strategy using degenerate oligonucleotides prepared based on conserved regions of other known G-protein-coupled receptor sequences and by the subsequent screening of a frog melanophore cDNA library. The cloned cDNA consists of 2,240 nucleotides, with an open reading frame coding for 444 amino acids containing an initial 20-amino acid signal sequence. The predicted mature peptide consists of 424 amino acids with a heptahelical structure common to the G-protein-coupled receptor surperfamily. Its deduced amino acid sequence is 47 and 52% identical to ET(A) and ET(B) receptors, respectively, while ET(A) and ET(B) are 48% identical to each other. Expression of cDNA in HeLa cells, which do not contain endothelin receptors, enables the cells to specifically bind [I-125]ET-3. Competition binding experiments performed on HeLa cells transiently expressing pET(C) show that the apparent K(i) values for ET-3 and ET-1 to displace [I-125]ET-3 are 45.5 +/- 16 and 114 +/- 22 nM, respectively.	YALE UNIV,SCH MED,INTERDEPARTMENTAL NEUROSCI PROGRAM,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT INTERNAL MED,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06510	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University								ADACHI M, 1991, BIOCHEM BIOPH RES CO, V180, P1265, DOI 10.1016/S0006-291X(05)81332-4; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; ARAMORI I, 1992, J BIOL CHEM, V267, P12468; AUMELAS A, 1991, NEUROCHEM INT, V18, P471, DOI 10.1016/0197-0186(91)90141-Y; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DANIOLOS A, 1990, PIGM CELL RES, V3, P38, DOI 10.1111/j.1600-0749.1990.tb00260.x; DIXON RAF, 1987, EMBO J, V6, P3269, DOI 10.1002/j.1460-2075.1987.tb02645.x; EMORI T, 1991, BIOCHEM BIOPH RES CO, V174, P228, DOI 10.1016/0006-291X(91)90510-E; GRAMINSKI GF, 1993, J BIOL CHEM, V268, P5957; HAUSDORFF WP, 1990, J BIOL CHEM, V265, P1388; HIGHSMITH RF, 1992, ANNU REV PHYSIOL, V54, P257, DOI 10.1146/annurev.ph.54.030192.001353; HUANG RRC, 1992, BIOCHEM BIOPH RES CO, V184, P966, DOI 10.1016/0006-291X(92)90685-E; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; IHARA M, 1991, BIOCHEM BIOPH RES CO, V178, P132, DOI 10.1016/0006-291X(91)91789-F; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KOBILKA B, 1992, ANNU REV NEUROSCI, V15, P87, DOI 10.1146/annurev.ne.15.030192.000511; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; LEFKOWITZ RJ, 1988, ADV SEC MESS PHOSPH, V21, P1; LIBERT F, 1989, SCIENCE, V244, P569, DOI 10.1126/science.2541503; MILLS RG, 1992, BIOCHEMISTRY-US, V31, P5640, DOI 10.1021/bi00139a030; NAGAYAMA Y, 1991, P NATL ACAD SCI USA, V88, P902, DOI 10.1073/pnas.88.3.902; NAKAJIMA K, 1989, BIOCHEM BIOPH RES CO, V163, P424, DOI 10.1016/0006-291X(89)92153-0; NAKAKI T, 1989, BIOCHEM BIOPH RES CO, V158, P880, DOI 10.1016/0006-291X(89)92804-0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; POTENZA MN, 1992, ANAL BIOCHEM, V206, P315, DOI 10.1016/0003-2697(92)90372-E; POTENZA MN, 1991, PIGM CELL RES, V4, P186, DOI 10.1111/j.1600-0749.1991.tb00437.x; RANDALL MD, 1989, BRIT J PHARMACOL, V98, P685, DOI 10.1111/j.1476-5381.1989.tb12644.x; SAEKI T, 1991, BIOCHEM BIOPH RES CO, V179, P286, DOI 10.1016/0006-291X(91)91367-L; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SAKURAI T, 1992, TRENDS PHARMACOL SCI, V13, P103; Sambrook J, 1989, MOL CLONING LABORATO; SAMSON WK, 1991, ENDOCRINOLOGY, V128, P1465, DOI 10.1210/endo-128-3-1465; SAMSON WK, 1990, BIOCHEM BIOPH RES CO, V169, P737, DOI 10.1016/0006-291X(90)90393-2; SIMONSON MS, 1989, J CLIN INVEST, V83, P708, DOI 10.1172/JCI113935; STRADER CD, 1987, J BIOL CHEM, V262, P16439; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; VIGNE P, 1991, J BIOL CHEM, V266, P5925; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WARNER TD, 1989, EUR J PHARMACOL, V159, P325, DOI 10.1016/0014-2999(89)90167-2; YADA Y, 1991, J BIOL CHEM, V266, P18352; YANAGISAWA M, 1989, TRENDS PHARMACOL SCI, V10, P374	45	374	382	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1993	268	25					19126	19133						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LV659	8360195				2022-12-27	WOS:A1993LV65900110
J	RATH, P; MARTI, T; SONAR, S; KHORANA, HG; ROTHSCHILD, KJ				RATH, P; MARTI, T; SONAR, S; KHORANA, HG; ROTHSCHILD, KJ			HYDROGEN-BONDING INTERACTIONS WITH THE SCHIFF-BASE OF BACTERIORHODOPSIN - RESONANCE RAMAN-SPECTROSCOPY OF THE MUTANTS D85N AND D85A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FTIR DIFFERENCE SPECTROSCOPY; SOLID-STATE C-13; SENSORY RHODOPSIN-I; POINT-CHARGE MODEL; RETINAL CHROMOPHORE; VISUAL PIGMENTS; PROTON TRANSLOCATION; PURPLE MEMBRANE; ADAPTED BACTERIORHODOPSIN; VIBRATIONAL SPECTROSCOPY	The bacteriorhodopsin (bR) mutants Asp-85 --> Asn (D85N) and Asp-85 --> Ala (D85A) have a red-shifted chromophore absorption and exhibit no proton pumping (Otto, H., Marti, T., Holz, M., Mogi, T., Stern, L., Engel, F., Khorana, H. G., and Heyn, M. P. (1990) Proc. Natl. Acad. Sci. U.S.A. 87, 1018-1022) consistent with the hypothesis that Asp-85 functions as a counterion and proton acceptor for the retinal Schiff base (Braiman, M. S., Mogi, T., Marti, T., Stern, L. J., Khorana, H. G., and Rothschild, K. J. (1988) Biochemistry 27, 8516-8520). Resonance Raman spectroscopy reveals that these mutants contain a mixture of all-trans and 13-cis/C=N syn chromophores, similar to dark-adapted purple membrane and acid-induced or deionized blue membrane. At high NaCl concentrations, both mutants adopt a predominantly all-trans chromophore structure similar to acid purple membrane. A comparison of the Schiff base C=NH+ stretch frequency (nu(C=N)) and deuterium isotope shift for D85N, D85A as well as various forms of bR, including light-adapted bR, blue membrane, and acid purple membrane, provides information about hydrogen bonding interactions to the Schiff base. D85N has as strong a hydrogen bond as light-adapted bR despite the loss of the negative charge at residue 85. In contrast, D85A has a weaker hydrogen bond. These results can be explained if a direct interaction exists between the Schiff base and Asn-85 in D85N and between the Schiff base and a substituted water molecule in D85A. Many of the properties of wild type bR, D85N, D85A, blue membrane, and acid purple membrane can be explained on the basis of changes in the local hydrogen bonding near the Schiff base.	BOSTON UNIV, DEPT PHYS, BOSTON, MA 02215 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA; BOSTON UNIV, PROGRAM CELLULAR BIOPHYS, BOSTON, MA 02215 USA; MIT, DEPT CHEM, CAMBRIDGE, MA 02139 USA	Boston University; Massachusetts Institute of Technology (MIT); Boston University; Massachusetts Institute of Technology (MIT)			Rothschild, Kenneth/P-6177-2018	Rothschild, Kenneth/0000-0002-2847-6671	NIAID NIH HHS [AI11479] Funding Source: Medline; NIGMS NIH HHS [GM28289] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI011479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028289, R37GM028289] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBECK A, 1992, J AM CHEM SOC, V114, P2400, DOI 10.1021/ja00033a015; ALSHUTH T, 1986, PHOTOCHEM PHOTOBIOL, V43, P55, DOI 10.1111/j.1751-1097.1986.tb05591.x; ALSHUTH T, 1985, FEBS LETT, V179, P55, DOI 10.1016/0014-5793(85)80190-3; ATON B, 1979, BIOCHIM BIOPHYS ACTA, V576, P424, DOI 10.1016/0005-2795(79)90417-3; ATON B, 1977, BIOCHEMISTRY-US, V16, P2995, DOI 10.1021/bi00632a029; ATON B, 1980, BIOPHYS J, V29, P79, DOI 10.1016/S0006-3495(80)85119-8; BAASOV T, 1987, BIOCHEMISTRY-US, V26, P3210, DOI 10.1021/bi00385a041; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; BARRY B, 1987, BIOCHEMISTRY-US, V26, P59, DOI 10.1021/bi00375a009; BIRGE RR, 1990, J CHEM PHYS, V92, P7179; BIRGE RR, 1990, BIOCHIM BIOPHYS ACTA, V1016, P293, DOI 10.1016/0005-2728(90)90163-X; BOUSCHE O, 1991, BIOCHEMISTRY-US, V30, P5395, DOI 10.1021/bi00236a010; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; CALLENDER R, 1977, ANNU REV BIOPHYS BIO, V6, P33, DOI 10.1146/annurev.bb.06.060177.000341; CALLENDER RH, 1976, BIOCHEMISTRY-US, V15, P1621, DOI 10.1021/bi00653a005; DEGROOT HJM, 1990, BIOCHEMISTRY-US, V29, P6873, DOI 10.1021/bi00481a017; DEGROOT HJM, 1989, BIOCHEMISTRY-US, V28, P3346, DOI 10.1021/bi00434a033; DENG H, 1987, BIOCHEMISTRY-US, V26, P7418, DOI 10.1021/bi00397a033; DILLER R, 1987, FEBS LETT, V217, P297, DOI 10.1016/0014-5793(87)80682-8; DOUKAS AG, 1981, BIOPHYS J, V33, P275, DOI 10.1016/S0006-3495(81)84889-8; EHRENBERG B, 1980, BIOCHIM BIOPHYS ACTA, V593, P454, DOI 10.1016/0005-2728(80)90080-8; FAHMY K, 1990, PHOTOCHEM PHOTOBIOL, V51, P459, DOI 10.1111/j.1751-1097.1990.tb01737.x; FODOR SPA, 1989, J BIOL CHEM, V264, P18280; GERWERT K, 1986, EMBO J, V5, P805, DOI 10.1002/j.1460-2075.1986.tb04285.x; GILSON HSR, 1988, BIOPHYS J, V53, P261, DOI 10.1016/S0006-3495(88)83087-X; HACKETT NR, 1987, J BIOL CHEM, V262, P9277; HARBISON GS, 1988, J AM CHEM SOC, V110, P7221, DOI 10.1021/ja00229a051; HARBISON GS, 1985, BIOCHEMISTRY-US, V24, P6955, DOI 10.1021/bi00345a031; HE YW, 1993, BIOCHEMISTRY-US, V32, P2282, DOI 10.1021/bi00060a021; HEYDE ME, 1971, J AM CHEM SOC, V93, P6776, DOI 10.1021/ja00754a012; HILDEBRANDT P, 1984, BIOCHEMISTRY-US, V23, P5539, DOI 10.1021/bi00318a025; HONIG B, 1979, J AM CHEM SOC, V101, P7084, DOI 10.1021/ja00517a060; HONIG B, 1979, P NATL ACAD SCI USA, V76, P2503, DOI 10.1073/pnas.76.6.2503; IPPOLITO JA, 1990, J MOL BIOL, V215, P457, DOI 10.1016/S0022-2836(05)80364-X; KAKITANI H, 1983, J PHYS CHEM-US, V87, P3620, DOI 10.1021/j100242a011; LIN SW, 1991, PHOTOCHEM PHOTOBIOL, V53, P341, DOI 10.1111/j.1751-1097.1991.tb03638.x; LUGTENBURG J, 1986, J AM CHEM SOC, V108, P3104, DOI 10.1021/ja00271a050; MAEDA A, 1985, BIOCHEMISTRY-US, V24, P2517, DOI 10.1021/bi00331a018; MARCUS MA, 1978, BIOCHEMISTRY-US, V17, P4722, DOI 10.1021/bi00615a019; MARTI T, 1991, J BIOL CHEM, V266, P6919; MARTI T, 1992, J BIOL CHEM, V267, P16922; MARTI T, 1991, J BIOL CHEM, V266, P18674; MASSIG G, 1985, CAN J CHEM, V63, P2012, DOI 10.1139/v85-333; MASSIG G, 1982, J RAMAN SPECTROSC, V12, P287, DOI 10.1002/jrs.1250120317; MATHEW MK, 1986, BIOPHYS J, V49, pA211; MATHIES R, 1982, METHOD ENZYMOL, V88, P633; MATHIES R, 1976, P NATL ACAD SCI USA, V73, P1, DOI 10.1073/pnas.73.1.1; MATHIES RA, 1991, ANNU REV BIOPHYS BIO, V20, P491, DOI 10.1146/annurev.bb.20.060191.002423; MOGI T, 1988, P NATL ACAD SCI USA, V85, P4148, DOI 10.1073/pnas.85.12.4148; NAKANISHI K, 1980, J AM CHEM SOC, V102, P7945, DOI 10.1021/ja00547a028; NEEDLEMAN R, 1991, J BIOL CHEM, V266, P11478; OHNO K, 1977, BIOCHIM BIOPHYS ACTA, V462, P575, DOI 10.1016/0005-2728(77)90102-5; OTTO H, 1990, P NATL ACAD SCI USA, V87, P1018, DOI 10.1073/pnas.87.3.1018; OTTOLENGHI M, 1989, J MEMBRANE BIOL, V112, P193, DOI 10.1007/BF01870951; PANDE C, 1985, PHOTOCHEM PHOTOBIOL, V42, P549, DOI 10.1111/j.1751-1097.1985.tb01608.x; PANDE C, 1989, BIOPHYS J, V55, P425, DOI 10.1016/S0006-3495(89)82836-X; RATH P, 1990, BIOPHYS J, V57, pA362; RATH P, 1993, BIOCHEMISTRY-US, V32, P2272, DOI 10.1021/bi00060a020; RATH P, 1992, BIOPHYS J, V61, pA533; ROTHSCHILD KJ, 1984, BIOCHEMISTRY-US, V23, P6103, DOI 10.1021/bi00320a031; ROTHSCHILD KJ, 1992, J BIOENERG BIOMEMBR, V24, P147, DOI 10.1007/BF00762674; ROTHSCHILD KJ, 1990, J BIOL CHEM, V265, P16985; SMITH SO, 1987, J PHYS CHEM-US, V91, P804, DOI 10.1021/j100288a011; SMITH SO, 1984, P NATL ACAD SCI-BIOL, V81, P2055, DOI 10.1073/pnas.81.7.2055; SMITH SO, 1986, P NATL ACAD SCI USA, V83, P967, DOI 10.1073/pnas.83.4.967; SMITH SO, 1985, J MEMBRANE BIOL, V85, P95, DOI 10.1007/BF01871263; SMITH SO, 1987, J AM CHEM SOC, V109, P3108, DOI 10.1021/ja00244a038; SMITH SO, 1984, J BIOL CHEM, V259, P2326; SMITH SO, 1983, BIOCHEMISTRY-US, V22, P6141, DOI 10.1021/bi00295a016; SMITH SO, 1985, BIOPHYS J, V47, P251, DOI 10.1016/S0006-3495(85)83899-6; SMITH SO, 1989, BIOCHEMISTRY-US, V28, P237, DOI 10.1021/bi00427a033; SONAR S, 1993, BIOCHEMISTRY-US, V32, P2263, DOI 10.1021/bi00060a019; SPUDICH JL, 1986, BIOPHYS J, V49, P479, DOI 10.1016/S0006-3495(86)83657-8; STERN LJ, 1989, BIOCHEMISTRY-US, V28, P10035, DOI 10.1021/bi00452a023; STOCKBURGER M, 1979, BIOCHEMISTRY-US, V18, P4886, DOI 10.1021/bi00589a017; SUBRAMANIAM S, 1990, P NATL ACAD SCI USA, V87, P1013, DOI 10.1073/pnas.87.3.1013; TERNER J, 1979, BIOPHYS J, V26, P527, DOI 10.1016/S0006-3495(79)85269-8; THORGEIRSSON TE, 1991, BIOCHEMISTRY-US, V30, P9133, DOI 10.1021/bi00102a003; Tittor J, 1991, CURR OPIN STRUC BIOL, V1, P534, DOI 10.1016/S0959-440X(05)80074-0; VANDERSTEEN R, 1986, J AM CHEM SOC, V108, P6410, DOI 10.1021/ja00280a060	82	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1993	268	24					17742	17749						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LT743	8349659				2022-12-27	WOS:A1993LT74300019
J	FULOP, C; WALCZ, E; VALYON, M; GLANT, TT				FULOP, C; WALCZ, E; VALYON, M; GLANT, TT			EXPRESSION OF ALTERNATIVELY SPLICED EPIDERMAL GROWTH FACTOR-LIKE DOMAINS IN AGGRECANS OF DIFFERENT SPECIES - EVIDENCE FOR A NOVEL MODULE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOGLYCAN CORE PROTEIN; BETA-HYDROXYASPARTIC ACID; COAGULATION FACTOR-X; BOVINE CARTILAGE PROTEOGLYCAN; K-DEPENDENT PROTEINS; EGF-LIKE DOMAIN; HUMAN FACTOR-IX; CALCIUM-BINDING; FACTOR-ALPHA; SEQUENCE	The carboxyl-terminal globular domain of human aggrecan has been shown previously to contain an alternatively spliced epidermal growth factor (EGF)-like module. We have used reverse transcription/polymerase chain reactions on cartilage-derived RNAs to investigate the heterogeneity in the EGF-like domain content of aggrecans from five species (mouse, rat, dog, bovine, and human). A novel alternatively spliced EGF-like module was detected in human aggrecan, establishing the presence of two of these domains. Highly homologous domains are present in aggrecans of other species, and the expression of these modules is identical (4-8%). They share significant homology with EGF-like domains of differentiation proteins and coagulation factors and have a putative calcium binding site. In contrast to this novel domain (EGF2), the previously described EGF-like module (EGF1) is expressed at a high level exclusively in human aggrecan. The expression of the two EGF-like domains in human aggrecan appears to be independent. Although the function of these domains is not understood, the uniform expression of the EGF2 domain may indicate a general role of this aggrecan module, while the expression of the EGF1 domain may reflect species specificity.	RUSH PRESBYTERIAN ST LUKES MED CTR, DEPT BIOCHEM, CHICAGO, IL 60612 USA; RUSH PRESBYTERIAN ST LUKES MED CTR, DEPT ORTHOPED SURG, CHICAGO, IL 60612 USA	Rush University; Rush University					PHS HHS [R01 40310] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANTONSSON P, 1989, J BIOL CHEM, V264, P16170; APPELLA E, 1987, J BIOL CHEM, V262, P4437; ASTERMARK J, 1992, J BIOL CHEM, V267, P3249; BALDWIN CT, 1989, J BIOL CHEM, V264, P15747; CHANDRASEKARAN L, 1992, BIOCHEM J, V288, P903, DOI 10.1042/bj2880903; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COOKE RM, 1987, NATURE, V327, P339, DOI 10.1038/327339a0; DAHLBACK B, 1990, J BIOL CHEM, V265, P18481; DAHLBACK B, 1990, J BIOL CHEM, V265, P16082; DEFEOJONES D, 1988, MOL CELL BIOL, V8, P2999, DOI 10.1128/MCB.8.8.2999; DOEGE K, 1987, J BIOL CHEM, V262, P17757; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; DOOLITTLE RF, 1984, NATURE, V307, P558, DOI 10.1038/307558a0; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; FERNLUND P, 1983, J BIOL CHEM, V258, P2509; FLEMING RJ, 1990, GENE DEV, V4, P2188, DOI 10.1101/gad.4.12a.2188; GRONKE RS, 1989, P NATL ACAD SCI USA, V86, P3609, DOI 10.1073/pnas.86.10.3609; HALBERG DF, 1988, J BIOL CHEM, V263, P9486; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; HURSH DA, 1990, SCIENCE, V249, P1487; KLINE TP, 1990, BIOCHEMISTRY-US, V29, P7805, DOI 10.1021/bi00486a005; KOROMIYA A, 1984, P NATL ACAD SCI USA, V81, P1351; KUETTNER KE, 1982, J CELL BIOL, V93, P743, DOI 10.1083/jcb.93.3.743; KUROSAWA S, 1988, J BIOL CHEM, V263, P5993; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; MONTELIONE GT, 1989, P NATL ACAD SCI USA, V86, P1519, DOI 10.1073/pnas.86.5.1519; MONTELIONE GT, 1987, P NATL ACAD SCI USA, V84, P5226, DOI 10.1073/pnas.84.15.5226; OHLIN AK, 1988, J BIOL CHEM, V263, P7411; OHLIN AK, 1988, J BIOL CHEM, V263, P19240; OLDBERG A, 1987, BIOCHEM J, V243, P255, DOI 10.1042/bj2430255; PATTHY L, 1987, FEBS LETT, V214, P1, DOI 10.1016/0014-5793(87)80002-9; PERSSON E, 1989, J BIOL CHEM, V264, P16897; PRZYSIECKI CT, 1987, P NATL ACAD SCI USA, V84, P7856, DOI 10.1073/pnas.84.22.7856; RAUCH U, 1992, J BIOL CHEM, V267, P19536; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SELANDER M, 1990, BIOCHEMISTRY-US, V29, P8111, DOI 10.1021/bi00487a018; SELANDERSUNNERHAGEN M, 1992, J BIOL CHEM, V267, P19642; STENFLO J, 1988, J BIOL CHEM, V263, P21; STENFLO J, 1991, ANN NY ACAD SCI, V614, P11; TANAKA T, 1988, J BIOL CHEM, V263, P15831; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; ULLNER M, 1992, BIOCHEMISTRY-US, V31, P5974, DOI 10.1021/bi00141a004; WEIR BS, 1990, GENETIC DATA ANAL ME, P261; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; WIGHT TN, 1991, CELL BIOL EXTRACELLU, P45, DOI DOI 10.1007/978-1-4615-3770-0_3; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x; ZUSHI M, 1991, J BIOL CHEM, V266, P19886	49	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1993	268	23					17377	17383						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LQ988	8349621				2022-12-27	WOS:A1993LQ98800073
J	MATHER, MW; SPRINGER, P; HENSEL, S; BUSE, G; FEE, JA				MATHER, MW; SPRINGER, P; HENSEL, S; BUSE, G; FEE, JA			CYTOCHROME-OXIDASE GENES FROM THERMUS-THERMOPHILUS - NUCLEOTIDE-SEQUENCE OF THE FUSED GENE AND ANALYSIS OF THE DEDUCED PRIMARY STRUCTURES FOR SUBUNIT-I AND SUBUNIT-III OF CYTOCHROME-CAA3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; AMINO-ACID-SEQUENCES; C-OXIDASE; EXTREME THERMOPHILE; ESCHERICHIA-COLI; MOLECULAR-CLONING; PROTON PUMP; RESPIRATORY PROTEINS; MEMBRANE-PROTEINS; MITOCHONDRIAL-DNA	Cytochrome caa3, a cytochrome c oxidase from Thermus thermophilus, has been purified and extensively characterized as a two-subunit enzyme containing the metal centers characteristic of cytochrome c oxidases (cytochromes a and a3; copper centers Cu(A) and Cu(B)) and an additional cytochrome c (Fee, J. A., Kuila, D., Mather, M. W., and Yoshida, T. (1986) Biochim. Biophys. Acta 853, 153-185). We have now cloned and sequenced the genes encoding the subunits of this enzyme. The smaller subunit consists of a typical oxidase subunit II sequence fused to a cytochrome c domain (Mather, M. W., Springer, P., and Fee, J. A. (1991) J. Biol. Chem. 266, 5025-5035). The larger subunit, the A-protein, is encoded by a fusion gene lying immediately downstream of the subunit IIc gene. The 5' portion of this gene encodes an oxidase subunit I homolog, whereas the 3' portion is homologous to oxidase subunits III. The A-protein from the purified enzyme appears too small from SDS-polyacrylamide gel electrophoresis and quantitative amino acid analyses to be a complete subunit I/III fusion, but it is currently not known if proteolytic processing occurs. Analyses of the sequences of oxidase subunits are presented which clearly identify T. thermophilus cytochrome caa3 as a bona fide member of the greater family of heme- and copper-requiring oxidases. As one consequence, it is confirmed that the set of invariant histidine residues (potential ligands of the metal centers) in cytochrome c oxidase subunits I and II is reduced to 8. Possible topological and helix packing models are developed based on considerations of homology, hydropathy, and variability.	LOS ALAMOS NATL LAB, BIOCHEM SECT, LOS ALAMOS, NM 87545 USA; LOS ALAMOS NATL LAB, STABLE ISOTOPE RESOURCE SPECT & BIOCHEM GRP, LOS ALAMOS, NM 87545 USA; RHEIN WESTFAL TH AACHEN, INST BIOCHEM, W-5100 AACHEN, GERMANY	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; RWTH Aachen University				Mather, Michael/0000-0002-1062-0137	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035342] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35342] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BABCOCK GT, 1983, BIOCHEMISTRY-US, V22, P2314, DOI 10.1021/bi00279a002; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; BISSON R, 1985, J INORG BIOCHEM, V23, P177, DOI 10.1016/0162-0134(85)85023-6; BONITZ SG, 1980, J BIOL CHEM, V255, P1927; BOWEN D, 1988, BIOCHEM J, V254, P509, DOI 10.1042/bj2540509; BURGER G, 1982, EMBO J, V1, P1385, DOI 10.1002/j.1460-2075.1982.tb01327.x; BUSE G, 1989, EUR J BIOCHEM, V181, P261, DOI 10.1111/j.1432-1033.1989.tb14720.x; CAPALDI RA, 1983, BIOCHIM BIOPHYS ACTA, V726, P135, DOI 10.1016/0304-4173(83)90003-4; CAPALDI RA, 1990, ARCH BIOCHEM BIOPHYS, V280, P252, DOI 10.1016/0003-9861(90)90327-U; CASEY RP, 1980, J BIOL CHEM, V255, P3994; CHAIT BT, 1992, SCIENCE, V257, P1885, DOI 10.1126/science.1411504; CHAN SI, 1990, BIOCHEMISTRY-US, V29, P1, DOI 10.1021/bi00453a001; CHEPURI V, 1990, J BIOL CHEM, V265, P11185; CHEPURI V, 1990, J BIOL CHEM, V265, P12978; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; CLINE J, 1983, J BIOL CHEM, V258, P5124; COVELLO PS, 1989, NATURE, V341, P662, DOI 10.1038/341662a0; COVELLO PS, 1990, NUCLEIC ACIDS RES, V18, P5189, DOI 10.1093/nar/18.17.5189; DEKKER K, 1991, J BACTERIOL, V173, P3078, DOI 10.1128/JB.173.10.3078-3083.1991; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Doolittle R. F., 1986, URFS ORFS PRIMER ANA; DOOLITTLE RF, 1981, SCIENCE, V214, P149, DOI 10.1126/science.7280687; ESPOSTI MD, 1989, ITAL J BIOCHEM, V38, P1; ESPOSTI MD, 1990, EUR J BIOCHEM, V190, P207; FAWCETT TW, 1990, BIOTECHNIQUES, V9, P46; FEE JA, 1988, ANN NY ACAD SCI, V550, P33, DOI 10.1111/j.1749-6632.1988.tb35319.x; FEE JA, 1980, P NATL ACAD SCI-BIOL, V77, P147, DOI 10.1073/pnas.77.1.147; FEE JA, 1986, BIOCHIM BIOPHYS ACTA, V853, P153, DOI 10.1016/0304-4173(86)90009-1; FEE JA, 1993, IN PRESS J BIOENERG; GOODMAN G, 1985, BIOCHEMISTRY-US, V24, P2310, DOI 10.1021/bi00330a028; GRIBSKOV M, 1984, NUCLEIC ACIDS RES, V12, P539, DOI 10.1093/nar/12.1Part2.539; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; GRIBSKOV M, 1988, COMPUT APPL BIOSCI, V4, P61; GUALBERTO JM, 1989, NATURE, V341, P660, DOI 10.1038/341660a0; GUALBERTO JM, 1990, NUCLEIC ACIDS RES, V18, P3771, DOI 10.1093/nar/18.13.3771; HALTIA T, 1991, EMBO J, V10, P2015, DOI 10.1002/j.1460-2075.1991.tb07731.x; HARDY CM, 1991, CURR GENET, V20, P99, DOI 10.1007/BF00312772; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HOLM L, 1987, EMBO J, V6, P2819, DOI 10.1002/j.1460-2075.1987.tb02578.x; HONNAMI K, 1984, BIOCHEMISTRY-US, V23, P454, DOI 10.1021/bi00298a009; ISHIZUKA M, 1990, J BIOCHEM-TOKYO, V108, P866, DOI 10.1093/oxfordjournals.jbchem.a123294; ITAYA M, 1991, NUCLEIC ACIDS RES, V19, P4443, DOI 10.1093/nar/19.16.4443; KAGAWA Y, 1984, J BIOL CHEM, V259, P2956; KOYAMA Y, 1990, J BACTERIOL, V172, P3490, DOI 10.1128/jb.172.6.3490-3495.1990; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANG BF, 1984, EMBO J, V3, P2129, DOI 10.1002/j.1460-2075.1984.tb02102.x; LAUER G, 1991, J BACTERIOL, V173, P5047, DOI 10.1128/jb.173.16.5047-5053.1991; LEMIEUX LJ, 1992, J BIOL CHEM, V267, P2105; LUBBEN M, 1992, EMBO J, V11, P805, DOI 10.1002/j.1460-2075.1992.tb05117.x; LUDWIG B, 1987, FEMS MICROBIOL LETT, V46, P41, DOI 10.1111/j.1574-6968.1987.tb02451.x; LUNDEEN M, 1986, INORG CHEM, V25, P4852, DOI 10.1021/ic00247a016; MAHENDRAN R, 1991, NATURE, V349, P434, DOI 10.1038/349434a0; MALATESTA F, 1982, BIOCHEM BIOPH RES CO, V109, P1180, DOI 10.1016/0006-291X(82)91901-5; MALMSTROM BG, 1990, CHEM REV, V90, P1247, DOI 10.1021/cr00105a008; MARTIN CT, 1985, J BIOL CHEM, V260, P2857; MATHER MW, 1991, J BIOL CHEM, V266, P5025; MATHER MW, 1988, BIOTECHNIQUES, V6, P444; MATHER MW, 1990, 41ST P MOSB C, P94; MINAGAWA J, 1992, J BIOL CHEM, V267, P2096; NUREKI O, 1991, J BIOL CHEM, V266, P3268; OSHIMA T, 1974, INT J SYST BACTERIOL, V24, P102, DOI 10.1099/00207713-24-1-102; PALMER G, 1987, PURE APPL CHEM, V59, P749, DOI 10.1351/pac198759060749; PEISACH J, 1978, FRONTIERS BIOL ENERG, V2, P873; PEL HJ, 1992, CURR GENET, V21, P139, DOI 10.1007/BF00318473; PLATT T, 1986, ANNU REV BIOCHEM, V55, P339, DOI 10.1146/annurev.bi.55.070186.002011; PUETTNER I, 1985, J BIOL CHEM, V260, P3719; RAITIO M, 1987, EMBO J, V6, P2825, DOI 10.1002/j.1460-2075.1987.tb02579.x; REES DC, 1989, ANNU REV BIOCHEM, V58, P607; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARASTE M, 1991, EUR J BIOCHEM, V195, P517, DOI 10.1111/j.1432-1033.1991.tb15732.x; SARASTE M, 1990, Q REV BIOPHYS, V23, P331, DOI 10.1017/S0033583500005588; SATO S, 1988, BIOCHIM BIOPHYS ACTA, V950, P303, DOI 10.1016/0167-4781(88)90126-1; SEIDLER L, 1987, NUCLEIC ACIDS RES, V15, P9263, DOI 10.1093/nar/15.22.9263; SHAPLEIGH JP, 1992, P NATL ACAD SCI USA, V89, P4786, DOI 10.1073/pnas.89.11.4786; SHAW JM, 1988, CELL, V53, P401, DOI 10.1016/0092-8674(88)90160-2; STEFFENS GJ, 1979, H-S Z PHYSIOL CHEM, V360, P613; STEVENS TH, 1981, J BIOL CHEM, V256, P1069; SURERUS KK, 1992, P NATL ACAD SCI USA, V89, P3195, DOI 10.1073/pnas.89.8.3195; THONYMEYER L, 1989, CELL, V57, P683, DOI 10.1016/0092-8674(89)90137-2; VAHRENHOLZ C, 1985, MOL GEN GENET, V201, P213, DOI 10.1007/BF00425662; VANDERSPEK H, 1990, EMBO J, V9, P257, DOI 10.1002/j.1460-2075.1990.tb08103.x; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WIKSTROM M, 1985, ENZYMES BIOL MEMBR, P111; XU J, 1991, BIOCHEM BIOPH RES CO, V176, P1313, DOI 10.1016/0006-291X(91)90429-B; YAKHNIN AV, 1990, NUCLEIC ACIDS RES, V18, P3659, DOI 10.1093/nar/18.12.3659; YASUNOBU KT, 1980, J SCI IND RES INDIA, V39, P796; YEATES TO, 1987, P NATL ACAD SCI USA, V84, P6438, DOI 10.1073/pnas.84.18.6438; YOSHIDA T, 1984, J BIOL CHEM, V259, P112	88	53	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1993	268	8					5395	5408						14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR822	8383670				2022-12-27	WOS:A1993KR82200012
J	LAXMINARAYAN, KM; MATZARIS, M; SPEED, CJ; MITCHELL, CA				LAXMINARAYAN, KM; MATZARIS, M; SPEED, CJ; MITCHELL, CA			PURIFICATION AND CHARACTERIZATION OF A 43-KDA MEMBRANE-ASSOCIATED INOSITOL POLYPHOSPHATE 5-PHOSPHATASE FROM HUMAN PLACENTA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-C; HUMAN-PLATELETS; RAT-LIVER; 1,4,5-TRISPHOSPHATE PHOSPHATASE; BRAIN; POLYPHOSPHATE-5-PHOSPHATASE; TETRAKISPHOSPHATE; IDENTIFICATION; METABOLISM	We have identified, isolated, and characterized a membrane-associated inositol polyphosphate 5-phosphatase (5-phosphatase) from the particulate fraction of human placenta. The enzyme was purified 3700-fold from a detergent extract of human placental membranes to apparent homogeneity, by chromatography on DEAE-Sepharose, S-Sepharose, hydroxylapatite, and Biosil SEC 250 HPLC gel filtration. The purified 5-phosphatase has a molecular mass of 43 kDa as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and gel filtration chromatography. The enzyme hydrolyzes inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) to inositol 1,4 bisphosphate (Ins(1,4)P2) with an apparent K(m) of 5 muM. The 43-kDa 5-phosphatase also hydrolyzes inositol 1,3,4,5-tetrakisphosphate (Ins(1,3,4,5)P4) with an apparent K(m) of 1.2 muM. The enzyme requires Mg2+ ions for activity and is inhibited by Ca2+ concentrations greater than 100 muM. Polyclonal antibodies developed against the membrane-associated enzyme immunoprecipitate the purified membrane-associated placental 5-phosphatase and the platelet Type I cytosolic enzyme, but not the 75-kDa platelet Type II 5-phosphatase. These results demonstrate that the purified membrane 5-phosphatase bears physical and immunological similarity with the Type I cytosolic platelet enzyme.			LAXMINARAYAN, KM (corresponding author), BOX HILL HOSPITAL,MONASH MED SCH,DEPT MED,MELBOURNE,AUSTRALIA.			Mitchell, Christina A/0000-0001-9372-3192				ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; BANSAL VS, 1990, ANNU REV CELL BIOL, V6, P41, DOI 10.1146/annurev.cellbio.6.1.41; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; CONNOLLY TM, 1985, J BIOL CHEM, V260, P7868; CONNOLLY TM, 1986, CELL, V46, P951, DOI 10.1016/0092-8674(86)90077-2; DOWNES CP, 1982, BIOCHEM J, V203, P169, DOI 10.1042/bj2030169; ERNEUX C, 1989, EUR J BIOCHEM, V181, P317, DOI 10.1111/j.1432-1033.1989.tb14726.x; ERNEUX C, 1986, BIOCHEM BIOPH RES CO, V134, P351, DOI 10.1016/0006-291X(86)90570-X; HANSEN CA, 1987, J BIOL CHEM, V262, P17319; HOLLANDE F, 1992, BIOCHEM J, V277, P293; JOSEPH SK, 1985, FEBS LETT, V180, P150, DOI 10.1016/0014-5793(85)81061-9; KHAN AA, 1992, SCIENCE, V257, P815, DOI 10.1126/science.1323146; KING WG, 1989, J BIOL CHEM, V264, P6070; KUKITA M, 1986, BIOCHIM BIOPHYS ACTA, V885, P121, DOI 10.1016/0167-4889(86)90046-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MERRIL CR, 1981, SCIENCE, V211, P3501; MITCHELL CA, 1989, J BIOL CHEM, V264, P8873; OGAWA Y, 1968, J BIOCHEM-TOKYO, V64, P255, DOI 10.1093/oxfordjournals.jbchem.a128887; RANA RS, 1990, PHYSIOL REV, V70, P115, DOI 10.1152/physrev.1990.70.1.115; RANA RS, 1986, J BIOL CHEM, V261, P5237; ROSS TS, 1991, J BIOL CHEM, V266, P20283; SEYFRED MA, 1984, J BIOL CHEM, V259, P3204; SHARP AH, 1992, J BIOL CHEM, V267, P7444; SHEARS SB, 1989, BIOCHEM J, V260, P313, DOI 10.1042/bj2600313; SHEARS SB, 1987, BIOCHEM J, V246, P139, DOI 10.1042/bj2460139; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMITH DE, 1984, J CELL BIOL, V99, P20, DOI 10.1083/jcb.99.1.20; STOREY DJ, 1984, NATURE, V312, P374, DOI 10.1038/312374a0; TAKIMOTO K, 1989, J BIOCHEM-TOKYO, V106, P684, DOI 10.1093/oxfordjournals.jbchem.a122917; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VEDIA LMM, 1986, J BIOL CHEM, V261, P10493; VERJANS B, 1992, EUR J BIOCHEM, V204, P1083, DOI 10.1111/j.1432-1033.1992.tb16732.x; VERJANS B, 1990, CELL SIGNAL, V2, P595, DOI 10.1016/0898-6568(90)90082-L	33	53	53	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1993	268	7					4968	4974						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP884	8383126				2022-12-27	WOS:A1993KP88400062
J	GRADIN, K; WILHELMSSON, A; POELLINGER, L; BERGHARD, A				GRADIN, K; WILHELMSSON, A; POELLINGER, L; BERGHARD, A			NONRESPONSIVENESS OF NORMAL HUMAN FIBROBLASTS TO DIOXIN CORRELATES WITH THE PRESENCE OF A CONSTITUTIVE XENOBIOTIC RESPONSE ELEMENT-BINDING FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYP1A1 MESSENGER-RNA; AMINO-ACID-SEQUENCE; HEAT-SHOCK PROTEIN; REGULATORY ELEMENTS; AH RECEPTOR; INDUCIBLE EXPRESSION; HYPERSENSITIVE SITES; P-450C GENE; DNA; MOUSE	Polychlorinated aromatic hydrocarbons such as 2,3,7,8-tetrachlorodibenzofuran (TCDF) have been shown to induce transcription of the cytochrome P-450IA1 gene by activating an intracellular receptor protein (the Ah- or dioxin receptor) to bind to specific DNA sequences, termed xenobiotic response elements (XREs). However, the expression and inducibility of the cytochrome P-450IA1 activity exhibit tissue-specific differences. With regard to the TCDF induction response, we have examined three human cell types of endodermal (the hepatoma cell line HepG2), ectodermal (normal keratinocytes), and mesodermal origin (normal fibroblasts). DNase I hypersensitivity analysis of the 5' flank and first intron of the P-450IA1 gene showed that in the nonresponsive fibroblasts the chromatin structure lacked open regions while in the two responsive cell types (keratinocytes and HepG2) several constitutive hypersensitive sites as well as TCDF-induced alterations in the chromatin structure could be detected. This observation might correlate with the fact that the XRE, in either the context of the P-450IA1 gene sequences or in front of a heterologous promoter, was inefficient in directing a TCDF induction response in fibroblasts. In in vitro DNA binding studies, the dioxin receptor was activated to a DNA-binding nuclear form in all three cell types. However, in fibroblast nuclear extracts two novel constitutive protein-XRE complexes were detected. The fibroblast factor(s) were immunochemically distinct from the receptor but exhibited indistinguishable DNA binding specificity. These data are compatible with a model where the P-450IA1 is noninducible in fibroblasts due to the presence of a putative repressor(s) which may compete effectively with the receptor for binding to the response element as indicated by in vitro DNA-binding off-rate experiments.	NOVUM,KAROLINSKA INST,CTR BIOTECHNOL,BLICKAGANGEN 6,S-14157 HUDDINGE,SWEDEN; NOVUM,KAROLINSKA INST,DEPT MED NUTR,S-14157 HUDDINGE,SWEDEN	Karolinska Institutet; Karolinska Institutet								ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; BERGHARD A, 1992, CARCINOGENESIS, V13, P651, DOI 10.1093/carcin/13.4.651; BERGHARD A, 1990, J BIOL CHEM, V265, P21086; BRADFIELD CA, 1991, MOL PHARMACOL, V39, P13; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEY A, 1989, P NATL ACAD SCI USA, V86, P7446, DOI 10.1073/pnas.86.19.7446; EMA M, 1992, BIOCHEM BIOPH RES CO, V184, P246, DOI 10.1016/0006-291X(92)91185-S; FAVREAU LV, 1991, J BIOL CHEM, V266, P4556; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; FOULKES NS, 1992, CELL, V68, P411, DOI 10.1016/0092-8674(92)90178-F; FUJIIKURIYAMA Y, 1992, FASEB J, V6, P706, DOI 10.1096/fasebj.6.2.1537460; FUJISAWASEHARA A, 1987, NUCLEIC ACIDS RES, V15, P4179, DOI 10.1093/nar/15.10.4179; GIACHELLI CM, 1991, J BIOL CHEM, V266, P3981; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; HAPGOOD J, 1991, MOL CELL BIOL, V11, P4314, DOI 10.1128/MCB.11.9.4314; HINES RN, 1988, CARCINOGENESIS, V9, P1599, DOI 10.1093/carcin/9.9.1599; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; IOANNIDES C, 1990, DRUG METAB REV, V22, P1, DOI 10.3109/03602539008991444; ISRAEL DI, 1985, J BIOL CHEM, V260, P5648; JAISWAL AK, 1985, SCIENCE, V228, P80, DOI 10.1126/science.3838385; JONES KW, 1990, MOL CELL BIOL, V10, P5098, DOI 10.1128/MCB.10.10.5098; JONES SN, 1991, NUCLEIC ACIDS RES, V19, P6547, DOI 10.1093/nar/19.23.6547; MIRKOVITCH J, 1991, GENE DEV, V5, P83, DOI 10.1101/gad.5.1.83; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; PAULSON KE, 1990, MOL CELL BIOL, V10, P1841, DOI 10.1128/MCB.10.5.1841; PERDEW GH, 1988, J BIOL CHEM, V263, P13802; POELLINGER L, 1992, TRENDS PHARMACOL SCI, V13, P241, DOI 10.1016/0165-6147(92)90076-I; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; POLAND A, 1991, MOL PHARMACOL, V39, P20; REINERS JJ, 1992, BIOCHEM BIOPH RES CO, V183, P193, DOI 10.1016/0006-291X(92)91627-3; RENKAWITZ R, 1990, TRENDS GENET, V6, P192, DOI 10.1016/0168-9525(90)90176-7; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; SAATCIOGLU F, 1990, MOL CELL BIOL, V10, P6408, DOI 10.1128/MCB.10.12.6408; Sambrook J, 1989, MOL CLONING LABORATO; SHU HP, 1987, REGUL TOXICOL PHARM, V7, P57, DOI 10.1016/0273-2300(87)90048-1; STRUHL K, 1990, CURRENT PROTOCOLS MO; SUSKIND RR, 1985, SCAND J WORK ENV HEA, V165, P165; TEIFELD RM, 1989, DNA-J MOLEC CELL BIO, V8, P329, DOI 10.1089/dna.1.1989.8.329; WANG X, 1991, ARCH BIOCHEM BIOPHYS, V287, P186, DOI 10.1016/0003-9861(91)90405-8; WATSON AJ, 1992, MOL CELL BIOL, V12, P2115, DOI 10.1128/MCB.12.5.2115; WATSON AJ, 1992, J BIOL CHEM, V266, P6874; WILHELMSSON A, 1990, EMBO J, V9, P69, DOI 10.1002/j.1460-2075.1990.tb08081.x; WU L, 1992, P NATL ACAD SCI USA, V89, P4811, DOI 10.1073/pnas.89.11.4811; YANAGIDA A, 1990, MOL CELL BIOL, V10, P1470, DOI 10.1128/MCB.10.4.1470	46	74	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1993	268	6					4061	4068						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KN533	8382688				2022-12-27	WOS:A1993KN53300042
J	PIPPIG, S; ANDEXINGER, S; DANIEL, K; PUZICHA, M; CARON, MG; LEFKOWITZ, RJ; LOHSE, MJ				PIPPIG, S; ANDEXINGER, S; DANIEL, K; PUZICHA, M; CARON, MG; LEFKOWITZ, RJ; LOHSE, MJ			OVEREXPRESSION OF BETA-ARRESTIN AND BETA-ADRENERGIC-RECEPTOR KINASE AUGMENT DESENSITIZATION OF BETA(2)-ADRENERGIC RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; BETA-2-ADRENERGIC RECEPTOR; CYCLIC-AMP; PHOSPHORYLATION SITES; OPERATIONAL MODEL; LYMPHOMA-CELLS; WILD-TYPE; EXPRESSION; ACTIVATION; RHODOPSIN	Receptor-specific or homologous desensitization of beta2-adrenergic receptors is thought to be effected via phosphorylation of the receptor by the beta-adrenergic receptor kinase (betaARK), followed by binding of beta-arrestin. We have generated stably transfected Chinese hamster ovary cell lines overexpressing either of the two regulatory proteins and also expressing low or high levels of beta2-adrenergic receptors (almost-equal-to 80 and almost-equal-to 600 fmol/mg of membrane protein). In these cells, we studied the process of desensitization induced by the beta-adrenergic receptor agonist isoproterenol. In cells expressing high levels of beta2-adrenergic receptors, desensitization to high concentrations of isoproterenol (previously shown to be mediated by both betaARK and protein kinase A) amounted to almost-equal-to 50% in control cells, almost-equal-to 80% in betaARK-overexpressing cells, and almost-equal-to 90% in beta-arrestin-overexpressing cells. In cells expressing low levels of beta2-adrenergic receptors, these values were almost-equal-to 50, almost-equal-to 60, and almost-equal-to 60%, respectively. Desensitization to low concentrations of isoproterenol (previously shown to be essentially protein kinase A-mediated and not receptor-specific, i.e. heterologous) was not affected by overexpression of either betaARK or beta-arrestin. These data suggest that in cells expressing high levels of beta2-adrenergic receptors, beta-arrestin and betaARK become limiting for homologous receptor desensitization. They provide further support for the involvement of these two proteins in the regulation of beta2-adrenergic receptor function.	DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,DURHAM,NC 27710	Duke University; Howard Hughes Medical Institute	PIPPIG, S (corresponding author), UNIV MUNICH,MAX PLANCK INST BIOCHEM,MOLEC BIOL LAB,W-8033 MARTINSRIED,GERMANY.		Lohse, Martin J/A-7160-2012; Lefkowitz, Robert/AAW-2649-2021	Lohse, Martin J/0000-0002-0599-3510; 				BAUER PH, 1992, NATURE, V358, P73, DOI 10.1038/358073a0; BENOVIC JL, 1991, J BIOL CHEM, V266, P14939; BENOVIC JL, 1987, J BIOL CHEM, V262, P9026; BENOVIC JL, 1985, J BIOL CHEM, V260, P7094; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; BENOVIC JL, 1986, NATURE, V322, P869; BLACK JW, 1985, BRIT J PHARMACOL, V84, P561, DOI 10.1111/j.1476-5381.1985.tb12941.x; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEUNG AH, 1989, MOL PHARMACOL, V34, P132; CLARK RB, 1988, P NATL ACAD SCI USA, V85, P1442, DOI 10.1073/pnas.85.5.1442; CLARK RB, 1987, FASEB J, V1, P289, DOI 10.1096/fasebj.1.4.2820824; COLLINS S, 1991, ANNU REV PHYSIOL, V53, P497, DOI 10.1146/annurev.physiol.53.1.497; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; HADCOCK JR, 1991, TRENDS NEUROSCI, V14, P242, DOI 10.1016/0166-2236(91)90124-D; HARLOW E, 1988, ANTIBODIES LABORATOR; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; JAKOBS KH, 1976, J CYCLIC NUCL PROT, V2, P381; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVITZKI A, 1988, SCIENCE, V241, P800, DOI 10.1126/science.2841758; LIGGETT SB, 1992, J BIOL CHEM, V267, P4740; LOHSE MJ, 1986, MOL PHARMACOL, V30, P403; LOHSE MJ, 1992, N-S ARCH PHARMACOL, V345, P444; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; LOHSE MJ, 1990, J BIOL CHEM, V265, P3210; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; LOHSE MJ, 1989, P NATL ACAD SCI USA, V86, P3011, DOI 10.1073/pnas.86.9.3011; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; LOHSE MJ, 1992, SIGNAL TRANSMISSION, P160; LORENZ W, 1991, P NATL ACAD SCI USA, V88, P8715, DOI 10.1073/pnas.88.19.8715; PITCHER J, 1992, BIOCHEMISTRY-US, V31, P3193, DOI 10.1021/bi00127a021; ROTH NS, 1991, P NATL ACAD SCI USA, V88, P6201, DOI 10.1073/pnas.88.14.6201; SHINOHARA T, 1987, P NATL ACAD SCI USA, V84, P6875; SUBRAMANI S, 1981, MOL CELL BIOL, V1, P854, DOI 10.1128/MCB.1.9.854; UNGERER M, 1993, IN PRESS CIRCULATION; WALSETH TF, 1979, BIOCHIM BIOPHYS ACTA, V562, P11, DOI 10.1016/0005-2787(79)90122-9; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; ZHOU XM, 1991, J BIOL CHEM, V266, P7462	43	194	195	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3201	3208						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8381421				2022-12-27	WOS:A1993KM16100030
J	CHAHINE, KG; BARACCHINI, E; GOLDMAN, D				CHAHINE, KG; BARACCHINI, E; GOLDMAN, D			COUPLING MUSCLE ELECTRICAL-ACTIVITY TO GENE-EXPRESSION VIA A CAMP-DEPENDENT 2ND MESSENGER SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR ALPHA-SUBUNIT; RAT SKELETAL-MUSCLE; PROTEIN KINASE-C; ACETYLCHOLINE-RECEPTOR; CYCLIC-AMP; BETA-SUBUNIT; NEUROMUSCULAR SYNAPSES; ADENYLATE-CYCLASE; CHICKEN MYOTUBES; GAMMA-SUBUNIT	Embryonic-type nicotinic acetylcholine receptor (nAChR) gene expression is regulated by muscle activity. The mechanism by which this activity is transduced to the genome is not known. We have addressed this issue by using a rat primary muscle cell culture system that mimics the in vivo effects of muscle activity on nAChR expression. We report here that the suppression of nAChR gene expression by muscle activity can be reversed by increasing intracellular cAMP levels. This effect is specific to the embryonic-type receptor genes. Electrically insensitive genes such as those encoding the adult-type nAChR epsilon-subunit and creatine kinase are not up-regulated by cAMP. In addition, muscle inactivity caused either by tetrodotoxin or denervation increases cAMP levels and protein kinase A activity, consistent with their proposed role in mediating nAChR gene expression. Finally, we report that this same mechanism appears to regulate other genes, such as those encoding the tetrodotoxin-insensitive sodium channel, MyoD, and myogenin which, like the nAChR, are regulated by muscle electrical activity. Based on these results it is proposed that muscle electrical activity is coupled to gene expression via a cAMP-dependent second messenger system.	UNIV MICHIGAN, MENTAL HLTH RES INST, 205 ZINA PITCHER PL, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT BIOL CHEM, ANN ARBOR, MI 48109 USA; SCRIPPS CLIN & RES FDN, LA JOLLA, CA 92037 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Scripps Research Institute								BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BETZ H, 1979, NATURE, V278, P749, DOI 10.1038/278749a0; BLOSSER JC, 1980, J BIOL CHEM, V255, P1235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER HR, 1990, NATURE, V344, P544, DOI 10.1038/344544a0; CARLSEN RC, 1975, J PHYSIOL-LONDON, V247, P343, DOI 10.1113/jphysiol.1975.sp010935; CHAHINE KG, 1992, DEVELOPMENT, V115, P213; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEGG CH, 1987, J BIOL CHEM, V262, P13111; CLELAND PJF, 1989, J BIOL CHEM, V264, P17704; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DUCLERT A, 1990, P NATL ACAD SCI USA, V87, P1391, DOI 10.1073/pnas.87.4.1391; EFTIMIE R, 1991, P NATL ACAD SCI USA, V88, P1349, DOI 10.1073/pnas.88.4.1349; FONTAINE B, 1987, J CELL BIOL, V105, P1337, DOI 10.1083/jcb.105.3.1337; GOLDMAN D, 1988, NEURON, V1, P329, DOI 10.1016/0896-6273(88)90081-5; GOLDMAN D, 1991, NEURON, V7, P649, DOI 10.1016/0896-6273(91)90377-C; GOLDMAN D, 1989, NEURON, V3, P219, DOI 10.1016/0896-6273(89)90035-4; GOLDMAN D, 1989, NUCLEIC ACIDS RES, V17, P3049, DOI 10.1093/nar/17.8.3049; GOLDMAN D, 1985, J NEUROSCI, V5, P2553; GREEN WN, 1991, P NATL ACAD SCI USA, V88, P854, DOI 10.1073/pnas.88.3.854; HOPKINS D, 1981, BIOCHIM BIOPHYS ACTA, V678, P388, DOI 10.1016/0304-4165(81)90119-7; HUANG CF, 1992, NEURON, V9, P671, DOI 10.1016/0896-6273(92)90030-H; JAYNES JB, 1986, MOL CELL BIOL, V6, P2855, DOI 10.1128/MCB.6.8.2855; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; KLARSFELD A, 1985, P NATL ACAD SCI USA, V82, P4558, DOI 10.1073/pnas.82.13.4558; KLARSFELD A, 1989, NEURON, V2, P1229, DOI 10.1016/0896-6273(89)90307-3; KLARSFELD A, 1987, MOL CELL BIOL, V7, P951, DOI 10.1128/MCB.7.2.951; LAUFER R, 1991, EUR J BIOCHEM, V202, P813, DOI 10.1111/j.1432-1033.1991.tb16437.x; MCMANAMAN JL, 1982, BIOCHIM BIOPHYS ACTA, V720, P28, DOI 10.1016/0167-4889(82)90035-0; MERLIE JP, 1984, J CELL BIOL, V99, P332, DOI 10.1083/jcb.99.1.332; MERLIE JP, 1989, NEURON, V2, P1295, DOI 10.1016/0896-6273(89)90067-6; MORIYAMA Y, 1976, EXP CELL RES, V101, P159, DOI 10.1016/0014-4827(76)90425-0; NGUYEN TV, 1990, J NEUROSCI, V10, P2825; NOVAK E, 1972, ARCH BIOCHEM BIOPHYS, V150, P511, DOI 10.1016/0003-9861(72)90069-0; OFFORD J, 1989, NEURON, V2, P147; PIASCIK MT, 1980, J BIOL CHEM, V255, P4176; RUBIN LL, 1985, P NATL ACAD SCI USA, V82, P7121, DOI 10.1073/pnas.82.20.7121; RYMOND M, 1982, EUR J BIOCHEM, V125, P395, DOI 10.1111/j.1432-1033.1982.tb06696.x; SAYERS ST, 1988, NEUROCHEM RES, V13, P1125, DOI 10.1007/BF00971629; SCHUETZE SM, 1987, ANNU REV NEUROSCI, V10, P403, DOI 10.1146/annurev.ne.10.030187.002155; SHERMAN SJ, 1985, J NEUROSCI, V5, P1570; SMITH MK, 1990, J BIOL CHEM, V265, P1837; SMITH PB, 1980, BIOCHIM BIOPHYS ACTA, V628, P19; TSAY HJ, 1990, FEBS LETT, V274, P69, DOI 10.1016/0014-5793(90)81331-H; WITZEMANN V, 1991, J CELL BIOL, V114, P125, DOI 10.1083/jcb.114.1.125; WITZEMANN V, 1990, EUR J BIOCHEM, V194, P437, DOI 10.1111/j.1432-1033.1990.tb15637.x; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; ZALIN RJ, 1974, CELL, V2, P103, DOI 10.1016/0092-8674(74)90098-1; ZALIN RJ, 1975, EXP CELL RES, V93, P55, DOI 10.1016/0014-4827(75)90422-X	50	57	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2893	2898						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8381416				2022-12-27	WOS:A1993KK81500093
J	CAMPION, SR; GECK, MK; NIYOGI, SK				CAMPION, SR; GECK, MK; NIYOGI, SK			CUMULATIVE EFFECT OF DOUBLE-SITE MUTATIONS OF HUMAN EPIDERMAL GROWTH-FACTOR ON RECEPTOR-BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; TYROSINE KINASE-ACTIVITY; DIRECTED MUTAGENESIS; PROTEIN; H-1-NMR; LEUCINE-47; DOMAIN; EGF	Using site-directed mutagenesis, it was previously found that mutation of the individual residues Tyr13, Tyr22, Ile23, or Leu26 in the amino-terminal domain or of the highly conserved Leu47 in the carboxyl-terminal domain of human epidermal growth factor (hEGF), resulted in significantly decreased receptor binding affinity. In the present study, the single-site hEGF mutants Tyr13 --> His, Tyr22 --> Asp, Ile23 --> Thr, and Leu26 --> Gly were genetically combined with the Leu47 --> Ala hEGF mutant to produce a series of double-site mutant hEGF gene products having alterations simultaneously at two sites, in separate domains, within the same hEGF molecule. Similarly, the combination of the single-site hEGF mutants Tyr13 --> His and Ile23 --> Thr generated a double-site mutant having two mutations within the same domain. Finally, combination of the hEGF mutation Ile23 --> Ala with Leu26 --> Ala altered two side chains located in close proximity within the large beta-sheet region of the molecule. Analysis of the relative receptor binding affinities, determined by radioreceptor competition assays of the various single- and double-site hEGF mutants, demonstrated that mutation at any one site does not substantially alter the effect of mutation at the second site in the molecule. The cumulative effect of simultaneous mutations on relative receptor binding affinity confirms the importance of residues, including those in the large amino-terminal beta-sheet, in receptor binding, and indicates that each of the separate sites functions essentially independently in the interaction of the hEGF molecule with its receptor.	UNIV TENNESSEE,OAK RIDGE GRAD SCH BIOMED SCI,DIV BIOL,OAK RIDGE NATL LAB,OAK RIDGE,TN 37831; OAK RIDGE NATL LAB,PROT ENGN & MOLEC MUTAGENESIS PROGRAM,OAK RIDGE,TN 37831	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory					NCI NIH HHS [CA 50735] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050735] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIYAMA T, 1985, BIOCHEM BIOPH RES CO, V131, P442, DOI 10.1016/0006-291X(85)91822-4; Campbell I D, 1989, Prog Growth Factor Res, V1, P13, DOI 10.1016/0955-2235(89)90038-0; CAMPION SR, 1992, J CELL BIOCHEM, V50, P35; CAMPION SR, 1990, BIOCHEMISTRY-US, V29, P9988, DOI 10.1021/bi00494a032; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; CARPENTER G, 1985, METHOD ENZYMOL, V109, P107; COOKE RM, 1987, NATURE, V327, P339, DOI 10.1038/327339a0; DUDGEON TJ, 1990, FEBS LETT, V261, P392, DOI 10.1016/0014-5793(90)80600-N; ENGLER DA, 1990, FEBS LETT, V271, P47, DOI 10.1016/0014-5793(90)80368-S; ENGLER DA, 1988, J BIOL CHEM, V263, P12384; ENGLER DA, 1992, J BIOL CHEM, V267, P2274; GREENFIELD NJ, 1991, FASEB J, V6, pA269; GUNTHER N, 1990, J BIOL CHEM, V265, P22082; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HOLLADAY LA, 1976, BIOCHEMISTRY-US, V15, P2624, DOI 10.1021/bi00657a023; HOMMEL U, 1991, BIOCHEMISTRY-US, V30, P8891, DOI 10.1021/bi00100a024; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; JANIN J, 1990, J BIOL CHEM, V265, P16027; KOHDA D, 1988, J BIOCHEM-TOKYO, V103, P741, DOI 10.1093/oxfordjournals.jbchem.a122338; KOIDE H, 1992, BIOCHIM BIOPHYS ACTA, V1120, P257, DOI 10.1016/0167-4838(92)90245-9; LAX I, 1988, MOL CELL BIOL, V8, P1831, DOI 10.1128/MCB.8.4.1831; MATSUNAMI RK, 1991, J CELL BIOCHEM, V46, P242, DOI 10.1002/jcb.240460307; MATSUNAMI RK, 1990, FEBS LETT, V264, P105, DOI 10.1016/0014-5793(90)80776-F; MONTELIONE GT, 1987, P NATL ACAD SCI USA, V84, P5226, DOI 10.1073/pnas.84.15.5226; MOY FJ, 1989, P NATL ACAD SCI USA, V86, P9836, DOI 10.1073/pnas.86.24.9836; RAY P, 1988, BIOCHEMISTRY-US, V27, P7289, DOI 10.1021/bi00419a017; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TADAKI DK, 1991, FASEB J, V5, pA1183; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WU DG, 1990, P NATL ACAD SCI USA, V87, P3151, DOI 10.1073/pnas.87.8.3151	30	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1742	1748						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380576				2022-12-27	WOS:A1993KH62000038
J	ZHOU, A; BLOOMQUIST, BT; MAINS, RE				ZHOU, A; BLOOMQUIST, BT; MAINS, RE			THE PROHORMONE CONVERTASES PC1 AND PC2 MEDIATE DISTINCT ENDOPROTEOLYTIC CLEAVAGES IN A STRICT TEMPORAL-ORDER DURING PROOPIOMELANOCORTIN BIOSYNTHETIC PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDORPHIN-DERIVED PEPTIDES; RAT INTERMEDIATE PITUITARY; PRO-ACTH-ENDORPHIN; ALPHA-AMIDATING MONOOXYGENASE; MICROINJECTED XENOPUS OOCYTES; SITE-DIRECTED MUTAGENESIS; AMINO-ACID-SEQUENCE; MOUSE PITUITARY; BETA-ENDORPHIN; PROADRENOCORTICOTROPIN ENDORPHIN	Two subtilisin-like endoproteases called PC1 and PC2 are distributed in a tissue-specific manner in the pituitary and in the brain. AtT-20 cells and corticotropes of the anterior pituitary express primarily PC1 and perform a limited number of cleavages of the proopiomelanocortin (POMC) precursor during biosynthesis. Melanotropes of the intermediate pituitary express both PC1 and PC2 and perform a more extensive set of cleavages during the biosynthetic processing of POMC. To investigate the role of PC2 in the biosynthetic processing of POMC, AtT-20 mouse corticotropes were stably transfected with a full length PC2 cDNA. The AtT-20 cells expressing PC2 acquired the ability to perform all the additional cleavages seen in the intermediate pituitary, but did not acquire the ability to alpha-N-acetylate the product peptides. The kinetics of the earliest steps in biosynthetic processing were unaltered by the expression of PC2, and the changes due to PC2 expression were seen only in the middle and late steps in biosynthetic processing. Thus, both the identity of the final product peptides and the kinetics of the processing steps in the AtT-20 cells expressing PC2 fit the patterns expected for melanotropes of the intermediate pituitary.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,725 N WOLFE ST,BALTIMORE,MD 21205	Johns Hopkins University				Zhou, An/0000-0002-9358-8012	NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-00266, DA-00097] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BENJANNET S, 1992, J BIOL CHEM, V267, P11417; BENNETT HPJ, 1986, PEPTIDES, V7, P615, DOI 10.1016/0196-9781(86)90036-7; BLOOMQUIST BT, 1991, MOL ENDOCRINOL, V5, P2014, DOI 10.1210/mend-5-12-2014; BLOOMQUIST BT, 1992, IN PRESS BRAIN BEHAV; CHRISTIE DL, 1991, J BIOL CHEM, V266, P15679; CULLEN EI, 1987, MOL ENDOCRINOL, V1, P583, DOI 10.1210/mend-1-9-583; DAY R, 1992, MOL ENDOCRINOL, V6, P485, DOI 10.1210/me.6.3.485; DICKERSON IM, 1990, J BIOL CHEM, V265, P2462; DICKERSON IM, 1990, ENDOCRINOLOGY, V127, P133, DOI 10.1210/endo-127-1-133; DIXON JE, 1984, METHOD ENZYMOL, V106, P170; DORES RM, 1986, BRAIN RES, V377, P251, DOI 10.1016/0006-8993(86)90866-8; Eipper B A, 1980, Endocr Rev, V1, P1; EIPPER BA, 1981, J BIOL CHEM, V256, P5689; EIPPER BA, 1983, J BIOL CHEM, V258, P7292; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; EIPPER BA, 1986, J BIOL CHEM, V261, P8686; EIPPER BA, 1982, J BIOL CHEM, V257, P4907; EMESON RB, 1986, J NEUROSCI, V6, P837; Fricker L D, 1991, NIDA Res Monogr, V111, P171; GLEMBOTSKI CC, 1981, J BIOL CHEM, V256, P7433; GLEMBOTSKI CC, 1982, J BIOL CHEM, V257, P501; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; HAKES DJ, 1991, ENDOCRINOLOGY, V129, P3053, DOI 10.1210/endo-129-6-3053; HATSUZAWA K, 1990, J BIOL CHEM, V265, P22075; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; HRUBY DE, 1990, CLIN MICROBIOL REV, V3, P153, DOI 10.1128/CMR.3.2.153-170.1990; Hutton JC, 1990, CURR OPIN CELL BIOL, V2, P1131, DOI 10.1016/0955-0674(90)90167-D; KIRCHMAIR R, 1992, FEBS LETT, V297, P302, DOI 10.1016/0014-5793(92)80560-4; LINDBERG I, 1991, MOL ENDOCRINOL, V5, P1361, DOI 10.1210/mend-5-10-1361; MAINS RE, 1981, J CELL BIOL, V89, P21, DOI 10.1083/jcb.89.1.21; MAINS RE, 1991, MOL ENDOCRINOL, V5, P187, DOI 10.1210/mend-5-2-187; MAINS RE, 1976, J BIOL CHEM, V251, P4115; MAINS RE, 1990, TRENDS ENDOCRIN MET, V1, P388, DOI 10.1016/1043-2760(90)90097-M; MARX J, 1991, SCIENCE, V252, P779, DOI 10.1126/science.1674172; MILGRAM SL, 1992, J CELL BIOL, V117, P717, DOI 10.1083/jcb.117.4.717; MISUMI Y, 1991, J BIOL CHEM, V266, P16954; NAGAHAMA M, 1991, EUR J BIOCHEM, V197, P135, DOI 10.1111/j.1432-1033.1991.tb15891.x; NAGAHAMA M, 1991, J BIOCHEM, V110, P806, DOI 10.1093/oxfordjournals.jbchem.a123664; NOEL G, 1991, MOL ENDOCRINOL, V5, P404, DOI 10.1210/mend-5-3-404; NOEL G, 1991, ENDOCRINOLOGY, V129, P1317, DOI 10.1210/endo-129-3-1317; PERKINS SN, 1990, MOL ENDOCRINOL, V4, P132, DOI 10.1210/mend-4-1-132; SATO SM, 1985, ENDOCRINOLOGY, V117, P773, DOI 10.1210/endo-117-2-773; SEIDAH NG, 1992, TRENDS ENDOCRIN MET, V3, P133, DOI 10.1016/1043-2760(92)90102-7; SEIDAH NG, 1991, MOL ENDOCRINOL, V5, P111, DOI 10.1210/mend-5-1-111; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; SHENNAN KIJ, 1991, J BIOL CHEM, V266, P24011; SHENNAN KIJ, 1991, FEBS LETT, V284, P277, DOI 10.1016/0014-5793(91)80703-6; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; STEINER D F, 1991, Current Biology, V1, P375, DOI 10.1016/0960-9822(91)90198-6; Steiner D. F., 1991, PEPTIDE BIOSYNTHESIS, P1; THOMAS L, 1991, P NATL ACAD SCI USA, V88, P5297, DOI 10.1073/pnas.88.12.5297; UHLER M, 1983, J BIOL CHEM, V258, P257; VINDROLA O, 1992, MOL ENDOCRINOL, V6, P1088, DOI 10.1210/me.6.7.1088; WATANABE T, 1992, J BIOL CHEM, V267, P8270; WISE RJ, 1990, P NATL ACAD SCI USA, V87, P9378, DOI 10.1073/pnas.87.23.9378	57	239	241	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1763	1769						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8380577				2022-12-27	WOS:A1993KH62000041
J	HINES, V; SCHATZ, G				HINES, V; SCHATZ, G			PRECURSOR BINDING TO YEAST MITOCHONDRIA - A GENERAL ROLE FOR THE OUTER-MEMBRANE PROTEIN MAS70P	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORT RECEPTOR; STEPS; CYTOCHROME-B2; VIABILITY; CARRIER; MATRIX; SPACE; SITES	Binding of precursors to import receptors on the mitochondrial surface is one of the earliest steps of protein import into mitochondria. In yeast, one of these receptors is a 70-kDa outer membrane protein termed Mas70p. Pulse-chase studies with intact yeast cells had indicated that Mas70p accelerates the import of all mitochondrial precursors tested. In contrast, import experiments with isolated mitochondria suggested that Mas70p accelerated import of only a subset of precursors (Hines, V., Brandt, A., Griffiths, G., Horstmann, H., Brutsch, H., and Schatz, G. (1990) EMBO J. 9, 3191-3200). To resolve this discrepancy, we have now studied the interaction of Mas70p-deficient and wild-type yeast mitochondria with a precursor (pre-alcohol dehydrogenase III) whose import into isolated mitochondria is not accelerated by Mas70p under the usual assay conditions. Mas70p enhanced binding of pre-alcohol dehydrogenase III to the surface of mitochondria in which the electrochemical potential across the inner membrane had been dissipated by an uncoupler; the bound precursor could be efficiently chased into the mitochondria if the potential was restored. The precursor to cytochrome c1 was also bound to mitochondria in a Mas70p-dependent manner. Mas70p also enhanced the direct import of pre-alcohol dehydrogenase III into isolated mitochondria, provided the precursor was first denatured with urea. Under these conditions, the import rate in vitro was more similar to that in intact cells. Mas70p had no effect on the binding or the import of artificial precursors containing mouse dihydrofolate as the ''mature'' domain. We conclude that Mas70p is an import receptor for most, if not all authentic mitochondrial precursor proteins, but that its function is not always rate-limiting in import experiments with isolated mitochondria.	UNIV BASEL,BIOCTR,CH-4056 BASEL,SWITZERLAND	University of Basel					NIGMS NIH HHS [2-RO1-GM-37803] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037803] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKER KP, 1990, NATURE, V348, P605, DOI 10.1038/348605a0; BAKER KP, 1991, NATURE, V349, P205, DOI 10.1038/349205a0; DAUM G, 1982, J BIOL CHEM, V257, P3028; EILERS M, 1988, EMBO J, V7, P1139, DOI 10.1002/j.1460-2075.1988.tb02923.x; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; GASSER SM, 1982, P NATL ACAD SCI-BIOL, V79, P267, DOI 10.1073/pnas.79.2.267; GLICK B, 1991, ANNU REV GENET, V25, P21; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; HARTL FU, 1990, SCIENCE, V247, P930, DOI 10.1126/science.2406905; HASE T, 1984, EMBO J, V3, P3157, DOI 10.1002/j.1460-2075.1984.tb02274.x; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; HURT EC, 1984, EMBO J, V3, P3149, DOI 10.1002/j.1460-2075.1984.tb02272.x; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; NICHOLSON DW, 1989, J BIOL CHEM, V264, P10156; PAIN D, 1990, NATURE, V347, P444, DOI 10.1038/347444a0; PFANNER N, 1987, J BIOL CHEM, V262, P7528; PILGRIM D, 1987, MOL CELL BIOL, V7, P294, DOI 10.1128/MCB.7.1.294; RIEZMAN H, 1983, EMBO J, V2, P2161, DOI 10.1002/j.1460-2075.1983.tb01717.x; SCHLEYER M, 1985, CELL, V43, P339, DOI 10.1016/0092-8674(85)90039-X; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; STUEBER D, 1984, EMBO J, V3, P3143, DOI 10.1002/j.1460-2075.1984.tb02271.x; VANLOON APGM, 1986, CELL, V44, P801, DOI 10.1016/0092-8674(86)90846-9; VANLOON APGM, 1986, EMBO J, V5, P161, DOI 10.1002/j.1460-2075.1986.tb04191.x; VESTWEBER D, 1988, J CELL BIOL, V107, P2037, DOI 10.1083/jcb.107.6.2037	25	79	80	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					449	454						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8380165				2022-12-27	WOS:A1993KE60300069
